PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ruiz, J; Macias, D; Rincon, MM; Pascual, A; Catalan, IA; Navarro, G				Ruiz, Javier; Macias, Diego; Rincon, Margarita M.; Pascual, Ananda; Catalan, Ignacio A.; Navarro, Gabriel			Recruiting at the Edge: Kinetic Energy Inhibits Anchovy Populations in the Western Mediterranean	PLOS ONE			English	Article							SARDINE SARDINA-PILCHARDUS; EARLY-LIFE-HISTORY; ALBORAN SEA; ENGRAULIS-ENCRASICOLUS; SEASONAL VARIABILITY; VERTICAL MOTION; CAMARINAL SILL; FISH LARVAE; IN-SITU; STRAIT	The Strait of Gibraltar replenishes the Mediterranean with Atlantic waters through an intense eastward current known as the Atlantic Jet (AJ). The AJ fertilizes the southwestern Mediterranean and is considered to be the ultimate factor responsible for the comparatively high fish production of this region. Here, we perform an analysis of the available historical catches and catch per unit effort (CPUE), together with a long series of surface currents, kinetic energy and chlorophyll concentration. We show that the high kinetic energy of the AJ increases primary production but also negatively impacts the recruitment of anchovy. We contend that anchovy recruitment in the region is inhibited by the advection and dispersion of larvae and post-larvae during periods of strong advection by the AJ. The inhibitory impact of kinetic energy on anchovy landings is not a transient but rather a persistent state of the system. An exceptional combination of events creates an outbreak of this species in the Alboran Sea. These events depend on the Mediterranean-Atlantic exchange of water masses and, therefore, are highly sensitive to climate changes that are projected, though not always negatively, for fish landings.	[Ruiz, Javier; Macias, Diego; Rincon, Margarita M.; Navarro, Gabriel] CSIC, Dept Coastal Ecol & Management, Inst Ciencias Marinas Andalucia, Cadiz, Spain; [Pascual, Ananda; Catalan, Ignacio A.] Inst Mediterrani Estudis Avancats IMEDEA CSIC UIB, Esporles, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Ruiz, J (corresponding author), CSIC, Dept Coastal Ecol & Management, Inst Ciencias Marinas Andalucia, Campus Rio San Pedro, Cadiz, Spain.	javier.ruiz@csic.es	Ruiz, Javier/G-3184-2016; Navarro, Gabriel/AAA-9528-2020; Pascual, Ananda/H-8214-2013; Catalan, Ignacio/C-5382-2011; Macías, Diego/G-1972-2010	Ruiz, Javier/0000-0002-3375-2327; Navarro, Gabriel/0000-0002-8919-0060; Catalan, Ignacio/0000-0002-6496-9182; Macías, Diego/0000-0002-7772-255X; Pascual, Ananda/0000-0001-9476-9272; Rincon Hidalgo, Margarita/0000-0002-2866-3178	project ECOKNOWS [FP7-244706]; project MEDEX [CTM2008-04036-E]; project PERSEUS [FP7-287600]; project G2Coupling [CTM2011-22580]; Junta de Andalucia [P09-RNM-5358]; JaeDOC contract of the Spanish Science and Technology Council (CSIC) [X0SC000087]	project ECOKNOWS; project MEDEX; project PERSEUS; project G2Coupling; Junta de Andalucia(Junta de Andalucia); JaeDOC contract of the Spanish Science and Technology Council (CSIC)	This work was supported by projects ECOKNOWS (FP7-244706), MEDEX (CTM2008-04036-E), PERSEUS (FP7-287600) and G2Coupling (CTM2011-22580). Margarita M. Rincon was funded by P09-RNM-5358 of the Junta de Andalucia. D. Macias was supported by a JaeDOC contract (X0SC000087) of the Spanish Science and Technology Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R., 1990, INF TEC I ESP OCEANO, V86, P48; Abad R, 1997, DATOS RESUMENES I ES, V4, P41; Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Aldanondo N, 2010, FISH OCEANOGR, V19, P196, DOI 10.1111/j.1365-2419.2010.00537.x; Beranger K, 2005, PROG OCEANOGR, V66, P341, DOI 10.1016/j.pocean.2004.07.013; BLAXTER JHS, 1982, ADV MAR BIOL, V20, P3; Bruno M, 2002, DEEP-SEA RES PT II, V49, P4097, DOI 10.1016/S0967-0645(02)00144-3; CADDY JF, 1995, OCEAN COAST MANAGE, V26, P1, DOI 10.1016/0964-5691(95)00015-T; CANDELA J, 1989, J GEOPHYS RES-OCEANS, V94, P12667, DOI 10.1029/JC094iC09p12667; Catalan IA, 2010, ESTUAR COAST SHELF S, V86, P299, DOI 10.1016/j.ecss.2009.11.033; Cole J, 1998, REV FISH BIOL FISHER, V8, P445, DOI 10.1023/A:1008861224731; CopeMed-II, 2011, COPEMED 2 ARTFIMED N; Crepon M, 1965, CAH OCEANOGR, V1, P15; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Erzini K, 2005, FISH OCEANOGR, V14, P195, DOI 10.1111/j.1365-2419.2005.00332.x; Flexas MM, 2006, PROG OCEANOGR, V70, P486, DOI 10.1016/j.pocean.2006.03.017; Freon P, 2005, B MAR SCI, V76, P385; Furnestin J., 1959, Revue des Travaux de l'Office des Peches Maritimes, V23, P79; Garcia A, 1996, SCI MAR, V60, P155; Garcia A, 2003, SCI MAR, V67, P155; Garcia-Lafuente J, 2002, J GEOPHYS RES, V107, P321, DOI DOI 10.1029/2001JC0011004; GARRETT C, 1990, NATO ADV SCI I C-MAT, V318, P271; Giraldez A, 2002, TECHNICAL REPORT; Giraldez A., 1991, INF TEC I ESP OCEANO, V105, P31; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ICES, 2012, REP WORK GROUP SMALL; Lafuente JG, 1998, DEEP-SEA RES PT I, V45, P39, DOI 10.1016/S0967-0637(97)00216-1; Le Traon P.-Y., 2001, SATELLITE ALTIMETRY, P171; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Leggett WC, 2008, OCEANOGR MAR BIOL, V46, P331; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Macias D, 2008, ESTUAR COAST SHELF S, V78, P250, DOI 10.1016/j.ecss.2007.12.008; Macias D, 2007, J MAR RES, V65, P523, DOI 10.1357/002224007782689085; Macias D, 2006, J MARINE SYST, V60, P177, DOI 10.1016/j.jmarsys.2005.12.003; Macias D, 2011, DEEP-SEA RES PT I, V58, P1175, DOI 10.1016/j.dsr.2011.08.013; Macias D, 2009, ESTUAR COAST SHELF S, V83, P197, DOI 10.1016/j.ecss.2009.03.032; Mafalda P, 2008, REV BIOL MAR OCEANOG, V43, P41; Maritorena S, 2005, REMOTE SENS ENVIRON, V94, P429, DOI 10.1016/j.rse.2004.08.014; Maritorena S, 2010, REMOTE SENS ENVIRON, V114, P1791, DOI 10.1016/j.rse.2010.04.002; Mercado J, 2009, PROGR OCEANOGR, V74, P273; Mercado JM, 2005, SCI MAR, V69, P451, DOI 10.3989/scimar.2005.69n4451; Millan M, 1999, FISH RES, V41, P73, DOI 10.1016/S0165-7836(99)00010-7; Morote E, 2010, ICES J MAR SCI, V67, P897, DOI 10.1093/icesjms/fsp302; Navarro G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049708; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Parrish R.H., 1983, FAO FISHERIES REPORT, V2, P731; Pascual A, 2007, J MARINE SYST, V65, P190, DOI 10.1016/j.jmarsys.2004.12.004; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Pujol MI, 2005, J MARINE SYST, V58, P121, DOI 10.1016/j.jmarsys.2005.07.005; Rio MH, 2007, J MARINE SYST, V65, P484, DOI 10.1016/j.jmarsys.2005.02.006; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; RODRIGUEZ J M, 1990, Boletin Instituto Espanol de Oceanografia, V6, P1; Rubin J, 2006, B I ESP OCEANOGR, V22, P1; Ruiz J, 2001, J MARINE SYST, V29, P277, DOI 10.1016/S0924-7963(01)00020-3; Ruiz J, 2005, CIESM WORKSHOP MONOG, V27, P87; Ruiz J, 2006, DEEP SEA RES 2, V53; Ruiz J, 2009, FISH OCEANOGR, V18, P62, DOI 10.1111/j.1365-2419.2008.00497.x; Sarhan T, 2000, J MARINE SYST, V23, P317, DOI 10.1016/S0924-7963(99)00068-8; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; Vargas-Yanez M, 2002, J MARINE SYST, V35, P229, DOI 10.1016/S0924-7963(02)00128-8; Vargas-Yanez M, 2008, GLOBAL PLANET CHANGE, V63, P177, DOI 10.1016/j.gloplacha.2007.09.001; Vargas-Yanez M, 2007, J MARINE SYST, V68, P421, DOI 10.1016/j.jmarsys.2007.01.004; Vazquez J, 1998, NOAA NASA AVHRR OCEA; Velez-Belchi P, 2005, PROG OCEANOGR, V66, P190, DOI 10.1016/j.pocean.2004.09.006	66	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55523	10.1371/journal.pone.0055523	http://dx.doi.org/10.1371/journal.pone.0055523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451027	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500002
J	Wei, CY; Thatcher, EJ; Olena, AF; Cha, DJ; Perdigoto, AL; Marshall, AF; Carter, BD; Broadie, K; Patton, JG				Wei, Chunyao; Thatcher, Elizabeth J.; Olena, Abigail F.; Cha, Diana J.; Perdigoto, Ana L.; Marshall, Andrew F.; Carter, Bruce D.; Broadie, Kendal; Patton, James G.			miR-153 Regulates SNAP-25, Synaptic Transmission, and Neuronal Development	PLOS ONE			English	Article							PROTEIN-RECEPTOR COMPLEX; T-SNARE SNAP-25; IDENTIFIED MOTONEURONS; BOTULINUM NEUROTOXIN; GENE-EXPRESSION; MEMBRANE-FUSION; AXONAL GROWTH; ZEBRAFISH DEVELOPMENT; NEURITE OUTGROWTH; PLASTICITY	SNAP-25 is a core component of the trimeric SNARE complex mediating vesicle exocytosis during membrane addition for neuronal growth, neuropeptide/growth factor secretion, and neurotransmitter release during synaptic transmission. Here, we report a novel microRNA mechanism of SNAP-25 regulation controlling motor neuron development, neurosecretion, synaptic activity, and movement in zebrafish. Loss of miR-153 causes overexpression of SNAP-25 and consequent hyperactive movement in early zebrafish embryos. Conversely, overexpression of miR-153 causes SNAP-25 down regulation resulting in near complete paralysis, mimicking the effects of treatment with Botulinum neurotoxin. miR-153-dependent changes in synaptic activity at the neuromuscular junction are consistent with the observed movement defects. Underlying the movement defects, perturbation of miR-153 function causes dramatic developmental changes in motor neuron patterning and branching. Together, our results indicate that precise control of SNAP-25 expression by miR-153 is critically important for proper neuronal patterning as well as neurotransmission.	[Wei, Chunyao; Thatcher, Elizabeth J.; Olena, Abigail F.; Cha, Diana J.; Marshall, Andrew F.; Broadie, Kendal; Patton, James G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA; [Wei, Chunyao; Thatcher, Elizabeth J.; Olena, Abigail F.; Cha, Diana J.; Perdigoto, Ana L.; Marshall, Andrew F.; Carter, Bruce D.; Broadie, Kendal; Patton, James G.] Sch Med, Nashville, TN USA; [Perdigoto, Ana L.; Carter, Bruce D.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Patton, JG (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA.	James.G.Patton@Vanderbilt.edu			National Institutes of Health (NIH) [GM 075790, EY019759, GM 54544, NS038220, T32 GM08556, F30 NS061403, T32 GM07347]; Zebrafish International Resource Center NIH-NCRR [RR12546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY019759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544, T32GM007347, R01GM075790, T32GM008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS061403, R01NS038220] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zebrafish International Resource Center NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) to JGP (GM 075790 and EY019759), KB (GM 54544), and BDC (NS038220) and by training fellowships to EJT (T32 GM08556) and ALP (F30 NS061403 and T32 GM07347). Antibodies were obtained from the Zebrafish International Resource Center NIH-NCRR, grant RR12546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Appel B, 1995, DEVELOPMENT, V121, P4117; Asakura T, 2010, GENETICS, V185, P573, DOI 10.1534/genetics.110.116293; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Bicker S, 2008, J CELL MOL MED, V12, P1466, DOI 10.1111/j.1582-4934.2008.00400.x; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Dessi F, 1997, NEUROREPORT, V8, P3685, DOI 10.1097/00001756-199712010-00006; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; EISEN JS, 1991, J NEUROSCI, V11, P311; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gray LJ, 2010, PSYCHIAT RES, V178, P374, DOI 10.1016/j.psychres.2008.07.012; Greenlee MHW, 2002, SEMIN CELL DEV BIOL, V13, P99, DOI 10.1016/S1084-9521(02)00015-0; Grosse G, 1999, J NEUROSCI RES, V56, P539, DOI 10.1002/(SICI)1097-4547(19990601)56:5<539::AID-JNR9>3.0.CO;2-Y; Hepp R, 2001, CELL TISSUE RES, V305, P247, DOI 10.1007/s004410100359; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Igarashi M, 1997, J NEUROSCI, V17, P1460; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jao LE, 2012, DEVELOPMENT, V139, P1316, DOI 10.1242/dev.074344; Kannenberg K, 2007, J NEUROENDOCRINOL, V19, P882, DOI 10.1111/j.1365-2826.2007.01602.x; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Keller JE, 2004, BIOCHEMISTRY-US, V43, P526, DOI 10.1021/bi0356698; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Li WY, 2003, J NEUROSCI, V23, P10467; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Matteoli M, 2009, NEUROSCIENCE, V158, P223, DOI 10.1016/j.neuroscience.2008.03.014; McKee AG, 2010, J NEUROCHEM, V112, P991, DOI 10.1111/j.1471-4159.2009.06516.x; MYERS PZ, 1986, J NEUROSCI, V6, P2278; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Qureshi IA, 2009, NEUROSCI LETT, V466, P73, DOI 10.1016/j.neulet.2009.07.093; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Risinger C, 1998, J NEUROSCI RES, V54, P563; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tafoya LCR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-105; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tsuji M, 2001, J BIOL CHEM, V276, P32779, DOI 10.1074/jbc.M101403200; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Vo NK, 2010, CURR OPIN NEUROBIOL; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Zhou Q, 2000, J NEUROSCI RES, V61, P321, DOI 10.1002/1097-4547(20000801)61:3<321::AID-JNR10>3.0.CO;2-L	84	48	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57080	10.1371/journal.pone.0057080	http://dx.doi.org/10.1371/journal.pone.0057080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451149	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500063
J	Gheorghe, A; Roberts, TE; Ives, JC; Fletcher, BR; Calvert, M				Gheorghe, Adrian; Roberts, Tracy E.; Ives, Jonathan C.; Fletcher, Benjamin R.; Calvert, Melanie			Centre Selection for Clinical Trials and the Generalisability of Results: A Mixed Methods Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; COST-EFFECTIVENESS ANALYSIS; CONSORT STATEMENT; EXTERNAL VALIDITY; NEED; TRANSFERABILITY; OUTCOMES; DESIGN	Background: The rationale for centre selection in randomised controlled trials (RCTs) is often unclear but may have important implications for the generalisability of trial results. The aims of this study were to evaluate the factors which currently influence centre selection in RCTs and consider how generalisability considerations inform current and optimal practice. Methods and Findings: Mixed methods approach consisting of a systematic review and meta-summary of centre selection criteria reported in RCT protocols funded by the UK National Institute of Health Research (NIHR) initiated between January 2005-January 2012; and an online survey on the topic of current and optimal centre selection, distributed to professionals in the 48 UK Clinical Trials Units and 10 NIHR Research Design Services. The survey design was informed by the systematic review and by two focus groups conducted with trialists at the Birmingham Centre for Clinical Trials. 129 trial protocols were included in the systematic review, with a total target sample size in excess of 317,000 participants. The meta-summary identified 53 unique centre selection criteria. 78 protocols (60%) provided at least one criterion for centre selection, but only 31 (24%) protocols explicitly acknowledged generalisability. This is consistent with the survey findings (n = 70), where less than a third of participants reported generalisability as a key driver of centre selection in current practice. This contrasts with trialists' views on optimal practice, where generalisability in terms of clinical practice, population characteristics and economic results were prime considerations for 60% (n = 42), 57% (n = 40) and 46% (n = 32) of respondents, respectively. Conclusions: Centres are rarely enrolled in RCTs with an explicit view to external validity, although trialists acknowledge that incorporating generalisability in centre selection should ideally be more prominent. There is a need to operationalize 'generalisability' and incorporate it at the design stage of RCTs so that results are readily transferable to 'real world' practice.	[Gheorghe, Adrian; Ives, Jonathan C.; Fletcher, Benjamin R.; Calvert, Melanie] Univ Birmingham, Birmingham, W Midlands, England; [Gheorghe, Adrian; Roberts, Tracy E.] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England; [Calvert, Melanie] Univ Birmingham, MRC Midland Hub Trials Methodol Res, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Calvert, M (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	m.calvert@bham.ac.uk	Roberts, Tracy/AAO-4610-2021; Calvert, Melanie/F-7055-2011; Ives, Jonathan/ABE-4437-2020	Roberts, Tracy/0000-0002-0624-0537; Calvert, Melanie/0000-0002-1856-837X; Ives, Jonathan/0000-0002-5233-5000; Fletcher, Benjamin/0000-0003-3633-7716	National Institute for Health Research (NIHR); MRC Midland Hub for Trials Methodology Research, University of Birmingham, UK (Medical Research Council Grant) [G0800808]; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC Midland Hub for Trials Methodology Research, University of Birmingham, UK (Medical Research Council Grant)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AG is supported by a National Institute for Health Research (NIHR, www.nihr.ac.uk) funded Research Support Facility PhD studentship. MC is a member of the MRC Midland Hub for Trials Methodology Research, University of Birmingham, UK (Medical Research Council Grant ID G0800808). No other funding sources reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-20; Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Bartlett C, 2005, HEALTH TECHNOL ASSES, V9, P1; Black N, 1996, BRIT MED J, V312, P1215; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Braslow JT, 2005, PSYCHIAT SERV, V56, P1261, DOI 10.1176/appi.ps.56.10.1261; Britton A, 1999, J Health Serv Res Policy, V4, P112; Calvert M, 2011, J CLIN EPIDEMIOL, V64, P711, DOI 10.1016/j.jclinepi.2010.12.010; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Costa DJ, 2011, J ALLERGY CLIN IMMUN, V127, P920, DOI 10.1016/j.jaci.2010.10.058; DeLong ER, 2005, BIOMETRICS, V61, P942, DOI 10.1111/j.1541-0420.2005.00358.x; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Drummond MF, 1992, INT J TECHNOL ASSESS, V8, P670; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Eldridge S, 2008, BMJ-BRIT MED J, V336, P876, DOI 10.1136/bmj.39517.495764.25; Falagas ME, 2010, INT J ANTIMICROB AG, V36, P1, DOI 10.1016/j.ijantimicag.2010.03.020; Glasgow RE, 2005, MED CARE, V43, P551, DOI 10.1097/01.mlr.0000163645.41407.09; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hoel AW, 2009, J VASC SURG, V50, P349, DOI 10.1016/j.jvs.2009.01.012; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; Kalata P, 2009, DIS COLON RECTUM, V52, P425, DOI 10.1007/DCR.0b013e318197d13c; Kraemer HC, 2006, JAMA-J AM MED ASSOC, V296, P1286, DOI 10.1001/jama.296.10.1286; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Liamputtong Pranee, 2011, FOCUS GROUP METHODOL; Maasland L, 2009, STROKE, V40, P2662, DOI 10.1161/STROKEAHA.109.551812; Manca A, 2005, HEALTH ECON, V14, P471, DOI 10.1002/hec.914; Manca A, 2007, MED DECIS MAKING, V27, P471, DOI 10.1177/0272989X07302132; Manca A, 2010, PHARMACOECONOMICS, V28, P1079, DOI 10.2165/11537760-000000000-00000; Moore D A, 2000, HIV Med, V1, P149, DOI 10.1046/j.1468-1293.2000.00019.x; NICE, 2009, IPG322 NICE; O'Brien BJ, 1997, AM J MANAG CARE, V3, pS33; Ramsey SD, 2001, ANNU REV PUBL HEALTH, V22, P129, DOI 10.1146/annurev.publhealth.22.1.129; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sandelowski M, 2003, NURS RES, V52, P226, DOI 10.1097/00006199-200307000-00004; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624	42	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56560	10.1371/journal.pone.0056560	http://dx.doi.org/10.1371/journal.pone.0056560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451055	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000316658800017
J	Goudy, S; Angel, P; Jacobs, B; Hill, C; Mainini, V; Smith, AL; Kousa, YA; Caprioli, R; Prince, LS; Baldwin, S; Schutte, BC				Goudy, Steven; Angel, Peggi; Jacobs, Britni; Hill, Cynthia; Mainini, Veronica; Smith, Arianna L.; Kousa, Youssef A.; Caprioli, Richard; Prince, Lawrence S.; Baldwin, Scott; Schutte, Brian C.			Cell-Autonomous and Non-Cell-Autonomous Roles for Irf6 during Development of the Tongue	PLOS ONE			English	Article							TASTE PAPILLA DEVELOPMENT; ORBICULARIS-ORIS MUSCLE; CRANIAL NEURAL CREST; SKELETAL-MUSCLE; CLEFT-LIP; CRANIOFACIAL DEVELOPMENT; EXPRESSION PATTERNS; MASS-SPECTROMETRY; PALATE; DIFFERENTIATION	Interferon regulatory factor 6 (IRF6) encodes a highly conserved helix-turn-helix DNA binding protein and is a member of the interferon regulatory family of DNA transcription factors. Mutations in IRF6 lead to isolated and syndromic forms of cleft lip and palate, most notably Van der Woude syndrome (VWS) and Popliteal Ptyerigium Syndrome (PPS). Mice lacking both copies of Irf6 have severe limb, skin, palatal and esophageal abnormalities, due to significantly altered and delayed epithelial development. However, a recent report showed that MCS9.7, an enhancer near Irf6, is active in the tongue, suggesting that Irf6 may also be expressed in the tongue. Indeed, we detected Irf6 staining in the mesoderm-derived muscle during development of the tongue. Dual labeling experiments demonstrated that Irf6 was expressed only in the Myf5+ cell lineage, which originates from the segmental paraxial mesoderm and gives rise to the muscles of the tongue. Fate mapping of the segmental paraxial mesoderm cells revealed a cell-autonomous Irf6 function with reduced and poorly organized Myf5+ cell lineage in the tongue. Molecular analyses showed that the Irf6-/- embryos had aberrant cytoskeletal formation of the segmental paraxial mesoderm in the tongue. Fate mapping of the cranial neural crest cells revealed non-cell-autonomous Irf6 function with the loss of the inter-molar eminence. Loss of Irf6 function altered Bmp2, Bmp4, Shh, and Fgf10 signaling suggesting that these genes are involved in Irf6 signaling. Based on these data, Irf6 plays important cell-autonomous and non-cell-autonomous roles in muscular differentiation and cytoskeletal formation in the tongue.	[Goudy, Steven; Jacobs, Britni; Hill, Cynthia] Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA; [Angel, Peggi; Caprioli, Richard] Vanderbilt Univ, Dept Imaging Biophys, Nashville, TN USA; [Mainini, Veronica] Univ Milano Bicocca, Dept Hlth Sci, Milan, Italy; [Smith, Arianna L.; Schutte, Brian C.] Michigan State Univ, Genet PhD Program, E Lansing, MI 48824 USA; [Kousa, Youssef A.; Schutte, Brian C.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Prince, Lawrence S.] Vanderbilt Univ, Div Neonatol, Nashville, TN USA; [Prince, Lawrence S.; Baldwin, Scott] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA; [Prince, Lawrence S.; Baldwin, Scott] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Baldwin, Scott] Vanderbilt Univ, Div Cardiol, Nashville, TN 37232 USA; [Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Schutte, Brian C.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Vanderbilt University; Vanderbilt University; University of Milano-Bicocca; Michigan State University; Michigan State University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Michigan State University; Michigan State University	Goudy, S (corresponding author), Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA.	steven.goudy@vanderbilt.edu		Kousa, MS, DO, PhD, Youssef A/0000-0001-6049-8144	National Institutes of Health; National Institute of Dental and Craniofacial Research (NIDCR) [K08 DE017953]; National Heart, Lung, and Blood Institute (NHLBI) [HL097195, HL086324, DK078640, HL086964, HL092551, HL105334, DE13413]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK058404]; National Institute of General Medical Sciences (NIGMS) [GM058008, GM103391]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027396] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086964, R01HL086324, RL1HL092551, T32HL105334, R01HL116358, R01HL097195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE017953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078640, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, P41GM103391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Here are the funding sources from National Institutes of Health: This work was supported by National Institute of Dental and Craniofacial Research (NIDCR) K08 DE017953 (SG), National Heart, Lung, and Blood Institute (NHLBI) HL097195 (LP), HL086324 (LP), DK078640 (SB), HL086964 (SB), HL092551 (SB), and HL105334 (SB), DE13413 (SG), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK058404 (RC), National Institute of General Medical Sciences (NIGMS) GM058008 (RC), GM103391 (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CM, 2009, DEV GROWTH DIFFER, V51, P473, DOI 10.1111/j.1440-169X.2009.01110.x; Barron F, 2011, DEVELOPMENT, V138, P2249, DOI 10.1242/dev.056929; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chai Y, 2000, DEVELOPMENT, V127, P1671; Fakhouri WD, 2012, DEV DYNAM, V241, P340, DOI 10.1002/dvdy.22786; GORLIN RJ, 1968, PEDIATRICS, V41, P503; Han D, 2012, DEVELOPMENT, V139, P1640, DOI 10.1242/dev.076653; Hill CR, 2012, CELL SIGNAL, V24, P1012, DOI 10.1016/j.cellsig.2011.12.022; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Jones JLP, 2010, J CRANIOFAC SURG, V21, P1350, DOI 10.1097/SCS.0b013e3181ec6aad; Jung HS, 1999, MECH DEVELOP, V81, P179, DOI 10.1016/S0925-4773(98)00234-2; Kablar B, 1997, DEVELOPMENT, V124, P4729; Kim JY, 2003, EXP CELL RES, V290, P217, DOI 10.1016/S0014-4827(03)00319-7; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Liu HX, 2004, DEV BIOL, V276, P280, DOI 10.1016/j.ydbio.2004.07.042; Neiswanger K, 2007, AM J MED GENET A, V143A, P1143, DOI 10.1002/ajmg.a.31760; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; PAULSON RB, 1985, J CRAN GENET DEV BIO, V5, P59; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rice R, 2006, GENE EXPR PATTERNS, V6, P206, DOI 10.1016/j.modgep.2005.06.005; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Richardson RJ, 2009, HUM MOL GENET, V18, P2632, DOI 10.1093/hmg/ddp201; Rogers CR, 2008, CLEFT PALATE-CRAN J, V45, P518, DOI 10.1597/07-115.1; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Saadi I, 2011, AM J HUM GENET, V89, P44, DOI 10.1016/j.ajhg.2011.05.023; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Weinberg SM, 2007, CLEFT PALATE-CRAN J, V44, P683, DOI 10.1597/07-104.1; Yamane A, 2005, CELL TISSUE RES, V322, P183, DOI 10.1007/s00441-005-0019-x; Yang JH, 2011, ANAL CHEM, V83, P5728, DOI 10.1021/ac200998a; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	39	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56270	10.1371/journal.pone.0056270	http://dx.doi.org/10.1371/journal.pone.0056270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451037	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800007
J	Puig, F; Fuster, G; Adda, M; Blanch, L; Farre, R; Navajas, D; Artigas, A				Puig, Ferranda; Fuster, Gemma; Adda, Melanie; Blanch, Lluis; Farre, Ramon; Navajas, Daniel; Artigas, Antonio			Barrier-Protective Effects of Activated Protein C in Human Alveolar Epithelial Cells	PLOS ONE			English	Article							ACUTE LUNG INJURY; THROMBIN; PERMEABILITY; PULMONARY; ZO-1; THROMBOMODULIN; COAGULATION; CONTRACTION; RECEPTOR-1; MICROSCOPY	Acute lung injury (ALI) is a clinical manifestation of respiratory failure, caused by lung inflammation and the disruption of the alveolar-capillary barrier. Preservation of the physical integrity of the alveolar epithelial monolayer is of critical importance to prevent alveolar edema. Barrier integrity depends largely on the balance between physical forces on cell-cell and cell-matrix contacts, and this balance might be affected by alterations in the coagulation cascade in patients with ALI. We aimed to study the effects of activated protein C (APC) on mechanical tension and barrier integrity in human alveolar epithelial cells (A549) exposed to thrombin. Cells were pretreated for 3 h with APC (50 mu g/ml) or vehicle (control). Subsequently, thrombin (50 nM) or medium was added to the cell culture. APC significantly reduced thrombin-induced cell monolayer permeability, cell stiffening, and cell contraction, measured by electrical impedance, optical magnetic twisting cytometry, and traction microscopy, respectively, suggesting a barrier-protective response. The dynamics of the barrier integrity was also assessed by western blotting and immunofluorescence analysis of the tight junction ZO-1. Thrombin resulted in more elongated ZO-1 aggregates at cell-cell interface areas and induced an increase in ZO-1 membrane protein content. APC attenuated the length of these ZO-1 aggregates and reduced the ZO-1 membrane protein levels induced by thrombin. In conclusion, pretreatment with APC reduced the disruption of barrier integrity induced by thrombin, thus contributing to alveolar epithelial barrier protection.	[Puig, Ferranda; Fuster, Gemma; Blanch, Lluis; Farre, Ramon; Navajas, Daniel; Artigas, Antonio] CIBER Enfermedades Resp, Bunyola, Spain; [Adda, Melanie; Blanch, Lluis; Artigas, Antonio] Univ Autonoma Barcelona, Crit Care Ctr, Hosp Sabadell, Inst Univ Parc Tauli, Sabadell, Spain; [Farre, Ramon; Navajas, Daniel] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Farre, Ramon] IDIBAPS, Barcelona, Spain; [Navajas, Daniel] Inst Bioengn Catalunya IBEC, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya	Artigas, A (corresponding author), CIBER Enfermedades Resp, Bunyola, Spain.	aartigas@tauli.cat	Fuster, Gemma/B-5468-2019; Fuster, Gemma/ACH-5814-2022; Navajas, Daniel/E-4233-2010; Farre, Ramon/L-2664-2017	Fuster, Gemma/0000-0002-4501-2422; Navajas, Daniel/0000-0001-7150-9363; antonio, artigas/0000-0002-8029-1017; Farre, Ramon/0000-0002-9084-7824	Ministerio de Ciencia e Innovacion [FISPI080646, FISPI081908, SAF200802991]; Fundacio Parc Tauli; CIBER de Enfermedades Respiratorias; Eli Lilly and Company; Eli Lilly	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Parc Tauli; CIBER de Enfermedades Respiratorias; Eli Lilly and Company(Eli Lilly); Eli Lilly(Eli Lilly)	This study was supported by grants from the Ministerio de Ciencia e Innovacion (FISPI080646, FISPI081908, and SAF200802991), from the Fundacio Parc Tauli, and from CIBER de Enfermedades Respiratorias; it was partially funded by Eli Lilly and Company. The funders had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.; This project was partially funded by the commercial company Eli Lilly and Company. Professor Antonio Artigas, the corresponding author, have received travel support, lecture fees and support patient recruitment (through his institution) from Eli Lilly. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adda M, 2009, CURR RESPIR MED REV, V5, P149, DOI 10.2174/157339809788922342; Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Brevier J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.268101; Brevier J, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016005; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Fabry B, 2001, J APPL PHYSIOL, V91, P986, DOI 10.1152/jappl.2001.91.2.986; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Gavara N, 2006, J APPL PHYSIOL, V101, P512, DOI 10.1152/japplphysiol.00185.2006; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hataji O, 2002, LUNG, V180, P47, DOI 10.1007/s004080000080; Hofstra JJ, 2010, J AEROSOL MED PULM D, V23, P105, DOI 10.1089/jamp.2009.0779; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; KOBAYASHI S, 1995, PHARMACEUT RES, V12, P1115, DOI 10.1023/A:1016295406473; Kotanidou A, 2006, VASC PHARMACOL, V45, P134, DOI 10.1016/j.vph.2006.06.016; Laterre PF, 2003, CRIT CARE MED, V31, pS329, DOI 10.1097/01.CCM.0000057912.71499.A5; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Maniatis NA, 2010, CRIT CARE, V14, DOI 10.1186/cc8976; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Puig F, 2009, EXP MECH, V49, P47, DOI 10.1007/s11340-007-9072-6; Ragsdale GK, 1997, BIOPHYS J, V73, P2798, DOI 10.1016/S0006-3495(97)78309-7; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shimizu S, 2003, AM J RESP CRIT CARE, V167, P1416, DOI 10.1164/rccm.200206-515OC; STEVENSON BR, 1989, BIOCHEM J, V263, P597, DOI 10.1042/bj2630597; Trepat X, 2005, J APPL PHYSIOL, V98, P1567, DOI 10.1152/japplphysiol.00925.2004; Waerhaug K, 2009, CRIT CARE, V13, DOI 10.1186/cc7777; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Ware LB, 2003, AM J PHYSIOL-LUNG C, V285, pL514, DOI 10.1152/ajplung.00442.2002; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Winton HL, 1998, CLIN EXP ALLERGY, V28, P1273, DOI 10.1046/j.1365-2222.1998.00354.x; Zeng W, 2004, CRIT CARE MED, V32, pS302, DOI 10.1097/01.CCM.0000128038.49201.8C	38	18	20	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56965	10.1371/journal.pone.0056965	http://dx.doi.org/10.1371/journal.pone.0056965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451122	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800055
J	Norais, C; Servant, P; Bouthier-de-la-Tour, C; Coureux, PD; Ithurbide, S; Vannier, F; Guerin, PP; Dulberger, CL; Satyshur, KA; Keck, JL; Armengaud, J; Cox, MM; Sommer, S				Norais, Cedric; Servant, Pascale; Bouthier-de-la-Tour, Claire; Coureux, Pierre-Damien; Ithurbide, Solenne; Vannier, Francoise; Guerin, Philippe P.; Dulberger, Charles L.; Satyshur, Kenneth A.; Keck, James L.; Armengaud, Jean; Cox, Michael M.; Sommer, Suzanne			The Deinococcus radiodurans DR1245 Protein, a DdrB Partner Homologous to YbjN Proteins and Reminiscent of Type III Secretion System Chaperones	PLOS ONE			English	Article							STRAND BREAK REPAIR; CRYSTAL-STRUCTURE; VIRULENCE FACTORS; ESCHERICHIA-COLI; BINDING; RADIATION; REVEALS; COMPLEX; RESISTANCE; PEPTIDE	The bacterium Deinococcus radiodurans exhibits an extreme resistance to ionizing radiation. A small subset of Deinococcus genus-specific genes were shown to be up-regulated upon exposure to ionizing radiation and to play a role in genome reconstitution. These genes include an SSB-like protein called DdrB. Here, we identified a novel protein encoded by the dr1245 gene as an interacting partner of DdrB. A strain devoid of the DR1245 protein is impaired in growth, exhibiting a generation time approximately threefold that of the wild type strain while radioresistance is not affected. We determined the three-dimensional structure of DR1245, revealing a relationship with type III secretion system chaperones and YbjN family proteins. Thus, DR1245 may display some chaperone activity towards DdrB and possibly other substrates.	[Norais, Cedric; Dulberger, Charles L.; Cox, Michael M.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI USA; [Norais, Cedric; Coureux, Pierre-Damien] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [Servant, Pascale; Bouthier-de-la-Tour, Claire; Ithurbide, Solenne; Vannier, Francoise; Sommer, Suzanne] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Servant, Pascale; Bouthier-de-la-Tour, Claire; Ithurbide, Solenne; Vannier, Francoise; Sommer, Suzanne] CNRS, F-91405 Orsay, France; [Guerin, Philippe P.; Armengaud, Jean] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol, Lab Biochim Syst Perturb, Bagnols Sur Ceze, France; [Satyshur, Kenneth A.; Keck, James L.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CEA; University of Wisconsin System; University of Wisconsin Madison	Sommer, S (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, Bat 409, F-91405 Orsay, France.	suzanne.sommer@igmors.u-psud.fr	Ithurbide, Solenne/AAV-3999-2020; Servant, pascale/V-9016-2017	Keck, James/0000-0002-5961-0220; Satyshur, Kenneth/0000-0001-9371-2493; ARMENGAUD, Jean/0000-0003-1589-445X; Ithurbide, Solenne/0000-0002-1533-8472	Centre National de la Recherche Scientifique; University Paris-Sud, Electricite de France [RB2007-11]; Agence Nationale de la Recherche [ANR-07-BLAN-0106]; United States National Institutes of Health [GM32335, GM068061]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM032335, R01GM067085, R01GM068061] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud, Electricite de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Centre National de la Recherche Scientifique, the University Paris-Sud, Electricite de France (RB2007-11 to SS), the Agence Nationale de la Recherche (ANR-07-BLAN-0106 to SS), and the United States National Institutes of Health (GM32335 and GM068061 to MMC and JLK, respectively). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bentchikou E, 2007, J BACTERIOL, V189, P4784, DOI 10.1128/JB.00452-07; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Buttner CR, 2005, PROTEIN SCI, V14, P1993, DOI 10.1110/ps.051474605; Chen XN, 2006, BIOCHEM BIOPH RES CO, V345, P834, DOI 10.1016/j.bbrc.2006.04.101; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; de la Tour CB, 2009, EXTREMOPHILES, V13, P827, DOI 10.1007/s00792-009-0270-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Gabant G, 2008, J MASS SPECTROM, V43, P360, DOI 10.1002/jms.1328; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Izore T, 2011, STRUCTURE, V19, P603, DOI 10.1016/j.str.2011.03.015; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Schreiner M, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-13; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Toueille M, 2012, J PROTEOMICS, V75, P2588, DOI 10.1016/j.jprot.2012.03.002; Vogelaar NJ, 2010, BIOCHEMISTRY-US, V49, P5870, DOI 10.1021/bi100432e; Wang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045038; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025293; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	49	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56558	10.1371/journal.pone.0056558	http://dx.doi.org/10.1371/journal.pone.0056558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441204	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200061
J	Triulzi, T; Casalini, P; Sandri, M; Ratti, M; Carcangiu, ML; Colombo, MP; Balsari, A; Menard, S; Orlandi, R; Tagliabue, E				Triulzi, Tiziana; Casalini, Patrizia; Sandri, Marco; Ratti, Manuela; Carcangiu, Maria L.; Colombo, Mario P.; Balsari, Andrea; Menard, Sylvie; Orlandi, Rosaria; Tagliabue, Elda			Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR; INVASION; SIGNATURE; SPARC; MIGRATION; OVEREXPRESSION; METAANALYSIS; MACROPHAGES; FIBROBLASTS	We recently showed that differential expression of extracellular matrix (ECM) genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4) with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted unsupervised clustering analyses in 6 additional independent datasets of invasive breast tumors from different platforms for a total of 643 samples. Use of four different clustering algorithms identified ECM3 tumors as an independent group in all datasets tested. ECM3 showed a homogeneous gene pattern, consisting of 58 genes encoding 43 structural ECM proteins. From 26 to 41% of the cases were ECM3-enriched, and analysis of datasets relevant to gene expression in neoplastic or corresponding stromal cells showed that both stromal and breast carcinoma cells can coordinately express ECM3 genes. In in vitro experiments, beta-estradiol induced ECM3 gene production in ER-positive breast carcinoma cell lines, whereas TGF beta induced upregulation of the genes leading to ECM3 gene classification, especially in ER-negative breast carcinoma cells and in fibroblasts. Multivariate analysis of distant metastasis-free survival in untreated breast tumor patients revealed a significant interaction between ECM3 and histological grade (p = 0.001). Cox models, estimated separately in grade I-II and grade III tumors, indicated a highly significant association between ECM3 and worse survival probability only in grade III tumors (HR = 3.0, 95% CI = 1.3-7.0, p = 0.0098). Gene Set Enrichment analysis of ECM3 compared to non-ECM3 tumors revealed significant enrichment of epithelial-mesenchymal transition (EMT) genes in both grade I-II and grade III subsets of ECM3 tumors. Thus, ECM3 is a robust cluster that identifies breast carcinomas with EMT features but with accelerated metastatic potential only in the undifferentiated (grade III) phenotype. These findings support the key relevance of neoplastic and stroma interaction in breast cancer progression.	[Triulzi, Tiziana; Casalini, Patrizia; Sandri, Marco; Ratti, Manuela; Menard, Sylvie; Orlandi, Rosaria; Tagliabue, Elda] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Targeting Unit, Milan, Italy; [Carcangiu, Maria L.] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Anat Pathol Unit A, Milan, Italy; [Colombo, Mario P.] Fdn IRCCS Ist Nazl Tumori, Mol Immunol Unit, Dept Expt Oncol & Mol Med, Milan, Italy; [Balsari, Andrea] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Tagliabue, E (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Targeting Unit, Milan, Italy.	elda.tagliabue@istitutotumori.mi.it	Tagliabue, Elda/B-9377-2017; Sandri, Marco/L-2875-2013; Colombo, Mario P./V-7166-2017; Triulzi, Tiziana/C-1070-2017; balsari, andrea/M-5657-2016; Orlandi, Rosaria/C-1182-2017	Tagliabue, Elda/0000-0001-9877-2903; Sandri, Marco/0000-0002-1422-5695; Colombo, Mario P./0000-0003-0042-7955; Triulzi, Tiziana/0000-0003-3050-8676; balsari, andrea/0000-0002-3250-2668; Orlandi, Rosaria/0000-0002-0533-9041	Associazione Italiana per la Ricerca sul Cancro (AIRC) [5496, 12162]; Cassa di Risparmio delle Provincie Lombarde (CARIPLO); Italian Bureau of Health	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cassa di Risparmio delle Provincie Lombarde (CARIPLO)(Fondazione Cariplo); Italian Bureau of Health	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) (Grants No. 5496 and No. 12162), Cassa di Risparmio delle Provincie Lombarde (CARIPLO) and Italian Bureau of Health (Alleanza contro il Cancro and funds obtained through a law by the Italian government which allowed Italian citizens to allocate the 5x1000 share of their tax payment to support a research or charitable institution of their choice). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Casey TM, 2008, BREAST CANCER RES TR, V110, P39, DOI 10.1007/s10549-007-9684-7; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cox D. R., 1984, ANAL SURVIVAL DATA; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; HajianTilaki KO, 1997, MED DECIS MAKING, V17, P94, DOI 10.1177/0272989X9701700111; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Ilic D, 1998, J CELL BIOL, V143, P547; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; McCready J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2578; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Myhre S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014002; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sangaletti S, 2005, J CELL SCI, V118, P3685, DOI 10.1242/jcs.02474; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Shabalin AA, 2009, ANN APPL STAT, V3, P985, DOI 10.1214/09-AOAS239; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; StataCorp, 2009, STAT STAT SOFTW REL; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang WG, 2002, CANCER RES, V62, P6278; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yan DJ, 2010, BIOSCI BIOTECH BIOCH, V74, P2103, DOI 10.1271/bbb.100286	55	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56761	10.1371/journal.pone.0056761	http://dx.doi.org/10.1371/journal.pone.0056761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441215	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200072
J	Zhang, CY; Song, XC; Zhu, MH; Shi, S; Li, M; Jin, L; Lang, JT; Li, GJ; Zheng, HL				Zhang, Caiyun; Song, Xicheng; Zhu, Minhui; Shi, Song; Li, Meng; Jin, Lei; Lang, Juntian; Li, Guojun; Zheng, Hongliang			Association between MMP1-1607 1G > 2G Polymorphism and Head and Neck Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MATRIX METALLOPROTEINASE-1 PROMOTER; ETS BINDING-SITE; FUNCTIONAL POLYMORPHISMS; TUMOR MICROENVIRONMENT; GENE PROMOTER; SUSCEPTIBILITY; EXPRESSION; EPIDEMIOLOGY; INVASION	Background: MMP1 is an important member of the MMP endopeptidase family that plays a critical role in the development of head and neck cancer (HNC). Several studies have investigated the association between the MMP1 -1607 1G > 2G polymorphism and risk of HNC, but their results have been inconsistent. Here, we conducted a meta-analysis to further explore the role of the MMP1 -1607 1G > 2G polymorphism in HNC development. Methods: We identified all eligible studies in the electronic databases of PubMed, ISI Web of Knowledge, MEDLINE, Embase, and Google Scholar (from January 2000 to June 2012). A meta-analysis was performed to evaluate the association between the MMP1 -1607 1G > 2G polymorphism and risk of HNC by calculating odds ratios (OR) and 95% confidence interval (CIs). Results: Twelve studies were included in this meta-analysis. In overall comparison, significant associations were found using the recessive and allelic contrast models (OR, 1.38; 95% CI, 1.07-1.79 and OR, 1.27; 95% CI, 1.05-1.53, respectively), but no association was detected using the dominant model. In the stratified analyses by several variables, significant associations were observed using the recessive, dominant, and allelic contrast models in the Asian population (OR, 1.64; 95% CI, 1.29-2.08; OR, 1.39; 95% CI, 1.06-1.82; and OR, 1.41; 95% CI, 1.21-1.65, respectively), European population (OR, 0.58; 95% CI, 0.40-0.84; OR, 0.64; 95% CI, 0.44-0.92; and OR, 0.68; 95% CI, 0.54-0.85, respectively), and population-based subgroup (OR, 1.24; 95% CI, 1.05-1.47; OR, 1.48; 95% CI, 1.04-2.12; and OR, 1.22; 95% CI, 1.07-1.38, respectively). Furthermore, significant associations were detected in oral cavity cancer and nasopharyngeal cancer under the recessive model. Conclusion: Our results suggest that the MMP1 -1607 1G > 2G polymorphism is associated with risk of HNC and that it plays different roles in Asian and European populations. Further studies with large sample size are needed to validate our findings.	[Zhang, Caiyun; Zhu, Minhui; Shi, Song; Li, Meng; Zheng, Hongliang] Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otolaryngol Head & Neck Surg, Yantai, Peoples R China; [Jin, Lei] So Med Univ, Sch Med, Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China; [Lang, Juntian] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Unit 1445, Houston, TX 77030 USA	Naval Medical University; Qingdao University; Southern Medical University - China; Naval Medical University; University of Texas System; UTMD Anderson Cancer Center	Zheng, HL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China.	zheng_hl2004@163.com			National Natural Science Foundation of China [81070775, 81170899]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by Grants from National Natural Science Foundation of China (No. 81070775, 81170899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Ben Nasr H, 2007, CLIN CHIM ACTA, V384, P57, DOI 10.1016/j.cca.2007.05.018; BLOT WJ, 1988, CANCER RES, V48, P3282; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Cao ZG, 2006, ORAL ONCOL, V42, P32, DOI [10.1016/j.oraloncology.2004.08.015, 10.1016/j.ooe.2005.08.006]; Freije JMP, 2003, ADV EXP MED BIOL, V532, P91; Hashimoto T, 2004, CANCER LETT, V211, P19, DOI 10.1016/j.canlet.2004.01.032; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KABAT GC, 1994, INT J EPIDEMIOL, V23, P1137, DOI 10.1093/ije/23.6.1137; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Kondo S, 2005, INT J CANCER, V115, P368, DOI 10.1002/ijc.20849; Lin SC, 2004, J ORAL PATHOL MED, V33, P323, DOI 10.1111/j.1600-0714.2004.00214.x; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nishizawa R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-187; O-Charoenrat P, 2006, INT J CANCER, V118, P2548, DOI 10.1002/ijc.21644; Rose BS, 2011, J CLIN ONCOL, V29, P3503, DOI 10.1200/JCO.2011.35.7301; Rutter JL, 1998, CANCER RES, V58, P5321; SANKARANARAYANAN R, 1992, HEAD NECK-J SCI SPEC, V14, P107, DOI 10.1002/hed.2880140206; Shimizu Y, 2008, AURIS NASUS LARYNX, V35, P381, DOI 10.1016/j.anl.2007.12.002; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; STETLERSTEVENSON WG, 1993, FASEB J, V7, P1434, DOI 10.1096/fasebj.7.15.8262328; Stokes A, 2010, CLIN CANCER RES, V16, P2022, DOI 10.1158/1078-0432.CCR-09-2525; Sturgis EM, 2002, CURR OPIN ONCOL, V14, P310, DOI 10.1097/00001622-200205000-00010; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013; Tower GB, 2002, BBA-MOL BASIS DIS, V1586, P265, DOI 10.1016/S0925-4439(01)00105-3; Vairaktaris E, 2007, ANTICANCER RES, V27, P459; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2006.04424.x; Zhou G, 2007, HUM MUTAT, V28, P1091, DOI 10.1002/humu.20570; Zinzindohoue F, 2004, ANTICANCER RES, V24, P2021; Ziober BL, 2000, ORAL ONCOL, V36, P365, DOI 10.1016/S1368-8375(00)00019-1	36	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56294	10.1371/journal.pone.0056294	http://dx.doi.org/10.1371/journal.pone.0056294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441173	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200030
J	Li, YY; Fu, KH; Gao, SG; Wu, Q; Fan, LL; Li, YQ; Chen, J				Li, Yingying; Fu, Kehe; Gao, Shigang; Wu, Qiong; Fan, Lili; Li, Yaqian; Chen, Jie			Impact on Bacterial Community in Midguts of the Asian Corn Borer Larvae by Transgenic Trichoderma Strain Overexpressing a Heterologous chit42 Gene with Chitin-Binding Domain	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DIVERSITY; MICROBIOTA; GUT; DISEASE; IDENTIFICATION; ENDOSYMBIONTS; CATERPILLARS; MICROFLORA; FORMOSANUS	This paper is the first report of the impact on the bacterial community in the midgut of the Asian corn borer (Ostrinia furnacalis) by the chitinase from the transgenic Trichoderma strain. In this study, we detected a change of the bacterial community in the midgut of the fourth instar larvae by using a culture-independent method. Results suggested that Proteobacteria and Firmicutes were the most highly represented phyla, being present in all the midgut bacterial communities. The observed species richness was simple, ranging from four to five of all the 16S rRNA clone libraries. When using Trichoderma fermentation liquids as additives, the percentages of the dominant flora in the total bacterial community in larval midgut changed significantly. The community of the genus Ochrobactrum in the midgut decreased significantly when the larvae were fed with the fermentation liquids of the transgenic Trichoderma strain Mc4. However, the Enterococcus community increased and then occupied the vacated niche of the Ochrobactrum members. Furthermore, the Shannon-Wiener (H) and the Simpson (1-D) indexes of the larval midgut bacterial library treated by feeding fermentation liquids of the transgenic Trichoderma strain Mc4 was the lowest compared with the culture medium, fermentation liquids of the wild type strain T30, and the sterile artificial diet. The Enterococcus sp. strain was isolated and characterized from the healthy larvae midgut of the Asian corn borer. An infection study of the Asian corn borer larvae using Enterococcus sp. ACB-1 revealed that a correlation existed between the increased Enterococcus community in the larval midgut and larval mortality. These results demonstrated that the transgenic Trichoderma strain could affect the composition of the midgut bacterial community. The change of the midgut bacterial community might be viewed as one of the factors resulting in the increased mortality of the Asian corn borer larvae.	[Li, Yingying; Fu, Kehe; Gao, Shigang; Wu, Qiong; Fan, Lili; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, Dept Resource & Environm Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chen, J (corresponding author), Shanghai Jiao Tong Univ, Dept Resource & Environm Sci, Sch Agr & Biol, Shanghai 200030, Peoples R China.	jiechen59@sjtu.edu.cn			China Agriculture Research System [CARS-02]; "948'' project of the Ministry of Agriculture of China [2011-G4]; key project from Shanghai Municipal Science and Technology Commission [09391910900]; National Department Public Benefit Research Foundation of China [200903052]; ministry of education research fund for the doctoral specialty [20090073110048]; "863'' national projects [2011AA10A205]	China Agriculture Research System; "948'' project of the Ministry of Agriculture of China; key project from Shanghai Municipal Science and Technology Commission; National Department Public Benefit Research Foundation of China; ministry of education research fund for the doctoral specialty; "863'' national projects	The research was supported by China Agriculture Research System (CARS-02), the "948'' project of the Ministry of Agriculture of China (2011-G4), the key project from Shanghai Municipal Science and Technology Commission (09391910900), the National Department Public Benefit Research Foundation of China (No. 200903052). The ministry of education research fund for the doctoral specialty (No. 20090073110048) and the "863'' national projects (2011AA10A205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bogo MR, 1998, CURR MICROBIOL, V37, P221, DOI 10.1007/s002849900368; BREZNAK JA, 1982, ANNU REV MICROBIOL, V36, P323, DOI 10.1146/annurev.mi.36.100182.001543; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Cappellozza S, 2011, J INVERTEBR PATHOL, V106, P386, DOI 10.1016/j.jip.2010.12.007; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Chen DQ, 1997, CURR MICROBIOL, V34, P220, DOI 10.1007/s002849900172; Dillon R, 2002, RES MICROBIOL, V153, P503, DOI 10.1016/S0923-2508(02)01361-X; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kiorboe T, 2003, APPL ENVIRON MICROB, V69, P3036, DOI 10.1128/AEM.69.6.3036-3047.2003; LANE DJ, 1991, NUCL ACID TECHNIQUES, P5; Li YY, 2013, J ENV SCI B IN PRESS, V48, P1; Limon MC, 2004, APPL MICROBIOL BIOT, V64, P675, DOI 10.1007/s00253-003-1538-6; LYSENKO O, 1958, J GEN MICROBIOL, V18, P774, DOI 10.1099/00221287-18-3-774; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Militza CCN, 2006, APPL ENVIRON MICROB, V72, P3175, DOI 10.1128/AEM.72.5.3175-3183.2006; NAFUS DM, 1991, TROP PEST MANAGE, V37, P41, DOI 10.1080/09670879109371535; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; Noda S, 2005, APPL ENVIRON MICROB, V71, P8811, DOI 10.1128/AEM.71.12.8811-8817.2005; Ohkuma M, 2006, SOIL BIOL, P303; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P461, DOI 10.1128/AEM.62.2.461-468.1996; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; Ravenschlag K, 1999, APPL ENVIRON MICROB, V65, P3982; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHLEIFER KH, 1984, INT J SYST BACTERIOL, V34, P31, DOI 10.1099/00207713-34-1-31; Shinzato N, 2007, BIOSCI BIOTECH BIOCH, V71, P906, DOI 10.1271/bbb.60540; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Xiang Hui, 2007, Acta Entomologica Sinica, V50, P222	39	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55555	10.1371/journal.pone.0055555	http://dx.doi.org/10.1371/journal.pone.0055555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457472	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700014
J	Canet, E; Zafrani, L; Lambert, J; Thieblemont, C; Galicier, L; Schnell, D; Raffoux, E; Lengline, E; Chevret, S; Darmon, M; Azoulay, E				Canet, Emmanuel; Zafrani, Lara; Lambert, Jerome; Thieblemont, Catherine; Galicier, Lionel; Schnell, David; Raffoux, Emmanuel; Lengline, Etienne; Chevret, Sylvie; Darmon, Michael; Azoulay, Elie			Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE-RENAL-FAILURE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CRITICALLY-ILL PATIENTS; ACUTE RESPIRATORY-FAILURE; REPLACEMENT THERAPY; CANCER-PATIENTS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; CELL TRANSPLANTATION; BURKITTS-LYMPHOMA	Background: Optimal chemotherapy with minimal toxicity is the main determinant of complete remission in patients with newly diagnosed hematological malignancies. Acute organ dysfunctions may impair the patient's ability to receive optimal chemotherapy. Design and Methods: To compare 6-month complete remission rates in patients with and without acute kidney injury (AKI), we collected prospective data on 200 patients with newly diagnosed high-grade malignancies (non-Hodgkin lymphoma, 53.5%; acute myeloid leukemia, 29%; acute lymphoblastic leukemia, 11.5%; and Hodgkin disease, 6%). Results: According to RIFLE criteria, 137 (68.5%) patients had AKI. Five causes of AKI accounted for 91.4% of cases: hypoperfusion, tumor lysis syndrome, tubular necrosis, nephrotoxic agents, and hemophagocytic lymphohistiocytosis. Half of the AKI patients received renal replacement therapy and 14.6% received suboptimal chemotherapy. AKI was associated with a lower 6-month complete remission rate (39.4% vs. 68.3%, P<0.01) and a higher mortality rate (47.4% vs. 30.2%, P<0.01) than patients without AKI. By multivariate analysis, independent determinants of 6-month complete remission were older age, poor performance status, number of organ dysfunctions, and AKI. Conclusion: AKI is common in patients with newly diagnosed high-grade malignancies and is associated with lower complete remission rates and higher mortality.	[Canet, Emmanuel; Zafrani, Lara; Schnell, David; Azoulay, Elie] St Louis Univ Hosp, Med Intens Care Unit, Paris, France; [Lambert, Jerome; Chevret, Sylvie] St Louis Univ Hosp, Dept Biostat, Paris, France; [Thieblemont, Catherine] St Louis Univ Hosp, Dept Hematol & Oncol, Paris, France; [Galicier, Lionel] St Louis Univ Hosp, Dept Clin Immunol, Paris, France; [Raffoux, Emmanuel; Lengline, Etienne] St Louis Univ Hosp, Dept Hematol, Paris, France; [Darmon, Michael] St Etienne Univ Hosp, Med Surg Intens Care Unit, St Etienne, France; [Chevret, Sylvie; Azoulay, Elie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; UDICE-French Research Universities; Universite Paris Cite	Canet, E (corresponding author), St Louis Univ Hosp, Med Intens Care Unit, Paris, France.	emmanuel.canet@sls.aphp.fr	schnell, david/AAG-2208-2020; Lambert, Jerome/AAN-3582-2020; Thieblemont, Catherine/AAZ-8423-2020; LENGLINE, Etienne/GZG-5476-2022	Thieblemont, Catherine/0000-0002-9941-2448; chevret, sylvie/0000-0001-6449-4730; Lengline, Etienne/0000-0003-0965-6615; Darmon, Michael/0000-0003-4198-8038	French Ministry of Health, Assistance-Publique Hopitaux de Paris [AOM 09006]	French Ministry of Health, Assistance-Publique Hopitaux de Paris	This work was supported by a grant from the French Ministry of Health, Assistance-Publique Hopitaux de Paris (AOM 09006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Azoulay E, 2010, AM J RESP CRIT CARE, V182, P1038, DOI 10.1164/rccm.201001-0018OC; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 1998, KIDNEY INT, V53, pS106; Benoit DD, 2005, NEPHROL DIAL TRANSPL, V20, P552, DOI 10.1093/ndt/gfh637; Benoit DD, 2003, CRIT CARE MED, V31, P104, DOI 10.1097/00003246-200301000-00017; Benoit DD, 2010, CRIT CARE CLIN, V26, P151, DOI 10.1016/j.ccc.2009.09.002; Blum KA, 2004, BLOOD, V104, P3009, DOI 10.1182/blood-2004-02-0405; Buemi M, 2009, J INVEST MED, V57, P892, DOI 10.2310/JIM.0b013e3181c5e762; Buyse S, 2010, INTENS CARE MED, V36, P1695, DOI 10.1007/s00134-010-1936-z; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Darmon M, 2007, INTENS CARE MED, V33, P765, DOI 10.1007/s00134-007-0579-1; Galicier L, 2007, BLOOD, V110, P2846, DOI 10.1182/blood-2006-10-051771; Howard SC, 2011, NEW ENGL J MED, V364, P1844, DOI 10.1056/NEJMra0904569; Janka GE, 2005, HEMATOLOGY, V10, P104, DOI 10.1080/10245330512331390087; Karras A, 2009, NAT REV NEPHROL, V5, P329, DOI 10.1038/nrneph.2009.73; Khassawneh BY, 2002, CHEST, V121, P185, DOI 10.1378/chest.121.1.185; Lameire NH, 2005, ANN MED, V37, P13, DOI 10.1080/07853890510007205; Lecuyer L, 2008, EUR RESPIR J, V32, P748, DOI 10.1183/09031936.00142907; Legrand M, 2012, CRIT CARE MED, V40, P43, DOI 10.1097/CCM.0b013e31822b50c2; Lengline E, 2012, LEUK LYMPHOMA; Lim ST, 2005, J CLIN ONCOL, V23, P4430, DOI 10.1200/JCO.2005.11.973; McGregor S, 2012, SEMIN DIAGN PATHOL, V29, P2, DOI 10.1053/j.semdp.2011.07.004; Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Parikh CR, 2006, KIDNEY INT, V69, P430, DOI 10.1038/sj.ki.5000055; Pulte D, 2009, BLOOD, V113, P1408, DOI 10.1182/blood-2008-06-164863; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Schafer ES, 2011, NAT REV CLIN ONCOL, V8, P417, DOI 10.1038/nrclinonc.2011.77; Smeland S, 2004, ANN ONCOL, V15, P1072, DOI 10.1093/annonc/mdh262; Soares M, 2006, J CLIN ONCOL, V24, P4003, DOI 10.1200/JCO.2006.05.7869; Thaunat O, 2006, KIDNEY INT, V69, P1892, DOI 10.1038/sj.ki.5000352; Thiery G, 2005, J CLIN ONCOL, V23, P4406, DOI 10.1200/JCO.2005.01.487; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	41	84	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55870	10.1371/journal.pone.0055870	http://dx.doi.org/10.1371/journal.pone.0055870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457485	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700026
J	Chibebe, J; Fuchs, BB; Sabino, CP; Junqueira, JC; Jorge, AC; Ribeiro, MS; Gilmore, MS; Rice, LB; Tegos, GP; Hamblin, MR; Mylonakis, E				Chibebe Junior, Jose; Fuchs, Beth B.; Sabino, Caetano P.; Junqueira, Juliana C.; Jorge, AntonioO. C.; Ribeiro, Martha S.; Gilmore, Michael S.; Rice, Louis B.; Tegos, George P.; Hamblin, Michael R.; Mylonakis, Eleftherios			Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus faecium in a Whole Animal Insect Model	PLOS ONE			English	Article							LOW-POWER LASER; GALLERIA-MELLONELLA; CRYPTOCOCCUS-NEOFORMANS; CAENORHABDITIS-ELEGANS; VIRULENCE; FAECALIS; CANDIDA; SUSCEPTIBILITY; HOST; PATHOGENICITY	Enterococcus faecium has emerged as one of the most important pathogens in healthcare-associated infections worldwide due to its intrinsic and acquired resistance to many antibiotics, including vancomycin. Antimicrobial photodynamic therapy (aPDT) is an alternative therapeutic platform that is currently under investigation for the control and treatment of infections. PDT is based on the use of photoactive dye molecules, widely known as photosensitizer (PS). PS, upon irradiation with visible light, produces reactive oxygen species that can destroy lipids and proteins causing cell death. We employed Galleria mellonella (the greater wax moth) caterpillar fatally infected with E. faecium to develop an invertebrate host model system that can be used to study the antimicrobial PDT (alone or combined with antibiotics). In the establishment of infection by E. faecium in G. mellonella, we found that the G. mellonella death rate was dependent on the number of bacterial cells injected into the insect hemocoel and all E. faecium strains tested were capable of infecting and killing G. mellonella. Antibiotic treatment with ampicillin, gentamicin or the combination of ampicillin and gentamicin prolonged caterpillar survival infected by E. faecium (P = 0.0003, P = 0.0001 and P = 0.0001, respectively). In the study of antimicrobial PDT, we verified that methylene blue (MB) injected into the insect followed by whole body illumination prolonged the caterpillar survival (P = 0.0192). Interestingly, combination therapy of larvae infected with vancomycin-resistant E. faecium, with antimicrobial PDT followed by vancomycin, significantly prolonged the survival of the caterpillars when compared to either antimicrobial PDT (P = 0.0095) or vancomycin treatment alone (P = 0.0025), suggesting that the aPDT made the vancomycin resistant E. faecium strain more susceptible to vancomycin action. In summary, G. mellonella provides an invertebrate model host to study the antimicrobial PDT and to explore combinatorial aPDT-based treatments.	[Chibebe Junior, Jose; Junqueira, Juliana C.; Jorge, AntonioO. C.] Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil; [Chibebe Junior, Jose; Fuchs, Beth B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Chibebe Junior, Jose] Fac Pindamonhangaba, Dept Restorat Dent, Sao Paulo, Brazil; [Sabino, Caetano P.; Tegos, George P.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Sabino, Caetano P.; Ribeiro, Martha S.] Ctr Lasers & Applicat, Nucl & Energy Res Inst, Sao Paulo, Brazil; [Gilmore, Michael S.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA; [Rice, Louis B.; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02903 USA; [Rice, Louis B.; Mylonakis, Eleftherios] Brown Univ, Miriam Hosp, Warren Alpert Med Sch, Providence, RI USA; [Tegos, George P.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Tegos, George P.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Tegos, George P.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Hamblin, Michael R.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA	Universidade Estadual Paulista; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Harvard University; Harvard Medical School; University of New Mexico; University of New Mexico; Harvard University	Chibebe, J (corresponding author), Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil.	juliana@fosjc.unesp.br; emylonakis@lifespan.org	Sabino, Caetano P/K-8356-2013; Ribeiro, Martha Simões/G-3517-2012; Hamblin, Mike/AAB-2511-2022; Junqueira, Juliana Campos/Q-3108-2019; Junqueira, Juliana JC/F-7785-2012; Hamblin, Michael R/H-2758-2019; Sabino, Caetano/D-4196-2016; Junqueira, Juliana/GQZ-4509-2022	Ribeiro, Martha Simões/0000-0002-4203-1134; Junqueira, Juliana Campos/0000-0001-6646-6856; Junqueira, Juliana JC/0000-0001-6646-6856; Hamblin, Michael R/0000-0001-6431-4605; Sabino, Caetano/0000-0002-2048-2823; 	CAPES [PDEE 2507-11-0]; NIH [RO1 AI050875, 5U54MH084690-02]; Harvard-wide Program on Antibiotic Resistance [P01 AI083214]; US Air Force MFEL Program [FA9550-04-1-0079]; DTRA [HDTRA1-13-C-0005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875, P01AI083214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-wide Program on Antibiotic Resistance; US Air Force MFEL Program; DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The first author thanks CAPES (PDEE 2507-11-0) for the scholarship during the "Sandwich'' PhD Program at Harvard Medical School. Research conducted in the Mylonakis Laboratory was supported by NIH (RO1 AI050875 to EM, and the Harvard-wide Program on Antibiotic Resistance [P01 AI083214] to EM and MSG). Research conducted in the Hamblin Laboratory was supported by NIH (RO1 AI050875 to MRH) and US Air Force MFEL Program (FA9550-04-1-0079). George P. Tegos is supported by the NIH (grant 5U54MH084690-02) and DTRA (contract HDTRA1-13-C-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Vera DMA, 2012, PHOTOCHEM PHOTOBIOL, V88, P499, DOI 10.1111/j.1751-1097.2012.01087.x; Lins RDAU, 2010, AN BRAS DERMATOL, V85, P849, DOI 10.1590/S0365-05962010000600011; Aperis G, 2007, MICROBES INFECT, V9, P729, DOI 10.1016/j.micinf.2007.02.016; Banville N, 2012, VIRULENCE, V3, P497, DOI 10.4161/viru.21972; Bhardwaj A, 2009, INT J FOOD MICROBIOL, V128, P513, DOI 10.1016/j.ijfoodmicro.2008.10.010; Costa ACBP, 2012, OR SURG OR MED OR PA, V114, P67, DOI 10.1016/j.oooo.2012.02.002; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Chabrier-Rosello Y, 2008, PHOTOCHEM PHOTOBIOL, V84, P1141, DOI 10.1111/j.1751-1097.2007.00280.x; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Coleman JJ, 2011, FUNGAL BIOL-UK, V115, P1279, DOI 10.1016/j.funbio.2011.09.005; Dahlen Gunnar, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10855; de Regt MJA, 2010, ANTIMICROB AGENTS CH, V54, P2801, DOI 10.1128/AAC.01765-09; Denis TGS, 2011, VIRULENCE, V2, P509, DOI 10.4161/viru.2.6.17889; Desalermos A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002451; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; Fuchs BB, 2006, CURR OPIN MICROBIOL, V9, P346, DOI 10.1016/j.mib.2006.06.004; Fuchs BB, 2010, MICROBES INFECT, V12, P488, DOI 10.1016/j.micinf.2010.03.001; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gaspar F, 2009, MICROBIOL-SGM, V155, P3564, DOI 10.1099/mic.0.030775-0; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Junqueira JC, 2012, LASERS MED SCI; Junqueira JC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-247; Junqueira JC, 2009, LASER MED SCI, V24, P877, DOI 10.1007/s10103-009-0673-4; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Kristich CJ, 2011, MBIO, V2, DOI 10.1128/mBio.00199-11; Lebreton F, 2011, J MOL MICROB BIOTECH, V21, P191, DOI 10.1159/000332737; Lindenstrauss AG, 2011, SYST APPL MICROBIOL, V34, P553, DOI 10.1016/j.syapm.2011.05.002; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; Martins JD, 2011, ORAL SURG ORAL MED O, V111, P71, DOI 10.1016/j.tripleo.2010.08.012; Michaux C, 2011, INFECT IMMUN, V79, P2638, DOI 10.1128/IAI.01132-10; Mitton D, 2008, PHOTODIAGN PHOTODYN, V5, P103, DOI 10.1016/j.pdpdt.2008.04.004; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Moy TI, 2004, INFECT IMMUN, V72, P4512, DOI 10.1128/IAI.72.8.4512-4520.2004; Murray PR, 2009, MED MICROBIOLOGY, Vx; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nandakumar R, 2009, ORAL MICROBIOL IMMUN, V24, P347, DOI 10.1111/j.1399-302X.2009.00520.x; Olsen RJ, 2011, VIRULENCE, V2, P111, DOI 10.4161/viru.2.2.14338; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Panesso D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-20; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rice LB, 2009, J BACTERIOL, V191, P3649, DOI 10.1128/JB.01834-08; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Snell SB, 2012, PHOTOCHEM PHOTOBIOL, V88, P596, DOI 10.1111/j.1751-1097.2011.01039.x; St Denis TG, 2011, PHOTOCHEM PHOTOBIOL, V87, P707, DOI 10.1111/j.1751-1097.2011.00902.x; Wainwright M, 1997, J PHOTOCH PHOTOBIO B, V40, P233, DOI 10.1016/S1011-1344(97)00061-4; Wainwright M, 2006, J PHOTOCH PHOTOBIO B, V84, P227, DOI 10.1016/j.jphotobiol.2006.03.002; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Zhu XF, 2010, J ENDODONT, V36, P1950, DOI 10.1016/j.joen.2010.08.053	65	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55926	10.1371/journal.pone.0055926	http://dx.doi.org/10.1371/journal.pone.0055926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457486	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700027
J	Frisch, S; Dukart, J; Vogt, B; Horstmann, A; Becker, G; Villringer, A; Barthel, H; Sabri, O; Muller, K; Schroeter, ML				Frisch, Stefan; Dukart, Juergen; Vogt, Barbara; Horstmann, Annette; Becker, Georg; Villringer, Arno; Barthel, Henryk; Sabri, Osama; Mueller, Karsten; Schroeter, Matthias L.			Dissociating Memory Networks in Early Alzheimer's Disease and Frontotemporal Lobar Degeneration - A Combined Study of Hypometabolism and Atrophy	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EPISODIC MEMORY; SEMANTIC DEMENTIA; FRONTAL VARIANT; HIPPOCAMPAL ATROPHY; NEUROPSYCHOLOGICAL PERFORMANCE; AUTOBIOGRAPHICAL MEMORIES; ENTORHINAL CORTEX; BRIEF BATTERY; FDG-PET	Introduction: We aimed at dissociating the neural correlates of memory disorders in Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD). Methods: We included patients with AD (n = 19, 11 female, mean age 61 years) and FTLD (n = 11, 5 female, mean age 61 years) in early stages of their diseases. Memory performance was assessed by means of verbal and visual memory subtests from the Wechsler Memory Scale (WMS-R), including forgetting rates. Brain glucose utilization was measured by [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) and brain atrophy by voxel-based morphometry (VBM) of T1-weighted magnetic resonance imaging (MRI) scans. Using a whole brain approach, correlations between test performance and imaging data were computed separately in each dementia group, including a group of control subjects (n = 13, 6 female, mean age 54 years) in both analyses. The three groups did not differ with respect to education and gender. Results: Patients in both dementia groups generally performed worse than controls, but AD and FTLD patients did not differ from each other in any of the test parameters. However, memory performance was associated with different brain regions in the patient groups, with respect to both hypometabolism and atrophy: Whereas in AD patients test performance was mainly correlated with changes in the parieto-mesial cortex, performance in FTLD patients was correlated with changes in frontal cortical as well as subcortical regions. There were practically no overlapping regions associated with memory disorders in AD and FTLD as revealed by a conjunction analysis. Conclusion: Memory test performance may not distinguish between both dementia syndromes. In clinical practice, this may lead to misdiagnosis of FTLD patients with poor memory performance. Nevertheless, memory problems are associated with almost completely different neural correlates in both dementia syndromes. Obviously, memory functions are carried out by distributed networks which break down in brain degeneration.	[Frisch, Stefan] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Frisch, Stefan; Dukart, Juergen; Vogt, Barbara; Horstmann, Annette; Villringer, Arno; Mueller, Karsten; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Dukart, Juergen] CHU Vaudois, LREN, Dept Neurosci, Lausanne, Switzerland; [Becker, Georg; Barthel, Henryk; Sabri, Osama] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Villringer, Arno; Schroeter, Matthias L.] Univ Leipzig, Day Clin Cognit Neurol, D-04109 Leipzig, Germany; [Dukart, Juergen; Villringer, Arno; Sabri, Osama; Schroeter, Matthias L.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany	Goethe University Frankfurt; Max Planck Society; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leipzig University; Leipzig University; Leipzig University	Frisch, S (corresponding author), Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany.	stefan.frisch@kgu.de	Horstmann, Annette/C-9083-2011	Horstmann, Annette/0000-0001-6184-8484; Villringer, Arno/0000-0003-2604-2404; Sabri, Osama/0000-0002-6425-3504; Kruse, Barbara/0000-0002-6050-314X; Frisch, Stefan/0000-0002-7294-4786; Dukart, Juergen/0000-0003-0492-5644	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study has been supported by LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig - funded by the European Union, European Regional Development Fund and by the Free State of Saxony within the framework of the excellence initiative (AV, OS and MLS) and by the German Consortium for Frontotemporal Lobar Degeneration, funded by the German Federal Ministry of Education and Research (MLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1998, J NEUROL NEUROSUR PS, V65, P126, DOI 10.1136/jnnp.65.1.126; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnes J, 2006, ARCH NEUROL-CHICAGO, V63, P1434, DOI 10.1001/archneur.63.10.1434; Boxer AL, 2003, ARCH NEUROL-CHICAGO, V60, P949, DOI 10.1001/archneur.60.7.949; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Caroli A, 2007, J NEUROL, V254, P1698, DOI 10.1007/s00415-007-0631-7; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Desgranges B, 2002, BRAIN, V125, P1116, DOI 10.1093/brain/awf097; Desgranges B, 1998, BRAIN, V121, P611, DOI 10.1093/brain/121.4.611; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl J, 2005, J GERIATR PSYCH NEUR, V18, P39, DOI 10.1177/0891988704272309; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018111; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Eustache F, 2004, BRAIN, V127, P1549, DOI 10.1093/brain/awh166; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Galton CJ, 2001, NEUROLOGY, V57, P216, DOI 10.1212/WNL.57.2.216; Giovagnoli AR, 2008, NEUROPSYCHOLOGIA, V46, P1495, DOI 10.1016/j.neuropsychologia.2007.12.023; Glosser G, 2002, NEUROPSYCHOLOGY, V16, P190, DOI 10.1037//0894-4105.16.2.190; Goldenberg G, 1999, J NEUROL NEUROSUR PS, V67, P163, DOI 10.1136/jnnp.67.2.163; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Graham A, 2005, BRAIN, V128, P597, DOI 10.1093/brain/awh348; Gregory CA, 1997, INT J GERIATR PSYCH, V12, P375, DOI 10.1002/(SICI)1099-1166(199703)12:3<375::AID-GPS518>3.0.CO;2-#; H?rting, 2000, WECHSLER GEDACHTNIST; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20203; Hodges JR, 1999, NEUROPSYCHOLOGY, V13, P31, DOI 10.1037/0894-4105.13.1.31; Hornberger M, 2010, NEUROLOGY, V74, P472, DOI 10.1212/WNL.0b013e3181cef85d; Hornberger M, 2012, BRAIN, V135, P3015, DOI 10.1093/brain/aws239; Hornberger M, 2012, BRAIN, V135, P678, DOI 10.1093/brain/aws011; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Juva K, 1995, Int Psychogeriatr, V7, P17, DOI 10.1017/S1041610295001815; Karas G, 2007, NEURORADIOLOGY, V49, P967, DOI 10.1007/s00234-007-0269-2; Kertesz A, 2003, ALZ DIS ASSOC DIS, V17, P223, DOI 10.1097/00002093-200310000-00005; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Leube DT, 2008, INT J GERIATR PSYCH, V23, P1114, DOI 10.1002/gps.2036; Levy JA, 2007, J GERIATR PSYCH NEUR, V20, P227, DOI 10.1177/0891988707308806; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Libon DJ, 2007, NEUROLOGY, V68, P369, DOI 10.1212/01.wnl.0000252820.81313.9b; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Matuszewski V, 2006, NEUROPSYCHOLOGIA, V44, P2386, DOI 10.1016/j.neuropsychologia.2006.04.031; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez MF, 2007, ARCH NEUROL-CHICAGO, V64, P830, DOI 10.1001/archneur.64.6.830; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Pennington C, 2011, J ALZHEIMERS DIS, V24, P261, DOI 10.3233/JAD-2011-101668; Pereira JMS, 2009, NEUROLOGY, V72, P1653, DOI 10.1212/WNL.0b013e3181a55fa2; Perri R, 2005, J NEUROL, V252, P1238, DOI 10.1007/s00415-005-0849-1; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Raczka KA, 2010, PSYCHIAT RES-NEUROIM, V182, P274, DOI 10.1016/j.pscychresns.2010.02.009; Razani J, 2001, J INT NEUROPSYCH SOC, V7, P468, DOI 10.1017/S1355617701744037; Rousset OG, 1998, J NUCL MED, V39, P904; Salmon E, 2008, NEUROPSYCHOLOGIA, V46, P1613, DOI 10.1016/j.neuropsychologia.2007.11.022; Schroeter ML, 2008, NEUROBIOL AGING, V29, P418, DOI 10.1016/j.neurobiolaging.2006.10.023; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schroeter ML, 2012, BRAIN, V135, DOI 10.1093/brain/aws030; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Schroeter ML, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00010; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Sporns O., 2009, NETWORKS BRAIN; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Thompson JC, 2005, J NEUROL NEUROSUR PS, V76, P920, DOI 10.1136/jnnp.2003.033779; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Wicklund AH, 2006, ALZ DIS ASSOC DIS, V20, P86, DOI 10.1097/01.wad.0000213811.97305.49; Xu Y, 2000, NEUROLOGY, V54, P1760, DOI 10.1212/WNL.54.9.1760; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P259, DOI 10.1076/jcen.20.2.259.1174	80	47	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55251	10.1371/journal.pone.0055251	http://dx.doi.org/10.1371/journal.pone.0055251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457466	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700015
J	Kim, DH; Cotton, SL; Manna, D; Welte, M				Kim, Dae-Hwan; Cotton, Sean L.; Manna, Dipak; Welte, Michael			Novel Isoforms of the Transport Regulator Klar	PLOS ONE			English	Article							DOMAIN PROTEINS MSP-300; NUCLEAR MIGRATION; INTRACELLULAR-TRANSPORT; DROSOPHILA; KLARSICHT; ENVELOPE; CONSEQUENCES; LOCALIZATION; MEMBRANE; ADAPTER	Klar is a regulator of microtubule-motor dependent transport processes in Drosophila, including nuclear migration, vesicle motility, and lipid-droplet transport. The single klar locus gives rise to multiple isoforms that presumably have unique functions. Up to now, three Klar isoforms (alpha, beta, gamma) were known. Here we describe two novel isoforms, delta and epsilon, whose expression depends on a previously uncharacterized promoter. Klar delta and/or epsilon are widely expressed during development, including in the embryonic and larval nervous system as well as in ovaries. When we specifically ablate Klar delta and epsilon expression genetically, no gross organismal phenotypes are apparent. However, ectopic expression of these isoforms causes nuclear mispositioning in developing photoreceptors and in oocytes, demonstrating their biological activity. Our analysis identifies novel forms of the Klar protein and provides new tools for functionally dissecting the complex klar locus.	[Kim, Dae-Hwan; Cotton, Sean L.; Welte, Michael] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Manna, Dipak; Welte, Michael] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Brandeis University; University of Rochester	Welte, M (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	michael.welte@rochester.edu	Manna, Dipak/AAH-7306-2019; Welte, Michael/AAH-5589-2019	Welte, Michael/0000-0001-5741-4720	National Institutes of Health through NIGMS grant [GM64687]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064687] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (http://www.nih.gov/) through NIGMS grant GM64687 to MAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Dworkin I, 2009, GENETICS, V181, P1065, DOI 10.1534/genetics.108.096453; Elhanany-Tamir H, 2012, J CELL BIOL, V198, P833, DOI 10.1083/jcb.201204102; Fischer JA, 2004, GENETICS, V168, P1385, DOI 10.1534/genetics.104.028662; FISCHERVIZE JA, 1994, DEVELOPMENT, V120, P2609; Fridolfsson HN, 2010, DEV BIOL, V338, P237, DOI 10.1016/j.ydbio.2009.12.004; Guo Y, 2005, MOL BIOL CELL, V16, P1406, DOI 10.1091/mbc.E04-10-0920; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Meyerzon M, 2009, DEVELOPMENT, V136, P2725, DOI 10.1242/dev.038596; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Myat MM, 2005, DEV BIOL, V281, P38, DOI 10.1016/j.ydbio.2005.02.005; Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; ROIHA H, 1988, GENETICS, V119, P75; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Technau M, 2008, FLY, V2, P82, DOI 10.4161/fly.6288; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wolff Tanya, 1993, P1277; Xie XH, 2008, FLY, V2, P74, DOI 10.4161/fly.6108; Yu YXV, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-9; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhao T, 2008, GENETICS, V178, P883, DOI 10.1534/genetics.107.082487	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55070	10.1371/journal.pone.0055070	http://dx.doi.org/10.1371/journal.pone.0055070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457459	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700013
J	D'Souza, AJ; Desai, SD; Rudner, XL; Kelly, MN; Ruan, S; Shellito, JE				D'Souza, Alain J.; Desai, Shyamal D.; Rudner, Xiaowen L.; Kelly, Michelle N.; Ruan, SanBao; Shellito, Judd E.			Suppression of the Macrophage Proteasome by Ethanol Impairs MHC Class I Antigen Processing and Presentation	PLOS ONE			English	Article							IMMUNE-SYSTEM; PROTEIN-DEGRADATION; UBIQUITIN SYSTEM; 26S PROTEASOMES; HOST-DEFENSE; 2 PARTS; ALCOHOL; EXPOSURE; ALPHA; ACTIVATION	Alcohol binge-drinking (acute ethanol consumption) is immunosuppressive and alters both the innate and adaptive arms of the immune system. Antigen presentation by macrophages (and other antigen presenting cells) represents an important function of the innate immune system that, in part, determines the outcome of the host immune response. Ethanol has been shown to suppress antigen presentation in antigen presenting cells though mechanisms of this impairment are not well understood. The constitutive and immunoproteasomes are important components of the cellular proteolytic machinery responsible for the initial steps critical to the generation of MHC Class I peptides for antigen presentation. In this study, we used an in-vitro cell culture model of acute alcohol exposure to study the effect of ethanol on the proteasome function in RAW 264.7 cells. Additionally, primary murine peritoneal macrophages obtained by peritoneal lavage from C57BL/6 mice were used to confirm our cell culture findings. We demonstrate that ethanol impairs proteasome function in peritoneal macrophages through suppression of chymotrypsin-like (Cht-L) proteasome activity as well as composition of the immunoproteasome subunit LMP7. Using primary murine peritoneal macrophages, we have further demonstrated that, ethanol-induced impairment of the proteasome function suppresses processing of antigenic proteins and peptides by the macrophage and in turn suppresses the presentation of these antigens to cells of adaptive immunity. The results of this study provide an important mechanism to explain the immunosuppressive effects of acute ethanol exposure.	[D'Souza, Alain J.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Desai, Shyamal D.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [D'Souza, Alain J.; Rudner, Xiaowen L.; Kelly, Michelle N.; Ruan, SanBao; Shellito, Judd E.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Pulmonary Crit Care Med, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Desai, SD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	sdesai@lsuhsc.edu; jshell@lsuhsc.edu		D'Souza, Alain/0000-0003-1851-5638	Public Health Service Grant [HL076100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076100] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Public Health Service Grant HL076100 (JES) (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; BALLARD HS, 1989, ALCOHOL CLIN EXP RES, V13, P706, DOI 10.1111/j.1530-0277.1989.tb00408.x; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Crabbe JC, 2011, ANN NY ACAD SCI, V1216, P24, DOI 10.1111/j.1749-6632.2010.05895.x; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; Delves PJ, 2000, NEW ENGL J MED, V343, P108, DOI 10.1056/NEJM200007133430207; Donohue TM, 2007, ALCOHOL CLIN EXP RES, V31, P1446, DOI 10.1111/j.1530-0277.2007.00454.x; Donohue TM, 2006, INT J BIOCHEM CELL B, V38, P92, DOI 10.1016/j.biocel.2005.07.010; GACZYNSKA M, 1993, ENZYME PROTEIN, V47, P354, DOI 10.1159/000468693; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Goral J, 2005, J IMMUNOL, V174, P456, DOI 10.4049/jimmunol.174.1.456; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Haorah J, 2004, CELL IMMUNOL, V229, P139, DOI 10.1016/j.cellimm.2004.07.005; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1609, DOI 10.1097/01.ALC.0000036926.46632.57; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Osna NA, HEPATOLOGY, V49, P1308; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Rivett AJ, 2004, CURR PROTEIN PEPT SC, V5, P153, DOI 10.2174/1389203043379774; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Stoltz DA, 2000, AM J RESP CRIT CARE, V161, P135, DOI 10.1164/ajrccm.161.1.9905016; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; SZABO G, 1993, J LEUKOCYTE BIOL, V54, P534, DOI 10.1002/jlb.54.6.534; Szabo G, 1996, ALCOHOL CLIN EXP RES, V20, P900, DOI 10.1111/j.1530-0277.1996.tb05269.x; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173	32	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56890	10.1371/journal.pone.0056890	http://dx.doi.org/10.1371/journal.pone.0056890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451104	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500040
J	Huang, YD; Ochieng, JK; Buscop-van Kempen, M; Boerema-de Munck, A; Swagemakers, S; van Ijcken, W; Grosveld, F; Tibboel, D; Rottier, RJ				Huang, Yadi; Ochieng, Joshua Kapere; Buscop-van Kempen, Marjon; Boerema-de Munck, Anne; Swagemakers, Sigrid; van Ijcken, Wilfred; Grosveld, Frank; Tibboel, Dick; Rottier, Robbert J.			Hypoxia Inducible Factor 3 alpha Plays a Critical Role in Alveolarization and Distal Epithelial Cell Differentiation during Mouse Lung Development	PLOS ONE			English	Article							PAS DOMAIN PROTEIN; TUMOR-SUPPRESSOR PROTEIN; HIGH-ALTITUDE ADAPTATION; FACTOR 2-ALPHA PLAYS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; FACTOR 1-ALPHA; PROLYL HYDROXYLATION; FACTOR (HIF)-1-ALPHA; NEGATIVE REGULATOR	Lung development occurs under relative hypoxia and the most important oxygen-sensitive response pathway is driven by Hypoxia Inducible Factors (HIF). HIFs are heterodimeric transcription factors of an oxygen-sensitive subunit, HIF alpha, and a constitutively expressed subunit, HIF1 beta. HIF1 alpha and HIF2 alpha, encoded by two separate genes, contribute to the activation of hypoxia inducible genes. A third HIF alpha gene, HIF3 alpha, is subject to alternative promoter usage and splicing, leading to three major isoforms, HIF3 alpha, NEPAS and IPAS. HIF3 alpha gene products add to the complexity of the hypoxia response as they function as dominant negative inhibitors (IPAS) or weak transcriptional activators (HIF3 alpha/NEPAS). Previously, we and others have shown the importance of the Hif1 alpha and Hif2 alpha factors in lung development, and here we investigated the role of Hif3 alpha during pulmonary development. Therefore, HIF3 alpha was conditionally expressed in airway epithelial cells during gestation and although HIF3 alpha transgenic mice were born alive and appeared normal, their lungs showed clear abnormalities, including a post-pseudoglandular branching defect and a decreased number of alveoli. The HIF3 alpha expressing lungs displayed reduced numbers of Clara cells, alveolar epithelial type I and type II cells. As a result of HIF3 alpha expression, the level of Hif2 alpha was reduced, but that of Hif1 alpha was not affected. Two regulatory genes, Rarb, involved in alveologenesis, and Foxp2, a transcriptional repressor of the Clara cell specific Ccsp gene, were significantly upregulated in the HIF3 alpha expressing lungs. In addition, aberrant basal cells were observed distally as determined by the expression of Sox2 and p63. We show that Hif3 alpha binds a conserved HRE site in the Sox2 promoter and weakly transactivated a reporter construct containing the Sox2 promoter region. Moreover, Hif3 alpha affected the expression of genes not typically involved in the hypoxia response, providing evidence for a novel function of Hif3 alpha beyond the hypoxia response.	[Huang, Yadi; Ochieng, Joshua Kapere; Buscop-van Kempen, Marjon; Boerema-de Munck, Anne; Tibboel, Dick; Rottier, Robbert J.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [van Ijcken, Wilfred] Erasmus MC, Dept Biom, Rotterdam, Netherlands; [Grosveld, Frank; Rottier, Robbert J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rottier, RJ (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands.	r.rottier@erasmusmc.nl	van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301; Rottier, Robbert/0000-0002-9291-4971	Sophia Foundation for Medical Research, SSWO [482]	Sophia Foundation for Medical Research, SSWO	This work was supported in part by the Sophia Foundation for Medical Research, SSWO nr. 482 (YH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Augstein A, 2011, CELL MOL LIFE SCI, V68, P2627, DOI 10.1007/s00018-010-0575-4; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hara S, 2001, BIOCHEM BIOPH RES CO, V287, P808, DOI 10.1006/bbrc.2001.5659; Heidbreder M, 2003, FASEB J, V17, P1541, DOI 10.1096/fj.02-0963fje; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2001, P NATL ACAD SCI USA, V98, P6692, DOI 10.1073/pnas.121494298; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Londhe VA, 2011, AM J RESP CELL MOL, V44, P804, DOI 10.1165/rcmb.2009-0429OC; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Malpel S, 2000, DEVELOPMENT, V127, P3057; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Raghoebir L, 2012, J MOL CELL BIOL; Rajatapiti P, 2008, PEDIATR DEVEL PATHOL, V11, P193, DOI 10.2350/07-04-0257.1; Rawlins EL, 2010, DEV DYN; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sowter HM, 2003, CANCER RES, V63, P6130; Stahlman MT, 2007, J HISTOCHEM CYTOCHEM, V55, P71, DOI 10.1369/jhc.6A6962.2006; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Torii S, 2011, CELL DEATH DIFFER, V18, P1711, DOI 10.1038/cdd.2011.47; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wongtrakool C, 2003, J BIOL CHEM, V278, P46911, DOI 10.1074/jbc.M307977200; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yoshida T, 2001, EXP TOXICOL PATHOL, V53, P123, DOI 10.1078/0940-2993-00183; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhou BY, 2008, AM J RESP CELL MOL, V38, P750, DOI 10.1165/rcmb.2007-0350OC	95	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57695	10.1371/journal.pone.0057695	http://dx.doi.org/10.1371/journal.pone.0057695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451260	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500127
J	Lutermann, H; Bennett, NC; Speakman, JR; Scantlebury, M				Lutermann, Heike; Bennett, Nigel C.; Speakman, John R.; Scantlebury, Michael			Energetic Benefits of Sociality Offset the Costs of Parasitism in a Cooperative Mammal	PLOS ONE			English	Article							CRYPTOMYS-HOTTENTOTUS; HELMINTH-PARASITES; HOST; INFECTION; BEHAVIOR; RISK; CONSEQUENCES; DETERMINANTS; PHYSIOLOGY; EVOLUTION	Sociality and particularly advanced forms of sociality such as cooperative breeding (living in permanent groups with reproductive division of labour) is relatively rare among vertebrates. A suggested constraint on the evolution of sociality is the elevated transmission rate of parasites between group members. Despite such apparent costs, sociality has evolved independently in a number of vertebrate taxa including humans. However, how the costs of parasitism are overcome in such cases remains uncertain. We evaluated the potential role of parasites in the evolution of sociality in a member of the African mole-rats, the only mammal family that exhibits the entire range of social systems from solitary to eusocial. Here we show that resting metabolic rates decrease whilst daily energy expenditure and energy stores (i.e. body fat) increase with group size in social Natal mole rats (Cryptomys hottentotus natalensis). Critically, larger groups also had reduced parasite abundance and infested individuals only showed measurable increases in energy metabolism at high parasite abundance. Thus, in some circumstances, sociality appears to provide energetic benefits that may be diverted into parasite defence. This mechanism is likely to be self-reinforcing and an important factor in the evolution of sociality.	[Lutermann, Heike; Bennett, Nigel C.; Scantlebury, Michael] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, South Africa; [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Scantlebury, Michael] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing, Peoples R China	University of Pretoria; University of Aberdeen; Queens University Belfast; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Lutermann, H (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, South Africa.	hlutermann@zoology.up.ac.za; m.scantlebury@qub.ac.uk	Speakman, John R./A-9494-2008; Lutermann, Heike/A-4692-2008; Bennett, Nigel/E-4238-2010	Speakman, John R./0000-0002-2457-1823; Lutermann, Heike/0000-0002-7521-2302; Bennett, Nigel/0000-0001-9748-2947	Department of Science and Technology/National Research Foundation-South African Research Chairs Initiative Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria Postdoctoral Research Fellowships; NRF-SAR Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria PDRF	Department of Science and Technology/National Research Foundation-South African Research Chairs Initiative Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria Postdoctoral Research Fellowships; NRF-SAR Chair for Mammalian Behavioural Ecology and Physiology; University of Pretoria PDRF	This research was funded by the Department of Science and Technology/National Research Foundation-South African Research Chairs Initiative Chair for Mammalian Behavioural Ecology and Physiology to N.C.B. and University of Pretoria Postdoctoral Research Fellowships to M.S. and H.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the owners for access to their property for animal capture and KwaZulu-Natal Nature Conservation Service for issuing the capture permit. This research was funded by the NRF-SAR Chair for Mammalian Behavioural Ecology and Physiology to NCB and University of Pretoria PDRF's to MS and HL. Many assistants were involved with fieldwork but we would especially like to thank Marietjie Oosthuizen and Craig Jackson for their help.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1993, Z SAUGETIERKD, V58, P362; Bordes F, 2007, BIOL LETTERS, V3, P692, DOI 10.1098/rsbl.2007.0393; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Degen AA, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P371, DOI 10.1007/978-4-431-36025-4_19; DELAHAY RJ, 1995, PARASITOLOGY, V110, P473, DOI 10.1017/S0031182000064817; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; Elsheikha HM, 2011, ESSENTIALS OF VETERINARY PARASITOLOGY, P1; Ewald PW, 1994, EVOLUTION INFECT DIS; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Hafner MS, 2000, LIFE UNDERGROUND, P370; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; HICKMAN GC, 1979, Z SAUGETIERKD, V44, P153; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; Hoste H, 2001, INT J PARASITOL, V31, P231, DOI 10.1016/S0020-7519(00)00167-3; Kam M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013686; Kleiber M., 1961, FIRE LIFE, DOI DOI 10.1002/JPS.2600510525; Kotze J, 2008, PHYSIOL BEHAV, V93, P215, DOI 10.1016/j.physbeh.2007.08.016; Kristan DM, 2004, J EXP BIOL, V207, P2351, DOI 10.1242/jeb.01020; Kristan DM, 2002, J EXP BIOL, V205, P3955; Kristan DM, 2001, AM J PHYSIOL-REG I, V281, pR502, DOI 10.1152/ajpregu.2001.281.2.R502; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Le Comber SC, 2002, CAN J ZOOL, V80, P436, DOI 10.1139/Z02-026; Lemen C, MLWPROGRAM DLWUSERGU; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Luna F, 2006, CAN J ZOOL, V84, P661, DOI 10.1139/Z06-040; Lutermann H, 2008, J ZOOL, V275, P26, DOI 10.1111/j.1469-7998.2007.00403.x; Lutermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052077; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Meldrum GE, 2009, ANIM BEHAV, V77, P919, DOI 10.1016/j.anbehav.2008.12.023; Morand S, 2000, P ROY SOC B-BIOL SCI, V267, P1999, DOI 10.1098/rspb.2000.1241; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Neilson R, 2005, PARASITOLOGY, V131, P279, DOI 10.1017/S0031182005007717; Oosthuizen MK, 2008, GEN COMP ENDOCR, V159, P236, DOI 10.1016/j.ygcen.2008.09.004; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Robar N, 2011, CAN J ZOOL, V89, P1146, DOI 10.1139/Z11-084; Rogerson JD, 2008, J WILDLIFE DIS, V44, P28, DOI 10.7589/0090-3558-44.1.28; Rossin MA, 2010, PARASITOLOGY, V137, P1569, DOI 10.1017/S0031182010000351; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Schwanz LE, 2006, J EXP BIOL, V209, P5029, DOI 10.1242/jeb.02601; SHERMAN PW, 1995, BEHAV ECOL, V6, P102, DOI 10.1093/beheco/6.1.102; Sichilima AM, 2008, J ZOOL, V275, P276, DOI 10.1111/j.1469-7998.2008.00439.x; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Speakman JR, 2003, P NATL ACAD SCI USA, V100, P14057, DOI 10.1073/pnas.2235671100; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Vicente J, 2006, PARASITOL RES, V98, P77, DOI 10.1007/s00436-005-0001-2; Viljoen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027003; Vitone ND, 2004, EVOL ECOL RES, V6, P183; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Zelova J, 2010, PHYSIOL BEHAV, V99, P54, DOI 10.1016/j.physbeh.2009.10.007	61	18	18	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57969	10.1371/journal.pone.0057969	http://dx.doi.org/10.1371/journal.pone.0057969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451285	Green Published, gold			2022-12-27	WOS:000316849500146
J	Rahman, MM; Gilmour, S; Saito, E; Sultana, P; Shibuya, K				Rahman, Md Mizanur; Gilmour, Stuart; Saito, Eiko; Sultana, Papia; Shibuya, Kenji			Health-Related Financial Catastrophe, Inequality and Chronic Illness in Bangladesh	PLOS ONE			English	Article							OF-POCKET PAYMENTS; LOW-INCOME SOCIETY; CARE EXPENDITURE; HOUSEHOLDS; POOR; DETERMINANTS; PROTECTION; FAMILIES; VIETNAM; IMPACT	Background: Bangladesh has a high proportion of households incurring catastrophic health expenditure, and very limited risk sharing mechanisms. Identifying determinants of out-of-pocket (OOP) payments and catastrophic health expenditure may reveal opportunities to reduce costs and protect households from financial risk. Objective: This study investigates the determinants of high healthcare expenditure and healthcare- related financial catastrophe. Methods: A cross-sectional household survey was conducted in Rajshahi city, Bangladesh, in 2011. Catastrophic health expenditure was estimated separately based on capacity to pay and proportion of non-food expenditure. Determinants of OOP payments and financial catastrophe were estimated using double hurdle and Poisson regression models respectively. Results: On average households spent 11% of their total budgets on health, half the residents spent 7% of the monthly per capita consumption expenditure for one illness, and nearly 9% of households faced financial catastrophe. The poorest households spent less on health but had a four times higher risk of catastrophe than the richest households. The risk of financial catastrophe and the level of OOP payments were higher for users of inpatient, outpatient public and private facilities respectively compared to using self-medication or traditional healers. Other determinants of OOP payments and catastrophic expenses were economic status, presence of chronic illness in the household, and illness among children and adults. Conclusion: Households that received inpatient or outpatient private care experienced the highest burden of health expenditure. The poorest members of the community also face large, often catastrophic expenses. Chronic illness management is crucial to reducing the total burden of disease in a household and its associated increased risk of level of OOP payments and catastrophic expenses. Households can only be protected from these situations by reducing the health system's dependency on OOP payments and providing more financial risk protection.	[Rahman, Md Mizanur; Gilmour, Stuart; Saito, Eiko; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Rahman, Md Mizanur] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Sultana, Papia] Rajshahi Univ, Dept Stat, Rajshahi 6205, Bangladesh	University of Tokyo; University of Rajshahi; University of Rajshahi	Rahman, MM (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	mizanur_rub@yahoo.com	Sultana, Papia/GRS-6420-2022	Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan [24030401]; University of Tokyo; Asian Development Bank (ADB)	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan(Ministry of Health, Labour and Welfare, Japan); University of Tokyo; Asian Development Bank (ADB)	This study was supported in part by Grants for Scientific Research (24030401) from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan. An Overseas Research Grant from the University of Tokyo and grants from the Asian Development Bank (ADB) were used to conduct this survey. The funders had no role in the study design, data collection, data analysis, interpretation or write up.	Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Ahmed SM, 2006, SOC SCI MED, V63, P2899, DOI 10.1016/j.socscimed.2006.07.024; Alamgir NI, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-622; Lara JLA, 2011, INT J HEALTH CARE FI, V11, P83, DOI 10.1007/s10754-011-9089-3; Aristei D, 2008, EMPIR ECON, V35, P29, DOI 10.1007/s00181-007-0142-5; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bangladesh Bureau of Statistics (BBS), 2005, HOUS INC EXP SURV HI; Bangladesh Bureau of Statistics (BBS), 2006, EC CENS 2001 2003 ZI; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Binnendijk E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-23; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Bredenkamp C, 2011, HEALTH POLICY PLANN, V26, P349, DOI 10.1093/heapol/czq070; Brinda EM RA, 2012, INT PSYCHOGERIATR, V22, P1; CRAGG JG, 1971, ECONOMETRICA, V39, P829, DOI 10.2307/1909582; Dror DM, 2008, INDIAN J MED RES, V127, P347; Ekman B, 2008, HEALTH POLICY PLANN, V23, P252, DOI 10.1093/heapol/czn009; Engelgau MM, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-9; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Grosh M., 2000, DESIGNING HOUSEHOLD; Hotchkiss DR, 1998, HEALTH POLICY PLANN, V13, P371, DOI 10.1093/heapol/13.4.371; JONES AM, 1989, J APPL ECONOM, V4, P23, DOI 10.1002/jae.3950040103; Kavosi Z, 2012, HEALTH POLICY PLANN, V27, P613, DOI 10.1093/heapol/czs001; Killingsworth JR, 1999, HEALTH POLICY PLANN, V14, P152, DOI 10.1093/heapol/14.2.152; Kim Y, 2011, HEALTH POLICY, V100, P239, DOI 10.1016/j.healthpol.2010.08.008; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Murray CJL, 2003, ASSESSING DISTRIBUTI, P513; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; O'Donnell O, 2007, WORLD BANK ECON REV, V21, P93, DOI 10.1093/wber/lhl009; Okunade AA, 2010, HEALTH ECON, V19, P365, DOI 10.1002/hec.1471; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Rous JJ, 2003, HEALTH ECON, V12, P431, DOI 10.1002/hec.727; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Thuan NBT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-283; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Waters HR, 2004, HEALTH POLICY, V69, P339, DOI 10.1016/j.healthpol.2004.01.003; WHO, 2012, WHO GLOB HLTH EXP AT; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization, 2000, WORLD HLTH REP 2000; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Xu K, 2005, DISTRIBUTION HLTH PA, V2, P2; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006; Zaidi S., 2002, GUIDELINES CONSTRUCT; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	55	75	78	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56873	10.1371/journal.pone.0056873	http://dx.doi.org/10.1371/journal.pone.0056873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451102	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500037
J	Khatibzadeh, N; Spector, AA; Brownell, WE; Anvari, B				Khatibzadeh, Nima; Spector, Alexander A.; Brownell, William E.; Anvari, Bahman			Effects of Plasma Membrane Cholesterol Level and Cytoskeleton F-Actin on Cell Protrusion Mechanics	PLOS ONE			English	Article							P-SELECTIN DETACHMENT; LEUKOCYTE INTERFACES; MICROSCALE DYNAMICS; OPTICAL TWEEZERS; LIVING CELLS; TETHERS; BEHAVIOR; MODEL; POLYMERIZATION; SEPARATION	Protrusions are deformations that form at the surface of living cells during biological activities such as cell migration. Using combined optical tweezers and fluorescent microscopy, we quantified the mechanical properties of protrusions in adherent human embryonic kidney cells in response to application of an external force at the cell surface. The mechanical properties of protrusions were analyzed by obtaining the associated force-length plots during protrusion formation, and force relaxation at constant length. Protrusion mechanics were interpretable by a standard linear solid (Kelvin) model, consisting of two stiffness parameters, k(0) and k(1) (with k(0)>k(1)), and a viscous coefficient. While both stiffness parameters contribute to the time-dependant mechanical behavior of the protrusions, k(0) and k(1) in particular dominated the early and late stages of the protrusion formation and elongation process, respectively. Lowering the membrane cholesterol content by 25% increased the k(0) stiffness by 74%, and shortened the protrusion length by almost half. Enhancement of membrane cholesterol content by nearly two-fold increased the protrusion length by 30%, and decreased the k(0) stiffness by nearly two-and-half-fold as compared with control cells. Cytoskeleton integrity was found to make a major contribution to protrusion mechanics as evidenced by the effects of F-actin disruption on the resulting mechanical parameters. Viscoelastic behavior of protrusions was further characterized by hysteresis and force relaxation after formation. The results of this study elucidate the coordination of plasma membrane composition and cytoskeleton during protrusion formation.	[Khatibzadeh, Nima] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Spector, Alexander A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Brownell, William E.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Anvari, Bahman] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside; Johns Hopkins University; Baylor College of Medicine; University of California System; University of California Riverside	Anvari, B (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	anvarib@ucr.edu	Spector, Alexander/A-3330-2010	Anvari, Bahman/0000-0002-2511-5854	National Science Foundation [NSF-BES-0522862]; National Institute of Deafness and Other Communication Disorders [NIH 2R01-DC02775]; Bourns College of Engineering and Bioengineering Center at University of California, Riverside; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002775] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Bourns College of Engineering and Bioengineering Center at University of California, Riverside; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding came from the National Science Foundation (NSF-BES-0522862) and the National Institute of Deafness and Other Communication Disorders (NIH 2R01-DC02775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge support provided by Bourns College of Engineering and Bioengineering Center at University of California, Riverside.	Allena R, 2012, J THEOR BIOL, V306, P15, DOI 10.1016/j.jtbi.2012.03.041; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Borghi N, 2007, BIOPHYS J, V93, P1369, DOI 10.1529/biophysj.106.087908; Byfield FJ, 2006, ACTA PHYSIOL, V187, P285, DOI 10.1111/j.1748-1716.2006.01555.x; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Chen Y, 2007, AM J PHYSIOL-CELL PH, V292, pC1272, DOI 10.1152/ajpcell.00251.2006; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Enculescu M, 2010, BIOPHYS J, V98, P1571, DOI [10.1016/j.bpj.2009.12.4311, 10.1016/j.bpj.2009.12.431]; Ermilov SA, 2007, J BIOMECH, V40, P476, DOI 10.1016/j.jbiomech.2005.12.006; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Gracia RS, 2010, SOFT MATTER, V6, P1472, DOI 10.1039/b920629a; Heinrich V, 2005, BIOPHYS J, V88, P2299, DOI 10.1529/biophysj.104.051706; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Khatibzadeh N, 2012, SOFT MATTER, V8, P8350, DOI 10.1039/c2sm25263e; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Marcus WD, 2002, ANN BIOMED ENG, V30, P1273, DOI 10.1114/1.1528614; Marion S, 2004, J CELL SCI, V117, P3271, DOI 10.1242/jcs.01178; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Murdock DR, 2005, BIOPHYS J, V89, P4090, DOI 10.1529/biophysj.105.069872; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Oh H, 2009, ARTERIOSCL THROM VAS, V29, P1290, DOI 10.1161/ATVBAHA.109.189571; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Qian F, 2004, REV SCI INSTRUM, V75, P2937, DOI 10.1063/1.1781382; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Ramachandran V, 2004, P NATL ACAD SCI USA, V101, P13519, DOI 10.1073/pnas.0403608101; Roy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037667; Schmidtke DW, 2000, J CELL BIOL, V149, P719, DOI 10.1083/jcb.149.3.719; Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; Sfondouris J, 2008, J BIOL CHEM, V283, P22473, DOI 10.1074/jbc.M803722200; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stamenovic D, 2007, BIOPHYS J, V93, pL39, DOI 10.1529/biophysj.107.116582; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Tatavarty V, 2012, MOL BIOL CELL, V23, P3167, DOI 10.1091/mbc.E12-02-0165; Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775; TSAI MA, 1994, BIOPHYS J, V66, P2166, DOI 10.1016/S0006-3495(94)81012-4; WAUGH RE, 1995, ANN BIOMED ENG, V23, P308, DOI 10.1007/BF02584431; Xu G, 2008, AM J PHYSIOL-CELL PH, V295, pC1434, DOI 10.1152/ajpcell.00136.2008; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; YC F, 1993, BIOMECHANICS MECH PR; Zhang XY, 2011, AM J PHYSIOL-CELL PH, V301, pC451, DOI 10.1152/ajpcell.00458.2010; Zhou EH, 2012, BIOMECH MODEL MECHAN, V11, P1075, DOI 10.1007/s10237-012-0374-y; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	50	47	47	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57147	10.1371/journal.pone.0057147	http://dx.doi.org/10.1371/journal.pone.0057147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451167	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800079
J	Luisi, I; Pavan, S; Fontanive, G; Tossi, A; Benedetti, F; Savoini, A; Maurizio, E; Sgarra, R; Sblattero, D; Berti, F				Luisi, Immacolata; Pavan, Silvia; Fontanive, Giampaolo; Tossi, Alessandro; Benedetti, Fabio; Savoini, Adriano; Maurizio, Elisa; Sgarra, Riccardo; Sblattero, Daniele; Berti, Federico			An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; GLUTATHIONE-S-TRANSFERASE; 3 RECOMBINANT DOMAINS; SCHISTOSOMA-JAPONICUM; PROTON-TRANSFER; PROTEINS; SPECIFICITY; SITE; NEOCARZINOSTATIN; EFAVIRENZ	We have identified a 101-amino-acid polypeptide derived from the sequence of the IIA binding site of human albumin. The polypeptide contains residues that make contact with IIA ligands in the parent protein, and eight cysteine residues to form disulfide bridges, that stabilize the polypeptide structure. Seventy-four amino acids are located in six alpha-helical regions, while the remaining thirty-seven amino acids form six connecting coil/loop regions. A soluble GST fusion protein was expressed in E. coli in yields as high as 4 mg/l. This protein retains the IIA fragment's capacity to bind typical ligands such as warfarin and efavirenz and other albumin's functional properties such as aldolase activity and the ability to direct the stereochemical outcome of a diketone reduction. This newly cloned polypeptide thus represents a valuable starting point for the construction of libraries of binders and catalysts with improved proficiency.	[Luisi, Immacolata; Pavan, Silvia; Fontanive, Giampaolo; Benedetti, Fabio; Berti, Federico] Univ Trieste, Dipartimento Sci Chim & Farmaceut, Trieste, Italy; [Luisi, Immacolata; Tossi, Alessandro; Maurizio, Elisa; Sgarra, Riccardo] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Savoini, Adriano] T&B Associati Srl, Trieste, Italy; [Sblattero, Daniele] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Salute, Novara, Italy	University of Trieste; University of Trieste; University of Eastern Piedmont Amedeo Avogadro	Sblattero, D (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Salute, Novara, Italy.	sblatter@med.unipmn.it; fberti@units.it	Tossi, Alessandro/U-2474-2017; Benedetti, Fabio/G-4787-2012; Tossi, Alessandro/ABC-9061-2020	Tossi, Alessandro/0000-0001-9087-5764; Benedetti, Fabio/0000-0002-8773-7413; Berti, Federico/0000-0001-5608-3798; Sblattero, Daniele/0000-0003-4309-242X; Sgarra, Riccardo/0000-0002-4496-2856	Commissariato del Governo nella Regione Friuli - Venezia Giulia (Fondo Trieste Grant) [597/08]; Regione Piemonte "Piattaforma ImmOnc"	Commissariato del Governo nella Regione Friuli - Venezia Giulia (Fondo Trieste Grant); Regione Piemonte "Piattaforma ImmOnc"	Commissariato del Governo nella Regione Friuli - Venezia Giulia (Fondo Trieste Grant 597/08 "Piccoli peptidi per lo sviluppo di biosensori'') has funded this research project and has granted Immacolata Luisi, Silvia Pavan and Giampaolo Fontanive. Regione Piemonte "Piattaforma ImmOnc'' has funded Daniele Sblattero. The funders (Commissariato del Governo nella regione Friuli - Venezia Giulia, fondo Trieste, grant 597/08; Regione Piemonte, piattaforma ImmunOc) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badalassi F, 2000, ANGEW CHEM INT EDIT, V39, P4067, DOI 10.1002/1521-3773(20001117)39:22<4067::AID-ANIE4067>3.0.CO;2-9; Benedetti F, 2002, CHEM COMMUN, P828, DOI 10.1039/b200474g; Benedetti F, 2011, ORG BIOMOL CHEM, V9, P4417, DOI 10.1039/c0ob01219j; Berti F, 2011, ORG BIOMOL CHEM, V9, P1987, DOI 10.1039/c0ob00648c; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; Bocedi A, 2004, IUBMB LIFE, V56, P609, DOI 10.1080/15216540400016286; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Di Niro R, 2009, METHODS MOL BIOL, V570, P353, DOI 10.1007/978-1-60327-394-7_20; Ding F, 2010, J MOL STRUCT, V975, P256, DOI 10.1016/j.molstruc.2010.04.033; Dockal M, 1999, J BIOL CHEM, V274, P29303, DOI 10.1074/jbc.274.41.29303; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Drevelle A, 2006, J MOL BIOL, V358, P455, DOI 10.1016/j.jmb.2006.02.002; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Heyd B, 2003, BIOCHEMISTRY-US, V42, P5674, DOI 10.1021/bi0273664; Hollfelder F, 2000, J AM CHEM SOC, V122, P1022, DOI 10.1021/ja993471y; Kaplan W, 1997, PROTEIN SCI, V6, P399; Kaur N, 2008, MOL PHARMACEUT, V5, P294, DOI 10.1021/mp700096e; Kikuchi K, 1996, J AM CHEM SOC, V118, P8184, DOI 10.1021/ja9617395; Klein G, 1998, BIOORG MED CHEM LETT, V8, P1113, DOI 10.1016/S0960-894X(98)00165-6; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Matsushita S, 2004, PHARM RES-DORDR, V21, P1924, DOI 10.1023/B:PHAM.0000045248.03337.0e; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Peters T., 1996, ALL ALBUMIN BIOCH GE; Pierce ME, 1998, J ORG CHEM, V63, P8536, DOI 10.1021/jo981170l; Revell JD, 2007, CURR OPIN CHEM BIOL, V11, P269, DOI 10.1016/j.cbpa.2007.05.015; Rich RL, 2001, ANAL BIOCHEM, V296, P197, DOI 10.1006/abio.2001.5314; Roucairol C, 2007, ANAL CHIM ACTA, V589, P142, DOI 10.1016/j.aca.2007.02.045; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; Sheedy C, 2007, BIOTECHNOL ADV, V25, P333, DOI 10.1016/j.biotechadv.2007.02.003; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Tanaka F, 2001, CHEM COMMUN, P769, DOI 10.1039/b100479b; Tanaka F, 2005, BIOCHEMISTRY-US, V44, P7583, DOI 10.1021/bi050216j; Tavirani M. Rezaei, 2006, J BIOCHEM MOL BIOL, V39, P530, DOI DOI 10.5483/BMBREP.2006.39.5.530; Twine SM, 2003, ARCH BIOCHEM BIOPHYS, V414, P83, DOI 10.1016/S0003-9861(03)00173-5; YVON M, 1988, FEBS LETT, V239, P237, DOI 10.1016/0014-5793(88)80924-4; Zhang QL, 2010, J PHARMACEUT BIOMED, V52, P280, DOI 10.1016/j.jpba.2010.01.006	46	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56469	10.1371/journal.pone.0056469	http://dx.doi.org/10.1371/journal.pone.0056469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451052	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800015
J	Suzuki, H; Sumiyoshi, A; Kawashima, R; Shimokawa, H				Suzuki, Hideaki; Sumiyoshi, Akira; Kawashima, Ryuta; Shimokawa, Hiroaki			Different Brain Activation under Left and Right Ventricular Stimulation: An fMRI Study in Anesthetized Rats	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PERIAQUEDUCTAL GRAY-MATTER; MAGNETIC-RESONANCE SIGNAL; MEDIAL THALAMUS; HEART; RESPONSES; PATHWAYS; PAIN; FOS; PROJECTIONS	Background: Myocardial ischemia in the anterior wall of the left ventricule (LV) and in the inferior wall and/or right ventricle (RV) shows different manifestations that can be explained by the different innervations of cardiac afferent nerves. However, it remains unclear whether information from different areas of the heart, such as the LV and RV, are differently processed in the brain. In this study, we investigated the brain regions that process information from the LV or RV using cardiac electrical stimulation and functional magnetic resonance imaging (fMRI) in anesthetized rats because the combination of these two approaches cannot be used in humans. Methodology/Principal Findings: An electrical stimulation catheter was inserted into the LV or RV (n = 12 each). Brain fMRI scans were recorded during LV or RV stimulation (9 Hz and 0.3 ms width) over 10 blocks consisting of alternating periods of 2 mA for 30 sec followed by 0.2 mA for 60 sec. The validity of fMRI signals was confirmed by first and second-level analyses and temporal profiles. Increases in fMRI signals were observed in the anterior cingulate cortex and the right somatosensory cortex under LV stimulation. In contrast, RV stimulation activated the right somatosensory cortex, which was identified more anteriorly compared with LV stimulation but did not activate the anterior cingulate cortex. Conclusion/Significance: This study provides the first evidence for differences in brain activation under LV and RV stimulation. These different brain processes may be associated with different clinical manifestations between anterior wall and inferoposterior wall and/or RV myocardial ischemia.	[Suzuki, Hideaki; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Sumiyoshi, Akira; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Adv Brain Sci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Suzuki, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	hd.suzuki.1870031@cardio.med.tohoku.ac.jp	Sumiyoshi, Akira/AGR-1704-2022	Shimokawa, Hiroaki/0000-0001-7534-4826; Sumiyoshi, Akira/0000-0001-9522-8064	Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan [20117009, 22390154]; Tohoku University Global COE for Conquest of Signal Transduction Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; Network Medicine from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; Tohoku University International Advanced Research and Education Organization	Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku University Global COE for Conquest of Signal Transduction Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; Network Medicine from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; Tohoku University International Advanced Research and Education Organization	This work was supported by grants-in-aid for Scientific Research (research project numbers 20117009, 22390154) and Tohoku University Global COE for Conquest of Signal Transduction Diseases with Network Medicine (http://www.nm-gcoe.med.tohoku.ac.jp/english/index.html), which are from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan, and Tohoku University International Advanced Research and Education Organization (http://www.iiare.tohoku.ac.jp/e/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Mr. Hiroi Nonaka for his technical assistance, Drs. Jorge J. Riera and Pedro A Valdes-Hernandez for their scientific communications and Tohoku University International Advanced Research and Education Organization for supporting our research.	Albutaihi IAM, 2004, NEUROSIGNALS, V13, P207, DOI 10.1159/000079336; Antman EM, 2008, BRAUNWALDS HEART DIS; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Austin VC, 2005, NEUROIMAGE, V24, P92, DOI 10.1016/j.neuroimage.2004.08.011; BALIS GU, 1964, PSYCHOPHARMACOLOGIA, V6, P1, DOI 10.1007/BF00710911; BURNS SM, 1985, BRAIN RES, V340, P71, DOI 10.1016/0006-8993(85)90774-7; Chan KC, 2009, IEEE ENG MED BIO, P4436, DOI 10.1109/IEMBS.2009.5332756; Chan KC, 2010, NEUROIMAGE, V49, P2013, DOI 10.1016/j.neuroimage.2009.10.069; Chandler MJ, 1996, J NEUROPHYSIOL, V76, P2555, DOI 10.1152/jn.1996.76.4.2555; Cheung MM, 2012, NEUROIMAGE, V61, P978, DOI 10.1016/j.neuroimage.2012.03.031; Cheung MM, 2012, NEUROIMAGE, V60, P1205, DOI 10.1016/j.neuroimage.2012.01.087; CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407; Craig AD, 2009, NAT REV NEUROSCI, V10, P466, DOI 10.1038/nrn2606-c1; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Faris OP, 2005, PACE, V28, P268, DOI 10.1111/j.1540-8159.2005.50035.x; Faris OP, 2006, CIRCULATION, V114, P1232, DOI 10.1161/CIRCULATIONAHA.106.647800; Fisk GD, 1997, BRAIN RES, V754, P204, DOI 10.1016/S0006-8993(97)00076-0; Foreman RD, 1999, ANNU REV PHYSIOL, V61, P143, DOI 10.1146/annurev.physiol.61.1.143; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Goldstein JA, 2002, J AM COLL CARDIOL, V40, P841, DOI 10.1016/S0735-1097(02)02048-X; HAGENDORFF A, 1994, CIRCULATION, V90, P400, DOI 10.1161/01.CIR.90.1.400; HARMANN PA, 1988, BRAIN RES, V441, P87, DOI 10.1016/0006-8993(88)91386-8; Henderson LA, 2004, J APPL PHYSIOL, V96, P693, DOI 10.1152/japplphysiol.00852.2003; Hennemeyer CT, 2001, RADIOLOGY, V219, P732, DOI 10.1148/radiology.219.3.r01jn33732; HERBERT H, 1992, J COMP NEUROL, V315, P34, DOI 10.1002/cne.903150104; HERRERO MT, 1991, BRAIN RES, V543, P201, DOI 10.1016/0006-8993(91)90029-U; Hobson AR, 1998, NEUROGASTROENT MOTIL, V10, P421; Hsu MM, 1997, NEUROREPORT, V8, P2701, DOI 10.1097/00001756-199708180-00013; HYDER F, 1994, J CEREBR BLOOD F MET, V14, P649, DOI 10.1038/jcbfm.1994.81; Johnson AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008573; Kapa S, 2008, BRAUNWALDS HEART DIS; Kastrup A, 1998, NEUROL RES, V20, P549; Kida I, 2011, NEUROIMAGE, V56, P1520, DOI 10.1016/j.neuroimage.2011.03.007; Kondoh T, 2009, ANN NY ACAD SCI, V1170, P77, DOI 10.1111/j.1749-6632.2009.03884.x; Lau C, 2011, NEUROIMAGE, V58, P878, DOI 10.1016/j.neuroimage.2011.06.055; Lau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018914; Lazovic J, 2005, NEUROGASTROENT MOTIL, V17, P548, DOI 10.1111/j.1365-2982.2005.00655.x; Maandag NJG, 2007, P NATL ACAD SCI USA, V104, P20546, DOI 10.1073/pnas.0709515104; MELLER ST, 1992, NEUROSCIENCE, V48, P501, DOI 10.1016/0306-4522(92)90398-L; Menon V, 2005, INT REV NEUROBIOL, V66, P291, DOI 10.1016/S0074-7742(05)66010-2; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5; POOL JL, 1949, J NEUROPHYSIOL, V12, P385, DOI 10.1152/jn.1949.12.6.385; Qiao M, 2007, J CEREBR BLOOD F MET, V27, P1280, DOI 10.1038/sj.jcbfm.9600436; QUIGG M, 1988, J AUTONOM NERV SYST, V25, P107, DOI 10.1016/0165-1838(88)90015-X; QUIGG M, 1991, J AUTONOM NERV SYST, V36, P13, DOI 10.1016/0165-1838(91)90125-M; ROSEN SD, 1994, LANCET, V344, P147, DOI 10.1016/S0140-6736(94)92755-3; Rosen SD, 1996, ANN INTERN MED, V124, P939, DOI 10.7326/0003-4819-124-11-199606010-00001; Rosen SD, 2000, ANN MED, V32, P350, DOI 10.3109/07853890008995938; Rosen SD, 2012, CAN J CARDIOL, V28, pS7, DOI 10.1016/j.cjca.2011.09.010; Serra J, 2012, PAIN, V153, P42, DOI 10.1016/j.pain.2011.08.015; Shyu BC, 2004, MAGN RESON MED, V52, P47, DOI 10.1002/mrm.20111; Stark JA, 2006, NEUROIMAGE, V31, P1228, DOI 10.1016/j.neuroimage.2006.01.046; Sumiyoshi A, 2012, NEUROIMAGE, V60, P738, DOI 10.1016/j.neuroimage.2011.12.082; Suzuki H, 2012, TOHOKU J EXP MED, V226, P3, DOI 10.1620/tjem.226.3; Takenouchi K, 1999, NEUROSCIENCE, V93, P1271, DOI 10.1016/S0306-4522(99)00216-X; Tsurugizawa T, 2010, NEUROSCIENCE, V165, P244, DOI 10.1016/j.neuroscience.2009.10.006; Tsurugizawa T, 2008, NEUROREPORT, V19, P1111, DOI 10.1097/WNR.0b013e328307c414; Tsurugizawa T, 2009, GASTROENTEROLOGY, V137, P262, DOI 10.1053/j.gastro.2009.02.057; Uematsu A, 2010, EUR J NEUROSCI, V31, P1136, DOI 10.1111/j.1460-9568.2010.07136.x; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; WALDROP TG, 1987, J APPL PHYSIOL, V63, P733, DOI 10.1152/jappl.1987.63.2.733; Wang R, 2006, NEUROIMAGE, V31, P1, DOI 10.1016/j.neuroimage.2005.12.004; Weisz J, 2001, NEUROREPORT, V12, P3233, DOI 10.1097/00001756-200110290-00018; Westlund KN, 2009, NEUROIMAGE, V44, P23, DOI 10.1016/j.neuroimage.2008.07.048	67	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56990	10.1371/journal.pone.0056990	http://dx.doi.org/10.1371/journal.pone.0056990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451129	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800059
J	Zhang, LJ; Wang, GQ; Liu, QH; Chen, CF; Li, J; Long, B; Yu, H; Zhang, ZL; He, J; Qu, ZY; Yu, JG; Liu, YN; Dong, T; Yao, N; Wang, Y; Cheng, XQ; Xu, JG				Zhang, Lijuan; Wang, Guiqiang; Liu, Qinghui; Chen, Chuangfu; Li, Jun; Long, Bo; Yu, Hong; Zhang, Zhilun; He, Jing; Qu, Zhangyi; Yu, Jiguang; Liu, Yuanni; Dong, Tuo; Yao, Na; Wang, Yong; Cheng, Xueqin; Xu, Jianguo			Molecular Analysis of Anaplasma phagocytophilum Isolated from Patients with Febrile Diseases of Unknown Etiology in China	PLOS ONE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; EHRLICHIA-CHAFFEENSIS; PHYLOGENETIC ANALYSIS; INFECTION; TICKS; SEQUENCE; OUTCOMES; JAPAN	Although anaplasmosis cases have been nationally identified in China, no human isolates of A. phagocytophilum have been obtained, which limits the analysis of any molecular and genetic contributions to patients' severe clinical manifestations and the study of the bacteria's pathogeneses in China. Given this situation, a joint project was conducted in 2009-2010. A total of 421 febrile cases of unknown etiology were collected and the patients' blood samples were collected for laboratory diagnoses including serologic diagnosis based on the four-fold rise in the anti- A. phagocytophilum IgG titer by indirect micro-immunofluorescence assay (IFA), positive PCR assay and confirmation of A. phagocytophilum DNA and positive culture of A. phagocytophilum and confirmed by amplification and sequencing of the 16S rRNA and ank A genes of the A. phagocytophilum isolates. A total of 570 ticks were collected from the patients' domestic animals (456) and from wild fields (114) for culturing and amplifying and sequencing the 16S rRNA gene of A. phagocytophilum. Phylogenetic analyses were performed on the 16S rRNA and ank A gene sequences of the isolates and the ticks tested in the study. A total of 46 (10.9%) confirmed and 16 (3.8%) probable cases were diagnosed and severe clinical features and higher mortality rates were observed in these Chinese patients. Five isolates were obtained and the 16S rRNA genes of the 5 isolates were conserved but variety for ank A genes. Two human isolates and 1 tick isolate from Shandong Peninsula, where all patients exhibited severe clinical manifestations, were grouped as one clan based on the phylogenetic analyses, while 2 other human isolates were clustered in a second clan. 43.5% of H. longicornis were infected with A. phagocytophilum. The present study is the first to obtain clinical isolates of A. phagocytophilum in China. The diversity of the ank A genes of Chinese isolates will help us to further discern the relationship between the variations in the ank A genes and the severity of the disease's clinical manifestations in China.	[Zhang, Lijuan; Dong, Tuo; Yao, Na; Wang, Yong; Cheng, Xueqin; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Rickettsiol, Beijing, Peoples R China; [Wang, Guiqiang; Li, Jun] Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China; [Liu, Qinghui] Shandong Laizhou Peoples Hosp, Dept Intens Care, Laizhou, Shandong, Peoples R China; [Chen, Chuangfu; Yao, Na; Wang, Yong] Shihezi Univ, Anim Sci & Technol Coll, Shihezi, Xinjiang Provin, Peoples R China; [Long, Bo; Yu, Hong; Yu, Jiguang; Liu, Yuanni] Yantai Infect Dis Hosp, Dept Infect Dis, Yantai, Shandong, Peoples R China; [Zhang, Zhilun] Tianjin Ctr Dis Control & Prevent, Dept Epidemiol, Tianjin, Peoples R China; [He, Jing] 302 Hosp PLA, Dept Infect Dis, Beijing, Peoples R China; [Qu, Zhangyi; Dong, Tuo] Harbin Med Univ, Sch Publ Hlth, Harbin, Heilongjiang Pr, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University; Shihezi University; Tianjin Center for Disease Control & Prevention; Fifth Medical Center of Chinese PLA General Hospital; Harbin Medical University	Zhang, LJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Rickettsiol, Beijing, Peoples R China.	zhanglijuan@icdc.cn; wanggq@hotmail.com	yao, na/HDL-8772-2022		National Basic Research Program of China (973 Program) [2010CB530206]; National Natural Science Foundation of China [30771854]; China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases [1U2GGH000018-01]; China Mega-Project for Infectious Disease [2011ZX10004-001]; National Key Science and Technology Projects of China [20122X10004215]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; China Mega-Project for Infectious Disease; National Key Science and Technology Projects of China	This study was supported by the National Basic Research Program of China (973 Program) 2010CB530206, the National Natural Science Foundation of China (No. 30771854), and the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases (No. 1U2GGH000018-01) and China Mega-Project for Infectious Disease (2011ZX10004-001) and National Key Science and Technology Projects of China ( Project no. 20122X10004215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chapes SK, 2008, VET PARASITOL, V158, P344, DOI 10.1016/j.vetpar.2008.09.028; Domingos MC, 2011, VET CLIN PATH, V40, P215, DOI 10.1111/j.1939-165X.2011.00321.x; Dumler JS, 2012, FEMS IMMUNOL MED MIC, V64, P13, DOI 10.1111/j.1574-695X.2011.00909.x; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; EREMEEVA ME, 1994, CLIN DIAGN LAB IMMUN, V1, P318, DOI 10.1128/CDLI.1.3.318-324.1994; Garcia-Garcia JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000488; Ge Y, 2006, CELL MICROBIOL, V8, P1406, DOI 10.1111/j.1462-5822.2006.00720.x; Guero-Rosenfeld M. E., 2003, MANUAL CLIN MICROBIO, P1015; Katargina O, 2012, CLIN MICROBIOL INFEC, V18, P40, DOI 10.1111/j.1469-0691.2010.03457.x; Kawahara M, 2006, APPL ENVIRON MICROB, V72, P1102, DOI 10.1128/AEM.72.2.1102-1109.2006; Li HY, 2011, INT J INFECT DIS, V15, pE859, DOI 10.1016/j.ijid.2011.09.008; 오재영, 2009, Journal of Bacteriology and Virology, V39, P257; Ohashi N, 2005, EMERG INFECT DIS, V11, P1780, DOI 10.3201/eid1111.050407; Pan L, 2011, J CLIN MICROBIOL, V49, P4117, DOI 10.1128/JCM.01085-11; Rejmanek D, 2012, MICROBIOL; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; ROUX V, 1995, RES MICROBIOL, V146, P385, DOI 10.1016/0923-2508(96)80284-1; Schaarschmidt-Kiener D, 2009, SCHWEIZ ARCH TIERH, V151, P336, DOI 10.1024/0036-7281.151.7.336; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; WALKER DH, 1994, NEW ENGL J MED, V331, P1651, DOI 10.1056/NEJM199412153312410; Wang SW, 2011, DIS SURVEIL, V26, P12; Wen BH, 2002, J CLIN MICROBIOL, V40, P3286, DOI 10.1128/JCM.40.9.3286-3290.2002; Yu Q, 2012, CLIN VACCINE IMMUNOL, V19, P919, DOI 10.1128/CVI.05709-11; Yu Qiang, 2012, Chinese Journal of Zoonoses, V28, P323; Zhan L, 2010, VET MICROBIOL, V144, P405, DOI 10.1016/j.vetmic.2010.02.018; Zhan L, 2010, EMERG INFECT DIS, V16, P764, DOI [10.3201/eid1605.021293, 10.3201/eid1605.091293]; Zhan L, 2009, EMERG INFECT DIS, V15, P1904, DOI 10.3201/eid1512.081141; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang LJ, 2008, EMERG INFECT DIS, V14, P938, DOI 10.3201/eid1406.071502; Zhang LJ, 2012, AM J TROP MED HYG, V87, P185, DOI 10.4269/ajtmh.2012.12-0005; Zhang LJ, 2011, ASIAN PAC J TROP MED, V4, P568, DOI 10.1016/S1995-7645(11)60148-X; Zhou ZY, 2010, RES VET SCI, V89, P262, DOI 10.1016/j.rvsc.2010.02.009	37	30	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57155	10.1371/journal.pone.0057155	http://dx.doi.org/10.1371/journal.pone.0057155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451170	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800081
J	Gritton, HJ; Stasiak, AM; Sarter, M; Lee, TM				Gritton, Howard J.; Stasiak, Ashley M.; Sarter, Martin; Lee, Theresa M.			Cognitive Performance as a Zeitgeber: Cognitive Oscillators and Cholinergic Modulation of the SCN Entrain Circadian Rhythms	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; ANTICIPATORY ACTIVITY; FEEDING SCHEDULES; RECEPTOR-IMMUNOREACTIVITY; PALATABLE MEAL; WATER ACCESS; C-FOS; RATS; ACETYLCHOLINE; EXPRESSION	The suprachiasmatic nucleus (SCN) is the primary circadian pacemaker in mammals that can synchronize or entrain to environmental cues. Although light exerts powerful influences on SCN output, other non-photic stimuli can modulate the SCN as well. We recently demonstrated that daily performance of a cognitive task requiring sustained periods of attentional effort that relies upon basal forebrain (BF) cholinergic activity dramatically alters circadian rhythms in rats. In particular, normally nocturnal rats adopt a robust diurnal activity pattern that persists for several days in the absence of cognitive training. Although anatomical and pharmacological data from non-performing animals support a relationship between cholinergic signaling and circadian rhythms, little is known about how endogenous cholinergic signaling influences SCN function in behaving animals. Here we report that BF cholinergic projections to the SCN provide the principal signal allowing for the expression of cognitive entrainment in light-phase trained animals. We also reveal that oscillator(s) outside of the SCN drive cognitive entrainment as daily timed cognitive training robustly entrains SCN-lesioned arrhythmic animals. Ablation of the SCN, however, resulted in significant impairments in task acquisition, indicating that SCN-mediated timekeeping benefits new learning and cognitive performance. Taken together, we conclude that cognition entrains non-photic oscillators, and cholinergic signaling to the SCN serves as a temporal timestamp attenuating SCN photic-driven rhythms, thereby permitting cognitive demands to modulate behavior.	[Gritton, Howard J.; Stasiak, Ashley M.; Sarter, Martin; Lee, Theresa M.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Gritton, Howard J.; Sarter, Martin; Lee, Theresa M.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lee, TM (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	terrilee@umich.edu		Lee, Theresa/0000-0002-9508-6382	National Institutes of Health: PHS Grant [RO1 MH079084]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007281, T32DA007268] Funding Source: NIH RePORTER	National Institutes of Health: PHS Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health: PHS Grant RO1 MH079084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Angeles-Castellanos M, 2010, NEUROSCIENCE, V165, P1115, DOI 10.1016/j.neuroscience.2009.11.061; Antoniadis EA, 2000, BEHAV BRAIN RES, V114, P219, DOI 10.1016/S0166-4328(00)00290-4; Arnold HM, 2002, NEUROSCIENCE, V114, P451, DOI 10.1016/S0306-4522(02)00292-0; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Beaule C, 2001, BRAIN RES, V894, P301, DOI 10.1016/S0006-8993(01)02021-2; BIELLO SM, 2009, AGE DORDR; Bina KG, 1996, BRAIN RES, V743, P202, DOI 10.1016/S0006-8993(96)01043-8; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Daan S, 2000, J BIOL RHYTHM, V15, P296, DOI 10.1177/074873000129001396; EARNEST DJ, 1983, SCIENCE, V219, P77, DOI 10.1126/science.6849121; Erhardt C, 2004, EUR J NEUROSCI, V19, P1773, DOI 10.1111/j.1460-9568.2004.03281.x; Gillette MU, 2001, LIFE SCI, V68, P2467, DOI 10.1016/S0024-3205(01)01040-2; Gritton HJ, 2012, LEARNING ME IN PRESS; Gritton HJ, 2009, BEHAV NEUROSCI, V123, P937, DOI 10.1037/a0017128; Haus E, 2006, CANCER CAUSE CONTROL, V17, P489, DOI 10.1007/s10552-005-9015-4; HECKERS S, 1994, J NEUROSCI, V14, P1271, DOI 10.1523/JNEUROSCI.14-03-01271.1994; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Hut RA, 2010, BEHAV BRAIN RES; Lee TM, 2010, TIMED SUSTAINED ATTE, P203; Madeira MD, 2004, NEUROSCIENCE, V125, P889, DOI 10.1016/j.neuroscience.2004.03.005; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; MISTLBERGER RE, 1985, PHYSIOL BEHAV, V34, P17, DOI 10.1016/0031-9384(85)90070-8; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; MISTLBERGER RE, 1992, J BIOL RHYTHM, V7, P149, DOI 10.1177/074873049200700206; MISTLBERGER RE, 1993, AM J PHYSIOL, V264, pR22, DOI 10.1152/ajpregu.1993.264.1.R22; MOORE RY, 1983, FED PROC, V42, P2783; Paolone G, 2012, J NEUROSCI, V32, P12115, DOI 10.1523/JNEUROSCI.2271-12.2012; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; Reid KJ, 2004, MED CLIN N AM, V88, P631, DOI 10.1016/j.mcna.2004.01.010; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Salgado-Delgado R, 2010, J BIOL RHYTHM, V25, P421, DOI 10.1177/0748730410383403; Scheer FAJL, 2005, NEUROSCIENCE, V132, P465, DOI 10.1016/j.neuroscience.2004.12.012; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Van der Zee EA, 2004, J NEUROSCI RES, V78, P508, DOI 10.1002/jnr.20300; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Yoshihara T, 1997, NEUROSCI LETT, V222, P95, DOI 10.1016/S0304-3940(97)13353-5	48	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56206	10.1371/journal.pone.0056206	http://dx.doi.org/10.1371/journal.pone.0056206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441168	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200025
J	Romagnoli, PA; Premenko-Lanier, MF; Loria, GD; Altman, JD				Romagnoli, Pablo A.; Premenko-Lanier, Mary F.; Loria, Gilbert D.; Altman, John D.			CD8 T Cell Memory Recall Is Enhanced by Novel Direct Interactions with CD4 T Cells Enabled by MHC Class II Transferred from APCs	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; DENDRITIC CELL; LYMPHOCYTIC CHORIOMENINGITIS; SECONDARY EXPANSION; CD8-T-CELL MEMORY; VIRAL-INFECTIONS; CD4-T-CELL HELP; CUTTING EDGE; IN-VIVO; EXPRESSION	Protection against many intracellular pathogens is provided by CD8 T cells, which are thought to need CD4 T cell help to develop into effective memory CD8 T cells. Because murine CD8 T cells do not transcribe MHC class II (MHC-II) genes, several models have proposed antigen presenting cells (APCs) as intermediaries required for CD4 T cells to deliver their help to CD8 T cells. Here, we demonstrate the presence of MHC-II molecules on activated murine CD8 T cells in vitro as well as in vivo. These MHC-II molecules are acquired via trogocytosis by CD8 T cells from their activating APCs, particularly CD11c positive dendritic cells (DCs). Transferred MHC-II molecules on activated murine CD8 T cells were functionally competent in stimulating specific indicator CD4 T cells. CD8 T cells that were "helped" in vitro and subsequently allowed to rest in vivo showed enhanced recall responses upon challenge compared to "helpless" CD8 T cells; in contrast, no differences were seen upon immediate challenge. These data indicate that direct CD8:CD4 T cell interactions may significantly contribute to help for CD8 T cells. Furthermore, this mechanism may enable CD8 T cells to communicate with different subsets of interacting CD4 T cells that could modulate immune responses.	[Romagnoli, Pablo A.; Loria, Gilbert D.; Altman, John D.] Emory Vaccine Ctr, Atlanta, GA USA; [Romagnoli, Pablo A.; Loria, Gilbert D.; Altman, John D.] Yerkes Natl Primate Res Ctr, Dept Microbiol & Immunol, Atlanta, GA USA; [Romagnoli, Pablo A.; Loria, Gilbert D.; Altman, John D.] Emory Univ, Sch Med, Atlanta, GA USA; [Premenko-Lanier, Mary F.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Premenko-Lanier, Mary F.] San Francisco Gen Hosp, San Francisco, CA 94110 USA	Emory University; Emory University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Altman, JD (corresponding author), Emory Vaccine Ctr, Atlanta, GA USA.	jaltman@emory.edu	Romagnoli, Pablo Alberto/AAF-4719-2019	Romagnoli, Pablo Alberto/0000-0002-6328-9070	National Institutes of Health (USA) [1RO1AI042373]; Emory Vaccine Center Flow Cytometry Core Facility, Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042373, P30AI050409] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Vaccine Center Flow Cytometry Core Facility, Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research came from National Institutes of Health (USA), grant 1RO1AI042373, and the Emory Vaccine Center Flow Cytometry Core Facility, Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2007, J IMMUNOL, V178, P5465, DOI 10.4049/jimmunol.178.9.5465; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208; Bahcheli D, 2011, AUTOIMMUNITY, V44, P607, DOI 10.3109/08916934.2011.571730; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BENNUN A, 1985, IMMUNOGENETICS, V22, P123, DOI 10.1007/BF00563509; Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; BURNET FM, 1968, LANCET, V2, P610; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; FRELINGER JA, 1974, J EXP MED, V140, P1273, DOI 10.1084/jem.140.5.1273; FU SM, 1978, J EXP MED, V148, P1423, DOI 10.1084/jem.148.5.1423; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; HUDSON L, 1974, NATURE, V251, P60, DOI 10.1038/251060a0; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; KRAMMER PH, 1975, J EXP MED, V142, P1403, DOI 10.1084/jem.142.6.1403; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; LORBER MI, 1982, J IMMUNOL, V128, P2798; Mannie MD, 1996, J IMMUNOL, V157, P1062; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MAURI D, 1995, J IMMUNOL, V155, P118; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Osborne DG, 2012, J IMMUNOL, V189, P4728, DOI 10.4049/jimmunol.1201507; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rosenits K, 2010, EUR J IMMUNOL, V40, P3450, DOI 10.1002/eji.201040743; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schooten E, 2005, IMMUNOGENETICS, V57, P795, DOI 10.1007/s00251-005-0051-8; SHARROW SO, 1981, J IMMUNOL, V126, P1327; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Thomas DB, 1996, J IMMUNOL, V157, P2386; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; YU DTY, 1980, J EXP MED, V151, P91, DOI 10.1084/jem.151.1.91; Zajac P, 1998, CANCER RES, V58, P4567; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	69	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56999	10.1371/journal.pone.0056999	http://dx.doi.org/10.1371/journal.pone.0056999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441229	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200086
J	Argimon, S; Alekseyenko, AV; DeSalle, R; Caufield, PW				Argimon, Silvia; Alekseyenko, Alexander V.; DeSalle, Rob; Caufield, Page W.			Phylogenetic Analysis of Glucosyltransferases and Implications for the Coevolution of Mutans Streptococci with Their Mammalian Hosts	PLOS ONE			English	Article							FUNCTIONAL DIVERGENCE; SOLUBLE GLUCAN; SWISS-MODEL; GTFC GENE; IN-SITU; EVOLUTION; BINDING; HYDROXYAPATITE; CARIOGENICITY; DIVERSITY	Glucosyltransferases (Gtfs) catalyze the synthesis of glucans from sucrose and are produced by several species of lactic-acid bacteria. The oral bacterium Streptococcus mutans produces large amounts of glucans through the action of three Gtfs. GtfD produces water-soluble glucan (WSG), GtfB synthesizes water-insoluble glucans (WIG) and GtfC produces mainly WIG but also WSG. These enzymes, especially those synthesizing WIG, are of particular interest because of their role in the formation of dental plaque, an environment where S. mutans can thrive and produce lactic acid, promoting the formation of dental caries. We sequenced the gtfB, gtfC and gtfD genes from several mutans streptococcal strains isolated from the oral cavity of humans and searched for their homologues in strains isolated from chimpanzees and macaque monkeys. The sequence data were analyzed in conjunction with the available Gtf sequences from other bacteria in the genera Streptococcus, Lactobacillus and Leuconostoc to gain insights into the evolutionary history of this family of enzymes, with a particular emphasis on S. mutans Gtfs. Our analyses indicate that streptococcal Gtfs arose from a common ancestral progenitor gene, and that they expanded to form two clades according to the type of glucan they synthesize. We also show that the clade of streptococcal Gtfs synthesizing WIG appeared shortly after the divergence of viviparous, dentate mammals, which potentially contributed to the formation of dental plaque and the establishment of several streptococci in the oral cavity. The two S. mutans Gtfs capable of WIG synthesis, GtfB and GtfC, are likely the product of a gene duplication event. We dated this event to coincide with the divergence of the genomes of ancestral early primates. Thus, the acquisition and diversification of S. mutans Gtfs predates modern humans and is unrelated to the increase in dietary sucrose consumption.	[Argimon, Silvia; Caufield, Page W.] NYU, Coll Dent, Dept Cariol & Comprehens Care, New York, NY 10003 USA; [Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	New York University; New York University; American Museum of Natural History (AMNH)	Argimon, S (corresponding author), NYU, Coll Dent, Dept Cariol & Comprehens Care, New York, NY 10003 USA.	sa91@nyu.edu		Alekseyenko, Alexander/0000-0002-5748-2085	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) [R01 DE13937]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013937] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grant R01 DE13937 National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Argimon S, 2011, J CLIN MICROBIOL, V49, P984, DOI 10.1128/JCM.01993-10; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEIGHTON D, 1977, J DENT RES, V56, P995, DOI 10.1177/00220345770560083101; BEIGHTON D, 1984, INT J SYST BACTERIOL, V34, P332, DOI 10.1099/00207713-34-3-332; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Caufield PW, 2007, J BACTERIOL, V189, P1238, DOI 10.1128/JB.01183-06; CAUFIELD PW, 1989, J CLIN MICROBIOL, V27, P274, DOI 10.1128/JCM.27.2.274-278.1989; CAUFIELD PW, 1993, J DENT RES, V72, P37, DOI 10.1177/00220345930720010501; Chia JS, 1998, INFECT IMMUN, V66, P4797, DOI 10.1128/IAI.66.10.4797-4803.1998; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gregoire S, 2011, APPL ENVIRON MICROB, V77, P6357, DOI 10.1128/AEM.05203-11; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HANADA N, 1989, INFECT IMMUN, V57, P2079, DOI 10.1128/IAI.57.7.2079-2085.1989; HANADA N, 1988, INFECT IMMUN, V56, P1999, DOI 10.1128/IAI.56.8.1999-2005.1988; Hannig C, 2008, ARCH ORAL BIOL, V53, P1003, DOI 10.1016/j.archoralbio.2008.04.005; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOTZ P, 1972, CARIES RES, V6, P103, DOI 10.1159/000259783; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kopec LK, 1997, GLYCOBIOLOGY, V7, P929, DOI 10.1093/glycob/7.7.929; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Loesche W.J., 1993, DENT CARIES TREATABL; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Matsumoto M, 2006, ORAL MICROBIOL IMMUN, V21, P42, DOI 10.1111/j.1399-302X.2005.00252.x; Mattos-Graner RO, 2004, J CLIN MICROBIOL, V42, P4586, DOI 10.1128/JCM.42.10.4586-4592.2004; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; Milton K, 1999, NUTRITION, V15, P488, DOI 10.1016/S0899-9007(99)00078-7; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Monsan P, 2001, INT DAIRY J, V11, P675, DOI 10.1016/S0958-6946(01)00113-3; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Okamoto M, 2012, INT J SYST EVOL MICR; Ooshima T, 2001, J DENT RES, V80, P1672, DOI 10.1177/00220345010800071401; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIMAMURA A, 1994, J BACTERIOL, V176, P4845, DOI 10.1128/jb.176.16.4845-4850.1994; Simpson Christine L, 1995, Microbiology (Reading), V141 ( Pt 6), P1451, DOI 10.1099/13500872-141-6-1451; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamesada M, 2004, J DENT RES, V83, P874, DOI 10.1177/154405910408301110; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurnheer T, 2006, CARIES RES, V40, P163, DOI 10.1159/000091065; Tsumori H, 1997, ORAL MICROBIOL IMMUN, V12, P274, DOI 10.1111/j.1399-302X.1997.tb00391.x; UEDA S, 1988, MOL MICROBIOL, V2, P135, DOI 10.1111/j.1365-2958.1988.tb00014.x; UEDA S, 1988, GENE, V69, P101, DOI 10.1016/0378-1119(88)90382-4; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; VaccaSmith AM, 1996, ARCH ORAL BIOL, V41, P291, DOI 10.1016/0003-9969(95)00129-8; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; YAMASHITA Y, 1992, INFECT IMMUN, V60, P1618, DOI 10.1128/IAI.60.4.1618-1624.1992; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zheng Y, 2007, J EXP ZOOL PART B, V308B, P85, DOI 10.1002/jez.b.21140; [No title captured]	71	23	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56305	10.1371/journal.pone.0056305	http://dx.doi.org/10.1371/journal.pone.0056305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457545	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700064
J	Ji, HX; Zou, YL; Duan, JJ; Jia, ZR; Li, XJ; Wang, Z; Li, L; Li, YW; Liu, GY; Tong, MQ; Li, XY; Zhang, GH; Dai, XR; He, L; Li, ZY; Cao, C; Yang, Y				Ji, Hai-xia; Zou, Yu-lian; Duan, Jing-jing; Jia, Zhi-rong; Li, Xian-jing; Wang, Zhuo; Li, Li; Li, Yong-wen; Liu, Gen-yan; Tong, Ming-Qing; Li, Xiao-yi; Zhang, Guo-hui; Dai, Xiang-rong; He, Ling; Li, Zhi-yu; Cao, Cong; Yang, Yong			The Synthetic Melanocortin (CKPV)(2) Exerts Anti-Fungal and Anti-Inflammatory Effects against Candida albicans Vaginitis via Inducing Macrophage M-2 Polarization	PLOS ONE			English	Article							VULVO-VAGINAL CANDIDIASIS; STIMULATING HORMONE PEPTIDES; ALPHA-MSH; TNF-ALPHA; ACTIVATION; CELLS; RECEPTOR; LIPOPOLYSACCHARIDE; EXPRESSION; SYSTEM	In this study, we examined anti-fungal and anti-inflammatory effects of the synthetic melanocortin peptide (Ac-Cys-Lys-Pro-Val-NH2)(2) or (CKPV)(2) against Candida albicans vaginitis. Our in vitro results showed that (CKPV)(2) dose-dependently inhibited Candida albicans colonies formation. In a rat Candida albicans vaginitis model, (CKPV)(2) significantly inhibited vaginal Candida albicans survival and macrophages sub-epithelial mucosa infiltration. For mechanisms study, we observed that (CKPV)(2) inhibited macrophages phagocytosis of Candida albicans. Meanwhile, (CKPV)(2) administration inhibited macrophage pro-inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6) release, while increasing the arginase activity and anti-inflammatory cytokine IL-10 production, suggesting macrophages M1 to M2 polarization. Cyclic AMP (cAMP) production was also induced by (CKPV)(2) administration in macrophages. These above effects on macrophages by (CKPV)(2) were almost reversed by melanocortin receptor-1(MC1R) siRNA knockdown, indicating the requirement of MC1R in the process. Altogether, our results suggest that (CKPV)(2) exerted anti-fungal and anti-inflammatory activities against Candida albicans vaginitis probably through inducing macrophages M1 to M2 polarization and MC1R activation.	[Ji, Hai-xia; Zou, Yu-lian; Duan, Jing-jing; Jia, Zhi-rong; Li, Xian-jing; Wang, Zhuo; He, Ling; Li, Zhi-yu; Yang, Yong] China Pharmaceut Univ, State Key Lab Nat Med, Acad Inst Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China; [Li, Li; Li, Yong-wen] Guilin Med Univ, Dept Pharmacol, Dept Physiol, Guilin, Guangxi, Peoples R China; [Liu, Gen-yan; Tong, Ming-Qing] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Li, Xiao-yi; Zhang, Guo-hui; Dai, Xiang-rong] Hefei Zhaoke Pharmaceut, Hefei, Peoples R China	China Pharmaceutical University; Guilin Medical University; Nanjing Medical University; Soochow University - China	Li, ZY (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Acad Inst Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China.	zhiyuli@263.net; caocong@suda.edu.cn; valianty@hotmail.com			National Natural Science Foundation of China [91129731, 81072661]; Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201102]; New Century Excellent Talents Program for YY; Ministry of Education of China [NCET-09-0771]; Natural Science Foundation of Jiangsu Province [BK2012025, BK2011632]; "Major Drug Discovery" science and technology major projects of China [2011ZX09102-001-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; New Century Excellent Talents Program for YY(Program for New Century Excellent Talents in University (NCET)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); "Major Drug Discovery" science and technology major projects of China	This work was supported by the National Natural Science Foundation of China (Nos. 91129731 and 81072661), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201102), the New Century Excellent Talents Program for YY supported by Ministry of Education of China (NCET-09-0771), the Natural Science Foundation of Jiangsu Province (No. BK2012025 and BK2011632), "Major Drug Discovery" science and technology major projects of China (No. 2011ZX09102-001-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Ballinger MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013962; Bonetto S, 2005, PEPTIDES, V26, P2302, DOI 10.1016/j.peptides.2005.04.002; Capsoni F, 2007, PEPTIDES, V28, P2016, DOI 10.1016/j.peptides.2007.08.001; Capsoni F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2827; Carrara MA, 2010, MYCOPATHOLOGIA, V170, P331, DOI 10.1007/s11046-010-9326-1; Catania A, 2006, THESCIENTIFICWORLDJO, V6, P1241, DOI 10.1100/tsw.2006.227; Catania A, 2005, J PEPT RES, V66, P19, DOI 10.1111/j.1399-3011.2005.00265.x; Chen JY, 2009, J WOMENS HEALTH, V18, P1997, DOI 10.1089/jwh.2008.1088; Cragnolini AB, 2006, NEUROSCI LETT, V409, P168, DOI 10.1016/j.neulet.2006.09.034; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Fidel Paul L Jr, 2002, Int Rev Immunol, V21, P515, DOI 10.1080/08830180215015; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; FIDEL PL, 1993, INFECT IMMUN, V61, P1990, DOI 10.1128/IAI.61.5.1990-1995.1993; Fong IW, 1996, PHARMACOECONOMICS, V9, P497, DOI 10.2165/00019053-199609060-00004; Gatti S, 2006, J SURG RES, V131, P209, DOI 10.1016/j.jss.2005.08.009; Getting SJ, 2002, TRENDS PHARMACOL SCI, V23, P447, DOI 10.1016/S0165-6147(02)02103-X; Getting SJ, 2003, J PHARMACOL EXP THER, V306, P631, DOI 10.1124/jpet.103.051623; Hill RP, 2006, PEPTIDES, V27, P421, DOI 10.1016/j.peptides.2005.03.061; Humphreys DT, 1999, CYTOKINE, V11, P773, DOI 10.1006/cyto.1998.0492; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Lam CW, 2006, PEPTIDES, V27, P404, DOI 10.1016/j.peptides.2005.01.031; Li DY, 2008, J LEUKOCYTE BIOL, V84, P191, DOI 10.1189/jlb.0707463; Liu X, 2012, EUR J CELL BIOL; Maaser C, 2006, GUT, V55, P1415, DOI 10.1136/gut.2005.083634; Madhuri, 2009, PEPTIDES, V30, P1627, DOI 10.1016/j.peptides.2009.06.020; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MCGILLIS JP, 1989, BIOCHEM BIOPH RES CO, V165, P935, DOI 10.1016/0006-291X(89)92693-4; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Moon EY, 2007, IMMUNOL LETT, V110, P121, DOI 10.1016/j.imlet.2007.04.002; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; Newton RA, 2005, PEPTIDES, V26, P1818, DOI 10.1016/j.peptides.2004.11.031; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Prabhu NV, 1999, J PEPT RES, V54, P394, DOI 10.1034/j.1399-3011.1999.00113.x; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Raap U, 2003, J IMMUNOL, V171, P353, DOI 10.4049/jimmunol.171.1.353; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Shiau MY, 2001, MEDIAT INFLAMM, V10, P199, DOI 10.1080/09629350120080393; Singh V, 2005, BIOCHEM BIOPH RES CO, V334, P1149, DOI 10.1016/j.bbrc.2005.07.018; Sobel JD, 1998, AM J OBSTET GYNECOL, V178, P203, DOI 10.1016/S0002-9378(98)80001-X; SOBEL JD, 1985, AM J OBSTET GYNECOL, V152, P924, DOI 10.1016/S0002-9378(85)80003-X; Stringaro A, 1998, MYCOPATHOLOGIA, V144, P147, DOI 10.1023/A:1007017012547; Szardenings M, 2000, PEPTIDES, V21, P239, DOI 10.1016/S0196-9781(99)00207-7; Tansini A, 2009, SCAND J IMMUNOL, V69, P310, DOI 10.1111/j.1365-3083.2008.02212.x; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200	50	10	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56004	10.1371/journal.pone.0056004	http://dx.doi.org/10.1371/journal.pone.0056004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457491	Green Submitted, gold, Green Published			2022-12-27	WOS:000315602700031
J	Fujii, Y; Kitaura, K; Matsutani, T; Shirai, K; Suzuki, S; Takasaki, T; Kumagai, K; Kametani, Y; Shiina, T; Takabayashi, S; Katoh, H; Hamada, Y; Kurane, I; Suzuki, R				Fujii, Yoshiki; Kitaura, Kazutaka; Matsutani, Takaji; Shirai, Kenji; Suzuki, Satsuki; Takasaki, Tomohiko; Kumagai, Kenichi; Kametani, Yoshie; Shiina, Takashi; Takabayashi, Shuji; Katoh, Hideki; Hamada, Yoshiki; Kurane, Ichiro; Suzuki, Ryuji			Immune-Related Gene Expression Profile in Laboratory Common Marmosets Assessed by an Accurate Quantitative Real-Time PCR Using Selected Reference Genes	PLOS ONE			English	Article							CLASS-I EXPRESSION; MHC CLASS-I; T-CELLS; CALLITHRIX-JACCHUS; BIOMEDICAL-RESEARCH; VIRUS; TH1; MODEL; LYMPHOCYTES; CYTOKINES	The common marmoset (Callithrix jacchus) is considered a novel experimental animal model of non-human primates. However, due to antibody unavailability, immunological and pathological studies have not been adequately conducted in various disease models of common marmoset. Quantitative real-time PCR (qPCR) is a powerful tool to examine gene expression levels. Recent reports have shown that selection of internal reference housekeeping genes are required for accurate normalization of gene expression. To develop a reliable qPCR method in common marmoset, we used geNorm applets to evaluate the expression stability of eight candidate reference genes (GAPDH, ACTB, rRNA, B2M, UBC, HPRT, SDHA and TBP) in various tissues from laboratory common marmosets. geNorm analysis showed that GAPDH, ACTB, SDHA and TBP were generally ranked high in stability followed by UBC. In contrast, HPRT, rRNA and B2M exhibited lower expression stability than other genes in most tissues analyzed. Furthermore, by using the improved qPCR with selected reference genes, we analyzed the expression levels of CD antigens (CD3 epsilon, CD4, CD8 alpha and CD20) and cytokines (IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 beta, IL-13, IFN-gamma and TNF-alpha) in peripheral blood leukocytes and compared them between common marmosets and humans. The expression levels of CD4 and IL-4 were lower in common marmosets than in humans whereas those of IL-10, IL-12 beta and IFN-gamma were higher in the common marmoset. The ratio of Th1-related gene expression level to that of Th2-related genes was inverted in common marmosets. We confirmed the inverted ratio of CD4 to CD8 in common marmosets by flow cytometric analysis. Therefore, the difference in Th1/Th2 balance between common marmosets and humans may affect host defense and/or disease susceptibility, which should be carefully considered when using common marmoset as an experimental model for biomedical research.	[Fujii, Yoshiki; Kitaura, Kazutaka; Shirai, Kenji; Kumagai, Kenichi; Suzuki, Ryuji] Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Allergy & Rheumatol, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan; [Fujii, Yoshiki; Kitaura, Kazutaka; Shirai, Kenji; Takasaki, Tomohiko; Kurane, Ichiro] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Matsutani, Takaji] Wakayama Med Univ, Lab Immune Regulat, Osaka, Japan; [Suzuki, Satsuki] Nippon Dent Univ Tokyo, Sect Biol Sci, Res Ctr Odontol, Sch Life Dent, Tokyo, Japan; [Kumagai, Kenichi; Hamada, Yoshiki] Tsurumi Univ, Dept Oral & Maxillofacial Surg, Sch Dent Med, Yokohama, Kanagawa, Japan; [Kametani, Yoshie] Tokai Univ, Sch Med, Dept Immunol, Div Basic Med Sci & Mol Med, Hiratsuka, Kanagawa 25912, Japan; [Shiina, Takashi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Hiratsuka, Kanagawa 25912, Japan; [Takabayashi, Shuji; Katoh, Hideki] Hamamatsu Univ Sch Med, Expt Anim Inst, Shizuoka, Japan; [Katoh, Hideki] Cent Inst Expt Anim, Lab Anim Breeding & Genet, Kawasaki, Kanagawa, Japan	National Institute of Infectious Diseases (NIID); Wakayama Medical University; Nippon Dental University; Tsurumi University; Tokai University; Tokai University; Hamamatsu University School of Medicine	Suzuki, R (corresponding author), Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Allergy & Rheumatol, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan.	r-suzuki@sagamihara-hosp.gr.jp	高林, 秀次/ABC-9307-2021; Suzuki, Satsuki/ABE-1283-2020; Fujii, Yoshiki/GOE-3566-2022	Shiina, Takashi/0000-0002-2067-6708	Ministry of Health, Labor, and Welfare, Japan [H20-shinkou-ippan-013, H23-shinkou-ippan-010]; Japan Society for the Promotion of Science [23659237]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor, and Welfare, Japan (Grants H20-shinkou-ippan-013 and H23-shinkou-ippan-010) as well as by Grant-in-Aid for Challenging Exploratory Research 23659237 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abbott DH, 2003, COMPARATIVE MED, V53, P339; Adams AP, 2008, J VIROL, V82, P9035, DOI 10.1128/JVI.00674-08; Ando K, 2008, PSYCHOPHARMACOLOGY, V195, P509, DOI 10.1007/s00213-007-0929-2; Bentwich Z, 1996, CLIN EXP IMMUNOL, V103, P239, DOI 10.1046/j.1365-2249.1996.d01-612.x; Bostik Pavel, 2004, Clin Dev Immunol, V11, P35, DOI 10.1080/10446670410001670472; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; DREZEN JM, 1993, J IMMUNOL, V150, P2805; Fukuoka T, 2010, NEUROSCI RES, V66, P62, DOI 10.1016/j.neures.2009.09.1709; Genain CP, 1997, J MOL MED, V75, P187, DOI 10.1007/s001090050103; GENAIN CP, 1994, J CLIN INVEST, V94, P1339, DOI 10.1172/JCI117454; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jeong AR, 2008, J MED PRIMATOL, V37, P290, DOI 10.1111/j.1600-0684.2008.00289.x; Kametani Y, 2009, EXP HEMATOL, V37, P1318, DOI 10.1016/j.exphem.2009.08.003; Keskinen P, 1997, IMMUNOLOGY, V91, P421, DOI 10.1046/j.1365-2567.1997.00258.x; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KLUG S, 1994, ARCH TOXICOL, V68, P619, DOI 10.1007/BF03208341; LAMPSON LA, 1995, MICROSC RES TECHNIQ, V32, P267, DOI 10.1002/jemt.1070320402; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Matrai Z, 2009, CLIN CHEM LAB MED, V47, P585, DOI 10.1515/CCLM.2009.137; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; QUINT DJ, 1990, IMMUNOLOGY, V69, P616; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; Yaguchi M, 2009, NEUROSCI RES, V65, P384, DOI 10.1016/j.neures.2009.08.016; Zuhlke U, 2003, Toxicol Pathol, V31 Suppl, P123, DOI 10.1080/01926230309767	37	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56296	10.1371/journal.pone.0056296	http://dx.doi.org/10.1371/journal.pone.0056296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451040	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500011
J	Griessenberger, H; Heib, DPJ; Lechinger, J; Luketina, N; Petzka, M; Moeckel, T; Hoedlmoser, K; Schabus, M				Griessenberger, Hermann; Heib, Dominik P. J.; Lechinger, Julia; Luketina, Nikolina; Petzka, Marit; Moeckel, Tina; Hoedlmoser, Kerstin; Schabus, Manuel			Susceptibility to Declarative Memory Interference Is Pronounced in Primary Insomnia	PLOS ONE			English	Article							LEARNING-DEPENDENT CHANGES; SLOW-WAVE SLEEP; REM-SLEEP; TIME-COURSE; EARLY BOOST; CONSOLIDATION; SPINDLES; PERFORMANCE; RIPPLES; CLASSIFICATION	Sleep has been shown to stabilize memory traces and to protect against competing interference in both the procedural and declarative memory domain. Here, we focused on an interference learning paradigm by testing patients with primary insomnia (N = 27) and healthy control subjects (N = 21). In two separate experimental nights with full polysomnography it was revealed that after morning interference procedural memory performance (using a finger tapping task) was not impaired in insomnia patients while declarative memory (word pair association) was decreased following interference. More specifically, we demonstrate robust associations of central sleep spindles (in N3) with motor memory susceptibility to interference as well as (cortically more widespread) fast spindle associations with declarative memory susceptibility. In general the results suggest that insufficient sleep quality does not necessarily show up in worse overnight consolidation in insomnia but may only become evident (in the declarative memory domain) when interference is imposed.	[Griessenberger, Hermann; Heib, Dominik P. J.; Lechinger, Julia; Luketina, Nikolina; Petzka, Marit; Moeckel, Tina; Hoedlmoser, Kerstin; Schabus, Manuel] Salzburg Univ, Dept Psychol, Lab Sleep Cognit & Consciousness Res, A-5020 Salzburg, Austria	Salzburg University	Schabus, M (corresponding author), Salzburg Univ, Dept Psychol, Lab Sleep Cognit & Consciousness Res, A-5020 Salzburg, Austria.	manuel.schabus@sbg.ac.at	Hoedlmoser, Kerstin/E-8236-2010; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; Schabus, Manuel/C-1704-2010	Hoedlmoser, Kerstin/0000-0001-5177-4389; Schabus, Manuel/0000-0001-5899-8772; Lechinger, Julia/0000-0002-6325-1988; Heib, Dominik/0000-0002-7977-8557	Austrian Science Fund (FWF) [P-21154-B18]; Doctoral College "Imaging the Mind" by the Austrian Science Fund [FWF-W1233]; Austrian Science Fund (FWF) [P 21154] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Doctoral College "Imaging the Mind" by the Austrian Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Research was supported by a research grant (P-21154-B18) from the Austrian Science Fund (FWF; http://www.fwf.ac.at/). DPJH was financially supported by the Doctoral College "Imaging the Mind" by the Austrian Science Fund (FWF-W1233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderer P, 2005, NEUROPSYCHOBIOLOGY, V51, P115, DOI 10.1159/000085205; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Broman Jan-Erik, 1992, Scandinavian Journal of Behaviour Therapy, V21, P115; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Espie CA, 2008, SLEEP, V31, P591, DOI 10.1093/sleep/31.5.591; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hotermans C, 2008, EUR J NEUROSCI, V28, P1216, DOI 10.1111/j.1460-9568.2008.06421.x; Hotermans C, 2006, LEARN MEMORY, V13, P580, DOI 10.1101/lm.239406; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Molle M, 2009, EUR J NEUROSCI, V29, P1071, DOI 10.1111/j.1460-9568.2009.06654.x; Morin A, 2008, SLEEP, V31, P1149; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Nissen C, 2011, J SLEEP RES, V20, P129, DOI 10.1111/j.1365-2869.2010.00872.x; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2005, BEHAV BRAIN SCI, V28, P78, DOI 10.1017/S0140525X05350023; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rosanova M, 2005, J NEUROSCI, V25, P9398, DOI 10.1523/JNEUROSCI.2149-05.2005; Roth T, 1999, SLEEP, V22, pS354; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schabus M, 2009, SLEEP, V32, P291, DOI 10.1093/sleep/32.3.291; Shekleton JA, 2009, SLEEP MED REV; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Steyer R., 1997, HANDANWEISUNG; Tamaki M, 2008, SLEEP, V31, P204, DOI 10.1093/sleep/31.2.204; Tamaki M, 2009, CLIN NEUROPHYSIOL, V120, P878, DOI 10.1016/j.clinph.2009.03.006; van Dongen EV, 2012, P NATL ACAD SCI USA, V109, P10575, DOI 10.1073/pnas.1201072109; Varkevisser Michael, 2007, Behav Sleep Med, V5, P279; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Walsh JK, 2004, J CLIN PSYCHIAT, V65, P13	61	16	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57394	10.1371/journal.pone.0057394	http://dx.doi.org/10.1371/journal.pone.0057394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451218	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500097
J	Tehrani, FR; Moslehi, N; Asghari, G; Gholami, R; Mirmiran, P; Azizi, F				Tehrani, Fahimeh Ramezani; Moslehi, Nazanin; Asghari, Golaleh; Gholami, Roya; Mirmiran, Parvin; Azizi, Fereidoun			Intake of Dairy Products, Calcium, Magnesium, and Phosphorus in Childhood and Age at Menarche in the Tehran Lipid and Glucose Study	PLOS ONE			English	Article							GROWTH-FACTOR-I; PROSPECTIVE COHORT; BONE MASS; INTERVENTION TRIAL; BODY-COMPOSITION; NUTRIENT INTAKE; IGF-I; GIRLS; MILK; CHILDREN	Purpose: Studies indicate that milk intake is associated with insulin-like growth factor 1 (IGF-1) concentrations and height in childhood, whether milk and other dairy products promote puberty remains unclear. This study aimed to investigate influences of pre-pubertal intakes of milk, yogurt and cheese on menarcheal age in Tehranian girls. The associations of total dietary calcium (Ca), magnesium (Mg), and phosphorus (P) with menarcheal age were also examined. Methods: This prospective study was conducted on 134 pre-pubertal girls, aged 4-12 years at baseline, who participated in the Tehran Lipid and Glucose Study (TLGS), and were followed for a median of 6.5 years. Dietary intakes were determined at initiation of the study using two non-consecutive 24-h dietary recalls and the age of menarche was documented during the follow-up. Logistic regression was used to calculate the risk of reaching menarche <= 12 years according to pre-pubertal levels of dairy or mineral intakes. Results: The risk of earlier menarche was higher in girls with higher intakes of milk [OR: 2.28 (95% CI: 1.03-5.05)], Ca [OR: 3.20 (95%CI: 1.39-7.42)], Mg [OR: 2.43 (95% CI: 1.12-5.27)] and P [OR: 3.37 (95 % CI: 1.44-7.87) after controlling for energy and protein intake, interval between the age at study initiation and the age of menarche, and maternal age at menarche (Model 1). Girls in the middle tertile of cheese intakes had a lower risk of reaching menarche <= 12 years than those in the lowest tertile after controlling for covariates in model 1. These associations remained significant after further adjustment of BMI Z-score at baseline. The relationship of Ca, Mg, and P with menarche remained after further adjustment for height Z-score at baseline, whereas the association between milk and cheese intakes became non-significant. Conclusions: Pre-pubertal intake of milk, but not cheese and yogurt, may hasten age at menarche.	[Tehrani, Fahimeh Ramezani; Gholami, Roya] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Moslehi, Nazanin; Asghari, Golaleh] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran; [Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Mirmiran, P (corresponding author), Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran.	mirmiran@endocrine.ac.ir	Gholami, Roya/D-7584-2019; Azizi, Fereidoun/ABD-4136-2021; Moslehi, Nazanin/R-8154-2019; Tehrani, Fahimeh Ramezani/H-6133-2017; asghari, golaleh/N-4521-2013; Mirmiran, Parvin/V-1433-2019	Gholami, Roya/0000-0002-7322-182X; Azizi, Fereidoun/0000-0002-6470-2517; Moslehi, Nazanin/0000-0001-8441-5200; Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; asghari, golaleh/0000-0002-7925-5158; Mirmiran, Parvin/0000-0003-2391-4924	National Research Council of the Islamic Republic of Iran [121]; Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences	National Research Council of the Islamic Republic of Iran; Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences	This study was supported by grant no. 121 from National Research Council of the Islamic Republic of Iran and Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayatollahi SMT, 2002, ANN HUM BIOL, V29, P355, DOI 10.1080/03014460110086817; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Berkey CS, 2009, CANCER EPIDEM BIOMAR, V18, P1881, DOI 10.1158/1055-9965.EPI-08-1163; Berkey CS, 1999, CANCER-AM CANCER SOC, V85, P2400, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2400::AID-CNCR15>3.0.CO;2-O; Berkey CS, 2000, AM J EPIDEMIOL, V152, P446, DOI 10.1093/aje/152.5.446; Bonofiglio D, 2004, J BONE MINER METAB, V22, P64, DOI 10.1007/s00774-003-0451-5; Boyne MS, 2010, J CLIN ENDOCR METAB, V95, P3194, DOI 10.1210/jc.2010-0080; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255; Chagas CEA, 2012, NUTR REV, V70, P294, DOI 10.1111/j.1753-4887.2012.00464.x; Cheng G, 2012, NUTR REV, V70, P133, DOI 10.1111/j.1753-4887.2011.00461.x; Chevalley T, 2005, J CLIN ENDOCR METAB, V90, P44, DOI 10.1210/jc.2004-1043; Collier RJ, 2008, DOMEST ANIM ENDOCRIN, V35, P16, DOI 10.1016/j.domaniend.2008.01.003; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Esterle L, 2009, OSTEOPOROSIS INT, V20, P567, DOI 10.1007/s00198-008-0708-x; Farahmand M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1064; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Frontini MG, 2003, INT J OBESITY, V27, P1398, DOI 10.1038/sj.ijo.0802422; Gerdhem P, 2004, J BONE MINER METAB, V22, P372, DOI 10.1007/s00774-004-0497-z; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Gunther ALB, 2010, J NUTR, V140, P565, DOI 10.3945/jn.109.114934; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Hoppe C, 2004, EUR J CLIN NUTR, V58, P1211, DOI 10.1038/sj.ejcn.1601948; Karapanou O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-115; KISSINGER DG, 1987, NUTR RES, V7, P471, DOI 10.1016/S0271-5317(87)80003-9; Koo MM, 2002, PUBLIC HEALTH NUTR, V5, P353, DOI 10.1079/PHN2002261; Kwok MK, 2012, PEDIATRICS, V130, pE631, DOI 10.1542/peds.2011-3697; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; MACLURE M, 1991, AM J CLIN NUTR, V54, P649, DOI 10.1093/ajcn/54.4.649; Maggio M, 2011, INT J ANDROL, V34, pE594, DOI 10.1111/j.1365-2605.2011.01193.x; Remer T, 1999, J CLIN ENDOCR METAB, V84, P3936, DOI 10.1210/jc.84.11.3936; Rogers IS, 2010, PUBLIC HEALTH NUTR, V13, P2052, DOI 10.1017/S1368980010001461; Singer MR, 1995, AM J PUBLIC HEALTH, V85, P1673, DOI 10.2105/AJPH.85.12.1673; Tehrani F. R., 2010, Eastern Mediterranean Health Journal, V16, P391; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Velie Ellen M, 2005, Breast Dis, V24, P17; Wang YF, 2002, J NUTR, V132, P430, DOI 10.1093/jn/132.3.430; Wiley AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014685; Wiley AS, 2009, ANN HUM BIOL, V36, P125, DOI 10.1080/03014460802680466; Zhu K, 2006, AM J CLIN NUTR, V83, P714, DOI 10.1093/ajcn.83.3.714	42	34	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57696	10.1371/journal.pone.0057696	http://dx.doi.org/10.1371/journal.pone.0057696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451261	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500128
J	Yassin, A; Orgogozo, V				Yassin, Amir; Orgogozo, Virginie			Coevolution between Male and Female Genitalia in the Drosophila melanogaster Species Subgroup	PLOS ONE			English	Article							MORPHOLOGICAL SHAPE DIFFERENCE; ANTAGONISTIC COEVOLUTION; SEXUAL SELECTION; GENETIC-ANALYSIS; PHOLCID SPIDERS; EVOLUTION; SPERM; DIVERGENCE; COPULATION; SANTOMEA	In contrast to male genitalia that typically exhibit patterns of rapid and divergent evolution among internally fertilizing animals, female genitalia have been less well studied and are generally thought to evolve slowly among closely-related species. As a result, few cases of male-female genital coevolution have been documented. In Drosophila, female copulatory structures have been claimed to be mostly invariant compared to male structures. Here, we re-examined male and female genitalia in the nine species of the D. melanogaster subgroup. We describe several new species-specific female genital structures that appear to coevolve with male genital structures, and provide evidence that the coevolving structures contact each other during copulation. Several female structures might be defensive shields against apparently harmful male structures, such as cercal teeth, phallic hooks and spines. Evidence for male-female morphological coevolution in Drosophila has previously been shown at the post-copulatory level (e.g., sperm length and sperm storage organ size), and our results provide support for male-female coevolution at the copulatory level.	[Yassin, Amir; Orgogozo, Virginie] Univ Paris Diderot, CNRS, Inst Jacques Monod, Unite Mixte Rech 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Yassin, A (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Unite Mixte Rech 7592, Paris, France.	yassin@legs.cnrs-gif.fr	Yassin, Amir/N-7957-2018; Yassin, Amir/P-5915-2019	Yassin, Amir/0000-0002-2590-5434; Courtier-Orgogozo, Virginie/0000-0002-9297-9230	CNRS ATIP-AVENIR	CNRS ATIP-AVENIR	This work has been funded by a CNRS ATIP-AVENIR research grant to VO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2010, GENETICS, V186, P595, DOI 10.1534/genetics.110.119735; Bachli G., 2004, FAUNA ENTOMOL SCAD, V39; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennan PLR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000418; Carayon J, 1966, ENTOMOL SOC AM, P88; Cariou ML, 2001, MOL ECOL, V10, P649, DOI 10.1046/j.1365-294x.2001.01225.x; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; COYNE JA, 1991, GENET RES, V57, P113, DOI 10.1017/S0016672300029177; Dalmasso C, 2005, BIOINFORMATICS, V21, P660, DOI 10.1093/bioinformatics/bti063; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dufour, 1844, ANN SCI NAT, V1, P224, DOI DOI 10.1111/J.1420-9101.2007.01323.X; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard WG, 2004, EVOLUTION, V58, P1947; Eberhard WG, 2004, ANN ENTOMOL SOC AM, V97, P1007, DOI 10.1603/0013-8746(2004)097[1007:FMOTMG]2.0.CO;2; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Grieshop K, 2012, EVOLUTION, V66, P2637, DOI 10.1111/j.1558-5646.2012.01638.x; Hosken DJ, 2009, ANNU REV ENTOMOL, V54, P361, DOI 10.1146/annurev.ento.54.110807.090608; Hruskova-Martisova M, 2010, J ZOOL, V282, P91, DOI 10.1111/j.1469-7998.2010.00718.x; Huber BA, 2003, ZOOL J LINN SOC-LOND, V139, P477, DOI 10.1046/j.0024-4082.2003.00082.x; Huber BA, 1999, J ARACHNOL, V27, P135; Huber Bernhard A., 2005, Zoologica (Stuttgart), V155, P1; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Joly D, 2010, GENETICA, V138, P105, DOI 10.1007/s10709-009-9392-9; Joly D, 2010, GENETICA, V138, P139, DOI 10.1007/s10709-009-9423-6; Kamimura Y, 2007, BIOL LETTERS, V3, P401, DOI 10.1098/rsbl.2007.0192; Kamimura Y, 2012, BEHAV ECOL SOCIOBIOL, V66, P1107, DOI 10.1007/s00265-012-1361-0; Kamimura Y, 2012, ENTOMOL SCI, V15, P197, DOI 10.1111/j.1479-8298.2011.00490.x; Kamimura Y, 2011, ENTOMOL SCI, V14, P399, DOI 10.1111/j.1479-8298.2011.00467.x; Kamimura Y, 2010, ZOOMORPHOLOGY, V129, P163, DOI 10.1007/s00435-010-0109-5; Kulkarni C. V., 1940, Records of the Indian Museum, V42, P379; LACHAISE D, 1981, AM NAT, V117, P600, DOI 10.1086/283745; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lachaise D, 2004, EVOLUTION OF POPULATION BIOLOGY, P315, DOI 10.1017/CBO9780511542619.019; Lang M, 2012, CONTRIB ZOOL, V81, P87, DOI 10.1163/18759866-08102003; Liu J, 1996, GENETICS, V142, P1129; Llopart A, 2005, EVOLUTION, V59, P2602, DOI 10.1111/j.0014-3820.2005.tb00972.x; Lung O, 1999, INSECT BIOCHEM MOLEC, V29, P1043, DOI 10.1016/S0965-1748(99)00078-8; Macdonald SJ, 1999, GENETICS, V153, P1683; Maddison W. P., 2012, MESQUITE MODULAR SYS; Masly John P., 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/247352; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; Ottiger M, 2000, J NEUROBIOL, V44, P57; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Peretti AV, 2007, J ETHOL, V25, P29, DOI 10.1007/s10164-006-0201-y; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI [10.2307/2640442, 10.1111/j.1558-5646.1999.tb04564.x]; Polak M, 2010, P ROY SOC B-BIOL SCI, V277, P1371, DOI 10.1098/rspb.2009.1720; PRATT HL, 1979, FISH B-NOAA, V77, P445; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; ROBERTSON H M, 1988, Pacific Science, V42, P72; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; Sanchez L, 1997, GENETICS, V147, P231; Simmons LW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1379; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tsacas L., 1971, Bull Soc Ent France, V76, P35; TSACAS L, 1978, Beitraege zur Entomologie, V28, P179; TSACAS L, 1974, Annales de l'Universite d'Abidjan Serie E Ecologie, V7, P193; Tsacas L., 1974, Bulletin Soc Ent France, V79, P42; TSACAS L, 1981, Revue Francaise d'Entomologie (Nouvelle Serie), V3, P146; Vahed K, 2002, ETHOLOGY, V108, P1065, DOI 10.1046/j.1439-0310.2002.00838.x; Zeng ZB, 2000, GENETICS, V154, P299	68	65	66	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57158	10.1371/journal.pone.0057158	http://dx.doi.org/10.1371/journal.pone.0057158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451172	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500071
J	Dada, J; Pinder, AG; Lang, D; James, PE				Dada, Jessica; Pinder, Andrew G.; Lang, Derek; James, Philip E.			Oxygen Mediates Vascular Smooth Muscle Relaxation in Hypoxia	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; RED-BLOOD-CELLS; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; CARBON-MONOXIDE; RADICAL GENERATION; NO; HEMOGLOBIN; HEME; VASODILATION	The activation of soluble guanylate cyclase (sGC) by nitric oxide (NO) and other ligands has been extensively investigated for many years. In the present study we considered the effect of molecular oxygen (O-2) on sGC both as a direct ligand and its affect on other ligands by measuring cyclic guanosine monophosphate (cGMP) production, as an index of activity, as well as investigating smooth muscle relaxation under hypoxic conditions. Our isolated enzyme studies confirm the function of sGC is impaired under hypoxic conditions and produces cGMP in the presence of O-2, importantly in the absence of NO. We also show that while O-2 could partially affect the magnitude of sGC stimulation by NO when the latter was present in excess, activation by the NO independent, haem-dependent sGC stimulator 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) was unaffected. Our in vitro investigation of smooth muscle relaxation confirmed that O-2 alone in the form of a buffer bolus (equilibrated at 95% O-2/5% CO2) had the ability to dilate vessels under hypoxic conditions and that this was dependent upon sGC and independent of eNOS. Our studies confirm that O-2 can be a direct and important mediator of vasodilation through an increase in cGMP production. In the wider context, these observations are key to understanding the relative roles of O-2 versus NO-induced sGC activation.	[Dada, Jessica; Pinder, Andrew G.; Lang, Derek; James, Philip E.] Cardiff Univ, Sch Med, Wales Heart Res Inst, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	James, PE (corresponding author), Cardiff Univ, Sch Med, Wales Heart Res Inst, Inst Mol & Expt Med, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	jamespp@cardiff.ac.uk			British Heart Foundation [FS/10/007/28077]	British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (PhD Studentship) [FS/10/007/28077]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BW, 2006, AM J PHYSIOL-HEART C, V291, pH1507, DOI 10.1152/ajpheart.00310.2006; Angelos MG, 2006, AM J PHYSIOL-HEART C, V290, pH341, DOI 10.1152/ajpheart.00223.2005; Berg JM, 2002, BIOCHEMISTY; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BRUNE B, 1990, EUR J BIOCHEM, V192, P683, DOI 10.1111/j.1432-1033.1990.tb19276.x; BRUNORI M, 1967, J BIOL CHEM, V242, P2295; Chen KJ, 2008, ANTIOXID REDOX SIGN, V10, P1185, DOI 10.1089/ars.2007.1959; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Friebe A, 1998, BIOCHEM J, V335, P527, DOI 10.1042/bj3350527; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1998, MOL PHARMACOL, V53, P123, DOI 10.1124/mol.53.1.123; Galle J, 1999, BRIT J PHARMACOL, V127, P195, DOI 10.1038/sj.bjp.0702495; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; JAMES PE, 1995, FREE RADICAL BIO MED, V18, P641, DOI 10.1016/0891-5849(94)00179-N; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Kim-Shapiro DB, 2005, J INORG BIOCHEM, V99, P237, DOI 10.1016/j.jinorgbio.2004.10.034; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Makino R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177576; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Patel RP, 2011, CARDIOVASC RES, V89, P507, DOI 10.1093/cvr/cvq323; Pinder AG, 2009, CIRC RES, V104, pE25, DOI 10.1161/CIRCRESAHA.108.191569; Pinder AG, 2009, ADV EXP MED BIOL, V645, P13, DOI 10.1007/978-0-387-85998-9_3; POST JM, 1992, AM J PHYSIOL, V262, pC882, DOI 10.1152/ajpcell.1992.262.4.C882; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Schrammel A, 1996, MOL PHARMACOL, V50, P1; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stone JR, 1995, BIOCHEMISTRY-US, V34, P16397, DOI 10.1021/bi00050a021; Yasmin W, 1997, CARDIOVASC RES, V33, P422, DOI 10.1016/S0008-6363(96)00254-4; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	47	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57162	10.1371/journal.pone.0057162	http://dx.doi.org/10.1371/journal.pone.0057162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451175	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000316658800083
J	Fossati-Jimack, L; Ling, GS; Cortini, A; Szajna, M; Malik, TH; McDonald, JU; Pickering, MC; Cook, HT; Taylor, PR; Botto, M				Fossati-Jimack, Liliane; Ling, Guang Sheng; Cortini, Andrea; Szajna, Marta; Malik, Talat H.; McDonald, Jacqueline U.; Pickering, Matthew C.; Cook, H. Terence; Taylor, Philip R.; Botto, Marina			Phagocytosis Is the Main CR3-Mediated Function Affected by the Lupus-Associated Variant of CD11b in Human Myeloid Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; T-CELLS; LEUKOCYTE ADHESION; SCAVENGER RECEPTOR; DISEASE-ACTIVITY; APOPTOTIC CELLS; IMPAIRED UPTAKE; ERYTHEMATOSUS; ITGAM; MACROPHAGES	The CD11b/CD18 integrin (complement receptor 3, CR3) is a surface receptor on monocytes, neutrophils, macrophages and dendritic cells that plays a crucial role in several immunological processes including leukocyte extravasation and phagocytosis. The minor allele of a non-synonymous CR3 polymorphism (rs1143679, conversation of arginine to histidine at position 77: R77H) represents one of the strongest genetic risk factor in human systemic lupus erythematosus, with heterozygosity (77R/H) being the most common disease associated genotype. Homozygosity for the 77H allele has been reported to reduce adhesion and phagocytosis in human monocytes and monocyte-derived macrophages, respectively, without affecting surface expression of CD11b. Herein we comprehensively assessed the influence of R77H on different CR3-mediated activities in monocytes, neutrophils, macrophages and dendritic cells. R77H did not alter surface expression of CD11b including its active form in any of these cell types. Using two different iC3b-coated targets we found that the uptake by heterozygous 77R/H macrophages, monocytes and neutrophils was significantly reduced compared to 77R/R cells. Allele-specific transduced immortalized macrophage cell lines demonstrated that the minor allele, 77H, was responsible for the impaired phagocytosis. R77H did not affect neutrophil adhesion, neutrophil transmigration in vivo or Toll-like receptor 7/8-mediated cytokine release by monocytes or dendritic cells with or without CR3 pre-engagement by iC3b-coated targets. Our findings demonstrate that the reduction in CR3-mediated phagocytosis associated with the 77H CD11b variant is not macrophage-restricted but demonstrable in other CR3-expressing professional phagocytic cells. The association between 77H and susceptibility to systemic lupus erythematosus most likely relates to impaired waste disposal, a key component of lupus pathogenesis.	[Fossati-Jimack, Liliane; Ling, Guang Sheng; Cortini, Andrea; Szajna, Marta; Malik, Talat H.; Pickering, Matthew C.; Cook, H. Terence; Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Immunol & Inflammat, Ctr Complement & Inflammat Res, London, England; [McDonald, Jacqueline U.; Taylor, Philip R.] Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Imperial College London; Cardiff University	Botto, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Immunol & Inflammat, Ctr Complement & Inflammat Res, London, England.	m.botto@imperial.ac.uk		Taylor, Philip/0000-0003-0163-1421; Pickering, Matthew/0000-0002-1153-0192	Wellcome Trust [088517]; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant number 088517) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya JM, 2012, AUTOIMMUN REV, V11, P276, DOI 10.1016/j.autrev.2011.07.007; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; BUYON JP, 1988, CLIN IMMUNOL IMMUNOP, V46, P141, DOI 10.1016/0090-1229(88)90014-1; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Coustet B, 2011, J RHEUMATOL, V38, P1033, DOI 10.3899/jrheum.101053; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DAGATI VD, 1986, KIDNEY INT, V30, P573, DOI 10.1038/ki.1986.223; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Green MRJ, 2007, ARTHRITIS RHEUM-US, V56, P303, DOI 10.1002/art.22326; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; HASLETT C, 1985, AM J PATHOL, V119, P101; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huynh L, 2012, J IMMUNOL, V188, P3447, DOI 10.4049/jimmunol.1102211; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; LHOTTA K, 1991, CLIN SCI, V81, P477, DOI 10.1042/cs0810477; Li Y, 2003, J BIOL CHEM, V278, P34395, DOI 10.1074/jbc.M304190200; MacPherson M, 2011, J BIOL CHEM, V286, P17303, DOI 10.1074/jbc.M110.182998; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Munoz LE, 2005, RHEUMATOLOGY, V44, P1101, DOI 10.1093/rheumatology/keh693; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Rhodes B, 2012, ANN RHEUM DIS; Rosas M, 2011, EUR J IMMUNOL, V41, P356, DOI 10.1002/eji.201040962; Sachs UJH, 2004, BLOOD, V104, P727, DOI 10.1182/blood-2003-11-3809; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Tas SW, 2006, ANN RHEUM DIS, V65, P216, DOI 10.1136/ard.2005.037143; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yoshida Y, 1998, J IMMUNOL, V161, P5873	55	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57082	10.1371/journal.pone.0057082	http://dx.doi.org/10.1371/journal.pone.0057082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451151	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000316658800069
J	Iyer, RP; Gu, SM; Nicholson, BJ; Jiang, JX				Iyer, Rugmani Padmanabhan; Gu, Sumin; Nicholson, Bruce J.; Jiang, Jean X.			Identification of a Disulfide Bridge Important for Transport Function of SNAT4 Neutral Amino Acid Transporter	PLOS ONE			English	Article							CYSTEINE RESIDUES; SYSTEM-A; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; ACTIVE-SITE; MEMBRANE; PROTEIN; LIVER; TRAFFICKING; ISOFORM	SNAT4 is a member of system N/A amino acid transport family that primarily expresses in liver and muscles and mediates the transport of L-alanine. However, little is known about the structure and function of the SNAT family of transporters. In this study, we showed a dose-dependent inhibition in transporter activity of SNAT4 with the treatment of reducing agents, dithiothreitol (DTT) and Tris(2-carboxyethyl) phosphine (TCEP), indicating the possible involvement of disulfide bridge(s). Mutation of residue Cys-232, and the two highly conserved residues Cys-249 and Cys-321, compromised the transport function of SNAT4. However, this reduction was not caused by the decrease of SNAT4 on the cell surface since the cysteine-null mutant generated by replacing all five cysteines with alanine was equally capable of being expressed on the cell surface as wild-type SNAT4. Interestingly, by retaining two cysteine residues, 249 and 321, a significant level of L-alanine uptake was restored, indicating the possible formation of disulfide bond between these two conserved residues. Biotinylation crosslinking of free thiol groups with MTSEA-biotin provided direct evidence for the existence of a disulfide bridge between Cys-249 and Cys-321. Moreover, in the presence of DTT or TCEP, transport activity of the mutant retaining Cys-249 and Cys-321 was reduced in a dose-dependent manner and this reduction is gradually recovered with increased concentration of H2O2. Disruption of the disulfide bridge also decreased the transport of L-arginine, but to a lesser degree than that of L-alanine. Together, these results suggest that cysteine residues 249 and 321 form a disulfide bridge, which plays an important role in substrate transport but has no effect on trafficking of SNAT4 to the cell surface.	[Iyer, Rugmani Padmanabhan; Gu, Sumin; Nicholson, Bruce J.; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu		Jiang, Jean/0000-0002-2185-5716; Nicholson, Bruce/0000-0003-1649-7173	National Institute of Health [EY012085]; The Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R01EY012085, R29EY012085] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by: 1. National Institute of Health (EY012085) URL: www.nih.gov; 2. The Welch Foundation (AQ-1507) URL: www.welch1.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Desforges M, 2009, J PHYSIOL-LONDON, V587, P61, DOI 10.1113/jphysiol.2008.161331; Dorn M, 2009, J BIOL CHEM, V284, P22123, DOI 10.1074/jbc.M109.023713; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gruarin P, 1997, BIOCHEM J, V328, P635, DOI 10.1042/bj3280635; Gu SM, 2003, BIOCHEM J, V371, P721, DOI 10.1042/BJ20030049; Gu SM, 2001, GENOMICS, V74, P262, DOI 10.1006/geno.2001.6567; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; Hu LA, 1998, J BIOL CHEM, V273, P20162, DOI 10.1074/jbc.273.32.20162; Kudou D, 2008, BIOSCI BIOTECH BIOCH, V72, P1722, DOI 10.1271/bbb.80015; Lambert G, 2000, J MEMBRANE BIOL, V176, P133, DOI 10.1007/s002320001082; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Nissen-Meyer LSH, 2011, J NEUROSCI, V31, P6565, DOI 10.1523/JNEUROSCI.3694-10.2011; Palmada Monica, 1998, Frontiers in Bioscience, V3, pD701; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Shi Q, 2011, J BIOL CHEM, V286, P38086, DOI 10.1074/jbc.M111.220277; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; SUBBARAMAIAH K, 1991, J BIOL CHEM, V266, P19023; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Tanaka K, 2004, BIOCHEM J, V380, P283, DOI 10.1042/BJ20031724; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	35	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56792	10.1371/journal.pone.0056792	http://dx.doi.org/10.1371/journal.pone.0056792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451088	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800037
J	Molina-Rueda, JJ; Tsai, CJ; Kirby, EG				Molina-Rueda, Juan Jesus; Tsai, Chung Jui; Kirby, Edward G.			The Populus Superoxide Dismutase Gene Family and Its Responses to Drought Stress in Transgenic Poplar Overexpressing a Pine Cytosolic Glutamine Synthetase (GS1a)	PLOS ONE			English	Article							OXIDATIVE STRESS; DIFFERENTIAL EXPRESSION; COPPER HOMEOSTASIS; ENHANCED TOLERANCE; ECTOPIC EXPRESSION; HYDROGEN-PEROXIDE; PLANTS; ARABIDOPSIS; INDUCTION; PROTEINS	Background: Glutamine synthetase (GS) plays a central role in plant nitrogen assimilation, a process intimately linked to soil water availability. We previously showed that hybrid poplar (Populus tremula X alba, INRA 717-1B4) expressing ectopically a pine cytosolic glutamine synthetase gene (GS1a) display enhanced tolerance to drought. Preliminary transcriptome profiling revealed that during drought, members of the superoxide dismutase (SOD) family were reciprocally regulated in GS poplar when compared with the wild-type control, in all tissues examined. SOD was the only gene family found to exhibit such patterns. Results: In silico analysis of the Populus genome identified 12 SOD genes and two genes encoding copper chaperones for SOD (CCSs). The poplar SODs form three phylogenetic clusters in accordance with their distinct metal co-factor requirements and gene structure. Nearly all poplar SODs and CCSs are present in duplicate derived from whole genome duplication, in sharp contrast to their predominantly single-copy Arabidopsis orthologs. Drought stress triggered plant-wide down-regulation of the plastidic copper SODs (CSDs), with concomitant up-regulation of plastidic iron SODs (FSDs) in GS poplar relative to the wild type; this was confirmed at the activity level. We also found evidence for coordinated down-regulation of other copper proteins, including plastidic CCSs and polyphenol oxidases, in GS poplar under drought conditions. Conclusions: Both gene duplication and expression divergence have contributed to the expansion and transcriptional diversity of the Populus SOD/CCS families. Coordinated down-regulation of major copper proteins in drought-tolerant GS poplars supports the copper cofactor economy model where copper supply is preferentially allocated for plastocyanins to sustain photosynthesis during drought. Our results also extend previous findings on the compensatory regulation between chloroplastic CSDs and FSDs, and suggest that this copper-mediated mechanism represents a common response to oxidative stress and other genetic manipulations, as in GS poplars, that affect photosynthesis.	[Molina-Rueda, Juan Jesus; Kirby, Edward G.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Tsai, Chung Jui] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Tsai, Chung Jui] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kirby, EG (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA.	ekirby@andromeda.rutgers.edu	Tsai, CJ/C-2450-2009	Tsai, CJ/0000-0002-9282-7704; Molina Rueda, Juan Jesus/0000-0003-1143-7008	US Department of Energy through the Consortium for Plant Biotechnology Research [GO12026-314]; ArborGen LLC (USA); ArborGen LLC	US Department of Energy through the Consortium for Plant Biotechnology Research(United States Department of Energy (DOE)); ArborGen LLC (USA); ArborGen LLC	This work was supported by a grant from the US Department of Energy through the Consortium for Plant Biotechnology Research (GO12026-314) (URL: www.cpbr.org) and by a grant from ArborGen LLC (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded in part through a commercial source, ArborGen LLC. This funding arrangement does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdel-Ghany SE, 2005, FEBS LETT, V579, P2307, DOI 10.1016/j.febslet.2005.03.025; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; BOWLER C, 1989, EMBO J, V8, P31, DOI 10.1002/j.1460-2075.1989.tb03345.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cohu CM, 2007, PHYSIOL PLANTARUM, V129, P747, DOI 10.1111/j.1399-3054.2007.00879.x; Cohu CM, 2009, MOL PLANT, V2, P1336, DOI 10.1093/mp/ssp084; Coleman HD, 2012, PLANT BIOTE IN PRESS, P1; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; de Hoon MJL, 2002, BIOINFORMATICS, V18, P1477, DOI 10.1093/bioinformatics/18.11.1477; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; El-Khatib RT, 2004, TREE PHYSIOL, V24, P729, DOI 10.1093/treephys/24.7.729; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Gallardo F, 1999, PLANTA, V210, P19, DOI 10.1007/s004250050649; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Molina-Rueda JJ, 2010, PLANTA, V232, P1471, DOI 10.1007/s00425-010-1268-9; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jiang Ke, 2011, BMC Res Notes, V4, P52, DOI 10.1186/1756-0500-4-52; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jing ZP, 2004, NEW PHYTOL, V164, P137, DOI 10.1111/j.1469-8137.2004.01173.x; Kathiresan A, 1997, PLANT PHYSIOL, V115, P129, DOI 10.1104/pp.115.1.129; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Kurepa J, 1997, PLANT CELL PHYSIOL, V38, P463, DOI 10.1093/oxfordjournals.pcp.a029190; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei YB, 2006, PHYSIOL PLANTARUM, V127, P182, DOI 10.1111/j.1399-3054.2006.00638.x; Liao ZH, 2004, PREP BIOCHEM BIOTECH, V34, P209, DOI 10.1081/PB-200026790; Lower SS, 2003, ENTOMOL EXP APPL, V107, P69, DOI 10.1046/j.1570-7458.2003.00037.x; Lu YZ, 2011, FUNCT PLANT BIOL, V38, P44, DOI 10.1071/FP10178; Man HM, 2005, NEW PHYTOL, V167, P31, DOI 10.1111/j.1469-8137.2005.01461.x; Man HM, 2011, J EXP BOT, V62, P4423, DOI 10.1093/jxb/err026; Marron N, 2006, ANN FOREST SCI, V63, P323, DOI 10.1051/forest:2006012; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Myouga F, 2008, PLANT CELL, V20, P3148, DOI 10.1105/tpc.108.061341; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; PARKER MW, 1988, FEBS LETT, V229, P377, DOI 10.1016/0014-5793(88)81160-8; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pradedova EV, 2009, BIOCHEM MOSC SUPPL S, V3, P24, DOI 10.1134/S1990747809010048; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Quaye A. K., 2009, J FORESTRY HORT SOIL, V3, P1; Ravet K, 2011, PLANT PHYSIOL, V157, P1300, DOI 10.1104/pp.111.183350; Roberts MR, 2007, PLANT SIGNAL BEHAV, V2, P408, DOI 10.4161/psb.2.5.4335; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SANDALIO LM, 1988, PLANT PHYSIOL, V88, P1215, DOI 10.1104/pp.88.4.1215; Solomon S, 2007, CLIMATE CHANGE 2007, V4; Srivastava V, 2009, PLANT PHYSIOL, V149, P1848, DOI 10.1104/pp.108.133371; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tewari RK, 2006, PLANTA, V223, P1145, DOI 10.1007/s00425-005-0160-5; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; TSANG EWT, 1991, PLANT CELL, V3, P783, DOI 10.1105/tpc.3.8.783; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VANCAMP W, 1990, P NATL ACAD SCI USA, V87, P9903, DOI 10.1073/pnas.87.24.9903; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang F, 2006, PLANT CELL REP, V24, P734, DOI 10.1007/s00299-005-0030-4; Wang FZ, 2005, J PLANT PHYSIOL, V162, P465, DOI 10.1016/j.jplph.2004.09.009; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Wang YC, 2010, MOL BIOL REP, V37, P1119, DOI 10.1007/s11033-009-9884-9; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wilkins MR, 1999, METH MOL B, V112, P531; Wintz H, 2002, BIOCHEM SOC T, V30, P732, DOI 10.1042/bst0300732; Wu GH, 1999, PLANT PHYSIOL, V120, P513, DOI 10.1104/pp.120.2.513; YAMAKURA F, 1984, BIOCHEM BIOPH RES CO, V122, P635, DOI 10.1016/S0006-291X(84)80080-7; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200	74	42	50	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56421	10.1371/journal.pone.0056421	http://dx.doi.org/10.1371/journal.pone.0056421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451045	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800011
J	Yang, FM; Wang, N; Shi, F; Ljungqvist, FC; Wang, SG; Fan, ZX; Lu, JW				Yang, Fengmei; Wang, Naiang; Shi, Feng; Ljungqvist, Fredrik Charpentier; Wang, Shigong; Fan, Zexin; Lu, Junwei			Multi-Proxy Temperature Reconstruction from the West Qinling Mountains, China, for the Past 500 Years	PLOS ONE			English	Article							TREE-RING RECORD; TIBETAN PLATEAU; CLIMATE VARIABILITY; QILIAN MOUNTAINS; DROUGHT; RESOLUTION; GROWTH; REGION; SERIES; WIDTH	A total of 290 tree-ring samples, collected from six sites in the West Qinling Mountains of China, were used to develop six new standard tree-ring chronologies. In addition, 73 proxy records were assembled in collaboration with Chinese and international scholars, from 27 publically available proxy records and 40 tree-ring chronologies that are not available in public datasets. These records were used to reconstruct annual mean temperature variability in the West Qinling Mountains over the past 500 years (AD 1500-1995), using a modified point-by-point regression (hybrid PPR) method. The results demonstrate that the hybrid PPR method successfully integrates the temperature signals from different types of proxies, and that the method preserves a high degree of low-frequency variability. The reconstruction shows greater temperature variability in the West Qinling Mountains than has been found in previous studies. Our temperature reconstruction for this region shows: 1) five distinct cold periods, at approximately AD 1520-1535, AD 1560-1575, AD 1610-1620, AD 1850-1875 and AD 1965-1985, and four warm periods, at approximately AD 1645-1660, AD 1705-1725, AD 1785-1795 and AD 19201945; 2) that in this region, the 20th century was not the warmest period of the past 500 years; and 3) that a dominant and persistent oscillation of ca. 64 years is significantly identified in the 1640-1790 period.	[Yang, Fengmei; Wang, Shigong] Lanzhou Univ, Key Lab Semiarid Climate Change, Minist Educ, Coll Atmospher Sci, Lanzhou 730000, Peoples R China; [Yang, Fengmei] China Meteorol Adm Training Ctr, Beijing, Peoples R China; [Wang, Naiang; Lu, Junwei] Lanzhou Univ, Ctr Climate Change & Hydrol Cycle Arid Reg, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Shi, Feng] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modelling Atmospher Sci & Geo, Beijing, Peoples R China; [Shi, Feng] Chinese Acad Sci, Key Lab Desert & Desertificat, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Ljungqvist, Fredrik Charpentier] Stockholm Univ, Dept Hist, S-10691 Stockholm, Sweden; [Fan, Zexin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China	Lanzhou University; Lanzhou University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Stockholm University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Shi, F (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modelling Atmospher Sci & Geo, Beijing, Peoples R China.	shifeng@lasg.iap.ac.cn	Shi, Feng/AAG-6973-2020; Fan, Ze-Xin/ABG-7176-2020; Charpentier Ljungqvist, Fredrik/I-5770-2012; Fan, Zexin/E-2344-2016; Wang, Yuesi/AAF-3317-2019	Shi, Feng/0000-0003-3963-1822; Fan, Ze-Xin/0000-0003-4623-6783; Charpentier Ljungqvist, Fredrik/0000-0003-0220-3947; Fan, Zexin/0000-0003-4623-6783; 	CAS Strategic Priority Research Program Grant [XDA05080801]; National Basic Research Program of China ( 973 Program) [2012CB957804]; Specialized Research Fund for the Doctoral Program of Higher Education [20090211110025]; Forty-ninth batch of China Postdoctoral Science Foundation [2012T50829]; China Meteorological Administration Drought Research Fund [IAM201109, IAM201213]; West Light Program for Talent Cultivation of Chinese Academy of Sciences	CAS Strategic Priority Research Program Grant; National Basic Research Program of China ( 973 Program)(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Forty-ninth batch of China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Meteorological Administration Drought Research Fund; West Light Program for Talent Cultivation of Chinese Academy of Sciences	The study was jointly funded by the CAS Strategic Priority Research Program Grant (XDA05080801), the National Basic Research Program of China (973 Program) (2012CB957804) and the Specialized Research Fund for the Doctoral Program of Higher Education (20090211110025). Fengmei Yang was supported by the Forty-ninth batch of China Postdoctoral Science Foundation (2012T50829) and the China Meteorological Administration Drought Research Fund (IAM201109). Feng Shi was supported by the China Meteorological Administration Drought Research Fund (IAM201213) and the West Light Program for Talent Cultivation of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Bradley RS, 2011, DEV PALEOENVIRON RES, V11, P3, DOI 10.1007/978-1-4020-5725-0_1; Brauning A, 2006, J GEOL SOC INDIA, V68, P485; Briffa KR, 2008, PHILOS T R SOC B, V363, P2271, DOI 10.1098/rstb.2007.2199; Briffa KR, 2011, DEV PALEOENVIRON RES, V11, P113, DOI 10.1007/978-1-4020-5725-0_5; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; D'Arrigo R, 2006, INT J CLIMATOL, V26, P1607, DOI 10.1002/joc.1326; Fan ZX, 2010, PALAEOGEOGR PALAEOCL, V296, P94, DOI 10.1016/j.palaeo.2010.06.017; Fan ZX, 2009, GLOBAL PLANET CHANGE, V65, P1, DOI 10.1016/j.gloplacha.2008.10.001; Fang KY, 2012, CLIM DYNAM, V39, P1697, DOI 10.1007/s00382-012-1371-7; Fang KY, 2012, GLOBAL PLANET CHANGE, V80-81, P190, DOI 10.1016/j.gloplacha.2011.10.009; Fang KY, 2011, J CLIMATE, V24, P3457, DOI 10.1175/2011JCLI3911.1; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Feng S, 2013, J CLIMATE, V26, P2192, DOI 10.1175/JCLI-D-12-00099.1; Fritts H. C., 1976, TREE RINGS CLIMATE; Ge QS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041281; GILMAN DL, 1963, J ATMOS SCI, V20, P182, DOI 10.1175/1520-0469(1963)020<0182:OTPSON>2.0.CO;2; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; He MH, 2013, HOLOCENE, V23, P36, DOI 10.1177/0959683612450198; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hughes MK, 2011, DEV PALEOENVIRON RES, V11, P17, DOI 10.1007/978-1-4020-5725-0_2; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; Li JB, 2011, NAT CLIM CHANGE, V1, P114, DOI [10.1038/nclimate1086, 10.1038/NCLIMATE1086]; Li ZS, 2012, CLIMATIC CHANGE, V110, P455, DOI 10.1007/s10584-011-0111-z; Liang EY, 2009, THEOR APPL CLIMATOL, V98, P9, DOI 10.1007/s00704-008-0085-6; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Linderholm HW, 2005, GEOGR ANN A, V87A, P231, DOI 10.1111/j.0435-3676.2005.00255.x; Liu H.B., 2000, ACTA METEOROL SIN, V58, P223, DOI [10.11676/qxxb2000.023, DOI 10.11676/QXXB2000.023]; Liu JJ, 2011, QUATERN INT, V236, P75, DOI 10.1016/j.quaint.2010.03.020; Liu X, 2007, ARCT ANTARCT ALP RES, V39, P651, DOI 10.1657/1523-0430(07-506)[LIU-X]2.0.CO;2; Liu Y, 2009, SCI CHINA SER D, V52, P348, DOI 10.1007/s11430-009-0025-z; Mann ME, 2005, J CLIMATE, V18, P4097, DOI 10.1175/JCLI3564.1; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Qin C, 2011, GLOBAL PLANET CHANGE, V75, P143, DOI 10.1016/j.gloplacha.2010.10.013; Riedwyl N, 2009, CLIM DYNAM, V32, P381, DOI 10.1007/s00382-008-0395-5; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Shao XM., 1999, QUATERNARY SCI, V19, P81, DOI DOI 10.3321/j.issn:1001-7410.1999.01.010; Shao XM, 2009, IAWA J, V30, P379, DOI 10.1163/22941932-90000226; Shi F, 2012, SCI CHINA EARTH SCI, V55, P2058, DOI 10.1007/s11430-012-4374-7; Shi F, 2012, THEOR APPL CLIMATOL, V109, P233, DOI 10.1007/s00704-011-0576-8; Smerdon JE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047372; Smerdon JE, 2011, J CLIMATE, V24, P1284, DOI 10.1175/2010JCLI4110.1; Sontakke NA, 2008, HOLOCENE, V18, P1055, DOI 10.1177/0959683608095576; Thompson LG, 2003, CLIMATIC CHANGE, V59, P137, DOI 10.1023/A:1024472313775; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Ting MF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048712; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vaganov EA, 2011, DEV PALEOENVIRON RES, V11, P37, DOI 10.1007/978-1-4020-5725-0_3; Wahl ER, 2007, CLIMATIC CHANGE, V85, P33, DOI 10.1007/s10584-006-9105-7; Wang SW, 2007, CHINESE SCI BULL, V52, P3272, DOI 10.1007/s11434-007-0425-4; Wang XC, 2011, J ATMOS SOL-TERR PHY, V73, P1959, DOI 10.1016/j.jastp.2011.06.001; Wei W, 2012, J CLIMATE, V25, P6989, DOI 10.1175/JCLI-D-11-00667.1; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wu GX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00404; [杨保 Yang Bao], 2012, [第四纪研究, Quaternary Sciences], V32, P81; Yang B, 2012, HOLOCENE, V22, P773, DOI 10.1177/0959683611430411; Yang B, 2011, INT J CLIMATOL, V31, P1166, DOI 10.1002/joc.2143; Yang B, 2010, HOLOCENE, V20, P1235, DOI 10.1177/0959683610371997; Yang F, 2009, RES TOURISM GEOGRAPH; Zhang QB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017425; Zhang Y, 2009, IAWA J, V30, P407, DOI 10.1163/22941932-90000228	77	17	21	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57638	10.1371/journal.pone.0057638	http://dx.doi.org/10.1371/journal.pone.0057638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451254	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800114
J	Neaux, D; Guy, F; Gilissen, E; Coudyzer, W; Vignaud, P; Ducrocq, S				Neaux, Dimitri; Guy, Franck; Gilissen, Emmanuel; Coudyzer, Walter; Vignaud, Patrick; Ducrocq, Stephane			Facial Orientation and Facial Shape in Extant Great Apes: A Geometric Morphometric Analysis of Covariation	PLOS ONE			English	Article							RELATIVE BRAIN SIZE; CRANIAL BASE ANGULATION; PARTIAL LEAST-SQUARES; PLATE SPLINE ANALYSIS; MORPHOLOGICAL INTEGRATION; DEVELOPMENTAL INTEGRATION; BASICRANIAL FLEXION; SEXUAL DIMORPHISM; AFRICAN APES; MODULARITY	The organization of the bony face is complex, its morphology being influenced in part by the rest of the cranium. Characterizing the facial morphological variation and craniofacial covariation patterns in extant hominids is fundamental to the understanding of their evolutionary history. Numerous studies on hominid facial shape have proposed hypotheses concerning the relationship between the anterior facial shape, facial block orientation and basicranial flexion. In this study we test these hypotheses in a sample of adult specimens belonging to three extant hominid genera (Homo, Pan and Gorilla). Intraspecific variation and covariation patterns are analyzed using geometric morphometric methods and multivariate statistics, such as partial least squared on three-dimensional landmarks coordinates. Our results indicate significant intraspecific covariation between facial shape, facial block orientation and basicranial flexion. Hominids share similar characteristics in the relationship between anterior facial shape and facial block orientation. Modern humans exhibit a specific pattern in the covariation between anterior facial shape and basicranial flexion. This peculiar feature underscores the role of modern humans' highly-flexed basicranium in the overall integration of the cranium. Furthermore, our results are consistent with the hypothesis of a relationship between the reduction of the value of the cranial base angle and a downward rotation of the facial block in modern humans, and to a lesser extent in chimpanzees.	[Neaux, Dimitri; Guy, Franck; Vignaud, Patrick; Ducrocq, Stephane] Univ Poitiers, CNRS UMR 7262, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Poitiers, France; [Gilissen, Emmanuel] Royal Museum Cent Africa, Dept African Zool, Tervuren, Belgium; [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, Brussels, Belgium; [Gilissen, Emmanuel] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Coudyzer, Walter] Katholieke Univ Leuven Hosp, Dept Radiol, B-3000 Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Royal Museum for Central Africa; Universite Libre de Bruxelles; University of Arkansas System; University of Arkansas Fayetteville; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Neaux, D (corresponding author), Univ Poitiers, CNRS UMR 7262, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Poitiers, France.	dimitri.neaux@univ-poitiers.fr	Neaux, Dimitri/V-2606-2019	GUY, Franck/0000-0001-7032-7963; Coudyzer, Walter/0000-0002-6406-7496; Neaux, Dimitri/0000-0001-9465-220X	Minisere Francais de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche [ANR-09-BLAN-0238]; Ministere Francais des Affaires Etrangeres et Europeennes	Minisere Francais de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere Francais des Affaires Etrangeres et Europeennes	This work was supported by Minisere Francais de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche (ANR-09-BLAN-0238), and Ministere Francais des Affaires Etrangeres et Europeennes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1994, AM J PHYS ANTHROPOL, V95, P409, DOI 10.1002/ajpa.1330950405; Baab KL, 2010, AM J PHYS ANTHROPOL, V141, P97, DOI 10.1002/ajpa.21120; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; Bastir M, 2004, AM J PHYS ANTHROPOL, V123, P340, DOI 10.1002/ajpa.10313; Bastir M, 2008, ARCH ORAL BIOL, V53, P295, DOI 10.1016/j.archoralbio.2007.09.011; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bastir M, 2010, J HUM EVOL, V58, P424, DOI 10.1016/j.jhevol.2010.03.001; Bastir M, 2009, EVOL BIOL, V36, P57, DOI 10.1007/s11692-008-9037-4; Bastir M, 2008, J ANTHROPOL SCI, V86, P37; Berge C, 2004, AM J PHYS ANTHROPOL, V124, P124, DOI 10.1002/ajpa.10333; Biegert J., 1963, CLASSIFICATION HUMAN, P77; Bienvenu T, 2011, AM J PHYS ANTHROPOL, V145, P231, DOI 10.1002/ajpa.21488; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bookstein FL., 1991, MORPHOMETRICS TOOLS; BROMAGE TG, 1992, J HUM EVOL, V23, P235, DOI 10.1016/S0047-2484(05)80002-8; Bruner E, 2010, J ANAT, V216, P589, DOI 10.1111/j.1469-7580.2010.01221.x; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Chernoff B., 1999, MORPHOLOGICAL INTEGR, P319; Cheverud JM, 1996, AM ZOOL, V36, P44; Claude J, 2008, MORPHOMETRICS R; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Enlow D H, 1975, Birth Defects Orig Artic Ser, V11, P217; Enlow DH, 1996, ESSENTIALS FACIAL GR; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Gkantidis N, 2011, J ANAT, V218, P426, DOI 10.1111/j.1469-7580.2011.01346.x; Goswami A, 2010, PALEONTOLOGICAL SOC, V16, P213; Gould SJ, 1966, BIOL REV CAMB PHILOS, V41, P87; Guy F, 2005, P NATL ACAD SCI USA, V102, P18836, DOI 10.1073/pnas.0509564102; Guy F, 2003, AM J PHYS ANTHROPOL, V121, P198, DOI 10.1002/ajpa.10261; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2004, J EXP ZOOL PART B, V302B, P207, DOI 10.1002/jez.b.21002; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Kuroe K, 2004, EUR J ORTHODONT, V26, P201, DOI 10.1093/ejo/26.2.201; Laffont R, 2009, EVOL DEV, V11, P302, DOI 10.1111/j.1525-142X.2009.00332.x; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Lieberman Daniel E., 2000, Linnean Society Symposium Series, V20, P85; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 1999, J HUM EVOL, V36, P487, DOI 10.1006/jhev.1998.0287; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; McCarthy RC, 2001, J HUM EVOL, V40, P41, DOI 10.1006/jhev.2000.0446; McCarthy RC, 2001, ANAT REC, V264, P247, DOI 10.1002/ar.1167; McCollum MA, 1997, AM J PHYS ANTHROPOL, V102, P377, DOI 10.1002/(SICI)1096-8644(199703)102:3<377::AID-AJPA7>3.0.CO;2-S; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; OHIGGINS P, 1993, J HUM EVOL, V24, P183, DOI 10.1006/jhev.1993.1014; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Pavlicev M, 2009, EVOL BIOL, V36, P157, DOI 10.1007/s11692-008-9042-7; Penin X, 2001, CR ACAD SCI III-VIE, V324, P87, DOI 10.1016/S0764-4469(00)01260-9; Penin X, 1999, C R ACAD SCI 3, P322; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1996, ADV MORPHOMETRICS, P131; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Rosas A, 2008, ARCH ORAL BIOL, V53, P826, DOI 10.1016/j.archoralbio.2008.02.005; ROSS C, 1995, AM J PHYS ANTHROPOL, V98, P575, DOI 10.1002/ajpa.1330980413; ROSS CF, 1993, AM J PHYS ANTHROPOL, V91, P305, DOI 10.1002/ajpa.1330910306; ROSS CF, 1995, J HUM EVOL, V29, P201, DOI 10.1006/jhev.1995.1057; SHEA BT, 1983, AM J PHYS ANTHROPOL, V62, P275, DOI 10.1002/ajpa.1330620307; SHEA BT, 1985, AM J PHYS ANTHROPOL, V68, P329, DOI 10.1002/ajpa.1330680304; Singh N, 2012, J HUM EVOL, V62, P155, DOI 10.1016/j.jhevol.2011.11.006; Spoor F, 1997, S AFR J SCI, V93, P182; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; WAGNER GP, 1990, Z ZOOL SYST EVOL, V28, P48; Weidenreich F., 1941, T AM PHILOS SOC, V31, P320, DOI DOI 10.2307/1005610; Wiley D. F., 2005, P IEEE VIS 2005; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	82	10	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57026	10.1371/journal.pone.0057026	http://dx.doi.org/10.1371/journal.pone.0057026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441232	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200089
J	Weibel, S; Basse-Luesebrink, TC; Hess, M; Hofmann, E; Seubert, C; Langbein-Laugwitz, J; Gentschev, I; Sturm, VJF; Ye, YX; Kampf, T; Jakob, PM; Szalay, AA				Weibel, Stephanie; Basse-Luesebrink, Thomas Christian; Hess, Michael; Hofmann, Elisabeth; Seubert, Carolin; Langbein-Laugwitz, Johanna; Gentschev, Ivaylo; Sturm, Volker Joerg Friedrich; Ye, Yuxiang; Kampf, Thomas; Jakob, Peter Michael; Szalay, Aladar A.			Imaging of Intratumoral Inflammation during Oncolytic Virotherapy of Tumors by F-19-Magnetic Resonance Imaging (MRI)	PLOS ONE			English	Article							IN-VIVO; VACCINIA VIRUS; F-19 MRI; NONINVASIVE DETECTION; CANCER-THERAPY; NUDE-MICE; MACROPHAGES; MICROENVIRONMENTS; TOMOGRAPHY; PROGRESS	Background: Oncolytic virotherapy of tumors is an up-coming, promising therapeutic modality of cancer therapy. Unfortunately, non-invasive techniques to evaluate the inflammatory host response to treatment are rare. Here, we evaluate F-19 magnetic resonance imaging (MRI) which enables the non-invasive visualization of inflammatory processes in pathological conditions by the use of perfluorocarbon nanoemulsions (PFC) for monitoring of oncolytic virotherapy. Methodology/Principal Findings: The Vaccinia virus strain GLV-1h68 was used as an oncolytic agent for the treatment of different tumor models. Systemic application of PFC emulsions followed by H-1/F-19 MRI of mock-infected and GLV-1h68-infected tumor-bearing mice revealed a significant accumulation of the F-19 signal in the tumor rim of virus-treated mice. Histological examination of tumors confirmed a similar spatial distribution of the F-19 signal hot spots and CD68(+)-macrophages. Thereby, the CD68(+)-macrophages encapsulate the GFP-positive viral infection foci. In multiple tumor models, we specifically visualized early inflammatory cell recruitment in Vaccinia virus colonized tumors. Furthermore, we documented that the F-19 signal correlated with the extent of viral spreading within tumors. Conclusions/Significance: These results suggest F-19 MRI as a non-invasive methodology to document the tumor-associated host immune response as well as the extent of intratumoral viral replication. Thus, F-19 MRI represents a new platform to non-invasively investigate the role of the host immune response for therapeutic outcome of oncolytic virotherapy and individual patient response.	[Weibel, Stephanie; Basse-Luesebrink, Thomas Christian; Hess, Michael; Hofmann, Elisabeth; Seubert, Carolin; Langbein-Laugwitz, Johanna; Gentschev, Ivaylo; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany; [Basse-Luesebrink, Thomas Christian; Sturm, Volker Joerg Friedrich; Ye, Yuxiang; Kampf, Thomas; Jakob, Peter Michael] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany; [Basse-Luesebrink, Thomas Christian; Jakob, Peter Michael] Res Ctr Magnet Resonance Bavaria EV, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr, Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Calif San Diego Hlth Syst, Dept Radiat Med & Appl Sci, La Jolla, CA USA; [Gentschev, Ivaylo; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego	Szalay, AA (corresponding author), Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/F-9454-2011; Gentschev, Ivaylo/AAJ-5819-2021	Gentschev, Ivaylo/0000-0003-3743-6329; Jakob, Peter/0000-0002-3481-5545	Genelux Corporation (RAMP;D facility in San Diego, CA, USA); Genelux Corporation	Genelux Corporation (RAMP;D facility in San Diego, CA, USA); Genelux Corporation	This work was supported by a research grant and a service grant from Genelux Corporation (R&D facility in San Diego, CA, USA) awarded to the University of Wuerzburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from Genelux Corporation (R&D facility in San Diego, CA, USA). SW, TCBL, EH, and CS received a postdoctoral fellowship, MH received a graduate fellowship by Genelux Corporation awarded to the University of Wuerzburg, Germany. IG and AAS are salaried employees of Genelux Corporation and have personal financial interests in Genelux Corporation. All authors fully adhere to all the PLOS ONE ploicies on sharing data and materials.	Advani SJ, 2012, CLIN CANCER RES, V18, P2579, DOI 10.1158/1078-0432.CCR-11-2394; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bourke MG, 2011, CANCER TREAT REV, V37, P618, DOI 10.1016/j.ctrv.2010.12.003; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Donat U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045942; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Flogel U, 2011, AM J TRANSPLANT, V11, P235, DOI 10.1111/j.1600-6143.2010.03372.x; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Fulci G, 2007, CANCER RES, V67, P9398, DOI 10.1158/0008-5472.CAN-07-1063; Fulci G, 2006, P NATL ACAD SCI USA, V103, P12873, DOI 10.1073/pnas.0605496103; Gentschev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022069; Greer S, 2001, INT J RADIAT ONCOL, V51, P791, DOI 10.1016/S0360-3016(01)01706-0; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; HURST J, 1993, BRIT J CANCER, V68, P274, DOI 10.1038/bjc.1993.327; Hyafil F, 2007, NAT MED, V13, P636, DOI 10.1038/nm1571; Kadayakkara DK, 2012, LAB INVEST, V92, P636, DOI 10.1038/labinvest.2012.7; Kleijn A, 2011, CLIN CANCER RES, V17, P4484, DOI 10.1158/1078-0432.CCR-11-0575; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meadowcroft MD, 2007, MAGN RESON MED, V57, P835, DOI 10.1002/mrm.21213; Miller Janet C, 2004, J Am Coll Radiol, V1, P4, DOI 10.1016/S1546-1440(03)00025-5; Morchel P, 2010, RADIOTHER ONCOL, V96, P123, DOI 10.1016/j.radonc.2010.05.006; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Prestwich RJ, 2008, EXPERT REV ANTICANC, V8, P1581, DOI 10.1586/14737140.8.10.1581; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Rowan K, 2010, J NATL CANCER I, V102, P590, DOI 10.1093/jnci/djq165; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sabatino M, 2008, CANCER RES, V68, P122, DOI 10.1158/0008-5472.CAN-07-1939; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Srinivas M, 2009, MAGN RESON MED, V62, P747, DOI 10.1002/mrm.22063; Stoll G, 2012, WIRES NANOMED NANOBI, V4, P438, DOI 10.1002/wnan.1168; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Temme S, 2012, WIRES NANOMED NANOBI, V4, P329, DOI 10.1002/wnan.1163; Thorne SH, 2011, IMMUNOL RES, V50, P286, DOI 10.1007/s12026-011-8211-4; Urruticoechea A, 2010, CURR PHARM DESIGN, V16, P3, DOI 10.2174/138161210789941847; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Weibel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-68; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	46	22	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56317	10.1371/journal.pone.0056317	http://dx.doi.org/10.1371/journal.pone.0056317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441176	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200033
J	Cai, QF; Wan, F; Huang, K; Zhang, HW				Cai, Qianfang; Wan, Fei; Huang, Kai; Zhang, Hanwang			Does the Number of Oocytes Retrieved Influence Pregnancy after Fresh Embryo Transfer?	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; OVARIAN STIMULATION; CLOMIPHENE CITRATE; PREDICTIVE FACTORS; POOR RESPONDER; IVF TREATMENT; MATERNAL AGE; RATES; MORPHOLOGY; OUTCOMES	Background: The nature of the association between the number of oocytes retrieved and in vitro fertilization (IVF) outcomes after fresh embryo transfer remains unclear because of conflicting results reported in the studies on this subject. In addition, the influence of the quality of the embryos transferred is usually neglected. The objective of this study is to assess the relationships of the number of oocytes retrieved, the number and quality of embryos transferred, and the prospects of pregnancy after fresh embryo transfer. Methods: The data on 3131 infertile women undergoing their first IVF treatment cycle between January 2009 and December 2010 were collected retrospectively. Restricted cubic splines and stratified analyses were used to explore the relationships between the number of oocytes retrieved, the number and quality of embryos transferred, and the IVF outcomes. Results: When stratified by the number and quality of transferred embryos, no significant differences in the chances for clinical pregnancy and live birth were found in three groups of oocytes yielded (<= 6, 7-14, or >= 15). The relationship between the number of oocytes retrieved and pregnancy is nearly a reflection of the pattern of the relationship between the number of oocytes retrieved and the probability of having two good-quality embryos transferred. The patients with the "optimal" number of oocytes were not only younger but also had the highest probability of having two good-quality embryos replaced. Conclusions: Similarly aged patients have similar pregnancy prospects after fresh embryo transfer when the same number and quality of embryos are replaced, irrespective of their number of oocytes. Selecting the desired number of good-quality embryos for transfer is the key to IVF success. Thus, aiming at retrieving an optimal number of oocytes to maximize IVF outcomes in a fresh cycle could place undue stress on the patients and may not be the best medical decision.	[Cai, Qianfang] Women & Childrens Hosp Guangdong Prov, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wan, Fei] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Huang, Kai; Zhang, Hanwang] Huazhong Univ Sci & Technol, Reprod Med Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	University of Pennsylvania; Huazhong University of Science & Technology	Zhang, HW (corresponding author), Huazhong Univ Sci & Technol, Reprod Med Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	hwzhang605@126.com	; Sampaolesi, Maurilio/H-6509-2013	Huang, Kai/0000-0003-0102-6862; Sampaolesi, Maurilio/0000-0002-2422-3757				Baruffi RLR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-36; Bosch E, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-82; Cai QF, 2011, HUM REPROD, V26, P2532, DOI 10.1093/humrep/der228; Collins J, 2009, HUM REPROD UPDATE, V15, P1, DOI 10.1093/humupd/dmn054; De Sutter P, 2003, FERTIL STERIL, V79, P1294, DOI 10.1016/S0015-0282(03)00264-4; Fisch JD, 2003, FERTIL STERIL, V80, P1352, DOI 10.1016/j.fertnstert.2003.05.013; Gleicher N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-48; HARRELL FE, 2001, REGRESSION MODELING, P20; Hosmer D. W., 2000, APPL LOGISTIC REGRES, P223; Hunault CC, 2002, FERTIL STERIL, V77, P725, DOI 10.1016/S0015-0282(01)03243-5; Marquez C, 2000, Reprod Biomed Online, V1, P17; Meniru GI, 1997, HUM REPROD, V12, P2129, DOI 10.1093/humrep/12.10.2129; Munne S, 2007, REPROD BIOMED ONLINE, V14, P628, DOI 10.1016/S1472-6483(10)61057-7; MUNNE S, 1995, FERTIL STERIL, V64, P382, DOI 10.1016/S0015-0282(16)57739-5; Ottosen LDM, 2007, J ASSIST REPROD GEN, V24, P29, DOI 10.1007/s10815-006-9082-9; Oudendijk JF, 2012, HUM REPROD UPDATE, V18, P1, DOI 10.1093/humupd/dmr037; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Pelinck MJ, 2008, HUM REPROD, V23, P1808, DOI 10.1093/humrep/den155; Popovic-Todorovic B, 2003, HUM REPROD, V18, P2275, DOI 10.1093/humrep/deg472; Roberts SA, 2010, HUM REPROD, V25, P2792, DOI 10.1093/humrep/deq213; Roberts SA, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14380; Roberts SA, 2009, HUM REPROD, V24, P122, DOI 10.1093/humrep/den355; Schimberni M, 2009, FERTIL STERIL, V92, P1297, DOI 10.1016/j.fertnstert.2008.07.1765; Segawa T, 2007, FERTIL STERIL, V88, pS286, DOI 10.1016/j.fertnstert.2007.07.967; Strandell A, 2000, HUM REPROD, V15, P2520, DOI 10.1093/humrep/15.12.2520; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; TASDEMIR M, 1995, HUM REPROD, V10, P2155; Teramoto S, 2007, REPROD BIOMED ONLINE, V15, P134, DOI 10.1016/S1472-6483(10)60701-8; Terriou P, 2001, FERTIL STERIL, V75, P525, DOI 10.1016/S0015-0282(00)01741-6; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; van der Gaast MH, 2006, REPROD BIOMED ONLINE, V13, P476, DOI 10.1016/S1472-6483(10)60633-5; van Loendersloot LL, 2010, HUM REPROD UPDATE, V16, P577, DOI 10.1093/humupd/dmq015; Yih MC, 2005, FERTIL STERIL, V83, P24, DOI 10.1016/j.fertnstert.2004.05.096	33	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56189	10.1371/journal.pone.0056189	http://dx.doi.org/10.1371/journal.pone.0056189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457525	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700025
J	Lu, CL; Liu, Q; Sarma, A; Fitzpatrick, C; Falzon, D; Mitnick, CD				Lu, Chunling; Liu, Qing; Sarma, Aartik; Fitzpatrick, Christopher; Falzon, Dennis; Mitnick, Carole D.			A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment	PLOS ONE			English	Article							COMMUNITY-BASED CARE; PULMONARY TUBERCULOSIS; FLUORESCENCE MICROSCOPY; SOUTH-AFRICA; INFECTED PATIENTS; RAPID DIAGNOSIS; ZIEHL-NEELSEN; CAPE-TOWN; SPUTUM; PERFORMANCE	Background: In 2011, World Health Organization revised its recommendation for microbiological monitoring during treatment for multidrug-resistant tuberculosis (MDR-TB) by increasing the frequency of culture examination from quarterly to monthly after culture conversion. Implementing the recommendation requires substantial additional investment in laboratory infrastructure. The objective of this review is to provide cost evidence that is needed for national TB programs to budget for optimal monitoring strategies. Methods and Findings: We conducted the first systematic literature review on unit cost estimates of three monitoring strategies: 1) smear only; 2) culture only; 3) combined smear and culture. 26 peer-reviewed studies were selected by searching 10 databases in English and Chinese for literature published between 1995 and 2012. Cost estimates were converted into 2010 constant USD and international dollars. We assessed the quality of the estimates using a matrix with five essential elements and provided a cost projection for the combined smear and culture tests where the data were available. The 26 studies reported the cost estimates in 16 predominantly high- or middle-income countries from 1993 to 2009. The estimated unit cost for smear, culture, and combined tests ranges from $0.26 to $10.50, $1.63 to $62.01, and $26.73 to $39.57, respectively. The ratio of culture to smear costs varies from 1.35 to 11.98. The wide range of estimates is likely attributable to using different laboratory methods in different regions and years and differing practices in collecting and reporting cost data. Most studies did not report information critical for generalizing their conclusions. Conclusion: The paucity and low quality of unit cost estimates for TB monitoring in resource-poor settings impose technical challenges in predicting the resources needed for strengthening microbiological monitoring. To improve the validity and comparability of the cost data, we strongly advocate the data collection, estimation, and reporting follow protocols proposed by WHO.	[Lu, Chunling] Brigham & Womens Hosp, Dept Med, Div Global Equ, Boston, MA 02115 USA; [Lu, Chunling; Mitnick, Carole D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Liu, Qing] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Sarma, Aartik] Harvard Univ, Sch Med, Boston, MA USA; [Fitzpatrick, Christopher; Falzon, Dennis] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; World Health Organization	Lu, CL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Global Equ, 75 Francis St, Boston, MA 02115 USA.	Chunling_Lu@hms.harvard.edu	Mitnick, Carole/GRO-1991-2022	Mitnick, Carole/0000-0002-3455-658X; Sarma, Aartik/0000-0002-7508-7345	NIH [1K0HD07 1929-01]; World Health Organization; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD071929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Health Organization(World Health Organization); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by NIH 1K0HD07 1929-01 and the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DF and CF are staff members of the World Health Organization (WHO). The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of WHO. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, nor concerning the delimitation of its frontiers or boundaries.	Albert H, 2004, INT J TUBERC LUNG D, V8, P240; Balabanova Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007129; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; [陈群飞 CHEN Qunfei], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P768; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Heymann SJ, 1997, PUBLIC HEALTH REP, V112, P513; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Kamolratanakul Pirom, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P321; Kanaujia GV, 2005, INT J TUBERC LUNG D, V9, P1120; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Lagrange PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043739; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Matee M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-68; Menzies D, 2008, CAN J PUBLIC HEALTH, V99, P391, DOI 10.1007/BF03405248; Migliori GB, 1999, B WORLD HEALTH ORGAN, V77, P467; Mueller DH, 2008, INT J TUBERC LUNG D, V12, P1196; Muniyandi M., 2006, Indian Journal of Tuberculosis, V53, P12; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Rajalahti I, 2004, EUR RESPIR J, V23, P446, DOI 10.1183/09031936.04.00009704; Rouse DJE, 2001, EC TB DRUG DEV NEW D; Scherer LC, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-216; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Sohn H, 2009, INT J TUBERC LUNG D, V13, P266; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Whitelaw A, 2011, EUR RESPIR J, V38, P1393, DOI 10.1183/09031936.00023211; WHO, 2005, EFF TB LAB SERV RUSS; Wurtz R, 1999, INT J TUBERC LUNG D, V3, P382	34	19	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56074	10.1371/journal.pone.0056074	http://dx.doi.org/10.1371/journal.pone.0056074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457502	Green Published, gold			2022-12-27	WOS:000315603700021
J	Nakaso, K; Tajima, N; Ito, S; Teraoka, M; Yamashita, A; Horikoshi, Y; Kikuchi, D; Mochida, S; Nakashima, K; Matsura, T				Nakaso, Kazuhiro; Tajima, Naoko; Ito, Satoru; Teraoka, Mari; Yamashita, Atsushi; Horikoshi, Yosuke; Kikuchi, Daisuke; Mochida, Shinsuke; Nakashima, Kenji; Matsura, Tatsuya			Dopamine-Mediated Oxidation of Methionine 127 in alpha-Synuclein Causes Cytotoxicity and Oligomerization of alpha-Synuclein	PLOS ONE			English	Article							SULFOXIDE-REDUCTASE-A; PARKINSONS-DISEASE; NERVOUS-SYSTEM; NEURODEGENERATION; NEUROTOXICITY; PATHOGENESIS; TYROSINASE; COMPONENT; RESIDUES; GENETICS	Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective loss of dopaminergic neurons and the presence of Lewy bodies. Many recent studies focused on the interaction between alpha-synuclein (alpha-syn) and dopamine in the pathogenesis of PD, and fluorescent anisotropy suggested that the C-terminal region of alpha-syn may be a target for modification by dopamine. However, it is not well understood why PD-related pathogenesis occurs selectively in dopaminergic neurons. We investigated the interaction between dopamine and alpha-syn with regard to cytotoxicity. A soluble oligomer was formed by co-incubating alpha-syn and dopamine in vitro. To clarify the effect of dopamine on alpha-syn in cells, we generated PC12 cells expressing human alpha-syn, as well as the alpha-syn mutants, M116A, Y125D, M127A, S129A, and M116A/M127A, in a tetracycline-inducible manner (PC12-TetOFF-alpha-syn). Overexpression of wildtype alpha-syn in catecholaminergic PC12 cells decreased cell viability in long-term cultures, while a competitive inhibitor of tyrosine hydroxylase blocked this vulnerability, suggesting that alpha-syn-related cytotoxicity is associated with dopamine metabolism. The vulnerabilities of all mutant cell lines were lower than that of wildtype alpha-syn-expressing cells. Moreover, alpha-syn containing dopamine-mediated oxidized methionine (Met(O)) was detected in PC12-TetOFF-alpha-syn. Met(O) was lower in methionine mutant cells, especially in the M127A or M116A/M127A mutants, but also in the Y125D and S129A mutants. Co-incubation of dopamine and the 125YEMPS129 peptide enhanced the production of H2O2, which may oxidize methionine residues and convert them to Met(O). Y125- or S129-lacking peptides did not enhance the dopamine-related production of H2O2. Our results suggest that M127 is the major target for oxidative modification by dopamine, and that Y125 and S129 may act as enhancers of this modification. These results may describe a mechanism of dopaminergic neuron-specific toxicity of alpha-syn in the pathogenesis of PD.	[Nakaso, Kazuhiro; Tajima, Naoko; Teraoka, Mari; Yamashita, Atsushi; Horikoshi, Yosuke; Kikuchi, Daisuke; Matsura, Tatsuya] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Med Biochem, Yonago, Tottori 683, Japan; [Ito, Satoru; Nakashima, Kenji] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, Yonago, Tottori 683, Japan; [Teraoka, Mari] Tottori Univ, Fac Med, Dept Surg, Div Emergency & Disaster Med, Yonago, Tottori 683, Japan; [Mochida, Shinsuke] Tottori Univ, Fac Med, Dept Surg, Div Anesthesiol & Crit Med, Yonago, Tottori 683, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Nakaso, K (corresponding author), Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Med Biochem, Yonago, Tottori 683, Japan.	kazuhiro@med.tottori-u.ac.jp		Horikoshi, Yosuke/0000-0001-6587-644X	Ministry of Education, Science, and Culture of Japan [24591262, 23592288, 23580168]; Grants-in-Aid for Scientific Research [23580168, 23590881] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Kazuhiro Nakaso: a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 24591262), Shinsuke Mochida: a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 23592288), Tatsuya Matsura: a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 23580168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Chadchankar H, 2011, BRAIN RES, V1382, P37, DOI 10.1016/j.brainres.2011.01.064; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Crosiers D, 2011, J CHEM NEUROANAT, V42, P131, DOI 10.1016/j.jchemneu.2011.07.003; Derkinderen P, 2011, NEUROLOGY, V77, P1761, DOI 10.1212/WNL.0b013e318236ef60; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ito S, 2010, NEUROSCI RES, V66, P124, DOI 10.1016/j.neures.2009.10.005; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Micieli G, 2003, NEUROL SCI, V24, pS32, DOI 10.1007/s100720300035; Mizuno Y, 2008, PHILOS T R SOC B, V363, P2215, DOI 10.1098/rstb.2008.2273; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Oien DB, 2009, J MOL NEUROSCI, V39, P323, DOI 10.1007/s12031-009-9274-8; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saiki S, 2012, J NEUROL NEUROSUR PS, V83, P430, DOI 10.1136/jnnp-2011-301205; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yoshimoto Y, 2005, FEBS LETT, V579, P1197, DOI 10.1016/j.febslet.2004.12.091; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	47	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55068	10.1371/journal.pone.0055068	http://dx.doi.org/10.1371/journal.pone.0055068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457458	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700012
J	Birrane, G; Mulvaney, EP; Pal, R; Kinsella, BT; Kocher, O				Birrane, Gabriel; Mulvaney, Eamon P.; Pal, Rinku; Kinsella, B. Therese; Kocher, Olivier			Molecular Analysis of the Prostacyclin Receptor's Interaction with the PDZ1 Domain of Its Adaptor Protein PDZK1	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; B TYPE-I; TARGET BINDING; C-TERMINUS; SR-BI; ISOPRENYLATION; IDENTIFICATION; RECOGNITION; SCAFFOLD; COMPLEX	The prostanoid prostacyclin, or prostaglandin I-2, plays an essential role in many aspects of cardiovascular disease. The actions of prostacyclin are mainly mediated through its activation of the prostacyclin receptor or, in short, the IP. In recent studies, the cytoplasmic carboxy-terminal domain of the IP was shown to bind several PDZ domains of the multi-PDZ adaptor PDZK1. The interaction between the two proteins was found to enhance cell surface expression of the IP and to be functionally important in promoting prostacyclin-induced endothelial cell migration and angiogenesis. To investigate the interaction of the IP with the first PDZ domain (PDZ1) of PDZK1, we generated a nine residue peptide (KK(411)IAACSLC(417)) containing the seven carboxy-terminal amino acids of the IP and measured its binding affinity to a recombinant protein corresponding to PDZ1 by isothermal titration calorimetry. We determined that the IP interacts with PDZ1 with a binding affinity of 8.2 mu M. Using the same technique, we also determined that the farnesylated form of carboxy-terminus of the IP does not bind to PDZ1. To understand the molecular basis of these findings, we solved the high resolution crystal structure of PDZ1 bound to a 7-residue peptide derived from the carboxy-terminus of the non-farnesylated form of IP ((411)IAACSLC(417)). Analysis of the structure demonstrates a critical role for the three carboxy-terminal amino acids in establishing a strong interaction with PDZ1 and explains the inability of the farnesylated form of IP to interact with the PDZ1 domain of PDZK1 at least in vitro.	[Birrane, Gabriel] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA; [Mulvaney, Eamon P.; Kinsella, B. Therese] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Pal, Rinku; Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Pal, Rinku; Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University College Dublin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kocher, O (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	okocher@bidmc.harvard.edu		Kinsella, B. Therese/0000-0003-3072-941X; Mulvaney, Eamon/0000-0003-3661-2116; Birrane, Gabriel/0000-0002-1759-5499	National Institute of Health [HL077780]; Science Foundation of Ireland [SFI:05/IN.1/B19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Health Grant HL077780 (to O.K.) and by the Science Foundation of Ireland Grant SFI:05/IN.1/B19 (to B. T. K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Gryglewski RJ, 2008, PHARMACOL REP, V60, P3; Hayes JS, 1999, J BIOL CHEM, V274, P23707, DOI 10.1074/jbc.274.34.23707; Hu SQ, 2009, CELL PHYSIOL BIOCHEM, V24, P231, DOI 10.1159/000233258; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212; Kawabe J, 2010, CIRC J, V74, P836, DOI 10.1253/circj.CJ-10-0195; Kim JK, 2012, J BIOL CHEM, V287, P21012, DOI 10.1074/jbc.M111.337865; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 1999, LAB INVEST, V79, P1161; Kocher O, 2011, J BIOL CHEM, V286, P25171, DOI 10.1074/jbc.M111.242362; Kocher O, 2010, J BIOL CHEM, V285, P34999, DOI 10.1074/jbc.M110.164418; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; MALTESE WA, 1990, FASEB J, V4, P3319, DOI 10.1096/fasebj.4.15.2123808; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miggin SM, 2002, EUR J BIOCHEM, V269, P1714, DOI 10.1046/j.1432-1327.2002.02817.x; O'Meara SJ, 2005, BIOCHEM J, V386, P177, DOI 10.1042/BJ20041290; O'Meara SJ, 2004, BRIT J PHARMACOL, V143, P318, DOI 10.1038/sj.bjp.0705956; O'Meara SJ, 2004, BRIT J PHARMACOL, V143, P292, DOI 10.1038/sj.bjp.0705947; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; RIBEIRO LGT, 1981, AM J CARDIOL, V47, P835, DOI 10.1016/0002-9149(81)90182-X; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Turner EC, 2011, MOL BIOL CELL, V22, P2664, DOI 10.1091/mbc.E11-04-0374; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007; Zhang Q, 2001, J BIOL CHEM, V276, P43216, DOI 10.1074/jbc.M105996200; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	49	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53819	10.1371/journal.pone.0053819	http://dx.doi.org/10.1371/journal.pone.0053819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23457445	Green Submitted, gold, Green Published			2022-12-27	WOS:000315153400017
J	Ibarra, JA; Garcia-Zacarias, CM; Lara-Ochoa, C; Carabarin-Lima, A; Tecpanecatl-Xihuitl, JS; Perez-Rueda, E; Martinez-Laguna, Y; Puente, JL				Antonio Ibarra, J.; Garcia-Zacarias, Claudia M.; Lara-Ochoa, Cristina; Carabarin-Lima, Alejandro; Sergio Tecpanecatl-Xihuitl, J.; Perez-Rueda, Ernesto; Martinez-Laguna, Ygnacio; Puente, Jose L.			Further Characterization of Functional Domains of PerA, Role of Amino and Carboxy Terminal Domains in DNA Binding	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; ALANINE-SCANNING MUTAGENESIS; BUNDLE-FORMING PILUS; TRANSCRIPTIONAL ACTIVATOR; ARAC/XYLS FAMILY; RNA-POLYMERASE; REGULATOR; VIRULENCE; PROTEIN; EXPRESSION	PerA is a key regulator of virulence genes in enteropathogenic E. coli. PerA is a member of the AraC/XylS family of transcriptional regulators that directly regulates the expression of the bfp and per operons in response to different environmental cues. Here, we characterized mutants in both the amino (NTD) and carboxy (CTD) terminal domains of PerA that affect its ability to activate the expression of the bfp and per promoters. Mutants at residues predicted to be important for DNA binding within the CTD had a significant defect in their ability to bind to the regulatory regions of the bfp and per operons and, consequently, in transcriptional activation. Notably, mutants in specific NTD residues were also impaired to bind to DNA suggesting that this domain is involved in structuring the protein for correct DNA recognition. Mutations in residues E116 and D168, located in the vicinity of the putative linker region, significantly affected the activation of the perA promoter, without affecting PerA binding to the per or bfp regulatory sequences. Overall these results provide additional evidence of the importance of the N-terminal domain in PerA activity and suggest that the activation of these promoters involves differential interactions with the transcriptional machinery. This study further contributes to the characterization of the functional domains of PerA by identifying critical residues involved in DNA binding, differential promoter activation and, potentially, in the possible response to environmental cues.	[Antonio Ibarra, J.; Lara-Ochoa, Cristina; Puente, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [Garcia-Zacarias, Claudia M.; Lara-Ochoa, Cristina; Carabarin-Lima, Alejandro; Sergio Tecpanecatl-Xihuitl, J.; Martinez-Laguna, Ygnacio] Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico	Ibarra, JA (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	ibarraj@usf.edu; puente@ibt.unam.mx	Perez-Rueda, Ernesto/F-8337-2013; Ibarra, J. Antonio/R-2030-2018; lima, Alejandro carabarin-/J-4004-2013; Garcia-Zacarias, Claudia Maria/AAX-9639-2020; Perez-Rueda, Ernesto/D-7468-2016	Ibarra, J. Antonio/0000-0002-5016-0622; lima, Alejandro carabarin-/0000-0002-0162-4929; Garcia-Zacarias, Claudia Maria/0000-0002-8909-6744; Puente, Jose/0000-0002-8411-4974; Perez-Rueda, Ernesto/0000-0002-6879-0673	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [60796, 154287, 36477-N]; Direccion General de Asuntos del Personal Academico (DGAPA) [IN227410, IN-209511]; CONACyT [86036, 165332, 180540]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico (DGAPA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia (CONACyT, www.conacyt.gob.mx) (60796 and 154287 to JLP and 36477-N to YML), and from Direccion General de Asuntos del Personal Academico (DGAPA, www.http://dgapa.unam.mx/) (IN227410 to JLP and IN-209511 for EPR). JAI, CLO and ACL were supported by fellowships from CONACyT (86036, 165332 and 180540 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basturea GN, 2008, J BACTERIOL, V190, P2279, DOI 10.1128/JB.01705-07; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Bustamante VH, 2011, MOL MICROBIOL, V82, P398, DOI 10.1111/j.1365-2958.2011.07819.x; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Childers BM, 2007, J MOL BIOL, V367, P1413, DOI 10.1016/j.jmb.2007.01.061; Childers BM, 2011, J BIOL CHEM, V286, P28644, DOI 10.1074/jbc.M111.258780; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Furnham N, 2006, STRUCTURE, V14, P1313, DOI 10.1016/j.str.2006.06.014; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gillette WK, 2000, J MOL BIOL, V299, P1245, DOI 10.1006/jmbi.2000.3827; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Griffith KL, 2002, J MOL BIOL, V322, P237, DOI 10.1016/S0022-2836(02)00782-9; Humphries RM, 2010, FUTURE MICROBIOL, V5, P1645, DOI 10.2217/FMB.10.124; Ibarra JA, 2008, GENETICA, V133, P65, DOI 10.1007/s10709-007-9185-y; Ibarra JA, 2003, J BACTERIOL, V185, P2835, DOI 10.1128/JB.185.9.2835-2847.2003; Iida M, 2010, MICROBIOL IMMUNOL, V54, P184, DOI 10.1111/j.1348-0421.2010.00212.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Mahon V, 2010, MICROBIOL-SGM, V156, P2796, DOI 10.1099/mic.0.038521-0; Martinez-Laguna Y, 1999, MOL MICROBIOL, V33, P153, DOI 10.1046/j.1365-2958.1999.01460.x; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Okeke IN, 2001, INFECT IMMUN, V69, P5553, DOI 10.1128/IAI.69.9.5553-5564.2001; Porter ME, 2004, MOL MICROBIOL, V54, P1117, DOI 10.1111/j.1365-2958.2004.04333.x; Porter ME, 2002, J BACTERIOL, V184, P531, DOI 10.1128/JB.184.2.531-539.2002; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Ruiz R, 2002, J BIOL CHEM, V277, P7282, DOI 10.1074/jbc.M110226200; Ruiz R, 2001, BIOCHEM BIOPH RES CO, V287, P519, DOI 10.1006/bbrc.2001.5615; Sambrook J., 2001, MOL CLONING LAB MANU; SOHEL I, 1993, MOL MICROBIOL, V7, P563, DOI 10.1111/j.1365-2958.1993.tb01147.x; Sohel I, 1996, J BACTERIOL, V178, P2613, DOI 10.1128/jb.178.9.2613-2628.1996; Stone KD, 1996, MOL MICROBIOL, V20, P325, DOI 10.1111/j.1365-2958.1996.tb02620.x; Tobe T, 1999, MOL MICROBIOL, V33, P741, DOI 10.1046/j.1365-2958.1999.01522.x; Tobe T, 1996, MOL MICROBIOL, V21, P963, DOI 10.1046/j.1365-2958.1996.531415.x	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56977	10.1371/journal.pone.0056977	http://dx.doi.org/10.1371/journal.pone.0056977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451127	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500050
J	Dukart, J; Perneczky, R; Forster, S; Barthel, H; Diehl-Schmid, J; Draganski, B; Obrig, H; Santarnecchi, E; Drzezga, A; Fellgiebel, A; Frackowiak, R; Kurz, A; Muller, K; Sabri, O; Schroeter, ML; Yakushev, I				Dukart, Juergen; Perneczky, Robert; Foerster, Stefan; Barthel, Henryk; Diehl-Schmid, Janine; Draganski, Bogdan; Obrig, Hellmuth; Santarnecchi, Emiliano; Drzezga, Alexander; Fellgiebel, Andreas; Frackowiak, Richard; Kurz, Alexander; Mueller, Karsten; Sabri, Osama; Schroeter, Matthias L.; Yakushev, Igor			Reference Cluster Normalization Improves Detection of Frontotemporal Lobar Degeneration by Means of FDG-PET	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; F-18-FDG PET; PARKINSONS-DISEASE; PATHOLOGICAL HETEROGENEITY; GLUCOSE-METABOLISM; DEMENTIA; METAANALYSIS; BRAIN	Positron emission tomography with [18F] fluorodeoxyglucose (FDG-PET) plays a well-established role in assisting early detection of frontotemporal lobar degeneration (FTLD). Here, we examined the impact of intensity normalization to different reference areas on accuracy of FDG-PET to discriminate between patients with mild FTLD and healthy elderly subjects. FDG-PET was conducted at two centers using different acquisition protocols: 41 FTLD patients and 42 controls were studied at center 1, 11 FTLD patients and 13 controls were studied at center 2. All PET images were intensity normalized to the cerebellum, primary sensorimotor cortex (SMC), cerebral global mean (CGM), and a reference cluster with most preserved FDG uptake in the aforementioned patients group of center 1. Metabolic deficits in the patient group at center 1 appeared 1.5, 3.6, and 4.6 times greater in spatial extent, when tracer uptake was normalized to the reference cluster rather than to the cerebellum, SMC, and CGM, respectively. Logistic regression analyses based on normalized values from FTLD-typical regions showed that at center 1, cerebellar, SMC, CGM, and cluster normalizations differentiated patients from controls with accuracies of 86%, 76%, 75% and 90%, respectively. A similar order of effects was found at center 2. Cluster normalization leads to a significant increase of statistical power in detecting early FTLD-associated metabolic deficits. The established FTLD-specific cluster can be used to improve detection of FTLD on a single case basis at independent centers - a decisive step towards early diagnosis and prediction of FTLD syndromes enabling specific therapies in the future.	[Dukart, Juergen; Draganski, Bogdan; Frackowiak, Richard] Univ Lausanne, LREN, Dept Neurosci Clin, CHUV, Lausanne, Switzerland; [Obrig, Hellmuth; Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany; [Dukart, Juergen; Obrig, Hellmuth; Mueller, Karsten; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Barthel, Henryk; Sabri, Osama; Schroeter, Matthias L.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Draganski, Bogdan] Charite, Mind Brain Inst, Berlin, Germany; [Draganski, Bogdan] Humboldt Univ, D-10099 Berlin, Germany; [Barthel, Henryk; Sabri, Osama] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Perneczky, Robert; Diehl-Schmid, Janine; Kurz, Alexander] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany; [Foerster, Stefan; Drzezga, Alexander; Yakushev, Igor] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany; [Santarnecchi, Emiliano] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Fellgiebel, Andreas; Yakushev, Igor] Univ Med Ctr Mainz, Mainz, Germany; [Perneczky, Robert] Univ London Imperial Coll Sci Technol & Med, Neuroepidemiol & Ageing Res Unit, Sch Publ Hlth, Fac Med, London, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leipzig University; Max Planck Society; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Leipzig University; Technical University of Munich; University of Munich; Technical University of Munich; University of Munich; University of Siena; Johannes Gutenberg University of Mainz; Imperial College London	Dukart, J (corresponding author), Univ Lausanne, LREN, Dept Neurosci Clin, CHUV, Lausanne, Switzerland.	dukart@cbs.mpg.de	Draganski, Bogdan/C-3096-2016; Frackowiak, Richard S/I-1809-2013; Perneczky, Robert/AAJ-2550-2020; Frackowiak, Richard/H-4383-2011; Santarnecchi, Emiliano/H-7528-2017	Draganski, Bogdan/0000-0002-5159-5919; Frackowiak, Richard/0000-0002-3151-822X; Santarnecchi, Emiliano/0000-0002-6533-7427; Dukart, Juergen/0000-0003-0492-5644; Diehl-Schmid, Janine/0000-0002-7745-1382; Drzezga, Alexander/0000-0001-6018-716X; Yakushev, Igor/0000-0003-4764-798X; Perneczky, Robert/0000-0003-1981-7435	Leipzig Research Center for Civilization Diseases (LIFE) at the University of Leipzig; European Union; European Regional Development Fund (ERFD); Free State of Saxony within the framework of the excellence initiative; German consortium; German Federal Ministry of Education and Research	Leipzig Research Center for Civilization Diseases (LIFE) at the University of Leipzig; European Union(European Commission); European Regional Development Fund (ERFD)(European Commission); Free State of Saxony within the framework of the excellence initiative; German consortium; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Henryk Barthel, Osama Sabri and Matthias L. Schroeter are supported by the Leipzig Research Center for Civilization Diseases (LIFE) at the University of Leipzig. LIFE is funded by the European Union, the European Regional Development Fund (ERFD) and the Free State of Saxony within the framework of the excellence initiative. Matthias L. Schroeter, Robert Perneczky, Alexander Kurz and Janine Diehl-Schmid are also supported by the German consortium for frontotemporal lobar degeneration, funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Berti V, 2012, Q J NUCL MED MOL IM, V56, P299; Borghammer P, 2012, ACTA NEUROL SCAND, V125, P303, DOI 10.1111/j.1600-0404.2011.01556.x; Borghammer P, 2012, J NEUROL SCI, V313, P123, DOI 10.1016/j.jns.2011.09.010; Borghammer P, 2009, NEUROIMAGE, V47, P1514, DOI 10.1016/j.neuroimage.2009.05.040; Borghammer P, 2009, NEUROIMAGE, V46, P981, DOI 10.1016/j.neuroimage.2009.03.021; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl-Schmid J, 2007, NEUROBIOL AGING, V28, P42, DOI 10.1016/j.neurobiolaging.2005.11.002; Dukart J, 2012, PSYCHIAT RES, DOI DOI 10.1016/J.PSCYCHRESNS.2012.1004.1007; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018111; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Gavrilescu M, 2002, NEUROIMAGE, V17, P532, DOI 10.1006/nimg.2002.1226; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Ibach B, 2004, NEUROIMAGE, V23, P739, DOI 10.1016/j.neuroimage.2004.06.041; Ishii K, 1998, J NUCL MED, V39, P293; Jeong Y, 2005, J NUCL MED, V46, P233; Kipps CM, 2009, BRAIN, V132, P2566, DOI 10.1093/brain/awp077; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MINOSHIMA S, 1995, J COMPUT ASSIST TOMO, V19, P541, DOI 10.1097/00004728-199507000-00006; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ana.20963; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Perneczky R, 2006, AM J GERIAT PSYCHIAT, V14, P139, DOI 10.1097/01.JGP.0000192478.82189.a8; Perneczky R, 2008, EUR J NUCL MED MOL I, V35, P605, DOI 10.1007/s00259-007-0626-8; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Poljansky S, 2011, EUR ARCH PSY CLIN N, V261, P433, DOI 10.1007/s00406-010-0184-0; Rostomian AH, 2011, J NUCL MED, V52, P173, DOI 10.2967/jnumed.110.082057; Sadeghi N, 2008, I S BIOMED IMAGING, P408, DOI 10.1109/ISBI.2008.4541019; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Samuraki M, 2007, EUR J NUCL MED MOL I, V34, P1658, DOI 10.1007/s00259-007-0454-x; Santens P, 2001, EUR NEUROL, V45, P19, DOI 10.1159/000052084; Schroeter ML, 2008, NEUROBIOL AGING, V29, P418, DOI 10.1016/j.neurobiolaging.2006.10.023; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schroeter ML, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00010; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Silverman DHS, 2004, J NUCL MED, V45, P594; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; TIEN RD, 1992, AM J ROENTGENOL, V158, P1155, DOI 10.2214/ajr.158.5.1566683; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Yakushev I, 2009, NEUROIMAGE, V44, P43, DOI 10.1016/j.neuroimage.2008.07.015; Yakushev I, 2008, PSYCHIAT RES-NEUROIM, V164, P143, DOI 10.1016/j.pscychresns.2007.11.004	47	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55415	10.1371/journal.pone.0055415	http://dx.doi.org/10.1371/journal.pone.0055415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451025	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500001
J	Aparisi, MJ; Garcia-Garcia, G; Aller, E; Sequedo, MD; de la Camara, CMF; Rodrigo, R; Armengot, M; Cortijo, J; Milara, J; Diaz-LLopis, M; Jaijo, T; Millan, JM				Jose Aparisi, Maria; Garcia-Garcia, Gema; Aller, Elena; Dolores Sequedo, Maria; Martinez-Fernandez de la Camara, Cristina; Rodrigo, Regina; Armengot, Miguel; Cortijo, Julio; Milara, Javier; Diaz-LLopis, Manuel; Jaijo, Teresa; Maria Millan, Jose			Study of USH1 Splicing Variants through Minigenes and Transcript Analysis from Nasal Epithelial Cells	PLOS ONE			English	Article							MUTATION; GENE; FAMILIES; FREQUENCY; PROFILE; MYO7A	Usher syndrome type I (USH1) is an autosomal recessive disorder characterized by congenital profound deafness, vestibular areflexia and prepubertal retinitis pigmentosa. The first purpose of this study was to determine the pathologic nature of eighteen USH1 putative splicing variants found in our series and their effect in the splicing process by minigene assays. These variants were selected according to bioinformatic analysis. The second aim was to analyze the USH1 transcripts, obtained from nasal epithelial cells samples of our patients, in order to corroborate the observed effect of mutations by minigenes in patient's tissues. The last objective was to evaluate the nasal ciliary beat frequency in patients with USH1 and compare it with control subjects. In silico analysis were performed using four bioinformatic programs: NNSplice, Human Splicing Finder, NetGene2 and Spliceview. Afterward, minigenes based on the pSPL3 vector were used to investigate the implication of selected changes in the mRNA processing. To observe the effect of mutations in the patient's tissues, RNA was extracted from nasal epithelial cells and RT-PCR analyses were performed. Four MYO7A (c.470G>A, c.1342_1343delAG, c.5856G>A and c.3652G>A), three CDH23 (c.2289+1G>A, c.6049G. A and c.8722+1delG) and one PCDH15 (c.3717+2dupTT) variants were observed to affect the splicing process by minigene assays and/or transcripts analysis obtained from nasal cells. Based on our results, minigenes are a good approach to determine the implication of identified variants in the mRNA processing, and the analysis of RNA obtained from nasal epithelial cells is an alternative method to discriminate neutral Usher variants from those with a pathogenic effect on the splicing process. In addition, we could observe that the nasal ciliated epithelium of USH1 patients shows a lower ciliary beat frequency than control subjects.	[Jose Aparisi, Maria; Garcia-Garcia, Gema; Aller, Elena; Dolores Sequedo, Maria; Martinez-Fernandez de la Camara, Cristina; Rodrigo, Regina; Jaijo, Teresa; Maria Millan, Jose] Inst Invest Sanitaria La Fe, Res Grp Sensorineural Dis, Valencia, Spain; [Aller, Elena; Jaijo, Teresa; Maria Millan, Jose] Biomed Network Res Ctr Rare Dis, Valencia, Spain; [Armengot, Miguel] Univ Valencia, Sch Med, Gen & Univ Hosp, Rhinol Unit, Valencia, Spain; [Cortijo, Julio] Univ Gen Hosp Valencia, Res Fdn, Valencia, Spain; [Cortijo, Julio; Milara, Javier] Biomed Network Res Ctr Resp Dis, Valencia, Spain; [Cortijo, Julio] Univ Valencia, Valencia, Spain; [Milara, Javier] Univ Clin Hosp, Clin Pharmacol Unit, Valencia, Spain; [Milara, Javier] Univ Gen Hosp Consortium, Res Unit, Valencia, Spain; [Diaz-LLopis, Manuel] Univ Valencia, La Fe Univ Hosp, Sch Med, Dept Ophthalmol, Valencia, Spain; [Maria Millan, Jose] La Fe Univ Hosp, Genet Unit, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Valencia; University of Valencia; University of Valencia	Jaijo, T (corresponding author), Inst Invest Sanitaria La Fe, Res Grp Sensorineural Dis, Valencia, Spain.	tjaijo@gmail.com	Garcia, Gema/AEN-8767-2022; Martinez, Cristina/ABH-7295-2020; Rodrigo, Regina/I-1868-2015; Armengot, Miguel/E-4664-2016; García-García, Gema/J-9387-2015; Jaijo, Teresa/A-4801-2010; Aller, Elena/A-4803-2010	Martinez, Cristina/0000-0002-6612-6162; Rodrigo, Regina/0000-0001-5875-986X; Armengot, Miguel/0000-0001-8258-6292; García-García, Gema/0000-0002-2113-0600; Aller, Elena/0000-0001-7973-5250; MILARA, JAVIER/0000-0001-6033-4211; Jaijo, Teresa/0000-0003-0973-9146; Aparisi, Maria Jose/0000-0002-6778-4415	Spanish Ministry of Science and Innovation [SAF2011-26443, FIS CP11/00293, PI11/02618, ADE10/00020, PI10/01825]; Regional Government (Generalitat Valenciana) [Prometeo/2008/045, GV/2012/028]; PROMIS from the Instituto de Salud Carlos III [II12/00023]; Ministerio de Educacion [AP2099-3344, AP2008-02760]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF)); PROMIS from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Educacion	This work was supported by grants SAF2011-26443, FIS CP11/00293, PI11/02618, ADE10/00020 and PI10/01825 from Spanish Ministry of Science and Innovation and grants Prometeo/2008/045 and GV/2012/028 from Regional Government (Generalitat Valenciana). CIBERER (CB/06/07/1030) and CIBERES (CB06/06/0027) are an initiative of the Institute of Health Carlos III from the Spanish Ministry of Science and Innovation. The bioanalyzer ABI3500xl was purchased with the grant PROMIS (II12/00023) from the Instituto de Salud Carlos III. MJA and GGG are recipient of a fellowship from the Ministerio de Educacion (REF: AP2099-3344 and AP2008-02760, respectively). RR has a Contrato-Investigador SNS Miguel Servet (CP09/118) from Instituto de Salud Carlos III, Ministerio Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Armengot M, 2012, INVEST OPHTH VIS SCI, V53, P2076, DOI 10.1167/iovs.11-8666; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; BONNEAU D, 1993, J MED GENET, V30, P253, DOI 10.1136/jmg.30.3.253; Bottillo I, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-4; Cohn E, 2006, 1 INT S USH SYNDR RE, P22; Davenport SHL, 1977, AMST EXC MED FDN INT, P87; Espinos C, 1998, Community Genet, V1, P223, DOI 10.1159/000016167; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Jaijo T, 2006, Hum Mutat, V27, P290, DOI 10.1002/humu.9404; Jaijo T, 2011, CLIN GENET, V79, P282, DOI 10.1111/j.1399-0004.2010.01454.x; Jaijo T, 2012, MOL VIS, V18, P1719; Jaijo T, 2010, INVEST OPHTH VIS SCI, V51, P1311, DOI 10.1167/iovs.09-4085; Jaworek TJ, 2012, J HUM GENET, V57, P633, DOI 10.1038/jhg.2012.79; Aparisi MJ, 2010, MOL VIS, V16, P2948; KIMBERLING WJ, 1995, AM J HUM GENET, V56, P216; Le Gueard-Mereuze S, 2010, HUM MUTAT, V31, P347, DOI 10.1002/humu.21193; Millan Jose M, 2011, J Ophthalmol, V2011, P417217, DOI 10.1155/2011/417217; Najera C., 1999, HUM MUTAT, V14, P181, DOI [3.0.CO;2-3, 10.1002/(SICI)1098-1004(1999)14:2&lt;181::AID-HUMU11&gt;3.0.CO;2-3]; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Vache C, 2010, HUM MUTAT, V31, P734, DOI 10.1002/humu.21255; VERNON M, 1969, J SPEECH HEAR RES, V12, P541, DOI 10.1044/jshr.1203.541	26	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57506	10.1371/journal.pone.0057506	http://dx.doi.org/10.1371/journal.pone.0057506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451239	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500111
J	Lin, YW; Yu, SL; Shao, HY; Lin, HY; Liu, CC; Hsiao, KN; Chitra, E; Tsou, YL; Chang, HW; Sia, C; Chong, PL; Chow, YH				Lin, Yi-Wen; Yu, Shu-Ling; Shao, Hsiao-Yun; Lin, Hsiang-Yin; Liu, Chia-Chyi; Hsiao, Kuang-Nan; Chitra, Ebenezer; Tsou, Yueh-Liang; Chang, Hsuen-Wen; Sia, Charles; Chong, Pele; Chow, Yen-Hung			Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SELECTIN GLYCOPROTEIN LIGAND-1; BRAIN-STEM ENCEPHALITIS; P-SELECTIN; MOUTH-DISEASE; NEUROLOGICAL DISEASE; CEREBROSPINAL-FLUID; VACCINE DEVELOPMENT; CYNOMOLGUS MONKEYS; CELL-CULTURE	Enterovirus 71 (EV71) and coxsackievirus (CVA) are the most common causative factors for hand, foot, and mouth disease (HFMD) and neurological disorders in children. Lack of a reliable animal model is an issue in investigating EV71-induced disease manifestation in humans, and the current clinical therapies are symptomatic. We generated a novel EV71-infectious model with hSCARB2-transgenic mice expressing the discovered receptor human SCARB2 (hSCARB2). The challenge of hSCARB2-transgenic mice with clinical isolates of EV71 and CVA16 resulted in HFMD-like and neurological syndromes caused by E59 (B4) and N2838 (B5) strains, and lethal paralysis caused by 5746 (C2), N3340 (C4), and CVA16. EV71 viral loads were evident in the tissues and CNS accompanied the upregulated pro-inflammatory mediators (CXCL10, CCL3, TNF-alpha, and IL-6), correlating to recruitment of the infiltrated T lymphocytes that result in severe diseases. Transgenic mice pre-immunized with live E59 or the FI-E59 vaccine was able to resist the subsequent lethal challenge with EV71. These results indicate that hSCARB2-transgenic mice are a useful model for assessing anti-EV71 medications and for studying the pathogenesis induced by EV71.	[Lin, Yi-Wen; Yu, Shu-Ling; Shao, Hsiao-Yun; Lin, Hsiang-Yin; Liu, Chia-Chyi; Hsiao, Kuang-Nan; Chitra, Ebenezer; Tsou, Yueh-Liang; Chang, Hsuen-Wen; Sia, Charles; Chong, Pele; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Sia, Charles; Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Chong, PL (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan.	pelechong@nhri.org.tw; choeyenh@nhri.org.tw	Chitra, Ebenezer/F-5984-2019; Chow, Yen-Hung/E-3863-2010; Chong, Pele/E-3855-2010; Sia, Dwo-Yuan/E-3860-2010; Liu, Chia-Chyi/A-8215-2012	Chitra, Ebenezer/0000-0002-5818-6587; Liu, Chia-Chyi/0000-0002-6257-0389	Taiwan National Science Council [99-2323-B-400-014-, 100-2311-B-400-003]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants (99-2323-B-400-014- and 100-2311-B-400-003) from the Taiwan National Science Council (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; APPELBERG R, 1992, J LEUKOCYTE BIOL, V52, P303, DOI 10.1002/jlb.52.3.303; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; HASHIMOTO I, 1978, ARCH VIROL, V56, P257, DOI 10.1007/BF01317855; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lane TE, 1998, J IMMUNOL, V160, P970; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin YW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030507, 10.1371/journal.pone.0052490]; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu JN, 2012, ARCH VIROL, V157, P539, DOI 10.1007/s00705-011-1198-2; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; Melnick J L, 1980, Intervirology, V12, P297; Muse M, 2008, VIROLOGY, V382, P132, DOI 10.1016/j.virol.2008.09.032; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Shih SR, 2000, VIRUS RES, V68, P127, DOI 10.1016/S0168-1702(00)00162-3; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Tani M, 1996, J CLIN INVEST, V98, P529, DOI 10.1172/JCI118821; Trifilo MJ, 2004, J VIROL, V78, P585, DOI 10.1128/JVI.78.2.585-594.2004; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; WATANABE K, 1989, J BIOL CHEM, V264, P19559; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	52	71	75	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57591	10.1371/journal.pone.0057591	http://dx.doi.org/10.1371/journal.pone.0057591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451246	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500117
J	Valiente-Echeverria, F; Vallejos, M; Monette, A; Pino, K; Letelier, A; Huidobro-Toro, JP; Mouland, AJ; Lopez-Lastra, M				Valiente-Echeverria, Fernando; Vallejos, Maricarmen; Monette, Anne; Pino, Karla; Letelier, Alejandro; Pablo Huidobro-Toro, J.; Mouland, Andrew J.; Lopez-Lastra, Marcelo			A cis-Acting Element Present within the gag Open Reading Frame Negatively Impacts on the Activity of the HIV-1 IRES	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; STRUCTURAL GENE-EXPRESSION; RIBOSOMAL ENTRY SITE; ENV MESSENGER-RNA; HEPATITIS-C VIRUS; TRANSLATION INITIATION; HNRNP A1; REV PROTEIN; LEADER RNA; 5-UNTRANSLATED REGION	Translation initiation from the human immunodeficiency virus type-1 (HIV-1) mRNA can occur through a cap or an IRES dependent mechanism. Cap-dependent translation initiation of the HIV-1 mRNA can be inhibited by the instability element (INS)-1, a cis-acting regulatory element present within the gag open reading frame (ORF). In this study we evaluated the impact of the INS-1 on HIV-1 IRES-mediated translation initiation. Using heterologous bicistronic mRNAs, we show that the INS-1 negatively impact on HIV-1 IRES-driven translation in in vitro and in cell-based experiments. Additionally, our results show that the inhibitory effect of the INS-1 is not general to all IRESes since it does not hinder translation driven by the HCV IRES. The inhibition by the INS-1 was partially rescued in cells by the overexpression of the viral Rev protein or hnRNPA1.	[Valiente-Echeverria, Fernando; Vallejos, Maricarmen; Pino, Karla; Letelier, Alejandro; Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Santiago, Chile; [Monette, Anne; Mouland, Andrew J.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, HIV Trafficking Lab 1, Montreal, PQ H3T 1E2, Canada; [Monette, Anne; Mouland, Andrew J.] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Mouland, Andrew J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Pablo Huidobro-Toro, J.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ctr Envejecimiento & Regenerac,CARE, Santiago, Chile	Pontificia Universidad Catolica de Chile; Lady Davis Institute; McGill University; McGill University; McGill University; Pontificia Universidad Catolica de Chile	Lopez-Lastra, M (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Alameda 340, Santiago, Chile.	malopez@med.puc.cl	Valiente-Echeverria, Fernando/I-6881-2018; Lopez-Lastra, Marcelo/HHM-9832-2022	Valiente-Echeverria, Fernando/0000-0001-9156-2516; Lopez-Lastra, Marcelo/0000-0002-7936-8478	CONICYT; predoctoral CIHR studentship; VRAID; PUC; Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT) [1090318]; Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo [P09/016-F]; FONDECYT [1110672]; Proyecto Basal CARE [12/2007]; Canadian Institutes of Health Research (CIHR) [MOP-56974]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); predoctoral CIHR studentship(Canadian Institutes of Health Research (CIHR)); VRAID; PUC; Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Basal CARE(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	FV-E and MV conducted this work as part of their PhD Thesis and were supported by a CONICYT doctoral fellowship, AM was supported by a predoctoral CIHR studentship, and AL, who also participated in this study as part of his PhD Thesis, was supported by a VRAID, PUC fellowship and by a CONICYT beca de extension. This study was supported by grants from the Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT) 1090318, Proyecto P09/016-F de la Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo to MLL, partial support from FONDECYT 1110672 and Proyecto Basal CARE 12/2007 to JPH-T, and the Canadian Institutes of Health Research (CIHR, MOP-56974) to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1997, J BIOL CHEM, V272, P2307, DOI 10.1074/jbc.272.4.2307; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; Black AC, 1996, VIRUS GENES, V12, P275, DOI 10.1007/BF00284648; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Cheunim T, 2008, VIRUS RES, V131, P189, DOI 10.1016/j.virusres.2007.09.006; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; COCHRANE AW, 1991, J VIROL, V65, P5305, DOI 10.1128/JVI.65.10.5305-5313.1991; COCHRANE AW, 1990, P NATL ACAD SCI USA, V87, P1198, DOI 10.1073/pnas.87.3.1198; de Breyne S, 2012, VIRUS RES IN PRESS; DILLON PJ, 1990, J VIROL, V64, P4428, DOI 10.1128/JVI.64.9.4428-4437.1990; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Gallego J, 2003, J BIOL CHEM, V278, P40385, DOI 10.1074/jbc.M301041200; GEBALLE AP, 1992, NUCLEIC ACIDS RES, V20, P4291, DOI 10.1093/nar/20.16.4291; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huffman KM, 1997, VIROLOGY, V234, P253, DOI 10.1006/viro.1997.8655; Barria MI, 2009, NUCLEIC ACIDS RES, V37, P957, DOI 10.1093/nar/gkn1022; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Ka WH, 2012, BIOCHEM BIOPH RES CO, V417, P501, DOI 10.1016/j.bbrc.2011.11.149; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Kress E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-8; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Liu JF, 2011, J NEUROIMMUNE PHARM, V6, P308, DOI 10.1007/s11481-011-9265-8; MALDARELLI F, 1991, J VIROL, V65, P5732, DOI 10.1128/JVI.65.11.5732-5743.1991; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Najera I, 1999, J MOL BIOL, V285, P1951, DOI 10.1006/jmbi.1998.2473; NASIOULAS G, 1994, J VIROL, V68, P2986, DOI 10.1128/JVI.68.5.2986-2993.1994; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; OLSEN HS, 1992, VIROLOGY, V191, P709, DOI 10.1016/0042-6822(92)90246-L; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; PARKIN N, 1988, MOL CELL BIOL, V8, P2875, DOI 10.1128/MCB.8.7.2875; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; SILVERMAN R H, 1990, Journal of Experimental Pathology (New York), V5, P69; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soto-Rifo R, 2012, NUCL ACIDS RES; Vallejos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035031; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Vallejos M, 2010, NUCLEIC ACIDS RES, V38, P618, DOI 10.1093/nar/gkp890; Wolff H, 2003, NUCLEIC ACIDS RES, V31, P2839, DOI 10.1093/nar/gkg390; Wolff H, 2006, BIOTECHNIQUES, V41, P688, DOI 10.2144/000112291; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	64	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56962	10.1371/journal.pone.0056962	http://dx.doi.org/10.1371/journal.pone.0056962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451120	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500047
J	Zhong, JH; Xiang, BD; Ma, L; You, XM; Li, LQ; Xie, GS				Zhong, Jian-Hong; Xiang, Bang-De; Ma, Liang; You, Xue-Mei; Li, Le-Qun; Xie, Gui-Sheng			Meta-Analysis of Microsomal Epoxide Hydrolase Gene Polymorphism and Risk of Hepatocellular Carcinoma	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; HEPATITIS-B-VIRUS; EPHX1 POLYMORPHISMS; LIVER-DISEASE; LUNG-CANCER; AFLATOXIN; SUSCEPTIBILITY; EPIDEMIOLOGY; POPULATION; EXPRESSION	Background: Hepatocarcinogenesis is a complex process that may be influenced by many factors, including polymorphism in microsomal epoxide hydrolase (mEH). Previous work suggests an association between the Tyr113His and His139Arg mEH polymorphisms and susceptibility to hepatocellular carcinoma (HCC), but the results have been inconsistent. Methods: PubMed, EMBASE, Google Scholar and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. A meta-analysis was performed to examine the association between Tyr113His and His139Arg mEH polymorphism and susceptibility to HCC. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Results: Eleven studies were included in the meta-analysis, involving 1,696 HCC cases and 3,600 controls. The 113His-mEH allele was significantly associated with increased risk of HCC based on allelic contrast (OR = 1.35, 95% CI = 1.04-1.75, p = 0.02), homozygote comparison (OR = 1.65, 95% CI = 1.07-2.54, p = 0.02) and a recessive genetic model (OR = 1.54, 95% CI = 1.21-1.96, p<0.001), while individuals carrying the Arg139Arg mEH genotype had no association with increased or decreased risk of HCC. Conclusion: The 113His- allele polymorphism in mEH may be a risk factor for hepatocarcinogenesis, while the mEH 139Arg-allele may not be a risk or protective factor. There is substantial evidence that mEH polymorphisms interact synergistically with other genes and the environment to modulate risk of HCC. Further large and well-designed studies are needed to confirm these conclusions.	[Zhong, Jian-Hong; Xiang, Bang-De; Ma, Liang; You, Xue-Mei; Li, Le-Qun] Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China; [Xie, Gui-Sheng] Guangxi Med Univ, Affiliated Hosp 3, Dept Gen Surg, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China.	xitongpingjia@163.com	LI, LI QING/GRR-8855-2022; li, li/HII-4157-2022; Zhong, Jian-Hong/D-6641-2018; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	National Natural Science Foundation of China [81160262/H1602]; Guangxi Natural Science Foundation [2011GXNSFD018032]; Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province [Z2012345]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (Project No: 81160262/H1602) and Guangxi Natural Science Foundation (Project No: 2011GXNSFD018032) to LL, and the Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province (Project No: Z2012345) to JHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter SW, 2002, CANCER LETT, V177, P75, DOI 10.1016/S0304-3835(01)00782-0; Bhaskar LV, 2012, AM J DRUG ALCOHOL AB; Cao Yan-yan, 2004, Fudan Xuebao (Yixuekexueban), V31, P363; Chen CZ, 2011, J FORMOS MED ASSOC, V110, P685, DOI 10.1016/j.jfma.2011.09.003; Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546; Dura P, 2012, ONCOL REP, V27, P1710, DOI 10.3892/or.2012.1734; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; Ghattas MH, 2012, ENDOCRINE; Goode EL, 2011, MOL CARCINOGEN, V50, P397, DOI 10.1002/mc.20714; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; He ShuJia, 2008, Tumor, V28, P125; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelly EJ, 2002, TOXICOL SCI, V65, P35, DOI 10.1093/toxsci/65.1.35; Kiran M, 2008, DNA CELL BIOL, V27, P687, DOI 10.1089/dna.2008.0805; Kiran M, 2009, DNA CELL BIOL, V28, P573, DOI 10.1089/dna.2009.0921; Kirk GD, 2005, CANCER EPIDEM BIOMAR, V14, P373, DOI 10.1158/1055-9965.EPI-04-0161; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kiyohara C, 2006, EPIDEMIOLOGY, V17, P89, DOI 10.1097/01.ede.0000187627.70026.23; Koutros S, 2011, PHARMACOGENET GENOM, V21, P615, DOI 10.1097/FPC.0b013e3283493a57; Lee WJ, 2002, BIOMARKERS, V7, P230, DOI 10.1080/13547500210121882; Li XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014749; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Long XD, 2006, HEPATOL RES, V36, P48, DOI 10.1016/j.hepres.2006.06.004; MAYANS MV, 1990, LANCET, V336, P1107, DOI 10.1016/0140-6736(90)92580-B; MCGLYNN KA, 1995, P NATL ACAD SCI USA, V92, P2384, DOI 10.1073/pnas.92.6.2384; McGlynn KA, 2003, CANCER RES, V63, P4594; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Nisa H, 2012, MOL CARCINOG; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Pinarbasi H, 2010, MOL MED REP, V3, P723, DOI 10.3892/mmr_00000324; Qin H, 2010, J INT MED RES, V38, P760, DOI 10.1177/147323001003800304; Rahat B, 2012, J CLIN EXP HEPATOL, V2, P104, DOI 10.1016/S0973-6883(12)60097-8; Shen F. M., 1997, CHINESE J MED GENET, V14, P96; Shou M, 1996, BIOCHEMISTRY-US, V35, P15807, DOI 10.1021/bi962042z; Sonzogni L, 2002, HEPATOLOGY, V36, P195, DOI 10.1053/jhep.2002.33898; Tiemersma EW, 2001, CANCER EPIDEM BIOMAR, V10, P785; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; WILD CP, 1990, CARCINOGENESIS, V11, P2271, DOI 10.1093/carcin/11.12.2271; WILD CP, 1992, CANCER EPIDEM BIOMAR, V1, P229; Wong NACS, 2000, TOXICOL LETT, V115, P17, DOI 10.1016/S0378-4274(00)00166-1; Zhao ZQ, 2012, TUMOR BIOL, V33, P523, DOI 10.1007/s13277-011-0287-x; Zhong JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032159	45	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57064	10.1371/journal.pone.0057064	http://dx.doi.org/10.1371/journal.pone.0057064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451147	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500060
J	Clark, ES; Stelkens, RB; Wedekind, C				Clark, Emily S.; Stelkens, Rike B.; Wedekind, Claus			Parental Influences on Pathogen Resistance in Brown Trout Embryos and Effects of Outcrossing within a River Network	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ADAPTIVE PHENOTYPIC PLASTICITY; GENETIC-VARIATION; LOCAL ADAPTATION; ATLANTIC SALMON; CHINOOK SALMON; REACTION NORMS; OUTBREEDING DEPRESSION; QUANTITATIVE GENETICS; RANA-TEMPORARIA	Phenotypic plasticity can increase tolerance to heterogeneous environments but the elevations and slopes of reaction norms are often population specific. Disruption of locally adapted reaction norms through outcrossing can lower individual viability. Here, we sampled five genetically distinct populations of brown trout (Salmo trutta) from within a river network, crossed them in a full-factorial design, and challenged the embryos with the opportunistic pathogen Pseudomonas fluorescens. By virtue of our design, we were able to disentangle effects of genetic crossing distance from sire and dam effects on early life-history traits. While pathogen infection did not increase mortality, it was associated with delayed hatching of smaller larvae with reduced yolk sac reserves. We found no evidence of a relationship between genetic distance (W, F-ST) and the expression of early-life history traits. Moreover, hybrids did not differ in phenotypic means or reaction norms in comparison to offspring from within-population crosses. Heritable variation in early life-history traits was found to remain stable across the control and pathogen environments. Our findings show that outcrossing within a rather narrow geographical scale can have neutral effects on F-1 hybrid viability at the embryonic stage, i.e. at a stage when environmental and genetic effects on phenotypes are usually large.	[Clark, Emily S.; Stelkens, Rike B.; Wedekind, Claus] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Stelkens, Rike B.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Lausanne; University of Liverpool	Wedekind, C (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	claus.wedekind@unil.ch	Wedekind, Claus/S-3353-2016; Clark, Emily/GVR-7159-2022	Wedekind, Claus/0000-0001-6143-4716; 	Swiss National Science Foundation; Foundation Maison de la Riviere; Marie Curie Intra-European Fellowship; Fischereiinspektorat Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Maison de la Riviere; Marie Curie Intra-European Fellowship(European Commission); Fischereiinspektorat Bern	This work was supported by the Swiss National Science Foundation, the Foundation Maison de la Riviere, and a Marie Curie Intra-European Fellowship to RBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Fischereiinspektorat Bern for their permissions and support, including B. Bracher, U. Gutmann, C. Kung, M. Schmid and H. Walther. We also wish to acknowledge E. Baumgartner, A. Brechon, P. Christe, J. Guthruf, M. dos Santos, L. Kocjancic-Curty, L. Muller, R. Nicolet, M. Pompini, A. Ross-Gillespie, C. van Oosterhout, and L. Wilkins for help in the field and/or useful discussions and two reviewers for comments on the manuscript.	Agrawal AA, 2002, EVOLUTION, V56, P2206, DOI 10.1111/j.0014-3820.2002.tb00145.x; Allendorf FW, 2004, CONSERV BIOL, V18, P1203, DOI 10.1111/j.1523-1739.2004.00305.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Austin B., 1999, BACTERIAL PATHOGENS, V3rd, P13; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BROWN AF, 1991, BIOL BULL, V181, P123, DOI 10.2307/1542494; Bubliy OA, 2001, HEREDITY, V86, P363, DOI 10.1046/j.1365-2540.2001.00837.x; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Carlsson J, 2001, T AM FISH SOC, V130, P36, DOI 10.1577/1548-8659(2001)130<0036:EOGSOG>2.0.CO;2; Darwish TL, 2009, CAN J FISH AQUAT SCI, V66, P83, DOI 10.1139/F08-185; Daszak P, 2000, SCIENCE, V287, P1756; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Evans ML, 2010, HEREDITY, V104, P449, DOI 10.1038/hdy.2009.121; Evans ML, 2010, J EVOLUTION BIOL, V23, P687, DOI 10.1111/j.1420-9101.2010.01934.x; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Goldberg TL, 2005, CONSERV BIOL, V19, P455, DOI 10.1111/j.1523-1739.2005.00091.x; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Goudet J, 2002, FSTAT 2 9 3 2 PROGRA; Griffiths AM, 2009, EVOL APPL, V2, P537, DOI 10.1111/j.1752-4571.2009.00092.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Heggenes J, 2006, ECOL FRESHW FISH, V15, P366, DOI 10.1111/j.1600-0633.2006.00146.x; Hermida M, 2009, GENET MOL BIOL, V32, P42, DOI 10.1590/S1415-47572009005000014; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; HOULE D, 1992, GENETICS, V130, P195; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Hutchings JA, 2007, P ROY SOC B-BIOL SCI, V274, P1693, DOI 10.1098/rspb.2007.0263; Jacob A, 2010, MOL ECOL, V19, P5296, DOI 10.1111/j.1365-294X.2010.04884.x; Jacob A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-207; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Jensen LF, 2005, CONSERV GENET, V6, P615, DOI 10.1007/s10592-005-9014-8; Johnson PTJ, 2011, FUNCT ECOL, V25, P726, DOI 10.1111/j.1365-2435.2010.01830.x; Junge C, 2011, HEREDITY, V106, P460, DOI 10.1038/hdy.2010.160; Kearsey M.J., 1996, GENETIC ANAL QUANTIT, DOI [10.1007/978-1-4899-4441-2, DOI 10.1007/978-1-4899-4441-2]; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Kinnison MT, 2008, MOL ECOL, V17, P405, DOI 10.1111/j.1365-294X.2007.03495.x; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; Laugen AT, 2005, GENET RES, V86, P161, DOI 10.1017/S0016672305007810; Laurila A, 2002, EVOLUTION, V56, P617; LEARY RF, 1995, AM FISH S S, V15, P91; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Lynch M., 1998, GENETICS ANAL QUANTI; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Merila J, 2004, CONSERV GENET, V5, P513, DOI 10.1023/B:COGE.0000041026.71104.0a; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Merila J, 1998, GENETICS, V148, P1233; Merila J, 1997, EVOLUTION, V51, P526, DOI 10.1111/j.1558-5646.1997.tb02440.x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Nielsen C, 2003, J FISH BIOL, V63, P1184, DOI 10.1046/j.1095-8649.2003.00237.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; OECD, 1992, OECD GUID TEST CHEM, P9; Orizaola G, 2009, EVOL ECOL, V23, P979, DOI 10.1007/s10682-008-9285-x; Pakkasmaa S, 2003, HEREDITY, V91, P117, DOI 10.1038/sj.hdy.6800289; Piche J, 2008, P ROY SOC B-BIOL SCI, V275, P1571, DOI 10.1098/rspb.2008.0251; Pigliucci M., 2001, SYN ECO EVO; Pitcher TE, 2007, CONSERV GENET, V8, P607, DOI 10.1007/s10592-006-9204-z; Pompini M, BEHAV ECOLO IN PRESS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Relyea RA, 2005, J EVOLUTION BIOL, V18, P856, DOI 10.1111/j.1420-9101.2005.00882.x; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; Ryce EKN, 2005, DIS AQUAT ORGAN, V63, P69, DOI 10.3354/dao063069; Sagvik J, 2005, CONSERV GENET, V6, P205, DOI 10.1007/s10592-004-7829-3; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; Snow AA, 2001, ECOL APPL, V11, P934, DOI 10.1890/1051-0761(2001)011[0934:FOHBWA]2.0.CO;2; Sollid SA, 2003, J AQUAT ANIM HEALTH, V15, P136, DOI 10.1577/H02-038; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Stelkens RB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-247; Stelkens RB, 2012, MOL ECOL, V21, P2896, DOI 10.1111/j.1365-294X.2012.05581.x; Stinchcombe JR, 2004, J EVOLUTION BIOL, V17, P197, DOI 10.1046/j.1420-9101.2003.00641.x; Uller T, 2009, OECOLOGIA, V160, P9, DOI 10.1007/s00442-009-1280-6; Uribe C, 2011, VET MED-CZECH, V56, P486, DOI 10.17221/3294-VETMED; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; VIA S, 1984, EVOLUTION, V38, P896, DOI 10.1111/j.1558-5646.1984.tb00360.x; von Siebenthal BA, 2009, FISH SHELLFISH IMMUN, V26, P531, DOI 10.1016/j.fsi.2009.02.008; Wang J, 2004, MOL ECOL, V13, P3169, DOI 10.1111/j.1365-294X.2004.02298.x; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; Wedekind C, 2005, GENETICS, V170, P1427, DOI 10.1534/genetics.105.040683; Wedekind C, 2004, J EVOLUTION BIOL, V17, P11, DOI 10.1046/j.1420-9101.2004.00669.x; Wedekind C, 2002, CURR BIOL, V12, P69, DOI 10.1016/S0960-9822(01)00627-3; Wedekind C, 2008, P ROY SOC B-BIOL SCI, V275, P1737, DOI 10.1098/rspb.2008.0072; Wedekind C, 2007, ENVIRON POLLUT, V148, P385, DOI 10.1016/j.envpol.2006.11.022; Zhang WW, 2009, VET MICROBIOL, V139, P183, DOI 10.1016/j.vetmic.2009.04.026; Zuur Alain F., 2009, P1	96	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57832	10.1371/journal.pone.0057832	http://dx.doi.org/10.1371/journal.pone.0057832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451273	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800118
J	Kollers, S; Rodemann, B; Ling, J; Korzun, V; Ebmeyer, E; Argillier, O; Hinze, M; Plieske, J; Kulosa, D; Ganal, MW; Roder, MS				Kollers, Sonja; Rodemann, Bernd; Ling, Jie; Korzun, Viktor; Ebmeyer, Erhard; Argillier, Odile; Hinze, Maike; Plieske, Joerg; Kulosa, Dagmar; Ganal, Martin W.; Roeder, Marion S.			Whole Genome Association Mapping of Fusarium Head Blight Resistance in European Winter Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; SPRING WHEAT; GENETIC-STRUCTURE; QTL ANALYSIS; MAJOR QTL; POPULATION; QUALITY; IDENTIFICATION; COMPONENTS; SELECTION	A total of 358 recent European winter wheat varieties plus 14 spring wheat varieties were evaluated for resistance to Fusarium head blight (FHB) caused by Fusarium graminearum and Fusarium culmorum in four separate environments. The FHB scores based on FHB incidence (Type I resistance) x FHB severity (Type II resistance) indicated a wide phenotypic variation of the varieties with BLUE (best linear unbiased estimation) values ranging from 0.07 to 33.67. Genotyping with 732 microsatellite markers resulted in 782 loci of which 620 were placed on the ITMI map. The resulting average marker distance of 6.8 cM allowed genome wide association mapping employing a mixed model. Though no clear population structure was discovered, a kinship matrix was used for stratification. A total of 794 significant (-log(10)(p)-value >= 3.0) associations between SSR-loci and environment-specific FHB scores or BLUE values were detected, which included 323 SSR alleles. For FHB incidence and FHB severity a total of 861 and 877 individual marker-trait associations (MTA) were detected, respectively. Associations for both traits co-located with FHB score in most cases. Consistent associations detected in three or more environments were found on all chromosomes except chromosome 6B, and with the highest number of MTA on chromosome 5B. The dependence of the number of favourable and unfavourable alleles within a variety to the respective FHB scores indicated an additive effect of favourable and unfavourable alleles, i.e. genotypes with more favourable or less unfavourable alleles tended to show greater resistance to FHB. Assessment of a marker specific for the dwarfing gene Rht-D1 resulted in strong effects. The results provide a prerequisite for designing genome wide breeding strategies for FHB resistance.	[Kollers, Sonja; Ling, Jie; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Resesarch I, Gatersleben, Germany; [Rodemann, Bernd] JKI, Braunschweig, Germany; [Kollers, Sonja; Korzun, Viktor; Ebmeyer, Erhard] KWS LOCHOW GMBH, Bergen, Germany; [Argillier, Odile] Syngenta Seeds SAS, Toulouse, France; [Hinze, Maike] Syngenta Seeds GmbH, Bad Salzuflen, Germany; [Plieske, Joerg; Kulosa, Dagmar; Ganal, Martin W.] TraitGenetics GmbH, Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Julius Kuhn-Institut; KWS Saat AG; Syngenta; Syngenta	Roder, MS (corresponding author), Leibniz Inst Plant Genet & Crop Plant Resesarch I, Gatersleben, Germany.	roder@ipk-gatersleben.de	Korzun, Viktor/U-6352-2019	Korzun, Viktor/0000-0003-0760-8249; Roder, Marion/0000-0002-9313-0650; Ling, Jie/0000-0001-7054-5119	project GABI-Wheat [0315067]; German Federal Ministry of Education and Research (BMBF)	project GABI-Wheat; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was conducted within the frame of the project GABI-Wheat (project No. 0315067) funded by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509; Anderson JA, 2007, CROP SCI, V47, pS112, DOI 10.2135/cropsci2007.04.0006IPBS; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bonin CM, 2009, CROP SCI, V49, P1304, DOI 10.2135/cropsci2008.08.0459; Bordes J, 2011, J CEREAL SCI, V54, P137, DOI 10.1016/j.jcs.2011.03.004; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Draeger R, 2007, THEOR APPL GENET, V115, P617, DOI 10.1007/s00122-007-0592-3; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Haberle J, 2009, THEOR APPL GENET, V119, P325, DOI 10.1007/s00122-009-1041-2; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Holzapfel J, 2008, THEOR APPL GENET, V117, P1119, DOI 10.1007/s00122-008-0850-z; Jayatilake D, 2011, THEOR APPL GENET, V122, P1189, DOI 10.1007/s00122-010-1523-2; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kulwal P, 2012, THEOR APPL GENET, V125, P793, DOI 10.1007/s00122-012-1872-0; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Le Couviour F, 2011, THEOR APPL GENET, V123, P715, DOI 10.1007/s00122-011-1621-9; Le Gouis J, 2012, THEOR APPL GENET, V124, P597, DOI 10.1007/s00122-011-1732-3; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Loffler M, 2009, MOL BREEDING, V23, P473, DOI 10.1007/s11032-008-9250-y; Ma HX, 2006, PHYTOPATHOLOGY, V96, P534, DOI 10.1094/PHYTO-96-0534; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Mardi M, 2006, PLANT BREEDING, V125, P313, DOI 10.1111/j.1439-0523.2006.01228.x; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2008, CROP SCI, V48, P2115, DOI 10.2135/cropsci2008.02.0107; Miedaner T, 2006, THEOR APPL GENET, V112, P562, DOI 10.1007/s00122-005-0163-4; Miedaner T, 2012, MOL BREEDING, V29, P731, DOI 10.1007/s11032-011-9586-6; Miedaner T, 2011, MOL BREEDING, V28, P647, DOI 10.1007/s11032-010-9516-z; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2011, THEOR APPL GENET, V123, P283, DOI 10.1007/s00122-011-1583-y; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Salameh A, 2011, MOL BREEDING, V28, P485, DOI 10.1007/s11032-010-9498-x; Schmolke M, 2005, THEOR APPL GENET, V111, P747, DOI 10.1007/s00122-005-2060-2; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Srinivasachary, 2008, THEOR APPL GENET, V116, P1145, DOI 10.1007/s00122-008-0742-2; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Steed A, 2005, THEOR APPL GENET, V111, P521, DOI 10.1007/s00122-005-2043-3; Steiner B, 2004, THEOR APPL GENET, V109, P215, DOI 10.1007/s00122-004-1620-1; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wilde F, 2008, THEOR APPL GENET, V117, P29, DOI 10.1007/s00122-008-0749-8; WRIGHT S, 1978, EVOLUTION GENETICS P, V4, P91; Yang ZP, 2005, GENOME, V48, P187, DOI [10.1139/G04-104, 10.1139/g04-104]; Yu LX, 2012, THEOR APPL GENET, V125, P749, DOI 10.1007/s00122-012-1867-x; Yu LX, 2011, THEOR APPL GENET, V123, P1257, DOI 10.1007/s00122-011-1664-y	60	114	120	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57500	10.1371/journal.pone.0057500	http://dx.doi.org/10.1371/journal.pone.0057500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451238	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800110
J	Reinwald, M; Buchheidt, D; Hummel, M; Duerken, M; Bertz, H; Schwerdtfeger, R; Reuter, S; Kiehl, MG; Barreto-Miranda, M; Hofmann, WK; Spiess, B				Reinwald, Mark; Buchheidt, Dieter; Hummel, Margit; Duerken, Matthias; Bertz, Hartmut; Schwerdtfeger, Rainer; Reuter, Stefan; Kiehl, Michael G.; Barreto-Miranda, Manuel; Hofmann, Wolf-Karsten; Spiess, Birgit			Diagnostic Performance of an Aspergillus-Specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BRONCHOALVEOLAR LAVAGE SAMPLES; REAL-TIME PCR; INVASIVE ASPERGILLOSIS; CEREBRAL-ASPERGILLOSIS; FUNGAL-INFECTIONS; GALACTOMANNAN; VORICONAZOLE; MENINGITIS; MANAGEMENT	Central nervous system (CNS) invasive aspergillosis (IA) is a fatal complication in immunocompromised patients. Confirming the diagnosis is rarely accomplished as invasive procedures are impaired by neutropenia and low platelet count. Cerebrospinal fluid (CSF) cultures or galactomannan (GM) regularly yield negative results thus suggesting the need for improving diagnostic procedures. Therefore the performance of an established Aspergillus-specific nested polymerase chain reaction assay (PCR) in CSF samples of immunocompromised patients with suspicion of CNS IA was evaluated. We identified 113 CSF samples from 55 immunocompromised patients for whom CNS aspergillosis was suspected. Of these patients 8/55 were identified as having proven/probable CNS IA while the remaining 47 patients were classified as having either possible (n = 22) or no CNS IA (n = 25). PCR positivity in CSF was observed for 8/8 proven/probable, in 4/22 possible CNS IA patients and in 2/25 NoIA patients yielding sensitivity and specificity values of 1.0 (95% CI 0.68-1) and 0.93 (95% CI 0.77-0.98) and a positive likelihood ratio of 14 and negative likelihood ratio of 0.0, respectively, thus resulting in a diagnostic odds ratio of infinity. The retrospective analysis of CSF samples from patients with suspected CNS IA yielded a high sensitivity of the nested PCR assay. PCR testing of CSF samples is recommended for patients for whom CNS IA is suspected, especially for those whose clinical condition does not allow invasive procedures as a positive PCR result makes the presence of CNS IA in that patient population highly likely.	[Reinwald, Mark; Buchheidt, Dieter; Hummel, Margit; Barreto-Miranda, Manuel; Hofmann, Wolf-Karsten; Spiess, Birgit] Heidelberg Univ, Dept Hematol & Oncol, Mannheim Univ Hosp, Mannheim, Germany; [Duerken, Matthias] Heidelberg Univ, Dept Pediat, Mannheim Univ Hosp, Mannheim, Germany; [Bertz, Hartmut] Heidelberg Univ, Freiburg Univ Hosp, Mannheim, Germany; [Schwerdtfeger, Rainer] Bone Marrow Transplantat Ctr Wiesbaden, Wiesbaden, Germany; [Reuter, Stefan] Univ Ulm, Ulm Univ Hosp, D-89069 Ulm, Germany; [Kiehl, Michael G.] Frankfurt Oder Gen Hosp, Frankfurt, Oder, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University	Buchheidt, D (corresponding author), Heidelberg Univ, Dept Hematol & Oncol, Mannheim Univ Hosp, Mannheim, Germany.	dieter.buchheidt@umm.de		Buchheidt, Dieter/0000-0002-4425-6134; Barreto Miranda, Manuel/0000-0003-2435-1326; Reinwald, Mark/0000-0002-6506-2136	Faculty of Medicine, Mannheim, University of Heidelberg	Faculty of Medicine, Mannheim, University of Heidelberg	The study was supported by internal funding of the Faculty of Medicine, Mannheim, University of Heidelberg. The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiee P, 2011, ARCH IRAN MED, V14, P381, DOI 011146/AIM.005; Boes B, 1994, J Neuroimaging, V4, P123; Buchheidt D, 2002, BRIT J HAEMATOL, V116, P803, DOI 10.1046/j.0007-1048.2002.03337.x; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Finelli PF, 2010, NEUROLOGIST, V16, P364, DOI 10.1097/NRL.0b013e3181b47001; Hori A, 2002, J HOSP INFECT, V50, P175, DOI 10.1053/jhin.2001.1170; Howard SC, 2000, JAMA-J AM MED ASSOC, V284, P2222, DOI 10.1001/jama.284.17.2222; Hummel M, 2006, J CLIN MICROBIOL, V44, P3989, DOI 10.1128/JCM.00466-06; Kami M, 1999, BRIT J HAEMATOL, V106, P536, DOI 10.1046/j.1365-2141.1999.01542.x; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Marchetti O, 2011, BONE MARROW TRANSPLA; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Morton CO, 2011, J MED MICROBIOL, V60, P913, DOI 10.1099/jmm.0.028399-0; Offiah CE, 2006, CLIN RADIOL, V61, P393, DOI 10.1016/j.crad.2006.01.008; Ruhnke M, 2012, ANN ONCOL, V23, P823, DOI 10.1093/annonc/mdr407; Schmidt-Hieber M, 2009, LEUKEMIA LYMPHOMA, V50, P24, DOI 10.1080/10428190802517740; Schwartz S, 2005, BLOOD, V106, P2641, DOI 10.1182/blood-2005-02-0733; Schwartz S, 2011, INFECTION, V39, P201, DOI 10.1007/s15010-011-0108-6; Skladny H, 1999, J CLIN MICROBIOL, V37, P3865, DOI 10.1128/JCM.37.12.3865-3871.1999; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS188, DOI 10.1086/376524; Tuon Felipe Francisco, 2007, Revista Iberoamericana de Micologia, V24, P89; Verweij PE, 1999, J CLIN MICROBIOL, V37, P1186, DOI 10.1128/JCM.37.4.1186-1189.1999; Viscoli C, 2002, J CLIN MICROBIOL, V40, P1496, DOI 10.1128/JCM.40.4.1496-1499.2002	24	45	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56706	10.1371/journal.pone.0056706	http://dx.doi.org/10.1371/journal.pone.0056706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451071	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800028
J	Voulgaridou, GP; Mantso, T; Chlichlia, K; Panayiotidis, MI; Pappa, A				Voulgaridou, Georgia-Persephoni; Mantso, Theodora; Chlichlia, Katerina; Panayiotidis, Mihalis I.; Pappa, Aglaia			Efficient E. coli Expression Strategies for Production of Soluble Human Crystallin ALDH3A1	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; HIGH-LEVEL PRODUCTION; ESCHERICHIA-COLI; ALDEHYDE DEHYDROGENASES; PROTEIN EXPRESSION; OXIDATIVE DAMAGE; PURIFICATION; AUTOINDUCTION; COEXPRESSION; CHAPERONES	Aldehyde dehydrogenase 3A1 (ALDH3A1) is a recently characterized corneal crystallin with its exact functions still being unclear. Expressing recombinant human ALDH3A1 has been difficult in Escherichia coli (E. coli) because of low solubility, yield and insufficient purity issues. In this report, we compared different E. coli expression strategies (namely the maltose binding protein; MBP- and the 6-his-tagged expression systems) under conditions of auto-induction and co-expression with E. coli's molecular chaperones where appropriate. Thus, we aimed to screen the efficiency of these expression strategies in order to improve solubility of recombinant ALDH3A1 when expressed in E. coli. We showed that the MBP- tagged expression in combination with lower-temperature culture conditions resulted in active soluble recombinant ALDH3A1. Expression of the fused 6-his tagged-ALDH3A1 protein resulted in poor solubility and neither lowering temperature culture conditions nor the auto-induction strategy improved its solubility. Furthermore, higher yield of soluble, active native form of 6-his tagged-ALDH3A1 was facilitated through co-expression of the two groups of E. coli's molecular chaperones, GroES/GroEL and DnaK/DnaJ/GrpE. Convenient one step immobilized affinity chromatography methods were utilized to purify the fused ALDH3A1 hybrids. Both fusion proteins retained their biological activity and could be used directly without removing the fusion tags. Taken together, our results provide a rational option for producing sufficient amounts of soluble and active recombinant ALDH3A1 using the E. coli expression system for conducting functional studies towards elucidating the biological role(s) of this interesting corneal crystallin.	[Voulgaridou, Georgia-Persephoni; Mantso, Theodora; Chlichlia, Katerina; Pappa, Aglaia] Democritus Univ Thrace, Dept Mol Biol & Genet, Dragana, Alexandroupolis, Greece; [Panayiotidis, Mihalis I.] Univ Ioannina, Sch Med, Anat Pathol Lab, GR-45110 Ioannina, Greece	Democritus University of Thrace; University of Ioannina	Pappa, A (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Univ Campus, Dragana, Alexandroupolis, Greece.	apappa@mbg.duth.gr	Panagiotidis, Mihalis/AAG-6274-2020; Pappa, Aglaia/E-8663-2011; Chlichlia, Katerina/Q-3948-2019; Voulgaridou, Georgia/AAB-5203-2021; Pappa, Aglaia/P-4663-2019	Panagiotidis, Mihalis/0000-0002-1450-3552; Voulgaridou, Georgia/0000-0003-0173-8560; Pappa, Aglaia/0000-0003-0913-4315; Panagiotidis, Mihalis/0000-0002-1130-5972; Chlichlia, Katerina/0000-0003-4952-0675	European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	European Union (European Social Fund-ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	This research has been co-financed by the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton SJ, 1999, PHOTOCHEM PHOTOBIOL, V70, P823, DOI 10.1111/j.1751-1097.1999.tb08289.x; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Black W, 2012, FREE RADICAL BIO MED, V52, P1937, DOI 10.1016/j.freeradbiomed.2012.02.050; Bunting KD, 1996, J BIOL CHEM, V271, P11891, DOI 10.1074/jbc.271.20.11891; Choi MS, 2010, BIOCHEM BIOPH RES CO, V393, P509, DOI 10.1016/j.bbrc.2010.02.036; Chou CP, 2007, APPL MICROBIOL BIOT, V76, P521, DOI 10.1007/s00253-007-1039-0; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; Estey T, 2007, J BIOL CHEM, V282, P4382, DOI 10.1074/jbc.M607546200; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Goenka S, 2001, PROTEIN EXPRES PURIF, V21, P260, DOI 10.1006/prep.2000.1359; Guo WH, 2011, PROTEIN EXPRES PURIF, V77, P185, DOI 10.1016/j.pep.2011.01.015; Harnois T, 2009, ARTIF CELL BLOOD SUB, V37, P106, DOI 10.1080/10731190902908445; HARTL FU, 1995, CURR OPIN STRUC BIOL, V5, P92; Islam RS, 2007, BIOTECHNOL PROGR, V23, P785, DOI 10.1021/bp070059a; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Lu ZS, 2010, PROTEIN EXPRES PURIF, V74, P217, DOI 10.1016/j.pep.2010.06.010; Ma N, 2012, PROTEIN EXPRES PURIF, V82, P263, DOI 10.1016/j.pep.2012.01.013; Nishi K, 2010, PROTEIN EXPRES PURIF, V69, P34, DOI 10.1016/j.pep.2009.09.013; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Oganesyan N, 2007, PROTEIN EXPRES PURIF, V52, P280, DOI 10.1016/j.pep.2006.09.015; Pappa A, 2005, J BIOL CHEM, V280, P27998, DOI 10.1074/jbc.M503698200; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Pappa A, 2003, FREE RADICAL BIO MED, V34, P1178, DOI 10.1016/S0891-5849(03)00070-4; Pappa A, 2001, CHEM-BIOL INTERACT, V130, P181, DOI 10.1016/S0009-2797(00)00233-7; Piatigorsky J, 2000, J OCUL PHARMACOL TH, V16, P173, DOI 10.1089/jop.2000.16.173; Piatigorsky J, 2001, CORNEA, V20, P853, DOI 10.1097/00003226-200111000-00015; Ray M, 2012, J BIOTECHNOL, V157, P12, DOI 10.1016/j.jbiotec.2011.09.022; Renner JN, 2011, PROTEIN EXPR PURIF; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Sahu SK, 2009, BIOTECHNOL LETT, V31, P1745, DOI 10.1007/s10529-009-0073-7; Semba H, 2010, METHODS MOL BIOL, V643, P133, DOI 10.1007/978-1-60761-723-5_10; Siurkus J, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-65; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tait AR, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-51; Tu W, 2009, PROTEIN EXPRES PURIF, V67, P169, DOI 10.1016/j.pep.2009.05.005; Uma L, 1996, EXP EYE RES, V63, P117, DOI 10.1006/exer.1996.0098; Wang XL, 2010, PROTEIN EXPRES PURIF, V71, P179, DOI 10.1016/j.pep.2010.01.011; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu SJ, 2009, PROTEIN EXPRES PURIF, V68, P49, DOI 10.1016/j.pep.2009.06.009	42	24	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56582	10.1371/journal.pone.0056582	http://dx.doi.org/10.1371/journal.pone.0056582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451057	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800019
J	Zucchi, FCR; Yao, YL; Ward, ID; Ilnytskyy, Y; Olson, DM; Benzies, K; Kovalchuk, I; Kovalchuk, O; Metz, GAS				Zucchi, Fabiola C. R.; Yao, Youli; Ward, Isaac D.; Ilnytskyy, Yaroslav; Olson, David M.; Benzies, Karen; Kovalchuk, Igor; Kovalchuk, Olga; Metz, Gerlinde A. S.			Maternal Stress Induces Epigenetic Signatures of Psychiatric and Neurological Diseases in the Offspring	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PRENATAL STRESS; MICRORNA EXPRESSION; GENE-EXPRESSION; MULTIPLE-SCLEROSIS; PROTEIN; RAT; GLUCOCORTICOIDS; MOUSE; SCHIZOPHRENIA	The gestational state is a period of particular vulnerability to diseases that affect maternal and fetal health. Stress during gestation may represent a powerful influence on maternal mental health and offspring brain plasticity and development. Here we show that the fetal transcriptome, through microRNA (miRNA) regulation, responds to prenatal stress in association with epigenetic signatures of psychiatric and neurological diseases. Pregnant Long-Evans rats were assigned to stress from gestational days 12 to 18 while others served as handled controls. Gestational stress in the dam disrupted parturient maternal behaviour and was accompanied by characteristic brain miRNA profiles in the mother and her offspring, and altered transcriptomic brain profiles in the offspring. In the offspring brains, prenatal stress upregulated miR-103, which is involved in brain pathologies, and downregulated its potential gene target Ptplb. Prenatal stress downregulated miR-145, a marker of multiple sclerosis in humans. Prenatal stress also upregulated miR-323 and miR-98, which may alter inflammatory responses in the brain. Furthermore, prenatal stress upregulated miR-219, which targets the gene Dazap1. Both miR-219 and Dazap1 are putative markers of schizophrenia and bipolar affective disorder in humans. Offspring transcriptomic changes included genes related to development, axonal guidance and neuropathology. These findings indicate that prenatal stress modifies epigenetic signatures linked to disease during critical periods of fetal brain development. These observations provide a new mechanistic association between environmental and genetic risk factors in psychiatric and neurological disease.	[Zucchi, Fabiola C. R.; Yao, Youli; Ward, Isaac D.; Metz, Gerlinde A. S.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Zucchi, Fabiola C. R.] Univ Mato Grosso State, Dept Biol Sci, Caceres, MG, Brazil; [Yao, Youli; Ilnytskyy, Yaroslav; Kovalchuk, Igor; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Olson, David M.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Benzies, Karen] Univ Calgary, Fac Nursing, Calgary, AB, Canada	University of Lethbridge; Universidade Estadual de Mato Grosso do Sul; University of Lethbridge; University of Alberta; University of Alberta; University of Alberta; University of Calgary	Metz, GAS (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca	Benzies, Karen/E-1452-2016; Zucchi, Fabiola/K-1296-2017	Benzies, Karen/0000-0002-9090-2395; Zucchi, Fabiola/0000-0002-2252-613X; Metz, Gerlinde/0000-0002-5801-7716	Alberta Innovates-Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant [200700595]; Canadian Institutes of Health Research; Hotchkiss Brain Institute; Norlien Foundation	Alberta Innovates-Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hotchkiss Brain Institute; Norlien Foundation	This research was supported by Alberta Innovates-Health Solutions (AI-HS; FZ and GM), Preterm Birth and Healthy Outcomes funded by the AI-HS Interdisciplinary Team Grant #200700595 (DMO, KB and GM), the Canadian Institutes of Health Research (GM), Hotchkiss Brain Institute (FZ), and the Norlien Foundation (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikmese B, 2012, BEHAV PHARMACOL, V23, P215, DOI 10.1097/FBP.0b013e3283512c6d; Aisa B, 2009, PSYCHONEUROENDOCRINO, V34, P1495, DOI 10.1016/j.psyneuen.2009.05.003; Andersson L, 2004, AM J EPIDEMIOL, V159, P872, DOI 10.1093/aje/kwh122; Babenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029441; Babenko O, 2012, BRAIN RES, V1444, P96, DOI 10.1016/j.brainres.2012.01.038; Bell JT, 2012, INT J EPIDEMIOL, V41, P140, DOI 10.1093/ije/dyr179; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Boksa P, 2008, J PSYCHIATR NEUROSCI, V33, P183; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buss C, 2010, PSYCHONEUROENDOCRINO, V35, P141, DOI 10.1016/j.psyneuen.2009.07.010; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Connolly M, 2011, ARTHRITIS RHEUM-US, V63, pS654; Corcoran C, 2009, SCHIZOPHRENIA BULL, V35, P596, DOI 10.1093/schbul/sbn089; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Dave RS, 2010, J CELL BIOCHEM, V110, P834, DOI 10.1002/jcb.22592; de Rooij SR, 2012, EARLY HUM DEV, V88, P321, DOI 10.1016/j.earlhumdev.2011.09.002; de Weerth C, 2005, NEUROSCI BIOBEHAV R, V29, P207, DOI 10.1016/j.neubiorev.2004.10.011; DENENBER.VH, 1969, BEHAVIOUR, V34, P1, DOI 10.1163/156853969X00369; Dinan TG, 2010, INT J NEUROPSYCHOPH, V13, P395, DOI 10.1017/S1461145709990800; Diz-Chaves Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-71; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellenbogen MA, 2011, J AFFECT DISORDERS, V132, P265, DOI 10.1016/j.jad.2011.01.007; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Fitzpatrick CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00047; Frankfurt M, 2011, SYNAPSE, V65, P955, DOI 10.1002/syn.20918; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Goyal R, 2011, REPROD SCI, V18, P180, DOI 10.1177/1933719110385134; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Ilnytskyy Y, 2008, BIOCHEM BIOPH RES CO, V377, P41, DOI 10.1016/j.bbrc.2008.09.080; Kaminsky Z, 2008, TWIN RES HUM GENET, V11, P1, DOI 10.1375/twin.11.1.1; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kinnunen AK, 2003, J NEUROCHEM, V86, P736, DOI 10.1046/j.1471-4159.2003.01873.x; Kirkland SW, 2008, BRAIN RES, V1201, P151, DOI 10.1016/j.brainres.2008.01.032; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kovalchuk I, 2007, MUTAT RES-FUND MOL M, V624, P101, DOI 10.1016/j.mrfmmm.2007.04.009; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lenroot RK, 2009, HUM BRAIN MAPP, V30, P163, DOI 10.1002/hbm.20494; Lim SH, 2009, EMBO J, V28, P3564, DOI 10.1038/emboj.2009.289; Lindsay DG, 2005, NUTR RES REV, V18, P249, DOI 10.1079/NRR2005110; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Markham JA, 2011, PSYCHOPHARMACOLOGY, V214, P89, DOI 10.1007/s00213-010-2035-0; Matrisciano F, 2012, NEUROPSYCHOPHARMACOL, V37, P929, DOI 10.1038/npp.2011.274; Matthews SG, 2012, EXP NEUROL, V233, P95, DOI 10.1016/j.expneurol.2011.01.009; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Merlot E, 2008, BRAIN BEHAV IMMUN, V22, P42, DOI 10.1016/j.bbi.2007.05.007; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GAS, 2001, PHYSIOL BEHAV, V72, P29, DOI 10.1016/S0031-9384(00)00371-1; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Migicovsky Zoe, 2011, Frontiers in Genetics, V2, P28, DOI 10.3389/fgene.2011.00028; Miller SM, 2011, BRAIN RES BULL, V86, P60, DOI 10.1016/j.brainresbull.2011.05.013; Mody N, 2011, DIABETOLOGIA, V54, P2143, DOI 10.1007/s00125-011-2160-2; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Munk-Olsen T, 2011, ARCH GEN PSYCHIAT; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; Ostiguy CS, 2011, PSYCHOL MED, V41, P2447, DOI 10.1017/S0033291711000523; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Owen D, 2005, NEUROSCI BIOBEHAV R, V29, P209, DOI 10.1016/j.neubiorev.2004.10.004; Pandis I, 2012, ANN RHEUM DIS, V71, P1716, DOI 10.1136/annrheumdis-2011-200803; Pereira M, 2011, J NEUROENDOCRINOL, V23, P1020, DOI 10.1111/j.1365-2826.2011.02200.x; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pogribny IP, 2007, TOXICOL APPL PHARM, V225, P61, DOI 10.1016/j.taap.2007.07.001; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rassoulzadegan M, 2007, BIOCHEM SOC T, V35, P623, DOI 10.1042/BST0350623; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schulz H., 1888, PFLUGERS ARCH GES PH, V42, P517, DOI DOI 10.1007/BF01669373; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Seckl JR, 2006, ANN NY ACAD SCI, V1071, P351, DOI 10.1196/annals.1364.027; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Takahashi N, 2011, BIOL PSYCHIAT, V70, P626, DOI 10.1016/j.biopsych.2011.06.016; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; van Hasselt FN, 2012, HIPPOCAMPUS, V22, P255, DOI 10.1002/hipo.20892; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Vyas A, 2002, J NEUROSCI, V22, P6810; Ward ID, BMC PREGNAN IN PRESS; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Whishaw IQ, 2001, DEV PSYCHOBIOL, V39, P151, DOI 10.1002/dev.1041; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546; Yehuda R, 2008, J PSYCHIATR RES, V42, P1104, DOI 10.1016/j.jpsychires.2008.01.002; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018; Yorty JL, 2004, AM J PHYSIOL-REG I, V287, pR1316, DOI 10.1152/ajpregu.00685.2003; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096; Zucchi FCR, 2009, BEHAV BRAIN RES, V205, P67, DOI 10.1016/j.bbr.2009.06.030	100	126	130	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56967	10.1371/journal.pone.0056967	http://dx.doi.org/10.1371/journal.pone.0056967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451123	Green Submitted, gold, Green Published			2022-12-27	WOS:000316658800056
J	Bronnum, H; Andersen, DC; Schneider, M; Sandberg, MB; Eskildsen, T; Nielsen, SB; Kalluri, R; Sheikh, SP				Bronnum, Hasse; Andersen, Ditte C.; Schneider, Mikael; Sandberg, Maria B.; Eskildsen, Tilde; Nielsen, Solveig B.; Kalluri, Raghu; Sheikh, Soren P.			miR-21 Promotes Fibrogenic Epithelial-to-Mesenchymal Transition of Epicardial Mesothelial Cells Involving Programmed Cell Death 4 and Sprouty-1	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; HEART-FAILURE; MICRORNA EXPRESSION; CARDIAC-HYPERTROPHY; PROGENITOR CELLS; DISEASE; PLASTICITY; CONTRIBUTE; FIBROSIS	The lining of the adult heart contains epicardial mesothelial cells (EMCs) that have the potential to undergo fibrogenic Epithelial-to-Mesenchymal Transition (EMT) during cardiac injury. EMT of EMCs has therefore been suggested to contribute to the heterogeneous fibroblast pool that mediates cardiac fibrosis. However, the molecular basis of this process is poorly understood. Recently, microRNAs (miRNAs) have been shown to regulate a number of sub-cellular events in cardiac disease. Hence, we hypothesized that miRNAs regulate fibrogenic EMT in the adult heart. Indeed pro-fibrogenic stimuli, especially TGF-beta, promoted EMT progression in EMC cultures, which resulted in differential expression of numerous miRNAs, especially the pleiotropic miR-21. Accordingly, ectopic expression of miR-21 substantially promoted the fibroblast-like phenotype arising from fibrogenic EMT, whereas an antagonist that targeted miR-21 blocked this effect, as assessed on the E-cadherin/alpha-smooth muscle actin balance, cell viability, matrix activity, and cell motility, thus making miR-21 a relevant target of EMC-derived fibrosis. Several mRNA targets of miR-21 was differentially regulated during fibrogenic EMT of EMCs and miR-21-dependent targeting of Programmed Cell Death 4 (PDCD4) and Sprouty Homolog 1 (SPRY1) significantly contributed to the development of a fibroblastoid phenotype. However, PDCD4- and SPRY1-targeting was not entirely ascribable to all phenotypic effects from miR-21, underscoring the pleiotropic biological role of miR-21 and the increasing number of recognized miR-21 targets.	[Bronnum, Hasse; Andersen, Ditte C.; Schneider, Mikael; Sandberg, Maria B.; Eskildsen, Tilde; Nielsen, Solveig B.; Sheikh, Soren P.] Univ So Denmark, Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Lab Mol & Cellular Cardiol, Odense, Denmark; [Bronnum, Hasse; Andersen, Ditte C.; Schneider, Mikael; Sandberg, Maria B.; Eskildsen, Tilde; Nielsen, Solveig B.; Sheikh, Soren P.] Univ So Denmark, Dept Cardiovasc & Renal Res, Odense, Denmark; [Bronnum, Hasse; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Bronnum, Hasse; Kalluri, Raghu] Harvard Univ, Sch Med, Boston, MA USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Sheikh, SP (corresponding author), Univ So Denmark, Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Lab Mol & Cellular Cardiol, Odense, Denmark.	soeren.sheikh@ouh.regionsyddanmark.dk	Schneider, Mikael/GLN-7716-2022; Andersen, Ditte Caroline/AAA-8774-2021; Andersen, Ditte/P-4523-2014; Schneider, Mikael/AAC-2742-2019; Sandberg, Maria Boysen/AAE-6889-2019; Schneider, Mikael/C-2036-2008; Kalluri, Raghu/E-2677-2015	Schneider, Mikael/0000-0002-3379-0235; Andersen, Ditte Caroline/0000-0003-4940-7912; Andersen, Ditte/0000-0003-4940-7912; Schneider, Mikael/0000-0002-3379-0235; Kalluri, Raghu/0000-0002-2190-547X	Odense University Hospital; John and Birthe Meyer Foundation; King Chr. X Foundation; Danish Heart Association, National Institutes of Health [DK 55001]; Danish National Research Council [09-073648]; Lundbeck Foundation; Hertha Christensens Foundation; Eva and Henry Fraenkels Foundation; Danish Ministry of Science, Technology and Innovation	Odense University Hospital; John and Birthe Meyer Foundation; King Chr. X Foundation; Danish Heart Association, National Institutes of Health; Danish National Research Council(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Hertha Christensens Foundation; Eva and Henry Fraenkels Foundation; Danish Ministry of Science, Technology and Innovation	This work was supported by Odense University Hospital, The John and Birthe Meyer Foundation, The King Chr. X Foundation, The Danish Heart Association, National Institutes of Health DK 55001, The Danish National Research Council (#09-073648), The Lundbeck Foundation, Hertha Christensens Foundation, Eva and Henry Fraenkels Foundation, and The Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Cottonham CL, 2010, J BIOL CHEM; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Di Meglio F, 2010, J MOL CELL CARDIOL; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Manner J, 1999, ANAT RECORD, V255, P212; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Penna Aubin, 2007, J Vis Exp, P264, DOI 10.3791/264; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Smart N, 2009, CURR PROTOC STEM CEL; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2011, J CLIN INVEST, V121, P461, DOI 10.1172/JCI45938; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Xia H, 2010, J BIOL CHEM; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	60	75	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56280	10.1371/journal.pone.0056280	http://dx.doi.org/10.1371/journal.pone.0056280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441172	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200029
J	Jausoro, I; Mestres, I; Quassollo, G; Masseroni, L; Heredia, F; Caceres, A				Jausoro, Ignacio; Mestres, Ivan; Quassollo, Gonzalo; Masseroni, Lujan; Heredia, Florencia; Caceres, Alfredo			Regulation of Spine Density and Morphology by IQGAP1 Protein Domains	PLOS ONE			English	Article							DENDRITIC SPINES; CELL POLARIZATION; ARP2/3 COMPLEX; SMALL GTPASES; ACTIN; CDC42; DYNAMICS; ROLES; RAC1; RHO	IQGAP1 is a scaffolding protein that regulates spine number. We now show a differential role for IQGAP1 domains in spine morphogenesis, in which a region of the N-terminus that promotes Arp2/3-mediated actin polymerization and branching stimulates spine head formation while a region that binds to Cdc42 and Rac is required for stalk extension. Conversely, IQGAP1 rescues spine deficiency induced by expression of dominant negative Cdc42 by stimulating formation of stubby spines. Together, our observations place IQGAP1 as a crucial regulator of spine number and shape acting through the N-Wasp Arp2/3 complex, as well as upstream and downstream of Cdc42.	[Jausoro, Ignacio; Mestres, Ivan; Quassollo, Gonzalo; Masseroni, Lujan; Heredia, Florencia; Caceres, Alfredo] INIMEC CONICET, Inst Mercedes & Martin Ferreyra, Neurobiol Lab, Cordoba, Argentina; [Jausoro, Ignacio; Mestres, Ivan; Quassollo, Gonzalo; Masseroni, Lujan; Heredia, Florencia; Caceres, Alfredo] Univ Nacl Cordoba, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Caceres, A (corresponding author), INIMEC CONICET, Inst Mercedes & Martin Ferreyra, Neurobiol Lab, Cordoba, Argentina.	acaceres@immf.uncor.edu		Quassollo, Gonzalo/0000-0003-3298-9688	MINCyT; CONICET; Agencia Cordoba Ciencia	MINCyT; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Cordoba Ciencia	This work was supported by grants from MINCyT, CONICET and Agencia Cordoba Ciencia to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Conde C, 2010, J NEUROSCI, V30, P6793, DOI 10.1523/JNEUROSCI.5420-09.2010; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jausoro I, 2012, HISTOL HISTOPATHOL, V27, P1385, DOI 10.14670/HH-27.1385; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Svitkina T, 2010, J NEUROSCI, V30, P14937, DOI 10.1523/JNEUROSCI.4276-10.2010; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Szebenyi G, 2005, CURR BIOL, V15, P1820, DOI 10.1016/j.cub.2005.08.069; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Weissbach L, 1994, J BIOL CHEM, V278, P9630	43	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56574	10.1371/journal.pone.0056574	http://dx.doi.org/10.1371/journal.pone.0056574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441206	Green Published, gold			2022-12-27	WOS:000315159200063
J	Lund, H; Krakauer, M; Skimminge, A; Sellebjerg, F; Garde, E; Siebner, HR; Paulson, OB; Hesse, D; Hanson, LG				Lund, Henrik; Krakauer, Martin; Skimminge, Arnold; Sellebjerg, Finn; Garde, Ellen; Siebner, Hartwig R.; Paulson, Olaf B.; Hesse, Dan; Hanson, Lars G.			Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							STATUS SCALE EDSS; COGNITIVE IMPAIRMENT; TIME MEASUREMENTS; RELAXATION-TIMES; AXONAL LOSS; MRI; DISABILITY; LESIONS; ABNORMALITIES; DEMYELINATION	Background: Multiple sclerosis (MS) affects the integrity of the blood-brain barrier (BBB). Contrast-enhanced T1 weighted magnetic resonance imaging (MRI) is widely used to characterize location and extent of BBB disruptions in focal MS lesions. We employed quantitative T1 measurements before and after the intravenous injection of a paramagnetic contrast agent to assess BBB permeability in the normal appearing white matter (NAWM) in patients with relapsing-remitting MS (RR-MS). Methodology/Principal Findings: Fifty-nine patients (38 females) with RR-MS undergoing immunomodulatory treatment and nine healthy controls (4 females) underwent quantitative T1 measurements at 3 tesla before and after injection of a paramagnetic contrast agent (0.2 mmol/kg Gd-DTPA). Mean T1 values were calculated for NAWM in patients and total cerebral white matter in healthy subjects for the T1 measurements before and after injection of Gd-DTPA. The pre-injection baseline T1 of NAWM (945 +/- 55 [SD] ms) was prolonged in RR-MS relative to healthy controls (903 +/- 23 ms, p = 0.028). Gd-DTPA injection shortened T1 to a similar extent in both groups. Mean T1 of NAWM was 866 +/- 47 ms in the NAWM of RR-MS patients and 824 +/- 13 ms in the white matter of healthy controls. The regional variability of T1 values expressed as the coefficient of variation (CV) was comparable between the two groups at baseline, but not after injection of the contrast agent. After intravenous Gd-DTPA injection, T1 values in NAWM were more variable in RR-MS patients (CV = 0.198 +/- 0.046) compared to cerebral white matter of healthy controls (CV = 0.166 +/- 0.018, p = 0.046). Conclusions/Significance: We found no evidence of a global BBB disruption within the NAWM of RR-MS patients undergoing immunomodulatory treatment. However, the increased variation of T1 values in NAWM after intravenous GdDTPA injection points to an increased regional inhomogeneity of BBB function in NAWM in relapsing-remitting MS.	[Lund, Henrik; Skimminge, Arnold; Garde, Ellen; Siebner, Hartwig R.; Paulson, Olaf B.; Hanson, Lars G.] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Krakauer, Martin; Sellebjerg, Finn; Hesse, Dan] Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Res Ctr, Dept Neurol, Hvidovre, Denmark; [Paulson, Olaf B.] Copenhagen Univ Hosp, Neurobiol Res Unit, Hvidovre, Denmark; [Hanson, Lars G.] Tech Univ Denmark, Biomed Engn Grp, DK-2800 Lyngby, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Lund, H (corresponding author), Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark.	hlund@drcmr.dk	Hanson, Lars/GRS-0733-2022; Krakauer, Martin/M-4657-2019; Siebner, Hartwig R/G-4052-2016; Paulson, Olaf B./N-6924-2016; Hanson, Lars G/E-8562-2010	Krakauer, Martin/0000-0002-2191-1861; Paulson, Olaf B./0000-0001-7712-8596; Hanson, Lars G/0000-0002-8204-6912; Garde, Ellen/0000-0002-9906-6880; Sellebjerg, Finn/0000-0002-1333-9623; Hesse, Dan/0000-0002-9670-6037	Danish Multiple Sclerosis Society [9007]; Henry Hansen og Hustrus Legat [2009]; Biogen Idec/HRS; Biogen Idec; Merck Serono; Sanofi-Aventis; Lundbeck Foundation [R59-2010-5399] Funding Source: researchfish	Danish Multiple Sclerosis Society; Henry Hansen og Hustrus Legat; Biogen Idec/HRS(Biogen); Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Lundbeck Foundation(Lundbeckfonden)	The work was supported by Danish Multiple Sclerosis Society (www.scleroseforeningen.dk): grant 9007, and by Henry Hansen og Hustrus Legat (www.jpb.dk): grant; HL - no competing interests/MK - no competing interests/AS - no competing interests/FS - no competing interests/EG - received honoraria for lecturing and travel expenses for attending meetings from Biogen Idec/HRS - received honoraria as Reviewing Editor for Neuroimage, as speaker for Biogen Idec Denmark A/S, and scientific Advisor from Lundbeck A/S, Valby, Denmark/OBP - no competing interests/DH - received funding for travel from Biogen Idec, Merck Serono, and Sanofi-Aventis and has received speaker honoraria from Biogen Idec and Sanofi-Aventis/LGH - no competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN IV, 1979, J NEUROL SCI, V41, P81, DOI 10.1016/0022-510X(79)90142-4; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; Barkhof F, 2002, J NEUROL, V249, P1451, DOI 10.1007/s00415-002-0835-9; Calabresi PA, 1997, NEUROLOGY, V48, P1446, DOI 10.1212/WNL.48.5.1446; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; CLAUDIO L, 1995, ACTA NEUROPATHOL, V90, P228; Comi G, 1999, J NEUROL SCI, V171, P135, DOI 10.1016/S0022-510X(99)00266-X; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Davies GR, 2005, J NEUROL, V252, P1037, DOI 10.1007/s00415-005-0808-x; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Filippi M, 2000, J NEUROL NEUROSUR PS, V68, P157, DOI 10.1136/jnnp.68.2.157; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; FRAHM J, 1985, J MAGN RESON, V64, P81, DOI 10.1016/0022-2364(85)90033-2; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gaitan MI, 2011, ANN NEUROL, V70, P22, DOI 10.1002/ana.22472; Gold Ralf, 2010, Ther Adv Neurol Disord, V3, P351, DOI 10.1177/1756285610385608; GROSSMAN RI, 1986, RADIOLOGY, V161, P721, DOI 10.1148/radiology.161.3.3786722; Hanson LG, 1998, P INT SOC MAGN RESON; Hanson LG, 2005, P INT SOC MAGN RESON; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Iannucci G, 2000, AM J NEURORADIOL, V21, P1034; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Lund H, 2012, ACTA NEUROL SCAND, V125, P338, DOI 10.1111/j.1600-0404.2011.01574.x; Mathiesen HK, 2006, ARCH NEUROL-CHICAGO, V63, P533, DOI 10.1001/archneur.63.4.533; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mottershead JP, 2003, J NEUROL, V250, P1293, DOI 10.1007/s00415-003-0192-3; Parry A, 2002, J NEUROL, V249, P1279, DOI 10.1007/s00415-002-0837-7; Rovaris M, 2011, MULT SCLER J, V17, P319, DOI 10.1177/1352458510388824; Sarchielli P, 1999, BRAIN, V122, P513, DOI 10.1093/brain/122.3.513; Schmierer K, 2004, MULT SCLER J, V10, P182, DOI 10.1191/1352458504ms996oa; Silver NC, 2001, MULT SCLER J, V7, P75, DOI 10.1177/135245850100700201; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Topp S, 1997, P INT SOC MAGN RESON; Vaithianathar L, 2002, J NEUROL SCI, V197, P45, DOI 10.1016/S0022-510X(02)00044-8; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; van Walderveen MAA, 2003, J MAGN RESON IMAGING, V18, P656, DOI 10.1002/jmri.10417; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Vrenken H, 2006, AM J NEURORADIOL, V27, P868; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zivadinov R, 2001, NEURORADIOLOGY, V43, P272, DOI 10.1007/s002340000500	48	25	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56375	10.1371/journal.pone.0056375	http://dx.doi.org/10.1371/journal.pone.0056375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441184	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200041
J	Muller, R; Daniel, C; Hugo, C; Amann, K; Mielenz, D; Endlich, K; Braun, T; van der Veen, B; Heeringa, P; Schett, G; Zwerina, J				Mueller, Ralf; Daniel, Christoph; Hugo, Christian; Amann, Kerstin; Mielenz, Dirk; Endlich, Karlhans; Braun, Tobias; van der Veen, Betty; Heeringa, Peter; Schett, Georg; Zwerina, Jochen			The Mitogen-Activated Protein Kinase p38 alpha Regulates Tubular Damage in Murine Anti-Glomerular Basement Membrane Nephritis	PLOS ONE			English	Article							P38 MAP KINASE; CRESCENTIC GLOMERULONEPHRITIS; SELECTIVE INHIBITOR; LOCALIZATION; CYTOSKELETON; EXPRESSION; EVOLUTION; ENDOTOXIN; PATHWAYS; MEMBER	p38 mitogen-activated protein kinase (MAPK) is thought to play a central role in acute and chronic inflammatory responses. Whether p38MAPK plays a pathogenic role in crescentic GN (GN) and which of its four isoforms is preferentially involved in kidney inflammation is not definitely known. We thus examined expression and activation of p38MAPK isoforms during antiglomerular basement membrane (GBM) nephritis. Therefore, p38 alpha conditional knockout mice (MxCre-p38 alpha(Delta/Delta)) were used to examine the role of p38 alpha in anti-GBM induced nephritis. Both wild type and MxCre-p38 alpha(Delta/Delta) mice developed acute renal failure over time. Histological examinations revealed a reduced monocyte influx and less tubular damage in MxCre-p38 alpha(Delta/Delta) mice, whereas glomerular crescent formation and renal fibrosis was similar. Likewise, the levels of pro-and anti-inflammatory cytokines such as TNF, IL-1 and IL-10 were similar, but IL-8 was even up-regulated in MxCre-p38 alpha(Delta/Delta) mice. In contrast, we could detect strong down-regulation of chemotactic cytokines such as CCL-2, -5 and -7, in the kidneys of MxCre-p38 alpha(Delta/Delta) mice. In conclusion, p38 alpha is the primary p38MAPK isoform expressed in anti-GBM nephritis and selectively affects inflammatory cell influx and tubular damage. Full protection from nephritis is however not achieved as renal failure and structural damage still occurs.	[Mueller, Ralf; Mielenz, Dirk; Braun, Tobias; Schett, Georg; Zwerina, Jochen] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Bavaria, Germany; [Daniel, Christoph] Univ Erlangen Nurnberg, Dept Internal Med 4, D-91054 Erlangen, Bavaria, Germany; [Hugo, Christian] Tech Univ Dresden, Med Clin 3, D-01062 Dresden, Saxony, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Bavaria, Germany; [Endlich, Karlhans] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Mecklenburg W Pomerania, Germany; [van der Veen, Betty; Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Technische Universitat Dresden; University of Erlangen Nuremberg; Ernst Moritz Arndt Universitat Greifswald; University of Groningen	Zwerina, J (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Bavaria, Germany.	jochen.zwerina@uk-erlangen.de	Endlich, Karlhans/G-5485-2013; Heeringa, Peter/A-6008-2009; Daniel, Christoph/AAK-2136-2021	Heeringa, Peter/0000-0001-8684-763X; Daniel, Christoph/0000-0002-6803-4755; Endlich, Karlhans/0000-0001-6052-6061	Deutsche Forschungsgemeinschaft (DFG) [SFB 423]; European Union; Interdisciplinary Centre for Clinical Research Erlangen (IZKF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); Interdisciplinary Centre for Clinical Research Erlangen (IZKF)	This work was supported by the grant SFB 423 of the Deutsche Forschungsgemeinschaft (DFG, projects A34 and Z2), the KINACEPT project of the European Union and the Interdisciplinary Centre for Clinical Research Erlangen (IZKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Asgeirdottir SA, 2007, MOL PHARMACOL, V72, P121, DOI 10.1124/mol.107.034140; Badger AM, 2000, ARTHRITIS RHEUM, V43, P175, DOI 10.1002/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S; Bariety J, 2005, KIDNEY INT, V68, P1109, DOI 10.1111/j.1523-1755.2005.00503.x; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; COBB BS, 1991, MOL CELL BIOL, V11, P5832, DOI 10.1128/MCB.11.12.5832; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Floege J, 1999, AM J KIDNEY DIS, V33, P434, DOI 10.1016/S0272-6386(99)70179-4; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HAN JH, 1993, J BIOL CHEM, V268, P25009; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; LAN HY, 1991, KIDNEY INT, V40, P425, DOI 10.1038/ki.1991.229; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Polzer K, 2008, ANN RHEUM DIS, V67, P602, DOI 10.1136/ard.2007.077263; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Sheryanna A, 2007, J AM SOC NEPHROL, V18, P1167, DOI 10.1681/ASN.2006010050; Song GY, 2001, SHOCK, V15, P42, DOI 10.1097/00024382-200115010-00007; Stambe C, 2004, J AM SOC NEPHROL, V15, P370, DOI 10.1097/01.ASN.0000109669.23650.56; Stambe C, 2004, J AM SOC NEPHROL, V15, P326, DOI 10.1097/01.ASN.0000108520.63445.E0; Stambe C, 2003, J AM SOC NEPHROL, V14, P338, DOI 10.1097/01.ASN.0000048715.12315.FD; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; van der Veen BS, 2011, ANN RHEUM DIS, V70, P356, DOI 10.1136/ard.2010.129106	41	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56316	10.1371/journal.pone.0056316	http://dx.doi.org/10.1371/journal.pone.0056316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441175	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200032
J	Prakash, R; Johnson, M; Fagan, SC; Ergul, A				Prakash, Roshini; Johnson, Maribeth; Fagan, Susan C.; Ergul, Adviye			Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes	PLOS ONE			English	Article							GLYCEMIC CONTROL; VASCULAR TREES; BLOOD-FLOW; BRAIN; ANGIOGENESIS; REACTIVITY; STROKE; RATS; QUANTIFICATION; PEROXYNITRITE	We previously reported intense pial cerebral collateralization and arteriogenesis in a mild and lean model of type 2 diabetes (T2D), Goto-Kakizaki (GK) rats. Increased cerebral neovascularization differed regionally and was associated with poor vessel wall maturity. Building upon these findings, the goals of this study were to determine whether a) glycemic control prevents this erratic cerebral neovascularization in the GK model, and b) this pathological neovascularization pattern occurs in Lepr(db/db) model, which is the most commonly used model of T2D for studies involving cerebral complications of diabetes. Vascular volume, surface area and structural parameters including microvessel/macrovessel ratio, non-FITC (fluorescein) perfusing vessel abundance, vessel tortuosity, and branch density were measured by 3D reconstruction of FITC stained vasculature in GK rats or Lepr(db/db) mice. GK rats exhibited an increase in all of these parameters, which were prevented by glycemic control with metformin. In Lepr(db/db) mice, microvascular density was increased but there was no change in nonFITC-perfusing vessels. Increased PA branch density was associated with reduced branch diameter. These results suggest that T2D leads to cerebral neovascularization and remodeling but some structural characteristics of newly formed vessels differ between these models of T2D. The prevention of dysfunctional cerebral neovascularization by early glucose control suggests that hyperglycemia is a mediator of this response.	[Prakash, Roshini; Fagan, Susan C.; Ergul, Adviye] Univ Georgia, Coll Pharm, Charlie Norwood Vet Adm Med Ctr, Augusta, GA USA; [Prakash, Roshini; Fagan, Susan C.; Ergul, Adviye] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA USA; [Johnson, Maribeth] Georgia Hlth Sci Univ, Dept Biostat, Augusta, GA USA; [Ergul, Adviye] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; University of Georgia; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Ergul, A (corresponding author), Univ Georgia, Coll Pharm, Charlie Norwood Vet Adm Med Ctr, Augusta, GA USA.	aergul@georgiahealth.edu		Prakash, Roshini/0000-0003-4309-3078	VA Merit Awards [BX000891, BX000347]; National Institutes of Health [NS063965, NS054688]; American Heart Association [EIA 0740002N, 10PRE4030037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083559, R01NS063965, R21NS070239, R03NS054688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000347] Funding Source: NIH RePORTER	VA Merit Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by VA Merit Awards to Susan C. Fagan (BX000891) and Adviye Ergul (BX000347), grants from the National Institutes of Health to Susan C. Fagan (NS063965) and to Adviye Ergul (NS054688), and grants from the American Heart Association to Adviye Ergul (EIA 0740002N) and Roshini Prakash (10PRE4030037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2006, CURR OPIN INVEST DR, V7, P619; BOROWSKY IW, 1989, J COMP NEUROL, V288, P401, DOI 10.1002/cne.902880304; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Dockery P, 2007, EXP MOL PATHOL, V82, P110, DOI 10.1016/j.yexmp.2006.12.011; Dore-Duffy P, 2007, ANTIOXID REDOX SIGN, V9, P1363, DOI 10.1089/ars.2007.1713; DUCKROW RB, 1987, STROKE, V18, P52, DOI 10.1161/01.STR.18.1.52; Elgebaly MM, 2010, J CEREBR BLOOD F MET, V30, P1928, DOI 10.1038/jcbfm.2010.120; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Faure P, 2008, CLIN SCI, V114, P251, DOI 10.1042/CS20070276; Heinzer S, 2008, NEUROIMAGE, V39, P1549, DOI 10.1016/j.neuroimage.2007.10.054; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; Kelly-Cobbs AI, 2012, J PHARMACOL EXP THER, V342, P407, DOI 10.1124/jpet.111.191296; Lechuga-Sancho AM, 2006, ENDOCRINOLOGY, V147, P5314, DOI 10.1210/en.2006-0766; Li WG, 2010, DIABETES, V59, P228, DOI 10.2337/db09-0902; Lokkegaard A, 2001, HIPPOCAMPUS, V11, P726, DOI 10.1002/hipo.1088; Macia I, 2012, KNOWL INF SYST, V30, P457, DOI 10.1007/s10115-010-0377-x; Mankovsky BN, 1996, J DIABETES COMPLICAT, V10, P228, DOI 10.1016/S1056-8727(96)90006-9; MCCALL AL, 1992, DIABETES, V41, P557, DOI 10.2337/diabetes.41.5.557; MCCUSKEY PA, 1984, MICROCIRC ENDOTH LYM, V1, P221; Muranyi M, 2006, DIABETES, V55, P349, DOI 10.2337/diabetes.55.02.06.db05-0654; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Rosen P, 2006, DIABETES-METAB RES, V22, P323, DOI 10.1002/dmrr.623; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Sachidanandam K, 2009, AM J PHYSIOL-REG I, V296, pR952, DOI 10.1152/ajpregu.90537.2008; Saravia FE, 2002, BRAIN RES, V957, P345, DOI 10.1016/S0006-8993(02)03675-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Secomb T W, 1995, Symp Soc Exp Biol, V49, P305; Silvestre JS, 2006, CIRC RES, V98, P4, DOI 10.1161/01.RES.0000200396.90220.41; Skyler J S, 1998, J Fla Med Assoc, V85, P7; Skyler JS, 2004, CLIN DIABETES, V22; Soltanian-Zadeh H, 2005, COMPUT BIOL MED, V35, P791, DOI 10.1016/j.compbiomed.2004.06.009; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016/j.pathophys.2008.04.007; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	37	59	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56264	10.1371/journal.pone.0056264	http://dx.doi.org/10.1371/journal.pone.0056264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441170	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200027
J	Duraffour, S; Mertens, B; Meyer, H; van den Oord, JJ; Mitera, T; Matthys, P; Snoeck, R; Andrei, G				Duraffour, Sophie; Mertens, Barbara; Meyer, Hermann; van den Oord, Joost J.; Mitera, Tania; Matthys, Patrick; Snoeck, Robert; Andrei, Graciela			Emergence of Cowpox: Study of the Virulence of Clinical Strains and Evaluation of Antivirals	PLOS ONE			English	Article							VIRUS-INFECTION; PET RATS; CYNOMOLGUS MACAQUES; VACCINIA VIRUS; CAMELPOX VIRUS; MICE; HUMANS; TRANSMISSION; CIDOFOVIR; SMALLPOX	The last years, cowpox infections are being increasingly reported through Eurasia. Cowpox viruses (CPXVs) have been reported to have different genotypes and may be subdivided in at least five genetically distinct monophyletic clusters. However, little is known about their in vitro and in vivo features. In this report, five genetically diverse CPXVs, including one reference strain (CPXV strain Brighton) and four clinical isolates from human and animal cases, were compared with regard to growth in cells, pathogenicity in mice and inhibition by antivirals. While all CPXVs replicated similarly in vitro and showed comparable antiviral susceptibility, marked discrepancies were seen in vivo, including differences in virulence with recorded mortality rates of 0%, 20% and 100%. The four CPXV clinical isolates appeared less pathogenic than two reference strains, CPXV Brighton and vaccinia virus Western-Reserve. Disease severity seemed to correlate with high viral DNA loads in several organs, virus titers in lung tissues and levels of IL-6 cytokine in the sera. Our study highlighted that the species CPXV consists of viruses that not only differ considerably in their genotypes but also in their in vivo phenotypes, indicating that CPXVs should not be longer classified as a single species. Lung virus titers and IL-6 cytokine level in mice may be used as biomarkers for predicting disease severity. We further demonstrated the potential benefit of cidofovir, CMX001 and ST-246 use as antiviral therapy.	[Duraffour, Sophie; Mertens, Barbara; Snoeck, Robert; Andrei, Graciela] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Louvain, Belgium; [Meyer, Hermann] Bundeswehr Inst Microbiol, Munich, Germany; [van den Oord, Joost J.] Univ Hosp Leuven, Lab Translat Cell & Tissue Res, Louvain, Belgium; [Mitera, Tania; Matthys, Patrick] Katholieke Univ Leuven, Rega Inst, Immunobiol Lab, Louvain, Belgium	KU Leuven; Bundeswehr Institute of Microbiology (IMB); KU Leuven; University Hospital Leuven; KU Leuven	Duraffour, S (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Louvain, Belgium.	sophie.duraffour@rega.kuleuven.be	Mertens, Barbara/D-9994-2018; Andrei, Graciela/V-7721-2017; Snoeck, Robert/V-3867-2017; Matthys, Patrick/B-4813-2018	Mertens, Barbara/0000-0002-0525-3184; Andrei, Graciela/0000-0003-2609-4896; Snoeck, Robert/0000-0002-7586-5434; Matthys, Patrick/0000-0002-9685-6836	FWO (Fund for Scientific Research-Flanders, Belgium) [G.0680.08]; GOA (Geconcerteerd Onderzoek Actie) [10/014]	FWO (Fund for Scientific Research-Flanders, Belgium)(FWO); GOA (Geconcerteerd Onderzoek Actie)	This work was supported by FWO (Fund for Scientific Research-Flanders, Belgium, Grant G.0680.08) and by GOA (Geconcerteerd Onderzoek Actie, Grant 10/014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzhanova D, 2010, MICROBES INFECT, V12, P900, DOI 10.1016/j.micinf.2010.07.007; Andrei G, 2010, VIRUSES-BASEL, V2, P2803, DOI 10.3390/v2122803; BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x; BAXBY D, 1975, ZBL VET MED B, V22, P480; Becker C, 2009, DTSCH ARZTEBL INT, V106, P329, DOI 10.3238/arztebl.2009.0329; Bennett M, 1997, J COMP PATHOL, V116, P35, DOI 10.1016/S0021-9975(97)80041-2; Bourquain D, 2012, VIRUS RES IN PRESS; Breithaupt A, 2012, VET PATHOL, V49, P941, DOI 10.1177/0300985812439077; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086; Duraffour S, 2007, ANTIMICROB AGENTS CH, V51, P4410, DOI 10.1128/AAC.00838-07; Duraffour S, 2012, J VIROL, V86, P7310, DOI 10.1128/JVI.00355-12; Duraffour S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021561; Duraffour S, 2010, IDRUGS, V13, P181; Duroffour S, 2008, ANTIVIR THER, V13, P977; EISHUBINGER AM, 1990, LANCET, V336, P880, DOI 10.1016/0140-6736(90)92387-W; FENNER F, 1957, VIROLOGY, V4, P305, DOI 10.1016/0042-6822(57)90065-X; Feore SM, 1997, P ROY SOC B-BIOL SCI, V264, P1457, DOI 10.1098/rspb.1997.0202; GASKELL RM, 1983, VET REC, V112, P164, DOI 10.1136/vr.112.8.164; Haase O, 2011, BRIT J DERMATOL, V164, P1116, DOI 10.1111/j.1365-2133.2011.10226.x; Hostetler KY, 2010, VIRUSES-BASEL, V2, P2213, DOI 10.3390/v2102213; Huemer HP, 2012, RES VET SCI, V92, P333, DOI 10.1016/j.rvsc.2011.03.011; Johnson RF, 2011, VIROLOGY, V418, P102, DOI 10.1016/j.virol.2011.07.013; Kinnunen PM, 2011, VECTOR-BORNE ZOONOT, V11, P1133, DOI 10.1089/vbz.2010.0170; Kurth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006883; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; Parker RF, 1941, J EXP MED, V74, P263, DOI 10.1084/jem.74.3.263; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; Reading PC, 2003, J GEN VIROL, V84, P1973, DOI 10.1099/vir.0.19285-0; Rubins KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015615; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Smee DF, 2008, INT J ANTIMICROB AG, V31, P352, DOI 10.1016/j.ijantimicag.2007.11.013; Smith AL, 2012, J GEN VIROL, V93, P159, DOI 10.1099/vir.0.036905-0; Vogel S, 2012, ACTA DERM-VENEREOL, V92, P126, DOI 10.2340/00015555-1227	36	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55808	10.1371/journal.pone.0055808	http://dx.doi.org/10.1371/journal.pone.0055808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457480	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700018
J	Wigman, JTW; Collip, D; Wichers, M; Delespaul, P; Derom, C; Thiery, E; Vollebergh, WAM; Lataster, T; Jacobs, N; Myin-Germeys, I; van Os, J				Wigman, Johanna T. W.; Collip, Dina; Wichers, Marieke; Delespaul, Philippe; Derom, Catherine; Thiery, Evert; Vollebergh, Wilma A. M.; Lataster, Tineke; Jacobs, Nele; Myin-Germeys, Inez; van Os, Jim			Altered Transfer of Momentary Mental States (ATOMS) as the Basic Unit of Psychosis Liability in Interaction with Environment and Emotions	PLOS ONE			English	Article							DAILY-LIFE STRESS; CHILDHOOD TRAUMA; POSITIVE EMOTIONS; COGNITIVE MODEL; GENETIC RISK; REACTIVITY; SYMPTOMS; SCHIZOPHRENIA; EXPERIENCES; DEPRESSION	Psychotic disorders are thought to represent altered neural function. However, research has failed to map diagnostic categories to alterations in neural networks. It is proposed that the basic unit of psychotic psychopathology is the moment-to-moment expression of subtle anomalous experiences of subclinical psychosis, and particularly its tendency to persist from moment-to-moment in daily life, under the influence of familial, environmental, emotional and cognitive factors. In a general population twin sample (n =579) and in a study of patients with psychotic disorder (n = 57), their non-psychotic siblings (n = 59) and unrelated controls (n = 75), the experience sampling paradigm (ESM; repetitive, random sampling of momentary mental states and context) was applied. We analysed, in a within-person prospective design, (i) transfer of momentary anomalous experience at time point (t-1) to time point (t) in daily life, and (ii) moderating effects of negative affect, positive affect, daily stressors, IQ and childhood trauma. Additionally, (iii) familial associations between persistence of momentary anomalous experience and psychotic symptomatology were investigated. Higher level of schizotypy in the twins (but not higher level of psychotic symptoms in patients) predicted more persistence of momentary anomalous experience in daily life, both within subjects and across relatives. Persistence of momentary anomalous experience was highest in patients, intermediate in their siblings and lowest in controls. In both studies, persistence of momentary anomalous experience was moderated by higher levels of negative affect, daily stressors and childhood trauma (only in twins), and by lower levels of positive affect. The study of alterations in the moment-to-moment transfer of subtle anomalous experience of psychosis, resulting in their persistence, helps to explain why psychotic and emotional dysregulation tend to cluster in a single phenotype such as schizophrenia, and how familial and environmental risks increase the risk of expression of psychosis from, first, subtle momentary anomalous experience to, second, observable clinical symptoms.	[Wigman, Johanna T. W.; Collip, Dina; Wichers, Marieke; Delespaul, Philippe; Lataster, Tineke; Jacobs, Nele; Myin-Germeys, Inez; van Os, Jim] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Wigman, Johanna T. W.; Vollebergh, Wilma A. M.] Univ Utrecht, Dept Interdisciplinary Social Sci, Utrecht, Netherlands; [Derom, Catherine] Catholic Univ, Dept Human Genet, Univ Hosp Gasthuisberg, Louvain, Belgium; [Thiery, Evert] Assoc Sci Res Multiple Births, Ghent, Belgium; [Jacobs, Nele] Open Univ Netherlands, Fac Psychol, Heerlen, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Kings Hlth Partners, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Utrecht University; KU Leuven; University Hospital Leuven; Open University Netherlands; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	Myin Germeys, Inez/HIR-3364-2022; Delespaul, Philippe/E-8982-2011; Delespaul, Philippe/L-1396-2019; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Wigman, Johanna/Y-8874-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Wichers, Marieke/N-6667-2014; Myin-Germeys, Inez/L-5106-2014	Myin Germeys, Inez/0000-0002-3731-4930; Delespaul, Philippe/0000-0001-7420-0898; Delespaul, Philippe/0000-0001-7420-0898; van Os, Jim/0000-0002-7245-1586; Wigman, Johanna/0000-0001-9504-4564; Wichers, Marieke/0000-0001-5024-9064; Derom, Catherine/0000-0001-5574-796X	Fund of Scientific Research; Flanders; Twins, a non-profit association for Scientific Research in Multiple Births (Belgium); Geestkracht program of the Netherlands Organization for Health Research and Development (ZonMw) [10-000-1002]; European Community's Seventh Framework Program [HEALTH-F2-2009-241909]; Janssen-Cilag; Eli Lilly and Co; AstraZeneca; Lundbeck	Fund of Scientific Research; Flanders(FWO); Twins, a non-profit association for Scientific Research in Multiple Births (Belgium); Geestkracht program of the Netherlands Organization for Health Research and Development (ZonMw); European Community's Seventh Framework Program; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly and Co(Eli Lilly); AstraZeneca(AstraZeneca); Lundbeck(Lundbeck Corporation)	The TWIN study has been partly supported by grants from the Fund of Scientific Research, Flanders and Twins, a non-profit association for Scientific Research in Multiple Births (Belgium). The infrastructure for the GROUP study is funded by grant 10-000-1002 from the Geestkracht program of the Netherlands Organization for Health Research and Development (ZonMw) and matching funds from participating universities and mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGZ De Grote Rivieren, and Parnassia Psychomedical Centre; Site Maastricht: Maastricht University Medical Center, GGZ Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ Noord-Midden Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum SintJozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem). Supported by the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interest. Prof van Os conducts other studies, not related to the study that is the subject of the authors' submission and approved by the standing ethics committee, that are in part supported by unrestricted grants from Janssen-Cilag, Eli Lilly and Co, AstraZeneca, and Lundbeck. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Collip I, 2011, PSYCHOL MED, V41, P911, DOI 10.1017/S0033291710001558; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883; Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004; Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312; Green AS, 2006, PSYCHOL METHODS, V11, P87, DOI 10.1037/1082-989X.11.1.87; Gurka MJ, 2011, STAT MED, V30, P2696, DOI 10.1002/sim.4293; Heinrichs RW, 2001, SEARCH MADNESS SCHIZ; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; HEMSLEY DR, 1993, BEHAV RES THER, V31, P633, DOI 10.1016/0005-7967(93)90116-C; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Jacobs N, 2005, LIFE SCI, V76, P2431, DOI 10.1016/j.lfs.2004.10.045; Jacobs N, 2006, PSYCHOSOM MED, V68, P201, DOI 10.1097/01.psy.0000204919.15727.43; Jacobs N, 2005, ACTA PSYCHIAT SCAND, V112, P394, DOI 10.1111/j.1600-0447.2005.00588.x; Jacobs N, 2011, BRIT J CLIN PSYCHOL, V50, P19, DOI 10.1348/014466510X491397; Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kramer IMA, 2012, PSYCHOL MED, V42, P283, DOI 10.1017/S0033291711001474; Lahera G, 2012, REV PSIQUIATR SALUD, DOI [10.1016/j.rpsmen.2012.05.003, DOI 10.1016/J.RPSMEN.2012.05.003]; Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x; Lataster T, 2009, ACTA PSYCHIAT SCAND, V119, P45, DOI 10.1111/j.1600-0447.2008.01263.x; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2005, BIOL PSYCHIAT, V58, P105, DOI 10.1016/j.biopsych.2005.02.012; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164; Nesselroade JR, 2007, MEAS-INTERDISCIP RES, V5, P217, DOI 10.1080/15366360701741807; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863; Rutter M, 2011, J CHILD PSYCHOL PSYC, V52, P647, DOI 10.1111/j.1469-7610.2011.02367.x; Simons CJP, 2007, SCHIZOPHR RES, V92, P24, DOI 10.1016/j.schres.2007.01.008; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; Smeets F, 2012, SCHIZOPHRENIA BULL, V38, P531, DOI 10.1093/schbul/sbq117; Spauwen J, 2006, BRIT J PSYCHIAT, V188, P527, DOI 10.1192/bjp.bp.105.011346; StataCorp, 2014, STAT 15 SURV AN REF; van Os J, 2009, ACTA PSYCHIAT SCAND, V120, P363, DOI 10.1111/j.1600-0447.2009.01456.x; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482; Wechsler D, 2001, WECHSLER ADULT INTEL; Wichers M, 2011, ACTA PSYCHIAT SCAND, V123, P402, DOI 10.1111/j.1600-0447.2011.01684.x; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66; Wichers M, 2008, J ABNORM PSYCHOL, V117, P699, DOI 10.1037/a0012909; Wichers M, 2007, BRIT J PSYCHIAT, V191, P218, DOI 10.1192/bjp.bp.106.032201; Wichers M, 2012, HEALTH PSYCHOL, V31, P135, DOI 10.1037/a0025688; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x; Wigman JTW, 2011, AM J MED GENET B, V156B, P546, DOI 10.1002/ajmg.b.31193	67	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e54653	10.1371/journal.pone.0054653	http://dx.doi.org/10.1371/journal.pone.0054653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457452	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700006
J	Bitencourt, AR; Vicentin, EC; Jimenez, MC; Ricci, R; Leite, JA; Costa, FT; Ferreira, LC; Russell, B; Nosten, F; Renia, L; Galinski, MR; Barnwell, JW; Rodrigues, MM; Soares, IS				Bitencourt, Amanda R.; Vicentin, Elaine C.; Jimenez, Maria C.; Ricci, Ricardo; Leite, Juliana A.; Costa, Fabio T.; Ferreira, Luis C.; Russell, Bruce; Nosten, Francois; Renia, Laurent; Galinski, Mary R.; Barnwell, John W.; Rodrigues, Mauricio M.; Soares, Irene S.			Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3	PLOS ONE			English	Article							LONG SYNTHETIC PEPTIDES; DUFFY BINDING-PROTEIN; BLOOD-STAGE VACCINE; C-TERMINAL REGIONS; MALARIA VACCINE; IMMUNE-RESPONSES; CIRCUMSPOROZOITE PROTEIN; PROTECTIVE EFFICACY; CANDIDATE MSP1(19); ANTIBODY-RESPONSE	A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against Plasmodium falciparum malaria. The present study evaluated the use of Plasmodium vivax MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria caused by P. vivax. Recombinant proteins representing MSP-3 alpha and MSP-3 beta of P. vivax were expressed as soluble histidine-tagged bacterial fusions. Antigenicity during natural infection was evaluated by detecting specific antibodies using sera from individuals living in endemic areas of Brazil. A large proportion of infected individuals presented IgG antibodies to PvMSP-3 alpha (68.2%) and at least 1 recombinant protein representing PvMSP-3 beta (79.1%). In spite of the large responder frequency, reactivity to both antigens was significantly lower than was observed for the immunodominant epitope present on the 19-kDa C-terminal region of PvMSP-1. Immunogenicity of the recombinant proteins was studied in mice in the absence or presence of different adjuvant formulations. PvMSP-3 beta, but not PvMSP-3 alpha, induced a TLR4-independent humoral immune response in the absence of any adjuvant formulation. The immunogenicity of the recombinant antigens were also tested in formulations containing different adjuvants (Alum, Salmonella enterica flagellin, CpG, Quil A, TiterMax (R) and incomplete Freunds adjuvant) and combinations of two adjuvants (Alum plus flagellin, and CpG plus flagellin). Recombinant PvMSP-3 alpha and PvMSP-3 beta elicited higher antibody titers capable of recognizing P. vivax-infected erythrocytes harvested from malaria patients. Our results confirm that P. vivax MSP-3 antigens are immunogenic during natural infection, and the corresponding recombinant proteins may be useful in elucidating their vaccine potential.	[Bitencourt, Amanda R.; Vicentin, Elaine C.; Jimenez, Maria C.; Ricci, Ricardo; Soares, Irene S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Leite, Juliana A.; Costa, Fabio T.] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Inst Biol, Campinas, SP, Brazil; [Ferreira, Luis C.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508 Sao Paulo, Brazil; [Russell, Bruce] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Russell, Bruce; Renia, Laurent] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, Singapore, Singapore; [Nosten, Francois] Churchill Hosp, Ctr Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Nosten, Francois] Mahidol Oxford Univ Trop Med Res Programme, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Galinski, Mary R.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Galinski, Mary R.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Galinski, Mary R.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Chamblee, GA USA; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, CTCMOL, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Oxford; Mahidol University; Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Universidade Federal de Sao Paulo (UNIFESP)	Soares, IS (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.	isoares@usp.br	Renia, Laurent/E-2117-2011; Rodrigues, Mauricio M./B-8512-2012; Russell, Bruce/A-9240-2011; Nosten, Francois/AAC-5509-2019; Costa, Fabio/E-1181-2012; Vicentin, Elaine/F-2651-2013; Soares, Irene Silva/C-5974-2012; Leite, Juliana/G-2563-2013; Soares, Irene/GQF-1984-2022; Ferreira, Luis/M-3954-2014	Renia, Laurent/0000-0003-0349-1557; Russell, Bruce/0000-0003-2333-4348; Nosten, Francois/0000-0002-7951-0745; Costa, Fabio/0000-0001-9969-7300; Soares, Irene Silva/0000-0002-3336-6856; Ferreira, Luis/0000-0002-4883-1693	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/09893-0]; National Institute for Vaccine Development and Technology (CNPq - INCTV); FAPESP; CNPq; US National Institutes of Health, National Institute for Allergy and Infectious Diseases [1R01AI24710]; SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore); Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024710] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute for Vaccine Development and Technology (CNPq - INCTV)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); US National Institutes of Health, National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2010/09893-0) and The National Institute for Vaccine Development and Technology (CNPq - INCTV). ARB, MCJ and JAL were supported by fellowships from FAPESP. ECV, RR, FTC, LCF, MMR and ISS were supported by fellowships from CNPq. Support is also acknowledged from the US National Institutes of Health, National Institute for Allergy and Infectious Diseases to MRG (1R01AI24710), from SIgN and from the Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore). SMRU is sponsored by The Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P25; Arevalo-Herrera M, 2011, AM J TROP MED HYG, V84, P35, DOI 10.4269/ajtmh.2011.09-0507; Barbedo MB, 2007, MEM I OSWALDO CRUZ, V102, P335, DOI 10.1590/S0074-02762007005000040; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Coler RN, 2009, PARASITE IMMUNOL, V31, P520, DOI 10.1111/j.1365-3024.2009.01142.x; Cunha MG, 2001, VACCINE, V20, P385, DOI 10.1016/S0264-410X(01)00359-0; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; Galinski MR, 2001, MOL BIOCHEM PARASIT, V115, P41, DOI 10.1016/S0166-6851(01)00267-5; Gentil F, 2010, VACCINE, V28, P6183, DOI 10.1016/j.vaccine.2010.07.017; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Herrera S, 2004, INT J PARASITOL, V34, P1535, DOI 10.1016/j.ijpara.2004.10.009; Herrera S, 2011, AM J TROP MED HYG, V84, P12, DOI 10.4269/ajtmh.2011.09-0516; Jimenez MCS, 2008, BBA-GEN SUBJECTS, V1780, P983, DOI 10.1016/j.bbagen.2008.03.016; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Bouillet LEM, 2011, INFECT IMMUN, V79, P3642, DOI 10.1128/IAI.05048-11; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Michon PA, 1998, AM J TROP MED HYG, V59, P597, DOI 10.4269/ajtmh.1998.59.597; Morais CG, 2005, PARASITOL RES, V95, P420, DOI 10.1007/s00436-005-1314-x; Morais CG, 2006, AM J TROP MED HYG, V75, P582, DOI 10.4269/ajtmh.2006.75.582; Mourao LC, 2012, MICROBES INFECT, V14, P730, DOI 10.1016/j.micinf.2012.02.011; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Rayner JC, 2002, PARASITOLOGY, V125, P393, DOI 10.1017/S0031182002002317; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Ribeiro RS, 2011, MEM I OSWALDO CRUZ, V106, P27, DOI 10.1590/S0074-02762011000900004; Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39; Rodriguesa MHC, 2005, INT J PARASITOL, V35, P185, DOI 10.1016/j.ijpara.2004.11.003; Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Sagara I, 2009, VACCINE, V27, P7292, DOI 10.1016/j.vaccine.2009.10.087; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Storti-Melo LM, 2011, AM J TROP MED HYG, V84, P58, DOI 10.4269/ajtmh.2011.10-0044; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; Valderrama-Aguirre A, 2005, AM J TROP MED HYG, V73, P16, DOI 10.4269/ajtmh.2005.73.16; Wu Yu-Huan, 2008, P3	43	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56061	10.1371/journal.pone.0056061	http://dx.doi.org/10.1371/journal.pone.0056061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457498	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700037
J	Danise, S; Twitchett, RJ; Little, CTS; Clemence, ME				Danise, Silvia; Twitchett, Richard J.; Little, Crispin T. S.; Clemence, Marie-Emilie			The Impact of Global Warming and Anoxia on Marine Benthic Community Dynamics: an Example from the Toarcian (Early Jurassic)	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; MASS EXTINCTION; CLIMATE-CHANGE; SEA-LEVEL; TAXONOMIC DISTINCTNESS; SEAWATER TEMPERATURE; ISOTOPE EVIDENCE; CLEVELAND BASIN; SW-GERMANY; EVENT	The Pliensbachian-Toarcian (Early Jurassic) fossil record is an archive of natural data of benthic community response to global warming and marine long-term hypoxia and anoxia. In the early Toarcian mean temperatures increased by the same order of magnitude as that predicted for the near future; laminated, organic-rich, black shales were deposited in many shallow water epicontinental basins; and a biotic crisis occurred in the marine realm, with the extinction of approximately 5% of families and 26% of genera. High-resolution quantitative abundance data of benthic invertebrates were collected from the Cleveland Basin (North Yorkshire, UK), and analysed with multivariate statistical methods to detect how the fauna responded to environmental changes during the early Toarcian. Twelve biofacies were identified. Their changes through time closely resemble the pattern of faunal degradation and recovery observed in modern habitats affected by anoxia. All four successional stages of community structure recorded in modern studies are recognised in the fossil data (i.e. Stage III: climax; II: transitional; I: pioneer; 0: highly disturbed). Two main faunal turnover events occurred: (i) at the onset of anoxia, with the extinction of most benthic species and the survival of a few adapted to thrive in low-oxygen conditions (Stages I to 0) and (ii) in the recovery, when newly evolved species colonized the re-oxygenated soft sediments and the path of recovery did not retrace of pattern of ecological degradation (Stages I to II). The ordination of samples coupled with sedimentological and palaeotemperature proxy data indicate that the onset of anoxia and the extinction horizon coincide with both a rise in temperature and sea level. Our study of how faunal associations co-vary with long and short term sea level and temperature changes has implications for predicting the long-term effects of "dead zones" in modern oceans.	[Danise, Silvia; Twitchett, Richard J.; Clemence, Marie-Emilie] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth PL4 8AA, Devon, England; [Little, Crispin T. S.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England	University of Plymouth; University of Leeds	Danise, S (corresponding author), Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth PL4 8AA, Devon, England.	silvia.danise@plymouth.ac.uk		Danise, Silvia/0000-0002-6098-609X; Little, Crispin/0000-0002-1917-4460	Natural Environment Research Council (NERC) [NE/I005641/1]; NERC PhD studentship; NERC [NE/I005641/1] Funding Source: UKRI; Natural Environment Research Council [NE/I005641/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by a Natural Environment Research Council (NERC) grant to RJT (NE/I005641/1) and by a NERC PhD studentship to CTSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M, 2002, GEOL SOC SPEC PUBL, V194, P127, DOI 10.1144/GSL.SP.2002.194.01.10; Aberhan M, 2003, GEOLOGY, V31, P1077, DOI 10.1130/G19938.1; Aberhan M, 1996, LETHAIA, V29, P181, DOI 10.1111/j.1502-3931.1996.tb01874.x; [Anonymous], 1985, P YORKS GEOL SOC, DOI DOI 10.1144/PYGS.45.4.261; Bailey TR, 2003, EARTH PLANET SC LETT, V212, P307, DOI 10.1016/S0012-821X(03)00278-4; BASSOULLET JP, 1991, B SOC GEOL FR, V162, P825, DOI 10.2113/gssgfbull.162.5.825; Belanger CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036290; Bonuso N, 2002, GEOLOGY, V30, P1055, DOI 10.1130/0091-7613(2002)030<1055:DCSYTA>2.0.CO;2; Bottjer DJK, 1995, MARINE PALAEOENVIRON, V83, P7; Brasier M.D., 1995, Geological Society Special Publication, V83, P113, DOI 10.1144/GSL.SP.1995.083.01.07; Bush AM, 2010, PALEOBIOLOGY, V36, P573, DOI 10.1666/07022.1; Caswell BA, 2012, PALAEOGEOGR PALAEOCL, V365, P124, DOI 10.1016/j.palaeo.2012.09.021; Caswell BA, 2009, J GEOL SOC LONDON, V166, P859, DOI 10.1144/0016-76492008-0831; Cecca F, 2004, LETHAIA, V37, P35, DOI 10.1080/00241160310008257; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clemence ME, 2005, VAR PAL BASS PAR DUR, V2005; Cohen AS, 2004, GEOLOGY, V32, P157, DOI 10.1130/G20158.1; Dera G, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002283; Dera G, 2009, EARTH PLANET SC LETT, V286, P198, DOI 10.1016/j.epsl.2009.06.027; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Erba E, 2004, MAR MICROPALEONTOL, V52, P85, DOI 10.1016/j.marmicro.2004.04.007; Gahr M.E., 2005, Journal of Iberian Geology, V31, P197; Gahr ME., 2002, BERINGERIA, V31, P3; Joral FG, 2011, PALAEOGEOGR PALAEOCL, V302, P367, DOI 10.1016/j.palaeo.2011.01.023; Ghadeer S.G., 2011, J GEOLOGICAL SOC LON, V168, P835; Gomez JJ, 2008, PALAEOGEOGR PALAEOCL, V258, P28, DOI 10.1016/j.palaeo.2007.11.005; Gomez JJ, 2011, PALAEOGEOGR PALAEOCL, V306, P176, DOI 10.1016/j.palaeo.2011.04.018; Gorley C.K., 2006, GETTING STARTED PRIM; HALLAM A, 1986, NATURE, V319, P765, DOI 10.1038/319765a0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harries PJ, 1999, PALAEOGEOGR PALAEOCL, V154, P39, DOI 10.1016/S0031-0182(99)00086-3; Hesselbo S.P., 1998, SOC EC PALEONTOLOGIS, V60, P561, DOI DOI 10.2110/PEC.98.02.0561; Hesselbo SP, 1995, FIELD GEOLOGY OF THE BRITISH JURASSIC, P105; Hesselbo SP, 2008, P GEOLOGIST ASSOC, V119, P19, DOI 10.1016/S0016-7878(59)80069-9; Hori RS, 1997, MAR MICROPALEONTOL, V30, P159, DOI 10.1016/S0377-8398(96)00024-2; Howard AS, 1984, THESIS U LONDON; Howarth M.K., 1973, Bulletin Br Mus nat Hist (Geol), V24, P238; Howarth M. K., 1962, Proceedings of the Yorkshire Geological Society, V33, P381; Howarth M. K., 1955, Proceedings of the Yorkshire Geological Society, V30, P147; Jefferies RPS, 1965, PALAEONTOLOGY, V8, P15; JENKYNS HC, 1988, AM J SCI, V288, P101, DOI 10.2475/ajs.288.2.101; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Johnson A.L.A., 1984, Zitteliana, V11, P1; Kemp DB, 2005, NATURE, V437, P396, DOI 10.1038/nature04037; Kemp WM, 2009, BIOGEOSCIENCES, V6, P2985, DOI 10.5194/bg-6-2985-2009; Korte C, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002160; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Layou KM, 2009, PALAIOS, V24, P118, DOI 10.2110/palo.2008.p08-012r; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Li Q, 2012, PALAEOGEOGR PALAEOCL, V315, P38, DOI 10.1016/j.palaeo.2011.11.006; Little Crispin T.S., 1996, Geological Society of America Special Paper, V307, P505; LITTLE CTS, 1995, GEOLOGY, V23, P495, DOI 10.1130/0091-7613(1995)023<0495:EJMEAG>2.3.CO;2; Little CTS, 1995, THESIS U LEEDS, P144; LUDVIGSEN R, 1986, GEOSCI CAN, V13, P139; Macquaker JHS, 1996, J GEOL SOC LONDON, V153, P759, DOI 10.1144/gsjgs.153.5.0759; Mailliot S, 2009, PALAEOGEOGR PALAEOCL, V273, P346, DOI 10.1016/j.palaeo.2008.05.014; McArthur JM, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001607; McArthur JM, 2000, EARTH PLANET SC LETT, V179, P269, DOI 10.1016/S0012-821X(00)00111-4; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; MILLER W, 1986, LETHAIA, V19, P225, DOI 10.1111/j.1502-3931.1986.tb00735.x; MORRIS KA, 1979, PALAEOGEOGR PALAEOCL, V26, P117, DOI 10.1016/0031-0182(79)90144-5; Morten SD, 2009, PALAEOGEOGR PALAEOCL, V284, P29, DOI 10.1016/j.palaeo.2009.08.023; Nikitenko BL, 2008, STRATIGR GEO CORREL+, V16, P59, DOI 10.1134/S086959380801005X; Nutzel A, 2008, FREUNDE BAYERISCHEN, V36, P42; Oliver PG, 2012, J MOLLUS STUD, V78, P81, DOI 10.1093/mollus/eyr045; Oliver PG, 2001, J MOLLUS STUD, V67, P225, DOI 10.1093/mollus/67.2.225; Olszewski TD, 2001, PALAIOS, V16, P444, DOI 10.2307/3515562; OSCHMANN W, 1993, J GEOL SOC LONDON, V150, P187, DOI 10.1144/gsjgs.150.1.0187; Palfy J, 2000, GEOLOGY, V28, P747, DOI 10.1130/0091-7613(2000)28<747:SBEJEO>2.0.CO;2; Palliani RB, 2002, MAR MICROPALEONTOL, V46, P223; Pancost RD, 2004, J GEOL SOC LONDON, V161, P353, DOI 10.1144/0016764903-059; Patzkowsky ME, 1999, PALAIOS, V14, P301, DOI 10.2307/3515459; Patzkowsky ME, 2012, STRATIGRAPHIC PALEOB; Pearce CR, 2008, GEOLOGY, V36, P231, DOI 10.1130/G24446A.1; Powell JH, 2010, P YORKS GEOL SOC, V58, P21, DOI 10.1144/pygs.58.1.278; Price GD, 2009, PALAIOS, V24, P273, DOI 10.2110/palo.2008.p08-067r; PYE K, 1986, GEOL MAG, V123, P191, DOI 10.1017/S0016756800034695; Rawson PF, 1995, FIELD GEOLOGY OF THE BRITISH JURASSIC, P173; Riedel B, 2012, MAR ECOL PROG SER, V458, P39, DOI 10.3354/meps09724; Rohl HJ, 2001, PALAEOGEOGR PALAEOCL, V165, P27, DOI 10.1016/S0031-0182(00)00152-8; Rosenberg R, 2002, MAR ECOL PROG SER, V234, P43, DOI 10.3354/meps234043; Roy K, 2001, ECOL LETT, V4, P366; Saelen G, 1996, PALAIOS, V11, P97, DOI 10.2307/3515065; Saelen G, 2000, PALAEOGEOGR PALAEOCL, V163, P163, DOI 10.1016/S0031-0182(00)00150-4; SAVRDA C E, 1989, Palaios, V4, P330, DOI 10.2307/3514557; Schouten S, 2000, AM J SCI, V300, P1, DOI 10.2475/ajs.300.1.1; Schwark L, 2004, CHEM GEOL, V206, P231, DOI 10.1016/j.chemgeo.2003.12.008; Shalaby S.E., 1980, P YORKS GEOL SOC, V42, P525; Stachowitsch M, 2007, LIMNOL OCEANOGR-METH, V5, P344, DOI 10.4319/lom.2007.5.344; Steckbauer A., 2011, ENVIRON RES LETT, V6, P1; Thorson G., 1957, TREATISE MARINE ECOL, V67, P461, DOI DOI 10.1130/MEM67V1-P461; Tomasovych A, 2007, PALAEOGEOGR PALAEOCL, V244, P170, DOI 10.1016/j.palaeo.2006.06.028; UNEP, 2004, GEO YB 2003; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine JW, 2010, PALAEONTOLOGY, V53, P1203, DOI 10.1111/j.1475-4983.2010.01005.x; Van Buchem FSP, 1998, SPECIAL PUBLICATION, V60, P545; Vaquer-Sunyer R, 2011, GLOBAL CHANGE BIOL, V17, P1788, DOI 10.1111/j.1365-2486.2010.02343.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; WARWICK RM, 1993, MAR ECOL PROG SER, V92, P221, DOI 10.3354/meps092221; Wignall PB, 2008, P GEOLOGIST ASSOC, V119, P73, DOI 10.1016/S0016-7878(08)80259-3; Wignall PB, 2005, AM J SCI, V305, P1014, DOI 10.2475/ajs.305.10.1014; WIGNALL PB, 1993, J GEOL SOC LONDON, V150, P323, DOI 10.1144/gsjgs.150.2.0323; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006	110	72	73	1	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56255	10.1371/journal.pone.0056255	http://dx.doi.org/10.1371/journal.pone.0056255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457537	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700062
J	Erickson, RP; Gross, SP; Yu, CC				Erickson, Robert P.; Gross, Steven P.; Yu, Clare C.			Filament-Filament Switching Can Be Regulated by Separation Between Filaments Together with Cargo Motor Number	PLOS ONE			English	Article							MOLECULAR MOTORS; MYOSIN-V; ACTIN; INTERSECTIONS; TRANSPORT; PROTEINS	How intracellular transport controls the probability that cargos switch at intersections between filaments is not well understood. In one hypothesis some motors on the cargo attach to one filament while others attach to the intersecting filament, and the ensuing tug-of-war determines which filament is chosen. We investigate this hypothesis using 3D computer simulations, and discover that switching at intersections increases with the number of motors on the cargo, but is not strongly dependent on motor number when the filaments touch. Thus, simply controlling the number of active motors on the cargo cannot account for in vivo observations that found reduced switching with increasing motor number, suggesting additional mechanisms of regulation. We use simulations to show that one possible way to regulate switching is by simultaneously adjusting the separation between planes containing the crossing filaments and the total number of active motors on the cargo. Heretofore, the effect of filament-filament separation on switching has been unexplored. We find that the switching probability decreases with increasing filament separation. This effect is particularly strong for cargos with only a modest number of motors. As the filament separation increases past the maximum head-to-head distance of the motor, individual motors walking along a filament will be unable to reach the intersecting filament. Thus, any switching requires that other motors on the cargo attach to the intersecting filament and haul the cargo along it, while motor(s) engaged on the original filament detach. Further, if the filament separation is large enough, the cargo can have difficulty proceeding along the initial filament because the engaged motors can walk underneath the intersecting filament, but the cargo itself cannot fit between the filaments. Thus, the cargo either detaches entirely from the original filament, or must dip to the side of the initial filament and then pass below the crossing filament.	[Erickson, Robert P.; Gross, Steven P.; Yu, Clare C.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92717 USA; [Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Gross, SP (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92717 USA.	sgross@uci.edu; cyu@uci.edu		Erickson, Robert/0000-0001-9683-5149	NIH/NIGMS [5R01GM079156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079156] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIGMS grant number 5R01GM079156 (www.nih.gov) to CCYu and SPGross. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Cassimeris L, 2011, LEWINS CELLS, Vxxiv; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Erickson RP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002032; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Snider J, 2004, P NATL ACAD SCI USA, V101, P13204, DOI 10.1073/pnas.0403092101; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	14	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54298	10.1371/journal.pone.0054298	http://dx.doi.org/10.1371/journal.pone.0054298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457447	Green Published, gold			2022-12-27	WOS:000315602700004
J	Frola, E; Patrizi, A; Goetz, T; Medrihan, L; Petrini, EM; Barberis, A; Wulff, P; Wisden, W; Sassoe-Pognetto, M				Frola, Elena; Patrizi, Annarita; Goetz, Thomas; Medrihan, Lucian; Petrini, Enrica Maria; Barberis, Andrea; Wulff, Peer; Wisden, William; Sassoe-Pognetto, Marco			Synaptic Competition Sculpts the Development of GABAergic Axo-Dendritic but Not Perisomatic Synapses	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; POSTSYNAPTIC GABA(A) RECEPTORS; WINNER CLIMBING FIBER; INHIBITORY SYNAPSES; PURKINJE-CELLS; GAMMA-2 SUBUNIT; A RECEPTORS; IN-VIVO; POSITIVE INTERNEURONS; MONOCLONAL-ANTIBODIES	The neurotransmitter GABA regulates many aspects of inhibitory synapse development. We tested the hypothesis that GABA(A) receptors (GABA(A)Rs) work together with the synaptic adhesion molecule neuroligin 2 (NL2) to regulate synapse formation in different subcellular compartments. We investigated mice ("gamma 2 knockdown mice'') with an engineered allele of the GABA(A)R gamma 2 subunit gene which produced a mosaic expression of synaptic GABAARs in neighboring neurons, causing a strong imbalance in synaptic inhibition. Deletion of the gamma 2 subunit did not abolish synapse formation or the targeting of NL2 to distinct types of perisomatic and axo-dendritic contacts. Thus synaptic localization of NL2 does not require synaptic GABA(A)Rs. However, loss of the gamma 2 subunit caused a selective decrease in the number of axo-dendritic synapses on cerebellar Purkinje cells and cortical pyramidal neurons, whereas perisomatic synapses were not significantly affected. Notably, gamma 2-positive cells had increased axo-dendritic innervation compared with both gamma 2-negative and wild-type counterparts. Moreover heterologous synapses on spines, that are found after total deletion of GABA(A)Rs from all Purkinje cells, were rare in cerebella of gamma 2 knockdown mice. These findings reveal a selective role of gamma 2 subunit-containing GABA(A)Rs in regulating synapse development in distinct subcellular compartments, and support the hypothesis that the refinement of axo-dendritic synapses is regulated by activity-dependent competition between neighboring neurons.	[Frola, Elena; Patrizi, Annarita; Sassoe-Pognetto, Marco] Univ Turin, Dept Neurosci, Turin, Italy; [Frola, Elena; Patrizi, Annarita; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Goetz, Thomas; Wulff, Peer; Wisden, William] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Medrihan, Lucian; Petrini, Enrica Maria; Barberis, Andrea] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy	University of Turin; University of Aberdeen; Istituto Italiano di Tecnologia - IIT	Wisden, W (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	w.wisden@imperial.ac.uk; marco.sassoe@unito.it	Barberis, Andrea/AAB-8806-2019; Sassoe-Pognetto, Marco/AAE-3536-2022; Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; Wulff, Peer/0000-0002-0282-7832; Frola, Elena/0000-0002-9706-4603; Medrihan, Lucian/0000-0002-8252-2595; Sassoe-Pognetto, Marco/0000-0001-8906-0613; Barberis, Andrea/0000-0002-5054-6517	Compagnia di San Paolo; Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata); Volkswagen Foundation [I/78 554]; Medical Research Council [G0800399]; Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development; MRC [G0800399, G0601498] Funding Source: UKRI; Medical Research Council [G0601498] Funding Source: researchfish	Compagnia di San Paolo(Compagnia di San Paolo); Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata)(Regione Piemonte); Volkswagen Foundation(Volkswagen); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Compagnia di San Paolo (2007) and Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata 2009) to MSP; J. Ernest Tait Estate to WW and TG; Volkswagen Foundation (grant I/78 554) to WW; Medical Research Council (grant G0800399) to PW and WW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Frederique Varoqueaux (Max Planck Institute for Experimental Medicine, Gottingen, Germany), Jean-Marc Fritschy (University of Zurich, Zurich, Switzerland), Masahiko Watanabe (Hokkaido University, Sapporo, Japan) and Rita Garbelli (Besta Neurological Institute, Milan) for their generous gift of the antibodies. The GAD-6 monoclonal antibody, developed by David I. Gottlieb (Washington University, St. Louis, MO), was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; Bosman LWJ, 2008, J NEUROSCI, V28, P798, DOI 10.1523/JNEUROSCI.4074-07.2008; Briatore F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012119; Bu J, 2003, EXP NEUROL, V182, P220, DOI 10.1016/S0014-4886(03)00094-3; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CELIO MR, 1988, CELL CALCIUM, V9, P81, DOI 10.1016/0143-4160(88)90027-9; CHANG YC, 1988, J NEUROSCI, V8, P2123; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cipelletti B, 2002, NEUROSCIENCE, V115, P657, DOI 10.1016/S0306-4522(02)00531-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cope DW, 2004, NEUROPHARMACOLOGY, V47, P17, DOI 10.1016/j.neuropharm.2004.03.007; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Ferraguti F, 2004, HIPPOCAMPUS, V14, P193, DOI 10.1002/hipo.10163; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; GOLDSTEIN ME, 1983, P NATL ACAD SCI-BIOL, V80, P3101, DOI 10.1073/pnas.80.10.3101; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Halasy K, 1996, HIPPOCAMPUS, V6, P306, DOI 10.1002/(SICI)1098-1063(1996)6:3<306::AID-HIPO8>3.0.CO;2-K; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638; Huesa G, 2002, CELL TISSUE RES, V309, P355, DOI 10.1007/s00441-002-0608-x; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Leppa E, 2011, EUR J PHARMACOL, V666, P111, DOI 10.1016/j.ejphar.2011.05.011; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lorez Matthias, 2000, Journal of Physiology (Cambridge), V527, P11, DOI 10.1111/j.1469-7793.2000.t01-1-00011.x; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Marchionni I, 2009, J PHYSIOL-LONDON, V587, P5691, DOI 10.1113/jphysiol.2009.179945; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mu WT, 1999, MOL BRAIN RES, V67, P137, DOI 10.1016/S0169-328X(99)00049-2; Ohtsuki G, 2008, EUR J NEUROSCI, V28, P2393, DOI 10.1111/j.1460-9568.2008.06539.x; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Sassoe-Pognetto M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00004; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tanaka J, 2000, EUR J NEUROSCI, V12, P781, DOI 10.1046/j.1460-9568.2000.00959.x; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Viltono L, 2008, J COMP NEUROL, V508, P579, DOI 10.1002/cne.21713; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wisden W, 1994, BIOL TECHNIQUES IN S, P9; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	90	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56311	10.1371/journal.pone.0056311	http://dx.doi.org/10.1371/journal.pone.0056311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457547	Green Published, gold			2022-12-27	WOS:000315602700066
J	Zhi, H; Tang, LH; Xia, YJ; Zhang, JH				Zhi, Hui; Tang, Leihan; Xia, Yiji; Zhang, Jianhua			Ssk1p-Independent Activation of Ssk2p Plays an Important Role in the Osmotic Stress Response in Saccharomyces cerevisiae: Alternative Activation of Ssk2p in Osmotic Stress	PLOS ONE			English	Article							KINASE KINASE KINASE; HOG MAPK PATHWAY; SIGNAL-TRANSDUCTION PATHWAY; ACTIN RECOVERY; GENE DELETION; DOCKING SITE; PBS2 MAPKK; YEAST; OSMOSENSOR; SCAFFOLD	In Saccharomyces cerevisiae, external high osmolarity activates the HOG MAPK pathway, which controls various aspects of osmoregulation. MAPKKK Ssk2 is activated by Ssk1 in the SLN1 branch of the osmoregulatory HOG MAPK pathway under hyperosmotic stress. We observed that Ssk2 can be activated independent of Ssk1 upon osmotic shock by an unidentified mechanism. The domain for the Ssk1p-independent activation was identified to be located between the amino acids 177 similar to 240. This region might be involved in the binding of an unknown regulator to Ssk2 which in turn activates Ssk2p without Ssk1p under hyperosmotic stress. The osmotic stress response through the Ssk1p-independent Ssk2p activation is strong, although its duration is short compared with the Ssk1p-dependent activation. The alternative Ssk2p activation is also important for the salt resistance.	[Zhi, Hui; Xia, Yiji] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Tang, Leihan] Hong Kong Baptist Univ, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Tang, Leihan] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jianhua] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University; Chinese University of Hong Kong	Tang, LH (corresponding author), Hong Kong Baptist Univ, Dept Phys, Hong Kong, Hong Kong, Peoples R China.	lhtang@hkbu.edu.hk; yxia@hkbu.edu.hk; jhzhang@cuhk.edu.hk	Tang, Lei-Han/ABB-3219-2020; Xia, Yiji/GRR-5126-2022	Tang, Lei-Han/0000-0002-2925-4691; Xia, Yiji/0000-0002-9543-8341; Zhang, Jianhua/0000-0002-3819-2437	Hong Kong Baptist University [FSRS/0708/01, SDF080603/P01]; Research Grants Council of the HKSAR [HKBU 201910]	Hong Kong Baptist University; Research Grants Council of the HKSAR(Hong Kong Research Grants Council)	The work was supported in part by the Hong Kong Baptist University through grants FSRS/0708/01 and SDF080603/P01 and by the Research Grants Council of the HKSAR under grant HKBU 201910. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bettinger BT, 2007, GENETICS, V175, P1637, DOI 10.1534/genetics.106.063370; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Burke D., 2000, METHODS YEAST GENETI, pxvii; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Ekiel I, 2009, MOL BIOL CELL, V20, P5117, DOI 10.1091/mbc.E09-07-0645; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Horie T, 2008, MOL CELL BIOL, V28, P5172, DOI 10.1128/MCB.00589-08; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Petrezselyova S, 2010, FUNGAL BIOL-UK, V114, P144, DOI 10.1016/j.funbio.2009.11.002; Porter SW, 2005, BBA-PROTEINS PROTEOM, V1748, P138, DOI 10.1016/j.bbapap.2004.12.009; Porter SW, 2003, EUKARYOT CELL, V2, P27, DOI 10.1128/EC.2.1.27-33.2003; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Tatebayashi K, 2003, EMBO J, V22, P3624, DOI 10.1093/emboj/cdg353; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu OP, 2003, STRUCTURE, V11, P1569, DOI 10.1016/j.str.2003.10.016; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yuzyuk T, 2003, MOL BIOL CELL, V14, P3013, DOI 10.1091/mbc.E02-11-0747; Yuzyuk T, 2002, MOL BIOL CELL, V13, P2869, DOI 10.1091/mbc.02-01-0004	39	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54867	10.1371/journal.pone.0054867	http://dx.doi.org/10.1371/journal.pone.0054867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457455	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700009
J	Mukherjee, J; Phillips, JJ; Zheng, SC; Wiencke, J; Ronen, SM; Pieper, RO				Mukherjee, Joydeep; Phillips, Joanna J.; Zheng, Shichun; Wiencke, John; Ronen, Sabrina M.; Pieper, Russell O.			Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma	PLOS ONE			English	Article							MESSENGER-RNA; CELL-METABOLISM; TUMOR-GROWTH; STEM-CELLS; CANCER; GLIOBLASTOMA; GLYCOLYSIS; ACTIVATION; ONCOGENES; COMPLEX	Normal tissues express the M1 isoform of pyruvate kinase (PK) that helps generate and funnel pyruvate into the mitochondria for ATP production. Tumors, in contrast, express the less active PKM2 isoform, which limits pyruvate production and spares glycolytic intermediates for the generation of macromolecules needed for proliferation. Although high PKM2 expression and low PK activity are considered defining features of tumors, very little is known about how PKM expression and PK activity change along the continuum from low grade to high grade tumors, and how these changes relate to tumor growth. To address this issue, we measured PKM isoform expression and PK activity in normal brain, neural progenitor cells, and in a series of over 100 astrocytomas ranging from benign grade I pilocytic astrocytomas to highly aggressive grade IV glioblastoma multiforme (GBM). All glioma exhibited comparably reduced levels of PKM1 expression and PK activity relative to normal brain. In contrast, while grade I-III gliomas all had modestly increased levels of PKM2 RNA and protein expression relative to normal brain, GBM, regardless of whether they arose de novo or progressed from lower grade tumors, showed a 3-5 fold further increase in PKM2 RNA and protein expression. Low levels of PKM1 expression and PK activity were important for cell growth as PKM1 over-expression and the accompanying increases in PK activity slowed the growth of GBM cells. The increased expression of PKM2, however, was also important, because shRNA-mediated PKM2 knockdown decreased total PKM2 and the already low levels of PK activity, but paradoxically also limited cell growth in vitro and in vivo. These results show that pyruvate kinase M expression, but not pyruvate kinase activity, is regulated in a grade-specific manner in glioma, but that changes in both PK activity and PKM2 expression contribute to growth of GBM.	[Mukherjee, Joydeep; Phillips, Joanna J.; Zheng, Shichun; Wiencke, John; Pieper, Russell O.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Phillips, Joanna J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Mukherjee, Joydeep; Phillips, Joanna J.; Zheng, Shichun; Wiencke, John; Ronen, Sabrina M.; Pieper, Russell O.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pieper, RO (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	rpieper@cc.ucsf.edu			National Institutes of Health [CA136774, CA097257, CA154915, NS063456]; NATIONAL CANCER INSTITUTE [R01CA136774, P50CA097257, R01CA154915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS063456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health grants CA136774 and CA097257 (SPORE) to ROP, CA154915 to SMR, and NS063456 to JJP. www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluemlein K, 2011, ONCOTARGET, V2, P393; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Chinnaiyan P, 2012, CANCER RES, V72, P5878, DOI 10.1158/0008-5472.CAN-12-1572-T; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Guminska M, 1997, ACTA BIOCHIM POL, V44, P711; Gupta V, 2010, PRO SCI, V19, P2131; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; IMAMURA K, 1986, MARKERS HUMAN NEUROE, P191; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kawaguchi T, 2006, CANCER RES, V66, P11331, DOI 10.1158/0008-5472.CAN-06-1540; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kleihues P, 2000, PATHOLOGY GENETICS T; Koss K, 2007, J CLIN PATHOL, V57, P1156; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2001, BIOCHEM J, V356, P247, DOI 10.1042/0264-6021:3560247; Mirzoeva OK, 2006, MOL CANCER THER, V5, P2757, DOI 10.1158/1535-7163.MCT-06-0183; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Steinberg P, 1999, VIRCHOWS ARCH, V434, P213, DOI 10.1007/s004280050330; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	40	67	70	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57610	10.1371/journal.pone.0057610	http://dx.doi.org/10.1371/journal.pone.0057610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451252	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500121
J	Stevens, RD; Tello, JS; Gavilanez, M				Stevens, Richard D.; Sebastian Tello, J.; Mercedes Gavilanez, Maria			Stronger Tests of Mechanisms Underlying Geographic Gradients of Biodiversity: Insights from the Dimensionality of Biodiversity	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; SPECIES-RICHNESS GRADIENTS; FUNCTIONAL DIVERSITY; NICHE CONSERVATISM; SPATIAL-PATTERNS; WORLD; BATS; SPECIATION; EVOLUTIONARY; SCALE	Inference involving diversity gradients typically is gathered by mechanistic tests involving single dimensions of biodiversity such as species richness. Nonetheless, because traits such as geographic range size, trophic status or phenotypic characteristics are tied to a particular species, mechanistic effects driving broad diversity patterns should manifest across numerous dimensions of biodiversity. We develop an approach of stronger inference based on numerous dimensions of biodiversity and apply it to evaluate one such putative mechanism: the mid-domain effect (MDE). Species composition of 10,000-km(2) grid cells was determined by overlaying geographic range maps of 133 noctilionoid bat taxa. We determined empirical diversity gradients in the Neotropics by calculating species richness and three indices each of phylogenetic, functional and phenetic diversity for each grid cell. We also created 1,000 simulated gradients of each examined metric of biodiversity based on a MDE model to estimate patterns expected if species distributions were randomly placed within the Neotropics. For each simulation run, we regressed the observed gradient onto the MDE-expected gradient. If a MDE drives empirical gradients, then coefficients of determination from such an analysis should be high, the intercept no different from zero and the slope no different than unity. Species richness gradients predicted by the MDE fit empirical patterns. The MDE produced strong spatially structured gradients of taxonomic, phylogenetic, functional and phenetic diversity. Nonetheless, expected values generated from the MDE for most dimensions of biodiversity exhibited poor fit to most empirical patterns. The MDE cannot account for most empirical patterns of biodiversity. Fuller understanding of latitudinal gradients will come from simultaneous examination of relative effects of random, environmental and historical mechanisms to better understand distribution and abundance of the current biota.	[Stevens, Richard D.; Sebastian Tello, J.; Mercedes Gavilanez, Maria] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Sebastian Tello, J.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO USA; [Sebastian Tello, J.] Pontificia Univ Catolica Ecuador, Museo Zool, Pichincha, Quito, Ecuador	Louisiana State University System; Louisiana State University; Missouri Botanical Gardens; Pontificia Universidad Catolica del Ecuador	Stevens, RD (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	rstevens@lsu.edu		Tello, J. Sebastian/0000-0003-2539-6796				Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; Arita HT, 2005, J THEOR BIOL, V232, P119, DOI 10.1016/j.jtbi.2004.08.004; Baker RJ, 2003, OCCAS PAP MUS TEXAS, V230, P1; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; CAMARGO JA, 1993, J THEOR BIOL, V161, P537, DOI 10.1006/jtbi.1993.1072; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Colwell RK, 2009, EVOL ECOL RES, V11, P355; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koleff P, 2001, ECOGRAPHY, V24, P341, DOI 10.1034/j.1600-0587.2001.240312.x; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lyons SK, 1997, OIKOS, V79, P568, DOI 10.2307/3546901; McClain CR, 2007, GLOBAL ECOL BIOGEOGR, V16, P257, DOI 10.1111/j.1466-8238.2007.00286.x; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; MCNAB BK, 1969, COMP BIOCHEM PHYSIOL, V31, P227, DOI 10.1016/0010-406X(69)91651-X; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PATTERSON B. D., 2007, DIGITAL DISTRIBUTION; Patterson BD, 2003, BAT ECOLOGY, P536; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; PIELOU EC, 1975, MATH ECOLOGY; Rangel TFLVB, 2005, ECOL LETT, V8, P783, DOI 10.1111/j.1461-0248.2005.00786.x; Rangel TFLVB, 2007, AM NAT, V170, P602, DOI 10.1086/521315; Ricklefs Robert E., 1994, P13; Rosenzweig ML, 1997, EVOL ECOL, V11, P733, DOI 10.1023/A:1018490419885; SCHUM M, 1984, ECOLOGY, V65, P1315, DOI 10.2307/1938336; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V235, P1; Sokal RR, 1995, BIOMETRY; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; Stevens RD, 2004, J BIOGEOGR, V31, P665, DOI 10.1111/j.1365-2699.2003.01042.x; Stevens RD, 2006, OIKOS, V112, P41, DOI 10.1111/j.0030-1299.2006.13167.x; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2000, OIKOS, V89, P367, DOI 10.1034/j.1600-0706.2000.890218.x; Stevens RD, 2006, P ROY SOC B-BIOL SCI, V273, P2283, DOI 10.1098/rspb.2006.3596; Stevens RD, 2011, P ROY SOC B-BIOL SCI, V278, P2528, DOI 10.1098/rspb.2010.2341; Swingland Ian R., 2001, P377; Tello JS, 2012, GLOBAL ECOL BIOGEOGR, V21, P212, DOI 10.1111/j.1466-8238.2011.00661.x; Tello JS, 2010, ECOGRAPHY, V33, P796, DOI 10.1111/j.1600-0587.2009.05991.x; Tello JS, 2013, INVESTIGACI IN PRESS; Villalobos F, 2010, GLOBAL ECOL BIOGEOGR, V19, P200, DOI 10.1111/j.1466-8238.2009.00503.x; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Willig MR, 2011, SCIENCE, V333, P1709, DOI 10.1126/science.1212453; WILLIG MR, 1989, J BIOGEOGR, V16, P189, DOI 10.2307/2845093; Willig MR, 1998, OIKOS, V81, P93, DOI 10.2307/3546471; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WILSON DE, 1973, SYST ZOOL, V22, P14, DOI 10.2307/2412374; Zapata FA, 2005, AM NAT, V166, pE144, DOI 10.1086/491685; Zapata FA, 2003, J ANIM ECOL, V72, P677, DOI 10.1046/j.1365-2656.2003.00741.x	68	18	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56853	10.1371/journal.pone.0056853	http://dx.doi.org/10.1371/journal.pone.0056853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451099	Green Published, gold			2022-12-27	WOS:000316849500035
J	Verma, D; Jin, SX; Kanagaraj, A; Singh, ND; Daniel, J; Kolattukudy, PE; Miller, M; Daniell, H				Verma, Dheeraj; Jin, Shuangxia; Kanagaraj, Anderson; Singh, Nameirakpam D.; Daniel, Jaiyanth; Kolattukudy, Pappachan E.; Miller, Michael; Daniell, Henry			Expression of Fungal Cutinase and Swollenin in Tobacco Chloroplasts Reveals Novel Enzyme Functions and/or Substrates	PLOS ONE			English	Article							PLANT-CELL WALL; ECTOPIC EXPRESSION; TRANSGENIC PLANTS; THYLAKOID LIPIDS; PHOTOSYSTEM-II; ARABIDOPSIS; EXPANSINS; MEMBRANES; PROTEIN; BIOMASS	In order to produce low-cost biomass hydrolyzing enzymes, transplastomic lines were generated that expressed cutinase or swollenin within chloroplasts. While swollenin expressing plants were homoplasmic, cutinase transplastomic lines remained heteroplasmic. Both transplastomic lines showed interesting modifications in their phenotype, chloroplast structure, and functions. Ultrastructural analysis of chloroplasts from cutinase- and swollenin-expressing plants did not show typical lens shape and granal stacks. But, their thylakoid membranes showed unique scroll like structures and chloroplast envelope displayed protrusions, stretching into the cytoplasm. Unusual honeycomb structures typically observed in etioplasts were observed in mature chloroplasts expressing swollenin. Treatment of cotton fiber with chloroplast-derived swollenin showed enlarged segments and the intertwined inner fibers were irreversibly unwound and fully opened up due to expansin activity of swollenin, causing disruption of hydrogen bonds in cellulose fibers. Cutinase transplastomic plants showed esterase and lipase activity, while swollenin transplastomic lines lacked such enzyme activities. Higher plants contain two major galactolipids, monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG), in their chloroplast thylakoid membranes that play distinct roles in their structural organization. Surprisingly, purified cutinase effectively hydrolyzed DGDG to MGDG, showing alpha galactosidase activity. Such hydrolysis resulted in unstacking of granal thylakoids in chloroplasts and other structural changes. These results demonstrate DGDG as novel substrate and function for cutinase. Both MGDG and DGDG were reduced up to 47.7% and 39.7% in cutinase and 68.5% and 67.5% in swollenin expressing plants. Novel properties and functions of both enzymes reported here for the first time should lead to better understanding and enhanced biomass hydrolysis.	[Verma, Dheeraj; Jin, Shuangxia; Kanagaraj, Anderson; Singh, Nameirakpam D.; Daniel, Jaiyanth; Kolattukudy, Pappachan E.; Daniell, Henry] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Miller, Michael] Auburn Univ, Res Instrumentat Facil, Auburn, AL 36849 USA	State University System of Florida; University of Central Florida; Auburn University System; Auburn University	Daniell, H (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	Henry.Daniell@ucf.edu	Daniell, Henry/L-3655-2019; KANAGARAJ, A/GZG-4720-2022	Daniell, Henry/0000-0003-4485-1176; , Palsamy Kanagaraj/0000-0003-3297-3125; Jin, Shuangxia/0000-0002-1495-9154	United States Department of Agriculture (USDA)-Cooperative State Research, Education, and Extension Service (CSREES) [2009-39200-19972]; USDA-National Institute of Food and Agriculture (NIFA) [2010-39200-21704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107904] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA)-Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-National Institute of Food and Agriculture (NIFA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported in part by United States Department of Agriculture (USDA)-Cooperative State Research, Education, and Extension Service (CSREES) 2009-39200-19972 and USDA-National Institute of Food and Agriculture (NIFA) 2010-39200-21704 to Henry Daniell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; An XP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001179; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Clarke JL, 2011, PLANT MOL BIOL, V76, P211, DOI 10.1007/s11103-011-9767-z; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; DANTZIG AH, 1986, J BACTERIOL, V168, P911, DOI 10.1128/jb.168.2.911-916.1986; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; ETTINGER WF, 1987, BIOCHEMISTRY-US, V26, P7883, DOI 10.1021/bi00398a052; FETT WF, 1992, CURR MICROBIOL, V25, P165, DOI 10.1007/BF01571025; FUKS B, 1994, BIOPHYS J, V66, P1404, DOI 10.1016/S0006-3495(94)80931-2; Gray-Mitsumune M, 2008, PLANT BIOTECHNOL J, V6, P62, DOI 10.1111/j.1467-7652.2007.00295.x; Grobe K, 1999, EUR J BIOCHEM, V263, P33, DOI 10.1046/j.1432-1327.1999.00462.x; Hanus J, 2006, BIOPOLYMERS, V82, P59, DOI 10.1002/bip.20460; Jager G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-33; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jin SX, 2011, PLANT PHYSIOL, V155, P222, DOI 10.1104/pp.110.160754; Jones MR, 2007, PROG LIPID RES, V46, P56, DOI 10.1016/j.plipres.2006.06.001; Kalamaki MS, 2003, J AGR FOOD CHEM, V51, P7465, DOI 10.1021/jf0341666; KOLATTUKUDY PE, 1984, METHOD ENZYMOL, V106, P210; KOLATTUKUDY PE, 1981, ANNU REV PLANT PHYS, V32, P539, DOI 10.1146/annurev.pp.32.060181.002543; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; Kota Z, 2002, P NATL ACAD SCI USA, V99, P12149, DOI 10.1073/pnas.192463899; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lee AG, 2000, CURR BIOL, V10, pR377, DOI 10.1016/S0960-9822(00)00477-2; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Leelavathi S, 2003, MOL BREEDING, V11, P59, DOI 10.1023/A:1022168321380; LIN TS, 1980, EUR J BIOCHEM, V106, P341, DOI 10.1111/j.1432-1033.1980.tb04580.x; Maeda H, 2005, APPL MICROBIOL BIOT, V67, P778, DOI 10.1007/s00253-004-1853-6; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Moon HS, 2010, ENVIRON MANAGE, V46, P531, DOI 10.1007/s00267-010-9503-5; Murphy CA, 1996, APPL ENVIRON MICROB, V62, P456, DOI 10.1128/AEM.62.2.456-460.1996; Neves Petersen MT, 1997, METHOD ENZYMOL, V284, P130; NUSSBERGER S, 1993, J MOL BIOL, V234, P347, DOI 10.1006/jmbi.1993.1591; Pali T, 2003, CELL MOL LIFE SCI, V60, P1591, DOI 10.1007/s00018-003-3173-x; Petersen K, 2011, PLANT MOL BIOL, V76, P311, DOI 10.1007/s11103-011-9742-8; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2824, DOI 10.1021/bi00684a006; Ransom C, 2007, APPL BIOCHEM BIOTECH, V137, P207, DOI 10.1007/s12010-007-9053-3; Rochange SF, 2001, PLANT MOL BIOL, V46, P581, DOI 10.1023/A:1010650217100; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; SEBASTIAN J, 1987, J BACTERIOL, V169, P131, DOI 10.1128/jb.169.1.131-136.1987; SEN A, 1981, BIOCHIM BIOPHYS ACTA, V663, P380, DOI 10.1016/0005-2760(81)90167-3; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Simidjiev I, 1998, BIOCHEMISTRY-US, V37, P4169, DOI 10.1021/bi972726m; Singh N. Dolendro, 2009, V483, P163, DOI 10.1007/978-1-59745-407-0_10; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; Smith M., 1991, ELECT MICROSCOPY BIO, P17; SOLIDAY CL, 1984, P NATL ACAD SCI-BIOL, V81, P3939, DOI 10.1073/pnas.81.13.3939; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; Szilagyi A, 2007, BBA-BIOMEMBRANES, V1768, P2310, DOI 10.1016/j.bbamem.2007.06.001; vanderVlugtBergmans CJB, 1997, MOL PLANT MICROBE IN, V10, P21, DOI 10.1094/MPMI.1997.10.1.21; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; Wang GY, 2002, FUNGAL GENET BIOL, V35, P261, DOI 10.1006/fgbi.2001.1320; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; Yu LX, 2007, J BIOTECHNOL, V131, P362, DOI 10.1016/j.jbiotec.2007.07.942; Ziegelhoffer T, 2009, PLANT BIOTECHNOL J, V7, P527, DOI 10.1111/j.1467-7652.2009.00421.x	73	32	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57187	10.1371/journal.pone.0057187	http://dx.doi.org/10.1371/journal.pone.0057187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451186	Green Published, gold			2022-12-27	WOS:000316849500077
J	Li, YB; Wang, DP; Wang, L; Yu, JH; Du, DH; Chen, Y; Gao, P; Wang, DM; Yu, J; Zhang, F; Fu, SL				Li, Yunbo; Wang, Dapeng; Wang, Lei; Yu, Jinhai; Du, Danhua; Chen, Ye; Gao, Peng; Wang, Duen-Mei; Yu, Jun; Zhang, Feng; Fu, Shuanglin			Distinct Genomic Aberrations between Low-Grade and High-Grade Gliomas of Chinese Patients	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; GENETIC ALTERATIONS; PATHWAY ACTIVATION; PROGRESSION; REVEALS; EXPRESSION; TUMORS; HYBRIDIZATION; ASTROCYTOMAS; METAANALYSIS	Background: Glioma is a type of tumor that develops in the central nerve system, mainly the brain. Alterations of genomic sequence and sequence segments (such as copy number variations or CNV and copy neutral loss of heterozygosities or cnLOH) are thought to be a major determinant of the tumor grade. Methods: We mapped genomic variations between low-grade and high-grade gliomas (LGG and HGG) in Chinese population based on Illumina's Beadchip and validated the results using real-time qPCR. Results: At the cytoband level, we discovered: (1) unique losses in LGG on 5q, 8p and 11q, and in HGG on 6q, 11p, 13q and 19q; (2) unique gains in the LGG on 1p and in HGG at 5p, 7p, 7q and 20q; and (3) cnLOH in HGG only on 3q, 8q, 10p, 14q, 15q, 17p, 17q, 18q and 21q. Subsequently, we confirmed well-characterized oncogenes among tumor-related loci (such as EGFR and KIT) and detected novel genes that gained chromosome sequences (such as AASS, HYAL4, NDUFA5 and SPAM1) in both LGG and HGG. In addition, we found gains, losses, and cnLOH in several genes, including VN1R2, VN1R4, and ZNF677, in multiple samples. Mapping grade-associated pathways and their related gene ontology (GO) terms, we classified LGG-associated functions as "arachidonic acid metabolism", "DNA binding" and "regulation of DNA-dependent transcription" and the HGG-associated as "neuroactive ligand-receptor interaction", "neuronal cell body" and "defense response to bacterium". Conclusion: LGG and HGG appear to have different molecular signatures in genomic variations and our results provide invaluable information for the diagnosis and treatment of gliomas in patients with variable duration or diverse tumor differentiation.	[Li, Yunbo; Yu, Jinhai; Du, Danhua; Gao, Peng; Fu, Shuanglin] Jilin Univ, Hosp 1, Changchun, Peoples R China; [Wang, Dapeng; Wang, Lei; Wang, Duen-Mei; Yu, Jun; Zhang, Feng] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chen, Ye] Jilin Univ, Norman Bethune Coll Med, Changchun 130023, Peoples R China; [Li, Yunbo] Jilin Univ, Changchun 130023, Peoples R China; [Zhang, Feng] NE Normal Univ, Changchun, Peoples R China	Jilin University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Jilin University; Jilin University; Northeast Normal University - China	Wang, DP (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	wangdp@big.ac.cn; zhangf@big.ac.cn; fu.shuanglin@yahoo.com.cn	Wang, Dapeng/HGD-4818-2022		Research Fund of the Health Department of Jilin Province [2008P004]	Research Fund of the Health Department of Jilin Province	This work was supported by 2008 Research Fund of the Health Department of Jilin Province 2008P004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Arslantas A, 2007, PATHOL ONCOL RES, V13, P39, DOI 10.1007/BF02893439; Batchelor TT, 2004, CLIN CANCER RES, V10, P228, DOI 10.1158/1078-0432.CCR-0841-3; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Campbell BA, 2008, J NEURO-ONCOL, V89, P37, DOI 10.1007/s11060-008-9597-2; Cavaliere R, 2005, LANCET NEUROL, V4, P760, DOI 10.1016/S1474-4422(05)70222-2; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Cheng JX, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-305; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Czernicki T, 2007, INT J ONCOL, V30, P55; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Ferrer-Luna R, 2009, J NEURO-ONCOL, V95, P343, DOI 10.1007/s11060-009-9944-y; Freire P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004076; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Hirose Y, 2003, CANCER GENET CYTOGEN, V142, P1, DOI 10.1016/S0165-4608(02)00791-4; Hu J, 2003, CHINESE MED J-PEKING, V116, P577; Idbaih A, 2008, J NEURO-ONCOL, V90, P133, DOI 10.1007/s11060-008-9644-z; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Jiang RC, 2006, PROTEOMICS, V6, P2964, DOI 10.1002/pmic.200500555; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koschny R, 2002, CANCER GENET CYTOGEN, V135, P147, DOI 10.1016/S0165-4608(01)00650-1; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kotliarov Y, 2009, CANCER RES, V69, P1596, DOI 10.1158/0008-5472.CAN-08-2496; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Liang BC, 1996, CANCER LETT, V105, P167, DOI 10.1016/0304-3835(96)04276-0; Liu FH, 2006, CANCER RES, V66, P10815, DOI 10.1158/0008-5472.CAN-06-1408; Marko NF, 2010, GENOMICS, V95, P16, DOI 10.1016/j.ygeno.2009.09.007; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pouratian N, 2010, CURR NEUROL NEUROSCI, V10, P224, DOI 10.1007/s11910-010-0105-7; Qaddoumi I, 2009, CANCER BIOL THER, V8, P4, DOI 10.4161/cbt.8.1.7237; RADHAKRISHNAN K, 1995, ANN NEUROL, V37, P67, DOI 10.1002/ana.410370113; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Taylor LP, 2010, NEUROLOGY, V75, pS28, DOI 10.1212/WNL.0b013e3181fb3661; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Vranova V, 2007, ONCOL REP, V17, P457; Wong KK, 2006, CANCER RES, V66, P11172, DOI 10.1158/0008-5472.CAN-06-2438; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	54	80	81	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57168	10.1371/journal.pone.0057168	http://dx.doi.org/10.1371/journal.pone.0057168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451178	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800085
J	Reising, A; Sambale, S; Donnerstag, F; Schmidt, JJ; Hafer, C; Schmidt, BMW; Kielstein, JT				Reising, Ansgar; Sambale, Saskia; Donnerstag, Frank; Schmidt, Julius J.; Hafer, Carsten; Schmidt, Bernhard M. W.; Kielstein, Jan T.			Effect of Isovolemic, Isothermic Hemodialysis on Cerebral Perfusion and Vascular Stiffness Using Contrast Computed Tomography and Pulse Wave Velocity	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; ARTERIAL STIFFNESS; BLOOD-FLOW; DIALYSIS; INDEX; MORTALITY; DYSFUNCTION; DECREASES; FAILURE	Background: Patients undergoing hemodialysis treatment have a six-fold increased risk for stroke relative to the general population. However, the effect of hemodialysis on cerebral blood flow is poorly studied and confounding factors like blood pressure and ultrafiltration as well as temperature changes have rarely been accounted for. The aim of our study was to use state-of-the-art technology to evaluate the effect of a single dialysis session on cerebral perfusion as well as on vascular stiffness. Methods: Chronic hemodialysis patients (7 male/3 female, mean age 58 years) were recruited. Cerebral blood flow and arterial pulse wave velocity were measured before and immediately after a hemodialysis session. To exclude effects of volume changes we kept ultrafiltration to a minimum, allowing no change in body weight. Isothermic conditions were maintained by using the GENIUS single-pass batch-dialysis system with a high-flux polysulfone dialyser. Cerebral blood flow was measured by contrast-enhanced computed tomography. Pulse wave velocity was measured using the SphygmoCor (AtCor Medical, USA) device by a single operator. Results: This study shows for the first time that isovolemic, isothermic hemodialysis neither affected blood pressure or heart rate, nor total or regional cerebral perfusion. There was also no change in pulse wave velocity. Conclusions: Mechanisms other than the dialysis procedure itself might be causative for the high incidence of ischemic strokes in this patient population. Moreover, the sole removal of uremic toxins does not lead to short-term effects on vascular stiffness, underlying the importance of volume control in this patient population.	[Reising, Ansgar; Sambale, Saskia; Schmidt, Julius J.; Hafer, Carsten; Schmidt, Bernhard M. W.; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Donnerstag, Frank] Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Kielstein, JT (corresponding author), Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany.	Kielstein@yahoo.com	Kielstein, Jan T./I-2956-2019; Donnerstag, Frank/N-6853-2017	Kielstein, Jan T./0000-0001-8110-9064; Donnerstag, Frank/0000-0002-6798-1929	Else-Kroner-Fresenius Foundation [P63/06//EKMS 06/03]; Fresenius Medical Care Germany	Else-Kroner-Fresenius Foundation; Fresenius Medical Care Germany	This study was supported by an unrestricted grant of the Else-Kroner-Fresenius Foundation (P63/06//EKMS 06/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JTK recieved unrestricted research support from Fresenius Medical Care Germany. JTK received speaker fees from Fresenius Medical Care Germany. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bisdas S, 2006, EUR RADIOL, V16, P2220, DOI 10.1007/s00330-006-0209-2; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 2003, KIDNEY INT, V63, P1852, DOI 10.1046/j.1523-1755.2003.00932.x; Chung AWY, 2010, NEPHROL DIAL TRANSPL, V25, P4031, DOI 10.1093/ndt/gfq202; Covic A, 2004, NEPHROL DIAL TRANSPL, V19, P637, DOI 10.1093/ndt/gfg568; Di Iorio B, 2010, NEPHROL DIAL TRANSPL, V25, P1579, DOI 10.1093/ndt/gfp662; Fliser D, 2006, NAT CLIN PRACT NEPHR, V2, P32, DOI 10.1038/ncpneph0060; Flythe JE, 2011, KIDNEY INT, V79, P250, DOI 10.1038/ki.2010.383; Georgianos PI, 2011, AM J NEPHROL, V34, P407, DOI 10.1159/000331700; Gusbeth-Tatomir P, 2007, KIDNEY BLOOD PRESS R, V30, P97, DOI 10.1159/000100905; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Hogas S, 2011, INT UROL NEPHROL; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Kooman JP, 2006, BLOOD PURIFICAT, V24, P218, DOI 10.1159/000091015; Kosch M, 2001, NEPHROL DIAL TRANSPL, V16, P1663, DOI 10.1093/ndt/16.8.1663; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; London GM, 2004, KIDNEY INT, V65, P700, DOI 10.1111/j.1523-1755.2004.00434.x; Lonnemann G, 2000, NEPHROL DIAL TRANSPL, V15, P1189, DOI 10.1093/ndt/15.8.1189; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Metry G, 2002, AM J KIDNEY DIS, V40, P996, DOI 10.1053/ajkd.2002.36333; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Selby NM, 2006, CLIN J AM SOC NEPHRO, V1, P1216, DOI 10.2215/CJN.02010606; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Su HM, 2007, HYPERTENS RES, V30, P965, DOI 10.1291/hypres.30.965; Usvyat LA, 2011, NEPHROL DIAL TRANSPL; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56396	10.1371/journal.pone.0056396	http://dx.doi.org/10.1371/journal.pone.0056396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451044	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800010
J	Sood, R; Carrington, B; Bishop, K; Jones, M; Rissone, A; Candotti, F; Chandrasekharappa, SC; Liu, P				Sood, Raman; Carrington, Blake; Bishop, Kevin; Jones, MaryPat; Rissone, Alberto; Candotti, Fabio; Chandrasekharappa, Settara C.; Liu, Paul			Efficient Methods for Targeted Mutagenesis in Zebrafish Using Zinc-Finger Nucleases: Data from Targeting of Nine Genes Using CompoZr or CoDA ZFNs	PLOS ONE			English	Article							POOL ENGINEERING OPEN; TAL EFFECTORS; GENOME; DNA; TRANSCRIPTION; INACTIVATION; SELECTION; PROTEINS; MUTATION; PROJECT	Recently, it has been shown that targeted mutagenesis using zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) can be used to generate knockout zebrafish lines for analysis of their function and/or developing disease models. A number of different methods have been developed for the design and assembly of gene-specific ZFNs and TALENs, making them easily available to most zebrafish researchers. Regardless of the choice of targeting nuclease, the process of generating mutant fish is similar. It is a time-consuming and multi-step process that can benefit significantly from development of efficient high throughput methods. In this study, we used ZFNs assembled through either the CompoZr (Sigma-Aldrich) or the CoDA (context-dependent assembly) platforms to generate mutant zebrafish for nine genes. We report our improved high throughput methods for 1) evaluation of ZFNs activity by somatic lesion analysis using colony PCR, eliminating the need for plasmid DNA extractions from a large number of clones, and 2) a sensitive founder screening strategy using fluorescent PCR with PIG-tailed primers that eliminates the stutter bands and accurately identifies even single nucleotide insertions and deletions. Using these protocols, we have generated multiple mutant alleles for seven genes, five of which were targeted with CompoZr ZFNs and two with CoDA ZFNs. Our data also revealed that at least five-fold higher mRNA dose was required to achieve mutagenesis with CoDA ZFNs than with CompoZr ZFNs, and their somatic lesion frequency was lower (<5%) when compared to CopmoZr ZFNs (9-98%). This work provides high throughput protocols for efficient generation of zebrafish mutants using ZFNs and TALENs.	[Sood, Raman; Carrington, Blake; Bishop, Kevin] NHGRI, Zebrafish Core Facil, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Jones, MaryPat; Chandrasekharappa, Settara C.] NHGRI, Genom Core, Genome Technol Branch, Bethesda, MD 20892 USA; [Rissone, Alberto; Candotti, Fabio] NHGRI, Disorders Immun Sect, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Liu, Paul] NHGRI, Oncogenesis & Dev Sect, Genet & Mol Biol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sood, R (corresponding author), NHGRI, Zebrafish Core Facil, Genet & Mol Biol Branch, Bethesda, MD 20892 USA.	rsood@mail.nih.gov	Liu, Paul/A-7976-2012	Liu, Paul/0000-0002-6779-025X; Candotti, Fabio/0000-0001-6399-6042	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIGHG200351, ZIAHG000102, ZIAHG000121] Funding Source: NIH RePORTER	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Ben J, 2011, DEVELOPMENT, V138, P4969, DOI 10.1242/dev.070862; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; BROWNSTEIN MJ, 1996, BIOTECHNIQUES, V20, P1008; Cade L, 2012, NUCL ACIDS RES; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gupta A, 2011, NUCLEIC ACIDS RES, V39, P381, DOI 10.1093/nar/gkq787; Guryev V, 2006, GENOME RES, V16, P491, DOI 10.1101/gr.4791006; Haffter P, 1996, DEVELOPMENT, V123, P1; Huang P, 2012, J GENET GENOMICS, V39, P421, DOI 10.1016/j.jgg.2012.07.004; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jao Li-En, 2008, Briefings in Functional Genomics & Proteomics, V7, P427, DOI 10.1093/bfgp/eln038; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Winkler S, 2011, METHODS MOL BIOL, V770, P475, DOI 10.1007/978-1-61779-210-6_19; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779	45	40	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57239	10.1371/journal.pone.0057239	http://dx.doi.org/10.1371/journal.pone.0057239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451191	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800094
J	Sur, S; Han, L; Tereshchenko, LG				Sur, Sanjoli; Han, Lichy; Tereshchenko, Larisa G.			Comparison of Sum Absolute QRST Integral, and Temporal Variability in Depolarization and Repolarization, Measured by Dynamic Vectorcardiography Approach, in Healthy Men and Women	PLOS ONE			English	Article							VENTRICULAR REPOLARIZATION; CARDIAC REPOLARIZATION; NORMAL LIMITS; QT INTERVAL; ELECTROCARDIOGRAPHIC PATTERN; SEX-DIFFERENCES; TIME-DOMAIN; HEART-RATE; GRADIENT; SYSTEM	Background: Recently we showed the predictive value of sum absolute QRST integral (SAI QRST) and repolarization lability for risk stratification of sudden cardiac death (SCD) in heart failure patients. The goal of this study was to compare SAI QRST and metrics of depolarization and repolarization variability in healthy men and women. Methods: Orthogonal ECGs were recorded at rest for 10 minutes in 160 healthy men and women (mean age 39.6 +/- 14.6, 80 men). Mean spatial TT' angle, and normalized variances of T loop area, of spatial T vector amplitude, of QT interval and Tpeak-Tend area were measured for assessment of repolarization lability. Normalized variances of spatial QRS vector and QRS loop area characterized variability of depolarization. In addition, variability indices (VI) were calculated to adjust for normalized heart rate variance. SAI QRST was measured as the averaged arithmetic sum of areas under the QRST curve. Results: Men were characterized by shorter QTc (430.3 +/- 21.7 vs. 444.7 +/- 22.2 ms; P<0.0001) and larger SAI QRST (282.1 +/- 66.7 vs. 204.9 +/- 58.5 mV*ms; P<0.0001). Repolarization lability negatively correlated with spatial T vector amplitude. Adjusted by normalized heart rate variance, QT variability index was significantly higher in women than in men (-1.54 +/- 0.38 vs. -1.70 +/- 0.33; P = 0.017). However, in multivariate logistic regression after adjustment for body surface area, QTc, and spatial T vector amplitude, healthy men had 1.5-3 fold higher probability of having larger repolarization lability, as compared to healthy women (T vector amplitude variability index odds ratio 3.88(95%CI 1.4-11.1; P = 0.012). Conclusions: Healthy men more likely than women have larger repolarization lability.	[Sur, Sanjoli; Han, Lichy] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD USA; [Tereshchenko, Larisa G.] Johns Hopkins Univ Hosp, Dept Med, Div Cardiol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Tereshchenko, LG (corresponding author), Johns Hopkins Univ Hosp, Dept Med, Div Cardiol, Baltimore, MD 21287 USA.	lteresh1@jhmi.edu	Tereshchenko, Larisa/X-4253-2019	Tereshchenko, Larisa/0000-0002-6976-1313	Open Access Promotion Fund of the Johns Hopkins University Libraries;  [AHA 10CRP2600257]	Open Access Promotion Fund of the Johns Hopkins University Libraries; 	This work was partially supported by grant AHA 10CRP2600257 to Larisa Tereshchenko. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abildskov J A, 1978, Adv Cardiol, V21, P59; ABILDSKOV JA, 1955, CIRCULATION, V12, P286, DOI 10.1161/01.CIR.12.2.286; Baumert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041920; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Bella JN, 1998, CIRCULATION, V98, P2538, DOI 10.1161/01.CIR.98.23.2538; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Bidoggia H, 2000, AM HEART J, V140, P678, DOI 10.1067/mhj.2000.109918; Bidoggia H, 2000, AM HEART J, V140, P430, DOI 10.1067/mhj.2000.108510; BURCH GE, 1954, CIRCULATION, V9, P381, DOI 10.1161/01.CIR.9.3.381; Cortez DL, 2010, J ELECTROCARDIOL, V43, P302, DOI 10.1016/j.jelectrocard.2010.03.010; Couderc JP, 2010, IEEE ENG MED BIO, P6252, DOI 10.1109/IEMBS.2010.5628067; Couderc JP, 2005, ANN NONINVAS ELECTRO, V10, P25, DOI 10.1111/j.1542-474X.2005.00593.x; GARDBERG M, 1959, CIRC RES, V7, P870, DOI 10.1161/01.RES.7.6.870; GESELOWITZ DB, 1983, IEEE T BIO-MED ENG, V30, P76, DOI 10.1109/TBME.1983.325172; Han L, 2013, INT J CARDIOL, V166, P543, DOI 10.1016/j.ijcard.2012.09.189; Han L, 2010, J ELECTROCARDIOL, V43, P577, DOI 10.1016/j.jelectrocard.2010.05.011; Hara M, 1998, J PHARMACOL EXP THER, V285, P1068; Hasan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049489; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Huxley VH, 2007, ADV PHYSIOL EDUC, V31, P17, DOI 10.1152/advan.00099.2006; Kors JA, 1999, CIRCULATION, V99, P1458, DOI 10.1161/01.CIR.99.11.1458; KORS JA, 1992, AM J CARDIOL, V70, P96, DOI 10.1016/0002-9149(92)91397-M; Krauss TT, 2009, PACE, V32, pS167, DOI 10.1111/j.1540-8159.2008.02278.x; Lehmann MH, 2001, CIRCULATION, V104, P32, DOI 10.1161/hc2601.091738; Liu XK, 1998, J PHARMACOL EXP THER, V285, P672; MCCALL BW, 1962, AM J CARDIOL, V10, P514, DOI 10.1016/0002-9149(62)90376-4; MILNOR WR, 1957, CIRCULATION, V16, P95, DOI 10.1161/01.CIR.16.1.95; Nearing BD, 2012, CIRC-ARRHYTHMIA ELEC, V5, P84, DOI 10.1161/CIRCEP.111.965434; PIPBERGER HV, 1967, CIRCULATION, V35, P536, DOI 10.1161/01.CIR.35.3.536; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Rautaharju PM, 2011, J ELECTROCARDIOL, V44, P309, DOI 10.1016/j.jelectrocard.2010.11.009; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Scherptong RWC, 2008, J ELECTROCARDIOL, V41, P648, DOI 10.1016/j.jelectrocard.2008.07.006; Surawicz B, 2003, ANN NONINVAS ELECTRO, V8, P333, DOI 10.1046/j.1542-474X.2003.08411.x; Tereshchenko LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051812; Tereshchenko LG, 2012, CIRC-ARRHYTHMIA ELEC, V5, P719, DOI 10.1161/CIRCEP.112.970541; Tereshchenko LG, 2011, J ELECTROCARDIOL, V44, P208, DOI 10.1016/j.jelectrocard.2010.08.012; Tereshchenko LG, 2010, HEART RHYTHM, V7, P1606, DOI 10.1016/j.hrthm.2010.08.022; Tereshchenko LG, 2010, J ELECTROCARDIOL, V43, P548, DOI 10.1016/j.jelectrocard.2010.07.013; Tereshchenko LG, 2009, CIRC-ARRHYTHMIA ELEC, V2, P276, DOI 10.1161/CIRCEP.108.829440; Tereshchenko LG, 2011, HEART RHYTHM, V8, pS130; Tereshchenko LG, 2012, CIRC-ARRHYTHMIA ELEC, DOI [10.1161/CIRCEP.112.970541, DOI 10.1161/CIR-CEP.112.970541]; Valverde ER, 2003, CARDIOVASC RES, V57, P625, DOI 10.1016/S0008-6363(02)00791-5; Wilson FN, 1933, J GEN PHYSIOL, V16, P423, DOI 10.1085/jgp.16.3.423; Wilson FN, 1934, AM HEART J, V10, P46, DOI DOI 10.1016/S0002-8703(34)90303-; Wilson FN, 1931, T ASS AM PHYS, V46; YANG TF, 1994, CLIN PHYSIOL, V14, P633, DOI 10.1111/j.1475-097X.1994.tb00420.x; YANG TF, 1993, J ELECTROCARDIOL, V26, P97, DOI 10.1016/0022-0736(93)90001-T; Zong W, 2003, COMPUT CARDIOL, V30, P737, DOI 10.1109/CIC.2003.1291261; Zong W, 2006, COMPUT CARDIOL, V33, P377	51	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57175	10.1371/journal.pone.0057175	http://dx.doi.org/10.1371/journal.pone.0057175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451181	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800087
J	Verleger, R; Dittmer, M; Smigasiewicz, K				Verleger, Rolf; Dittmer, Marie; Smigasiewicz, Kamila			Cooperation or Competition of the Two Hemispheres in Processing Characters Presented at Vertical Midline	PLOS ONE			English	Article							VISUAL-FIELD; CEREBRAL HEMISPHERES; SPATIAL ATTENTION; WORD RECOGNITION; MODULATION; ACTIVATION; ASYMMETRY; STIMULUS; TASK	Little is known about how the hemispheres interact in processing of stimuli presented at vertical midline. Processing might be mutually independent or cooperative. Here we measured target identification and visually evoked EEG potentials while stimulus streams containing two targets, T1 and T2, were either presented at vertical midline above and below fixation, or laterally, left and right. With left and right streams, potentials evoked by filler stimuli and by T2 were earlier at the right than the left visual cortex, and T2 was better identified left than right, confirming earlier results and suggesting better capabilities of the right hemisphere in this task. With streams above and below fixation, EEG potentials evoked by filler stimuli and by T2 were likewise earlier at the right than the left hemisphere, and T2 was generally identified as well as, but not better than left T2, in one target constellation even worse (T2 in lower stream preceded by T1 in upper stream). These results suggest right-hemisphere preference for this task even with stimuli at vertical midline, and no added value through hemispheric cooperation. Lacking asymmetry for T1 amidst asymmetries for filler stimuli and for T2 might indicate alternating access of the hemispheres to midline stimuli as one means of hemispheric division of labor.	[Verleger, Rolf; Dittmer, Marie; Smigasiewicz, Kamila] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	University of Lubeck	Verleger, R (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	rolf.verleger@neuro.uni-luebeck.de			Deutsche Forschungsgemeinschaft, as part of the package proposal "neuro-cognitive mechanisms of conscious and unconscious visual perception" [VE110/15-2, PAK270]	Deutsche Forschungsgemeinschaft, as part of the package proposal "neuro-cognitive mechanisms of conscious and unconscious visual perception"	This research was funded by grant VE110/15-2 from the Deutsche Forschungsgemeinschaft (www.dfg.de) to the first author, as part of the package proposal "neuro-cognitive mechanisms of conscious and unconscious visual perception" (PAK270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brysbaert M, 2005, J RES READ, V28, P216, DOI 10.1111/j.1467-9817.2005.00266.x; Delvenne JF, 2012, COGNITION, V122, P258, DOI 10.1016/j.cognition.2011.10.015; Ellis AW, 2010, NEUROPSYCHOLOGIA, V48, P353, DOI 10.1016/j.neuropsychologia.2009.08.021; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Greene DJ, 2011, NEUROPSYCHOLOGIA, V49, P61, DOI 10.1016/j.neuropsychologia.2010.11.007; HELLIGE JB, 1979, J EXP PSYCHOL GEN, V108, P251, DOI 10.1037/0096-3445.108.2.251; Hollander A, 2005, NEUROPSYCHOLOGIA, V43, P35, DOI 10.1016/j.neuropsychologia.2004.06.006; Hunter ZR, 2007, J COGNITIVE NEUROSCI, V19, P1373, DOI 10.1162/jocn.2007.19.8.1373; Jaskowski P, 2002, PSYCHOL SCI, V13, P48, DOI 10.1111/1467-9280.00408; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2341, DOI 10.1016/j.neuropsychologia.2008.07.020; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kraft A, 2007, BRAIN RES, V1133, P123, DOI 10.1016/j.brainres.2006.11.043; Leff A, 2004, BRAIN LANG, V88, P268, DOI 10.1016/S0093-934X(03)00161-5; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1993, J COGNITIVE NEUROSCI, V5, P188, DOI 10.1162/jocn.1993.5.2.188; Marzi CA, 2009, NEUROPSYCHOLOGIA, V47, P3007, DOI 10.1016/j.neuropsychologia.2009.05.007; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Milner A. D., 1995, VISUAL BRAIN ACTION; Miniussi C, 1998, J COGNITIVE NEUROSCI, V10, P216, DOI 10.1162/089892998562663; Okon-Singer N, 2011, NEUROIMAGE, V54, P3010, DOI 10.1016/j.neuroimage.2010.10.078; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Putnam MC, 2010, J COGNITIVE NEUROSCI, V22, P1662, DOI 10.1162/jocn.2009.21290; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Scalf PE, 2007, J EXP PSYCHOL HUMAN, V33, P298, DOI 10.1037/0096-1523.33.2.298; Smigasiewicz K, 2010, NEUROPSYCHOLOGIA, V48, P2852, DOI 10.1016/j.neuropsychologia.2010.05.027; Thomas NA, 2011, BRAIN RES, V1387, P108, DOI 10.1016/j.brainres.2011.02.063; Verleger R, 2012, PSYCHOPHYSIOLOGY, V49, P1254, DOI 10.1111/j.1469-8986.2012.01408.x; Verleger R, 2012, ADV COGN PSYCHOL, V8, P19, DOI [10.5709/acp-0098-9, 10.2478/v10053-008-0098-9]; Verleger R, 2011, BRAIN COGNITION, V77, P138, DOI 10.1016/j.bandc.2011.05.004; Verleger R, 2010, EXP BRAIN RES, V203, P355, DOI 10.1007/s00221-010-2237-z; Verleger R, 2009, J COGNITIVE NEUROSCI, V21, pD; Wascher E, 2005, EXP BRAIN RES, V163, P430, DOI 10.1007/s00221-004-2198-1; Wascher E, 1996, ELECTROEN CLIN NEURO, V99, P149, DOI 10.1016/0013-4694(96)95602-3; Wyble B, 2011, J EXP PSYCHOL GEN, V140, P488, DOI 10.1037/a0023612; Zeki S., 1993, VISION BRAIN	39	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57421	10.1371/journal.pone.0057421	http://dx.doi.org/10.1371/journal.pone.0057421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451226	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800106
J	Yang, JH; Dong, SM; Jiang, QC; Kuang, TJ; Huang, WT; Yang, JX				Yang, Jianghua; Dong, Siming; Jiang, Qichen; Kuang, Tengjiao; Huang, Wenting; Yang, Jiaxin			Changes in Expression of Manganese Superoxide Dismutase, Copper and Zinc Superoxide Dismutase and Catalase in Brachionus calyciflorus during the Aging Process	PLOS ONE			English	Article							LIFE-SPAN; DIETARY RESTRICTION; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; CALORIC RESTRICTION; GENE-EXPRESSION; RESVERATROL; DROSOPHILA; EXTENSION; OVEREXPRESSION	Rotifers are useful model organisms for aging research, owing to their small body size (0.1-1 mm), short lifespan (6-14 days) and the relative easy in which aging and senescence phenotypes can be measured. Recent studies have shown that antioxidants can extend the lifespan of rotifers. In this paper, we analyzed changes in the mRNA expression level of genes encoding the antioxidants manganese superoxide dismutase (MnSOD), copper and zinc SOD (CuZnSOD) and catalase (CAT) during rotifer aging to clarify the function of these enzymes in this process. We also investigated the effects of common life-prolonging methods [dietary restriction (DR) and resveratrol] on the mRNA expression level of these genes. The results showed that the mRNA expression level of MnSOD decreased with aging, whereas that of CuZnSOD increased. The mRNA expression of CAT did not change significantly. This suggests that the ability to eliminate reactive oxygen species (ROS) in the mitochondria reduces with aging, thus aggravating the damaging effect of ROS on the mitochondria. DR significantly increased the mRNA expression level of MnSOD, CuZnSOD and CAT, which might explain why DR is able to extend rotifer lifespan. Although resveratrol also increased the mRNA expression level of MnSOD, it had significant inhibitory effects on the mRNA expression of CuZnSOD and CAT. In short, mRNA expression levels of CAT, MnSOD and CuZnSOD are likely to reflect the ability of mitochondria to eliminate ROS and delay the aging process.	[Yang, Jiaxin] Nanjing Normal Univ, Jiangsu Prov Key Lab Biodivers & Biotechnol, Sch Biol Sci, Nanjing, Jiangsu, Peoples R China; Nanjing Normal Univ, Jiangsu Prov Key Lab Aquat Live Food, Sch Biol Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University	Yang, JX (corresponding author), Nanjing Normal Univ, Jiangsu Prov Key Lab Biodivers & Biotechnol, Sch Biol Sci, Nanjing, Jiangsu, Peoples R China.	yangjx@njnu.edu.cn			National Natural Science Foundation of China [31272388]; National Natural Science Foundation of China for Talents Training in Basic Science [J1103507]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Talents Training in Basic Science	This work was supported by the National Natural Science Foundation of China (No.: 31272388) to JXY and National Natural Science Foundation of China for Talents Training in Basic Science (J1103507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; ASTM, 2001, ANN BOOK ASTM STAND, V1105; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; DERCKS W, 1989, PHYSIOL MOL PLANT P, V34, P189, DOI 10.1016/0885-5765(89)90043-X; Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; FANESTIL DD, 1965, J GERONTOL, V20, P462; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIDOVICH I, 1972, ACCOUNTS CHEM RES, V5, P321, DOI 10.1021/ar50058a001; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HIRATA H, 1987, HYDROBIOLOGIA, V147, P283, DOI 10.1007/BF00025755; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kailasam M, 2011, FISHERIES SCI, V77, P403, DOI 10.1007/s12562-011-0334-y; Kaneko G, 2005, HYDROBIOLOGIA, V546, P117, DOI 10.1007/s10750-005-4107-4; Kaneko G, 2002, FISHERIES SCI, V68, P1317, DOI 10.1046/j.1444-2906.2002.00570.x; Kaneko G, 2011, FUNCT ECOL, V25, P209, DOI 10.1111/j.1365-2435.2010.01773.x; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Masoro EJ, 1996, J GERONTOL A-BIOL, V51, pB387, DOI 10.1093/gerona/51A.6.B387; MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Muller F, 2000, J AM AGING ASSOC, V23, P227, DOI 10.1007/s11357-000-0022-9; Oo AKS, 2010, J COMP PHYSIOL B, V180, P105, DOI 10.1007/s00360-009-0389-6; Orallo F, 2002, MOL PHARMACOL, V61, P294, DOI 10.1124/mol.61.2.294; Ozaki Y, 2010, HYDROBIOLOGIA, V649, P267, DOI 10.1007/s10750-010-0269-9; Ozdemir N, 2009, J ANIM VET ADV, V8, P669; Ozkan OV, 2009, TOHOKU J EXP MED, V218, P251, DOI 10.1620/tjem.218.251; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Snell TW, 2008, J EXP MAR BIOL ECOL, V363, P104, DOI 10.1016/j.jembe.2008.06.031; Snell TW, 2007, HYDROBIOLOGIA, V593, P227, DOI 10.1007/s10750-007-9045-x; Snell TW, 2012, BIOGERONTOLOGY, V13, P261, DOI 10.1007/s10522-012-9371-x; SNELL TW, 1991, ECOTOX ENVIRON SAFE, V21, P308, DOI 10.1016/0147-6513(91)90070-6; Snell TW, 1995, HYDROBIOLOGIA, V313, P231, DOI 10.1007/BF00025956; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Sun JT, 2002, GENETICS, V161, P661; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Weithoff G, 2007, OECOLOGIA, V153, P303, DOI 10.1007/s00442-007-0739-6; Wheelock CE, 2002, AQUAT TOXICOL, V61, P89, DOI 10.1016/S0166-445X(02)00044-9; WINSTON GW, 1991, COMP BIOCHEM PHYS C, V100, P173, DOI 10.1016/0742-8413(91)90148-M; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang JH, 2013, MOL BIOL REP, V40, P2927, DOI 10.1007/s11033-012-2308-2; Ye K, 2010, J RADIAT RES, V51, P473, DOI 10.1269/jrr.10009; Yoshinaga T, 2000, J EXP MAR BIOL ECOL, V253, P253, DOI 10.1016/S0022-0981(00)00268-9	61	23	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57186	10.1371/journal.pone.0057186	http://dx.doi.org/10.1371/journal.pone.0057186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451185	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800090
J	Zhao, B; Bohonowych, JES; Timme-Laragy, A; Jung, D; Affatato, AA; Rice, RH; Di Giulio, RT; Denison, MS				Zhao, Bin; Bohonowych, Jessica E. S.; Timme-Laragy, Alicia; Jung, Dawoon; Affatato, Alessandra A.; Rice, Robert H.; Di Giulio, Richard T.; Denison, Michael S.			Common Commercial and Consumer Products Contain Activators of the Aryl Hydrocarbon (Dioxin) Receptor	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; RECOMBINANT CELL BIOASSAYS; AH-RECEPTOR; BINDING AFFINITY; TIRE EXTRACTS; CHEMICALS; AGONISTS; PATHWAY; GENE; IDENTIFICATION	Activation of the Ah receptor (AhR) by halogenated aromatic hydrocarbons (HAHs), such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin), can produce a wide variety of toxic and biological effects. While recent studies have shown that the AhR can bind and be activated by structurally diverse chemicals, how widespread of these AhR agonists are in environmental, biological and synthetic materials remains to be determined. Using AhR-based assays, we demonstrate the presence of potent AhR agonists in a variety of common commercial and consumer items. Solvent extracts of paper, rubber and plastic products contain chemicals that can bind to and stimulate AhR DNA binding and/or AhR-dependent gene expression in hepatic cytosol, cultured cell lines, human epidermis and zebrafish embryos. In contrast to TCDD and other persistent dioxin-like HAHs, activation of AhR-dependent gene expression by these extracts was transient, suggesting that the agonists are metabolically labile. Solvent extracts of rubber products produce AhR-dependent developmental toxicity in zebrafish in vivo, and inhibition of expression of the metabolic enzyme CYP1A, significantly increased their toxic potency. Although the identity of the responsible AhR-active chemicals and their toxicological impact remain to be determined, our data demonstrate that AhR active chemicals are widely distributed in everyday products.	[Zhao, Bin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, Beijing, Peoples R China; [Zhao, Bin; Bohonowych, Jessica E. S.; Affatato, Alessandra A.; Rice, Robert H.; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Timme-Laragy, Alicia; Jung, Dawoon; Di Giulio, Richard T.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of California System; University of California Davis; Duke University	Zhao, B (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, POB 934, Beijing, Peoples R China.	binzhao@rcees.ac.cn; msdenison@ucdavis.edu	Jung, Dawoon/F-9893-2010; Rice, Robert/AAP-7813-2021	Jung, Dawoon/0000-0001-5193-3626; Timme-Laragy, Alicia/0000-0002-8835-5038	National Institutes of Environmental Health Sciences [R01-ES012498, R01-ES007685, P42-ES004699, P42-ES010356, P30-ES011961]; California Agricultural Experiment Station; Chinese Academy of Sciences Key Program of Knowledge Innovation [KZCX2-EW-411]; National Natural Science Foundation of China [20921063, 21177150]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, P30ES011961, P42ES010356, R01ES012498, P42ES004699] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; Chinese Academy of Sciences Key Program of Knowledge Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Environmental Health Sciences [R01-ES012498, R01-ES007685, P42-ES004699, P42-ES010356, P30-ES011961], the California Agricultural Experiment Station, the Chinese Academy of Sciences Key Program of Knowledge Innovation (KZCX2-EW-411) and National Natural Science Foundation of China (20921063, 21177150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Andersen HH, 2002, NUCL INSTRUM METH B, V187, P1; [Anonymous], 2011, AH RECEPTOR BIOL TOX; Baston DS, 2011, TALANTA, V83, P1415, DOI 10.1016/j.talanta.2010.11.035; Behnisch PA, 2001, ENVIRON INT, V27, P413, DOI 10.1016/S0160-4120(01)00028-9; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Bohonowych JE, 2007, TOXICOL SCI, V98, P99, DOI 10.1093/toxsci/kfm085; Bohonowych JES, 2008, TOXICOL SCI, V102, P278, DOI 10.1093/toxsci/kfn011; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; Chou PH, 2006, WATER SCI TECHNOL, V53, P35, DOI 10.2166/wst.2006.335; Chou PH, 2007, ENVIRON SCI TECHNOL, V41, P652, DOI 10.1021/es061500g; Denison M, 1998, MOL BIOL APPROACHES, P393; Denison M.S., 2002, CURRENT PROTOCOLS TO, p(48)1; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; DENISON MS, 1986, J BIOL CHEM, V261, P3987; Denison MS, 2004, TALANTA, V63, P1123, DOI 10.1016/j.talanta.2004.05.032; Denison MS, 1998, TOXICOL APPL PHARM, V152, P406, DOI 10.1006/taap.1998.9999; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Farfan A, 1999, PROMEGA NOTES, P25; Flaveny Colin A, 2009, Mol Cell Pharmacol, V1, P119; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Han D, 2004, BIOFACTORS, V20, P11, DOI 10.1002/biof.5520200102; He GC, 2011, ENVIRON TOXICOL CHEM, V30, P1915, DOI 10.1002/etc.581; Henry EC, 2008, ARCH BIOCHEM BIOPHYS, V472, P77, DOI 10.1016/j.abb.2008.02.005; Houtman CJ, 2004, ENVIRON TOXICOL CHEM, V23, P32, DOI 10.1897/02-544; Huang RL, 2011, ENVIRON HEALTH PERSP, V119, P1142, DOI 10.1289/ehp.1002952; Jeuken A, 2003, J AGR FOOD CHEM, V51, P5478, DOI 10.1021/jf030252u; Kruger T, 2008, TOXICOLOGY, V246, P112, DOI 10.1016/j.tox.2007.12.028; Leusch FDL, 2010, ENVIRON SCI TECHNOL, V44, P3853, DOI 10.1021/es903899d; Long WP, 1998, MOL PHARMACOL, V53, P691, DOI 10.1124/mol.53.4.691; Ma Q, 2002, ARCH BIOCHEM BIOPHYS, V404, P309, DOI 10.1016/S0003-9861(02)00339-9; Mankidy R, 2012, TOXICOL LETT; Morohoshi K, 2005, TOXICOL IN VITRO, V19, P457, DOI 10.1016/j.tiv.2005.01.004; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Noguerol TN, 2006, ANAL BIOANAL CHEM, V385, P1012, DOI 10.1007/s00216-006-0476-4; Ogawa Y, 2006, FOOD ADDIT CONTAM A, V23, P422, DOI 10.1080/02652030500482371; Ozaki A, 2003, FOOD ADDIT CONTAM, V20, P92, DOI 10.1080/0265203021000014798; Petkov PI, 2010, SAR QSAR ENVIRON RES, V21, P187, DOI 10.1080/10629360903570933; Rice RH, 2009, CHEM-BIOL INTERACT, V181, P359, DOI 10.1016/j.cbi.2009.08.007; Rogers JM, 2000, IN VITRO MOL TOXICOL, V13, P67; Rogers JM, 2002, MOL PHARMACOL, V61, P1393, DOI 10.1124/mol.61.6.1393; SAFE S, 1990, CRIT REV TOXICOL, V21, P51, DOI 10.3109/10408449009089873; Satoh K, 2008, BIOL PHARM BULL, V31, P375, DOI 10.1248/bpb.31.375; Seidel SD, 2000, TOXICOL SCI, V55, P107, DOI 10.1093/toxsci/55.1.107; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Zhang QH, 2002, B ENVIRON CONTAM TOX, V69, P863, DOI 10.1007/s00128-002-0139-x; Zhao B, 2006, J BIOCHEM MOL TOXIC, V20, P103, DOI 10.1002/jbt.20126	53	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56860	10.1371/journal.pone.0056860	http://dx.doi.org/10.1371/journal.pone.0056860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441220	Green Published, gold			2022-12-27	WOS:000315159200077
J	Gray, RT; Prestage, GP; Down, I; Ghaus, MH; Hoare, A; Bradley, J; Wilson, DP				Gray, Richard T.; Prestage, Garrett P.; Down, Ian; Ghaus, Muhammad Haris; Hoare, Alexander; Bradley, Jack; Wilson, David P.			Increased HIV Testing Will Modestly Reduce HIV Incidence among Gay Men in NSW and Would Be Acceptable if HIV Testing Becomes Convenient	PLOS ONE			English	Article							HOMOSEXUAL-MEN; SEX; AUSTRALIA; RISK; INFECTION; SYDNEY; COHORT	Objective: Determine the acceptability and epidemiological impact of increases in HIV testing in gay men in New South Wales (NSW), Australia- particularly pertinent when considering treatment as prevention and the need to reduce undiagnosed infections. Methods: We conducted an online survey and focus groups to assess whether increases in HIV testing would be acceptable to gay men in NSW. In parallel, we assessed the potential impact of increases in testing coverage and/or frequency using an individual-based model of HIV transmission. Results: If sexual practices and the rate of initiating HIV treatment are unchanged then increasing HIV testing reduces infections. Increasing testing frequency has the largest impact, with a 13.8% reduction in HIV infections over 10 years if the similar to 55-75% of men who test at least once per year increased their testing frequency to four times per year. If testing levels decrease from current levels then we expect an increase in HIV infections with a sharply rising trend over time. Increasing HIV testing would be acceptable if testing was more convenient. However, only similar to 25% of men surveyed were 'very likely' to increase their level of HIV testing. Men delayed or avoided testing due to the slowness in obtaining results and if they believed they had not put themselves at risk. Conclusions: An increase in HIV testing alone is unlikely to reduce HIV incidence substantially in NSW gay men-however, the relatively high testing levels need to continue to prevent an increase in HIV infections. In jurisdictions with lower levels of HIV testing, increases in testing coverage and frequency are likely to have a larger impact. Successful treatment as prevention interventions will require increases in testing rates; such increases would be acceptable to gay men in NSW but only if more convenient testing and rapid communication of results were available.	[Gray, Richard T.; Prestage, Garrett P.; Down, Ian; Ghaus, Muhammad Haris; Hoare, Alexander; Bradley, Jack; Wilson, David P.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Prestage, Garrett P.] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; La Trobe University	Gray, RT (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	rgray@kirby.unsw.edu.au	Wilson, David P/G-4614-2013	Prestage, Garrett/0000-0003-3917-8992; Gray, Richard/0000-0002-2885-0483; Down, Ian/0000-0001-9275-8692	Australian Government Department of Health and Ageing; Australian Research Council [FT0991990]; National Health and Medical Research Council [630495]; University of New South Wales	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales	This study was funded from the following sources: the Australian Government Department of Health and Ageing; Australian Research Council (FT0991990); the National Health and Medical Research Council (630495); the University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dept Health and Ageing, 2010, 6 NAT HIV STRAT 2010; Fogarty A., 2006, HLTH MEN POSITIVE HL; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Gray RT, 2011, VACCINE, V29, P6125, DOI 10.1016/j.vaccine.2011.06.061; Grulich AE, 2008, SEX HEALTH, V5, P113, DOI 10.1071/SH07075; Guy R, 2010, SEX TRANSM INFECT, V86, P371, DOI 10.1136/sti.2009.040972; Hammer SM, 2011, NEW ENGL J MED, V4, P1; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Kirby Institute, 2011, HIV VIR HEP SEX TRAN; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; National Centre in HIV Social Research, 2009, SYDN GAY COMM PER SU; Prestage G, 2008, SEX HEALTH, V5, P97, DOI 10.1071/SH07080; Prestage G, 2012, SEX TRANSM DIS, V39, P167, DOI 10.1097/OLQ.0b013e31823e67a9; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; The Ministerial Advisory Committee on AIDS, 2006, NAT HIV TEST POL 200; Wilson DP, 2010, SEX TRANSM DIS, V37, P13, DOI 10.1097/OLQ.0b013e3181b35549; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Wilson DP, 2011, NSW HIV MODELLING AC; Zablotska I, 2007, SYDNEY GAY COMMUNITY; Zablotska IB, 2008, INT J STD AIDS, V19, P758, DOI 10.1258/ijsa.2008.008193; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9	23	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55449	10.1371/journal.pone.0055449	http://dx.doi.org/10.1371/journal.pone.0055449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457470	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700013
J	Van Ly, D; Faiz, A; Jenkins, C; Crossett, B; Black, JL; McParland, B; Burgess, JK; Oliver, BGG				Van Ly, David; Faiz, Alen; Jenkins, Christine; Crossett, Ben; Black, Judith L.; McParland, Brent; Burgess, Janette K.; Oliver, Brian G. G.			Characterising the Mechanism of Airway Smooth Muscle beta(2) Adrenoceptor Desensitization by Rhinovirus Infected Bronchial Epithelial Cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; NF-KAPPA-B; INDUCED EXACERBATIONS; RECEPTOR; EXPRESSION; ASTHMA; MACROPHAGES; RELAXATION; CHILDREN; SEQUENCE	Rhinovirus (RV) infections account for approximately two thirds of all virus-induced asthma exacerbations and often result in an impaired response to beta 2 agonist therapy. Using an in vitro model of RV infection, we investigated the mechanisms underlying RV-induced beta 2 adrenoceptor desensitization in primary human airway smooth muscle cells (ASMC). RV infection of primary human bronchial epithelial cells (HBEC) for 24 hours produced conditioned medium that caused beta 2 adrenoceptor desensitization on ASMCs without an effect on ASMCs viability. Less than 3 kDa size fractionation together with trypsin digestion of RV-induced conditioned medium did not prevent beta 2 adrenoceptor desensitization, suggesting it could potentially be mediated by a small peptide or lipid. RV infection of BECs, ASMCs and fibroblasts produced prostaglandins, of which PGE(2), PGF(2 alpha) and PGI(2) had the ability to cause beta(2) adrenoceptor desensitization on ASMCs. RV-induced conditioned medium from HBECs depleted of PGE(2) did not prevent ASMC beta(2) adrenoceptor desensitization; however this medium induced PGE(2) from ASMCs, suggesting that autocrine prostaglandin production may be responsible. Using inhibitors of cyclooxygenase and prostaglandin receptor antagonists, we found that beta(2) adrenoceptor desensitization was mediated through ASMC derived COX-2 induced prostaglandins. Since ASMC prostaglandin production is unlikely to be caused by RV-induced epithelial derived proteins or lipids we next investigated activation of toll-like receptors (TLR) by viral RNA. The combination of TLR agonists poly I:C and imiquimod induced PGE(2) and beta(2) adrenoceptor desensitization on ASMC as did the RNA extracted from RV-induced conditioned medium. Viral RNA but not epithelial RNA caused beta(2) adrenoceptor desensitization confirming that viral RNA and not endogenous human RNA was responsible. It was deduced that the mechanism by which beta(2) adrenoceptor desensitization occurs was by pattern recognition receptor activation of COX-2 induced prostaglandins.	[Van Ly, David; Faiz, Alen; Jenkins, Christine; Black, Judith L.; McParland, Brent; Burgess, Janette K.; Oliver, Brian G. G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Van Ly, David; Faiz, Alen; Black, Judith L.; McParland, Brent; Burgess, Janette K.; Oliver, Brian G. G.] Univ Sydney, Resp Res Grp, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Jenkins, Christine] Concord Gen Hosp, Dept Resp Med, Sydney, NSW, Australia; [Crossett, Ben] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Van Ly, D (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	dvan7422@gmail.com	Faiz, Alen/AAB-7132-2019; McParland, Brent E/A-2841-2012; Faiz, Alen/HII-9884-2022; Burgess, Janette/M-7117-2019; Burgess, Janette K/A-3597-2010; Black, Judith L/C-6559-2008; Oliver, Brian/E-7939-2010; Crossett, Ben/G-2316-2011	Faiz, Alen/0000-0003-1740-3538; Faiz, Alen/0000-0003-1740-3538; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966; Van Ly, David/0000-0001-8807-7448	National Health and Medical Research Council Career Development Fellowship [1032695, APP1026880]; National Health and Medical Research Council Senior Principal Research Fellowship [571098]; University of Sydney	National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney)	JKB is supported by a National Health and Medical Research Council Career Development Fellowship #1032695. JLB is supported by a National Health and Medical Research Council Senior Principal Research Fellowship #571098. BGGO is supported by a National Health and Medical Research Council Career Development Fellowship APP1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the collaborative effort of the cardiopulmonary transplant team and the pathologists at St Vincent's Hospital, Sydney; the thoracic physicians and pathologists at Royal Prince Alfred Hospital, Strathfield Private Hospital and Rhodes Pathology, Sydney; and Dr Lucy Morgan and Professor Matthew Peters at Concord Repatriation General Hospital, Sydney. The mass spectrometry was facilitated by access to the Sydney University Proteome Research Unit established under the Australian Government's Major National Research Facilities program and supported by the University of Sydney.	Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Belsham GJ, 1996, MICROBIOL REV, V60, P499, DOI 10.1128/MMBR.60.3.499-511.1996; Clarke DL, 2005, MOL PHARMACOL, V67, P383, DOI 10.1124/mol.104.006486; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; Cuthbert AW, 2011, BRIT J PHARMACOL, V162, P508, DOI 10.1111/j.1476-5381.2010.01058.x; Edwards MR, 2006, PULM PHARMACOL THER, V19, P320, DOI 10.1016/j.pupt.2005.09.005; GINA GIFA, 2011, GINA REP; Girotti M, 2009, AM J PHYSIOL-ENDOC M, V296, pE888, DOI 10.1152/ajpendo.90946.2008; Gomez E, 2008, AM J PHYSIOL-HEART C, V295, pH2198, DOI 10.1152/ajpheart.00507.2008; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; HIRST SJ, 1992, AM J RESP CELL MOL, V7, P574, DOI 10.1165/ajrcmb/7.6.574; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kang Kyung Ho, 1996, Korean Journal of Internal Medicine (English Edition), V11, P74; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kelsen SG, 1997, AM J PHYSIOL-LUNG C, V273, pL694, DOI 10.1152/ajplung.1997.273.3.L694; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Kuper C, 2012, AM J PHYSIOL-RENAL, V302, pF38, DOI 10.1152/ajprenal.00590.2010; Kuo C, 2011, AM J PHYSIOL-LUNG C, V300, pL951, DOI 10.1152/ajplung.00411.2010; Kuo C, 2011, RESPIROLOGY, V16, P367, DOI 10.1111/j.1440-1843.2010.01918.x; Ly L, 2011, J PROTEOME RES, V10, P4855, DOI 10.1021/pr200672n; Mak JCW, 2002, BRIT J PHARMACOL, V135, P987, DOI 10.1038/sj.bjp.0704545; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Oliver BGG, 2008, THORAX, V63, P519, DOI 10.1136/thx.2007.081752; Olman MA, 2009, NAT MED, V15, P1360, DOI 10.1038/nm1209-1360; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Reddel H, 1999, LANCET, V353, P364, DOI 10.1016/S0140-6736(98)06128-5; ROTH M, 1992, TISSUE CELL, V24, P455, DOI 10.1016/0040-8166(92)90061-B; Rovati GE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-103; Rueter K, 2012, J PEDIATR-US, V160, P82, DOI 10.1016/j.jpeds.2011.06.025; Seymour ML, 2002, J INFECT DIS, V185, P540, DOI 10.1086/338570; Seymour ML, 2001, AM J RESP CRIT CARE, V164, P2051, DOI 10.1164/ajrccm.164.11.2008137; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Trian T, 2010, AM J RESP CELL MOL, V43, P227, DOI 10.1165/rcmb.2009-0126OC; Van Ly David, 2011, J Allergy (Cairo), V2011, P457169, DOI 10.1155/2011/457169; Villamon E, 2005, RES MICROBIOL, V156, P115, DOI 10.1016/j.resmic.2004.08.003; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Wos M, 2008, AM J RESP CRIT CARE; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1332, DOI 10.1152/ajprenal.00131.2006	46	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56058	10.1371/journal.pone.0056058	http://dx.doi.org/10.1371/journal.pone.0056058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457497	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700020
J	Trotter, CL; Yaro, S; Njanpop-Lafourcade, BM; Drabo, A; Kroman, SS; Idohou, RS; Sanou, O; Bowen, L; Findlow, H; Diagbouga, S; Gessner, BD; Borrow, R; Mueller, JE				Trotter, Caroline L.; Yaro, Seydou; Njanpop-Lafourcade, Berthe-Marie; Drabo, Aly; Kroman, Sita S.; Idohou, Regina S.; Sanou, Oumarou; Bowen, Leah; Findlow, Helen; Diagbouga, Serge; Gessner, Bradford D.; Borrow, Ray; Mueller, Judith E.			Seroprevalence of Bactericidal, Specific IgG Antibodies and Incidence of Meningitis Due to Group A Neisseria meningitidis by Age in Burkina Faso 2008	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; SEROGROUP-C; CAPSULAR POLYSACCHARIDE; IMMUNITY; VACCINES; ENGLAND; CARRIAGE; EPIDEMIC; BELT; VACCINATION	Background: We investigated serological correlates of protection against Neisseria meningitidis serogroup A (NmA) in Burkina Faso before the introduction of NmA conjugate vaccine. Methodology/Principal Findings: We collected blood from a representative sample (N = 1022) of Bobo-Dioulasso residents. Sera were evaluated for serum bactericidal antibody (SBA) activity against NmA strains of immunotype L11 (F8238) and L10 (3125) and NmA-specific IgG. Seroprevalence was compared to the age-specific NmA meningitis incidence in Bobo-Dioulasso during March 2007-February 2008. Meningococcal carriage was evaluated in a subset (N = 538). Geometric mean titres (GMT)/concentrations (GMC) of SBA and NmA-specific IgG increased with age, peaking around age 20 years. Overall, 70% of our sample had NmA-specific IgG >= 2 ug/mL. Meningitis incidence was highest in those aged <6 months and 5-19 years. No NmA carriers were found. Compared to the reference strain SBA, GMTs were higher against a locally isolated strain and around 40-fold lower against Dutch strain 3125. Conclusions/Significance: This study provides estimates of natural immunity to NmA, according to a variety of antibody measures, which will be helpful in ascertaining antibody persistence after MenAfriVac (TM) introduction. Age-specific seroprevalence of reference strain SBA titres most likely reflects exposure to meningococci and consecutive reactive immunity. We could not define any serological correlate of protection.	[Trotter, Caroline L.; Bowen, Leah] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Yaro, Seydou; Drabo, Aly; Diagbouga, Serge] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Njanpop-Lafourcade, Berthe-Marie; Kroman, Sita S.; Idohou, Regina S.; Sanou, Oumarou; Gessner, Bradford D.; Mueller, Judith E.] Agence Med Prevent, Paris, France; [Findlow, Helen; Borrow, Ray] Manchester Royal Infirm, Hlth Protect Agcy, Vaccine Evaluat Unit, Manchester M13 9WL, Lancs, England; [Diagbouga, Serge] Inst Natl Rech Sci Sante, Ouagadougou, Burkina Faso; [Borrow, Ray] Univ Manchester, Sch Translat Med, Inflammat Sci Res Grp, Manchester, Lancs, England; [Mueller, Judith E.] Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Paris, France	University of Bristol; Centre Muraz; Agence de Medecine Preventive; Health Protection Agency; University of Manchester; University of Manchester	Trotter, CL (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	caroline.trotter@bristol.ac.uk	Trotter, Caroline L/H-5077-2013	DIAGBOUGA, Serge/0000-0003-0920-1725; Trotter, Caroline/0000-0003-4000-2708	UK Medical Research Council [G0701269]; Sanofi Pasteur; GlaxoSmithKline; Pfizer; Merck; Novartis Vaccines; Baxter Bioscience; Sanofi Pasteur MSD; Alexion Pharmaceuticals Inc; MRC [G0701269] Funding Source: UKRI; Medical Research Council [G0701269] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Merck(Merck & Company); Novartis Vaccines; Baxter Bioscience; Sanofi Pasteur MSD; Alexion Pharmaceuticals Inc; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the UK Medical Research Council (Grant G0701269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BL, SSK, OS, RSI, and BDG work, and JEM until recently worked, for the Agence de Medecine Preventive, which receives unrestricted support from Sanofi Pasteur as well as grant specific support from Sanofi Pasteur, GlaxoSmithKline, Pfizer, and Merck. RB and HF have performed contract research on behalf of the Health Protection Agency, funded by Pfizer, Novartis Vaccines, Baxter Bioscience, GlaxoSmithKline, Sanofi Pasteur, Sanofi Pasteur MSD, Alexion Pharmaceuticals Inc, and Merck. All other authors declare no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amir J, 2005, VACCINE, V23, P977, DOI 10.1016/j.vaccine.2004.07.042; Baril L, 2004, CLIN EXP IMMUNOL, V135, P474, DOI 10.1111/j.1365-2249.2003.02357.x; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; BROOME CV, 1983, B WORLD HEALTH ORGAN, V61, P325; Burrage M, 2002, INFECT IMMUN, V70, P4946, DOI 10.1128/IAI.70.9.4946-4954.2002; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; ENGLUND JA, 1995, J INFECT DIS, V171, P99, DOI 10.1093/infdis/171.1.99; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Granoff DM, 2001, METH MOLEC MED, V66, P305, DOI 10.1385/1-59259-148-5:305; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; GUIRGUIS N, 1985, J EXP MED, V162, P1837, DOI 10.1084/jem.162.6.1837; Irving TJ, 2012, EPIDEMIOL INFECT, V140, P897, DOI 10.1017/S0950268811001385; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Lal G, 2004, CLIN DIAGN LAB IMMUN, V11, P272, DOI 10.1128/CDLI.11.2.272-279.2004; Lapeyssonnie L., 1963, B WHO              S, V28, P3; MAKELA PH, 1975, LANCET, V2, P883; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Mueller JE, 2006, J INFECT DIS, V193, P812, DOI 10.1086/500511; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mueller JE, 2006, EXPERT REV VACCINES, V5, P319, DOI 10.1586/14760584.5.3.319; Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Norheim G, 2006, J CLIN MICROBIOL, V44, P861, DOI 10.1128/JCM.44.3.861-871.2006; PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302; Poolman JT, 2011, CLIN VACCINE IMMUNOL, V18, P1108, DOI 10.1128/CVI.00549-10; ROBBINS JB, 1975, J ALLERGY CLIN IMMUN, V56, P141, DOI 10.1016/0091-6749(75)90119-0; Sikkema DJ, 2000, CLIN DIAGN LAB IMMUN, V7, P764, DOI 10.1128/CDLI.7.5.764-768.2000; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Trotter C, 2003, VACCINE, V21, P1094, DOI 10.1016/S0264-410X(02)00630-8; Trotter C, 2007, CLIN VACCINE IMMUNOL, V14, P863, DOI 10.1128/CVI.00102-07; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; Trotter CL, 2012, CLIN VACCINE IMMUNOL, V19, P219, DOI 10.1128/CVI.05515-11; VANN WF, 1976, INFECT IMMUN, V13, P1654, DOI 10.1128/IAI.13.6.1654-1662.1976; *WHO, 2010, LAUNCH MEN CONJ VACC; WHO, 1998, WHO PRACT GUID; World Health Organization, 2012, CHILD GROWTH STAND W	40	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55486	10.1371/journal.pone.0055486	http://dx.doi.org/10.1371/journal.pone.0055486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457471	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700018
J	Belderok, SM; van den Hoek, A; Roeffen, W; Sauerwein, R; Sonder, GJB				Belderok, Sanne-Meike; van den Hoek, Anneke; Roeffen, Will; Sauerwein, Robert; Sonder, Gerard J. B.			Adherence to Chemoprophylaxis and Plasmodium falciparum Anti-Circumsporozoite Seroconversion in a Prospective Cohort Study of Dutch Short-Term Travelers	PLOS ONE			English	Article							MALARIA CHEMOPROPHYLAXIS; ATOVAQUONE-PROGUANIL; NONIMMUNE TRAVELERS; IMPORTED MALARIA; DECLINING INCIDENCE; NORTH-AMERICAN; RISK; PROPHYLAXIS; DETERMINANTS; TRANSMISSION	Background: We conducted a prospective study in a cohort of short-term travelers assessing the incidence rate of anti-circumsporozoite seroconversion, adherence to chemoprophylaxis, symptoms of malaria during travel, and malaria treatment abroad. Methods: Adults were recruited from the travel clinic of the Public Health Service Amsterdam. They kept a structured daily travel diary and donated blood samples before and after travel. Blood samples were serologically tested for the presence of Plasmodium falciparum anti-circumsporozoite antibodies. Results: Overall, the incidence rate (IR) of anti-circumsporozoite seroconversion was 0.8 per 100 person-months. Of 945 travelers, 620 (66%) visited high-endemic areas and were advised about both chemoprophylaxis and preventive measures against mosquito bites. Most subjects (520/620 = 84%) took at least 75% of recommended prophylaxis during travel. Travel to Africa, use of mefloquine, travel duration of 14-29 days in endemic areas, and concurrent use of DEET (N,N-diethyl-metatoluamide) were associated with good adherence practices. Four travelers without fever seroconverted, becoming anti-circumsporozoite antibody-positive. All four had been adherent to chemoprophylaxis; two visited Africa, one Suriname, one India. Ten subjects with fever were tested for malaria while abroad and of these, three received treatment. All three were adherent to chemoprophylaxis and tested negative for anti-circumsporozoite antibodies. Conclusion: Travel to Africa, using mefloquine, travel duration of 14-29 days in endemic areas, and use of DEET were associated with good adherence to chemoprophylaxis. The combination of chemoprophylaxis and other preventive measures were sufficient to protect seroconverting travelers from clinical malaria. Travelers who were treated for malaria abroad did not seroconvert.	[Belderok, Sanne-Meike; van den Hoek, Anneke; Sonder, Gerard J. B.] Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands; [Belderok, Sanne-Meike; van den Hoek, Anneke; Sonder, Gerard J. B.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Roeffen, Will; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Sonder, Gerard J. B.] Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Belderok, SM (corresponding author), Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.	sbelderok@ggd.amsterdam.nl	Sauerwein, Robert/C-8519-2013; Roeffen, W.F.G./L-4607-2015		the Netherlands Organization for Health Research and Development (ZonMw) [7115 0001]	the Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was conducted within the Amsterdam Academic Collaborative Center on Public Health: a collaboration between the Public Health Service of Amsterdam & the Academic Medical Center of the University of Amsterdam, the Netherlands. The Amsterdam Academic Collaborative Center on Public Health is financially supported by the Netherlands Organization for Health Research and Development (ZonMw; grant number 7115 0001, http://www.zonmw.nl/nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens RH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-114; Behrens RH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-266; Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235; Chen LH, 2005, INFECT DIS CLIN N AM, V19, P185, DOI 10.1016/j.idc.2004.10.006; Cobelens FGJ, 1998, AM J TROP MED HYG, V58, P75, DOI 10.4269/ajtmh.1998.58.75; Cobelens FGJ, 1997, TROP MED INT HEALTH, V2, P705, DOI 10.1046/j.1365-3156.1997.d01-357.x; DePetrillo JC, 2010, J TRAVEL MED, V17, P217, DOI 10.1111/j.1708-8305.2010.00426.x; DRUILHE P, 1986, INFECT IMMUN, V53, P393, DOI 10.1128/IAI.53.2.393-397.1986; Goodyer L, 2011, J TRAVEL MED, V18, P245, DOI 10.1111/j.1708-8305.2011.00534.x; GYORKOS TW, 1995, AM J TROP MED HYG, V53, P511, DOI 10.4269/ajtmh.1995.53.511; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hogh B, 2000, LANCET, V356, P1888, DOI 10.1016/S0140-6736(00)03260-8; Huzly, 1996, J Travel Med, V3, P148, DOI 10.1111/j.1708-8305.1996.tb00729.x; Jelinek T, 1998, AM J TROP MED HYG, V59, P35, DOI 10.4269/ajtmh.1998.59.35; Jelinek T., 2008, Eurosurveillance, V13, P19077; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Knappik M, 2002, TROP MED INT HEALTH, V7, P652, DOI 10.1046/j.1365-3156.2002.00906.x; Lalloo DG, 2008, BMJ-BRIT MED J, V336, P1362, DOI 10.1136/bmj.a153; [Landelijk Cordinatiecentrum Reizigersadvisering National Coordination Centre for Traveller's Health Advice], 2007, NAT COORD CTR TRAV H; Leder K, 2008, J TRAVEL MED, V15, P263, DOI 10.1111/j.1708-8305.2008.00218.x; LOBEL HO, 1990, B WORLD HEALTH ORGAN, V68, P209; Lobel HO, 2001, J TRAVEL MED, V8, P167, DOI 10.2310/7060.2001.22206; Neave PE, 2010, J TRAVEL MED, V17, P346, DOI 10.1111/j.1708-8305.2010.00440.x; Nothdurft HD, 1999, CLIN INFECT DIS, V28, P641, DOI 10.1086/515155; Orlandi-Pradines E, 2006, AM J TROP MED HYG, V74, P979; Overbosch D, 2001, CLIN INFECT DIS, V33, P1015, DOI 10.1086/322694; Petersen E, 2000, J TRAVEL MED, V7, P79; Resseguier N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-41; Robert V, 2000, PARASITE IMMUNOL, V22, P589, DOI 10.1046/j.1365-3024.2000.00340.x; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Ropers G, 2008, J TRAVEL MED, V15, P162, DOI 10.1111/j.1708-8305.2008.00188.x; Sagui E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-232; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Schlagenhauf P, 2008, CLIN MICROBIOL REV, V21, P466, DOI 10.1128/CMR.00059-07; United Nations Statistics Division, 2011, COMP MACR CONT REG G; van Rijckevorsel GGC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-300; WEBSTER HK, 1987, J CLIN MICROBIOL, V25, P1002, DOI 10.1128/JCM.25.6.1002-1008.1987; Williams Christopher J, 2007, Travel Med Infect Dis, V5, P295, DOI 10.1016/j.tmaid.2007.05.001; World Health Organization, 2012, MAL FACTSH	39	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56863	10.1371/journal.pone.0056863	http://dx.doi.org/10.1371/journal.pone.0056863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451100	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500036
J	Henderson, WR; Ye, X; Lai, Y; Ni, ZL; Bollinger, JG; Tien, YT; Chi, EY; Gelb, MH				Henderson, William R., Jr.; Ye, Xin; Lai, Ying; Ni, Zhanglin; Bollinger, James G.; Tien, Ying-Tzang; Chi, Emil Y.; Gelb, Michael H.			Key Role of Group V Secreted Phospholipase A(2) in Th2 Cytokine and Dendritic Cell-Driven Airway Hyperresponsiveness and Remodeling	PLOS ONE			English	Article							MOUSE ASTHMA MODEL; ALLERGIC PULMONARY INFLAMMATION; ARACHIDONIC-ACID RELEASE; GROUP-X; CYSTEINYL LEUKOTRIENES; IMMUNE-RESPONSES; PERITONEAL-MACROPHAGES; PROSTAGLANDIN E-2; HUMAN NEUTROPHILS; RECEPTOR	Background: Previous work has shown that disruption of the gene for group X secreted phospholipase A(2) (sPLA(2)-X) markedly diminishes airway hyperresponsiveness and remodeling in a mouse asthma model. With the large number of additional sPLA(2)s in the mammalian genome, the involvement of other sPLA(2)s in the asthma model is possible - in particular, the group V sPLA(2) (sPLA(2)-V) that like sPLA(2)-X is highly active at hydrolyzing membranes of mammalian cells. Methodology and Principal Findings: The allergen-driven asthma phenotype was significantly reduced in sPLA(2)-V-deficient mice but to a lesser extent than observed previously in sPLA(2)-X-deficient mice. The most striking difference observed between the sPLA(2)-V and sPLA(2)-X knockouts was the significant impairment of the primary immune response to the allergen ovalbumin (OVA) in the sPLA(2)-V-/- mice. The impairment in eicosanoid generation and dendritic cell activation in sPLA(2)-V-/- mice diminishes Th2 cytokine responses in the airways. Conclusions: This paper illustrates the diverse roles of sPLA(2)s in the immunopathogenesis of the asthma phenotype and directs attention to developing specific inhibitors of sPLA(2)-V as a potential new therapy to treat asthma and other allergic disorders.	[Henderson, William R., Jr.; Ye, Xin] Univ Washington, Dept Med, UW Med South Lake Union, Ctr Allergy & Inflammat, Seattle, WA 98195 USA; [Lai, Ying; Ni, Zhanglin; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Tien, Ying-Tzang; Chi, Emil Y.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Henderson, WR (corresponding author), Univ Washington, Dept Med, UW Med South Lake Union, Ctr Allergy & Inflammat, Seattle, WA 98195 USA.	wrhchem@u.washington.edu; gelb@chem.washington.edu		gelb, michael/0000-0001-7000-5219	National Institutes of Health [RO1 AI 42989, HL 73722, R37 HL36235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R01HL073722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants RO1 AI 42989 and HL 73722 (WRH) and R37 HL36235 (MHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Barrett NA, 2012, J IMMUNOL, V189, P4556, DOI 10.4049/jimmunol.1201865; BARTOLI F, 1994, J BIOL CHEM, V269, P15625; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Chizzolini C, 2009, IMMUNOL CELL BIOL, V87, P510, DOI 10.1038/icb.2009.56; Dannull J, 2012, BLOOD, V119, P3113, DOI 10.1182/blood-2011-10-385930; de Faudeur G, 2008, IMMUNOL LETT, V118, P21, DOI 10.1016/j.imlet.2008.02.006; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Del Prete A, 2007, BLOOD, V109, P626, DOI 10.1182/blood-2006-02-003665; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Giannattasio G, 2010, J IMMUNOL, V185, P4430, DOI 10.4049/jimmunol.1001384; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Hallstrand TS, 2011, CLIN EXP ALLERGY, V41, P801, DOI 10.1111/j.1365-2222.2010.03676.x; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2000, J IMMUNOL, V164, P1086, DOI 10.4049/jimmunol.164.2.1086; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Machida I, 2004, J IMMUNOL, V172, P1833, DOI 10.4049/jimmunol.172.3.1833; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Okunishi K, 2004, J IMMUNOL, V173, P6393, DOI 10.4049/jimmunol.173.10.6393; Parameswaran K, 2004, J ALLERGY CLIN IMMUN, V114, P73, DOI 10.1016/j.jaci.2004.03.054; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Radhakrishnan S, 2005, P NATL ACAD SCI USA, V102, P11438, DOI 10.1073/pnas.0501420102; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Saiga A, 2001, BBA-MOL CELL BIOL L, V1530, P67, DOI 10.1016/S1388-1981(00)00167-0; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Shin EH, 2006, BIOCHEM BIOPH RES CO, V348, P606, DOI 10.1016/j.bbrc.2006.07.084; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Singh P, 2012, BLOOD, V119, P1671, DOI 10.1182/blood-2011-03-342428; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Thivierge M, 2006, J ALLERGY CLIN IMMUN, V117, P1155, DOI 10.1016/j.jaci.2005.12.1342; Thivierge M, 2009, J IMMUNOL, V183, P6778, DOI 10.4049/jimmunol.0901800; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woszczek G, 2008, J IMMUNOL, V180, P7597, DOI 10.4049/jimmunol.180.11.7597; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	53	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56172	10.1371/journal.pone.0056172	http://dx.doi.org/10.1371/journal.pone.0056172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451035	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500007
J	Matic, M; Bryzgalova, G; Gao, H; Antonson, P; Humire, P; Omoto, Y; Portwood, N; Pramfalk, C; Efendic, S; Berggren, PO; Gustafsson, JA; Dahlman-Wright, K				Matic, Marko; Bryzgalova, Galyna; Gao, Hui; Antonson, Per; Humire, Patricia; Omoto, Yoko; Portwood, Neil; Pramfalk, Camilla; Efendic, Suad; Berggren, Per-Olof; Gustafsson, Jan-Ake; Dahlman-Wright, Karin			Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action	PLOS ONE			English	Article							LONG-TERM CONTROL; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; OVARIAN HORMONES; OB/OB MICE; MECHANISMS; RESISTANCE; SPECIFICITY; ACTIVATION; EXPRESSION	An increasing body of evidence now links estrogenic signalling with the metabolic syndrome (MS). Despite the beneficial estrogenic effects in reversing some of the MS symptoms, the underlying mechanisms remain largely undiscovered. We have previously shown that total estrogen receptor alpha (ER alpha) knockout (KO) mice exhibit hepatic insulin resistance. To determine whether liver-selective ablation of ER alpha recapitulates metabolic phenotypes of ERKO mice we generated a liver-selective ER alpha KO mouse model, LERKO. We demonstrate that LERKO mice have efficient reduction of ER alpha selectively within the liver. However, LERKO and wild type control mice do not differ in body weight, and have a comparable hormone profile as well as insulin and glucose response, even when challenged with a high fat diet. Furthermore, LERKO mice display very minor changes in their hepatic transcript profile. Collectively, our findings indicate that hepatic ER alpha action may not be the responsible factor for the previously identified hepatic insulin resistance in ER alpha KO mice.	[Matic, Marko; Gao, Hui; Antonson, Per; Humire, Patricia; Omoto, Yoko; Gustafsson, Jan-Ake; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Bryzgalova, Galyna; Portwood, Neil; Efendic, Suad; Berggren, Per-Olof] Karolinska Inst, Karolinska Univ Hosp L1, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signalling, Houston, TX USA; [Pramfalk, Camilla] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston; Karolinska Institutet	Dahlman-Wright, K (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	karin.dahlman-wright@ki.se	Gao, Hui/AAF-9770-2019	Pramfalk, Camilla/0000-0003-4928-1256; Berggren, Per-Olof/0000-0001-8991-413X; Antonson, Per/0000-0001-9335-9941	Swedish Research Council; Cancerfonden [080482, 090678, 100404, 110588]; Novo Nordisk Foundation; Strategic Research Area in Diabetes at the Karolinska Institute; Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; BioCrine AB; Karolinska Bioinformatics and Expression Analysis core facility; Swedish Cancer Society; Robert A. Welch Foundation [E-0004];  [K2009-54X-21122-01-3];  [K2008-54X-20640-01-3];  [K2011-54X-20640-04-6]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Strategic Research Area in Diabetes at the Karolinska Institute; Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; BioCrine AB(HOGANAS ABStatisticon AB); Karolinska Bioinformatics and Expression Analysis core facility; Swedish Cancer Society(Swedish Cancer Society); Robert A. Welch Foundation(The Welch Foundation); ; ; 	This work is supported by the Swedish Research Council (http://www.vr.se/; The involvement of estrogen receptor signaling in insulin resistance and type 2 diabetes (project # K2009-54X-21122-01-3), Estrogen signaling in metabolic disease; a functional genomics approach (project # K2008-54X-20640-01-3) and Tissue-specific estrogen signaling - new insights in metabolic disease development (project # K2011-54X-20640-04-6)), Cancerfonden (http://www.cancerfonden.se; grant # 080482, 090678, 100404 and 110588), Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/; Estrogen signaling in metabolic disease (2006), Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen (2008), Genetic dissection of estrogen signaling in mice (2009), Genetic dissection of estrogen signaling in metabolic disease (2011)), the Strategic Research Area in Diabetes at the Karolinska Institute (http://ki.se/srp-diabetes; SFO/TM Diabetes (2010)), Center for Biosciences (http://ki.se/cb; grant # n/a (2009-2011)), the KI Endomet network (http://researchnetworks.ki.se/converis/; grant details n/a), King Gustaf V and Queen Victoria's Freemason's Foundation (http://www.frimurarorden.se; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen (2008, 2009, 2010, 2011)); and BioCrine AB (website and grant details n/a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by BioCrine AB. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; The authors gratefully acknowledge the support and technical expertise of the Karolinska Bioinformatics and Expression Analysis core facility (www.bea.ki.se), and Dr. Rongrong Fan. J-A G is grateful to the Swedish Cancer Society and the Robert A. Welch Foundation (E-0004) for support.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AHLBORG G, 1986, J CLIN INVEST, V77, P690, DOI 10.1172/JCI112363; AHMEDSOROUR H, 1980, HORM RES, V13, P396, DOI 10.1159/000179307; Antonson P, 2012, BIOCHEM BIOPH RES CO, V424, P710, DOI 10.1016/j.bbrc.2012.07.016; Aragno M, 2009, FREE RADICAL BIO MED, V47, P1067, DOI 10.1016/j.freeradbiomed.2009.07.016; Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; BAILEY CJ, 1980, DIABETOLOGIA, V19, P475, DOI 10.1007/BF00281829; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eshtiaghi R, 2010, MATURITAS, V65, P262, DOI 10.1016/j.maturitas.2009.11.004; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; Jones MEE, 2007, NAT CLIN PRACT ENDOC, V3, P414, DOI 10.1038/ncpendmet0477; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Katzenellenbogen BS, 2000, J STEROID BIOCHEM, V74, P279, DOI 10.1016/S0960-0760(00)00104-7; Kendall DM, 2002, AM J MANAG CARE, V8, pS635; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lindberg MK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740167; Lundholm L, 2008, J ENDOCRINOL, V199, P275, DOI [10.1677/JOE-08-0192, 10.1530/JOE-08-0192e]; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Munoz J, 2002, OBES RES, V10, P424, DOI 10.1038/oby.2002.59; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ribas V, 2011, P NATL ACAD SCI USA; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Takeda K, 2003, J ENDOCRINOL, V176, P237, DOI 10.1677/joe.0.1760237; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	52	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57458	10.1371/journal.pone.0057458	http://dx.doi.org/10.1371/journal.pone.0057458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451233	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500106
J	Vigren, P; Tisell, A; Engstrom, M; Karlsson, T; Dahlqvist, OL; Lundberg, P; Landtblom, AM				Vigren, Patrick; Tisell, Anders; Engstrom, Maria; Karlsson, Thomas; Dahlqvist, Olof Leinhard; Lundberg, Peter; Landtblom, Anne-Marie			Low Thalamic NAA-Concentration Corresponds to Strong Neural Activation in Working Memory in Kleine-Levin Syndrome	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYLASPARTATE; BRAIN; LOAD; PATTERNS; SPECT	Background: Kleine Levin Syndrome (KLS) is a rare disorder of periodic hypersomnia and behavioural disturbances in young individuals. It has previously been shown to be associated with disturbances of working memory (WM), which, in turn, was associated with higher activation of the thalamus with increasing WM load, demonstrated with functional magnetic resonance imaging (fMRI). In this study we aimed to further elucidate how these findings are related to the metabolism of the thalamus. Methods: fMRI and magnetic resonance spectroscopy were applied while performing a WM task. Standard metabolites were examined: n-acetylaspartate (NAA), myo-inositol, choline, creatine and glutamate-glutamine. Fourteen KLS-patients and 15 healthy controls participated in the study. The patients with active disease were examined in asymptomatic periods. Results: There was a statistically significant negative correlation between thalamic fMRI-activation and thalamic NAA, i.e., high fMRI-activation corresponded to low NAA-levels. This correlation was not seen in healthy controls. Thalamic levels of NAA in patients and controls showed no significant differences between the groups. None of the other metabolites showed any co-variation with fMRI-activiation. Conclusion: This study shows negative correlation between NAA-levels and fMRI-activity in the left thalamus of KLS-patients while performing a WM task. This correlation could not be found in healthy control subjects, primarily interpreted as an effect of increased effort in the patient group upon performing the task. It might indicate a disturbance in the neuronal networks responsible for WM in KLS patients, resulting in higher effort at lower WM load, compared with healthy subjects. The general relationship between NAA and BOLD-signal is also discussed in the article.	[Vigren, Patrick; Landtblom, Anne-Marie] Linkoping Univ, Dept Clin & Expt Med IKE Neurosci, Linkoping, Sweden; [Vigren, Patrick] Cty Council Ostergotland, Dept Neurosurg, Linkoping, Sweden; [Vigren, Patrick; Tisell, Anders; Engstrom, Maria; Karlsson, Thomas; Dahlqvist, Olof Leinhard; Lundberg, Peter; Landtblom, Anne-Marie] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Tisell, Anders; Engstrom, Maria; Dahlqvist, Olof Leinhard; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Lundberg, Peter] Cty Council Ostergotland, Dept Radiat Phys UHL, Linkoping, Sweden; [Lundberg, Peter] Cty Council Ostergotland, Dept Radiol UHL, Linkoping, Sweden; [Landtblom, Anne-Marie] Cty Council Ostergotland, Dept Neurol, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University; Linkoping University; Linkoping University; City Council Ostergotland; City Council Ostergotland; City Council Ostergotland	Vigren, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med IKE Neurosci, Linkoping, Sweden.	patrick.vigren@lio.se	Dahlqvist Leinhard, Olof/K-4228-2013; Lundberg, Peter/AGD-9679-2022	Dahlqvist Leinhard, Olof/0000-0002-6189-0807; Engstrom, Maria/0000-0002-2167-2450; Landtblom, Anne-Marie/0000-0001-9567-470X	County Council of Ostergotland; Swedish Research Council; KLS foundation	County Council of Ostergotland; Swedish Research Council(Swedish Research CouncilEuropean Commission); KLS foundation	Funding was obtained from the County Council of Ostergotland, the Swedish Research Council and the KLS foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arnulf I, 2005, BRAIN, V128, P2763, DOI 10.1093/brain/awh620; Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Billings ME, 2011, SLEEP MED, V12, P532, DOI 10.1016/j.sleep.2011.01.009; Bor J, 2011, SCHIZOPHR RES, V125, P49, DOI 10.1016/j.schres.2010.10.018; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Ende G, 2003, EUR ARCH PSY CLIN N, V253, P9, DOI 10.1007/s00406-003-0398-5; Engstrom M, 2009, SLEEP, V32, P681, DOI 10.1093/sleep/32.5.681; Friedman NP, 2005, BEHAV RES METHODS, V37, P581, DOI 10.3758/BF03192728; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; Hagino H, 2002, PSYCHIAT CLIN NEUROS, V56, P499, DOI 10.1046/j.1440-1819.2002.01045.x; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Huang YS, 2005, SLEEP, V28, P955, DOI 10.1093/sleep/28.8.955; Huang YS, 2012, SLEEP, V35, P123, DOI 10.5665/sleep.1600; Hyder F, 2001, NMR BIOMED, V14, P413, DOI 10.1002/nbm.733; Kleine W, 1925, MON PSYCHIATR NEUROL, V57, P285; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Landtblom AM, 2003, ACTA NEUROL SCAND, V108, P363, DOI 10.1034/j.1600-0404.2003.00171.x; Landtblom AM, 2002, ACTA NEUROL SCAND, V105, P318, DOI 10.1034/j.1600-0404.2002.1c162.x; Levin M, 1936, BRAIN, V59, P494, DOI 10.1093/brain/59.4.494; Lundin F, 2011, J NEUROL NEUROSUR PS, V82, P772, DOI 10.1136/jnnp.2010.223529; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Manoach DS, 2003, NEUROIMAGE, V20, P1670, DOI 10.1016/j.neuroimage.2003.08.002; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Murillo-Rodriguez E, 2009, CNS NEUROL DISORD-DR, V8, P245, DOI 10.2174/187152709788921654; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nyberg L, 2009, SCAND J PSYCHOL, V50, P41, DOI 10.1111/j.1467-9450.2008.00678.x; Poryazova R, 2007, J NEUROL, V254, P1445, DOI 10.1007/s00415-007-0531-x; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ross AJ, 2004, BRAIN RES REV, V44, P83, DOI 10.1016/j.brainresrev.2003.11.001; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tisell AL, 2009, ABSOLUTE QUANTIFICAT; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635	40	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56279	10.1371/journal.pone.0056279	http://dx.doi.org/10.1371/journal.pone.0056279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451038	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500009
J	Andrade-Vieira, R; Xu, ZL; Colp, P; Marignani, PA				Andrade-Vieira, Rafaela; Xu, Zhaolin; Colp, Patricia; Marignani, Paola A.			Loss of lkb1 Expression Reduces the Latency of ErbB2-Mediated Mammary Gland Tumorigenesis, Promoting Changes in Metabolic Pathways	PLOS ONE			English	Article							BREAST-CANCER; TUMOR-GROWTH; KINASE LKB1; MTOR; ACTIVATION; TRASTUZUMAB; CONTRIBUTES; SUPPRESSION; DEFICIENCY; RESISTANCE	The tumor suppressor kinase LKB1 is mutated in a broad range of cancers however, the role of LKB1 mammary gland tumorigenesis is not fully understood. Evaluation of human breast cancer tissue microarrays, indicate that 31% of HER2 positive samples lacked LKB1 expression. To expand on these observations, we crossed STK11(fl/fl) mice with mice genetically engineered to express activated Neu/HER2-MMTV-Cre (NIC) under the endogenous Erbb2 promoter, to generate STK11(-/-)/NIC mice. In these mice, the loss of lkb1 expression reduced the latency of ErbB2-mediated tumorigenesis compared to the latency of tumorigenesis in NIC mice alone. Analysis of STK11(-/-)/NIC mammary tumors revealed hyperactivation of mammalian target of rapamycin (mTOR) through both mTORC1 and mTORC2 pathways as determined by the phosphorylation status of ribosomal protein S6 and AKT. Furthermore, STK11(-/-)/NIC mammary tumors had elevated ATP levels along with changes in metabolic enzymes and metabolites. The treatment of primary mammary tumor cells with specific mTOR inhibitors AZD8055 and Torin1, that target both mTOR complexes, attenuated mTOR activity and decreased expression of glycolytic enzymes. Our findings underscore the existence of a molecular interplay between LKB1-AMPK-mTORC1 and ErbB2-AKT-mTORC2 pathways with mTOR at its epicenter, suggestive that loss of LKB1 expression may serve as a marker for hyperactivated mTOR in HER2 positive breast cancer and warranting further investigation into therapeutics that target LKB1-AMPK-mTOR and glycolytic pathways.	[Andrade-Vieira, Rafaela; Marignani, Paola A.] Dalhousie Univ, Fac Med, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Xu, Zhaolin; Colp, Patricia; Marignani, Paola A.] Dalhousie Univ, Dept Pathol, Fac Med, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Marignani, PA (corresponding author), Dalhousie Univ, Fac Med, Dept Biochem & Mol Biol, Halifax, NS, Canada.	pmarigna@dal.ca		Marignani, Paola/0000-0001-8070-905X	CIHR-CRTP (Canadian Institutes of Health Research - The Cancer Research Training Program); Nova Scotia Health research Foundation; Beatrice Hunter Cancer Research Institute; CIHR-CRTP	CIHR-CRTP (Canadian Institutes of Health Research - The Cancer Research Training Program)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health research Foundation; Beatrice Hunter Cancer Research Institute; CIHR-CRTP(Canadian Institutes of Health Research (CIHR))	RA is supported by CIHR-CRTP (Canadian Institutes of Health Research - The Cancer Research Training Program). PM is supported by the Nova Scotia Health research Foundation, the Beatrice Hunter Cancer Research Institute and by private donations administered through the Dalhousie Medical Research Foundation, Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Jean Marshall and Jason Berman for their support. We thank Ria Sayat for her technical support. We thank the animal care staff in the Faculty of Medicine, Dalhousie University. RA is supported by CIHR-CRTP. PM is supported by the Nova Scotia Health Research Foundation, the Beatrice Hunter Cancer Research Institute and by private donations administered through the Dalhousie Medical Research Foundation.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eskens F, 2008, BRIT J CANCER, V98, P80, DOI 10.1038/sj.bjc.6604108; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Garcia-Martinez JM, 2011, BRIT J CANCER, V104, P1116, DOI 10.1038/bjc.2011.83; Gatenby RA, 1996, CANCER RES, V56, P5745; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lim W, 2003, BRIT J CANCER, V89, P308, DOI 10.1038/sj.bjc.6601030; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Loden M, 2002, ONCOGENE, V21, P4680, DOI 10.1038/sj.onc.1205578; Marignani P.A., 2010, EMERGING SIGNALLING, P71; McCarthy A, 2009, J PATHOL, V219, P306, DOI 10.1002/path.2599; Mercier P, 2011, J BIOMOL NMR, V49, P307, DOI 10.1007/s10858-011-9480-x; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nath-Sain S, 2009, MOL BIOL CELL, V20, P2785, DOI 10.1091/mbc.E08-11-1138; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schade B, 2009, J BIOL CHEM, V284, P19018, DOI 10.1074/jbc.M109.018937; Scott KD, 2007, CANCER RES, V67, P5622, DOI 10.1158/0008-5472.CAN-07-0762; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; VARLEY JM, 1987, ONCOGENE, V1, P423; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668	40	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56567	10.1371/journal.pone.0056567	http://dx.doi.org/10.1371/journal.pone.0056567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451056	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800018
J	Li, P; Li, F; Fang, YJ; Wan, DS; Pan, ZZ; Chen, G; Ma, G				Li, Pan; Li, Fen; Fang, Yujing; Wan, Desen; Pan, Zhizhong; Chen, Gong; Ma, Gang			Efficacy, Compliance and Reasons for Refusal of Postoperative Chemotherapy for Elderly Patients with Colorectal Cancer: A Retrospective Chart Review and Telephone Patient Questionnaire	PLOS ONE			English	Article							III COLON-CANCER; TRADITIONAL CHINESE MEDICINE; ADJUVANT-CHEMOTHERAPY; STAGE-II; POOLED ANALYSIS; RECTAL-CANCER; 1ST-LINE TREATMENT; THERAPY; AGE; CAPECITABINE	Background: Numerous clinical trials have demonstrated that elderly patients with colorectal cancer (CRC) can benefit from chemotherapy, yet compliance in real-world practice is low. The purpose of this study is to investigate the efficacy, compliance and reasons for refusal of postoperative chemotherapy for elderly patients with CRC and to provide corresponding strategies. Patients and methods: The clinico-pathological and biochemical data of the chemotherapy group and chemo-refusing group were compared among 386 elderly patients (>70 years old) with CRC who underwent surgery. 226 patients received chemotherapy and 160 patients refused. Follow-up of the subjective reasons for refusal was investigated using the elderly caner patients' chemo-refusal reason questionnaire (ECPCRRQ) prepared by the authors and a group of psychologists. The questionnaire is administrated by telephone. A predictive model for 5-year disease-free survival (DFS) and 5-year overall survival (OS) was constructed by using Kaplan-Meier analysis, logistic and Cox regression. Results: Among stage III patients, receiving chemotherapy was associated with a significantly higher OS (68%) compared to those who refused (OS50%) (HR: 2.05, 95%CI: 1.12-3.77, P = 0.02). The Chemo-refusal group had more female and elderly patients, significantly higher rate of severe complications, and lower body mass index (BMI). Follow-up phone questionnaire analysis showed the doctors' uncertainty of chemotherapy benefit, economic difficulties, uncomfortable feeling, superstition of Traditional Chinese Medicine, concealing information and lack of social support were the main factors for elderly CRC patients to decline chemotherapy. Conclusion: The receipt of post-operative chemotherapy in elderly patients with resected stage III CRC was associated with a more favorable survival. The low compliance rate (160/386) of postoperative chemotherapy was influenced by various subjective and objective factors.	[Li, Pan; Fang, Yujing; Wan, Desen; Pan, Zhizhong; Chen, Gong] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Fen] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China; [Ma, Gang] Sun Yat Sen Univ, Ctr Canc, Dept Intens Care Unit, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Huazhong University of Science & Technology; Sun Yat Sen University	Chen, G (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China.	violet.lipan@163.com; magang@sysucc.org.com						Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224; BALDUCCI L, 2002, AM J CANC, V1, P101; Balducci L, 2005, SENIOR ADULT ONCOLOG, V1, P38; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Bouvier AM, 2005, ALIMENT PHARM THERAP, V22, P233, DOI 10.1111/j.1365-2036.2005.02559.x; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Cheung WY, 2009, DIS COLON RECTUM, V52, P1054, DOI 10.1007/DCR.0b013e3181a51173; Czaykowski P, 2007, ASCO GASTR CANC S; Faivre-Finn C, 2002, GUT, V51, P60, DOI 10.1136/gut.51.1.60; Feliu J, 2006, BRIT J CANCER, V94, P969, DOI 10.1038/sj.bjc.6603047; Feliu J, 2005, J CLIN ONCOL, V23, P3104, DOI 10.1200/JCO.2005.06.035; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; Folprecht G, 2004, ANN ONCOL, V15, P1330, DOI 10.1093/annonc/mdh344; Goldberg RM, 2006, J CLIN ONCOL, V24, P4085, DOI 10.1200/JCO.2006.06.9039; Gurney H, 1996, J CLIN ONCOL, V14, P2590, DOI 10.1200/JCO.1996.14.9.2590; Haberland J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-52; Haen E, 2011, PHARMACOPSYCHIATRY, V44, P254, DOI 10.1055/s-0031-1286285; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jensen SA, 2006, ACTA ONCOL, V45, P67, DOI 10.1080/02841860500375213; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Lima IS, 2002, CANCER, V10, P25954; Liu G, 1997, J CLIN ONCOL, V15, P110, DOI 10.1200/JCO.1997.15.1.110; Mahoney T, 2000, ARCH SURG-CHICAGO, V135, P182, DOI 10.1001/archsurg.135.2.182; National Institutes of Health, 1990, ADJ THER PAT COL REC, P1; Neugut AI, 2002, J CLIN ONCOL, V20, P2643, DOI 10.1200/JCO.2002.08.062; Pasetto LM, 2005, CRIT REV ONCOL HEMAT, V54, P145, DOI 10.1016/j.critrevonc.2004.12.003; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; REILLY JJ, 1993, CANCER CHEMOTH PHARM, V32, P411, DOI 10.1007/BF00685883; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Sasaki K, 2007, J CLIN ONCOL, V25; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Schrag D, 2001, J CLIN ONCOL, V19, P3712, DOI 10.1200/JCO.2001.19.17.3712; Simmonds P, 2000, LANCET, V356, P968, DOI 10.1016/S0140-6736(00)02713-6; Tan KY, 2008, TECH COLOPROCTOL, V12, P1, DOI 10.1007/s10151-008-0392-z; Tao L, 2010, ARITCLE CHINESE, P1159; Yang YF, 2008, CHIN J INTEGR MED, V14, P251, DOI 10.1007/s11655-008-0251-9	38	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e55494	10.1371/journal.pone.0055494	http://dx.doi.org/10.1371/journal.pone.0055494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451026	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800003
J	Nicholson, A; Ford, E; Davies, KA; Smith, HE; Rait, G; Tate, AR; Petersen, I; Cassell, J				Nicholson, Amanda; Ford, Elizabeth; Davies, Kevin A.; Smith, Helen E.; Rait, Greta; Tate, A. Rosemary; Petersen, Irene; Cassell, Jackie			Optimising Use of Electronic Health Records to Describe the Presentation of Rheumatoid Arthritis in Primary Care: A Strategy for Developing Code Lists	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; MEDICAL-RECORDS; OVARIAN-CANCER; PATIENT; DIAGNOSIS; DISEASE; EPIDEMIOLOGY; QUALITY	Background: Research using electronic health records (EHRs) relies heavily on coded clinical data. Due to variation in coding practices, it can be difficult to aggregate the codes for a condition in order to define cases. This paper describes a methodology to develop 'indicator markers' found in patients with early rheumatoid arthritis (RA); these are a broader range of codes which may allow a probabilistic case definition to use in cases where no diagnostic code is yet recorded. Methods: We examined EHRs of 5,843 patients in the General Practice Research Database, aged >= 30y, with a first coded diagnosis of RA between 2005 and 2008. Lists of indicator markers for RA were developed initially by panels of clinicians drawing up code-lists and then modified based on scrutiny of available data. The prevalence of indicator markers, and their temporal relationship to RA codes, was examined in patients from 3y before to 14d after recorded RA diagnosis. Findings: Indicator markers were common throughout EHRs of RA patients, with 83.5% having 2 or more markers. 34% of patients received a disease-specific prescription before RA was coded; 42% had a referral to rheumatology, and 63% had a test for rheumatoid factor. 65% had at least one joint symptom or sign recorded and in 44% this was at least 6-months before recorded RA diagnosis. Conclusion: Indicator markers of RA may be valuable for case definition in cases which do not yet have a diagnostic code. The clinical diagnosis of RA is likely to occur some months before it is coded, shown by markers frequently occurring >= 6 months before recorded diagnosis. It is difficult to differentiate delay in diagnosis from delay in recording. Information concealed in free text may be required for the accurate identification of patients and to assess the quality of care in general practice.	[Nicholson, Amanda; Ford, Elizabeth; Davies, Kevin A.; Smith, Helen E.; Cassell, Jackie] Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England; [Rait, Greta; Petersen, Irene] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Tate, A. Rosemary] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of Brighton; University of Sussex; University of London; University College London; University of Sussex	Ford, E (corresponding author), Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England.	e.m.ford@bsms.ac.uk	Smith, Helen E/M-2449-2016; Greiver, Michelle/N-8764-2015; Tate, Anne Rosemary/AAK-4512-2020; Petersen, Irene/C-5702-2009	Smith, Helen E/0000-0003-1883-6124; Greiver, Michelle/0000-0001-8957-0285; Petersen, Irene/0000-0002-0037-7524; Ford, Elizabeth/0000-0001-5613-8509; Cassell, Jackie/0000-0003-0777-0385; Rait, Greta/0000-0002-7216-7294; Davies, Kevin/0000-0003-1639-7017	Wellcome Trust - PREP (Patient Record Enhancement Project) study [086105/Z/08/Z]	Wellcome Trust - PREP (Patient Record Enhancement Project) study	The study was funded by the Wellcome Trust (http://www.wellcome.ac.uk/), grant number 086105/Z/08/Z - the PREP (Patient Record Enhancement Project) study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt U, 2007, RHEUMATOL INT, V28, P21, DOI 10.1007/s00296-007-0382-x; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Carroll Robert J, 2011, AMIA Annu Symp Proc, V2011, P189; Cassell JA, 2006, BMJ-BRIT MED J, V332, P332, DOI 10.1136/bmj.38726.404120.7C; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; DeLisle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013377; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Edwards CJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P1151, DOI 10.1002/art.23003; Edwards CJ, 2005, RHEUMATOLOGY, V44, P1394, DOI 10.1093/rheumatology/kei024; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Hansen K., 2010, UK MILLENNIUM COHORT; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2007, TIME SERIES ANAL SEL; Houssien DA, 1998, SCAND J RHEUMATOL, V27, P300; Jordan K, 2006, RHEUMATOLOGY, V45, P126, DOI 10.1093/rheumatology/kei265; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P791, DOI 10.1016/j.jclinepi.2005.12.008; Koeling R., 2011, INT WORKSH HLTH TEXT, P43; Kumar K, 2007, RHEUMATOLOGY, V46, P1438, DOI 10.1093/rheumatology/kem130; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Linder JA, 2010, PHARMACOEPIDEM DR S, V19, P1211, DOI 10.1002/pds.2027; Manuel DG, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4226; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Meystre SM, 2008, YB MED INFORM, V128, P128; National Institute of Clinical Excellent (NICE), 2009, RHEUM ARTHR MAN RHEU, V79; Pakhomov SSV, 2007, AM HEART J, V153, P666, DOI 10.1016/j.ahj.2006.12.022; Pascoe SW, 2008, FAM PRACT, V25, P215, DOI 10.1093/fampra/cmn023; Sharp J, 2010, MEANINGFUL USE EHR D; Tate AR, 2010, BRIT J CANCER, V102, P947, DOI 10.1038/sj.bjc.6605593; Tate AR, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-42; Thiru K, 2003, BMJ-BRIT MED J, V326, P1070, DOI 10.1136/bmj.326.7398.1070; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van der Horst-Bruinsma IE, 1998, BRIT J RHEUMATOL, V37, P1084	36	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e54878	10.1371/journal.pone.0054878	http://dx.doi.org/10.1371/journal.pone.0054878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451024	Green Published, Green Accepted, gold			2022-12-27	WOS:000316658800002
J	Rodriguez, RM; Suarez-Alvarez, B; Salvanes, R; Muro, M; Martinez-Camblor, P; Colado, E; Sanchez, MA; Diaz, MG; Fernandez, AF; Fraga, MF; Lopez-Larrea, C				Rodriguez, Ramon M.; Suarez-Alvarez, Beatriz; Salvanes, Ruben; Muro, Manuel; Martinez-Camblor, Pablo; Colado, Enrique; Alcoceba Sanchez, Miguel; Gonzalez Diaz, Marcos; Fernandez, Agustin F.; Fraga, Mario F.; Lopez-Larrea, Carlos			DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; IFN-GAMMA PROMOTER; T-HELPER-CELL; INTERFERON-GAMMA; FAS-LIGAND; GENE; DIFFERENTIATION; EPIGENETICS; EXPRESSION; CYTOKINE	Epigenetic deregulation is considered a common hallmark of cancer. Nevertheless, recent publications have demonstrated its association with a large array of human diseases. Here, we explore the DNA methylation dynamics in blood samples during hematopoietic cell transplant and how they are affected by pathophysiological events during transplant evolution. We analyzed global DNA methylation in a cohort of 47 patients with allogenic transplant up to 12 months post-transplant. Recipients stably maintained the donor's global methylation levels after transplant. Nonetheless, global methylation is affected by chimerism status. Methylation analysis of promoters revealed that methylation in more than 200 genes is altered 1 month post-transplant when compared with non-pathological methylation levels in the donor. This number decreased by 6 months post-transplant. Finally, we analyzed methylation in IFN-gamma, FASL, IL-10, and PRF1 and found association with the severity of the acute graft-versus-host disease. Our results provide strong evidence that methylation changes in blood are linked to underlying physiological events and demonstrate that DNA methylation analysis is a viable strategy for the study of transplantation and for development of biomarkers.	[Rodriguez, Ramon M.; Fernandez, Agustin F.; Fraga, Mario F.] Univ Oviedo, HUCA, IUOPA, Canc Epigenet Lab, Oviedo, Spain; [Suarez-Alvarez, Beatriz; Salvanes, Ruben; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Muro, Manuel] Hosp Virgen Arrixaca, Dept Immunol, Murcia, Spain; [Martinez-Camblor, Pablo] OIB, CAIBER, Unidad Apoyo Invest, Oviedo, Spain; [Colado, Enrique] Hosp Univ Cent Asturias, Dept Hematol, Oviedo, Spain; [Alcoceba Sanchez, Miguel; Gonzalez Diaz, Marcos] Hosp Univ Salamanca, Serv Hematol & Hemoterapia, Salamanca, Spain; [Fraga, Mario F.] CSIC, Dept Immunol & Oncol, CNB, Madrid, Spain; [Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain	Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; Hospital Clinico Universitario Virgen de la Arrixaca; Central University Hospital Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Fraga, MF (corresponding author), Univ Oviedo, HUCA, IUOPA, Canc Epigenet Lab, Oviedo, Spain.	mffraga@cnb.csic.es; inmuno@hca.es	Colado, Enrique/Z-6326-2019; Alcoceba, Miguel/B-7873-2017; Alcoceba, Miguel/AAH-2784-2020; Camblor, Pablo Martinez/Z-4834-2019; Fraga, Mario F/H-7824-2017; Colado, Enrique/GXF-7705-2022; Martinez-Camblor, Pablo/Q-1715-2015; Fernandez, Agustin F./N-7302-2014; Rodriguez, Ramon Maria/AAF-9376-2019; Alcoceba, Miguel/GXH-4002-2022; RG, SMABSS/N-3322-2018	Colado, Enrique/0000-0001-8675-8207; Alcoceba, Miguel/0000-0002-3819-4846; Camblor, Pablo Martinez/0000-0001-7845-3905; Fraga, Mario F/0000-0001-8450-2603; Fernandez, Agustin F./0000-0002-3792-4085; Rodriguez, Ramon Maria/0000-0002-6770-5123; Alcoceba, Miguel/0000-0002-3819-4846; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942; Lopez-Larrea, Carlos/0000-0001-9988-1730; Martinez-Camblor, Pablo/0000-0003-3032-9598; RG, SMABSS/0000-0001-9944-3861	Red de Investigacion Renal (REDinREN); Institute "Carlos III" [FIS PI08/0566]	Red de Investigacion Renal (REDinREN); Institute "Carlos III"(Instituto de Salud Carlos III)	This work was supported by the Spanish grants from Red de Investigacion Renal (REDinREN) and the FIS PI08/0566 from Institute "Carlos III". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Jaksch M, 2004, TRANSPLANTATION, V77, P195, DOI 10.1097/01.TP.0000100465.83529.42; Janson PCJ, 2011, J IMMUNOL, V186, P92, DOI 10.4049/jimmunol.1000960; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanda Y, 1998, BONE MARROW TRANSPL, V22, P751, DOI 10.1038/sj.bmt.1701427; Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lu QJ, 2003, J IMMUNOL, V170, P5124, DOI 10.4049/jimmunol.170.10.5124; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miura Y, 2002, BLOOD, V100, P2650, DOI 10.1182/blood-2002-01-0176; Naesens M, 2010, NAT REV NEPHROL, V6, P614, DOI 10.1038/nrneph.2010.113; Narasimhan Supraja, 2009, BMC Res Notes, V2, P104, DOI 10.1186/1756-0500-2-104; Nishiyama R, 2005, MOL CANCER RES, V3, P617, DOI 10.1158/1541-7786.MCR-05-0146; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Puliaev R, 2004, J IMMUNOL, V173, P910, DOI 10.4049/jimmunol.173.2.910; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shustov A, 1998, J IMMUNOL, V161, P2848; Takatsuta H, 1999, BONE MARROW TRANSPL, V24, P1005, DOI 10.1038/sj.bmt.1702010; Tato C, 2004, J IMMUNOL, V173, P1514, DOI 10.4049/jimmunol.173.3.1514; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Volkmar M, 2010, EMBO J; Yang YG, 2005, CELL MOL IMMUNOL, V2, P323; Zediak VP, 2011, CURR OPIN GENET DEV, V21, P154, DOI 10.1016/j.gde.2011.01.016; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335	50	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56931	10.1371/journal.pone.0056931	http://dx.doi.org/10.1371/journal.pone.0056931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451113	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800049
J	Yung, CF; Andrews, N; Hoschler, K; Miller, E				Yung, Chee-Fu; Andrews, Nick; Hoschler, Katja; Miller, Elizabeth			Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England	PLOS ONE			English	Article							IMMUNE-RESPONSE; INFLUENZA VACCINATION; INFECTION; ANTIBODY; ADULTS; VIRUS; YOUNG; AGE	In England, during pandemic 2009 H1N1, vaccine efficacy and immunogenicity population studies in priority groups were rolled out in parallel to evaluate the pandemic vaccination programme. This provided a unique opportunity to compare immunogenicity and clinical protection in the same population and thus provide insights into the correlates of protection for the pandemic H1N1 2009 vaccine in risk groups. While clinical protection from AS03-adjuvanted pandemic 2009 H1N1 vaccine was high in those aged <25 years and pregnant women, effectiveness in older adults with chronic conditions has been found to be surprisingly poor. Here we present results from the immunogenicity study derived from the same population. Individuals from priority groups eligible for pandemic vaccination attending participating general practices were recruited. Pre and post-vaccination blood samples were collected and HI antibody testing to assess immune response to vaccination performed. The final cohort consisted of 610 individuals: 60 healthy children aged <5 years; 32 healthy pregnant women; 518 individuals from risk groups. Seroconversion rate in healthy children aged <5 years (87%, 95% CI: 75% to 94%) was higher than that of risk groups combined (65%, 95% CI: 61% to 69%) (p<0.001). Multivariable analysis of risk groups showed that the size of response in those who did seroconvert was lower in those who received the 2009/10 seasonal TIV (Fold effect: 0.52, 0.35 to 0.78). Predicted immunological boosting from higher pre-vaccine titres after 2009 pandemic H1N1 vaccination only occurred in children (seroconversion rate = 92%) and not in individuals aged 10 to 39 from risk groups (seroconversion rate = 74%). The lack of clinical protection identified in the same population in older adults from risk groups could be attributed to these lower seroresponses. Current immunogenicity licensing criteria for pandemic influenza vaccine may not correlate with clinical protection in individuals with chronic disease or immunocompromised.	[Yung, Chee-Fu] Tan Tock Seng Hosp, Communicable Dis Ctr, Dept Clin Epidemiol, Singapore, Singapore; [Yung, Chee-Fu; Miller, Elizabeth] Hlth Protect Agcy, Hlth Protect Serv, Immunisat Hepatitis & Blood Safety Dept, London, England; [Andrews, Nick] Hlth Protect Agcy, Stat Unit, Hlth Protect Serv, London, England; [Hoschler, Katja] Hlth Protect Agcy, Microbiol Serv, Virus Reference Dept, Resp Virus Unit, London, England	Tan Tock Seng Hospital; Health Protection Agency; Health Protection Agency; Health Protection Agency	Yung, CF (corresponding author), Tan Tock Seng Hosp, Communicable Dis Ctr, Dept Clin Epidemiol, Singapore, Singapore.	chee_fu_yung@ttsh.com.sg			DH Research and Development Directorate grant [039/0031]; Sanofi-Pasteur; GlaxoSmithKline; CSL Australia; Baxter	DH Research and Development Directorate grant; Sanofi-Pasteur; GlaxoSmithKline(GlaxoSmithKline); CSL Australia; Baxter	DH Research and Development Directorate grant number 039/0031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; N. Andrews and E. Miller have declared that no competing interests exist. C.F. Yung has received financial assistance from Sanofi-Pasteur and GlaxoSmithKline to attend conferences. K. Hoschler has been an investigator for clinical trials sponsored by Sanofi Pasteur, CSL Australia and Baxter but received no payment for this. K. Hoschler has on one occasion received financial assistance from Sanofi-Pasteur to attend a conference. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; [Anonymous], NOT GUID HARM REQ IN; [Anonymous], SUMMARY PRODUCT CHAR; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Emborg HD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7901; Hardelid P, 2011, EUROSURVEILLANCE, V16, P12; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hsu JP, 2012, INT J INFECT DIS, V16, pE621, DOI 10.1016/j.ijid.2012.04.010; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nauta JJP, 2009, BIOLOGICALS, V37, P216, DOI 10.1016/j.biologicals.2009.02.002; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Peeters M, 2012, VACCINE, V30, P6483, DOI 10.1016/j.vaccine.2012.07.081; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Roman F, 2010, CLIN INFECT DIS, V51, P668, DOI 10.1086/655830; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	23	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56844	10.1371/journal.pone.0056844	http://dx.doi.org/10.1371/journal.pone.0056844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451097	Green Published, gold			2022-12-27	WOS:000316658800042
J	Bornert, O; Moller, TC; Boeuf, J; Candusso, MP; Wagner, R; Martinez, KL; Simonin, F				Bornert, Olivier; Moller, Thor C.; Boeuf, Julien; Candusso, Marie-Pierre; Wagner, Renaud; Martinez, Karen L.; Simonin, Frederic			Identification of a Novel Protein-Protein Interaction Motif Mediating Interaction of GPCR-Associated Sorting Proteins with G Protein-Coupled Receptors	PLOS ONE			English	Article							DELTA-OPIOID RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; RESONANCE SPECTROSCOPY; BINDING; ARRESTIN; TOLERANCE; RHODOPSIN; SNX1; GASP	GPCR desensitization and down-regulation are considered key molecular events underlying the development of tolerance in vivo. Among the many regulatory proteins that are involved in these complex processes, GASP-1 have been shown to participate to the sorting of several receptors toward the degradation pathway. This protein belongs to the recently identified GPCR-associated sorting proteins (GASPs) family that comprises ten members for which structural and functional details are poorly documented. We present here a detailed structure-function relationship analysis of the molecular interaction between GASPs and a panel of GPCRs. In a first step, GST-pull down experiments revealed that all the tested GASPs display significant interactions with a wide range of GPCRs. Importantly, the different GASP members exhibiting the strongest interaction properties were also characterized by the presence of a small, highly conserved and repeated "GASP motif'' of 15 amino acids. We further showed using GST-pull down, surface plasmon resonance and co-immunoprecipitation experiments that the central domain of GASP-1, which contains 22 GASP motifs, is essential for the interaction with GPCRs. We then used site directed mutagenesis and competition experiments with synthetic peptides to demonstrate that the GASP motif, and particularly its highly conserved core sequence SWFW, is critically involved in the interaction with GPCRs. Overall, our data show that several members of the GASP family interact with GPCRs and highlight the presence within GASPs of a novel protein-protein interaction motif that might represent a new target to investigate the involvement of GASPs in the modulation of the activity of GPCRs.	[Bornert, Olivier; Boeuf, Julien; Candusso, Marie-Pierre; Wagner, Renaud; Simonin, Frederic] Univ Strasbourg, Inst Rech ESBS, Lab Excellence MEDALIS, CNRS,UMR 7242, Illkirch Graffenstaden, France; [Bornert, Olivier] BioXtal, St Felix, France; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Dept Chem, Bionanotechnol & Nanomed Lab, DK-2100 Copenhagen, Denmark; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Copenhagen; University of Copenhagen	Simonin, F (corresponding author), Univ Strasbourg, Inst Rech ESBS, Lab Excellence MEDALIS, CNRS,UMR 7242, Illkirch Graffenstaden, France.	simonin@unistra.fr	Mosca, Antonella/L-2523-2018; Møller, Thor C/T-9452-2018; Boeuf, JP/H-1421-2011; Martinez, Karen/W-3709-2019; martinez, karen L/J-5933-2013	Mosca, Antonella/0000-0001-9646-7462; Møller, Thor C/0000-0002-2256-577X; Boeuf, JP/0000-0003-1023-222X; Martinez, Karen/0000-0003-0932-8080; martinez, karen L/0000-0003-0932-8080; Wagner, Renaud/0000-0002-4249-9853	Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (MENSER); Association pour la Recherche sur le Cancer [3423]; Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique; Universite Louis Pasteur; Lundbeck Foundation Center for Biomembranes and Nanomedicine; program BioScaRT; program UNIK Synthetic Biology	Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (MENSER); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Louis Pasteur; Lundbeck Foundation Center for Biomembranes and Nanomedicine; program BioScaRT; program UNIK Synthetic Biology	This work was supported by Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (MENSER) fellowship, Association pour la Recherche sur le Cancer (No3423), Fondation pour la Recherche Medicale, Centre National de la Recherche Scientifique, Universite Louis Pasteur, the Lundbeck Foundation Center for Biomembranes and Nanomedicine, and the programs BioScaRT and UNIK Synthetic Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Helo A, 2010, PHARMACOL THERAPEUT, V126, P244, DOI 10.1016/j.pharmthera.2010.03.004; Alves ID, 2004, J BIOL CHEM, V279, P44673, DOI 10.1074/jbc.M404713200; Alves ID, 2003, J BIOL CHEM, V278, P48890, DOI 10.1074/jbc.M306866200; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Boeuf J, 2009, EUR J NEUROSCI, V30, P860, DOI 10.1111/j.1460-9568.2009.06865.x; Bomert O., 2012, CURR PROTOC PROTEIN; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fruh V, 2011, CHEM REV, V111, P640, DOI 10.1021/cr900088s; Georgieva T, 2008, EUR J PHARMACOL, V581, P19, DOI 10.1016/j.ejphar.2007.11.053; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Komolov KE, 2010, ANAL BIOANAL CHEM, V397, P2967, DOI 10.1007/s00216-010-3876-4; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Martini L, 2010, NEUROPSYCHOPHARMACOL, V35, P1363, DOI 10.1038/npp.2010.6; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	27	20	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56336	10.1371/journal.pone.0056336	http://dx.doi.org/10.1371/journal.pone.0056336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441177	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200034
J	Camp, JV; Chu, YK; Chung, DH; McAllister, RC; Adcock, RS; Gerlach, RL; Wiemken, TL; Peyrani, P; Ramirez, JA; Summersgill, JT; Jonsson, CB				Camp, Jeremy V.; Chu, Yong-Kyu; Chung, Dong-Hoon; McAllister, Ryan C.; Adcock, Robert S.; Gerlach, Rachael L.; Wiemken, Timothy L.; Peyrani, Paula; Ramirez, Julio A.; Summersgill, James T.; Jonsson, Colleen B.			Phenotypic Differences in Virulence and Immune Response in Closely Related Clinical Isolates of Influenza A 2009 H1N1 Pandemic Viruses in Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ALVEOLAR MACROPHAGES; RECEPTOR SPECIFICITY; EPITHELIAL-CELLS; DISEASE SEVERITY; INFECTION; HEMAGGLUTININ; CYTOKINE; LUNG; NEUTROPHILS	To capture the possible genotypic and phenotypic differences of the 2009 influenza A virus H1N1 pandemic (H1N1pdm) strains circulating in adult hospitalized patients, we isolated and sequenced nine H1N1pdm viruses from patients hospitalized during 2009-2010 with severe influenza pneumonia in Kentucky. Each viral isolate was characterized in mice along with two additional H1N1 pandemic strains and one seasonal strain to assess replication and virulence. All isolates showed similar levels of replication in nasal turbinates and lung, but varied in their ability to cause morbidity. Further differences were identified in cytokine and chemokine responses. IL-6 and KC were expressed early in mice infected with strains associated with higher virulence. Strains that showed lower pathogenicity in mice had greater IFN gamma, MIG, and IL-10 responses. A principal component analysis (PCA) of the cytokine and chemokine profiles revealed 4 immune response phenotypes that correlated with the severity of disease. A/KY/180/10, which showed the greatest virulence with a rapid onset of disease progression, was compared in additional studies with A/KY/136/09, which showed low virulence in mice. Analyses comparing a low (KY/136) versus a high (KY/180) virulent isolate showed a significant difference in the kinetics of infection within the lower respiratory tract and immune responses. Notably by 4 DPI, virus titers within the lung, bronchoalveolar lavage fluid (BALf), and cells within the BAL (BALc) revealed that the KY/136 replicated in BALc, while KY/180 replication persisted in lungs and BALc. In summary, our studies suggest four phenotypic groups based on immune responses that result in different virulence outcomes in H1N1pdm isolates with a high degree of genetic similarity. In vitro studies with two of these isolates suggested that the more virulent isolate, KY/180, replicates productively in macrophages and this may be a key determinant in tipping the response toward a more severe disease progression.	[Camp, Jeremy V.; Chung, Dong-Hoon; McAllister, Ryan C.; Adcock, Robert S.; Gerlach, Rachael L.; Jonsson, Colleen B.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Chu, Yong-Kyu; Chung, Dong-Hoon; Jonsson, Colleen B.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA; [Wiemken, Timothy L.; Peyrani, Paula; Ramirez, Julio A.; Summersgill, James T.] Univ Louisville, Dept Med, Div Infect Dis, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Jonsson, CB (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	cbjons01@louisville.edu	Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/X-2360-2019; Jonsson, Colleen/GPC-4424-2022	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672; Ramirez, Julio/0000-0001-7801-5374	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Support was provided in part by the Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville to CBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Abed Y, 2011, J INFECT DIS, V204, P1008, DOI 10.1093/infdis/jir483; Anton A, 2010, DIAGN MICR INFEC DIS, V67, P207, DOI 10.1016/j.diagmicrobio.2010.02.002; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Fezeu L, 2011, OBES REV, V12, P653, DOI 10.1111/j.1467-789X.2011.00864.x; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Inoue E, 2010, MICROBIOL IMMUNOL, V54, P129, DOI 10.1111/j.1348-0421.2009.00193.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Josset L, 2012, J VIROL, V86, P7192, DOI 10.1128/JVI.00563-12; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Kilander A, 2010, EUROSURVEILLANCE, V4, P15; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kuster SP, 2010, EUR J CLIN MICROBIOL, V29, P835, DOI 10.1007/s10096-010-0935-x; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Lucker LM, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13177; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Mao HW, 2010, J VIROL, V84, P4148, DOI 10.1128/JVI.02340-09; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Patel JR, 2011, VIRAL IMMUNOL, V24, P89, DOI 10.1089/vim.2010.0122; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; PESCHKE T, 1993, IMMUNOBIOLOGY, V189, P340, DOI 10.1016/S0171-2985(11)80365-7; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Reading PC, 2010, IMMUNOL CELL BIOL, V88, P641, DOI 10.1038/icb.2010.11; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; Seo SH, 2004, VIROLOGY, V329, P270, DOI 10.1016/j.virol.2004.08.019; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Stein-Streilein J, 1988, Reg Immunol, V1, P100; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; STEINSTREILEIN J, 1983, J IMMUNOL, V131, P2699; Suphaphiphat P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-157; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Takemae N, 2010, J GEN VIROL, V91, P938, DOI 10.1099/vir.0.016691-0; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Trammell RA, 2012, MICROBES INFECT, V14, P50, DOI 10.1016/j.micinf.2011.08.008; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Watanabe T, 2011, J VIROL, V85, P13195, DOI 10.1128/JVI.00859-11; Weinheimer VK, 2012, J INFECT DIS; Wijburg OLC, 1997, J VIROL, V71, P9450, DOI 10.1128/JVI.71.12.9450-9457.1997; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020698; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145	91	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56602	10.1371/journal.pone.0056602	http://dx.doi.org/10.1371/journal.pone.0056602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441208	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200065
J	Eriksen, KT; Raaschou-Nielsen, O; McLaughlin, JK; Lipworth, L; Tjonneland, A; Overvad, K; Sorensen, M				Eriksen, Kirsten T.; Raaschou-Nielsen, Ole; McLaughlin, Joseph K.; Lipworth, Loren; Tjonneland, Anne; Overvad, Kim; Sorensen, Mette			Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population	PLOS ONE			English	Article							FLUOROCHEMICAL PRODUCTION WORKERS; PERFLUOROOCTANOIC ACID; SERUM-LIPIDS; LIVER-ENZYMES; EXPOSURE; HEALTH; PARAMETERS; RESIDENTS; CANCER	Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) are used in a variety of consumer products and have been detected worldwide in human blood. Recent studies mainly of highly exposed populations have indicated that PFOA and PFOS may affect serum cholesterol levels, but the magnitude of the effect may be inconsistent across exposure levels. The aim of the present cross-sectional study was to investigate the association between plasma PFOA and PFOS and total cholesterol in a general, middle-aged Danish population. The study population comprised 753 individuals (663 men and 90 women), 50-65 years of age, nested within a Danish cohort of 57,053 participants. Blood samples were taken from all cohort members at enrolment (1993-1997) and stored in a biobank at -150 degrees C. Plasma levels of PFOA and PFOS and serum levels of total cholesterol were measured. The associations between plasma PFOA and PFOS levels and total cholesterol levels were analysed by generalized linear models, both crude and adjusted for potential confounders. We observed statistically significant positive associations between both perfluorinated compounds and total cholesterol, e.g. a 4.4 [95% CI = 1.1-7.8] higher concentration of total cholesterol (mg/dL) per interquartile range of PFOA plasma level. Sex and prevalent diabetes appeared to modify the association between PFOA and PFOS, respectively, and cholesterol. In conclusion, this study indicated positive associations between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population, although whether the observed pattern of results reflects a causal association is unclear.	[Eriksen, Kirsten T.; Raaschou-Nielsen, Ole; Tjonneland, Anne; Sorensen, Mette] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [McLaughlin, Joseph K.; Lipworth, Loren] Int Epidemiol Inst, Rockville, MD USA; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark	Danish Cancer Society; Aarhus University	Eriksen, KT (corresponding author), Danish Canc Soc Res Ctr, Copenhagen, Denmark.	kirsthor@cancer.dk	Raaschou-Nielsen, Ole/GOK-0338-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; Sorensen, Mette/0000-0002-7302-4789	Danish Cancer Society; International Epidemiology Institute (IEI); 3M Company; International Epidemiology Institute	Danish Cancer Society(Danish Cancer Society); International Epidemiology Institute (IEI); 3M Company(3M); International Epidemiology Institute	The present project was supported by the Danish Cancer Society and by the International Epidemiology Institute (IEI), which received an unrestricted research grant from the 3M Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by the International Epidemiology Institute, which received funding from a commercial source (unrestricted research grant from the 3M Company). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Butenhoff JL, 2006, ENVIRON HEALTH PERSP, V114, P1776, DOI 10.1289/ehp.9060; Calafat AM, 2006, CHEMOSPHERE, V63, P490, DOI 10.1016/j.chemosphere.2005.08.028; Calafat AM, 2006, ENVIRON SCI TECHNOL, V40, P2128, DOI 10.1021/es0517973; Chateau-Degat ML, 2010, ENVIRON RES, V110, P710, DOI 10.1016/j.envres.2010.07.003; Costa G, 2009, J OCCUP ENVIRON MED, V51, P364, DOI 10.1097/JOM.0b013e3181965d80; Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008; Emmett EA, 2006, J OCCUP ENVIRON MED, V48, P771, DOI 10.1097/01.jom.0000233380.13087.37; Eriksen KT, 2011, ENVIRON SCI TECHNOL, V45, P8137, DOI 10.1021/es100626h; Eriksen KT, 2009, JNCI-J NATL CANCER I, V101, P605, DOI 10.1093/jnci/djp041; Frisbee SJ, 2010, ARCH PEDIAT ADOL MED, V164, P860, DOI 10.1001/archpediatrics.2010.163; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Kennedy GL, 2004, CRIT REV TOXICOL, V34, P351, DOI 10.1080/10408440490464705; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Midasch O, 2006, INT J HYG ENVIR HEAL, V209, P489, DOI 10.1016/j.ijheh.2006.06.002; Nelson JW, 2010, ENVIRON HEALTH PERSP, V118, P197, DOI 10.1289/ehp.0901165; Olsen GW, 2007, INT ARCH OCC ENV HEA, V81, P231, DOI 10.1007/s00420-007-0213-0; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2003, J OCCUP ENVIRON MED, V45, P260, DOI 10.1097/01.jom.0000052958.59271.10; Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14; Sakr CJ, 2007, J OCCUP ENVIRON MED, V49, P1086, DOI 10.1097/JOM.0b013e318156eca3; Sakr CJ, 2007, J OCCUP ENVIRON MED, V49, P872, DOI 10.1097/JOM.0b013e318124a93f; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P1100, DOI 10.1289/ehp.0901827; Steenland K, 2009, AM J EPIDEMIOL, V170, P1268, DOI 10.1093/aje/kwp279; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; U.S. Environmental Protection Agency, PERFL AC PFOA BAS IN	26	93	95	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56969	10.1371/journal.pone.0056969	http://dx.doi.org/10.1371/journal.pone.0056969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441227	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200084
J	Paproski, RJ; Yao, SYM; Favis, N; Evans, D; Young, JD; Cass, CE; Zemp, RJ				Paproski, Robert J.; Yao, Sylvia Y. M.; Favis, Nicole; Evans, David; Young, James D.; Cass, Carol E.; Zemp, Roger J.			Human Concentrative Nucleoside Transporter 3 Transfection with Ultrasound and Microbubbles in Nucleoside Transport Deficient HEK293 Cells Greatly Increases Gemcitabine Uptake	PLOS ONE			English	Article							PANCREATIC-CANCER; GENE DELIVERY; IN-VITRO; PREDICT RESPONSE; DNA TRANSFECTION; EXPRESSION; SURVIVAL; ADENOCARCINOMA; CYTOTOXICITY; THERAPY	Gemcitabine is a hydrophilic clinical anticancer drug that requires nucleoside transporters to cross plasma membranes and enter cells. Pancreatic adenocarcinomas with low levels of nucleoside transporters are generally resistant to gemcitabine and are currently a clinical problem. We tested whether transfection of human concentrative nucleoside transporter 3 (hCNT3) using ultrasound and lipid stabilized microbubbles could increase gemcitabine uptake and sensitivity in HEK293 cells made nucleoside transport deficient by pharmacologic treatment with dilazep. To our knowledge, no published data exists regarding the utility of using hCNT3 as a therapeutic gene to reverse gemcitabine resistance. Our ultrasound transfection system - capable of transfection of cell cultures, mouse muscle and xenograft CEM/araC tumors - increased hCNT3 mRNA and H-3-gemcitabine uptake by >2,000- and 3,400-fold, respectively, in dilazep-treated HEK293 cells. Interestingly, HEK293 cells with both functional human equilibrative nucleoside transporters and hCNT3 displayed 5% of H-3-gemcitabine uptake observed in cells with only functional hCNT3, suggesting that equilibrative nucleoside transporters caused significant efflux of H-3-gemcitabine. Efflux assays confirmed that dilazep could inhibit the majority of H-3-gemcitabine efflux from HEK293 cells, suggesting that hENTs were responsible for the majority of efflux from the tested cells. Oocyte uptake transport assays were also performed and provided support for our hypothesis. Gemcitabine uptake and efflux assays were also performed on pancreatic cancer AsPC-1 and MIA PaCa-2 cells with similar results to that of HEK293 cells. Using the MTS proliferation assay, dilazep-treated HEK293 cells demonstrated 13-fold greater resistance to gemcitabine compared to dilazep-untreated HEK293 cells and this resistance could be reversed by transfection of hCNT3 cDNA. We propose that transfection of hCNT3 cDNA using ultrasound and microbubbles may be a method to reverse gemcitabine resistance in pancreatic tumors that have little nucleoside transport activity which are resistant to almost all current anticancer therapies.	[Paproski, Robert J.; Zemp, Roger J.] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Yao, Sylvia Y. M.; Young, James D.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Favis, Nicole; Evans, David] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Cass, Carol E.] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Yao, Sylvia Y. M.; Young, James D.; Cass, Carol E.] Univ Alberta, Membrane Prot Dis Res Grp, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Zemp, RJ (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.	rzemp@ualberta.ca	Evans, David/M-1912-2016	Evans, David/0000-0001-5871-299X	Canadian Institutes of Health Research [190869]; Natural Sciences and Engineering Research Council of Canada [355544-2008, 375340-2009, STPGP 396444]; Terry Fox Foundation; Canadian Cancer Society [TFF 019237, TFF 019240, CCS 2011-700718]; Alberta Cancer Research Institute [ACB 23728]; Canada Foundation for Innovation [NIF11625]; Leaders Opportunity Fund [18472]; Alberta Advanced Education & Technology, Small Equipment Grants Program [URSI09007SEG]; Microsystems Technology Research Initiative [MSTRI RES0003166]; Microsystems Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Terry Fox Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Research Institute; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Leaders Opportunity Fund; Alberta Advanced Education & Technology, Small Equipment Grants Program; Microsystems Technology Research Initiative; Microsystems Technology	Funding for this work was provided by Canadian Institutes of Health Research (190869), Natural Sciences and Engineering Research Council of Canada (355544-2008, 375340-2009, STPGP 396444), Terry Fox Foundation and the Canadian Cancer Society (TFF 019237, TFF 019240, CCS 2011-700718), the Alberta Cancer Research Institute (ACB 23728), the Canada Foundation for Innovation (NIF11625), Leaders Opportunity Fund (18472), Alberta Advanced Education & Technology, Small Equipment Grants Program (URSI09007SEG), and Microsystems Technology Research Initiative (MSTRI RES0003166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Although the authors have received funding from Microsystems Technology, these funds were for another research project which does not involve the work presented in the Cover Letter submitted manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Cass CE, 1998, BIOCHEM CELL BIOL, V76, P761, DOI 10.1139/bcb-76-5-761; Chen SY, 2006, P NATL ACAD SCI USA, V103, P8469, DOI 10.1073/pnas.0602921103; Damaraju VL, 2012, NUCLEOS NUCLEOT NUCL, V31, P236, DOI 10.1080/15257770.2011.652330; Del Re AM, 2005, DRUG ALCOHOL DEPEN, V78, P221, DOI 10.1016/j.drugalcdep.2004.10.005; Deshpande MC, 2007, J CONTROL RELEASE, V118, P126, DOI 10.1016/j.jconrel.2006.12.010; Farrell JJ, 2009, GASTROENTEROLOGY, V136, P187, DOI 10.1053/j.gastro.2008.09.067; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Lang TT, 2004, MOL PHARMACOL, V65, P925, DOI 10.1124/mol.65.4.925; Lang TT, 2001, MOL PHARMACOL, V60, P1143, DOI 10.1124/mol.60.5.1143; Li YS, 2009, CANCER LETT, V273, P62, DOI 10.1016/j.canlet.2008.07.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YK, 2008, J LIPOSOME RES, V18, P341, DOI [10.1080/03639040802509868, 10.1080/03639040802509868 ]; Mackey JR, 1998, CANCER RES, V58, P4349; Marechal R, 2009, CLIN CANCER RES, V15, P2913, DOI 10.1158/1078-0432.CCR-08-2080; Michalski CW, 2008, BRIT J CANCER, V99, P760, DOI 10.1038/sj.bjc.6604528; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Paproski RJ, 2010, BIOCHEM PHARMACOL, V79, P587, DOI 10.1016/j.bcp.2009.09.025; Pennycooke M, 2001, BIOCHEM BIOPH RES CO, V280, P951, DOI 10.1006/bbrc.2000.4205; Perez-Torras S, 2008, BIOCHEM PHARMACOL, V76, P322, DOI 10.1016/j.bcp.2008.05.011; Qiu YY, 2010, J CONTROL RELEASE, V145, P40, DOI 10.1016/j.jconrel.2010.04.010; Rahim AA, 2006, J GENE MED, V8, P1347, DOI 10.1002/jgm.962; Sheeran PS, 2011, LANGMUIR, V27, P10412, DOI 10.1021/la2013705; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Tlaxca JL, 2010, ULTRASOUND MED BIOL, V36, P1907, DOI 10.1016/j.ultrasmedbio.2010.05.014; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Tsunoda S, 2005, BIOCHEM BIOPH RES CO, V336, P118, DOI 10.1016/j.bbrc.2005.08.052; Veltkamp SA, 2008, MOL CANCER THER, V7, P2415, DOI 10.1158/1535-7163.MCT-08-0137	33	21	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56423	10.1371/journal.pone.0056423	http://dx.doi.org/10.1371/journal.pone.0056423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441192	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200049
J	Yu, CF; Hong, JH; Chiang, CS				Yu, Ching-Fang; Hong, Ji-Hong; Chiang, Chi-Shiun			The Roles of Macrophages and Nitric Oxide in Interleukin-3-Enhanced HSV-Sr39tk-Mediated Prodrug Therapy	PLOS ONE			English	Article							VIRUS-THYMIDINE-KINASE; GENE-THERAPY; IN-VIVO; SUICIDE GENE; PARTICULATE ANTIGEN; GANCICLOVIR SYSTEM; HSV-TK; EXPRESSION; CELLS; IL-3	The herpes simplex virus thymidine kinase/ganciclovir (HSV-sr39tk/GCV) system is a well-established prodrug system used in cancer gene therapy. However, this system is currently not effective enough to eradicate malignant tumors completely. This study aimed to evaluate whether co-expression of interleukin-3 (IL-3) could enhance the anti-tumor activity of HSV-sr39tk/GCV prodrug gene therapy using a murine TRAMP-C1 prostate tumor model. In vitro results demonstrated that HSV-sr39tk-transfected cells exhibited enhanced sensitivity to the GCV prodrug, which was not affected by co-expression of the mIL-3 gene. However, in vivo studies showed that co-expression of the mIL-3 gene significantly increased the HSV-sr39tk/GCV-induced tumor growth delay and even cured the tumor. The TRAMP-C1-specific immune response of spleen lymphocytes from mice bearing HSV-sr39tk- and IL-3-expressing TRAMP-C1 tumors was measured by ELISA. Results showed that IL-3-activated IL-4-dominant lymphocytes became IFN-gamma- dominant lymphocytes after combined HSV-sr39tk/GCV therapy. The efficacy of combined therapies on tumor regression was reduced when macrophages populations were depleted by carrageenan or NO production was inhibited by administration of the iNOS inhibitor, L-NAME. These results suggest that utilizing a bicistronic vector to express HSV-sr39tk and the IL-3 gene induced an enhanced macrophage- or NO-dependent anti-tumor effect.	[Yu, Ching-Fang; Chiang, Chi-Shiun] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Hong, Ji-Hong] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Hong, Ji-Hong] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University	Chiang, CS (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cschiang@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129	 [NHRI-EX101-10132BI];  [NSC 101-2627-N-007-001];  [NTHU101N2050E1];  [NHTU-101N2760E1]	; ; ; 	This study is supported by NHRI-EX101-10132BI, NSC 101-2627-N-007-001, NTHU101N2050E1, and NHTU-101N2760E1 grants to Chiang, C. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiani A, 2010, CANCER GENE THER, V17, P86, DOI 10.1038/cgt.2009.60; Black ME, 2001, CANCER RES, V61, P3022; Chiang CS, 1997, CANCER RES, V57, P3899; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Elshami AA, 1996, GENE THER, V3, P85; FARIASEISNER R, 1994, P NATL ACAD SCI USA, V91, P9407, DOI 10.1073/pnas.91.20.9407; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; FREEMAN SM, 1995, CANCER LETT, V92, P167, DOI 10.1016/0304-3835(95)03771-N; FRENDL G, 1990, J IMMUNOL, V144, P3400; FRENDL G, 1990, J IMMUNOL, V144, P3392; Hanari N, 2007, ANTICANCER RES, V27, P2305; IHLE JN, 1992, CHEM IMMUNOL, V51, P65; Kagaya T, 2006, CANCER GENE THER, V13, P357, DOI 10.1038/sj.cgt.7700908; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Lord EM, 1998, J IMMUNOTHER, V21, P205, DOI 10.1097/00002371-199805000-00006; McBride WH, 1996, ANTICANCER RES, V16, P1139; MOOLTEN FL, 1986, CANCER RES, V46, P5276; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Orucevic A, 1999, INT J CANCER, V81, P889, DOI 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2; PULASKI BA, 1993, CANCER RES, V53, P2112; Pulaski BA, 1996, P NATL ACAD SCI USA, V93, P3669, DOI 10.1073/pnas.93.8.3669; Ramesh R, 1996, EXP HEMATOL, V24, P829; Ramesh R, 1996, CANCER GENE THER, V3, P373; Ramesh R, 1998, ADV EXP MED BIOL, V451, P125; Ren WH, 2004, CANCER RES, V64, P6645, DOI 10.1158/0008-5472.CAN-04-1084; SCHRADER JW, 1986, ANNU REV IMMUNOL, V4, P205, DOI 10.1146/annurev.iy.04.040186.001225; Stefani AL, 2005, J HEPATOL, V42, P728, DOI 10.1016/j.jhep.2004.12.037; Tsai CH, 2006, CANCER GENE THER, V13, P1082, DOI 10.1038/sj.cgt.7700977; Van Dillen Ingrid J., 2002, Current Gene Therapy, V2, P307, DOI 10.2174/1566523023347733; VILE RG, 1994, CANCER RES, V54, P6228; Vile RG, 1997, INT J CANCER, V71, P267; Wiewrodt R, 2003, CANCER GENE THER, V10, P353, DOI 10.1038/sj.cgt.7700589; Yamazaki M, 2004, CANCER GENE THER, V11, P8, DOI 10.1038/sj.cgt.7700636; Yeh KY, 1998, J IMMUNOL, V160, P5773; Zhang JH, 2004, WORLD J GASTROENTERO, V10, P26	35	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56508	10.1371/journal.pone.0056508	http://dx.doi.org/10.1371/journal.pone.0056508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441198	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200055
J	Yakkundi, A; McCallum, L; O'Kane, A; Dyer, H; Worthington, J; McKeen, HD; McClements, L; Elliott, C; McCarthy, HO; Hirst, DG; Robson, T				Yakkundi, Anita; McCallum, Lynn; O'Kane, Anthony; Dyer, Hayder; Worthington, Jenny; McKeen, Hayley D.; McClements, Lana; Elliott, Christopher; McCarthy, Helen O.; Hirst, David G.; Robson, Tracy			The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway	PLOS ONE			English	Article							BREAST-CANCER; CELL-MIGRATION; ANGIOGENESIS; EXPRESSION; INVASION; BEVACIZUMAB; INVOLVEMENT; METASTASIS; ACTIVATION; INHIBITOR	FK506 binding protein-like (FKBPL) and its peptide derivatives exert potent anti-angiogenic activity in vitro and in vivo and control tumour growth in xenograft models, when administered exogenously. However, the role of endogenous FKBPL in angiogenesis is not well characterised. Here we investigated the molecular effects of the endogenous protein and its peptide derivative, AD-01, leading to their anti-migratory activity. Inhibition of secreted FKBPL using a blocking antibody or siRNA-mediated knockdown of FKBPL accelerated the migration of human microvascular endothelial cells (HMEC-1). Furthermore, MDA-MB-231 tumour cells stably overexpressing FKBPL inhibited tumour vascular development in vivo suggesting that FKBPL secreted from tumour cells could inhibit angiogenesis. Whilst FKBPL and AD-01 target CD44, the nature of this interaction is not known and here we have further interrogated this aspect. We have demonstrated that FKBPL and AD-01 bind to the CD44 receptor and inhibit tumour cell migration in a CD44 dependant manner; CD44 knockdown abrogated AD-01 binding as well as its anti-migratory activity. Interestingly, FKBPL overexpression and knockdown or treatment with AD-01, regulated CD44 expression, suggesting a co-regulatory pathway for these two proteins. Downstream of CD44, alterations in the actin cytoskeleton, indicated by intense cortical actin staining and a lack of cell spreading and communication were observed following treatment with AD-01, explaining the anti-migratory phenotype. Concomitantly, AD-01 inhibited Rac-1 activity, up-regulated RhoA and the actin binding proteins, profilin and vinculin. Thus the anti-angiogenic protein, FKBPL, and AD-01, offer a promising and alternative approach for targeting both CD44 positive tumours and vasculature networks.	[Yakkundi, Anita; McCallum, Lynn; Dyer, Hayder; McKeen, Hayley D.; McClements, Lana; McCarthy, Helen O.; Hirst, David G.; Robson, Tracy] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [O'Kane, Anthony; Elliott, Christopher] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland; [Worthington, Jenny] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland	Queens University Belfast; Queens University Belfast; Ulster University	Robson, T (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	T.Robson@qub.ac.uk	McClements, Lana/S-9458-2019; O'Kane, Anthony/AAE-6100-2020; McCallum, Lynn/AAE-9232-2020	McClements, Lana/0000-0002-4911-1014; O'Kane, Anthony/0000-0001-7969-388X; McCarthy, Helen/0000-0002-1254-3745; Robson, Tracy/0000-0003-4262-6872	Almac Discovery, Northern Ireland, United Kingdom; Biotechnological and Biological Research Council, United Kingdom [BB/I006958/1]; Department of Education and Learning, Northern Ireland; BBSRC; Almac Discovery, Northern Ireland; BBSRC [BB/I006958/1] Funding Source: UKRI; MRC [G1001473] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I006958/1] Funding Source: researchfish; Medical Research Council [G1001473] Funding Source: researchfish	Almac Discovery, Northern Ireland, United Kingdom; Biotechnological and Biological Research Council, United Kingdom; Department of Education and Learning, Northern Ireland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Almac Discovery, Northern Ireland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support was recieved from Almac Discovery, Northern Ireland, United Kingdom, Biotechnological and Biological Research Council, United Kingdom (grant number BB/I006958/1) and Department of Education and Learning, Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors have received financial support from BBSRC and Almac Discovery, Northern Ireland for consumables and salaries of authors AY, L. McCallum, HD at various times. Furthermore TR and DGH are patent holders on: Robson T, Hirst GH, Valentine A, O'Rourke M. FKBP- L AND USES THEREOF. PCT/GB2007/002107 ( WO/2007/141533). AU, CA, EP, JP, NZ, US. 2007. This patent was licensed to Almac Discovery from QUB in 2006. The authors declare that this does not alter their adherence to PLOS ONE's policies on sharing data and materials.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Brew CT, 2009, INT J CANCER, V124, P2294, DOI 10.1002/ijc.24210; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; Couzin-Frankel J, 2011, SCIENCE, V333, P143, DOI 10.1126/science.333.6039.143; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ghosh SC, 2012, EXPERT OPIN THER TAR, V16, P635, DOI 10.1517/14728222.2012.687374; Gong Y, 2005, HISTOPATHOLOGY, V46, P24, DOI 10.1111/j.1365-2559.2004.01981.x; Guidolin D, 2010, EXPERT OPIN THER TAR, V14, P1135, DOI 10.1517/14728222.2010.524048; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jaeger EB, 2001, CANCER METAST REV, V20, P279, DOI 10.1023/A:1015587411668; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Lenzer J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4244; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; McKeen HD, 2008, ENDOCRINOLOGY, V149, P5724, DOI 10.1210/en.2008-0168; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; McKeen HD, 2010, CANCER RES, V70, P1090, DOI 10.1158/0008-5472.CAN-09-2515; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Robson T, 2000, INT J RADIAT BIOL, V76, P617, DOI 10.1080/095530000138277; Robson T, 1999, RADIAT RES, V152, P451, DOI 10.2307/3580140; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Stone EM, 2006, NEW ENGL J MED, V355, P1493, DOI 10.1056/NEJMe068191; Sun HM, 2013, CLIN TRANSL ONCOL, V15, P46, DOI 10.1007/s12094-012-0891-2; Sunnotel O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-22; Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410; Turley EA, 2012, FRONT BIOSCI-LANDMRK, V17, P1775, DOI 10.2741/4018; Valentine A, 2011, CLIN CANCER RES, V17, P1044, DOI 10.1158/1078-0432.CCR-10-2241; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Yu FSX, 1998, INVEST OPHTH VIS SCI, V39, P710; Zhang LJ, 2011, DEVELOPMENT, V138, P455, DOI 10.1242/dev.046870; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	50	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55075	10.1371/journal.pone.0055075	http://dx.doi.org/10.1371/journal.pone.0055075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457460	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700008
J	Chen, YC; Hsiao, CC; Chen, KD; Hung, YC; Wu, CY; Lie, CH; Liu, SF; Sung, MT; Chen, CJ; Wang, TY; Chang, JC; Tang, P; Fang, WF; Wang, YH; Chung, YH; Chao, TY; Leung, SY; Su, MC; Wang, CC; Lin, MC				Chen, Yung-Che; Hsiao, Chang-Chun; Chen, Kuang-Den; Hung, Yu-Chiang; Wu, Ching-Yuan; Lie, Chien-Hao; Liu, Shih-Feng; Sung, Ming-Tse; Chen, Chung-Jen; Wang, Ting-Ya; Chang, Jen-Chieh; Tang, Petrus; Fang, Wen-Feng; Wang, Yi-Hsi; Chung, Yu-Hsiu; Chao, Tung-Ying; Leung, Sum-Yee; Su, Mao-Chang; Wang, Chin-Chou; Lin, Meng-Chih			Peripheral Immune Cell Gene Expression Changes in Advanced Non-Small Cell Lung Cancer Patients Treated with First Line Combination Chemotherapy	PLOS ONE			English	Article							SUPPRESSOR-CELLS; BREAST-CANCER; GEMCITABINE; MACROPHAGES; SIGNATURE; INVASION; RECEPTOR; SURVIVAL; THERAPY; CYCLOPHOSPHAMIDE	Introduction: Increasing evidence has shown that immune surveillance is compromised in a tumor-promoting microenvironment for patients with non-small cell lung cancer (NSCLC), and can be restored by appropriate chemotherapy. Methods: To test this hypothesis, we analyzed microarray gene expression profiles of peripheral blood mononuclear cells from 30 patients with newly-diagnosed advanced stage NSCLC, and 20 age-, sex-, and co-morbidity-matched healthy controls. All the patients received a median of four courses of chemotherapy with cisplatin and gemcitabine for a 28-day cycle as first line treatment. Results: Sixty-nine differentially expressed genes between the patients and controls, and 59 differentially expressed genes before and after chemotherapy were identified. The IL4 pathway was significantly enriched in both tumor progression and chemotherapy signatures. CXCR4 and IL2RG were down-regulated, while DOK2 and S100A15 were up-regulated in the patients, and expressions of all four genes were partially or totally reversed after chemotherapy. Real-time quantitative RT-PCR for the four up-regulated (S100A15, DOK2) and down-regulated (TLR7, TOP1MT) genes in the patients, and the six up-regulated (TLR7, CRISP3, TOP1MT) and down-regulated (S100A15, DOK2, IL2RG) genes after chemotherapy confirmed the validity of the microarray results. Further immunohistochemical analysis of the paraffin-embedded lung cancer tissues identified strong S100A15 nuclear staining not only in stage IV NSCLC as compared to stage IIIB NSCLC (p = 0.005), but also in patients with stable or progressive disease as compared to those with a partial response (p = 0.032). A high percentage of S100A15 nuclear stained cells (HR 1.028, p = 0.01) was the only independent factor associated with three-year overall mortality. Conclusions: Our results suggest a potential role of the IL4 pathway in immune surveillance of advanced stage NSCLC, and immune potentiation of combination chemotherapy. S100A15 may serve as a potential biomarker for tumor staging, and a predictor of poor prognosis in NSCLC.	[Chen, Yung-Che; Lie, Chien-Hao; Liu, Shih-Feng; Wang, Ting-Ya; Fang, Wen-Feng; Wang, Yi-Hsi; Chung, Yu-Hsiu; Chao, Tung-Ying; Leung, Sum-Yee; Su, Mao-Chang; Wang, Chin-Chou; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Chen, Kuang-Den; Hung, Yu-Chiang; Wu, Ching-Yuan; Lie, Chien-Hao; Liu, Shih-Feng; Sung, Ming-Tse; Chen, Chung-Jen; Wang, Ting-Ya; Chang, Jen-Chieh; Fang, Wen-Feng; Wang, Yi-Hsi; Chung, Yu-Hsiu; Chao, Tung-Ying; Leung, Sum-Yee; Su, Mao-Chang; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Kuang-Den] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Hung, Yu-Chiang; Wu, Ching-Yuan] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Liu, Shih-Feng] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan; [Sung, Ming-Tse] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chen, Chung-Jen] Kaohsiung Chang Gung Mem Hosp, Div Rheumatol, Kaohsiung, Taiwan; [Chang, Jen-Chieh] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chen, Yung-Che; Hsiao, Chang-Chun; Tang, Petrus] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan.	linmengchih@hotmail.com	Chen, Yung-Che/AAL-5167-2020; Fang, Wen-Feng/AAT-6296-2021; Hung, yu-chiang/ABE-7636-2020; Leung, Suet Yi/T-9620-2019	Chen, Yung-Che/0000-0001-8695-5227; Fang, Wen-Feng/0000-0003-0350-9059; Leung, Suet Yi/0000-0001-8614-4619; Hsiao, Chang-Chun/0000-0002-7275-4675; Chen, Chung-Jen/0000-0002-7405-2335; Liu, Shih-Feng/0000-0003-1394-5401; Tang, Petrus/0000-0002-2779-0116	Committee on Chinese Medicine and Pharmacy of the Department of Health, Executive Yuan, Taiwan [CCMP96-RD-202]; Chang Gung Memorial Hospital [CMRPG891301, CMRPG881031]	Committee on Chinese Medicine and Pharmacy of the Department of Health, Executive Yuan, Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant (CCMP96-RD-202) from the Committee on Chinese Medicine and Pharmacy of the Department of Health, Executive Yuan, Taiwan, and also supported in part by grants from the Chang Gung Memorial Hospital (CMRPG891301 to K.D. Chen, and CMRPG881031 to Y. C. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI W, 1995, BRIT MED J, V311, P899; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Buechau AS, 2007, J INVEST DERMATOL, V127, P2596, DOI 10.1038/sj.jid.5700946; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Caras I, 2004, CANCER IMMUNOL IMMUN, V53, P1146, DOI 10.1007/s00262-004-0556-2; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cherfils-Vicini J, 2010, J CLIN INVEST, V120, P1285, DOI 10.1172/JCI36551; Dahlman A, 2010, PROSTATE CANCER P D, V13, P369, DOI 10.1038/pcan.2010.25; Dai FQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-220; Delbaldo C, 2004, JAMA-J AM MED ASSOC, V292, P470, DOI 10.1001/jama.292.4.470; Della Peruta M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-61; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dumitru CD, 2010, CANCER BIOL THER, V10, P155, DOI 10.4161/cbt.10.2.12163; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Fransson S, 2012, ONCOGENE, V31, P3277, DOI 10.1038/onc.2011.492; Grills C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014635; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hu JT, 2005, ONCOGENE, V24, P1212, DOI 10.1038/sj.onc.1208242; Kawakami M, 2002, CLIN CANCER RES, V8, P3503; Kawashima O, 2000, ANN SURG ONCOL, V7, P239, DOI 10.1007/BF02523660; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; KOHN EC, 1995, CANCER RES, V55, P1856; Kossenkov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034392; Kossenkov AV, 2011, CLIN CANCER RES, V17, P5867, DOI 10.1158/1078-0432.CCR-11-0737; Lee JM, 2008, CRIT REV ONCOL HEMAT, V66, P208, DOI 10.1016/j.critrevonc.2008.01.004; Liu WM, 2010, BRIT J CANCER, V102, P115, DOI 10.1038/sj.bjc.6605465; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Mailloux AW, 2010, INT J CANCER, V127, P2598, DOI 10.1002/ijc.25281; Mazzoccoli G, 2012, CLIN EXP MED, V12, P181, DOI 10.1007/s10238-011-0153-6; Merritt RE, 2003, J THORAC CARDIOV SUR, V126, P1609, DOI 10.1016/S0022-5223(03)00707-4; Nowak AK, 2002, CANCER RES, V62, P2353; Okabe M, 2008, MOL CANCER THER, V7, P3081, DOI 10.1158/1535-7163.MCT-08-0539; Oliveras-Ferraros C, 2011, INT J ONCOL, V39, P1455, DOI 10.3892/ijo.2011.1155; Otsuka S, 2008, J THORAC ONCOL, V3, P1379, DOI 10.1097/JTO.0b013e31818dda9d; Perez-Pinera P, 2007, MOL CELL BIOCHEM, V295, P19, DOI 10.1007/s11010-006-9267-7; Plate JMD, 2005, CANCER IMMUNOL IMMUN, V54, P915, DOI 10.1007/s00262-004-0638-1; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Saviouk V, 2007, SCHIZOPHR RES, V96, P100, DOI 10.1016/j.schres.2007.07.031; Shepherd FA, 2011, J THORAC ONCOL, V6, P1763, DOI 10.1097/JTO.0b013e31822e28fc; Shojaei H, 2009, CANCER RES, V69, P8710, DOI 10.1158/0008-5472.CAN-09-1602; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sun ZF, 2008, J CLIN ONCOL, V26, P877, DOI 10.1200/JCO.2007.13.1516; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Vasievich EA, 2011, MOL PHARMACEUT, V8, P635, DOI 10.1021/mp1004228; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Wolf R, 2011, AMINO ACIDS, V41, P789, DOI 10.1007/s00726-010-0666-4; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Zhang H, 2008, THORAX, V63, P352, DOI 10.1136/thx.2007.087015; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	63	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57053	10.1371/journal.pone.0057053	http://dx.doi.org/10.1371/journal.pone.0057053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451142	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500055
J	Freeman, SL; England, GCW				Freeman, Sarah L.; England, Gary C. W.			Storage and Release of Spermatozoa from the Pre-Uterine Tube Reservoir	PLOS ONE			English	Article							OVIDUCTAL SPERM RESERVOIR; FEMALE REPRODUCTIVE-TRACT; EPITHELIAL-CELLS; DOG SPERMATOZOA; ARTIFICIAL-INSEMINATION; ACROSOME REACTION; GENITAL-TRACT; CAPACITATION; BITCH; INDUCTION	In mammals, after coitus a small number of spermatozoa enter the uterine tube and following attachment to uterine tube epithelium are arrested in a non-capacitated state until peri-ovulatory signalling induces their detachment. Whilst awaiting release low numbers of spermatozoa continually detach from the epithelium and the uterine tube reservoir risks depletion. There is evidence of attachment of spermatozoa to uterine epithelium in several species which might form a potential pre-uterine tube reservoir. In this study we demonstrate that: (1) dog spermatozoa attach to uterine epithelium and maintain flagellar activity, (2) in non-capacitating conditions spermatozoa progressively detach with a variety of motility characteristics, (3) attachment is not influenced by epithelial changes occurring around ovulation, (4) attachment to uterine epithelium slows capacitation, (5) capacitated spermatozoa have reduced ability to attach to uterine epithelium, (6) under capacitating conditions increased numbers of spermatozoa detach and exhibit transitional and hyperactive motility which differ to those seen in non-capacitating conditions, (7) detachment of spermatozoa and motility changes can be induced by post-ovulation but not pre-ovulation uterine tube flush fluid and by components of follicular fluid and solubilised zona pellucida, (8) prolonged culture does not change the nature of the progressive detachment seen in non-capacitating conditions nor the potential for increased detachment in capacitating conditions. We postulate that in some species binding of spermatozoa to uterine epithelium is an important component of the transport of spermatozoa. Before ovulation low numbers of spermatozoa continually detach, including those which are non-capacitated with fast forward progressive motility allowing the re-population of the uterine tube, whilst around the time of ovulation, signalling from as-yet unknown factors associated with follicular fluid, oocytes and uterine tube secretion promotes the detachment of large numbers of capacitated spermatozoa with hyperactive motility that may contribute to the fertilising pool.	[Freeman, Sarah L.; England, Gary C. W.] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Surg, Nottingham NG7 2RD, Leics, England	University of Nottingham	England, GCW (corresponding author), Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Surg, Sutton Bonington Campus, Nottingham NG7 2RD, Leics, England.	gary.england@nottingham.ac.uk	Freeman, Sarah/H-1228-2011; England, Gary C.W./G-5432-2011	Freeman, Sarah/0000-0002-3119-2207; England, Gary/0000-0001-5800-3106				Burgess CM, 2012, VET J, V192, P398, DOI 10.1016/j.tvjl.2011.08.026; BURKHARDT J, 1949, J AGR SCI, V39, P201, DOI 10.1017/S0021859600005025; Chatdarong K, 2004, THERIOGENOLOGY, V62, P1027, DOI 10.1016/j.theriogenology.2003.12.014; DEMOTT RP, 1992, BIOL REPROD, V46, P779, DOI 10.1095/biolreprod46.5.779; DOAK RL, 1967, J REPROD FERTIL, V13, P51, DOI 10.1530/jrf.0.0130051; Dunson DB, 2001, HUM REPROD, V16, P2278, DOI 10.1093/humrep/16.11.2278; ELLINGTON JE, 1995, VET REC, V136, P542, DOI 10.1136/vr.136.21.542; England GCW, 2006, THERIOGENOLOGY, V66, P1410, DOI 10.1016/j.theriogenology.2006.01.025; England GCW, 1999, THERIOGENOLOGY, V52, P981, DOI 10.1016/S0093-691X(99)00187-9; England GCW, 2012, VET J IN PRESS; Fazeli A, 1999, BIOL REPROD, V60, P879, DOI 10.1095/biolreprod60.4.879; Hewitt DA, 1998, ANIM REPROD SCI, V51, P321, DOI 10.1016/S0378-4320(98)00079-7; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; Karre I, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-49; Kawakami E, 1998, J VET MED SCI, V60, P197, DOI 10.1292/jvms.60.197; Kawakami E, 2000, J VET MED SCI, V62, P65, DOI 10.1292/jvms.62.65; Kawakami E, 2002, J VET MED SCI, V64, P867, DOI 10.1292/jvms.64.867; Kawakami E, 2001, ANIM REPROD SCI, V68, P121, DOI 10.1016/S0378-4320(01)00135-X; LEFEBVRE R, 1995, BIOL REPROD, V53, P1066, DOI 10.1095/biolreprod53.5.1066; Lefebvre R, 1996, BIOL REPROD, V54, P575, DOI 10.1095/biolreprod54.3.575; MAHI CA, 1978, GAMETE RES, V1, P101, DOI 10.1002/mrd.1120010203; Moxon R, 2010, VET REC, V167, P528, DOI 10.1136/vr.c5082; Murray SC, 1997, FERTIL STERIL, V68, P351, DOI 10.1016/S0015-0282(97)81528-2; Osycka-Salut C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030671; PACEY AA, 1995, HUM REPROD, V10, P2603, DOI 10.1093/oxfordjournals.humrep.a135754; Pacey AA, 2000, THERIOGENOLOGY, V54, P109, DOI 10.1016/S0093-691X(00)00329-0; PURSEL VG, 1978, BIOL REPROD, V19, P69, DOI 10.1095/biolreprod19.1.69; Rath D, 2008, REPROD DOMEST ANIM, V43, P2, DOI 10.1111/j.1439-0531.2008.01250.x; Rijsselaere T, 2004, REPRODUCTION, V128, P801, DOI 10.1530/rep.1.00273; Rodriguez-Martinez H, 2001, J REP FER S, P129; Smith SC, 2001, J REP FER S, P151; Smith SC, 1999, THESIS U LONDON; Smith TT, 1998, BIOL REPROD, V58, P1102, DOI 10.1095/biolreprod58.5.1102; SMITH TT, 1990, BIOL REPROD, V42, P450, DOI 10.1095/biolreprod42.3.450; SMITH TT, 1991, J REPROD FERTIL, V91, P567, DOI 10.1530/jrf.0.0910567; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 1998, BIOL REPROD, V58, P1105, DOI 10.1095/biolreprod58.5.1105; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Talevi R, 2001, BIOL REPROD, V64, P491, DOI 10.1095/biolreprod64.2.491; Taylor U, 2008, REPROD DOMEST ANIM, V43, P166, DOI 10.1111/j.1439-0531.2007.00872.x; Taylor U, 2009, Soc Reprod Fertil Suppl, V66, P83; TSUTSUI T, 1989, J REPROD FERTIL, P269; WILDT DE, 1979, BIOL REPROD, V20, P648, DOI 10.1095/biolreprod20.3.648	43	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57006	10.1371/journal.pone.0057006	http://dx.doi.org/10.1371/journal.pone.0057006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451135	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500053
J	Nagy, ZS; Ross, JA; Rodriguez, G; Balint, BL; Szeles, L; Nagy, L; Kirken, RA				Nagy, Zsuzsanna S.; Ross, Jeremy A.; Rodriguez, Georgialina; Balint, Balint L.; Szeles, Lajos; Nagy, Laszlo; Kirken, Robert A.			Genome Wide Mapping Reveals PDE4B as an IL-2 Induced STAT5 Target Gene in Activated Human PBMCs and Lymphoid Cancer Cells	PLOS ONE			English	Article							T-CELLS; TRANSCRIPTIONAL ACTIVATION; BINDING-SITES; APOPTOSIS; RECEPTOR; JAK; PROTEINS; CD4(+); LINE; DIFFERENTIATION	IL-2 is the primary growth factor for promoting survival and proliferation of activated T cells that occurs following engagement of the Janus Kinase (JAK)1-3/and Signal Transducer and Activator of Transcription (STAT) 5 signaling pathway. STAT5 has two isoforms: STAT5A and STAT5B ( commonly referred to as STAT5) which, in T cells, play redundant roles transcribing cell cycle and survival genes. As such, inhibition of STAT5 by a variety of mechanisms can rapidly induce apoptosis in certain lymphoid tumor cells, suggesting that it and its target genes represent therapeutic targets to control certain lymphoid diseases. To search for these molecules we aligned IL-2 regulated genes detected by Affymetrix gene expression microarrays with the STAT5 cistrome identified by chip-on-ChIP analysis in an IL-2-dependent human leukemia cell line, Kit225. Select overlapping genes were then validated using qRT(2)PCR medium-throughput arrays in human PHA-activated PBMCs. Of 19 putative genes, one key regulator of T cell receptor signaling, PDE4B, was identified as a novel target, which was readily up-regulated at the protein level (3 h) in IL-2 stimulated, activated human PBMCs. Surprisingly, only purified CD8+ primary T-cells expressed PDE4B, but not CD4+ cells. Moreover, PDE4B was found to be highly expressed in CD4+ lymphoid cancer cells, which suggests that it may represent a physiological role unique to the CD8+ and lymphoid cancer cells and thus might represent a target for pharmaceutical intervention for certain lymphoid diseases.	[Nagy, Zsuzsanna S.; Ross, Jeremy A.; Rodriguez, Georgialina; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Nagy, Zsuzsanna S.; Balint, Balint L.; Szeles, Lajos; Nagy, Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary; [Nagy, Zsuzsanna S.; Balint, Balint L.; Szeles, Lajos; Nagy, Laszlo] Hlth Sci Ctr, Debrecen, Hungary	University of Texas System; University of Texas El Paso; University of Debrecen	Nagy, ZS (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	nagyzsu@med.unideb.hu	Nagy, Laszlo/A-3814-2008	Nagy, Laszlo/0000-0001-6653-2155; Szeles, Lajos/0000-0003-1206-8515; Balint, Balint/0000-0002-6163-7190	National Institutes of Health (NIH) [AI053566]; NIGMS SCORE program [S06 GM008012-37]; National Center for Research Resources [5G12RR008124]; NIH; Janos Bolyai Research Felowship from the Hungarian Academy of Sciences; NKTH-OTKA-EU 7KP (Marie Curie actions) Reintegration Grant [OTKA MB08C 84630]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008012] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS SCORE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janos Bolyai Research Felowship from the Hungarian Academy of Sciences; NKTH-OTKA-EU 7KP (Marie Curie actions) Reintegration Grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant number AI053566 to RAK and a pilot project grant to ZSN (NIGMS SCORE program, grant S06 GM008012-37), and made possible by Grant Number 5G12RR008124 from the National Center for Research Resources, a component of the NIH. ZSN is the recipient of the Janos Bolyai Research Felowship from the Hungarian Academy of Sciences and is supported by the NKTH-OTKA-EU 7KP (Marie Curie actions) Reintegration Grant (OTKA MB08C 84630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barta E., 2011, EMBNET J, V17, P13, DOI DOI 10.14806/EJ.17.1.209; Behbod F, 2003, J IMMUNOL, V171, P3919, DOI 10.4049/jimmunol.171.8.3919; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; GAZDAR AF, 1980, BLOOD, V55, P409; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; HORI T, 1987, BLOOD, V70, P1069; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; KAMMER GM, 1988, P NATL ACAD SCI USA, V85, P792, DOI 10.1073/pnas.85.3.792; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; LeBaron MJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-6; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MINOWADA J, 1972, J NATL CANCER I, V49, P891; MIYOSHI I, 1981, GANN, V72, P978; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nagy ZS, 2004, CRIT REV IMMUNOL, V24, P87, DOI 10.1615/CritRevImmunol.v24.i2.10; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Nagy ZS, 2006, J IMMUNOL, V177, P5032, DOI 10.4049/jimmunol.177.8.5032; Nagy ZS, 2010, FEBS LETT, V584, P1515, DOI 10.1016/j.febslet.2010.02.071; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Peter D, 2007, J IMMUNOL, V178, P4820, DOI 10.4049/jimmunol.178.8.4820; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; YODOI J, 1985, J IMMUNOL, V134, P1623; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	47	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57326	10.1371/journal.pone.0057326	http://dx.doi.org/10.1371/journal.pone.0057326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451206	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000316849500089
J	Shaner, PJL; Chen, YR; Lin, JW; Kolbe, JJ; Lin, SM				Shaner, Pei-Jen L.; Chen, Ying-Ru; Lin, Jhan-Wei; Kolbe, Jason J.; Lin, Si-Min			Sex-Specific Correlations of Individual Heterozygosity, Parasite Load, and Scalation Asymmetry in a Sexually Dichromatic Lizard	PLOS ONE			English	Article							FITNESS CORRELATIONS; MULTILOCUS HETEROZYGOSITY; MICROSATELLITE VARIATION; GENETIC-VARIATION; GALLOTIA-GALLOTI; COMMON LIZARD; MATE CHOICE; HEAD SIZE; POPULATIONS; DIMORPHISM	Heterozygosity-fitness correlations (HFCs) provide insights into the genetic bases of individual fitness variation in natural populations. However, despite decades of study, the biological significance of HFCs is still under debate. In this study, we investigated HFCs in a large population of the sexually dimorphic lizard Takydromus viridipunctatus (Lacertidae). Because of the high prevalence of parasitism from trombiculid mites in this lizard, we expect individual fitness (i.e., survival) to decrease with increasing parasite load. Furthermore, because morphological asymmetry is likely to influence individuals' mobility (i.e., limb asymmetry) and male biting ability during copulation (i.e., head asymmetry) in this species, we also hypothesize that individual fitness should decrease with increasing morphological asymmetry. Although we did not formally test the relationship between morphological asymmetry and fitness in this lizard, we demonstrated that survival decreased with increasing parasite load using a capture-mark-recapture data set. We used a separate sample of 140 lizards to test the correlations between individual heterozygosity (i.e., standardized mean d(2) and HL based on 10 microsatellite loci) and the two fitness traits (i.e., parasite load and morphological asymmetry). We also evaluated and excluded the possibility that single-locus effects produced spurious HFCs. Our results suggest male-only, negative correlations between individual heterozygosity and parasite load and between individual heterozygosity and asymmetry, suggesting sex-specific, positive HFCs. Male T. viridipunctatus with higher heterozygosity tend to have lower parasite loads (i.e., higher survival) and lower asymmetry, providing a rare example of HFC in reptiles.	[Shaner, Pei-Jen L.; Chen, Ying-Ru; Lin, Jhan-Wei; Lin, Si-Min] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Kolbe, Jason J.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	National Taiwan Normal University; University of Rhode Island	Lin, SM (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	fish@ntnu.edu.tw		Shaner, Pei-Jen/0000-0001-8112-4299	National Science Council, Taiwan [NSC96-2628-B-034-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The funding was provided by National Science Council, Taiwan (NSC96-2628-B-034-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, MOL ECOL, V15, P1973, DOI 10.1111/j.1365-294X.2006.02903.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; ANDERSON RA, 1990, OECOLOGIA, V84, P145, DOI 10.1007/BF00318265; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Britten HB, 1996, EVOLUTION, V50, P2158, DOI 10.1111/j.1558-5646.1996.tb03606.x; Campos JL, 2006, CONSERV GENET, V7, P515, DOI 10.1007/s10592-005-9063-z; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Christian KA, 1995, CAN J ZOOL, V73, P2302, DOI 10.1139/z95-272; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Curtis JL, 2008, HERPETOLOGICA, V64, P189, DOI 10.1655/07-052.1; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; DUNLAP KD, 1993, COPEIA, P1045; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Gvozdik L, 2003, J ZOOL, V259, P7, DOI 10.1017/S0952836902003308; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Harrison XA, 2011, MOL ECOL, V20, P4786, DOI 10.1111/j.1365-294X.2011.05283.x; Harrison XA, 2010, MOL ECOL, V19, P5484, DOI 10.1111/j.1365-294X.2010.04852.x; Hedrick P, 2001, EVOLUTION, V55, P1256; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Hoffman JI, 2006, MOL ECOL, V15, P1995, DOI 10.1111/j.1365-294X.2006.02894.x; Laloi D, 2011, BEHAV PROCESS, V88, P149, DOI 10.1016/j.beproc.2011.08.011; Lappin AK, 2006, BIOL J LINN SOC, V88, P215, DOI 10.1111/j.1095-8312.2006.00615.x; LeBas NR, 2002, EVOLUTION, V56, P371, DOI 10.1111/j.0014-3820.2002.tb01347.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lens L, 2000, J EVOLUTION BIOL, V13, P889, DOI 10.1046/j.1420-9101.2000.00232.x; Lesbarreres D, 2005, MOL ECOL, V14, P311, DOI 10.1111/j.1365-294X.2004.02394.x; Lin SM, 2006, MOL ECOL NOTES, V6, P57, DOI 10.1111/j.1471-8286.2005.01136.x; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V52, P342, DOI 10.1007/s00265-002-0514-y; Lou CH, 2012, THESIS NATL TAIWAN N; Lue KY, 2008, HERPETOLOGICA, V64, P379, DOI 10.1655/07-030.1; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; MacDougall-Shackleton EA, 2005, BIOL LETTERS, V1, P105, DOI 10.1098/rsbl.2004.0264; Main AR, 2000, OECOLOGIA, V122, P574, DOI 10.1007/s004420050981; Martin J, 2000, P ROY SOC B-BIOL SCI, V267, P1265, DOI 10.1098/rspb.2000.1137; Miller HC, 2009, P ROY SOC B-BIOL SCI, V276, P1695, DOI 10.1098/rspb.2008.1840; Molina-Borja M, 1998, ETHOLOGY, V104, P314; Moore JA, 2009, J HERPETOL, V43, P570, DOI 10.1670/08-290.1; Pritchard JK, 2000, GENETICS, V155, P945; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rijks JM, 2008, HEREDITY, V100, P587, DOI 10.1038/hdy.2008.18; Shine R, 2005, FUNCT ECOL, V19, P306, DOI 10.1111/j.1365-2435.2005.00963.x; SHULL GH, 1948, GENETICS, V33, P439; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Slate J, 2006, CURR BIOL, V16, pR790, DOI 10.1016/j.cub.2006.08.047; Smith AL, 2009, APPL HERPETOL, V6, P300, DOI 10.1163/157075408X386150; Sorci G, 1995, J EVOLUTION BIOL, V8, P711, DOI 10.1046/j.1420-9101.1995.8060711.x; Sorci G, 1996, OIKOS, V76, P121, DOI 10.2307/3545754; Sperry JH, 2009, J ZOOL, V278, P100, DOI 10.1111/j.1469-7998.2009.00549.x; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Ujvari B, 2006, BEHAV ECOL, V17, P20, DOI 10.1093/beheco/ari091; Vervust B, 2008, J HERPETOL, V42, P369, DOI 10.1670/07-1202.1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	54	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56720	10.1371/journal.pone.0056720	http://dx.doi.org/10.1371/journal.pone.0056720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451073	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500023
J	Tiwari, N; Meyer-Schaller, N; Arnold, P; Antoniadis, H; Pachkov, M; van Nimwegen, E; Christofori, G				Tiwari, Neha; Meyer-Schaller, Nathalie; Arnold, Phil; Antoniadis, Helena; Pachkov, Mikhail; van Nimwegen, Erik; Christofori, Gerhard			Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER PATIENTS; TUMOR-SUPPRESSOR; STEM-CELLS; DOWN-REGULATION; PROGRESSION; EXPRESSION; GROWTH; DIFFERENTIATION	We have identified the zinc-finger transcription factor Kruppel-like factor 4 (Klf4) among the transcription factors that are significantly downregulated in their expression during epithelial-mesenchymal transition (EMT) in mammary epithelial cells and in breast cancer cells. Loss and gain of function experiments demonstrate that the down-regulation of Klf4 expression is required for the induction of EMT in vitro and for metastasis in vivo. In addition, reduced Klf4 expression correlates with shorter disease-free survival of subsets of breast cancer patients. Yet, reduced expression of Klf4 also induces apoptosis in cells undergoing TGF beta-induced EMT. Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct Klf4 target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), beta-catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8). Thereby, Klf4 acts as a transcriptional activator of epithelial genes and as a repressor of mesenchymal genes. Specifically, increased expression of Jnk1 (Mapk8) upon down-regulation of its transcriptional repressor Klf4 is required for EMT cell migration and for the induction of apoptosis. The data demonstrate a central role of Klf4 in the maintenance of epithelial cell differentiation and the prevention of EMT and metastasis.	[Tiwari, Neha; Meyer-Schaller, Nathalie; Antoniadis, Helena; Christofori, Gerhard] Univ Basel, Dept Biomed, Basel, Switzerland; [Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland; [Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland	University of Basel; University of Basel; Swiss Institute of Bioinformatics	Christofori, G (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	Gerhard.christofori@unibas.ch	van Nimwegen, Erik/ABF-1085-2021	van Nimwegen, Erik/0000-0001-6338-1312; Tiwari, Neha/0000-0001-7931-4085	Swiss National Science Foundation; SystemsX.ch RTD project Cellplasticity; Swiss Cancer League	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch RTD project Cellplasticity; Swiss Cancer League	This work was supported by the Swiss National Science Foundation, the SystemsX.ch RTD project Cellplasticity, and the Swiss Cancer League. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cellurale C, 2012, CANCER RES, V72, P472, DOI 10.1158/0008-5472.CAN-11-1628; Cellurale C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012469; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Santibanez JF, 2006, FEBS LETT, V580, P5385, DOI 10.1016/j.febslet.2006.09.003; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Van der Velden JL, 2010, AM J RESP CELL MOL B, V47, P306; Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	49	82	87	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57329	10.1371/journal.pone.0057329	http://dx.doi.org/10.1371/journal.pone.0057329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451207	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500090
J	Knapp, S; Vorontsova, MS; Prohens, J				Knapp, Sandra; Vorontsova, Maria S.; Prohens, Jaime			Wild Relatives of the Eggplant (Solanum melongena L.: Solanaceae): New Understanding of Species Names in a Complex Group	PLOS ONE			English	Article							TOMATO; DEFINITION; RESISTANCE; INCANUM	Background: The common or brinjal eggplant (Solanum melongena L.) belongs to the Leptostemonum Clade (the "spiny'' solanums) of the species-rich genus Solanum (Solanaceae). Unlike most of the genus, the eggplant and its relatives are from the Old World; most eggplant wild relatives are from Africa. An informal system for naming eggplant wild relatives largely based on crossing and other biosystematics data has been in use for approximately a decade. This system recognises several forms of two broadly conceived species, S. incanum L. and S. melongena. Recent morphological and molecular work has shown that species-level differences exist between these entities, and a new species-level nomenclature has been identified as necessary for plant breeders and for the maintenance of accurately named germplasm. Methodology/Principal Findings: We examined herbarium specimens from throughout the wild species ranges as part of a larger revision of the spiny solanums of Africa. Based on these morphological and molecular studies, we delimited species in the group to which the common eggplant belongs and constructed identification keys for the group. We also examined the monophyly of the group considered as the eggplant relatives by previous authors. Conclusions/Significance: We recognise ten species in this group: S. aureitomentosum Bitter, S. campylacanthum A. Rich., S. cerasiferum Dunal, S. incanum L., S. insanum L., S. lichtensteinii Willd., S. linnaeanum Hepper & P.-M.L. Jaeger, S. melongena L., S. rigidum Lam. and S. umtuma Voronts. & S. Knapp. We review the history of naming and provide keys and character lists for all species. Ploidy level differences have not been investigated in the eggplant wild relatives; we identify this as a priority for improvement of crop wild relative use in breeding. The application of species-level names to these entities will help focus new collecting efforts for brinjal eggplant improvement and help facilitate information exchange.	[Knapp, Sandra] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Vorontsova, Maria S.] Royal Bot Gardens Kew, Herbarium, Richmond, Surrey, England; [Prohens, Jaime] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, E-46071 Valencia, Spain	Natural History Museum London; Royal Botanic Gardens, Kew; Universitat Politecnica de Valencia	Knapp, S (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk	Prohens, Jaime/H-2228-2015; Fuller, Dorian/AAF-7400-2019; Fuller, Dorian Q/C-1908-2008; Prohens, Jaime/ABF-1229-2021; Knapp, Sandra/A-4856-2011; Vorontsova, Maria S/H-9263-2015	Prohens, Jaime/0000-0003-1181-9065; Fuller, Dorian/0000-0002-4859-080X; Fuller, Dorian Q/0000-0002-4859-080X; Prohens, Jaime/0000-0003-1181-9065; Knapp, Sandra/0000-0001-7698-3945; 	National Science Foundation; Planetary Biodiversity Inventory (PBI) project "Solanum: A worldwide treatment'' [DEB-0316614]	National Science Foundation(National Science Foundation (NSF)); Planetary Biodiversity Inventory (PBI) project "Solanum: A worldwide treatment''	SK and MSV's work in Solanum taxonomy has been funded by the National Science Foundation, Planetary Biodiversity Inventory (PBI) project "Solanum: A worldwide treatment'' (DEB-0316614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaso H. U., 1989, Nucleus (Calcutta), V32, P4; ANASO H U, 1990, Cytologia (Tokyo), V55, P1, DOI 10.1508/cytologia.55.1; Bitter G, 1923, REPERTORIUM SPECIERU, V16, P1; Bohs L., 2005, SYST BOT, V104, P27, DOI DOI 10.1111/J.1365-2699.2007.01870.X; Brickell CD, 2009, SCRIPTA HORTICULTURA, V10; Cai XK, 2011, PHYTOPATHOLOGY, V101, P1074, DOI 10.1094/PHYTO-02-11-0060; Daunay M.-C., 2012, HDB VEGETABLES, P257, DOI DOI 10.1016/B978-0-08-040826-2.50028-X; Daunay Marie-Christine, 2001, P199; Daunay MC, 2007, CHRONICA HORTICULTUR, V47, P16; DEB DB, 1989, TAXON, V38, P138, DOI 10.2307/1220916; Doglanar S, 2002, GENETICS, V161, P1697; Dunal MF, 1852, PRODROMUS SYSTEMATIS, V13, P1, DOI DOI 10.5962/BHL.TITLE.286; ESHED Y, 1995, GENETICS, V141, P1147; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Goncalves AE, 2002, FLORA CABO VERDE, V71, P5; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hasan SMZ, 1986, THESIS U BIRMINGHAM; HEPPER F N, 1985, Kew Bulletin, V40, P387, DOI 10.2307/4108264; Hepper FN, 1986, KEW B, V41, P433, DOI DOI 10.2307/4102956; Hurtado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041748; Jarvis C. E., 2007, ORDER OUT CHAOS LINN; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; KNAPP S, 1990, BOT J LINN SOC, V104, P325, DOI 10.1111/j.1095-8339.1990.tb02227.x; Knapp S, 1997, B NATURAL HIST MUSEU, V27, P31; Knapp S, 2008, BIOL J LINN SOC, V95, P17, DOI 10.1111/j.1095-8312.2008.01090.x; Knapp S, 2011, TAXON, V60, P1498, DOI 10.1002/tax.605031; Lebeau A, 2011, PHYTOPATHOLOGY, V101, P154, DOI 10.1094/PHYTO-02-10-0048; Lester R. N., 1991, SOLANACEAE, P369; LESTER RN, 1990, TAXON, V39, P521, DOI 10.2307/1223119; Linnaeus C., 1759, SYSTEMA NATURAE, V12th; Mace ES, 1999, THEOR APPL GENET, V99, P626, DOI 10.1007/s001220051277; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Manoko M.L.K., 2007, THESIS RADBOUD U NIJ; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; McNeill J, 2012, REGNUM VEG, V154, P1; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Miller P, 1768, GARDENERS DICT; Moyle LC, 2010, SCIENCE, V329, P1521, DOI 10.1126/science.1193063; Ovchinnikova A, 2011, BOT J LINN SOC, V165, P107, DOI 10.1111/j.1095-8339.2010.01107.x; Peralta I. E., 2008, Systematic Botany Monographs, V84; Samuels J, 2012, KEW B, V67, P1; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scaldaferro M, 2012, GENET RESOUR CROP EV, V59, P1833, DOI 10.1007/s10722-012-9807-9; Simon R, 2010, INVAS PLANT SCI MANA, V3, P286, DOI 10.1614/IPSM-D-09-00043.1; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; SPOONER DM, 2004, SYST BOT MONOGR, V68, P1, DOI DOI 10.2307/25027915; Stern S, 2011, TAXON, V60, P1429, DOI 10.1002/tax.605018; SZYMKOWIAK EJ, 1992, PLANT CELL, V4, P1089, DOI 10.1105/tpc.4.9.1089; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tepe EJ, 2011, SYST BOT, V36, P1068, DOI 10.1600/036364411X605074; Tumbilen Y, 2011, TURK J BIOL, V35, P125, DOI 10.3906/biy-0906-57; Vavilov N.I, 1951, ORIGIN VARIATION IMM; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; Vilanova S., 2010, ADV GENETICS BREEDIN, P435; Vorontsova M.S., 2012, FLORA TROPICAL E AFR, p[164, 198, 220]; Vorontsova MS, 2010, TAXON, V59, P1585, DOI 10.1002/tax.595024; Vorontsova MS, 2013, BOT J LINN IN PRESS; Wang JX, 2008, ANN BOT-LONDON, V102, P891, DOI 10.1093/aob/mcn179; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; WHALEN M D, 1984, Gentes Herbarum, V12, P179; Whalen M. D., 1986, SOLANACEAE BIOL SYST, P285; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	63	86	91	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57039	10.1371/journal.pone.0057039	http://dx.doi.org/10.1371/journal.pone.0057039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451138	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800064
J	Phillips, MJ; Haouchar, D; Pratt, RC; Gibb, GC; Bunce, M				Phillips, Matthew J.; Haouchar, Dalal; Pratt, Renae C.; Gibb, Gillian C.; Bunce, Michael			Inferring Kangaroo Phylogeny from Incongruent Nuclear and Mitochondrial Genes	PLOS ONE			English	Article							ROCK-WALLABIES; DNA-SEQUENCES; MARSUPIALIA; MACROPODIDAE; INTROGRESSION; EVOLUTION; INFERENCE; HYBRIDIZATION; PETROGALE; HISTORY	The marsupial genus Macropus includes three subgenera, the familiar large grazing kangaroos and wallaroos of M. (Macropus) and M. (Osphranter), as well as the smaller mixed grazing/browsing wallabies of M. (Notamacropus). A recent study of five concatenated nuclear genes recommended subsuming the predominantly browsing Wallabia bicolor (swamp wallaby) into Macropus. To further examine this proposal we sequenced partial mitochondrial genomes for kangaroos and wallabies. These sequences strongly favour the morphological placement of W. bicolor as sister to Macropus, although place M. irma (black-gloved wallaby) within M. (Osphranter) rather than as expected, with M. (Notamacropus). Species tree estimation from separately analysed mitochondrial and nuclear genes favours retaining Macropus and Wallabia as separate genera. A simulation study finds that incomplete lineage sorting among nuclear genes is a plausible explanation for incongruence with the mitochondrial placement of W. bicolor, while mitochondrial introgression from a wallaroo into M. irma is the deepest such event identified in marsupials. Similar such coalescent simulations for interpreting gene tree conflicts will increase in both relevance and statistical power as species-level phylogenetics enters the genomic age. Ecological considerations in turn, hint at a role for selection in accelerating the fixation of introgressed or incompletely sorted loci. More generally the inclusion of the mitochondrial sequences substantially enhanced phylogenetic resolution. However, we caution that the evolutionary dynamics that enhance mitochondria as speciation indicators in the presence of incomplete lineage sorting may also render them especially susceptible to introgression.	[Phillips, Matthew J.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Haouchar, Dalal; Bunce, Michael] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Pratt, Renae C.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Gibb, Gillian C.] Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand	Queensland University of Technology (QUT); Murdoch University; Australian National University; Massey University	Phillips, MJ (corresponding author), Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia.	mphillips.biol@gmail.com	Gibb, Gillian/AAF-9175-2020	Gibb, Gillian/0000-0002-4283-9790; Bunce, Michael/0000-0002-0302-4206	Australian Research Council [DP07745015, FT0991741]	Australian Research Council(Australian Research Council)	This work has been supported by Australian Research Council grants to MJP (DP07745015) and MB (FT0991741). The website for the funder is www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane C, 2007, MOL BIOL EVOL, V24, P412; ARCHER M, 1984, VERTEBRATE ZOOGEOGRA, P385; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126, DOI 10.1093/oxfordjournals.molbev.a026394; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; BAVERSTOCK PR, 1989, SYST ZOOL, V38, P38, DOI 10.2307/2992434; BEE CA, 1993, GENET RES, V61, P21, DOI 10.1017/S0016672300031074; Briscoe D.A., 1982, P73; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Bulazel KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r170; Burk Angela, 2000, Journal of Mammalian Evolution, V7, P213, DOI 10.1023/A:1009488431055; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Cardillo M, 2004, J ZOOL, V264, P11, DOI 10.1017/S0952836904005539; Christensen P., 1995, MAMMALS AUSTR, P341; Chung YJ, 2011, SYST BIOL, V60, P261, DOI 10.1093/sysbio/syr003; CLOSE RL, 1990, AUST J ZOOL, V37, P259, DOI 10.1071/ZO9890259; DAWSON L, 1985, AUST J ZOOL, V33, P473, DOI 10.1071/ZO9850473; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; ELDRIDGE MDB, 1992, AUST J ZOOL, V40, P605, DOI 10.1071/ZO9920605; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FLANNERY TF, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P1; Flannery TF, 1992, FIELDIANA GEOLOGY, V25, P1; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GANSLOSSER U, 1992, Australian Mammalogy, V15, P89; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; HOLLIS CJ, 1986, AUST WILDLIFE RES, V13, P355, DOI 10.1071/WR9860355; Jesus FF, 2006, GENET MOL RES, V5, P466; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kear BP, 2007, AUST J ZOOL, V55, P331, DOI 10.1071/ZO08002; Kear BP, 2002, ALCHERINGA, V26, P299, DOI 10.1080/03115510208619259; KIRSCH JAW, 1977, AUST J ZOOL, P1; KIRSCH JAW, 1995, BIOL J LINN SOC, V55, P309, DOI 10.1111/j.1095-8312.1995.tb01068.x; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knowles LL, 2010, ESTIMATING SPECIES T, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynch M, 1998, GENETICA, V102-3, P29, DOI 10.1023/A:1017022522486; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Meredith RW, 2008, AUST J ZOOL, V56, P395, DOI 10.1071/ZO08044; Milne N, 2002, J ZOOL, V256, P523, DOI 10.1017/S0952836902000572; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Neaves LE, 2010, HEREDITY, V104, P502, DOI 10.1038/hdy.2009.137; Neaves LE, 2012, J BIOGEOGR, V39, P1545, DOI 10.1111/j.1365-2699.2012.02702.x; Phillips MJ, 2008, MOL PHYLOGENET EVOL, V46, P594, DOI 10.1016/j.ympev.2007.09.008; Phillips MJ, 2006, SYST BIOL, V55, P122, DOI 10.1080/10635150500481614; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prideaux GJ, 2010, ZOOL J LINN SOC-LOND, V159, P954, DOI 10.1111/j.1096-3642.2009.00607.x; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; RAMBAUT A, 1996, SEQUENCE ALIGMENT ED; Rambaut A., 2007, TRACER V1 5; Rannala B, 2003, GENETICS, V164, P1645; Raven H. C., 1946, AMER MUS NOVITATCS, V1309, P1; Retief JD, 1995, J MOL EVOL, V37, P426; RICHARSON B J, 1978, Australian Mammalogy, V2, P43; RIDE W. D. L., 1957, PROC ZOOL SOC LONDON, V128, P327; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; SANSON GD, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P151; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strahan R., 1995, MAMMALS AUSTR, V2nd; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tate G. H. H., 1948, Bulletin of the American Museum of Natural History, V91, P233; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; van Gelder R. G., 1977, American Mus. Novit., VNo. 2635, P1; Wann J. M., 1997, Journal of the Royal Society of Western Australia, V80, P55; Westerman Michael, 2002, Journal of Mammalian Evolution, V9, P209, DOI 10.1023/A:1022697300092; Westerman M, 2010, J HERED, V101, P690, DOI 10.1093/jhered/esq076; Woodburne Michael O., 1993, Journal of Vertebrate Paleontology, V13, P483; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	84	52	52	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57745	10.1371/journal.pone.0057745	http://dx.doi.org/10.1371/journal.pone.0057745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451266	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800117
J	Santha, S; Bommareddy, A; Rule, B; Guillermo, R; Kaushik, RS; Young, A; Dwivedi, C				Santha, Sreevidya; Bommareddy, Ajay; Rule, Brittny; Guillermo, Ruth; Kaushik, Radhey S.; Young, Alan; Dwivedi, Chandradhar			Antineoplastic Effects of alpha-Santalol on Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancer Cells through Cell Cycle Arrest at G2/M Phase and Induction of Apoptosis	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; SKIN TUMOR-DEVELOPMENT; SANDALWOOD OIL; FRAGMENTATION; CHECKPOINT; CARCINOMA; CLEAVAGE; DISTINCT; TARGET; DEATH	Anticancer efficacy and the mechanism of action of alpha-santalol, a terpenoid isolated from sandalwood oil, were investigated in human breast cancer cells by using p53 wild-type MCF-7 cells as a model for estrogen receptor(ER)-positive and p53 mutated MDA-MB-231 cells as a model for ER-negative breast cancer. alpha-Santalol inhibited cell viability and proliferation in a concentration and time-dependent manner in both cells regardless of their ER and/or p53 status. However, alpha-santalol produced relatively less toxic effect on normal breast epithelial cell line, MCF-10A. It induced G2/M cell cycle arrest and apoptosis in both MCF-7 and MDA-MB-231 cells. Cell cycle arrest induced by a-santalol was associated with changes in the protein levels of BRCA1, Chk1, G2/M regulatory cyclins, Cyclin dependent kinases (CDKs), Cell division cycle 25B (Cdc25B), Cdc25C and Ser-216 phosphorylation of Cdc25C. An up-regulated expression of CDK inhibitor p21 along with suppressed expression of mutated p53 was observed in MDA-MB-231 cells treated with alpha-santalol. On the contrary, alpha-santalol did not increase the expression of wild-type p53 and p21 in MCF-7 cells. In addition, alpha-santalol induced extrinsic and intrinsic pathways of apoptosis in both cells with activation of caspase-8 and caspase-9. It led to the activation of the executioner caspase-6 and caspase-7 in alpha-santalol-treated MCF-7 cells and caspase-3 and caspase-6 in MDA-MB-231 cells along with strong cleavage of poly(ADP-ribose) polymerase (PARP) in both cells. Taken together, this study for the first time identified strong anti-neoplastic effects of alpha-santalol against both ER-positive and ER-negative breast cancer cells.	[Santha, Sreevidya; Guillermo, Ruth; Dwivedi, Chandradhar] S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA; [Bommareddy, Ajay; Rule, Brittny] Wilkes Univ, Dept Pharmaceut Sci, Wilkes Barre, PA 18766 USA; [Kaushik, Radhey S.] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Kaushik, Radhey S.; Young, Alan] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA	South Dakota State University; Wilkes University; South Dakota State University; South Dakota State University	Dwivedi, C (corresponding author), S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA.	Chandradhar.Dwivedi@sdstate.edu	kaushik, Radhey Shyam/AAE-3773-2020		South Dakota Governor's Office of Economic Development	South Dakota Governor's Office of Economic Development	The Translational Cancer Research Center is funded by the South Dakota Governor's Office of Economic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2001, J CLIN ONCOL, V19, P18, DOI 10.1200/JCO.2001.19.1.18; Bommareddy A, 2012, PHYTOMEDICINE, V19, P804, DOI 10.1016/j.phymed.2012.04.003; Burdock GA, 2008, FOOD CHEM TOXICOL, V46, P421, DOI 10.1016/j.fct.2007.09.092; Chen JSK, 2004, J CELL PHYSIOL, V200, P223, DOI 10.1002/jcp.20014; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; CROWE JP, 1991, SURG GYNECOL OBSTET, V173, P273; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Dwivedi C, 2003, CANCER EPIDEM BIOMAR, V12, P151; Dwivedi C, 2006, CARCINOGENESIS, V27, P1917, DOI 10.1093/carcin/bgl058; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Ferreira CG, 2002, CLIN CANCER RES, V8, P2024; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Howes MJR, 2004, J CHROMATOGR A, V1028, P307, DOI 10.1016/j.chroma.2003.11.093; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kaur M, 2005, CARCINOGENESIS, V26, P369, DOI 10.1093/carcin/bgh325; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Megyesi J, 1996, AM J PHYSIOL, V1, P1211; Michalides RJAM, 1999, J CLIN PATHOL, V52, P555, DOI 10.1136/jcp.52.8.555; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Nizamutdinova IT, 2008, INT J ONCOL, V33, P485, DOI 10.3892/ijo_00000031; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Park MT, 2003, J BIOCHEM MOL BIOL, V36, P60; PARL FF, 1984, CANCER, V54, P2237, DOI 10.1002/1097-0142(19841115)54:10<2237::AID-CNCR2820541029>3.0.CO;2-V; Rivera E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2573; Rochefort H, 2003, ENDOCR-RELAT CANCER, V10, P261, DOI 10.1677/erc.0.0100261; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Swerdlow AJ, 2005, JNCI-J NATL CANCER I, V97, P375, DOI 10.1093/jnci/dji057; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhang Xiaoying, 2011, Front Biosci (Schol Ed), V3, P777, DOI 10.2741/s186; Zhang Xiaoying, 2010, BMC Res Notes, V3, P220, DOI 10.1186/1756-0500-3-220	45	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56982	10.1371/journal.pone.0056982	http://dx.doi.org/10.1371/journal.pone.0056982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451128	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800058
J	Zhang, YJ; Liu, QQ; Wang, D; Chen, SH; Wang, SQ				Zhang, Yingjie; Liu, Qiqi; Wang, Dou; Chen, Suhong; Wang, Shengqi			Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization	PLOS ONE			English	Article							ADAMANTANE RESISTANCE; H1N1 VIRUS; SEASON; SENSITIVITY; EMERGENCE; CHINA	Presently, the resistance of Influenza A virus isolates causes great difficulty for the prevention and treatment of influenza A virus infection. It is important to establish a drug-resistance detection method for epidemiological study and personalized medicine in the clinical setting. Consequently, a cost-effective oligonucleotide microarray visualization method, which was based on quantum dot-catalyzed silver deposition, was developed and evaluated for the simultaneous detection of neuraminidase H275Y and E119V; matrix protein 2 V27A and S31N mutations of influenza A (H3N2), seasonal influenza A (H1N1), and 2009 influenza A (H1N1). Then, 307 clinical throat swab specimens were detected and the drug-resistance results showed that 100% (17/17) of influenza A (H3N2) and 100% (259/259) of 2009 influenza A (H1N1) samples were resistant to amantadine and susceptible to oseltamivir; and 100% (5/5) of seasonal influenza A (H1N1) samples were resistant to both amantadine and oseltamivir.	[Zhang, Yingjie; Liu, Qiqi; Wang, Dou; Chen, Suhong; Wang, Shengqi] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China; [Liu, Qiqi; Wang, Shengqi] Shenzhen Puruikang Biotech Co Ltd, Shenzhen, Peoples R China	Academy of Military Medical Sciences - China	Chen, SH (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	doudoucsh@sina.com; sqwang@bmi.ac.cn	Zhang, Yingjie/HHM-3016-2022; Wang, Dou/V-4758-2019		National High Technology Research and Development Program (863 Program) of China [2010AA022803]; National Science and Technology Major Project [2012ZX09301003-005]; Cooperation Project in Industry, Education and Research of Guangdong Province and Ministry of Education of P. R. China [2011A090200071]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Science and Technology Major Project; Cooperation Project in Industry, Education and Research of Guangdong Province and Ministry of Education of P. R. China	This work was financially supported by the National High Technology Research and Development Program (863 Program) of China (No. 2010AA022803), the National Science and Technology Major Project (No. 2012ZX09301003-005), and the Cooperation Project in Industry, Education and Research of Guangdong Province and Ministry of Education of P. R. China (No.2011A090200071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, ANTIVIR RES, V77, P163, DOI 10.1016/j.antiviral.2007.08.008; Alonso M, 2011, J CLIN VIROL, V50, P114, DOI 10.1016/j.jcv.2010.10.007; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536; Crameri A, 2007, J CLIN MICROBIOL, V45, P3685, DOI 10.1128/JCM.01178-07; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Hoopes JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029778; Hurt AC, 2011, EUROSURVEILLANCE, V16, P2; Hurt AC, 2012, EMERG INFECT DIS, V18, P109, DOI 10.3201/eid1801.111079; Karthick V, 2012, PROTOPLASMA; Kim WY, 2011, ANTIMICROB AGENTS CH, V55, P5703, DOI 10.1128/AAC.05529-11; Kolquist KA, 2011, CANCER GENET-NY, V204, P603, DOI 10.1016/j.cancergen.2011.10.004; Lan Y, 2010, ANTIVIR THER, V15, P853, DOI 10.3851/IMP1656; Layne SP, 2001, SCIENCE, V293, P1729, DOI 10.1126/science.293.5536.1729; Li L, 2011, BIOSENS BIOELECTRON, V26, P3688, DOI 10.1016/j.bios.2011.01.040; Mazzatti D, 2012, ARCH PHYSL BIOCH; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Memoli MJ, 2010, CLIN INFECT DIS, V50, P1252, DOI 10.1086/651605; Nguyen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031006; Redlberger-Fritz M, 2011, EUR J CLIN MICROBIOL; Richard M, 2011, ANTIMICROB AGENTS CH, V55, P2942, DOI 10.1128/AAC.01699-10; Sanvicens N, 2011, ANAL BIOANAL CHEM, V399, P2755, DOI 10.1007/s00216-010-4624-5; Sheu TG, 2011, J INFECT DIS, V203, P13, DOI 10.1093/infdis/jiq005; Simon P, 2011, J CLIN MICROBIOL, V49, P715, DOI 10.1128/JCM.01732-10; Townsend MB, 2008, J CLIN VIROL, V42, P117, DOI 10.1016/j.jcv.2007.12.019; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Zhou J, 2011, J CLIN MICROBIOL, V49, P2651, DOI 10.1128/JCM.00535-11	30	9	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57154	10.1371/journal.pone.0057154	http://dx.doi.org/10.1371/journal.pone.0057154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451169	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800080
J	Zhang, YM; Li, CX; Zhang, YJ; Zhu, HX; Kang, YY; Liu, HY; Wang, JY; Qin, YL; Mao, RC; Xie, Y; Huang, YX; Zhang, JM				Zhang, Yongmei; Li, Chenxiao; Zhang, Yijun; Zhu, Haoxiang; Kang, Yaoyue; Liu, Hongyan; Wang, Jinyu; Qin, Yanli; Mao, Richeng; Xie, Yi; Huang, Yuxian; Zhang, Jiming			Comparative Analysis of CpG Islands among HBV Genotypes	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CLOSED CIRCULAR DNA; PHYLOGENETIC RELATEDNESS; METHYLATION; INFECTION; SEQUENCE; SUBGENOTYPES; MECHANISMS; STRAINS; GENOME	DNA methylation is being increasingly recognized to play a role in regulation of hepatitis B virus (HBV) gene expression. The aim of this study was to compare the CpG island distribution among different HBV genotypes. We analyzed 176 full-length HBV genomic sequences obtained from the GenBank database, belonging to genotypes A through J, to identify the CpG islands in the HBV genomes. Our results showed that while 79 out of 176 sequences contained three conventional CpG islands (I-III) as previously described, 83 HBV sequences harbored only two of the three known islands. Novel CpG islands were identified in the remaining 14 HBV isolates and named as CpG island IV, V, and VI. Among the eight known HBV genotypes and two putative genotypes, while HBV genomes containing three CpG islands were predominant in genotypes A, B, D, E, and I; genotypes C, F, G, and H tended to contain only two CpG islands (II and III). In conclusion, the CpG islands, which are potential targets for DNA methylation mediated by the host functions, differ among HBV genotypes, and these genotype-specific differences in CpG island distribution could provide new insights into the understanding of epigenetic regulation of HBV gene expression and hepatitis B disease outcome.	[Zhang, Yongmei; Zhang, Yijun; Zhu, Haoxiang; Kang, Yaoyue; Liu, Hongyan; Wang, Jinyu; Qin, Yanli; Mao, Richeng; Xie, Yi; Huang, Yuxian; Zhang, Jiming] Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Jiming] Fudan Univ, Key Lab Med Mol Virol, MOH, Shanghai 200433, Peoples R China; [Zhang, Jiming] Fudan Univ, MOE, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Li, Chenxiao] Fudan Univ, Dept Basic Med Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Huang, YX (corresponding author), Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	yxhuang@fudan.edu.cn; jmzhang@fudan.edu.cn			National Natural Science Foundation of China [81071354, 81271833, 81201277, 3735636]; '973' project [2012CB519001]; Shanghai Science and Technology Committee [11DZ2291900]; National Science and Technology Major Project of China [2012ZX10002007-001-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '973' project(National Basic Research Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Science and Technology Major Project of China	This work was supported by National Natural Science Foundation of China (81071354, 81271833, 81201277, 3735636), '973' project (2012CB519001), Shanghai Science and Technology Committee (11DZ2291900), and National Science and Technology Major Project of China (2012ZX10002007-001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Block Timothy M, 2007, Clin Liver Dis, V11, P685, DOI 10.1016/j.cld.2007.08.002; Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; Cortes-Mancera F, 2011, HEPAT RES TREAT, V2011; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grabarczyk P, 2010, J VIRAL HEPATITIS, V17, P444, DOI 10.1111/j.1365-2893.2009.01192.x; Gunther S, 2006, J CLIN VIROL, V36, pS3, DOI 10.1016/S1386-6532(06)80002-8; Guo YH, 2009, J MED VIROL, V81, P1177, DOI 10.1002/jmv.21525; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Karayiannis P, 1995, HEPATOLOGY, V22, P1628, DOI 10.1016/0270-9139(95)90183-3; Kato H, 2002, J VIROL, V76, P6131, DOI 10.1128/JVI.76.12.6131-6137.2002; Kaur P, 2010, J INFECT DIS, V202, P700, DOI 10.1086/655398; Kim JW, 2011, INTERVIROLOGY, V54, P316, DOI 10.1159/000321450; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; MILLER RH, 1983, P NATL ACAD SCI-BIOL, V80, P2534, DOI 10.1073/pnas.80.9.2534; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; PREISLERADAMS S, 1993, ARCH VIROL, V133, P385, DOI 10.1007/BF01313777; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Shibayama T, 2005, J MED VIROL, V76, P24, DOI 10.1002/jmv.20319; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Vivekanandan P, 2008, J VIRAL HEPATITIS, V15, P103, DOI 10.1111/j.1365-2893.2007.00905.x; Vivekanandan P, 2008, CLIN INFECT DIS, V46, P1227, DOI 10.1086/529437; Vivekanandan P, 2009, J INFECT DIS, V199, P1286, DOI 10.1086/597614; Wang ZH, 2007, HEPATOL RES, V37, pS36, DOI 10.1111/j.1872-034X.2007.00102.x; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	47	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56711	10.1371/journal.pone.0056711	http://dx.doi.org/10.1371/journal.pone.0056711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451072	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800029
J	Geissmann, Q				Geissmann, Quentin			OpenCFU, a New Free and Open-Source Software to Count Cell Colonies and Other Circular Objects	PLOS ONE			English	Article							ALGORITHM	Counting circular objects such as cell colonies is an important source of information for biologists. Although this task is often time-consuming and subjective, it is still predominantly performed manually. The aim of the present work is to provide a new tool to enumerate circular objects from digital pictures and video streams. Here, I demonstrate that the created program, OpenCFU, is very robust, accurate and fast. In addition, it provides control over the processing parameters and is implemented in an intuitive and modern interface. OpenCFU is a cross-platform and open-source software freely available at http://opencfu.sourceforge.net.	[Geissmann, Quentin] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Geissmann, Quentin] Free Univ Berlin, Inst Biol, Berlin, Germany	University of Sheffield; Free University of Berlin	Geissmann, Q (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	qgeissmann@gmail.com	Geissmann, Quentin/J-3120-2019	Geissmann, Quentin/0000-0001-6546-4306	European Research Council	European Research Council(European Research Council (ERC)European Commission)	This study is part of the project "Multidrug resistance and the evolutionary ecology of insect immunity'' (http://cordis.europa.eu/projects/rcn/ 96082_en.html) funded by the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, OPENMP APPL PROGR IN; Bewes JM, 2008, PHYS MED BIOL, V53, P5991, DOI 10.1088/0031-9155/53/21/007; Bradski G., 2000, DOBBS J SOFTWARE TOO; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033695; Cai ZL, 2011, INT J RADIAT BIOL, V87, P1135, DOI 10.3109/09553002.2011.622033; Clarke ML, 2010, CYTOM PART A, V77A, P790, DOI 10.1002/cyto.a.20864; Costa CM, 2009, ANN BOT-LONDON, V104, P1005, DOI 10.1093/aob/mcp186; Forero MG, 2010, CYTOM PART A, V77A, P371, DOI 10.1002/cyto.a.20877; Kachouie NN, 2009, BIOTECHNIQUES, V47, pIX, DOI 10.2144/000113202; MANSBERG HP, 1957, SCIENCE, V126, P823, DOI 10.1126/science.126.3278.823; Marotz J, 2001, COMPUT METH PROG BIO, V66, P183, DOI 10.1016/S0169-2607(00)00128-0; Mello CAB, 2008, IEEE ENG MED BIO, P3103, DOI 10.1109/IEMBS.2008.4649860; MUKHERJEE DP, 1995, INT J BIOMED COMPUT, V38, P131, DOI 10.1016/0020-7101(94)01043-Z; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Putman M, 2005, J IMMUNOL METHODS, V302, P99, DOI 10.1016/j.jim.2005.05.003; R Core Team, 2021, R LANGUAGE ENV STAT; Severini AD, 2011, CROP SCI, V51, P2796, DOI 10.2135/cropsci2011.03.0147; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; Vokes Martha S, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1417s82; Yati A, 2011, BIOTECHNIQUES, V51, P347, DOI 10.2144/000113753	20	208	215	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e54072	10.1371/journal.pone.0054072	http://dx.doi.org/10.1371/journal.pone.0054072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457446	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700004
J	Liao, MH; Shih, CC; Tsao, CM; Chen, SJ; Wu, CC				Liao, Mei-Hui; Shih, Chih-Chin; Tsao, Cheng-Ming; Chen, Shiu-Jen; Wu, Chin-Chen			RhoA/Rho-Kinase and Nitric Oxide in Vascular Reactivity in Rats with Endotoxaemia	PLOS ONE			English	Article							INDUCED CA2+ SENSITIZATION; SMOOTH-MUSCLE; MYOSIN PHOSPHATASE; PROTEIN-KINASE; SEPTIC SHOCK; RHO-KINASE; INDUCED HYPOTENSION; IN-VIVO; PHOSPHORYLATION; CONTRACTION	RhoA/Rho-kinase (RhoA/ROK) pathway promotes vasoconstriction by calcium sensitivity mechanism. LPS causes nitric oxide (NO) overproduction to induce vascular hyporeactivity. Thus, we tried to examine the role of RhoA/ROK and NO in the regulation of vascular reactivity in different time-point of endotoxaemia. Male Wistar rats were intravenously infused for 10 min with saline or E. coli endotoxin (lipopolysaccharide, LPS, 10 mg/kg) and divided to five groups (n = 8 in each group): (i) Control, sacrificed at 6 h after saline infusion; (ii) LPS1h, sacrificed at 1 h after LPS infusion; (iii) LPS2h, sacrificed at 2 h after LPS infusion; (iv) LPS4h, sacrificed at 4 h after LPS infusion; and (v) LPS6h, sacrificed at 6 h after LPS infusion. LPS1h and LPS2h were regarded as early endotoxaemia, whereas LPS4h and LPS6h were regarded as late endotoxaemia. Indeed, our results showed that LPS reproduced a biphasic hypotension and sustained vascular hyporeactivity to noradrenaline (NA) in vivo. Interestingly, this hyporeactivity did not occur in ex vivo during early endotoxaemia. This could be due to increases of aortic RhoA activity (n = 5, P<0.05) and myosin phosphatase targeting subunit 1 phosphorylation (n = 3, P<0.05). In addition, pressor response to NA and vascular reactivity in early endotoxaemia were inhibited by ROK inhibitor, Y27632. Furthermore, plasma bradykinin was increased at 10 min (24.6 +/- 13.7 ng/mL, n = 5, P<0.05) and aortic endothelial NO synthase expression was increased at 1 h (+200%. n = 3, P<0.05) after LPS. In late endotoxaemia, the vascular hyporeactivity was associated with aortic inducible NO synthase expression (n = 3, P<0.05) and an increased serum NO level (n = 8, P<0.05). Thus, an increased RhoA activity could compensate vascular hyporeactivity in early endotoxaemia, and the large NO production inhibiting RhoA activity would lead to vascular hyporeactivity eventually.	[Liao, Mei-Hui; Shih, Chih-Chin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Shih, Chih-Chin; Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Yang Ming Univ, Dept Anesthesiol, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Tsao, Cheng-Ming] Natl Def Med Ctr, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, SJ (corresponding author), Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan.	sjchen@knjc.edu.tw; ccwu@ndmctsgh.edu.tw			National Science Council, R.O.C., Taiwan [NSC 97-2320-B-345-001-MY2, 97-2320-B-016-006-MY3]	National Science Council, R.O.C., Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC 97-2320-B-345-001-MY2 and 97-2320-B-016-006-MY3 from the National Science Council, R.O.C., Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; Chen SJ, 2010, SHOCK, V33, P473, DOI 10.1097/SHK.0b013e3181bea334; Chitaley K, 2002, HYPERTENSION, V39, P438, DOI 10.1161/hy02t2.102960; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; da Silva-Santos JE, 2009, CRIT CARE MED, V37, P1716, DOI 10.1097/CCM.0b013e31819efb43; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; FLEMING I, 1991, EUR J PHARMACOL, V200, P375, DOI 10.1016/0014-2999(91)90602-M; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Ito K, 2003, J PHYSIOL-LONDON, V546, P823, DOI 10.1113/jphysiol.2002.030775; JONES SB, 1994, SHOCK, V2, P370, DOI 10.1097/00024382-199411000-00012; JULOUSCHAEFFER G, 1990, AM J PHYSIOL, V259, pH1038, DOI 10.1152/ajpheart.1990.259.4.H1038; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; KATORI M, 1989, BRIT J PHARMACOL, V98, P1383, DOI 10.1111/j.1476-5381.1989.tb12688.x; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; PALSSON J, 1988, CIRC SHOCK, V24, P133; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Shih CC, 2008, CRIT CARE MED, V36, P1864, DOI 10.1097/CCM.0b013e318173f982; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SZABO C, 1993, BRIT J PHARMACOL, V108, P786, DOI 10.1111/j.1476-5381.1993.tb12879.x; Takakura K, 2003, ANESTHESIOLOGY, V98, P928, DOI 10.1097/00000542-200304000-00020; Takakura K, 2002, CRIT CARE MED, V30, P894, DOI 10.1097/00003246-200204000-00030; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; Tsao CM, 2011, SHOCK, V35, P210, DOI 10.1097/SHK.0b013e3181f229f8; UENO A, 1995, BRIT J PHARMACOL, V114, P1250, DOI 10.1111/j.1476-5381.1995.tb13340.x; VanBavel E, 2001, EXP PHYSIOL, V86, P585, DOI 10.1113/eph8602217; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Wu CC, 1999, EUR J PHARMACOL, V373, P41, DOI 10.1016/S0014-2999(99)00265-4; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Yeon DS, 2002, CARDIOVASC RES, V53, P431, DOI 10.1016/S0008-6363(01)00496-5	34	21	23	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56331	10.1371/journal.pone.0056331	http://dx.doi.org/10.1371/journal.pone.0056331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457552	gold, Green Submitted, Green Published			2022-12-27	WOS:000315603700042
J	Augusto, DG; Piovezan, BZ; Tsuneto, LT; Callegari-Jacques, SM; Petzl-Erler, ML				Augusto, Danillo Gardenal; Piovezan, Bruno Zagonel; Tsuneto, Luiza Tamie; Callegari-Jacques, Sidia Maria; Petzl-Erler, Maria Luiza			KIR Gene Content in Amerindians Indicates Influence of Demographic Factors	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; KILLER-CELL RECEPTOR; MHC CLASS-I; NK CELLS; HAPLOTYPES CONTAIN; GENOMIC DIVERSITY; CUTTING EDGE; PCR-SSOP; HLA; POPULATIONS	Although the KIR gene content polymorphism has been studied worldwide, only a few isolated or Amerindian populations have been analyzed. This extremely diverse gene family codifies receptors that are expressed mainly in NK cells and bind HLA class I molecules. KIR-HLA combinations have been associated to several diseases and population studies are important to comprehend their evolution and their role in immunity. Here we analyzed, by PCR-SSP (specific sequencing priming), 327 individuals from four isolated groups of two of the most important Brazilian Amerindian populations: Kaingang and Guarani. The pattern of KIR diversity among these and other ten Amerindian populations disclosed a wide range of variation for both KIR haplotypes and gene frequencies, indicating that demographic factors, such as bottleneck and founder effects, were the most important evolutionary factors in shaping the KIR polymorphism in these populations.	[Augusto, Danillo Gardenal; Piovezan, Bruno Zagonel; Petzl-Erler, Maria Luiza] Univ Fed Parana, Lab Genet Mol Humana, BR-80060000 Curitiba, Parana, Brazil; [Tsuneto, Luiza Tamie] Univ Estadual Maringa, Lab Imunogenet, Maringa, Parana, Brazil; [Callegari-Jacques, Sidia Maria] Univ Fed Rio Grande do Sul, Dept Estat, Porto Alegre, RS, Brazil	Universidade Federal do Parana; Universidade Estadual de Maringa; Universidade Federal do Rio Grande do Sul	Petzl-Erler, ML (corresponding author), Univ Fed Parana, Lab Genet Mol Humana, BR-80060000 Curitiba, Parana, Brazil.	perler@ufpr.br	Petzl-Erler, Maria Luiza/H-8221-2012; Callegari-Jacques, Sidia M/H-1774-2016; Augusto, Danillo G/H-8179-2019; Augusto, Danillo/F-3147-2013	Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Augusto, Danillo G/0000-0001-5665-8547; CALLEGARI JACQUES, SIDIA M./0000-0002-2489-2539	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); PRONEX; Institutos do Milenio; Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX; Institutos do Milenio; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project received financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), PRONEX, Institutos do Milenio, Fundacao Araucaria, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by PRONEX (Programa de Apoio a Nucleos de Excelencia - Fundacao Araucaria and CNPq). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Augusto DG, 2012, IMMUNOGENETICS, V64, P143, DOI 10.1007/s00251-011-0565-1; Augusto DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039991; Braun-Prado K, 2000, TISSUE ANTIGENS, V56, P417, DOI 10.1034/j.1399-0039.2000.560504.x; Caggiari L, 2011, INT J BIOL MARKER, V26, P221, DOI 10.5301/JBM.2011.8903; Capittini C, 2012, GENES IMMUN, V13, P452, DOI 10.1038/gene.2012.14; Crum KA, 2000, TISSUE ANTIGENS, V56, P313, DOI 10.1034/j.1399-0039.2000.560403.x; Ewerton PD, 2007, IMMUNOGENETICS, V59, P625, DOI 10.1007/s00251-007-0229-3; Du ZY, 2007, IMMUNOGENETICS, V59, P1, DOI 10.1007/s00251-006-0168-4; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Flores AC, 2007, TISSUE ANTIGENS, V69, P568, DOI 10.1111/j.1399-0039.2007.00824.x; Foley B, 2008, INT IMMUNOL, V20, P555, DOI 10.1093/intimm/dxn013; Garcia-Leon JA, 2011, MOL IMMUNOL, V48, P1896, DOI 10.1016/j.molimm.2011.05.018; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gomez-Lozano N, 2005, EUR J IMMUNOL, V35, P16, DOI 10.1002/eji.200425493; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goodridge JP, 2007, EUR J IMMUNOL, V37, P199, DOI 10.1002/eji.200636316; Goodridge JP, 2003, J IMMUNOL, V171, P1768, DOI 10.4049/jimmunol.171.4.1768; Gutierrez-Rodriguez ME, 2006, HUM IMMUNOL, V67, P85, DOI 10.1016/j.humimm.2005.11.007; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Kulkarni S, 2010, METHODS MOL BIOL, V612, P365, DOI 10.1007/978-1-60761-362-6_25; Long EO, 1996, IMMUNOL TODAY, V17, P100, DOI 10.1016/0167-5699(96)80590-1; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Moesta AK, 2010, J IMMUNOL, V185, P4233, DOI 10.4049/jimmunol.1001951; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Connor GM, 2011, J IMMUNOL, V187, P2162, DOI 10.4049/jimmunol.1002906; Ordonez D, 2008, GENES IMMUN, V9, P431, DOI 10.1038/gene.2008.34; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parham P, 2004, IMMUNOL LETT, V92, P11, DOI 10.1016/j.imlet.2003.11.016; PETZLERLER ML, 1993, TISSUE ANTIGENS, V41, P227; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Rajalingam R, 2002, IMMUNOGENETICS, V53, P1009, DOI 10.1007/s00251-001-0425-5; Rajalingam R, 2008, IMMUNOGENETICS, V60, P207, DOI 10.1007/s00251-008-0286-2; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Slik ARVD, 2006, TISSUE ANTIGENS, P101; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Toneva M, 2001, TISSUE ANTIGENS, V57, P358, DOI 10.1034/j.1399-0039.2001.057004358.x; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Winter CC, 1998, J IMMUNOL, V161, P571; Witt CS, 1999, TRANSPLANTATION, V68, P1784, DOI 10.1097/00007890-199912150-00024; Yoo YJ, 2007, BIOINFORMATICS, V23, P2399, DOI 10.1093/bioinformatics/btm371; Yusa S, 2002, J IMMUNOL, V168, P5047, DOI 10.4049/jimmunol.168.10.5047; Zhi DJ, 2011, DIABETES-METAB RES, V27, P872, DOI 10.1002/dmrr.1264	56	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56755	10.1371/journal.pone.0056755	http://dx.doi.org/10.1371/journal.pone.0056755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451080	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500027
J	Chan, PC; Huang, SH; Yu, MC; Lee, SW; Huang, YW; Chien, ST; Lee, JJ				Chan, Pei-Chun; Huang, Su-Hua; Yu, Ming-Chih; Lee, Shih-Wei; Huang, Yi-Wen; Chien, Shun-Tien; Lee, Jen-Jyh		TMTC	Effectiveness of a Government-Organized and Hospital-Initiated Treatment for Multidrug-Resistant Tuberculosis Patients-A Retrospective Cohort Study	PLOS ONE			English	Article							TREATMENT OUTCOMES; TAIWAN; SURVIVAL; THERAPY; LATVIA	Background: In contrast to the conventional model of hospital-treated and government directly observed treatment (DOT) for multidrug-resistant tuberculosis (MDR-TB) patient care, the Taiwan MDR-TB Consortium (TMTC) was launched in May 2007 with the collaboration of five medical care groups that have provided both care and DOT. This study aimed to determine whether the TMTC provided a better care model for MDR-TB patients than the conventional model. Methods and Findings: A total of 651 pulmonary MDR-TB patients that were diagnosed nation-wide from January 2000-August 2008 were enrolled. Of those, 290 (45%) MDR-TB patients whose initial sputum sample was taken in January 2007 or later were classified as patients in the TMTC era. All others were classified as patients in the pre-TMTC era. The treatment success rate at 36 months was better in the TMTC era group (82%) than in the pre-TMTC era group (61%) (p<0.001). With multiple logistic regressions, diagnosis in the TMTC era (adjusted odds ratio (aOR) 2.8, 95% confidence interval (CI) 1.9-4.2) was an independent predictor of a higher treatment success rate at 36 months. With the time-dependent proportional hazards method, a higher treatment success rate was still observed in the TMTC era group compared to the pre-TMTC era group (adjusted hazard ratio 6.3, 95% CI 4.2-9.5). Conclusion: The improved treatment success observed in the TMTC era compared to the pre-TMTC era is encouraging. The detailed TMTC components that contribute the most to the improved outcome will need confirmation in follow-up studies with large numbers of MDR-TB patients.	[Chan, Pei-Chun; Huang, Su-Hua] Ctr Dis Control, Div 3, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Dept Internal Med, Wan Fang Hosp, Taipei, Taiwan; [Lee, Shih-Wei] Tao Yuan Gen Hosp, Dept Hlth, Pulm & Crit Care Unit, Tao Yuan, Taiwan; [Huang, Yi-Wen] Chang Hua Hosp, Dept Hlth, Pulm & Crit Care Unit, Changhua, Taiwan; [Chien, Shun-Tien] Chest Hosp, Dept Hlth, Pulm & Crit Care Unit, Tainan, Taiwan; [Lee, Jen-Jyh] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University; Taipei Municipal WanFang Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Chan, PC (corresponding author), Ctr Dis Control, Div 3, Taipei, Taiwan.	pcanita.tw@cdc.gov.tw			Centers for Disease Control, Taiwan [DOH 100-DC-2005]	Centers for Disease Control, Taiwan	This study was supported by the Centers for Disease Control, Taiwan (Grant DOH 100-DC-2005), to which interim progress reports were submitted. The funding body had no role in study design, data analysis, data interpretation or writing of the report, except data collection.	[Anonymous], 2008, GUID PROGR MAN DRUG; Bloss E, 2012, INT J TUBERC LUNG D, V16, P462, DOI 10.5588/ijtld.11.0121; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2009, INT J TUBERC LUNG D, V13, P548; Chiang CY, 2002, INT J TUBERC LUNG D, V6, P974; Furin J, 2011, INT J TUBERC LUNG D, V15, P1294, DOI 10.5588/ijtld.10.0591; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Huang SH, 2009, TAIWAN EPIDEMIOLOGY, V25, P86; Jeon DS, 2011, J KOREAN MED SCI, V26, P33, DOI 10.3346/jkms.2011.26.1.33; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Leimane V, 2010, EUR RESPIR J, V36, P584, DOI 10.1183/09031936.00003710; Li YH, 2010, HEALTH POLICY PLANN, V25, P334, DOI 10.1093/heapol/czq006; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Sadaphal P, 2001, CLIN INFECT DIS, V33, P1687, DOI 10.1086/323896; Su CT, 2010, TAIWAN EPIDEMIOLOGY, V26, P400; Taiwan CDC, 2009, TAIW TUB CONTR REP 2; Tang SJ, 2011, SCAND J INFECT DIS, V43, P280, DOI 10.3109/00365548.2010.548080; Tsai WC, 2010, J INFECTION, V61, P235, DOI 10.1016/j.jinf.2010.06.016; World Health Organization, 2006, GUID PROGR MAN DRUG; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4	25	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57719	10.1371/journal.pone.0057719	http://dx.doi.org/10.1371/journal.pone.0057719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451263	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500130
J	Koch, O; Cappel, D; Nocker, M; Jager, T; Flohe, L; Sotriffer, CA; Selzer, PM				Koch, Oliver; Cappel, Daniel; Nocker, Monika; Jaeger, Timo; Flohe, Leopold; Sotriffer, Christoph A.; Selzer, Paul M.			Molecular Dynamics Reveal Binding Mode of Glutathionylspermidine by Trypanothione Synthetase	PLOS ONE			English	Article							CRITHIDIA-FASCICULATA; TRYPANOSOMA-CRUZI; RESP MODEL; BIOSYNTHESIS; CHEMOTHERAPY; METABOLISM; BRUCEI; SYSTEM; LEISHMANIASIS; PURIFICATION	The trypanothione synthetase (TryS) catalyses the two-step biosynthesis of trypanothione from spermidine and glutathione and is an attractive new drug target for the development of trypanocidal and antileishmanial drugs, especially since the structural information of TryS from Leishmania major has become available. Unfortunately, the TryS structure was solved without any of the substrates and lacks loop regions that are mechanistically important. This contribution describes docking and molecular dynamics simulations that led to further insights into trypanothione biosynthesis and, in particular, explains the binding modes of substrates for the second catalytic step. The structural model essentially confirm previously proposed binding sites for glutathione, ATP and two Mg2+ ions, which appear identical for both catalytic steps. The analysis of an unsolved loop region near the proposed spermidine binding site revealed a new pocket that was demonstrated to bind glutathionylspermidine in an inverted orientation. For the second step of trypanothione synthesis glutathionylspermidine is bound in a way that preferentially allows N-1-glutathionylation of N-8-glutathionylspermidine, classifying N-8-glutathionylspermidine as the favoured substrate. By inhibitor docking, the binding site for N-8-glutathionylspermidine was characterised as druggable.	[Koch, Oliver; Selzer, Paul M.] MSD Anim Hlth Innovat GmbH, Schwabenheim, Germany; [Koch, Oliver; Jaeger, Timo] MOLISA GmbH, Magdeburg, Germany; [Cappel, Daniel; Nocker, Monika; Sotriffer, Christoph A.] Univ Wurzburg, Inst Pharm & Food Chem, D-97070 Wurzburg, Germany; [Flohe, Leopold] Otto von Guericke Univ, Magdeburg, Germany; [Selzer, Paul M.] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Selzer, Paul M.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Selzer, Paul M.] Univ Glasgow, Fac Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland	Merck & Company; Intervet International B.V.; University of Wurzburg; Otto von Guericke University; Eberhard Karls University of Tubingen; University of Glasgow; University of Glasgow	Koch, O (corresponding author), TU Dortmund Univ, Fac Chem, Dortmund, Germany.	oliver.koch@tu-dortmund.de; paul.selzer@msd.de	Koch, Oliver/E-4599-2018	Cappel, Daniel/0000-0002-8460-7867; Koch, Oliver/0000-0001-9228-217X	Bundesministerium fur Bildung und Forschung of the German Federal Republic [FKZ 0315814A]	Bundesministerium fur Bildung und Forschung of the German Federal Republic	The work was performed in the context of the COST Action CM0801 "New Drugs for Neglected Diseases'' and supported by the Bundesministerium fur Bildung und Forschung of the German Federal Republic (FKZ 0315814A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Castro H, 2008, ANTIOXID REDOX SIGN, V10, P1593, DOI 10.1089/ars.2008.2050; Comini M, 2003, BIOL CHEM, V384, P653, DOI 10.1515/BC.2003.072; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1986, MOL BIOCHEM PARASIT, V21, P247, DOI 10.1016/0166-6851(86)90130-1; Flohe L, 2012, BIOTECHNOL ADV, V30, P294, DOI 10.1016/j.biotechadv.2011.05.012; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; HENDERSON GB, 1990, BIOCHEMISTRY-US, V29, P3924, DOI 10.1021/bi00468a019; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Korb O, 2010, J CHEMOINF, V2, P25; Krauth-Siegel Luise R., 2007, V44, P231; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lin CH, 1997, CHEM BIOL, V4, P859, DOI 10.1016/S1074-5521(97)90118-6; McGuire JJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P140, DOI 10.1016/j.abb.2009.06.017; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oza SL, 2008, FEBS J, V275, P5408, DOI 10.1111/j.1742-4658.2008.06670.x; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Pai CH, 2006, EMBO J, V25, P5970, DOI 10.1038/sj.emboj.7601440; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shlomai J, 2010, ANTIOXID REDOX SIGN, V13, P1429, DOI 10.1089/ars.2009.3029; SMITH K, 1992, PROTEIN SCI, V1, P874, DOI 10.1002/pro.5560010705; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WHO Expert Committee, 2010, M WHO EXP COMM CONTR; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x	45	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56788	10.1371/journal.pone.0056788	http://dx.doi.org/10.1371/journal.pone.0056788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451087	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500030
J	Kumar, NP; Sridhar, R; Banurekha, VV; Nair, D; Jawahar, MS; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Sridhar, Rathinam; Banurekha, Vaithilingam V.; Nair, Dina; Jawahar, Mohideen S.; Nutman, Thomas B.; Babu, Subash			Expansion of Pathogen-Specific Mono- and Multifunctional Th1 and Th17 Cells in Multi-Focal Tuberculous Lymphadenitis	PLOS ONE			English	Article							REGULATORY T-CELLS; ACTIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; INTERFERON-GAMMA; IMMUNE-RESPONSES; EXPRESSION; IL-23; IL-17; DIFFERENTIATION	Background: Th1 and Th17 responses are known to play an important role in immunity to pulmonary tuberculosis (PTB), although little is known about their role in extrapulmonary forms of tuberculosis (TB). Methods: To identify the role of Th1, Th17, and Th22 cells in multi-focal TB lymphadenitis (TBL), we examined mycobacteria-specific immune responses in the whole blood of individuals with PTB (n = 20) and compared them with those with TBL (n = 25). Results: Elevated frequencies of CD4(+) T cells expressing IFN- gamma, TNF-alpha, and IL-2 were present in individuals with TBL compared with those with PTB at baseline and in response to ESAT-6 and CFP-10. Similarly, increased frequencies of CD4(+) T cells expressing IL-17A, IL-17F, and IFN-gamma were also present in individuals with TBL at baseline and following ESAT-6 and CFP-10 stimulation although no significant difference in frequency of Th22 cells was observed. Finally, frequencies of Th1 (but not Th17) cells exhibited a significantly negative correlation with natural regulatory T cell frequencies at baseline. Conclusions: Multi-focal TB lymphadenitis is therefore characterized by elevated frequencies of Th1 and Th17 cells, indicating that Th1 and Th17 responses in TB disease are probably correlates of disease severity rather than of protective immunity.	[Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Chennai, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Chennai, Tamil Nadu, India; [Banurekha, Vaithilingam V.; Nair, Dina; Jawahar, Mohideen S.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Int Ctr Excellence Res, Natl Inst Hlth, Chennai, Tamil Nadu, India.	sbabu@mail.nih.gov	Kumar, Nathella Pavan/AAU-2328-2021; Babu, Subash/GXG-4746-2022		Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000197, ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Cooper AM, 2012, CURR OPIN IMMUNOL; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handa U, 2012, J INFECT DEV COUNTR, V6, P6, DOI 10.3855/jidc.2090; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020165; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Millington KA, 2010, J INFECT DIS, V202, P1685, DOI 10.1086/656772; Mohapatra Prasanta Raghab, 2009, J Assoc Physicians India, V57, P585; Nemeth J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035290; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Qiao D, 2011, SCAND J IMMUNOL, V73, P330, DOI 10.1111/j.1365-3083.2011.02512.x; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Rutz S, 2011, CURR OPIN IMMUNOL, V23, P605, DOI 10.1016/j.coi.2011.07.018; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Winkler S, 2005, MICROBES INFECT, V7, P1161, DOI 10.1016/j.micinf.2005.03.020; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57123	10.1371/journal.pone.0057123	http://dx.doi.org/10.1371/journal.pone.0057123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451159	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500066
J	Lee, M; Kim, SE; Kim, WS; Lee, J; Yoo, HK; Park, KD; Choi, KG; Jeong, SY; Kim, BG; Lee, HW				Lee, Mina; Kim, Song E.; Kim, Won Sup; Lee, Jungyeun; Yoo, Hye Kyung; Park, Kee-Duk; Choi, Kyoung-Gyu; Jeong, Seon-Yong; Kim, Byung Gon; Lee, Hyang Woon			Interaction of Motor Training and Intermittent Theta Burst Stimulation in Modulating Motor Cortical Plasticity: Influence of BDNF Val66Met Polymorphism	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SYNAPTIC-TRANSMISSION; CORTICOSPINAL EXCITABILITY; ANTIDEPRESSANT RESPONSE; DEPENDENT PLASTICITY; BRAIN-STIMULATION; CHRONIC STROKE; CORTEX; METAPLASTICITY; RECOVERY	Cortical physiology in human motor cortex is influenced by behavioral motor training (MT) as well as repetitive transcranial magnetic stimulation protocol such as intermittent theta burst stimulation (iTBS). This study aimed to test whether MT and iTBS can interact with each other to produce additive changes in motor cortical physiology. We hypothesized that potential interaction between MT and iTBS would be dependent on BDNF Val66Met polymorphism, which is known to affect neuroplasticity in the human motor cortex. Eighty two healthy volunteers were genotyped for BDNF polymorphism. Thirty subjects were assigned for MT alone, 23 for iTBS alone, and 29 for MT + iTBS paradigms. TMS indices for cortical excitability and motor map areas were measured prior to and after each paradigm. MT alone significantly increased the motor cortical excitability and expanded the motor map areas. The iTBS alone paradigm also enhanced excitability and increased the motor map areas to a slightly greater extent than MT alone. A combination of MT and iTBS resulted in the largest increases in the cortical excitability, and the representational motor map expansion of MT + iTBS was significantly greater than MT or iTBS alone only in Val/Val genotype. As a result, the additive interaction between MT and iTBS was highly dependent on BDNF Val66Met polymorphism. Our results may have clinical relevance in designing rehabilitative strategies that combine therapeutic cortical stimulation and physical exercise for patients with motor disabilities.	[Lee, Mina; Kim, Song E.; Kim, Won Sup; Lee, Jungyeun; Yoo, Hye Kyung; Park, Kee-Duk; Choi, Kyoung-Gyu; Lee, Hyang Woon] Ewha Womans Univ, Dept Neurol, Sch Med, Seoul, South Korea; [Lee, Mina; Kim, Song E.; Kim, Won Sup; Lee, Hyang Woon] Ewha Med Res Inst, Seoul, South Korea; [Jeong, Seon-Yong] Ajou Univ, Sch Med, Dept Med Genet, Suwon 441749, South Korea; [Kim, Byung Gon] Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea	Ewha Womans University; Ewha Womans University; Ajou University; Ajou University	Kim, BG (corresponding author), Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea.	kimbg@ajou.ac.kr; leeh@ewha.ac.kr	Kim, Byung Gon/L-6884-2019	Kim, Byung Gon/0000-0003-2233-9569; LEE, Jungyeun/0000-0002-3544-1098	Chronic Inflammatory Disease Research Center through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012051429, R01-2001-0015788, KRF-2009-006-5721, 2009-007-2164]; Ewha Global Top 5 Grant of Ewha Womans University; Korean Science and Engineering Foundation Grant; South Korean government (MOST) [R01-2007-000-11080-0]; Basic Science Research Program through the National Research Foundation of Korea	Chronic Inflammatory Disease Research Center through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ewha Global Top 5 Grant of Ewha Womans University; Korean Science and Engineering Foundation Grant(Korea Science and Engineering Foundation); South Korean government (MOST)(Ministry of Science & Technology (MOST), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Chronic Inflammatory Disease Research Center through the National Research Foundation of Korea (http://www.nrf.re.kr/html/en/) funded by the Ministry of Education, Science and Technology 2012051429) to BGK, and by the Ewha Global Top 5 Grant 2011 of Ewha Womans University and by the Korean Science and Engineering Foundation Grant (http://www.kosef.re.kr/) funded by the South Korean government (MOST) (R01-2007-000-11080-0), and by the Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re.kr/html/en/) funded by the Ministry of Education, Science and Technology (R01-2001-0015788, KRF-2009-006-5721 and 2009-007-2164) to HWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Butefisch CM, 2002, ANN NEUROL, V51, P59, DOI 10.1002/ana.10056; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Dobkin BH, 2008, NAT CLIN PRACT NEURO, V4, P76, DOI 10.1038/ncpneuro0709; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Gur RC, 2002, AM J GERIAT PSYCHIAT, V10, P72, DOI 10.1176/appi.ajgp.10.1.72; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang YZ, 2011, CLIN NEUROPHYSIOL, V122, P1011, DOI 10.1016/j.clinph.2010.08.016; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Iezzi E, 2008, J NEUROPHYSIOL, V100, P2070, DOI 10.1152/jn.90521.2008; Iezzi E, 2011, EUR J NEUROSCI, V33, P1908, DOI 10.1111/j.1460-9568.2011.07674.x; Iyer MB, 2003, J NEUROSCI, V23, P10867; Jung P, 2009, J NEUROSCI, V29, P5597, DOI 10.1523/JNEUROSCI.0222-09.2009; Kaneko K, 1996, ELECTROMYOGR MOTOR C, V101, P478, DOI 10.1016/S0921-884X(96)96021-X; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Malcolm MP, 2007, AM J PHYS MED REHAB, V86, P707, DOI 10.1097/PHM.0b013e31813e0de0; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Paulus W, 2005, NEURON, V45, P181, DOI 10.1016/j.neuron.2005.01.008; Rose CR, 2004, BIOESSAYS, V26, P1185, DOI 10.1002/bies.20118; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schwenkreis P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-35; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P333, DOI 10.1016/j.clinph.2006.10.014; Tsai SJ, 2003, AM J MED GENET B, V123B, P19, DOI 10.1002/ajmg.b.20026; Tyc F, 2006, REV NEUROSCIENCE, V17, P469; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Wu K, 2004, MOL BRAIN RES, V130, P178, DOI 10.1016/j.molbrainres.2004.07.019; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	51	35	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57690	10.1371/journal.pone.0057690	http://dx.doi.org/10.1371/journal.pone.0057690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451258	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500125
J	Xing, W; He, XZ; Kassir, MA; Chen, J; Ding, JL; Sun, J; Hu, JN; Zhang, ZS; Haacke, EM; Dai, YM				Xing, Wei; He, Xiaozhou; Kassir, Mohammad A.; Chen, Jie; Ding, Jiule; Sun, Jun; Hu, Jiani; Zhang, Zishu; Haacke, E. Mark; Dai, Yongming			Evaluating Hemorrhage in Renal Cell Carcinoma Using Susceptibility Weighted Imaging	PLOS ONE			English	Article							MRI; LESIONS; CT; EXPERIENCE; CHILDREN; SUBTYPES; TUMORS; SWI	Background: Intratumoral hemorrhage is a frequent occurrence in renal cell carcinoma and is an indicator of tumor subtype. We hypothesize that susceptibility weighted imaging (SWI) is sensitive to hemorrhage in renal cell carcinoma and can give a more diagnostic image when compared to conventional imaging techniques. Materials and Methods: A retrospective review of 32 patients with clear cell renal cell carcinoma was evaluated. All patients underwent magnetic resonance imaging (MRI) and 22 out of 32 patients also underwent a computed tomography (CT) scan. Hemorrhage was classified into 3 different categories according to shape and distribution. Histopathology was obtained from all masses by radical nephrectomy. The ability to detect the presence of hemorrhage using CT, non-contrast conventional MRI and SWI was evaluated, and the patterns of hemorrhage were compared. Results: Using pathologic results as the gold standard, the sensitivities of non-contrast conventional MRI, SWI and CT in detecting hemorrhage in clear cell renal cell carcinoma were 65.6%, 100% and 22.7%, respectively. Accuracy of non-contrast conventional MRI and SWI in evaluating hemorrhagic patterns were 31.3% and 100%, respectively. Conclusion: These results demonstrate that SWI can better reveal hemorrhage and characterize the pattern more accurately than either non-contrast conventional MRI or CT. This suggests that SWI is the technique of choice for detecting hemorrhagic lesions in patients with renal cancer.	[Xing, Wei; Chen, Jie; Ding, Jiule; Sun, Jun] Suzhou Univ, Dept Radiol, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China; [He, Xiaozhou] Suzhou Univ, Dept Urol, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China; [Kassir, Mohammad A.; Hu, Jiani; Zhang, Zishu; Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Dai, Yongming] MR Collaborat NE Asia, Siemens Healthcare China, Shanghai, Peoples R China	Wayne State University; Siemens AG	He, XZ (corresponding author), Suzhou Univ, Dept Urol, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China.	czxiaozhouhe@sina.com						Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Casillas VJ, 2000, RADIOGRAPHICS, V20, P367, DOI 10.1148/radiographics.20.2.g00mc10367; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036454; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Grignon DJ, 2005, CLIN LAB MED, V25, P305, DOI 10.1016/j.cll.2005.01.012; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; John G, 1997, JMRI-J MAGN RESON IM, V7, P157, DOI 10.1002/jmri.1880070123; Kim JK, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781499; Kim S, 2010, J MAGN RESON IMAGING, V31, P348, DOI 10.1002/jmri.22038; Latif F, 2011, J PAK MED ASSOC, V61, P224; Leveridge MJ, 2010, NAT REV UROL, V7, P311, DOI 10.1038/nrurol.2010.63; Linehan MW, 2001, PRINCIPLES PRACTICE, P1362; LJUNGBERG B, 1995, J UROLOGY, V154, P1681, DOI 10.1016/S0022-5347(01)66749-1; Martorana G, 2006, EUR UROL SUPPL, V5, P600, DOI 10.1016/j.eursup.2006.04.002; McAninch JW, 2002, CAMPBELLS UROLOGY, V4, p3,707; MCCLENNAN BL, 1994, RADIOL CLIN N AM, V32, P55; McKinney AM, 2012, AM J NEURORADIOL, V33, P896, DOI 10.3174/ajnr.A2886; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; PAAJANEN H, 1987, INVEST RADIOL, V22, P792, DOI 10.1097/00004424-198710000-00005; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Razek AAKA, 2011, J COMPUT ASSIST TOMO, V35, P332, DOI 10.1097/RCT.0b013e318219fe76; Rofsky N M, 1997, Magn Reson Imaging Clin N Am, V5, P67; ROUBIDOUX MA, 1994, RADIOGRAPHICS, V14, P1033, DOI 10.1148/radiographics.14.5.7991812; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Shinmoto H, 1998, JMRI-J MAGN RESON IM, V8, P690, DOI 10.1002/jmri.1880080327; Silverman SG, 2007, RADIOGRAPHICS, V27, P1131, DOI 10.1148/rg.274065147; Simon JW, 2000, CLIN ONCOLOGY, P1784; Thomsen TW, 2004, J EMERG MED, V26, P331, DOI 10.1016/j.jemermed.2003.12.012; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wagner B J, 1997, Magn Reson Imaging Clin N Am, V5, P13; Walsh DO, 2000, MAGNET RESON MED, V43, P682, DOI 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617	34	19	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57691	10.1371/journal.pone.0057691	http://dx.doi.org/10.1371/journal.pone.0057691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451259	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500126
J	Yoon, JH; Han, KH; Kim, EK; Moon, HJ; Kim, MJ; Suh, YJ; Choi, JS; Park, BW				Yoon, Jung Hyun; Han, Kyung Hwa; Kim, Eun-Kyung; Moon, Hee Jung; Kim, Min Jung; Suh, Young Joo; Choi, Ji Soo; Park, Byeong-Woo			Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; NEURON-SPECIFIC ENOLASE; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN-19 FRAGMENTS; NEOADJUVANT CHEMOTHERAPY; SERUM CYFRA-21-1; PLEURAL FLUID; HIGH-RISK; ULTRASOUND; BIOPSY	Introduction: To assess whether the value of CYFRA21-1 in the aspirates of ultrasonography-guided fine-needle aspiration biopsy (US-FNAB) can contribute to improving the performances of US-FNAB in the diagnosis of axillary lymph node (LN) metastasis in breast cancer patients. Methods: US-FNAB was performed in 156 axillary LNs in 152 breast cancer patients (mean age: 51.4 years, range: 17-92 years). Concentrations of CYFRA21-1 were measured from washouts of the syringe used during US-FNAB. Tumor marker concentrations, US-FNAB, intraoperative sentinel node biopsy (SNB), and surgical pathology results were reviewed and analyzed. For comparison, the values of CEA and CA15-3 were also measured from washouts. Results: Among the 156 LNs, 75 (48.1%) were benign, and 81 (51.9%) were metastases. Mean concentrations of CYFRA21-1 were significantly higher in metastasis compared to benign LNs (P<0.001). US-FNAB combined to CYFRA21-1 showed significantly higher sensitivity, NPV, and accuracy compared to US-FNAB alone (all values P<0.05). All diagnostic indices of US-FNAB combined to CYFRA21-1 were significantly higher compared to US-FNAB combined with CEA or CA15-3 (all P<0.001). Of the 28 metastatic LNs which showed metastasis on SNB, CYFRA21-1 showed higher positive rate of 75.0% (CEA or CA15-3:60.7%, P = 0.076). Conclusion: Measuring CYFRA 21-1 concentrations from US-FNAB aspirates improves sensitivity, NPV, and accuracy of US-FNAB alone, and may contribute to reducing up to 75.0% of unnecessary intraoperative SNB. Compared to CEA or CA15-3, CYFRA21-1 shows significantly higher performances when combined to US-FNAB in the preoperative diagnosis of LN metastasis in breast cancer patients.	[Yoon, Jung Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Kim, Min Jung; Suh, Young Joo] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Yoon, Jung Hyun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea; [Han, Kyung Hwa] Yonsei Univ, Coll Med, Dept Res Affairs, Seoul, South Korea; [Choi, Ji Soo] Natl Canc Ctr, Dept Radiol, Goyang, South Korea; [Park, Byeong-Woo] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Suh, Young Joo/0000-0002-2078-5832; Yoon, Jung Hyun/0000-0002-2100-3513; Moon, Hee Jung/0000-0002-5643-5885; Han, Kyunghwa/0000-0002-5687-7237; Park, Byeong-Woo/0000-0003-1353-2607	faculty research grant of Yonsei University College of Medicine [6-2010-0116]	faculty research grant of Yonsei University College of Medicine	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2010(6-2010-0116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikuwari E, 2008, CANCER CYTOPATHOL, V114, P89, DOI 10.1002/cncr.23344; Altomare V, 2007, SURG TODAY, V37, P735, DOI 10.1007/s00595-006-3366-7; Bedrosian I, 2003, ANN SURG ONCOL, V10, P1025, DOI 10.1245/ASO.2003.12.017; Bonnema J, 1997, WORLD J SURG, V21, P270, DOI 10.1007/s002689900227; Choi JS, 2012, ULTRASOUND MED BIOL, V38, P1881, DOI 10.1016/j.ultrasmedbio.2012.07.011; Ciatto S, 2007, BREAST CANCER RES TR, V103, P85, DOI 10.1007/s10549-006-9355-0; Davis JT, 2006, ANN SURG ONCOL, V13, P1545, DOI 10.1245/s10434-006-9095-8; de Kanter AY, 1999, BRIT J SURG, V86, P1459, DOI 10.1046/j.1365-2168.1999.01243.x; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Ferrer J, 1999, CANCER-AM CANCER SOC, V86, P1488, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y; Godey F, 2012, BREAST CANCER RES TR, V131, P509, DOI 10.1007/s10549-011-1808-4; Houssami N, 2011, ANN SURG, V254, P243, DOI 10.1097/SLA.0b013e31821f1564; Hughes SJ, 2006, ANN SURG, V243, P389, DOI 10.1097/01.sla.0000201541.68577.6a; Ishitobi M, 2012, CANCER-AM CANCER SOC, V118, P4385, DOI 10.1002/cncr.27377; Kim MJ, 2010, RADIOLOGY, V254, P691, DOI 10.1148/radiol.09091031; Koelliker SL, 2008, RADIOLOGY, V246, P81, DOI 10.1148/radiol.2463061463; Krishnamurthy S, 2002, CANCER, V95, P982, DOI 10.1002/cncr.10786; Kuenen-Boumeester V, 2003, EUR J CANCER, V39, P170, DOI 10.1016/S0959-8049(02)00501-4; Lee JH, 2005, CHEST, V128, P2298, DOI 10.1378/chest.128.4.2298; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mitas M, 2001, INT J CANCER, V93, P162, DOI 10.1002/ijc.1312; Moore A, 2008, BRIT J RADIOL, V81, P630, DOI 10.1259/bjr/21933846; Nakata B, 2004, BRIT J CANCER, V91, P873, DOI 10.1038/sj.bjc.6602074; Nakata B, 2000, CANCER, V89, P1285, DOI 10.1002/1097-0142(20000915)89:6<1285::AID-CNCR13>3.0.CO;2-G; NCCN, 2012, NCCN GUID ONC BREAST; Nissan A, 2006, BRIT J CANCER, V94, P681, DOI 10.1038/sj.bjc.6602992; Papa MZ, 2008, J SURG ONCOL, V98, P403, DOI 10.1002/jso.21128; Park SH, 2010, ANN SURG ONCOL; Rodriguez CA, 2002, CANCER, V95, P670, DOI 10.1002/cncr.10692; Schem C, 2009, VIRCHOWS ARCH, V454, P203, DOI 10.1007/s00428-008-0703-9; Snook KL, 2011, BRIT J SURG, V98, P527, DOI 10.1002/bjs.7347; Suh YJ, 2011, AM J ROENTGENOL, V197, pW730, DOI 10.2214/AJR.11.6713; Tamaki Y, 2012, CANCER-AM CANCER SOC, V118, P3477, DOI 10.1002/cncr.26683; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Vegue LB, 2012, DIAGN MOL PATHOL; Vilardell F, 2012, VIRCHOWS ARCH, V460, P569, DOI 10.1007/s00428-012-1241-z; Yoshihara E, 2012, BREAST; Zhang L, 2012, SURG ONCOL, V21, P252, DOI 10.1016/j.suronc.2012.06.006	38	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57248	10.1371/journal.pone.0057248	http://dx.doi.org/10.1371/journal.pone.0057248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451192	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500080
J	Andrews, J; Pruessner, JC				Andrews, Julie; Pruessner, Jens C.			The Combined Propranolol/TSST Paradigm - A New Method for Psychoneuroendocrinology	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; STRESS RESPONSES; NERVOUS-SYSTEM; BLOOD-PRESSURE; CORTISOL; DISORDERS; HUMANS; GLUCOCORTICOIDS; NOREPINEPHRINE; DEPRESSION	Upon perception of a stimulus as stressful, the human brain reacts with the activation of the hypothalamus-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS), to mobilize energy resources to better cope with the stressor. Since the perception of the stressor is the initial stimulus, a synchronicity between the subjective perception of stress and the physiological stress reactivity should be expected. However, according to a recent meta-analysis, these associations are weak and inconsistent. The goal of the current study was to investigate the interaction between the SNS, HPA and subjective stress perceptions, by introducing an experimental manipulation of this interaction. For this purpose, we combined the SNS inhibitor propranolol with the Trier Social Stress Test, and measured endocrinological and psychological responses to the stressor. Thirty healthy male participants were recruited and randomly assigned to either a propranolol (PROP; n = 15) or placebo (PLC; n = 15) group. All subjects were administered 80 mg of propranolol 60 minutes prior to exposure to psychosocial stress. Salivary cortisol and alpha amylase (sAA), heart rate, blood pressure and subjective stress responses were assessed throughout the study. We observed significantly reduced sAA levels and heart rate increases in the PROP group in response to stress, with no effects of the drug on systolic or diastolic blood pressure changes. In line with previous studies, a significant increase in cortisol was seen in response to the stress exposure. Importantly, the cortisol increase was significantly higher in the PROP group. A typical increase in subjective stress could be seen in both groups, with no significant group differences emerging. Complementing previous work, this study further demonstrates a significant interaction between the HPA and the SNS during acute stress. The HPA activity was found to be elevated in the presence of a suppressed SNS in reactivity to the TSST.	[Andrews, Julie] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Pruessner, Jens C.] McGill Univ, Fac Med, McGill Ctr Studies Aging, Montreal, PQ, Canada	McGill University; McGill University	Pruessner, JC (corresponding author), McGill Univ, Fac Med, McGill Ctr Studies Aging, Montreal, PQ, Canada.	jens.pruessner@mcgill.ca		Pruessner, Jens/0000-0002-8582-2980	Canadian Institutes of Health Research (CIHR); NERC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by grants from the Canadian Institutes of Health Research (CIHR) and NERC to JCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038994; Bauer AM, 2002, J DEV BEHAV PEDIATR, V23, P102, DOI 10.1097/00004703-200204000-00007; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benschop RJ, 1996, FASEB J, V10, P517, DOI 10.1096/fasebj.10.4.8647351; Campbell J., 2012, PSYCHONEUROENDOCRINO; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; DANIELL HB, 1976, J PHARMACOL EXP THER, V196, P657; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Engert V, 2011, PSYCHONEUROENDOCRINO; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; FRAUNDORFER PF, 1994, J PHARMACOL EXP THER, V270, P665; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Gordis EB, 2008, HORM BEHAV, V53, P96, DOI 10.1016/j.yhbeh.2007.09.002; Hellhammer J, 2011, PSYCHONEUROENDOCRINO; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kizildere S, 2003, EUR J ENDOCRINOL, V148, P45, DOI 10.1530/eje.0.1480045; Krampen G, 1991, COMPETENCE CONTROL Q; LASSER NL, 1989, AM J MED, V86, P98, DOI 10.1016/0002-9343(89)90142-3; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; Ledowski T, 2011, EUR J ANAESTH, V28, P433, DOI 10.1097/EJA.0b013e328343d524; Maheu FS, 2005, J CLIN ENDOCR METAB, V90, P1697, DOI 10.1210/jc.2004-0009; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Oei NYL, 2010, NEUROBIOL LEARN MEM, V93, P388, DOI 10.1016/j.nlm.2009.12.005; Pacak K, 2000, PHYSIOL RES, V49, pS11; PACAK K, 1995, FRONT NEUROENDOCRIN, V16, P89, DOI 10.1006/frne.1995.1004; Palermo TM, 2007, CLIN J PAIN, V23, P812, DOI 10.1097/AJP.0b013e318156ca63; PARKER G, 1979, BRIT J PSYCHIAT, V134, P138, DOI 10.1192/bjp.134.2.138; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; SAELENS DA, 1977, J PHARMACOL EXP THER, V202, P635; SALEM SAM, 1984, BRIT J CLIN PHARMACO, V17, P31, DOI 10.1111/j.1365-2125.1984.tb04995.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Simeckova M, 2000, J THERM BIOL, V25, P437, DOI 10.1016/S0306-4565(00)00007-3; TACKETT RL, 1981, SCIENCE, V213, P911, DOI 10.1126/science.7256285; TUROSS N, 1986, J PHARMACOL EXP THER, V237, P739; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Viru A, 2007, EUR J APPL PHYSIOL, V100, P241, DOI 10.1007/s00421-007-0416-9; Winzer A, 1999, PSYCHOPHYSIOLOGY, V36, P591, DOI 10.1111/1469-8986.3650591; Young R, 2009, PSYCHOPHARMACOLOGY, V203, P369, DOI 10.1007/s00213-008-1317-2	46	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57567	10.1371/journal.pone.0057567	http://dx.doi.org/10.1371/journal.pone.0057567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451243	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800111
J	Oishi, K; Miyamoto, Y; Saito, H; Murase, K; Ono, K; Sawada, M; Watanabe, M; Noguchi, Y; Fujiwara, T; Hayashi, S; Noguchi, H				Oishi, Koichi; Miyamoto, Yoshitaka; Saito, Hiroaki; Murase, Katsutoshi; Ono, Kenji; Sawada, Makoto; Watanabe, Masami; Noguchi, Yasufumi; Fujiwara, Toshiyoshi; Hayashi, Shuji; Noguchi, Hirofumi			In Vivo Imaging of Transplanted Islets Labeled with a Novel Cationic Nanoparticle	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; MAGNETIC NANOPARTICLES; PANCREATIC-ISLETS; PROTEIN TRANSDUCTION; CELLS; LANGERHANS; REJECTION; TRACKING; DELIVERY; MOUSE	To monitor pancreatic islet transplantation efficiency, reliable noninvasive imaging methods, such as magnetic resonance imaging (MRI) are needed. Although an efficient uptake of MRI contrast agent is required for islet cell labeling, commercially-available magnetic nanoparticles are not efficiently transduced into cells. We herein report the in vivo detection of transplanted islets labeled with a novel cationic nanoparticle that allowed for noninvasive monitoring of islet grafts in diabetic mice in real time. The positively-charged nanoparticles were transduced into a beta-cell line, MIN6 cells, and into isolated islets for 1 hr. MRI showed a marked decrease in the signal intensity on T1- and T2-weighted images at the implantation site of the labeled MIN 6 cells or islets in the left kidneys of mice. These data suggest that the novel positively-charged nanoparticle could be useful to detect and monitor islet engraftment, which would greatly aid in the clinical management of islet transplant patients.	[Oishi, Koichi; Miyamoto, Yoshitaka; Hayashi, Shuji; Noguchi, Hirofumi] Nagoya Univ, Grad Sch Med, Dept Adv Med Biotechnol & Robot, Nagoya, Aichi 4648601, Japan; [Saito, Hiroaki; Murase, Katsutoshi] MEITO Sangyo Co Ltd, Nagoya Res Lab, Nagoya, Aichi, Japan; [Ono, Kenji; Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Div Stress Adaptat & Protect, Dept Brain Funct, Nagoya, Aichi 464, Japan; [Watanabe, Masami] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Ctr Gene & Cell Therapy, Okayama 7008530, Japan; [Noguchi, Yasufumi] Hiroshima Int Univ, Dept Socioenvironm Design, Kure, Hiroshima, Japan; [Fujiwara, Toshiyoshi; Noguchi, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan	Nagoya University; Nagoya University; Okayama University; Okayama University	Noguchi, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Adv Med Biotechnol & Robot, Nagoya, Aichi 4648601, Japan.	noguch-h@cc.okayama-u.ac.jp	Ono, Kenji/I-6163-2014; Miyamoto, Yoshitaka/X-6637-2018	Ono, Kenji/0000-0002-5402-6535; Miyamoto, Yoshitaka/0000-0001-6697-7453; Noguchi, Hirofumi/0000-0002-0880-6805	Ministry of Education, Science and Culture; Ministry of Health, Labour and Welfare	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by the Ministry of Education, Science and Culture, the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581; Bennet W, 2001, TRANSPLANTATION, V72, P312, DOI 10.1097/00007890-200107270-00026; Bennet W, 2000, TRANSPLANTATION, V69, P711; Eriksson O, 2009, AM J TRANSPLANT, V9, P2816, DOI 10.1111/j.1600-6143.2009.02844.x; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Jiao Y, 2008, TRANSPL P, V40, P3615, DOI 10.1016/j.transproceed.2008.04.026; Jirak D, 2004, MAGN RESON MED, V52, P1228, DOI 10.1002/mrm.20282; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Juang JH, 2010, TRANSPL P, V42, P2104, DOI 10.1016/j.transproceed.2010.05.103; Kim DH, 2009, J BIOMED MATER RES A, V88A, P1, DOI 10.1002/jbm.a.31775; Kriz J, 2005, TRANSPLANTATION, V80, P1596, DOI 10.1097/01.tp.0000183959.73681.b9; Lee KJ, 2012, J NANOSCI NANOTECHNO, V12, P1611, DOI 10.1166/jnn.2012.4632; Lee KJ, 2010, J NANOSCI NANOTECHNO, V10, P6962, DOI 10.1166/jnn.2010.2985; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Medarova Z, 2009, NAT REV ENDOCRINOL, V5, P444, DOI 10.1038/nrendo.2009.130; Moody JB, 2004, J MAGN RESON, V167, P36, DOI 10.1016/j.jmr.2003.11.004; Noguchi H, 2006, AM J TRANSPLANT, V6, P2476, DOI 10.1111/j.1600-6143.2006.01499.x; Noguchi H, 2005, DIABETES, V54, P2859, DOI 10.2337/diabetes.54.10.2859; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Oishi K, 2012, CELL MED, V3, P43, DOI 10.3727/215517912X639397; Oishi K, 2010, CELL TRANSPLANT, V19, P887, DOI 10.3727/096368910X509013; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Robertson RP, 2000, DIABETES CARE, V23, P112, DOI 10.2337/diacare.23.1.112; Saudek F, 2010, TRANSPLANTATION, V90, P1602, DOI 10.1097/TP.0b013e3181ffba5e; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Zhang SZ, 2009, PANCREAS, V38, P293, DOI 10.1097/MPA.0b013e318190d77a	31	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57046	10.1371/journal.pone.0057046	http://dx.doi.org/10.1371/journal.pone.0057046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451139	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800065
J	De Giorgi, V; Buonaguro, L; Worschech, A; Tornesello, ML; Izzo, F; Marincola, FM; Wang, E; Buonaguro, FM				De Giorgi, Valeria; Buonaguro, Luigi; Worschech, Andrea; Tornesello, Maria Lina; Izzo, Francesco; Marincola, Francesco M.; Wang, Ena; Buonaguro, Franco M.			Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENE-EXPRESSION; CLASS-I; MOTILE PHENOTYPE; UNITED-STATES; UP-REGULATION; TARGET; IDENTIFICATION; PATHOGENESIS; CANCER	Hepatocellular carcinomas (HCCs) are a heterogeneous group of tumors that differ in risk factors and genetic alterations. In Italy, particularly Southern Italy, chronic hepatitis C virus (HCV) infection represents the main cause of HCC. Using high-density oligoarrays, we identified consistent differences in gene-expression between HCC and normal liver tissue. Expression patterns in HCC were also readily distinguishable from those associated with liver metastases. To characterize molecular events relevant to hepatocarcinogenesis and identify biomarkers for early HCC detection, gene expression profiling of 71 liver biopsies from HCV-related primary HCC and corresponding HCV-positive non-HCC hepatic tissue, as well as gastrointestinal liver metastases paired with the apparently normal peri-tumoral liver tissue, were compared to 6 liver biopsies from healthy individuals. Characteristic gene signatures were identified when normal tissue was compared with HCV-related primary HCC, corresponding HCV-positive non-HCC as well as gastrointestinal liver metastases. Pathway analysis classified the cellular and biological functions of the genes differentially expressed as related to regulation of gene expression and post-translational modification in HCV-related primary HCC; cellular Growth and Proliferation, and Cell-To-Cell Signaling and Interaction in HCV-related non HCC samples; Cellular Growth and Proliferation and Cell Cycle in metastasis. Also characteristic gene signatures were identified of HCV-HCC progression for early HCC diagnosis. Conclusions: A diagnostic molecular signature complementing conventional pathologic assessment was identified.	[Buonaguro, Luigi; Tornesello, Maria Lina; Buonaguro, Franco M.] Ist Naz Tumori Fond G Pascale, Mol Biol & Viral Oncogenesis & AIDS Refer Ctr, Naples, Italy; [De Giorgi, Valeria; Marincola, Francesco M.; Wang, Ena] NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [De Giorgi, Valeria; Marincola, Francesco M.; Wang, Ena] NIH, Trans NIH Ctr Human Immunol CHI, Bethesda, MD 20892 USA; [Worschech, Andrea] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany; [Izzo, Francesco] Ist Naz Tumori Fond G Pascale, Hepatobiliary Surg Dept, Naples, Italy	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Wurzburg	De Giorgi, V (corresponding author), NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	degiorgiv@mail.nih.gov; irccsvir@unina.it	Izzo, Francesco/P-3042-2019; Buonaguro, Franco M./T-6028-2019; Buonaguro, Luigi/AAV-5655-2020; De Giorgi, Valeria/D-4582-2017; Tornesello, Maria Lina/A-1964-2008; Guennoun, Andrea/AAF-5281-2020	Izzo, Francesco/0000-0003-3093-5408; Buonaguro, Franco M./0000-0002-7491-7220; Tornesello, Maria Lina/0000-0002-3523-3264; Guennoun, Andrea/0000-0002-4303-8653; Buonaguro, Luigi/0000-0002-6380-7114	Italian Ministry of Health - Ministero Italiano Salute [ACC4/2007-2012, RO 4/2007]	Italian Ministry of Health - Ministero Italiano Salute(Ministry of Health, Italy)	Italian Ministry of Health - Ministero Italiano Salute (Ricerca Corrente 2010-11; Programma Ricerca Oncologica Grant no ACC4/2007-2012; Programma Integrato Oncologia Grant no RO 4/2007 (2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sukhun S, 2003, CANCER, V97, P2064, DOI 10.1002/cncr.11289; Blight KJ, 1998, ANTIVIR THER, V3, P71; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Buendia MA, 1998, BIOMED PHARMACOTHER, V52, P34, DOI 10.1016/S0753-3322(97)86239-7; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Davila JA, 2003, J CLIN EPIDEMIOL, V56, P487, DOI 10.1016/S0895-4356(02)00605-4; De Giorgi V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-85; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Falk CS, 2002, J IMMUNOL, V169, P3257, DOI 10.4049/jimmunol.169.6.3257; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Groen K A, 1999, Semin Oncol Nurs, V15, P48, DOI 10.1016/S0749-2081(99)80039-4; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; Kim JW, 2003, CARCINOGENESIS, V24, P363, DOI 10.1093/carcin/24.3.363; Koike K, 2002, J GASTROEN HEPATOL, V17, P394, DOI 10.1046/j.1440-1746.2002.02763.x; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Midorikawa Y, 2003, INT J CANCER, V103, P455, DOI 10.1002/ijc.10856; Midorikawa Y, 2010, HEPATOL RES, V40, P49, DOI 10.1111/j.1872-034X.2009.00583.x; Momburg F, 2001, J VIROL, V75, P5663, DOI 10.1128/JVI.75.12.5663-5671.2001; MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X; Ohata K, 2007, BIOORG MED CHEM LETT, V17, P4070, DOI 10.1016/j.bmcl.2007.04.067; Okabe H, 2004, INT J ONCOL, V24, P43; Okabe H, 2003, CANCER RES, V63, P3043; Pang EYT, 2007, HEPATOLOGY, V46, P436, DOI 10.1002/hep.21691; Romeo R, 2002, TOXICOLOGY, V181, P39, DOI 10.1016/S0300-483X(02)00252-4; Rosenberg W, 1999, GUT, V44, P759, DOI 10.1136/gut.44.5.759; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sakamoto M, 2008, INTERVIROLOGY, V51, P42, DOI 10.1159/000122603; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Silva FP, 2005, NEOPLASIA, V7, P348, DOI 10.1593/neo.04544; Sy SMH, 2006, MODERN PATHOL, V19, P1108, DOI 10.1038/modpathol.3800626; Theise Neil D, 2002, Clin Liver Dis, V6, P497, DOI 10.1016/S1089-3261(02)00006-5; Theodorescu D, 2003, HISTOL HISTOPATHOL, V18, P259, DOI 10.14670/HH-18.259; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Yagyu R, 2002, INT J ONCOL, V20, P1173; Yamane B, 2009, SURG CLIN N AM, V89, P97, DOI 10.1016/j.suc.2008.10.004; Zender L, 2008, ONKOLOGIE, V31, P550, DOI 10.1159/000151586	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56153	10.1371/journal.pone.0056153	http://dx.doi.org/10.1371/journal.pone.0056153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441164	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200021
J	Ertl, NG; Elizur, A; Brooks, P; Kuballa, AV; Anderson, TA; Knibb, WR				Ertl, Nicole G.; Elizur, Abigail; Brooks, Peter; Kuballa, Anna V.; Anderson, Trevor A.; Knibb, Wayne R.			Molecular Characterisation of Colour Formation in the Prawn Fenneropenaeus merguiensis	PLOS ONE			English	Article							ARGININE KINASE; STRUCTURAL CHEMISTRY; PIGMENT MOVEMENTS; BETA-CRUSTACYANIN; BINDING-PROTEIN; GENE-EXPRESSION; MOLT CYCLE; BLUE-CRAB; LIPOCALIN; LOBSTER	Introduction: Body colouration in animals can have a range of functions, with predator protection an important aspect of colour in crustaceans. Colour determination is associated with the carotenoid astaxanthin, which is taken up through the diet and stabilised in the tissues by the protein crustacyanin. As a variety of genes are found to play a role in colour formation in other systems, a holistic approach was employed in this study to determine the factors involved in Fenneropenaeus merguiensis colouration. Results: Full length F. merguiensis crustacyanin subunit A and C sequences were isolated. Crustacyanin subunit A and C were found in the F. merguiensis transcriptomes of the muscle/cuticle tissue, hepatopancreas, eye stalk and nervous system, using 454 next generation sequencing technology. Custom microarray analysis of albino, light and dark F. merguiensis cuticle tissue showed genes encoding actin, sarcoplasmic calcium-binding protein and arginine kinase to be 4-fold or greater differentially expressed (p<0.05) and down-regulated in albinos when compared to light and dark samples. QPCR expression analysis of crustacyanin and total astaxanthin pigment extraction revealed significantly (p<0.05) lower crustacyanin subunit A and C gene transcript copy numbers and total astaxanthin levels in albinos than in the light and dark samples. Additionally, crustacyanin subunit A and C expression levels correlated positively with each other. Conclusions: This study identified gene products putatively involved in crustacean colouration, such as crustacyanin, sarcoplasmic calcium-binding protein and forms of actin, and investigated differences in gene expression and astaxanthin levels between albino, light and dark coloured prawns. These genes open a path to enhance our understanding of the biology and regulation of colour formation.	[Ertl, Nicole G.; Elizur, Abigail; Brooks, Peter; Kuballa, Anna V.; Anderson, Trevor A.; Knibb, Wayne R.] Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia	University of the Sunshine Coast	Elizur, A (corresponding author), Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia.	AElizur@usc.edu.au		Brooks, Peter/0000-0003-4915-4986; Elizur, Abigail/0000-0002-2960-302X; ERTL, Nicole/0000-0002-0442-3882; Knibb, Wayne/0000-0003-2593-0303	Fisheries Research & Development Corporation (FRDC); Australian Seafood Cooperative Research Centre (CRC) [2009/724, 2009/776]; University of the Sunshine Coast, Australia; Australian Seafood CRC scholarship; University of the Sunshine Coast	Fisheries Research & Development Corporation (FRDC)(Fisheries R&D Corp); Australian Seafood Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast, Australia; Australian Seafood CRC scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast	The project was funded by the Fisheries Research & Development Corporation (FRDC - http://frdc.com.au/) and the Australian Seafood Cooperative Research Centre (CRC - http://www.seafoodcrc.com/) (2009/724 to WRK, 2009/776 to WRK and NGE), and the University of the Sunshine Coast, Australia. NGE was supported by an Australian Seafood CRC scholarship and a scholarship from the University of the Sunshine Coast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 2000, P 10 BIENN C INT I F; BECKERLE MC, 1983, J CELL BIOL, V96, P354, DOI 10.1083/jcb.96.2.354; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; BILLINGHAM RE, 1960, Q REV BIOL, V35, P1, DOI 10.1086/402951; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; BURNSIDE B, 1983, INVEST OPHTH VIS SCI, V24, P1; Canonaco F, 2003, BIOTECHNOL LETT, V25, P1013, DOI 10.1023/A:1024172518062; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Caro T, 2009, PHILOS T R SOC B, V364, P537, DOI 10.1098/rstb.2008.0221; Carvalho LN, 2006, NEOTROP ICHTHYOL, V4, P219, DOI 10.1590/S1679-62252006000200008; Charron JBF, 2002, FEBS LETT, V517, P129, DOI 10.1016/S0014-5793(02)02606-6; Chayen NE, 2003, ACTA CRYSTALLOGR D, V59, P2072, DOI 10.1107/S0907444903025952; Chung ACK, 1998, GEN COMP ENDOCR, V109, P375, DOI 10.1006/gcen.1997.7046; Cianci M, 2002, P NATL ACAD SCI USA, V99, P9795, DOI 10.1073/pnas.152088999; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; FINGERMAN M, 1975, BIOL BULL, V149, P165, DOI 10.2307/1540487; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Flower DR, 1996, BIOCHEM J, V318, P1; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Garcia-Orozco KD, 2007, INT ARCH ALLERGY IMM, V144, P23, DOI 10.1159/000102610; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Healy M, 2003, ACTA BIOTECHNOL, V23, P151, DOI 10.1002/abio.200390023; Helliwell JR, 2010, CRYSTALLOGR REV, V16, P231, DOI 10.1080/08893111003747084; Holt SM, 2002, J EXP BIOL, V205, P1775; Ilagan RP, 2005, J PHYS CHEM A, V109, P3120, DOI 10.1021/jp0444161; Jiang H, 2009, PROTEOMICS, V9, P3353, DOI 10.1002/pmic.200800518; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; KEEN JN, 1991, EUR J BIOCHEM, V202, P31, DOI 10.1111/j.1432-1033.1991.tb16340.x; Kinsey ST, 2003, COMP BIOCHEM PHYS B, V135, P521, DOI 10.1016/S1096-4959(03)00121-0; KOTZ KJ, 1994, J CELL BIOL, V124, P463, DOI 10.1083/jcb.124.4.463; Kuballa AV, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-45; Kuballa AV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-575; Latscha T., 1989, ADV TROPICAL AQUACUL, V9, P319; LITTLE CC, 1958, Q REV BIOL, V33, P103, DOI 10.1086/402319; Liu YS, 2003, PLANT BIOTECHNOL J, V1, P195, DOI 10.1046/j.1467-7652.2003.00018.x; Lopez M, 2004, TALANTA, V64, P726, DOI 10.1016/j.talanta.2004.03.048; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mantiri DMH, 2004, J CRUSTACEAN BIOL, V24, P592, DOI 10.1651/C-2488; Matsukawa T, 2004, J NEUROSCI, V24, P8346, DOI 10.1523/JNEUROSCI.1809-04.2004; McArdle K, 1998, J CELL BIOL, V143, P1201, DOI 10.1083/jcb.143.5.1201; McNamara JC, 1999, J EXP ZOOL, V283, P19, DOI 10.1002/(SICI)1097-010X(19990101)283:1<19::AID-JEZ4>3.3.CO;2-Z; Mykles DL, 2000, J EXP ZOOL, V286, P329, DOI 10.1002/(SICI)1097-010X(20000301)286:4<329::AID-JEZ1>3.0.CO;2-M; Pan CH, 2010, AQUAC RES, V41, P973, DOI 10.1111/j.1365-2109.2009.02380.x; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Ponce-Palafox J.T., 2006, REV MEXICANA INGENIE, V5, P157; Qiu LH, 2008, MOL BIOL REP, V35, P431, DOI 10.1007/s11033-007-9103-5; Sachindra NM, 2005, J SCI FOOD AGR, V85, P167, DOI 10.1002/jsfa.1977; Salier JP, 2000, BBA-PROTEIN STRUCT M, V1482, P25, DOI 10.1016/S0167-4838(00)00144-8; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sanchez D, 2000, INT J DEV BIOL, V44, P349; Shih Jin-Taur, 1997, Biological Bulletin National Taiwan Normal University, V32, P53; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Tanaka M, 2007, BRAIN RES, V1153, P34, DOI 10.1016/j.brainres.2007.03.075; Tlusty MF, 2009, NEW ZEAL J MAR FRESH, V43, P247, DOI 10.1080/00288330909509998; Tuma MC, 1999, PIGM CELL RES, V12, P283, DOI 10.1111/j.1600-0749.1999.tb00762.x; Tume RK, 2009, AQUACULTURE, V296, P129, DOI 10.1016/j.aquaculture.2009.08.006; Untalan PM, 2005, INSECT BIOCHEM MOLEC, V35, P141, DOI 10.1016/j.ibmb.2004.10.009; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Wade N, 2005, COMP BIOCHEM PHYS B, V141, P307, DOI 10.1016/j.cbpc.2005.04.004; Wade NM, 2008, J EXP BIOL, V211, P1512, DOI 10.1242/jeb.012930; Wade NM, 2012, J EXP BIOL, V215, P343, DOI 10.1242/jeb.064592; Wade NM, 2009, MOL BIOL EVOL, V26, P1851, DOI 10.1093/molbev/msp092; Wade NM, 2006, CRUSTACEAN SHELL COL; Wang MR, 2007, COMP BIOCHEM PHYS B, V147, P222, DOI 10.1016/j.cbpb.2007.01.003; Weesie RJ, 1999, BIOSPECTROSCOPY, V5, P358, DOI 10.1002/(SICI)1520-6343(1999)5:6<358::AID-BSPY5>3.0.CO;2-1; Xu JY, 2008, CELL PHYSIOL BIOCHEM, V21, P473, DOI 10.1159/000129640	73	23	23	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56920	10.1371/journal.pone.0056920	http://dx.doi.org/10.1371/journal.pone.0056920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441225	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200082
J	Hay, T; Fraud, S; Lau, CHF; Gilmour, C; Poole, K				Hay, Thomas; Fraud, Sebastien; Lau, Calvin Ho-Fung; Gilmour, Christie; Poole, Keith			Antibiotic Inducibility of the mexXY Multidrug Efflux Operon of Pseudomonas aeruginosa: Involvement of the MexZ Anti-Repressor ArmZ	PLOS ONE			English	Article							AMINOGLYCOSIDE RESISTANCE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SYSTEM; PUMP; MECHANISMS; PA5471; STRAINS; OPRM	Expression of the mexXY multidrug efflux operon in wild type Pseudomonas aeruginosa is substantially enhanced by the ribosome-targeting antimicrobial spectinomycin (18-fold) and this is wholly dependent upon the product of the PA5471 gene. In a mutant strain lacking the mexZ gene encoding a repressor of mexXY gene expression, expression of the efflux operon increases modestly (5-fold) and is still responsive (18-fold) to spectinomycin. Spectinomycin induction of mexXY expression in the mexZ mutant is, however, independent of PA5471 suggesting that PA5471 functions as an anti-repressor (dubbed ArmZ for anti-repressor MexZ) that serves only to modulate MexZ's repressor activity, with additional gene(s)/gene product(s) providing for the bulk of the antimicrobial-inducible mexXY expression. Consistent with PA5471/ArmZ functioning as a MexZ anti-repressor, an interaction between MexZ and ArmZ was confirmed using a bacterial 2-hybrid assay. Mutations compromising this interaction (P68S, G76S, R216C, R221W, R221Q, G231D and G252S) were identified and localized to one region of an ArmZ structural model that may represent a MexZ-interacting domain. Introduction of representative mutations into the chromosome of P. aeruginosa reduced (P68S, G76S) or obviated (R216C, R2211W) antimicrobial induction of mexXY gene expression, rendering the mutants pan-aminoglycoside-susceptible. These data confirm the importance of an ArmZ-MexZ interaction for antimicrobial-inducible mexXY expression and intrinsic aminoglycoside resistance in P. aeruginosa.	[Hay, Thomas; Fraud, Sebastien; Lau, Calvin Ho-Fung; Gilmour, Christie; Poole, Keith] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Poole, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall, Kingston, ON, Canada.	poolek@queensu.ca		Lau, Calvin (Ho-Fung)/0000-0003-3407-4924	Cystic Fibrosis Canada	Cystic Fibrosis Canada	This work was supported by an operating grant from Cystic Fibrosis Canada (http://www.cysticfibrosis.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; Alguel Y, 2010, J STRUCT BIOL, V172, P305, DOI 10.1016/j.jsb.2010.07.012; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Caughlan RE, 2009, ANTIMICROB AGENTS CH, V53, P5015, DOI 10.1128/AAC.00253-09; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Daigle DM, 2007, J BACTERIOL, V189, P5441, DOI 10.1128/JB.00543-07; Dmitrova M, 1998, MOL GEN GENET, V257, P205; El'Garch F, 2007, ANTIMICROB AGENTS CH, V51, P1016, DOI 10.1128/AAC.00704-06; GarinotSchneider C, 1996, J MOL BIOL, V260, P731, DOI 10.1006/jmbi.1996.0433; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Islam S, 2009, CLIN MICROBIOL INFEC, V15, P60, DOI 10.1111/j.1469-0691.2008.02097.x; Islam S, 2004, CLIN MICROBIOL INFEC, V10, P877, DOI 10.1111/j.1469-0691.2004.00991.x; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jo JTH, 2003, ANTIMICROB AGENTS CH, V47, P1101, DOI 10.1128/AAC.47.3.1101-1111.2003; Lau CHF, 2012, ANTIMICROB AGENTS CH, V56, P5171, DOI 10.1128/AAC.00846-12; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Martinez-Argudo I, 2004, J BACTERIOL, V186, P601, DOI 10.1128/JB.186.3.601-610.2004; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; MASUDA N, 1992, ANTIMICROB AGENTS CH, V36, P1847, DOI 10.1128/AAC.36.9.1847; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Matsuo Y, 2004, FEMS MICROBIOL LETT, V238, P23, DOI 10.1016/j.femsle.2004.07.010; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mine T, 1999, ANTIMICROB AGENTS CH, V43, P415, DOI 10.1128/AAC.43.2.415; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Morita Y, 2009, J BACTERIOL, V191, P4966, DOI 10.1128/JB.00073-09; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Poole K, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P635; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Sambrook J., 2001, MOL CLONING LAB MANU, V3; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Sun X, 2011, J BACTERIOL, V193, P2717, DOI 10.1128/JB.00149-11; Vettoretti L, 2009, ANTIMICROB AGENTS CH, V53, P1987, DOI 10.1128/AAC.01024-08; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975; Whitworth DE, 2001, MOL MICROBIOL, V42, P809, DOI 10.1046/j.1365-2958.2001.02679.x; Yamamoto M, 2009, MICROBIOL-SGM, V155, P3312, DOI 10.1099/mic.0.028993-0; [No title captured]	44	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56858	10.1371/journal.pone.0056858	http://dx.doi.org/10.1371/journal.pone.0056858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441219	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200076
J	Carr, JA; D'Odorico, P; Laio, F; Ridolfi, L				Carr, Joel A.; D'Odorico, Paolo; Laio, Francesco; Ridolfi, Luca			Recent History and Geography of Virtual Water Trade	PLOS ONE			English	Article							FOOTPRINT; CONFLICT; GREEN; BLUE	The global trade of goods is associated with a virtual transfer of the water required for their production. The way changes in trade affect the virtual redistribution of freshwater resources has been recently documented through the analysis of the virtual water network. It is, however, unclear how these changes are contributed by different types of products and regions of the world. Here we show how the global patterns of virtual water transport are contributed by the trade of different commodity types, including plant, animal, luxury (e.g., coffee, tea, and alcohol), and other products. Major contributors to the virtual water network exhibit different trade patterns with regard to these commodity types. The net importers rely on the supply of virtual water from a small percentage of the global population. However, discrepancies exist among the different commodity networks. While the total virtual water flux through the network has increased between 1986 and 2010, the proportions associated with the four commodity groups have remained relatively stable. However, some of the major players have shown significant changes in the virtual water imports and exports associated with those commodity groups. For instance, China has switched from being a net exporter of virtual water associated with other products (non-edible plant and animal products typically used for manufacturing) to being the largest importer, accounting for 31% of the total water virtually transported with these products. Conversely, in the case of The United states of America, the commodity proportions have remained overall unchanged throughout the study period: the virtual water exports from The United States of America are dominated by plant products, whereas the imports are comprised mainly of animal and luxury products.	[Carr, Joel A.; D'Odorico, Paolo] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Laio, Francesco; Ridolfi, Luca] Politecn Torino, Dept Environm Land & Infrastruct Engn, Turin, Italy	University of Virginia; Polytechnic University of Turin	Carr, JA (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	jac6t@virginia.edu	D'Odorico, Paolo/A-5836-2008; Laio, Francesco/F-6203-2013	D'Odorico, Paolo/0000-0002-0007-5833; Carr, Joel/0000-0002-9164-4156; Laio, Francesco/0000-0003-3931-1482; RIDOLFI, Luca/0000-0003-2947-8641				Allan JA, 1998, GROUND WATER, V36, P545, DOI 10.1111/j.1745-6584.1998.tb02825.x; Allan T, 1993, P C PRIOR WAT RES AL; Carr J, 2012, EOS T AGU, P93; Carr JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051247; Chapagain A.K, 2008, GLOBALIZATION WATER; D'Odorico P., 2012, ENV RES LETT, V7, DOI 10.1088/1748-9326/7/3/034007; D'Odorico P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043167; Dalin C, 2012, P NATL ACAD SCI USA, V109, P5989, DOI 10.1073/pnas.1203176109; Dan W, 2009, J EC WATER RESOURCES, V3, P019; GLEICK PH, 1993, INT SECURITY, V18, P79, DOI 10.2307/2539033; Gleick PH, 1999, HUMAN RIGHT WATER PA; Government Office for Science, 2011, FOR FUT FOOD FARM; Hoekstra A.Y., 2002, IHE UNESCO, P248; Konar M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010307; Mason MB, 2012, IMPLEMENTING EVOLVIN; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Mekonnen MM, 2010, HYDROL EARTH SYST SC, V14, P1259, DOI 10.5194/hess-14-1259-2010; Morison JIL, 2008, PHILOS T R SOC B, V363, P639, DOI 10.1098/rstb.2007.2175; Schade Carleton, 2010, Environment Development and Sustainability, V12, P245, DOI 10.1007/s10668-009-9192-5; Seekell DA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024017; Seekell DA, 2011, SOC NATUR RESOUR, V24, P1205, DOI 10.1080/08941920.2011.557712; Suweis S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046837; Wichelns D, 2004, AGR WATER MANAGE, V66, P49, DOI 10.1016/j.agwat.2003.09.006; Wolf AT, 1999, NATO ASI 2, V65, P251	24	83	85	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55825	10.1371/journal.pone.0055825	http://dx.doi.org/10.1371/journal.pone.0055825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457481	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700019
J	Maulik, U; Sarkar, A				Maulik, Ujjwal; Sarkar, Anasua			Searching Remote Homology with Spectral Clustering with Symmetry in Neighborhood Cluster Kernels	PLOS ONE			English	Article							PROTEIN; SEQUENCE; IDENTIFICATION; ALGORITHM	Remote homology detection among proteins utilizing only the unlabelled sequences is a central problem in comparative genomics. The existing cluster kernel methods based on neighborhoods and profiles and the Markov clustering algorithms are currently the most popular methods for protein family recognition. The deviation from random walks with inflation or dependency on hard threshold in similarity measure in those methods requires an enhancement for homology detection among multi-domain proteins. We propose to combine spectral clustering with neighborhood kernels in Markov similarity for enhancing sensitivity in detecting homology independent of "recent'' paralogs. The spectral clustering approach with new combined local alignment kernels more effectively exploits the unsupervised protein sequences globally reducing inter-cluster walks. When combined with the corrections based on modified symmetry based proximity norm deemphasizing outliers, the technique proposed in this article outperforms other state-of-the-art cluster kernels among all twelve implemented kernels. The comparison with the state-of-the-art string and mismatch kernels also show the superior performance scores provided by the proposed kernels. Similar performance improvement also is found over an existing large dataset. Therefore the proposed spectral clustering framework over combined local alignment kernels with modified symmetry based correction achieves superior performance for unsupervised remote homolog detection even in multi-domain and promiscuous domain proteins from Genolevures database families with better biological relevance. Source code available upon request. Contact: sarkar@labri.fr.	[Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [Maulik, Ujjwal] German Canc Res Ctr, Heidelberg, Germany; [Sarkar, Anasua] Univ Bordeaux 1, LaBRI, F-33405 Talence, France	Jadavpur University; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Maulik, U (corresponding author), Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India.	umaulik@cse.jdvu.ac.in	Maulik, Ujjwal/AAO-8754-2020; Sarkar, Anasua/L-7314-2013	Sarkar, Anasua/0000-0001-7365-3924; Maulik, Ujjwal/0000-0003-1167-0774				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; B S J SA, 2002, LEARNING KERNELS; Ballard DH, 1982, COMPUTER VISION; BERG C, 1984, HARMONIC ANAL SEMIGR; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Hue M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-144; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Ji XN, 2010, NEUROCOMPUTING, V73, P2363, DOI 10.1016/j.neucom.2009.12.038; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kestler HA, 2001, COMPUT METH PROG BIO, V64, P133, DOI 10.1016/S0169-2607(00)00098-5; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Leslie C., 2003, ADV NEURAL INFORMATI, P1417; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIAO L, 2002, P 6 ANN INT C COMP M, P225, DOI DOI 10.1145/565196.565225; Melia M, 2001, P INT WORKSH AI STAT; Morgado L, 2009, LECT NOTES ARTIF INT, V5572, P409, DOI 10.1007/978-3-642-02319-4_49; Mu-Chun Su, 2005, International Journal of Fuzzy Systems, V7, P175; Ng AY, 2001, NEUR INF PROC S 2001, V2001; Nikolski M, 2007, BIOINFORMATICS, V23, pE71, DOI 10.1093/bioinformatics/btl314; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; R Core Team, 2021, R LANGUAGE ENV STAT; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rangwala H, 2005, BIOINFORMATICS, V21, P4239, DOI 10.1093/bioinformatics/bti687; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Sherman D, 2006, NUCLEIC ACIDS RES, V34, pD432, DOI 10.1093/nar/gkj160; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Su MS, 2001, IEEE T PATTERN ANAL, V23, P674, DOI 10.1109/34.927466; van Dongen S, 2000, THESIS U UTRECHT; Weston J, 2005, BIOINFORMATICS, V21, P3241, DOI 10.1093/bioinformatics/bti497; Weston J, 2005, SPIDER MACHINE LEARN; Weston J, 2004, ADV NEURAL INFORM PR, V16; Wieser Daniela, 2009, In Silico Biology, V9, P89, DOI 10.3233/ISB-2009-0390	48	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e46468	10.1371/journal.pone.0046468	http://dx.doi.org/10.1371/journal.pone.0046468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457439	Green Published, gold			2022-12-27	WOS:000315603700001
J	Chen, CC; Chen, CM; Tyler, CW				Chen, Chien-Chung; Chen, Chin-Mei; Tyler, Christopher W.			Depth Structure from Asymmetric Shading Supports Face Discrimination	PLOS ONE			English	Article							LIGHTING DIRECTION; FACIAL SURFACES; RECOGNITION; SHAPE; PERCEPTION; IDENTIFICATION; SYMMETRY; POSITION; PARAMETERS; SELECTION	To examine the effect of illumination direction on the ability of observers to discriminate between faces, we manipulated the direction of illumination on scanned 3D face models. In order to dissociate the surface reflectance and illumination components of front-view face images, we introduce a symmetry algorithm that can separate the symmetric and asymmetric components of the face in both low and high spatial frequency bands. Based on this approach, hybrid faces stimuli were constructed with different combinations of symmetric and asymmetric spatial content. Discrimination results with these images showed that asymmetric illumination information biased face perception toward the structure of the shading component, while the symmetric illumination information had little, if any, effect. Measures of perceived depth showed that this property increased systematically with the asymmetric but not the symmetric low spatial frequency component. Together, these results suggest that (1) the asymmetric 3D shading information dramatically affects both the perceived facial information and the perceived depth of the facial structure; and (2) these effects both increase as the illumination direction is shifted to the side. Thus, our results support the hypothesis that face processing has a strong 3D component.	[Chen, Chien-Chung; Chen, Chin-Mei] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Tyler, Christopher W.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	National Taiwan University; National Taiwan University; The Smith-Kettlewell Eye Research Institute	Chen, CC (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.	c3chen@ntu.edu.tw		Chen, Chien-Chung/0000-0002-3848-0180	NSC (Taiwan) [96-2413-H-002-006-MY3]; AFOSR (USA) [09-NL-072]; Minister of Education (Taiwan) AIM for Top University Excellent Research Project [102R892101]	NSC (Taiwan)(Ministry of Science and Technology, Taiwan); AFOSR (USA)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Minister of Education (Taiwan) AIM for Top University Excellent Research Project	Supported by NSC (Taiwan) 96-2413-H-002-006-MY3 to CCC and AFOSR (USA) grant 09-NL-072 to CWT. Minister of Education (Taiwan) AIM for Top University Excellent Research Project 102R892101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atick JJ, 1996, NEURAL COMPUT, V8, P1321, DOI 10.1162/neco.1996.8.6.1321; Biswas S, 2009, IEEE T PATTERN ANAL, V31, P884, DOI 10.1109/TPAMI.2007.12.0830; Blinn JF, 1977, SIGGRAPH 77 P 4 ANN; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braje WL, 1998, PSYCHOBIOLOGY, V26, P371; Braje WL, 2003, J VISION, V3, P161, DOI 10.1167/3.2.4; Brewster D, 1868, LETT NATURAL MAGIC; Brewster D., 1826, EDINBURGH J SCI, V4, P99; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; BRUCE V, 1991, PERCEPTION, V20, P755, DOI 10.1068/p200755; Chen CC, 2009, SPIE P, V7242; Collin CA, 2006, PERCEPT PSYCHOPHYS, V68, P879, DOI 10.3758/BF03193351; Curran W, 1996, VISION RES, V36, P1399, DOI 10.1016/0042-6989(95)00213-8; Dovgard R, 2004, LECT NOTES COMPUT SC, V3022, P99; Gaspar C, 2008, VISION RES, V48, P2817, DOI 10.1016/j.visres.2008.09.015; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gilad S, 2009, P NATL ACAD SCI USA, V106, P5353, DOI 10.1073/pnas.0812396106; Gold J, 1999, VISION RES, V39, P3537, DOI 10.1016/S0042-6989(99)00080-2; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Gregory RL, 1966, EYE BRAIN PSYCHOL SE; Gregory RL, 1970, INTELLIGENT EYE; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; Hill H, 1996, J EXP PSYCHOL HUMAN, V22, P986, DOI 10.1037/0096-1523.22.4.986; Horn BK, 1986, ROBOT VISION, V1st; Horn BKP, 1989, SHAPE SHADING; JOHNSTON A, 1992, PERCEPTION, V21, P365, DOI 10.1068/p210365; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Lin IC, 2005, VISUAL COMPUT, V21, P355, DOI 10.1007/s00371-005-0291-5; Lin IC, 2002, IEEE COMPUT GRAPH, V22, P72, DOI 10.1109/MCG.2002.1046631; Liu CH, 1997, PERCEPTION, V26, P1289, DOI 10.1068/p261289; Liu CH, 1999, VISION RES, V39, P4003, DOI 10.1016/S0042-6989(99)00109-1; Liu CH, 2000, PERCEPTION, V29, P729, DOI 10.1068/p3065; Mamassian P, 2001, COGNITION, V81, pB1, DOI 10.1016/S0010-0277(01)00116-0; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Parker DM, 1999, CURR PSYCHOL, V18, P118, DOI 10.1007/s12144-999-1021-3; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1988, SCI AM, V259, P76, DOI 10.1038/scientificamerican0888-76; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Rhodes G, 2005, P ROY SOC B-BIOL SCI, V272, P1379, DOI 10.1098/rspb.2005.3093; Rhodes G, 2002, PERCEPTION, V31, P315, DOI 10.1068/p3129; RHODES G, 1988, PERCEPTION, V17, P43, DOI 10.1068/p170043; Rhodes G, 2009, PERCEPTION, V38, P232, DOI 10.1068/p6110; Ruiz-Soler M, 2006, PSYCHOL RES-PSYCH FO, V70, P273, DOI 10.1007/s00426-005-0215-z; Schyns PG, 1997, PERCEPTION, V26, P1027, DOI 10.1068/p261027; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Shyi GC-W, 2010, DATABASE FACIAL EXPR; Sun J, 1998, NAT NEUROSCI, V1, P183, DOI 10.1038/630; Troje NF, 1998, VISION RES, V38, P79, DOI 10.1016/S0042-6989(97)00165-X; Tyler CW, 1997, SPATIAL VISION, V10, P479, DOI 10.1163/156856897X00410; Walker PM, 2003, PERCEPTION, V32, P1117, DOI 10.1068/p5098	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55865	10.1371/journal.pone.0055865	http://dx.doi.org/10.1371/journal.pone.0055865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457484	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000315602700025
J	Levy-Assaraf, M; Voronov-Goldman, M; Grinberg, IR; Weiserman, G; Shimon, LJW; Jindou, S; Borovok, I; White, BA; Bayer, EA; Lamed, R; Frolow, F				Levy-Assaraf, Maly; Voronov-Goldman, Milana; Grinberg, Inna Rozman; Weiserman, Gloria; Shimon, Linda J. W.; Jindou, Sadanari; Borovok, Ilya; White, Bryan A.; Bayer, Edward A.; Lamed, Raphael; Frolow, Felix			Crystal Structure of an Uncommon Cellulosome-Related Protein Module from Ruminococcus flavefaciens That Resembles Papain-Like Cysteine Peptidases	PLOS ONE			English	Article							L-ALANINE AMIDASE; CELL-SEPARATION; GENE-CLUSTER; DIVERSITY; IDENTIFICATION; ENZYMES; BINDING; SUPERFAMILY; SPECIFICITY; FEATURES	Background: Ruminococcus flavefaciens is one of the predominant fiber-degrading bacteria found in the rumen of herbivores. Bioinformatic analysis of the recently sequenced genome indicated that this bacterium produces one of the most intricate cellulosome systems known to date. A distinct ORF, encoding for a multi-modular protein, RflaF_05439, was discovered during mining of the genome sequence. It is composed of two tandem modules of currently undefined function that share 45% identity and a C-terminal X-dockerin modular dyad. Gaining insight into the diversity, architecture and organization of different types of proteins in the cellulosome system is essential for broadening our understanding of a multi-enzyme complex, considered to be one of the most efficient systems for plant cell wall polysaccharide degradation in nature. Methodology/Principal Findings: Following bioinformatic analysis, the second tandem module of RflaF_05439 was cloned and its selenium-labeled derivative was expressed and crystallized. The crystals belong to space group P21 with unit-cell parameters of alpha = 65.81, b = 60.61, c = 66.13 angstrom, beta = 107.66 degrees and contain two protein molecules in the asymmetric unit. The crystal structure was determined at 1.38-angstrom resolution by X-ray diffraction using the single-wavelength anomalous dispersion (SAD) method and was refined to R-factor and R-free of 0.127 and 0.152 respectively. The protein molecule mainly comprises a beta-sheet flanked by short alpha-helixes, and a globular a-helical domain. The structure was found to be structurally similar to members of the NlpC/P60 superfamily of cysteine peptidases. Conclusions/Significance: The 3D structure of the second repeat of the RflaF_05439 enabled us to propose a role for the currently undefined function of this protein. Its putative function as a cysteine peptidase is inferred from in silico structural homology studies. It is therefore apparent that cellulosomes integrate proteins with other functions in addition to the classic well-defined carbohydrate active enzymes.	[Levy-Assaraf, Maly; Voronov-Goldman, Milana; Grinberg, Inna Rozman; Weiserman, Gloria; Jindou, Sadanari; Borovok, Ilya; Lamed, Raphael; Frolow, Felix] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Levy-Assaraf, Maly; Voronov-Goldman, Milana; Grinberg, Inna Rozman; Lamed, Raphael; Frolow, Felix] Tel Aviv Univ, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel; [Shimon, Linda J. W.] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Jindou, Sadanari] Meijo Univ, Fac Agr, Nagoya, Aichi, Japan; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Tel Aviv University; Tel Aviv University; Weizmann Institute of Science; Meijo University; University of Illinois System; University of Illinois Urbana-Champaign; Weizmann Institute of Science	Frolow, F (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	mbfrolow@post.tau.ac.il	BOROVOK, ILYA/ABB-7370-2022	BOROVOK, ILYA/0000-0003-1602-4499; Shimon, Linda/0000-0002-7861-9247	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Israel Science Foundation [291/08, 159/07, 966/09]; Sidney E. Frank Foundation through the Israel Science Foundation (ISF) [24/11]	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Sidney E. Frank Foundation through the Israel Science Foundation (ISF)	This was supported by regular and energy grants from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel and by the Israel Science Foundation (grants 291/08, 159/07 and 966/09). Additional support was received by a grant (No. 24/11) issued to RL by the Sidney E. Frank Foundation through the Israel Science Foundation (ISF). (http://www.isf.org.il/) (http://www.bsf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber O, 2009, PROTEINS, V77, P699, DOI 10.1002/prot.22483; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Chayen Naomi E., 2003, Journal of Structural and Functional Genomics, V4, P115, DOI 10.1023/A:1026174727482; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; COSIER J, 1986, J APPL CRYSTALLOGR, V19, P105, DOI 10.1107/S0021889886089835; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; Gallo M, 2009, J MOL BIOL, V385, P1142, DOI 10.1016/j.jmb.2008.11.017; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Julliand V, 1999, APPL ENVIRON MICROB, V65, P3738; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kang SH, 2006, MOL MICROBIOL, V60, P1344, DOI 10.1111/j.1365-2958.2006.05182.x; Krause DO, 1999, MICROBIOL-UK, V145, P1797, DOI 10.1099/13500872-145-7-1797; Llull D, 2006, FEBS LETT, V580, P1959, DOI 10.1016/j.febslet.2006.02.060; Margot P, 1999, MICROBIOL-SGM, V145, P57, DOI 10.1099/13500872-145-1-57; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rossi P, 2009, PROTEINS, V74, P515, DOI 10.1002/prot.22267; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stout G. H., 1968, XRAY STRUCTURE DETER; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WEDEKIND KJ, 1988, APPL ENVIRON MICROB, V54, P1530, DOI 10.1128/AEM.54.6.1530-1535.1988; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamaguchi H, 2004, J BIOSCI BIOENG, V98, P174, DOI 10.1263/jbb.98.174; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199	44	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56138	10.1371/journal.pone.0056138	http://dx.doi.org/10.1371/journal.pone.0056138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457513	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700047
J	Belalov, IS; Lukashev, AN				Belalov, Ilya S.; Lukashev, Alexander N.			Causes and Implications of Codon Usage Bias in RNA Viruses	PLOS ONE			English	Article							BACKGROUND NUCLEOTIDE COMPOSITION; AMINO-ACID USAGE; TRANSLATIONAL SELECTION; MUTATIONAL BIAS; GENOMES; GENE; EVOLUTION; BACTERIA; TRANSCRIPTION; PREFERENCES	Choice of synonymous codons depends on nucleotide/dinucleotide composition of the genome (termed mutational pressure) and relative abundance of tRNAs in a cell (translational pressure). Mutational pressure is commonly simplified to genomic GC content; however mononucleotide and dinucleotide frequencies in different genomes or mRNAs may vary significantly, especially in RNA viruses. A series of in silico shuffling algorithms were developed to account for these features and analyze the relative impact of mutational pressure components on codon usage bias in RNA viruses. Total GC content was a poor descriptor of viral genome composition and causes of codon usage bias. Genomic nucleotide content was the single most important factor of synonymous codon usage. Moreover, the choice between compatible amino acids (e.g., leucine and isoleucine) was strongly affected by genomic nucleotide composition. Dinucleotide composition at codon positions 2-3 had additional effect on codon usage. Together with mononucleotide composition bias, it could explain almost the entire codon usage bias in RNA viruses. On the other hand, strong dinucleotide content bias at codon position 3-1 found in some viruses had very little effect on codon usage. A hypothetical innate immunity sensor for CpG in RNA could partially explain the codon usage bias, but due to dependence of virus translation upon biased host translation machinery, experimental studies are required to further explore the source of dinucleotide bias in RNA viruses.	[Belalov, Ilya S.; Lukashev, Alexander N.] Russian Acad Med Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia; [Lukashev, Alexander N.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Russian Academy of Medical Sciences; University of Bonn	Lukashev, AN (corresponding author), Russian Acad Med Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia.	alexander_lukashev@hotmail.com	Belalov, Ilya/K-2195-2016; Lukashev, Alexander/G-2777-2013	Belalov, Ilya/0000-0002-5447-4872; Lukashev, Alexander/0000-0001-7365-0352	Deutsche Forschungsgemeinschaft [DR772/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft [grant DR772/2-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P113, DOI 10.1007/s00705-003-0186-6; Arora R, 1996, J MOL BIOL, V258, P433, DOI 10.1006/jmbi.1996.0260; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Burns CC, 2010, INTRO CPG UPA DINUCL, P68; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chamary JV, 2004, MOL BIOL EVOL, V21, P1014, DOI 10.1093/molbev/msh087; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Fernandez V, 2001, PARASITOLOGY, V123, P203, DOI 10.1017/S0031182001008150; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; FRADKIN LG, 1987, MOL CELL BIOL, V7, P3880, DOI 10.1128/MCB.7.11.3880; Fuglsang A, 2006, MOL BIOL EVOL, V23, P1345, DOI 10.1093/molbev/msl009; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Gutierrez G, 1996, NUCLEIC ACIDS RES, V24, P2525, DOI 10.1093/nar/24.13.2525; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; HOEFFLER WK, 1985, CELL, V41, P955, DOI 10.1016/S0092-8674(85)80076-3; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lukashev A, 2012, J GEN VIROL; MARSHAK A, 1950, BIOL BULL, V99, P332; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Pan A, 1998, GENE, V215, P405, DOI 10.1016/S0378-1119(98)00257-1; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Rispe C, 2004, GENOME RES, V14, P44, DOI 10.1101/gr.1358104; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109; Woo PCY, 2007, VIROLOGY, V369, P431, DOI 10.1016/j.virol.2007.08.010; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	52	85	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56642	10.1371/journal.pone.0056642	http://dx.doi.org/10.1371/journal.pone.0056642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451064	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500020
J	Liu, YG; Liu, CC; Wang, SJ; Guo, K; Yang, J; Zhang, XS; Li, GQ				Liu, Yuguo; Liu, Changcheng; Wang, Shijie; Guo, Ke; Yang, Jun; Zhang, Xinshi; Li, Guoqing			Organic Carbon Storage in Four Ecosystem Types in the Karst Region of Southwestern China	PLOS ONE			English	Article							BRAZILIAN AMAZON; FORESTS; BIOMASS; VEGETATION; SEQUESTRATION; GRASSLANDS; GUIZHOU; POOLS	Karst ecosystems are important landscape types that cover about 12% of the world's land area. The role of karst ecosystems in the global carbon cycle remains unclear, due to the lack of an appropriate method for determining the thickness of the solum, a representative sampling of the soil and data of organic carbon stocks at the ecosystem level. The karst region in southwestern China is the largest in the world. In this study, we estimated biomass, soil quantity and ecosystem organic carbon stocks in four vegetation types typical of karst ecosystems in this region, shrub grasslands (SG), thorn shrubbery (TS), forest - shrub transition (FS) and secondary forest (F). The results showed that the biomass of SG, TS, FS, and F is 0.52, 0.85, 5.9 and 19.2 kg m(-2), respectively and the corresponding organic cabon storage is 0.26, 0.40, 2.83 and 9.09 kg m(-2), respectively. Nevertheless, soil quantity and corresponding organic carbon storage are very small in karst habitats. The quantity of fine earth overlaying the physical weathering zone of the carbonate rock of SG, TS, FS and F is 38.10, 99.24, 29.57 and 61.89 kg m(-2), respectively, while the corresponding organic carbon storage is only 3.34, 4.10, 2.37, 5.25 kg m(-2), respectively. As a whole, ecosystem organic carbon storage of SG, TS, FS, and F is 3.81, 4.72, 5.68 and 15.1 kg m(-2), respectively. These are very low levels compared to other ecosystems in non-karst areas. With the restoration of degraded vegetation, karst ecosystems in southwestern China may play active roles in mitigating the increasing CO2 concentration in the atmosphere.	[Liu, Yuguo; Liu, Changcheng; Guo, Ke; Yang, Jun; Zhang, Xinshi; Li, Guoqing] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Liu, Yuguo; Li, Guoqing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Shijie] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS	Guo, K (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	guoke@ibcas.ac.cn			National Key Basic Research Program of China [2013CB956701]; "Strategic Priority Research Program'' of the Chinese Academy of Sciences [XDA05070400]	National Key Basic Research Program of China(National Basic Research Program of China); "Strategic Priority Research Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Key Basic Research Program of China (2013CB956701) and "Strategic Priority Research Program'' of the Chinese Academy of Sciences (No. XDA05070400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Delaney M, 1997, J TROP ECOL, V13, P697, DOI 10.1017/S0266467400010877; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Dong M, 1996, OBSERVATION ANAL TER; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Fang JY, 2007, SCI CHINA SER D, V50, P1341, DOI 10.1007/s11430-007-0049-1; Fang JY, 2003, FRONT ECOL ENVIRON, V1, P293; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang S, 2007, J ENVIRON MANAGE, V85, P672, DOI 10.1016/j.jenvman.2006.09.014; Fang SZ, 2010, AGROFOREST SYST, V79, P213, DOI 10.1007/s10457-010-9307-x; Feldpausch TR, 2004, ECOL APPL, V14, pS164; Feller C, 2008, WASTE MANAGE, V28, P734, DOI 10.1016/j.wasman.2007.09.022; Golubiewski NE, 2006, ECOL APPL, V16, P555, DOI 10.1890/1051-0761(2006)016[0555:UIGCPE]2.0.CO;2; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Huang CY, 2000, PEDOLOGY, P224; Huang DZ, 2006, PROTECTION FOREST SC, V1, P16; Huang W., 1988, VEGETATION GUIZHOU; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Keller M, 2004, GLOBAL CHANGE BIOL, V10, P784, DOI 10.1111/j.1529-8817.2003.00770.x; Li ZP, 2007, GEODERMA, V138, P119, DOI 10.1016/j.geoderma.2006.11.007; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Lin Fang, 2006, Acta Agriculturae Universitatis Jiangxiensis, V28, P74; Liu C.Q., 2009, BIOGEOCHEMICAL PROCE; Liu Chang-Cheng, 2009, Chinese Journal of Plant Ecology, V33, P698, DOI 10.3773/j.issn.1005-264x.2009.04.008; Liu G., 1996, SOIL PHYS CHEM ANAL; Liu T, 2009, KARST DESERTIFICATIO; Liu YG, 2011, SCI SILVAE SINICAE, V3, P82; Liu Yu-Guo, 2011, Chinese Journal of Plant Ecology, V35, P1009, DOI 10.3724/SP.J.1258.2011.01009; Lu XT, 2010, FOREST ECOL MANAG, V260, P1798, DOI 10.1016/j.foreco.2010.08.024; Luo Dong-Hui, 2010, Chinese Journal of Plant Ecology, V34, P611, DOI 10.3773/j.issn.1005-264x.2010.05.015; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Ni J, 2004, CLIMATIC CHANGE, V67, P237, DOI 10.1007/s10584-004-0070-8; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002634; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Schuur EAG, 2001, ECOLOGY, V82, P3182, DOI 10.1890/0012-9658(2001)082[3182:CCASCS]2.0.CO;2; Smith P, 2004, EUR J AGRON, V20, P229, DOI 10.1016/j.eja.2003.08.002; Soil Survey Staff, 2010, KEYS SOIL TAX; TU YL, 1995, J GUIZHOU NORMAL U N, V13, P27; Wang K.L., 1999, J MT SCI-ENGL, V17, P125; Wang SJ, 2004, LAND DEGRAD DEV, V15, P115, DOI 10.1002/ldr.592; Xia H.B., 2010, GUIZHOU FORESTRY SCI, V38, P1; Yao FengPing, 2003, Journal of Zhejiang Forestry Science and Technology, V23, P74; Yu W., 2010, J SUBTROP RESOUR ENV, V5, P25; Zhang XB, 2011, SCI CHINA EARTH SCI, V54, P431, DOI 10.1007/s11430-010-4105-x; Zhang ZH, 2010, ECOL RES, V25, P1151, DOI 10.1007/s11284-010-0740-0; Zhu S-Q, 2003, ECOLOGICAL RES KARST; Zhu SQ, 1995, ECOLOGICAL RES KARST	49	20	31	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56443	10.1371/journal.pone.0056443	http://dx.doi.org/10.1371/journal.pone.0056443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451047	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500015
J	Ruiz-Benito, P; Lines, ER; Gomez-Aparicio, L; Zavala, MA; Coomes, DA				Ruiz-Benito, Paloma; Lines, Emily R.; Gomez-Aparicio, Lorena; Zavala, Miguel A.; Coomes, David A.			Patterns and Drivers of Tree Mortality in Iberian Forests: Climatic Effects Are Modified by Competition	PLOS ONE			English	Article							PINE-OAK FORESTS; INDIVIDUAL TREES; STAND STRUCTURE; TRADE-OFFS; DROUGHT; GROWTH; MECHANISMS; SURVIVAL; DECLINE; MODELS	Tree mortality is a key process underlying forest dynamics and community assembly. Understanding how tree mortality is driven by simultaneous drivers is needed to evaluate potential effects of climate change on forest composition. Using repeat-measure information from c. 400,000 trees from the Spanish Forest Inventory, we quantified the relative importance of tree size, competition, climate and edaphic conditions on tree mortality of 11 species, and explored the combined effect of climate and competition. Tree mortality was affected by all of these multiple drivers, especially tree size and asymmetric competition, and strong interactions between climate and competition were found. All species showed L-shaped mortality patterns (i.e. showed decreasing mortality with tree size), but pines were more sensitive to asymmetric competition than broadleaved species. Among climatic variables, the negative effect of temperature on tree mortality was much larger than the effect of precipitation. Moreover, the effect of climate (mean annual temperature and annual precipitation) on tree mortality was aggravated at high competition levels for all species, but especially for broadleaved species. The significant interaction between climate and competition on tree mortality indicated that global change in Mediterranean regions, causing hotter and drier conditions and denser stands, could lead to profound effects on forest structure and composition. Therefore, to evaluate the potential effects of climatic change on tree mortality, forest structure must be considered, since two systems of similar composition but different structure could radically differ in their response to climatic conditions.	[Ruiz-Benito, Paloma] Inst Nacl Invest & Tecnol Agr & Alimentaria CIFOR, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain; [Ruiz-Benito, Paloma; Zavala, Miguel A.] Univ Alcala, Dept Life Sci, Forest Ecol & Restorat Grp, Madrid, Spain; [Ruiz-Benito, Paloma; Lines, Emily R.; Coomes, David A.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Lines, Emily R.] UCL, Dept Geog, London, England; [Gomez-Aparicio, Lorena] CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Alcala; University of Cambridge; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Ruiz-Benito, P (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria CIFOR, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain.	ruiz.paloma@inia.es	Zavala, Miguel A./H-3603-2015; Ruiz-Benito, Paloma/E-5833-2012; Lines, Emily/B-4646-2013; Gómez-Aparicio, Lorena/K-6905-2014	Zavala, Miguel A./0000-0003-1456-0132; Ruiz-Benito, Paloma/0000-0002-2781-5870; Coomes, David/0000-0002-8261-2582; Lines, Emily/0000-0002-5357-8741	FPU fellowship [AP2008-01325]; CARBO-Extreme [FP7-ENV-2008-1-226701]; REMEDINAL-2 [S2009/AMB-1783];  [INTERBOS3-CGL2008-04503-C03-03];  [SUM2008-00004-C03-01]	FPU fellowship(Spanish Government); CARBO-Extreme; REMEDINAL-2; ; 	Paloma Ruiz-Benito was supported by a FPU fellowship (AP2008-01325). This research was supported by INTERBOS3-CGL2008-04503-C03-03 (http://www.irnase.csic.es/users/interbos/inicio.php), SUM2008-00004-C03-01,CARBO-Extreme (FP7-ENV-2008-1-226701, http://www.carbo-extreme.eu/) and REMEDINAL-2(S2009/AMB-1783, http://www.remedinal.org/) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; [Anonymous], CUADERNOS SOC ESPANO; [Anonymous], 1997, BOSQUES IB RICOS INT; Ashton PMS, 1997, J APPL ECOL, V34, P915, DOI 10.2307/2405282; Barbero Marcel, 1998, P153; Begon M., 1996, ECOLOGY; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; BUCHMAN RG, 1983, CAN J FOREST RES, V13, P601, DOI 10.1139/x83-087; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Linares JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P485, DOI 10.1111/j.1466-8238.2009.00465.x; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Dietze MC, 2011, GLOBAL CHANGE BIOL, V17, P3312, DOI 10.1111/j.1365-2486.2011.02477.x; Eid T, 2001, FOREST ECOL MANAG, V154, P69, DOI 10.1016/S0378-1127(00)00634-4; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Galan P., 1998, ARBOLES ARBUSTOS PEN; Galiano L, 2010, ECOSYSTEMS, V13, P978, DOI 10.1007/s10021-010-9368-8; Gelman A., 2004, BAYESIAN DATA ANAL; Gil-Tena A, 2009, GLOBAL CHANGE BIOL, V15, P474, DOI 10.1111/j.1365-2486.2008.01730.x; Gomez-Aparicio L, 2011, GLOBAL CHANGE BIOL, V17, P2400, DOI 10.1111/j.1365-2486.2011.02421.x; Gomez-Aparicio L, 2009, ECOL APPL, V19, P2124, DOI 10.1890/08-1656.1; Harper J. L., 1977, POPULATION BIOL PLAN; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hurst JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026670; Kobe RK, 1996, ECOL MONOGR, V66, P181, DOI 10.2307/2963474; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LORIMER CG, 1983, FOREST ECOL MANAG, V6, P343, DOI 10.1016/0378-1127(83)90042-7; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Olano JM, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest:2008074; MONSERUD RA, 1976, FOREST SCI, V22, P438; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pausas JG, 2004, PLANT ECOL, V171, P209, DOI 10.1023/B:VEGE.0000029381.63336.20; PEET RK, 1987, BIOSCIENCE, V37, P586, DOI 10.2307/1310669; PIGOTT CD, 1993, J ECOL, V81, P557, DOI 10.2307/2261534; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; R Core Team, 2021, R LANGUAGE ENV STAT; Rohner B, 2012, J VEG SCI, V23, P892, DOI 10.1111/j.1654-1103.2012.01408.x; Sanchez-Gomez D, 2006, NEW PHYTOL, V170, P795, DOI 10.1111/j.1469-8137.2006.01711.x; Sanchez-Salguero R, 2012, FOREST ECOL MANAG, V271, P158, DOI 10.1016/j.foreco.2012.01.040; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Stephenson NL, 2011, ECOL MONOGR, V81, P527, DOI 10.1890/10-1077.1; Torras O, 2008, FOREST ECOL MANAG, V255, P3322, DOI 10.1016/j.foreco.2008.02.013; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Valladares F, 2002, PLANT CELL ENVIRON, V25, P749, DOI 10.1046/j.1365-3040.2002.00856.x; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Vayreda J, 2012, GLOBAL CHANGE BIOL, V18, P1028, DOI 10.1111/j.1365-2486.2011.02606.x; Vila-Cabrera A, 2011, ECOL APPL, V21, P1162, DOI 10.1890/10-0647.1; Villaescusa R., 1998, 2 INVENTARIO FORESTA; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Zavala MA, 2000, BOT REV, V66, P119, DOI 10.1007/BF02857785; Zavala MA, 2004, PLANT ECOL, V171, P197, DOI 10.1023/B:VEGE.0000029387.15947.b7; Zavala MA, 2011, CAN J FOREST RES, V41, P1432, DOI [10.1139/X11-050, 10.1139/x11-050]	68	147	149	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56843	10.1371/journal.pone.0056843	http://dx.doi.org/10.1371/journal.pone.0056843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451096	gold, Green Published			2022-12-27	WOS:000316849500034
J	Wang, HL; Kimberley, MO; Wilks, PJ				Wang, Hailong; Kimberley, Mark O.; Wilks, Peter J.			Economic Analysis of a Pine Plantation Receiving Repeated Applications of Biosolids	PLOS ONE			English	Article							SEWAGE-SLUDGE; FOREST SOIL; RADIATA PLANTATION; GROWTH-RESPONSE; MANAGEMENT; PHOSPHORUS; FERTILIZER; RESIDUALS; MUNICIPAL; ISLAND	Treated biosolids have been applied to 750-ha of a Pinus radiata forest plantation on Rabbit Island near Nelson City in New Zealand since 1996. A long-term research trial was established in 1997 to investigate the effects of the biosolids applications on the receiving environment and tree growth. An analysis of the likely economic impact of biosolids application shows that biosolids application has been beneficial. Stem volume of the high treatment (biosolids applied at 600 kg N ha(-1) every three years) was 36% greater than the control treatment (no biosolids applied), and stem volume of the standard treatment (300 kg N ha(-1)) was 27% greater than the control treatment at age 18 years of age. Biosolids treatments have effectively transformed a low productivity forest site to a medium productivity site. Although this increased productivity has been accompanied by some negative influences on wood quality attributes with reduced wood stiffness, wood density, and larger branches, an economic analysis shows that the increased stem volume and greater average log diameter in the biosolids treatments outweighs these negative effects. The high and standard biosolids treatments are predicted to increase the net stumpage value of logs by 24% and 14% respectively at harvesting, providing a large positive impact on the forest owner's economic return.	[Wang, Hailong] Zhejiang Agr & Forestry Univ, Zhejiang Prov Key Lab Carbon Cycling Forest Ecosy, Linan, Zhejiang, Peoples R China; [Wang, Hailong] Zhejiang Agr & Forestry Univ, Sch Environm & Resource Sci, Linan, Zhejiang, Peoples R China; [Wang, Hailong; Kimberley, Mark O.] Scion, Rotorua, New Zealand; [Wilks, Peter J.] PF Olsen Ltd, Nelson, New Zealand	Zhejiang A&F University; Zhejiang A&F University; Scion	Wang, HL (corresponding author), Zhejiang Agr & Forestry Univ, Zhejiang Prov Key Lab Carbon Cycling Forest Ecosy, Linan, Zhejiang, Peoples R China.	nzhailongwang@gmail.com	Wang, Hailong/C-2641-2011	Wang, Hailong/0000-0002-6107-5095	New Zealand Foundation for Research Science and Technology [C03X0902]; National Natural Science Foundation of China [41271337]; Research and Development Fund of Zhejiang A F University [2010FR097]; PF Olsen Ltd.; Tasman District Council; Nelson Regional Sewerage Business Unit	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Development Fund of Zhejiang A F University; PF Olsen Ltd.; Tasman District Council; Nelson Regional Sewerage Business Unit	The work was supported by New Zealand Foundation for Research Science and Technology (C03X0902), National Natural Science Foundation of China (41271337), the Research and Development Fund of Zhejiang A & F University (2010FR097), PF Olsen Ltd., Tasman District Council, the Nelson Regional Sewerage Business Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Peter J. Wilks is affiliated with PF Olsen Ltd, who provided some of the funding for the study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Brown S, 2011, ENVIRON SCI TECHNOL, V45, P7451, DOI 10.1021/es2010418; Carter P., 2005, P 14 INT S NOND TEST, P161; Dunlop JD, 1995, FRI B; Ferreiro-Dominguez N, 2012, SCI TOTAL ENVIRON, V424, P39, DOI 10.1016/j.scitotenv.2012.02.042; Hamuda HEAFB, 2011, J RESIDUALS SCI TECH, V8, P143; Hewitt AE, 1998, LANDSCAPE RES SCI SE; Kimberley Mark, 2005, New Zealand Journal of Forestry, V50, P13; Kimberley MO, 2004, FOREST ECOL MANAG, V189, P345, DOI 10.1016/j.foreco.2003.09.003; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lopez-Diaz ML, 2009, FOREST ECOL MANAG, V257, P1363, DOI 10.1016/j.foreco.2008.12.001; MacLaren JP, 2005, NZ TREE GROWER, P24; Magesan GN, 2003, AUST J SOIL RES, V41, P557, DOI 10.1071/SR02134; Mosquera-Losada MR, 2012, AGR ECOSYST ENVIRON, V161, P165, DOI 10.1016/j.agee.2012.08.001; Pratt WA, 2009, J ENVIRON QUAL, V38, P2106, DOI 10.2134/jeq2008.0350; Prescott CE, 2005, CAN J FOREST RES, V35, P211, DOI 10.1139/x04-146; Su JJ, 2008, AUST J SOIL RES, V46, P502, DOI 10.1071/SR07203; Su J, 2007, ENVIRON SCI POLLUT R, V14, P529, DOI 10.1065/espr2007.08.443; Thiart J, 2012, BUSINESS PLAN 2012 1; Walker R. F., 2011, Journal of Sustainable Forestry, V30, P263, DOI 10.1080/10549811.2010.490107; Wang HL, 2008, ENVIRON SCI POLLUT R, V15, P308, DOI 10.1007/s11356-008-0012-5; Wang H, 2006, CAN J FOREST RES, V36, P1921, DOI 10.1139/X06-084; Wang HL, 2004, PLANT SOIL, V267, P255, DOI 10.1007/s11104-005-0107-4; Wilks Peter, 2009, New Zealand Journal of Forestry, V54, P33	23	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57705	10.1371/journal.pone.0057705	http://dx.doi.org/10.1371/journal.pone.0057705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451262	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500129
J	Popov, S; Jury, A; Laxton, R; Doey, L; Kandasamy, N; Al-Sarraj, S; Jurgensmeier, JM; Jones, C				Popov, Sergey; Jury, Alexa; Laxton, Ross; Doey, Lawrence; Kandasamy, Naga; Al-Sarraj, Safa; Juergensmeier, Juliane M.; Jones, Chris			IDH1-Associated Primary Glioblastoma in Young Adults Displays Differential Patterns of Tumour and Vascular Morphology	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; IDH2 MUTATIONS; MULTIFORME; CELL; DISTINCT; GLIOMA; OLIGODENDROGLIOMA; AMPLIFICATION; ANGIOGENESIS; TEMOZOLOMIDE	Glioblastoma is a highly aggressive tumour with marked heterogeneity at the morphological level in both the tumour cells and the associated highly prominent vasculature. As we begin to develop an increased biological insight into the underlying processes driving the disease, fewer attempts have thus far been made to understand these phenotypic differences. We sought to address this by carefully assessing the morphological characteristics of both the tumour cells and the associated vasculature, relating these observations to the IDH1/MGMT status, with a particular focus on the early onset population of young adults who develop primary glioblastoma. 276 primary glioblastoma specimens were classified into their predominant cell morphological type (fibrillary, gemistocytic, giant cell, small cell, oligodendroglial, sarcomatous), and assessed for specific tumour (cellularity, necrosis, palisades) and vascular features (glomeruloid structures, arcades, pericyte proliferation). IDH1 positive glioblastomas were associated with a younger age at diagnosis, better clinical outcome, prominent oligodendroglial and small cell tumour cell morphology, pallisading necrosis and glomeruloid vascular proliferation in the absence of arcade-like structures. These features widen the phenotype of IDH1 mutation-positive primary glioblastoma in young adults and provide correlative evidence for a functional role of mutant IDH1 in the differential nature of neo-angiogenesis in different subtypes of glioblastoma.	[Popov, Sergey; Jury, Alexa; Jones, Chris] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Popov, Sergey; Jury, Alexa; Jones, Chris] Inst Canc Res, Div Canc Therapeut, Sutton, Surrey, England; [Laxton, Ross; Doey, Lawrence; Al-Sarraj, Safa] Kings Coll Hosp, Dept Neuropathol, London, England; [Kandasamy, Naga] Kings Coll Hosp, Dept Neuroradiol, London, England; [Juergensmeier, Juliane M.] AstraZeneca, Macclesfield, Cheshire, England	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; AstraZeneca	Jones, C (corresponding author), Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England.	chris.jones@icr.ac.uk	Juergensmeier, Juliane/I-4117-2013; Jones, Chris/ABE-6059-2021; Laxton, Ross C/G-1205-2010	Jones, Chris/0000-0001-8118-2296; Laxton, Ross C/0000-0002-3164-1201	AstraZeneca; NHS	AstraZeneca(AstraZeneca); NHS	JMJ is an employee of AstraZeneca. CJ receives research grant funding from AstraZeneca. SP, AJ, SEL, AB and CJ acknowledge NHS funding to the Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-2; De Carli E, 2009, NEW ENGL J MED, V360, P2248, DOI 10.1056/NEJMc090593; HADDAD SF, 1992, J NEUROPATH EXP NEUR, V51, P488, DOI 10.1097/00005072-199209000-00002; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2012, ACTA NEUROPATHOL; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Miyanaga T, 2008, NEUROPATHOLOGY, V28, P116, DOI 10.1111/j.1440-1789.2007.00853.x; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perry A, 2004, CANCER, V101, P2318, DOI 10.1002/cncr.20625; Quezado M, 2005, CLIN NEUROPATHOL, V24, P163; Reardon DA, 2011, J NATL COMPR CANC NE, V9, P414, DOI 10.6004/jnccn.2011.0038; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tuettenberg J, 2006, CRIT REV ONCOL HEMAT, V59, P181, DOI 10.1016/j.critrevonc.2006.01.004; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; WESSELING P, 1995, J NEUROPATH EXP NEUR, V54, P304, DOI 10.1097/00005072-199505000-00003; Williams SC, 2011, ACTA NEUROPATHOL, V121, P279, DOI 10.1007/s00401-010-0790-y; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	27	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56328	10.1371/journal.pone.0056328	http://dx.doi.org/10.1371/journal.pone.0056328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451042	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800009
J	Rizzetto, L; Giovannini, G; Bromley, M; Bowyer, P; Romani, L; Cavalieri, D				Rizzetto, Lisa; Giovannini, Gloria; Bromley, Michael; Bowyer, Paul; Romani, Luigina; Cavalieri, Duccio			Strain Dependent Variation of Immune Responses to A-fumigatus: Definition of Pathogenic Species	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ASPERGILLUS-FUMIGATUS; FUNGAL-INFECTIONS; IN-VITRO; TRYPTOPHAN CATABOLISM; CANDIDA-ALBICANS; CELL-WALL; RECOGNITION; RECEPTOR; VIRULENCE	For over a century microbiologists and immunologist have categorized microorganisms as pathogenic or non-pathogenic species or genera. This definition, clearly relevant at the strain and species level for most bacteria, where differences in virulence between strains of a particular species are well known, has never been probed at the strain level in fungal species. Here, we tested the immune reactivity and the pathogenic potential of a collection of strains from Aspergillus spp, a fungus that is generally considered pathogenic in immuno-compromised hosts. Our results show a wide strain-dependent variation of the immune response elicited indicating that different isolates possess diverse virulence and infectivity. Thus, the definition of markers of inflammation or pathogenicity cannot be generalized. The profound understanding of the molecular mechanisms subtending the different immune responses will result solely from the comparative study of strains with extremely diverse properties.	[Rizzetto, Lisa; Cavalieri, Duccio] Univ Florence, Dept Neurosci Pharmacol & Childs Hlth NEUROFARBA, Florence, Italy; [Giovannini, Gloria; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Bromley, Michael; Bowyer, Paul] Univ Manchester, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England; [Bromley, Michael; Bowyer, Paul] Univ Manchester, Univ S Manchester Hosp, Mycol Reference Ctr, Manchester, Lancs, England; [Bromley, Michael; Bowyer, Paul] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Manchester, Lancs, England; [Cavalieri, Duccio] Edmund Mach Fdn, Innovat & Res Ctr, San Michele All Adige, TN, Italy	University of Florence; University of Perugia; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Fondazione Edmund Mach	Cavalieri, D (corresponding author), Univ Florence, Dept Neurosci Pharmacol & Childs Hlth NEUROFARBA, Florence, Italy.	duccio.cavalieri@fmach.it	Rizzetto, Lisa/C-7304-2016; CAVALIERI, DUCCIO/T-3097-2017; Romani, Luigina/O-9987-2018	Rizzetto, Lisa/0000-0002-2170-9276; CAVALIERI, DUCCIO/0000-0001-6426-5719; Bromley, Michael/0000-0002-7611-0201; bowyer, paul/0000-0002-1083-9286; Romani, Luigina/0000-0002-1356-525X	European Community [242220]	European Community(European Commission)	This work was supported by funding from the European Communitys Integrative Project FP7, SYBARIS (Grant Agreement 242220, www.sybaris.eu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Beauvais A, 1997, INFECT IMMUN, V65, P3042, DOI 10.1128/IAI.65.8.3042-3047.1997; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Bourgeois C, 2010, CURR OPIN MICROBIOL, V13, P401, DOI 10.1016/j.mib.2010.05.004; Bourgeois Christelle, 2009, V470, P125, DOI 10.1007/978-1-59745-204-5_11; Carvalho A, 2011, BEST PRACT RES CL HA, V24, P435, DOI 10.1016/j.beha.2011.04.006; Chai LYA, 2011, MICROBES INFECT, V13, P151, DOI 10.1016/j.micinf.2010.10.005; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Chai LYA, 2009, INFECT IMMUN, V77, P2184, DOI 10.1128/IAI.01455-08; Clemons KV, 2005, MED MYCOL, V43, pS101, DOI 10.1080/13693780500051919; Cramer RA, 2011, CURR OPIN INFECT DIS, V24, P315, DOI 10.1097/QCO.0b013e328348b159; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; DEnfert C, 1996, INFECT IMMUN, V64, P4401, DOI 10.1128/IAI.64.10.4401-4405.1996; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Ene IV, 2012, INFECT IMMUN; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Foligne B, 2010, APPL ENVIRON MICROB, V76, P8259, DOI 10.1128/AEM.01976-10; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Peran L, 2005, WORLD J GASTROENTERO, V11, P5185; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Ramaprakash H, 2009, INFECT IMMUN, V77, P108, DOI 10.1128/IAI.00998-08; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sorrell TC, 2009, ADV EXP MED BIOL, V666, P108; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006	45	65	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56651	10.1371/journal.pone.0056651	http://dx.doi.org/10.1371/journal.pone.0056651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441211	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200068
J	Ruan, HL; Qin, HD; Shugart, YY; Bei, JX; Luo, FT; Zeng, YX; Jia, WH				Ruan, Hong-Lian; Qin, Hai-De; Shugart, Yin Yao; Bei, Jin-Xin; Luo, Fu-Tian; Zeng, Yi-Xin; Jia, Wei-Hua			Developing Genetic Epidemiological Models to Predict Risk for Nasopharyngeal Carcinoma in High-Risk Population of China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER RISK; SUSCEPTIBILITY LOCUS; FAMILY-HISTORY; VARIANTS; POLYMORPHISMS; SCORE	To date, the only established model for assessing risk for nasopharyngeal carcinoma (NPC) relies on the sero-status of the Epstein-Barr virus (EBV). By contrast, the risk assessment models proposed here include environmental risk factors, family history of NPC, and information on genetic variants. The models were developed using epidemiological and genetic data from a large case-control study, which included 1,387 subjects with NPC and 1,459 controls of Cantonese origin. The predictive accuracy of the models were then assessed by calculating the area under the receiver-operating characteristic curves (AUC). To compare the discriminatory improvement of models with and without genetic information, we estimated the net reclassification improvement (NRI) and integrated discrimination index (IDI). Well-established environmental risk factors for NPC include consumption of salted fish and preserved vegetables and cigarette smoking (in pack years). The environmental model alone shows modest discriminatory ability (AUC = 0.68; 95% CI: 0.66, 0.70), which is only slightly increased by the addition of data on family history of NPC (AUC = 0.70; 95% CI: 0.68, 0.72). With the addition of data on genetic variants, however, our model's discriminatory ability rises to 0.74 (95% CI: 0.72, 0.76). The improvements in NRI and IDI also suggest the potential usefulness of considering genetic variants when screening for NPC in endemic areas. If these findings are confirmed in larger cohort and population-based case-control studies, use of the new models to analyse data from NPC-endemic areas could well lead to earlier detection of NPC.	[Ruan, Hong-Lian; Bei, Jin-Xin; Zeng, Yi-Xin; Jia, Wei-Hua] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Ruan, Hong-Lian; Luo, Fu-Tian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Qin, Hai-De; Shugart, Yin Yao] NIMH, Unit Stat Genom, Div Intramural Res Program, NIH, Bethesda, MD 20892 USA	State Key Lab Oncology South China; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zeng, YX (corresponding author), State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China.	zengyx@sysucc.org.cn; jiaweih@mail.sysu.edu.cn	Bei, Jin-Xin/AAO-1259-2020	YAO, YIN/0000-0003-3053-8429	National Natural Science Foundation of China Projects of International Cooperation and Exchanges [81220108022]; National High Technology Research and Development Program of China [2012AA02A206, 2012AA02A501]; State Basic Research Development Program of China [2011CB504303]; Ministry of Science and Technology of China [2011ZX11307]; National Science and Technology Major Project [2008ZX09312-002]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002929, ZIAMH002930] Funding Source: NIH RePORTER	National Natural Science Foundation of China Projects of International Cooperation and Exchanges; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Basic Research Development Program of China(State Key Development Program for Basic Research of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Natural Science Foundation of China Projects of International Cooperation and Exchanges (81220108022), the National High Technology Research and Development Program of China (2012AA02A206 and 2012AA02A501), the State Basic Research Development Program of China (2011CB504303), the Ministry of Science and Technology of China (2011ZX11307), and the National Science and Technology Major Project (2008ZX09312-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, IARC SCI PUBL, VVIII, P1; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Cao SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019100; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Facio FM, 2010, GENET MED, V12, P370, DOI 10.1097/GIM.0b013e3181e15bd5; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; HENDERSON BE, 1976, NEW ENGL J MED, V295, P1101, DOI 10.1056/NEJM197611112952003; Hsu FC, 2008, CANCER GENET CYTOGEN, V183, P94, DOI 10.1016/j.cancergencyto.2008.02.008; Hsu FC, 2010, CANCER EPIDEM BIOMAR, V19, P1083, DOI 10.1158/1055-9965.EPI-09-1176; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Janssens ACJW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d631; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; Jia WH, 2012, SEMIN CANCER BIOL, V22, P117, DOI 10.1016/j.semcancer.2012.01.009; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Johansson M, 2012, INT J CANCER, V130, P129, DOI 10.1002/ijc.25986; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lu CC, 2005, INT J CANCER, V115, P742, DOI 10.1002/ijc.20946; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Ng CC, 2009, J HUM GENET, V54, P392, DOI 10.1038/jhg.2009.49; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Xu FH, 2012, JNCI-J NATL CANCER I, V104, P1396, DOI 10.1093/jnci/djs320; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2009, CLIN CANCER RES, V15, P1105, DOI 10.1158/1078-0432.CCR-08-1743; Zheng W, 2010, JNCI-J NATL CANCER I, V102, P972, DOI 10.1093/jnci/djq170	40	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56128	10.1371/journal.pone.0056128	http://dx.doi.org/10.1371/journal.pone.0056128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457511	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700024
J	Dugas, AF; Jalalpour, M; Gel, Y; Levin, S; Torcaso, F; Igusa, T; Rothman, RE				Dugas, Andrea Freyer; Jalalpour, Mehdi; Gel, Yulia; Levin, Scott; Torcaso, Fred; Igusa, Takeru; Rothman, Richard E.			Influenza Forecasting with Google Flu Trends	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; SURVEILLANCE; TRANSMISSION; ASSOCIATION; PREDICTION; PNEUMONIA; EPIDEMICS; OUTBREAKS; DYNAMICS; SPREAD	Background: We developed a practical influenza forecast model based on real-time, geographically focused, and easy to access data, designed to provide individual medical centers with advanced warning of the expected number of influenza cases, thus allowing for sufficient time to implement interventions. Secondly, we evaluated the effects of incorporating a real-time influenza surveillance system, Google Flu Trends, and meteorological and temporal information on forecast accuracy. Methods: Forecast models designed to predict one week in advance were developed from weekly counts of confirmed influenza cases over seven seasons (2004-2011) divided into seven training and out-of-sample verification sets. Forecasting procedures using classical Box-Jenkins, generalized linear models (GLM), and generalized linear autoregressive moving average (GARMA) methods were employed to develop the final model and assess the relative contribution of external variables such as, Google Flu Trends, meteorological data, and temporal information. Results: A GARMA(3,0) forecast model with Negative Binomial distribution integrating Google Flu Trends information provided the most accurate influenza case predictions. The model, on the average, predicts weekly influenza cases during 7 out-of-sample outbreaks within 7 cases for 83% of estimates. Google Flu Trend data was the only source of external information to provide statistically significant forecast improvements over the base model in four of the seven out-of-sample verification sets. Overall, the p-value of adding this external information to the model is 0.0005. The other exogenous variables did not yield a statistically significant improvement in any of the verification sets. Conclusions: Integer-valued autoregression of influenza cases provides a strong base forecast model, which is enhanced by the addition of Google Flu Trends confirming the predictive capabilities of search query based syndromic surveillance. This accessible and flexible forecast model can be used by individual medical centers to provide advanced warning of future influenza cases.	[Dugas, Andrea Freyer; Levin, Scott; Rothman, Richard E.] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21218 USA; [Jalalpour, Mehdi; Gel, Yulia; Levin, Scott; Torcaso, Fred; Igusa, Takeru] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD USA; [Gel, Yulia] Univ Waterloo, Waterloo, ON N2L 3G1, Canada	Johns Hopkins University; Johns Hopkins University; University of Waterloo	Dugas, AF (corresponding author), Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21218 USA.	adugas1@jhmi.edu	Igusa, Takeru/A-3218-2010	Igusa, Takeru/0000-0002-3632-2867; Rothman, Richard/0000-0002-1017-9505	Department of Homeland Security (PACER: National Center for Study of Preparedness and Response) [2010-ST-061-PA0001]; National Science Foundation Systems Engineering and Design Program [NSF CMMI 0927207]; Natural Sciences and Engineering Research Council of Canada	Department of Homeland Security (PACER: National Center for Study of Preparedness and Response)(United States Department of Homeland Security (DHS)); National Science Foundation Systems Engineering and Design Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Department of Homeland Security (PACER: National Center for Study of Preparedness and Response [grant number: 2010-ST-061-PA0001]); the National Science Foundation Systems Engineering and Design Program [grant number: NSF CMMI 0927207]; and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SA, 2002, METEOROLOGY UNDERSTA; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Buehler JW, 2009, BIOSECUR BIOTERROR, V7, P165, DOI 10.1089/bsp.2009.0013; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Dukic V, 2012, J AM STAT ASSOC, V107, P1410, DOI 10.1080/01621459.2012.713876; Farias DR, 2010, DISASTER MED PUBLIC, V4, P207, DOI 10.1001/dmp.2010.29; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; Google, 2012, GOOGL FLU TRENDS; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Jalalpour M, 2012, GARMA TOOLKIT; Kedem B, 2005, REGRESSION MODELS TI, V488; Kim MJ, 2011, IIE T HEALTHCARE SYS, V1, P37; LONGINI IM, 1986, AM J EPIDEMIOL, V123, P383, DOI 10.1093/oxfordjournals.aje.a114253; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McDonnell WM, 2012, AM J EMERG MED, V30, P275, DOI 10.1016/j.ajem.2010.11.027; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Pines JM, 2006, ACAD EMERG MED, V13, P873, DOI [10.1197/j.aem.2006.03.568, 10.1111/j.1553-2712.2006.tb01741.x]; Pines JM, 2010, ACAD EMERG MED, V17, P276, DOI 10.1111/j.1553-2712.2009.00676.x; Pines JM, 2009, ACAD EMERG MED, V16, P617, DOI 10.1111/j.1553-2712.2009.00456.x; Quenel P, 1998, EUR J EPIDEMIOL, V14, P275, DOI 10.1023/A:1007467814485; Rebmann T, 2009, AM J INFECT CONTROL, V37, P271, DOI 10.1016/j.ajic.2008.12.002; Reeder Blaine, 2011, BMC Res Notes, V4, P187, DOI 10.1186/1756-0500-4-187; Schull MJ, 2004, ANN EMERG MED, V44, P61, DOI 10.1016/j.annemergmed.2003.12.008; Sloan C, 2011, CTS-CLIN TRANSL SCI, V4, P48, DOI 10.1111/j.1752-8062.2010.00257.x; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; STROUP DF, 1988, STAT MED, V7, P1045, DOI 10.1002/sim.4780071006; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Warden GL, 2006, ANN EMERG MED, V48, P115, DOI 10.1016/j.annemergmed.2006.06.015; WHO, 2009, INFL SEAS	36	186	199	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56176	10.1371/journal.pone.0056176	http://dx.doi.org/10.1371/journal.pone.0056176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457520	Green Published, gold			2022-12-27	WOS:000315602700054
J	Dutta, S; Guin, S; Ghosh, S; Pazhani, GP; Rajendran, K; Bhattacharya, MK; Takeda, Y; Nair, GB; Ramamurthy, T				Dutta, Sanjucta; Guin, Sucharita; Ghosh, Santanu; Pazhani, Gururaja P.; Rajendran, Krishnan; Bhattacharya, Mihir K.; Takeda, Yoshifumi; Nair, G. Balakrish; Ramamurthy, Thandavarayan			Trends in the Prevalence of Diarrheagenic Escherichia coli among Hospitalized Diarrheal Patients in Kolkata, India	PLOS ONE			English	Article							DISEASE BURDEN; CHILDREN; IDENTIFICATION; INFECTION; EPIDEMIOLOGY; PATHOGENS; INFANTS	Background: To analyse the trends in the prevalence of different pathogroups of diarrheagenic Escherichia coli (DEC) among hospitalized acute diarrheal patients. Methodology/Principal Findings: From the active surveillance of diarrheal disease at the Infectious Diseases Hospital, Kolkata, 3826 stool specimens collected during 2008-2011 were screened for DEC and other enteric pathogens. PCR was used in the detection of enterotoxigenic, enteropathogenic and enteroaggregative E. coli and 10 major colonization factor antigens (CFs) of enterotoxigenic E. coli. The relationship between DEC infected patient's age group and clinical symptoms were also investigated. Multiplex PCR assay showed that the prevalence of EAEC was most common (5.7%) followed by ETEC (4.2%) and EPEC (1.8%). In diarrheal children >2 year of age, EAEC and EPEC were detected significantly (p = 0.000 and 0.007, respectively). In children >2 to 5 and >5 to 14 years, ETEC was significantly associated with diarrhea (p = 0.000 each). EAEC was significantly associated with diarrheal patients with age groups >14 to 30 and >30 to 50 years (p = 0.001, and p = 0.009, respectively). Clinical symptoms such as vomiting, abdominal pain, watery diarrhea, were recorded in patients infected with ETEC. Dehydration status was severe among patients infected by ST-ETEC (19%) and EPEC (15%). CS6 was frequently detected (37%) among ETEC. Conclusions/Significance: Hospital based surveillance reviled that specific pathogroups of DEC are important to certain age groups and among ETEC, CS6 was predominant.	[Dutta, Sanjucta; Ghosh, Santanu; Pazhani, Gururaja P.; Rajendran, Krishnan; Ramamurthy, Thandavarayan] Okayama Univ Infect Dis India, Div Bacteriol, Collaborat Res Ctr, Kolkata, W Bengal, India; [Guin, Sucharita; Bhattacharya, Mihir K.] Okayama Univ Infect Dis India, Clin Div, Inst Cholera & Enter Dis, Collaborat Res Ctr, Kolkata, W Bengal, India; [Takeda, Yoshifumi] Natl Inst Cholera & Enter Dis, Kolkata, W Bengal, India; [Nair, G. Balakrish] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India	Okayama University; Okayama University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Ramamurthy, T (corresponding author), Okayama Univ Infect Dis India, Div Bacteriol, Collaborat Res Ctr, Kolkata, W Bengal, India.	tramu@vsnl.net	KRISHNAN, RAJENDRAN/L-6274-2019	dutta, sanjucta/0000-0002-8850-9914; Pazhani, Gururaja Perumal/0000-0001-9500-006X	Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; Indian Council of Medical Research, New Delhi, India	Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan; Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported in part by the Japan Initiative for Global Research Network on Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology, Japan and from intramural grants of the Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1995, J CLIN MICROBIOL, V33, P973, DOI 10.1128/JCM.33.4.973-977.1995; BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; BINSZTEIN N, 1991, J CLIN MICROBIOL, V29, P1893, DOI 10.1128/JCM.29.9.1893-1898.1991; CASALINO M, 1988, T ROY SOC TROP MED H, V82, P637, DOI 10.1016/0035-9203(88)90542-1; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Cho SH, 2006, J MICROBIOL, V44, P327; Clarke SC, 2001, DIAGN MICR INFEC DIS, V41, P93, DOI 10.1016/S0732-8893(01)00303-0; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; ECHEVERRIA P, 1983, DIAGN MICR INFEC DIS, V1, P193, DOI 10.1016/0732-8893(83)90018-4; ECHEVERRIA P, 1991, J INFECT DIS, V164, P550, DOI 10.1093/infdis/164.3.550; Estrada-Garcia T, 2009, J CLIN MICROBIOL, V47, P93, DOI 10.1128/JCM.01166-08; Faruque ASG, 1998, SCAND J INFECT DIS, V30, P393, DOI 10.1080/00365549850160701; Ghosal A, 2007, J CLIN MICROBIOL, V45, P3068, DOI 10.1128/JCM.00646-07; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Jafari F, 2009, J INFECTION, V58, P21, DOI 10.1016/j.jinf.2008.10.013; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; Kahali S, 2004, J CLIN MICROBIOL, V42, P4111, DOI 10.1128/JCM.42.9.4111-4120.2004; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Melo AR, 2005, SCAND J IMMUNOL, V61, P511, DOI 10.1111/j.1365-3083.2005.01626.x; Moyo SJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-92; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Nataro JP, 2006, CLIN INFECT DIS, V43, P402, DOI 10.1086/505867; Nguyen RN, 2006, EMERG INFECT DIS, V12, P597; Nguyen TV, 2005, J CLIN MICROBIOL, V43, P755, DOI 10.1128/JCM.43.2.755-760.2005; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Ochoa TJ, 2009, CLIN INFECT DIS, V49, P1694, DOI 10.1086/648069; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Paniagua M, 1997, J CLIN MICROBIOL, V35, P1404, DOI 10.1128/JCM.35.6.1404-1410.1997; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Rao MR, 2003, J CLIN MICROBIOL, V41, P4862, DOI 10.1128/JCM.41.10.4862-4864.2003; Regua-Mangia AH, 2004, J INFECTION, V48, P161, DOI 10.1016/S0163-4453(03)00138-5; Sarantuya J, 2004, J CLIN MICROBIOL, V42, P133, DOI 10.1128/JCM.42.1.133-139.2004	35	36	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56068	10.1371/journal.pone.0056068	http://dx.doi.org/10.1371/journal.pone.0056068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457500	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700039
J	Zhu, BQ; Xiao, D; Zhang, HF; Zhang, YC; Gao, Y; Xu, L; Lv, J; Wang, YT; Zhang, JZ; Shao, ZJ				Zhu, Bingqing; Xiao, Di; Zhang, Huifang; Zhang, Yongchan; Gao, Yuan; Xu, Li; Lv, Jing; Wang, Yingtong; Zhang, Jianzhong; Shao, Zhujun			MALDI-TOF MS Distinctly Differentiates Nontypable Haemophilus influenzae from Haemophilus haemolyticus	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; FLIGHT MASS-SPECTROMETRY; RAPID IDENTIFICATION; STRAINS; GENES; MEDIA	Nontypable Haemophilus influenzae (NTHi) and Haemophilus haemolyticus exhibit different pathogenicities, but to date, there remains no definitive and reliable strategy for differentiating these strains. In this study, we evaluated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) as a potential method for differentiating NTHi and H. haemolyticus. The phylogenetic analysis of concatenated 16S rRNA and recombinase A (recA) gene sequences, outer membrane protein P6 gene sequencing and single-gene PCR were used as reference methods. The original reference database (ORD, provided with the Biotyper software) and new reference database (NRD, extended with Chinese strains) were compared for the evaluation of MALDI-TOF MS. Through a search of the ORD, 76.9% of the NTHi (40/52) and none of the H. haemolyticus (0/20) strains were identified at the species level. However, all NTHi and H. haemolyticus strains used for identification were accurately recognized at the species level when searching the NRD. From the dendrogram clustering of the main spectra projections, the Chinese and foreign H. influenzae reference strains were categorized into two distinct groups, and H. influenzae and H. haemolyticus were also separated into two categories. Compared to the existing methods, MALDI-TOF MS has the advantage of integrating high throughput, accuracy and speed. In conclusion, MALDI-TOF MS is an excellent method for differentiating NTHi and H. haemolyticus. This method can be recommended for use in appropriately equipped laboratories.	[Zhu, Bingqing; Xiao, Di; Zhang, Huifang; Zhang, Yongchan; Gao, Yuan; Xu, Li; Zhang, Jianzhong; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Lv, Jing] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Wang, Yingtong] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, JZ (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	zhangjianzhong@icdc.cn; shaozhujun@icdc.cn	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022; Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206	Acute Meningitis-Encephalitis Syndrome Surveillance project; National Basic Research Program of China (973 Program) [2011CB504904]; National Key Program for Infectious Disease of China [2008ZX10004-002]; China Mega-Project for Infectious Disease [2011ZX10004-001]	Acute Meningitis-Encephalitis Syndrome Surveillance project; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Program for Infectious Disease of China; China Mega-Project for Infectious Disease	This research was supported by the Acute Meningitis-Encephalitis Syndrome Surveillance project and grants (2011CB504904) from the National Basic Research Program of China (973 Program), the National Key Program for Infectious Disease of China (Contract No. 2008ZX10004-002) and the China Mega-Project for Infectious Disease (Contract No. 2011ZX10004-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeldaim GMK, 2009, DIAGN MICR INFEC DIS, V64, P366, DOI 10.1016/j.diagmicrobio.2009.03.030; Anderson R, 2012, J CLIN MICROBIOL, V50, P2462, DOI 10.1128/JCM.06575-11; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Chang A, 2010, J CLIN MICROBIOL, V48, P3756, DOI 10.1128/JCM.01255-10; De Bruyne K, 2011, SYST APPL MICROBIOL, V34, P20, DOI 10.1016/j.syapm.2010.11.003; Doan NTL, 2012, LETT APPL MICROBIOL, V55, P265, DOI 10.1111/j.1472-765X.2012.03287.x; Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020223; Martiny D, 2011, CLIN MICROBIOL INFEC, V17, P1001, DOI 10.1111/j.1469-0691.2010.03328.x; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; Mukundan D, 2007, J CLIN MICROBIOL, V45, P3207, DOI 10.1128/JCM.00492-07; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Murugaiyan J, 2012, CLIN MICROBIOL INFEC, V18, P461, DOI 10.1111/j.1469-0691.2011.03593.x; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; Norskov-Lauritsen N, 2009, J CLIN MICROBIOL, V47, P2590, DOI 10.1128/JCM.00013-09; Pichichero ME, 2008, CLIN PEDIATR, V47, P901, DOI 10.1177/0009922808319966; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Spanu T, 2011, CLIN MICROBIOL INFEC, V17, P44, DOI 10.1111/j.1469-0691.2010.03181.x; Tao LL, 2012, CHINESE MED J-PEKING, V125, P2967, DOI 10.3760/cma.j.issn.0366-6999.2012.17.002; Theodore MJ, 2012, J CLIN MICROBIOL, V50, P1422, DOI 10.1128/JCM.06702-11; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005; Vanlaere E, 2008, J MICROBIOL METH, V75, P279, DOI 10.1016/j.mimet.2008.06.016; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Xiao D, 2012, DIAGN MICR INFEC DIS, V73, P301, DOI 10.1016/j.diagmicrobio.2012.04.004; Yan YJ, 2011, J CLIN MICROBIOL, V49, P2528, DOI 10.1128/JCM.00339-11	28	37	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56139	10.1371/journal.pone.0056139	http://dx.doi.org/10.1371/journal.pone.0056139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457514	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700048
J	Nurhonen, M; Cheng, AC; Auranen, K				Nurhonen, Markku; Cheng, Allen C.; Auranen, Kari			Pneumococcal Transmission and Disease In Silico: A Microsimulation Model of the Indirect Effects of Vaccination	PLOS ONE			English	Article							INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINATION; SEROTYPE REPLACEMENT; NASOPHARYNGEAL CARRIAGE; CHILDREN YOUNGER; POPULATION; IMPACT; VACCINES; IMMUNITY	Background: The degree and time frame of indirect effects of vaccination (serotype replacement and herd immunity) are key determinants in assessing the net effectiveness of vaccination with pneumococcal conjugate vaccines (PCV) in control of pneumococcal disease. Using modelling, we aimed to quantify these effects and their dependence on coverage of vaccination and the vaccine's efficacy against susceptibility to pneumococcal carriage. Methods and Findings: We constructed an individual-based simulation model that explores the effects of large-scale PCV programmes and applied it in a developed country setting (Finland). A population structure with transmission of carriage taking place within relevant mixing groups (families, day care groups, schools and neighbourhoods) was considered in order to properly assess the dependency of herd immunity on coverage of vaccination and vaccine efficacy against carriage. Issues regarding potential serotype replacement were addressed by employing a novel competition structure between multiple pneumococcal serotypes. Model parameters were calibrated from pre-vaccination data about the age-specific carriage prevalence and serotype distribution. The model predicts that elimination of vaccine-type carriage and disease among those vaccinated and, due to a substantial herd effect, also among the general population takes place within 5-10 years since the onset of a PCV programme with high (90%) coverage of vaccination and moderate (50%) vaccine efficacy against acquisition of carriage. A near-complete replacement of vaccine-type carriage by non-vaccine-type carriage occurs within the same time frame. Conclusions: The changed patterns in pneumococcal carriage after PCV vaccination predicted by the model are unequivocal. The overall effect on disease incidence depends crucially on the magnitude of age-and serotype-specific case-to-carrier ratios of the remaining serotypes relative to those of the vaccine types. Thus the availability of reliable data on the incidence of both pneumococcal carriage and disease is essential in assessing the net effectiveness of PCV vaccination in a given epidemiological setting.	[Nurhonen, Markku; Auranen, Kari] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Cheng, Allen C.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cheng, Allen C.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia	Finland National Institute for Health & Welfare; Monash University; Florey Institute of Neuroscience & Mental Health	Nurhonen, M (corresponding author), Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland.	markku.nurhonen@thl.fi		Cheng, Allen/0000-0003-3152-116X	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative; Academy of Finland [138068]	Bill and Melinda Gates Foundation through Grand Challenges in Global Health Initiative; Academy of Finland(Academy of Finland)	This study is a part of the research of the PneumoCarr Consortium (www.pneumocarr.org) funded by a grant from the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative. Additional funding was provided by grant 138068 from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auranen K, 2004, EPIDEMIOL INFECT, V132, P947, DOI 10.1017/S0950268804002493; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Cobey S, 2012, SCIENCE, V335, P1376, DOI 10.1126/science.1215947; De Wals P, 2009, CLIN THER, V31, P2152, DOI 10.1016/j.clinthera.2009.10.014; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Halloran ME., 2010, DESIGN ANAL VACCINE; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hoti F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-102; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Karlsson D, 2011, EPIDEMIOL INFECT, V139, P1351, DOI 10.1017/S0950268810002773; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Levine OS, 2010, CURR OPIN INFECT DIS, V23, P236, DOI 10.1097/QCO.0b013e328338c135; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Palmu AA, 2002, 3 INT S PNEUM PNEUM; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Talbird SE, 2010, VACCINE, V28, pG3, DOI 10.1016/j.vaccine.2010.06.013; Temime L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003244; Van Effelterre T, 2010, VACCINE, V28, P3650, DOI 10.1016/j.vaccine.2010.03.030; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x	41	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56079	10.1371/journal.pone.0056079	http://dx.doi.org/10.1371/journal.pone.0056079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23457504	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400199
J	Chung, SD; Liu, SP; Lin, HC				Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Herng-Ching			Association between Prostate Cancer and Urinary Calculi: A Population-Based Study	PLOS ONE			English	Article							UNITED-STATES; INSULIN-RESISTANCE; METABOLIC SYNDROME; KIDNEY-STONES; TIME-TRENDS; EPIDEMIOLOGY; RISK; NEPHROLITHIASIS; PREVALENCE; DATABASE	Background: Understanding the reasons underlying the emerging trend and the changing demographics of Asian prostate cancer (PC) has become an important field of study. This study set out to explore the possibility that urinary calculi (UC) and PC may share an association by conducting a case-control study on a population-based database in Taiwan. Methods: The cases of this study included 2,900 subjects >= 40 years-old who had received their first-time diagnosis of PC and 14,500 randomly selected controls without PC. Conditional logistic regressions were employed to explore the association between PC and having been previously diagnosed with UC. Results: We found that prior UC was found among 608 (21.0%) cases and 2,037 (14.1%) controls (p<0.001). Conditional logistic regression analysis revealed that compared to controls, the odds ratio (OR) of prior UC for cases was 1.63 (95% CI = 1.47-1.80). Furthermore, we found that cases were more likely to have been previously diagnosed with kidney calculus (OR = 1.71; 95% CI = 1.42-2.05), bladder calculus (OR = 2.06; 95% CI = 1.32-3.23), unspecified calculus (OR = 1.66; 95% CI = 1.37-2.00), and >= 2 locations of UC (OR = 1.73; 1.47-2.02) than controls. However, there was no significant relationship between PC and prior ureter calculus. We also found that of the patients with UC, there was no significant difference between PC and treatment method. Conclusions: This investigation detected an association between PC and prior UC. These results highlight a potential target population for PC screening.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Div Urol, Dept Surg, New Taipei City, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cullen Jennifer, 2012, J Carcinog, V11, P7, DOI 10.4103/1477-3163.94025; Ferlay J, 2001, GLOBOSCAN 2000 CANC; Goldfarb DS, 2003, KIDNEY INT, V63, P1951, DOI 10.1046/j.1523-1755.2003.00942.x; GU FL, 1994, UROLOGY, V44, P688, DOI 10.1016/S0090-4295(94)80207-6; Iba A, 2010, BJU INT, V106, P1550, DOI 10.1111/j.1464-410X.2010.09216.x; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Long L O, 2007, Minerva Urol Nefrol, V59, P317; Lopez M, 2010, PEDIATR NEPHROL, V25, P49, DOI 10.1007/s00467-008-0960-5; MUIR CS, 1991, ACTA ONCOL, V30, P133, DOI 10.3109/02841869109092336; Pelucchi C, 2006, EUR J CANCER PREV, V15, P254, DOI 10.1097/01.cej.0000198897.40303.d4; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Sakhaee K, 2002, KIDNEY INT, V62, P971, DOI 10.1046/j.1523-1755.2002.00508.x; Sakhaee K, 2008, CURR OPIN NEPHROL HY, V17, P304, DOI 10.1097/MNH.0b013e3282f8b34d; Santner SJ, 1998, J CLIN ENDOCR METAB, V83, P2104, DOI 10.1210/jc.83.6.2104; SEVERSON RK, 1989, CANCER RES, V49, P1857; Signorello LB, 1997, CANCER CAUSE CONTROL, V8, P632, DOI 10.1023/A:1018454632045; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; YU H, 1991, INT J EPIDEMIOL, V20, P76, DOI 10.1093/ije/20.1.76	23	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57743	10.1371/journal.pone.0057743	http://dx.doi.org/10.1371/journal.pone.0057743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451265	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500131
J	Vaishnavi, V; Manikandan, M; Tiwary, BK; Munirajan, AK				Vaishnavi, Varadarajan; Manikandan, Mayakannan; Tiwary, Basant K.; Munirajan, Arasambattu Kannan			Insights on the Functional Impact of MicroRNAs Present in Autism-Associated Copy Number Variants	PLOS ONE			English	Article							RARE DE-NOVO; SYNAPTIC-TRANSMISSION; GENE; NETWORK; EXPRESSION; PLASTICITY; DEFICITS; MICRODELETION; DUPLICATIONS; OVERGROWTH	Autism spectrum disorder is a complex neurodevelopmental disorder that appears during the first three years of infancy and lasts throughout a person's life. Recently a large category of genomic structural variants, denoted as copy number variants (CNVs), were established to be a major contributor of the pathophysiology of autism. To date almost all studies have focussed only on the genes present in the CNV loci, but the impact of non-coding regulatory microRNAs (miRNAs) present in these regions remain largely unexplored. Hence we attempted to elucidate the biological and functional significance of miRNAs present in autism-associated CNV loci and their target genes by using a series of computational tools. We demonstrate that nearly 11% of the CNV loci harbor miRNAs and a few of these miRNAs were previously reported to be associated with autism. A systematic analysis of the CNV-miRNAs based on their interactions with the target genes enabled the identification of top 10 miRNAs namely hsa-miR-590-3p, hsa-miR-944, hsa-miR-570, hsa-miR-34a, hsa-miR-124, hsa-miR-548f, hsa-miR-429, hsa-miR-200b, hsa-miR-195 and hsa-miR-497 as hub molecules. Further, the CNV-miRNAs formed a regulatory loop with transcription factors and their downstream target genes, and annotation of these target genes indicated their functional involvement in neurodevelopment and synapse. Moreover, miRNAs present in deleted and duplicated CNV loci may explain the difference in dosage of the crucial genes controlled by them. These CNV-miRNAs can also impair the global processing and biogenesis of all miRNAs by targeting key molecules in the miRNA pathway. To our knowledge, this is the first report to highlight the significance of CNV-microRNAs and their target genes to contribute towards the genetic heterogeneity and phenotypic variability of autism.	[Vaishnavi, Varadarajan; Manikandan, Mayakannan; Munirajan, Arasambattu Kannan] Univ Madras, Dept Genet, Dr ALM PG Inst Basic Med Sci, Madras, Tamil Nadu, India; [Tiwary, Basant K.] Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Pondicherry, India	University of Madras; Pondicherry University	Munirajan, AK (corresponding author), Univ Madras, Dept Genet, Dr ALM PG Inst Basic Med Sci, Madras, Tamil Nadu, India.	akmunirajan@unom.ac.in	Munirajan, Arasambattu/S-1096-2019; MUNIRAJAN, A K/P-5953-2019; Tiwary, Basant K/A-9617-2011	MUNIRAJAN, A K/0000-0003-1337-9008; Tiwary, Basant K/0000-0002-8194-5860; Manikandan, Mayakannan/0000-0002-6659-8987	Department of Biotechnology, New Delhi, India [BT/PR10023/AGR/36/27/2007]; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology, New Delhi, India to AKM (Grant No. BT/PR10023/AGR/36/27/2007). MM is supported by a research fellowship from the Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21093, DOI 10.1073/pnas.1112061109; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Akerblom M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00014; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bauman ML, 2010, NEUROTHERAPEUTICS, V7, P320, DOI 10.1016/j.nurt.2010.06.001; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Courchesne E, 2005, INT J DEV NEUROSCI, V23, P153, DOI 10.1016/j.ijdevneu.2005.01.003; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; El Baroudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014742; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gkogkas CG, 2012, NATURE; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hsu R, 2012, MOL CELL NEUROSCI, V50, P283, DOI 10.1016/j.mcn.2012.06.002; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Marshall CR, 2012, METHODS MOL BIOL, V838, P115, DOI 10.1007/978-1-61779-507-7_5; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice GM, 2011, AM J MED GENET A; Rozen SG, 2012, AM J HUM GENET, V91, P890, DOI 10.1016/j.ajhg.2012.09.003; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Santini E, 2012, NATURE; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Schofield CM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-11; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sengupta D, 2011, MOL BIOSYST, V7, P1966, DOI 10.1039/c0mb00347f; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Van der Aa N, 2012, AUTISM RES; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Waltereit R, 2011, BEHAV GENET, V41, P364, DOI 10.1007/s10519-010-9399-0; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	67	55	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56781	10.1371/journal.pone.0056781	http://dx.doi.org/10.1371/journal.pone.0056781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451085	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500028
J	Bertin, A; Chanson, M; Delaveau, J; Mercerand, F; Mostl, E; Calandreau, L; Arnould, C; Leterrier, C; Collin, A				Bertin, Aline; Chanson, Marine; Delaveau, Joel; Mercerand, Frederic; Moestl, Erich; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine; Collin, Anne			Moderate Heat Challenge Increased Yolk Steroid Hormones and Shaped Offspring Growth and Behavior in Chickens	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; SPARROW PASSER-DOMESTICUS; JAPANESE-QUAIL HATCHLINGS; TONIC IMMOBILITY REACTION; GALLUS-GALLUS-DOMESTICUS; LAYING HENS; AMBIENT-TEMPERATURE; FEEDING-BEHAVIOR; MATERNAL TESTOSTERONE; DIVERGENT SELECTION	Background: Environmental challenges might affect the maternal organism and indirectly affect the later ontogeny of the progeny. We investigated the cross-generation impact of a moderate heat challenge in chickens. We hypothesized that a warm temperature-within the thermotolerance range-would affect the hormonal environment provided to embryos by mothers, and in turn, affect the morphology and behavioral phenotype of offspring. Methodology/Principal Findings: Laying hens were raised under a standard thermal condition at 21 degrees C (controls) or 30 degrees C (experimental) for 5 consecutive weeks. A significant increase was observed in the internal temperature of hens exposed to the warm treatment; however plasma corticosterone levels remained unaffected. The laying rate was not affected, but experimental hens laid lighter eggs than the controls during the treatment. As expected, the maternal thermal environment affected yolk hormone contents. Eggs laid by the experimental hens showed significantly higher concentrations of yolk progesterone, testosterone, and estradiol. All chicks were raised under standard thermal conditions. The quality of hatchlings, growth, feeding behavior and emotional reactivity of chicks were analyzed. Offspring of experimental hens (C30 chicks) were lighter but obtained better morphological quality scores at hatching than the controls (C21 chicks). C30 chicks expressed lesser distress calls when exposed to a novel food. Unlike C21 chicks, C30 chicks expressed no preference for energetic food. Conclusion/Significance: Our findings suggest that moderate heat challenge triggers maternal effects and modulate the developmental trajectory of offspring in a way that may be adaptive. This suggests that the impact of heat challenges on captive or wild populations might have a cross-generation effect.	[Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] CNRS, UMR7247, Nouzilly, France; [Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] Univ Tours, Tours, France; [Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] IFCE, Nouzilly, France; [Delaveau, Joel; Mercerand, Frederic] INRA, UE1295, PEAT, F-37380 Nouzilly, France; [Moestl, Erich] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Collin, Anne] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE; University of Veterinary Medicine Vienna; INRAE	Bertin, A (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	aline.bertin@tours.inra.fr	Moreira, Nei/AAK-1357-2020; Leterrier, Christine/AAY-7201-2020	Moreira, Nei/0000-0002-9236-667X; 	Department PHASE of INRA	Department PHASE of INRA	The authors were supported by the Department PHASE of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DH, 2005, J EVOLUTION BIOL, V18, P884, DOI 10.1111/j.1420-9101.2005.00955.x; ARIELI A, 1980, BRIT POULTRY SCI, V21, P471, DOI 10.1080/00071668008416699; Barnagaud JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032819; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bertin A, 2010, ETHOLOGY, V116, P1027, DOI 10.1111/j.1439-0310.2010.01820.x; Bertin A, 2009, HORM BEHAV, V56, P416, DOI 10.1016/j.yhbeh.2009.07.008; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; CAMPO JL, 1994, ARCH GEFLUGELKD, V58, P75; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; DONOGHUE DJ, 1989, BIOL REPROD, V41, P419, DOI 10.1095/biolreprod41.3.419; Dzialowski EM, 2004, J EXP BIOL, V207, P597, DOI 10.1242/jeb.00792; Fasenko GM, 2008, POULTRY SCI, V87, P594, DOI 10.3382/ps.2007-00352; FAURE JM, 1983, BIOL BEHAV, V8, P103; GENTLE MJ, 1972, BRIT POULTRY SCI, V13, P141, DOI 10.1080/00071667208415928; Greenberg RS, 2003, ANIMAL INNOVATION; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guesdon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023941; Guibert F, 2011, APPL ANIM BEHAV SCI, V132, P51, DOI 10.1016/j.applanim.2011.03.012; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Harper LV, 2005, PSYCHOL BULL, V131, P340, DOI 10.1037/0033-2909.131.3.340; Hegyi G, 2010, J AVIAN BIOL, V41, P258, DOI 10.1111/j.1600-048X.2009.04787.x; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; HUANG ESR, 1979, BIOL REPROD, V20, P442, DOI 10.1095/biolreprod20.3.442; Ipek A., 2007, Journal of Biological & Environmental Sciences, V1, P117; IQBAL A, 1990, J THERM BIOL, V15, P149, DOI 10.1016/0306-4565(90)90032-D; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P66, DOI 10.1016/j.applanim.2006.09.016; JONES RB, 1986, BEHAV PROCESS, V12, P261, DOI 10.1016/0376-6357(86)90040-9; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONSON KM, 1976, BRAIN RES BULL, V1, P133, DOI 10.1016/0361-9230(76)90056-3; Kjaer JB, 2009, PHYSIOL BEHAV, V96, P370, DOI 10.1016/j.physbeh.2008.10.023; Kyriazakis I, 1999, P NUTR SOC, V58, P765, DOI 10.1017/S0029665199001044; Lecuelle S, 2010, APPL ANIM BEHAV SCI, V125, P132, DOI 10.1016/j.applanim.2010.04.009; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; MacLeod MG, 1997, BRIT POULTRY SCI, V38, P586, DOI 10.1080/00071669708418040; Marples NM, 1999, EVOL ECOL, V13, P641, DOI 10.1023/A:1011077731153; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; Okuliarova M., 2006, ACTA VET BRNO, V75, P325; Okuliarova M, 2010, GEN COMP ENDOCR, V165, P91, DOI 10.1016/j.ygcen.2009.06.007; Pfannkuche KA, 2011, GEN COMP ENDOCR, V172, P487, DOI 10.1016/j.ygcen.2011.04.014; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Rozenboim I, 2007, POULTRY SCI, V86, P1760, DOI 10.1093/ps/86.8.1760; Sauveur B., 1988, REPROD VOLAILLES PRO; SAVORY CJ, 1986, PHYSIOL BEHAV, V38, P353, DOI 10.1016/0031-9384(86)90106-X; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 2007, AM NAT, V170, P196, DOI 10.1086/519397; Sockman KW, 2001, GEN COMP ENDOCR, V122, P205, DOI 10.1006/gcen.2001.7626; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; Tobler M, 2007, HORM BEHAV, V52, P640, DOI 10.1016/j.yhbeh.2007.07.016; Tona K, 2003, POULTRY SCI, V82, P736, DOI 10.1093/ps/82.5.736; Vedder O, 2007, J AVIAN BIOL, V38, P625, DOI 10.1111/j.2007.0908-8857.04018.x; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; Wauters AM, 2002, DEV PSYCHOBIOL, V41, P25, DOI 10.1002/dev.10042; Yahav S, 2000, AVIAN POULT BIOL REV, V11, P81; Yahav S, 2009, WORLD POULTRY SCI J, V65, P719, DOI 10.1017/S004393390900049X; Yahav S, 2000, BRIT POULTRY SCI, V41, P660, DOI 10.1080/713654988; Yo T, 1998, POULTRY SCI, V77, P502, DOI 10.1093/ps/77.4.502; ZADWORNY D, 1989, GEN COMP ENDOCR, V74, P468, DOI 10.1016/S0016-6480(89)80044-9	74	20	20	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57670	10.1371/journal.pone.0057670	http://dx.doi.org/10.1371/journal.pone.0057670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451257	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800115
J	Gabaldon, C; Montero-Pau, J; Serra, M; Carmona, MJ				Gabaldon, Carmen; Montero-Pau, Javier; Serra, Manuel; Jose Carmona, Maria			Morphological Similarity and Ecological Overlap in Two Rotifer Species	PLOS ONE			English	Article							BRACHIONUS-PLICATILIS; BODY-SIZE; RESOURCE COMPETITION; SEXUAL REPRODUCTION; NICHE CONSERVATISM; PARTICLE-SIZE; LIMITING SIMILARITY; MOLECULAR ECOLOGY; POPULATION-GROWTH; FOOD SIZE	Co-occurrence of cryptic species raises theoretically relevant questions regarding their coexistence and ecological similarity. Given their great morphological similitude and close phylogenetic relationship (i.e., niche retention), these species will have similar ecological requirements and are expected to have strong competitive interactions. This raises the problem of finding the mechanisms that may explain the coexistence of cryptic species and challenges the conventional view of coexistence based on niche differentiation. The cryptic species complex of the rotifer Brachionus plicatilis is an excellent model to study these questions and to test hypotheses regarding ecological differentiation. Rotifer species within this complex are filtering zooplankters commonly found inhabiting the same ponds across the Iberian Peninsula and exhibit an extremely similar morphology-some of them being even virtually identical. Here, we explore whether subtle differences in body size and morphology translate into ecological differentiation by comparing two extremely morphologically similar species belonging to this complex: B. plicatilis and B. manjavacas. We focus on three key ecological features related to body size: (1) functional response, expressed by clearance rates; (2) tolerance to starvation, measured by growth and reproduction; and (3) vulnerability to copepod predation, measured by the number of preyed upon neonates. No major differences between B. plicatilis and B. manjavacas were found in the response to these features. Our results demonstrate the existence of a substantial niche overlap, suggesting that the subtle size differences between these two cryptic species are not sufficient to explain their coexistence. This lack of evidence for ecological differentiation in the studied biotic niche features is in agreement with the phylogenetic limiting similarity hypothesis but requires a mechanistic explanation of the coexistence of these species not based on differentiation related to biotic niche axes.	[Gabaldon, Carmen; Montero-Pau, Javier; Serra, Manuel; Jose Carmona, Maria] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain	University of Valencia	Gabaldon, C (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	carmen.gabaldon-tebar@uv.es	Serra, Manuel/H-7817-2015; Carmona, María José/AAM-4340-2020; Montero-Pau, Javier/H-6711-2015; GABALDÓN, CARMEN/N-3245-2017; Carmona, María José/H-6452-2015	Serra, Manuel/0000-0003-1731-1529; Carmona, María José/0000-0002-4835-6933; Montero-Pau, Javier/0000-0002-0864-8157; Carmona, María José/0000-0002-4835-6933	Ministerio de Ciencia [CGL2009-07364]; Spanish Ministerio de Ciencia e Innovacion [BES2010-036384]	Ministerio de Ciencia(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was founded by a grant from the Ministerio de Ciencia (CGL2009-07364) to MS. CG was supported by a fellowship from the Spanish Ministerio de Ciencia e Innovacion (BES2010-036384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, TREATISE LIMNOL; Barlow KE, 1997, P ROY SOC B-BIOL SCI, V264, P1695, DOI 10.1098/rspb.1997.0235; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BOGDAN KG, 1984, P NATL ACAD SCI-BIOL, V81, P6427, DOI 10.1073/pnas.81.20.6427; Bundy MH, 2002, J PLANKTON RES, V24, P215, DOI 10.1093/plankt/24.3.215; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Carmona MJ, 1995, HYDROBIOLOGIA, V313, P365, DOI 10.1007/BF00025971; Caswell H., 2006, ENCY ENV, VSecond, DOI 10.1002/9780470057339.vam006m; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHOTIYAPUTTA C, 1978, MAR BIOL, V45, P105, DOI 10.1007/BF00390546; Ciros-Perez J, 2004, LIMNOL OCEANOGR, V49, P40, DOI 10.4319/lo.2004.49.1.0040; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Conde-Porcuna JM, 1998, J PLANKTON RES, V20, P605, DOI 10.1093/plankt/20.4.605; Cox D. R., 1984, ANAL SURVIVAL DATA; DeMott WR, 1989, PLANKTON ECOLOGY SUC; DUMONT HJ, 1977, ARCH HYDROBIOL BEIH, V8, P98; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Futuyma DJ, 1996, PHILOS T R SOC B, V351, P1361, DOI 10.1098/rstb.1996.0119; Garcia-Roger EM, 2009, LIMNOL OCEANOGR, V54, P1845, DOI 10.4319/lo.2009.54.6.1845; Garcia-Roger EM, 2006, J PLANKTON RES, V28, P257, DOI 10.1093/plankt/fbi062; Geange SW, 2011, METHODS ECOL EVOL, V2, P175, DOI 10.1111/j.2041-210X.2010.00070.x; Gilbert J.J., 1984, P97; Gilbert JJ, 2004, FRESHWATER BIOL, V49, P1505, DOI 10.1111/j.1365-2427.2004.01282.x; GILBERT JJ, 1978, OECOLOGIA, V37, P13, DOI 10.1007/BF00349987; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Gomez A, 2005, HYDROBIOLOGIA, V546, P83, DOI 10.1007/s10750-005-4104-7; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Gomez A, 1997, OECOLOGIA, V111, P350, DOI 10.1007/s004420050245; GOMEZ A, 1995, J EVOLUTION BIOL, V8, P601, DOI 10.1046/j.1420-9101.1995.8050601.x; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; GUWICZ Z. M., 1980, EVOLUTION ECOLOGY ZO, V3, P282; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; Hansen B, 1997, J EXP MAR BIOL ECOL, V215, P217, DOI 10.1016/S0022-0981(97)00053-1; HANSEN B, 1991, MAR BIOL, V111, P263, DOI 10.1007/BF01319708; HINO A, 1984, B JPN SOC SCI FISH, V50, P1139; HINO A, 1980, B JPN SOC SCI FISH, V46, P1217; Hubbell Stephen P., 2001, V32, pi; KERFOOT WC, 1977, LIMNOL OCEANOGR, V22, P316, DOI 10.4319/lo.1977.22.2.0316; Kirk KL, 1997, ECOLOGY, V78, P434, DOI 10.1890/0012-9658(1997)078[0434:LHRTVE]2.0.CO;2; Kong LF, 2009, MAR BIOL, V156, P1507, DOI 10.1007/s00227-009-1190-5; Lapesa S, 2004, FRESHWATER BIOL, V49, P1053, DOI 10.1111/j.1365-2427.2004.01249.x; Lapesa S, 2002, FRESHWATER BIOL, V47, P1685, DOI 10.1046/j.1365-2427.2002.00926.x; Lapesa S, 2004, EFECTO DEPREDACION I; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; McPeek MA, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P355; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021530; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Moore PA, 1999, LIMNOL OCEANOGR, V44, P166, DOI 10.4319/lo.1999.44.1.0166; OBRIEN WJ, 1976, ECOLOGY, V57, P1304, DOI 10.2307/1935055; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Peters R.H., 1984, MANUAL METHODS ASSES, V17, P336; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pitta Paraskevi, 1997, Hydrobiologia, V363, P97, DOI 10.1023/A:1003121704913; Pourriot R., 1977, ARCHIV F R HYDROBIOL, V8, P243; Quinn GP, 2005, EXPT DESIGN DATA ANA; Ricci C, 2006, FUNCT ECOL, V20, P340, DOI 10.1111/j.1365-2435.2006.01082.x; RIGLER FH, 1961, CAN J ZOOLOG, V39, P857, DOI 10.1139/z61-080; ROCHE K, 1990, HYDROBIOLOGIA, V198, P153, DOI 10.1007/BF00048632; ROCHE KF, 1987, HYDROBIOLOGIA, V147, P229, DOI 10.1007/BF00025747; Rodriguez-Puebla C, 1998, INT J CLIMATOL, V18, P299, DOI 10.1002/(SICI)1097-0088(19980315)18:3&lt;299::AID-JOC247&gt;3.0.CO;2-L; ROTHHAUPT KO, 1990, LIMNOL OCEANOGR, V35, P16, DOI 10.4319/lo.1990.35.1.0016; ROTHHAUPT KO, 1990, FRESHWATER BIOL, V23, P561, DOI 10.1111/j.1365-2427.1990.tb00295.x; ROTHHAUPT KO, 1990, ARCH HYDROBIOL, V118, P1; ROTHHAUPT KO, 1990, LIMNOL OCEANOGR, V35, P24, DOI 10.4319/lo.1990.35.1.0024; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SCHULZE PC, 1995, LIMNOL OCEANOGR, V40, P33, DOI 10.4319/lo.1995.40.1.0033; SERRA M, 1987, HYDROBIOLOGIA, V147, P83, DOI 10.1007/BF00025729; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; Sommer U., 1989, P57; Stearns S.C., 1992, pi; Stelzer CP, 2006, LIMNOL OCEANOGR, V51, P125, DOI 10.4319/lo.2006.51.1.0125; Stelzer CP, 2003, LIMNOL OCEANOGR, V48, P939, DOI 10.4319/lo.2003.48.2.0939; Stelzer CP, 2001, ECOLOGY, V82, P2521; STEMBERGER RS, 1987, ECOLOGY, V68, P181, DOI 10.2307/1938818; STEMBERGER RS, 1985, ECOLOGY, V66, P1151, DOI 10.2307/1939167; Stemberger RS, 1982, MECH CONTROLLING SEL; STEWART AJ, 1986, ARCH HYDROBIOL, V106, P1; THRELKELD ST, 1976, FRESHWATER BIOL, V6, P489, DOI 10.1111/j.1365-2427.1976.tb01640.x; Tilman D., 1982, Monographs in Population Biology, pi; Tortajada AM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-312; Turner JT, 2005, DEEP-SEA RES PT II, V52, P2801, DOI 10.1016/j.dsr2.2005.06.011; VADSTEIN O, 1993, HYDROBIOLOGIA, V255, P261, DOI 10.1007/BF00025847; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; WARE DM, 1972, J FISH RES BOARD CAN, V29, P1193, DOI 10.1139/f72-175; WARE DM, 1973, J FISH RES BOARD CAN, V30, P787, DOI 10.1139/f73-134; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; WILLIAMSON CE, 1987, LIMNOL OCEANOGR, V32, P167, DOI 10.4319/lo.1987.32.1.0167; WILSON DS, 1975, AM NAT, V109, P769, DOI 10.1086/283042; Yoshinaga T, 2003, J EXP MAR BIOL ECOL, V287, P261, DOI 10.1016/S0022-0981(02)00574-9; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhang DY, 1998, J THEOR BIOL, V193, P465, DOI 10.1006/jtbi.1998.0712; Zhou WL, 2009, CHIN J OCEANOL LIMN, V27, P473, DOI 10.1007/s00343-009-9208-x	109	28	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57087	10.1371/journal.pone.0057087	http://dx.doi.org/10.1371/journal.pone.0057087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451154	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800071
J	Pomat, WS; van den Biggelaar, AHJ; Phuanukoonnon, S; Francis, J; Jacoby, P; Siba, PM; Alpers, MP; Reeder, JC; Holt, PG; Richmond, PC; Lehmann, D				Pomat, William S.; van den Biggelaar, Anita H. J.; Phuanukoonnon, Suparat; Francis, Jacinta; Jacoby, Peter; Siba, Peter M.; Alpers, Michael P.; Reeder, John C.; Holt, Patrick G.; Richmond, Peter C.; Lehmann, Deborah		Neonatal Pneumococcal Conjugate	Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial	PLOS ONE			English	Article							SEROTYPE-SPECIFIC HYPORESPONSIVENESS; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; DISEASE; IMMUNIZATION; HIGHLANDS; CARRIAGE; EFFICACY; MENINGITIS; RESPONSES	Background: Approximately 826,000 children, mostly young infants, die annually from invasive pneumococcal disease. A 6-10-14-week schedule of pneumococcal conjugate vaccine (PCV) is efficacious but neonatal PCV may provide earlier protection and better coverage. We conducted an open randomized controlled trial in Papua New Guinea to compare safety, immunogenicity and priming for memory of 7-valent PCV (PCV7) given in a 0-1-2-month (neonatal) schedule with that of the routine 1-2-3-month (infant) schedule. Methods: We randomized 318 infants at birth to receive PCV7 in the neonatal or infant schedule or no PCV7. All infants received 23-valent pneumococcal polysaccharide vaccine (PPV) at age 9 months. Serotype-specific serum IgG for PCV7 (VT) serotypes and non-VT serotypes 2, 5 and 7F were measured at birth and 2, 3, 4, 9, 10 and 18 months of age. Primary outcomes were geometric mean concentrations (GMCs) and proportions with concentration >= 0.35 mu g/ml of VT serotype-specific pneumococcal IgG at age 2 months and one month post-PPV. Results: We enrolled 101, 105 and 106 infants, respectively, into neonatal, infant and control groups. Despite high background levels of maternally derived antibody, both PCV7 groups had higher GMCs than controls at age 2 months for serotypes 4 (p < 0.001) and 9V (p < 0.05) and at age 3 months for all VTs except 6B. GMCs for serotypes 4, 9V, 18C and 19F were significantly higher (p < 0.001) at age 2 months in the neonatal (one month post-dose2 PCV7) than in the infant group (one month post-dose1 PCV7). PPV induced significantly higher VT antibody responses in PCV7-primed than unprimed infants, with neonatal and infant groups equivalent. High VT and non-VT antibody concentrations generally persisted to age 18 months. Conclusions: PCV7 is well-tolerated and immunogenic in PNG neonates and young infants and induces immunologic memory to PPV booster at age 9 months with antibody levels maintained to age 18 months.	[Pomat, William S.; Phuanukoonnon, Suparat; Francis, Jacinta; Siba, Peter M.; Reeder, John C.] Papua New Guinean Inst Med Res, Goroka, Papua N Guinea; [Pomat, William S.; van den Biggelaar, Anita H. J.; Jacoby, Peter; Holt, Patrick G.; Lehmann, Deborah] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Alpers, Michael P.] Curtin Univ Technol, Ctr Int Hlth, Perth, WA, Australia; [Reeder, John C.] Burnet Inst, Melbourne, Vic, Australia; [Richmond, Peter C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia	PNG Institute Of Medical Research; Telethon Kids Institute; University of Western Australia; Curtin University; Burnet Institute; University of Western Australia	Lehmann, D (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	deborahl@ichr.uwa.edu.au	Holt, Patrick G/H-1548-2011; Laing, Ingrid/I-7092-2013; Richmond, Peter C/G-3379-2012	Holt, Patrick G/0000-0003-1193-0935; Laing, Ingrid/0000-0002-1641-9899; Richmond, Peter C/0000-0001-7562-7228; Reeder, John/0000-0003-1395-1289	International Collaborative Project Grant of the Wellcome Trust, UK [071613/Z/03/Z]; Australian National Health and Medical Research Council [303123]; Australian National Health and Medical Research Council (NHMRC) R. Douglas Wright Biomedical Career Development Award [458780]; NHMRC [353514, 572590]; NHMRC Principal Research Fellowship; GlaxoSmithKline Biologicals; Merck; Pfizer Australia; GSK Australia	International Collaborative Project Grant of the Wellcome Trust, UK; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council (NHMRC) R. Douglas Wright Biomedical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); GlaxoSmithKline Biologicals(GlaxoSmithKline); Merck(Merck & Company); Pfizer Australia(PfizerPfizer Australia); GSK Australia	This project was funded by an International Collaborative Project Grant of the Wellcome Trust, UK (071613/Z/03/Z) http://www.wellcome.ac.uk/ and the Australian National Health and Medical Research Council (303123) http://www.nhmrc.gov.au/. AHJvdB was a recipient of an Australian National Health and Medical Research Council (NHMRC) R. Douglas Wright Biomedical Career Development Award (458780). DL received funding from an NHMRC Program grant (#353514) and a Project Grant (#572590). JCR was supported by an NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: P Richmond has been a member of vaccine advisory boards for Wyeth and CSL Ltd and has received institutional funding for investigator- initiated research from GlaxoSmithKline Biologicals and Merck and received travel support from Pfizer and Baxter to present study data at international meetings. D Lehmann has been a member of the GSK Australia Pneumococcal-Haemophilus influenzae-Protein D conjugate vaccine ("Phid-CV'') Advisory Panel, has received support from Pfizer Australia and GSK Australia to attend conferences, has received an honorarium from Merck Vaccines to give a seminar at their offices in Pennsylvania and to attend a conference, and is an investigator on an investigator-initiated research grant funded by Pfizer Australia. WS Pomat has received funding from Pfizer Australia to attend a conference. A. H. J. van den Biggelaar has received support from Pfizer Australia and GSK Australia to attend conferences; she was awarded and received a Pfizer- supported Robert Austrian Award in Pneumococcal Vaccinology ( 2008); she is currently an employee of Crucell/Johnson and Johnson, The Netherlands. All work related to this publication was conducted prior to employment at Crucell/Johnson and Johnson. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. S Phuanukoonnon, J Francis, P Jacoby, PM Siba, JC Reeder, MP Alpers and Patrick G Holt have declared that no competing interests exist. Vaccines used in this trial were purchased from manufacturers.	[Anonymous], 1998, Wkly Epidemiol Rec, V73, P187; Balloch A, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.008; BARKER J, 1989, J INFECT DIS, V159, P348, DOI 10.1093/infdis/159.2.348; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2010, J INFECT DIS, V201, P1570, DOI 10.1086/652006; Francis JP, 2009, CLIN VACCINE IMMUNOL, V16, P1633, DOI 10.1128/CVI.00247-09; GRATTEN M, 1986, BIOL NEONATE, V50, P114, DOI 10.1159/000242576; GRATTEN M, 1991, PAPUA NEW GUINEA MED, V34, P185; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Kakazo Mexy, 1999, Papua New Guinea Medical Journal, V42, P13; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Kieninger DM, 2010, VACCINE, V28, P4192, DOI 10.1016/j.vaccine.2010.04.008; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kumar D, 2010, J HEALTH POPUL NUTR, V28, P300; Lehmann D, 2005, INT J EPIDEMIOL, V34, P138, DOI 10.1093/ije/dyh262; Lehmann D, 1999, ANN TROP PAEDIATR, V19, P21, DOI 10.1080/02724939992608; LEHMANN D, 1991, ANN TROP PAEDIATR, V11, P247, DOI 10.1080/02724936.1991.11747510; Lehmann D, 1996, REPORT DATA COLLECTE; Lehmann D, 2010, CLIN INFECT DIS, V50, P1477, DOI 10.1086/652440; Moisi JC, 2010, VACCINE, V28, P5725, DOI 10.1016/j.vaccine.2010.06.011; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS17; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; O'Grady KA, 2009, VACCINE, V27, P307, DOI 10.1016/j.vaccine.2008.09.096; Olusanya BO, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-1; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; Papua New Guinea Department of Health, 2005, STAND TREATM COMM IL; Phuanukoonnon S., 2010, Papua New Guinea Medical Journal, V53, P191; Pomat W, 2012, 8 INT S PNEUM PNEUM; POMAT WS, 1994, INFECT IMMUN, V62, P1848, DOI 10.1128/IAI.62.5.1848-1853.1994; RILEY ID, 1986, LANCET, V2, P877; Roche PW, 2008, COMMUN DIS INTELL, V32, P18; Russell FM, 2010, VACCINE, V28, P3341, DOI 10.1016/j.vaccine.2010.02.087; Russell FM, 2010, VACCINE, V28, P3086, DOI 10.1016/j.vaccine.2010.02.065; Saha SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032134; Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Toikilik S, 2010, VACCINE, V28, P4673, DOI 10.1016/j.vaccine.2010.04.063; Vakevainen M, 2010, J PEDIATR-US, V157, P778, DOI 10.1016/j.jpeds.2010.04.071; van den Biggelaar AHJ, 2012, PEDIATR INFECT DIS J, V31, P243, DOI 10.1097/INF.0b013e318245a5a8; van den Biggelaar AHJ, 2011, VACCINE, V29, P5414, DOI 10.1016/j.vaccine.2011.05.065; van den Biggelaar AHJ, 2009, VACCINE, V27, P1340, DOI 10.1016/j.vaccine.2008.12.046; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO PNEUM SER REF, TRAIN MAN ENZ LINK I; World Health Organization, 2005, WHO TECHN REP SER, P1; Yoannes M, 2012, 8 INT S PNEUM PNEUM	53	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56698	10.1371/journal.pone.0056698	http://dx.doi.org/10.1371/journal.pone.0056698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451070	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800027
J	Bahia, AC; Oliveira, JHM; Kubota, MS; Araujo, HRC; Lima, JBP; Rios-Velasquez, CM; Lacerda, MVG; Oliveira, PL; Traub-Cseko, YM; Pimenta, PFP				Bahia, Ana C.; Oliveira, Jose Henrique M.; Kubota, Marina S.; Araujo, Helena R. C.; Lima, Jose B. P.; Rios-Velasquez, Claudia Maria; Lacerda, Marcus Vinicius G.; Oliveira, Pedro L.; Traub-Csekoe, Yara M.; Pimenta, Paulo F. P.			The Role of Reactive Oxygen Species in Anopheles aquasalis Response to Plasmodium vivax Infection	PLOS ONE			English	Article							FAMILY NADPH OXIDASES; IMMUNE DEFENSES; INNATE IMMUNITY; DUAL OXIDASE; GAMBIAE; SUPEROXIDE; MECHANISMS; BACTERIA; PCR	Malaria affects millions of people worldwide and hundreds of thousands of people each year in Brazil. The mosquito Anopheles aquasalis is an important vector of Plasmodium vivax, the main human malaria parasite in the Americas. Reactive oxygen species (ROS) have been shown to have a role in insect innate immune responses as a potent pathogen-killing agent. We investigated the mechanisms of free radicals modulation after A. aquasalis infection with P. vivax. ROS metabolism was evaluated in the vector by studying expression and activity of three key detoxification enzymes, one catalase and two superoxide dismutases (SOD3A and SOD3B). Also, the involvement of free radicals in the mosquito immunity was measured by silencing the catalase gene followed by infection of A. aquasalis with P. vivax. Catalase, SOD3A and SOD3B expression in whole A. aquasalis were at the same levels of controls at 24 h and upregulated 36 h after ingestion of blood containing P. vivax. However, in the insect isolated midgut, the mRNA for these enzymes was not regulated by P. vivax infection, while catalase activity was reduced 24 h after the infectious meal. RNAi-mediated silencing of catalase reduced enzyme activity in the midgut, resulted in increased P. vivax infection and prevalence, and decreased bacterial load in the mosquito midgut. Our findings suggest that the interactions between A. aquasalis and P. vivax do not follow the model of ROS-induced parasite killing. It appears that P. vivax manipulates the mosquito detoxification system in order to allow its own development. This can be an indirect effect of fewer competitive bacteria present in the mosquito midgut caused by the increase of ROS after catalase silencing. These findings provide novel information on unique aspects of the main malaria parasite in the Americas interaction with one of its natural vectors.	[Bahia, Ana C.; Kubota, Marina S.; Traub-Csekoe, Yara M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil; [Oliveira, Jose Henrique M.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, Lab Bioquim Artropodes Hematofagos, Rio De Janeiro, Brazil; [Araujo, Helena R. C.; Pimenta, Paulo F. P.] Inst Rene Rachou, Lab Entomol Med, Belo Horizonte, MG, Brazil; [Lima, Jose B. P.] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, Brazil; [Rios-Velasquez, Claudia Maria] Fiocruz MS, Lab Biodiversidade Saude, Ctr Pesquisa Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Lacerda, Marcus Vinicius G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Traub-Cseko, YM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	ytraub@ioc.fiocruz.br; pimenta@cpqrr.fiocruz.br	Traub-Cseko, Yara M/F-2723-2015; Pimenta, Paulo/AAH-1502-2020; Araujo, Helena/J-9209-2015; Rios Velasquez, Claudia Maria/K-2901-2015; Nascimento, Ana Cristina Bahia/G-2372-2015; L. Oliveira, Pedro/A-9438-2010	Araujo, Helena/0000-0002-2021-2217; Nascimento, Ana Cristina Bahia/0000-0002-4584-1888; L. Oliveira, Pedro/0000-0003-0307-354X; Oliveira, Jose Henrique M./0000-0003-3814-5312	CNPq; PRONEX; FIOCRUZ; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX; FIOCRUZ; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by CNPq, PRONEX, FIOCRUZ, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Bahia AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001317; Bahia AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009795; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Brazilian Ministry of Health, 2009, MAL DOENC A Z; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P489, DOI 10.1590/S0037-86822007000400026; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gentile C, 2005, Mem. Inst. Oswaldo Cruz, V100, P545, DOI 10.1590/S0074-02762005000600008; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Horosko S, 1997, J AM MOSQUITO CONTR, V13, P95; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Liochev SI, 2002, REDOX REP, V7, P55, DOI 10.1179/135100002125000190; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; World Health Organization, 2008, 20081 WHOHTMGMP	44	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57014	10.1371/journal.pone.0057014	http://dx.doi.org/10.1371/journal.pone.0057014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441231	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200088
J	Capurro, V; Busquet, P; Lopes, JP; Bertorelli, R; Tarozzo, G; Bolognesi, ML; Piomelli, D; Reggiani, A; Cavalli, A				Capurro, Valeria; Busquet, Perrine; Lopes, Joao Pedro; Bertorelli, Rosalia; Tarozzo, Glauco; Bolognesi, Maria Laura; Piomelli, Daniele; Reggiani, Angelo; Cavalli, Andrea			Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID CASCADE HYPOTHESIS; TARGET-DIRECTED LIGANDS; MORRIS WATER MAZE; OBJECT RECOGNITION; PASSIVE-AVOIDANCE; MEMORY IMPAIRMENT; MOUSE MODEL; MICE; BETA; ACCUMULATION	Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior. Over 30 million people worldwide suffer from AD and available therapies are still palliative rather than curative. Recently, Memoquin (MQ), a quinone-bearing polyamine compound, has emerged as a promising anti-AD lead candidate, mainly thanks to its multi-target profile. MQ acts as an acetylcholinesterase and beta-secretase-1 inhibitor, and also possesses anti-amyloid and anti-oxidant properties. Despite this potential interest, in vivo behavioral studies with MQ have been limited. Here, we report on in vivo studies with MQ (acute and sub-chronic treatments; 7-15 mg/kg per os) carried out using two different mouse models: i) scopolamine- and ii) beta-amyloid peptide-(A beta-) induced amnesia. Several aspects related to memory were examined using the T-maze, the Morris water maze, the novel object recognition, and the passive avoidance tasks. At the dose of 15 mg/kg, MQ was able to rescue all tested aspects of cognitive impairment including spatial, episodic, aversive, short and long-term memory in both scopolamine-and Ab-induced amnesia models. Furthermore, when tested in primary cortical neurons, MQ was able to fully prevent the Ab-induced neurotoxicity mediated by oxidative stress. The results support the effectiveness of MQ as a cognitive enhancer, and highlight the value of a multi-target strategy to address the complex nature of cognitive dysfunction in AD.	[Capurro, Valeria; Busquet, Perrine; Lopes, Joao Pedro; Bertorelli, Rosalia; Tarozzo, Glauco; Piomelli, Daniele; Reggiani, Angelo; Cavalli, Andrea] Ist Italiano Tecnol, Genoa, Italy; [Bolognesi, Maria Laura; Cavalli, Andrea] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Istituto Italiano di Tecnologia - IIT; University of Bologna; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Cavalli, A (corresponding author), Ist Italiano Tecnol, Genoa, Italy.	andrea.cavalli@iit.it	Lopes, Joao P/A-2332-2017; Bolognesi, Maria Laura/AAL-8062-2021	Lopes, Joao P/0000-0002-5122-1802; Bolognesi, Maria Laura/0000-0002-1289-5361; BERTORELLI, Rosalia/0000-0002-7913-3564; CAVALLI, ANDREA/0000-0002-6370-1176	Fondazione Istituto Italiano di Tecnologia	Fondazione Istituto Italiano di Tecnologia	The study reported in this paper was funded by Fondazione Istituto Italiano di Tecnologia. The founders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bolognesi ML, 2009, CURR OPIN CHEM BIOL, V13, P303, DOI 10.1016/j.cbpa.2009.04.619; Bolognesi ML, 2007, J MED CHEM, V50, P4882, DOI 10.1021/jm070559a; Bolognesi ML, 2011, CURR TOP MED CHEM, V11, P2797; Bolognesi ML, 2011, BIOORG MED CHEM LETT, V21, P2655, DOI 10.1016/j.bmcl.2010.12.093; Bolognesi ML, 2009, NEUROTHERAPEUTICS, V6, P152, DOI 10.1016/j.nurt.2008.10.042; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bores GM, 1996, J PHARMACOL EXP THER, V277, P728; Cavalli A, 2012, MULTITARGETED DRUGS, P441; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; Cavalli A, 2007, ANGEW CHEM INT EDIT, V46, P3689, DOI 10.1002/anie.200700256; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Gacar N, 2011, PHARMACOL BIOCHEM BE, V99, P316, DOI 10.1016/j.pbb.2011.05.017; Gutzmann H, 1998, J NEURAL TRANSM-SUPP, P301; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kanski J, 2003, BRAIN RES, V988, P173, DOI 10.1016/S0006-8993(03)03369-9; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim DH, 2010, PHARMACOL BIOCHEM BE, V97, P239, DOI 10.1016/j.pbb.2010.08.005; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Lau LF, 2008, TOP MED CHEM SER, V2, P1, DOI 10.1007/7355_2007_017; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Mazzola C, 2003, EUR J PHARMACOL, V477, P219, DOI 10.1016/j.ejphar.2003.08.026; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Meunier J, 2013, EUR J PHARMACOL, V698, P193, DOI 10.1016/j.ejphar.2012.10.033; Mohamed T, 2011, BIOORG MED CHEM LETT, V21, P5881, DOI 10.1016/j.bmcl.2011.07.091; Morgan D, 2008, J ALZHEIMERS DIS, V15, P605; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Palacios HH, 2011, CNS NEUROL DISORD-DR, V10, P149; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Raina AK, 1999, REDOX REP, V4, P23, DOI 10.1179/135100099101534701; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; SantaCruz KS, 2004, NEUROBIOL AGING, V25, P63, DOI 10.1016/S0197-4580(03)00117-9; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Snowden JS, 2011, BRAIN, V134, P2478, DOI 10.1093/brain/awr189; Spowart-Manning L, 2004, BEHAV BRAIN RES, V151, P37, DOI 10.1016/j.bbr.2003.08.004; Stone JG, 2011, THER ADV CHRONIC DIS, V2, P9, DOI 10.1177/2040622310382817; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Tsuji M, 2003, NEUROPSYCHOPHARMACOL, V28, P664, DOI 10.1038/sj.npp.1300080; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Valgimigli L, 2008, J ORG CHEM, V73, P1830, DOI 10.1021/jo7024543; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang Y, 2000, NAD P H QUINONE OXID; Zhang HY, 2005, FEBS LETT, V579, P5260, DOI 10.1016/j.febslet.2005.09.006	50	67	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56870	10.1371/journal.pone.0056870	http://dx.doi.org/10.1371/journal.pone.0056870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441223	gold, Green Published			2022-12-27	WOS:000315159200080
J	Wang, SS; Li, EC; Gao, YH; Wang, Y; Guo, Z; He, JR; Zhang, JN; Gao, ZC; Wang, Q				Wang, Shanshan; Li, Encheng; Gao, Yanghui; Wang, Yan; Guo, Zhe; He, Jiarui; Zhang, Jianing; Gao, Zhancheng; Wang, Qi			Study on Invadopodia Formation for Lung Carcinoma Invasion with a Microfluidic 3D Culture Device	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; PERFUSION-CULTURE; CANCER-CELLS; TUMOR-CELLS; N-WASP; CORTACTIN; MIGRATION; SYSTEM; PODOSOMES	Invadopodia or invasive feet, which are actin-rich membrane protrusions with matrix degradation activity formed by invasive cancer cells, are a key determinant in the malignant invasive progression of tumors and represent an important target for cancer therapies. In this work, we presented a microfluidic 3D culture device with continuous supplement of fresh media via a syringe pump. The device mimicked tumor microenvironment in vivo and could be used to assay invadopodia formation and to study the mechanism of human lung cancer invasion. With this device, we investigated the effects of epidermal growth factor (EGF) and matrix metalloproteinase (MMP) inhibitor, GM6001 on invadopodia formation by human non-small cell lung cancer cell line A549 in 3D matrix model. This device was composed of three units that were capable of achieving the assays on one control group and two experimental groups' cells, which were simultaneously pretreated with EGF or GM6001 in parallel. Immunofluorescence analysis of invadopodia formation and extracellular matrix degradation was conducted using confocal imaging system. We observed that EGF promoted invadopodia formation by A549 cells in 3D matrix and that GM6001 inhibited the process. These results demonstrated that epidermal growth factor receptor (EGFR) signaling played a significant role in invadopodia formation and related ECM degradation activity. Meanwhile, it was suggested that MMP inhibitor (GM6001) might be a powerful therapeutic agent targeting invadopodia formation in tumor invasion. This work clearly demonstrated that the microfluidic-based 3D culture device provided an applicable platform for elucidating the mechanism of cancer invasion and could be used in testing other anti-invasion agents.	[Wang, Shanshan; Li, Encheng; Gao, Yanghui; Wang, Yan; Guo, Zhe; He, Jiarui] Dalian Med Univ, Grad Sch, Dalian, Peoples R China; [Zhang, Jianing] Dalian Med Univ, Inst Glycobiol, Dept Biochem, Dalian, Peoples R China; [Gao, Zhancheng] Peking Univ Peoples Hosp, Dept Resp, Beijing, Peoples R China; [Gao, Zhancheng] Peking Univ Peoples Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Wang, Qi] Dalian Med Univ, Hosp 2, Dept Resp Med, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Peking University; Peking University; Dalian Medical University	Gao, ZC (corresponding author), Peking Univ Peoples Hosp, Dept Resp, Beijing, Peoples R China.	gaozhancheng5446@163.com; wqdmu@yahoo.com.cn	He, Jiarui/AAF-7206-2020	He, Jiarui/0000-0003-4665-2306	National High-tech R&D Program (973 Program) [2012CB822103]; National Natural Science Foundation of China [91129733, 81071228]	National High-tech R&D Program (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High-tech R&D Program (973 Program, No. 2012CB822103) and National Natural Science Foundation of China (No. 91129733 and 81071228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Corn PG, 2000, CLIN CANCER RES, V6, P4243; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Dubey S, 2009, AM J RESP CRIT CARE, V179, P860, DOI 10.1164/rccm.200902-0289UP; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elstner A, 2007, CLIN EXP METASTAS, V24, P57, DOI 10.1007/s10585-007-9057-y; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Frisk T, 2007, ELECTROPHORESIS, V28, P4705, DOI 10.1002/elps.200700342; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hase T, 2011, CANCER SCI, V102, P1493, DOI 10.1111/j.1349-7006.2011.01973.x; Hirooka S, 2011, PATHOBIOLOGY, V78, P10, DOI 10.1159/000322734; Hwang YS, 2012, ARCH ORAL BIOL, V57, P335, DOI 10.1016/j.archoralbio.2011.08.019; Jia DS, 2010, BMC CANCER, V10, P12; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062; Kim JH, 2011, GENE DEV, V25, P730, DOI 10.1101/gad.2028611; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Kim SM, 2008, LAB CHIP, V8, P1015, DOI 10.1039/b800835c; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Li XJ, 2008, ANAL CHEM, V80, P4095, DOI 10.1021/ac800231k; Lii J, 2008, ANAL CHEM, V80, P3640, DOI 10.1021/ac8000034; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Liu D, 2007, J BIOTECHNOL, V131, P286, DOI 10.1016/j.jbiotec.2007.06.014; Liu TJ, 2009, ELECTROPHORESIS, V30, P4285, DOI 10.1002/elps.200900289; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ra GS, 2008, J NANOSCI NANOTECHNO, V8, P4588, DOI 10.1166/jnn.2008.IC83; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; Tanaka Y, 2009, J BIOMED NANOTECHNOL, V5, P516, DOI 10.1166/jbn.2009.1057; Toh YC, 2007, LAB CHIP, V7, P302, DOI 10.1039/b614872g; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Weaver AM, 2008, AFR ARTS, V41, P89, DOI 10.1162/afar.2008.41.4.89; Wong AP, 2008, BIOMATERIALS, V29, P1853, DOI 10.1016/j.biomaterials.2007.12.044; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang LC, 2010, ELECTROPHORESIS, V31, P3763, DOI 10.1002/elps.201000265; Zhang Q, 2012, LAB CHIP, V12, P2837, DOI 10.1039/c2lc00030j; Zhao L, 2010, BIOMED MICRODEVICES, V12, P325, DOI 10.1007/s10544-009-9388-3	55	38	41	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56448	10.1371/journal.pone.0056448	http://dx.doi.org/10.1371/journal.pone.0056448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441195	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200052
J	Lutz, NW; Fernandez, C; Pellissier, JF; Cozzone, PJ; Beraud, E				Lutz, Norbert W.; Fernandez, Carla; Pellissier, Jean-Francois; Cozzone, Patrick J.; Beraud, Evelyne			Cerebral Biochemical Pathways in Experimental Autoimmune Encephalomyelitis and Adjuvant Arthritis: A Comparative Metabolomic Study	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; NMR SPECTROSCOPIC ANALYSIS; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; MULTIPARAMETRIC OPTIMIZATION; FREUNDS-ADJUVANT; RAT HIPPOCAMPUS; KETONE-BODIES; PAIN; ACTIVATION	Many diseases, including brain disorders, are associated with perturbations of tissue metabolism. However, an often overlooked issue is the impact that inflammations outside the brain may have on brain metabolism. Our main goal was to study similarities and differences between brain metabolite profiles of animals suffering from experimental autoimmune encephalomyelitis (EAE) and adjuvant arthritis (AA) in Lewis rat models. Our principal objective was the determination of molecular protagonists involved in the metabolism underlying these diseases. EAE was induced by intraplantar injection of complete Freund's adjuvant (CFA) and spinal-cord homogenate (SC-H), whereas AA was induced by CFA only. Naive rats served as controls (n = 9 for each group). Two weeks after inoculation, animals were sacrificed, and brains were removed and processed for metabolomic analysis by NMR spectroscopy or for immunohistochemistry. Interestingly, both inflammatory diseases caused similar, though not identical, changes in metabolites involved in regulation of brain cell size and membrane production: among the osmolytes, taurine and the neuronal marker, N-acetylaspartate, were decreased, and the astrocyte marker, myo-inositol, slightly increased in both inoculated groups compared with controls. Also ethanolamine-containing phospholipids, sources of inflammatory agents, and several glycolytic metabolites were increased in both inoculated groups. By contrast, the amino acids, aspartate and isoleucine, were less concentrated in CFA/SC-H and control vs. CFA rats. Our results suggest that inflammatory brain metabolite profiles may indicate the existence of either cerebral (EAE) or extra-cerebral (AA) inflammation. These inflammatory processes may act through distinct pathways that converge toward similar brain metabolic profiles. Our findings open new avenues for future studies aimed at demonstrating whether brain metabolic effects provoked by AA are pain/stress-mediated and/or due to the presence of systemic proinflammatory molecules. Regardless of the nature of these mechanisms, our findings may be of interest for future clinical studies, e.g. by in-vivo magnetic resonance spectroscopy.	[Lutz, Norbert W.; Cozzone, Patrick J.] Aix Marseille Univ, CRMBM, Natl Ctr Sci Res, Joint Res U7339, Marseille, France; [Fernandez, Carla; Pellissier, Jean-Francois; Beraud, Evelyne] Aix Marseille Univ, Biol Oncol & Oncopharmacol Res Ctr CRO2, Natl Inst Hlth & Med Res, Joint Res U911, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lutz, NW (corresponding author), Aix Marseille Univ, CRMBM, Natl Ctr Sci Res, Joint Res U7339, Marseille, France.	Norbert.Lutz@univ-amu.fr			CNRS [UMR 7339]; INSERM [UMR 911]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Financial support from CNRS (UMR 7339) and INSERM (UMR 911) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; BALASSE EO, 1978, J APPL PHYSIOL, V44, P5, DOI 10.1152/jappl.1978.44.1.5; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; BENNUN A, 1981, EUR J IMMUNOL, V11, P949, DOI 10.1002/eji.1830111119; Beraud E, 2006, ANN NEUROL, V60, P586, DOI 10.1002/ana.21007; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Chen FL, 2012, BRAIN RES BULL, V87, P60, DOI 10.1016/j.brainresbull.2011.09.022; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; DEBRUIN LA, 1990, AM J PHYSIOL, V259, pR773, DOI 10.1152/ajpregu.1990.259.4.R773; Division of Comparative Medicine, 2007, POSTPR CAR MIC RATS; EISENSTEIN A, 1973, AM J CLIN NUTR, V26, P113, DOI 10.1093/ajcn/26.1.113; Elekes O, 1996, ACTA NEUROCHIR SUPPL, V67, P1; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308; FEURER C, 1985, J NEUROIMMUNOL, V10, P159, DOI 10.1016/0165-5728(85)90006-2; Fonteh Alfred N., 2004, P1; Gao YJ, 2010, PAIN, V148, P309, DOI 10.1016/j.pain.2009.11.017; Gomez F, 1998, AM J PHYSIOL-REG I, V274, pR420, DOI 10.1152/ajpregu.1998.274.2.R420; Griffin JL, 2004, FEBS LETT, V568, P49, DOI 10.1016/j.febslet.2004.04.096; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kim EY, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2755; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liu T, 2007, J PROTEOME RES, V6, P2565, DOI 10.1021/pr070012k; Lutz NW, 2011, CURR PHARM BIOTECHNO, V12, P1016; Lutz NW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000595; Lutz NW, 2010, ANAL CHEM, V82, P5433, DOI 10.1021/ac100514n; Lutz NW, 2010, ANAL CHEM, V82, P5441, DOI 10.1021/ac100515y; Milligan ED, 2003, J NEUROSCI, V23, P1026; Namer IJ, 2000, J NEUROIMMUNOL, V103, P63, DOI 10.1016/S0165-5728(99)00236-2; PEARSON CM, 1963, AM J PATHOL, V42, P73; Pelletier D, 2004, J NEUROIMAGING, V14, p11S, DOI 10.1111/j.1552-6569.2004.tb00274.x; Quintana FJ, 2002, J IMMUNOL, V169, P3422, DOI 10.4049/jimmunol.169.6.3422; Rabchevsky AG, 1999, BRAIN RES, V832, P84, DOI 10.1016/S0006-8993(99)01479-1; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; REIBER H, 1984, J NEUROL SCI, V63, P55, DOI 10.1016/0022-510X(84)90108-4; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Roysommuti S, 2003, THAI J PHYSL SCI, V16, P17; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; 't Hart BA, 2004, TRENDS MOL MED, V10, P85, DOI 10.1016/j.molmed.2003.12.008; Tal, 1999, Curr Rev Pain, V3, P440; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; VOLPE JJ, 1986, J NEUROCHEM, V46, P475, DOI 10.1111/j.1471-4159.1986.tb12992.x; Wisniewski HM, 1991, BRAIN PATHOL, V1, P89, DOI 10.1111/j.1750-3639.1991.tb00645.x	46	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56101	10.1371/journal.pone.0056101	http://dx.doi.org/10.1371/journal.pone.0056101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457507	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700044
J	Murakami, K; Ichinohe, Y; Koike, M; Sasaoka, N; Iemura, S; Natsume, T; Kakizuka, A				Murakami, Katsuhiro; Ichinohe, Yuzuru; Koike, Masaaki; Sasaoka, Norio; Iemura, Shun-ichiro; Natsume, Tohru; Kakizuka, Akira			VCP Is an Integral Component of a Novel Feedback Mechanism that Controls Intracellular Localization of Catalase and H2O2 Levels	PLOS ONE			English	Article							P97/VALOSIN-CONTAINING PROTEIN VCP; AMINO-ACID-SEQUENCE; ATPASE ACTIVITY; PEROXISOMES; DISEASE; GENE	Catalase is a key antioxidant enzyme that catalyzes the decomposition of hydrogen peroxide (H2O2) to water and oxygen, and it appears to shuttle between the cytoplasm and peroxisome via unknown mechanisms. Valosin-containing protein (VCP) belongs to the AAA class of ATPases and is involved in diverse cellular functions, e.g. cell cycle and protein degradation, etc. Here we show that VCP and PEX19, a protein essential for peroxisome biogenesis, interact with each other. Knockdown of either VCP or PEX19 resulted in a predominantly cytoplasmic redistribution of catalase, and loss of VCP ATPase activity also increased its cytoplasmic redistribution. Moreover, VCP knockdown decreased intracellular ROS levels in normal and H2O2-treated cells, and an oxidation-resistant VCP impaired the ROS-induced cytoplasmic redistribution of catalase. These observations reveal a novel feedback mechanism, in which VCP can sense H2O2 levels, and regulates them by controlling the localization of catalase.	[Murakami, Katsuhiro; Ichinohe, Yuzuru; Koike, Masaaki; Sasaoka, Norio; Kakizuka, Akira] Kyoto Univ, Lab Funct Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr JBIRC, Kohtoh Ku, Tokyo, Japan	Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST)	Kakizuka, A (corresponding author), Kyoto Univ, Lab Funct Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan.	kakizuka@lif.kyoto-u.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Solution Oriented Research for Science and Technology (SORST) of Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	Solution Oriented Research for Science and Technology (SORST) of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by research grants from Solution Oriented Research for Science and Technology (SORST) of Japan Science and Technology Agency (JST), the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; COHEN G, 1988, EUR J BIOCHEM, V176, P159; Funato Y, 2010, FREE RADICAL RES, V44, P379, DOI 10.3109/10715761003610745; HARTIG A, 1986, EUR J BIOCHEM, V160, P487, DOI 10.1111/j.1432-1033.1986.tb10065.x; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hu CT, 2011, CLIN EXP METASTAS, V28, P851, DOI 10.1007/s10585-011-9416-6; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kakizuka A, 2008, BIOCHEM SOC T, V36, P105, DOI 10.1042/BST0360105; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Maynard EL, 2004, PROTEINS, V55, P856, DOI 10.1002/prot.20112; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Terlecky SR, 2006, BBA-MOL CELL RES, V1763, P1749, DOI 10.1016/j.bbamcr.2006.08.017; Togo SH, 2000, EUR J BIOCHEM, V267, P1307, DOI 10.1046/j.1432-1327.2000.01091.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035	21	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56012	10.1371/journal.pone.0056012	http://dx.doi.org/10.1371/journal.pone.0056012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457492	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700032
J	Roellig, DM; Savage, MY; Fujita, AW; Barnabe, C; Tibayrenc, M; Steurer, FJ; Yabsley, MJ				Roellig, Dawn M.; Savage, Mason Y.; Fujita, A. Wendy; Barnabe, Christian; Tibayrenc, Michel; Steurer, Frank J.; Yabsley, Michael J.			Genetic Variation and Exchange in Trypanosoma cruzi Isolates from the United States	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ST-CATHERINES ISLAND; CHAGAS-DISEASE; AUTOCHTHONOUS TRANSMISSION; AMERICAN TRYPANOSOMIASIS; PHYLOGENETIC LINEAGES; NUCLEOTIDE-SEQUENCES; BASIC MECHANISM; DIVERSITY; DNA	Trypanosoma cruzi, the causative agent of Chagas disease, is a multiclonal parasite with high levels of genetic diversity and broad host and geographic ranges. Molecular characterization of South American isolates of T. cruzi has demonstrated homologous recombination and nuclear hybridization, as well as the presence of 6 main genetic clusters or "discrete typing units'' (DTUs). Few studies have extensively investigated such exchange events and genetic diversity in North American isolates. In the current study, we genetically characterized over 50 US isolates from wildlife reservoirs (e.g., raccoons, opossums, armadillos, skunks), domestic dogs, humans, nonhuman primates, and reduviid vectors from nine states (TX, CA, OK, SC, FL, GA, MD, LA, TN) using a multilocus sequencing method. Single nucleotide polymorphisms were identified in sequences of the mismatch-repair class 2 (MSH2) and Tc52 genes. Typing based on the two genes often paralleled genotyping by classic methodologies using mini-exon and 18S and 24S alpha rRNA genes. Evidence for genetic exchange was obtained by comparing sequence phylogenies of nuclear and mitochondrial gene targets, dihydrofolate reductase-thymidylate synthase (DHFR-TS) and the cytochrome oxidase subunit II- NADH dehydrogenase subunit I region (COII-ND1), respectively. We observed genetic exchange in several US isolates as demonstrated by incongruent mitochondrial and nuclear genes phylogenies, which confirms a previous finding of a single genetic exchange event in a Florida isolate. The presence of SNPs and evidence of genetic exchange illustrates that strains from the US are genetically diverse, even though only two phylogenetic lineages have been identified in this region.	[Roellig, Dawn M.; Savage, Mason Y.; Fujita, A. Wendy; Yabsley, Michael J.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Roellig, Dawn M.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Barnabe, Christian] Univ Montpellier I, MIVEGEC, IRD, CNRS 5290,IRD 224, La Paz, Bolivia; [Barnabe, Christian] Univ Montpellier 2, MIVEGEC, IRD, CNRS 5290,IRD 224, La Paz, Bolivia; [Tibayrenc, Michel] Univ Montpellier I, Ctr Natl Rech Sci, Inst Rech Dev, MIVEGEC,CNRS 5290,IRD 224,IRD Ctr, Montpellier, France; [Tibayrenc, Michel] Univ Montpellier 2, Univ Montpellier 1, Ctr Natl Rech Sci, MIVEGEC,CNRS 5290,IRD 224,Inst Rech Dev,IRD Ctr, Montpellier, France; [Steurer, Frank J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Yabsley, Michael J.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia	Roellig, DM (corresponding author), Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	iyd4@cdc.gov	Barnabé, Christian/R-2904-2016; Tibayrenc, Michel/AAY-7494-2021; Savage, Mason/Q-1544-2019	Barnabé, Christian/0000-0003-1857-0741; Yabsley, Michael/0000-0003-2452-5015; Savage, Mason/0000-0001-8210-8207	National Institutes of Health, National Institute of Allergy and Infectious Diseases grant [R15 AI067304]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI067304] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases grant R15 AI067304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto-Pinto L, 2003, GENETICS, V164, P117; Augusto-Pinto L, 2001, GENE, V272, P323, DOI 10.1016/S0378-1119(01)00549-2; Barnabe C, 2001, EXP PARASITOL, V99, P73, DOI 10.1006/expr.2001.4651; Barnabe C, 2012, INFECT GENET EVOL, V12, P1879, DOI 10.1016/j.meegid.2012.08.018; Barrera-Perez M., 2001, REV BIOMED, V12, P224; Barretto M.P., 1979, Revista do Instituto Adolfo Lutz, V39, P25; Bertoli M, 2006, PARASITOL RES, V99, P7, DOI 10.1007/s00436-005-0122-7; Bosseno MF, 2002, J CLIN MICROBIOL, V40, P627, DOI 10.1128/JCM.40.2.627-632.2002; Brisse S, 2001, INT J PARASITOL, V31, P1218, DOI 10.1016/S0020-7519(01)00238-7; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Brown EL, 2010, VECTOR-BORNE ZOONOT, V10, P757, DOI 10.1089/vbz.2009.0009; Campos PC, 2011, MOL BIOCHEM PARASIT, V176, P8, DOI 10.1016/j.molbiopara.2010.11.001; CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x; CLARK CG, 1994, MOL BIOCHEM PARASIT, V66, P175, DOI 10.1016/0166-6851(94)90045-0; Ramirez JD, 2012, INFECT GENET EVOL, V12, P1743, DOI 10.1016/j.meegid.2012.06.018; Ramirez JD, 2012, MOL ECOL, V21, P4216, DOI 10.1111/j.1365-294X.2012.05699.x; Sanchez-Guillen MD, 2006, MEM I OSWALDO CRUZ, V101, P585, DOI 10.1590/S0074-02762006000600002; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Espinoza B, 1998, ACTA TROP, V70, P63, DOI 10.1016/S0001-706X(98)00005-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreira RC, 2012, INFECT GENET EVOL, V12, P1064, DOI 10.1016/j.meegid.2012.03.010; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Hall CA, 2007, J PARASITOL, V93, P93, DOI 10.1645/GE-936R.1; Herrera C, 2007, INFECT GENET EVOL, V7, P535, DOI 10.1016/j.meegid.2006.12.003; Herwaldt BL, 2000, J INFECT DIS, V181, P395, DOI 10.1086/315212; Hoare CA, 1972, TRYPANOSOMES MAMMALS, P753; Iwagami M, 2007, PARASITOL RES, V102, P129, DOI 10.1007/s00436-007-0739-9; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lisboa CV, 2007, EXP PARASITOL, V116, P150, DOI 10.1016/j.exppara.2006.12.005; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Mathieu-Daude F, 2007, PARASITOL RES, V101, P1355, DOI 10.1007/s00436-007-0651-3; Miles M.A., 1979, P117; MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; O'Connor O, 2007, INFECT GENET EVOL, V7, P587, DOI 10.1016/j.meegid.2007.05.003; Ocana-Mayorga S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000915; Ochs DE, 1996, AM J TROP MED HYG, V54, P526, DOI 10.4269/ajtmh.1996.54.526; Ouaissi A, 1995, IMMUNOL LETT, V48, P221, DOI 10.1016/0165-2478(95)02463-8; Ouaissi MA, 1995, EXP PARASITOL, V81, P453, DOI 10.1006/expr.1995.1138; Oury B, 2005, EXP PARASITOL, V111, P198, DOI 10.1016/j.exppara.2005.07.001; Pung OJ, 1998, J ZOO WILDLIFE MED, V29, P25; Roellig DM, 2008, EMERG INFECT DIS, V14, P1123, DOI 10.3201/eid1407.080175; Roellig DM, 2010, AM J TROP MED HYG, V83, P519, DOI 10.4269/ajtmh.2010.09-0663; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHIFFLER RJ, 1984, JAMA-J AM MED ASSOC, V251, P2983, DOI 10.1001/jama.251.22.2983; Spotorno AE, 2008, INFECT GENET EVOL, V8, P898, DOI 10.1016/j.meegid.2008.08.006; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Sturm NR, 2003, INT J PARASITOL, V33, P269, DOI 10.1016/S0020-7519(02)00264-3; Subileau M, 2009, EXP PARASITOL, V122, P328, DOI 10.1016/j.exppara.2009.04.008; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; WOODY NC, 1955, JAMA-J AM MED ASSOC, V159, P676, DOI 10.1001/jama.1955.02960240042010a; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024; Yeo M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001049; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009; Zumaya-Estrada FA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-226	61	43	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56198	10.1371/journal.pone.0056198	http://dx.doi.org/10.1371/journal.pone.0056198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457528	gold, Green Submitted, Green Published			2022-12-27	WOS:000315602700060
J	Foley, RC; Gleason, CA; Anderson, JP; Hamann, T; Singh, KB				Foley, Rhonda C.; Gleason, Cynthia A.; Anderson, Jonathan P.; Hamann, Thorsten; Singh, Karam B.			Genetic and Genomic Analysis of Rhizoctonia solani Interactions with Arabidopsis; Evidence of Resistance Mediated through NADPH Oxidases	PLOS ONE			English	Article							PLANT DEFENSE; TRANSCRIPTION FACTORS; DISEASE RESISTANCE; ROOT-ROT; MEDICAGO-TRUNCATULA; ABIOTIC STRESS; SUGAR-BEET; NECROTROPHIC PATHOGENS; BIOTIC INTERACTIONS; FUSARIUM-OXYSPORUM	Rhizoctonia solani is an important soil-borne necrotrophic fungal pathogen, with a broad host range and little effective resistance in crop plants. Arabidopsis is resistant to R. solani AG8 but susceptible to R. solani AG2-1. A screen of 36 Arabidopsis ecotypes and mutants affected in the auxin, camalexin, salicylic acid, abscisic acid and ethylene/jasmonic acid pathways did not reveal any variation in response to R. solani and demonstrated that resistance to AG8 was independent of these defense pathways. The Arabidopsis Affymetrix ATH1 Genome array was used to assess global gene expression changes in plants infected with AG8 and AG2-1 at seven days post-infection. While there was considerable overlap in the response, some gene families were differentially affected by AG8 or AG2-1 and included those involved in oxidative stress, cell wall associated proteins, transcription factors and heat shock protein genes. Since a substantial proportion of the gene expression changes were associated with oxidative stress responses, we analysed the role of NADPH oxidases in resistance. While single NADPH oxidase mutants had no effect, a NADPH oxidase double mutant atrbohf atrbohd resulted in an almost complete loss of resistance to AG8, suggesting that reactive oxidative species play an important role in Arabidopsis's resistance to R. solani.	[Foley, Rhonda C.; Gleason, Cynthia A.; Anderson, Jonathan P.; Singh, Karam B.] CSIRO Plant Ind, Ctr Environm & Life Sci, Perth, WA, Australia; [Anderson, Jonathan P.; Singh, Karam B.] Univ Western Australia, Univ Western Australia Inst Agr, Perth, WA 6009, Australia; [Hamann, Thorsten] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Imperial College London	Singh, KB (corresponding author), CSIRO Plant Ind, Ctr Environm & Life Sci, Perth, WA, Australia.	Karam.singh@csiro.au	Singh, Karam B/C-3235-2012; Anderson, Jonathan P/A-7244-2008; Foley, Rhonda C/G-6716-2012	Singh, Karam B/0000-0002-2777-7448; Anderson, Jonathan P/0000-0002-4783-5393; 	Grains Research and Development Corportation [CSP00061, CSP00114]	Grains Research and Development Corportation	Funding provided by Grains Research and Development Corportation (CSP00061 and CSP00114) (http://www.grdc.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson JP, 2010, PLANT PHYSIOL, V154, P861, DOI 10.1104/pp.110.163949; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; BANVILLE GJ, 1989, AM POTATO J, V66, P821, DOI 10.1007/BF02853963; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2008, TRENDS PLANT SCI, V13, P145, DOI 10.1016/j.tplants.2007.12.004; Bibikov SI, 2000, P NATL ACAD SCI USA, V97, P5830, DOI 10.1073/pnas.100118697; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carling DE, 2002, PHYTOPATHOLOGY, V92, P43, DOI 10.1094/PHYTO.2002.92.1.43; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cook RJ, 2002, CAN J PLANT PATHOL, V24, P349; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Ferrari S, 2008, PLANT PHYSIOL, V146, P669, DOI 10.1104/pp.107.109686; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Geraats BPJ, 2003, PHYTOPATHOLOGY, V93, P813, DOI 10.1094/PHYTO.2003.93.7.813; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gonzalez D, 2006, MOL PHYLOGENET EVOL, V40, P459, DOI 10.1016/j.ympev.2006.03.022; Grefen C, 2004, PLANTA, V219, P733, DOI 10.1007/s00425-004-1316-4; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; HIDE GA, 1992, ANN APPL BIOL, V120, P391, DOI 10.1111/j.1744-7348.1992.tb04899.x; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kasajima I, 2004, PLANT MOL BIOL REP, V22, P49, DOI 10.1007/BF02773348; Keijer J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P149; Khangura RK, 1999, PLANT DIS, V83, P714, DOI 10.1094/PDIS.1999.83.8.714; Kiewnick S, 2001, PLANT DIS, V85, P718, DOI 10.1094/PDIS.2001.85.7.718; Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kluth C, 2010, CROP PROT, V29, P230, DOI 10.1016/j.cropro.2009.12.002; Knecht K, 2010, MOL PLANT MICROBE IN, V23, P446, DOI 10.1094/MPMI-23-4-0446; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kuhn J, 2009, J PLANT NUTR SOIL SC, V172, P661, DOI 10.1002/jpln.200700186; Kuninaga S, 1997, CURR GENET, V32, P237, DOI 10.1007/s002940050272; Lazniewska J, 2010, ACTA PHYSIOL PLANT, V32, P1, DOI 10.1007/s11738-009-0372-6; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; MacNish GC, 1996, PLANT DIS, V80, P965, DOI 10.1094/PD-80-0965; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; MUSHEGIAN AR, 1995, PROTEIN SCI, V4, P1243, DOI 10.1002/pro.5560040623; Okubara P, 2009, THEORETICAL APPL GEN; Okubara PA, 2005, PLANT SOIL, V274, P215, DOI 10.1007/s11104-004-7328-9; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Penmetsa RV, 2008, PLANT J, V55, P580, DOI 10.1111/j.1365-313X.2008.03531.x; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Pogany M, 2009, PLANT PHYSIOL, V151, P1459, DOI 10.1104/pp.109.141994; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Sharon M, 2011, PHYTOPATHOLOGY, V101, P828, DOI 10.1094/PHYTO-09-10-0247; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sneh B, 1996, 2 INT S RHIZ NOORDW, pxvi+589; Srinivasachary, 2011, EUPHYTICA, V178, P1, DOI 10.1007/s10681-010-0296-7; Stodart BJ, 2007, MYCOL RES, V111, P891, DOI 10.1016/j.mycres.2007.05.008; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Thatcher LF, 2005, FUNCT PLANT BIOL, V32, P1, DOI 10.1071/FP04135; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Venu RC, 2007, MOL GENET GENOMICS, V278, P421, DOI 10.1007/s00438-007-0260-y; Verma PR, 1996, PHYTOPROTECTION, V77, P99, DOI 10.7202/706106ar; VILGALYS R, 1994, ANNU REV PHYTOPATHOL, V32, P135, DOI 10.1146/annurev.py.32.090194.001031; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Wang HZ, 2011, PLANT J, V68, P1104, DOI 10.1111/j.1365-313X.2011.04764.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Weinhold AR, 1995, RHIZOCTONIA SOLANI P, P163; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427	84	45	45	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56814	10.1371/journal.pone.0056814	http://dx.doi.org/10.1371/journal.pone.0056814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451091	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500031
J	Harrington, WE; Morrison, R; Fried, M; Duffy, PE				Harrington, Whitney E.; Morrison, Robert; Fried, Michal; Duffy, Patrick E.			Intermittent Preventive Treatment in Pregnant Women Is Associated with Increased Risk of Severe Malaria in Their Offspring	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PLACENTAL MALARIA; FACILITATION; INFECTIONS; RESISTANCE; MORBIDITY; PARASITES; EFFICACY; IMMUNITY; MODEL	Background: In areas of widespread sulfadoxine-pyrimethamine resistance, intermittent treatment in pregnancy (IPTp) fails to prevent placental malaria (PM) and may exacerbate drug resistant infections. Because PM predicts increased susceptibility to parasitemia during infancy, we hypothesized that IPTp would also increase susceptibility to malaria infection and disease in the offspring. Methods: In a birth cohort from NE Tanzania, we evaluated the association between maternal IPTp use and risk of parasitemia and severe malaria in the offspring. Using Cox Proportional Hazards Models as well as Generalized Estimating Equations, we evaluated the effects of IPTp on the entire cohort and on subgroups stratified by PM status at delivery. Results and Conclusions: Offspring of PM+ women who received IPTp had a dose-dependent decrease in time to first parasitemia (AHR = 2.13, p = 0.04 [95%CI: 1.04, 4.38]). Among all offspring, IPTp was associated with earlier first severe malaria episode (AHR = 2.32, p = 0.02 [95%CI: 1.12, 4.78]) as well as increased overall odds of severe malaria (AOR = 2.31, p = 0.03 [95%CI: 1.09, 4.88]). Cost-benefit analyses of IPTp regimens should consider the long term effects on offspring in addition to pregnancy outcomes.	[Harrington, Whitney E.] Univ Washington, Sch Med, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Morrison, Robert] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Fried, Michal; Duffy, Patrick E.] NIAID, NIH, Rockville, MD USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Center for Infectious Disease Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Duffy, PE (corresponding author), NIAID, NIH, Rockville, MD USA.	patrick.duffy@nih.gov			Bill & Melinda Gates Foundation [29202]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative [1364]; U.S. National Institutes of Health Fogarty International Center (FIC) [D43 TW005509]; National Institute of Allergy and Infectious Diseases [R01AI52059]; National Heart, Lung, and Blood Institute (NIH Fellowship) [1F30HL096298]; FOGARTY INTERNATIONAL CENTER [D43TW005509] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001134, R01AI052059, ZIAAI001056] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institutes of Health Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute (NIH Fellowship); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Bill & Melinda Gates Foundation (Grant 29202), the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (Grant 1364), the U.S. National Institutes of Health Fogarty International Center (FIC) (Grant D43 TW005509), and the National Institute of Allergy and Infectious Diseases (R01AI52059) to PED, and by the National Heart, Lung, and Blood Institute (NIH Fellowship 1F30HL096298) to WEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not represent the official views of the funding sources.	Aitken EH, PLOS ONE, V7; [Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Brabin B., 2001, Malaria in pregnancy: deadly parasite, susceptible host, P27, DOI 10.4324/9780203302255_chapter_2; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; DESOWITZ RS, 1988, ANN TROP MED PARASIT, V82, P121, DOI 10.1080/00034983.1988.11812218; Duffy PE, 2005, CURR TOP MICROBIOL, V295, P169; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; May K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007986; Milner DA, 2008, TRENDS PARASITOL, V24, P590, DOI 10.1016/j.pt.2008.09.001; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; NYIRJESY P, 1993, CLIN INFECT DIS, V16, P127, DOI 10.1093/clinids/16.1.127; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Serra-Casas E, J INFECT DIS, V201, P123; Staalsoe T, 2004, INFECT IMMUN, V72, P5027, DOI 10.1128/IAI.72.9.5027-5030.2004; Staszewski V, 2012, P ROY SOC B-BIOL SCI, V279, P2487, DOI 10.1098/rspb.2011.1563; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Wargo AR, 2007, P NATL ACAD SCI USA, V104, P19914, DOI 10.1073/pnas.0707766104	25	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56183	10.1371/journal.pone.0056183	http://dx.doi.org/10.1371/journal.pone.0056183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451036	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500008
J	Luchetti, A; Mantovani, B				Luchetti, Andrea; Mantovani, Barbara			Non-LTR R2 Element Evolutionary Patterns: Phylogenetic Incongruences, Rapid Radiation and the Maintenance of Multiple Lineages	PLOS ONE			English	Article							RETROTRANSPOSABLE ELEMENTS; TRANSPOSABLE ELEMENTS; SATELLITE DNAS; RNA; R1; IDENTIFICATION; BRANCHIOPODA; DIVERSITY; TURNOVER; DYNAMICS	Retrotransposons of the R2 superclade specifically insert within the 28S ribosomal gene. They have been isolated from a variety of metazoan genomes and were found vertically inherited even if their phylogeny does not always agree with that of the host species. This was explained with the diversification/extinction of paralogous lineages, being proved the absence of horizontal transfer. We here analyze the widest available collection of R2 sequences, either newly isolated from recently sequenced genomes or drawn from public databases, in a phylogenetic framework. Results are congruent with previous analyses, but new important issues emerge. First, the N-terminal end of the R2-B clade protein, so far unknown, presents a new zinc fingers configuration. Second, the phylogenetic pattern is consistent with an ancient, rapid radiation of R2 lineages: being the estimated time of R2 origin (850-600 Million years ago) placed just before the metazoan Cambrian explosion, the wide element diversity and the incongruence with the host phylogeny could be attributable to the sudden expansion of available niches represented by host's 28S ribosomal genes. Finally, we detect instances of coexisting multiple R2 lineages showing a non-random phylogenetic pattern, strongly similar to that of the "library" model known for tandem repeats: a collection of R2s were present in the ancestral genome and then differentially activated/repressed in the derived species. Models for activation/repression as well as mechanisms for sequence maintenance are also discussed within this framework.	[Luchetti, Andrea; Mantovani, Barbara] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy	University of Bologna	Luchetti, A (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy.	andrea.luchetti@unibo.it		Luchetti, Andrea/0000-0002-2986-721X	Canziani funds	Canziani funds	The work has been supported by Canziani funds to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BRIEF BIOINFORM, V9, P286; Bunikis J, 2005, INSECT MOL BIOL, V14, P465, DOI 10.1111/j.1365-2583.2005.00577.x; BURKE WD, 1993, MOL BIOL EVOL, V10, P163; Burke WD, 2002, MOL BIOL EVOL, V19, P619, DOI 10.1093/oxfordjournals.molbev.a004121; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; Cesari M, 2003, GENE, V312, P289, DOI 10.1016/S0378-1119(03)00625-5; Christensen SM, 2006, P NATL ACAD SCI USA, V103, P17602, DOI 10.1073/pnas.0605476103; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Dover G, 2002, TRENDS GENET, V18, P587, DOI 10.1016/S0168-9525(02)02789-0; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; EICKBUSH DG, 1995, GENETICS, V139, P671; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Gentile KL, 2001, MOL BIOL EVOL, V18, P235, DOI 10.1093/oxfordjournals.molbev.a003797; Ghesini S, 2011, J MOL EVOL, V72, P296, DOI 10.1007/s00239-011-9430-y; Gladyshev EA, 2009, GENE, V448, P145, DOI 10.1016/j.gene.2009.08.016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; JAKUBCZAK JL, 1992, GENETICS, V131, P129; Jamburuthugoda VK, 2011, J MOL BIOL, V407, P661, DOI 10.1016/j.jmb.2011.02.015; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kojima KK, 2006, MOL BIOL EVOL, V23, P1984, DOI 10.1093/molbev/msl067; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Luchetti A, 2012, GENOMICS, V100, P51, DOI 10.1016/j.ygeno.2012.04.005; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Mestrovic N, 2009, MOL PHYLOGENET EVOL, V50, P204, DOI 10.1016/j.ympev.2008.10.013; Mingazzini V, 2011, HEREDITY, V106, P567, DOI 10.1038/hdy.2010.86; Perez-Gonzalez CE, 2001, GENETICS, V158, P1557; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Stage DE, 2010, INSECT MOL BIOL, V19, P37, DOI 10.1111/j.1365-2583.2009.00949.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson Blaine K, 2011, Mob Genet Elements, V1, P29; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; Zhang X, 2008, GENETICS, V180, P1617, DOI 10.1534/genetics.108.093716	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57076	10.1371/journal.pone.0057076	http://dx.doi.org/10.1371/journal.pone.0057076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451148	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500061
J	Mao, XG; He, GM; Zhang, JP; Rossiter, SJ; Zhang, SY				Mao, Xiuguang; He, Guimei; Zhang, Junpeng; Rossiter, Stephen J.; Zhang, Shuyi			Lineage Divergence and Historical Gene Flow in the Chinese Horseshoe Bat (Rhinolophus sinicus)	PLOS ONE			English	Article							DNA-SEQUENCE; POPULATION-STRUCTURE; COMPUTER-PROGRAM; MITOCHONDRIAL; PHYLOGEOGRAPHY; COALESCENT; SPECIATION; MIGRATION; INFERENCE; EVOLUTION	Closely related taxa living in sympatry provide good opportunities to investigate the origin of barriers to gene flow as well as the extent of reproductive isolation. The only two recognized subspecies of the Chinese rufous horseshoe bat Rhinolophus sinicus are characterized by unusual relative distributions in which R. s. septentrionalis is restricted to a small area within the much wider range of its sister taxon R. s. sinicus. To determine the history of lineage divergence and gene flow between these taxa, we applied phylogenetic, demographic and coalescent analyses to multi-locus datasets. MtDNA gene genealogies and microsatellite-based clustering together revealed three divergent lineages of sinicus, corresponding to Central China, East China and the offshore Hainan Island. However, the central lineage of sinicus showed a closer relationship with septentrionalis than with other lineages of R. s. sinicus, in contrary to morphological data. Paraphyly of sinicus could result from either past asymmetric mtDNA introgression between these two taxa, or could suggest septentrionalis evolved in situ from its more widespread sister subspecies. To test between these hypotheses, we applied coalescent-based phylogenetic reconstruction and Approximate Bayesian Computation (ABC). We found that septentrionalis is likely to be the ancestral taxon and therefore a recent origin of this subspecies can be ruled out. On the other hand, we found a clear signature of asymmetric mtDNA gene flow from septentrionalis into central populations of sinicus yet no nuclear gene flow, thus strongly pointing to historical mtDNA introgression. We suggest that the observed deeply divergent lineages within R. sinicus probably evolved in isolation in separate Pleistocene refugia, although their close phylogeographic correspondence with distinct eco-environmental zones suggests that divergent selection might also have promoted broad patterns of population genetic structure.	[Mao, Xiuguang; He, Guimei; Zhang, Junpeng; Zhang, Shuyi] E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Mao, Xiuguang; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University of London; Queen Mary University London	Rossiter, SJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	s.j.rossiter@qmul.ac.uk; syzhang@bio.ecnu.edu.cn	Rossiter, Stephen J/E-2111-2011	He, Guimei/0000-0002-4889-0933; Rossiter, Stephen/0000-0002-3881-4515	Key Construction Program of the National "985'' Project; Key Construction Program of the National "211'' Project; China Postdoctoral Science Foundation; Marie Curie Actions-International Incoming Fellowships (IIF); Royal Society Fellowship (UK)	Key Construction Program of the National "985'' Project; Key Construction Program of the National "211'' Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Marie Curie Actions-International Incoming Fellowships (IIF); Royal Society Fellowship (UK)(Royal Society of London)	This work was funded by a grant awarded to S. Zhang under the Key Construction Program of the National "985'' Project and "211'' Project. X. Mao was supported by China Postdoctoral Science Foundation funded project and Marie Curie Actions-International Incoming Fellowships (IIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S. Rossiter was supported by a Royal Society Fellowship (UK).	Andersen K., 1905, ANN MAGAZINE NATURAL, V16, P289; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beaumont MA, 2002, GENETICS, V162, P2025; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Chattopadhyay B, 2012, CONSERV GENET, V13, P1435, DOI 10.1007/s10592-012-0361-y; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; CHENG J, 2001, GEOSCIENCE, V15, P290; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Coyne J.A., 2004, SPECIATION; Csorba G., 2003, HORSESHOE BATS WORLD; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Hulva P, 2004, MOL PHYLOGENET EVOL, V32, P1023, DOI 10.1016/j.ympev.2004.04.007; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kondo B, 2008, EVOLUTION, V62, P1182, DOI 10.1111/j.1558-5646.2008.00345.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Li G, 2006, J MAMMAL, V87, P1234, DOI 10.1644/05-MAMM-A-395R2.1; Lim BK, 2008, BIOL J LINN SOC, V93, P189; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2009, SYST BIOL, V58, P452, DOI 10.1093/sysbio/syp034; Liu WC, 2009, MOL ECOL RESOUR, V9, P183, DOI 10.1111/j.1755-0998.2008.02434.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Mao XG, 2007, CHROMOSOME RES, V15, P835, DOI 10.1007/s10577-007-1167-5; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nielsen R, 2001, GENETICS, V158, P885; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2007, TRACER 1 4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su Z., 2006, QUATERNARY GLACIATIO; Swofford DL, 2002, PAUP VER 4 0 B10 PHY; Thomas NM, 1997, THESIS HARRISON ZOLL; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Xu WX, 2005, SICHUAN J ZOOL, V24, P467; Yeung CKL, 2011, MOL BIOL EVOL, V28, P473, DOI 10.1093/molbev/msq210; You YY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-208; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; ZHANG W, 1985, Acta Theriologica Sinica, V5, P95	71	25	27	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56786	10.1371/journal.pone.0056786	http://dx.doi.org/10.1371/journal.pone.0056786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451086	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500029
J	Colombo, M; De Vecchi, G; Caleca, L; Foglia, C; Ripamonti, CB; Ficarazzi, F; Barile, M; Varesco, L; Peissel, B; Manoukian, S; Radice, P				Colombo, Mara; De Vecchi, Giovanna; Caleca, Laura; Foglia, Claudia; Ripamonti, Carla B.; Ficarazzi, Filomena; Barile, Monica; Varesco, Liliana; Peissel, Bernard; Manoukian, Siranoush; Radice, Paolo			Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations	PLOS ONE			English	Article							SEQUENCE VARIANTS; MESSENGER-RNA; UNCLASSIFIED VARIANTS; SITE PREDICTION; OVARIAN-CANCER; BREAST-CANCER; MISSENSE SUBSTITUTIONS; CLINICAL-SIGNIFICANCE; GERMLINE MUTATIONS; DNA VARIANTS	Several unclassified variants (UVs) have been identified in splicing regions of disease-associated genes and their characterization as pathogenic mutations or benign polymorphisms is crucial for the understanding of their role in disease development. In this study, 24 UVs located at BRCA1 and BRCA2 splice sites were characterized by transcripts analysis. These results were used to evaluate the ability of nine bioinformatics programs in predicting genetic variants causing aberrant splicing (spliceogenic variants) and the nature of aberrant transcripts. Eleven variants in BRCA1 and 8 in BRCA2, including 8 not previously characterized at transcript level, were ascertained to affect mRNA splicing. Of these, 16 led to the synthesis of aberrant transcripts containing premature termination codons (PTCs), 2 to the up-regulation of naturally occurring alternative transcripts containing PTCs, and one to an in-frame deletion within the region coding for the DNA binding domain of BRCA2, causing the loss of the ability to bind the partner protein DSS1 and ssDNA. For each computational program, we evaluated the rate of non-informative analyses, i.e. those that did not recognize the natural splice sites in the wild-type sequence, and the rate of false positive predictions, i.e., variants incorrectly classified as spliceogenic, as a measure of their specificity, under conditions setting sensitivity of predictions to 100%. The programs that performed better were Human Splicing Finder and Automated Splice Site Analyses, both exhibiting 100% informativeness and specificity. For 10 mutations the activation of cryptic splice sites was observed, but we were unable to derive simple criteria to select, among the different cryptic sites predicted by the bioinformatics analyses, those actually used. Consistent with previous reports, our study provides evidences that in silico tools can be used for selecting splice site variants for in vitro analyses. However, the latter remain mandatory for the characterization of the nature of aberrant transcripts.	[Colombo, Mara; De Vecchi, Giovanna; Caleca, Laura; Foglia, Claudia; Ripamonti, Carla B.; Radice, Paolo] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Ficarazzi, Filomena] Cogentech, Consortium Genom Technol, Milan, Italy; [Ficarazzi, Filomena; Radice, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Varesco, Liliana] IRCCS San Martino IST Ist Nazl Ric Canc, Dept Epidemiol Prevent & Special Funct, Unit Hereditary Canc, Genoa, Italy; [Peissel, Bernard; Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Genoa; IRCCS AOU San Martino IST; Fondazione IRCCS Istituto Nazionale Tumori Milan	Colombo, M (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy.	mara.colombo@istitutotumori.mi.it	Foglia, Claudia/AAB-3098-2021; Varesco, Liliana/AAF-6521-2019; manoukian, siranoush/E-7132-2017; Ripamonti, Carla Barbara/D-2247-2017; Colombo, Mara/D-2236-2017; Caleca, Laura/C-2111-2017; Radice, Paolo/O-3119-2013; Peissel, Bernard/E-8187-2017	Foglia, Claudia/0000-0002-5505-7667; Varesco, Liliana/0000-0003-4871-6668; manoukian, siranoush/0000-0002-6034-7562; Ripamonti, Carla Barbara/0000-0002-2892-8164; Colombo, Mara/0000-0001-5465-354X; Caleca, Laura/0000-0002-3381-7493; Radice, Paolo/0000-0001-6298-4111; Peissel, Bernard/0000-0001-9233-3571	Italian Association for Cancer Research (AIRC grant) [5757]; Soroptimist International d'Italia (club di Varese)	Italian Association for Cancer Research (AIRC grant)(Fondazione AIRC per la ricerca sul cancro); Soroptimist International d'Italia (club di Varese)	This study was supported by the Italian Association for Cancer Research (AIRC grant No 5757; www.airc.it). G.D.V. was supported by a fellowship from the Soroptimist International d'Italia (club di Varese). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3202; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bonatti F, 2006, CANCER GENET CYTOGEN, V170, P93, DOI 10.1016/j.cancergencyto.2006.05.005; Bonnet C, 2008, J MED GENET, V45, P438, DOI 10.1136/jmg.2007.056895; Brandao RD, 2011, BREAST CANCER RES TR, V129, P971, DOI 10.1007/s10549-011-1599-7; Brendel V, 2004, BIOINFORMATICS, V20, P1157, DOI 10.1093/bioinformatics/bth058; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Campos Berta, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9176; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chen XW, 2006, HUM MUTAT, V27, P427, DOI 10.1002/humu.20319; Claes K, 2003, GENE CHROMOSOME CANC, V37, P314, DOI 10.1002/gcc.10221; Colombo M, 2009, ANN ONCOL, V20, P1143, DOI 10.1093/annonc/mdp241; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Gaildrat P, 2012, J MED GENET, V49, P609, DOI 10.1136/jmedgenet-2012-100965; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Houdayer C, 2012, HUM MUTAT, V33, P1228, DOI 10.1002/humu.22101; Houdayer C, 2011, METHODS MOL BIOL, V760, P269, DOI 10.1007/978-1-61779-176-5_17; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026; Karchin R, 2008, CANCER INFORM, V6, P203; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Li LL, 2009, HUM MUTAT, V30, P1543, DOI 10.1002/humu.21101; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Machackova E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-140; Manoukian S, 2007, EUR J CANCER, V43, P601, DOI 10.1016/j.ejca.2006.09.024; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Menendez M, 2012, BREAST CANCER RES TR, V132, P979, DOI 10.1007/s10549-011-1661-5; Mucaki EJ, 2011, HUM MUTAT, V32, P735, DOI 10.1002/humu.21513; Nalla VK, 2005, HUM MUTAT, V25, P334, DOI 10.1002/humu.20151; Ozcelik H, 1999, HUM MUTAT, V14, P540, DOI 10.1002/(SICI)1098-1004(199912)14:6<540::AID-HUMU13>3.3.CO;2-3; Peelen T, 2000, BRIT J CANCER, V82, P151, DOI 10.1054/bjoc.1999.0892; Pensabene M, 2009, ANN ONCOL, V20, P874, DOI 10.1093/annonc/mdn724; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Sanz DJ, 2010, CLIN CANCER RES, V16, P1957, DOI 10.1158/1078-0432.CCR-09-2564; Schneider TD, 1997, NUCLEIC ACIDS RES, V25, P4408, DOI 10.1093/nar/25.21.4408; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sharp Andrew, 2004, Hum Mutat, V24, P272, DOI 10.1002/humu.9267; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Spurdle AB, 2010, CURR OPIN GENET DEV, V20, P315, DOI 10.1016/j.gde.2010.03.009; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tesoriero A A, 2005, Hum Mutat, V26, P495, DOI 10.1002/humu.9379; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Thomassen M, 2012, BREAST CANCER RES TR, V132, P1009, DOI 10.1007/s10549-011-1674-0; Vreeswijk MPG, 2009, HUM MUTAT, V30, P107, DOI 10.1002/humu.20811; Walker LC, 2010, HUM MUTAT, V31, pE1484, DOI 10.1002/humu.21267; Whiley PJ, 2011, HUM MUTAT, V32, P678, DOI 10.1002/humu.21495; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang YP, 2003, HUM MOL GENET, V12, P2121, DOI 10.1093/hmg/ddg222; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang LY, 2011, BREAST CANCER RES TR, V130, P1051, DOI 10.1007/s10549-011-1732-7; Zhang LY, 2009, MUTAT RES-FUND MOL M, V663, P84, DOI 10.1016/j.mrfmmm.2008.11.010	59	43	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57173	10.1371/journal.pone.0057173	http://dx.doi.org/10.1371/journal.pone.0057173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451180	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800086
J	Cutrullis, RA; Petray, PB; Schapachnik, E; Sanchez, R; Postan, M; Gonzalez, MN; Martin, V; Corral, RS				Cutrullis, Romina A.; Petray, Patricia B.; Schapachnik, Edgardo; Sanchez, Ruben; Postan, Miriam; Gonzalez, Mariela N.; Martin, Valentina; Corral, Ricardo S.			Elevated Serum Levels of Macrophage Migration Inhibitory Factor Are Associated with Progressive Chronic Cardiomyopathy in Patients with Chagas Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI ANTIGENS; IFN-GAMMA; T-CELLS; SUPPRESSOR-CELLS; FACTOR MIF; HEART; MYOCARDITIS; PATHOGENESIS; EXPRESSION; INFECTION	Clinical symptoms of chronic Chagas disease occur in around 30% of the individuals infected with Trypanosoma cruzi and are characterized by heart inflammation and dysfunction. The pathogenesis of chronic chagasic cardiomyopathy (CCC) is not completely understood yet, partially because disease evolution depends on complex host-parasite interactions. Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine that promotes numerous pathophysiological processes. In the current study, we investigated the link between MIF and CCC progression. Immunohistochemical analysis demonstrated MIF overexpression in the hearts from chronically T. cruzi-infected mice, particularly those showing intense inflammatory infiltration. We also found that MIF exogenously added to parasite-infected murine macrophage cultures is capable of enhancing the production of TNF-alpha and reactive oxygen species, both with pathogenic roles in CCC. Thus, the integrated action of MIF and other cytokines and chemokines may account for leukocyte influx to the infected myocardium, accompanied by enhanced local production of multiple inflammatory mediators. We further examined by ELISA the level of MIF in the sera from chronic indeterminate and cardiomyopathic chagasic patients, and healthy subjects. CCC patients displayed significantly higher MIF concentrations than those recorded in asymptomatic T. cruzi-infected and uninfected individuals. Interestingly, increased MIF levels were associated with severe progressive Chagas heart disease, in correlation with elevated serum concentration of high sensitivity C-reactive protein and also with several echocardiographic indicators of left ventricular dysfunction, one of the hallmarks of CCC. Our present findings represent the first evidence that enhanced MIF production is associated with progressive cardiac impairment in chronic human infection with T. cruzi, strengthening the relationship between inflammatory response and parasite-driven pathology. These observations contribute to unravel the elements involved in the pathogenesis of CCC and may also be helpful for the design of novel therapies aimed to control long-term morbidity in chagasic patients.	[Cutrullis, Romina A.; Petray, Patricia B.; Corral, Ricardo S.] Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol Chagas, Buenos Aires, DF, Argentina; [Schapachnik, Edgardo] Hosp Gen Agudos Dr Cosme Argerich, Serv Cardiol, Buenos Aires, DF, Argentina; [Sanchez, Ruben] Hosp Gen Agudos Dr Jose Maria Ramos Mejia, Serv Cardiol, Buenos Aires, DF, Argentina; [Postan, Miriam; Gonzalez, Mariela N.] Inst Nacl Parasitol Dr Mario Fatala Chaben ANLIS, Buenos Aires, DF, Argentina; [Martin, Valentina] Univ Nacl San Martin, ECyT, Ctr Salud & Medio Ambiente CESyMA, Lab Inmunol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; University of Buenos Aires; Hospital Ramos Mejia	Corral, RS (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol Chagas, Buenos Aires, DF, Argentina.	ricardocorral56@hotmail.com		GONZALEZ, MARIELA NATACHA/0000-0002-7274-4282	CONICET; FONCyT, Argentina [PICT 2010-2148]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT, Argentina(FONCyT)	RSC, PBP, MP and VM are members of the Research Career Program from National Research Council (CONICET, Argentina). RAC and MNG thank CONICET for fellowship granted. The study was funded by CONICET and by a grant (PICT 2010-2148) to MP from FONCyT, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cutrullis RA, 2009, PATHOBIOLOGY, V76, P170, DOI 10.1159/000218333; Bergeron M, 2008, PARASITE IMMUNOL, V30, P280, DOI 10.1111/j.1365-3024.2008.01022.x; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; Biolo A, 2010, PROG CARDIOVASC DIS, V52, P300, DOI 10.1016/j.pcad.2009.11.008; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Camargo MM, 1997, J IMMUNOL, V158, P5890; Cavalcanti MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025259; Chen PF, 2010, MOL MED, V16, P400, DOI 10.2119/molmed.2009.00128; Chuang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037613; Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928; da Silva CA, 2010, REV ESP CARDIOL, V63, P1096, DOI 10.1016/S0300-8932(10)70233-5; Rosado JD, 2011, INT J BIOL SCI, V7, P1239; Dhiman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028449; Donn RP, 2004, J ENDOCRINOL, V182, P1, DOI 10.1677/joe.0.1820001; Drigo SA, 2006, MICROBES INFECT, V8, P598, DOI 10.1016/j.micinf.2005.08.009; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Girard E, 2012, BRIT J CANCER, V107, P1498, DOI 10.1038/bjc.2012.392; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2011, ADV PARASIT, V76, P153, DOI 10.1016/B978-0-12-385895-5.00007-4; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Hardison JL, 2006, INFECT IMMUN, V74, P135, DOI 10.1128/IAI.74.1.135-143.2006; Higuchi MD, 1997, AM J TROP MED HYG, V56, P485; Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4; HO JL, 1992, INFECT IMMUN, V60, P1984, DOI 10.1128/IAI.60.5.1984-1993.1992; Jain Vidhan, 2009, BMC Res Notes, V2, P36, DOI 10.1186/1756-0500-2-36; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kimura K, 2006, CLIN VACCINE IMMUNOL, V13, P415, DOI 10.1128/CVI.13.3.415-419.2006; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lorena VMB, 2010, SCAND J IMMUNOL, V72, P529, DOI 10.1111/j.1365-3083.2010.02462.x; Luo HH, 2010, CARDIOVASC RES, V85, P347, DOI 10.1093/cvr/cvp225; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Matsui Y, 2004, J MOL CELL CARDIOL, V37, P557, DOI 10.1016/j.yjmcc.2004.05.016; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Mocelin AO, 2005, EUR J HEART FAIL, V7, P869, DOI 10.1016/j.ejheart.2004.10.014; MOLINA HA, 1988, T ROY SOC TROP MED H, V82, P241, DOI 10.1016/0035-9203(88)90432-4; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Muller II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038376; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; Paiva CN, 2007, EUR J IMMUNOL, V37, P1355, DOI 10.1002/eji.200636705; Pan American Health Organization, 2009, JOINT M SO CON CENTR; POSTAN M, 1986, T ROY SOC TROP MED H, V80, P50, DOI 10.1016/0035-9203(86)90193-8; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Regis EG, 2010, VIROLOGY, V399, P31, DOI 10.1016/j.virol.2009.12.018; REIS DD, 1993, AM J TROP MED HYG, V48, P637, DOI 10.4269/ajtmh.1993.48.637; Reyes JL, 2006, INFECT IMMUN, V74, P3170, DOI 10.1128/IAI.01648-05; Santos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Talvani A, 2000, MICROBES INFECT, V2, P851, DOI 10.1016/S1286-4579(00)00388-9; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; Terrazas CA, 2011, INT J BIOL SCI, V7, P1298, DOI 10.7150/ijbs.7.1298; Vogt J, 2008, MICROBES INFECT, V10, P781, DOI 10.1016/j.micinf.2008.04.013; Wakabayashi K, 2012, MOD RHEUMATOL, V22, P59, DOI 10.1007/s10165-011-0466-z; Wen JJ, 2006, FREE RADICAL BIO MED, V41, P270, DOI 10.1016/j.freeradbiomed.2006.04.009; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; Yamada G, 2002, CLIN IMMUNOL, V104, P123, DOI 10.1006/clim.2002.5255; Yu CM, 2003, J HISTOCHEM CYTOCHEM, V51, P625, DOI 10.1177/002215540305100508; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Yu XH, 2012, CHINESE MED J-PEKING, V125, P50, DOI 10.3760/cma.j.issn.0366-6999.2012.01.010; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	71	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57181	10.1371/journal.pone.0057181	http://dx.doi.org/10.1371/journal.pone.0057181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451183	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800088
J	Diao, HL; Xiao, S; Li, R; Zhao, F; Ye, XQ				Diao, Honglu; Xiao, Shuo; Li, Rong; Zhao, Fei; Ye, Xiaoqin			Distinct Spatiotemporal Expression of Serine Proteases Prss23 and Prss35 in Periimplantation Mouse Uterus and Dispensable Function of Prss35 in Fertility	PLOS ONE			English	Article							EMBRYO IMPLANTATION; MICE; DECIDUALIZATION; LOCALIZATION; ENDOMETRIUM; DEFICIENT; OVARIAN; FAMILY; CYCLE; ISP2	PRSS23 and PRSS35 are homologous proteases originally identified in mouse ovaries. In the periimplantation mouse uterus, Prss23 was highly expressed in the preimplantation gestation day 3.5 (D3.5) uterine luminal epithelium (LE). It disappeared from the postimplantation LE and reappeared in the stromal compartment next to the myometrium on D6.5. It was undetectable in the embryo from D4.5 to D6.5 but highly expressed in the embryo on D7.5. Prss35 became detectable in the uterine stromal compartment surrounding the embryo on D4.5 and shifted towards the mesometrial side of the stromal compartment next to the embryo from D5.5 to D7.5. In the ovariectomized uterus, Prss23 was moderately and Prss35 was dramatically downregulated by progesterone and 17 beta-estradiol. Based on the expression of Prss35 in granulosa cells and corpus luteum of the ovary and the early pregnant uterus, we hypothesized that PRSS35 might play a role in female reproduction, especially in oocyte development, ovulation, implantation, and decidualization. This hypothesis was tested in Prss35((-/-)) mice, which proved otherwise. Between wild type (WT) and Prss35((-/-)) mice, superovulation of immature females produced comparable numbers of cumulus-oocyte complexes; there were comparable numbers of implantation sites detected on D4.5 and D7.5; there were no obvious differences in the expression of implantation and decidualization marker genes in D4.5 or D7.5 uteri. Comparable mRNA expression levels of a few known protease-related genes in the WT and Prss35((-/-)) D4.5 uteri indicated no compensatory upregulation. Comparable litter sizes from WT x WT and Prss35((-/-)) x Prss35((-/-)) crosses suggested that Prss35 gene was unessential for fertility and embryo development. Prss35 gene has been linked to cleft lip/palate in humans. However, no obvious such defects were observed in Prss35((-/-)) mice. This study demonstrates the distinct expression of Prss23 and Prss35 in the periimplantation uterus and the dispensable role of Prss35 in fertility and embryo development.	[Diao, Honglu; Xiao, Shuo; Li, Rong; Zhao, Fei; Ye, Xiaoqin] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Xiao, Shuo; Li, Rong; Zhao, Fei; Ye, Xiaoqin] Univ Georgia, Interdisciplinary Toxicol Program, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ye, XQ (corresponding author), Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA.	ye@uga.edu	Li, Rong/O-5558-2018		National Institutes of Health [NIH R15HD066301, NIH R01HD065939]; Office of the Vice President for Research; Graduate School; Department of Physiology Pharmacology; Interdisciplinary Toxicology Program at University of Georgia, Athens, Georgia, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065939] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD066301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research; Graduate School; Department of Physiology Pharmacology; Interdisciplinary Toxicology Program at University of Georgia, Athens, Georgia, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the grants from the National Institutes of Health (NIH R15HD066301 and NIH R01HD065939 to X.Y.), and funding from the Office of the Vice President for Research, the Graduate School, the Department of Physiology & Pharmacology, and the Interdisciplinary Toxicology Program at University of Georgia, Athens, Georgia, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bany BM, 2006, DEV BIOL, V294, P445, DOI 10.1016/j.ydbio.2006.03.006; Brown N, 2004, BIOL REPROD, V71, P2003, DOI 10.1095/biolreprod.104.031864; Chan HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030397; Chen W, 2010, CELL TISSUE RES, V341, P441, DOI 10.1007/s00441-010-1013-5; Chen Y, 2006, J MOL ENDOCRINOL, V37, P147, DOI 10.1677/jme.1.02009; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Diao HL, 2011, FERTIL STERIL, V95, P2087, DOI 10.1016/j.fertnstert.2011.01.160; Diao HL, 2010, FERTIL STERIL, V94, P2808, DOI 10.1016/j.fertnstert.2010.06.034; FINN CA, 1967, J REPROD FERTIL, V13, P259; Forde N, 2012, BIOL REPROD; Grummer R, 1996, INT J DEV BIOL, V40, P361; Hamm ML, 2004, BIOL REPROD, V71, P66, DOI 10.1095/biolreprod.104.027292; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; KINDER JE, 1995, J REPROD FERTIL, P393; Letra A, 2010, J DENT RES, V89, P927, DOI 10.1177/0022034510370004; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Liu H C, 1995, Early Pregnancy, V1, P281; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Mitko K, 2008, REPRODUCTION, V135, P225, DOI 10.1530/REP-07-0415; Miyakoshi K, 2006, BIOL REPROD, V75, P823, DOI 10.1095/biolreprod.106.052290; O'Sullivan CM, 2002, MOL REPROD DEV, V62, P328, DOI 10.1002/mrd.10142; O'Sullivan CM, 2001, REPRODUCTION, V122, P235, DOI 10.1530/rep.0.1220235; Pelch KE, 2010, FERTIL STERIL, V93, P1615, DOI 10.1016/j.fertnstert.2009.03.086; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; SAFRANSKI TJ, 1993, BIOL REPROD, V48, P669, DOI 10.1095/biolreprod48.3.669; Salamonsen LA, 2003, PLACENTA, V24, pS76, DOI 10.1053/plac.2002.0928; Salamonsen Lois A, 2002, Rev Endocr Metab Disord, V3, P133, DOI 10.1023/A:1015407012559; Wahlberg P, 2008, ENDOCRINOLOGY, V149, P5070, DOI 10.1210/en.2007-1736; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	33	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56757	10.1371/journal.pone.0056757	http://dx.doi.org/10.1371/journal.pone.0056757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451081	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800033
J	Hamilton, SA; Tower, CL; Jones, RL				Hamilton, Sarah A.; Tower, Clare L.; Jones, Rebecca L.			Identification of Chemokines Associated with the Recruitment of Decidual Leukocytes in Human Labour: Potential Novel Targets for Preterm Labour	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; HUMAN ENDOMETRIUM; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; TERM; CELLS; SECRETION; CYTOKINES; CERVIX	Current therapies for preterm labour (PTL) focus on arresting myometrial contractions but are largely ineffective, thus alternative therapeutic targets need to be identified. Leukocytes infiltrate the uterus around the time of labour, and are in particularly abundant in decidua (maternal-fetal interface). Moreover, decidual inflammation precedes labour in rat pregnancies and thus may contribute to initiation of labour. We hypothesized that chemokines mediate decidual leukocyte trafficking during preterm labour (PTL) and term labour (TL), thus representing potential targets for preventing PTL. Women were recruited into 4 groups: TL, term not in labour (TNL), idiopathic PTL and PTL with infection (PTLI). Choriodecidual RNA was subjected to a pathway-specific PCR array for chemokines. Differential expression of 12 candidate chemokines was validated by real time RT-PCR and Bioplex assay, with immunohistochemistry to confirm cellular origin. 25 chemokines were upregulated in choriodecidua from TL compared to TNL. A similar pattern was detected in PTL, however a distinct profile was observed in PTLI consistent with differences in leukocyte infiltration. Upregulation of CCL2, CCL4, CCL5, CXCL8 and CXCL10 mRNA and protein was confirmed in TL, with CCL8 upregulated in PTL. Significant correlations were detected between these chemokines and decidual leukocyte abundance previously assessed by immunohistochemical and image analysis. Chemokines were primarily expressed by decidual stromal cells. In addition, CXCL8 and CCL5 were significantly elevated in maternal plasma during labour, suggesting chemokines contribute to peripheral inflammatory events during labour. Differences in chemokine expression patterns between TL and idiopathic PTL may be attributable to suppression of chemokine expression by betamethasone administered to women in PTL; this was supported by in vitro evidence of chemokine downregulation by clinically relevant concentrations of the steroid. The current study provides compelling evidence that chemokines regulate decidual leukocyte recruitment during labour. The 6 chemokines identified represent potential novel therapeutic targets to block PTL.	[Hamilton, Sarah A.; Tower, Clare L.; Jones, Rebecca L.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Inst Human Dev, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester	Jones, RL (corresponding author), Univ Manchester, Maternal & Fetal Hlth Res Ctr, Inst Human Dev, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	Rebecca.Lee.Jones@manchester.ac.uk	Jones, Rebecca/E-4481-2011	Jones, Rebecca/0000-0002-8871-0589; Tower, Clare/0000-0001-8532-5354	James Tudor Foundation; Tommy's the Baby Charity	James Tudor Foundation; Tommy's the Baby Charity	This study was supported by a research grant from the James Tudor Foundation and Tommy's the Baby Charity. (http://www.jamestudor.org.uk/http://www.tommys.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ofi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042217; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Anderson J, 2007, GENE THER, V14, P1287, DOI 10.1038/sj.gt.3302958; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; BERKMAN N, 1995, AM J PHYSIOL-LUNG C, V269, pL443, DOI 10.1152/ajplung.1995.269.4.L443; Bollopragada S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.032; Brown NL, 1998, J ENDOCRINOL, V159, P519, DOI 10.1677/joe.0.1590519; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; CASEY ML, 1988, CLIN OBSTET GYNECOL, V31, P533, DOI 10.1097/00003081-198809000-00005; Chan J, 2007, J ENDOCRINOL, V195, P7, DOI 10.1677/JOE-07-0289; Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; Denison FC, 1998, HUM REPROD, V13, P3560, DOI 10.1093/humrep/13.12.3560; Dominguez F, 2008, MOL HUM REPROD, V14, P423, DOI 10.1093/molehr/gan032; Dubicke A, 2008, MOL HUM REPROD, V14, P641, DOI 10.1093/molehr/gan060; Engert S, 2007, AM J REPROD IMMUNOL, V58, P129, DOI 10.1111/j.1600-0897.2007.00498.x; Esplin MS, 2005, PLACENTA, V26, P661, DOI 10.1016/j.placenta.2004.09.012; Gibb W, 1998, ANN MED, V30, P235, DOI 10.3109/07853899809005850; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2009, J REPROD IMMUNOL, V80, P122, DOI 10.1016/j.jri.2009.01.002; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Hamilton S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095505; Hassan SS, 2006, AM J OBSTET GYNECOL, V195, P778, DOI 10.1016/j.ajog.2006.06.021; Huang SJ, 2006, J REPROD IMMUNOL, V72, P60, DOI 10.1016/j.jri.2006.03.002; Ishihara O, 1996, PROSTAGLANDINS, V52, P199, DOI 10.1016/S0090-6980(96)00097-4; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Jones RL, 1997, HUM REPROD, V12, P1300; Krzysiek R, 1999, J IMMUNOL, V162, P4455; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Li AH, 2004, CLIN EXP METASTAS, V21, P571; Li M, 2011, J CLIN ENDOCR METAB, V96, P2502, DOI 10.1210/jc.2011-0055; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034707; Marret S, 2007, OBSTET GYNECOL, V110, P72, DOI 10.1097/01.AOG.0000267498.95402.bd; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Marvin KW, 2002, MOL HUM REPROD, V8, P399, DOI 10.1093/molehr/8.4.399; Menzies FM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094631; MITCHELL MD, 1995, REPROD FERT DEVELOP, V7, P623, DOI 10.1071/RD9950623; Mittal P, 2008, AM J REPROD IMMUNOL, V60, P246, DOI 10.1111/j.1600-0897.2008.00620.x; Norman Jane E, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS7, DOI 10.1186/1471-2393-7-S1-S7; Osman I, 2006, J SOC GYNECOL INVEST, V13, P97, DOI 10.1016/j.jsgi.2005.12.002; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Reich ES, 2012, NATURE, V485, P20, DOI 10.1038/485020a; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Shire D, 2000, METH MOL B, V137, P59; Shynlova O, 2008, J IMMUNOL, V181, P1470, DOI 10.4049/jimmunol.181.2.1470; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Tan T. C., 2006, SMJ Singapore Medical Journal, V47, P361; Tattersall M, 2008, REPRODUCTION, V135, P569, DOI 10.1530/REP-07-0461; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-39; Tower CL, 2010, REPRODUCTION, V140, P931, DOI 10.1530/REP-10-0307; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; WILCOX MA, 1993, BRIT J OBSTET GYNAEC, V100, P342, DOI 10.1111/j.1471-0528.1993.tb12977.x; Winkler M, 2001, J PERINAT MED, V29, P519, DOI 10.1515/JPM.2001.072; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	57	89	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56946	10.1371/journal.pone.0056946	http://dx.doi.org/10.1371/journal.pone.0056946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451115	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800050
J	Lowery, JW; LaVigne, AW; Kokabu, S; Rosen, V				Lowery, Jonathan W.; LaVigne, Anna W.; Kokabu, Shoichiro; Rosen, Vicki			Comparative Genomics Identifies the Mouse Bmp3 Promoter and an Upstream Evolutionary Conserved Region (ECR) in Mammals	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-3; PULMONARY ARTERIAL-HYPERTENSION; FACTOR-BETA SUPERFAMILY; TGF-BETA; GENE-EXPRESSION; GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; SIGNALING PATHWAYS; FRACTURE CALLUS; XENOPUS EMBRYOS	The Bone Morphogenetic Protein (BMP) pathway is a multi-member signaling cascade whose basic components are found in all animals. One member, BMP3, which arose more recently in evolution and is found only in deuterostomes, serves a unique role as an antagonist to both the canonical BMP and Activin pathways. However, the mechanisms that control BMP3 expression, and the cis-regulatory regions mediating this regulation, remain poorly defined. With this in mind, we sought to identify the Bmp3 promoter in mouse (M. musculus) through functional and comparative genomic analyses. We found that the minimal promoter required for expression in resides within 0.8 kb upstream of Bmp3 in a region that is highly conserved with rat (R. norvegicus). We also found that an upstream region abutting the minimal promoter acts as a repressor of the minimal promoter in HEK293T cells and osteoblasts. Strikingly, a portion of this region is conserved among all available eutherian mammal genomes (47/47), but not in any non-eutherian animal (0/136). We also identified multiple conserved transcription factor binding sites in the Bmp3 upstream ECR, suggesting that this region may preserve common cis-regulatory elements that govern Bmp3 expression across eutherian mammals. Since dysregulation of BMP signaling appears to play a role in human health and disease, our findings may have application in the development of novel therapeutics aimed at modulating BMP signaling in humans.	[Lowery, Jonathan W.; LaVigne, Anna W.; Kokabu, Shoichiro; Rosen, Vicki] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine	Rosen, V (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.	vicki_rosen@hsdm.harvard.edu		Kokabu, Shoichiro/0000-0002-6663-4327	American Recovery & Reinvestment Act Award; Harvard School of Dental Medicine Dean's Scholars Award; Harvard College Research Program Award	American Recovery & Reinvestment Act Award; Harvard School of Dental Medicine Dean's Scholars Award; Harvard College Research Program Award	This work was supported by: an American Recovery & Reinvestment Act Award (VR); the Harvard School of Dental Medicine Dean's Scholars Award (JWL and SK); and the Harvard College Research Program Award (AWL). The funders had no role in study design, data collection and analysis, decision to publish, or prparation of the manuscript.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Bahamonde ME, 2001, J BONE JOINT SURG AM, V83A, pS56; Bonner C, 2011, J BIOL CHEM, V286, P25719, DOI 10.1074/jbc.M110.215525; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; Dwivedi PP, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-45; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Fajardo RJ, 2010, BONE, V46, P64, DOI 10.1016/j.bone.2009.09.018; Faucheux C, 1999, J CELL BIOCHEM, V73, P11, DOI 10.1002/(SICI)1097-4644(19990401)73:1<11::AID-JCB2>3.0.CO;2-4; Gamer LW, 2008, DEV DYNAM, V237, P1691, DOI 10.1002/dvdy.21561; Gamer LW, 2009, DEV DYNAM, V238, P2374, DOI 10.1002/dvdy.22048; Gamer LW, 2005, DEV BIOL, V285, P156, DOI 10.1016/j.ydbio.2005.06.012; Gil H, 2008, GROWTH HORM IGF RES, V18, P353, DOI 10.1016/j.ghir.2008.01.009; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Haque T, 2008, BONE, V42, P1144, DOI 10.1016/j.bone.2008.01.028; Hardy G, 2000, SADJ, V55, P136; Hino J, 2004, FRONT BIOSCI-LANDMRK, V9, P1520, DOI 10.2741/1355; Hino J, 2003, DEV BIOL, V260, P138, DOI 10.1016/S0012-1606(03)00223-9; Holstein TW, 2011, CURR TOP DEV BIOL, V97, P137, DOI 10.1016/B978-0-12-385975-4.00012-7; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Jaatinen R, 1996, J CLIN ENDOCR METAB, V81, P3877, DOI 10.1210/jc.81.11.3877; Jiang S, 2010, BIOCHEM BIOPH RES CO, V392, P124, DOI 10.1016/j.bbrc.2009.12.157; Johnson KJ, 2010, BIOL REPROD, V83, P774, DOI 10.1095/biolreprod.110.085175; Katoh Y, 2006, INT J MOL MED, V17, P951; Kemoun P, 2007, TISSUE CELL, V39, P257, DOI 10.1016/j.tice.2007.06.001; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Kloen P, 2003, BONE, V33, P362, DOI 10.1016/S8756-3282(03)00191-1; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kokabu S, 2012, MOL ENDOCRINOL, V26, P87, DOI 10.1210/me.2011-1168; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; Ku GM, 2012, MOL ENDOCRINOLOGY; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lotinun S, 2010, BONE, V46, P1082, DOI 10.1016/j.bone.2010.01.370; Lowery JW, 2011, CRIT REV EUKAR GENE, V21, P177, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.60; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Martinovic S, 2006, ARCH HISTOL CYTOL, V69, P23, DOI 10.1679/aohc.69.23; Murakami K, 2010, EXP BIOL MED, V235, P805, DOI 10.1258/ebm.2010.009383; Nacamuli RP, 2005, PLAST RECONSTR SURG, V116, P1353, DOI 10.1097/01.prs.0000182223.85978.34; Newfeld SJ, 1999, GENETICS, V152, P783; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Nie XG, 2005, CHINESE MED J-PEKING, V118, P1710; Nie XG, 2005, ANAT EMBRYOL, V210, P125, DOI 10.1007/s00429-005-0009-5; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Owen Thomas A., 2008, V455, P3, DOI 10.1007/978-1-59745-104-8_1; PARTRIDGE NC, 1980, FEBS LETT, V115, P139, DOI 10.1016/0014-5793(80)80744-7; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; REDDI AH, 1989, CONNECT TISSUE RES, V20, P303, DOI 10.3109/03008208909023901; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064; Takahashi H, 1996, DEV DYNAM, V207, P439, DOI 10.1002/(SICI)1097-0177(199612)207:4<439::AID-AJA8>3.0.CO;2-I; Takao M, 1996, BIOCHEM BIOPH RES CO, V219, P656, DOI 10.1006/bbrc.1996.0289; Tamura K, 2011, MOL BIOL EVOLUTION; Thomadakis G, 1999, EUR J ORAL SCI, V107, P368, DOI 10.1046/j.0909-8836.1999.eos107508.x; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yamashiro T, 2003, J DENT RES, V82, P172, DOI 10.1177/154405910308200305; Yao SM, 2010, CONNECT TISSUE RES, V51, P59, DOI 10.3109/03008200903019703; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zheng L, 2005, EUR J ORAL SCI, V113, P318, DOI 10.1111/j.1600-0722.2005.00226.x; Zode GS, 2009, GLIA, V57, P755, DOI 10.1002/glia.20803; Zoricic S, 2003, J ANAT, V202, P269, DOI 10.1046/j.1469-7580.2003.00158.x	74	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57840	10.1371/journal.pone.0057840	http://dx.doi.org/10.1371/journal.pone.0057840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451274	gold, Green Published			2022-12-27	WOS:000316658800119
J	Mo, WJ; Zhang, JY; Li, X; Meng, DL; Gao, Y; Yang, S; Wan, XC; Zhou, CH; Guo, FH; Huang, Y; Amente, S; Avvedimento, EV; Xie, Y; Li, Y				Mo, Wenjuan; Zhang, Jiyuan; Li, Xia; Meng, Delong; Gao, Yun; Yang, Shu; Wan, Xuechao; Zhou, Caihong; Guo, Fenghua; Huang, Yan; Amente, Stefano; Avvedimento, Enrico V.; Xie, Yi; Li, Yao			Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer	PLOS ONE			English	Article							EXPRESSION; GROWTH; RECEPTOR; PROTEIN; KINASE; PROSAPOSIN; PREDICTION; MECHANISM; CLUSTER; COMPLEX	MicroRNAs (miRNAs) have been recognized as significantly involved in prostate cancer (PCa). Since androgen receptor (AR) plays a central role in PCa carcinogenesis and progression, it is imperative to systematically elucidate the causal association between AR and miRNAs, focusing on the molecular mechanisms by which miRNAs mediate AR signalling. In this study, we performed a series of time-course microarrays to observe the dynamic genome-wide expressions of mRNAs and miRNAs in parallel in hormone-sensitive prostate cancer LNCaP cells stimulated by androgen. Accordingly, we introduced Response Score to identify AR target miRNAs, as well as Modulation Score to identify miRNA target mRNAs. Based on theoretical identification and experimental validation, novel mechanisms addressing cell viability in PCa were unravelled for 3 miRNAs newly recognized as AR targets. (1) miR-19a is directly up-regulated by AR, and represses SUZ12, RAB13, SC4MOL, PSAP and ABCA1, respectively. (2) miR-27a is directly up-regulated by AR, and represses ABCA1 and PDS5B. (3) miR-133b is directly upregulated by AR, and represses CDC2L5, PTPRK, RB1CC1, and CPNE3, respectively. Moreover, we found miR-133b is essential to PCa cell survival. Our study gives certain clues on miRNAs mediated AR signalling to cell viability by influencing critical pathways, especially by breaking through androgen's growth restriction effect on normal prostate tissue.	[Mo, Wenjuan; Zhang, Jiyuan; Li, Xia; Meng, Delong; Gao, Yun; Yang, Shu; Wan, Xuechao; Zhou, Caihong; Guo, Fenghua; Huang, Yan; Xie, Yi; Li, Yao] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Amente, Stefano] Univ Naples Federico II, Dept Biol, Naples, Italy; [Avvedimento, Enrico V.] Univ Naples Federico II, Dept Mol Med & Biotechnol, Naples, Italy	Fudan University; University of Naples Federico II; University of Naples Federico II	Avvedimento, EV (corresponding author), Univ Naples Federico II, Dept Mol Med & Biotechnol, Naples, Italy.	avvedim@unina.it; yaoli@fudan.edu.cn	Amente, Stefano/AAU-7605-2020; Li, Yao/AAE-3550-2019; Yang, Shu/CAG-1493-2022; Meng, Delong/K-8937-2019	Amente, Stefano/0000-0003-0612-6096; Yang, Shu/0000-0001-8909-1962; Meng, Delong/0000-0001-5183-4564	National Natural Science Foundation of China [31071142, 31171246]; Shanghai Key Laboratory of Intelligent Information Processing of China [IIPL-2010-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Intelligent Information Processing of China	This work is supported in part by two grants 31071142 and 31171246 from the National Natural Science Foundation of China, and by Shanghai Key Laboratory of Intelligent Information Processing of China (No. IIPL-2010-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Anazawa Y, 2004, ONCOGENE, V23, P7621, DOI 10.1038/sj.onc.1207270; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Caudell EG, 2000, BIOCHEMISTRY-US, V39, P13034, DOI 10.1021/bi001250v; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Hamzeh M, 2011, J ENDOCRINOL, V209, P55, DOI 10.1530/JOE-10-0223; He MA, 2011, J CLIN INVEST, V121, P976, DOI 10.1172/JCI42650; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; Kanda I, 2008, ONCOGENE, V27, P1687, DOI 10.1038/sj.onc.1210812; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Koochekpour S, 2008, J CELL BIOCHEM, V104, P2272, DOI 10.1002/jcb.21786; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Maffini MV, 2002, ENDOCRINOLOGY, V143, P2708, DOI 10.1210/en.143.7.2708; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Patron JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035345; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Snedecor GW, 1980, STAT METHODS, V7th; STABEL S, 1985, EMBO J, V4, P2329, DOI 10.1002/j.1460-2075.1985.tb03934.x; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Wang WH, 2011, HEPATOLOGY, V53, P1137, DOI 10.1002/hep.24163; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yang CM, 2012, J NUTR BIOCHEM, V23, P8, DOI 10.1016/j.jnutbio.2010.10.006	47	90	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56592	10.1371/journal.pone.0056592	http://dx.doi.org/10.1371/journal.pone.0056592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451058	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800020
J	Yongye, AB; Vivoli, M; Lindberg, I; Appel, JR; Houghten, RA; Martinez-Mayorga, K				Yongye, Austin B.; Vivoli, Mirella; Lindberg, Iris; Appel, Jon R.; Houghten, Richard A.; Martinez-Mayorga, Karina			Identification of a Small Molecule That Selectively Inhibits Mouse PC2 over Mouse PC1/3: A Computational and Experimental Study	PLOS ONE			English	Article							SYNTHETIC COMBINATORIAL LIBRARIES; PROPROTEIN CONVERTASES; PROHORMONE CONVERTASES; CRYSTAL-STRUCTURE; FURIN INHIBITORS; SPECIFICITY; PEPTIDE; 7B2; ACTIVATION; CHEMISTRY	The calcium-dependent serine endoproteases prohormone convertase 1/3 (PC1/3) and prohormone convertase 2 (PC2) play important roles in the homeostatic regulation of blood glucose levels, hence implicated in diabetes mellitus. Specifically, the absence of PC2 has been associated with chronic hypoglycemia. Since there is a reasonably good conservation of the catalytic domain between species translation of inhibitory effects is likely. In fact, similar results have been found using both mouse and human recombinant enzymes. Here, we employed computational structure-based approaches to screen 14,400 compounds from the Maybridge small molecule library towards mouse PC2. Our most remarkable finding was the identification of a potent and selective PC2 inhibitor. Kinetic data showed the compound to be an allosteric inhibitor. The compound identified is one of the few reported selective, small-molecule inhibitors of PC2. In addition, this new PC2 inhibitor is structurally different and of smaller size than those reported previously. This is advantageous for future studies where structural analogues can be built upon.	[Yongye, Austin B.; Houghten, Richard A.; Martinez-Mayorga, Karina] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Vivoli, Mirella; Lindberg, Iris] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Appel, Jon R.; Houghten, Richard A.] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Martinez-Mayorga, Karina] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City, DF, Mexico	Torrey Pines Institute for Molecular Studies, Florida; University System of Maryland; University of Maryland Baltimore; Torrey Pines Institute for Molecular Studies, California; Universidad Nacional Autonoma de Mexico	Martinez-Mayorga, K (corresponding author), Torrey Pines Inst Mol Studies, Port St Lucie, FL USA.	kmartinez@tpims.org	Lindberg, Iris/Q-3825-2019	Vivoli Vega, Mirella/0000-0002-1148-5651	State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development;  [DA05084]; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA005084, R01DA005084] Funding Source: NIH RePORTER	State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development to RAH and KMM, and DA05084 to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SCHROD L GLID 5 5; [Anonymous], SOFTW OS ROCS VERS 2; [Anonymous], 2009, SCHROD L PRIM VERS 2; [Anonymous], 2008, SCHROD L LIGPREP 2 2; Apletalina E, 1998, J BIOL CHEM, V273, P26589, DOI 10.1074/jbc.273.41.26589; Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Basak A, 1999, BIOCHEM J, V338, P107, DOI 10.1042/0264-6021:3380107; Becker GL, 2010, J MED CHEM, V53, P1067, DOI 10.1021/jm9012455; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Boudreault A, 1998, J BIOL CHEM, V273, P31574, DOI 10.1074/jbc.273.47.31574; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Cameron A, 2000, FEBS LETT, V473, P135, DOI 10.1016/S0014-5793(00)01511-8; Cameron A, 2002, ENZYMES, P291; Cornwall GA, 2003, ENDOCRINOLOGY, V144, P901, DOI 10.1210/en.2002-220997; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Fugere M, 2002, CURR PHARM DESIGN, V8, P549, DOI 10.2174/1381612023395736; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; Hoshino A., 2012, C SERIES NEUROPEPTID, V1, P1; Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v; Houghten RA, 2008, J COMB CHEM, V10, P3, DOI 10.1021/cc7001205; Hubbard S. J., 1993, NACCESS; Inc CCG, 2008, MOE 2008 10; JEAN F, 1995, J BIOL CHEM, V270, P19225, DOI 10.1074/jbc.270.33.19225; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kowalska D, 2009, MOL PHARMACOL, V75, P617, DOI 10.1124/mol.108.051334; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P7780, DOI 10.1021/bi00023a027; Lopez-Vallejo F, 2012, BIOORGAN MED CHEM, V20, P4462, DOI 10.1016/j.bmc.2012.05.029; Lopez-Vallejo F, 2011, COMB CHEM HIGH T SCR, V14, P475, DOI 10.2174/138620711795767866; McGann MR, 2003, BIOPOLYMERS, V68, P76, DOI 10.1002/bip.10207; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Nicholls A, 2008, J COMPUT AID MOL DES, V22, P239, DOI 10.1007/s10822-008-9170-2; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Pinilla C, 2003, NAT MED, V9, P118, DOI 10.1038/nm0103-118; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rouille Y, 1997, FEBS LETT, V413, P119, DOI 10.1016/S0014-5793(97)00892-2; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Vivoli M, 2012, MOL PHARMACOL, V81, P440, DOI 10.1124/mol.111.077040; Yongye AB, 2011, J MOL MODEL, V17, P1473, DOI 10.1007/s00894-010-0850-1; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56957	10.1371/journal.pone.0056957	http://dx.doi.org/10.1371/journal.pone.0056957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451118	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800053
J	DeCicco-Skinner, KL; Nolan, SJ; Deshpande, MM; Trovato, EL; Dempsey, TA; Wiest, JS				DeCicco-Skinner, Kathleen L.; Nolan, Sabrina J.; Deshpande, Monika M.; Trovato, Erika L.; Dempsey, Taylor A.; Wiest, Jonathan S.			Altered Prostanoid Signaling Contributes to Increased Skin Tumorigenesis in Tpl2 Knockout Mice	PLOS ONE			English	Article							PROSTAGLANDIN RECEPTOR EP2; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; MOUSE SKIN; CYCLOOXYGENASE-2 EXPRESSION; TUMOR PROGRESSION; NF-KAPPA-B1 P105; KERATINOCYTE PROLIFERATION; CANCER-CHEMOTHERAPY; COT ONCOGENE	Squamous cell carcinoma is the second most common form of skin cancer with the incidence expected to double over the next 20 years. Inflammation is believed to be a critical component in skin cancer progression. Therefore, understanding genes involved in the regulation of inflammatory pathways is vital to the design of targeted therapies. Numerous studies show cyclooxygenases (COXs) play an essential role in inflammation-associated cancers. Tpl2 (MAP3K8) is a protein kinase in the MAP Kinase signal transduction cascade. Previous research using a two-stage skin carcinogenesis model revealed that Tpl2(-/-) mice have significantly higher tumor incidence and inflammatory response than wild-type (WT) controls. The current study investigates whether cyclooxygenase-2 (COX-2) and COX-2- regulated prostaglandins and prostaglandin receptors drive the highly tumorigenic state of Tpl2(-/-) mice by investigating the relationship between Tpl2 and COX-2. Keratinocytes from newborn WT or Tpl2(-/-) mice were treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) for various times over 24 hours. Western analysis revealed significant differences in COX-2 and COX-2 dependent prostanoids and prostanoid receptors. Additionally, in vivo experiments confirmed that COX-2 and COX-2 downstream factors were elevated in TPA-treated Tpl2(-/-) skin, as well as in papillomas from Tpl2(-/-) mice. Use of the selective COX-2 inhibitor Celecoxib showed the increased tumorigenesis in the Tpl2(-/-) mice to primarily be mediated through COX-2. These experiments illustrate COX-2 induction in the absence of Tpl2 may be responsible for the increased tumorigenesis found in Tpl2(-/-) mice. Defining the relationship between Tpl2 and COX-2 may lead to new ways to downregulate COX-2 through the modulation of Tpl2.	[DeCicco-Skinner, Kathleen L.; Nolan, Sabrina J.; Trovato, Erika L.; Dempsey, Taylor A.] American Univ, Dept Biol, Washington, DC 20016 USA; [Deshpande, Monika M.; Trovato, Erika L.; Wiest, Jonathan S.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	American University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wiest, JS (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	jwiest@mail.nih.gov		DeCicco-Skinner, Kathleen/0000-0002-0256-5609	Intramural Research Program of the National Cancer Institute, National Institutes of Health; National Cancer Institute [UA5CA152907]; NATIONAL CANCER INSTITUTE [ZIABC011108] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health and by grant number UA5CA152907 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; AIZU E, 1990, EUR J PHARMACOL, V182, P19; An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; Ansari KM, 2008, MOL CANCER RES, V6, P1003, DOI 10.1158/1541-7786.MCR-07-2144; Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; AOKI M, 1991, ONCOGENE, V6, P1515; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Brouxhon S, 2007, J INVEST DERMATOL, V127, P439, DOI 10.1038/sj.jid.5700547; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Clark AM, 2004, GENE CHROMOSOME CANC, V41, P99, DOI 10.1002/gcc.20069; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dajani EZ, 2008, J PHYSIOL PHARMACOL, V59, P117; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeCicco-Skinner KL, 2011, ONCOGENE, V30, P389, DOI 10.1038/onc.2010.447; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Fischer Susan M., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P183; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; FURSTENBERGER G, 1978, BIOCHEM BIOPH RES CO, V84, P1103, DOI 10.1016/0006-291X(78)91697-2; Ghosh N, 2010, PHARMACOL REP, V62, P233, DOI 10.1016/S1734-1140(10)70262-0; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hussain M, 2012, PHARMACOL RES, V66, P7, DOI 10.1016/j.phrs.2012.02.003; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Klein T, 2007, BBA-MOL CELL RES, V1773, P1605, DOI 10.1016/j.bbamcr.2007.09.001; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Lee JL, 2005, J INVEST DERMATOL, V125, P818, DOI 10.1111/j.0022-202X.2005.23829.x; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Maldve RE, 2000, J LIPID RES, V41, P873; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Muller-Decker K, 2007, MOL CARCINOGEN, V46, P705, DOI 10.1002/mc.20326; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Muller-Decker K, 1998, MOL CARCINOGEN, V23, P36, DOI 10.1002/(SICI)1098-2744(199809)23:1<36::AID-MC5>3.0.CO;2-F; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; Rundhaug Joyce E, 2010, Cancers (Basel), V2, P436, DOI 10.3390/cancers2020436; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; Sung YM, 2006, ONCOGENE, V25, P5507, DOI 10.1038/sj.onc.1209538; Sung YM, 2005, CANCER RES, V65, P9304, DOI 10.1158/0008-5472.CAN-05-1015; Tiano HF, 2002, CANCER RES, V62, P3395; Trifan OC, 2003, J CELL MOL MED, V7, P207, DOI 10.1111/j.1582-4934.2003.tb00222.x; Tsatsanis C, 2000, INT J MOL MED, V5, P583; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Xie J, 2008, ADV EXP MED BIOL, V624, P241, DOI 10.1007/978-0-387-77574-6_19	53	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56212	10.1371/journal.pone.0056212	http://dx.doi.org/10.1371/journal.pone.0056212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457529	gold, Green Submitted, Green Published			2022-12-27	WOS:000315603700027
J	Flouty, OE; Oya, H; Kawasaki, H; Reddy, CG; Fredericks, DC; Gibson-Corley, KN; Jeffery, ND; Gillies, GT; Howard, MA				Flouty, Oliver E.; Oya, Hiroyuki; Kawasaki, Hiroto; Reddy, Chandan G.; Fredericks, Douglas C.; Gibson-Corley, Katherine N.; Jeffery, Nicholas D.; Gillies, George T.; Howard, Matthew A., III			Intracranial Somatosensory Responses with Direct Spinal Cord Stimulation in Anesthetized Sheep	PLOS ONE			English	Article							BACK SURGERY SYNDROME; BRAIN-STEM IMPLANT; ELECTRICAL-STIMULATION; NONHUMAN-PRIMATES; PAIN; EFFICACY; COLUMNS; FIBERS; DORSAL	The efficacy of spinal cord stimulators is dependent on the ability of the device to functionally activate targeted structures within the spinal cord, while avoiding activation of near-by non-targeted structures. In theory, these objectives can best be achieved by delivering electrical stimuli directly to the surface of the spinal cord. The current experiments were performed to study the influence of different stimulating electrode positions on patterns of spinal cord electrophysiological activation. A custom-designed spinal cord neurostimulator was used to investigate the effects of lead position and stimulus amplitude on cortical electrophysiological responses to spinal cord stimulation. Brain recordings were obtained from subdural grids placed in four adult sheep. We systematically varied the position of the stimulating lead relative to the spinal cord and the voltage delivered by the device at each position, and then examined how these variables influenced cortical responses. A clear relationship was observed between voltage and electrode position, and the magnitude of high gamma-band oscillations. Direct stimulation of the dorsal column contralateral to the grid required the lowest voltage to evoke brain responses to spinal cord stimulation. Given the lower voltage thresholds associated with direct stimulation of the dorsal column, and its possible impact on the therapeutic window, this intradural modality may have particular clinical advantages over standard epidural techniques now in routine use.	[Flouty, Oliver E.; Oya, Hiroyuki; Kawasaki, Hiroto; Reddy, Chandan G.; Howard, Matthew A., III] Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA; [Fredericks, Douglas C.] Univ Iowa Hosp & Clin, Dept Orthopaed Surg, Iowa City, IA 52242 USA; [Gibson-Corley, Katherine N.] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA; [Jeffery, Nicholas D.] Iowa State Univ, Dept Vet Clin Sci, Ames, IA USA; [Gillies, George T.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA	University of Iowa; University of Iowa; University of Iowa; Iowa State University; University of Virginia	Howard, MA (corresponding author), Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA.	matthew-howard@uiowa.edu	flouty, oliver/AAO-2469-2021; Oya, Hiroyuki/Q-2989-2018	Oya, Hiroyuki/0000-0002-1733-5478; Kawasaki, Hiroto/0000-0002-7688-9171; Reddy, Chandan/0000-0001-5053-8085; Gibson-Corley, Katherine/0000-0002-1846-1580; Jeffery, Nick/0000-0002-9812-1788; Howard, Matthew/0000-0003-3935-8889				Cameron T, 2004, J NEUROSURG, V100, P254, DOI 10.3171/spi.2004.100.3.0254; Feirabend HKP, 2002, BRAIN, V125, P1137, DOI 10.1093/brain/awf111; Flouty O, 2012, PHYSIOL MEAS, V33, P2003, DOI 10.1088/0967-3334/33/12/2003; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Gibson-Corley KN, 2012, J INVEST SURG, V25, P366, DOI 10.3109/08941939.2012.677967; Hamilton L, 2009, BMC VET RES, V4, DOI 10.1186/1746-6148-4-47; Hamilton L, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-77; Holsheimer J, 2002, NEUROMODULATION, V5, P25, DOI 10.1046/j.1525-1403.2002._2005.x; Howard MA, 2011, J APPL PHYS, V110, DOI 10.1063/1.3626469; Kishima H, 2010, NEUROIMAGE, V49, P2564, DOI 10.1016/j.neuroimage.2009.10.054; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Kumar K, 2009, J NEUROSURG-SPINE, V10, P564, DOI 10.3171/2009.2.SPINE0865; KUPERS RC, 1994, PAIN, V56, P211, DOI 10.1016/0304-3959(94)90096-5; LINTHICUM FH, 1991, AM J OTOL, V12, P245; Manrique M, 2000, ANN OTO RHINOL LARYN, V109, P163, DOI 10.1177/000348940010900210; Manrique M, 2008, ANN OTO RHINOL LARYN, V117, P212, DOI 10.1177/000348940811700309; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Meyerson Bjorn A, 2006, J Pain Symptom Manage, V31, pS6, DOI 10.1016/j.jpainsymman.2005.12.009; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Otto SR, 2012, LARYNGOSCOPE, V122, P645, DOI 10.1002/lary.22491; Oya H., 2012, Journal of Medical Engineering & Technology, V36, P169, DOI 10.3109/03091902.2011.649884; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; SMITH MC, 1984, BRAIN, V107, P671, DOI 10.1093/brain/107.3.671; Stancak A, 2008, EUR J PAIN, V12, P137, DOI 10.1016/j.ejpain.2007.03.003; SUTTON D, 1984, ARCH OTOLARYNGOL, V110, P164; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Turner JA, 2010, PAIN, V148, P14, DOI 10.1016/j.pain.2009.08.014; Ulink NCC, 1999, NEURMODULATION, V2, P33; Utz M, 2011, J APPL PHYS, V110; WALL PD, 1960, J NEUROPHYSIOL, V23, P197, DOI 10.1152/jn.1960.23.2.197; Wilson S., 2012, Journal of Medical Engineering & Technology, V36, P22, DOI 10.3109/03091902.2011.632061; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1	32	19	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56266	10.1371/journal.pone.0056266	http://dx.doi.org/10.1371/journal.pone.0056266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457542	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700038
J	Radonjic, M; Wielinga, PY; Wopereis, S; Kelder, T; Goelela, VS; Verschuren, L; Toet, K; van Duyvenvoorde, W; van der Vat, BV; Stroeve, JHM; Cnubben, N; Kooistra, T; van Ommen, B; Kleemann, R				Radonjic, Marijana; Wielinga, Peter Y.; Wopereis, Suzan; Kelder, Thomas; Goelela, Varshna S.; Verschuren, Lars; Toet, Karin; van Duyvenvoorde, Wim; van der Vat, Bianca van der Werff; Stroeve, Johanna H. M.; Cnubben, Nicole; Kooistra, Teake; van Ommen, Ben; Kleemann, Robert			Differential Effects of Drug Interventions and Dietary Lifestyle in Developing Type 2 Diabetes and Complications: A Systems Biology Analysis in LDLr-/- Mice	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; ATHEROSCLEROSIS; ROSIGLITAZONE; PROGRESSION; METFORMIN; MICROALBUMINURIA; INFLAMMATION; PREVENTION; REGRESSION	Excess caloric intake leads to metabolic overload and is associated with development of type 2 diabetes (T2DM). Current disease management concentrates on risk factors of the disease such as blood glucose, however with limited success. We hypothesize that normalizing blood glucose levels by itself is insufficient to reduce the development of T2DM and complications, and that removal of the metabolic overload with dietary interventions may be more efficacious. We explored the efficacy and systems effects of pharmaceutical interventions versus dietary lifestyle intervention (DLI) in developing T2DM and complications. To mimic the situation in humans, high fat diet (HFD)-fed LDLr-/- mice with already established disease phenotype were treated with ten different drugs mixed into HFD or subjected to DLI (switch to low-fat chow), for 7 weeks. Interventions were compared to untreated reference mice kept on HFD or chow only. Although most of the drugs improved HFD-induced hyperglycemia, drugs only partially affected other risk factors and also had limited effect on disease progression towards microalbuminuria, hepatosteatosis and atherosclerosis. By contrast, DLI normalized T2DM risk factors, fully reversed hepatosteatosis and microalbuminuria, and tended to attenuate atherogenesis. The comprehensive beneficial effect of DLI was reflected by normalized metabolite profiles in plasma and liver. Analysis of disease pathways in liver confirmed reversion of the metabolic distortions with DLI. This study demonstrates that the pathogenesis of T2DM towards complications is reversible with DLI and highlights the differential effects of current pharmacotherapies and their limitation to resolve the disease.	[Radonjic, Marijana; Wopereis, Suzan; Kelder, Thomas; Goelela, Varshna S.; Verschuren, Lars; van der Vat, Bianca van der Werff; Stroeve, Johanna H. M.; Cnubben, Nicole; van Ommen, Ben] TNO, NL-3700 AJ Zeist, Netherlands; [Wielinga, Peter Y.; Toet, Karin; van Duyvenvoorde, Wim; Kooistra, Teake; Kleemann, Robert] TNO, Leiden, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research	Wielinga, PY (corresponding author), TNO, Leiden, Netherlands.	peter.wielinga@tno.nl						Abbas Aamer, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P124; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; Balvers MGJ, 2012, METABOLOMICS, V8, P1130, DOI 10.1007/s11306-012-0421-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunkley AJ, 2012, DIABETES OBES METAB; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Friedland SN, 2012, AM J MED, V125, P126, DOI 10.1016/j.amjmed.2011.08.025; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gijbels MJJ, 1999, ATHEROSCLEROSIS, V143, P15, DOI 10.1016/S0021-9150(98)00263-9; Goldberg RB, 2009, DIABETES CARE, V32, P726, DOI 10.2337/dc08-0494; Grundy SM, 2009, NAT REV DRUG DISCOV, V8, P341, DOI 10.1038/nrd2894; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Ismail-Beigi F, 2012, NEW ENGL J MED, V366, P1319, DOI 10.1056/NEJMcp1013127; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kleemann R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-125; Koek MM, 2011, METABOLOMICS, V7, P307, DOI 10.1007/s11306-010-0254-3; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Little PJ, 2011, PHARMACOL THERAPEUT, V131, P255, DOI 10.1016/j.pharmthera.2011.04.001; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Peng DC, 2010, ATHEROSCLEROSIS, V208, P126, DOI 10.1016/j.atherosclerosis.2009.07.016; Peng D, 2009, ATHEROSCLEROSIS, V203, P59, DOI 10.1016/j.atherosclerosis.2008.05.058; Pistrosch F, 2005, DIABETES, V54, P2206, DOI 10.2337/diabetes.54.7.2206; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Remedi MS, 2008, PLOS MED, V5, P1473, DOI 10.1371/journal.pmed.0050206; Riedel AA, 2007, PHARMACOTHERAPY, V27, P1102, DOI 10.1592/phco.27.8.1102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Terry T, 2012, CURR CARDIOL REP, V14, DOI 10.1007/s11886-011-0238-6; Tolman KG, 2011, EXPERT OPIN DRUG SAF, V10, P419, DOI 10.1517/14740338.2011.534982; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Verschuren L, 2009, J LIPID RES, V50, P301, DOI 10.1194/jlr.M800374-JLR200; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wielinga PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018432; Wierzbicki AS, 2006, INT J CLIN PRACT, V60, P442, DOI 10.1111/j.1368-5031.2006.00882.x; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9	46	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56122	10.1371/journal.pone.0056122	http://dx.doi.org/10.1371/journal.pone.0056122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457508	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700022
J	Chuang, I; Sedegah, M; Cicatelli, S; Spring, M; Polhemus, M; Tamminga, C; Patterson, N; Guerrero, M; Bennett, JW; McGrath, S; Ganeshan, H; Belmonte, M; Farooq, F; Abot, E; Banania, JG; Huang, J; Newcomer, R; Rein, L; Litilit, D; Richie, NO; Wood, C; Murphy, J; Sauerwein, R; Hermsen, CC; McCoy, AJ; Kamau, E; Cummings, J; Komisar, J; Sutamihardja, A; Shi, M; Epstein, JE; Maiolatesi, S; Tosh, D; Limbach, K; Angov, E; Bergmann-Leitner, E; Bruder, JT; Doolan, DL; King, CR; Carucci, D; Dutta, S; Soisson, L; Diggs, C; Hollingdale, MR; Ockenhouse, CF; Richie, TL				Chuang, Ilin; Sedegah, Martha; Cicatelli, Susan; Spring, Michele; Polhemus, Mark; Tamminga, Cindy; Patterson, Noelle; Guerrero, Melanie; Bennett, Jason W.; McGrath, Shannon; Ganeshan, Harini; Belmonte, Maria; Farooq, Fouzia; Abot, Esteban; Banania, Jo Glenna; Huang, Jun; Newcomer, Rhonda; Rein, Lisa; Litilit, Dianne; Richie, Nancy O.; Wood, Chloe; Murphy, Jittawadee; Sauerwein, Robert; Hermsen, Cornelus C.; McCoy, Andrea J.; Kamau, Edwin; Cummings, James; Komisar, Jack; Sutamihardja, Awalludin; Shi, Meng; Epstein, Judith E.; Maiolatesi, Santina; Tosh, Donna; Limbach, Keith; Angov, Evelina; Bergmann-Leitner, Elke; Bruder, Joseph T.; Doolan, Denise L.; King, C. Richter; Carucci, Daniel; Dutta, Sheetij; Soisson, Lorraine; Diggs, Carter; Hollingdale, Michael R.; Ockenhouse, Christian F.; Richie, Thomas L.			DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P-falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; CYTOTOXIC T-LYMPHOCYTES; PHASE 2A TRIAL; NAIVE ADULTS; CIRCUMSPOROZOITE PROTEIN; NEUTRALIZING ANTIBODIES; DOUBLE-BLIND; IMMUNIZATION; INDUCTION; RESPONSES	Background: Gene-based vaccination using prime/boost regimens protects animals and humans against malaria, inducing cell-mediated responses that in animal models target liver stage malaria parasites. We tested a DNA prime/adenovirus boost malaria vaccine in a Phase 1 clinical trial with controlled human malaria infection. Methodology/Principal Findings: The vaccine regimen was three monthly doses of two DNA plasmids (DNA) followed four months later by a single boost with two non-replicating human serotype 5 adenovirus vectors (Ad). The constructs encoded genes expressing P. falciparum circumsporozoite protein (CSP) and apical membrane antigen-1 (AMA1). The regimen was safe and well-tolerated, with mostly mild adverse events that occurred at the site of injection. Only one AE (diarrhea), possibly related to immunization, was severe (Grade 3), preventing daily activities. Four weeks after the Ad boost, 15 study subjects were challenged with P. falciparum sporozoites by mosquito bite, and four (27%) were sterilely protected. Antibody responses by ELISA rose after Ad boost but were low (CSP geometric mean titer 210, range 44-817; AMA1 geometric mean micrograms/milliliter 11.9, range 1.5-102) and were not associated with protection. Ex vivo IFN-gamma ELISpot responses after Ad boost were modest (CSP geometric mean spot forming cells/million peripheral blood mononuclear cells 86, range 13-408; AMA1 348, range 88-1270) and were highest in three protected subjects. ELISpot responses to AMA1 were significantly associated with protection (p = 0.019). Flow cytometry identified predominant IFN-gamma mono-secreting CD8+ T cell responses in three protected subjects. No subjects with high pre-existing anti-Ad5 neutralizing antibodies were protected but the association was not statistically significant. Significance: The DNA/Ad regimen provided the highest sterile immunity achieved against malaria following immunization with a gene-based subunit vaccine (27%). Protection was associated with cell-mediated immunity to AMA1, with CSP probably contributing. Substituting a low seroprevalence vector for Ad5 and supplementing CSP/AMA1 with additional antigens may improve protection.	[Chuang, Ilin; Sedegah, Martha; Tamminga, Cindy; Patterson, Noelle; McGrath, Shannon; Ganeshan, Harini; Belmonte, Maria; Farooq, Fouzia; Abot, Esteban; Banania, Jo Glenna; Huang, Jun; Litilit, Dianne; McCoy, Andrea J.; Sutamihardja, Awalludin; Epstein, Judith E.; Maiolatesi, Santina; Limbach, Keith; Doolan, Denise L.; Carucci, Daniel; Hollingdale, Michael R.; Richie, Thomas L.] USN, US Mil Malaria Vaccine Program, Med Res Ctr, Silver Spring, MD USA; [Cicatelli, Susan; Spring, Michele; Polhemus, Mark; Guerrero, Melanie; Bennett, Jason W.; Newcomer, Rhonda; Rein, Lisa; Richie, Nancy O.; Wood, Chloe; Murphy, Jittawadee; Kamau, Edwin; Cummings, James; Komisar, Jack; Shi, Meng; Tosh, Donna; Angov, Evelina; Bergmann-Leitner, Elke; Dutta, Sheetij; Ockenhouse, Christian F.] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Sauerwein, Robert; Hermsen, Cornelus C.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Bruder, Joseph T.; King, C. Richter] GenVec Inc, Gaithersburg, MD USA; [Soisson, Lorraine; Diggs, Carter] USAID, Washington, DC USA	United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Radboud University Nijmegen; United States Agency for International Development (USAID)	Richie, TL (corresponding author), USN, US Mil Malaria Vaccine Program, Med Res Ctr, Silver Spring, MD USA.	thomas.richie@med.navy.mil	Sauerwein, Robert/C-8519-2013; Bergmann-Leitner, Elke/I-5431-2019; Bennett, Jason W/B-3547-2011; Hermsen, C.C./L-4368-2015; Bergmann-Leitner, Elke S./B-3548-2011; Doolan, Denise L/F-1969-2015	Bergmann-Leitner, Elke/0000-0002-8571-8956; Bergmann-Leitner, Elke S./0000-0002-8571-8956; Doolan, Denise/0000-0001-7354-8817; Richie, Thomas/0000-0002-2946-5456; Farooq, Fouzia/0000-0001-6491-6323	USAID "Development of Adenovirus-Vectored Malaria Vaccines" [GHA-P-00-03-00006-01, 936-3118]; Congressionally Directed Medical Research Program "Development of Recombinant Adenoviral-based Vaccines against Malaria" [W81XWH-05-2-0041]; Military Infectious Research Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-nave adults" [62787A 870 F 1432]	USAID "Development of Adenovirus-Vectored Malaria Vaccines"(United States Agency for International Development (USAID)); Congressionally Directed Medical Research Program "Development of Recombinant Adenoviral-based Vaccines against Malaria"; Military Infectious Research Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-nave adults"	This work was supported by USAID "Development of Adenovirus-Vectored Malaria Vaccines" Grant #: GHA-P-00-03-00006-01, Project Number 936-3118; and the Congressionally Directed Medical Research Program "Development of Recombinant Adenoviral-based Vaccines against Malaria" Grant #: W81XWH-05-2-0041.. Website: https://cdmrp.org. Military Infectious Research Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity & protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-nave adults", work unit number 62787A 870 F 1432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; Brun A, 2011, VIRUS RES, V157, P1, DOI 10.1016/j.virusres.2011.02.006; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Frimpong-Boateng K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012281; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/ERV.11.7, 10.1586/erv.11.7]; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Jiang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006559; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Le TP, 2000, VACCINE, V18, P1893, DOI 10.1016/S0264-410X(99)00407-7; Liu MA, 2010, CURR OPIN MOL THER, V12, P86; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; PMI, 2011, 5 ANN C; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Redding L, 2009, EXPERT REV VACCINES, V8, P1251, DOI 10.1586/erv.09.77; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Wang RB, 1998, INFECT IMMUN, V66, P4193; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WHO, 2011, WORLD MALARIA REPORT 2011, P1	52	101	104	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55571	10.1371/journal.pone.0055571	http://dx.doi.org/10.1371/journal.pone.0055571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457473	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000315602700019
J	Lee, Y; Song, B; Park, C; Kwon, KS				Lee, Younglang; Song, Byeongwoon; Park, Chankyu; Kwon, Ki-Sun			TRIM11 Negatively Regulates IFN beta Production and Antiviral Activity by Targeting TBK1	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; DOUBLE-STRANDED-RNA; BINDING KINASE 1; NF-KAPPA-B; I INTERFERON; RIG-I; FAMILY PROTEINS; VIRUS-INFECTION; ACTIVATION; DEGRADATION	The innate immune response is a host defense mechanism against infection by viruses and bacteria. Type I interferons (IFN alpha/beta) play a crucial role in innate immunity. If not tightly regulated under normal conditions and during immune responses, IFN production can become aberrant, leading to inflammatory and autoimmune diseases. In this study, we identified TRIM11 (tripartite motif containing 11) as a novel negative regulator of IFN beta production. Ectopic expression of TRIM11 decreased IFN beta promoter activity induced by poly (I: C) stimulation or overexpression of RIG-I (retinoic acid-inducible gene-I) signaling cascade components RIG-IN (constitutively active form of RIG-I), MAVS (mitochondrial antiviral signaling protein), or TBK1 (TANK-binding kinase-1). Conversely, TRIM11 knockdown enhanced IFN beta promoter activity induced by these stimuli. Moreover, TRIM11 overexpression inhibited the phosphorylation and dimerization of IRF3 and expression of IFN beta mRNA. By contrast, TRIM11 knockdown increased the IRF3 phosphorylation and IFN beta mRNA expression. We also found that TRIM11 and TBK1, a key kinase that phosphorylates IRF3 in the RIG-I pathway, interacted with each other through CC and CC2 domain, respectively. This interaction was enhanced in the presence of the TBK1 adaptor proteins, NAP1 (NF-kappa B activating kinase-associated protein-1), SINTBAD (similar to NAP1 TBK1 adaptor) or TANK (TRAF family member-associated NF-kappa B activator). Consistent with its inhibitory role in RIG-I-mediated IFN beta signaling, TRIM11 overexpression enhanced viral infectivity, whereas TRIM11 knockdown produced the opposite effect. Collectively, our results suggest that TRIM11 inhibits RIG-I-mediated IFN beta production by targeting the TBK1 signaling complex.	[Lee, Younglang; Park, Chankyu] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Younglang; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Lab Cell Signaling, Aging Res Ctr, Taejon, South Korea; [Song, Byeongwoon] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California Davis	Kwon, KS (corresponding author), Korea Res Inst Biosci & Biotechnol, Lab Cell Signaling, Aging Res Ctr, Taejon, South Korea.	kwonks@kribb.re.kr	Park, Chankyu/C-1936-2011	CHEN, Tsung-Chih/0000-0001-8256-6240; Huang, Hsu-Shan/0000-0001-8162-5608	KRIBB Research Initiative Program; National Research Foundation of Korea [20110027762, 20120009082, 20120005073]	KRIBB Research Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from the KRIBB Research Initiative Program and National Research Foundation of Korea (Grants 20110027762, 20120009082 and 20120005073, K.-S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BENJAMIN WR, 1982, P NATL ACAD SCI-BIOL, V79, P5379, DOI 10.1073/pnas.79.17.5379; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Charoenthongtrakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053717; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2006, FEBS LETT, V580, P4784, DOI 10.1016/j.febslet.2006.07.066; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Parodi S, 2012, J MOL MED, V90, P1025, DOI 10.1007/s00109-012-0868-1; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506	50	67	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63255	10.1371/journal.pone.0063255	http://dx.doi.org/10.1371/journal.pone.0063255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23451039	Green Submitted, Green Published, gold			2022-12-27	WOS:000319036100031
J	Cohen, MX; Ridderinkhof, KR				Cohen, Michael X.; Ridderinkhof, K. Richard			EEG Source Reconstruction Reveals Frontal-Parietal Dynamics of Spatial Conflict Processing	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; TASK-RELATED CHANGES; EVENT-RELATED FMRI; COGNITIVE CONTROL; RESPONSE CONFLICT; NEUROCOGNITIVE MECHANISMS; CORTICAL SYNCHRONIZATION; ATTENTIONAL CONTROL; PREFRONTAL CORTEX; ACTION SELECTION	Cognitive control requires the suppression of distracting information in order to focus on task-relevant information. We applied EEG source reconstruction via time-frequency linear constrained minimum variance beamforming to help elucidate the neural mechanisms involved in spatial conflict processing. Human subjects performed a Simon task, in which conflict was induced by incongruence between spatial location and response hand. We found an early (similar to 200 ms post-stimulus) conflict modulation in stimulus-contralateral parietal gamma (30-50 Hz), followed by a later alpha-band (8-12 Hz) conflict modulation, suggesting an early detection of spatial conflict and inhibition of spatial location processing. Inter-regional connectivity analyses assessed via cross-frequency coupling of theta (4-8 Hz), alpha, and gamma power revealed conflict-induced shifts in cortical network interactions: Congruent trials (relative to incongruent trials) had stronger coupling between frontal theta and stimulus-contrahemifield parietal alpha/gamma power, whereas incongruent trials had increased theta coupling between medial frontal and lateral frontal regions. These findings shed new light into the large-scale network dynamics of spatial conflict processing, and how those networks are shaped by oscillatory interactions.	[Cohen, Michael X.; Ridderinkhof, K. Richard] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cohen, Michael X.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Ridderinkhof, K. Richard] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Arizona; University of Amsterdam	Cohen, MX (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	mikexcohen@gmail.com	Cohen, Michael/A-3092-2016; Cohen, Michael X/H-8748-2019	Cohen, Michael/0000-0002-1879-3593; Cohen, Michael X/0000-0002-1879-3593	Organization for Scientific Research (NWO)	Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2011, P NATL ACAD SCI USA, V108, P17556, DOI 10.1073/pnas.1103475108; Appelbaum LG, 2011, J COGNITIVE NEUROSCI, V23, P2620, DOI 10.1162/jocn.2010.21575; Bardi L, 2012, J COGN NEUROSCI; Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cho RY, 2009, J EXP PSYCHOL HUMAN, V35, P1161, DOI 10.1037/a0014491; Cohen M. X., 2012, CEREB CORTEX; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cohen MX, 2012, HUM BRAIN MAPP, V33, P246, DOI 10.1002/hbm.21195; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Cohen MX, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.054.2009; Compton RJ, 2012, PSYCHOPHYSIOLOGY, V49, P583, DOI 10.1111/j.1469-8986.2012.01354.x; Compton RJ, 2011, PSYCHOPHYSIOLOGY, V48, P583, DOI 10.1111/j.1469-8986.2010.01124.x; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Dalal SS, 2004, NEUROL CLIN NEUROPHY, V52, P2004; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Gramfort A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/923703; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Green JJ, 2009, BRAIN SIGNAL ANALYSIS: ADVANCES IN NEUROELECTRIC AND NEUROMAGNETIC METHODS, P79; Hartwigsen G, 2012, J NEUROSCI, V32, P16162, DOI 10.1523/JNEUROSCI.1010-12.2012; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jin Y, 2010, EXP BRAIN RES, V205, P131, DOI 10.1007/s00221-010-2336-x; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Marco-Pallares J, 2008, J COGNITIVE NEUROSCI, V20, P1595, DOI 10.1162/jocn.2008.20117; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Mazaheri A, 2009, HUM BRAIN MAPP, V30, P1791, DOI 10.1002/hbm.20763; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Milner A. D., 1995, VISUAL BRAIN ACTION; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Phillips S, 2009, INT J PSYCHOPHYSIOL, V73, P350, DOI 10.1016/j.ijpsycho.2009.05.011; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Ruiz MH, 2011, NEUROIMAGE, V55, P1791, DOI 10.1016/j.neuroimage.2010.12.050; Rusconi E, 2007, COGN NEUROPSYCHOL, V24, P373, DOI 10.1080/02643290701309425; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Schiff S, 2011, J COGNITIVE NEUROSCI, V23, P3998, DOI 10.1162/jocn_a_00080; Sekihara K, 2008, SER BIOMED ENG, P1; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Sturmer B, 2003, EXP BRAIN RES, V153, P35, DOI 10.1007/s00221-003-1579-1; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; Trujillo LT, 2007, CLIN NEUROPHYSIOL, V118, P645, DOI 10.1016/j.clinph.2006.11.009; van de Vijver I, 2011, J COGN NEUROSCI; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; Van Der Werf J, 2012, CEREB CORTEX; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Walsh BJ, 2011, J COGNITIVE NEUROSCI, V23, P2211, DOI 10.1162/jocn.2010.21595; Wittfoth M, 2008, BRAIN RES, V1194, P118, DOI 10.1016/j.brainres.2007.11.067; Wittfoth M, 2006, NEUROIMAGE, V32, P921, DOI 10.1016/j.neuroimage.2006.03.034; Woolrich M, 2011, NEUROIMAGE, V57, P1466, DOI 10.1016/j.neuroimage.2011.04.041; Worden MS, 2000, J NEUROSCI, V20; Wuhr P, 2005, Q J EXP PSYCHOL-A, V58, P705, DOI 10.1080/02724980443000269; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x	81	77	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57293	10.1371/journal.pone.0057293	http://dx.doi.org/10.1371/journal.pone.0057293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451201	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500086
J	Coulstock, E; Sosabowski, J; Ovecka, M; Prince, R; Goodall, L; Mudd, C; Sepp, A; Davies, M; Foster, J; Burnet, J; Dunlevy, G; Walker, A				Coulstock, Edward; Sosabowski, Jane; Ovecka, Milan; Prince, Rob; Goodall, Laura; Mudd, Clare; Sepp, Armin; Davies, Marie; Foster, Julie; Burnet, Jerome; Dunlevy, Grainne; Walker, Adam			Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain Antibodies	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HUMAN ASIALOGLYCOPROTEIN RECEPTOR; PLUS RIBAVIRIN; CELLS; INHIBITION; LIPOSOMES; THERAPY; BINDING; GENE; HEPATOCYTES	Interferon alpha (IFN alpha) is used for the treatment of hepatitis C infection and whilst efficacious it is associated with multiple adverse events including reduced leukocyte, erythrocyte, and platelet counts, fatigue, and depression. These events are most likely caused by systemic exposure to interferon. We therefore hypothesise that targeting the therapeutic directly to the intended site of action in the liver would reduce exposure in blood and peripheral tissue and hence improve the safety and tolerability of IFN alpha therapy. We genetically fused IFN to a domain antibody (dAb) specific to a hepatocyte restricted antigen, asialoglycoprotein receptor (ASGPR). Our results show that the murine IFN alpha 2 homolog (mIFN alpha 2) fused to an ASGPR specific dAb, termed DOM26h-196-61, could be expressed in mammalian tissue culture systems and retains the desirable biophysical properties and activity of both fusion partners when measured in vitro. Furthermore a clear increase in in vivo targeting of the liver by mIFN alpha 2-ASGPR dAb fusion protein, compared to that observed with either unfused mIFN alpha 2 or mIFN alpha 2 fused to an isotype control dAb V(H)D2 (which does not bind ASGPR) was demonstrated using microSPECT imaging. We suggest that these findings may be applicable in the development of a liver-targeted human IFN molecule with improved safety and patient compliance in comparison to the current standard of care, which could ultimately be used as a treatment for human hepatitis virus infections.	[Coulstock, Edward; Ovecka, Milan; Prince, Rob; Goodall, Laura; Mudd, Clare; Sepp, Armin; Davies, Marie; Dunlevy, Grainne; Walker, Adam] GlaxoSmithKline, Biopharm R&D, Innovat Biopharm Discovery Unit, Cambridge, England; [Sosabowski, Jane; Foster, Julie; Burnet, Jerome] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England	GlaxoSmithKline; University of London; Queen Mary University London	Walker, A (corresponding author), GlaxoSmithKline, Biopharm R&D, Innovat Biopharm Discovery Unit, Cambridge, England.	adam.z.walker@gsk.com		Sosabowski, Jane/0000-0001-7653-5923	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The authors have read the journal's policy and have the following conflicts: All authors (except JS, JF, and JB) were employees of GlaxoSmithKline at the time this work was carried out. JS, JF, and JB are researchers at Queen Mary University of London whose work on this project was funded by GlaxoSmithKline. All relevant patents have been declared, and there are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abe M, 2003, BIOCONJUGATE CHEM, V14, P997, DOI 10.1021/bc034081a; Deal KA, 1998, NUCL MED BIOL, V25, P379, DOI 10.1016/S0969-8051(97)00222-9; Dieperink E, 2003, PSYCHOSOMATICS, V44, P104, DOI 10.1176/appi.psy.44.2.104; DUNCAN R, 1986, BIOCHIM BIOPHYS ACTA, V880, P62, DOI 10.1016/0304-4165(86)90120-0; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Eto T, 1999, NAT MED, V5, P577, DOI 10.1038/8462; Fried MW, 2004, SEMIN LIVER DIS, V24, P47, DOI 10.1055/s-2004-832928; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gay RD, 2010, MABS-AUSTIN, V2, P625, DOI 10.4161/mabs.2.6.13493; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Iorio R, 1997, PEDIATR INFECT DIS J, V16, P984, DOI 10.1097/00006454-199710000-00016; Iyer U, 2011, J PHARMACOL TOX MET, V64, P207, DOI 10.1016/j.vascn.2011.07.005; Jeong YI, 2005, INT J PHARMACEUT, V296, P151, DOI 10.1016/j.ijpharm.2005.02.027; Kabat EA, 1991, SEQUENCES PROTEINS I; Kallinteri P, 2001, J DRUG TARGET, V9, P155, DOI 10.3109/10611860108997925; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Pacifico F, 2003, MOL CELL ENDOCRINOL, V208, P51, DOI 10.1016/j.mce.2003.06.001; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Park JH, 1998, BIOCHEM BIOPH RES CO, V244, P304, DOI 10.1006/bbrc.1998.8256; Peng DJ, 2007, CANCER GENE THER, V14, P66, DOI 10.1038/sj.cgt.7700985; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saunier B, 2003, J VIROL, V77, P546, DOI 10.1128/JVI.77.1.546-559.2003; Seow YYT, 2002, NEPHRON, V91, P431, DOI 10.1159/000064283; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; Trahtenherts A, 2009, HYBRIDOMA, V28, P225, DOI 10.1089/hyb.2009.0019; TREICHEL U, 1994, J GEN VIROL, V75, P3021, DOI 10.1099/0022-1317-75-11-3021; van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138; Walker A, 2010, PROTEIN ENG DES SEL, V23, P271, DOI 10.1093/protein/gzp091; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Yang DY, 2007, J DIGEST DIS, V8, P89, DOI 10.1111/j.1443-9573.2007.00291.x; Zhang XQ, 2005, J CONTROL RELEASE, V102, P749, DOI 10.1016/j.jconrel.2004.10.024; Zhang Y, 2007, J CONTROL RELEASE, V117, P281, DOI 10.1016/j.jconrel.2006.11.006	34	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57263	10.1371/journal.pone.0057263	http://dx.doi.org/10.1371/journal.pone.0057263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451195	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500082
J	Otranto, D; Dantas-Torres, F; de Caprariis, D; Di Paola, G; Tarallo, VD; Latrofa, MS; Lia, RP; Annoscia, G; Breitshwerdt, EB; Cantacessi, C; Capelli, G; Stanneck, D				Otranto, Domenico; Dantas-Torres, Filipe; de Caprariis, Donato; Di Paola, Giancarlo; Tarallo, Viviana D.; Latrofa, Maria S.; Lia, Riccardo P.; Annoscia, Giada; Breitshwerdt, Edward B.; Cantacessi, Cinzia; Capelli, Gioia; Stanneck, Dorothee			Prevention of Canine Leishmaniosis in a Hyper-Endemic Area Using a Combination of 10% Imidacloprid/4.5% Flumethrin	PLOS ONE			English	Article							VECTOR-BORNE DISEASES; IMPREGNATED DOG COLLARS; VISCERAL LEISHMANIASIS; PHLEBOTOMINE SANDFLIES; YOUNG-DOGS; TRANSMISSION; BRAZIL; PERMETHRIN; DIAGNOSIS; DYNAMICS	Background: Dogs are the main reservoir hosts of Leishmania infantum, the agent of human zoonotic visceral leishmaniosis. This study investigated the efficacy of a polymer matrix collar containing a combination of 10% imidacloprid and 4.5% flumethrin as a novel prophylactic measure to prevent L. infantum infections in young dogs from a hyper-endemic area of southern Italy, with a view towards enhancing current control strategies against both human and canine leishmaniosis. Methodology/Principal Findings: The study was carried out on 124 young dogs, of which 63 were collared (Group A) while 61 were left untreated (Group B), from March-April 2011 until March 2012. Blood and skin samples were collected at baseline (April 2011) and at the first, second, third and fourth follow-up time points (July, September 2011 and November 2011, and March 2012, respectively). Bone marrow and conjunctiva were sampled at baseline and at the fourth follow-up. Serological, cytological and molecular tests were performed to detect the presence of L. infantum in the different tissues collected. At the end of the trial, no dog from Group A proved positive for L. infantum at any follow-up, whereas 22 dogs from Group B were infected (incidence density rate = 45.1%); therefore, the combination of 10% imidacloprid and 4.5% flumethrin was 100% efficacious for the prevention of L. infantum infection in young dogs prior to their first exposure to the parasite in a hyper-endemic area for CanL. Conclusions: The use of collars containing 10% imidacloprid and 4.5% flumethrin conferred long-term protection against infection by L. infantum to dogs located in a hyper-endemic area, thus representing a reliable and sustainable strategy to decrease the frequency and spread of this disease among the canine population which will ultimately result in the reduction of associated risks to human health.	[Otranto, Domenico; Dantas-Torres, Filipe; de Caprariis, Donato; Di Paola, Giancarlo; Tarallo, Viviana D.; Latrofa, Maria S.; Lia, Riccardo P.; Annoscia, Giada; Cantacessi, Cinzia] Univ Bari, Dipartimento Med Vet, Valenzano, Italy; [Dantas-Torres, Filipe] Ctr Pesquisas Aggeu Magalhaes Fiocruz PE, Dept Imunol, Recife, PE, Brazil; [Breitshwerdt, Edward B.] N Carolina State Univ, Coll Vet Med, Intracellular Pathogens Res Lab, Raleigh, NC USA; [Cantacessi, Cinzia] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Australia; [Capelli, Gioia] Ist Zooprofilatt Sperimentale Venezie, Parasitol Lab, Legnaro, Italy; [Stanneck, Dorothee] Bayer Anim Hlth GmbH, Leverkusen, Germany	Universita degli Studi di Bari Aldo Moro; Fundacao Oswaldo Cruz; University of North Carolina; North Carolina State University; James Cook University; IZS delle Venezie; Bayer AG	Otranto, D (corresponding author), Univ Bari, Dipartimento Med Vet, Valenzano, Italy.	domenico.otranto@uniba.it	Otranto, Domenico/Y-3249-2019; Dantas-Torres, Filipe/AAC-5982-2020; Cantacessi, Cinzia/B-7356-2014; Dantas-Torres, Filipe/G-1617-2012	Dantas-Torres, Filipe/0000-0002-1496-6274; Cantacessi, Cinzia/0000-0001-6863-2950; Otranto, Domenico/0000-0002-7518-476X; Latrofa, Maria Stefania/0000-0001-9061-437X; Breitschwerdt, Edward/0000-0002-3506-0279; Lia, Riccardo Paolo/0000-0001-7239-1694	Bayer Animal Health GmbH (Germany)	Bayer Animal Health GmbH (Germany)	This project was funded by Bayer Animal Health GmbH (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by Bayer Animal Health GmbH (Germany) and Dr. Dorothee Stanneck is an employee of Bayer Animal Health GmbH, Leverkusen, Germany. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; Athanasiou LV, 2012, ACTA TROP, V122, P291, DOI 10.1016/j.actatropica.2012.02.003; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Dantas-Torres F, 2006, VET PARASITOL, V140, P54, DOI 10.1016/j.vetpar.2006.03.008; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P531, DOI 10.1016/j.pt.2012.08.007; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Dogan N, 2006, J TROP PEDIATRICS, V52, P212, DOI 10.1093/tropej/fmi102; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Manzillo VF, 2006, VET PARASITOL, V142, P142, DOI 10.1016/j.vetpar.2006.06.029; Maroli M., 1994, Parassitologia (Rome), V36, P251; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Maroli M, 2012, MED VET ENTOMOL, DOI [10.1111/j.1365-2915.2012.01034, DOI 10.1111/J.1365-2915.2012.01034]; Maroli M, 2008, TROP MED INT HEALTH, V13, P256, DOI [10.1111/j.1365-3156.2007.01998, 10.1111/j.1365-3156.2007.01998.x]; Menn B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-34; Moreira ED, 2004, VET PARASITOL, V122, P245, DOI 10.1016/j.vetpar.2004.05.019; NERY-GUIMARAES F., 1954, REV BRASIL MALARIOL E DOENCAS TROP, V6, P127; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Otranto D, 2010, VET PARASITOL, V172, P323, DOI 10.1016/j.vetpar.2010.05.017; Otranto D, 2009, CLIN VACCINE IMMUNOL, V16, P337, DOI 10.1128/CVI.00268-08; Otranto D, 2007, VET PARASITOL, V144, P270, DOI 10.1016/j.vetpar.2006.09.012; Otranto D, 2010, J CLIN MICROBIOL, V48, P3316, DOI 10.1128/JCM.00379-10; Otranto D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S2; Paradies P, 2006, J VET MED B, V53, P295, DOI 10.1111/j.1439-0450.2006.00964.x; Petersen CA, 2009, VET CLIN N AM-SMALL, V39, P1065, DOI 10.1016/j.cvsm.2009.06.008; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Stanneck D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-73; Stanneck D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-66; Talmi-Frank D, 2006, CLIN VACCINE IMMUNOL, V13, P271, DOI 10.1128/CVI.13.2.271-276.2006; Tarallo VD, 2010, ACTA TROP, V116, P227, DOI 10.1016/j.actatropica.2010.08.013; Vlkova M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001344	35	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56374	10.1371/journal.pone.0056374	http://dx.doi.org/10.1371/journal.pone.0056374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451043	Green Published, Green Accepted, gold			2022-12-27	WOS:000316849500013
J	Shi, JN; Tao, T; Chen, W; Cheng, L; Wang, L; Zhang, XL				Shi, Jiannong; Tao, Ting; Chen, Wei; Cheng, Li; Wang, Long; Zhang, Xingli			Sustained Attention in Intellectually Gifted Children Assessed Using a Continuous Performance Test	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; RESPONSE-INHIBITION; WORKING-MEMORY; VIGILANCE; ADHD; INTELLIGENCE; TASK; TIME; DEFICITS; GO/NOGO	This study aimed to investigate two aspects of sustained attention in intellectually gifted children: first, the differences to intellectually average children; second, the differences between receiving standard education and enrichment education. Study 1 compared sustained attention between 24 intellectually gifted and 26 intellectually average children. The results showed that intellectually gifted children had better performance than their average peers, not only for the whole task but also on all indices. Study 2 compared sustained attention between 24 intellectually gifted children who received standard education and 24 intellectually gifted children who received enrichment education. The results showed that intellectually gifted children who received enrichment education performed better than those who received standard education. These findings are consistent with previous work and provide support for the implementation of enrichment education for intellectually gifted children.	[Shi, Jiannong; Tao, Ting; Chen, Wei; Wang, Long; Zhang, Xingli] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Tao, Ting; Chen, Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cheng, Li] Beijing Normal Univ, Fac Educ, Beijing 100875, Peoples R China; [Shi, Jiannong] Aalborg Univ, Dept Learning & Philosophy, Aalborg, Denmark	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University; Aalborg University	Zhang, XL (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zhangxl@psych.a.cn		Chen, Wei/0000-0003-0121-6172	National Natural Science Foundation of China [31100754]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (No. 31100754) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; Ashkenazi S, 2009, NEUROPSYCHOLOGY, V23, P535, DOI 10.1037/a0015347; Baum SM, 1998, GIFTED CHILD QUART, V42, P96, DOI 10.1177/001698629804200204; Chae PK, 2003, GIFTED CHILD QUART, V47, P192, DOI 10.1177/001698620304700303; [程黎 CHENG Li], 2009, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V17, P408; [程黎 CHENG Li], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P637; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Cowan N, 2006, MEM COGNITION, V34, P1754, DOI 10.3758/BF03195936; Duan X., 2010, PSYCHOL TEST ASSESSM, V52, P419, DOI DOI 10.1044/2F2016_JSLHR-L-15-0310; Duan XJ, 2010, GIFTED CHILD QUART, V54, P85, DOI 10.1177/0016986209355971; Duan XJ, 2009, NEUROSCI LETT, V457, P45, DOI 10.1016/j.neulet.2009.04.006; Dux PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003330; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Gordon N, 1990, ASSESSMENT TREATMENT; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Helton WS, 2007, J CLIN EXP NEUROPSYC, V29, P545, DOI 10.1080/13803390600814757; Hitchcock E.M., 2003, THEOR ISS ERGON SCI, V4, P89, DOI [10.1080/14639220210159726, DOI 10.1080/14639220210159726]; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; Koski L, 2001, NEUROPSYCHOLOGIA, V39, P268, DOI 10.1016/S0028-3932(00)00110-X; Lin CCH, 1999, J ABNORM CHILD PSYCH, V27, P403, DOI 10.1023/A:1021932119311; Liu T, 2011, NEUROSCIENCE, V189, P250, DOI 10.1016/j.neuroscience.2011.05.009; Liu T, 2011, NEUROSCIENCE, V180, P122, DOI 10.1016/j.neuroscience.2011.02.022; Liu TR, 2011, NEUROSCI LETT, V490, P101, DOI 10.1016/j.neulet.2010.12.035; Liu Tongran., 2008, PSYCHOL SCI Q, V50, P259; Lubinski D, 2006, PSYCHOL SCI, V17, P194, DOI 10.1111/j.1467-9280.2006.01685.x; Lubinski D, 2001, J APPL PSYCHOL, V86, P718, DOI 10.1037/0021-9010.86.4.718; Lubinski D., 2004, NATION DECEIVED SCH, V2, P23; Luciano M, 2001, BEHAV GENET, V31, P581, DOI 10.1023/A:1013397428612; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; MacLean KA, 2009, ATTEN PERCEPT PSYCHO, V71, P1042, DOI 10.3758/APP.71.5.1042; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Mass R, 2000, EUR ARCH PSY CLIN N, V250, P24, DOI 10.1007/PL00007535; NICHOLS RC, 1978, HOMO, V29, P158; Parasuraman, 1998, ATTENTIVE BRAIN; PARASURAMAN R, 1979, SCIENCE, V205, P924, DOI 10.1126/science.472714; Park G, 2007, PSYCHOL SCI, V18, P948, DOI 10.1111/j.1467-9280.2007.02007.x; Passow A. H., 1982, CURRICULA GIFTED, P4; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Schweizer K, 2004, INTELLIGENCE, V32, P329, DOI 10.1016/j.intell.2004.06.006; Snyder KE, 2011, GIFTED CHILD QUART, V55, P181, DOI 10.1177/0016986211412769; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szalma JL, 2004, HUM FACTORS, V46, P219, DOI 10.1518/hfes.46.2.219.37334; Tharpe AM, 2002, J SPEECH LANG HEAR R, V45, P403, DOI 10.1044/1092-4388(2002/032); Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Trautmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032279; Tucha L, 2009, J ATTEN DISORD, V12, P410, DOI 10.1177/1087054708315065; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; WEBB JT, 1993, EXCEPT CHILDREN, V60, P183, DOI 10.1177/001440299306000213; Westberg K. L., 1993, RES MONOGRAPH; Zha Z, 1984, ACTA PSYCHOL SINICA, V16, P27; Zha Z, 1998, MYSTERY DEV SUPERNOR, P1; Zhu Y, 2000, EXPT PSYCHOL; Zillessen KE, 2001, CLIN NEUROPHYSIOL, V112, P1166, DOI 10.1016/S1388-2457(01)00535-1	56	15	18	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57417	10.1371/journal.pone.0057417	http://dx.doi.org/10.1371/journal.pone.0057417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451224	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500101
J	Sultana, R; Abdel-Fatah, T; Perry, C; Moseley, P; Albarakti, N; Mohan, V; Seedhouse, C; Chan, S; Madhusudan, S				Sultana, Rebeka; Abdel-Fatah, Tarek; Perry, Christina; Moseley, Paul; Albarakti, Nada; Mohan, Vivek; Seedhouse, Claire; Chan, Stephen; Madhusudan, Srinivasan			Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells	PLOS ONE			English	Article							DNA-REPAIR; GENETIC POLYMORPHISMS; DAMAGE; CHEMOTHERAPY; MECHANISMS; CISPLATIN	Introduction: Ataxia telangiectasia mutated and Rad3 Related (ATR) protein kinase is a key sensor of single-stranded DNA associated with stalled replication forks and repair intermediates generated during DNA repair. XRCC1 is a critical enzyme in single strand break repair and base excision repair. XRCC1-LIG3 complex is also an important contributor to the ligation step of the nucleotide excision repair response. Methods: In the current study, we investigated synthetic lethality in XRCC1 deficient and XRCC1 proficient Chinese Hamster ovary (CHO) and human ovarian cancer cells using ATR inhibitors (NU6027). In addition, we also investigated the ability of ATR inhibitors to potentiate cisplatin cytotoxicity in XRCC1 deficient and XRCC1 proficient CHO and human cancer cells. Clonogenic assays, alkaline COMET assays, gamma H2AX immunocytochemistry, FACS for cell cycle as well as FITC-annexin V flow cytometric analysis were performed. Results: ATR inhibition is synthetically lethal in XRCC1 deficient cells as evidenced by increased cytotoxicity, accumulation of double strand DNA breaks, G2/M cell cycle arrest and increased apoptosis. Compared to cisplatin alone, combination of cisplatin and ATR inhibitor results in enhanced cytotoxicity in XRCC1 deficient cells compared to XRCC1 proficient cells. Conclusions: Our data provides evidence that ATR inhibition is suitable for synthetic lethality application and cisplatin chemopotentiation in XRCC1 deficient ovarian cancer cells.	[Sultana, Rebeka; Perry, Christina; Albarakti, Nada; Mohan, Vivek; Madhusudan, Srinivasan] Univ Nottingham, Univ Nottingham Hosp, Mol Oncol Lab, Acad Unit Oncol,Sch Mol Med Sci, Nottingham NG7 2RD, England; [Abdel-Fatah, Tarek; Moseley, Paul; Chan, Stephen] Univ Nottingham Hosp, Dept Clin Oncol, Nottingham NG7 2UH, England; [Seedhouse, Claire] Univ Nottingham, Univ Nottingham Hosp, Sch Mol Med Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Nottingham	Madhusudan, S (corresponding author), Univ Nottingham, Univ Nottingham Hosp, Mol Oncol Lab, Acad Unit Oncol,Sch Mol Med Sci, Nottingham NG7 2RD, England.	srinivasan.madhusudan@nottingham.ac.uk	SEEDHOUSE, CLAIRE/B-3570-2009	Albarakati, Nada/0000-0001-5135-8684; Moseley, Paul/0000-0003-0795-9751; Madhusudan, Srinivasan/0000-0002-5354-5480; Seedhouse, Claire/0000-0003-2280-4045	Medical Research Council [MR/J008001/1] Funding Source: Medline; MRC [MR/J008001/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdel-Fatah T, 2013, INT J CANCER, V132, P2778, DOI 10.1002/ijc.27980; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1992, NUCLEIC ACIDS RES, V20, P4575, DOI 10.1093/nar/20.17.4575; Caporali S, 2004, MOL PHARMACOL, V66, P478; Chen T, 2012, DRUG DISCOV TODAY, V17, P194, DOI 10.1016/j.drudis.2011.12.009; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Corso G, 2009, J GASTROINTEST SURG, V13, P2233, DOI 10.1007/s11605-009-0980-x; Fan JH, 2007, ENVIRON MOL MUTAGEN, V48, P491, DOI 10.1002/em.20312; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gossage L, 2007, MOL DIAGN THER, V11, P361, DOI 10.1007/BF03256260; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Kim K, 2008, GYNECOL ONCOL, V111, P509, DOI 10.1016/j.ygyno.2008.08.034; Ladiges WC, 2006, ONCOGENE, V25, P1612, DOI 10.1038/sj.onc.1209370; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Peasland A, 2011, BRIT J CANCER, V105, P372, DOI 10.1038/bjc.2011.243; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Serrano MA, 2012, ONCOGENE; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sirbu BM, 2012, PLOS ONE, V6, P1; Sultana R, 2012, INT J CANCER, V131, P2433, DOI 10.1002/ijc.27512; Sun XC, 2009, LUNG CANCER, V65, P230, DOI 10.1016/j.lungcan.2008.11.014; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Zhang R, 2010, TOXICOL LETT, V192, P108, DOI 10.1016/j.toxlet.2009.10.012	35	58	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57098	10.1371/journal.pone.0057098	http://dx.doi.org/10.1371/journal.pone.0057098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451157	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500065
J	Vigneswara, V; Berry, M; Logan, A; Ahmed, Z				Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair			Caspase-2 Is Upregulated after Sciatic Nerve Transection and Its Inhibition Protects Dorsal Root Ganglion Neurons from Apoptosis after Serum Withdrawal	PLOS ONE			English	Article							SATELLITE GLIAL-CELLS; PRIMARY SENSORY NEURONS; DNA-DAMAGE; PC12 CELLS; SYMPATHETIC NEURONS; DEATH; INJURY; REGENERATION; ELIMINATION; GROWTH	Sciatic nerve (SN) transection-induced apoptosis of dorsal root ganglion neurons (DRGN) is one factor determining the efficacy of peripheral axonal regeneration and the return of sensation. Here, we tested the hypothesis that caspase-2 (CASP2) orchestrates apoptosis of axotomised DRGN both in vivo and in vitro by disrupting the local neurotrophic supply to DRGN. We observed significantly elevated levels of cleaved CASP2 (C-CASP2), compared to cleaved caspase-3 (C-CASP3), within TUNEL+DRGN and DRG glia (satellite and Schwann cells) after SN transection. A serum withdrawal cell culture model, which induced 40% apoptotic death in DRGN and 60% in glia, was used to model DRGN loss after neurotrophic factor withdrawal. Elevated C-CASP2 and TUNEL were observed in both DRGN and DRG glia, with C-CASP2 localisation shifting from the cytosol to the nucleus, a required step for induction of direct CASP2-mediated apoptosis. Furthermore, siRNA-mediated downregulation of CASP2 protected 50% of DRGN from apoptosis after serum withdrawal, while downregulation of CASP3 had no effect on DRGN or DRG glia survival. We conclude that CASP2 orchestrates the death of SN-axotomised DRGN directly and also indirectly through loss of DRG glia and their local neurotrophic factor support. Accordingly, inhibiting CASP2 expression is a potential therapy for improving both the SN regeneration response and peripheral sensory recovery.	[Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair] Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair] Neuregenix Ltd, Birmingham, W Midlands, England	University of Birmingham	Ahmed, Z (corresponding author), Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Birmingham, W Midlands, England.	z.ahmed.1@bham.ac.uk	Ahmed, Zubair/AAN-1869-2021	Logan, Ann/0000-0003-3215-5042	Neuregenix Ltd; Wellcome Trust; International Spinal Research Trust [STR103] Funding Source: researchfish	Neuregenix Ltd; Wellcome Trust(Wellcome TrustEuropean Commission); International Spinal Research Trust	This work was funded by grants from Neuregenix Ltd, a University-based not-for-profit company and by a Project Grant from the Wellcome Trust to ZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by grants from Neuregenix Ltd, with whom all authors have an affiliation to. Quark Pharmaceuticals Inc., Israel, provided the stable modified siCASP2 and Scr-siCASP2 used in this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P509, DOI 10.1016/j.mcn.2004.11.002; Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Ahmed Z, 2010, NEUROBIOL DIS, V39, P292, DOI 10.1016/j.nbd.2010.04.013; Ahmed Z, 2009, NEUROBIOL DIS, V36, P142, DOI 10.1016/j.nbd.2009.07.016; ALDSKOGIUS H, 1985, BRAIN RES REV, V10, P27, DOI 10.1016/0165-0173(85)90006-2; Arkhipova S S, 2010, Neurosci Behav Physiol, V40, P609, DOI 10.1007/s11055-010-9303-7; Cao XF, 2008, J BIOL CHEM, V283, P14490, DOI 10.1074/jbc.M801107200; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Guseva D, 2006, CELL MOL NEUROBIOL, V26, P1225, DOI 10.1007/s10571-006-9005-4; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hart AM, 2002, EXP BRAIN RES, V142, P308, DOI 10.1007/s00221-001-0929-0; Hart AM, 2008, NEUROL RES, V30, P999, DOI 10.1179/174313208X362479; Haviv R, 1998, J NEUROSCI RES, V52, P491, DOI 10.1002/(SICI)1097-4547(19980601)52:5<491::AID-JNR1>3.0.CO;2-7; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; JANCSO G, 1992, EXP PHYSIOL, V77, P405, DOI 10.1113/expphysiol.1992.sp003603; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kumar S, 2002, SCIENCE, V297, P1290, DOI 10.1126/science.1076118; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lin CR, 2011, J NEUROSCI RES, V89, P689, DOI 10.1002/jnr.22589; Madro A, 2008, J PHYSIOL PHARMACOL, V59, P239; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Raginov I S, 2005, Neurosci Behav Physiol, V35, P17, DOI 10.1023/B:NEAB.0000049647.19397.30; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Schaeffer V, 2010, GLIA, V58, P169, DOI 10.1002/glia.20910; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Stefanis L, 1997, J NEUROCHEM, V69, P1425; Terenghi G, 2011, J HAND SURG-EUR VOL, V36E, P730, DOI 10.1177/1753193411422202; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Tong JX, 1997, J NEUROCYTOL, V26, P771, DOI 10.1023/A:1018566431912; Troy CM, 1997, J NEUROSCI, V17, P1911; Troy CM, 2000, J NEUROSCI, V20, P1386; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	44	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57861	10.1371/journal.pone.0057861	http://dx.doi.org/10.1371/journal.pone.0057861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451279	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500142
J	Yang, H; Cai, HW; Wan, L; Liu, S; Li, SF; Cheng, JQ; Lu, XF				Yang, Hao; Cai, Huawei; Wan, Lin; Liu, Shan; Li, Shengfu; Cheng, Jingqiu; Lu, Xiaofeng			Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells	PLOS ONE			English	Article							IN-VITRO; RADIONUCLIDE THERAPY; PROSTATE-CANCER; RECEPTOR; ANTAGONISTS; BINDING; DEATH	Tumor-homing peptides that recognize specific markers on tumor cells have shown potential as drug carriers for targeted cancer therapy. Bombesin receptors are frequently overexpressed or ectopically expressed in a wide range of human tumors. Bombesin and its analogues have been widely used as drug carriers for tumor imaging and tumor therapy. However, the cargos used in previous studies, including radioactive and chemotherapeutic agents, are usually small molecules. Mitochondrial-disrupting peptides depolarize the mitochondria and trigger apoptosis after entering tumor cells. We are interested in whether the bombesin analogue, Bn(6-14), which contains a bombesin receptor-binding motif, can specifically deliver the mitochondria-disrupting peptide, B28, to tumor cells. To this end, we created a chimeric peptide, B28Bn(6-14), by conjugating B28 to Bn(6-14) at its N-terminus. The cytotoxicity of B28Bn(6-14) in tumor cells was much stronger than unconjugated B28. The IC50 values of B28Bn(6-14) in tumor cells (1.7-3.5 mu M) were approximately 10 times lower than B28. However, conjugation of B28 to Bn(2-7), which lacks the bombesin receptor-binding motif, did not increase its cytotoxicity. In addition, the IC50 values of B28Bn(6-14) in tumor cells (1.7-3.5 mu M) was 3-10 times lower than in normal cells (10.8-16.8 mu M). We found that selective binding of B28Bn(6-14) to tumor cells is Bn(6-14)-dependent. Upon entering the tumor cell, B28Bn(6-14) accumulated in the mitochondria and triggered caspase-dependent apoptosis. Intratumoral and intraperitoneal administration of B28Bn(6-14) substantially suppressed the growth of DU145 tumor xenografts in mice. These results demonstrate that Bn(6-14) is able to deliver the mitochondria-disrupting peptide to tumor cells, and B28Bn(6-14) should be further developed as novel anti-cancer agent.	[Yang, Hao; Cai, Huawei; Wan, Lin; Liu, Shan; Li, Shengfu; Cheng, Jingqiu; Lu, Xiaofeng] Sichuan Univ, West China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610064, Peoples R China	Sichuan University	Lu, XF (corresponding author), Sichuan Univ, West China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610064, Peoples R China.	xiaofenglu@yahoo.com	Yang, Hao/ABV-4834-2022; Lu, Xiaofeng/ABD-9075-2021	Yang, Hao/0000-0003-2214-9474; Cai, Huawei/0000-0003-1341-8417	Natural Science Fund of China [81072566]; China Postdoctoral Science Foundation [201104645, 20100481392]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Natural Science Fund of China (81072566) and China Postdoctoral Science Foundation funded project (201104645, 20100481392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiraj K, 2011, J NUCL MED, V52, P1970, DOI 10.2967/jnumed.111.094375; Aluri S, 2009, ADV DRUG DELIVER REV, V61, P940, DOI 10.1016/j.addr.2009.07.002; Beer M, 2012, PROSTATE, V72, P318, DOI 10.1002/pros.21434; Bombardieri E, 2010, EUR J NUCL MED MOL I, V37, P1441, DOI 10.1007/s00259-010-1473-6; Cescato R, 2008, J NUCL MED, V49, P318, DOI 10.2967/jnumed.107.045054; Chanda N, 2010, P NATL ACAD SCI USA, V107, P8760, DOI 10.1073/pnas.1002143107; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Corti A, 2012, MED RES REV, V32, P1078, DOI 10.1002/med.20238; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dapp S, 2011, NUCL MED BIOL, V38, P997, DOI 10.1016/j.nucmedbio.2011.02.014; Do TN, 2003, ONCOGENE, V22, P1431, DOI 10.1038/sj.onc.1206258; Engel JB, 2005, CLIN CANCER RES, V11, P2408, DOI 10.1158/1078-0432.CCR-04-1670; GARGOSKY SE, 1987, BIOCHEM J, V247, P427, DOI 10.1042/bj2470427; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harsman A, 2012, J BIOL CHEM, V287, P31437, DOI 10.1074/jbc.M112.392118; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Kapoor P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035187; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kwekkeboom DJ, 2011, ENDOCRIN METAB CLIN, V40, P173, DOI 10.1016/j.ecl.2010.12.003; Li Q, 2005, ANTIMICROB AGENTS CH, V49, P388, DOI 10.1128/AAC.49.1.388-397.2005; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; Modlin IM, 2010, ALIMENT PHARM THER, V31, P169, DOI 10.1111/j.1365-2036.2009.04174.x; Moody TW, 2006, J PHARMACOL EXP THER, V318, P1265, DOI 10.1124/jpet.106.104141; Rege K, 2007, CANCER RES, V67, P6368, DOI 10.1158/0008-5472.CAN-06-3658; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Safavy A, 2006, BIOCONJUGATE CHEM, V17, P565, DOI 10.1021/bc050224c; Sancho V, 2011, CURR DRUG DELIV, V8, P79, DOI 10.2174/156720111793663624; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Stangelberger A, 2005, CLIN CANCER RES, V11, P49; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; van Essen M, 2009, NAT REV ENDOCRINOL, V5, P382, DOI 10.1038/nrendo.2009.105; Wagh NK, 2012, BIOCONJUGATE CHEM, V23, P527, DOI 10.1021/bc200600w; Weber HC, 2009, CURR OPIN ENDOCRINOL, V16, P66, DOI 10.1097/MED.0b013e32831cf5aa; Yang H, 2007, PROTEIN EXPRES PURIF, V54, P309, DOI 10.1016/j.pep.2007.03.006; Yang H, 2010, J BIOL CHEM, V285, P25666, DOI 10.1074/jbc.M109.089417	41	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57358	10.1371/journal.pone.0057358	http://dx.doi.org/10.1371/journal.pone.0057358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451211	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500092
J	Chachadi, VB; Ali, MF; Cheng, PW				Chachadi, Vishwanath B.; Ali, Mohamed F.; Cheng, Pi-Wan			Prostatic Cell-Specific Regulation of the Synthesis of MUC1-Associated Sialyl Lewis a	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CANCER-CELLS; HUMAN COLON; ABERRANT EXPRESSION; ALTERED EXPRESSION; DNA METHYLATION; E-SELECTIN; ANTIGEN; MUC1; BETA-3GAL-T5	Sialyl Lewis antigens are selectin ligands involved in leukocyte trafficking and cancer metastasis. Biosynthesis of these selectin ligands occurs by the sequential actions of several glycosyltransferases in the Golgi apparatus following synthesis of the protein backbone in the endoplasmic reticulum. In this study, we examine how the synthesis of sialyl Lewis a (sLe(a)) is regulated in prostatic cells and identify a mucin that carries this glycotope. We treat human prostatic cells including one normal and three cancerous cells with histone deacetylase inhibitors, valproic acid, tricostatin A (TSA), and suberoylanilide hydroxamic acid (SAHA), and then monitor the expression of sLe(a). We have found that SAHA enhances the production of sLe(a) in normal prostatic RWPE-1 cells but not prostatic cancer cells. Employing siRNA technology and co-immunoprecipitation, we show that the sLe(a) is associated with MUC1, which is confirmed by confocal immunofluorescence microscopy and proximity ligation assay. The SAHA-induced production of sLe(a) in RWPE-1 cells is resulted from upregulation of B3GALT1 gene via enhancement of acetylated histone-3 and histone-4. Interestingly, PC3 and LNCaP C-81 cells do not produce detectable amounts of sLe(a) despite expressing high levels of B3GALT1. However, the MUC1-associated sLe(a) is generated in these cells after introduction of MUC1 cDNA. We conclude that the synthesis of sLe(a) is controlled by not only peptide backbone of the glycoprotein but also glycoprotein-specific glycosyltransferases involved in the synthesis of sLe(a). Further, the SAHA induction of this selectin ligand in normal prostatic cells may pose a potentially serious side effect of this drug recently approved by the US Food and Drug Administration.	[Chachadi, Vishwanath B.; Ali, Mohamed F.; Cheng, Pi-Wan] Vet Adm Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE USA; [Chachadi, Vishwanath B.; Ali, Mohamed F.; Cheng, Pi-Wan] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Cheng, PW (corresponding author), Vet Adm Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE USA.	pcheng@unmc.edu	Chachadi, Vishwanath/ABG-8002-2021	Chachadi, Vishwanath/0000-0002-4488-419X	Department of Veteran Affairs [1I1BX000985]; National Institutes of Health [2RO1HL48282];  [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048282] Funding Source: NIH RePORTER	Department of Veteran Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Department of Veteran Affairs 1I1BX000985; the National Institutes of Health 2RO1HL48282; and Nebraska LB506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez-Lugo JA, 2012, J MOL MODEL, V18, P2301, DOI 10.1007/s00894-011-1240-z; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Butler LM, 2000, CANCER RES, V60, P5165; Caretti A, 2012, INT J BIOCHEM CELL B, V44, P84, DOI 10.1016/j.biocel.2011.09.010; Chachadi VB, 2011, INT J BIOCHEM CELL B, V43, P586, DOI 10.1016/j.biocel.2010.12.015; Chakraborty AK, 2006, GENE, V374, P166, DOI 10.1016/j.gene.2006.01.031; Santos MDL, 2007, MOL CANCER THER, V6, P1425, DOI 10.1158/1535-7163.MCT-06-0623; Demers M, 2009, BIOCHEM BIOPH RES CO, V387, P425, DOI 10.1016/j.bbrc.2009.07.015; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Fernandez-Rodriguez J, 2001, GLYCOCONJUGATE J, V18, P925, DOI 10.1023/A:1022208727512; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fukuda M, 1996, CANCER RES, V56, P2237; Giordanengo V, 2004, FASEB J, V18, P1961, DOI 10.1096/fj.04-2467fje; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi N, 2004, PATHOBIOLOGY, V71, P26, DOI 10.1159/000072959; Hey NA, 1996, GLYCOCONJUGATE J, V13, P769, DOI 10.1007/BF00702341; Holgersson J, 2006, GLYCOBIOLOGY, V16, P584, DOI 10.1093/glycob/cwj090; Ishihara K, 2004, BRIT J PHARMACOL, V142, P1020, DOI 10.1038/sj.bjp.0705869; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kannagi Reiji, 2007, Chang Gung Med J, V30, P189; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; Kawarada Y, 2000, PATHOL RES PRACT, V196, P259, DOI 10.1016/S0344-0338(00)80075-8; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; Kim YS, 2008, GASTROENTEROLOGY, V135, P305, DOI 10.1053/j.gastro.2008.06.013; Kishimoto T, 1996, INT J CANCER, V69, P290, DOI 10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Mare L, 2004, EUR J BIOCHEM, V271, P186, DOI 10.1046/j.1432-1033.2003.03919.x; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Matsui T, 2004, JPN J CLIN ONCOL, V34, P588, DOI 10.1093/jjco/hyh110; Mitchell S, 2002, NEOPLASIA, V4, P9, DOI 10.1038/sj.neo.7900194; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; NAKAYAMA T, 1995, CANCER, V75, P2051, DOI 10.1002/1097-0142(19950415)75:8<2051::AID-CNCR2820750804>3.0.CO;2-4; Oetke C, 2003, BIOCHEM BIOPH RES CO, V308, P892, DOI 10.1016/S0006-291X(03)01471-2; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Paganuzzi M, 2003, ONCOLOGY-BASEL, V65, P52, DOI 10.1159/000071205; Radhakrishnan P, 2007, BIOCHEM BIOPH RES CO, V359, P457, DOI 10.1016/j.bbrc.2007.05.165; Rajabi H, 2011, PROSTATE, V71, P1299, DOI 10.1002/pros.21344; Salvini R, 2001, J BIOL CHEM, V276, P3564, DOI 10.1074/jbc.M006662200; Sato M, 1997, ANTICANCER RES, V17, P3505; Serpa J, 2006, CANCER LETT, V242, P191, DOI 10.1016/j.canlet.2005.11.009; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Sumikura S, 2003, CANCER LETT, V200, P77, DOI 10.1016/S0304-3835(03)00388-4; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tomlinson J, 2000, INT J ONCOL, V16, P347; Ugorski M, 2002, ACTA BIOCHIM POL, V49, P303; Wang QY, 2003, J EXP CLIN CANC RES, V22, P431; Yusa A, 2010, CANCER RES, V70, P4064, DOI 10.1158/0008-5472.CAN-09-2383; Zhang K, 1997, TUMOR BIOL, V18, P175, DOI 10.1159/000218028	60	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57416	10.1371/journal.pone.0057416	http://dx.doi.org/10.1371/journal.pone.0057416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451223	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800105
J	Romero, MD; Holmgren-Holm, F; Grasa, MD; Esteve, M; Remesar, X; Fernandez-Lopez, JA; Alemany, M				del Mar Romero, Maria; Holmgren-Holm, Fredrik; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria			Modulation in Wistar Rats of Blood Corticosterone Compartmentation by Sex and a Cafeteria Diet	PLOS ONE			English	Article							CORTISOL-BINDING AFFINITY; WHITE ADIPOSE-TISSUE; INSULIN-RESISTANCE; PROTEINASE-INHIBITORS; SERPIN SUPERFAMILY; METABOLIC SYNDROME; ABDOMINAL OBESITY; IN-VIVO; GLOBULIN; GLUCOCORTICOIDS	In the metabolic syndrome, glucocorticoid activity is increased, but circulating levels show little change. Most of blood glucocorticoids are bound to corticosteroid-binding globulin (CBG), which liver expression and circulating levels are higher in females than in males. Since blood hormones are also bound to blood cells, and the size of this compartment is considerable for androgens and estrogens, we analyzed whether sex or eating a cafeteria diet altered the compartmentation of corticosterone in rat blood. The main corticosterone compartment in rat blood is that specifically bound to plasma proteins, with smaller compartments bound to blood cells or free. Cafeteria diet increased the expression of liver CBG gene, binding plasma capacity and the proportion of blood cell-bound corticosterone. There were marked sex differences in blood corticosterone compartmentation in rats, which were unrelated to testosterone. The use of a monoclonal antibody ELISA and a polyclonal Western blot for plasma CBG compared with both specific plasma binding of corticosterone and CBG gene expression suggested the existence of different forms of CBG, with varying affinities for corticosterone in males and females, since ELISA data showed higher plasma CBG for males, but binding and Western blot analyses (plus liver gene expression) and higher physiological effectiveness for females. Good cross-reactivity to the antigen for polyclonal CBG antibody suggests that in all cases we were measuring CBG. The different immunoreactivity and binding affinity may help explain the marked sex-related differences in plasma hormone binding as sex-linked different proportions of CBG forms.	[del Mar Romero, Maria; Holmgren-Holm, Fredrik; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [del Mar Romero, Maria; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Inst Biomed, Barcelona, Spain; [del Mar Romero, Maria; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Inst Hlth Carlos III, CIBER Obes & Nutr, Madrid, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Alemany, M (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	malemany@ub.edu	Alemany, Marià/H-5224-2011; Remesar, Xavier/L-4555-2019; del Mar Romero, Maria/K-9004-2017; Esteve, Montserrat/L-6272-2014; Remesar, Xavier/G-5703-2013; Esteve, Montserrat/AAR-4146-2021; López, José Antonio Fernández/C-5467-2017; Grasa Martínez, Maria del Mar/L-8031-2014	Alemany, Marià/0000-0002-9783-8293; Remesar, Xavier/0000-0002-9707-7287; del Mar Romero, Maria/0000-0001-6274-5743; Esteve, Montserrat/0000-0003-2128-7859; Remesar, Xavier/0000-0002-9707-7287; Esteve, Montserrat/0000-0003-2128-7859; López, José Antonio Fernández/0000-0002-2856-7223; Grasa Martínez, Maria del Mar/0000-0001-6362-0504	Plan Nacional de Investigacion en Biomedicina [SAF2009-11739]; Plan Nacional de Ciencia y Tecnologia de los Alimentos [AGL-2011-23635]; Fondo de Investigaciones Sanitarias of the Government of Spain [PI09/00505]; CIBER (Centro de Investigacion Biomedica en Red) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Spain	Plan Nacional de Investigacion en Biomedicina; Plan Nacional de Ciencia y Tecnologia de los Alimentos; Fondo de Investigaciones Sanitarias of the Government of Spain; CIBER (Centro de Investigacion Biomedica en Red) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Spain	This study was funded by grants SAF2009-11739 of the Plan Nacional de Investigacion en Biomedicina, AGL-2011-23635 from the Plan Nacional de Ciencia y Tecnologia de los Alimentos and PI09/00505 from the Fondo de Investigaciones Sanitarias of the Government of Spain. The salary of M.M. Romero was funded by CIBER (Centro de Investigacion Biomedica en Red) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Spain. F. Holmgren-Holm was a visiting student with an Erasmus grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard Vincent, 2006, Metabolic Syndrome and Related Disorders, V4, P129, DOI 10.1089/met.2006.4.129; Alemany M, 2012, FRONTIERS ENDOCRINOL, V3; Alemany M, 2012, HORMONES, V11, P254; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burt MG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1426, DOI 10.1152/ajpendo.00524.2006; Cakir M, 2005, ENDOCR RES, V31, P213, DOI 10.1080/07435800500373199; CHADER GJ, 1968, J BIOL CHEM, V243, P928; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Cvoro A, 2011, J IMMUNOL, V186, P4354, DOI 10.4049/jimmunol.1002205; Davenport A.P., 1996, CURRENT DIRECTIONS R, P169, DOI DOI 10.1007/978-94-009-1768-2_11; Romero MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034381; Diederich S, 2002, J CLIN ENDOCR METAB, V87, P5695, DOI 10.1210/jc.2002-020970; Duclos M, 2005, OBES RES, V13, P1157, DOI 10.1038/oby.2005.137; Emptoz-Bonneton A, 2000, J CLIN ENDOCR METAB, V85, P361, DOI 10.1210/jc.85.1.361; Esteve M, 2012, OBESITY FACTS, V5, P118; Feldman D, 1979, AM J PHYSIOL, V287, pG493; Fernandez-Real JM, 2002, J CLIN ENDOCR METAB, V87, P4686, DOI 10.1210/jc.2001-011843; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; GALA RR, 1965, ENDOCRINOLOGY, V77, P841, DOI 10.1210/endo-77-5-841; Garrel DR, 1996, HORM RES, V45, P245, DOI 10.1159/000184796; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goldstein RE, 2002, AM J PHYSIOL-ENDOC M, V283, pE946, DOI 10.1152/ajpendo.00320.2002; Grasa MD, 2001, MOL CELL BIOCHEM, V228, P25, DOI 10.1023/A:1013304223967; Grasa MM, 2001, HORM METAB RES, V33, P407, DOI 10.1055/s-2001-16228; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; Hautanen A, 1997, J INTERN MED, V241, P451; Ibarrola I, 1996, BBA-BIOMEMBRANES, V1284, P41, DOI 10.1016/0005-2736(96)00110-1; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jirikowski GF, 2007, J CHEM NEUROANAT, V34, P22, DOI 10.1016/j.jchemneu.2007.03.007; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Komesaroff PA, 1999, J CLIN ENDOCR METAB, V84, P606, DOI 10.1210/jc.84.2.606; KUHN RW, 1988, ANN NY ACAD SCI, V538, P146; LEA OA, 1972, J STEROID BIOCHEMIST, V3, P409, DOI 10.1016/0022-4731(72)90087-8; Lewis JG, 2004, DIABETES OBES METAB, V6, P259, DOI 10.1111/j.1462-8902.2004.00343.x; Lewis JG, 2011, J STEROID BIOCHEM, V127, P289, DOI 10.1016/j.jsbmb.2011.08.006; MACADAMS MR, 1986, ANN INTERN MED, V104, P648, DOI 10.7326/0003-4819-104-5-648; Manco M, 2007, DIABETES CARE, V30, P1494, DOI 10.2337/dc06-1353; MAROTTA SF, 1975, HORM METAB RES, V7, P334, DOI 10.1055/s-0028-1093725; MATARADZE GD, 1992, J ENDOCRINOL, V132, P235, DOI 10.1677/joe.0.1320235; May RC, 1996, KIDNEY INT, V49, P679, DOI 10.1038/ki.1996.96; Natsui K, 2006, OSTEOPOROSIS INT, V17, P105, DOI 10.1007/s00198-005-1923-3; Ousova O, 2004, MOL ENDOCRINOL, V18, P1687, DOI 10.1210/me.2004-0005; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Perogamvros I, 2011, CLIN ENDOCRINOL, V74, P30, DOI 10.1111/j.1365-2265.2010.03897.x; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; Qian XX, 2011, ENDOCRINOLOGY, V152, P3738, DOI 10.1210/en.2011-1008; Reynolds RM, 2003, DIABETES OBES METAB, V5, P5, DOI 10.1046/j.1463-1326.2003.00221.x; RITZEN EM, 1971, ENDOCRINOLOGY, V89, P143; Romero MD, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-26; STRAIN GW, 1982, METABOLISM, V31, P209, DOI 10.1016/0026-0495(82)90054-3; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; VANBAELEN H, 1982, J BIOL CHEM, V257, P3397; VYTASEK R, 1982, ANAL BIOCHEM, V120, P243, DOI 10.1016/0003-2697(82)90342-6; Wang M, 2005, NUTR METAB, V2; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Wolf G, 2002, NUTR REV, V60, P148	59	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57342	10.1371/journal.pone.0057342	http://dx.doi.org/10.1371/journal.pone.0057342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451210	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800101
J	Monceau, V; Meziani, L; Strup-Perrot, C; Morel, E; Schmidt, M; Haagen, J; Escoubet, B; Dorr, W; Vozenin, MC				Monceau, Virginie; Meziani, Lydia; Strup-Perrot, Carine; Morel, Eric; Schmidt, Magret; Haagen, Julia; Escoubet, Brigitte; Doerr, Wolfgang; Vozenin, Marie-Catherine			Enhanced Sensitivity to Low Dose Irradiation of ApoE-/- Mice Mediated by Early Pro-Inflammatory Profile and Delayed Activation of the TGF beta 1 Cascade Involved in Fibrogenesis	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; INDUCED HEART-DISEASE; IONIZING-RADIATION; CARDIAC-FUNCTION; MORTALITY; RADIOTHERAPY; MECHANISMS; FIBROSIS; CANCER; CELLS	Aim: Investigating long-term cardiac effects of low doses of ionizing radiation is highly relevant in the context of interventional cardiology and radiotherapy. Epidemiological data report that low doses of irradiation to the heart can result in significant increase in the cardiovascular mortality by yet unknown mechanisms. In addition co-morbidity factor such as hypertension or/and atherosclerosis can enhance cardiac complications. Therefore, we explored the mechanisms that lead to long-term cardiac remodelling and investigated the interaction of radiation-induced damage to heart and cardiovascular systems with atherosclerosis, using wild-type and ApoE-deficient mice. Methods and Results: ApoE-/- and wild-type mice were locally irradiated to the heart at 0, 0.2 and 2 Gy (RX). Twenty, 40 and 60 weeks post-irradiation, echocardiography were performed and hearts were collected for cardiomyocyte isolation, histopathological analysis, study of inflammatory infiltration and fibrosis deposition. Common and strain-specific pathogenic pathways were found. Significant alteration of left ventricular function (eccentric hypertrophy) occurred in both strains of mice. Low dose irradiation (0.2 Gy) induced premature death in ApoE-/- mice (47% died at 20 weeks). Acute inflammatory infiltrate was observed in scarring areas with accumulation of M1-macrophages and secretion of IL-6. Increased expression of the fibrogenic factors (TGF-beta 1 and PAI-1) was measured earlier in cardiomyocytes isolated from ApoE-/- than in wt animals. Conclusion: The present study shows that cardiac exposure to low dose of ionizing radiation induce significant physiological, histopathological, cellular and molecular alterations in irradiated heart with mild functional impairment. Atherosclerotic predisposition precipitated cardiac damage induced by low doses with an early pro-inflammatory polarization of macrophages.	[Monceau, Virginie; Meziani, Lydia; Vozenin, Marie-Catherine] INSERM, U1030, Villejuif, France; [Monceau, Virginie; Meziani, Lydia; Vozenin, Marie-Catherine] Univ Paris 11, Le Kremlin Bicetre, France; [Monceau, Virginie; Meziani, Lydia; Vozenin, Marie-Catherine] Inst Gustave Roussy, Villejuif, France; [Monceau, Virginie; Strup-Perrot, Carine] LRTE SRBE DRPH, Inst Radioprtect & Surete Nucl, Fontenay Aux Roses, France; [Morel, Eric] INSERM, UMR S 769, Chatenay Malabry, France; [Schmidt, Magret; Haagen, Julia; Doerr, Wolfgang] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Radiotherapy & Radiat Oncol, Dresden, Germany; [Escoubet, Brigitte] Hop Bichat Claude Bernard, AP HP, Dept Physiol Explorat Fonct, F-75877 Paris, France; [Escoubet, Brigitte] Univ Paris 07, Paris, France; [Escoubet, Brigitte] INSERM, U872, Paris, France; [Doerr, Wolfgang] Med Univ, Dept Radiat Oncol, Vienna, Austria; [Doerr, Wolfgang] Med Univ, Christian Doppler Lab Med Radiat Res Radio Oncol, Vienna, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Monceau, V (corresponding author), INSERM, U1030, Villejuif, France.	virginie.monceau@igr.fr	Vozenin, Marie-Catherine/AAR-2268-2021; Doerr, Wolfgang/J-9344-2014	Vozenin, Marie-Catherine/0000-0002-2109-8073; Meziani, Lydia/0000-0002-1127-0183; Morel, Eric/0000-0001-6945-6442; Monceau, Virginie/0000-0002-1717-8935; Doerr, Wolfgang/0000-0003-1477-6849	CARDIORISK; European Commission (FP7); ANR [ANR-10-LABX-33]	CARDIORISK; European Commission (FP7)(European CommissionEuropean Commission Joint Research Centre); ANR(French National Research Agency (ANR))	This work was supported by CARDIORISK which is an Integrated Project funded by the European Commission (FP7-Fission-2007-3.1.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Olivia Bawa and Benoit Petit for excellent technical assistance in histology and IGR-SCEA for animal care. We thank Pr MJ McKay for critical reading of the MS and English edition. We thank the Department of LIPA for the use of ultrasonographic system (Aplio, Toshiba). Inserm U1030 is a member of the Laboratory of Excellence LERMIT supported by a grant from ANR (ANR-10-LABX-33).	Andratschke N, 2011, RADIOTHER ONCOL, V100, P160, DOI 10.1016/j.radonc.2010.08.010; Ashmore JP, 1998, AM J EPIDEMIOL, V148, P564, DOI 10.1093/oxfordjournals.aje.a009682; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Boerma M, 2005, CANCER RES, V65, P3100, DOI 10.1158/0008-5472.CAN-04-4333; Bouillon K, 2011, J AM COLL CARDIOL, V57, P445, DOI 10.1016/j.jacc.2010.08.638; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Cao TM, 2008, AM J HEMATOL, V83, P390, DOI 10.1002/ajh.21104; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; Fox JJ, 2013, NUCL ONCOLOGY, P763; Franken NAP, 1997, BRIT J RADIOL, V70, P1004, DOI 10.1259/bjr.70.838.9404203; Gabriels K, 2012, RADIOTHER ONCOL; Gervaz P, 2009, CURR MOL MED, V9, P273, DOI 10.2174/156652409787847164; Guldner L, 2006, RADIOTHER ONCOL, V81, P47, DOI 10.1016/j.radonc.2006.08.020; Haydont V, 2008, AM J PHYSIOL-CELL PH, V294, pC1332, DOI 10.1152/ajpcell.90626.2007; Hilbers FSM, 2012, RADIOTHER ONCOL, V102, P115, DOI 10.1016/j.radonc.2011.10.017; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Joiner MC, 2001, INT J RADIAT ONCOL, V49, P379, DOI 10.1016/S0360-3016(00)01471-1; KLONER RA, 1974, AM J PATHOL, V74, P399; Kreuzer M, 2006, RADIAT ENVIRON BIOPH, V45, P159, DOI 10.1007/s00411-006-0056-1; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Monceau V, 2010, CURR DRUG TARGETS, V11, P1395, DOI 10.2174/1389450111009011395; Nabeebaccus A, 2011, HEART FAIL REV, V16, P5, DOI 10.1007/s10741-010-9186-2; Pollick C, 1995, J Am Soc Echocardiogr, V8, P602, DOI 10.1016/S0894-7317(05)80373-6; Prech M, 2010, AM J CARDIOL, V105, P1240, DOI 10.1016/j.amjcard.2009.12.039; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Reinders JG, 1999, RADIOTHER ONCOL, V51, P35, DOI 10.1016/S0167-8140(99)00026-2; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SCHULTZHECTOR S, 1992, RADIAT RES, V129, P281, DOI 10.2307/3578027; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Zaman AKMT, 2009, EXP BIOL MED, V234, P246, DOI 10.3181/0811-RM-321	47	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57052	10.1371/journal.pone.0057052	http://dx.doi.org/10.1371/journal.pone.0057052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451141	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800067
J	Shi, K; Pandey, KK; Bera, S; Vora, AC; Grandgenett, DP; Aihara, H				Shi, Ke; Pandey, Krishan K.; Bera, Sibes; Vora, Ajaykumar C.; Grandgenett, Duane P.; Aihara, Hideki			A Possible Role for the Asymmetric C-Terminal Domain Dimer of Rous Sarcoma Virus Integrase in Viral DNA Binding	PLOS ONE			English	Article							HIV-1 INTEGRASE; RETROVIRAL INTEGRASE; CRYSTAL-STRUCTURE; TYPE-1 INTEGRASE; CATALYTIC CORE; PROTEIN; ORGANIZATION; MODEL; PHOSPHORYLATION; ARCHITECTURE	Integration of the retrovirus linear DNA genome into the host chromosome is an essential step in the viral replication cycle, and is catalyzed by the viral integrase (IN). Evidence suggests that IN functions as a dimer that cleaves a dinucleotide from the 3' DNA blunt ends while a dimer of dimers (tetramer) promotes concerted integration of the two processed ends into opposite strands of a target DNA. However, it remains unclear why a dimer rather than a monomer of IN is required for the insertion of each recessed DNA end. To help address this question, we have analyzed crystal structures of the Rous sarcoma virus (RSV) IN mutants complete with all three structural domains as well as its two-domain fragment in a new crystal form at an improved resolution. Combined with earlier structural studies, our results suggest that the RSV IN dimer consists of highly flexible N-terminal domains and a rigid entity formed by the catalytic and C-terminal domains stabilized by the well-conserved catalytic domain dimerization interaction. Biochemical and mutational analyses confirm earlier observations that the catalytic and the C-terminal domains of an RSV IN dimer efficiently integrates one viral DNA end into target DNA. We also show that the asymmetric dimeric interaction between the two C-terminal domains is important for viral DNA binding and subsequent catalysis, including concerted integration. We propose that the asymmetric C-terminal domain dimer serves as a viral DNA binding surface for RSV IN.	[Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Pandey, Krishan K.; Bera, Sibes; Vora, Ajaykumar C.; Grandgenett, Duane P.] St Louis Univ, Hlth Sci Ctr, Inst Mol Virol, St Louis, MO 63103 USA	University of Minnesota System; University of Minnesota Twin Cities; Saint Louis University	Aihara, H (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	aihar001@umn.edu		Pandey, Krishan/0000-0002-3973-9844; , Ke/0000-0003-4175-3714	National Institutes of Health [AI087098, AI081629]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087098, R33AI087098, R21AI081629, R21AI100682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the National Institutes of Health (NIH) grants AI087098 (HA), AI081629 (DG), and Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballandras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023032; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; BUSHMAN FD, 1994, J VIROL, V68, P2215, DOI 10.1128/JVI.68.4.2215-2223.1994; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Chiu R, 2003, J VIROL, V77, P6482, DOI 10.1128/JVI.77.11.6482-6492.2003; Craigie R, 2002, MOBILE DNA, P613; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; HIPPENMEYER PJ, 1984, VIROLOGY, V137, P358, DOI 10.1016/0042-6822(84)90228-9; HORTON R, 1991, J VIROL, V65, P1141, DOI 10.1128/JVI.65.3.1141-1148.1991; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Katz RA, 1996, VIROLOGY, V217, P178, DOI 10.1006/viro.1996.0105; KATZMAN M, 1989, J VIROL, V63, P5319, DOI 10.1128/JVI.63.12.5319-5327.1989; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; MUMM SR, 1992, J VIROL, V66, P1995, DOI 10.1128/JVI.66.4.1995-1999.1992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; Peletskaya E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027751; PyMOL, PYMOL MOL GRAPHICS S; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Vora AC, 1997, J BIOL CHEM, V272, P23938, DOI 10.1074/jbc.272.38.23938; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yao X, 2010, PROTEIN CELL, V1, P363, DOI 10.1007/s13238-010-0047-5; Zhou HB, 2001, J VIROL, V75, P1359, DOI 10.1128/JVI.75.3.1359-1370.2001	51	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56892	10.1371/journal.pone.0056892	http://dx.doi.org/10.1371/journal.pone.0056892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451105	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800045
J	Tveraa, T; Stien, A; Bardsen, BJ; Fauchald, P				Tveraa, Torkild; Stien, Audun; Bardsen, Bard-J.; Fauchald, Per			Population Densities, Vegetation Green-Up, and Plant Productivity: Impacts on Reproductive Success and Juvenile Body Mass in Reindeer	PLOS ONE			English	Article							LARGE HERBIVORES; CLIMATE-CHANGE; SVALBARD REINDEER; SPRING CONDITIONS; TROPHIC MISMATCH; LINKING CLIMATE; PHENOLOGY; NDVI; DYNAMICS; ALLOCATION	Global warming is expected to cause earlier springs and increased primary productivity in the Arctic. These changes may improve food availability for Arctic herbivores, but may also have negative effects by generating a mismatch between the surge of high quality food in the spring and the timing of reproduction. We analyzed a 10 year dataset of satellite derived measures of vegetation green-up, population densities, calf body masses and female reproductive success in 19 reindeer (Rangifer tarandus) populations in Northern Norway. An early onset of spring and high peak plant productivity had positive effects on calf autumn body masses and female reproductive success. In addition, body masses and reproductive success were both negatively related to population density. The quantity of food available, as determined by the onset of vegetation green-up and plant productivity over the summer were the main drivers of body mass growth and reproductive success. We found no evidence for an effect of the speed of spring green-up. Nor did we detect a negative mismatch between early springs and subsequent recruitment. Effects of global warming on plant productivity and onset of spring is likely to positively affect sub-Arctic reindeer.	[Tveraa, Torkild; Stien, Audun; Bardsen, Bard-J.; Fauchald, Per] NINA Norwegian Inst Nat Res, FRAM High North Res Ctr Climate & Environm, Tromso, Norway	Norwegian Institute Nature Research	Tveraa, T (corresponding author), NINA Norwegian Inst Nat Res, FRAM High North Res Ctr Climate & Environm, Tromso, Norway.	torkild.tveraa@nina.no	Bårdsen, Bård-Jørgen/B-6984-2015; Fauchald, Per/AAV-4242-2021	Bårdsen, Bård-Jørgen/0000-0001-6818-5249; Stien, Audun/0000-0001-8046-7337; Tveraa, Torkild/0000-0002-7501-3696	Norwegian Directorate of Nature Management	Norwegian Directorate of Nature Management	The work was financed by the Norwegian Directorate of Nature Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes R, 2002, ECOL LETT, V5, P445, DOI 10.1046/j.1461-0248.2002.00340.x; Aanes R, 2000, ECOGRAPHY, V23, P437, DOI 10.1034/j.1600-0587.2000.230406.x; Aanes R, 2003, CAN J ZOOL, V81, P103, DOI 10.1139/Z02-227; ACIA: Arctic Climate Impact Assessment, 2004, IMP WARM ARCT ARCT C; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; [Anonymous], 1999, NATL ATLAS NORWAY VE; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bardsen BJ, 2012, J ANIM ECOL, V81, P364, DOI 10.1111/j.1365-2656.2011.01913.x; Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; Beck PSA, 2007, INT J REMOTE SENS, V28, P4311, DOI 10.1080/01431160701241936; Beck PSA, 2006, REMOTE SENS ENVIRON, V100, P321, DOI 10.1016/j.rse.2005.10.021; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Busetto L, 2010, GLOBAL CHANGE BIOL, V16, P2504, DOI 10.1111/j.1365-2486.2010.02189.x; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Epstein HE, 2000, ECOL APPL, V10, P824, DOI 10.1890/1051-0761(2000)010[0824:ATNBMO]2.0.CO;2; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Forchhammer MC, 2002, POPUL ECOL, V44, P113, DOI 10.1007/s101440200013; Garel M, 2011, J MAMMAL, V92, P1112, DOI 10.1644/10-MAMM-A-056.1; Grotan V, 2009, OECOLOGIA, V161, P685, DOI 10.1007/s00442-009-1419-5; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Herfindal I, 2006, OECOLOGIA, V150, P213, DOI 10.1007/s00442-006-0519-8; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; NETELER M, 2002, OPEN SOURCE GIS GRAS; Paruelo JM, 1998, J BIOGEOGR, V25, P721, DOI 10.1046/j.1365-2699.1998.2540721.x; Pettorelli N, 2005, P ROY SOC B-BIOL SCI, V272, P2357, DOI 10.1098/rspb.2005.3218; Pettorelli N, 2005, BIOL LETT-UK, V1, P24, DOI 10.1098/rsbl.2004.0262; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pinheiro J, 2001, MIXED EFFECTS MODELS; Portier C, 1998, J ZOOL, V245, P271, DOI 10.1111/j.1469-7998.1998.tb00101.x; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2008, P ROY SOC B-BIOL SCI, V275, P2005, DOI 10.1098/rspb.2008.0463; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reimers E., 1983, RANGIFER, V3, P3, DOI DOI 10.7557/2.3.1.463; Sother B. E., 1997, TRENDS ECOL EVOL, V12, P143; Tews J, 2007, ECOL MODEL, V207, P85, DOI 10.1016/j.ecolmodel.2007.04.011; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	54	84	84	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56450	10.1371/journal.pone.0056450	http://dx.doi.org/10.1371/journal.pone.0056450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451049	Green Published, gold			2022-12-27	WOS:000316658800012
J	Ambroggio, X; Jiang, LB; Aebig, J; Obiakor, H; Lukszo, J; Narum, DL				Ambroggio, Xavier; Jiang, Lubin; Aebig, Joan; Obiakor, Harold; Lukszo, Jan; Narum, David L.			The Epitope of Monoclonal Antibodies Blocking Erythrocyte Invasion by Plasmodium falciparum Map to The Dimerization and Receptor Glycan Binding Sites of EBA-175	PLOS ONE			English	Article							SIALIC-ACID; ANTIGEN 175; MALARIA; PROTEIN; LIGAND; REGION; DOMAIN; PROTECTION; PATHWAYS; CRYSTAL	The malaria parasite, Plasmodium falciparum, and related parasites use a variety of proteins with Duffy-Binding Like (DBL) domains to bind glycoproteins on the surface of host cells. Among these proteins, the 175 kDa erythrocyte binding antigen, EBA-175, specifically binds to glycophorin A on the surface of human erythrocytes during the process of merozoite invasion. The domain responsible for glycophorin A binding was identified as region II (RII) which contains two DBL domains, F1 and F2. The crystal structure of this region revealed a dimer that is presumed to represent the glycophorin A binding conformation as sialic acid binding sites and large cavities are observed at the dimer interface. The dimer interface is largely composed of two loops from within each monomer, identified as the F1 and F2 beta-fingers that contact depressions in the opposing monomers in a similar manner. Previous studies have identified a panel of five monoclonal antibodies (mAbs) termed R215 to R218 and R256 that bind to RII and inhibit invasion of erythrocytes to varying extents. In this study, we predict the F2 beta-finger region as the conformational epitope for mAbs, R215, R217, and R256, and confirm binding for the most effective blocking mAb R217 and R215 to a synthetic peptide mimic of the F2 beta-finger. Localization of the epitope to the dimerization and glycan binding sites of EBA-175 RII and site-directed mutagenesis within the predicted epitope are consistent with R215 and R217 blocking erythrocyte invasion by Plasmodium falciparum by preventing formation of the EBA-175- glycophorin A complex.	[Ambroggio, Xavier] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA; [Jiang, Lubin] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Aebig, Joan; Obiakor, Harold; Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Lukszo, Jan] NIAID, Res Technol Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Narum, DL (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA.	dnarum@niaid.nih.gov		Narum, David/0000-0003-3041-5402	Phase II NIAID Small Business Innovative Research Grant from NIAID [AI36758]; Intramural Research Program of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI036758, R44AI036758] Funding Source: NIH RePORTER	Phase II NIAID Small Business Innovative Research Grant from NIAID; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by a Phase II NIAID Small Business Innovative Research Grant Number AI36758 supplement from NIAID and by the Intramural Research Program of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Jiang LB, 2009, MOL BIOCHEM PARASIT, V168, P49, DOI 10.1016/j.molbiopara.2009.06.006; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Li XR, 2012, MOL BIOCHEM PARASIT, V183, P23, DOI 10.1016/j.molbiopara.2012.01.002; Liang H, 1997, MOL BIOCHEM PARASIT, V84, P241, DOI 10.1016/S0166-6851(96)02791-0; Lin DH, 2012, J BIOL CHEM, V287, P36830, DOI 10.1074/jbc.M112.409276; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maruyama K, 1999, PEPTIDES, V20, P881, DOI 10.1016/S0196-9781(99)00076-5; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; McCarra MB, 2011, PEDIATR INFECT DIS J, V30, P1037, DOI 10.1097/INF.0b013e31822d1451; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Narum DL, 2009, MOL DESIGN RECOMBINA; Ockenhouse CF, 2001, MOL BIOCHEM PARASIT, V113, P9, DOI 10.1016/S0166-6851(00)00375-3; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Sim BKL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018393; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302	35	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56326	10.1371/journal.pone.0056326	http://dx.doi.org/10.1371/journal.pone.0056326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457550	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700040
J	Rui, T; Tang, QZ				Rui, Tao; Tang, Qizhu			IL-33 Attenuates Anoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Inhibition of PKC beta/JNK Pathway	PLOS ONE			English	Article							INDUCED MYOCARDIAL APOPTOSIS; ISCHEMIA-REPERFUSION INJURY; CARDIAC MYOCYTE APOPTOSIS; ACTIVATED PROTEIN-KINASES; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; PROINFLAMMATORY PHENOTYPE; DIABETIC COMPLICATIONS; TNF-ALPHA; HEART	Background: Interleukin-33 (IL-33) is a new member of the IL-1 cytokine family. The objectives of present study are to assess whether IL-33 can protect cardiomyocytes from anoxia/reoxygenation (A/R)-induced injury and the mechanism involved in the protection. Methods: Cardiomyocytes derived from either wild type or JNK1(-/-) mice were challenged with an A/R with or without IL-33. Myocyte apoptosis was assessed by measuring caspase 3 activity, fragmented DNA and TUNEL staining. In addition, cardiomyocyte oxidative stress was assessed by measuring DHR123 oxidation; PKC beta II and JNK phosphorylation were assessed with Western blot. Results: Challenge of cardiomyocytes with an A/R resulted in cardiomyocyte oxidative stress, PKC beta II and JNK phosphorylation, and myocyte apoptosis. Treatment of the cardiomyocytes with IL-33 attenuated the A/R-induced myocyte oxidative stress, prevented PKC beta II and JNK phosphorylation and attenuated the A/R-induced myocyte apoptosis. The protective effect of the IL-33 did not show in cardiac myocytes with siRNA specific to PKC beta II or myocytes deficient in JNK1. Inhibition of PKC beta II prevented the A/R-induced JNK phosphorylation, but inhibition of JNK1 showed no effect on A/R-induced PKC beta II phosphorylation. Conclusions: Our results indicate that IL-33 prevents the A/R-induced myocyte apoptosis through inhibition of PKC beta/JNK pathway.	[Rui, Tao; Tang, Qizhu] Wuhan Univ, Div Cardiol, Dept Med, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China; [Rui, Tao] Jiangsu Univ, Div Cardiol, Dept Med, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China; [Rui, Tao] Lawson Hlth Res Inst, London, ON, Canada; [Rui, Tao] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada	Wuhan University; Jiangsu University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Tang, QZ (corresponding author), Wuhan Univ, Div Cardiol, Dept Med, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China.	qztang@whu.edu.cn	Rui, Tao/H-7044-2016		National Natural Science Foundation of China [81170210]; Heart and Stroke Foundation of Ontario [GIA 000212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This study was supported by the following grants: National Natural Science Foundation of China (81170210) and Heart and Stroke Foundation of Ontario (GIA 000212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Harja E, 2009, FASEB J, V23, P1081, DOI 10.1096/fj.08-120345; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Karin M, 1996, PHILOS T ROY SOC B, V351, P127, DOI 10.1098/rstb.1996.0008; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kong L, 2008, AM J PHYSIOL-HEART C, V294, pH1862, DOI 10.1152/ajpheart.01346.2007; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Logue SE, 2005, J MOL CELL CARDIOL, V38, P21, DOI 10.1016/j.yjmcc.2004.11.009; Lopez-Bergami P, 2008, INT J BIOCHEM CELL B, V40, P1055, DOI 10.1016/j.biocel.2007.11.011; Michel MC, 2001, N-S ARCH PHARMACOL, V363, P245, DOI 10.1007/s002100000363; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rui T, 2005, FASEB J, V19, P1908, DOI 10.1096/fj.05-4028fje; Rui T, 2003, CARDIOVASC RES, V59, P901, DOI 10.1016/S0008-6363(03)00502-9; Rui T, 2001, AM J PHYSIOL-HEART C, V281, pH440, DOI 10.1152/ajpheart.2001.281.1.H440; Rui T, 2012, CARDIOVASC RES, V94, P370, DOI 10.1093/cvr/cvs015; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Yan SF, 2006, J AM COLL CARDIOL, V48, pA47, DOI 10.1016/j.jacc.2006.05.063; Yang M, 2008, AM J PHYSIOL-HEART C, V294, pH994, DOI 10.1152/ajpheart.01044.2007; Yao YW, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0267-3; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	31	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56089	10.1371/journal.pone.0056089	http://dx.doi.org/10.1371/journal.pone.0056089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457506	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700043
J	Antti, H; Fahlgren, A; Nasstrom, E; Kouremenos, K; Sunden-Cullberg, J; Guo, YZ; Moritz, T; Wolf-Watz, H; Johansson, A; Fallman, M				Antti, Henrik; Fahlgren, Anna; Nasstrom, Elin; Kouremenos, Konstantinos; Sunden-Cullberg, Jonas; Guo, YongZhi; Moritz, Thomas; Wolf-Watz, Hans; Johansson, Anders; Fallman, Maria			Metabolic Profiling for Detection of Staphylococcus aureus Infection and Antibiotic Resistance	PLOS ONE			English	Article							SEVERE SEPSIS; SEPTIC SHOCK; FATTY-ACIDS; BACTEREMIA; MORTALITY; ELEVATION; DISEASE; GROWTH	Due to slow diagnostics, physicians must optimize antibiotic therapies based on clinical evaluation of patients without specific information on causative bacteria. We have investigated metabolomic analysis of blood for the detection of acute bacterial infection and early differentiation between ineffective and effective antibiotic treatment. A vital and timely therapeutic difficulty was thereby addressed: the ability to rapidly detect treatment failures because of antibiotic-resistant bacteria. Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) were used in vitro and for infecting mice, while natural MSSA infection was studied in humans. Samples of bacterial growth media, the blood of infected mice and of humans were analyzed with combined Gas Chromatography/Mass Spectrometry. Multivariate data analysis was used to reveal the metabolic profiles of infection and the responses to different antibiotic treatments. In vitro experiments resulted in the detection of 256 putative metabolites and mice infection experiments resulted in the detection of 474 putative metabolites. Importantly, ineffective and effective antibiotic treatments were differentiated already two hours after treatment start in both experimental systems. That is, the ineffective treatment of MRSA using cloxacillin and untreated controls produced one metabolic profile while all effective treatment combinations using cloxacillin or vancomycin for MSSA or MRSA produced another profile. For further evaluation of the concept, blood samples of humans admitted to intensive care with severe sepsis were analyzed. One hundred thirty-three putative metabolites differentiated severe MSSA sepsis (n = 6) from severe Escherichia coli sepsis (n = 10) and identified treatment responses over time. Combined analysis of human, in vitro, and mice samples identified 25 metabolites indicative of effective treatment of S. aureus sepsis. Taken together, this study provides a proof of concept of the utility of analyzing metabolite patterns in blood for early differentiation between ineffective and effective antibiotic treatment in acute S. aureus infections.	[Antti, Henrik; Nasstrom, Elin] Umea Univ, Dept Chem, Umea, Sweden; [Fahlgren, Anna] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Umea, Sweden; [Johansson, Anders] Umea Univ, Dept Clin Microbiol, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden; [Sunden-Cullberg, Jonas] Karolinska Univ Hosp, Karolinska Inst, Ctr Infect Med, Dept Med F59, Stockholm, Sweden; [Guo, YongZhi] SLU, Fac Vet Med & Agr Sci, Div Reprod, Dept Clin Sci, Uppsala, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Wolf-Watz, Hans; Fallman, Maria] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden	Umea University; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University	Johansson, A (corresponding author), Umea Univ, Dept Clin Microbiol, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden.	anders.johansson@climi.umu.se; maria.fallman@molbiol.umu.se	Johansson, Anders/H-9362-2017; Johansson, Anders/D-2928-2012; Sundén-Cullberg, Jonas/AAW-5210-2020	Johansson, Anders/0000-0003-0548-5943; Johansson, Anders/0000-0003-0548-5943; Sundén-Cullberg, Jonas/0000-0002-8189-4960; Moritz, Thomas/0000-0002-4258-3190; Nasstrom, Elin/0000-0001-6499-3281; Kouremenos, Konstantinos/0000-0002-0625-2044	VINNOVA; Swedish Governmental Agency for Innovation Systems; Swedish Research Council [2010-4284, K2011-56X-11222-17-6]; Vasterbotten County Council Centrala ALF; Stockholm County Council ALF-medel	VINNOVA(Vinnova); Swedish Governmental Agency for Innovation Systems(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vasterbotten County Council Centrala ALF; Stockholm County Council ALF-medel(Stockholm County Council)	This work was funded by VINNOVA, the Swedish Governmental Agency for Innovation Systems (HA AJ); the the Swedish Research Council VR Dnr: 2010-4284 (HA MF) and K2011-56X-11222-17-6 (MF); Vasterbotten County Council Centrala ALF (AJ); and Stockholm County Council ALF-medel (JSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Antunes LCM, 2011, J BACTERIOL, V193, P4719, DOI 10.1128/JB.05132-11; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chan, 2012, ANTIMICROBIAL RESIST; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Hanberger H, 2011, INT J ANTIMICROB AG, V38, P331, DOI 10.1016/j.ijantimicag.2011.05.013; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Mandell GL, 2010, MANDELL DOUGLAS BENN; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; Thatcher JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3119tr3; Walker B, 2009, SCIENCE, V325, P1345, DOI 10.1126/science.1175325; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	27	27	27	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56971	10.1371/journal.pone.0056971	http://dx.doi.org/10.1371/journal.pone.0056971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451124	gold, Green Published			2022-12-27	WOS:000316849500048
J	Daniels, AH; Paller, DJ; Koruprolu, S; Palumbo, MA; Crisco, JJ				Daniels, Alan H.; Paller, David J.; Koruprolu, Sarath; Palumbo, Mark A.; Crisco, Joseph J.			Dynamic Biomechanical Examination of the Lumbar Spine with Implanted Total Spinal Segment Replacement (TSSR) Utilizing a Pendulum Testing System	PLOS ONE			English	Article							TOTAL DISC REPLACEMENT; INVESTIGATIONAL DEVICE EXEMPTION; CHARITE ARTIFICIAL DISC; PRODISC-L; DISPLACEMENT; ARTHRODESIS; KINEMATICS; COMPONENTS; STIFFNESS; BEHAVIOR	Background: Biomechanical investigations of spinal motion preserving implants help in the understanding of their in vivo behavior. In this study, we hypothesized that the lumbar spine with implanted total spinal segment replacement (TSSR) would exhibit decreased dynamic stiffness and more rapid energy absorption compared to native functional spinal units under simulated physiologic motion when tested with the pendulum system. Methods: Five unembalmed, frozen human lumbar functional spinal units were tested on the pendulum system with axial compressive loads of 181 N, 282 N, 385 N, and 488 N before and after Flexuspine total spinal segment replacement implantation. Testing in flexion, extension, and lateral bending began by rotating the pendulum to 5 degrees; resulting in unconstrained oscillatory motion. The number of rotations to equilibrium was recorded and bending stiffness (N-m/degrees) was calculated and compared for each testing mode. Results: The total spinal segment replacement reached equilibrium with significantly fewer cycles to equilibrium compared to the intact functional spinal unit at all loads in flexion (p<0.011), and at loads of 385 N and 488 N in lateral bending (p<0.020). Mean bending stiffness in flexion, extension, and lateral bending increased with increasing load for both the intact functional spinal unit and total spinal segment replacement constructs (p<0.001), with no significant differences in stiffness between the intact functional spinal unit and total spinal segment replacement in any of the test modes (p>0.18). Conclusions: Lumbar functional spinal units with implanted total spinal segment replacement were found to have similar dynamic bending stiffness, but absorbed energy at a more rapid rate than intact functional spinal units during cyclic loading with an unconstrained pendulum system. Although the effects on clinical performance of motion preserving devices is not fully known, these results provide further insight into the biomechanical behavior of this device under approximated physiologic loading conditions.	[Daniels, Alan H.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; Rhode Isl Hosp, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Daniels, AH (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA.	alandanielsmd@gmail.com	Koruprolu, Sarath C/A-3825-2017	Koruprolu, Sarath C/0000-0003-4036-3212; Crisco, Joseph/0000-0002-8786-0905	RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by the RIH Orthopaedic Foundation. Flexuspine provided the implants for the investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WM, 2009, SPINE, V34, pE716, DOI 10.1097/BRS.0b013e3181ae23d1; Chung SK, 2009, SPINE, V34, P1281, DOI 10.1097/BRS.0b013e3181a4ec2d; Crisco JJ, 2007, J BIOMECH, V40, P2767, DOI 10.1016/j.jbiomech.2006.12.013; Cunningham BW, 2009, SPINE J, V9, P735, DOI 10.1016/j.spinee.2009.03.011; Cunningham BW, 2003, SPINE, V28, pS110, DOI 10.1097/01.BRS.0000092209.27573.90; Daniels AH, 2012, SPINE PHILA PA 1976; Davis R, 2012, 12 ANN M INT SOC ADV; Delamarter R, 2011, J BONE JOINT SURG AM, V93A, P705, DOI [10.2106/JBJS.I.00680, 10.2106/JBJS.1.00680]; Demetropoulos CK, 2010, SPINE, V35, P26, DOI 10.1097/BRS.0b013e3181c4eb9a; EDWARDS WT, 1987, J BIOMECH ENG-T ASME, V109, P35, DOI 10.1115/1.3138639; Ferguson SJ, 2003, EUR SPINE J, V12, pS97, DOI 10.1007/s00586-003-0621-0; Gardner-Morse MG, 2004, J BIOMECH, V37, P205, DOI 10.1016/j.jbiomech.2003.10.003; Goel VK, 2005, SPINE, V30, P2755, DOI 10.1097/01.brs.0000195897.17277.67; GOEL VK, 1995, SPINE, V20, P2354, DOI 10.1097/00007632-199511000-00017; GOEL VK, 1985, SPINE, V10, P543, DOI 10.1097/00007632-198507000-00008; GOEL VK, 1988, SPINE, V13, P294, DOI 10.1097/00007632-198803000-00012; GOEL VK, 1994, J BIOMECH ENG-T ASME, V116, P377, DOI 10.1115/1.2895787; Grassmann S, 1998, SPINE, V23, P1155, DOI 10.1097/00007632-199805150-00016; Guyer RD, 2009, SPINE J, V9, P374, DOI 10.1016/j.spinee.2008.08.007; Harrop JS, 2008, SPINE, V33, P1701, DOI 10.1097/BRS.0b013e31817bb956; Holm S, 2007, VET COMP ORTHOPAED, V20, P29; Izambert O, 2003, EUR SPINE J, V12, P562, DOI 10.1007/s00586-003-0569-0; Kosmopoulos V, 2009, EUR SPINE J, V18, P59, DOI 10.1007/s00586-008-0828-1; MILLER JAA, 1986, J BIOMECH, V19, P79, DOI 10.1016/0021-9290(86)90111-9; NACHEMSON A, 1979, SPINE, V4, P513, DOI 10.1097/00007632-197911000-00011; PANJABI MM, 1977, ORTHOP CLIN N AM, V8, P169; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413, DOI 10.2106/00004623-199403000-00012; Rawlinson JJ, 2007, J NEUROSURG-SPINE, V7, P165, DOI 10.3171/SPI-07/08/166; Rohlmann A, 2011, EUR SPINE J; Rohlmann A, 2009, EUR SPINE J, V18, P89, DOI 10.1007/s00586-008-0836-1; Rousseau Marc-Antoine, 2006, Spine J, V6, P258, DOI 10.1016/j.spinee.2005.07.004; Schmidt H, 2010, EUR SPINE J; Spenciner David, 2006, Spine J, V6, P248, DOI 10.1016/j.spinee.2005.08.020; Tang SJ, 2011, J ORTHOP SCI, V16, P221, DOI 10.1007/s00776-011-0037-3; White A.A., 1990, CLIN BIOMECH; Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014; Yue J.J., 2008, MOTION PRESERVATION	37	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57412	10.1371/journal.pone.0057412	http://dx.doi.org/10.1371/journal.pone.0057412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451222	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500100
J	Feldmann, R; Geikowski, A; Weidner, C; Witzke, A; Kodelja, V; Schwarz, T; Gabriel, M; Erker, T; Sauer, S				Feldmann, Radmila; Geikowski, Anne; Weidner, Christopher; Witzke, Annabell; Kodelja, Vitam; Schwarz, Thomas; Gabriel, Mario; Erker, Thomas; Sauer, Sascha			Foam Cell Specific LXR alpha Ligand	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; ATHEROSCLEROSIS; MACROPHAGES; MICE	Objective: The liver X receptor alpha (LXR alpha) is a ligand-dependent nuclear receptor and the major regulator of reverse cholesterol transport in macrophages. This makes it an interesting target for mechanistic study and treatment of atherosclerosis. Methods and Results: We optimized a promising stilbenoid structure (STX4) in order to reach nanomolar effective concentrations in LXR alpha reporter-gene assays. STX4 displayed the unique property to activate LXR alpha effectively but not its subtype LXR beta. The potential of STX4 to increase transcriptional activity as an LXR alpha ligand was tested with gene expression analyses in THP1-derived human macrophages and oxLDL-loaded human foam cells. Only in foam cells but not in macrophage cells STX4 treatment showed athero-protective effects with similar potency as the synthetic LXR ligand T0901317 (T09). Surprisingly, combinatorial treatment with STX4 and T09 resulted in an additive effect on reporter-gene activation and target gene expression. In physiological tests the cellular content of total and esterified cholesterol was significantly reduced by STX4 without the undesirable increase in triglyceride levels as observed for T09. Conclusions: STX4 is a new LXR alpha-ligand to study transcriptional regulation of anti-atherogenic processes in cell or ex vivo models, and provides a promising lead structure for pharmaceutical development.	[Feldmann, Radmila; Geikowski, Anne; Weidner, Christopher; Witzke, Annabell; Kodelja, Vitam; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany; [Feldmann, Radmila] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Geikowski, Anne] Beuth Univ Appl Sci, Dept Life Sci & Technol, Berlin, Germany; [Schwarz, Thomas; Gabriel, Mario; Erker, Thomas] Univ Vienna, Dept Med Chem, Vienna, Austria	Max Planck Society; Free University of Berlin; University of Vienna	Sauer, S (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.	sauer@molgen.mpg.de		Schwarz, Thomas/0000-0002-1951-9676; Plauth, Annabell/0000-0002-4521-1368	BMBF [0315082]; NGFN [01 GS 0828]; European Union (FP7) [262055]; Max Planck Society; Hochschuljubilaumsstiftung of the City Vienna [H2158/2010]	BMBF(Federal Ministry of Education & Research (BMBF)); NGFN; European Union (FP7)(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Hochschuljubilaumsstiftung of the City Vienna	This work is supported by the BMBF (grant number 0315082), the NGFN (grant number 01 GS 0828), the European Union (FP7/2007-2013], under grant agreement no 262055 (ESGI)), and the Max Planck Society. The financial support from the Hochschuljubilaumsstiftung of the City Vienna (project number H2158/2010) is greatly appreciated for the synthetic part of the study (T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Bischoff ED, 2010, J LIPID RES, V51, P900, DOI [10.1194/jlr.M900096-JLR200, 10.1194/jlr.M900096]; Chinetti-Gbaguidi G, 2009, BBA-MOL CELL BIOL L, V1791, P486, DOI 10.1016/j.bbalip.2009.01.009; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Fievet C, 2009, BIOCHEM PHARMACOL, V77, P1316, DOI 10.1016/j.bcp.2008.11.026; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabas I, 2011, NAT MED, V17, P791, DOI 10.1038/nm0711-791; Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109; Zanotti I, 2008, J LIPID RES, V49, P954, DOI 10.1194/jlr.M700254-JLR200	17	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57311	10.1371/journal.pone.0057311	http://dx.doi.org/10.1371/journal.pone.0057311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451202	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000316849500087
J	Cashins, SD; Grogan, LF; McFadden, M; Hunter, D; Harlow, PS; Berger, L; Skerratt, LF				Cashins, Scott D.; Grogan, Laura F.; McFadden, Michael; Hunter, David; Harlow, Peter S.; Berger, Lee; Skerratt, Lee F.			Prior Infection Does Not Improve Survival against the Amphibian Disease Chytridiomycosis	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; IMMUNE DEFENSES; FROG; SKIN; RESISTANCE; DYNAMICS; DECLINES; CONSERVATION; VACCINATION	Many amphibians have declined globally due to introduction of the pathogenic fungus Batrachochytrium dendrobatidis (Bd). Hundreds of species, many in well-protected habitats, remain as small populations at risk of extinction. Currently the only proven conservation strategy is to maintain species in captivity to be reintroduced at a later date. However, methods to abate the disease in the wild are urgently needed so that reintroduced and wild animals can survive in the presence of Bd. Vaccination has been widely suggested as a potential strategy to improve survival. We used captive-bred offspring of critically endangered booroolong frogs (Litoria booroolongensis) to test if vaccination in the form of prior infection improves survival following re exposure. We infected frogs with a local Bd isolate, cleared infection after 30 days (d) using itraconazole just prior to the onset of clinical signs, and then re-exposed animals to Bd at 110 d. We found prior exposure had no effect on survival or infection intensities, clearly showing that real infections do not stimulate a protective adaptive immune response in this species. This result supports recent studies suggesting Bd may evade or suppress host immune functions. Our results suggest vaccination is unlikely to be useful in mitigating chytridiomycosis. However, survival of some individuals from all experimental groups indicates existence of protective innate immunity. Understanding and promoting this innate resistance holds potential for enabling species recovery.	[Cashins, Scott D.; Grogan, Laura F.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [McFadden, Michael; Harlow, Peter S.] Taronga Conservat Soc Australia, Herpetofauna Div, Mosman, NSW, Australia; [Hunter, David] New South Wales Off Environm & Heritage, Biodivers Conservat Sect, Queanbeyan, Australia	James Cook University; Office of Environment & Heritage - New South Wales	Cashins, SD (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia.	scashins@gmail.com	Skerratt, Lee Francis/L-2797-2013; Grogan, Laura F/G-4047-2015	Grogan, Laura F/0000-0002-2553-7598; McFadden, Michael/0000-0001-6811-8505; Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439; Hunter, David/0000-0002-7330-7500	Australian Department of Sustainability, Environment, Water, Population and Communities (SEWPaC); Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease (AB-CRC); Australian Research Council (ARC) Linkage Grant [LP110200240]; Taronga Conservation Society (TCS); New South Wales Office of Environment and Heritage; Wilson HTM Foundation; SITA Australia's	Australian Department of Sustainability, Environment, Water, Population and Communities (SEWPaC)(Australian Government); Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease (AB-CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council (ARC) Linkage Grant(Australian Research Council); Taronga Conservation Society (TCS); New South Wales Office of Environment and Heritage; Wilson HTM Foundation; SITA Australia's	This work was jointly funded by the Australian Department of Sustainability, Environment, Water, Population and Communities (SEWPaC), the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease (AB-CRC), Australian Research Council (ARC) Linkage Grant LP110200240, Taronga Conservation Society (TCS), New South Wales Office of Environment and Heritage and Wilson HTM Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge SITA Australia's funding to amphibian conservation which helped enable this research.	Agnandji ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018559; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Berger Lee, 2009, Amphibian Biology, V8, P2986; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; Cassone A, 2008, LANCET INFECT DIS, V8, P114, DOI 10.1016/S1473-3099(08)70016-1; Chai LYA, 2009, INFECT IMMUN, V77, P2184, DOI 10.1128/IAI.01455-08; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; Garland S, 2009, DIS AQUAT ORGAN, P1; Hero J-M, 2011, IUCN 2011 IUCN RED L; Hunter DA, 2010, DIS AQUAT ORGAN, V92, P209, DOI 10.3354/dao02118; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kurtz J, 2007, ANIM CONSERV, V10, P422, DOI 10.1111/j.1469-1795.2007.00149.x; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lindenmayer D, 2010, CONSERV BIOL, V24, P1459, DOI 10.1111/j.1523-1739.2010.01544.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Nichols D.K., 2000, P GETT JUMP AMPH DIS, P51; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Robbins AH, 1998, J AM VET MED ASSOC, V213, P1407; Rocke TE, 2008, J WILDLIFE DIS, V44, P1; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soorae PS, 2010, GLOBAL REINTRODUCTIO, pxii; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stockwell M. P., 2008, Australian Zoologist, V34, P379; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; VIGGERS KL, 1993, WILDLIFE RES, V20, P687, DOI 10.1071/WR9930687; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Waters H, 2011, NAT MED, V17, P1329, DOI 10.1038/nm1111-1329b; White A.W., 2006, Herpetofauna (Sydney), V36, P93; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	53	50	50	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56747	10.1371/journal.pone.0056747	http://dx.doi.org/10.1371/journal.pone.0056747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451076	gold, Green Accepted, Green Published			2022-12-27	WOS:000316658800031
J	Curseu, PL; Jansen, RJG; Chappin, MMH				Curseu, Petru Lucian; Jansen, Rob J. G.; Chappin, Maryse M. H.			Decision Rules and Group Rationality: Cognitive Gain or Standstill?	PLOS ONE			English	Article							DIVERSITY; PERFORMANCE; DISPARITY; VARIETY	Recent research in group cognition points towards the existence of collective cognitive competencies that transcend individual group members' cognitive competencies. Since rationality is a key cognitive competence for group decision making, and group cognition emerges from the coordination of individual cognition during social interactions, this study tests the extent to which collaborative and consultative decision rules impact the emergence of group rationality. Using a set of decision tasks adapted from the heuristics and biases literature, we evaluate rationality as the extent to which individual choices are aligned with a normative ideal. We further operationalize group rationality as cognitive synergy (the extent to which collective rationality exceeds average or best individual rationality in the group), and we test the effect of collaborative and consultative decision rules in a sample of 176 groups. Our results show that the collaborative decision rule has superior synergic effects as compared to the consultative decision rule. The ninety one groups working in a collaborative fashion made more rational choices (above and beyond the average rationality of their members) than the eighty five groups working in a consultative fashion. Moreover, the groups using a collaborative decision rule were closer to the rationality of their best member than groups using consultative decision rules. Nevertheless, on average groups did not outperformed their best member. Therefore, our results reveal how decision rules prescribing interpersonal interactions impact on the emergence of collective cognitive competencies. They also open potential venues for further research on the emergence of collective rationality in human decision-making groups.	[Curseu, Petru Lucian; Jansen, Rob J. G.; Chappin, Maryse M. H.] Tilburg Univ, Dept Org Studies, NL-5000 LE Tilburg, Netherlands; [Curseu, Petru Lucian; Chappin, Maryse M. H.] Tilburg Univ, Ctr Innovat Res, NL-5000 LE Tilburg, Netherlands	Tilburg University; Tilburg University	Curseu, PL (corresponding author), Tilburg Univ, Dept Org Studies, NL-5000 LE Tilburg, Netherlands.	P.L.Curseu@uvt.nl	Curseu, Petru Lucian/AAD-5084-2019; Jansen, Rob/B-1939-2012; Chappin, Maryse/N-4387-2013; Curseu, Petru Lucian/H-7620-2012	Curseu, Petru Lucian/0000-0003-0067-6310; Jansen, Rob/0000-0003-1922-7961; Chappin, Maryse/0000-0001-6247-1930; Curseu, Petru Lucian/0000-0003-0067-6310				Akdere M, 2011, TOTAL QUAL MANAG BUS, V22, P1317, DOI 10.1080/14783363.2011.625180; Curseu P, 2012, MANAGE DECIS, V50, P1062, DOI 10.1108/00251741211238337; Curseu PL, 2007, GROUP DYN-THEOR RES, V11, P187, DOI 10.1037/1089-2699.11.3.187; Curseu PL, 2013, INT J HEALTH PLAN M, V28, P238, DOI 10.1002/hpm.2130; Curseu PL, 2012, EDUC PSYCHOL MEAS, V72, P1053, DOI 10.1177/0013164412448066; Curseu PL, 2006, STUD PSYCHOL, V48, P141; Edwards SC, 2009, P ROY SOC B-BIOL SCI, V276, P3655, DOI 10.1098/rspb.2009.0981; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Hackman J. R., 1987, HDB ORG BEHAV; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Hinsz VB, 1997, PSYCHOL BULL, V121, P43, DOI 10.1037/0033-2909.121.1.43; Hinsz VB, 2004, TEAM COGNITION UNDER, P33, DOI DOI 10.1037/10690-003; Huber GP, 2010, ACAD MANAGE REV, V35, P6, DOI 10.5465/AMR.2010.45577787; Katsikopoulos KV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015505; Katsikopoulos KV, 2010, JUDGM DECIS MAK, V5, P244; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Larson JR, 2007, SMALL GR RES, V38, P413, DOI 10.1177/1046496407301972; Larson JR., 2010, SEARCH SYNERGY SMALL; Luan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031043; Nicolis SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018901; Parker AM, 2005, J BEHAV DECIS MAKING, V18, P1, DOI 10.1002/bdm.481; Reimer T, 2004, COGNITIVE SCI, V28, P1009, DOI 10.1016/j.cogsci.2004.06.004; Roberts ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022377; Sasaki T, 2012, CURR BIOL, V22, pR827, DOI 10.1016/j.cub.2012.07.058; Sasaki T, 2011, BEHAV ECOL, V22, P276, DOI 10.1093/beheco/arq198; Shafir E, 2002, ANNU REV PSYCHOL, V53, P491, DOI 10.1146/annurev.psych.53.100901.135213; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Tost LP, 2013, ACAD MANAGE J, V56, P1465, DOI 10.5465/amj.2011.0180; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; WATSON W, 1991, J APPL PSYCHOL, V76, P803, DOI 10.1037/0021-9010.76.6.803; Woodley MA, 2011, INTELLIGENCE, V39, P79, DOI 10.1016/j.intell.2011.01.004; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	32	29	29	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56454	10.1371/journal.pone.0056454	http://dx.doi.org/10.1371/journal.pone.0056454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451050	Green Published, gold			2022-12-27	WOS:000316658800013
J	Jia, LF; Wei, SB; Gong, K; Gan, YH; Yu, GY				Jia, Ling-fei; Wei, Su-bi; Gong, Kai; Gan, Ye-hua; Yu, Guang-yan			Prognostic Implications of MicoRNA miR-195 Expression in Human Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							CHROMOSOME 11Q13 AMPLIFICATION; SUPPRESSES TUMORIGENICITY; HEPATOCELLULAR-CARCINOMA; GENE AMPLIFICATION; PROMOTES APOPTOSIS; BCL-2 EXPRESSION; POOR-PROGNOSIS; CYCLIN D1; MICRORNA; CANCER	Background: miR-195 is aberrantly expressed in multiple types of disease. But little is known about the dysregulation of miR-195 in tongue squamous cell carcinoma (TSCC). In this study, we investigated the roles of miR-195 in the development and progression of TSCC. Methods: Using quantitative reverse transcription-polymerase chain reaction (qRT-PCR), we evaluated miR-195 expression in TSCC samples from 81 patients. Overall survival of these patients was examined using Kaplan-Meier curves with log-rank tests and the Cox proportional hazards model. The expression of two known miR-195 target genes, Cyclin D1 and Bcl-2, was also examined in the TSCC samples by immunohistochemistry. The effects of miR-195 overexpression on cell cycle progression and apoptosis and its effects on the expression of Cyclin D1 and Bcl-2 were examined in transfected TSCC cell lines (SCC-15 and Cal27) using fluorescence-activated cell sorting assays, luciferase reporter assays, and Western blots. Results: Reduced miR-195 expression was associated with tumor size and the clinical stage of TSCC tumors. Kaplan-Meier survival analysis indicated that the TSCC patients with reduced expression of miR-195 had poor overall survival and in multivariable analyses low levels of miR-195 emerged as an independent prognostic factor for this clinical outcome. Levels of miR-195 expression were inversely correlated with the expression of Cyclin D1 and Bcl-2. Overexpression of miR-195 inhibited cell cycle progression, promoted apoptosis, and reduced Cyclin D1 and Bcl-2 expression in two TSCC cell lines. Conclusions: miR-195 may have potential applications as a prognostic factor for TSCC patients.	[Jia, Ling-fei; Yu, Guang-yan] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Wei, Su-bi] Tsinghua Univ, Med Syst Biol Res Ctr, Beijing 100084, Peoples R China; [Gong, Kai] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China; [Gan, Ye-hua] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Tsinghua University; Tsinghua University; Peking University	Gan, YH (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	kqyehuagan@bjmu.edu.cn; gyyu@263.net						Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell RB, 2007, J ORAL MAXIL SURG, V65, P229, DOI 10.1016/j.joms.2005.11.094; Bova RJ, 1999, CLIN CANCER RES, V5, P2810; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Coutinho-Camillo CM, 2010, HISTOPATHOLOGY, V57, P304, DOI 10.1111/j.1365-2559.2010.03621.x; Davidson BJ, 1996, HEAD NECK-J SCI SPEC, V18, P512, DOI 10.1002/(SICI)1097-0347(199611/12)18:6<512::AID-HED5>3.3.CO;2-7; de Vicente JC, 2006, J ORAL PATHOL MED, V35, P140; Edge SB, 2010, AJCC CANC STAGING MA; ELNAGGAR AK, 1995, CYTOMETRY, V21, P47, DOI 10.1002/cyto.990210110; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; He JF, 2011, J BIOCHEM MOL TOXIC, V25, P404, DOI 10.1002/jbt.20396; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; LEONARD JH, 1991, INT J CANCER, V48, P511, DOI 10.1002/ijc.2910480406; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li LJ, 2003, J CELL SCI, V116, P3687, DOI 10.1242/jcs.00644; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; MARX J, 1994, SCIENCE, V263, P319, DOI 10.1126/science.8278804; MEREDITH SD, 1995, ARCH OTOLARYNGOL, V121, P790; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Popovic B, 2007, ANN NY ACAD SCI, V1095, P19, DOI 10.1196/annals.1397.003; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaw RJ, 2009, BRIT J ORAL MAX SURG, V47, P356, DOI 10.1016/j.bjoms.2008.09.017; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; WILLIAMS ME, 1993, ARCH OTOLARYNGOL, V119, P1238; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu YW, 2010, J NEUROSCI, V30, P8710, DOI 10.1523/JNEUROSCI.6323-09.2010; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yao L, 1999, ORAL ONCOL, V35, P56, DOI 10.1016/S1368-8375(98)00055-4; Yuen APW, 2002, HEAD NECK-J SCI SPEC, V24, P513, DOI 10.1002/hed.10094; Yuen PW, 1998, AM J SURG, V175, P242, DOI 10.1016/S0002-9610(97)00282-1	47	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56634	10.1371/journal.pone.0056634	http://dx.doi.org/10.1371/journal.pone.0056634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451060	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800021
J	Wu, CC; Lin, YH; Lu, YC; Chen, PJ; Yang, WS; Hsu, CJ; Chen, PL				Wu, Chen-Chi; Lin, Yin-Hung; Lu, Ying-Chang; Chen, Pei-Jer; Yang, Wei-Shiung; Hsu, Chuan-Jen; Chen, Pei-Lung			Application of Massively Parallel Sequencing to Genetic Diagnosis in Multiplex Families with Idiopathic Sensorineural Hearing Impairment	PLOS ONE			English	Article							MYOSIN-VIIA GENE; ENLARGED VESTIBULAR AQUEDUCT; CONNEXIN-26 GJB2 GENE; PALMOPLANTAR KERATODERMA; MUTATION SPECTRUM; DEAFNESS GENES; CHILDREN; VARIANTS; PERFORMANCE; ANNOTATION	Despite the clinical utility of genetic diagnosis to address idiopathic sensorineural hearing impairment (SNHI), the current strategy for screening mutations via Sanger sequencing suffers from the limitation that only a limited number of DNA fragments associated with common deafness mutations can be genotyped. Consequently, a definitive genetic diagnosis cannot be achieved in many families with discernible family history. To investigate the diagnostic utility of massively parallel sequencing (MPS), we applied the MPS technique to 12 multiplex families with idiopathic SNHI in which common deafness mutations had previously been ruled out. NimbleGen sequence capture array was designed to target all protein coding sequences (CDSs) and 100 bp of the flanking sequence of 80 common deafness genes. We performed MPS on the Illumina HiSeq2000, and applied BWA, SAMtools, Picard, GATK, Variant Tools, ANNOVAR, and IGV for bioinformatics analyses. Initial data filtering with allele frequencies (<5% in the 1000 Genomes Project and 5400 NHLBI exomes) and PolyPhen2/SIFT scores (>0.95) prioritized 5 indels (insertions/deletions) and 36 missense variants in the 12 multiplex families. After further validation by Sanger sequencing, segregation pattern, and evolutionary conservation of amino acid residues, we identified 4 variants in 4 different genes, which might lead to SNHI in 4 families compatible with autosomal dominant inheritance. These included GJB2 p.R75Q, MYO7A p.T381M, KCNQ4 p.S680F, and MYH9 p.E1256K. Among them, KCNQ4 p.S680F and MYH9 p.E1256K were novel. In conclusion, MPS allows genetic diagnosis in multiplex families with idiopathic SNHI by detecting mutations in relatively uncommon deafness genes.	[Wu, Chen-Chi; Lin, Yin-Hung; Lu, Ying-Chang; Hsu, Chuan-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Wu, Chen-Chi; Yang, Wei-Shiung; Chen, Pei-Lung] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Lin, Yin-Hung] Natl Taiwan Univ, Coll Med, Grad Inst Mol Med, Taipei 10764, Taiwan; [Chen, Pei-Jer; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Pei-Jer; Yang, Wei-Shiung; Chen, Pei-Lung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yang, Wei-Shiung; Chen, Pei-Lung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chen, Pei-Lung] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Hsu, CJ (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.	cjhsu@ntu.edu.tw; paylong@ntu.edu.tw	Chen, Pei-Lung/A-3520-2010	Chen, Pei-Lung/0000-0002-5640-3074; YANG, WEI-SHIUNG/0000-0001-5087-373X; Chen, Pei-Jer/0000-0001-8316-3785; WU, CHEN-CHI/0000-0002-5047-2204	National Health Research Institute [NHRI-EX101-10147PI]; National Science Council of the Executive Yuan of the Republic of China [NSC 100-2314-B-002-031-MY3]; National Taiwan University [UN1UN101-013]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of the Executive Yuan of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was supported by research grants from the National Health Research Institute (NHRI-EX101-10147PI), National Science Council of the Executive Yuan of the Republic of China (NSC 100-2314-B-002-031-MY3), and National Taiwan University (UN1UN101-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Brownstein Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-245; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; De Keulenaer S, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-17; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Even-Ram S, 2007, CELL ADHES MIGR, V1, P152, DOI 10.4161/cam.1.3.5089; Feldmann D, 2005, AM J MED GENET A, V137A, P225, DOI 10.1002/ajmg.a.30765; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HARRIS H, 1968, ANN NY ACAD SCI, V151, P232, DOI 10.1111/j.1749-6632.1968.tb11893.x; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Janecke AR, 2001, HUM GENET, V108, P269, DOI 10.1007/s004390100484; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Morgan JE, 2010, HUM MUTAT, V31, P484, DOI 10.1002/humu.21216; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nie LP, 2008, CURR OPIN OTOLARYNGO, V16, P441, DOI 10.1097/MOO.0b013e32830f4aa3; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Su MC, 2009, INT J PEDIATR OTORHI, V73, P811, DOI 10.1016/j.ijporl.2009.02.009; Tang WX, 2012, GENET TEST MOL BIOMA, V16, P536, DOI 10.1089/gtmb.2011.0187; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Uyguner O, 2002, CLIN GENET, V62, P306, DOI 10.1034/j.1399-0004.2002.620409.x; Van Eyken E, 2007, OTOL NEUROTOL, V28, P970; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu CC, 2005, LARYNGOSCOPE, V115, P132, DOI 10.1097/01.mlg.0000150691.85387.3f; Wu CC, 2008, AUDIOL NEURO-OTOL, V13, P172, DOI 10.1159/000112425; Wu CC, 2008, ARCH PEDIAT ADOL MED, V162, P269, DOI 10.1001/archpediatrics.2007.59; Wu CC, 2011, LARYNGOSCOPE, V121, P1287, DOI 10.1002/lary.21751; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P311, DOI 10.1159/000284349; Wu CC, 2009, LARYNGOSCOPE, V119, P2411, DOI 10.1002/lary.20621; Yang JJ, 2010, HUM GENET, V128, P303, DOI 10.1007/s00439-010-0856-x	51	46	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57369	10.1371/journal.pone.0057369	http://dx.doi.org/10.1371/journal.pone.0057369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451214	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800103
J	Ye, RS; Xi, QY; Qi, Q; Cheng, X; Chen, T; Li, HY; Kallon, S; Shu, G; Wang, SB; Jiang, QY; Zhang, YL				Ye, Rui-Song; Xi, Qian-Yun; Qi, Qien; Cheng, Xiao; Chen, Ting; Li, Hongyi; Kallon, Sanpha; Shu, Gang; Wang, Song-Bo; Jiang, Qing-Yan; Zhang, Yong-Liang			Differentially Expressed miRNAs after GnRH Treatment and Their Potential Roles in FSH Regulation in Porcine Anterior Pituitary Cell	PLOS ONE			English	Article							GONADOTROPIN SUBUNIT; MICRORNA EXPRESSION; PULSE FREQUENCY; DOWN-REGULATION; LH-SECRETION; HORMONE; RECEPTOR; GROWTH; TRANSCRIPTION; STIMULATION	Hypothalamic gonadotropin-releasing hormone (GnRH) is a major regulator of follicle-stimulating hormone (FSH) secretion in gonadotrope cell in the anterior pituitary gland. microRNAs (miRNAs) are small RNA molecules that control gene expression by imperfect binding to the 3'-untranslated region (3'-UTR) of mRNA at the post-transcriptional level. It has been proven that miRNAs play an important role in hormone response and/or regulation. However, little is known about miRNAs in the regulation of FSH secretion. In this study, primary anterior pituitary cells were treated with 100 nM GnRH. The supernatant of pituitary cell was collected for FSH determination by enzyme-linked immunosorbent assay (ELISA) at 3 hours and 6 hours post GnRH treatment respectively. Results revealed that GnRH significantly promoted FSH secretion at 3 h and 6 h post-treatment by 1.40-fold and 1.80-fold, respectively. FSH beta mRNA at 6 h post GnRH treatment significantly increased by 1.60-fold. At 6 hours, cells were collected for miRNA expression profile analysis using MiRCURY LNA Array and quantitative PCR (qPCR). Consequently, 21 up-regulated and 10 down-regulated miRNAs were identified, and qPCR verification of 10 randomly selected miRNAs showed a strong correlation with microarray results. Chromosome location analysis indicated that 8 miRNAs were mapped to chromosome 12 and 4 miRNAs to chromosome X. Target and pathway analysis showed that some miRNAs may be associated with GnRH regulation pathways. In addition, In-depth analysis indicated that 10 up-regulated and 3 down-regulated miRNAs probably target FSHb mRNA 3'-UTR directly, including miR-361-3p, a highly conserved X-linked miRNA. Most importantly, functional experimental results showed that miR-361-3p was involved in FSH secretion regulation, and up-regulated miR-361-3p expression inhibited FSH secretion, while down-regulated miR-361-3p expression promoted FSH secretion in pig pituitary cell model. These differentially expressed miRNAs resolved in this study provide the first guide for post-transcriptional regulation of pituitary gonadotrope FSH secretion in pig, as well as in other mammals.	[Ye, Rui-Song; Xi, Qian-Yun; Qi, Qien; Cheng, Xiao; Chen, Ting; Li, Hongyi; Kallon, Sanpha; Shu, Gang; Wang, Song-Bo; Jiang, Qing-Yan; Zhang, Yong-Liang] South China Agr Univ, Coll Anim Sci, Guandong Prov Key Lab Agroanim Genom & Mol Breedi, Guangzhou, Guangdong, Peoples R China; [Li, Hongyi] Longyan Univ, Sch Life Sci, Longyan, Peoples R China	South China Agricultural University; Longyan University	Zhang, YL (corresponding author), South China Agr Univ, Coll Anim Sci, Guandong Prov Key Lab Agroanim Genom & Mol Breedi, Guangzhou, Guangdong, Peoples R China.	zhangyl@scau.edu.cn	Ye, Ruisong/ABH-3897-2020; Ye, Ruisong/AAL-8956-2020	Ye, Ruisong/0000-0002-7970-1015	National 973 Project of China [2011CB944200]; National Natural Science Foundation of China [31272529]	National 973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work were supported by National 973 Project of China (2011CB944200) and National Natural Science Foundation of China (31272529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa S, 2004, BIOCHEM BIOPH RES CO, V324, P946, DOI 10.1016/j.bbrc.2004.09.124; Aroua S, 2012, GEN COMP ENDOCR, V175, P82, DOI 10.1016/j.ygcen.2011.10.002; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; BARB CR, 1990, J REPROD FERTIL, V90, P213, DOI 10.1530/jrf.0.0900213; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cook T, 2000, Oncologist, V5, P162, DOI 10.1634/theoncologist.5-2-162; Curry E, 2009, MOL REPROD DEV, V76, DOI 10.1002/mrd.20980; Curry E, 2011, THERIOGENOLOGY; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kakar SS, 1997, ANTI-CANCER DRUG, V8, P369, DOI 10.1097/00001813-199704000-00009; Keller A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-290; Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9; Lau Man-Tat, 2012, Front Endocrinol (Lausanne), V3, P47, DOI 10.3389/fendo.2012.00047; Lee HJ, 2006, P NATL ACAD SCI USA, V103, P15669, DOI 10.1073/pnas.0605781103; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Lin J, 2003, DOMEST ANIM ENDOCRIN, V24, P95, DOI 10.1016/S0739-7240(02)00209-6; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Miles LEC, 2004, ENDOCRINOLOGY, V145, P194, DOI 10.1210/en.2003-0551; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Nemoto T, 2012, AM J PHYSIOL-ENDOC M, V302, pE781, DOI 10.1152/ajpendo.00616.2011; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ogura K, 2001, EUR J ENDOCRINOL, V144, P653, DOI 10.1530/eje.0.1440653; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roth C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038248; Schotte D, 2011, LEUKEMIA, V25, P1389, DOI 10.1038/leu.2011.105; Stanislaus D, 1998, MOL CELL ENDOCRINOL, V144, P1, DOI 10.1016/S0303-7207(98)00126-9; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Thompson I, 2012, END ABSTR, V28, pP257; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wu S, 2011, J NEUROSCI, V31, P184, DOI 10.1523/JNEUROSCI.2974-10.2011; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Yuen T, 2009, MOL CELL ENDOCRINOL, V302, P12, DOI 10.1016/j.mce.2008.12.013; Zhang L, 2009, DEVELOPMENT, V136, P3043, DOI 10.1242/dev.039008; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x	49	45	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57156	10.1371/journal.pone.0057156	http://dx.doi.org/10.1371/journal.pone.0057156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451171	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800082
J	He, B; Osterholm, AM; Ojala, JRM; Andersson, AC; Tryggvason, K				He, Bing; Osterholm, Anne-May; Ojala, Juha R. M.; Andersson, Ann-Charlotte; Tryggvason, Karl			A Remote Cis-Acting Variant at 3q Links Glomerular NCK1 to Diabetic Nephropathy	PLOS ONE			English	Article							KIDNEY DEVELOPMENT; CHROMOSOME 3Q; CELL BIOLOGY; ZEBRAFISH; PODOCYTE; NEPHRIN; DISEASE; GENES; LOCUS; RISK	We have previously reported genetic association of a single nucleotide polymorphism (SNP), rs1866813, at 3q locus with increased risk of diabetic nephropathy (DN). The SNP is located approximately 70 kb downstream of a cluster of four genes. This raises a question how the remote noncoding polymorphism affects the risk of DN. In this study, we tested a long-range regulatory potential of this variant by a series of experiments. In a luciferase assay, two alleles of the SNP showed differential effects on the luciferase activity in transfected cells in vitro. Using transgenic zebrafish, we further demonstrated in vivo that two alleles of the SNP differentially regulated GFP expression in zebrafish podocytes. Immunofluorescence staining and Western blotting verified that only Nck1 of the four nearby genes was predominantly expressed in mouse glomeruli as well as in podocytes. Furthermore, genotypes of the SNP rs1866813 were correlated with NCK1 expression in immortalized lymphocytes from diabetic patients. The risk allele was associated with increased NCK1 expression compared to the non-risk allele, consistent with the results of the reporter-based studies. Interestingly, differential expression of glomerular Nck1 between mouse strains carrying the nephropathy-prone 129/Sv allele and nephropathy-resistant C57BL/6 allele was also observed. Our results show that the DN-associated SNP rs1866813 is a remote cis-acting variant differentially regulating glomerular NCK1 expression. This finding implicates an important role for glomerular NCK1 in DN pathogenesis under hyperglycemia.	[He, Bing; Osterholm, Anne-May; Ojala, Juha R. M.; Andersson, Ann-Charlotte; Tryggvason, Karl] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden	Karolinska Institutet	Tryggvason, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden.	karl.tryggvason@ki.se		Ojala, Juha/0000-0003-2018-6124	Foundation of Knut and Alice Wallenberg; Foundation of Soderberg; Foundation of Hedlund; Swedish Medical Research Council; Swedish Foundation for Strategic Research	Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Soderberg; Foundation of Hedlund; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported in part by grants from Foundations of Knut and Alice Wallenberg (http://www.wallenberg.com), Soderberg (http://www.ragnarsoderbergsstiftelse.se) Hedlund (http://www.hedlundsstiftelse.se), the Swedish Medical Research Council (http://www.vr.se) and the Swedish Foundation for Strategic Research (http://www.stratresearch.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bowden DW, 2004, KIDNEY INT, V66, P1517, DOI 10.1111/j.1523-1755.2004.00915.x; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carramolino L, 1997, GENE, V195, P151, DOI 10.1016/S0378-1119(97)00121-2; Conway BR, 2009, NEPHRON CLIN PRACT, V112, pC213, DOI 10.1159/000224787; Drummond IA, 2000, PEDIATR NEPHROL, V14, P428, DOI 10.1007/s004670050788; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; He B, 2009, AM J HUM GENET, V84, P5, DOI 10.1016/j.ajhg.2008.11.012; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Moczulski DK, 1998, DIABETES, V47, P1164, DOI 10.2337/diabetes.47.7.1164; Molitch ME, 2003, DIABETES CARE, V26, P2702, DOI 10.2337/diacare.26.9.2702; Mooyaart AL, 2011, DIABETOLOGIA, V54, P544, DOI 10.1007/s00125-010-1996-1; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Osterholm AM, 2007, KIDNEY INT, V71, P140, DOI 10.1038/sj.ki.5001933; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1717, DOI 10.1681/ASN.2012030252; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Vidal C, 2011, J MOL ENDOCRINOL, V47, P327, DOI 10.1530/JME-11-0067; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; White KE, 2006, DIABETIC MED, V23, P715, DOI 10.1111/j.1464-5491.2006.01790.x; Wolf G, 2007, NEPHRON PHYSIOL, V106, P26, DOI 10.1159/000101797	36	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56414	10.1371/journal.pone.0056414	http://dx.doi.org/10.1371/journal.pone.0056414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441190	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200047
J	Maruyama, T; Miyamoto, Y; Yamamoto, G; Yamada, A; Yoshimura, K; Suzawa, T; Takami, M; Akiyama, T; Hoshino, M; Iwasa, F; Ikumi, N; Tachikawa, T; Mishima, K; Baba, K; Kamijo, R				Maruyama, Toshifumi; Miyamoto, Yoichi; Yamamoto, Gou; Yamada, Atsushi; Yoshimura, Kentaro; Suzawa, Tetsuo; Takami, Masamichi; Akiyama, Tomohito; Hoshino, Marie; Iwasa, Fuminori; Ikumi, Noriharu; Tachikawa, Tetsuhiko; Mishima, Kenji; Baba, Kazuyoshi; Kamijo, Ryutaro			Downregulation of Carbonic Anhydrase IX Promotes Col10a1 Expression in Chondrocytes	PLOS ONE			English	Article							PROTEIN-KINASE-II; CADHERIN-MEDIATED ADHESION; HYPERTROPHIC DIFFERENTIATION; HYPOXIA; CELLS; GROWTH; SOX9; INHIBITION; CARTILAGE; HYPOXIA-INDUCIBLE-FACTOR-2-ALPHA	Carbonic anhydrase (CA) IX is a transmembrane isozyme of CAs that catalyzes reversible hydration of CO2. While it is known that CA IX is distributed in human embryonic chondrocytes, its role in chondrocyte differentiation has not been reported. In the present study, we found that Car9 mRNA and CA IX were expressed in proliferating but not hypertrophic chondrocytes. Next, we examined the role of CA IX in the expression of marker genes of chondrocyte differentiation in vitro. Introduction of Car9 siRNA to mouse primary chondrocytes obtained from costal cartilage induced the mRNA expressions of Col10a1, the gene for type X collagen alpha-1 chain, and Epas1, the gene for hypoxia-responsible factor-2 alpha (HIF-2 alpha), both of which are known to be characteristically expressed in hypertrophic chondrocytes. On the other hand, forced expression of CA IX had no effect of the proliferation of chondrocytes or the transcription of Col10a1 and Epas1, while the transcription of Col2a1 and Acan were up-regulated. Although HIF-2 alpha has been reported to be a potent activator of Col10a1 transcription, Epas1 siRNA did not suppress Car9 siRNA-induced increment in Col10a1 expression, indicating that down-regulation of CA IX induces the expression of Col10a1 in chondrocytes in a HIF-2 alpha-independent manner. On the other hand, cellular cAMP content was lowered by Car9 siRNA. Furthermore, the expression of Col10a1 mRNA after Car9 silencing was augmented by an inhibitor of protein kinase A, and suppressed by an inhibitor for phosphodiesterase as well as a brominated analog of cAMP. While these results suggest a possible involvement of cAMP-dependent pathway, at least in part, in induction of Col10a1 expression by down-regulation of Car9, more detailed study is required to clarify the role of CA IX in regulation of Col10a1 expression in chondrocytes.	[Maruyama, Toshifumi; Miyamoto, Yoichi; Yamada, Atsushi; Yoshimura, Kentaro; Suzawa, Tetsuo; Takami, Masamichi; Akiyama, Tomohito; Hoshino, Marie; Ikumi, Noriharu; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa, Tokyo, Japan; [Maruyama, Toshifumi; Akiyama, Tomohito; Hoshino, Marie; Iwasa, Fuminori; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Shinagawa, Tokyo, Japan; [Yamamoto, Gou; Tachikawa, Tetsuhiko; Mishima, Kenji] Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Pathol, Shinagawa, Tokyo, Japan	Showa University; Showa University; Showa University	Miyamoto, Y (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa, Tokyo, Japan.	yoichim@dent.showa-u.jp	Baba, Kazuyoshi/AAY-2304-2021	Takami, Masamichi/0000-0002-4506-3975; Baba, Kazuyoshi/0000-0001-8025-2168	Japan Society for the Promotion of Science; Project to Establish Strategic Research Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24659830, 24592813, 23592718] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project to Establish Strategic Research Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, and the Project to Establish Strategic Research Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Araldi E, 2010, BONE, V47, P190, DOI 10.1016/j.bone.2010.04.606; Bursell L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2308; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Chiche J, 2010, ADV ENZYME REGUL, V50, P20, DOI 10.1016/j.advenzreg.2009.10.005; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Chung UI, 2004, ENDOCR J, V51, P19, DOI 10.1507/endocrj.51.19; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hilvo M, 2004, J HISTOCHEM CYTOCHEM, V52, P1313, DOI 10.1369/jhc.3A6225.2004; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Liao SY, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-22; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Miyazawa T, 2002, ENDOCRINOLOGY, V143, P3604, DOI 10.1210/en.2002-220307; R Core Team, 2012, R LANG ENV STAT COMP; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Sato M, 2002, AM J RESP CELL MOL, V26, P127, DOI 10.1165/ajrcmb.26.1.4319; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Schipani E, 2001, GENE DEV, V15, P2865; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Thiry A, 2008, J MED CHEM, V51, P3051, DOI 10.1021/jm701526d; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Wang XG, 2010, J CELL PHYSIOL, V225, P709, DOI 10.1002/jcp.22267; Wang YP, 2008, MOL CANCER THER, V7, P3867, DOI 10.1158/1535-7163.MCT-08-0603; Wykoff CC, 2000, CANCER RES, V60, P7075; Yoshimura K, 2011, J BIOL CHEM, V286, P14744, DOI 10.1074/jbc.M111.221259; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111	40	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56984	10.1371/journal.pone.0056984	http://dx.doi.org/10.1371/journal.pone.0056984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441228	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200085
J	van Beuge, MM; Prakash, J; Lacombe, M; Post, E; Reker-Smit, C; Beljaars, L; Poelstra, K				van Beuge, Marike Marjolijn; Prakash, Jai; Lacombe, Marie; Post, Eduard; Reker-Smit, Catharina; Beljaars, Leonie; Poelstra, Klaas			Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; MANNOSE 6-PHOSPHATE; SELECTIVE DELIVERY; KINASE INHIBITOR; RAT; RECEPTOR; ACTIVATION; FIBROSIS; ALK5	Transforming growth factor-beta (TGF-beta) is a major pro-fibrotic cytokine, causing the overproduction of extracellular matrix molecules in many fibrotic diseases. Inhibition of its type-I receptor (ALK5) has been shown to effectively inhibit fibrosis in animal models. However, apart from its pro-fibrotic effects, TGF-beta also has a regulatory role in the immune system and influences tumorigenesis, which limits the use of inhibitors. We therefore explored the cell-specific delivery of an ALK5-inhibitor to hepatic stellate cells, a key cell in the development of liver fibrosis. We synthesized a conjugate of the ALK5-inhibitor LY-364947 coupled to mannose-6-phosphate human serum albumin (M6PHSA), which binds to the insulin-like growth factor II receptor on activated HSC. The effectivity of the conjugate was evaluated in primary HSC and in an acute liver injury model in mice. In vitro, the free drug and the conjugate significantly inhibited fibrotic markers in HSC. In hepatocytes, TGF-beta-dependent signaling was inhibited by free drug, but not by the conjugate, thus showing its cell-specificity. In vivo, the conjugate localized in desmin-positive cells in the liver and not in hepatocytes or immune cells. In the acute liver injury model in mice, the conjugate reduced fibrogenic markers and collagen deposition more effectively than free drug. We conclude that we can specifically deliver an ALK5-inhibitor to HSC using the M6PHSA carrier and that this targeted drug reduces fibrogenic parameters in vivo, without affecting other cell-types.	[van Beuge, Marike Marjolijn; Prakash, Jai; Post, Eduard; Reker-Smit, Catharina; Beljaars, Leonie; Poelstra, Klaas] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands; [Lacombe, Marie] Kreatech Diagnost, Amsterdam, Netherlands	University of Groningen	van Beuge, MM (corresponding author), Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, NL-9713 AV Groningen, Netherlands.	m.m.van.beuge@rug.nl	Prakash, Jai/C-8015-2014	Prakash, Jai/0000-0003-1050-650X; Post, Eduard/0000-0001-5885-0081; Beljaars, Leonie/0000-0003-3659-1896	European Framework program FP6 [LSHB-CT-2007-036644]	European Framework program FP6(European Commission)	This work was made possible by a grant from the European Framework program FP6 (LSHB-CT-2007-036644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; Arribillaga L, 2011, CYTOKINE, V53, P327, DOI 10.1016/j.cyto.2010.11.019; Beljaars L, 1999, HEPATOLOGY, V29, P1486, DOI 10.1002/hep.510290526; Beljaars L, 2001, LIVER, V21, P320, DOI 10.1034/j.1600-0676.2001.210504.x; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; de Gouville AC, 2006, DRUG NEWS PERSPECT, V19, P85, DOI 10.1358/dnp.2006.19.2.977444; DEBLESER PJ, 1995, HEPATOLOGY, V21, P1429, DOI 10.1016/0270-9139(95)90066-7; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dooley S, 2009, DIGEST DIS, V27, P93, DOI 10.1159/000218340; Fu K, 2008, ARTERIOSCL THROM VAS, V28, P665, DOI 10.1161/ATVBAHA.107.158030; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Greupink R, 2006, PHARM RES-DORDR, V23, P1827, DOI 10.1007/s11095-006-9025-2; Hageman J, 2005, CLIN CANCER RES, V11, P5956, DOI 10.1158/1078-0432.CCR-05-0427; Higashiyama H, 2007, EXP MOL PATHOL, V83, P39, DOI 10.1016/j.yexmp.2006.12.003; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Laping NJ, 2007, CLIN CANCER RES, V13, P3087, DOI 10.1158/1078-0432.CCR-06-1811; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Ling L, 2011, CURR PHARM BIOTECHNO, V12, P2202; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Prakash J, 2008, PHARM RES-DORDR, V25, P2427, DOI 10.1007/s11095-007-9515-x; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Sedlaczek N, 2001, AM J PATHOL, V158, P1239, DOI 10.1016/S0002-9440(10)64074-6; Sherman M, 2010, DIGEST LIVER DIS, V42, pS215, DOI 10.1016/S1590-8658(10)60508-7; van Beuge MM, 2011, PHARM RES-DORDR, V28, P2045, DOI 10.1007/s11095-011-0430-9; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	30	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56442	10.1371/journal.pone.0056442	http://dx.doi.org/10.1371/journal.pone.0056442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441194	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200051
J	Bronstein, I; Montgomery, P				Bronstein, Israel; Montgomery, Paul			Sleeping Patterns of Afghan Unaccompanied Asylum-Seeking Adolescents: A Large Observational Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; REFUGEE CHILDREN; CIRCADIAN PREFERENCE; IMAGERY REHEARSAL; EXPERIENCES; NIGHTMARES; VALIDITY; CULTURE; HABITS	Unaccompanied asylum-seeking children (UASC)have experienced multiple traumas and are a high-risk group for posttraumatic stress disorder (PTSD). The effects of trauma are known to be associated with sleep problems; indeed sleeping problems are core features of PTSD. However, there has been no systematic research examining the sleep of this high risk group of children. This study presents the first evidence on the sleeping patterns of Afghan UASC living in the UK. A total of 222 male Afghan children, aged 13-18, were interviewed using validated self-report questionnaires measuring sleeping patterns and PTSD. Overall, UASC patterns for bed time and rise time appear acculturated to the country of asylum. Mean UASC sleep onset latency scores were approximately 20 minutes greater compared with normative scores, which may be a reflection of UASC pre-migration and post-migration experiences. As expected, UASC who screened above the clinical cut-off for PTSD reported significantly greater sleep onset latency, increased nightmares, and less total sleep time compared to the non-PTSD group. The results may be of particular interest to clinicians given that, compared to screening for PTSD, screening for sleep problems may be a less culturally disputed form of initial assessment indicating distress in UASC. Similarly, the field of UASC and refugee child interventions is largely focused on trauma, yet sleep may provide a novel avenue for equally or more effective treatment.	[Bronstein, Israel; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England; [Bronstein, Israel] Bar Ilan Univ, Louis & Gabi Weisfeld Sch Social Work, Ramat Gan, Israel	University of Oxford; Bar Ilan University	Bronstein, I (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England.	raeli.bronstein@gmail.com		Bronstein, Israel/0000-0002-5136-1311; Montgomery, Paul/0000-0001-8008-1370	John Fell Fund (Oxford University Press)	John Fell Fund (Oxford University Press)	This research was supported by the John Fell Fund (Oxford University Press) - http://www.admin.ox.ac.uk/pras/jff/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abunimah A, 2010, CHILD CARE PRACTICE, V16, P129, DOI DOI 10.1080/13575270903482799; Bean T, 2006, J TRAUMA STRESS, V19, P241, DOI 10.1002/jts.20093; Bean T, 2004, REACTIONS ADOLESCENT, V45; Boland K, 2010, CHILDREN MOVE REPORT; Bronstein I, 2012, J TRAUMA STRESS, V25, P551, DOI 10.1002/jts.21740; Bronstein I, 2011, CLIN CHILD FAM PSYCH, V14, P44, DOI 10.1007/s10567-010-0081-0; Carskadon MA, 1991, SLEEP RES, V20, P175; Casement MD, 2012, CLIN PSYCHOL REV, V32, P566, DOI 10.1016/j.cpr.2012.06.002; Chase E, 2008, EMOTIONAL WELL BEING; Corkum P, 1998, J AM ACAD CHILD PSY, V37, P637, DOI 10.1097/00004583-199806000-00014; Ehntholt KA, 2006, J CHILD PSYCHOL PSYC, V47, P1197, DOI 10.1111/j.1469-7610.2006.01638.x; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Field A, 2006, INTRO STAT METHODS S; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Groark Claire, 2011, Clin Child Psychol Psychiatry, V16, P421, DOI 10.1177/1359104510370405; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Home Office, 2010, HOM OFF STAT B, V15; Huemer Julia, 2009, Child Adolesc Psychiatry Ment Health, V3, P13, DOI 10.1186/1753-2000-3-13; Jenni OG, 2005, PEDIATRICS, V115, P204, DOI 10.1542/peds.2004-0815B; Jordans MJD, 2009, CHILD ADOL MENT H-UK, V14, P2, DOI 10.1111/j.1475-3588.2008.00515.x; KLEINMAN A, 1987, BRIT J PSYCHIAT, V151, P447, DOI 10.1192/bjp.151.4.447; Levy K. J., 1978, Journal of Statistical Computation and Simulation, V8, P49, DOI 10.1080/00949657808810247; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Montgomery E, 2001, EUR J PUBLIC HEALTH, V11, P18, DOI 10.1093/eurpub/11.1.18; Mougne C, 2010, TREES ONLY MOVE WIND; Murray KE, 2010, AM J ORTHOPSYCHIAT, V80, P576, DOI 10.1111/j.1939-0025.2010.01062.x; National Sleep Foundation, 2006, SUMM FIND 2006 SLEEP; Nickerson A, 2011, CLIN PSYCHOL REV, V31, P399, DOI 10.1016/j.cpr.2010.10.004; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Owens Judith A, 2006, Behav Sleep Med, V4, P114, DOI 10.1207/s15402010bsm0402_4; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sadeh A, 1996, CHILD ADOL PSYCH CL, V5, P685, DOI 10.1016/S1056-4993(18)30356-0; Separated Children in Europe Programme, 2004, STAT GOOD PRACT; Soffer-Dudek N, 2010, PSYCHIATRY, V73, P264, DOI 10.1521/psyc.2010.73.3.264; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; St-Onge M, 2009, BEHAV SLEEP MED, V7, P81, DOI 10.1080/15402000902762360; Stanley K, 2001, COLD COMFORT YOUNG S; Thabet AAM, 2004, J CHILD PSYCHOL PSYC, V45, P533, DOI 10.1111/j.1469-7610.2004.00243.x; Thomas S, 2004, CHILD CARE HLTH DEV, V30, P113, DOI 10.1111/j.1365-2214.2003.00404.x; Van Ommeren M, 2003, BRIT J PSYCHIAT, V182, P376, DOI 10.1192/bjp.182.5.376; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Watters C, 2001, SOC SCI MED, V52, P1709, DOI 10.1016/S0277-9536(00)00284-7; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Worthman CM, 2002, ADOLESCENT SLEEP PAT; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	50	14	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56156	10.1371/journal.pone.0056156	http://dx.doi.org/10.1371/journal.pone.0056156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457517	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700051
J	Preininger, B; Duda, G; Gerigk, H; Bruckner, J; Ellinghaus, A; Sass, FA; Perka, C; Schmidt-Bleek, K; Dienelt, A				Preininger, Bernd; Duda, Georg; Gerigk, Hinnerk; Bruckner, Jonas; Ellinghaus, Agnes; Sass, F. Andrea; Perka, Carsten; Schmidt-Bleek, Katharina; Dienelt, Anke			CD133: Enhancement of Bone Healing by Local Transplantation of Peripheral Blood Cells in a Biologically Delayed Rat Osteotomy Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CORD BLOOD; GROWTH-FACTOR; IN-VITRO; ADULT; ANGIOGENESIS; FRACTURE; AGE; EXPRESSION; CALLUS	Sufficient angiogenesis is crucial during tissue regeneration and therefore also pivotal in bone defect healing. Recently, peripheral blood derived progenitor cells have been identified to have in addition to their angiogenic potential also osteogenic characteristics, leading to the hypothesis that bone regeneration could be stimulated by local administration of these cells. The aim of this study was to evaluate the angiogenic potential of locally administered progenitor cells to improve bone defect healing. Cells were separated from the peripheral blood of donor animals using the markers CD34 and CD133. Results of the in vitro experiments confirmed high angiogenic potential in the CD133(+) cell group. CD34(+) and CD133(+) cells were tested in an in vivo rat femoral defect model of delayed healing for their positive effect on the healing outcome. An increased callus formation and higher bone mineral density of callus tissue was found after the CD133(+) cell treatment compared to the group treated with CD34(+) cells and the control group without cells. Histological findings confirmed an increase in vessel formation and mineralization at day 42 in the osteotomy gap after CD133(+) cell transplantation. The higher angiogenic potential of CD133(+) cells from the in vitro experients therefore correlates with the in vivo data. This study demonstrates the suitability of angiogenic precursors to further bone healing and gives an indication that peripheral blood is a promising source for progenitor cells circumventing the problems associated with bone marrow extraction.	[Preininger, Bernd; Duda, Georg; Gerigk, Hinnerk; Bruckner, Jonas; Ellinghaus, Agnes; Sass, F. Andrea; Perka, Carsten; Schmidt-Bleek, Katharina; Dienelt, Anke] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Preininger, Bernd; Duda, Georg; Gerigk, Hinnerk; Bruckner, Jonas; Ellinghaus, Agnes; Sass, F. Andrea; Perka, Carsten; Schmidt-Bleek, Katharina; Dienelt, Anke] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Preininger, Bernd; Perka, Carsten] Charite, Dept Orthopaed, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Duda, Georg; Dienelt, Anke] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Duda, G (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	georg.duda@charite.de	Sass, Andrea F/M-6962-2017; Schmidt-Bleek, Katharina/O-9816-2015; Perka, Carsten/ABG-6505-2021; Duda, Georg N/H-2085-2016	Sass, Andrea F/0000-0001-6098-3609; Duda, Georg N/0000-0001-7605-3908; Perka, Carsten/0000-0002-0993-581X	German Research Foundation [DFG SFB 760]; BMBF	German Research Foundation(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported partially by the German Research Foundation (DFG SFB 760) and through the BMBF funded Berlin-Brandenburg Center for Regenerative Therapies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Bonanno G, 2004, TRANSFUSION, V44, P1087, DOI 10.1111/j.1537-2995.2004.03252.x; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Chen C H, 1994, J Hematother, V3, P3, DOI 10.1089/scd.1.1994.3.3; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; David V, 2006, AM J PHYSIOL-ENDOC M, V290, pE440, DOI 10.1152/ajpendo.00293.2004; Demir B, 2008, MATURITAS, V60, P253, DOI 10.1016/j.maturitas.2008.07.011; Dienelt A, 2011, STEM CELLS DEV, V20, P465, DOI 10.1089/scd.2010.0205; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Elkhafif N, 2011, APMIS, V119, P66, DOI 10.1111/j.1600-0463.2010.02693.x; Fassbender M, 2011, EUR CELLS MATER, V22, P1; Finney MR, 2010, CYTOTHERAPY, V12, P67, DOI 10.3109/14653240903300658; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Giannicola G, 2010, J TISSUE ENG REGEN M, V4, P273, DOI 10.1002/term.238; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Kawachi Y, 1996, BRIT J HAEMATOL, V94, P413, DOI 10.1046/j.1365-2141.1996.d01-1807.x; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolar P, TISSUE ENG B; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Marie PJ, 2012, GENE, V498, P1, DOI 10.1016/j.gene.2012.01.086; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Meyer RA, 2001, J ORTHOP RES, V19, P428, DOI 10.1016/S0736-0266(00)90034-2; Meyer RA, 2006, J ORTHOP RES, V24, P1933, DOI 10.1002/jor.20124; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; NASH TJ, 1994, BONE, V15, P203, DOI 10.1016/8756-3282(94)90709-9; OLAH AJ, 1977, STAIN TECHNOL, V52, P331, DOI 10.3109/10520297709116809; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Preininger B, 2012, EUR CELLS MATER, V23, P262, DOI 10.22203/eCM.v023a20; Schindeler A, 2009, DIFFERENTIATION, V77, P12, DOI 10.1016/j.diff.2008.09.007; Shah P, 2012, J ORAL IMPLANTOL; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Strube P, 2008, J BIOMECH, V41, P2696, DOI 10.1016/j.jbiomech.2008.06.009; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Strube P, 2009, BONE, V45, P1065, DOI 10.1016/j.bone.2009.08.005; Summers YJ, 2004, STEM CELLS, V22, P704, DOI 10.1634/stemcells.22-5-704; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Weiss S, 2009, ARCH ORTHOP TRAUM SU, V129, P989, DOI 10.1007/s00402-008-0777-5; Yamada M, 2007, J SHOULDER ELB SURG, V16, P596, DOI 10.1016/j.jse.2007.01.006; Zeng Hui, 2003, Chin J Traumatol, V6, P229	46	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e52650	10.1371/journal.pone.0052650	http://dx.doi.org/10.1371/journal.pone.0052650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457441	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700001
J	Yang, CC; Sun, WC; Wang, WY; Huang, CH; Lu, FS; Tseng, SM; Chen, CW				Yang, Chien-Chin; Sun, We-Chi; Wang, Wan-Yu; Huang, Chi-Hung; Lu, Fang-Shy; Tseng, Shu-Min; Chen, Carton W.			Mutational Analysis of the Terminal Protein Tpg of Streptomyces Chromosomes: Identification of the Deoxynucleotidylation Site	PLOS ONE			English	Article							IN-VITRO DEOXYNUCLEOTIDYLATION; ADENOVIRUS DNA-REPLICATION; AMINO-ACID-SEQUENCE; LINEAR PLASMID; ESCHERICHIA-COLI; GENOME SEQUENCE; PHAGE-PHI-29; TELOMERES; REPLICON; LIVIDANS	The linear chromosomes and linear plasmids of Streptomyces are capped by terminal proteins (TPs) covalently bound to the 59 ends of the DNA. The TPs serve as primers for DNA synthesis that patches in the single-stranded gaps at the telomeres resulting from the bi-directional replication ('end patching'). Typical Streptomyces TPs, designated Tpgs, are conserved in sequence and size (about 185 amino acids), and contain a predicted helix-turn-helix domain and a functional nuclear localization signal. The Tpg-encoding gene (tpg) is often accompanied by an upstream gene tap that encodes an essential telomere-associating protein. Five lone tpg variants (not accompanied by tap) from various Streptomyces species were tested, and three were found to be pseudogenes. The lone tpg variant on the SLP2 plasmid, although functional, still requires the presence of tap on the chromosome for end patching. Using a combination of in vitro deoxynucleotidylation, physical localization, and genetic analysis, we identified the threonine at position 114 (T114) in Tpg of Streptomyces lividans chromosome as the deoxynucleotidylated site. Interestingly, T114 could be substituted by a serine without destroying the priming activity of Tpg in vitro and in vivo. Such T114S substitution is seen in and a number of pseudogenes as well as functional Tpgs. T114 lies in a predicted coil flanked by two short helixes in a highly hydrophilic region. The location and structural arrangement of the deoxynucleotidylated site in Tpg is similar to those in the TPs of phage circle divide 29 and adenoviruses. However, these TPs are distinct in their sequences and sizes, indicating that they have evolved independently during evolution. Using naturally occurring and artificially created tpg variants, we further identified several amino acid residues in the N-terminus and the helix-turn-helix domain that were important for functionality.	[Yang, Chien-Chin; Sun, We-Chi; Wang, Wan-Yu; Lu, Fang-Shy; Tseng, Shu-Min] Chung Yuan Christian Univ, Dept Chem, Chungli 32023, Taiwan; [Huang, Chi-Hung] Natl Taipei Univ Technol, Inst Biotechnol, Taipei, Taiwan; [Chen, Carton W.] Natl Yang Ming Univ, Dept Life Sci, Inst Genome Sci, Taipei 112, Taiwan	Chung Yuan Christian University; National Taipei University of Technology; National Yang Ming Chiao Tung University	Yang, CC (corresponding author), Chung Yuan Christian Univ, Dept Chem, Chungli 32023, Taiwan.	ccyang@cycu.edu.tw; cwchen@ym.edu.tw	Chen, Carton W/GVS-7763-2022	Chen, Carton W/0000-0001-8891-1623	Ministry of Education, ROC; Chung-Yuan Christian University; National Science Council, ROC [NSC98-2311-B-010-004-MY3, NSC99-2811-B-010-027]	Ministry of Education, ROC; Chung-Yuan Christian University; National Science Council, ROC(Ministry of Science and Technology, Taiwan)	CWC is the recipient of a National Professorship from the Ministry of Education, ROC. This study was funded by research funds from Chung-Yuan Christian University, research grants from National Science Council, ROC. (NSC98-2311-B-010-004-MY3; NSC99-2811-B-010-027) and a grant (Aim for the Top University Plan) from Ministry of Education, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bao K, 2003, GENE DEV, V17, P774, DOI 10.1101/gad.1060303; Bao K, 2001, GENE DEV, V15, P1518, DOI 10.1101/gad.896201; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; Chaconas George, 2005, P525; Chen Carton W., 2007, V7, P33, DOI 10.1007/7171_2007_090; Choulet F, 2006, MOL BIOL EVOL, V23, P2361, DOI 10.1093/molbev/msl108; Coligan JE, 1995, CURRENT PROTOCOLS PR; de Jong RN, 1999, GENE, V236, P1, DOI 10.1016/S0378-1119(99)00249-8; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; GARCIA P, 1986, J VIROL, V58, P31; GARMENDIA C, 1988, NUCLEIC ACIDS RES, V16, P5727, DOI 10.1093/nar/16.13.5727; GARMENDIA C, 1990, GENE, V88, P73, DOI 10.1016/0378-1119(90)90061-U; Garnier J, 1996, METHOD ENZYMOL, V266, P540; HERMOSO JM, 1985, NUCLEIC ACIDS RES, V13, P7715, DOI 10.1093/nar/13.21.7715; Hsu CC, 2010, J BACTERIOL, V192, P307, DOI 10.1128/JB.01192-09; Huang CH, 2003, MOL MICROBIOL, V47, P1563, DOI 10.1046/j.1365-2958.2003.03403.x; Huang CH, 2007, MOL MICROBIOL, V63, P1710, DOI 10.1111/j.1365-2958.2007.05616.x; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kinashi H, 1998, BIOSCI BIOTECH BIOCH, V62, P1892, DOI 10.1271/bbb.62.1892; Kirby R, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P5; Kolkenbrock S, 2010, FEMS MICROBIOL LETT, V304, P169, DOI 10.1111/j.1574-6968.2010.01900.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai C-h, 2010, THESIS NATL YANG MIN; Lin Y-L, 1998, THESIS NATL YANG MIN; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; PARGELLIS CA, 1988, J BIOL CHEM, V263, P7678; Qin ZJ, 2002, MOL MICROBIOL, V45, P785, DOI 10.1046/j.1365-2958.2002.03051.x; Qin ZJ, 1998, MOL MICROBIOL, V28, P893, DOI 10.1046/j.1365-2958.1998.00838.x; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; REDENBACH M, 1993, MOL GEN GENET, V241, P255, DOI 10.1007/BF00284676; Salas M, 1991, ANNU REV BIOCHEM, V60, P37; SHIFFMAN D, 1992, P NATL ACAD SCI USA, V89, P6129, DOI 10.1073/pnas.89.13.6129; SMART JE, 1982, J BIOL CHEM, V257, P13499; Spatz K, 2002, FEMS MICROBIOL LETT, V213, P87, DOI 10.1111/j.1574-6968.2002.tb11290.x; Suzuki H, 2008, BIOSCI BIOTECH BIOCH, V72, P2973, DOI 10.1271/bbb.80454; Tsai HH, 2011, NUCL ACIDS RES; Tsai HH, 2011, NUCLEIC ACIDS RES, V39, P2165, DOI 10.1093/nar/gkq1204; Tsai HH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1170; Westermeier J, 1990, ELECTROPHORESIS PRAC; Yang CC, 2002, MOL MICROBIOL, V43, P297, DOI 10.1046/j.1365-2958.2002.02760.x; Yang CC, 2006, APPL ENVIRON MICROB, V72, P7959, DOI 10.1128/AEM.01857-06; Zhang R, 2006, APPL ENVIRON MICROB, V72, P5728, DOI 10.1128/AEM.00707-06	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56322	10.1371/journal.pone.0056322	http://dx.doi.org/10.1371/journal.pone.0056322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457549	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700068
J	Curt, JR; de Navas, LF; Sanchez-Herrero, E				Curt, Jesus R.; de Navas, Luis F.; Sanchez-Herrero, Ernesto			Differential Activity of Drosophila Hox Genes Induces Myosin Expression and Can Maintain Compartment Boundaries	PLOS ONE			English	Article							ULTRABITHORAX PROTEINS; LINEAGE RESTRICTION; AFFINITY BOUNDARY; BITHORAX COMPLEX; NOTCH; MUTANTS; DORSAL; SEGMENTATION; MAINTENANCE; POLARITY	Compartments are units of cell lineage that subdivide territories with different developmental potential. In Drosophila, the wing and haltere discs are subdivided into anterior and posterior (A/P) compartments, which require the activity of Hedgehog, and into dorsal and ventral (D/V) compartments, needing Notch signaling. There is enrichment in actomyosin proteins at the compartment boundaries, suggesting a role for these proteins in their maintenance. Compartments also develop in the mouse hindbrain rhombomeres, which are characterized by the expression of different Hox genes, a group of genes specifying different structures along their main axis of bilaterians. We show here that the Drosophila Hox gene Ultrabithorax can maintain the A/P and D/V compartment boundaries when Hedgehog or Notch signaling is compromised, and that the interaction of cells with and without Ultrabithorax expression induces high levels of non-muscle myosin II. In the absence of Ultrabithorax there is occasional mixing of cells from different segments. We also show a similar role in cell segregation for the Abdominal-B Hox gene. Our results suggest that the juxtaposition of cells with different Hox gene expression leads to their sorting out, probably through the accumulation of non-muscle myosin II at the boundary of the different cell territories. The increase in myosin expression seems to be a general mechanism used by Hox genes or signaling pathways to maintain the segregation of different groups of cells.	[Sanchez-Herrero, Ernesto] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Sanchez-Herrero, E (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	esherrero@cbm.uam.es	Sánchez-Herrero, Ernesto/ABE-3595-2020	Rodriguez Curt, Jesus/0000-0002-5712-3031	Ministerio de Ciencia e Innovacion [2004-2OE172, BMC2005-04342, BFU2008-00632]; Consolider Program [CSD2007-0008]; Ramon Areces Foundation; CSIC-JAE fellowship from the Spanish Ministerio de Ciencia e Innovacion; FPU fellowship from the Spanish Ministerio de Ciencia e Innovacion	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider Program(Spanish Government); Ramon Areces Foundation; CSIC-JAE fellowship from the Spanish Ministerio de Ciencia e Innovacion; FPU fellowship from the Spanish Ministerio de Ciencia e Innovacion	The work was supported by grants from Ministerio de Ciencia e Innovacion (numbers 2004-2OE172, BMC2005-04342 and BFU2008-00632), the Consolider Program (CSD2007-0008) and an institutional grant from the Ramon Areces Foundation. J. R. is supported by a CSIC-JAE fellowship and L. de N. was supported by a FPU fellowship, both from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2005, MOL CELL BIOL, V25, P3140, DOI 10.1128/MCB.25.8.3140-3150.2005; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; Becam I, 2008, DEV BIOL, V322, P190, DOI 10.1016/j.ydbio.2008.07.028; Blair SS, 2003, CURR BIOL, V13, pR548, DOI 10.1016/S0960-9822(03)00469-X; Blair SS, 1997, DEVELOPMENT, V124, P4053; BROWER DL, 1987, DEVELOPMENT, V101, P83; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Duncan D, 2010, DEV BIOL, V347, P82, DOI 10.1016/j.ydbio.2010.08.012; Estrada B, 2001, DEVELOPMENT, V128, P331; Filas BA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/066007; Foronda D, 2009, INT J DEV BIOL, V53, P1409, DOI 10.1387/ijdb.072462df; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Gandille P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013946; GARCIABELLIDO A, 1976, DEV BIOL, V48, P400, DOI 10.1016/0012-1606(76)90101-9; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GARCIABELLIDO A, 1968, GENETICS, V59, P487; GARCIABELLIDO A, 1966, DEV BIOL, V14, P278, DOI 10.1016/0012-1606(66)90017-0; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; Hejnol A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-65; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lebreton G, 2008, DEVELOPMENT, V135, P2301, DOI 10.1242/dev.017053; LEWIS EB, 1963, AM ZOOL, V3, P33; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 1999, MOL CELL, V4, P1073, DOI 10.1016/S1097-2765(00)80235-X; Monier B, 2005, DEVELOPMENT, V132, P5283, DOI 10.1242/dev.02091; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; MORATA G, 1976, ROUX ARCH DEV BIOL, V179, P125, DOI 10.1007/BF00848298; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Narita Y, 2009, CURR TOP DEV BIOL, V88, P139, DOI 10.1016/S0070-2153(09)88005-8; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; WHITE RAH, 1985, NATURE, V318, P563, DOI 10.1038/318563a0; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	47	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57159	10.1371/journal.pone.0057159	http://dx.doi.org/10.1371/journal.pone.0057159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451173	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500072
J	Ho, MC; Wilczek, C; Bonanno, JB; Xing, L; Seznec, J; Matsui, T; Carter, LG; Onikubo, T; Kumar, PR; Chan, MK; Brenowitz, M; Cheng, RH; Reimer, U; Almo, SC; Shechter, D				Ho, Meng-Chiao; Wilczek, Carola; Bonanno, Jeffrey B.; Xing, Li; Seznec, Janina; Matsui, Tsutomu; Carter, Lester G.; Onikubo, Takashi; Kumar, P. Rajesh; Chan, Man K.; Brenowitz, Michael; Cheng, R. Holland; Reimer, Ulf; Almo, Steven C.; Shechter, David			Structure of the Arginine Methyltransferase PRMT5-MEP50 Reveals a Mechanism for Substrate Specificity	PLOS ONE			English	Article							WD-REPEAT; SYMMETRIC DIMETHYLATION; CRYSTAL-STRUCTURE; DATA-ACQUISITION; HISTONE-BINDING; PRMT5; METHYLATION; NUCLEOPLASMIN; PROTEINS; SYSTEM	The arginine methyltransferase PRMT5-MEP50 is required for embryogenesis and is misregulated in many cancers. PRMT5 targets a wide variety of substrates, including histone proteins involved in specifying an epigenetic code. However, the mechanism by which PRMT5 utilizes MEP50 to discriminate substrates and to specifically methylate target arginines is unclear. To test a model in which MEP50 is critical for substrate recognition and orientation, we determined the crystal structure of Xenopus laevis PRMT5-MEP50 complexed with S-adenosylhomocysteine (SAH). PRMT5-MEP50 forms an unusual tetramer of heterodimers with substantial surface negative charge. MEP50 is required for PRMT5-catalyzed histone H2A and H4 methyltransferase activity and binds substrates independently. The PRMT5 catalytic site is oriented towards the cross-dimer paired MEP50. Histone peptide arrays and solution assays demonstrate that PRMT5-MEP50 activity is inhibited by substrate phosphorylation and enhanced by substrate acetylation. Electron microscopy and reconstruction showed substrate centered on MEP50. These data support a mechanism in which MEP50 binds substrate and stimulates PRMT5 activity modulated by substrate post-translational modifications.	[Ho, Meng-Chiao; Wilczek, Carola; Bonanno, Jeffrey B.; Onikubo, Takashi; Kumar, P. Rajesh; Chan, Man K.; Brenowitz, Michael; Almo, Steven C.; Shechter, David] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA; [Almo, Steven C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY USA; [Ho, Meng-Chiao] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Seznec, Janina; Reimer, Ulf] JPT Peptide Technol, Berlin, Germany; [Matsui, Tsutomu; Carter, Lester G.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Xing, Li; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Academia Sinica - Taiwan; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Davis	Ho, MC (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA.	joeho@gate.sinica.edu.tw; david.shechter@einstein.yu.edu	Cheng, Holland/A-8973-2008; Ho, Meng-Chiao/H-2448-2015; Shechter, David/B-4660-2008; Carter, Lester/G-6561-2014	Ho, Meng-Chiao/0000-0002-5424-4524; Shechter, David/0000-0001-9388-6004; Reimer, Ulf/0000-0002-3375-6889; Kumar, P. Rajesh/0000-0002-0576-6967; Matsui, Tsutomu/0000-0001-7101-5259	Office of Biological and Environmental Research of the US Department of Energy; Office of Basic Energy Sciences of the US Department of Energy; National Center for Research Resources (NCRR) [P41RR012408]; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [P41GM103473]; DOE Office of Biological and Environmental Research; NIH, NCRR, Biomedical Technology Program [P41RR001209]; Academia Sinica, Taiwan; National Science Council, Taiwan [NSC101-2311-B-001-002]; NIH [GM093342, AI095382]; Albert Einstein Cancer Center [CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662, U54GM093342, P41GM103473] Funding Source: NIH RePORTER	Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NCRR, Biomedical Technology Program; Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for this study were measured at beamline X25 and X29A of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources (NCRR, P41RR012408) and the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health (NIH). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the NIH, NCRR, Biomedical Technology Program (P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. This research was partially supported by grants from Academia Sinica, Taiwan, and from the National Science Council, Taiwan (NSC101-2311-B-001-002) to MHC, the NIH (GM093342 to SCA and AI095382 to RHC) and the Albert Einstein Cancer Center (CA013330). DS is a Scholar of the Alexander and Alexandrine Sinsheimer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Arnan C, 2005, ARCH BIOCHEM BIOPHYS, V437, P205, DOI 10.1016/j.abb.2005.03.011; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eckert D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furuno K, 2006, BIOCHEM BIOPH RES CO, V345, P1051, DOI 10.1016/j.bbrc.2006.05.014; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanade SR, 2012, J BIOL CHEM, V287, P7313, DOI 10.1074/jbc.M111.331660; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 2006, INT TABLES CRYSTALLO, P353; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Majumder S, 2010, J CELL BIOCHEM, V109, P553, DOI 10.1002/jcb.22432; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; Masch A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4_13; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Moscoso CG, 2011, P NATL ACAD SCI USA, V108, P6091, DOI 10.1073/pnas.1016113108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panse S, 2004, MOL DIVERS, V8, P291, DOI 10.1023/B:MODI.0000036240.39384.eb; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Ramos I, 2010, J BIOL CHEM, V285, P33771, DOI 10.1074/jbc.M110.150664; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Rouhana L, 2012, DEVELOPMENT, V139, P1083, DOI 10.1242/dev.076182; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; West AL, 2012, P NATL ACAD SCI USA, V109, P5633, DOI 10.1073/pnas.1120283109; Wilczek C, 2011, J BIOL CHEM, V286, P42221, DOI 10.1074/jbc.M111.303677; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6	71	92	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57008	10.1371/journal.pone.0057008	http://dx.doi.org/10.1371/journal.pone.0057008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451136	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500054
J	Neuhauser, L; Ivey, SL; Huang, D; Engelman, A; Tseng, W; Dahrouge, D; Gurung, S; Kealey, M				Neuhauser, Linda; Ivey, Susan L.; Huang, Debbie; Engelman, Alina; Tseng, Winston; Dahrouge, Donna; Gurung, Sidhanta; Kealey, Melissa			Availability and Readability of Emergency Preparedness Materials for Deaf and Hard-of-Hearing and Older Adult Populations: Issues and Assessments	PLOS ONE			English	Article							HEALTH LITERACY; COMMUNICATION; KATRINA; RISK	A major public health challenge is to communicate effectively with vulnerable populations about preparing for disasters and other health emergencies. People who are Deaf or Hard of Hearing (Deaf/HH) and older adults are particularly vulnerable during health emergencies and require communications that are accessible and understandable. Although health literacy studies indicate that the readability of health communication materials often exceeds people's literacy levels, we could find no research about the readability of emergency preparedness materials (EPM) intended for Deaf/HH and older adult populations. The objective of this study was to explore issues related to EPM for Deaf/HH and older adult populations, to assess the availability and readability of materials for these populations, and to recommend improvements. In two California counties, we interviewed staff at 14 community-based organizations (CBOs) serving Deaf/HH clients and 20 CBOs serving older adults selected from a stratified, random sample of 227 CBOs. We collected 40 EPM from 10 CBOs and 2 public health departments and 40 EPM from 14 local and national websites with EPM for the public. We used computerized assessments to test the U. S. grade reading levels of the 16 eligible CBO and health department EPM, and the 18 eligible website materials. Results showed that less than half of CBOs had EPM for their clients. All EPM intended for clients of Deaf/HH-serving CBOs tested above the recommended 4th grade reading level, and 91% of the materials intended for clients of older adult-serving CBOs scored above the recommended 6th grade level. EPM for these populations should be widely available through CBOs and public health departments, adhere to health literacy principles, and be accessible in alternative formats including American Sign Language. Developers should engage the intended users of EPM as co-designers and testers. This study adds to the limited literature about EPM for these populations.	[Neuhauser, Linda; Ivey, Susan L.; Huang, Debbie; Engelman, Alina; Tseng, Winston; Dahrouge, Donna; Gurung, Sidhanta; Kealey, Melissa] Univ Calif Berkeley, Sch Publ Hlth, Hlth Res Act Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Neuhauser, L (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Hlth Res Act Ctr, Berkeley, CA 94720 USA.	lindan@berkeley.edu			Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention [5P01TP000295, FOA RFA-TP-08-001]	Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention	This study was supported by a Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention, under FOA RFA-TP-08-001, to the University of California at Berkeley (grant number 5P01TP000295). The CDC had helpful suggestions to enhance the authors' study design, but had no role in data collection, data analysis, decision to publish, or preparation of this manuscript. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.	Aguirre B.E., 1988, INT J MASS EMERGENCI, V6, P65; Aldrich N, 2008, CDCS DISASTER PLANNI; Altevogt BM, 2008, RES PRIORITIES EMERG; [Anonymous], 1999, REP COUNC SCI AFF; Baker DW, 2000, J GERONTOL B-PSYCHOL, V55, pS368, DOI 10.1093/geronb/55.6.S368; Barnett S, 2011, PREV CHRONIC DIS, V8; Beckman HT, 1997, J CLIN PSYCHOL, V53, P785, DOI 10.1002/(SICI)1097-4679(199712)53:8<785::AID-JCLP1>3.0.CO;2-F; Canadian Council on Learning, 2007, HLTH LIT CAN IN RES; CDC, 2008, PUBL HLTH PREP MOB S, P1; Centers for Disease Control and Prevention, 2006, PROM PREP PROT HLT 4; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; Deaf and Hard of Hearing Consumer Advocacy Network, 2004, EM PREP EM COMM ACC; Department of Homeland Security, 2008, NAT RESP FRAM; Doak CC, 1996, TEACHING PATIENTS LO; Doak L G, 1996, Oncol Nurs Forum, V23, P1305; Fothergill A, 1999, DISASTERS, V23, P156, DOI 10.1111/1467-7717.00111; Friedman DB, 2008, PREHOSP DISASTER MED, V23, P438, DOI 10.1017/S1049023X00006178; Glanz K., 2002, HLTH BEHAV HLTH ED T; Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123; Government Accountability Office, 2008, NAT DIS RESP FEMA SH; Green L. W., 2003, COMMUNITY BASED PART; Guidry J, 1997, J CANCER EDUC, P108; Hayunga M, 2006, WE CAN DO BETTER LES; Heppner C, 2006, M FED COMM COMM IND; James X, 2007, J HOMEL SECUR EMERG, V4; Kailes J.I., 2007, J DISABIL POLICY STU, V17, P230, DOI [10.1177/10442073070170040601, DOI 10.1177/10442073070170040601]; Kealey M, 2012, EMERGENCY PREPAREDNE; KIRSCH IS, 1993, ADULT LIT AM 1 LOOK; Klinenberg E., 2002, HEAT WAVE SOCIAL AUT; Kouznetsova S, 2010, WEB ACCESSIBILITY US; Kreps G, 2005, COMMUNITY PREPAREDNE, V3, P191; Kutner M., 2005, NATL ASSESSMENT ADUL; LaVigne M, 2003, WISC LAW REV, P843; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Marschark M, 2002, ED DEAF STUD RES PRA; Mensah GA, 2005, PREV CHRONIC DIS, V2; Merriam B.S., 2007, LEARNING ADULTHOOD C; Messias DKH, 2007, J HEALTH CARE POOR U, V18, P443, DOI 10.1353/hpu.2007.0041; Micro Power & LIght Co, 2005, READ CALC; Mohrmann CC, 2000, J CANCER EDUC, V15, P23; National Organization on Disability, 2005, EM PREP IN GUID SPEC; Neuhauser L, 2009, AM J PUBLIC HEALTH, V99, P2188, DOI 10.2105/AJPH.2008.155648; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Organization for Economic Co-Operation Development and Statistics Canada, 2000, LIT INF AG FIN REP I; Osborne H., 2005, HLTH LITERACY A Z PR; Paasche-Orlow MK, 2005, UNDERSTANDING HLTH L, P119; Perry R.W., 1986, MINORITY CITIZENS DI; Phillips B.D., 2007, NAT HAZARDS REV, V8, P61, DOI [10.1061/(ASCE)1527-6988(2007)8:3(61), DOI 10.1061/(ASCE)1527-6988(2007)8:3(61)]; Phillips B.D., 1993, INT J MASS EMERGENCI, V11, P99; Pollard RQ, 2009, REHABIL PSYCHOL, V54, P232, DOI 10.1037/a0015772; Pollard RQ, 1998, PSYCHOLOGICAL PERSPECTIVES ON DEAFNESS, VOL 2, P171; Pollard RQ, 2005, DEAF ROCHESTER NEWS, P10; Rudd R, 2000, HLTH LITERACY REV ME; Rudd RE, 2007, REV ADULT LEARNING L, V7; Rudd Rima E., 2007, HLTH LITERACY UPDATE; Satariano WA, 2006, EPIDEMIOLOGY AGING E; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Shi Leiyu, 2007, Organ Ethic, V4, P35; SHIN HB, 2003, LANGUAGE USE ENGLISH; Stebnicki J A, 1999, J Transcult Nurs, V10, P350, DOI 10.1177/104365969901000413; Swartzberg J, 2005, UNDERSTANDING HLTH L; Traxler C.B., 2000, J DEAF STUD DEAF EDU, V5, P337, DOI DOI 10.1093/DEAFED/5.4.337; U.S. Department of Health and Human Services, QUICK GUID HLTH LIT; [US Department of Health and Human Services Centers for Disease Control and Prevention (CDC)], SIMPL PUT; US Department of Health and Human Services Centers for Medicare and Medicaid Services, TOOLK MAK WRITT MAT; US Government, 2004, EX ORD IND DIS EM PR; Vanderford ML, 2007, J APPL COMMUN RES, V35, P9, DOI 10.1080/00909880601065649; Villaire M., 2007, HLTH LITERACY PRIMAR; Wallis D, 2004, J DEAF STUDIES DEAF, P9; WEISS BD, 2005, UNDERSTANDING HLTH L, P17; Wilbourn MP, 2007, INFANT BEHAV DEV, V30, P153, DOI 10.1016/j.infbeh.2006.08.006; Wilson FL, 2003, J CLIN NURS, V12, P275, DOI 10.1046/j.1365-2702.2003.00711.x; Wood VT, 2003, B AM METEOROLOGICAL, V84, P148; World Health Organization, 1998, HLTH PROM GLOSS; Zarcadoolas C, 2005, HEALTH PROMOT INT, V20, P195, DOI 10.1093/heapro/dah609	75	33	33	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55614	10.1371/journal.pone.0055614	http://dx.doi.org/10.1371/journal.pone.0055614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451029	Green Published, gold			2022-12-27	WOS:000316849500003
J	Ning, DG; Jiang, Y; Liu, ZY; Xu, QG				Ning, Degang; Jiang, Yan; Liu, Zhaoying; Xu, Qinggang			Characterization of a Chromosomal Type II Toxin-Antitoxin System mazEaFa in the Cyanobacterium Anabaena sp PCC 7120	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; PHOSPHORUS BIOAVAILABILITY; HETEROCYST DEVELOPMENT; PERSISTER CELLS; EXPRESSION; MODULE; GROWTH; GENE; MAZF	Cyanobacteria have evolved to survive stressful environmental changes by regulating growth, however, the underlying mechanism for this is obscure. The ability of chromosomal type II toxin-antitoxin (TA) systems to modulate growth or cell death has been documented in a variety of prokaryotes. A chromosomal mazEaFa locus of Anabaena sp. PCC 7120 has been predicted as a putative mazEF TA system. Here we demonstrate that mazEaFa form a bicistronic operon that is co-transcribed under normal growth conditions. Overproduction of MazFa induced Anabaena growth arrest which could be neutralized by co-expression of MazEa. MazFa also inhibited the growth of Escherichia coli cells, and this effect could be overcome by simultaneous or subsequent expression of MazEa via formation of the MazEa-MazFa complex in vivo, further confirming the nature of the mazEaFa locus as a type II TA system. Interestingly, like most TA systems, deletion of mazEaFa had no effect on the growth of Anabaena during the tested stresses. Our data suggest that mazEaFa, or together with other chromosomal type II TA systems, may promote cells to cope with particular stresses by inducing reversible growth arrest of Anabaena.	[Ning, Degang; Liu, Zhaoying] Jiangsu Univ, Dept Environm Sci, Sch Environm, Zhenjiang, Jiangsu, Peoples R China; [Jiang, Yan; Xu, Qinggang] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Ning, DG (corresponding author), Jiangsu Univ, Dept Environm Sci, Sch Environm, Zhenjiang, Jiangsu, Peoples R China.	306502@ujs.edu.cn		xu, qinggang/0000-0002-8659-7041	National Natural Science Foundation of China [30771176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by a grant from the National Natural Science Foundation of China (grant no. 30771176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2007, FEBS LETT, V581, P1727, DOI 10.1016/j.febslet.2007.03.051; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Munoz-Martin MA, 2011, ANAL BIOANAL CHEM, V400, P3573, DOI 10.1007/s00216-011-5017-0; [Anonymous], 1984, ANNU REV MICROBIOL, V69, P114; Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Boileau C, 2011, NEW PHYTOL, V191, P1108, DOI 10.1111/j.1469-8137.2011.03774.x; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; [常家宁 CHANG Jia-Ning], 2009, [微生物学通报, Microbiology], V36, P31; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; DEMARSAC NT, 1993, FEMS MICROBIOL LETT, V104, P119; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Erental A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001281; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Florek P, 2008, FEMS MICROBIOL LETT, V278, P177, DOI 10.1111/j.1574-6968.2007.00984.x; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova K.S., 2009, BIOL DIRECT, V4, DOI [10.1186/1745-6150-1184-1119, DOI 10.1186/1745-6150-1184-1119]; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nieto C, 2007, J BACTERIOL, V189, P1266, DOI 10.1128/JB.01130-06; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; Ning DG, 2004, MICROBIOL-SGM, V150, P447, DOI 10.1099/mic.0.26747-0; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schopf J. W., 2002, ECOLOGY CYANOBACTERI, P12; Schreiter PPY, 2001, BIOSENS BIOELECTRON, V16, P811, DOI 10.1016/S0956-5663(01)00224-X; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Singletary LA, 2009, J BACTERIOL, V191, P7456, DOI 10.1128/JB.00963-09; Syed MA, 2011, J BACTERIOL, V193, P1122, DOI 10.1128/JB.01114-10; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhao LX, 2008, FEBS LETT, V582, P710, DOI 10.1016/j.febslet.2008.01.045	52	8	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56035	10.1371/journal.pone.0056035	http://dx.doi.org/10.1371/journal.pone.0056035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451033	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500006
J	Rentsch, CA; Biot, C; Gsponer, JR; Bachmann, A; Albert, ML; Breban, R				Rentsch, Cyrill A.; Biot, Claire; Gsponer, Joel R.; Bachmann, Alexander; Albert, Matthew L.; Breban, Romulus			BCG-Mediated Bladder Cancer Immunotherapy: Identifying Determinants of Treatment Response Using a Calibrated Mathematical Model	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; 27 MG; THERAPY	Intravesical Bacillus Calmette Guerin (BCG) immunotherapy is considered the standard of care for treatment of non-muscle invasive bladder cancer; however the treatment parameters were established empirically. In order to evaluate potential optimization of clinical parameters of BCG induction therapy, we constructed and queried a new mathematical model. Specifically, we assessed the impact of (1) duration between resection and the first instillation; (2) BCG dose; (3) indwelling time; and (4) treatment interval of induction therapy - using cure rate as the primary endpoint. Based on available clinical and in vitro experimental data, we constructed and parameterized a stochastic mathematical model describing the interactions between BCG, the immune system, the bladder mucosa and tumor cells. The primary endpoint of the model was the probability of tumor extinction following BCG induction therapy in patients with high risk for tumor recurrence. We theoretically demonstrate that extending the duration between the resection and the first BCG instillation negatively influences treatment outcome. Simulations of higher BCG doses and longer indwelling times both improved the probability of tumor extinction. A remarkable finding was that an inter-instillation interval two times longer than the seven-day interval used in the current standard of care would substantially improve treatment outcome. We provide insight into relevant clinical questions using a novel mathematical model of BCG immunotherapy. Our model predicts an altered regimen that may decrease side effects of treatment while improving response to therapy.	[Rentsch, Cyrill A.; Gsponer, Joel R.; Bachmann, Alexander] Univ Basel, Univ Basel Hosp, Dept Urol, Basel, Switzerland; [Rentsch, Cyrill A.; Biot, Claire; Gsponer, Joel R.; Albert, Matthew L.] Inst Pasteur, Unite Immunol Cellules Dendrit, Paris, France; [Biot, Claire] Ecole Natl Super Mines, Paris, France; [Biot, Claire; Albert, Matthew L.] Inst Natl Sante & Rech Med, U818, Paris, France; [Breban, Romulus] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France	University of Basel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Breban, R (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	romulus.breban@pasteur.fr	Albert, Matthew L/C-9782-2009	Breban, Romulus/0000-0002-5821-8139; Rentsch, Cyrill/0000-0002-8085-6006	La Ligue Contre le Cancer; Association pour la Recherche sur le Cancer; Swiss National Foundation	La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by La Ligue Contre le Cancer and Association pour la Recherche sur le Cancer. CAR acknowledges support from the Swiss National Foundation. The opinions and statements in this article are those of the authors and do not represent the official policy, endorsement, or views of Institute Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal MS, 2007, UROLOGY, V70, P1075, DOI 10.1016/j.urology.2007.07.017; Andius P, 2005, BJU INT, V96, P1290, DOI 10.1111/j.1464-410X.2005.05817.x; Bassi P, 2000, EUR UROL, V37, P31, DOI 10.1159/000052380; Biot C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003586; Bisiaux A, 2009, J UROLOGY, V181, P1571, DOI 10.1016/j.juro.2008.11.124; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Breban R, 2012, ONCOIMMUNOLOGY, V1, P9, DOI 10.4161/onci.1.1.17884; Bunimovich-Mendrazitsky S, 2008, B MATH BIOL, V70, P2055, DOI 10.1007/s11538-008-9344-z; Bunimovich-Mendrazitsky S, 2007, B MATH BIOL, V69, P1847, DOI 10.1007/s11538-007-9195-z; Bunimovich-Mendrazitsky S, 2011, MATH BIOSCI ENG, V8, P529, DOI 10.3934/mbe.2011.8.529; Bunimovich-Mendrazitsky S, 2011, J THEOR BIOL, V277, P27, DOI 10.1016/j.jtbi.2011.02.008; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; de Boer EC, 2005, EUR UROL, V48, P333, DOI 10.1016/j.eururo.2005.05.004; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; Losa A, 2000, J UROLOGY, V163, P68, DOI 10.1016/S0022-5347(05)67974-8; MACK D, 1995, BRIT J UROL, V75, P185, DOI 10.1111/j.1464-410X.1995.tb07308.x; Martinez-Pineiro JA, 2002, BJU INT, V89, P671, DOI 10.1046/j.1464-410X.2002.02722.x; MORALES A, 1976, J UROLOGY, V115, P377, DOI 10.1016/S0022-5347(17)59210-1; Ojea A, 2007, EUR UROL, V52, P1398, DOI 10.1016/j.eururo.2007.04.062; PAGANO F, 1991, J UROLOGY, V146, P32, DOI 10.1016/S0022-5347(17)37707-8; van der Meijden APM, 2003, EUR UROL, V44, P429, DOI 10.1016/S0302-2838(03)00357-9	22	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56327	10.1371/journal.pone.0056327	http://dx.doi.org/10.1371/journal.pone.0056327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451041	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500012
J	Bancos, I; Bida, JP; Tian, DF; Bundrick, M; John, K; Holte, MN; Her, YF; Evans, D; Saenz, DT; Poeschla, EM; Hook, D; Georg, G; Maher, LJ				Bancos, Irina; Bida, John Paul; Tian, Defeng; Bundrick, Mary; John, Kristen; Holte, Molly Nelson; Her, Yeng F.; Evans, Debra; Saenz, Dyana T.; Poeschla, Eric M.; Hook, Derek; Georg, Gunda; Maher, L. James			High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma	PLOS ONE			English	Article							SUCCINATE-DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; PROLYL HYDROXYLASE; CRYSTAL-STRUCTURE; PHEOCHROMOCYTOMA; MUTATIONS; GENE; ASSAY; SDHC; DISULFIRAM	Classical tumor suppressor genes block neoplasia by regulating cell growth and death. A remarkable puzzle is therefore presented by familial paraganglioma (PGL), a neuroendocrine cancer where the tumor suppressor genes encode subunits of succinate dehydrogenase (SDH), an enzyme of the tricarboxylic acid (TCA) cycle of central metabolism. Loss of SDH initiates PGL through mechanisms that remain unclear. Could this metabolic defect provide a novel opportunity for chemotherapy of PGL? We report the results of high throughput screening to identify compounds differentially toxic to SDH mutant cells using a powerful S. cerevisiae (yeast) model of PGL. Screening more than 200,000 compounds identifies 12 compounds that are differentially toxic to SDH-mutant yeast. Interestingly, two of the agents, dequalinium and tetraethylthiuram disulfide (disulfiram), are anti-malarials with the latter reported to be a glycolysis inhibitor. We show that four of the additional hits are potent inhibitors of yeast alcohol dehydrogenase. Because alcohol dehydrogenase regenerates NAD(+) in glycolytic cells that lack TCA cycle function, this result raises the possibility that lactate dehydrogenase, which plays the equivalent role in human cells, might be a target of interest for PGL therapy. We confirm that human cells deficient in SDH are differentially sensitive to a lactate dehydrogenase inhibitor.	[Bancos, Irina; Bida, John Paul; Bundrick, Mary; Holte, Molly Nelson; Her, Yeng F.; Evans, Debra; Maher, L. James] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Bida, John Paul; Her, Yeng F.; Evans, Debra] Mayo Clin, Coll Med, Mayo Grad Sch, Rochester, MN USA; [Tian, Defeng; John, Kristen; Hook, Derek; Georg, Gunda] Univ Minnesota Twin Cities, Coll Pharm, Inst Therapeut Discovery & Dev, Minneapolis, MN USA; [Saenz, Dyana T.; Poeschla, Eric M.] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Maher, LJ (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	maher@mayo.edu	Bancos, Irina/J-6560-2019	Georg, Gunda/0000-0002-8900-9460; Bancos, Irina/0000-0001-9332-2524	Mayo Foundation; Minnesota Partnership for Genomics and Biotechnology grant; Fraternal Order of Eagles grant; Ann and George M. Fisher Endowed Research Fund for Individualized Medicine grant; Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER	Mayo Foundation; Minnesota Partnership for Genomics and Biotechnology grant; Fraternal Order of Eagles grant; Ann and George M. Fisher Endowed Research Fund for Individualized Medicine grant; Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mayo Foundation, by a Minnesota Partnership for Genomics and Biotechnology grant to GG and LJM, by a Fraternal Order of Eagles grant to LJM, and by an Ann and George M. Fisher Endowed Research Fund for Individualized Medicine grant to LJM. JPB, YH and DE were supported by Mayo Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baysal BE, 2004, J MED GENET, V41, P703, DOI 10.1136/jmg.2004.019224; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; Baysal BE, 2011, HUMAN MOL GEN; Bikhazi PH, 2000, LARYNGOSCOPE, V110, P1346, DOI 10.1097/00005537-200008000-00023; Bryant J, 2003, J NATL CANCER I, V95, P1196, DOI 10.1093/jnci/djg024; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; CARPER WR, 1987, CLIN CHEM, V33, P1906; CARRATLA R, 1950, Hospital (Rio J), V38, P277; Chrisoulidou A, 2007, ENDOCR-RELAT CANCER, V14, P569, DOI 10.1677/ERC-07-0074; Cottier V, 2006, ANTIMICROB AGENTS CH, V50, P565, DOI 10.1128/AAC.50.2.565-571.2006; Elder EE, 2003, EUR J SURG ONCOL, V29, P278, DOI 10.1053/ejso.2002.1413; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Favier J, 2010, BEST PRACT RES CL EN, V24, P957, DOI 10.1016/j.beem.2010.10.004; Garcia-Perez AI, 2011, LEUKEMIA RES, V35, P1395, DOI 10.1016/j.leukres.2011.03.012; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Goldstein RE, 1999, ANN SURG, V229, P755, DOI 10.1097/00000658-199906000-00001; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Gunde T, 2005, BIOTECHNIQUES, V39, P541, DOI 10.2144/000112011; Guterman L, 2011, CHEM ENG NEWS, V89, P19, DOI 10.1021/cen-v089n036.p019; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huth JR, 2007, CHEM RES TOXICOL, V20, P1752, DOI 10.1021/tx700319t; Inabnet WB, 2000, SURGERY, V128, P1007, DOI 10.1067/msy.2000.110846; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Langeland BT, 1996, ALCOHOL ALCOHOLISM, V31, P75; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; LESTER D, 1950, Q J STUD ALCOHOL, V11, P391; Li-Weber M., 2010, CANC LETT; Lloyd R, 2004, WHO CLASSIFICATION T; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; Maxwell PH, 2005, CANCER CELL, V8, P91, DOI 10.1016/j.ccr.2005.07.012; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Miest T, 2009, METHODS, V47, P298, DOI 10.1016/j.ymeth.2008.11.001; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Nieuwenhuijsen BW, 2003, J BIOMOL SCREEN, V8, P676, DOI 10.1177/1087057103258287; Plouin PF, 2012, HORM METAB RES, V44, P390, DOI 10.1055/s-0031-1299707; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	56	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56827	10.1371/journal.pone.0056827	http://dx.doi.org/10.1371/journal.pone.0056827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451094	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800041
J	Chen, X; Liu, BG; Li, QH; Honorio, S; Liu, X; Liu, C; Multani, AS; Calhoun-Davis, T; Tang, DG				Chen, Xin; Liu, Bigang; Li, Qiuhui; Honorio, Sofia; Liu, Xin; Liu, Can; Multani, Asha S.; Calhoun-Davis, Tammy; Tang, Dean G.			Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-gamma Mice	PLOS ONE			English	Article							STEM-LIKE CELLS; INITIATING CELLS; STEM/PROGENITOR CELLS; ANDROGEN INDEPENDENCE; EXPRESSION PROFILES; PROGENITOR CELLS; SIDE POPULATION; IN-VIVO; METASTASIS; IDENTIFICATION	Reconstitution of tumor development in immunodeficient mice from disaggregated primary human tumor cells is always challenging. The main goal of the present study is to establish a reliable assay system that would allow us to reproducibly reconstitute human prostate tumor regeneration in mice using patient tumor-derived single cells. Using many of the 114 untreated primary human prostate cancer (HPCa) samples we have worked on, here we show that: 1) the subcutaneum represents the most sensitive site that allows the grafting of the implanted HPCa pieces; 2) primary HPCa cells by themselves fail to regenerate tumors in immunodeficient hosts; 3) when coinjected in Matrigel with rUGM (rat urogenital sinus mesenchyme), CAF (carcinoma-associated fibroblasts), or Hs5 (immortalized bone marrow derived stromal) cells, primary HPCa cells fail to initiate serially transplantable tumors in NOD/SCID mice; and 4) however, HPCa cells coinjected with the Hs5 cells into more immunodeficient NOD/SCID-IL2R gamma(-/-) (NSG) mice readily regenerate serially transplantable tumors. The HPCa/Hs5 reconstituted 'prostate' tumors present an overall epithelial morphology, are of the human origin, and contain cells positive for AR, CK8, and racemase. Cytogenetic analysis provides further evidence for the presence of karyotypically abnormal HPCa cells in the HPCa/Hs5 tumors. Of importance, HPCa/Hs5 xenograft tumors contain EpCAM(+) cells that are both clonogenic and tumorigenic. Surprisingly, all HPCa/Hs5 reconstituted tumors are undifferentiated, even for HPCa cells derived from Gleason 7 tumors. Our results indicate that primary HPCa cells coinjected with the immortalized Hs5 stromal cells generate undifferentiated tumors in NSG mice and we provide evidence that undifferentiated HPCa cells might be the cells that possessed tumorigenic potential and regenerated HPCa/Hs5 xenograft tumors.	[Chen, Xin; Liu, Bigang; Li, Qiuhui; Honorio, Sofia; Liu, Xin; Liu, Can; Calhoun-Davis, Tammy; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Chen, Xin; Liu, Can; Tang, Dean G.] Univ Texas Houston, Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX USA; [Li, Qiuhui] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Stomatol, Tongji Hosp, Wuhan 430074, Peoples R China; [Liu, Xin] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Multani, Asha S.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, RNA Interference & Noncoding RNAs & Mol Carcinoge, Ctr Canc Epigenet Stem Cell & Dev Biol, Houston, TX 77030 USA; [Tang, Dean G.] Tongji Univ, Sch Med, Res Ctr Translat Med, Canc Stem Cell Inst,East Hosp, Shanghai 200092, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tongji University	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Chen, Xin/0000-0002-0566-7678	NIH [R01-CA155693-01A]; Department of Defense [W81XWH-11-1-0331]; CPRIT [RP120380]; M.D. Anderson Cancer Center the Center for Cancer Epigenetics; Laura and John Arnold Foundation RNA Center pilot grant; Cockrell fellowship from Department of Molecular Carcinogenesis, M.D. Anderson Cancer Center;  [CCSG-5 P30 CA016672-34];  [ES007784]; NATIONAL CANCER INSTITUTE [R01CA155693, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); CPRIT; M.D. Anderson Cancer Center the Center for Cancer Epigenetics; Laura and John Arnold Foundation RNA Center pilot grant; Cockrell fellowship from Department of Molecular Carcinogenesis, M.D. Anderson Cancer Center; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from NIH (R01-CA155693-01A), Department of Defense (W81XWH-11-1-0331), CPRIT funding (RP120380), and the M.D. Anderson Cancer Center the Center for Cancer Epigenetics and Laura and John Arnold Foundation RNA Center pilot grant (to DGT) and by two Center Grants (CCSG-5 P30 CA016672-34 and ES007784). XC was supported by Cockrell fellowship from Department of Molecular Carcinogenesis, M.D. Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia B, 2008, INT J CANCER, V122, P1483, DOI 10.1002/ijc.23222; Cespedes M V, 2006, Clin Transl Oncol, V8, P318; CHUNG LWK, 1989, INT J CANCER, V43, P1179, DOI 10.1002/ijc.2910430636; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colombel M, 2012, PROSTATE, V72, P713, DOI 10.1002/pros.21473; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Delk NA, 2012, AUTOPHAGY, V8, P650, DOI 10.4161/auto.19226; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Germann M, 2012, STEM CELLS, V30, P1076, DOI 10.1002/stem.1087; Goldstein AS, 2011, NAT PROTOC, V6, P656, DOI 10.1038/nprot.2011.317; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Hayward SW, 2001, CANCER RES, V61, P8135; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Lacombe L, 1996, INT J CANCER, V69, P110, DOI 10.1002/(SICI)1097-0215(19960422)69:2<110::AID-IJC7>3.0.CO;2-3; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li H, 2009, METHODS MOL BIOL, V568, P85, DOI 10.1007/978-1-59745-280-9_7; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nishida S, 2012, J UROLOGY, V188, P294, DOI 10.1016/j.juro.2012.02.2555; O'Connor JC, 2007, MOL CANCER RES, V5, P585, DOI 10.1158/1541-7786.MCR-06-0408; Olumi AF, 1999, CANCER RES, V59, P5002; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Penson DF, 2007, NIH PUBLICATION, V07-5512, P71; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Placencio VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012920; PRETLOW TG, 1991, CANCER RES, V51, P3814; Priolo C, 2010, AM J PATHOL, V176, P1901, DOI 10.2353/ajpath.2010.090873; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Schwab TS, 2000, PROSTATE, V44, P164; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silvers CR, 2010, PROSTATE, V70, P1379, DOI 10.1002/pros.21171; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Toivanen R, 2011, STEM CELLS, V29, P1310, DOI 10.1002/stem.668; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042653; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; Zhao HJ, 2010, AM J PATHOL, V177, P229, DOI 10.2353/ajpath.2010.090821; Zhou JJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-112	71	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56903	10.1371/journal.pone.0056903	http://dx.doi.org/10.1371/journal.pone.0056903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451107	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800046
J	Kim, H; Kim, MS; Wee, G; Lee, CI; Kim, H; Kim, JS				Kim, Hyojin; Kim, Myung-Sun; Wee, Gabbine; Lee, Choong-il; Kim, Hyongbum; Kim, Jin-Soo			Magnetic Separation and Antibiotics Selection Enable Enrichment of Cells with ZFN/TALEN-Induced Mutations	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; MAJOR HISTOCOMPATIBILITY COMPLEX; HYGROMYCIN-B PHOSPHOTRANSFERASE; CD4(+) T-CELLS; ESCHERICHIA-COLI; GENE CORRECTION; RESISTANCE; EXPRESSION; MOUSE; TRANSLOCATION	The ability to enrich cells with targeted mutations greatly facilitates the process of using engineered nucleases, including zinc-finger nucleases and transcription activator-like effector nucleases, to construct such cells. We previously used surrogate reporters to enrich cells containing nuclease-induced mutations via flow cytometry. This method is, however, limited by the availability of flow cytometers. Furthermore, sorted cells occasionally fail to form colonies after exposure to a strong laser and hydrostatic pressure. Here we describe two different types of novel reporters that enable mutant cell enrichment without the use of flow cytometers. We designed reporters that express H-2K(k), a surface antigen, and the hygromycin resistance protein (Hygro(R)), respectively, when insertions or deletions are generated at the target sequences by the activity of engineered nucleases. After cotransfection of these reporters and the engineered nuclease-encoding plasmids, H-2K(k)- and Hygro(R)-expressing cells were isolated using magnetic separation and hygromycin treatment, respectively. We found that mutant cells were drastically enriched in the isolated cells, suggesting that these two reporters enable efficient enrichment of mutants. We propose that these two reporters will greatly facilitate the use of engineered nucleases in a wider range of biomedical research.	[Kim, Hyojin; Wee, Gabbine; Lee, Choong-il; Kim, Jin-Soo] Seoul Natl Univ, Natl Creat Res Initiat Ctr Genome Engn, Seoul, South Korea; [Kim, Hyojin; Wee, Gabbine; Lee, Choong-il; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Kim, Myung-Sun; Kim, Hyongbum] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University	Kim, H (corresponding author), Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea.	hkim1@hanyang.ac.kr; jskim01@snu.ac.kr	Kim, Hyongbum Henry/D-5804-2019; KIM, Jin-Soo/M-6918-2013	Kim, Hyongbum Henry/0000-0002-4693-738X; KIM, Jin-Soo/0000-0003-4847-1306	National Research Foundation of Korea [2012-0001225, 2012-0003376, 2012-0006735]	National Research Foundation of Korea(National Research Foundation of Korea)	J-SK and Hyongbum K. are supported in part by the National Research Foundation of Korea (J-SK, 2012-0001225; HK, 2012-0003376, 2012-0006735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; CABANAS MJ, 1978, EUR J BIOCHEM, V87, P21, DOI 10.1111/j.1432-1033.1978.tb12347.x; DAMJANOVICH S, 1984, MOL IMMUNOL, V21, P1151, DOI 10.1016/0161-5890(84)90003-8; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Gu Y, 2012, J VIROL METHODS, V182, P9, DOI 10.1016/j.jviromet.2012.02.007; Herrmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020913; HOOD L, 1983, ANNU REV IMMUNOL, V1, P529, DOI 10.1146/annurev.iy.01.040183.002525; Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; KUHSTOSS S, 1983, GENE, V26, P295, DOI 10.1016/0378-1119(83)90200-7; McMahon MA, 2012, NAT METHODS, V9, P28, DOI 10.1038/nmeth.1811; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porter CM, 2002, J IMMUNOL, V168, P4936, DOI 10.4049/jimmunol.168.10.4936; RAO RN, 1983, ANTIMICROB AGENTS CH, V24, P689, DOI 10.1128/AAC.24.5.689; SANTERRE RF, 1984, GENE, V30, P147, DOI 10.1016/0378-1119(84)90115-X; STEINMETZ M, 1983, SCIENCE, V222, P727, DOI 10.1126/science.6356354; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wei Q, 2001, POULTRY SCI, V80, P1671, DOI 10.1093/ps/80.12.1671; Willasch A, 2010, BONE MARROW TRANSPL, V45, P181, DOI 10.1038/bmt.2009.89; Zborowski M, 2011, ANAL CHEM, V83, P8050, DOI 10.1021/ac200550d; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	27	47	53	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56476	10.1371/journal.pone.0056476	http://dx.doi.org/10.1371/journal.pone.0056476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441197	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200054
J	Dambach, M; Irnov, I; Winkler, WC				Dambach, Michael; Irnov, Irnov; Winkler, Wade C.			Association of RNAs with Bacillus subtilis Hfq	PLOS ONE			English	Article							ESCHERICHIA-COLI HFQ; BINDING RNAS; PROTEIN; REVEALS; IDENTIFICATION; BACTERIA; GENE; RIBOSWITCHES; REPRESSION; EXPRESSION	The prevalence and characteristics of small regulatory RNAs (sRNAs) have not been well characterized for Bacillus subtilis, an important model system for Gram-positive bacteria. However, B. subtilis was recently found to synthesize many candidate sRNAs during stationary phase. In the current study, we performed deep sequencing on Hfq-associated RNAs and found that a small subset of sRNAs associates with Hfq, an enigmatic RNA-binding protein that stabilizes sRNAs in Gram-negatives, but whose role is largely unknown in Gram-positive bacteria. We also found that Hfq associated with antisense RNAs, antitoxin transcripts, and many mRNA leaders. Several new candidate sRNAs and mRNA leader regions were also discovered by this analysis. Additionally, mRNA fragments overlapping with start or stop codons associated with Hfq, while, in contrast, relatively few full-length mRNAs were recovered. Deletion of hfq reduced the intracellular abundance of several representative sRNAs, suggesting that B. subtilis Hfq-sRNA interactions may be functionally significant in vivo. In general, we anticipate this catalog of Hfq-associated RNAs to serve as a resource in the functional characterization of Hfq in B. subtilis.	[Dambach, Michael; Irnov, Irnov] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Winkler, Wade C.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Maryland; University of Maryland College Park	Winkler, WC (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	wwinkler@umd.edu		Irnov, Irnov/0000-0001-8631-4075	University of Texas Southwestern Medical Center Endowed Scholars Program; National Institutes of Health (NIH) [R01GM081882]; NIH T32 [GM008203]; Sara and Frank McKnight; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081882] Funding Source: NIH RePORTER	University of Texas Southwestern Medical Center Endowed Scholars Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara and Frank McKnight; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by the University of Texas Southwestern Medical Center Endowed Scholars Program and National Institutes of Health (NIH) R01GM081882. MD was supported by the NIH T32 training grant GM008203. II was supported by the Sara and Frank McKnight graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Attia AS, 2008, INFECT IMMUN, V76, P2520, DOI 10.1128/IAI.01652-07; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick Jeffrey E., 2009, V540, P1, DOI 10.1007/978-1-59745-558-9_1; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Durand S, 2012, PLOS GENET, V8; Eiamphungporn W, 2009, J BACTERIOL, V191, P1101, DOI 10.1128/JB.01530-08; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gottesman S, 2010, COLD SPRING HARB PER; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hopkins JF, 2011, NUCLEIC ACIDS RES, V39, P5193, DOI 10.1093/nar/gkr062; Huttenhofer A, 2006, COLD SPRING HARB SYM, V71, P135, DOI 10.1101/sqb.2006.71.007; Hwang W, 2011, NUCLEIC ACIDS RES, V39, P5131, DOI 10.1093/nar/gkr075; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032; Maki K, 2010, MOL MICROBIOL, V76, P782, DOI 10.1111/j.1365-2958.2010.07141.x; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; MANTSALA P, 1992, J BACTERIOL, V174, P1883; Marchais A, 2011, RNA BIOL, V8, P358, DOI 10.4161/rna.8.3.14998; MELIN L, 1987, J BACTERIOL, V169, P3232, DOI 10.1128/jb.169.7.3232-3236.1987; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Ramesh A, 2011, J MOL BIOL, V407, P556, DOI 10.1016/j.jmb.2011.01.049; Ramesh A, 2010, RNA BIOL, V7, P77, DOI 10.4161/rna.7.1.10490; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; Schilling D, 2009, J BACTERIOL, V191, P5553, DOI 10.1128/JB.00490-09; Schmalisch M, 2010, J BACTERIOL, V192, P5402, DOI 10.1128/JB.00534-10; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Silvaggi JM, 2005, J BACTERIOL, V188, P532; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sittka A, 2009, RNA BIOL, V6, P266, DOI 10.4161/rna.6.3.8332; Smaidone GT, 2012, J BACTERIOL, V194, P2586, DOI 10.1128/JB.05567-11; Someya T, 2012, NUCLEIC ACIDS RES, V40, P1856, DOI 10.1093/nar/gkr892; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Winkler WC, 2007, BACILLUS CELLULAR MO, P167; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	74	50	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55156	10.1371/journal.pone.0055156	http://dx.doi.org/10.1371/journal.pone.0055156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457461	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700009
J	Rae, M; Grace, C; Hogg, K; Wilson, LM; McHaffie, SL; Ramaswamy, S; MacCallum, J; Connolly, F; McNeilly, AS; Duncan, C				Rae, Mick; Grace, Cathal; Hogg, Kirsten; Wilson, Lisa Marie; McHaffie, Sophie L.; Ramaswamy, Seshadri; MacCallum, Janis; Connolly, Fiona; McNeilly, Alan S.; Duncan, Colin			The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS)	PLOS ONE			English	Article							BETA-CELL FUNCTION; PRENATAL TESTOSTERONE EXCESS; GROWTH-FACTOR-II; INSULIN SENSITIVITY; FEMALE SHEEP; MATERNAL UNDERNUTRITION; NEUROENDOCRINE FUNCTION; METABOLIC DYSFUNCTION; GLUCOSE-HOMEOSTASIS; ISLET DEVELOPMENT	Using an ovine model of polycystic ovary syndrome (PCOS), (pregnant ewes injected with testosterone propionate (TP) (100 mg twice weekly) from day (d)62 to d102 of d147 gestation (maternal injection - MI-TP)), we previously reported female offspring with normal glucose tolerance but hyperinsulinemia. We therefore examined insulin signalling and pancreatic morphology in these offspring using quantitative (Q) RT-PCR and western blotting. In addition the fetal pancreatic responses to MI-TP, and androgenic and estrogenic contributions to such responses (direct fetal injection (FI) of TP (20 mg) or diethylstilbestrol (DES) (20 mg) at d62 and d82 gestation) were assessed at d90 gestation. Fetal plasma was assayed for insulin, testosterone and estradiol, pancreatic tissue was cultured, and expression of key beta-cell developmental genes was assessed by QRT-PCR. In female d62MI-TP offspring insulin signalling was unaltered but there was a pancreatic phenotype with increased numbers of beta-cells (P<0.05). The fetal pancreas expressed androgen receptors in islets and genes involved in beta-cell development and function (PDX1, IGF1R, INSR and INS) were up-regulated in female fetuses after d62MI-TP treatment (P<0.05-0.01). In addition the d62MI-TP pancreas showed increased insulin secretion under euglycaemic conditions (P<0.05) in vitro. The same effects were not seen in the male fetal pancreas or when MI-TP was started at d30, before the male programming window. As d62MI-TP increased both fetal plasma testosterone (P<0.05) and estradiol concentrations (P<0.05) we assessed the relative contribution of androgens and estrogens. FI-TP (commencing d62) (not FIDES treatment) caused elevated basal insulin secretion in vitro and the genes altered by d62MI-TP treatment were similarly altered by FI-TP but not FI-DES. In conclusion, androgen over-exposure alters fetal pancreatic development and beta-cell numbers in offspring. These data suggest that that there may be a primary pancreatic phenotype in models of PCOS, and that there may be a distinct male and female pancreas.	[Rae, Mick; Grace, Cathal; Wilson, Lisa Marie; Ramaswamy, Seshadri; MacCallum, Janis] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Hogg, Kirsten; McHaffie, Sophie L.; Connolly, Fiona; McNeilly, Alan S.; Duncan, Colin] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	Edinburgh Napier University; University of Edinburgh	Rae, M (corresponding author), Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland.	m.rae@napier.ac.uk		McHaffie, Sophie/0000-0002-9088-2646	Medical Research Council (MRC) [G0500717]; MRC project grant [G0901807]; University of Edinburgh; SFC; MRC [G1100355, G1002033, G0901807, G0500717] Funding Source: UKRI; Medical Research Council [G0901807, G0500717, G1002033, G1100355] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC project grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh; SFC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Medical Research Council (MRC) project grant (G0500717) to CD and ASM and MRC project grant (G0901807) to CD, MTR and ASM. KH has a University of Edinburgh CMVM studentship. CD is supported by a Scottish Senior Clinical Fellowship from the SFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Arslanian SA, 2001, J CLIN ENDOCR METAB, V86, P66, DOI 10.1210/jc.86.1.66; ATTAL J, 1969, ENDOCRINOLOGY, V85, P280, DOI 10.1210/endo-85-2-280; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; BARNES RB, 1994, J CLIN ENDOCR METAB, V79, P1328, DOI 10.1210/jcem.79.5.7962325; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; Birch RA, 2003, ENDOCRINOLOGY, V144, P1426, DOI 10.1210/en.2002-220965; Breant B, 2006, HORM RES, V65, P98, DOI 10.1159/000091513; Cao WH, 2010, AM J PHYSIOL-ENDOC M, V298, pE372, DOI 10.1152/ajpendo.00677.2009; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Ciampelli M, 1997, HUM REPROD, V12, P1897, DOI 10.1093/humrep/12.9.1897; Colilla S, 2001, J CLIN ENDOCR METAB, V86, P2027, DOI 10.1210/jc.86.5.2027; de Miguel-Santos L, 2010, J MOL ENDOCRINOL, V44, P25, DOI 10.1677/JME-09-0045; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; Dickinson RE, 2008, ENDOCRINOLOGY, V149, P5024, DOI 10.1210/en.2008-0204; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fujimoto K, 2009, DIABETES OBES METAB, V11, P30, DOI 10.1111/j.1463-1326.2009.01121.x; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006; Green AS, 2011, AM J PHYSIOL-ENDOC M, V300, pE817, DOI 10.1152/ajpendo.00572.2010; Hogg K, 2012, ENDOCRINOLOGY, V153, P450, DOI 10.1210/en.2011-1607; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; HOLTE J, 1995, J CLIN ENDOCR METAB, V80, P2586, DOI 10.1210/jc.80.9.2586; Husted SM, 2008, DOMEST ANIM ENDOCRIN, V34, P419, DOI 10.1016/j.domaniend.2007.12.002; Li R, 2008, MAR GEOD, V31, P1, DOI 10.1080/01490410701860856; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; Melloul D, 2004, ANN NY ACAD SCI, V1014, P28, DOI 10.1196/annals.1294.003; Messer C, 2012, ENDOCR PRACT, V1, P1; Morimoto S, 2005, J ENDOCRINOL, V187, P217, DOI 10.1677/joe.1.06357; Morimoto S, 2001, ENDOCRINOLOGY, V142, P1442, DOI 10.1210/en.142.4.1442; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Padmanabhan V, 2006, MOL CELL ENDOCRINOL, V246, P165, DOI 10.1016/j.mce.2005.11.016; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Palomar-Morales M, 2010, PANCREAS, V39, P193, DOI 10.1097/MPA.0b013e3181c156d9; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petrik J, 1999, ENDOCRINOLOGY, V140, P2353, DOI 10.1210/en.140.5.2353; Quirke LD, 2001, BIOL REPROD, V65, P216, DOI 10.1095/biolreprod65.1.216; Rae MT, 2002, REPRODUCTION, V124, P33, DOI 10.1530/rep.0.1240033; Rajkhowa M, 2009, BIOCHEM J, V418, P665, DOI 10.1042/BJ20082176; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; Ren ZH, 2010, CELL BIOL INT, V34, P523, DOI 10.1042/CBI20090390; Roberts EK, 2008, BIOL REPROD, V79, P43, DOI 10.1095/biolreprod.107.067074; Robles-Diaz G, 2001, ISRAEL MED ASSOC J, V3, P364; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Savabieasfahani M, 2005, BIOL REPROD, V72, P221, DOI 10.1095/biolreprod.104.031070; Steckler T, 2007, ENDOCRINOLOGY, V148, P3532, DOI 10.1210/en.2007-0339	53	39	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56263	10.1371/journal.pone.0056263	http://dx.doi.org/10.1371/journal.pone.0056263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457541	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700037
J	Busse, S; Genet, C; Hornschemeyer, T				Buesse, Sebastian; Genet, Cecile; Hoernschemeyer, Thomas			Homologization of the Flight Musculature of Zygoptera (Insecta: Odonata) and Neoptera (Insecta)	PLOS ONE			English	Article							WING BASE SCLERITES; EPHEMEROPTERA; PTEROTHORAX; MORPHOLOGY; HOMOLOGY; THORAX; MUSCLES	Among the winged insects (Pterygota) the Dragonflies and Damselflies (Odonata) are unique for several reasons. Behaviourally they are aerial predators that hunt and catch their prey in flight, only. Morphologically the flight apparatus of Odonata is significantly different from what is found in the remaining Pterygota. However, to understand the phylogenetic relationships of winged insects and the origin and evolution of insect flight in general, it is essential to know how the elements of the odonatan flight apparatus relate to those of the other Pterygota. Here we present a comprehensive, comparative morphological investigation of the thoracic flight musculature of damselflies (Zygoptera). Based on our new data we propose a homologization scheme for the thoracic musculature throughout Pterygota. The new homology hypotheses will allow for future comparative work and especially for phylogenetic analyses using characters of the thoracic musculature throughout all winged insects. This will contribute to understand the early evolution of pterygote insects and their basal phylogenetic relationship.	[Buesse, Sebastian; Genet, Cecile; Hoernschemeyer, Thomas] Univ Gottingen, Dept Morphol Systemat & Evolutionary Biol, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany	University of Gottingen	Busse, S (corresponding author), Univ Gottingen, Dept Morphol Systemat & Evolutionary Biol, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	sebastian.buesse@biologie.uni-goettingen.de	Hörnschemeyer, Thomas/AAU-9813-2020	Hörnschemeyer, Thomas/0000-0002-4924-5389	DFG (Deutsche Forschungsgemeinschaft) [HO2306/6-1]; DFG Heisenberg [HO2306/7-1]; Swiss Light Source, Villigen, Switzerland [20080794, 20100088]; Deutsches Elektronen Synchrotron (DESY) in Hamburg, Germany [I-20090102]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG Heisenberg(German Research Foundation (DFG)); Swiss Light Source, Villigen, Switzerland; Deutsches Elektronen Synchrotron (DESY) in Hamburg, Germany	The project was partly financed through the DFG (Deutsche Forschungsgemeinschaft) grant HO2306/6-1, and TH was directly supported through the DFG Heisenberg grant HO2306/7-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank Prof. Dr. R. Willmann for his generous support of their work. We are also grateful for the support by the staff at the synchrotron facilities at the Swiss Light Source, Villigen, Switzerland (Proposal no. 20080794 & 20100088, ThH) and the Deutsches Elektronen Synchrotron (DESY) in Hamburg, Germany, (Proposal no. I-20090102, SB). Furthermore, we want to thank C. Fischer for proofreading and K. Yoshizawa and an unknown reviewer for their helpful comments.	Asahina S, 1954, MORPHOLOGICAL STUDY; Bechly Gunter, 1996, Petalura Special-Volume, V2, P1; Blanke A, 2013, ORG DIVERS EVOL, V13, P55, DOI 10.1007/s13127-012-0097-z; Brodsky A. K., 1994, EVOLUTION INSECT FLI; Busse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038132; CHAO HSIU-FU, 1953, SMITHSONIAN MISC COLL, V122, P1; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Dudley R, 1990, BIOMECHANICS FLIGHT; Friedrich F, 2008, ARTHROPOD STRUCT DEV, V37, P29, DOI 10.1016/j.asd.2007.04.003; HATCH G, 1966, ANN ENTOMOL SOC AM, V59, P702, DOI 10.1093/aesa/59.4.702; Hornschemeyer T, 2002, ZOOL SCR, V31, P17, DOI 10.1046/j.0300-3256.2001.00086.x; Keler S.v., 1963, ENTOMOLOGISCHES WORT; Maloeuf NSR, 1935, J MORPHOL, V58, P87, DOI 10.1002/jmor.1050580104; MATSUDA R, 1970, MEM ENTOMOL SOC CAN, P1; Ninomiya T, 2009, SYST ENTOMOL, V34, P334, DOI 10.1111/j.1365-3113.2008.00455.x; PFAU H K, 1986, Tijdschrift voor Entomologie, V129, P35; Romeis B., 1987, MIKROSKOPISCHE TECHN; Ruppel G., 1993, Odonatologica, V22, P295; Russenberger H. M., 1960, MITT NATURFORSCH GES, V27, P1; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Tannert W., 1958, Deutsche Entomologische Zeitschrift NF, V5, P394; WILLKOMMEN J, 2008, STUTTG BEITR NA 0430, P203; Willkommen J, 2007, ARTHROPOD STRUCT DEV, V36, P253, DOI 10.1016/j.asd.2007.01.003; Xylander WER, 2005, LEHRB SPEZIELLE, P167; Yoshizawa K, 2007, ARTHROPOD STRUCT DEV, V36, P277, DOI 10.1016/j.asd.2007.05.004	26	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55787	10.1371/journal.pone.0055787	http://dx.doi.org/10.1371/journal.pone.0055787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457479	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700022
J	Faeh, D; Braun, J; Rufibach, K; Puhan, MA; Marques-Vidal, P; Bopp, M				Faeh, David; Braun, Julia; Rufibach, Kaspar; Puhan, Milo A.; Marques-Vidal, Pedro; Bopp, Matthias		SNC	Population Specific and Up to Date Cardiovascular Risk Charts Can Be Efficiently Obtained with Record Linkage of Routine and Observational Data	PLOS ONE			English	Article							EUROPEAN GUIDELINES; SCORE; MORTALITY; DISEASE; PREVENTION	Background: Only few countries have cohorts enabling specific and up-to-date cardiovascular disease (CVD) risk estimation. Individual risk assessment based on study samples that differ too much from the target population could jeopardize the benefit of risk charts in general practice. Our aim was to provide up-to-date and valid CVD risk estimation for a Swiss population using a novel record linkage approach. Methods: Anonymous record linkage was used to follow-up (for mortality, until 2008) 9,853 men and women aged 25-74 years who participated in the Swiss MONICA (MONItoring of trends and determinants in CVD) study of 1983-92. The linkage success was 97.8%, loss to follow-up 1990-2000 was 4.7%. Based on the ESC SCORE methodology (Weibull regression), we used age, sex, blood pressure, smoking, and cholesterol to generate three models. We compared the 1) original SCORE model with a 2) recalibrated and a 3) new model using the Brier score (BS) and cross-validation. Results: Based on the cross-validated BS, the new model (BS = 14107 x 10(-6)) was somewhat more appropriate for risk estimation than the original (BS = 14190 x 10(-6)) and the recalibrated (BS = 14172 x 10(-6)) model. Particularly at younger age, derived absolute risks were consistently lower than those from the original and the recalibrated model which was mainly due to a smaller impact of total cholesterol. Conclusion: Using record linkage of observational and routine data is an efficient procedure to obtain valid and up-to-date CVD risk estimates for a specific population.	[Faeh, David; Braun, Julia; Rufibach, Kaspar; Bopp, Matthias] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; [Puhan, Milo A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Marques-Vidal, Pedro] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland	University of Zurich; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bopp, M (corresponding author), Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland.	bopp@ifspm.uzh.ch	Puhan, Milo/ABE-6298-2020; Rufibach, Kaspar/F-1163-2010; Marques-Vidal, Pedro M/C-9449-2009	Puhan, Milo/0000-0003-4721-1879; Rufibach, Kaspar/0000-0002-2634-1167; Marques-Vidal, Pedro M/0000-0002-4548-8500; Bopp, Matthias/0000-0003-0766-3723	Swiss National Science Foundation [3347CO-108806, 33CS30-134273, 32473B-125710]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grants 3347CO-108806, 33CS30-134273, 32473B-125710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bopp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030795; Bopp M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-562; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Faeh D, 2009, J EPIDEMIOL COMMUN H, V63, P639, DOI 10.1136/jech.2008.081042; Faeh D, 2011, EUR J CARDIOVASC PRE; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gaspoz JM, 2009, SUIVI FACTEURS RISQU; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Hartz I, 2005, EUR HEART J, V26, P2673, DOI 10.1093/eurheartj/ehi556; Marques-Vidal P, 2008, EUR J CARDIOV PREV R, V15, P402, DOI 10.1097/HJR.0b013e3282fb040f; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; OECD, 2011, HLTH GLANC EUR 2010; Panagiotakos Demosthenes B, 2007, Hellenic J Cardiol, V48, P55; Sans S, 2007, REV ESP CARDIOL, V60, P476, DOI 10.1016/S1885-5857(07)60188-1; Steiger VS, 2009, SWISS MED WKLY, V139, P453, DOI smw-12607; Steyerberg E., 2009, CLIN PREDICTION MODE; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Wietlisbach V, 1997, PREV MED, V26, P523, DOI 10.1006/pmed.1997.0167; WIETLISBACH V, 1987, SOZ PRAVENTIV MED, V32, P52	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56149	10.1371/journal.pone.0056149	http://dx.doi.org/10.1371/journal.pone.0056149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457516	Green Published, gold			2022-12-27	WOS:000315602700050
J	Cho, YY; Kim, DJ; Lee, HS; Jeong, CH; Cho, EJ; Kim, MO; Byun, S; Lee, KY; Yao, K; Carper, A; Langfald, A; Bode, AM; Dong, ZG				Cho, Yong-Yeon; Kim, Dong Joon; Lee, Hye Suk; Jeong, Chul-Ho; Cho, Eun-Jin; Kim, Myong-Ok; Byun, Sanguine; Lee, Kun-Yeong; Yao, Ke; Carper, Andria; Langfald, Alyssa; Bode, Ann M.; Dong, Zigang			Autophagy and Cellular Senescence Mediated by Sox2 Suppress Malignancy of Cancer Cells	PLOS ONE			English	Article							INHIBITION; INDUCTION; GROWTH; DEATH; PTEN; PLURIPOTENCY; MECHANISMS; PHENOTYPE; APOPTOSIS; PATHWAY	Autophagy is a critical cellular process required for maintaining cellular homeostasis in health and disease states, but the molecular mechanisms and impact of autophagy on cancer is not fully understood. Here, we found that Sox2, a key transcription factor in the regulation of the "stemness'' of embryonic stem cells and induced-pluripotent stem cells, strongly induced autophagic phenomena, including intracellular vacuole formation and lysosomal activation in colon cancer cells. The activation occurred through Sox2-mediated ATG10 gene expression and resulted in the inhibition of cell proliferation and anchorage-independent colony growth ex vivo and tumor growth in vivo. Further, we found that Sox2-induced-autophagy enhanced cellular senescence by up-regulating tumor suppressors or senescence factors, including p16(INK4a), p21 and phosphorylated p53 (Ser15). Notably, knockdown of ATG10 in Sox2-expressing colon cancer cells restored cancer cell properties. Taken together, our results demonstrated that regulation of autophagy mediated by Sox2 is a mechanism-driven novel strategy to treat human colon cancers.	[Kim, Dong Joon; Jeong, Chul-Ho; Cho, Eun-Jin; Kim, Myong-Ok; Byun, Sanguine; Lee, Kun-Yeong; Yao, Ke; Carper, Andria; Langfald, Alyssa; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Cho, Yong-Yeon; Lee, Hye Suk] Catholic Univ Korea, Coll Pharm, Gyeonggi Do, South Korea	University of Minnesota System; Catholic University of Korea	Cho, YY (corresponding author), Catholic Univ Korea, Coll Pharm, Gyeonggi Do, South Korea.	yongyeon@catholic.ac.kr; zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; Byun, Sanguine/AAR-5451-2021	Byun, Sanguine/0000-0003-3903-5887; Cho, Yong-Yeon/0000-0003-1107-2651	Hormel Foundation; National Institutes of Health [CA111536, CA120388, CA077646, R37CA081064, ES016548]; Catholic University of Korea [M-2011-B0002-00025]; NATIONAL CANCER INSTITUTE [R37CA081064, R01CA120388, R01CA111536, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catholic University of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by The Hormel Foundation and National Institutes of Health grants CA111536, CA120388, CA077646, R37CA081064 and ES016548, and by the Research Fund, M-2011-B0002-00025 of The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kanzawa T, 2003, CANCER RES, V63, P2103; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Oh S, 2011, CELL DEATH DIFFER, V18, P452, DOI 10.1038/cdd.2010.116; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sauer H, 2004, EXP CELL RES, V294, P313, DOI 10.1016/j.yexcr.2003.10.032; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wacnik PW, 2005, PAIN, V115, P95, DOI 10.1016/j.pain.2005.02.024; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XL, 2005, J BIOL CHEM, V280, P19635, DOI 10.1074/jbc.M502262200; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	49	27	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57172	10.1371/journal.pone.0057172	http://dx.doi.org/10.1371/journal.pone.0057172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451179	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500075
J	Gramlich, OW; Beck, S; Hohenstein-Blaul, NVU; Boehm, N; Ziegler, A; Vetter, JM; Pfeiffer, N; Grus, FH				Gramlich, Oliver W.; Beck, Sabine; Hohenstein-Blaul, Nadine von Thun Und; Boehm, Nils; Ziegler, Anika; Vetter, Jan M.; Pfeiffer, Norbert; Grus, Franz H.			Enhanced Insight into the Autoimmune Component of Glaucoma: IgG Autoantibody Accumulation and Pro-Inflammatory Conditions in Human Glaucomatous Retina	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; NORMAL-PRESSURE GLAUCOMA; NORMAL-TENSION GLAUCOMA; MYELIN BASIC-PROTEIN; MEMORY B-CELLS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; AQUEOUS-HUMOR; SYSTEMIC INFLAMMATION	Background: There is accumulating evidence that autoimmune components, such as autoantibodies and autoantibody depositions, play a role in the pathogenesis of neurodegenerative diseases like Alzheimers disease or Multiple Sclerosis. Due to alterations of autoantibody patterns in sera and aqueous humor, an autoimmune component is also assumed in the pathogenesis of glaucoma, a common reason for irreversible blindness worldwide. So far there has been no convincing evidence that autoantibodies are accumulated in the retina of glaucoma patients and that the local immune homeostasis might be affected. Methods and Results: Six human glaucomatous donor eyes and nine samples from donors with no recorded ocular disease were included. Antibody microarrays were used to examine the patterns of pro-inflammatory proteins and complement proteins. Analysis of TNF-alpha and interleukin levels revealed a slight up-regulation exclusively in the glaucomatous group, while complement protein levels were not altered. IgG autoantibody accumulations and/or cellular components were determined by immunohistology (n = 4 per group). A significantly reduced number of retinal ganglion cells was found in the glaucomatous group (healthy: 104 +/- 7 nuclei/mm, glaucoma: 67 +/- 9 nuclei/mm; p = 0.0007). Cell loss was accompanied by strong retinal IgG autoantibody accumulations, which were at least twice as high as in healthy subjects (healthy: 5.0 +/- 0.5 IgG deposits/100 cells, glaucoma: 9.4 +/- 1.9 IgG deposits/100 cells; p = 0.004). CD27(+) cells and CD27(+)/IgG(+) plasma cells were observed in all glaucomatous subjects, but not in controls. Conclusion: This work provides serious evidence for the occurrence of IgG antibody deposition and plasma cells in human glaucomatous retina. Moreover, the results suggest that these IgG deposits occurred in a pro-inflammatory environment which seems to be maintained locally by immune-competent cells like microglia. Thereby, glaucoma features an immunological involvement comparable to other neurodegenerative diseases, but also shows a multifactorial pathomechanism, which diverges and might be linked to the specific nature of both eye and retina.	[Gramlich, Oliver W.; Beck, Sabine; Hohenstein-Blaul, Nadine von Thun Und; Boehm, Nils; Ziegler, Anika; Pfeiffer, Norbert; Grus, Franz H.] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Vetter, Jan M.] Univ Med Ctr Mainz, Dept Ophthalmol, Cornea Bank Rhineland Palatine, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	grus@eye-research.org	Pfeiffer, Norbert/AAO-7586-2020; Thun-Blaul, Nadine/B-6106-2018	Gramlich, Oliver W/0000-0001-6948-0522	Deutsche Forschungsgesellschaft (DFG) [Gr-1463/4-2]	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	This work was sponsored in parts by Deutsche Forschungsgesellschaft (DFG) Gr-1463/4-2. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, INDIAN J OPHTHALMOL, V57, P257, DOI 10.4103/0301-4738.53049; Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; BIGLER RD, 1988, J IMMUNOL, V141, P21; Chua J, 2012, MOL VIS, V18, P431; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; D'Andrea MR, 2005, MED HYPOTHESES, V64, P458, DOI 10.1016/j.mehy.2004.08.024; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Martin MD, 2007, FRONT BIOSCI-LANDMRK, V12, P2735, DOI 10.2741/2268; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; Duane TD, 2001, DUANES CLIN OPHTHALM; EGS, 2006, TERM GUID GLAUC; Emmerling MR, 2000, BBA-MOL BASIS DIS, V1502, P158, DOI 10.1016/S0925-4439(00)00042-9; Fecteau JF, 2009, IMMUNOLOGY, V128, pe353, DOI 10.1111/j.1365-2567.2008.02976.x; Gramlich OW, 2011, GRAEF ARCH CLIN EXP, V249, P1009, DOI 10.1007/s00417-011-1633-9; Grus FH, 2006, INVEST OPHTH VIS SCI, V47, P968, DOI 10.1167/iovs.05-0685; Grus FH, 2004, MOL VIS, V10, P132; Grus FH, 2003, INVEST OPHTH VIS SCI, V44, P2100; Grus FH, 2005, INVEST OPHTH VIS SCI, V46, P1285; Grus FH, 2008, J GLAUCOMA, V17, P79, DOI 10.1097/IJG.0b013e318156a592; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Ikeda Y, 2002, JPN J OPHTHALMOL, V46, P13, DOI 10.1016/S0021-5155(01)00455-5; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Janciauskiene S, 2011, EUR J OPHTHALMOL, V21, P104, DOI 10.5301/EJO.2010.2108; Joachim SC, 2005, GRAEF ARCH CLIN EXP, V243, P817, DOI 10.1007/s00417-004-1094-5; Joachim SC, 2003, EUR J OPHTHALMOL, V13, P752, DOI 10.1177/1120672103013009-1003; Joachim SC, 2004, INVEST OPHTH VIS SCI, V45, P879; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Joachim SC, 2007, MOL VIS, V13, P1573; Joachim SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040616; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kimura A, 2008, LUPUS, V17, P16, DOI 10.1177/0961203307085112; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Kremmer S, 2001, CLIN EXP IMMUNOL, V125, P211, DOI 10.1046/j.1365-2249.2001.01578.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Laspas P, 2011, INVEST OPHTH VIS SCI, V52, P8835, DOI 10.1167/iovs.10-6889; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Maruyama I, 2000, INVEST OPHTH VIS SCI, V41, P1657; MAURER D, 1990, EUR J IMMUNOL, V20, P2679, DOI 10.1002/eji.1830201223; MAURER D, 1992, J IMMUNOL, V148, P3700; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Osborne NN, 2010, NEUROCHEM RES, V35, P2027, DOI 10.1007/s11064-010-0273-5; Petrescu Simona, 2008, Oftalmologia, V52, P3; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ray K, 2009, J GENET, V88, P451, DOI 10.1007/s12041-009-0065-3; Reichelt J, 2008, CURR EYE RES, V33, P253, DOI 10.1080/02713680701871157; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Streilein JW, 1999, PROG RETIN EYE RES, V18, P357, DOI 10.1016/S1350-9462(98)00022-6; Streilein JW, 2003, J LEUKOCYTE BIOL, V74, P179, DOI 10.1189/jlb.1102574; SUGITA K, 1992, J IMMUNOL, V149, P3208; SUTTER A, 1991, PATHOBIOLOGY, V59, P254; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Tezel G, 2000, ARCH OPHTHALMOL-CHIC, V118, P511, DOI 10.1001/archopht.118.4.511; Tezel G, 2003, INVEST OPHTH VIS SCI, V44, P3025, DOI 10.1167/iovs.02-1136; Tezel G, 1999, ARCH OPHTHALMOL-CHIC, V117, P917; Tezel G, 2011, EXP EYE RES, V93, P178, DOI 10.1016/j.exer.2010.07.009; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P5071, DOI 10.1167/iovs.10-5289; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P27, DOI 10.1097/00005072-199401000-00004; Veerhuis R, 2011, CURR ALZHEIMER RES, V8, P34, DOI 10.2174/156720511794604589; Vojdani A, 2003, J INTERN MED, V254, P363, DOI 10.1046/j.1365-2796.2003.01203.x; WARREN KG, 1994, ANN NEUROL, V35, P280, DOI 10.1002/ana.410350307; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wax MB, 1998, ARCH OPHTHALMOL-CHIC, V116, P993, DOI 10.1001/archopht.116.8.993; Wax MB, 1998, AM J OPHTHALMOL, V125, P145, DOI 10.1016/S0002-9394(99)80084-1; WAX MB, 1994, AM J OPHTHALMOL, V117, P561, DOI 10.1016/S0002-9394(14)70059-5; Wax MB, 2010, EXP EYE RES; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P1273; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	87	84	85	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57557	10.1371/journal.pone.0057557	http://dx.doi.org/10.1371/journal.pone.0057557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451242	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500114
J	Grousl, T; Ivanov, P; Malcova, I; Pompach, P; Frydlova, I; Slaba, R; Senohrabkova, L; Novakova, L; Hasek, J				Grousl, Tomas; Ivanov, Pavel; Malcova, Ivana; Pompach, Petr; Frydlova, Ivana; Slaba, Renata; Senohrabkova, Lenka; Novakova, Lenka; Hasek, Jiri			Heat Shock-Induced Accumulation of Translation Elongation and Termination Factors Precedes Assembly of Stress Granules in S. cerevisiae	PLOS ONE			English	Article							CYTOPLASMIC PROCESSING BODIES; GUANINE-NUCLEOTIDE EXCHANGE; EUKARYOTIC MESSENGER-RNAS; SACCHAROMYCES-CEREVISIAE; P-BODIES; BUDDING YEAST; EIF2-ALPHA PHOSPHORYLATION; FISSION YEAST; POLYSOMES; BODY	In response to severe environmental stresses eukaryotic cells shut down translation and accumulate components of the translational machinery in stress granules (SGs). Since they contain mainly mRNA, translation initiation factors and 40S ribosomal subunits, they have been referred to as dominant accumulations of stalled translation preinitiation complexes. Here we present evidence that the robust heat shock-induced SGs of S. cerevisiae also contain translation elongation factors eEF3 (Yef3p) and eEF1B gamma 2 (Tef4p) as well as translation termination factors eRF1 (Sup45p) and eRF3 (Sup35p). Despite the presence of the yeast prion protein Sup35 in heat shock-induced SGs, we found out that its prion-like domain is not involved in the SGs assembly. Factors eEF3, eEF1B gamma 2 and eRF1 were accumulated and co-localized with Dcp2 foci even upon a milder heat shock at 42 degrees C independently of P-bodies scaffolding proteins. We also show that eEF3 accumulations at 42 degrees C determine sites of the genuine SGs assembly at 46 degrees C. We suggest that identification of translation elongation and termination factors in SGs might help to understand the mechanism of the eIF2 alpha factor phosphorylation-independent repression of translation and SGs assembly.	[Grousl, Tomas; Ivanov, Pavel; Malcova, Ivana; Pompach, Petr; Frydlova, Ivana; Slaba, Renata; Senohrabkova, Lenka; Novakova, Lenka; Hasek, Jiri] Inst Microbiol AS CR, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Hasek, J (corresponding author), Inst Microbiol AS CR, Vvi, Prague, Czech Republic.	hasek@biomed.cas.cz	Malcova, Ivana/ABB-6413-2021; Ivanov, Pavel/AAZ-9197-2021; Malcova, Ivana/H-2439-2014; Hasek, Jiri/H-2427-2014; Pompach, Petr/J-6209-2014; Groušl, Tomáš/AAF-3655-2019; Ivanov, Pavel/F-3339-2016; Groušl, Tomáš/I-1727-2014; Senohrábková, Lenka/I-1668-2014; Lejskova, Renata/I-1669-2014	Malcova, Ivana/0000-0002-4385-3842; Ivanov, Pavel/0000-0002-7986-7760; Malcova, Ivana/0000-0002-4385-3842; Hasek, Jiri/0000-0001-6634-2386; Pompach, Petr/0000-0002-0606-0851; Groušl, Tomáš/0000-0002-6996-1323; Ivanov, Pavel/0000-0002-7986-7760; Groušl, Tomáš/0000-0002-6996-1323; Lejskova, Renata/0000-0002-5664-7837	Czech Science Foundation [204/09/1924, P305/12/0480, P305/10/P253, RVO61388971]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the grants of the Czech Science Foundation 204/09/1924, P305/12/0480 and P305/10/P253, and RVO61388971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Balagopal V, 2012, BIOCH BIOPHYS ACTA; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Brachmann CB, 1998, YEAST, V14, P115; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Campbell SG, 2005, J CELL BIOL, V170, P925, DOI 10.1083/jcb.200503162; Campbell SG, 2006, CELL CYCLE, V5, P678, DOI 10.4161/cc.5.7.2607; Chakraburtty K, 2001, RES MICROBIOL, V152, P391, DOI 10.1016/S0923-2508(01)01210-4; Cowart LA, 2010, BIOCHEM J, V431, P31, DOI 10.1042/BJ20100307; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Derkatch IL, 1996, GENETICS, V144, P1375; Dori D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000872; Dunand-Sauthier I, 2002, MOL BIOL CELL, V13, P1626, DOI 10.1091/mbc.01-06-0301; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hinnebusch AG, 2005, NAT STRUCT MOL BIOL, V12, P835, DOI 10.1038/nsmb1005-835; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kato K, 2011, YEAST, V28, P339, DOI 10.1002/yea.1842; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; MORTIMER RK, 1986, GENETICS, V113, P35; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU; Scarcelli JJ, 2008, GENETICS, V179, P1945, DOI 10.1534/genetics.108.091256; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Simpson CE, 2012, BIOCHEM SOC T, V40, P794, DOI 10.1042/BST20120078; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Van Dyke N, 2009, NUCLEIC ACIDS RES, V37, P6116, DOI 10.1093/nar/gkp645; Zou TT, 2012, AM J PHYSIOL-CELL PH, V303, pC102, DOI 10.1152/ajpcell.00009.2012	56	41	41	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57083	10.1371/journal.pone.0057083	http://dx.doi.org/10.1371/journal.pone.0057083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451152	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500064
J	Jiang, X; Sun, LJ; Wang, BX; Yang, XJ; Shang, L; Zhang, YH				Jiang, Xun; Sun, Lijun; Wang, Baoxi; Yang, Xianjun; Shang, Lei; Zhang, Yuhai			Health-Related Quality of Life among Children with Recurrent Respiratory Tract Infections in Xi'an, China	PLOS ONE			English	Article							GENERIC CORE SCALES; FAMILY IMPACT MODULE; CHRONIC PAIN; SELF-REPORT; RELIABILITY; VALIDITY; PEDSQL(TM); AGREEMENT; PARENTS; VERSION	Objective: The aim of this study was to investigate the health-related quality of life (HRQOL) in 2-7-year-old children diagnosed with recurrent respiratory tract infections (RRTIs) and the impact of RRTIs on affected families. Methods: This was a cross-sectional case-control study evaluating 2-7-year-old children with RRTIs (n = 352), 2-7-year-old healthy children (n = 376), and associated caregivers (parents and/or grandparents). A Chinese version of the PedsQL (TM) 4.0 Generic Core Scale was used to assess childhood HRQOL, and a Chinese version of the Family Impact Module (FIM) was used to assess the impact of RRTIs on family members. HRQOL scores were compared between children with RRTIs and healthy children. In addition, a multiple step-wise regression with demographic variables of children and their caregivers, family economic status, and caregiver's HRQOL as independent variables determined factors that influenced HRQOL in children with RRTIs. Results: Children with RRTIs showed significantly lower physical, emotional, social, and school functioning scores than healthy children (p<0.05). Caregivers for children with RRTIs also scored significantly lower than caregivers for healthy children on physical, emotional, social, cognitive, and communication functioning (p<0.05). Caregivers for RRTIs affected children also reported significantly higher levels of worry. Multivariate analyses showed that children's age, children's relation with caregivers, the frequency of respiratory tract infections in the preceding year, caregiver's educational level, and caregiver's own HRQOL influenced HRQOL in children with RRTIs. Conclusions: The current data demonstrated that RRTIs were associated with lower HRQOL in both children and their caregivers and negatively influenced family functioning. In addition, caregivers' social characteristics also significantly affected HRQOL in children with RRTIs.	[Jiang, Xun; Wang, Baoxi] Fourth Mil Med Univ, Tangdu Hosp, Dept Pediat, Xian 710032, Shaanxi, Peoples R China; [Sun, Lijun; Yang, Xianjun; Shang, Lei; Zhang, Yuhai] Fourth Mil Med Univ, Dept Hlth Stat, Sch Publ Hlth, Xian 710032, Shaanxi, Peoples R China; [Sun, Lijun; Yang, Xianjun; Shang, Lei; Zhang, Yuhai] Fourth Mil Med Univ, Minist Educ, Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shang, L (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Sch Publ Hlth, Xian 710032, Shaanxi, Peoples R China.	shanglei@fmmu.edu.cn; zhyh@fmmu.edu.cn	Yang, Xian/GVU-9087-2022	Jiang, Xun/0000-0002-3344-4797	National Natural Science Funds [81273175]; Social Development Research Funds of Shaanxi Province [2011K12-31]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Social Development Research Funds of Shaanxi Province	This study was supported by National Natural Science Funds (No. 81273175) and Social Development Research Funds of Shaanxi Province (No. 2011K12-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullinger M, 1995, EUR REV APPL PSYCHOL, V45, P245; Cazzola M, 2012, PULM PHARMACOL THER, V25, P62, DOI 10.1016/j.pupt.2011.11.002; Chang PC, 2005, PSYCHO-ONCOLOGY, V14, P125, DOI 10.1002/pon.828; Chen RQ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-16; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; Eiser C, 2001, J DEV BEHAV PEDIATR, V22, P248, DOI 10.1097/00004703-200108000-00007; Esposito S, 2003, VACCINE, V21, P3162, DOI 10.1016/S0264-410X(03)00253-6; Gerson AC, 2010, PEDIATRICS, V125, pE349, DOI 10.1542/peds.2009-0085; Goldstein SL, 2008, AM J KIDNEY DIS, V51, P285, DOI 10.1053/j.ajkd.2007.09.021; Goldstein SL, 2006, PEDIATR NEPHROL, V21, P846, DOI 10.1007/s00467-006-0081-y; Hao YT, 2010, QUAL LIFE RES, V19, P1229, DOI 10.1007/s11136-010-9672-y; Huang IC, 2009, VALUE HEALTH, V12, P773, DOI 10.1111/j.1524-4733.2008.00487.x; Hunfeld JAM, 2001, J PEDIATR PSYCHOL, V26, P145, DOI 10.1093/jpepsy/26.3.145; Jokovic A, 2004, QUAL LIFE RES, V13, P1297, DOI 10.1023/B:QURE.0000037480.65972.eb; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; Korppi M, 1997, PEDIATR PULM, P144; [卢奕云 LU Yiyun], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P328; Mano KEJ, 2011, J PEDIATR PSYCHOL, V36, P517, DOI 10.1093/jpepsy/jsp099; Rajmil L, 2011, INT J NURS STUD, V48, P549, DOI 10.1016/j.ijnurstu.2010.09.004; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Sawyer MG, 2004, QUAL LIFE RES, V13, P1309, DOI 10.1023/B:QURE.0000037489.41344.b2; Shen X, 2008, PEDIATRICS, P259; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Williams S, 2000, J URBAN HEALTH, V77, P268, DOI 10.1007/BF02390538; Yackobovitch-Gavan M, 2009, NUTR RES, V29, P397, DOI 10.1016/j.nutres.2009.05.007	31	19	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56945	10.1371/journal.pone.0056945	http://dx.doi.org/10.1371/journal.pone.0056945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451114	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500045
J	Laokri, S; Drabo, MK; Weil, O; Kafando, B; Dembele, SM; Dujardin, B				Laokri, Samia; Drabo, Maxime Koine; Weil, Olivier; Kafando, Benoit; Dembele, Sary Mathurin; Dujardin, Bruno			Patients Are Paying Too Much for Tuberculosis: A Direct Cost-Burden Evaluation in Burkina Faso	PLOS ONE			English	Article							CASE-MANAGEMENT; 2 DISTRICTS; SERVICES; CARE; BARRIERS; ACCESS	Background: Paying for health care may exclude poor people. Burkina Faso adopted the DOTS strategy implementing "free care" for Tuberculosis (TB) diagnosis and treatment. This should increase universal health coverage and help to overcome social and economic barriers to health access. Methods: Straddling 2007 and 2008, in-depth interviews were conducted over a year among smear-positive pulmonary tuberculosis patients in six rural districts of Burkina Faso. Out-of-pocket expenses (direct costs) associated with TB were collected according to the different stages of their healthcare pathway. Results: Median direct cost associated with TB was US$ 101 (n = 229) (i.e. 2.8 months of household income). Respectively 72% of patients incurred direct costs during the pre-diagnosis stage (i.e. self-medication, travel, traditional healers' services), 95% during the diagnosis process (i.e. user fees, travel costs to various providers, extra sputum smears microscopy and chest radiology), 68% during the intensive treatment (i.e. medical and travel costs) and 50% during the continuation treatment (i.e. medical and travel costs). For the diagnosis stage, median direct costs already amounted to 35% of overall direct costs. Conclusions: The patient care pathway analysis in rural Burkina Faso showed substantial direct costs and healthcare system delay within a "free care" policy for TB diagnosis and treatment. Whether in terms of redefining the free TB package or rationalizing the care pathway, serious efforts must be undertaken to make "free" health care more affordable for the patients. Locally relevant for TB, this case-study in Burkina Faso has a real potential to document how health programs' weaknesses can be identified and solved.	[Laokri, Samia; Dujardin, Bruno] Univ Libre Brussels, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium; [Drabo, Maxime Koine] LNSP, Ouagadougou, Burkina Faso; [Weil, Olivier] HLSP Inst, London, England; [Kafando, Benoit] Bur Suivi Evaluat, Direct Regionale Sante DRS Plateau Cent, Ouagadougou, Burkina Faso; [Dembele, Sary Mathurin] Programme Natl Lutte AntiTB PNLAT, Ouagadougou, Burkina Faso	Universite Libre de Bruxelles	Laokri, S (corresponding author), Univ Libre Brussels, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium.	slaokri@ulb.ac.be	Laokri, Samia/AFT-2884-2022	Laokri, Samia/0000-0002-9814-5405	EUROPAID/COMMISSION EUROPEENNE [SANTE/2004/078-590]	EUROPAID/COMMISSION EUROPEENNE	Data was collected within the framework of a FORESA research-action project funded by PROJET SANTE/2004/078-590 EUROPAID/COMMISSION EUROPEENNE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET, V379, P1076, DOI DOI 10.1016/S0140-6736(12)60446-2; Auston Bonnie J, 2010, Find Brief, V13, P1; Aye R, 2011, TROP MED INT HEALTH, V16, P307, DOI 10.1111/j.1365-3156.2010.02710.x; Das P, 2012, LANCET, V379, P1089, DOI 10.1016/S0140-6736(12)60447-4; Dembele SM, 2006, INT J TUBERC LUNG D, V10, P436; Drabo KM, 2006, INT J TUBERC LUNG D, V10, P93; Gibson N, 1998, INT J TUBERC LUNG D, V2, P726; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Laokri S, 2011, TROP MED INT HEALTH, V16, P340; Laokri S, 2012, B WHO; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Mauch V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-43; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mumba M, 2003, TROP MED INT HEALTH, V8, P544, DOI 10.1046/j.1365-3156.2003.01064.x; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Ravallion M, 2010, WORKING PAPER; Ridde V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-409; Sanou A, 2004, INT J TUBERC LUNG D, V8, P1479; Ukwaja KN, 2012, INT J TUBERC LUNG DI; Umar NA, 2012, INT J TUBERC LUNG D, V16, P835, DOI 10.5588/ijtld.10.0774; Van Wyk SS, 2011, INT J TUBERC LUNG D, V15, P1069, DOI 10.5588/ijtld.10.0615; Xu K., 2005, DESIGNING HLTH FINAN	23	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56752	10.1371/journal.pone.0056752	http://dx.doi.org/10.1371/journal.pone.0056752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451079	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500026
J	Long, YQ; Kong, DL; Chen, ZX; Zeng, H				Long, Yingqian; Kong, Deliang; Chen, Zhengxia; Zeng, Hui			Variation of the Linkage of Root Function with Root Branch Order	PLOS ONE			English	Article							HYDRAULIC ARCHITECTURE; HAINAN ISLAND; ANATOMY; CARBON; WOOD; TRAITS; XYLEM; HETEROGENEITY; STRATEGIES; ALLOCATION	Mounting evidence has shown strong linkage of root function with root branch order. However, it is not known whether this linkage is consistent in different species. Here, root anatomic traits of the first five branch order were examined in five species differing in plant phylogeny and growth form in tropical and subtropical forests of south China. In Paramichelia baillonii, one tree species in Magnoliaceae, the intact cortex as well as mycorrhizal colonization existed even in the fifth-order root suggesting the preservation of absorption function in the higher-order roots. In contrast, dramatic decreases of cortex thickness and mycorrhizal colonization were observed from lower- to higher-order roots in three other tree species, Cunninghamia lanceolata, Acacia auriculiformis and Gordonia axillaries, which indicate the loss of absorption function. In a fern, Dicranopteris dichotoma, there were several cortex layers with prominently thickened cell wall and no mycorrhizal colonization in the third- and fourth-order roots, also demonstrating the loss of absorptive function in higher-order roots. Cluster analysis using these anatomic traits showed a different classification of root branch order in P. baillonii from other four species. As for the conduit diameter-density relationship in higher-order roots, the mechanism underpinning this relationship in P. baillonii was different from that in other species. In lower-order roots, different patterns of coefficient of variance for conduit diameter and density provided further evidence for the two types of linkage of root function with root branch order. These linkages corresponding to two types of ephemeral root modules have important implication in the prediction of terrestrial carbon cycling, although we caution that this study was pseudo-replicated. Future studies by sampling more species can test the generality of these two types of linkage.	[Long, Yingqian; Kong, Deliang; Chen, Zhengxia; Zeng, Hui] Peking Univ, Shenzhen Grad Sch, Key Lab Sci & Technol Urban Environm, Shenzhen, Peoples R China; [Kong, Deliang] Henan Univ, Sch Life Sci, Kaifeng, Peoples R China; [Zeng, Hui] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Zeng, Hui] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China	Peking University; University Town of Shenzhen; Henan University; Peking University; Peking University	Kong, DL (corresponding author), Peking Univ, Shenzhen Grad Sch, Key Lab Sci & Technol Urban Environm, Shenzhen, Peoples R China.	deliangkong1999@126.com; zengh@pkusz.edu.cn			Innovative Research Group Project of National Natural Science Foundation of China [31021001]; Natural Science Foundation of China (NSFC grant) [31200344]	Innovative Research Group Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China (NSFC grant)(National Natural Science Foundation of China (NSFC))	This study was funded by Innovative Research Group Project of National Natural Science Foundation of China (31021001), and funded by Natural Science Foundation of China (NSFC grant 31200344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas P., 2004, EVOLUTION PLANT PHYS, DOI DOI 10.1016/B978-012339552-8/50016-0; Baylis GTS, 1975, ENDOMYCORRHIZAS, V373, P389; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Christensen-Dalsgaard KK, 2007, J EXP BOT, V58, P4095, DOI 10.1093/jxb/erm268; Christensen-Dalsgaard KK, 2007, NEW PHYTOL, V176, P610, DOI 10.1111/j.1469-8137.2007.02227.x; Comas LH, 2004, FUNCT ECOL, V18, P388, DOI 10.1111/j.0269-8463.2004.00835.x; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Eissenstat DM, 1999, NEW PHYTOL, V141, P309, DOI 10.1046/j.1469-8137.1999.00342.x; Esau K., 1977, ANATOMY SEED PLANTS; Espeleta JF, 2009, ECOLOGY, V90, P1773, DOI 10.1890/08-0056.1; FALSTER DS, 2006, SMART STANDARDISED M; Fan ZX, 2009, IAWA J, V30, P1, DOI 10.1163/22941932-90000198; Fan ZX, 2012, J ECOLOGY; Farm K, 2002, S CHINA FOREST BIODI; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; Fitter Alastair H, 2004, New Phytol, V164, P15, DOI 10.1111/j.1469-8137.2004.01193.x; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Hacke UG, 2004, AM J BOT, V91, P386, DOI 10.3732/ajb.91.3.386; Hishi T, 2007, J FOREST RES-JPN, V12, P126, DOI 10.1007/s10310-006-0260-5; Hummel I, 2007, NEW PHYTOL, V173, P313, DOI 10.1111/j.1469-8137.2006.01912.x; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Keel SG, 2012, NEW PHYTOL, V194, P972, DOI 10.1111/j.1469-8137.2012.04120.x; Kong DL, 2010, PLANT SOIL, V336, P209, DOI 10.1007/s11104-010-0467-2; Lux A., 2004, ROOT RES, V13, P117, DOI [DOI 10.3117/ROOTRES.13.117, 10.3117/rootres.13.117]; Pittermann J, 2005, SCIENCE, V310, P1924, DOI 10.1126/science.1120479; Pittermann J, 2006, AM J BOT, V93, P1265, DOI 10.3732/ajb.93.9.1265; Pittermann J, 2011, NEW PHYTOL, V192, P449, DOI 10.1111/j.1469-8137.2011.03817.x; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Raven JA, 2001, J EXP BOT, V52, P381, DOI 10.1093/jexbot/52.suppl_1.381; Rewald B, 2011, PLANT CELL ENVIRON, V34, P33, DOI 10.1111/j.1365-3040.2010.02223.x; Robert EMR, 2009, FUNCT ECOL, V23, P649, DOI 10.1111/j.1365-2435.2009.01551.x; Rowe N, 2004, J PLANT GROWTH REGUL, V23, P108, DOI 10.1007/s00344-004-0044-0; Shen WJ, 2000, ACTA PHYTOECOLOGICA, V2; Sperry JS, 2008, PLANT CELL ENVIRON, V31, P632, DOI 10.1111/j.1365-3040.2007.01765.x; Sperry JS, 2006, AM J BOT, V93, P1490, DOI 10.3732/ajb.93.10.1490; St. John T. V., 1980, Acta Amazonica, V10, P527; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sun Y, 2011, PLANT SOIL, V347, P351, DOI 10.1007/s11104-011-0854-3; Tyree M. T., 2002, SPR S WOOD; Valenzuela-Estrada LR, 2008, AM J BOT, V95, P1506, DOI 10.3732/ajb.0800092; Valenzuela-Estrada LR, 2009, J EXP BOT, V60, P1241, DOI 10.1093/jxb/ern367; Verdaguer D, 2002, AM J BOT, V89, P1189, DOI 10.3732/ajb.89.8.1189; Vogt K., 1991, TECHNIQUES APPROACHE, P477; Wahl S, 2000, NEW PHYTOL, V148, P459, DOI 10.1046/j.1469-8137.2000.00775.x; Wang JJ, 2012, ENVIRON SCI TECHNOL, V46, P769, DOI 10.1021/es2018708; Wei Xing, 2008, Zhiwu Shengtai Xuebao, V32, P1238, DOI 10.3773/j.issn.1005-264x.2008.06.004; Xia MX, 2010, NEW PHYTOL, V188, P1065, DOI 10.1111/j.1469-8137.2010.03423.x; Xiong YM, 2008, PLANT SOIL, V304, P179, DOI 10.1007/s11104-007-9536-6; Xu Yang, 2011, Chinese Journal of Plant Ecology, V35, P955, DOI 10.3724/SP.J.1258.2011.00955; Zhou Zhang, 2009, Shengtaixue Zazhi, V28, P1006	54	32	44	7	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57153	10.1371/journal.pone.0057153	http://dx.doi.org/10.1371/journal.pone.0057153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451168	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500070
J	Ranieri, D; Raffa, S; Parente, A; Del Monte, SR; Ziparo, V; Torrisi, MR				Ranieri, Danilo; Raffa, Salvatore; Parente, Andrea; Del Monte, Simone Rossi; Ziparo, Vincenzo; Torrisi, Maria Rosaria			High Adhesion of Tumor Cells to Mesothelial Monolayers Derived from Peritoneal Wash of Disseminated Gastrointestinal Cancers	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; IN-VITRO; COLORECTAL-CANCER; GASTRIC-CARCINOMA; OVARIAN-CARCINOMA; METASTASIS; GROWTH; EXPRESSION	The role of the mesothelial layer in the peritoneal spreading of cancer cells is only partially clarified. Here we attempted to better define the mesothelial contribution to the tumor cell adhesion using a direct adhesion test applied to human primary cultures of mesothelial cells (HPMCs) derived from the peritoneal washes of patients with gastric and colorectal cancers. Gastric and colon carcinoma cells were seeded on different mesothelial monolayers and quantitative fluorescence analysis was performed to analyze their growth and adhesive properties. The adhesion of the cancer cells was not affected by the origin of the HPMCs when derived from patients with different cancers or with benign disease. In contrast, the high levels of ICAM1 expression and ROS production, which characterize these senescent mesothelial cells, enhanced the tumor cell adhesion. These results suggest that the mesothelial adhesive properties are dependent on the cell senescence, while are not affected by the tumor environment. The use of peritoneal washes as a source to isolate HPMCs provides a practical and reliable tool for the in vitro analysis of the mesothelial conditions affecting the peritoneal carcinomatosis.	[Ranieri, Danilo; Raffa, Salvatore; Parente, Andrea; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Inst Pasteur Fdn Cenci Bolognetti, Dept Clin & Mol Med, Rome, Italy; [Del Monte, Simone Rossi; Ziparo, Vincenzo] Univ Roma La Sapienza, Dept Gen Surg, Rome, Italy; [Raffa, Salvatore; Ziparo, Vincenzo; Torrisi, Maria Rosaria] St Andrea Hosp, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Raffa, S (corresponding author), Univ Roma La Sapienza, Inst Pasteur Fdn Cenci Bolognetti, Dept Clin & Mol Med, Rome, Italy.	salvatore.raffa@uniroma1.it	RAFFA, SALVATORE/AAL-5514-2020; Raffa, Salvatore/AAW-7060-2020; Raffa, Salvatore/GPX-5723-2022	Raffa, Salvatore/0000-0001-9501-7638; Parente, Andrea/0000-0001-6820-9474	MIUR; AIRC - Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]	MIUR(Ministry of Education, Universities and Research (MIUR)); AIRC - Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from MIUR and from AIRC - Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhamesi NA, 2005, CLIN EXP METASTAS, V22, P449, DOI 10.1007/s10585-005-2893-8; Benevolo M, 1998, J CLIN ONCOL, V16, P3406, DOI 10.1200/JCO.1998.16.10.3406; Cabourne EJ, 2010, J SURG RES, V164, pE265, DOI 10.1016/j.jss.2010.09.041; Cardinali G, 2006, EXP MOL PATHOL, V81, P31, DOI 10.1016/j.yexmp.2005.10.001; Casey RC, 2003, CLIN EXP METASTAS, V20, P343, DOI 10.1023/A:1024009131191; Ceelen WP, 2009, LANCET ONCOL, V10, P72, DOI 10.1016/S1470-2045(08)70335-8; Del Monte SR, 2012, J SURG ONCOL, V106, P17, DOI 10.1002/jso.23052; Harada N, 2001, INT J CANCER, V91, P67, DOI 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D; Heyman L, 2008, TUMOR BIOL, V29, P231, DOI 10.1159/000152941; Ivarsson ML, 1998, SCAND J CLIN LAB INV, V58, P195, DOI 10.1080/00365519850186580; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Jayne DG, 1999, CLIN EXP METASTAS, V17, P515, DOI 10.1023/A:1006606006878; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kovacs D, 2009, J DERMATOL SCI, V54, P106, DOI 10.1016/j.jdermsci.2009.01.005; Ksiazek K, 2008, FREE RADICAL BIO MED, V45, P460, DOI 10.1016/j.freeradbiomed.2008.04.032; Ksiazek K, 2010, INT J CANCER, V127, P293, DOI 10.1002/ijc.25036; Ksiazek K, 2009, AM J PATHOL, V174, P1230, DOI 10.2353/ajpath.2009.080613; Nekarda H, 1999, BRIT J CANCER, V79, P611, DOI 10.1038/sj.bjc.6690096; Sadeghi B, 2000, CANCER-AM CANCER SOC, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Saito Y, 2010, CLIN EXP METASTAS, V27, P197, DOI 10.1007/s10585-010-9314-3; Sikkink CJJM, 2009, TRANSL RES, V153, P240, DOI 10.1016/j.trsl.2009.01.003; Sugarbaker PH, 2000, ONCOLOGY-BASEL, V58, P96, DOI 10.1159/000012086; Takatsuki H, 2004, CANCER RES, V64, P6065, DOI 10.1158/0008-5472.CAN-04-0321; van Grevenstein WMU, 2007, DIGEST DIS SCI, V52, P2775, DOI 10.1007/s10620-007-9778-4; Visco V, 2004, J CELL PHYSIOL, V200, P31, DOI 10.1002/jcp.10385; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Ziprin P, 2003, CELL COMMUN ADHES, V10, P141, DOI 10.1080/15419060390262561	27	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57659	10.1371/journal.pone.0057659	http://dx.doi.org/10.1371/journal.pone.0057659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451255	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500123
J	Wattacheril, J; Seeley, EH; Angel, P; Chen, HD; Bowen, BP; Lanciault, C; Caprioli, RM; Abumrad, N; Flynn, CR				Wattacheril, Julia; Seeley, Erin H.; Angel, Peggi; Chen, Heidi; Bowen, Benjamin P.; Lanciault, Christian; Caprioli, Richard M.; Abumrad, Naji; Flynn, Charles Robb			Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; LOW-DENSITY LIPOPROTEIN; PLASMA HIGH-DENSITY; MASS-SPECTROMETRY; RAT-LIVER; METABOLIC ZONATION; HEPATOCYTE HETEROGENEITY; GLUTAMINE-SYNTHETASE; LIPIDOMIC ANALYSIS	Nonalcoholic fatty liver disease (NAFLD) occurs frequently in a setting of obesity, dyslipidemia and insulin resistance, but the etiology of the disease, particularly the events favoring progression to nonalcoholic steatohepatitis (NASH) as opposed to simple steatosis (SS), are not fully understood. Based on known zonation patterns in protein, glucose and lipid metabolism, coupled with evidence that phosphatidylcholine may play a role in NASH pathogenesis, we hypothesized that phospholipid zonation exists in liver and that specific phospholipid abundance and distribution may be associated with histologic disease. A survey of normal hepatic protein expression profiles in the Human Protein Atlas revealed pronounced zonation of enzymes involved in lipid utilization and storage, particularly those facilitating phosphatidylcholine (PC) metabolism. Immunohistochemistry of obese normal, SS and NASH liver specimens with anti-phosphatidylethanomine N-methyltransferase (PEMT) antibodies showed a progressive decrease in the zonal distribution of this PC biosynthetic enzyme. Phospholipid quantitation by liquid chromatography mass spectrometry (LC-MS) in hepatic extracts of Class III obese patients with increasing NAFLD severity revealed that most PC species with 32, 34 and 36 carbons as well as total PC abundance was decreased with SS and NASH. Matrix assisted laser desorption ionization - imaging mass spectrometry (MALDI-IMS) imaging revealed strong zonal distributions for 32, 34 and 36 carbon PCs in controls (minimal histologic findings) and SS that was lost in NASH specimens. Specific lipid species such as PC 34: 1 and PC 36: 2 best illustrated this phenomenon. These findings suggest that phospholipid zonation may be associated with the presence of an intrahepatic proinflammatory phenotype and thus have broad implications in the etiopathogenesis of NASH.	[Wattacheril, Julia] Columbia Univ, Coll Phys & Surg, Med Ctr, New York, NY USA; [Seeley, Erin H.; Angel, Peggi; Caprioli, Richard M.] Vanderbilt Univ, Med Ctr, Mass Spectrometry Res Ctr, Nashville, TN USA; [Chen, Heidi] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Bowen, Benjamin P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, GTL Bioenergy & Struct Biol, Berkeley, CA 94720 USA; [Lanciault, Christian] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Abumrad, Naji; Flynn, Charles Robb] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37212 USA	Columbia University; Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Vanderbilt University; Vanderbilt University	Flynn, CR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37212 USA.	robb.flynn@vanderbilt.edu	Flynn, Charles/M-3895-2015	Flynn, Charles/0000-0002-3749-0598; Seeley, Erin/0000-0002-8000-5754	Vanderbilt Clinical and Translational Science Award [UL1 RR024975]; NIH/NIDDK [3RO1 DK07860, 5R01 DK091748, 2T32 DK007673-16]; Vanderbilt Diabetes Research and Training Center [P30 DK020593]; NIH/NIGMS [5R01 GM58008]; Vanderbilt Ingram Cancer Center Core Support Grant [P30 CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, T32DK007673, R01DK091748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008] Funding Source: NIH RePORTER	Vanderbilt Clinical and Translational Science Award; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Vanderbilt Diabetes Research and Training Center; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vanderbilt Ingram Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding support was from the following National Institutes of Health grants: UL1 RR024975 (Vanderbilt Clinical and Translational Science Award to CRF, JW and NA), NIH/NIDDK 3RO1 DK07860 and 5R01 DK091748 to NNA, P30 DK020593 (Vanderbilt Diabetes Research and Training Center) to CRF, P30 DK058404 (Vanderbilt Digestive Disease Research Center) to CRF and JW, NIH/NIGMS 5R01 GM58008 to RMC, NIH/NIDDK 2T32 DK007673-16 to JW and Vanderbilt Ingram Cancer Center Core Support Grant P30 CA68485 to EHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Berry KAZ, 2011, J LIPID RES, V52, P1551, DOI 10.1194/jlr.M015750; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Castro-Perez JM, 2010, J PROTEOME RES, V9, P2377, DOI 10.1021/pr901094j; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Chen S, 2009, BIOINFORMATICS, V25, P808, DOI 10.1093/bioinformatics/btp060; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Debois D, 2009, ANAL CHEM, V81, P2823, DOI 10.1021/ac900045m; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; ELIAS H, 1963, LIVER, P41; GEBHARDT R, 1991, EUR J CELL BIOL, V56, P464; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Gebhardt R, 2007, PROG HISTOCHEM CYTO, V41, P201, DOI 10.1016/j.proghi.2006.12.001; Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775; GUZMAN M, 1989, BIOCHEM J, V264, P107, DOI 10.1042/bj2640107; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; HAUSSINGER D, 1992, ENZYME, V46, P72; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; KATZ N, 1976, H-S Z PHYSIOL CHEM, V357, P359, DOI 10.1515/bchm2.1976.357.1.359; KATZ N, 1977, FEBS LETT, V83, P272, DOI 10.1016/0014-5793(77)81021-1; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; MORRISON GR, 1965, ARCH BIOCHEM BIOPHYS, V111, P448, DOI 10.1016/0003-9861(65)90208-0; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Nygren H, 2011, METHODS MOL BIOL, V708, P247, DOI 10.1007/978-1-61737-985-7_15; Petkovic M, 2001, ANAL BIOCHEM, V289, P202, DOI 10.1006/abio.2000.4926; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; QUISTORFF B, 1992, ENZYME, V46, P59, DOI 10.1159/000468778; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; ROYO T, 1995, J CELL PHYSIOL, V162, P103, DOI 10.1002/jcp.1041620112; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; SUNDLER R, 1975, BIOCHEM J, V146, P309, DOI 10.1042/bj1460309; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; TOSH D, 1988, BIOCHEM J, V256, P197, DOI 10.1042/bj2560197; van der Veen JN, 2012, J BIOL CHEM, V287, P23418, DOI 10.1074/jbc.M112.381723; Vance DE, 1997, BBA-LIPID LIPID MET, V1348, P142, DOI 10.1016/S0005-2760(97)00108-2; WEISS SB, 1956, NATURE, V178, P594, DOI 10.1038/178594a0; Weltman MD, 1996, GASTROENTEROLOGY, V111, P1645, DOI 10.1016/S0016-5085(96)70028-8; YAO ZM, 1988, J BIOL CHEM, V263, P2998	46	43	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57165	10.1371/journal.pone.0057165	http://dx.doi.org/10.1371/journal.pone.0057165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451176	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500074
J	Begue, G; Douillard, A; Galbes, O; Rossano, B; Vernus, B; Candau, R; Py, G				Begue, Gwenaelle; Douillard, Aymeric; Galbes, Olivier; Rossano, Bernadette; Vernus, Barbara; Candau, Robin; Py, Guillaume			Early Activation of Rat Skeletal Muscle IL-6/STAT1/STAT3 Dependent Gene Expression in Resistance Exercise Linked to Hypertrophy	PLOS ONE			English	Article							SATELLITE CELL; MYOGENIC DIFFERENTIATION; MOLECULAR RESPONSES; ECCENTRIC EXERCISE; TRAPEZIUS MUSCLE; GROWTH-FACTOR; TNF-ALPHA; INTERLEUKIN-6; STAT3; HUMANS	Cytokine interleukin-6 (IL-6) is an essential regulator of satellite cell-mediated hypertrophic muscle growth through the transcription factor signal transducer and activator of transcription 3 (STAT3). The importance of this pathway linked to the modulation of myogenic regulatory factors expression in rat skeletal muscle undergoing hypertrophy following resistance exercise, has not been investigated. In this study, the phosphorylation and nuclear localization of STAT3, together with IL-6/STAT3-responsive gene expression, were measured after both a single bout of resistance exercise and 10 weeks of training. Flexor Digitorum Profundus muscle samples from Wistar rats were obtained 2 and 6 hours after a single bout of resistance exercise and 72 h after the last bout of either 2, 4, or 10 weeks of resistance training. We observed an increase in IL-6 and SOCS3 mRNAs concomitant with phosphorylation of STAT1 and STAT3 after 2 and 6 hours of a single bout of exercise (p<0.05). STAT3-dependent early responsive genes such as CyclinD1 and cMyc were also upregulated whereas MyoD and Myf5 mRNAs were downregulated (p<0.05). BrdU-positive satellite cells increased at 2 and 6 hours after exercise (p<0.05). Muscle fiber hypertrophy reached up to 100% after 10 weeks of training and the mRNA expression of Myf5, c-Myc and Cyclin-D1 decreased, whereas IL-6 mRNA remained upregulated. We conclude that the IL-6/STAT1/STAT3 signaling pathway and its responsive genes after a single bout of resistance exercise are an important event regulating the SC pool and behavior involved in muscle hypertrophy after ten weeks of training in rat skeletal muscle.	[Begue, Gwenaelle; Douillard, Aymeric; Galbes, Olivier; Rossano, Bernadette; Vernus, Barbara; Candau, Robin; Py, Guillaume] Univ Montpellier I, INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France	INRAE; Universite de Montpellier	Py, G (corresponding author), Univ Montpellier I, INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	guillaume.py@univ-montp1.fr	Begue, Gwenaelle/X-8347-2019	Begue, Gwenaelle/0000-0002-0636-8303; candau, robin/0000-0002-5930-8750	World Anti-doping Agency	World Anti-doping Agency	This project was supported and funded by World Anti-doping Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY PJ, 1994, SPORTS MED, V17, P22, DOI 10.2165/00007256-199417010-00003; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Bickel CS, 2005, J APPL PHYSIOL, V98, P482, DOI 10.1152/japplphysiol.00895.2004; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Charifi N, 2003, MUSCLE NERVE, V28, P87, DOI 10.1002/mus.10394; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Costa A, 2007, EUR J APPL PHYSIOL, V101, P427, DOI 10.1007/s00421-007-0510-z; Dominov JA, 2001, DEV DYNAM, V220, P18, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1088>3.0.CO;2-#; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Haddad F, 2002, J APPL PHYSIOL, V93, P394, DOI 10.1152/japplphysiol.01153.2001; Hiscock N, 2004, FASEB J, V18, P992, DOI 10.1096/fj.03-1259fje; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Jenab S, 1996, ENDOCRINOLOGY, V137, P4738, DOI 10.1210/en.137.11.4738; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Matsui T, 2002, J BIOL CHEM, V277, P36167, DOI 10.1074/jbc.M203184200; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Parker PJ, 1999, J PEDIATR ORTHOP B, V8, P64; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Penkowa M, 2003, FASEB J, V17, DOI 10.1096/fj.03-0311fje; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Puntschart A, 1998, AM J PHYSIOL-CELL PH, V274, pC129, DOI 10.1152/ajpcell.1998.274.1.C129; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rennie MJ, 2004, ANNU REV PHYSIOL, V66, P799, DOI 10.1146/annurev.physiol.66.052102.134444; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Sakuma K, 1999, BBA-GEN SUBJECTS, V1428, P284, DOI 10.1016/S0304-4165(99)00086-0; SCHINDLER R, 1990, BLOOD, V75, P40; SCHULTZ E, 1989, MED SCI SPORT EXER, V21, pS181; Schultz E, 2006, DEV DYNAM, V235, P3230, DOI 10.1002/dvdy.20976; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Steensberg A, 2006, BRAIN BEHAV IMMUN, V20, P585, DOI 10.1016/j.bbi.2006.03.002; Sun DQ, 2008, J CELL SCI, V121, P3815, DOI 10.1242/jcs.035493; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; TAMAKI T, 1992, MED SCI SPORT EXER, V24, P881; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; Trenerry MK, 2011, MUSCLE NERVE, V43, P385, DOI 10.1002/mus.21875; Vierck J, 2000, CELL BIOL INT, V24, P263, DOI 10.1006/cbir.2000.0499; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yang YP, 2009, CYTOKINE, V46, P137, DOI 10.1016/j.cyto.2008.12.015; Yoshida N, 1998, J CELL SCI, V111, P769	63	84	87	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57141	10.1371/journal.pone.0057141	http://dx.doi.org/10.1371/journal.pone.0057141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451164	Green Published, gold			2022-12-27	WOS:000316658800077
J	Kai, L; Dotsch, V; Kaldenhoff, R; Bernhard, F				Kai, Lei; Doetsch, Volker; Kaldenhoff, Ralf; Bernhard, Frank			Artificial Environments for the Co-Translational Stabilization of Cell-Free Expressed Proteins	PLOS ONE			English	Article							THERMAL-STABILITY; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; IN-VITRO; OSMOLYTES; ACCUMULATION; AGGREGATION; INHIBITION; TREHALOSE; ARGININE	An approach for designing individual expression environments that reduce or prevent protein aggregation and precipitation is described. Inefficient folding of difficult proteins in unfavorable translation environments can cause significant losses of overexpressed proteins as precipitates or inclusion bodies. A number of chemical chaperones including alcohols, polyols, polyions or polymers are known to have positive effects on protein stability. However, conventional expression approaches can use such stabilizing agents only post-translationally during protein extraction and purification. Proteins that already precipitate inside of the producer cells cannot be addressed. The open nature of cell-free protein expression systems offers the option to include single chemicals or cocktails of stabilizing compounds already into the expression environment. We report an approach for systematic screening of stabilizers in order to improve the solubility and quality of overexpressed proteins co-translationally. A comprehensive list of representative protein stabilizers from the major groups of naturally occurring chemical chaperones has been analyzed and their concentration ranges tolerated by cell-free expression systems have been determined. As a proof of concept, we have applied the method to improve the yield of proteins showing instability and partial precipitation during cell-free synthesis. Stabilizers that co-translationally improve the solubility and functional folding of human glucosamine 6-phosphate N-acetyltransferase have been identified and cumulative effects of stabilizers have been studied.	[Kai, Lei; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60054 Frankfurt, Germany; [Kai, Lei; Kaldenhoff, Ralf] Tech Univ Darmstadt, Inst Bot, Darmstadt, Germany	Goethe University Frankfurt; Technical University of Darmstadt	Bernhard, F (corresponding author), Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60054 Frankfurt, Germany.	fbern@bpc.uni-frankfurt.de	Kai, Lei/ABI-2652-2020	Kai, Lei/0000-0003-0879-7918; Bernhard, Frank/0000-0002-4860-1783; Dotsch, Volker/0000-0001-5720-212X	Collaborative Research Center of the German Research Foundation (DFG) [(SFB) 807]; European Drug Initiative on Channels and Transporters (EDICT) [HEALTH-F4-2007-201924]; European initiative on Structural Biology of Membrane Proteins (SBMP) [PITN-GA-2008-211800]	Collaborative Research Center of the German Research Foundation (DFG)(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters (EDICT); European initiative on Structural Biology of Membrane Proteins (SBMP)	This work was supported by the Collaborative Research Center (SFB) 807 of the German Research Foundation (DFG). The authors further thank the European Drug Initiative on Channels and Transporters (EDICT), contract number HEALTH-F4-2007-201924 and the European initiative on Structural Biology of Membrane Proteins (SBMP), contract number PITN-GA-2008-211800 for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Arora A, 2004, FEBS LETT, V564, P121, DOI 10.1016/S0014-5793(04)00326-6; ASAKURA T, 1978, J BIOL CHEM, V253, P6423; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Bolen DW, 2004, METHODS, V34, P312, DOI 10.1016/j.ymeth.2004.03.022; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Busche A, 2012, ACS CHEM BIOL, V7, P377, DOI 10.1021/cb200352q; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chandrasekaran A, 2010, J PROTEOME RES, V9, P5677, DOI 10.1021/pr1003938; da Costa M. S., 1998, V61, P117; DAVID ET, 1983, J BIOL CHEM, V258, P7702; Endo Yaeta, 2004, Journal of Structural and Functional Genomics, V5, P45, DOI 10.1023/B:JSFG.0000029208.83739.49; Ge XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028707; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jamal S, 2009, FEBS J, V276, P6024, DOI 10.1111/j.1742-4658.2009.07317.x; Kai L, 2012, METHODS MOL BIOL, V800, P201, DOI 10.1007/978-1-61779-349-3_14; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Khnouf R, 2010, ANAL CHEM, V82, P7021, DOI 10.1021/ac1015479; Lamosa P, 1998, APPL ENVIRON MICROB, V64, P3591; Nakano H, 1996, J BIOTECHNOL, V46, P275, DOI 10.1016/0168-1656(96)00022-3; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Schwarz D, 2010, PROTEOMICS, V10, P1762, DOI 10.1002/pmic.200900485; Singh Somnath, 2003, AAPS PharmSciTech, V4, pE42; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Treetharnmathurot B, 2008, INT J PHARMACEUT, V1-2, P252; Tsumoto K, 2003, BIOCHEM BIOPH RES CO, V312, P1383, DOI 10.1016/j.bbrc.2003.11.055; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Welsh DT, 1999, FEMS MICROBIOL LETT, V174, P57, DOI 10.1016/S0378-1097(99)00122-6; Yang WC, 2012, BIOTECHNOL PROGR, V28, P413, DOI 10.1002/btpr.1509	32	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56637	10.1371/journal.pone.0056637	http://dx.doi.org/10.1371/journal.pone.0056637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451062	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800022
J	Li, Y; Xu, N; Cai, L; Gao, ZJ; Shen, L; Zhang, QM; Hou, WG; Zhong, HX; Wang, Q; Xiong, LZ				Li, Yan; Xu, Ning; Cai, Lei; Gao, Zijun; Shen, Lan; Zhang, Qiaomei; Hou, Wugang; Zhong, Haixing; Wang, Qiang; Xiong, Lize			NDRG2 Is a Novel p53-Associated Regulator of Apoptosis in C6-Originated Astrocytes Exposed to Oxygen-Glucose Deprivation	PLOS ONE			English	Article							DIFFERENTIATION-RELATED GENE; TARGET GENE; CELL-DEATH; P53; EXPRESSION; MYC; TRANSLOCATION; ACTIVATION; PROTEINS; BRAIN	N-myc downstream-regulated gene 2 (NDRG2) has been documented to be a pro-differentiative and anti-proliferative gene in cancer research. Our previous study found a significant NDRG2 up-regulation in reactive astrocytes of penumbra after transient focal cerebral ischemia, which was parallel to the enhancement of TUNEL-positive signals. However, it is still uncertain whether NDRG2 participates in cellular apoptosis induced by ischemia-reperfusion injury in brain. In this study, we investigated the role of NDRG2 in cellular apoptosis induced by oxygen-glucose deprivation (OGD) in IL-6-differentiated C6 glioma cells. The results showed that NDRG2 was up-regulated and translocated from the cytoplasm to the nucleus after OGD exposure. NDRG2 over-expression exhibited an anti-proliferative effect and increased the Bax/Bcl-2 ratio after OGD exposure, while NDRG2 silencing promoted the cellular proliferation and attenuated the up-regulation of Bax/Bcl-2 ratio. The pro-apoptotic effect of p53 was verified by the results in which p53 silencing greatly reduced the percentage of OGD-induced apoptotic cells. p53 silencing also reduced the OGD-induced NDRG2 up-regulation. However, over-expression of p53 did not further improve the NDRG2 up-regulation. In conclusion, NDRG2 is a p53-associated regulator of apoptosis in C6-originated astrocytes after OGD exposure. These findings bring insight to the roles of NDRG2 in ischemic-hypoxic injury and provide potential targets for future clinical therapies on stroke.	[Li, Yan; Xu, Ning; Gao, Zijun; Zhang, Qiaomei; Hou, Wugang; Zhong, Haixing; Wang, Qiang; Xiong, Lize] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Li, Yan] Shaanxi Prov Maternal & Child Hlth Hosp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China; [Cai, Lei] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Gastrointestinal Surg, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Shen, Lan] Fourth Mil Med Univ, Inst Mol Biol, Xian 710032, Shaanxi, Peoples R China; [Shen, Lan] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, Q (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China.	wangqiang@fmmu.edu.cn; lxiong@fmmu.edu.cn		Li, Yan/0000-0003-0096-0813; XIONG, Lize/0000-0002-9204-8129	Major Program of National Natural Science Foundation of China [30930091]; National Natural Science Foundation of China [81072888, 81071060, 81000563, 30900462]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Program of National Natural Science Foundation of China (No. 30930091), and the National Natural Science Foundation of China (No. 81072888, No. 81071060, No. 81000563 and No. 30900462). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danilov CA, 2008, GLIA, V56, P801, DOI 10.1002/glia.20655; de Almodovar CR, 2004, J BIOL CHEM, V279, P4093, DOI 10.1074/jbc.M311243200; Deng YC, 2001, PROG BIOCHEM BIOPHYS, V28, P72; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Fang L, 2001, EMBO J, V20, P1931, DOI 10.1093/emboj/20.8.1931; Hwang J, 2011, J BIOL CHEM, V286, P12450, DOI 10.1074/jbc.M110.170803; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Li Y, 2011, BRAIN RES, V1382, P252, DOI 10.1016/j.brainres.2011.01.023; Liu JY, 2010, EXP CELL RES, V316, P1985, DOI 10.1016/j.yexcr.2010.02.028; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Patel JR, 2008, EXP NEUROL, V213, P93, DOI 10.1016/j.expneurol.2008.05.007; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shen L, 2008, NEUROREPORT, V19, P927, DOI 10.1097/WNR.0b013e32830163d0; Taga T, 2005, CLIN REV ALLERG IMMU, V28, P249, DOI 10.1385/CRIAI:28:3:249; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200	37	112	120	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57130	10.1371/journal.pone.0057130	http://dx.doi.org/10.1371/journal.pone.0057130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451161	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800076
J	Pasquali, M; Spanu, F; Scherm, B; Balmas, V; Hoffmann, L; Hammond-Kosack, KE; Beyer, M; Migheli, Q				Pasquali, Matias; Spanu, Francesca; Scherm, Barbara; Balmas, Virgilio; Hoffmann, Lucien; Hammond-Kosack, Kim E.; Beyer, Marco; Migheli, Quirico			FcStuA from Fusarium culmorum Controls Wheat Foot and Root Rot in a Toxin Dispensable Manner	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; TRANSCRIPTION FACTOR; MYCOTOXIN PRODUCTION; GENE-EXPRESSION; ENZYME SETS; CROWN ROT; PATHOGENICITY; GRAMINEARUM; REGULATORS; GROWTH	Fusarium culmorum is one of the most harmful pathogens of durum wheat and is the causal agent of foot and root rot (FRR) disease. F. culmorum produces the mycotoxin deoxynivalenol (DON) that is involved in the pathogenic process. The role of the gene FcStuA, a StuA ortholog protein with an APSES domain sharing 98.5% homology to the FgStuA protein (FGSG10129), was determined by functional characterisation of deletion mutants obtained from two F. culmorum wild-type strains, FcUk99 (a highly pathogenic DON producer) and Fc233B (unable to produce toxin and with a mild pathogenic behavior). The Delta FcStuA mutants originating from both strains showed common phenotypic characters including stunted vegetative growth, loss of hydrophobicity of the mycelium, altered pigmentation, decreased activity of polygalacturonic enzymes and catalases, altered and reduced conidiation, delayed conidial germination patterns and complete loss of pathogenicity towards wheat stem base/root tissue. Glycolytic process efficiency [measured as growth on glucose as sole carbon (C) source] was strongly impaired and growth was partially restored on glutamic acid. Growth on pectin-like sources ranked in between glucose and glutamic acid with the following order (the lowest to the highest growth): beechwood xylan, sugarbeet arabinan, polygalacturonic acid, citrus pectin, apple pectin, potato azogalactan. DON production in the mutants originating from FcUK99 strain was significantly decreased (-95%) in vitro. Moreover, both sets of mutants were unable to colonise non-cereal plant tissues, i.e. apple and tomato fruits and potato tubers. No differences between mutants, ectopic and wild-type strains were observed concerning the level of resistance towards four fungicides belonging to three classes, the demethylase inhibitors epoxiconazole and tebuconzole, the succinate dehydrogenase inhibitor isopyrazam and the cytochrome bc1 inhibitor trifloxystrobin. StuA, given its multiple functions in cell regulation and pathogenicity control, is proposed as a potential target for novel disease management strategies.	[Pasquali, Matias; Hoffmann, Lucien; Beyer, Marco] Ctr Rech Publ Gabriel Lippmann, Environm & Agrobiotechnol Dept, Belvaux, Luxembourg; [Spanu, Francesca; Scherm, Barbara; Balmas, Virgilio; Migheli, Quirico] Univ Sassari, Dipartimento Agr, Sez Patol Vegetale & Entomol, I-07100 Sassari, Italy; [Spanu, Francesca; Scherm, Barbara; Balmas, Virgilio; Migheli, Quirico] Univ Sassari, Unita Ric Ist Nazl Biostrutture & Biosistemi, I-07100 Sassari, Italy; [Hammond-Kosack, Kim E.] Rothamsted Res, Wheat Pathogen Plant Biol & Crop Sci Dept, Harpenden, Herts, England; [Migheli, Quirico] Univ Sassari, Ctr Interdisciplinare Sviluppo Ric Biotecnol & St, I-07100 Sassari, Italy	Luxembourg Institute of Science & Technology; University of Sassari; University of Sassari; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Sassari	Pasquali, M (corresponding author), Ctr Rech Publ Gabriel Lippmann, Environm & Agrobiotechnol Dept, Belvaux, Luxembourg.	pasquali@lippmann.lu	Beyer, Marco/S-9197-2019; Scherm, Barbara/J-8092-2015; Balmas, Virgilio/J-8194-2015; Beyer, Marco/T-1139-2019; Beyer, Marco/K-7198-2012; Migheli, Quirico/B-7203-2009; pasquali, matias/A-6362-2009; Migheli, Quirico/K-7065-2019	Scherm, Barbara/0000-0001-6122-7186; Balmas, Virgilio/0000-0003-3213-3089; Migheli, Quirico/0000-0002-2459-5833; pasquali, matias/0000-0002-9102-2066; Migheli, Quirico/0000-0002-2459-5833; Hammond-Kosack, kim/0000-0002-9699-485X; Beyer, Marco/0000-0002-9415-4718	Ministry of University and Research; Regione Autonoma della Sardegna (Legge Regionale); Qatar National Research Fund (National Priorities Research Program) [4 - 259 - 2 - 083]; Administration des Services Techniques de l'Agriculture du Luxembourg; PhD fellowship (XXIV cycle); AGRIS SARDEGNA - Agenzia per la Ricerca in Agricoltura; AM2c program of the National Research Fund of Luxembourg; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom through the Institute Strategic Programme [20:20 Wheat(R)]; BBSRC [BBS/E/C/00005192, BBS/E/C/00005203] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005192, BBS/E/C/00005203] Funding Source: researchfish	Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Autonoma della Sardegna (Legge Regionale); Qatar National Research Fund (National Priorities Research Program); Administration des Services Techniques de l'Agriculture du Luxembourg; PhD fellowship (XXIV cycle); AGRIS SARDEGNA - Agenzia per la Ricerca in Agricoltura; AM2c program of the National Research Fund of Luxembourg; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom through the Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Ministry of University and Research, by Regione Autonoma della Sardegna (Legge Regionale 7 agosto 2007, n. 7 "Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna'') and by Qatar National Research Fund (National Priorities Research Program Grant number 4 - 259 - 2 - 083) and by 'Administration des Services Techniques de l'Agriculture du Luxembourg'. FS acknowledges receipt of a PhD fellowship (XXIV cycle) sponsored by AGRIS SARDEGNA - Agenzia per la Ricerca in Agricoltura. MP acknowledges the AM2c program of the National Research Fund of Luxembourg. KHK is supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom through the Institute Strategic Programme Grant 20:20 Wheat (R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleandri MP, 2007, PLANT PATHOL, V56, P517, DOI 10.1111/j.1365-3059.2007.01574.x; Aleandri MP, 2008, PLANT PATHOL, V57, P1017, DOI 10.1111/j.1365-3059.2008.01859.x; Aramayo R, 1996, GENETICS, V144, P991; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Balmas V, 2006, J AGR FOOD CHEM, V54, P480, DOI 10.1021/jf0523014; Beccari G, 2011, PLANT PATHOL, V60, P671, DOI 10.1111/j.1365-3059.2011.02425.x; Benoit I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-321; Borneman AR, 2002, MOL MICROBIOL, V44, P621, DOI 10.1046/j.1365-2958.2002.02906.x; Breakspear A, 2011, FUNGAL GENET BIOL, V48, P725, DOI 10.1016/j.fgb.2011.03.001; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cools HJ, 2013, MOL PLANT PATHOL, V14, P197, DOI 10.1111/mpp.12001; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; Cuzick A, 2008, NEW PHYTOL, V177, P990, DOI 10.1111/j.1469-8137.2007.02333.x; de Groot MJL, 2003, MICROBIOL-SGM, V149, P1183, DOI 10.1099/mic.0.25993-0; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dubos T, 2013, PESTIC BIOCHEM PHYS, V105, P28, DOI 10.1016/j.pestbp.2012.11.004; Dubos T, 2011, EUR J PLANT PATHOL, V130, P239, DOI 10.1007/s10658-011-9749-7; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; Acero FJF, 2011, INT J MOL SCI, V12, P795, DOI 10.3390/ijms12010795; Garcia-Pedrajas MD, 2010, MOL PLANT MICROBE IN, V23, P211, DOI 10.1094/MPMI-23-2-0211; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; Giraud F, 2010, FOOD ADDIT CONTAM A, V27, P825, DOI 10.1080/19440040903567232; Ipcho SVS, 2010, EUKARYOT CELL, V9, P1100, DOI 10.1128/EC.00064-10; Iyer LM, 2002, GENOME BIOL, V3; Jaroszuk-Scisel J, 2011, MYCOLOGIA, V103, P929, DOI 10.3852/10-300; Jiao F, 2008, FEMS MICROBIOL LETT, V285, P212, DOI 10.1111/j.1574-6968.2008.01235.x; Kang Z, 2000, J PHYTOPATHOL, V148, P263, DOI 10.1046/j.1439-0434.2000.00489.x; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; LANGIN T, 1990, CURR GENET, V17, P313, DOI 10.1007/BF00314878; Lee BN, 2005, EUKARYOT CELL, V4, P545, DOI 10.1128/EC.4.3.545-555.2005; Lowe RGT, 2010, MOL PLANT MICROBE IN, V23, P1605, DOI 10.1094/MPMI-04-10-0092; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Maier FJ, 2006, MOL PLANT PATHOL, V7, P449, DOI 10.1111/j.1364-3703.2006.00351.x; MALALASEKERA RA, 1973, T BRIT MYCOL SOC, V60, P453, DOI 10.1016/S0007-1536(73)80030-0; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McKinney HH, 1923, J AGRIC RES, V26, P0195; MERSONDAVIES LA, 1992, J GEN MICROBIOL, V138, P461, DOI 10.1099/00221287-138-3-461; Migheli Q, 1996, MOL ECOL, V5, P641, DOI 10.1111/j.1365-294X.1996.tb00359.x; MILLER KY, 1992, GENE DEV, V6, P1770, DOI 10.1101/gad.6.9.1770; MILLER KY, 1991, MOL GEN GENET, V227, P285, DOI 10.1007/BF00259682; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; NIRENBERG HI, 1990, STUD MYCOL, P91; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Ohara T, 2004, EUKARYOT CELL, V3, P1412, DOI 10.1128/EC.3.6.1412-1422.2004; Pasquali M, 2010, INT J FOOD MICROBIOL, V137, P246, DOI 10.1016/j.ijfoodmicro.2009.11.009; Pasquali Matias, 2010, J Vis Exp, DOI 10.3791/1690; Ponts N, 2009, FEMS MICROBIOL LETT, V293, P255, DOI 10.1111/j.1574-6968.2009.01521.x; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Ramirez-Zavala B, 2008, FEMS YEAST RES, V8, P511, DOI 10.1111/j.1567-1364.2008.00370.x; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scherm B, 2013, MOL PLANT PATHOL, V14, P323, DOI 10.1111/mpp.12011; Scherm B, 2011, MOL PLANT PATHOL, V12, P759, DOI 10.1111/J.1364-3703.2011.00709.X; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Skov J, 2004, PHYSIOL MOL PLANT P, V64, P245, DOI 10.1016/j.pmpp.2004.09.005; Skovgaard K, 2003, MYCOLOGIA, V95, P630, DOI 10.2307/3761939; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Spanu F, 2012, MOL PLANT PATHOL, V13, P1149, DOI 10.1111/j.1364-3703.2012.00823.x; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; SZECSI A, 1990, J PHYTOPATHOL, V130, P188, DOI 10.1111/j.1439-0434.1990.tb01167.x; TAYLOR RJ, 1988, PHYTOPATHOLOGY, V78, P1101, DOI 10.1094/Phyto-78-1101; Teertstra WR, 2006, MICROBIOL-SGM, V152, P3607, DOI 10.1099/mic.0.29034-0; Tong XZ, 2007, MOL PLANT MICROBE IN, V20, P1102, DOI 10.1094/MPMI-20-9-1102; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Wagacha JM, 2007, CROP PROT, V26, P877, DOI 10.1016/j.cropro.2006.09.003; WARD MP, 1995, MOL CELL BIOL, V15, P6854; Wu JG, 1997, MOL CELL BIOL, V17, P6191, DOI 10.1128/MCB.17.10.6191; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1	74	30	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57429	10.1371/journal.pone.0057429	http://dx.doi.org/10.1371/journal.pone.0057429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451228	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800107
J	Saini, S; Jagadish, N; Gupta, A; Bhatnagar, A; Suri, A				Saini, Shikha; Jagadish, Nirmala; Gupta, Anju; Bhatnagar, Amar; Suri, Anil			A Novel Cancer Testis Antigen, A-Kinase Anchor Protein 4 (AKAP4) Is a Potential Biomarker for Breast Cancer	PLOS ONE			English	Article							TUMOR-GROWTH; MAGE-A; EXPRESSION; IMMUNOTHERAPY; AUTOANTIBODIES; TARGET; PKA	Background: Breast cancer is the second leading cause of cancer related deaths in women worldwide. Reports about the early diagnosis of breast cancer are suggestive of an improved clinical outcome and overall survival rate in cancer patients. Therefore, cancer screening biomarker for early detection and diagnosis is urgently required for timely treatment and better cancer management. In this context, we investigated an association of cancer testis antigen, A-Kinase anchor protein 4 (AKAP4) with breast carcinoma. Methodology/Findings: We first compared the AKAP4 gene and protein expression in four breast cancer cells (MCF7, MDA-MB-231, SK-BR3 and BT474) and normal human mammary epithelial cells. In addition, 91 clinical specimens of breast cancer patients of various histotypes including ductal carcinoma in situ, infiltrating ductal carcinoma and infiltrating lobular carcinoma and 83 available matched adjacent non-cancerous tissues were examined for AKAP4 gene and protein expression by employing in situ RNA hybridization and immunohistochemistry respectively. Humoral response against AKAP4 was also investigated in breast cancer patients employing ELISA. Our in vitro studies in all breast cancer cells revealed AKAP4 gene and protein expression whereas, normal human mammary epithelial cells failed to show any expression. Using in situ RNA hybridization and immunohistochemistry, 85% (77/91) tissue specimens irrespective of histotypes, stages and grades of breast cancer clinical specimens revealed AKAP4 gene and protein expression. However, matched adjacent non-cancerous tissues failed to display any AKAP4 gene and protein expression. Furthermore, humoral response was observed in 79% (72/91) of total breast cancer patients. Interestingly, we observed that 94% (72/77) of breast cancer patients found positive for AKAP4 protein expression generated humoral response against AKAP4 protein. Conclusions: Collectively, our data suggests that AKAP4 may be used as serum based diagnostic test for an early detection and diagnosis of breast cancer and may be a potential target for immunotherapeutic use.	[Saini, Shikha; Jagadish, Nirmala; Suri, Anil] Natl Inst Immunol, Canc Microarray Genes & Prot Lab, New Delhi 110067, India; [Gupta, Anju] Vidyasagar Inst Mental Hlth & Neurosci, NMC Imaging & Diagnost Ctr, New Delhi, India; [Bhatnagar, Amar] Safdarjang Hosp, Dept Canc Surg, New Delhi, India; [Bhatnagar, Amar] Vardhman Mahavir Med Coll, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital	Suri, A (corresponding author), Natl Inst Immunol, Canc Microarray Genes & Prot Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	anil@nii.res.in	Suri, Anil/P-5128-2016; Jagadish, Nirmala/AAR-3046-2020; Saini, Shikha/ABC-7231-2020	Suri, Anil/0000-0001-5231-5555; Saini, Shikha/0000-0003-0557-1649; Jagadish, Nirmala/0000-0002-5812-9283	Indo-UK Cancer Research Program, Centre for Molecular Medicine, NII-core funding, Department of Biotechnology, Government of India	Indo-UK Cancer Research Program, Centre for Molecular Medicine, NII-core funding, Department of Biotechnology, Government of India	This work is supported by grants from Indo-UK Cancer Research Program, Centre for Molecular Medicine, NII-core funding, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2001, JPN J PHARMACOL, V87, P181, DOI 10.1254/jjp.87.181; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chiriva-Internati M, 2008, BRIT J HAEMATOL, V140, P465, DOI 10.1111/j.1365-2141.2007.06940.x; Chiriva-Internati M, 2012, PROSTATE, V72, P12, DOI 10.1002/pros.21400; Garg M, 2008, CANCER RES, V68, P8240, DOI 10.1158/0008-5472.CAN-08-1708; Garg M, 2007, CLIN CANCER RES, V13, P1421, DOI 10.1158/1078-0432.CCR-06-2340; Garg M, 2009, J CLIN ENDOCR METAB, V94, P4613, DOI 10.1210/jc.2009-0703; Garg M, 2009, CANCER-AM CANCER SOC, V115, P2671, DOI 10.1002/cncr.24293; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gu L, 2009, CLIN CANCER RES, V15, P7196, DOI 10.1158/1078-0432.CCR-09-0585; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Houssami N, 2009, ANN ONCOL, V20, P1505, DOI 10.1093/annonc/mdp037; Kanojia D, 2011, AM J PATHOL, V178, P1009, DOI 10.1016/j.ajpath.2010.11.047; Kanojia D, 2010, LEUKEMIA RES, V34, P858, DOI 10.1016/j.leukres.2010.01.017; Kanojia D, 2009, CANCER EPIDEM BIOMAR, V18, P630, DOI 10.1158/1055-9965.EPI-08-0629; Kruger S, 2007, PATHOL ONCOL RES, V13, P91; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Matkovic B, 2011, CROAT MED J, V52, P171, DOI 10.3325/cmj.2011.52.171; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Miller WR, 2002, ANN NY ACAD SCI, V968, P37, DOI 10.1111/j.1749-6632.2002.tb04325.x; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Mohapatra B, 1998, BIOCHEM BIOPH RES CO, V244, P540, DOI 10.1006/bbrc.1998.8079; Otte M, 2001, CANCER RES, V61, P6682; Radhi S, 2012, J CLIN ONCOL S, V30; Scudellari M, 2011, NAT MED, V17, P916, DOI 10.1038/nm0811-916; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Taplin S, 2008, J NATL CANCER I, V100, P876, DOI 10.1093/jnci/djn172; Tortora G, 2002, CLIN CANCER RES, V8, P303; Yu P, 2012, INT J GYNECOL CANCER, V22, P87, DOI 10.1097/IGC.0b013e3182370f2e; Zhong L, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2091	35	31	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57095	10.1371/journal.pone.0057095	http://dx.doi.org/10.1371/journal.pone.0057095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451156	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800073
J	Asai, H; Fujiwara, H; An, J; Ochi, T; Miyazaki, Y; Nagai, K; Okamoto, S; Mineno, J; Kuzushima, K; Shiku, H; Inoue, H; Yasukawa, M				Asai, Hiroaki; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Miyazaki, Yukihiro; Nagai, Kozo; Okamoto, Sachiko; Mineno, Junichi; Kuzushima, Kiyotaka; Shiku, Hiroshi; Inoue, Hirofumi; Yasukawa, Masaki			Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ANTITUMOR-ACTIVITY; ANTILEUKEMIA REACTIVITY; LUNG-CARCINOMA; WT1 PEPTIDE; LYMPHOCYTES; CHEMOKINE; MIGRATION; IMMUNOTHERAPY; KINASE	Background and Purpose: Although gene-modification of T cells to express tumor-related antigen-specific T-cell receptor (TCR) or chimeric antigen receptor (CAR) has clinically proved promise, there still remains room to improve the clinical efficacy of re-directed T-cell based antitumor adoptive therapy. In order to achieve more objective clinical responses using ex vivo-expanded tumor-responsive T cells, the infused T cells need to show adequate localized infiltration into the tumor. Methodology/Principal Findings: Human lung cancer cells variously express a tumor antigen, Wilms' Tumor gene product 1 (WT1), and an inflammatory chemokine, CCL2. However, CCR2, the relevant receptor for CCL2, is rarely expressed on activated T-lymphocytes. A HLA-A2402(+) human lung cancer cell line, LK79, which expresses high amounts of both CCL2 and WT1 mRNA, was employed as a target. Normal CD8(+) T cells were retrovirally gene-modified to express both CCR2 and HLA-A*2402-restricted and WT1235-243 nonapeptide-specific TCR as an effector. Anti-tumor functionality mediated by these effector cells against LK79 cells was assessed both in vitro and in vivo. Finally the impact of CCL2 on WT1 epitope-responsive TCR signaling mediated by the effector cells was studied. Introduced CCR2 was functionally validated using gene-modified Jurkat cells and human CD3(+) T cells both in vitro and in vivo. Double gene-modified CD3(+) T cells successfully demonstrated both CCL2-tropic tumor trafficking and cytocidal reactivity against LK79 cells in vitro and in vivo. CCL2 augmented the WT1 epitope-responsive TCR signaling shown by relevant luciferase production in double gene-modified Jurkat/MA cells to express luciferase and WT1-specific TCR, and CCL2 also dose-dependently augmented WT1 epitope-responsive IFN-gamma production and CD107a expression mediated by these double gene-modifiedCD3(+) T cells. Conclusion/Significance: Introduction of the CCL2/CCR2 axis successfully potentiated in vivo anti-lung cancer reactivity mediated by CD8(+) T cells double gene-modified to express WT1-specific TCR and CCR2 not only via CCL2-tropic tumor trafficking, but also CCL2-enhanced WT1-responsiveness.	[Asai, Hiroaki; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Miyazaki, Yukihiro; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Matsuyama, Ehime 790, Japan; [Fujiwara, Hiroshi; Yasukawa, Masaki] Ehime Univ, Proteomed Res Ctr, Dept Cell Growth & Tumor Regulat, Matsuyama, Ehime 790, Japan; [Ochi, Toshiki] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON, Canada; [Nagai, Kozo] Ehime Univ, Grad Sch Med, Dept Pediat, Matsuyama, Ehime 790, Japan; [Okamoto, Sachiko; Mineno, Junichi] Takara Bio Inc, Ctr Cell & Gene Therapy, Tokyo, Shiga, Japan; [Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Canc Vaccine & Immunogene Therapy, Tsu, Mie, Japan; [Inoue, Hirofumi] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Matsuyama, Ehime 790, Japan	Ehime University; Ehime University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ehime University; Takara Bio Inc.; Mie University; Ehime University	Fujiwara, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Matsuyama, Ehime 790, Japan.	yunarief@m.ehime-u.ac.jp; yasukawa@m.ehime-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare; Takara Bio, Inc.; Grants-in-Aid for Scientific Research [24390245] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takara Bio, Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HF and MY, and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare to MY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors except SO, JM and HS have declared that no competing interest exist. SO and JM are employee of Takara Bio, Inc.. HS is provided with research funding from Takara Bio, Inc.. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berencsi K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-33; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Calogero A, 2000, ANTICANCER RES, V20, P1793; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; Daurkin I, 2011, CANCER RES, V71, P6400, DOI 10.1158/0008-5472.CAN-11-1261; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Gomi S, 1999, J IMMUNOL, V163, P4994; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hayashi S, 2012, CANCER INVEST, V30, P165, DOI 10.3109/07357907.2011.633291; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ichinohasama R, 2010, CANCER SCI, V101, P1089, DOI 10.1111/j.1349-7006.2010.01522.x; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Izhak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028305; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Makita M, 2002, CLIN CANCER RES, V8, P2626; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Nagai K, 2012, BLOOD, V119, P368, DOI 10.1182/blood-2011-06-360354; NAKAO M, 1995, CANCER RES, V55, P4248; Niiya M, 2003, CANCER CHEMOTH PHARM, V52, P391, DOI 10.1007/s00280-003-0665-1; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Ochi T, 2009, BLOOD, V113, P66, DOI 10.1182/blood-2008-06-164889; Ohminami H, 2000, BLOOD, V95, P286; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Peng WY, 2010, CLIN CANCER RES, V16, P5458, DOI 10.1158/1078-0432.CCR-10-0712; Penido C, 2008, INT IMMUNOL, V20, P129, DOI 10.1093/intimm/dxm128; POCKAJ BA, 1994, CANCER, V73, P1731, DOI 10.1002/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Schaeuble K, 2011, J IMMUNOL, V187, P5645, DOI 10.4049/jimmunol.1101850; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Song LP, 2009, J CLIN INVEST, V119, P1524, DOI 10.1172/JCI37869; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhang TQ, 2006, EUR J IMMUNOL, V36, P457, DOI 10.1002/eji.200526208	48	34	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56820	10.1371/journal.pone.0056820	http://dx.doi.org/10.1371/journal.pone.0056820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441216	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200073
J	Dutta, A; Katarkar, A; Chaudhuri, K				Dutta, Avirup; Katarkar, Atul; Chaudhuri, Keya			In-Silico Structural and Functional Characterization of a V-cholerae O395 Hypothetical Protein Containing a PDZ1 and an Uncommon Protease Domain	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUBCELLULAR-LOCALIZATION; PATHOGENICITY ISLANDS; QUALITY-CONTROL; CRYSTAL-STRUCTURE; SERINE PROTEASES; CELLULAR STRESS; GAP PENALTIES; SWISS-MODEL; HTRA FAMILY	Vibrio cholerae, the causative agent of epidemic cholera, has been a constant source of concern for decades. It has constantly evolved itself in order to survive the changing environment. Acquisition of new genetic elements through genomic islands has played a major role in its evolutionary process. In this present study a hypothetical protein was identified which was present in one of the predicted genomic island regions of the large chromosome of V. cholerae O395 showing a strong homology with a conserved phage encoded protein. In-silico physicochemical analysis revealed that the hypothetical protein was a periplasmic protein. Homology modeling study indicated that the hypothetical protein was an unconventional and atypical serine protease belonging to HtrA protein family. The predicted 3D-model of the hypothetical protein revealed a catalytic centre serine utilizing a single catalytic residue for proteolysis. The predicted catalytic triad may help to deduce the active site for the recruitment of the substrate for proteolysis. The active site arrangements of this predicted serine protease homologue with atypical catalytic triad is expected to allow these proteases to work in different environments of the host.	[Dutta, Avirup] CSIR Indian Inst Chem Biol, Mol & Human Genet Div, CSIR SRF, Kolkata, W Bengal, India; [Katarkar, Atul] CSIR Indian Inst Chem Biol, Mol & Human Genet Div, ICMR SRF, Kolkata, W Bengal, India; [Chaudhuri, Keya] CSIR Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, W Bengal, India; [Chaudhuri, Keya] CSIR Indian Inst Chem Biol, Acad Affairs Div, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chaudhuri, K (corresponding author), CSIR Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, W Bengal, India.	keya.chaudhuri@gmail.com		Dutta, Avirup/0000-0002-3595-6198	Council of Scientific and Industrial Research (CSIR), Govt. of India; CSIR; ICMR, Govt. of India	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR, Govt. of India(Indian Council of Medical Research (ICMR))	The study was funded by Council of Scientific and Industrial Research (CSIR), Govt. of India. AD and AK are recipients of fellowships from CSIR and ICMR, Govt. of India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Bates PA, 2001, PROTEINS, P39; Chatterjee R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-150; CHOI KS, 1992, J BACTERIOL, V174, P6270, DOI 10.1128/JB.174.19.6270-6276.1992; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cortes G, 2002, INFECT IMMUN, V70, P4772, DOI 10.1128/IAI.70.9.4772-4776.2002; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HACKER J, 1999, PATHOGENICITY ISLAND, P1; Hansen G, 2012, CELL MOL LIFE SCI; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hewitt L, 2000, J MOL BIOL, V302, P887, DOI 10.1006/jmbi.2000.4105; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jones CH, 2001, INFECT IMMUN, V69, P5538, DOI 10.1128/IAI.69.9.5538-5545.2001; KAPER JB, 1984, NATURE, V308, P655, DOI 10.1038/308655a0; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Kim Y, 2002, J BIOL CHEM, V277, P2823, DOI 10.1074/jbc.M108888200; Kirk R, 2010, SENSORY MECHANISMS IN BACTERIA: MOLECULAR ASPECTS OF SIGNAL RECOGNITION, P231; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Lewis C, 2009, MICROBIOL-SGM, V155, P873, DOI 10.1099/mic.0.023754-0; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Mo E, 2006, MICROB PATHOGENESIS, V41, P174, DOI 10.1016/j.micpath.2006.07.004; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Shea YA, 2004, MICROBIOL-SGM, V150, P4053, DOI 10.1099/mic.0.27172-0; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Schrodinger L., 2020, PYMOL; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang WW, 2008, APPL ENVIRON MICROB, V74, P6254, DOI 10.1128/AEM.00109-08; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	78	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56725	10.1371/journal.pone.0056725	http://dx.doi.org/10.1371/journal.pone.0056725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441214	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200071
J	Kandeel, M; Kitade, Y				Kandeel, Mahmoud; Kitade, Yukio			Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ARGONAUTE; STABILITY; PROTEINS; INSIGHTS; BINDING	RNA interference (RNAi) is a highly specialized process of protein-siRNA interaction that results in the regulation of gene expression and cleavage of target mRNA. The PAZ domain of the Argonaute proteins binds to the 3' end of siRNA, and during RNAi the attaching end of the siRNA switches between binding and release from its binding pocket. This biphasic interaction of the 3' end of siRNA with the PAZ domain is essential for RNAi activity; however, it remains unclear whether stronger or weaker binding with PAZ domain will facilitate or hinder the overall RNAi process. Here we report the correlation between the binding of modified siRNA 3' overhang analogues and their in vivo RNAi efficacy. We found that higher RNAi efficacy was associated with the parameters of lower Ki value, lower total intermolecular energy, lower free energy, higher hydrogen bonding, smaller total surface of interaction and fewer van der Waals interactions. Electrostatic interaction was a minor contributor to compounds recognition, underscoring the presence of phosphate groups in the modified analogues. Thus, compounds with lower binding affinity are associated with better gene silencing. Lower binding strength along with the smaller interaction surface, higher hydrogen bonding and fewer van der Waals interactions were among the markers for favorable RNAi activity. Within the measured parameters, the interaction surface, van der Waals interactions and inhibition constant showed a statistically significant correlation with measured RNAi efficacy. The considerations provided in this report will be helpful in the design of new compounds with better gene silencing ability.	[Kandeel, Mahmoud; Kitade, Yukio] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Kitade, Yukio] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 50111, Japan; [Kandeel, Mahmoud] Kafrelshikh Univ, Fac Vet Med, Dept Pharmacol, Kafrelshikh, Egypt	Gifu University; Gifu University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Kitade, Y (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan.	ykkitade@gifu-u.ac.jp	Kandeel, Mahmoud/G-3636-2016	Kandeel, Mahmoud/0000-0003-3668-5147	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [24390025]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Research support from Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid for scientific Research (Grant no. 24390025) from the Japan Society for the Promotion of Science (JSPS) (URL: http://www.mext.go.jp/english/, http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparailly F, 2012, NATURE REV RHEUMATOL; Avino A, 2012, CHEM BIODIVERS, V9, P557, DOI 10.1002/cbdv.201100321; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Bouasker S, 2009, NATURE, V461, P743, DOI 10.1038/461743a; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gong W, 2012, BIOORG MED CHEM LETT, V22, P6934, DOI 10.1016/j.bmcl.2012.09.009; Gu S, 2012, CURR BIOL, V22, P1536, DOI 10.1016/j.cub.2012.06.040; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Jaronczyk K, 2005, BIOCHEM J, V387, P561, DOI 10.1042/BJ20041822; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Kuboe S, 2010, CHEM COMMUN, V46, P7367, DOI 10.1039/c0cc02450c; Li Y, 2011, CHEM BIOL DRUG DESIG; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; Rajasekaran R, 2012, J MOL MODELING; Sipa K, 2007, RNA, V13, P1301, DOI 10.1261/rna.538907; Somoza A, 2010, CHEM COMMUN, V46, P4270, DOI 10.1039/c003221b; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Taniho K, 2012, BIOORG MED CHEM LETT, V22, P2518, DOI 10.1016/j.bmcl.2012.01.132; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Ueno Y, 2005, J ORG CHEM, V70, P7925, DOI 10.1021/jo050635m; Ueno Y, 2008, BIOORG MED CHEM LETT, V18, P5194, DOI 10.1016/j.bmcl.2008.08.086; Ueno Yoshihito, 2009, Nucleic Acids Symp Ser (Oxf), P27, DOI 10.1093/nass/nrp014; Ueno Yoshihito, 2008, Nucleic Acids Symp Ser (Oxf), P503, DOI 10.1093/nass/nrn255; Ueno Y, 2009, BIOORGAN MED CHEM, V17, P1974, DOI 10.1016/j.bmc.2009.01.033; Wang J, 2012, TRANSL ANDROL UROL, V1, P33, DOI 10.3978/j.issn.2223-4683.2011.12.04; Wang L, 2013, BIOMATERIALS, V34, P262, DOI 10.1016/j.biomaterials.2012.09.037; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yoshikawa K, 2011, BIOCONJUGATE CHEM, V22, P42, DOI 10.1021/bc100301w; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zeng L, 2011, PROTEINS, V79, P2004, DOI 10.1002/prot.23003	37	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57140	10.1371/journal.pone.0057140	http://dx.doi.org/10.1371/journal.pone.0057140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441235	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200092
J	Jasinska, M; Siucinska, E; Jasek, E; Litwin, JA; Pyza, E; Kossut, M				Jasinska, Malgorzata; Siucinska, Ewa; Jasek, Ewa; Litwin, Jan A.; Pyza, Elzbieta; Kossut, Malgorzata			Fear Learning Increases the Number of Polyribosomes Associated with Excitatory and Inhibitory Synapses in the Barrel Cortex	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; SOMATOSENSORY CORTEX; INDUCED ENHANCEMENT; DENDRITIC SPINES; NMDA RECEPTORS; MESSENGER-RNA; PLASTICITY; SYNAPTOGENESIS; TRANSLATION; EXPRESSION	Associative fear learning, resulting from whisker stimulation paired with application of a mild electric shock to the tail in a classical conditioning paradigm, changes the motor behavior of mice and modifies the cortical functional representation of sensory receptors involved in the conditioning. It also induces the formation of new inhibitory synapses on double-synapse spines of the cognate barrel hollows. We studied density and distribution of polyribosomes, the putative structural markers of enhanced synaptic activation, following conditioning. By analyzing serial sections of the barrel cortex by electron microscopy and stereology, we found that the density of polyribosomes was significantly increased in dendrites of the barrel activated during conditioning. The results revealed fear learning-induced increase in the density of polyribosomes associated with both excitatory and inhibitory synapses located on dendritic spines (in both single- and double-synapse spines) and only with the inhibitory synapses located on dendritic shafts. This effect was accompanied by a significant increase in the postsynaptic density area of the excitatory synapses on single-synapse spines and of the inhibitory synapses on double-synapse spines containing polyribosomes. The present results show that associative fear learning not only induces inhibitory synaptogenesis, as demonstrated in the previous studies, but also stimulates local protein synthesis and produces modifications of the synapses that indicate their potentiation.	[Jasinska, Malgorzata; Jasek, Ewa; Litwin, Jan A.] Jagiellonian Univ, Coll Med, Dept Histol, Krakow, Poland; [Siucinska, Ewa; Kossut, Malgorzata] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland; [Kossut, Malgorzata] Warsaw Sch Social Psychol, Warsaw, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Jagiellonian University; SWPS University of Social Sciences & Humanities	Kossut, M (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	kossut@nencki.gov.pl	Jasek-Gajda, Ewa/ACT-6284-2022; Siucinska, Ewa/W-7969-2018	Jasek-Gajda, Ewa/0000-0002-2030-0356; Siucinska, Ewa/0000-0002-4541-2864; Kossut, Malgorzata/0000-0001-7808-1101; Jasinska, Malgorzata/0000-0002-8102-6039	Polish Ministry of Science and Higher Education [IP2010 014970]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was supported by Iuventus Plus grant IP2010 014970 from the Polish Ministry of Science and Higher Education to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; Bekisz M, 2010, EUR J NEUROSCI, V32, P1715, DOI 10.1111/j.1460-9568.2010.07453.x; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Bourne JN, 2007, HIPPOCAMPUS, V17, P1, DOI 10.1002/hipo.20238; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cybulska-Klosowicz A, 2009, BEHAV BRAIN RES, V204, P102, DOI 10.1016/j.bbr.2009.05.024; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gierdalski M, 2001, CEREB CORTEX, V11, P806, DOI 10.1093/cercor/11.9.806; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Holtmaat A, 2008, BEHAV BRAIN RES, V192, P20, DOI 10.1016/j.bbr.2008.04.005; HUNTER A, 1993, BRAIN RES, V605, P251, DOI 10.1016/0006-8993(93)91747-G; Jasinska M, 2006, ACTA NEUROBIOL EXP, V66, P99; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jones MS, 1997, BRAIN RES, V768, P167, DOI 10.1016/S0006-8993(97)00639-2; Kleim JA, 1996, J NEUROSCI, V16, P4529; Knafo S, 2004, HIPPOCAMPUS, V14, P819, DOI 10.1002/hipo.10219; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lushnikova I, 2011, NEUROPHARMACOLOGY, V60, P757, DOI 10.1016/j.neuropharm.2010.12.014; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ostroff LE, 2010, P NATL ACAD SCI USA, V107, P9418, DOI 10.1073/pnas.0913384107; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; Saar D, 2012, J NEUROPHYSIOL, V107, P1222, DOI 10.1152/jn.00356.2011; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Siucinska E, 1996, CEREB CORTEX, V6, P506, DOI 10.1093/cercor/6.3.506; Siucinska E, 1999, BRAIN RES, V843, P62, DOI 10.1016/S0006-8993(99)01881-8; Skibinska A, 2005, BRAIN RES, V1065, P26, DOI 10.1016/j.brainres.2005.10.021; Skibinska A, 2001, NEUROREPORT, V12, P2907, DOI 10.1097/00001756-200109170-00030; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1986, J NEUROSCI, V6, P3079; STEWARD O, 1982, J NEUROSCI, V2, P284; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tokarski K, 2007, EUR J NEUROSCI, V26, P134, DOI 10.1111/j.1460-9568.2007.05629.x; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yu HB, 2011, P NATL ACAD SCI USA, V108, P21235, DOI 10.1073/pnas.1108270109	52	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54301	10.1371/journal.pone.0054301	http://dx.doi.org/10.1371/journal.pone.0054301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457448	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700005
J	Singh, A; Ramnath, RD; Foster, RR; Wylie, EC; Friden, V; Dasgupta, I; Haraldsson, B; Welsh, GI; Mathieson, PW; Satchell, SC				Singh, Anurag; Ramnath, Raina D.; Foster, Rebecca R.; Wylie, Emma C.; Friden, Vincent; Dasgupta, Ishita; Haraldsson, Borje; Welsh, Gavin I.; Mathieson, Peter W.; Satchell, Simon C.			Reactive Oxygen Species Modulate the Barrier Function of the Human Glomerular Endothelial Glycocalyx	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEPARAN-SULFATE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CELL GLYCOCALYX; IN-VITRO; PERMEABILITY; PROTEINURIA; KIDNEY; GLYCOSAMINOGLYCANS	Reactive oxygen species (ROS) play a key role in the pathogenesis of proteinuria in glomerular diseases like diabetic nephropathy. Glomerular endothelial cell (GEnC) glycocalyx covers the luminal aspect of the glomerular capillary wall and makes an important contribution to the glomerular barrier. ROS are known to depolymerise glycosaminoglycan (GAG) chains of proteoglycans, which are crucial for the barrier function of GEnC glycocalyx. The aim of this study is to investigate the direct effects of ROS on the structure and function of GEnC glycocalyx using conditionally immortalised human GEnC. ROS were generated by exogenous hydrogen peroxide. Biosynthesis and cleavage of GAG chains was analyzed by radiolabelling (S 35 and 3 H-glucosamine). GAG chains were quantified on GEnC surface and in the cell supernatant using liquid chromatography and immunofluorescence techniques. Barrier properties were estimated by measuring transendothelial passage of albumin. ROS caused a significant loss of WGA lectin and heparan sulphate staining from the surface of GEnC. This lead to an increase in trans-endothelial albumin passage. The latter could be inhibited by catalase and superoxide dismutase. The effect of ROS on GEnC was not mediated via the GAG biosynthetic pathway. Quantification of radiolabelled GAG fractions in the supernatant confirmed that ROS directly caused shedding of HS GAG. This finding is clinically relevant and suggests a mechanism by which ROS may cause proteinuria in clinical conditions associated with high oxidative stress.	[Singh, Anurag; Ramnath, Raina D.; Foster, Rebecca R.; Wylie, Emma C.; Dasgupta, Ishita; Welsh, Gavin I.; Mathieson, Peter W.; Satchell, Simon C.] Southmead Hosp, Acad Renal Unit, Bristol, Avon, England; [Singh, Anurag] Chilliwack Gen Hosp, Fraser Hlth Author Chilliwack, Div Med, Chilliwack, BC, Canada; [Friden, Vincent; Haraldsson, Borje] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Renal Unit, Gothenburg, Sweden	Southmead Hospital; University of Gothenburg	Singh, A (corresponding author), Southmead Hosp, Acad Renal Unit, Bristol, Avon, England.	anuragsing@hotmail.com	Haraldsson, Borje/B-3871-2010; Ramnath, Raina/AAO-1180-2020; Foster, Rebecca/GSM-6886-2022; Foster, Becky/ABC-4433-2020	Haraldsson, Borje/0000-0002-7536-973X; Foster, Rebecca/0000-0002-9645-1476; Ramnath, Raina/0000-0001-8472-5081; Welsh, Gavin Iain/0000-0002-2148-6658	Kidney Research UK [TF22/2004]; Academy of Medical Sciences/Wellcome Trust UK; Diabetes UK [10/0004003]; MRC [G0800200] Funding Source: UKRI; British Heart Foundation [FS/10/017/28249] Funding Source: researchfish; Medical Research Council [G0800200] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Academy of Medical Sciences/Wellcome Trust UK; Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A. Singh is the recipient of a research training fellowship from Kidney Research UK (Grant TF22/2004) and an Academy of Medical Sciences/Wellcome Trust UK starter grant for clinical lecturers. The work was also supported by Diabetes UK (Grant 10/0004003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI T, 1993, BIOCHEM J, V289, P523, DOI 10.1042/bj2890523; Amann K, 2006, J AM SOC NEPHROL, V17, P2112, DOI 10.1681/ASN.2006030204; Andersson M, 2007, AM J PHYSIOL-RENAL, V292, pF1802, DOI 10.1152/ajprenal.00152.2006; BECKER M, 1994, AM J PHYSIOL, V267, pH925, DOI 10.1152/ajpheart.1994.267.3.H925; BRENNER BM, 1977, KIDNEY INT, V12, P229, DOI 10.1038/ki.1977.107; de Vega JMA, 2002, CRIT CARE MED, V30, P1782, DOI 10.1097/00003246-200208000-00018; Deen WM, 2001, AM J PHYSIOL-RENAL, V281, pF579; Edge ASB, 2000, DIABETOLOGIA, V43, P1056, DOI 10.1007/s001250051489; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Franco M, 2011, AM J MED, V124, P95, DOI 10.1016/j.amjmed.2010.08.015; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harrison D, 2003, AM J CARDIOL, V91, p7A; Harrison DG, 2003, J RENIN-ANGIO-ALDO S, V4, P51, DOI 10.3317/jraas.2003.014; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Hjalmarsson C, 2004, MICROVASC RES, V67, P9, DOI 10.1016/j.mvr.2003.10.001; Jeansson M, 2006, AM J PHYSIOL-RENAL, V290, pF111, DOI 10.1152/ajprenal.00173.2005; Kevil CG, 1998, FREE RADICAL BIO MED, V24, P1015, DOI 10.1016/S0891-5849(97)00433-4; MOSELEY R, 1995, BBA-GEN SUBJECTS, V1244, P245, DOI 10.1016/0304-4165(95)00010-9; Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; SHASBY DM, 1985, BLOOD, V65, P605; SiflingerBirnboim A, 1996, AM J PHYSIOL-LUNG C, V270, pL973, DOI 10.1152/ajplung.1996.270.6.L973; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Stan RV, 2007, J AM SOC NEPHROL, V18, P2432, DOI 10.1681/ASN.2007060687; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; TAY M, 1990, BIOCHEM INT, V20, P767; Witting PK, 2007, CELL PHYSIOL BIOCHEM, V20, P255, DOI 10.1159/000107512; YOSHIOKA T, 1991, J AM SOC NEPHROL, V2, P902; Ysebaert DK, 2000, NEPHROL DIAL TRANSPL, V15, P1562, DOI 10.1093/ndt/15.10.1562	39	101	111	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55852	10.1371/journal.pone.0055852	http://dx.doi.org/10.1371/journal.pone.0055852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457483	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700024
J	Fernandez, JM; Di Giusto, G; Kalstein, M; Melamud, L; Rivarola, V; Ford, P; Capurro, C				Fernandez, Juan M.; Di Giusto, Gisela; Kalstein, Maia; Melamud, Luciana; Rivarola, Valeria; Ford, Paula; Capurro, Claudia			Cell Volume Regulation in Cultured Human Retinal Muller Cells Is Associated with Changes in Transmembrane Potential	PLOS ONE			English	Article							OSMOTIC SWELLING CHARACTERISTICS; ACTIVATED CATION CHANNELS; GLIAL-CELLS; CHLORIDE CHANNELS; AMINO-ACIDS; POTASSIUM; ASTROCYTES; DECREASE; RELEASE; K+	Muller cells are mainly involved in controlling extracellular homeostasis in the retina, where intense neural activity alters ion concentrations and osmotic gradients, thus favoring cell swelling. This increase in cell volume is followed by a regulatory volume decrease response (RVD), which is known to be partially mediated by the activation of K+ and anion channels. However, the precise mechanisms underlying osmotic swelling and subsequent cell volume regulation in Muller cells have been evaluated by only a few studies. Although the activation of ion channels during the RVD response may alter transmembrane potential (V-m), no studies have actually addressed this issue in Muller cells. The aim of the present work is to evaluate RVD using a retinal Muller cell line (MIO-M1) under different extracellular ionic conditions, and to study a possible association between RVD and changes in V-m. Cell volume and V-m changes were evaluated using fluorescent probe techniques and a mathematical model. Results show that cell swelling and subsequent RVD were accompanied by V-m depolarization followed by repolarization. This response depended on the composition of extracellular media. Cells exposed to a hypoosmotic solution with reduced ionic strength underwent maximum RVD and had a larger repolarization. Both of these responses were reduced by K+ or Cl- channel blockers. In contrast, cells facing a hypoosmotic solution with the same ionic strength as the isoosmotic solution showed a lower RVD and a smaller repolarization and were not affected by blockers. Together, experimental and simulated data led us to propose that the efficiency of the RVD process in Muller glia depends not only on the activation of ion channels, but is also strongly modulated by concurrent changes in the membrane potential. The relationship between ionic fluxes, changes in ion permeabilities and ion concentrations -all leading to changes in V-m- define the success of RVD.	[Fernandez, Juan M.; Di Giusto, Gisela; Kalstein, Maia; Melamud, Luciana; Rivarola, Valeria; Ford, Paula; Capurro, Claudia] Univ Buenos Aires, Fac Med, Lab Biomembranas, Dept Fisiol & Biofis, Buenos Aires, DF, Argentina; [Melamud, Luciana] Univ Buenos Aires, Fac Med, Ctr Univ Neurol Dr JM Ramos Mejia, Consultorio Neuroinmunol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Capurro, C (corresponding author), Univ Buenos Aires, Fac Med, Lab Biomembranas, Dept Fisiol & Biofis, Buenos Aires, DF, Argentina.	capurro@retina.ar	Rivarola, Valeria/R-7128-2019	Rivarola, Valeria/0000-0002-8879-1198; Di Giusto, Gisela/0000-0002-7622-5172; Ford, Paula/0000-0002-3656-0806; Capurro, Claudia/0000-0003-3773-0202	Fondo Nacional para la Ciencia y la Tecnologia (FONCYT) [PICT 07-1060]; UBACYT Universidad de Buenos Aires (UBA) [MO 648/11]	Fondo Nacional para la Ciencia y la Tecnologia (FONCYT); UBACYT Universidad de Buenos Aires (UBA)	This work was supported by PICT 07-1060 Fondo Nacional para la Ciencia y la Tecnologia (FONCYT), http://www.agencia.gov.ar; UBACYT MO 648/11 Universidad de Buenos Aires (UBA), http://www.uba.rec.ar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLANYI K, 1990, GLIA, V3, P151, DOI 10.1002/glia.440030302; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; CHRISTENSEN O, 1992, J MEMBRANE BIOL, V129, P13; Di Giusto G, 2012, J CELL BIOCHEM, V113, P3721, DOI 10.1002/jcb.24246; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; EBERHARDT W, 1987, NEUROSCIENCE, V22, P687, DOI 10.1016/0306-4522(87)90365-4; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Ford P, 2005, BIOL CELL, V97, P687, DOI 10.1042/BC20040116; Franco R, 2001, PFLUG ARCH EUR J PHY, V442, P791; Galizia L, 2008, AM J PHYSIOL-RENAL, V294, pF582, DOI 10.1152/ajprenal.00427.2007; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hernandez JA, 1998, AM J PHYSIOL-CELL PH, V275, pC1067, DOI 10.1152/ajpcell.1998.275.4.C1067; Hirrlinger PG, 2008, J NEUROCHEM, V105, P1405, DOI 10.1111/j.1471-4159.2008.05243.x; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Ilyaskin A. V., 2011, Biophysics, V56, P516, DOI 10.1134/S0006350911030092; KIMELBERG HK, 1990, BRAIN RES, V529, P262, DOI 10.1016/0006-8993(90)90836-Z; KIMELBERG HK, 1988, GLIA, V1, P219, DOI 10.1002/glia.440010307; KIMELBERG HK, 1981, BIOCHIM BIOPHYS ACTA, V646, P179, DOI 10.1016/0005-2736(81)90285-6; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kuhrt H, 2008, INT J DEV NEUROSCI, V26, P745, DOI 10.1016/j.ijdevneu.2008.07.003; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; LEWIS R, 2011, J CELL PHYSL; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Olson JE, 1997, GLIA, V20, P254, DOI 10.1002/(SICI)1098-1136(199707)20:3<254::AID-GLIA9>3.0.CO;2-7; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, J NEUROIMMUNOL, V161, P145, DOI 10.1016/j.jneuroim.2005.01.003; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2010, J NEUROSCI RES, V88, P2877, DOI 10.1002/jnr.22437; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Pasantes-Morales H, 2002, NEUROCHEM RES, V27, P59, DOI 10.1023/A:1014850505400; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC172, DOI 10.1152/ajpcell.1994.266.1.C172; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC165, DOI 10.1152/ajpcell.1994.266.1.C165; Poignard C, 2011, EUR BIOPHYS J BIOPHY, V40, P235, DOI 10.1007/s00249-010-0641-8; VITARELLA D, 1994, J NEUROCHEM, V63, P1143; WANG K, 1992, AM J PHYSIOL, V263, pG566, DOI 10.1152/ajpgi.1992.263.4.G566; Welsh DG, 2000, J PHYSIOL-LONDON, V527, P139, DOI 10.1111/j.1469-7793.2000.t01-1-00139.x; Wurm A, 2006, GLIA, V54, P411, DOI 10.1002/glia.20391; Wurm A, 2009, MOL VIS, V15, P1858	43	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57268	10.1371/journal.pone.0057268	http://dx.doi.org/10.1371/journal.pone.0057268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451196	gold, Green Published			2022-12-27	WOS:000316849500083
J	Gueugneau, N; Bove, M; Avanzino, L; Jacquin, A; Pozzo, T; Papaxanthis, C				Gueugneau, Nicolas; Bove, Marco; Avanzino, Laura; Jacquin, Agnes; Pozzo, Thierry; Papaxanthis, Charalambos			Interhemispheric Inhibition during Mental Actions of Different Complexity	PLOS ONE			English	Article							IPSILATERAL MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL EXCITABILITY; FINGER MOVEMENTS; INTRACORTICAL INHIBITION; VOLUNTARY MOVEMENT; FUNCTIONAL-CHANGES; HAND MUSCLES; IMAGERY; MODULATION	Several investigations suggest that actual and mental actions trigger similar neural substrates. Yet, neurophysiological evidences on the nature of interhemispheric interactions during mental movements are still meagre. Here, we asked whether the content of mental images, investigated by task complexity, is finely represented in the inhibitory interactions between the two primary motor cortices (M1s). Subjects' left M1 was stimulated by means of transcranial magnetic stimulation (TMS) while they were performing actual or mental movements of increasing complexity with their right hand and exerting a maximum isometric force with their left thumb and index. Thus, we simultaneously assessed the corticospinal excitability in the right opponent pollicis muscle (OP) and the ipsilateral silent period (iSP) in the left OP during actual and mental movements. Corticospinal excitability in right OP increased during actual and mental movements, but task complexity-dependent changes were only observed during actual movements. Interhemispheric motor inhibition in the left OP was similarly modulated by task complexity in both mental and actual movements. Precisely, the duration and the area of the iSP increased with task complexity in both movement conditions. Our findings suggest that mental and actual movements share similar inhibitory neural circuits between the two homologous primary motor cortex areas.	[Gueugneau, Nicolas; Pozzo, Thierry; Papaxanthis, Charalambos] Univ Bourgogne, Unite Format & Rech Sci & Techn Activites Phys &, Dijon, France; [Gueugneau, Nicolas; Pozzo, Thierry; Papaxanthis, Charalambos] Inst Natl Sante & Rech Med INSERM, U1093, Dijon, France; [Bove, Marco; Avanzino, Laura] Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy; [Bove, Marco; Avanzino, Laura] Univ Genoa, Ctr Polifunz Sci Motorie, Genoa, Italy; [Pozzo, Thierry] Italian Inst Technol, Genoa, Italy; [Pozzo, Thierry] Inst Univ France IUF, Paris, France; [Jacquin, Agnes] Fac Med Dijon, Serv Neurol, Dijon, France	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of Genoa; University of Genoa; Istituto Italiano di Tecnologia - IIT; Institut Universitaire de France; Universite de Bourgogne	Papaxanthis, C (corresponding author), Univ Bourgogne, Unite Format & Rech Sci & Techn Activites Phys &, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr	JACQUIN, Agnès/AFN-9891-2022; Avanzino, Laura/K-6623-2016	AVANZINO, LAURA/0000-0001-6286-1509; Pozzo, Thierry/0000-0002-0585-7965				Abbruzzese G, 1999, NEUROSCI LETT, V263, P113, DOI 10.1016/S0304-3940(99)00120-2; Avanzino L, 2007, J PHYSIOL-LONDON, V583, P99, DOI 10.1113/jphysiol.2007.134510; Avanzino L, 2008, EUR J NEUROSCI, V27, P1285, DOI 10.1111/j.1460-9568.2008.06086.x; Avanzino L, 2009, NEUROSCI LETT, V466, P11, DOI 10.1016/j.neulet.2009.09.036; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; Debarnot U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026717; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; Demougeot L, 2011, J NEUROSCI, V31, P10712, DOI 10.1523/JNEUROSCI.6032-10.2011; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Gueugneau N, 2010, CHRONOBIOL INT, V27, P620, DOI 10.3109/07420521003664205; Gueugneau N, 2009, NEUROREHAB NEURAL RE, V23, P237, DOI 10.1177/1545968308321775; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hubers A, 2008, EUR J NEUROSCI, V28, P364, DOI 10.1111/j.1460-9568.2008.06335.x; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Koch G, 2008, J NEUROSCI, V28, P5944, DOI 10.1523/JNEUROSCI.0957-08.2008; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Koch G, 2010, NEUROIMAGE, V51, P300, DOI 10.1016/j.neuroimage.2010.02.022; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Kumru H, 2008, EXP BRAIN RES, V189, P373, DOI 10.1007/s00221-008-1433-6; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Lebon F, 2012, EUR J NEUROSCI, V35, P323, DOI 10.1111/j.1460-9568.2011.07938.x; Liang N, 2008, NEUROSCI LETT, V433, P135, DOI 10.1016/j.neulet.2007.12.058; Liang N, 2011, CLIN NEUROPHYSIOL, V122, P550, DOI 10.1016/j.clinph.2010.07.024; Liepert J, 2009, J NEURAL TRANSM, V116, P1613, DOI 10.1007/s00702-009-0287-9; Malouin F, 2004, NEUROREHAB NEURAL RE, V18, P66, DOI 10.1177/0888439004266304; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Morishita T, 2011, BRAIN RES, V1371, P65, DOI 10.1016/j.brainres.2010.11.049; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Papaxanthis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051191; Park WH, 2011, NEUROSCI LETT, V494, P255, DOI 10.1016/j.neulet.2011.03.027; Pelgrims B, 2011, HUM BRAIN MAPP, V32, P1471, DOI 10.1002/hbm.21121; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Porro CA, 1996, J NEUROSCI, V16, P7688; Porro CA, 2000, EUR J NEUROSCI, V12, P3059, DOI 10.1046/j.1460-9568.2000.00182.x; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reynolds C, 1999, NEUROLOGY, V53, P730, DOI 10.1212/WNL.53.4.730; Roosink M, 2010, BEHAV BRAIN RES, V213, P35, DOI 10.1016/j.bbr.2010.04.027; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Stinear CM, 2004, EXP BRAIN RES, V157, P351, DOI 10.1007/s00221-004-1851-z; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; Tia B, 2010, NEUROSCI LETT, V480, P138, DOI 10.1016/j.neulet.2010.06.026; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Trompetto C, 2004, EXP BRAIN RES, V158, P133, DOI 10.1007/s00221-004-1881-6; van den Berg FE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017742; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	72	17	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56973	10.1371/journal.pone.0056973	http://dx.doi.org/10.1371/journal.pone.0056973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451125	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500049
J	Lee, DW; Ramakrishnan, D; Valenta, J; Parney, IF; Bayless, KJ; Sitcheran, R				Lee, Dong Whan; Ramakrishnan, Dhivya; Valenta, John; Parney, Ian F.; Bayless, Kayla J.; Sitcheran, Raquel			The NF-kappa B RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; STEM-CELLS; PROLIFERATION; GROWTH; DIFFERENTIATION; TRANSCRIPTION; SUBCLASSES; PHENOTYPE; MIGRATION; SUBTYPES	High-grade gliomas, such as glioblastomas (GBMs), are very aggressive, invasive brain tumors with low patient survival rates. The recent identification of distinct glioma tumor subtypes offers the potential for understanding disease pathogenesis, responses to treatment and identification of molecular targets for personalized cancer therapies. However, the key alterations that drive tumorigenesis within each subtype are still poorly understood. Although aberrant NF-kappa B activity has been implicated in glioma, the roles of specific members of this protein family in tumorigenesis and pathogenesis have not been elucidated. In this study, we show that the NF-kappa B protein RelB is expressed in a particularly aggressive mesenchymal subtype of glioma, and loss of RelB significantly attenuated glioma cell survival, motility and invasion. We find that RelB promotes the expression of mesenchymal genes including YKL-40, a marker of the MES glioma subtype. Additionally, RelB regulates expression of Olig2, a regulator of cancer stem cell proliferation and a candidate marker for the cell of origin in glioma. Furthermore, loss of RelB in glioma cells significantly diminished tumor growth in orthotopic mouse xenografts. The relevance of our studies for human disease was confirmed by analysis of a human GBM genome database, which revealed that high RelB expression strongly correlates with rapid tumor progression and poor patient survival rates. Thus, our findings demonstrate that RelB is an oncogenic driver of mesenchymal glioma tumor growth and invasion, highlighting the therapeutic potential of inhibiting the noncanonical NF-kappa B (RelB-mediated) pathway to treat these deadly tumors.	[Lee, Dong Whan; Ramakrishnan, Dhivya; Valenta, John; Bayless, Kayla J.; Sitcheran, Raquel] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Parney, Ian F.] Mayo Clin, Ctr Canc, Dept Neurol Surg, Rochester, MN USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Mayo Clinic	Sitcheran, R (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	sitcheran@tamhsc.edu		Sitcheran, Raquel/0000-0001-8916-9707; Parney, Ian/0000-0002-9702-8047	National Cancer Institute of the National Institutes of Health [KO1-CA118274, 1P50CA108961-06I]; NATIONAL CANCER INSTITUTE [P50CA108961, K01CA118274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082554] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Cancer Institute of the National Institutes of Health under award numbers KO1-CA118274 (RS) and 1P50CA108961-06I (IFP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bhat KP, 2008, FEBS LETT, V582, P3193, DOI 10.1016/j.febslet.2008.08.010; Bosma I, 2009, NEURO-ONCOLOGY, V11, P51, DOI 10.1215/15228517-2008-049; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbrainres.2004.10.010; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Nutt CL, 2005, CLIN CANCER RES, V11, P2258, DOI 10.1158/1078-0432.CCR-04-1601; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Smith D, 2008, MOL CELL BIOCHEM, V307, P141, DOI 10.1007/s11010-007-9593-4; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun Y, 2011, NEURON, V69, P906, DOI 10.1016/j.neuron.2011.02.005; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	41	44	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57489	10.1371/journal.pone.0057489	http://dx.doi.org/10.1371/journal.pone.0057489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451236	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500109
J	Sanchez-Carron, G; Garcia-Garcia, MI; Zapata-Perez, R; Takami, H; Garcia-Carmona, F; Sanchez-Ferrer, A				Sanchez-Carron, Guiomar; Inmaculada Garcia-Garcia, Maria; Zapata-Perez, Ruben; Takami, Hideto; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro			Biochemical and Mutational Analysis of a Novel Nicotinamidase from Oceanobacillus iheyensis HTE831	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; CRYSTAL-STRUCTURE; SALVAGE PATHWAY; NAD(+); PURIFICATION; MECHANISM; SEQUENCE; SIR2; METABOLISM	Nicotinamidases catalyze the hydrolysis of nicotinamide to nicotinic acid and ammonia, an important reaction in the NAD(+) salvage pathway. This paper reports a new nicotinamidase from the deep-sea extremely halotolerant and alkaliphilic Oceanobacillus iheyensis HTE831 (OiNIC). The enzyme was active towards nicotinamide and several analogues, including the prodrug pyrazinamide. The enzyme was more nicotinamidase (k(cat)/K-m = 43.5 mM(-1) s(-1)) than pyrazinamidase (k(cat)/K-m = 3.2 mM(-1) s(-1)). Mutational analysis was carried out on seven critical amino acids, confirming for the first time the importance of Cys133 and Phe68 residues for increasing pyrazinamidase activity 2.9- and 2.5-fold, respectively. In addition, the change in the fourth residue involved in the ion metal binding (Glu65) was detrimental to pyrazinamidase activity, decreasing it 6-fold. This residue was also involved in a new distinct structural motif DAHXXXDXXHPE described in this paper for Firmicutes nicotinamidases. Phylogenetic analysis revealed that OiNIC is the first nicotinamidase described for the order Bacillales.	[Sanchez-Carron, Guiomar; Inmaculada Garcia-Garcia, Maria; Zapata-Perez, Ruben; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Murcia, Spain; [Inmaculada Garcia-Garcia, Maria; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB, Murcia, Spain; [Takami, Hideto] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Microbial Genome Res Grp, Inst Biogeosci, Yokosuka, Kanagawa, Japan	University of Murcia; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum,Cam, Murcia, Spain.	alvaro@um.es	Garcia-Carmona, Francisco/K-6520-2017; GARCIA, MARIA/L-2643-2014; Takami, Hideto/D-4200-2012; Sánchez-Ferrer, Alvaro/M-1631-2014; Zapata-Perez, Ruben/AAA-9782-2020	Takami, Hideto/0000-0003-3433-7018; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Zapata-Perez, Ruben/0000-0003-4432-9652; Garcia-Carmona, Francisco/0000-0002-1318-7690	MINECO-FEDER [BIO2010-22225-C02-01]; Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca [04541/GERM/06]; Ministerio de Educacion; Fundacion Seneca	MINECO-FEDER(Spanish Government); Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca(Fundacion Seneca); Ministerio de Educacion; Fundacion Seneca(Fundacion Seneca)	This study was partially supported by Spanish grants from MINECO-FEDER (BIO2010-22225-C02-01) and from the Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca (04541/GERM/06, Plan Regional de Ciencia y Tecnologia 2007-2010). GSC is supported by a predoctoral fellowship from Ministerio de Educacion and MIGG is a holder of a predoctoral fellowship associated with the above project from Fundacion Seneca. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Boshoff HIM, 1998, J BACTERIOL, V180, P5809, DOI 10.1128/JB.180.22.5809-5814.1998; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; French JB, 2010, BIOCHEMISTRY-US, V49, P8803, DOI 10.1021/bi1012436; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Gazanion E, 2012, INT J PARASITOL, V42, P323, DOI 10.1016/j.ijpara.2012.02.007; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu G, 2007, ARCH BIOCHEM BIOPHYS, V461, P66, DOI 10.1016/j.abb.2007.01.037; JOSHI JG, 1962, J BIOL CHEM, V237, P929; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kim S, 2004, FEMS MICROBIOL LETT, V234, P289, DOI [10.1111/j.1574-6968.2004.tb09546.x, 10.1016/j.femsle.2004.03.038]; Kruger D, 2001, EUR J BIOCHEM, V268, P3831, DOI 10.1046/j.1432-1327.2001.02297.x; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lu J, 2001, FEMS MICROBIOL LETT, V205, P291, DOI 10.1111/j.1574-6968.2001.tb10963.x; Murphy DJ, 2004, ANAL BIOCHEM, V327, P61, DOI 10.1016/j.ab.2003.12.018; PARDEE AB, 1971, J BIOL CHEM, V246, P6792; Petrella S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015785; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sanchez-Carron G, 2011, APPL ENVIRON MICROB, V77, P2471, DOI 10.1128/AEM.02927-10; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanigawa Y, 1980, Methods Enzymol, V66, P132; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; YAN C, 1987, J BIOL CHEM, V262, P9082; ZEREZ CR, 1990, BLOOD, V75, P1705; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; Zhang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039546	60	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56727	10.1371/journal.pone.0056727	http://dx.doi.org/10.1371/journal.pone.0056727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451075	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500024
J	Stirling, WC; Felin, T				Stirling, Wynn C.; Felin, Teppo			Game Theory, Conditional Preferences, and Social Influence	PLOS ONE			English	Article							FAIRNESS	Neoclassical noncooperative game theory is based on a simple, yet powerful synthesis of mathematical and logical concepts: unconditional and immutable preference orderings and individual rationality. Although this structure has proven useful for characterizing competitive multi-player behavior, its applicability to scenarios involving complex social relationships is problematic. In this paper we directly address this limitation by the introduction of a conditional preference structure that permits players to modulate their preference orderings as functions of the preferences of other players. Embedding this expanded preference structure in a formal and graphical framework provides a systematic approach for characterizing a complex society. The result is an influence network that allows conditional preferences to propagate through the community, resulting in an emergent social model which characterizes all of the social relationships that exist and which leads to solution concepts that account for both group and individual interests. The Ultimatum game is presented as an example of how social influence can be modeled with conditional preferences.	[Stirling, Wynn C.] Brigham Young Univ, Dept Elect & Comp Engn, Provo, UT 84602 USA; [Felin, Teppo] Brigham Young Univ, Marriott Sch, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Felin, T (corresponding author), Brigham Young Univ, Marriott Sch, Provo, UT 84602 USA.	teppo.felin@byu.edu		Felin, Teppo/0000-0003-2044-0145				Abbas AE, 2005, DECIS ANAL, V2, P195; Abel N.H., 1881, OEUVRES COMPLETES, V2, P36; Abell P, 2008, MANAG DECIS ECON, V29, P489, DOI 10.1002/mde.1413; [Anonymous], 1995, EVOLUTIONARY GAME TH; Armendt B, 1988, CAUSATION DECISION B, P3; Arrow K., 1963, SOCIAL CHOICE INDIVI; Arrow KJ, 1986, RATIONAL CHOICE; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bicchieri C, 2010, POLIT PHILOS ECON, V9, P297, DOI 10.1177/1470594X10369276; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Boutilier C, 2004, J ARTIF INTELL RES, V21, P135, DOI 10.1613/jair.1234; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 2004, ROUNDTABLE SER BEHAV, P1; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032890; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Durlauf SN, 1999, P NATL ACAD SCI USA, V96, P10582, DOI 10.1073/pnas.96.19.10582; Easley D, 2010, NETWORKS CROWDS MARK; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Friedman M, 1961, PRICE THEORY; Gaertner W., 2006, PRIMER SOCIAL CHOICE; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; Gibbard A, 1974, J ECON THEORY, V7, P617; Gintis Herbert, 2009, BOUNDS REASON GAME T; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Goyal S., 2007, CONNECTIONS; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harsanyi John C., 1977, RATIONAL BEHAV BARGA; Hausman D.M., 2012, PREFERENCE VALUE CHO; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Jaynes E.T., 2003, PROBABILITY THEORY L; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Margolis H, 1990, SELF INTEREST; Maynard-Smith J, 1982, EVOLUTION THEORY GAM; Palmer F., 1971, GRAMMAR; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; RABIN M, 1993, AM ECON REV, V83, P1281; Rawls J., 1971, THEORY JUSTICE; Shubik M, 1982, GAME THEORY SOCIAL S; Shubik M, 2001, ES14 YAL SCH MAN; Slatkin M, 1980, Science, V210, P633, DOI 10.1126/science.210.4470.633; Stirling W., 2012, THEORY CONDITIONAL G; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; Szolnoki A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38002; Vega-Redondo F., 2007, COMPLEX SOCIAL NETWO, P268; Wang T, 2003, J ECON THEORY, V108, P286, DOI 10.1016/S0022-0531(03)00028-0	49	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56751	10.1371/journal.pone.0056751	http://dx.doi.org/10.1371/journal.pone.0056751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451078	Green Published, gold			2022-12-27	WOS:000316849500025
J	Vila, B; Oms, O; Galobart, A; Bates, KT; Egerton, VM; Manning, PL				Vila, Bernat; Oms, Oriol; Galobart, Angel; Bates, Karl T.; Egerton, Victoria M.; Manning, Phillip L.			Dynamic Similarity in Titanosaur Sauropods: Ichnological Evidence from the Fumanya Dinosaur Tracksite (Southern Pyrenees)	PLOS ONE			English	Article							TRACKWAYS; GAUGE; MANUS; SPEEDS	The study of a small sauropod trackway from the Late Cretaceous Fumanya tracksite (southern Pyrenees, Catalonia) and further comparisons with larger trackways from the same locality suggest a causative relationship between gait, gauge, and body proportions of the respective titanosaur trackmakers. This analysis, conducted in the context of scaling predictions and using geometric similarity and dynamic similarity hypotheses, reveals similar Froude numbers and relative stride lengths for both small and large trackmakers from Fumanya. Evidence for geometric similarity in these trackways suggests that titanosaurs of different sizes moved in a dynamically similar way, probably using an amble gait. The wide gauge condition reported in trackways of small and large titanosaurs implies that they possessed similar body (trunk and limbs) proportions despite large differences in body size. These results strengthen the hypothesis that titanosaurs possessed a distinctive suite of anatomical characteristics that are well reflected in their tracks and trackways.	[Vila, Bernat] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Vila, Bernat; Galobart, Angel] Sabadell, Inst Catala Paleontol Miquel Crusafont, Barcelona, Catalonia, Spain; [Oms, Oriol] Univ Autonoma Barcelona, Fac Ciencies, Dept Geol Estratig, E-08193 Barcelona, Catalonia, Spain; [Bates, Karl T.] Univ Liverpool, Inst Aging & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3BX, Merseyside, England; [Egerton, Victoria M.; Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Zaragoza; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona; University of Liverpool; University of Manchester; University of Pennsylvania	Vila, B (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	bernat.vila@unizar.es	Manning, Phillip/F-9966-2011; Oms, Oriol/AAZ-6312-2020; VILA, BERNAT/AAA-7367-2021; Galobart, Àngel À/H-5024-2011	Manning, Phillip/0000-0002-7161-6246; VILA, BERNAT/0000-0002-5935-1732; Galobart, Àngel À/0000-0003-1508-4561; Oms, Oriol/0000-0001-8355-847X; Egerton, Victoria/0000-0002-0739-6533	Ministerio de Ciencia e Innovacion [CGL 2008-06533-C03-02, CGL2011-30069-C02-01]; Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))(Ministry of Science and Innovation, Spain (MICINN))	Funding is provided by CGL 2008-06533-C03-02 and CGL2011-30069-C02-01 project (Ministerio de Ciencia e Innovacion; http://www.idi.mineco.gob.es/portal/site/MICINN/). B. Vila acknowledges support from the Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC) 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Bravo A.M., 2005, REV ESPANOLA PALEONT, V10, P49; Carballido JL, 2012, PALAEONTOLOGY, V55, P567, DOI 10.1111/j.1475-4983.2012.01139.x; Carrano MT, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P229; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christian Andreas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P63; Christian Andreas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P81; Christiansen Per, 1997, Gaia, V14, P45; Falkingham PL, 2012, J GEOL SOC LONDON, V169, P365, DOI 10.1144/0016-76492011-019; Farlow J.O., 1989, P371; Gonzalez-Riga BJ, 2010, AN ACAD BRAS CIENC, V83, P1; Le Loeuff J., 1997, Geogaceta, V21, P151; Lockley M, 2002, CRETACEOUS RES, V23, P363, DOI 10.1006/cres.2002.1005; Lockley M, 2002, CRETACEOUS RES, V23, P383, DOI 10.1006/cres.2002.1006; Lockley Martin G., 2001, New Mexico Geological Society Field Conference Guidebook, V52, P181; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; Marmi J, 2010, J VERTEBR PALEONTOL, V30, P970, DOI 10.1080/02724631003758011; Marmi J, 2009, CRETACEOUS RES, V30, P1307, DOI 10.1016/j.cretres.2009.07.008; MARTY D., 2008, GEOFOCUS, V21, P1; Marty Daniel, 2003, Ichnos, V10, P209, DOI 10.1080/10420940390256212; Mazzetta Gerardo V., 2004, Historical Biology, V16, P71, DOI 10.1080/08912960410001715132; Mazzetta GV, 2001, ACTA PALAEONTOL POL, V46, P235; Oms O, 2007, PALAEOGEOGR PALAEOCL, V255, P35, DOI 10.1016/j.palaeo.2007.02.039; Riera V, 2010, PALAEOGEOGR PALAEOCL, V288, P82, DOI 10.1016/j.palaeo.2010.01.037; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Romano M., 2007, Ichnos, V14, P257, DOI 10.1080/10420940601050014; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schulp Anne S., 1999, Ichnos, V6, P239; Schwarz Daniela, 2007, Historical Biology, V19, P225, DOI 10.1080/08912960601118651; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Thulborn RA., 1990, DINOSAUR TRACKS; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Vila B, 2005, LETHAIA, V38, P211, DOI 10.1080/00241160510013312; Vila B, 2008, ORYCTOS, V8, P150; Vila B, 2010, LETHAIA, V43, P197, DOI 10.1111/j.1502-3931.2009.00183.x; Wilhite DR, 2005, LIFE O PAST, P268; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; Wright JL, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P252	45	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57408	10.1371/journal.pone.0057408	http://dx.doi.org/10.1371/journal.pone.0057408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451221	Green Published, gold			2022-12-27	WOS:000316849500099
J	Bentancor, LV; Bilen, MF; Mejias, MP; Fernandez-Brando, RJ; Panek, CA; Ramos, MV; Fernandez, GC; Isturiz, M; Ghiringhelli, PD; Palermo, MS				Bentancor, Leticia V.; Bilen, Marcos F.; Mejias, Maria P.; Fernandez-Brando, Romina J.; Panek, Cecilia A.; Ramos, Maria V.; Fernandez, Gabriela C.; Isturiz, Martin; Ghiringhelli, Pablo D.; Palermo, Marina S.			Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; HEMOLYTIC-UREMIC SYNDROME; IN-VIVO TRANSDUCTION; BACTERIOPHAGE-LAMBDA; PROTECTIVE IMMUNITY; GENE-EXPRESSION; PHAGE; DNA; TRANSCRIPTION; EPIDEMIOLOGY	Shiga toxins (Stx) are the main virulence factors in enterohemorrhagic Escherichia coli (EHEC) infections, causing diarrhea and hemolytic uremic syndrome (HUS). The genes encoding for Shiga toxin-2 (Stx2) are located in a bacteriophage. The toxin is formed by a single A subunit and five B subunits, each of which has its own promoter sequence. We have previously reported the expression of the B subunit within the eukaryotic environment, probably driven by their own promoter. The aim of this work was to evaluate the ability of the eukaryotic machinery to recognize stx2 sequences as eukaryotic-like promoters. Vero cells were transfected with a plasmid encoding Stx2 under its own promoter. The cytotoxic effect on these cells was similar to that observed upon incubation with purified Stx2. In addition, we showed that Stx2 expression in Stx2-insensitive BHK eukaryotic cells induced drastic morphological and cytoskeletal changes. In order to directly evaluate the capacity of the wild promoter sequences of the A and B subunits to drive protein expression in mammalian cells, GFP was cloned under eukaryotic-like putative promoter sequences. GFP expression was observed in 293T cells transfected with these constructions. These results show a novel and alternative way to synthesize Stx2 that could contribute to the global understanding of EHEC infections with immediate impact on the development of treatments or vaccines against HUS.	[Bentancor, Leticia V.; Mejias, Maria P.; Fernandez-Brando, Romina J.; Panek, Cecilia A.; Ramos, Maria V.; Fernandez, Gabriela C.; Isturiz, Martin; Palermo, Marina S.] Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, Div Immunol, Buenos Aires, DF, Argentina; [Bilen, Marcos F.; Ghiringhelli, Pablo D.] Univ Nacl Quilmes, Lab Ingn Genet & Biol Celular & Mol, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bentancor, LV (corresponding author), Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, Div Immunol, Buenos Aires, DF, Argentina.	lbentan@unq.edu.ar	Ghiringhelli, Pablo D/N-8073-2017	Ghiringhelli, Pablo D/0000-0002-2003-0106	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 06/591]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by PICT 06/591 from the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (to MSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PDG, MSP, GCF, MVR and MFB are members of the Research Career of CONICET (Consejo Nacional de Ciencia y Tecnologia).	Acheson DWK, 1998, INFECT IMMUN, V66, P4496; Baumann M, 2010, MOL BIOTECHNOL, V45, P241, DOI 10.1007/s12033-010-9265-6; Bentancor LV, 2009, CLIN VACCINE IMMUNOL, V16, P712, DOI 10.1128/CVI.00328-08; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Clark JR, 2004, FEMS IMMUNOL MED MIC, V40, P21, DOI 10.1016/S0928-8244(03)00344-4; Cornick NA, 2006, APPL ENVIRON MICROB, V72, P5086, DOI 10.1128/AEM.00157-06; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Gahan ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006062; Gamage SD, 2003, INFECT IMMUN, V71, P3107, DOI 10.1128/IAI.71.6.3107-3115.2003; GEIER MR, 1972, VIROLOGY, V47, P638, DOI 10.1016/0042-6822(72)90553-3; George AA, 2006, EMBO J, V25, P811, DOI 10.1038/sj.emboj.7600966; GOTTESMAN S, 1975, P NATL ACAD SCI USA, V72, P2188, DOI 10.1073/pnas.72.6.2188; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; KARMALI MA, 1985, J CLIN MICROBIOL, V22, P614, DOI 10.1128/JCM.22.4.614-619.1985; Lankes HA, 2007, J APPL MICROBIOL, V102, P1337, DOI 10.1111/j.1365-2672.2006.03182.x; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LITTLE JW, 1995, REGULATION GENE EXPR, P453; Lopez EL, 2000, INFECT DIS CLIN N AM, V14, P41, DOI 10.1016/S0891-5520(05)70217-8; MERRIL CR, 1971, NATURE, V233, P398, DOI 10.1038/233398a0; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Nakagawa I, 1999, MOL MICROBIOL, V33, P1190, DOI 10.1046/j.1365-2958.1999.01564.x; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Paglia P, 1998, J LEUKOCYTE BIOL, P92; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Ptashne M, 2004, GENETIC SWITCH PHAGE; Ptashne M, 1992, GENETIC SWITCH PHAGE; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Sapinoro R, 2008, VIROLOGY, V373, P274, DOI 10.1016/j.virol.2007.12.013; Schmidt H, 2001, RES MICROBIOL, V152, P687, DOI 10.1016/S0923-2508(01)01249-9; Shimada O, 1999, CELL STRUCT FUNCT, V24, P237, DOI 10.1247/csf.24.237; Shimada O, 1999, CELL STRUCT FUNCT, V24, P247, DOI 10.1247/csf.24.247; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Takenouchi H, 2004, J CELL SCI, V117, P3911, DOI 10.1242/jcs.01246; Teel LD, 2002, INFECT IMMUN, V70, P4282, DOI 10.1128/IAI.70.8.4282-4291.2002; Thompson GS, 2000, BIOCHEMISTRY-US, V39, P13153, DOI 10.1021/bi001394+; Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001; Zanghi CN, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm146; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57128	10.1371/journal.pone.0057128	http://dx.doi.org/10.1371/journal.pone.0057128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451160	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800075
J	Eckerle, I; Rosenberger, KD; Zwahlen, M; Junghanss, T				Eckerle, Isabella; Rosenberger, Kerstin Daniela; Zwahlen, Marcel; Junghanss, Thomas			Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review	PLOS ONE			English	Review							HEPATITIS-B-VACCINE; PNEUMOCOCCAL CONJUGATE VACCINE; VARICELLA-ZOSTER-VIRUS; INFLUENZA VACCINATION; IMMUNE-RESPONSE; ANTIBODY-RESPONSE; LIVER-TRANSPLANT; CALCINEURIN INHIBITORS; PEDIATRIC LIVER; RECIPIENTS	Background: Infectious diseases after solid organ transplantation (SOT) are one of the major complications in transplantation medicine. Vaccination-based prevention is desirable, but data on the response to active vaccination after SOT are conflicting. Methods: In this systematic review, we identify the serologic response rate of SOT recipients to post-transplantation vaccination against tetanus, diphtheria, polio, hepatitis A and B, influenza, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitides, tick-borne encephalitis, rabies, varicella, mumps, measles, and rubella. Results: Of the 2478 papers initially identified, 72 were included in the final review. The most important findings are that (1) most clinical trials conducted and published over more than 30 years have all been small and highly heterogeneous regarding trial design, patient cohorts selected, patient inclusion criteria, dosing and vaccination schemes, follow up periods and outcomes assessed, (2) the individual vaccines investigated have been studied predominately only in one group of SOT recipients, i.e. tetanus, diphtheria and polio in RTX recipients, hepatitis A exclusively in adult LTX recipients and mumps, measles and rubella in paediatric LTX recipients, (3) SOT recipients mount an immune response which is for most vaccines lower than in healthy controls. The degree to which this response is impaired varies with the type of vaccine, age and organ transplanted and (4) for some vaccines antibodies decline rapidly. Conclusion: Vaccine-based prevention of infectious diseases is far from satisfactory in SOT recipients. Despite the large number of vaccination studies preformed over the past decades, knowledge on vaccination response is still limited. Even though the protection, which can be achieved in SOT recipients through vaccination, appears encouraging on the basis of available data, current vaccination guidelines and recommendations for post-SOT recipients remain poorly supported by evidence. There is an urgent need to conduct appropriately powered vaccination trials in well-defined SOT recipient cohorts.	[Eckerle, Isabella; Rosenberger, Kerstin Daniela; Junghanss, Thomas] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany; [Eckerle, Isabella] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany; [Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	Ruprecht Karls University Heidelberg; University of Bonn; University of Bern	Eckerle, I (corresponding author), Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.	eckerle@virology-bonn.de	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346; Rosenberger, Kerstin/0000-0003-3459-3812; Eckerle, Isabella/0000-0002-4850-7172	Swiss School of Public Health	Swiss School of Public Health	Marcel Zwahlen's position is currently funded by the Swiss School of Public Health (http://www.ssphplus.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admon D, 1997, VACCINE, V15, P1518, DOI 10.1016/S0264-410X(97)00193-X; Arslan M, 2001, TRANSPLANTATION, V72, P272, DOI 10.1097/00007890-200107270-00019; Ballet C, 2006, AM J TRANSPLANT, V6, P2796, DOI 10.1111/j.1600-6143.2006.01533.x; Barton M, 2009, PEDIATR INFECT DIS J, V28, P688, DOI 10.1097/INF.0b013e31819d97be; BERNER J, 1993, TRANSPLANT P, V25, P1751; Birdwell KA, 2009, AM J KIDNEY DIS, V54, P112, DOI 10.1053/j.ajkd.2008.09.023; Blumberg EA, 1998, J HEART LUNG TRANSPL, V17, P1075; Blumberg EA, 1996, CLIN INFECT DIS, V22, P295, DOI 10.1093/clinids/22.2.295; Blumberg EA, 2001, CLIN INFECT DIS, V32, P307, DOI 10.1086/318482; BRIGGS WA, 1980, ANN INTERN MED, V92, P471, DOI 10.7326/0003-4819-92-4-471; Burbach G, 1999, TRANSPLANTATION, V67, P753, DOI 10.1097/00007890-199903150-00019; Candon S, 2009, AM J TRANSPLANT, V9, P2346, DOI 10.1111/j.1600-6143.2009.02787.x; Cavdar C, 2003, SCAND J UROL NEPHROL, V37, P71, DOI 10.1080/00365590310008749; Chalasani N, 1998, LIVER TRANSPLANT SUR, V4, P128, DOI 10.1002/lt.500040208; Chaves TDS, 2005, PEDIATR TRANSPLANT, V9, P192, DOI 10.1111/j.1399-3046.2005.00279.x; Cramer CH, 2008, PEDIATR TRANSPLANT, V12, P874, DOI 10.1111/j.1399-3046.2008.00936.x; Danerseau Angela Marie, 2008, World J Pediatr, V4, P254, DOI 10.1007/s12519-008-0047-1; de Jonge H, 2009, THER DRUG MONIT, V31, P416, DOI 10.1097/FTD.0b013e3181aa36cd; Dengler TJ, 1999, VACCINE, V17, P867, DOI 10.1016/S0264-410X(98)00272-2; Dengler TJ, 1998, TRANSPLANTATION, V66, P1340, DOI 10.1097/00007890-199811270-00014; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diana A, 2007, PEDIATR TRANSPLANT, V11, P31, DOI 10.1111/j.1399-3046.2006.00596.x; Duca P, 2001, J PEDIATR GASTR NUTR, V32, P168, DOI 10.1097/00005176-200102000-00014; Duchini A, 2001, LIVER TRANSPLANT, V7, P311, DOI 10.1053/jlts.2001.23010; Dumot JA, 1999, AM J GASTROENTEROL, V94, P1601, DOI 10.1111/j.1572-0241.1999.01150.x; Edvardsson VO, 1996, CLIN TRANSPLANT, V10, P556; Enke BU, 1997, TRANSPLANTATION, V64, P237, DOI 10.1097/00007890-199707270-00010; Evison J, 2009, CLIN INFECT DIS, V48, P1402, DOI 10.1086/598193; Fishman JA, 2011, LIVER TRANSPLANT, V17, pS34, DOI 10.1002/lt.22378; Fraund S, 1999, J HEART LUNG TRANSPL, V18, P220, DOI 10.1016/S1053-2498(98)00013-8; Fuchshuber A, 1996, NEPHROL DIAL TRANSPL, V11, P468; FURTH SL, 1995, PEDIATR NEPHROL, V9, P566, DOI 10.1007/BF00860934; Gaeta GB, 2009, VACCINE, V27, P3373, DOI 10.1016/j.vaccine.2009.01.077; Gattringer R, 2011, TRANSPL INFECT DIS, V13, P540, DOI 10.1111/j.1399-3062.2011.00628.x; Gennery AR, 1998, LANCET, V351, P1778, DOI 10.1016/S0140-6736(97)08486-9; Gentile G, 2011, CLIN MICROBIOL INFEC, V17, P1769, DOI 10.1111/j.1469-0691.2011.03680.x; Ghio L, 1997, J PEDIATR-US, V130, P987, DOI 10.1016/S0022-3476(97)70288-9; GIRNDT M, 1995, AM J KIDNEY DIS, V26, P454, DOI 10.1016/0272-6386(95)90491-3; Gotoh K, 2011, PEDIATR TRANSPLANT, V15, P112, DOI 10.1111/j.1399-3046.2010.01420.x; GREKAS D, 1993, INT J CLIN PHARM TH, V31, P553; Grossi PA, 2012, TRANSPLANTATION, V93, pS4, DOI 10.1097/TP.0b013e3182481347; Gunther M, 2001, TRANSPLANTATION, V71, P477; Harris K, 2009, VACCINE, V27, P2335, DOI 10.1016/j.vaccine.2009.02.026; Hayney Mary S, 2004, Prog Transplant, V14, P346; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hojsak I, 2011, PEDIATR INFECT DIS J, V30, P491, DOI 10.1097/INF.0b013e31820b7c22; HUANG KL, 1983, INFECT IMMUN, V40, P421, DOI 10.1128/IAI.40.1.421-424.1983; Huzly D, 1997, TRANSPLANTATION, V63, P839, DOI 10.1097/00007890-199703270-00008; Kano H, 2002, TRANSPLANTATION, V74, P543, DOI 10.1097/00007890-200208270-00020; Kazancioglu R, 2000, CLIN TRANSPLANT, V14, P61, DOI 10.1034/j.1399-0012.2000.140111.x; Kelesidis T, 2011, INT J INFECT DIS, V15, pE2, DOI 10.1016/j.ijid.2010.03.025; Keshtkar-Jahromi M, 2008, AM J NEPHROL, V28, P654, DOI 10.1159/000119742; Khan S, 2006, PEDIATR TRANSPLANT, V10, P78, DOI 10.1111/j.1399-3046.2005.00403.x; Kimball P, 2000, TRANSPLANTATION, V69, P2449, DOI 10.1097/00007890-200006150-00042; Kimball P, 2001, TRANSPLANT P, V33, P1785, DOI 10.1016/S0041-1345(00)02679-8; KOBASHIGAWA JA, 1993, TRANSPLANT P, V25, P2738; Kotton CN, 2009, AM J TRANSPLANT, V9, pS273, DOI 10.1111/j.1600-6143.2009.02920.x; Kotton CN, 2008, CURR OPIN ORGAN TRAN, V13, P500, DOI 10.1097/MOT.0b013e328310b0a4; Kotton CN, 2008, EXPERT REV VACCINES, V7, P663, DOI 10.1586/14760584.7.5.663; Kumar D, 2007, AM J TRANSPLANT, V7, P633, DOI 10.1111/j.1600-6143.2007.01668.x; Kumar D, 2011, AM J TRANSPLANT, V11, P2020, DOI 10.1111/j.1600-6143.2011.03753.x; Kumar D, 2003, J INFECT DIS, V187, P1639, DOI 10.1086/374784; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Laferriere C, 2011, VACCINE, V29, P6838, DOI 10.1016/j.vaccine.2011.07.097; Lawal A, 2004, AM J TRANSPLANT, V4, P1805, DOI 10.1111/j.1600-6143.2004.00564.x; LEFEBURE AF, 1993, VACCINE, V11, P397, DOI 10.1016/0264-410X(93)90278-6; Lin CC, 2007, AM J TRANSPLANT, V7, P195, DOI 10.1111/j.1600-6143.2006.01618.x; Mack D R, 1996, Liver Transpl Surg, V2, P431, DOI 10.1002/lt.500020605; Martin ST, 2012, ANN PHARMACOTHER, V46, P255, DOI 10.1345/aph.1Q436; MAUCH TJ, 1995, J PEDIATR-US, V127, P957, DOI 10.1016/S0022-3476(95)70037-4; Mazzone PJ, 2001, EUR RESPIR J, V18, P971, DOI 10.1183/09031936.01.00215201; Moher David, 2009, Open Med, V3, pe123; Nailescu C, 2011, PEDIATR NEPHROL, V26, P459, DOI 10.1007/s00467-010-1729-1; Ni YH, 2008, TRANSPLANTATION, V86, P1531, DOI 10.1097/TP.0b013e318189064c; Pedrazzi C, 1999, Pediatr Transplant, V3, P109, DOI 10.1034/j.1399-3046.1999.00013.x; Pitsiou GG, 2011, RESP MED, V105, P1776, DOI 10.1016/j.rmed.2011.07.008; Plotkin S., 2008, VACCINES, P1; Prelog M, 2010, PEDIATR TRANSPLANT, V14, P41, DOI 10.1111/j.1399-3046.2009.01204.x; Puissant-Lubrano B, 2010, EXP CLIN TRANSPLANT, V8, P19; Quteineh L, 2010, CURR OPIN ORGAN TRAN, V15, P601, DOI 10.1097/MOT.0b013e32833de1d0; RAND EB, 1993, J PEDIATR-US, V123, P87, DOI 10.1016/S0022-3476(05)81545-8; Rodriguez-Romo R, 2011, TRANSPL INFECT DIS, V13, P492, DOI 10.1111/j.1399-3062.2011.00665.x; Salles MJC, 2010, CLIN TRANSPLANT, V24, pE17, DOI 10.1111/j.1399-0012.2009.01095.x; Sanchez-Fructuoso AI, 2000, TRANSPLANTATION, V69, P436, DOI 10.1097/00007890-200002150-00023; Scharpe J, 2008, AM J TRANSPLANT, V8, P332, DOI 10.1111/j.1600-6143.2007.02066.x; Sever MS, 1999, NEPHRON, V81, P55, DOI 10.1159/000045246; Shinjoh M, 2008, VACCINE, V26, P6859, DOI 10.1016/j.vaccine.2008.09.076; Soesman NMR, 2000, J MED VIROL, V61, P85, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;85::AID-JMV14&gt;3.0.CO;2-H; WAGNER D, 1992, CLIN INVESTIGATOR, V70, P585; Weinberg A, 2006, AM J TRANSPLANT, V6, P565, DOI 10.1111/j.1600-6143.2005.01210.x; Willcocks LC, 2007, AM J TRANSPLANT, V7, P2006, DOI 10.1111/j.1600-6143.2007.01869.x; Wyzgal J, 2002, TRANSPLANT P, V34, P572, DOI 10.1016/S0041-1345(01)02849-4; ZAMORA I, 1994, PEDIATR NEPHROL, V8, P190, DOI 10.1007/BF00865476; Zlamy M, 2011, VACCINE, V29, P6163, DOI 10.1016/j.vaccine.2011.06.033	94	107	110	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56974	10.1371/journal.pone.0056974	http://dx.doi.org/10.1371/journal.pone.0056974			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451126	Green Published, gold			2022-12-27	WOS:000316658800057
J	Kreitler, J; Papenfus, M; Byrd, K; Labiosa, W				Kreitler, Jason; Papenfus, Michael; Byrd, Kristin; Labiosa, William			Interacting Coastal Based Ecosystem Services: Recreation and Water Quality in Puget Sound, WA	PLOS ONE			English	Article							GEOGRAPHICAL INFORMATION-SYSTEMS; TRAVEL COST METHOD; ECONOMIC VALUATION; MODELING DEMAND; BEACH USE; BIODIVERSITY; BENEFITS; CONSERVATION; MANAGEMENT; STRATEGIES	Coastal recreation and water quality are major contributors to human well-being in coastal regions. They can also interact, creating opportunities for ecosystem based management, ecological restoration, and water quality improvement that can positively affect people and the environment. Yet the effect of environmental quality on human behavior is often poorly quantified, but commonly assumed in coastal ecosystem service studies. To clarify this effect we investigate a water quality dataset for evidence that environmental condition partially explains variation in recreational visitation, our indicator of human behavior. In Puget Sound, WA, we investigate variation in visitation in both visitation rate and fixed effects (FE) models. The visitation rate model relates the differences in annual recreational visitation among parks to environmental conditions, park characteristics, travel cost, and recreational demand. In our FE model we control for all time-invariant unobserved variables and compare monthly variation at the park level to determine how water quality affects visitation during the summer season. The results of our first model illustrate how visitation relates to various amenities and costs. In the FE analysis, monthly visitation was negatively related to water quality while controlling for monthly visitation trends. This indicates people are responding to changes in water quality, and an improvement would yield an increase in the value of recreation. Together, these results could help in prioritizing water quality improvements, could assist the creation of new parks or the modification of existing recreational infrastructure, and provide quantitative estimates for the expected benefits from potential changes in recreational visitation and water quality improvements. Our results also provide an example of how recreational visitation can be quantified and used in ecosystem service assessments.	[Kreitler, Jason] US Geol Survey, Western Geog Sci Ctr, Boise, ID USA; [Papenfus, Michael] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Byrd, Kristin] US Geol Survey, Western Geog Sci Ctr, Menlo Pk, CA 94025 USA; [Labiosa, William] US Geol Survey, Western Geog Sci Ctr, Seattle, WA USA	United States Department of the Interior; United States Geological Survey; Stanford University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Kreitler, J (corresponding author), US Geol Survey, Western Geog Sci Ctr, Boise, ID USA.	jkreitler@usgs.gov	Papenfus, Michael/GNM-9563-2022	Byrd, Kristin/0000-0002-5725-7486	Environmental Protection Agency [IA DW 14-95762701]; United States Geological Survey Geographical Analysis and Monitoring Program	Environmental Protection Agency(United States Environmental Protection Agency); United States Geological Survey Geographical Analysis and Monitoring Program	This project was supported by Environmental Protection Agency Interagency Agreement IA DW 14-95762701 and the United States Geological Survey Geographical Analysis and Monitoring Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; [Anonymous], 2006, MARINE COASTAL ECOSY; Arnberger A, 2007, J LEISURE RES, V39, P345, DOI 10.1080/00222216.2007.11950111; Assessment M.E., 2005, ECOSYSTEM HUMAN WELL; Baack B.D., 1972, THESIS U WASHINGTON; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Bateman IJ, 1999, REG STUD, V33, P191, DOI 10.1080/00343409950082391; Bateman IJ, 1996, J AGR ECON, V47, P191, DOI 10.1111/j.1477-9552.1996.tb00684.x; Beaumont NJ, 2007, MAR POLLUT BULL, V54, P253, DOI 10.1016/j.marpolbul.2006.12.003; Brainard J, 2001, FORESTRY, V74, P423, DOI 10.1093/forestry/74.5.423; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Busch J, 2009, COAST MANAGE, V37, P529, DOI 10.1080/08920750903044865; Byrd K, 2011, TOOLS EVALUATING REF; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan Kai Ma, 2010, F1000 Biol Rep, V2, P54, DOI 10.3410/B2-54; Clawson M., 1959, METHODS MEASURING DE; Coombes EG, 2009, COAST MANAGE, V37, P94, DOI 10.1080/08920750802527127; Coombes EG, 2010, GLOBAL ENVIRON CHANG, V20, P303, DOI 10.1016/j.gloenvcha.2009.12.004; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Deacon RT, 2000, J WATER RES PL-ASCE, V126, P374, DOI 10.1061/(ASCE)0733-9496(2000)126:6(374); Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; ENGLIN J, 1995, REV ECON STAT, V77, P104, DOI 10.2307/2109996; ESRI, 2008, ARCGIS DESKT 9 3; Farber S, 2006, BIOSCIENCE, V56, P121, DOI 10.1641/0006-3568(2006)056[0121:LEAEFE]2.0.CO;2; Gelfenbaum G, 2006, COASTAL HABITATS PUG; Given S, 2006, ENVIRON SCI TECHNOL, V40, P4851, DOI 10.1021/es060679s; Gossling S, 1999, ECOL ECON, V29, P303, DOI 10.1016/S0921-8009(99)00012-9; Guerry AD, 2011, THEORY PRACTICE ECOS; Haneman M, 2004, USING REVEALED PREFE; Hanley N, 2003, ENVIRON RESOUR ECON, V24, P273, DOI 10.1023/A:1022904706306; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Hicks CC, 2009, ECOL SOC, V14; Hilbe J., 2008, NEGATIVE BINOMIAL RE; Iceland C., 2008, IDENTIFYING IMPORTAN; KNETSCH JL, 1963, LAND ECON, V39, P387, DOI 10.2307/3144843; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Leggett CG, 2000, J ENVIRON ECON MANAG, V39, P121, DOI 10.1006/jeem.1999.1096; Leschine TM, 2007, 20077 PUG SOUND NEAR; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lew DK, 2005, COAST MANAGE, V33, P71, DOI 10.1080/08920750590883079; McLeod K., 2009, ECOSYSTEM BASED MANA; Mendelsohn R, 2009, ANNU REV ENV RESOUR, V34, P325, DOI [10.1146/annurev-environ-011509-135201, 10.1146/annurev.environ.011509-135201]; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Naidoo R, 2005, ENVIRON DEV ECON, V10, P159, DOI 10.1017/S1355770X0400186X; National Research Council, 2005, VAL EC SERV BETT ENV; Nelsen C., 2007, SHORE BEACH, V75, P32; Nelson Erik J, 2010, F1000 Biol Rep, V2, P53, DOI 10.3410/B2-53; Parsons GR, 2003, TRAVEL COST MODEL PR, P263; Pendleton L, 2001, MAR POLLUT BULL, V42, P1155, DOI 10.1016/S0025-326X(01)00131-X; Pendleton L, 2008, COAST MANAGE, V36, P165, DOI 10.1080/08920750701866352; PRISM Climate Group, 2010, PRISM; Puget Sound Partnership, 2009, STAT SOUND; Puget Sound Partnership, 2008, DRAFT 2020 ACT AG PU, P96; RANDALL A, 1994, LAND ECON, V70, P88, DOI 10.2307/3146443; StataCorp, 2021, STATA STAT SOFTWARE; Stinchfield, 2009, SOCIAL EC CONSIDERAT; Termansen M, 2004, ENVIRON PLANN A, V36, P1085, DOI 10.1068/a36164; U.S. Environmental Protection Agency, 2010, GUID PREP EC AN; Wilson MA, 1999, ECOL APPL, V9, P772, DOI 10.1890/1051-0761(1999)009[0772:EVOFES]2.0.CO;2; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	62	16	16	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56670	10.1371/journal.pone.0056670	http://dx.doi.org/10.1371/journal.pone.0056670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451067	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800025
J	Lombino, F; Biundo, F; Tamayev, R; Arancio, O; D'Adamio, L				Lombino, Franco; Biundo, Fabrizio; Tamayev, Robert; Arancio, Ottavio; D'Adamio, Luciano			An Intracellular Threonine of Amyloid-beta Precursor Protein Mediates Synaptic Plasticity Deficits and Memory Loss	PLOS ONE			English	Article							JNK-INTERACTING PROTEIN-1; C-TERMINAL FRAGMENTS; A-BETA; ALZHEIMERS-DISEASE; DANISH DEMENTIA; CYTOPLASMIC DOMAIN; MOUSE MODEL; PHOSPHORYLATION; APP; MICE	Mutations in Amyloid-beta Precursor Protein (APP) and BRI2/ITM2b genes cause Familial Alzheimer and Danish Dementias (FAD/FDD), respectively. APP processing by BACE1, which is inhibited by BRI2, yields sAPP beta and beta-CTF. beta-CTF is cleaved by gamma-secretase to produce A beta. A knock-in mouse model of FDD, called FDDKI, shows deficits in memory and synaptic plasticity, which can be attributed to sAPP beta/beta-CTF but not A beta. We have investigated further the pathogenic function of beta-CTF focusing on Thr(668) of beta-CTF because phosphorylation of Thr(668) is increased in AD cases. We created a knock-in mouse bearing a Thr(668)Ala mutation (APP(TA) mice) that prevents phosphorylation at this site. This mutation prevents the development of memory and synaptic plasticity deficits in FDDKI mice. These data are consistent with a role for the carboxyl-terminal APP domain in the pathogenesis of dementia and suggest that averting the noxious role of Thr(668) is a viable therapeutic strategy for human dementias.	[Lombino, Franco; Biundo, Fabrizio; Tamayev, Robert; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Pathol & Cell Biol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University	D'Adamio, L (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	luciano.dadamio@einstein.yu.edu	Biundo, Fabrizio/ABH-7843-2020; biundo, fabrizio/A-4611-2019; arancio, ottavio/AAB-7959-2019; Biundo, Fabrizio/AAJ-1715-2021	D'Adamio, Luciano/0000-0002-2204-9441; Biundo, Fabrizio/0000-0003-2264-1872; arancio, ottavio/0000-0001-6335-164X; Lombino, Franco Luis/0000-0003-2326-6920; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer's Association [IIRG-09-129984, ZEN-11-201425]; Edward N. & Della L. Thome Memorial Foundation grant; National Institutes of Health (NIH) [R01AG033007, R01NS049442]; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033007, R01AG041531, R21AG041577] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Edward N. & Della L. Thome Memorial Foundation grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Cellular and Molecular Biology and Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Alzheimer's Association (IIRG-09-129984 and ZEN-11-201425 to L.D.), the Edward N. & Della L. Thome Memorial Foundation grant (to L.D.), the National Institutes of Health (NIH; R01AG033007 to L.D. and R01NS049442 to O.A.), the Training Program in Cellular and Molecular Biology and Genetics T32 GM007491 to R.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; D'Ambrosio C, 2006, MOL CELL PROTEOMICS, V5, P97, DOI 10.1074/mcp.M500226-MCP200; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; GARRINGER HJ, 2009, BRAIN STRUCT FUNCT; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Matrone C, 2012, AGING CELL, V11, P1084, DOI 10.1111/acel.12009; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, J ALZHEIMERS DIS, V27, P385, DOI 10.3233/JAD-2011-110785; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; Matsushima T, 2012, J BIOL CHEM, V287, P19715, DOI 10.1074/jbc.M111.334847; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Shin RW, 2007, ACTA NEUROPATHOL, V113, P627, DOI 10.1007/s00401-007-0211-z; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Tamayev R, 2012, MOL NEURODEGENER S1, V7, pL9; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-60; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vitale M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728178; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57120	10.1371/journal.pone.0057120	http://dx.doi.org/10.1371/journal.pone.0057120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451158	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800074
J	Moore, BT; Jordan, JM; Baugh, LR				Moore, Brad T.; Jordan, James M.; Baugh, L. Ryan			WormSizer: High-throughput Analysis of Nematode Size and Shape	PLOS ONE			English	Article							BIOLOGICAL-IMAGE-ANALYSIS; CAENORHABDITIS-ELEGANS; GROWTH; REPRODUCTION; LONGEVITY; DBL-1; DAF-2; GENE	The fundamental phenotypes of growth rate, size and morphology are the result of complex interactions between genotype and environment. We developed a high-throughput software application, WormSizer, which computes size and shape of nematodes from brightfield images. Existing methods for estimating volume either coarsely model the nematode as a cylinder or assume the worm shape or opacity is invariant. Our estimate is more robust to changes in morphology or optical density as it only assumes radial symmetry. This open source software is written as a plugin for the well-known image-processing framework Fiji/ImageJ. It may therefore be extended easily. We evaluated the technical performance of this framework, and we used it to analyze growth and shape of several canonical Caenorhabditis elegans mutants in a developmental time series. We confirm quantitatively that a Dumpy (Dpy) mutant is short and fat and that a Long (Lon) mutant is long and thin. We show that daf-2 insulin-like receptor mutants are larger than wild-type upon hatching but grow slow, and WormSizer can distinguish dauer larvae from normal larvae. We also show that a Small (Sma) mutant is actually smaller than wild-type at all stages of larval development. WormSizer works with Uncoordinated (Unc) and Roller (Rol) mutants as well, indicating that it can be used with mutants despite behavioral phenotypes. We used our complete data set to perform a power analysis, giving users a sense of how many images are needed to detect different effect sizes. Our analysis confirms and extends on existing phenotypic characterization of well-characterized mutants, demonstrating the utility and robustness of WormSizer.	[Moore, Brad T.] Duke Univ, PhD Program Computat Biol & Bioinformat, Durham, NC USA; [Jordan, James M.; Baugh, L. Ryan] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Baugh, L. Ryan] Duke Univ, Duke Ctr Syst Biol, Durham, NC USA	Duke University; Duke University; Duke University	Baugh, LR (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	ryan.baugh@duke.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Jordan, James/0000-0002-7620-462X; Moore, Bradley/0000-0003-4322-8841	National Science Foundation [IOS-1120206]; National Institutes of Health Training Grant [T32 GM071340]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071340] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Science Foundation (IOS-1120206) supported this work. Brad T. Moore is supported by National Institutes of Health Training Grant T32 GM071340 (P.I. Hartemink). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BIOSTATISTICAL ANAL; Arganda-Carreras I., 2008, SKELETONIZE3D; Baek J, 2002, J NEUROSCI METH, V00, P1; BYERLY L, 1975, REV SCI INSTRUM, V46, P517, DOI 10.1063/1.1134262; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Castle M., 2007, ROLLING BALL BACKGRO; Davis PJ, 1984, METHODS NUMERICAL IN, P51; Gems D, 1998, GENETICS, V150, P129; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Landini G, 2011, AUTOTHRESHOLD; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lewis JA, 1995, METHOD CELL BIOL, V48, P4; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; MADURO M, 1995, GENETICS, V141, P977; Morita K, 2002, EMBO J, V21, P1063, DOI 10.1093/emboj/21.5.1063; Peixoto CA, 1998, J PARASITOL, V84, P45, DOI 10.2307/3284528; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Rasband W, IMAGEJ; Ruaud AF, 2011, GENETICS, V187, P337, DOI 10.1534/genetics.110.123323; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Thacker C, 2006, CELL MOL LIFE SCI, V63, P1193, DOI 10.1007/s00018-006-6012-z; Wahlby C, 2012, NATURE METHODS	25	74	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57142	10.1371/journal.pone.0057142	http://dx.doi.org/10.1371/journal.pone.0057142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451165	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800078
J	Ellenbroek, JH; Tons, HA; de Graaf, N; Loomans, CJ; Engelse, MA; Vrolijk, H; Voshol, PJ; Rabelink, TJ; Carlotti, F; de Koning, EJ				Ellenbroek, Johanne H.; Tons, Hendrica A.; de Graaf, Natascha; Loomans, Cindy J.; Engelse, Marten A.; Vrolijk, Hans; Voshol, Peter J.; Rabelink, Ton J.; Carlotti, Francoise; de Koning, Eelco J.			Topologically Heterogeneous Beta Cell Adaptation in Response to High-Fat Diet in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; ISLET FUNCTION; RAT ISLETS; PANCREAS; GROWTH; MASS; DORSAL; PROLIFERATION; LANGERHANS	Aims: Beta cells adapt to an increased insulin demand by enhancing insulin secretion via increased beta cell function and/or increased beta cell number. While morphological and functional heterogeneity between individual islets exists, it is unknown whether regional differences in beta cell adaptation occur. Therefore we investigated beta cell adaptation throughout the pancreas in a model of high-fat diet (HFD)-induced insulin resistance in mice. Methods: C57BL/6J mice were fed a HFD to induce insulin resistance, or control diet for 6 weeks. The pancreas was divided in a duodenal (DR), gastric (GR) and splenic (SR) region and taken for either histology or islet isolation. The capacity of untreated islets from the three regions to adapt in an extrapancreatic location was assessed by transplantation under the kidney capsule of streptozotocin-treated mice. Results: SR islets showed 70% increased beta cell proliferation after HFD, whereas no significant increase was found in DR and GR islets. Furthermore, isolated SR islets showed twofold enhanced glucose-induced insulin secretion after HFD, as compared with DR and GR islets. In contrast, transplantation of islets isolated from the three regions to an extrapancreatic location in diabetic mice led to a similar decrease in hyperglycemia and no difference in beta cell proliferation. Conclusions: HFD-induced insulin resistance leads to topologically heterogeneous beta cell adaptation and is most prominent in the splenic region of the pancreas. This topological heterogeneity in beta cell adaptation appears to result from extrinsic factors present in the islet microenvironment.	[Ellenbroek, Johanne H.; Tons, Hendrica A.; de Graaf, Natascha; Engelse, Marten A.; Rabelink, Ton J.; Carlotti, Francoise; de Koning, Eelco J.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Loomans, Cindy J.; de Koning, Eelco J.] Hubrecht Inst, Utrecht, Netherlands; [Vrolijk, Hans] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Voshol, Peter J.] Univ Cambridge, Inst Metab Sci, Cambridge, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	de Koning, EJ (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	e.dekoning@lumc.nl	Carlotti, Françoise/AAN-5018-2021; Carlotti, Françoise/H-1060-2014; Rabelink, Ton J./A-5316-2008; de Koning, Eelco JP/H-6030-2011	Carlotti, Françoise/0000-0001-7929-8468; Carlotti, Françoise/0000-0001-7929-8468; Rabelink, Ton J./0000-0001-6780-5186; de Koning, Eelco JP/0000-0002-1232-7022	Diabetes Cell Therapy Initiative consortium; Medical Research Council [G0600717B, G0600717, MC_UU_12012/5/B, MC_UU_12012/5] Funding Source: researchfish; MRC [G0600717, MC_UU_12012/5] Funding Source: UKRI	Diabetes Cell Therapy Initiative consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Diabetes Cell Therapy Initiative consortium including the Dutch Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2006, DIABETES, V55, pS98, DOI 10.2337/db06-S013; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Barreto SG, 2010, AM J PHYSIOL-GASTR L, V299, pG10, DOI 10.1152/ajpgi.00077.2010; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cano DA, 2007, GASTROENTEROLOGY, V132, P745, DOI 10.1053/j.gastro.2006.12.054; DEKONING EJP, 1993, DIABETOLOGIA, V36, P378, DOI 10.1007/BF00402271; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; Hornblad A, 2011, ISLETS, V3, P204, DOI 10.4161/isl.3.4.16417; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Inderbitzin D, 2006, MICROSURG, V26, P465, DOI 10.1002/micr.20271; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Lau J, 2012, DIABETOLOGIA, V55, P1390, DOI 10.1007/s00125-012-2476-6; Lindsay TH, 2006, NEUROSCIENCE, V137, P1417, DOI 10.1016/j.neuroscience.2005.10.055; MALAISSELAGAE F, 1983, EXPERIENTIA, V39, P1045, DOI 10.1007/BF01989796; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Ogilvie RF, 1933, J PATHOL BACTERIOL, V37, P473, DOI 10.1002/path.1700370314; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pissios P, 2007, DIABETES, V56, P311, DOI 10.2337/db06-0708; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596; TRIMBLE ER, 1981, AM J PHYSIOL, V240, pE422, DOI 10.1152/ajpendo.1981.240.4.E422; TRIMBLE ER, 1982, J CLIN INVEST, V69, P405, DOI 10.1172/JCI110464; WITTINGEN J, 1974, ANN SURG, V179, P412, DOI 10.1097/00000658-197404000-00005	29	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56922	10.1371/journal.pone.0056922	http://dx.doi.org/10.1371/journal.pone.0056922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441226	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200083
J	Ma, ZM; Liu, Y; Xu, Y; Huang, Y; Xu, M; Zhu, XL; Zhang, HJ; Xu, BH; Huang, F; Yang, Z; Li, XY; Wang, WQ; Bi, YF				Ma, Zhimin; Liu, Yu; Xu, Yu; Huang, Yun; Xu, Min; Zhu, Xiaolin; Zhang, Huijie; Xu, Baihui; Huang, Fei; Yang, Zhi; Li, Xiaoying; Wang, Weiqing; Bi, Yufang			Impaired Lung Function Is Associated with Increased Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; PULMONARY-FUNCTION; METABOLIC SYNDROME; INFLAMMATION; MORTALITY; HYPOXIA; MARKERS; DECLINE	Background: Impairment of lung function was reported to be associated with cardiovascular disease (CVD). The aim of the present study is to evaluate the relationship between lung function and carotid intima-media thickness (cIMT) in participants without chronic pulmonary disease. Methodology and Principal Findings: A total of 6,423 participants aged 40 years and above were recruited from Jiading District, Shanghai, China. Lung function, evaluated by forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) was measured with standard spirometry. CIMT was measured with high-resolution ultrasonography by trained physicians. Mean values of FVC (% pred) and FEV1 (% pred) in participants with elevated cIMT were significantly lower than in those without (0.92 +/- 0.20 vs. 0.99 +/- 0.19, 0.83 +/- 0.24 vs. 0.90 +/- 0.22; both p-values < 0.0001). The levels of cIMT in the lowest quartile of FVC (% pred) and FEV1 (% pred) were markedly higher than in the second, third and fourth quartile, respectively (p < 0.0001 for all). The lowest quartile of FVC (% pred) and FEV1 (% pred) was associated with increased odds of elevated cIMT, with the fully adjusted odds ratio of 1.34 and 1.41 ( 95% confidence interval (CI) 1.09-1.65, p = 0.006, 95% CI 1.15-1.72, p = 0.0008), respectively. Conclusions and Significance: Impaired lung function is associated with elevated cIMT in middle-aged and elderly Chinese. These findings suggest the need to screen impairment of lung function in people without respiratory disease for the presence of subclinical atherosclerosis in CVD prevention.	[Ma, Zhimin; Liu, Yu; Xu, Yu; Xu, Min; Zhu, Xiaolin; Zhang, Huijie; Xu, Baihui; Huang, Fei; Yang, Zhi; Li, Xiaoying; Wang, Weiqing; Bi, Yufang] Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200030, Peoples R China; [Ma, Zhimin; Liu, Yu; Xu, Yu; Huang, Yun; Xu, Min; Zhang, Huijie; Xu, Baihui; Huang, Fei; Yang, Zhi; Li, Xiaoying; Wang, Weiqing; Bi, Yufang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bi, YF (corresponding author), Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200030, Peoples R China.	byf10784@rjh.com.cn	Zhu, Xiaolin/GLV-1533-2022; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Zhu, Xiaolin/0000-0002-3221-595X; Li, Xiaoying/0000-0002-9383-5757	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Sector Funds of Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; National Natural Science Foundation of China [81222008, 81100564, 30911120493, 81130016]; New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Sector Funds of Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the National Natural Science Foundation of China (number 81222008, number 81100564, number 30911120493 and number 81130016) and New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabek ME, 2008, J PEDIATR ENDOCR MET, V21, P603; Cao JJ, 2007, CIRCULATION, V116, P32, DOI 10.1161/CIRCULATIONAHA.106.645606; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Engstrom G, 2001, ATHEROSCLEROSIS, V155, P237, DOI 10.1016/S0021-9150(00)00557-8; GAINER JL, 1987, ATHEROSCLEROSIS, V68, P263, DOI 10.1016/0021-9150(87)90206-1; Georgiopoulou VV, 2011, AM J MED, V124, P334, DOI 10.1016/j.amjmed.2010.12.006; Guazzi M, 2002, AM J CARDIOL, V89, P191, DOI 10.1016/S0002-9149(01)02199-3; Hozawa A, 2006, CHEST, V130, P1642, DOI 10.1378/chest.130.6.1642; Huang Y, 2010, J CLIN ENDOCR METAB, V95, P5122, DOI 10.1210/jc.2010-0544; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Kwon CH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-38; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Pathan SS, 2011, EUR J NEUROL, V18, P888, DOI 10.1111/j.1468-1331.2010.03340.x; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schroeder EB, 2005, ATHEROSCLEROSIS, V180, P367, DOI 10.1016/j.atherosclerosis.2004.12.012; Simanonok JP, 1996, MED HYPOTHESES, V46, P155, DOI 10.1016/S0306-9877(96)90017-1; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Wannamethee SG, 2010, DIABETES CARE, V33, P1990, DOI 10.2337/dc10-0324	25	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e53153	10.1371/journal.pone.0053153	http://dx.doi.org/10.1371/journal.pone.0053153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457443	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700003
J	Wang, C; Jiang, K; Gao, DM; Kang, XN; Sun, C; Zhang, QL; Li, Y; Sun, L; Zhang, S; Guo, K; Liu, YK				Wang, Cun; Jiang, Kai; Gao, Dongmei; Kang, Xiaonan; Sun, Chun; Zhang, Qinle; Li, Yan; Sun, Lu; Zhang, Shu; Guo, Kun; Liu, Yinkun			Clusterin Protects Hepatocellular Carcinoma Cells from Endoplasmic Reticulum Stress Induced Apoptosis through GRP78	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CUSTIRSEN OGX-011; RESISTANCE; EXPRESSION; OVEREXPRESSION; METASTASIS; COMBINATION; SORAFENIB; INHIBITOR; SURVIVAL	Clusterin (CLU) is a stress-activated chaperone, which plays an important role in cancer development and progression through promoting cell survival. However, the exact mechanism of how CLU exerts its cell protective role under ER stress condition is still unclear. Therefore, in order to explore the molecular mechanisms by which CLU inhibited ER stress-induced apoptosis, HCC cell lines were treated with tunicamycin (TN), an ER stress inducer. We found that the expressions of both CLU and GRP78 were increased after TN treatment. Knockdown of CLU expression in SMMC7721 and HCCLM3 cells inhibited GRP78 expression after TN treatment and enhanced ER stress-induced apoptosis, whereas over-expression of CLU in HepG2 cells increased GRP78 expression after TN induction and abolished the effect of TN on cell apoptosis. Furthermore, knockdown of GRP78 expression in CLU-HepG2 cells abrogated the protective role of CLU under ER stress condition. Co-immunoprecipitation (co-IP) and confocal microscopy experiments confirmed the direct interaction between CLU and GRP78 under ER stress condition. The effect of CLU knockdown on GRP78 expression and cell apoptosis in HCC tumors were further determined in orthotopic xenograft tumor model. Knockdown of CLU expression in HCCLM3 cells inhibited GRP78 expression in tumor tissues, accompanied with increased number of apoptotic cancer cells. Moreover, the correlation between CLU and GRP78 expression was further determined in clinical HCC specimens. Taken together, these findings reveal that CLU protects HCC cells from ER stress induced apoptosis at least partially through interacting with GRP78.	[Wang, Cun; Gao, Dongmei; Sun, Chun; Li, Yan; Zhang, Shu; Guo, Kun; Liu, Yinkun] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200433, Peoples R China; [Wang, Cun; Jiang, Kai; Kang, Xiaonan; Sun, Chun; Zhang, Qinle; Sun, Lu; Liu, Yinkun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Guo, K (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200433, Peoples R China.	jacky.guo.joan@gmail.com; liu.yinkun@zs-hospital.sh.cn			China National Key Projects for Infectious Diseases [2012ZX10002-012, 2012ZX10002-009]; National Basic Research Program of China (973 Program) [2011CB910604]; China National Natural Science Foundation [81001057]	China National Key Projects for Infectious Diseases; National Basic Research Program of China (973 Program)(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was financially supported by China National Key Projects for Infectious Diseases (2012ZX10002-012 and 2012ZX10002-009), National Basic Research Program of China (973 Program: 2011CB910604), and China National Natural Science Foundation (81001057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Chang YJ, 2011, ANN SURG ONCOL, V18, P2395, DOI 10.1245/s10434-011-1597-3; Chen KF, 2010, J HEPATOL, V52, P88, DOI 10.1016/j.jhep.2009.10.011; Chiou JF, 2010, ANN SURG ONCOL, V17, P603, DOI 10.1245/s10434-009-0718-8; Gan L, 2010, ONCOL REP, V23, P1037, DOI 10.3892/or_00000730; Hung CS, 2012, ANN SURG ONCOL, V19, P2744, DOI 10.1245/s10434-011-2188-z; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; Kang YK, 2004, HUM PATHOL, V35, P1340, DOI 10.1016/j.humpath.2004.07.021; Kususda Y, 2012, BRIT J CANCER, V106, P1945, DOI 10.1038/bjc.2012.209; Lamoureux F, 2011, CANCER RES, V71, P5838, DOI 10.1158/0008-5472.CAN-11-0994; Laskin JJ, 2012, J THORAC ONCOL, V7, P579, DOI 10.1097/JTO.0b013e31823f459c; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; Lu Q, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.30; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Park DC, 2008, NEOPLASIA, V10, P964, DOI 10.1593/neo.08604; Redondo M, 2009, ADV CANCER RES, V105, P21, DOI 10.1016/S0065-230X(09)05002-7; Saad F, 2011, CLIN CANCER RES, V17, P5765, DOI 10.1158/1078-0432.CCR-11-0859; Sallman DA, 2007, MOL CANCER THER, V6, P2938, DOI 10.1158/1535-7163.MCT-07-0345; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Sun Q, 2012, MOL BIOL REP, V39, P6753, DOI 10.1007/s11033-012-1500-8; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Wang C, 2012, INT J BIOCHEM CELL B, V44, P2308, DOI 10.1016/j.biocel.2012.09.012; Wang C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-166; Wei L, 2009, INT J CANCER, V125, P791, DOI 10.1002/ijc.24316; Xie D, 2005, WORLD J GASTROENTERO, V11, P3285, DOI 10.3748/wjg.v11.i21.3285; Yom CK, 2009, ANTICANCER RES, V29, P3909; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	35	38	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55981	10.1371/journal.pone.0055981	http://dx.doi.org/10.1371/journal.pone.0055981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457489	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700029
J	Yoshioka, S; Tsukamoto, Y; Hijiya, N; Nakada, C; Uchida, T; Matsuura, K; Takeuchi, I; Seto, M; Kawano, K; Moriyama, M				Yoshioka, Shunichi; Tsukamoto, Yoshiyuki; Hijiya, Naoki; Nakada, Chisato; Uchida, Tomohisa; Matsuura, Keiko; Takeuchi, Ichiro; Seto, Masao; Kawano, Kenji; Moriyama, Masatsugu			Genomic Profiling of Oral Squamous Cell Carcinoma by Array-Based Comparative Genomic Hybridization	PLOS ONE			English	Article							DNA COPY-NUMBER; ELECTIVE NECK DISSECTION; LYMPH-NODE INVOLVEMENT; TUMOR THICKNESS; GENE-EXPRESSION; BREAST-CANCER; METASTASIS FORMATION; SUPRAOMOHYOID NECK; PROSTATE-CANCER; HEAD	We designed a study to investigate genetic relationships between primary tumors of oral squamous cell carcinoma (OSCC) and their lymph node metastases, and to identify genomic copy number aberrations (CNAs) related to lymph node metastasis. For this purpose, we collected a total of 42 tumor samples from 25 patients and analyzed their genomic profiles by array-based comparative genomic hybridization. We then compared the genetic profiles of metastatic primary tumors (MPTs) with their paired lymph node metastases (LNMs), and also those of LNMs with non-metastatic primary tumors (NMPTs). Firstly, we found that although there were some distinctive differences in the patterns of genomic profiles between MPTs and their paired LNMs, the paired samples shared similar genomic aberration patterns in each case. Unsupervised hierarchical clustering analysis grouped together 12 of the 15 MPT-LNM pairs. Furthermore, similarity scores between paired samples were significantly higher than those between non-paired samples. These results suggested that MPTs and their paired LNMs are composed predominantly of genetically clonal tumor cells, while minor populations with different CNAs may also exist in metastatic OSCCs. Secondly, to identify CNAs related to lymph node metastasis, we compared CNAs between grouped samples of MPTs and LNMs, but were unable to find any CNAs that were more common in LNMs. Finally, we hypothesized that subpopulations carrying metastasis-related CNAs might be present in both the MPT and LNM. Accordingly, we compared CNAs between NMPTs and LNMs, and found that gains of 7p, 8q and 17q were more common in the latter than in the former, suggesting that these CNAs may be involved in lymph node metastasis of OSCC. In conclusion, our data suggest that in OSCCs showing metastasis, the primary and metastatic tumors share similar genomic profiles, and that cells in the primary tumor may tend to metastasize after acquiring metastasis-associated CNAs.	[Yoshioka, Shunichi; Tsukamoto, Yoshiyuki; Hijiya, Naoki; Nakada, Chisato; Uchida, Tomohisa; Matsuura, Keiko; Moriyama, Masatsugu] Oita Univ, Dept Mol Pathol, Fac Med, Oita 87011, Japan; [Yoshioka, Shunichi; Kawano, Kenji] Oita Univ, Dept Dent & Oral Maxillofacial Surg, Fac Med, Oita 87011, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Dept Comp Sci Sci & Engn Simulat, Nagoya, Aichi, Japan; [Seto, Masao] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan	Oita University; Oita University; Nagoya Institute of Technology; Aichi Cancer Center	Tsukamoto, Y (corresponding author), Oita Univ, Dept Mol Pathol, Fac Med, Oita 87011, Japan.	tuka@oita-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan;  [20592205]; Grants-in-Aid for Scientific Research [24591952] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by the Ministry of Education, Science, Sports and Culture of Japan, and a Grant-in-Aid for Scientific Research (C), No. 20592205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakage T, 1998, CANCER, V82, P1443, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bockmuhl U, 2002, GENE CHROMOSOME CANC, V33, P29, DOI 10.1002/gcc.1209.abs; Cai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036944; Capote A, 2007, HEAD NECK-J SCI SPEC, V29, P3, DOI 10.1002/hed.20482; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Childs G, 2012, NAT CELL BIOL, V14, P337, DOI 10.1038/ncb2477; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Clark JR, 2006, OTOLARYNG HEAD NECK, V135, P748, DOI 10.1016/j.otohns.2006.05.751; Davies JJ, 2005, CHROMOSOME RES, V13, P237, DOI 10.1007/s10577-005-2168-x; Dias FL, 2001, OTOLARYNG HEAD NECK, V125, P23, DOI 10.1067/mhn.2001.116188; Dias FL, 2006, OTOLARYNG HEAD NECK, V134, P460, DOI 10.1016/j.otohns.2005.09.025; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Garnis C, 2003, CANCER RES, V63, P8582; Garnis C, 2004, GENE CHROMOSOME CANC, V39, P93, DOI 10.1002/gcc.10294; Hao SP, 2002, ORAL ONCOL, V38, P309, DOI 10.1016/S1368-8375(01)00061-6; Harada K, 1998, CANCER RES, V58, P4694; Harada T, 2002, CANCER RES, V62, P835; Helliwell TR, 2001, J PATHOL, V194, P289, DOI 10.1002/1096-9896(200107)194:3<289::AID-PATH912>3.0.CO;2-L; Heng HHQ, 2010, J CELL BIOCHEM, V109, P1072, DOI 10.1002/jcb.22497; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Huang SH, 2009, CANCER-AM CANCER SOC, V115, P1489, DOI 10.1002/cncr.24161; Jones A S, 1994, Eur J Cancer B Oral Oncol, V30B, P8, DOI 10.1016/0964-1955(94)90044-2; KALNINS IK, 1977, AM J SURG, V134, P450, DOI 10.1016/0002-9610(77)90376-2; Keski-Santti H, 2006, ORAL ONCOL, V42, P96, DOI 10.1016/j.oraloncology.2005.06.018; Kujawski M, 1999, GENE CHROMOSOME CANC, V26, P253, DOI 10.1002/(SICI)1098-2264(199911)26:3<253::AID-GCC10>3.0.CO;2-A; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu CJ, 2008, J PATHOL, V214, P489, DOI 10.1002/path.2306; Liu CJ, 2006, MOL CARCINOGEN, V45, P721, DOI 10.1002/mc.20213; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; MOORE C, 1986, CANCER-AM CANCER SOC, V58, P158, DOI 10.1002/1097-0142(19860701)58:1<158::AID-CNCR2820580127>3.0.CO;2-B; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Noutomi Y, 2006, J PATHOL, V210, P67, DOI 10.1002/path.2015; O-charoenrat P, 2003, ORAL ONCOL, V39, P386, DOI 10.1016/S1368-8375(02)00142-2; Pathare SM, 2011, ONCOL LETT, V2, P445, DOI 10.3892/ol.2011.271; Patmore HS, 2004, BRIT J CANCER, V90, P1976, DOI 10.1038/sj.bjc.6601756; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Polyak K, 2008, CLIN CANCER RES, V14, P339, DOI 10.1158/1078-0432.CCR-07-2188; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Sugahara K, 2011, INT J ONCOL, V39, P761, DOI 10.3892/ijo.2011.1094; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wreesmann VB, 2004, HEAD NECK-J SCI SPEC, V26, P10, DOI 10.1002/hed.10344; Wu Z, 2009, NEOPLASIA, V11, P66, DOI 10.1593/neo.81048; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Yu SB, 2006, AM J SURG, V191, P94, DOI 10.1016/j.amjsurg.2005.10.008	56	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56165	10.1371/journal.pone.0056165	http://dx.doi.org/10.1371/journal.pone.0056165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457519	gold, Green Submitted, Green Published			2022-12-27	WOS:000315602700053
J	Farina, F; Sancini, G; Battaglia, C; Tinaglia, V; Mantecca, P; Camatini, M; Palestini, P				Farina, Francesca; Sancini, Giulio; Battaglia, Cristina; Tinaglia, Valentina; Mantecca, Paride; Camatini, Marina; Palestini, Paola			Milano Summer Particulate Matter (PM10) Triggers Lung Inflammation and Extra Pulmonary Adverse Events in Mice	PLOS ONE			English	Article							AIR-POLLUTION; GENE-EXPRESSION; HEME OXYGENASE-1; CARDIOVASCULAR-DISEASE; ULTRAFINE PARTICLES; ENDOTHELIN SYSTEM; FINE PARTICLES; SHORT-TERM; IN-VIVO; TRANSLOCATION	Recent studies have suggested a link between particulate matter (PM) exposure and increased mortality and morbidity associated with pulmonary and cardiovascular diseases; accumulating evidences point to a new role for air pollution in CNS diseases. The purpose of our study is to investigate PM10sum effects on lungs and extra pulmonary tissues. Milano PM10sum has been intratracheally instilled into BALB/c mice. Broncho Alveolar Lavage fluid, lung parenchyma, heart and brain were screened for markers of inflammation (cell counts, cytokines, ET-1, HO-1, MPO, iNOS), cytotoxicity (LDH, ALP, Hsp70, Caspase8-p18, Caspase3-p17) for a putative pro-carcinogenic marker (Cyp1B1) and for TLR4 pathway activation. Brain was also investigated for CD68, TNF-alpha, GFAP. In blood, cell counts were performed while plasma was screened for endothelial activation (sP-selectin, ET-1) and for inflammation markers (TNF-alpha, MIP-2, IL-1 beta, MPO). Genes up-regulation (HMOX1, Cyp1B1, IL-1 beta, MIP-2, MPO) and miR-21 have been investigated in lungs and blood. Inflammation in the respiratory tract of PM10sum-treated mice has been confirmed in BALf and lung parenchyma by increased PMNs percentage, increased ET-1, MPO and cytokines levels. A systemic spreading of lung inflammation in PM10sum-treated mice has been related to the increased blood total cell count and neutrophils percentage, as well as to increased blood MPO. The blood-endothelium interface activation has been confirmed by significant increases of plasma ET-1 and sP-selectin. Furthermore PM10sum induced heart endothelial activation and PAHs metabolism, proved by increased ET-1 and Cyp1B1 levels. Moreover, PM10sum causes an increase in brain HO-1 and ET-1. These results state the translocation of inflammation mediators, ultrafine particles, LPS, metals associated to PM10sum, from lungs to bloodstream, thus triggering a systemic reaction, mainly involving heart and brain. Our results provided additional insight into the toxicity of PM10sum and could facilitate shedding light on mechanisms underlying the development of urban air pollution related diseases.	[Farina, Francesca; Sancini, Giulio; Palestini, Paola] Univ Milano Bicocca, Dept Hlth Sci, POLARIS Res Ctr, Monza, Italy; [Battaglia, Cristina; Tinaglia, Valentina] Univ Milan, PhD Sch Mol Med, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy; [Mantecca, Paride; Camatini, Marina] Univ Milano Bicocca, Dept Environm Sci, POLARIS Res Ctr, Milan, Italy	University of Milano-Bicocca; University of Milan; University of Milano-Bicocca	Sancini, G (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, POLARIS Res Ctr, Monza, Italy.	giulio.sancini@unimib.it	Sancini, Giulio/I-5136-2012; Battaglia, Cristina/E-5166-2017; Palestini, PAOLA/AAD-9376-2019	Sancini, Giulio/0000-0003-2567-109X; Battaglia, Cristina/0000-0003-3025-9657; Palestini, PAOLA/0000-0002-1045-8838; Mantecca, Paride/0000-0002-6962-049X	CARIPLO Foundation; Scuola di Dottorato di Medicina Molecolare, Universita degli Studi di Milano	CARIPLO Foundation(Fondazione Cariplo); Scuola di Dottorato di Medicina Molecolare, Universita degli Studi di Milano	This research has received a financial support by the CARIPLO Foundation to the project TOSCA "Toxicity of particulate matter and marker of risk''. Francesca Farina obtained a grant for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank the researchers of the Atmospheric Chemistry group directed by Prof. E. Bolzacchini, operating in the POLARIS Research Center, Department of Environmental Science, University of Milano Bicocca, for their precious contribution in PM sampling and chemical characterization. Thanks to Prof. A. Pesci, Azienda Ospedaliera San Gerardo, Monza, for his precious contribution in microscope analyses. Valentina Tinaglia is recipient of PhD fellowship from Scuola di Dottorato di Medicina Molecolare, Universita degli Studi di Milano. We thank Maria Carla Proverbio (Universita degli Studi di Milano) for technical assistance with gene expression analysis.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bourotte Christine Laure Marie, 2011, Rev. bras. meteorol., V26, P419, DOI 10.1590/S0102-77862011000300008; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Calderon-Garciduenas L, 2007, TOXICOL PATHOL, V35, P154, DOI 10.1080/01926230601059985; Camatini M, 2012, ENVIRON TOXICOL, V27, P63, DOI 10.1002/tox.20611; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Campen MJ, 2010, TOXICOL APPL PHARM, V242, P310, DOI 10.1016/j.taap.2009.10.021; Cao Q, 2007, TOXICOL LETT, V171, P126, DOI 10.1016/j.toxlet.2007.05.007; Case SR, 2011, EXP LUNG RES, V37, P500, DOI 10.3109/01902148.2011.596895; Chauhan V, 2005, CELL BIOL TOXICOL, V21, P191, DOI 10.1007/s10565-005-0162-x; Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016; Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9; DULARAY B, 1990, CLIN EXP IMMUNOL, V79, P195; Emmerechts J, 2010, J THROMB HAEMOST, V8, P2651, DOI 10.1111/j.1538-7836.2010.04081.x; Fagan KA, 2001, RESP RES, V2, P90, DOI 10.1186/rr44; Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; Gilmour MI, 2007, INHAL TOXICOL, V19, P7, DOI 10.1080/08958370701490379; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558; Graff DW, 2004, ENVIRON HEALTH PERSP, V112, P792, DOI 10.1289/ehp.112-1241994; Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003; Gunnison A, 2005, INHAL TOXICOL, V17, P225, DOI 10.1080/08958370590912851; Guo L, 2012, J HAZARD MATER, V213, P28, DOI 10.1016/j.jhazmat.2012.01.034; Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908; Hasegawa G, 2011, INHAL TOXICOL, V23, P897, DOI 10.3109/08958378.2011.625058; Henderson RF, 2005, EXP TOXICOL PATHOL, V57, P155, DOI 10.1016/j.etp.2005.05.004; JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458; Kang J, 2005, J HARD TISSUE BIOL, V14, P1; Kang Y James, 2002, Cardiovasc Toxicol, V2, P253, DOI 10.1385/CT:2:4:253; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kreyling WG, 2010, NAT BIOTECHNOL, V28, P1275, DOI 10.1038/nbt.1735; Langrish JP, 2009, HYPERTENSION, V54, P910, DOI 10.1161/HYPERTENSIONAHA.109.135947; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; Lund AK, 2009, ARTERIOSCL THROM VAS, V29, P511, DOI 10.1161/ATVBAHA.108.176107; MacNee W, 2003, EUR RESPIR J, V21, p47S, DOI 10.1183/09031936.03.00403203; Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002; Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; MohanKumar SMJ, 2008, NEUROTOXICOLOGY, V29, P479, DOI 10.1016/j.neuro.2007.12.004; Naota M, 2009, TOXICOL PATHOL, V37, P456, DOI 10.1177/0192623309335059; Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Perrone MG, 2012, SCI TOTAL ENVIRON, V414, P343, DOI 10.1016/j.scitotenv.2011.11.026; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x; Reiter TA, 2005, FREE RADICAL BIO MED, V39, P1075, DOI 10.1016/j.freeradbiomed.2005.05.023; Samet JM, 2009, AM J RESP CRIT CARE, V179, P1034, DOI 10.1164/rccm.200807-1043OC; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Schicker B, 2009, EUR J APPL PHYSIOL, V105, P771, DOI 10.1007/s00421-008-0962-9; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P84, DOI 10.1196/annals.1306.007; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Shah KB, 2009, CLIN CHEM, V55, P59, DOI 10.1373/clinchem.2008.108159; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007; Thomson E, 2005, TOXICOL SCI, V88, P103, DOI 10.1093/toxsci/kfi272; Utell MJ, 2000, J AEROSOL MED, V13, P355, DOI 10.1089/jam.2000.13.355; van Eeden Stephan F, 2005, Proc Am Thorac Soc, V2, P61; Watterson TL, 2009, TOXICOL SCI, V112, P111, DOI 10.1093/toxsci/kfp186; WEINBERGER I, 1992, AM J CARDIOL, V70, P981, DOI 10.1016/0002-9149(92)90347-2; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; XU WB, 1995, THORAX, V50, P1136, DOI 10.1136/thx.50.11.1136	75	72	73	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56636	10.1371/journal.pone.0056636	http://dx.doi.org/10.1371/journal.pone.0056636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451061	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500019
J	Hegeman, MA; Hennus, MP; Cobelens, PM; Kavelaars, A; Jansen, NJG; Schultz, MJ; van Vught, AJ; Heijnen, CJ				Hegeman, Maria A.; Hennus, Marije P.; Cobelens, Pieter M.; Kavelaars, Annemieke; Jansen, Nicolaas J. G.; Schultz, Marcus J.; van Vught, Adrianus J.; Heijnen, Cobi J.			Dexamethasone Attenuates VEGF Expression and Inflammation but Not Barrier Dysfunction in a Murine Model of Ventilator-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; METHYLPREDNISOLONE INFUSION; ARDS; CORTICOSTEROIDS; RATS; PERMEABILITY; PULMONARY; GLUCOCORTICOIDS; ACTIVATION; INFLATION	Background: Ventilator-induced lung injury (VILI) is characterized by vascular leakage and inflammatory responses eventually leading to pulmonary dysfunction. Vascular endothelial growth factor (VEGF) has been proposed to be involved in the pathogenesis of VILI. This study examines the inhibitory effect of dexamethasone on VEGF expression, inflammation and alveolar-capillary barrier dysfunction in an established murine model of VILI. Methods: Healthy male C57Bl/6 mice were anesthetized, tracheotomized and mechanically ventilated for 5 hours with an inspiratory pressure of 10 cmH(2)O ("lower" tidal volumes of similar to 7.5 ml/kg; LVT) or 18 cmH(2)O ("higher" tidal volumes of similar to 15 ml/kg; HVT). Dexamethasone was intravenously administered at the initiation of HVT-ventilation. Non-ventilated mice served as controls. Study endpoints included VEGF and inflammatory mediator expression in lung tissue, neutrophil and protein levels in bronchoalveolar lavage fluid, PaO2 to FiO(2) ratios and lung wet to dry ratios. Results: Particularly HVT-ventilation led to alveolar-capillary barrier dysfunction as reflected by reduced PaO2 to FiO(2) ratios, elevated alveolar protein levels and increased lung wet to dry ratios. Moreover, VILI was associated with enhanced VEGF production, inflammatory mediator expression and neutrophil infiltration. Dexamethasone treatment inhibited VEGF and pro-inflammatory response in lungs of HVT-ventilated mice, without improving alveolar-capillary permeability, gas exchange and pulmonary edema formation. Conclusions: Dexamethasone treatment completely abolishes ventilator-induced VEGF expression and inflammation. However, dexamethasone does not protect against alveolar-capillary barrier dysfunction in an established murine model of VILI.	[Hegeman, Maria A.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Hegeman, Maria A.; Cobelens, Pieter M.; Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Hegeman, Maria A.; Hennus, Marije P.; Jansen, Nicolaas J. G.; van Vught, Adrianus J.] Univ Med Ctr Utrecht, Dept Pediat Intens Care, Utrecht, Netherlands; [Cobelens, Pieter M.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	c.heijnen@umcutrecht.nl	Schultz, Marcus/AAB-6379-2021; Hennus, Marije/D-1643-2014	Schultz, Marcus/0000-0003-3969-7792; Hennus, Marije/0000-0003-1508-0456	Catharijne Foundation of the University Medical Center Utrecht, the Netherlands	Catharijne Foundation of the University Medical Center Utrecht, the Netherlands(Netherlands Government)	This research was financially supported by the Catharijne Foundation of the University Medical Center Utrecht, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Agarwal R, 2007, RESPIROLOGY, V12, P585, DOI 10.1111/j.1440-1843.2007.01060.x; Annane D, 2006, CRIT CARE MED, V34, P22, DOI 10.1097/01.CCM.0000194723.78632.62; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; Brower RG, 2001, CHEST, V120, P1347, DOI 10.1378/chest.120.4.1347; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; Edelman JL, 2005, EXP EYE RES, V80, P249, DOI 10.1016/j.exer.2004.09.013; EGAN EA, 1982, J APPL PHYSIOL, V53, P121, DOI 10.1152/jappl.1982.53.1.121; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Fischer S, 2001, EUR J PHARMACOL, V411, P231, DOI 10.1016/S0014-2999(00)00915-8; Hegeman MA, 2011, BRIT J PHARMACOL, V163, P1048, DOI 10.1111/j.1476-5381.2011.01314.x; Hegeman MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015653; Hegeman MA, 2009, CRIT CARE, V13, DOI 10.1186/cc8168; HOOPER RG, 1990, CHEST, V97, P138, DOI 10.1378/chest.97.1.138; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; KAWANO T, 1987, J APPL PHYSIOL, V62, P27, DOI 10.1152/jappl.1987.62.1.27; Kuipers MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050559; Lahm T, 2007, SHOCK, V28, P4, DOI 10.1097/shk.0b013e31804d1998; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Li LF, 2011, TRANSL RES, V157, P293, DOI 10.1016/j.trsl.2010.12.009; Luce JM, 2002, CRIT CARE CLIN, V18, P79, DOI 10.1016/S0749-0704(03)00066-6; Meduri GU, 2008, INTENS CARE MED, V34, P61, DOI 10.1007/s00134-007-0933-3; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; MEDURI GU, 1994, CHEST, V105, P1516, DOI 10.1378/chest.105.5.1516; Muller-Redetzky HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035832; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; Nin N, 2006, CRIT CARE MED, V34, P1093, DOI 10.1097/01.CCM.0000205663.92384.E7; Nin N, 2008, INTENS CARE MED, V34, P948, DOI 10.1007/s00134-007-0959-6; Nin N, 2009, SHOCK, V31, P429, DOI 10.1097/SHK.0b013e318188b720; Ohta N, 2001, CRIT CARE MED, V29, P1012, DOI 10.1097/00003246-200105000-00027; Papaioannou AI, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-128; PARKER JC, 1984, J APPL PHYSIOL, V57, P1809, DOI 10.1152/jappl.1984.57.6.1809; Ramsay PL, 1998, BIOCHEM PHARMACOL, V56, P259, DOI 10.1016/S0006-2952(98)00138-5; Seam N, 2012, CRIT CARE MED, V40, P495, DOI 10.1097/CCM.0b013e318232da5e; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Uematsu S, 2012, CRIT CARE MED; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Wang K, 2008, BIOL PHARM BULL, V31, P1541, DOI 10.1248/bpb.31.1541; WEIGELT JA, 1985, ARCH SURG-CHICAGO, V120, P536; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57374	10.1371/journal.pone.0057374	http://dx.doi.org/10.1371/journal.pone.0057374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451215	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500094
J	Schaefer, JS; Montufar-Solis, D; Nakra, N; Vigneswaran, N; Klein, JR				Schaefer, Jeremy S.; Montufar-Solis, Dina; Nakra, Niyati; Vigneswaran, Nadarajah; Klein, John R.			Small Intestine Inflammation in Roquin-Mutant and Roquin-Deficient Mice	PLOS ONE			English	Article							T-CELL SUBSETS; BOWEL-DISEASE; IL-10-DEFICIENT MICE; IL-10(-/-) MICE; MESSENGER-RNA; SCID MICE; AUTOIMMUNITY; EXPRESSION; COLITIS; MANIFESTATIONS	Roquin, an E3 ubiquitin ligase that localizes to cytosolic RNA granules, is involved in regulating mRNA stability and translation. Mice that have a M199R mutation in the Roquin protein (referred to as sanroque or Roquin(san/san) mice) develop autoimmune pathologies, although the extent to which these occur in the intestinal mucosa has not been determined. Here, we demonstrate that Roquin(san/san) mice reproducibly develop intestinal inflammation in the small intestine but not the colon. Similarly, mice generated in our laboratory in which the Roquin gene was disrupted by insertion of a gene trap cassette (Roquin(gt/gt) mice) had small intestinal inflammation that mimicked that of Roquin(san/san) mice. MLN cells in Roquin(san/san) mice consisted of activated proliferating T cells, and had increased numbers of CD44(hi) CD62L(lo) KLRG1(+) short-lived effector cells. Proportionally more small intestinal intraepithelial lymphocytes in Roquin(san/san) mice expressed the ICOS T cell activation marker. Of particular interest, small intestinal lamina propria lymphocytes in Roquin(san/san) mice consisted of a high proportion of Gr-1(+) T cells that included IL-17A(+) cells and CD8(+) IFN-gamma(+) cells. Extensive cytokine dysregulation resulting in both over-expression and under-expression of chemotactic cytokines occurred in the ileum of Roquin(san/san) mice, the region most prone to the development of inflammation. These findings demonstrate that chronic inflammation ensues in the intestine following Roquin alteration either as a consequence of protein mutation or gene disruption, and they have implications for understanding how small intestinal inflammation is perpetuated in Crohn's disease (CD). Due to the paucity of animal models of CD-like pathophysiology in the small intestine, and because the primary gene/protein defects of the Roquin animal systems used here are well-defined, it will be possible to further elucidate the underlying genetic and molecular mechanisms that drive the disease process.	[Schaefer, Jeremy S.; Montufar-Solis, Dina; Nakra, Niyati; Vigneswaran, Nadarajah; Klein, John R.] Univ Texas Hlth Sci Ctr Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77225 USA		Klein, JR (corresponding author), Univ Texas Hlth Sci Ctr Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77225 USA.	john.r.klein@uth.tmc.edu			United States National Institutes of Health [5R01DK035566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035566] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding came from the United States National Institutes of Health (http://www.nih.gov/) (5R01DK035566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1917, INT IMMUNOL; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Basseri B, 2010, J CROHNS COLITIS, V4, P390, DOI 10.1016/j.crohns.2010.03.008; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Chang PP, 2012, J IMMUNOL, V189, P701, DOI 10.4049/jimmunol.1102432; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Claesson MH, 1996, CLIN EXP IMMUNOL, V104, P491, DOI 10.1046/j.1365-2249.1996.48757.x; Egan C.E., 2011, IMMUNOL CELL BIOL; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Ji YR, 2012, J BIOL CHEM, V287, P42269, DOI 10.1074/jbc.M112.374835; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002; Manganelli C, 2009, EUR REV MED PHARMACO, V13, P11; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; Matsuzaki J, 2003, CELL IMMUNOL, V224, P98, DOI 10.1016/j.cellimm.2003.08.009; Montufar-Solis D, 2007, J LEUKOCYTE BIOL, V82, P1166, DOI 10.1189/jlb.0207108; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Srivastava AS, 2007, BIOCHEM BIOPH RES CO, V361, P953, DOI 10.1016/j.bbrc.2007.07.139; Veloso FT, 2011, WORLD J GASTROENTERO, V17, P2702, DOI 10.3748/wjg.v17.i22.2702; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vocanson M, 2010, J ALLERGY CLIN IMMUN, V126, P280, DOI 10.1016/j.jaci.2010.05.022; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	30	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56436	10.1371/journal.pone.0056436	http://dx.doi.org/10.1371/journal.pone.0056436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451046	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500014
J	Cai, H; Chiorean, EG; Chiorean, MV; Rex, DK; Robb, BW; Hahn, NM; Liu, ZY; Loehrer, PJ; Harrison, ML; Xu, Y				Cai, Hui; Chiorean, Elena G.; Chiorean, Michael V.; Rex, Douglas K.; Robb, Bruce W.; Hahn, Noah M.; Liu, Ziyue; Loehrer, Patrick J.; Harrison, Marietta L.; Xu, Yan			Elevated Phospholipase A(2) Activities in Plasma Samples from Multiple Cancers	PLOS ONE			English	Article							OVARIAN-CANCER; LUNG-CANCER; COLORECTAL-CANCER; INFLAMMATION; CELLS; TESTS	Only in recent years have phospholipase A(2) enzymes (PLA(2)s) emerged as cancer targets. In this work, we report the first detection of elevated PLA(2) activities in plasma from patients with colorectal, lung, pancreatic, and bladder cancers as compared to healthy controls. Independent sets of clinical plasma samples were obtained from two different sites. The first set was from patients with colorectal cancer (CRC; n = 38) and healthy controls (n = 77). The second set was from patients with lung (n = 95), bladder (n = 31), or pancreatic cancers (n = 38), and healthy controls (n = 79). PLA(2) activities were analyzed by a validated quantitative fluorescent assay method and subtype PLA(2) activities were defined in the presence of selective inhibitors. The natural PLA(2) activity, as well as each subtype of PLA(2) activity was elevated in each cancer group as compared to healthy controls. PLA(2) activities were increased in late stage vs. early stage cases in CRC. PLA(2) activities were not influenced by sex, smoking, alcohol consumption, or body-mass index (BMI). Samples from the two independent sites confirmed the results. Plasma PLA(2) activities had approximately 70% specificity and sensitivity to detect cancer. The marker and targeting values of PLA(2) activity have been suggested.	[Cai, Hui; Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN USA; [Cai, Hui] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Thorac Oncosurg, Xian 710049, Peoples R China; [Chiorean, Elena G.; Chiorean, Michael V.; Rex, Douglas K.; Robb, Bruce W.; Hahn, Noah M.; Loehrer, Patrick J.] Indiana Univ Sch Med, Dept Med, Indiana Univ Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Hahn, Noah M.] Hoosier Oncol Grp, Indianapolis, IN USA; [Liu, Ziyue] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Harrison, Marietta L.] Purdue Univ, Ctr Canc Res, Oncol Sci Ctr, W Lafayette, IN 47907 USA	Indiana University System; Indiana University Bloomington; Xi'an Jiaotong University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xu, Y (corresponding author), Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN USA.	xu2@iupui.edu	Chiorean, Michael/AAZ-5305-2021		Cancer Care Engineering Project, Department of Defense, USAMRMC [W81XWH-08-1-0065, W81XWH-10-1-0540]; National Institutes of Health [R21 CA133744]; Mary Fendrich Hulman Charitable Trust; Walther Cancer Institute Foundation, Indianapolis, IN; NATIONAL CANCER INSTITUTE [P30CA082709, R21CA133744] Funding Source: NIH RePORTER	Cancer Care Engineering Project, Department of Defense, USAMRMC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Fendrich Hulman Charitable Trust; Walther Cancer Institute Foundation, Indianapolis, IN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the Cancer Care Engineering Project, Department of Defense, USAMRMC, W81XWH-08-1-0065 and W81XWH-10-1-0540 (http://www.grants.gov/search/search.do?mode = AGENCYSEARCH&agency = DOD), as well as National Institutes of Health R21 CA133744 (http://www.cancer.gov/researchandfunding) and the Mary Fendrich Hulman Charitable Trust to YX. Funding for the Hoosier Oncology Group Study was provided by the Walther Cancer Institute Foundation, Indianapolis, IN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Cai Q, 2012, FASEB J; Cho WCS, 2011, EXPERT OPIN THER TAR, V15, P1127, DOI 10.1517/14728222.2011.599801; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cummings BS, 2007, BIOCHEM PHARMACOL, V74, P949, DOI 10.1016/j.bcp.2007.04.021; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; Khochikar MV, 2011, INDIAN J UROL, V27, P218, DOI 10.4103/0970-1591.82841; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Moossavi S, 2012, ARCH IRAN MED, V15, P166, DOI 012153/AIM.0012; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Mutti Antonio, 2008, Acta Biomed, V79 Suppl 1, P11; Pastorino U, 2010, BRIT J CANCER, V102, P1681, DOI 10.1038/sj.bjc.6605660; Pox C, 2011, DIGEST DIS, V29, P56, DOI 10.1159/000331127; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Sengupta S, 2007, ONCOGENE, V26, P2894, DOI 10.1038/sj.onc.1210093; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x; Xu Yan, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P23, DOI 10.2174/1568008033340414; Xu Y, 2009, CANCER TREAT RES, V149, P241, DOI 10.1007/978-0-387-98094-2_12; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	27	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57081	10.1371/journal.pone.0057081	http://dx.doi.org/10.1371/journal.pone.0057081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451150	Green Submitted, gold, Green Published			2022-12-27	WOS:000316658800068
J	Jamsai, D; O'Connor, AE; DeBoer, KD; Clark, BJ; Smith, SJ; Browne, CM; Bensley, JG; Merriman, JA; Yuen, WS; Koopman, P; Jones, KT; O'Bryan, MK				Jamsai, Duangporn; O'Connor, Anne E.; DeBoer, Kathleen D.; Clark, Brett J.; Smith, Stephanie J.; Browne, Catherine M.; Bensley, Jonathan G.; Merriman, Julie A.; Yuen, Wai Shan; Koopman, Peter; Jones, Keith T.; O'Bryan, Moira K.			Loss of GGN Leads to Pre-Implantation Embryonic Lethality and Compromised Male Meiotic DNA Double Strand Break Repair in the Mouse	PLOS ONE			English	Article							FANCONI-ANEMIA; TARGETED DISRUPTION; GENE LEADS; MICE; PATHWAY; FERTILITY; DEFICIENT; COMPLEX; BRCA1; CELLS	The integrity of male germ cell genome is critical for the correct progression of spermatogenesis, successful fertilization, and proper development of the offspring. Several DNA repair pathways exist in male germ cells. However, unlike somatic cells, key components of such pathways remain largely unidentified. Gametogenetin (GGN) is a testis-enriched protein that has been shown to bind to the DNA repair protein FANCL via yeast-two-hybrid assays. This finding and its testis-enriched expression pattern raise the possibility that GGN plays a role in DNA repair during spermatogenesis. Herein we demonstrated that the largest isoform GGN1 interacted with components of DNA repair machinery in the mouse testis. In addition to FANCL, GGN1 interacted with the critical component of the Fanconi Anemia (FA) pathway FANCD2 and a downstream component of the BRCA pathway, BRCC36. To define the physiological function of GGN, we generated a Ggn null mouse line. A complete loss of GGN resulted in embryonic lethality at the very earliest period of pre-implantation development, with no viable blastocysts observed. This finding was consistent with the observation that Ggn mRNA was also expressed in lower levels in the oocyte and pre-implantation embryos. Moreover, pachytene spermatocytes of the Ggn heterozygous knockout mice showed an increased incidence of unrepaired DNA double strand breaks (DSBs). Together, our results suggest that GGN plays a role in male meiotic DSB repair and is absolutely required for the survival of pre-implantation embryos.	[Jamsai, Duangporn; O'Connor, Anne E.; Smith, Stephanie J.; Bensley, Jonathan G.; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Jamsai, Duangporn; O'Connor, Anne E.; DeBoer, Kathleen D.; Clark, Brett J.; Smith, Stephanie J.; Browne, Catherine M.; Koopman, Peter; O'Bryan, Moira K.] Monash Univ, Australian Res Council Ctr Excellence Biotechnol, Clayton, Vic 3800, Australia; [Browne, Catherine M.; Koopman, Peter] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Merriman, Julie A.; Yuen, Wai Shan; Jones, Keith T.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	Monash University; Monash University; University of Queensland; University of Newcastle	Jamsai, D (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	duangporn.jamsai@monash.edu	Jones, Keith/C-9821-2013; Koopman, Peter A/C-9416-2009; O'Connor, Anne/AAI-6479-2020; O'Bryan, Moira K/F-8256-2012; Jones, Keith/AAA-3479-2021	Jones, Keith/0000-0002-0294-0851; Koopman, Peter A/0000-0001-6939-0914; O'Connor, Anne/0000-0001-9334-4256; O'Bryan, Moira K/0000-0001-7298-4940; Jones, Keith/0000-0002-0294-0851; Bensley, Jonathan/0000-0003-2926-1856	NHMRC [143786]; ARC [CEO348239, DP110102288]; NHMRC Fellowships [384297, 384132]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the NHMRC (#143786) and the ARC (CEO348239,DP110102288). DJ and MKO'B are the recipient of the NHMRC Fellowships (#384297, #384132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Brown EJ, 2000, GENE DEV, V14, P397; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Cohen PE, 2006, ENDOCR REV, V27, P398, DOI 10.1210/er.2005-0017; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Jamsai D, 2011, INT J ANDROL, V34, P624, DOI 10.1111/j.1365-2605.2010.01127.x; Jamsai D, 2008, REPRODUCTION, V135, P751, DOI 10.1530/REP-07-0485; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Leduc F, 2008, SYST BIOL REPROD MED, V54, P3, DOI 10.1080/19396360701876823; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Lu BS, 2003, J BIOL CHEM, V278, P16289, DOI 10.1074/jbc.M211023200; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Mukherjee S, 2010, CURR OPIN UROL, V20, P525, DOI 10.1097/MOU.0b013e32833f1c21; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698; Reinholdt LG, 2009, CHROMOSOMA, V118, P723, DOI 10.1007/s00412-009-0230-8; Sanchez-Partida LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021597; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Tamburrino L, 2012, ASIAN J ANDROL, V14, P24, DOI 10.1038/aja.2011.59; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Whitney MA, 1996, BLOOD, V88, P49; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435; Zhang J, 2005, FEBS LETT, V579, P559, DOI 10.1016/j.febslet.2004.10.112	38	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56955	10.1371/journal.pone.0056955	http://dx.doi.org/10.1371/journal.pone.0056955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451117	Green Published, gold			2022-12-27	WOS:000316658800052
J	Planson, AG; Guijarro, JI; Chaffotte, AF				Planson, Anne-Gaelle; Guijarro, J. Inaki; Chaffotte, Alain F.			New Insights for Native Production of MSP1(19), the Disulfide-Rich C-Terminal Fragment from Plasmodium falciparum Merozoite Surface Protein 1	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; MALARIA VACCINE; IDENTIFICATION; ANTIBODIES; PARASITE; IMMUNITY; COMPLEX	Malaria represents a major public health problem and an important cause of mortality and morbidity. The malaria parasites are becoming resistant to drugs used to treat the disease and still no efficient vaccine has been developed. One promising vaccine candidate is the merozoite surface protein 1 (MSP1), which has been extensively investigated as a vaccine target. The surface protein MSP1 plays an essential role in the erythrocyte invasion process and is an accessible target for the immune system. Antibodies to the carboxy-terminal region of the protein, named MSP1(19), can inhibit erythrocyte invasion and parasite growth. In order to develop an effective MSP1(19)- based vaccine against malaria, production of an antigen that is recognized by protective antibodies is mandatory. To this aim, we propose a method to produce the disulfide-rich MSP1(19) in its native conformation based on its in vitro oxidative refolding. The native conformation of the renatured MSP1(19) is carefully established by immunochemical reactivity experiments, circular dichroism and NMR. MSP1(19) can successfully be refolded in vitro as an isolated protein or as a fusion with the maltose binding protein. The possibility to properly fold MSP1(19) in vitro paves the way to new approaches for high titer production of native MSP1(19) using Escherichia coli as a host.	[Planson, Anne-Gaelle; Guijarro, J. Inaki; Chaffotte, Alain F.] Inst Pasteur, Unite RMN Biomol, Paris, France; [Guijarro, J. Inaki; Chaffotte, Alain F.] CNRS, UMR 3528, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Guijarro, JI (corresponding author), Inst Pasteur, Unite RMN Biomol, Paris, France.	inaki.guijarro@pasteur.fr; alain.chaffotte@pasteur.fr	Planson, Anne-Gaëlle/AAK-9595-2021; Guijarro, J. Inaki/E-6438-2019	Guijarro, J. Inaki/0000-0002-3826-5245; Planson, Anne-Gaelle/0000-0003-4343-3386	Institut Pasteur; CNRS; Pasteur-Weizmann program; Region Ile de France	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur-Weizmann program; Region Ile de France(Region Ile-de-France)	This work was supported by funds from the Institut Pasteur, the CNRS and the Pasteur-Weizmann program. The 600 MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bentley GA, 2006, CURR OPIN MICROBIOL, V9, P395, DOI 10.1016/j.mib.2006.06.002; Betton JM, 1998, J BIOL CHEM, V273, P8897, DOI 10.1074/jbc.273.15.8897; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; DALY TM, 1995, J IMMUNOL, V155, P236; Dluzewski AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003085; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Ellis RD, 2010, HUM VACCINES, V6, P627, DOI 10.4161/hv.6.8.11446; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Holm I, 1997, MOL BIOCHEM PARASIT, V89, P313, DOI 10.1016/S0166-6851(97)00128-X; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Perraut R, 2005, MICROBES INFECT, V7, P682, DOI 10.1016/j.micinf.2005.01.002; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; Planson AG, 2003, BIOCHEMISTRY-US, V42, P13202, DOI 10.1021/bi035321c; Reed ZH, 2009, VACCINE, V27, P1651, DOI 10.1016/j.vaccine.2008.10.093; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Thera MA, 2012, ANNU REV MED, V63, P345, DOI 10.1146/annurev-med-022411-192402; Vaughan AM, 2012, CURR OPIN IMMUNOL, V24, P324, DOI 10.1016/j.coi.2012.03.009; WHO, 2011, WORLD MALARIA REPORT 2011, P1	35	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57086	10.1371/journal.pone.0057086	http://dx.doi.org/10.1371/journal.pone.0057086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451153	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800070
J	Figueroa, M; Alderman, S; Garvin, DF; Pfender, WF				Figueroa, Melania; Alderman, Stephen; Garvin, David F.; Pfender, William F.			Infection of Brachypodium distachyon by Formae Speciales of Puccinia graminis: Early Infection Events and Host-Pathogen Incompatibility	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; NONHOST RESISTANCE; MODEL SYSTEM; STEM RUST; PERENNIAL RYEGRASS; DISEASE RESISTANCE; TALL FESCUE; GRASS; BARLEY; CEREAL	Puccinia graminis causes stem rust, a serious disease of cereals and forage grasses. Important formae speciales of P. graminis and their typical hosts are P. graminis f. sp. tritici (Pg-tr) in wheat and barley, P. graminis f. sp. lolii (Pg-lo) in perennial ryegrass and tall fescue, and P. graminis f. sp. phlei-pratensis (Pg-pp) in timothy grass. Brachypodium distachyon is an emerging genetic model to study fungal disease resistance in cereals and temperate grasses. We characterized the P. graminis-Brachypodium pathosystem to evaluate its potential for investigating incompatibility and non-host resistance to P. graminis. Inoculation of eight Brachypodium inbred lines with Pg-tr, Pg-lo or Pg-pp resulted in sporulating lesions later accompanied by necrosis. Histological analysis of early infection events in one Brachypodium inbred line (Bd1-1) indicated that Pg-lo and Pg-pp were markedly more efficient than Pg-tr at establishing a biotrophic interaction. Formation of appressoria was completed (60-70% of germinated spores) by 12 h post-inoculation (hpi) under dark and wet conditions, and after 4 h of subsequent light exposure fungal penetration structures (penetration peg, substomatal vesicle and primary infection hyphae) had developed. Brachypodium Bd1-1 exhibited pre-haustorial resistance to Pg-tr, i.e. infection usually stopped at appressorial formation. By 68 hpi, only 0.3% and 0.7% of the Pg-tr urediniospores developed haustoria and colonies, respectively. In contrast, development of advanced infection structures by Pg-lo and Pg-pp was significantly more common; however, Brachypodium displayed post-haustorial resistance to these isolates. By 68 hpi the percentage of urediniospores that only develop a haustorium mother cell or haustorium in Pg-lo and Pg-pp reached 8% and 5%, respectively. The formation of colonies reached 14% and 13%, respectively. We conclude that Brachypodium is an apt grass model to study the molecular and genetic components of incompatiblity and non-host resistance to P. graminis.	[Figueroa, Melania; Alderman, Stephen; Pfender, William F.] ARS, Forage Seed & Cereal Res Unit, USDA, Corvallis, OR USA; [Garvin, David F.] ARS, Plant Sci Res Unit, USDA, St Paul, MN USA; [Garvin, David F.] ARS, Dept Agron & Plant Genet, USDA, St Paul, MN USA; [Pfender, William F.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Oregon State University	Pfender, WF (corresponding author), ARS, Forage Seed & Cereal Res Unit, USDA, Corvallis, OR USA.	pfenderw@onid.orst.edu	Figueroa, Melania/R-7696-2017; Figueroa, Melania/AAI-8692-2021	Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X	USDA Agricultural Research Service [5358-22000-031-00D]	USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research was supported by basic operating funds of the USDA Agricultural Research Service, Project 5358-22000-031-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2006, MYCOLOGIA, V98, P896, DOI 10.3852/mycologia.98.6.896; Anikster Y., 1984, CEREAL RUSTS, P124; [Anonymous], 1971, RUST CEREALS GRASSES; Ayliffe M, 2011, EUPHYTICA, V179, P33, DOI 10.1007/s10681-010-0280-2; Barbieri M, 2012, GENOME, V55, P152, DOI [10.1139/G2012-001, 10.1139/g2012-001]; Barbieri M, 2011, PLANT DIS, V95, P1339, DOI 10.1094/PDIS-11-10-0825; Barker RE, 2003, CROP SCI, V43, P75, DOI 10.2135/cropsci2003.0075; CUMMINS GB, 2004, ILLUSTRATED GENERA R; da Cunha L, 2006, MICROBES INFECT, V8, P1372, DOI 10.1016/j.micinf.2005.12.018; Drader T, 2010, GENOME, V53, P406, DOI [10.1139/G10-014, 10.1139/g10-014]; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Eriksson J., 1894, BER DEUT BOT GES, V12, P292; Fehser S, 2010, J PLANT PATHOL, V92, P709; Garvin D. F., 2011, Borlaug Global Rust Initiative (BGRI) 2011 Technical Workshop, 13-16 June, St Paul, Minnesota, USA. Oral Presentations, P89; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Harder D.E., 1984, CEREAL RUSTS, V1, P416; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; HEATH MC, 1981, PHYTOPATHOLOGY, V71, P1121, DOI 10.1094/Phyto-71-1121; Heath MC, 1982, HOST DEFENSE MECH IN, P223; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Huo NX, 2011, THEOR APPL GENET, V123, P455, DOI 10.1007/s00122-011-1598-4; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Jafary H, 2008, GENETICS, V178, P2327, DOI 10.1534/genetics.107.077552; Jeuken M, 2002, THEOR APPL GENET, V105, P384, DOI 10.1007/s00122-002-0943-z; Kamoun S, 1999, TRENDS PLANT SCI, V4, P196, DOI 10.1016/S1360-1385(99)01404-1; LENNOX CL, 1989, PLANT PATHOL, V38, P547, DOI 10.1111/j.1365-3059.1989.tb01450.x; LENNOX CL, 1994, J PHYTOPATHOL, V140, P165, DOI 10.1111/j.1439-0434.1994.tb00188.x; Leonard KJ, 2005, MOL PLANT PATHOL, V6, P489, DOI 10.1111/J.1364-3703.2005.00299.X; Loehrer M, 2008, MOL PLANT MICROBE IN, V21, P1421, DOI 10.1094/MPMI-21-11-1421; Mellersh DG, 2003, MOL PLANT MICROBE IN, V16, P398, DOI 10.1094/MPMI.2003.16.5.398; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; Peraldi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-100; Pfender W, 2009, PHYTOPATHOLOGY, V99, P1185, DOI 10.1094/PHYTO-99-10-1185; Pfender WF, 2001, PLANT DIS, V85, P993, DOI 10.1094/PDIS.2001.85.9.993; Pfender WF, 2001, PHYTOPATHOLOGY, V91, P111, DOI 10.1094/PHYTO.2001.91.1.111; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Roelfs A.P., 1992, RUST DIS WHEAT CONCE, P34; ROELFS AP, 1988, PHYTOPATHOLOGY, V78, P526, DOI 10.1094/Phyto-78-526; ROWELL JB, 1958, PHYTOPATHOLOGY, V48, P371; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Savile D, 1984, CEREAL RUSTS, VI, P89; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; SELLAM MA, 1976, PHYTOPATHOLOGY, V66, P667, DOI 10.1094/Phyto-66-667; Singh R.P., 2006, CAB REV, V1, P54, DOI [10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, 10.1079/PAVSNNR20061054]; SKIPP RA, 1974, CAN J BOT, V52, P1107, DOI 10.1139/b74-140; STAPLES RC, 2004, CEREAL RUSTS, V1, P250; URBAN Z., 1967, Encyclopedie mycologique, V34, P5; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; Vogel J, 2009, PLANT GENET GENOMICS, V7, P427, DOI 10.1007/978-0-387-77489-3_16; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; WATERHOUSE W. L., 1951, PROC LINN SOC N S WALES, V76, P57; WELTY RE, 1989, PLANT DIS, V73, P775, DOI 10.1094/PD-73-0775A; YIRGOU D, 1968, PHYTOPATHOLOGY, V58, P500; Zhang L, 2008, FUNCT INTEGR GENOMIC, V8, P187, DOI 10.1007/s10142-007-0069-0	60	41	42	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56857	10.1371/journal.pone.0056857	http://dx.doi.org/10.1371/journal.pone.0056857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441218	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200075
J	Yang, XA; Vasudevan, P; Parekh, V; Penev, A; Cunningham, JM				Yang, Xinan; Vasudevan, Prabhakaran; Parekh, Vishwas; Penev, Aleks; Cunningham, John M.			Bridging Cancer Biology with the Clinic: Relative Expression of a GRHL2-Mediated Gene-Set Pair Predicts Breast Cancer Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR; SIGNATURE; LUNG; PROGRESSION; PROGNOSIS; SURVIVAL; IDENTIFICATION; DISSEMINATION; CONTRIBUTES	Identification and characterization of crucial gene target(s) that will allow focused therapeutics development remains a challenge. We have interrogated the putative therapeutic targets associated with the transcription factor Grainy head-like 2 (GRHL2), a critical epithelial regulatory factor. We demonstrate the possibility to define the molecular functions of critical genes in terms of their personalized expression profiles, allowing appropriate functional conclusions to be derived. A novel methodology, relative expression analysis with gene-set pairs (RXA-GSP), is designed to explore the potential clinical utility of cancer-biology discovery. Observing that Grhl2-overexpression leads to increased metastatic potential in vitro, we established a model assuming Grhl2-induced or -inhibited genes confer poor or favorable prognosis respectively for cancer metastasis. Training on public gene expression profiles of 995 breast cancer patients, this method prioritized one gene-set pair (GRHL2, CDH2, FN1, CITED2, MKI67 versus CTNNB1 and CTNNA3) from all 2717 possible gene-set pairs (GSPs). The identified GSP significantly dichotomized 295 independent patients for metastasis-free survival (log-rank tested p = 0.002; severe empirical p = 0.035). It also showed evidence of clinical prognostication in another independent 388 patients collected from three studies (log-rank tested p = 3.3e-6). This GSP is independent of most traditional prognostic indicators, and is only significantly associated with the histological grade of breast cancer (p = 0.0017), a GRHL2-associated clinical character (p = 6.8e-6, Spearman correlation), suggesting that this GSP is reflective of GRHL2-mediated events. Furthermore, a literature review indicates the therapeutic potential of the identified genes. This research demonstrates a novel strategy to integrate both biological experiments and clinical gene expression profiles for extracting and elucidating the genomic impact of a novel factor, GRHL2, and its associated gene-sets on the breast cancer prognosis. Importantly, the RXA-GSP method helps to individualize breast cancer treatment. It also has the potential to contribute considerably to basic biological investigation, clinical tools, and potential therapeutic targets.	[Yang, Xinan; Vasudevan, Prabhakaran; Parekh, Vishwas; Penev, Aleks; Cunningham, John M.] Univ Chicago, Dept Pediat, Comer Childrens Hosp, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Yang, XA (corresponding author), Univ Chicago, Dept Pediat, Comer Childrens Hosp, Hematol Oncol Sect, Chicago, IL 60637 USA.	xyang2@uchicago.edu	Parekh, Vishwas/B-7162-2014	Parekh, Vishwas/0000-0003-3131-2958; Yang, Xinan Holly/0000-0001-8061-8692; Penev, Alex/0000-0002-6358-7780	Hecktman Senior Fellow Award; NATIONAL CANCER INSTITUTE [R21CA167305] Funding Source: NIH RePORTER	Hecktman Senior Fellow Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the financial support of the Hecktman Senior Fellow Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buness A, 2007, BIOINFORMATICS, V23, P2273, DOI 10.1093/bioinformatics/btm340; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; De Rienzo A, 2011, CLIN CANCER RES, V17, P310, DOI 10.1158/1078-0432.CCR-10-0806; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Eddy JA, 2010, TECHNOL CANCER RES T, V9, P149, DOI 10.1177/153303461000900204; Espinosa-Neira R, 2011, INT J BIOCHEM CELL B, V43, P1782, DOI 10.1016/j.biocel.2011.08.017; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Itoh S, 2012, J BIOCHEM, V151, P559, DOI 10.1093/jb/mvs042; Leth-Larsen R, 2012, MOL MED; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma Ji, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P784; Magis AT, 2011, BIOINFORMATICS, V27, P872, DOI 10.1093/bioinformatics/btr033; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meehan M, 2007, GENE CHROMOSOME CANC, V46, P587, DOI 10.1002/gcc.20443; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MING T, 2011, CANCER RES, P30; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Moleirinho S, 2012, ONCOGENE; Morrogh M, 2012, BREAST CANCER RES TR, V132, P641, DOI 10.1007/s10549-011-1860-0; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pennacchio LA, 2003, J CLIN INVEST, V111, P1099, DOI 10.1172/JCI200317842; Pulaski B.A., 2001, CURR PROTOC IMMUNOL, V20; Ravnan MC, 2011, FORMULARY; Rennstam K, 2003, CANCER RES, V63, P8861; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Soikkeli J, 2010, AM J PATHOL, V177, P387, DOI 10.2353/ajpath.2010.090748; Thomassen M, 2007, CLIN CANCER RES, V13, P5355, DOI 10.1158/1078-0432.CCR-07-0249; van Agthoven T, 2009, BRIT J CANCER, V101, P1824, DOI 10.1038/sj.bjc.6605423; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Yamamoto S IM, 2012, BREAST CANC; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5	47	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56195	10.1371/journal.pone.0056195	http://dx.doi.org/10.1371/journal.pone.0056195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441166	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200023
J	Christians, JK; de Zwaan, DR; Fung, SHY				Christians, Julian Kenneth; de Zwaan, Devin Rhys; Fung, Sunny Ho Yeung			Pregnancy Associated Plasma Protein A2 (PAPP-A2) Affects Bone Size and Shape and Contributes to Natural Variation in Postnatal Growth in Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; FACTOR-BINDING-PROTEIN; MANDIBLE SHAPE; EXPRESSION; GENE; POLYMORPHISM; PROTEOLYSIS; RODENTIA; PAPPA2; LIFE	Pregnancy associated plasma protein A2 (PAPP-A2) is a protease of insulin-like growth factor binding protein 5 and is receiving increasing attention for its roles in pregnancy and postnatal growth. The goals of the present study were to characterize the effects of PAPP-A2 deletion on bone size and shape in mice at 10 weeks of age, and to determine whether Pappa2 is the gene responsible for a previously-identified quantitative trait locus (QTL) contributing to natural variation in postnatal growth in mice. Mice homozygous for constitutive PAPP-A2 deletion were lighter than wild-type littermates, and had smaller mandible dimensions and shorter skull, humerus, femur, tibia, pelvic girdle, and tail bone. Furthermore, PAPP-A2 deletion reduced mandible dimensions and the lengths of the skull, femur, pelvic girdle, and tail bone more than would be expected due to the effect on body mass. In addition to its effects on bone size, PAPP-A2 deficiency also altered the shape of the mandible and pelvic girdle, as assessed by geometric morphometrics. Mice homozygous for the PAPP-A2 deletion had less deep mandibles, and pelvic girdles with a more feminine shape. Using a quantitative complementation test, we confirmed that Pappa2 is responsible for the effects of the previously-identified QTL, demonstrating that natural variation in the Pappa2 gene contributes to variation in postnatal growth in mice. If similar functional variation in the Pappa2 gene exists in other species, effects of this variation on the shape of the pelvic girdle might explain the previously-reported associations between Pappa2 SNPs and developmental dysplasia of the hip in humans, and birthing in cattle.	[Christians, Julian Kenneth; de Zwaan, Devin Rhys; Fung, Sunny Ho Yeung] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Christians, JK (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	julian_christians@sfu.ca	Christians, J.K./AAL-2547-2020; de Zwaan, Devin R/L-4628-2016	Christians, J.K./0000-0003-1797-0591; de Zwaan, Devin R/0000-0001-5418-0754	Natural Sciences and Engineering Research Council (NSERC) [326791-11]; Simon Fraser University; Simon Fraser University President's Research Grant; NSERC	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University; Simon Fraser University President's Research Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council (NSERC) operating grant (326791-11), start-up funds from Simon Fraser University and a Simon Fraser University President's Research Grant to JKC and by a NSERC undergraduate student research award (USRA) to DRDZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 2011, BIOL J LINN SOC, V102, P828, DOI 10.1111/j.1095-8312.2011.01622.x; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Chen BK, 2003, J CLIN ENDOCR METAB, V88, P4465, DOI 10.1210/jc.2003-030193; Cheverud JM, 2010, J LIPID RES, V51, P907, DOI 10.1194/jlr.M900128; Christians JK, 2005, CURR BIOL, V15, pR19, DOI 10.1016/j.cub.2004.12.013; Christians JK, 2004, MAMM GENOME, V15, P482, DOI 10.1007/s00335-004-3046-0; Christians JK, 2003, MAMM GENOME, V14, P175, DOI 10.1007/s00335-002-3041-2; Christians JK, 2007, MAMM GENOME, V18, P240, DOI 10.1007/s00335-007-9018-4; Christians JK, 2006, GENETICS, V173, P1547, DOI 10.1534/genetics.106.057513; Christians JK, 2010, PRENATAL DIAG, V30, P815, DOI 10.1002/pd.2583; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x; Conover CA, 2011, ENDOCRINOLOGY, V152, P2837, DOI 10.1210/en.2011-0036; Govoni KE, 2005, PEDIATR NEPHROL, V20, P261, DOI 10.1007/s00467-004-1658-y; Jia JY, 2012, OSTEOARTHR CARTILAGE, V20, P60, DOI 10.1016/j.joca.2011.10.004; Kaski JC, 2006, EUR HEART J, V27, P1637, DOI 10.1093/eurheartj/ehl118; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Luna-Nevarez P, 2011, J ANIM SCI, V89, P926, DOI 10.2527/jas.2010-3483; Luna-Nevarez P, 2012, REV MEX CIENC PECU, V3, P185; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; Renaud S, 2003, J BIOGEOGR, V30, P1617, DOI 10.1046/j.1365-2699.2003.00932.x; Schutz H, 2009, J MORPHOL, V270, P834, DOI 10.1002/jmor.10723; Tanner SJ, 2008, J BONE MINER RES, V23, P655, DOI 10.1359/JBMR.071210; Wagner PK, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-90; Wang J, 2009, J ENDOCRINOL, V202, P337, DOI 10.1677/JOE-09-0136; Wickramasinghe S, 2011, J DAIRY SCI, V94, P1552, DOI 10.3168/jds.2010-3237; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yan XL, 2010, J CLIN ENDOCR METAB, V95, P1412, DOI 10.1210/jc.2009-2277	30	38	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56260	10.1371/journal.pone.0056260	http://dx.doi.org/10.1371/journal.pone.0056260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457539	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700035
J	Parravicini, F; Natalello, A; Papaleo, E; De Gioia, L; Doglia, SM; Lotti, M; Brocca, S				Parravicini, Federica; Natalello, Antonino; Papaleo, Elena; De Gioia, Luca; Doglia, Silvia Maria; Lotti, Marina; Brocca, Stefania			Reciprocal Influence of Protein Domains in the Cold-Adapted Acyl Aminoacyl Peptidase from Sporosarcina psychrophila	PLOS ONE			English	Article							AEROPYRUM-PERNIX K1; TRANSFORM INFRARED-SPECTROSCOPY; PROLYL OLIGOPEPTIDASE; ACYLPEPTIDE HYDROLASE; ACYLAMINOACYL PEPTIDASE; STRUCTURE PREDICTION; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; BETA-PROPELLERS; SERVER	Acyl aminoacyl peptidases are two-domain proteins composed by a C-terminal catalytic alpha/beta-hydrolase domain and by an N-terminal beta-propeller domain connected through a structural element that is at the N-terminus in sequence but participates in the 3D structure of the C-domain. We investigated about the structural and functional interplay between the two domains and the bridge structure (in this case a single helix named alpha 1-helix) in the cold-adapted enzyme from Sporosarcina psychrophila (SpAAP) using both protein variants in which entire domains were deleted and proteins carrying substitutions in the alpha 1-helix. We found that in this enzyme the inter-domain connection dramatically affects the stability of both the whole enzyme and the beta-propeller. The alpha 1-helix is required for the stability of the intact protein, as in other enzymes of the same family; however in this psychrophilic enzyme only, it destabilizes the isolated beta-propeller. A single charged residue (E10) in the alpha 1-helix plays a major role for the stability of the whole structure. Overall, a strict interaction of the SpAAP domains seems to be mandatory for the preservation of their reciprocal structural integrity and may witness their co-evolution.	[Parravicini, Federica; Natalello, Antonino; Papaleo, Elena; De Gioia, Luca; Doglia, Silvia Maria; Lotti, Marina; Brocca, Stefania] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Milano-Bicocca	Lotti, M (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	marina.lotti@unimib.it; stefania.brocca@unimib.it	Papaleo, Elena/M-6629-2014; Natalello, Antonino/B-9659-2012; Brocca, Stefania/AAE-1299-2021; Lotti, Marina/AAU-1630-2020; De Gioia, Luca/K-6439-2016	Papaleo, Elena/0000-0002-7376-5894; Natalello, Antonino/0000-0002-1489-272X; Lotti, Marina/0000-0001-5419-7572; , Elena/0000-0003-2296-898X; BROCCA, STEFANIA/0000-0001-7256-4436	University of Milano-Bicocca (Fondo di Ateneo); CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant	University of Milano-Bicocca (Fondo di Ateneo); CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant	This work was partly supported by grants of the University of Milano-Bicocca (Fondo di Ateneo) to SB, ML, LDG, SMD. This research was also supported by CASPUR (Consorzio Interuniversitario per le Applicazioni di Supercalcolo per Universita e Ricerca) Standard HPC Grant 2011 and 2012 to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Brunialti EAS, 2011, BIOCHIMIE, V93, P1543, DOI 10.1016/j.biochi.2011.05.010; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gogliettino M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037921; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Ishikawa K, 1998, J BIOL CHEM, V273, P17726, DOI 10.1074/jbc.273.28.17726; Juhasz T, 2005, J MOL BIOL, V346, P907, DOI 10.1016/j.jmb.2004.12.014; Kaushik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026251; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Liu C, 2011, PROTEIN CELL, V2, P497, DOI 10.1007/s13238-011-1057-7; Matsumura I, 2005, BIOMOL ENG, V22, P73, DOI 10.1016/j.bioeng.2004.10.004; Natalello A, 2005, BIOCHEM J, V385, P511, DOI 10.1042/BJ20041296; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Papaleo E, 2012, J MOL GRAPH IN PRESS; Papaleo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035686; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; POLGAR L, 1992, FEBS LETT, V311, P281, DOI 10.1016/0014-5793(92)81120-B; RAWLINGS ND, 1991, BIOCHEM J, V279, P907, DOI 10.1042/bj2790907; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; SHARMA KK, 1993, EUR J BIOCHEM, V216, P631, DOI 10.1111/j.1432-1033.1993.tb18183.x; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Szeltner Z, 2009, BBA-PROTEINS PROTEOM, V1794, P1204, DOI 10.1016/j.bbapap.2009.03.004; Van Elzen R, 2011, CNS NEUROL DISORD-DR, V10, P297, DOI 10.2174/187152711794653814; Wang QY, 2006, J BIOL CHEM, V281, P18618, DOI 10.1074/jbc.M601015200; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yang GY, 2009, BBA-PROTEINS PROTEOM, V1794, P94, DOI 10.1016/j.bbapap.2008.09.007; Zhang HF, 2005, ACTA BIOCH BIOPH SIN, V37, P613, DOI 10.1111/j.1745-7270.2005.00085.x; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	49	11	11	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56254	10.1371/journal.pone.0056254	http://dx.doi.org/10.1371/journal.pone.0056254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457536	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700033
J	Shao, DC; Liu, J; Ni, J; Wang, Z; Shen, Y; Zhou, L; Huang, Y; Wang, J; Xue, H; Zhang, W; Lu, LM				Shao, Decui; Liu, Jia; Ni, Jun; Wang, Zhen; Shen, Yang; Zhou, Li; Huang, Yu; Wang, Jun; Xue, Hong; Zhang, Wei; Lu, Limin			Suppression of XBP1S Mediates High Glucose-Induced Oxidative Stress and Extracellular Matrix Synthesis in Renal Mesangial Cell and Kidney of Diabetic Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NADPH OXIDASE; ANGIOTENSIN-II; ER STRESS; MESENCHYMAL TRANSITION; NAD(P)H OXIDASE; NEPHROPATHY; PATHWAY; XBP-1; PROLIFERATION	Recent evidences suggest that endoplasmic reticulum (ER) stress was involved in multi pathological conditions, including diabetic nephropathy (DN). X-box binding protein 1(XBP1), as a key mediator of ER stress, has been proved having the capability of preventing oxidative stress. In this study, we investigated the effects of spliced XBP1 (XBP1S), the dominant active form of XBP1, on high glucose (HG)-induced reactive oxygen species (ROS) production and extracellular matrix (ECM) synthesis in cultured renal mesangial cells (MCs) and renal cortex of STZ-induced diabetic rats. Real time PCR and Western blot were used to evaluate the mRNA and protein levels respectively. Transfection of recombinant adenovirus vector carrying XBP1S gene (Ad-XBP1S) was used to upregulate XBP1S expression. XBP1S siRNA was used to knockdown XBP1S expression. ROS level was detected by dihydroethidium (DHE) fluorescent probe assay. The results showed that HG treatment significantly reduced XBP1S protein and mRNA level in the cultured MCs while no obvious change was observed in unspliced XBP1 (XBP1U). In the mean time, the ROS production, collagen IV and fibronectin expressions were increased. Diphenylene-chloride iodonium (DPI), a NADPH oxidase inhibtor, prevented HG-induced increases in ROS as well as collagen IV and fibronectin expressions. Transfection of Ad-XBP1S reversed HG-induced ROS production and ECM expressions. Knockdown intrinsic XBP1S expression induced increases in ROS production and ECM expressions. Supplementation of supreoxide reversed the inhibitory effect of Ad-XBP1S transfection on ECM synthesis. P47phox was increased in HG-treated MCs. Ad-XBP1S transfection reversed HG-induced p47phox increase while XBP1S knockdown upregulated p47phox expression. In the renal cortex of diabetic rats, the expression of XBP1S was reduced while p47phox, collagen IV and fibronectin expression were elevated. These results suggested that XBP1S pathway of ER stress was involved in HG-induced oxidative stress and ECM synthesis. A downstream target of XBP1S in regulating ROS formation might be NADPH oxidase.	[Shao, Decui; Liu, Jia; Ni, Jun; Wang, Zhen; Shen, Yang; Zhou, Li; Xue, Hong; Zhang, Wei; Lu, Limin] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Jun] Fudan Univ, Dept Integrat Med, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, Yu] Chinese Univ Hong Kong, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Lu, LM (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	lulimin@shmu.edu.cn	Huang, Yu/K-2866-2017	Huang, Yu/0000-0002-1277-6784; SHEN, YANG/0000-0002-2448-8405	Natural Science Foundation of China [81070577, 81170636, 8110053]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Natural Science Foundation of China (No. 81070577, 81170636) to LL and (No. 81100531) to ZW (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; ADLER S, 1994, J AM SOC NEPHROL, V5, P1165; Asaba K, 2005, KIDNEY INT, V67, P1890, DOI 10.1111/j.1523-1755.2005.00287.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chandy A, 2008, SAUDI J KIDNEY DIS T, V19, P924; Chen JC, 2012, MOL CELL BIOL, V32, P981, DOI 10.1128/MCB.06410-11; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; El Nahas AM, 2003, KIDNEY INT, V64, P1553, DOI 10.1046/j.1523-1755.2003.00255.x; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Geoffroy K, 2005, FEBS LETT, V579, P1249, DOI 10.1016/j.febslet.2004.12.094; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Jaimes EA, 2010, AM J PHYSIOL-RENAL, V298, pF125, DOI 10.1152/ajprenal.00248.2009; Jeong SI, 2012, FOOD CHEM TOXICOL, V50, P1045, DOI 10.1016/j.fct.2011.11.028; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Li XJ, 2010, J BIOL CHEM, V285, P35169, DOI 10.1074/jbc.M110.164475; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu GC, 2012, DIABETOLOGIA; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Nam SM, 2009, DIABETES RES CLIN PR, V83, P176, DOI 10.1016/j.diabres.2008.10.007; Reimold AM, 2000, GENE DEV, V14, P152; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Shinya S, 2011, NUCLEIC ACIDS RES, V39, P5245, DOI 10.1093/nar/gkr132; Sims-Robinson C, 2012, DIABETOLOGIA, V55, P2276, DOI 10.1007/s00125-012-2573-6; Stegbauer J, 2011, BRIT J PHARMACOL, V163, P974, DOI 10.1111/j.1476-5381.2011.01295.x; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Titan SM, 2011, CLIN NEPHROL, V76, P273, DOI 10.5414/CN107013; Tojo A, 2007, EXPERT OPIN THER TAR, V11, P1011, DOI 10.1517/14728222.11.8.1011; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Xue H, 2012, REGUL PEPTIDES, V177, P12, DOI 10.1016/j.regpep.2012.04.002; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yu HY, 2005, MED CHEM, V1, P461, DOI 10.2174/1573406054864052; Zhang JY, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-25; Zhang LY, 2012, INT J BIOCHEM CELL B, V44, P629, DOI 10.1016/j.biocel.2012.01.001; Zhong YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038616; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	41	26	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56124	10.1371/journal.pone.0056124	http://dx.doi.org/10.1371/journal.pone.0056124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457509	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000315602700045
J	Syfert, MM; Smith, MJ; Coomes, DA				Syfert, Mindy M.; Smith, Matthew J.; Coomes, David A.			The Effects of Sampling Bias and Model Complexity on the Predictive Performance of MaxEnt Species Distribution Models	PLOS ONE			English	Article							PSEUDO-ABSENCES; TREE FERNS; CLIMATE; CONSERVATION; SIZE; EVAPOTRANSPIRATION; INFORMATION; PATTERNS; IMPACTS; ERRORS	Species distribution models (SDMs) trained on presence-only data are frequently used in ecological research and conservation planning. However, users of SDM software are faced with a variety of options, and it is not always obvious how selecting one option over another will affect model performance. Working with MaxEnt software and with tree fern presence data from New Zealand, we assessed whether (a) choosing to correct for geographical sampling bias and (b) using complex environmental response curves have strong effects on goodness of fit. SDMs were trained on tree fern data, obtained from an online biodiversity data portal, with two sources that differed in size and geographical sampling bias: a small, widely-distributed set of herbarium specimens and a large, spatially clustered set of ecological survey records. We attempted to correct for geographical sampling bias by incorporating sampling bias grids in the SDMs, created from all georeferenced vascular plants in the datasets, and explored model complexity issues by fitting a wide variety of environmental response curves (known as "feature types" in MaxEnt). In each case, goodness of fit was assessed by comparing predicted range maps with tree fern presences and absences using an independent national dataset to validate the SDMs. We found that correcting for geographical sampling bias led to major improvements in goodness of fit, but did not entirely resolve the problem: predictions made with clustered ecological data were inferior to those made with the herbarium dataset, even after sampling bias correction. We also found that the choice of feature type had negligible effects on predictive performance, indicating that simple feature types may be sufficient once sampling bias is accounted for. Our study emphasizes the importance of reducing geographical sampling bias, where possible, in datasets used to train SDMs, and the effectiveness and essentialness of sampling bias correction within MaxEnt.	[Syfert, Mindy M.; Coomes, David A.] Univ Cambridge, Dept Plant Sci, Forest Ecol & Conservat Grp, Cambridge, England; [Syfert, Mindy M.; Smith, Matthew J.] Microsoft Res, Sci Computat Lab, Computat Ecol & Environm Sci Grp, Cambridge, England	University of Cambridge; Microsoft	Syfert, MM (corresponding author), Univ Cambridge, Dept Plant Sci, Forest Ecol & Conservat Grp, Cambridge, England.	mmsyfert@gmail.com; matthew.smith@microsoft.com; dac18@cam.ac.uk		Coomes, David/0000-0002-8261-2582; Smith, Matthew/0000-0002-5401-1763	Microsoft Research through its PhD Scholarship Programme	Microsoft Research through its PhD Scholarship Programme(Microsoft)	This work was supported by Microsoft Research through its PhD Scholarship Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Brummitt Neil, 2008, Endangered Species Research, V6, P127, DOI 10.3354/esr00135; Bystriakova N, 2008, ECOLOGY BIOGEOGRAPHY; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Coomes DA, 2002, FOREST ECOL MANAG, V164, P89, DOI 10.1016/S0378-1127(01)00592-8; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FRANK DA, 1994, J BIOGEOGR, V21, P401, DOI 10.2307/2845758; Franklin J, 2009, MAPPING SPECIES DIST; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Korall P, 2007, AM J BOT, V94, P873, DOI 10.3732/ajb.94.5.873; Korall P, 2006, MOL PHYLOGENET EVOL, V39, P830, DOI 10.1016/j.ympev.2006.01.001; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2217, DOI 10.1023/A:1021398729516; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Newbold T, 2009, BIODIVERS CONSERV, V18, P3629, DOI 10.1007/s10531-009-9668-5; Payton IJ, 2004, NZ CARBON MONITORING; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Richardson SJ, 2009, FOREST ECOL MANAG, V258, P2456, DOI 10.1016/j.foreco.2009.08.022; Rivers MC, 2011, BIOL CONSERV, V144, P2541, DOI 10.1016/j.biocon.2011.07.014; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; Stephenson NL, 2000, 0062 US GEOL SURV; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Trabucco A., 2010, GLOBAL HIGH RESOLUTI; Trabucco A, 2009, CGIAR CONSORT SPATIA; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wiser SK, 2001, NEW ZEAL J ECOL, V25, P1; Wiser SK, 2011, APPL VEG SCI, V14, P506, DOI 10.1111/j.1654-109X.2011.01146.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; Yackulic CB, 2012, METHODS ECOLOGY EVOL; Yates CJ, 2010, DIVERS DISTRIB, V16, P187, DOI 10.1111/j.1472-4642.2009.00623.x; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	60	373	383	15	268	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55158	10.1371/journal.pone.0055158	http://dx.doi.org/10.1371/journal.pone.0055158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457462	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700014
J	Taylor, KM; Meyers, E; Phipps, M; Kishnani, PS; Cheng, SH; Scheule, RK; Moreland, RJ				Taylor, Kristin M.; Meyers, Elizabeth; Phipps, Michael; Kishnani, Priya S.; Cheng, Seng H.; Scheule, Ronald K.; Moreland, Rodney J.			Dysregulation of Multiple Facets of Glycogen Metabolism in a Murine Model of Pompe Disease	PLOS ONE			English	Article							SKELETAL-MUSCLE; SUPPRESSION; MICE; AUTOPHAGY; THERAPY; ENZYME	Pompe disease, also known as glycogen storage disease (GSD) type II, is caused by deficiency of lysosomal acid alpha-glucosidase (GAA). The resulting glycogen accumulation causes a spectrum of disease severity ranging from a rapidly progressive course that is typically fatal by 1 to 2 years of age to a slower progressive course that causes significant morbidity and early mortality in children and adults. The aim of this study is to better understand the biochemical consequences of glycogen accumulation in the Pompe mouse. We evaluated glycogen metabolism in heart, triceps, quadriceps, and liver from wild type and several strains of GAA(-/-) mice. Unexpectedly, we observed that lysosomal glycogen storage correlated with a robust increase in factors that normally promote glycogen biosynthesis. The GAA(-/-) mouse strains were found to have elevated glycogen synthase (GS), glycogenin, hexokinase, and glucose-6-phosphate (G-6-P, the allosteric activator of GS). Treating GAA(-/-) mice with recombinant human GAA (rhGAA) led to a dramatic reduction in the levels of glycogen, GS, glycogenin, and G-6-P. Lysosomal glycogen storage also correlated with a dysregulation of phosphorylase, which normally breaks down cytoplasmic glycogen. Analysis of phosphorylase activity confirmed a previous report that, although phosphorylase protein levels are identical in muscle lysates from wild type and GAA(-/-) mice, phosphorylase activity is suppressed in the GAA(-/-) mice in the absence of AMP. This reduction in phosphorylase activity likely exacerbates lysosomal glycogen accumulation. If the dysregulation in glycogen metabolism observed in the mouse model of Pompe disease also occurs in Pompe patients, it may contribute to the observed broad spectrum of disease severity.	[Taylor, Kristin M.; Meyers, Elizabeth; Phipps, Michael; Cheng, Seng H.; Scheule, Ronald K.; Moreland, Rodney J.] Genzyme Corp, Framingham, MA 01701 USA; [Kishnani, Priya S.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27706 USA	Sanofi-Aventis; Genzyme Corporation; Duke University	Moreland, RJ (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	Rod.Moreland@genzyme.com	Cheng, Seng H/AAC-6564-2022		Genzyme; Duke University Medical Center; Sanofi Company	Genzyme(Sanofi-AventisGenzyme Corporation); Duke University Medical Center; Sanofi Company	No current external funding sources for this study. Support for these studies was provided by Genzyme, a Sanofi Company, through the employment of Kristin M. Taylor, Elizabeth Meyers, Michael Phipps, Seng H. Cheng, Ronald K. Scheule, and Rodney J. Moreland. Support for Priya S. Kishnani was provided by Duke University Medical Center. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; Kristin M. Taylor, Elizabeth Meyers, Michael Phipps, Seng H. Cheng, Ronald K. Scheule, and Rodney J. Moreland are all employees of Genzyme, a Sanofi Company, who funded this study. The described studies were part of the drug development program at Genzyme Corporation. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], [No title captured]; Ashe KM, 2010, MOL GENET METAB, V100, P309, DOI 10.1016/j.ymgme.2010.05.001; Douillard-Guilloux G, 2010, HUM MOL GENET, V19, P684, DOI 10.1093/hmg/ddp535; Douillard-Guilloux G, 2008, HUM MOL GENET, V17, P3876, DOI 10.1093/hmg/ddn290; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Kroos MA, 2007, NEUROLOGY, V68, P110, DOI 10.1212/01.wnl.0000252798.25690.76; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Niederwanger A, 2005, J CHROMATOGR B, V820, P143, DOI 10.1016/j.jchromb.2005.02.019; Orth M, 2003, NEUROMUSCULAR DISORD, V13, P49, DOI 10.1016/S0960-8966(02)00186-4; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2010, AUTOPHAGY, V6, P1078, DOI 10.4161/auto.6.8.13378; Schliselfeld LH, 2002, BIOCHEM BIOPH RES CO, V290, P874, DOI 10.1006/bbrc.2001.6292	15	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56181	10.1371/journal.pone.0056181	http://dx.doi.org/10.1371/journal.pone.0056181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457523	Green Submitted, gold, Green Published			2022-12-27	WOS:000315602700057
J	Rivera, MF; Lee, JY; Aneja, M; Goswami, V; Liu, LY; Velsko, IM; Chukkapalli, SS; Bhattacharyya, I; Chen, H; Lucas, AR; Kesavalu, LN				Rivera, Mercedes F.; Lee, Ju-Youn; Aneja, Monika; Goswami, Vishalkant; Liu, Liying; Velsko, Irina M.; Chukkapalli, Sasanka S.; Bhattacharyya, Indraneel; Chen, Hao; Lucas, Alexandra R.; Kesavalu, Lakshmyya N.			Polymicrobial Infection with Major Periodontal Pathogens Induced Periodontal Disease and Aortic Atherosclerosis in Hyperlipidemic ApoE(null) Mice	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SITU HYBRIDIZATION FISH; CORONARY-HEART-DISEASE; FUSOBACTERIUM-NUCLEATUM; CARDIOVASCULAR-DISEASE; DIRECT VISUALIZATION; TREPONEMA-DENTICOLA; ORAL INFECTION; MESSENGER-RNA; RAT MODEL	Periodontal disease (PD) and atherosclerosis are both polymicrobial and multifactorial and although observational studies supported the association, the causative relationship between these two diseases is not yet established. Polymicrobial infection-induced periodontal disease is postulated to accelerate atherosclerotic plaque growth by enhancing atherosclerotic risk factors of orally infected Apolipoprotein E deficient (ApoE(null)) mice. At 16 weeks of infection, samples of blood, mandible, maxilla, aorta, heart, spleen, and liver were collected, analyzed for bacterial genomic DNA, immune response, inflammation, alveolar bone loss, serum inflammatory marker, atherosclerosis risk factors, and aortic atherosclerosis. PCR analysis of polymicrobial-infected (Porphyromonas gingivalis [P. gingivalis], Treponema denticola [T. denticola], and Tannerella forsythia [T. forsythia]) mice resulted in detection of bacterial genomic DNA in oral plaque samples indicating colonization of the oral cavity by all three species. Fluorescent in situ hybridization detected P. gingivalis and T. denticola within gingival tissues of infected mice and morphometric analysis showed an increase in palatal alveolar bone loss (p<0.0001) and intrabony defects suggesting development of periodontal disease in this model. Polymicrobial-infected mice also showed an increase in aortic plaque area (p<0.05) with macrophage accumulation, enhanced serum amyloid A, and increased serum cholesterol and triglycerides. A systemic infection was indicated by the detection of bacterial genomic DNA in the aorta and liver of infected mice and elevated levels of bacterial specific IgG antibodies (p<0.0001). This study was a unique effort to understand the effects of a polymicrobial infection with P. gingivalis, T. denticola and T. forsythia on periodontal disease and associated atherosclerosis in ApoE(null) mice.	[Rivera, Mercedes F.; Lee, Ju-Youn; Aneja, Monika; Goswami, Vishalkant; Velsko, Irina M.; Chukkapalli, Sasanka S.; Kesavalu, Lakshmyya N.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32610 USA; [Kesavalu, Lakshmyya N.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Liu, Liying; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, Gainesville, FL USA; [Liu, Liying; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Div Cardiovasc Med, Gainesville, FL USA; [Bhattacharyya, Indraneel] Univ Florida, Coll Dent, Dept Oral Diagnost Sci, Gainesville, FL USA; [Lee, Ju-Youn] Pusan Natl Univ, Sch Dent, Dept Periodontol, Yangsan, Gyeongsangnam D, South Korea	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pusan National University; Pusan National University Hospital	Kesavalu, LN (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32610 USA.	Kesavalu@dental.ufl.edu	Bhattacharyya, Indraneel/U-7752-2019	LEE, JUYOUN/0000-0002-0772-033X; Bhattacharyya, Indraneel/0000-0002-0334-9051; Chen, Hao/0000-0003-0018-480X	NIH NIDCR [RO1 DE020820]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER	NIH NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by NIH NIDCR RO1 DE020820 to Kesavalu Lakshmyya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz K, 2012, MOL MED; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bartee MY, 2009, METHOD ENZYMOL, V460, P209, DOI 10.1016/S0076-6879(09)05210-0; Brodala N, 2005, ARTERIOSCL THROM VAS, V25, P1446, DOI 10.1161/01.ATV.0000167525.69400.9c; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kolenbrander PE, 2011, INT J ORAL SCI, V3, P49, DOI 10.4248/IJOS11025; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3204, DOI 10.1128/IAI.57.10.3204-3209.1989; KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4584, DOI 10.1128/IAI.63.12.4584-4588.1995; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kumon Y, 1999, J RHEUMATOL, V26, P785; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Liu D, 2004, TRANSPLANTATION, V77, P1652, DOI 10.1097/01.TP.0000131173.52424.84; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Lockhart PB, 2012, CIRCULATION; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Manz W, 1999, METHOD ENZYMOL, V310, P79; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Miyamoto M, 2006, INFECT IMMUN, V74, P2462, DOI 10.1128/IAI.74.4.2462-2467.2006; Miyamoto T, 2006, INFECT IMMUN, V74, P1376, DOI 10.1128/IAI.74.2.1376-1380.2006; Mkonyi LE, 2012, AM J PATHOL, V181, P907, DOI 10.1016/j.ajpath.2012.05.027; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Nahid MA, 2011, INFECT IMMUN, V79, P1597, DOI 10.1128/IAI.01062-10; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nonnenmacher C, 2007, J PERIODONTOL, V78, P1724, DOI 10.1902/jop.2007.060345; Okuda K, 2001, J CLIN MICROBIOL, V39, P1114, DOI 10.1128/JCM.39.3.1114-1117.2001; OTT K, 1982, DEUT ZAHNAERZTL Z, V37, P634; Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x; Rudney JD, 2005, J DENT RES, V84, P1165, DOI 10.1177/154405910508401214; Saadi-Thiers K, 2012, J PERIODONTOL; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Verma RK, 2010, INTERDISCIP PERSPECT, V2010, DOI DOI 10.1155/2010/605125; Yamazaki M, 2007, AM J PHYSIOL-HEART C, V292, pH539, DOI 10.1152/ajpheart.00640.2006; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x	55	59	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57178	10.1371/journal.pone.0057178	http://dx.doi.org/10.1371/journal.pone.0057178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451182	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500076
J	van Steenbeek, FG; Van den Bossche, L; Grinwis, GCM; Kummeling, A; van Gils, IHM; Koerkamp, MJAG; van Leenen, D; Holstege, FCP; Penning, LC; Rothuizen, J; Leegwater, PAJ; Spee, B				van Steenbeek, Frank G.; Van den Bossche, Lindsay; Grinwis, Guy C. M.; Kummeling, Anne; van Gils, Ingrid H. M.; Koerkamp, Marian J. A. Groot; van Leenen, Dik; Holstege, Frank C. P.; Penning, Louis C.; Rothuizen, Jan; Leegwater, Peter A. J.; Spee, Bart			Aberrant Gene Expression in Dogs with Portosystemic Shunts	PLOS ONE			English	Article							IRISH WOLFHOUNDS; DUCTUS-ARTERIOSUS; OXYGEN-SATURATION; LIVER-DISEASE; CATS; DIAGNOSIS; ANATOMY; BIRTH; INHERITANCE; PREDICTION	Congenital portosystemic shunts are developmental anomalies of the splanchnic vascular system that cause portal blood to bypass the liver. Large-breed dogs are predisposed for intrahepatic portosystemic shunts (IHPSS) and small-breed dogs for extrahepatic portosystemic shunts (EHPSS). While the phenotype resulting from portal bypass of the liver of the two types of shunt is identical, the genotype and molecular pathways involved are probably different. The aim of this study was to gain insight into the pathways involved in the different types of portosystemic shunting. Microarray analysis of mRNA expression in liver tissue from dogs with EHPSS and IHPSS revealed that the expression of 26 genes was altered in either IHPSS or EHPSS samples compared with that in liver samples from control dogs. Quantitative real-time PCR of these genes in 14 IHPSS, 17 EHPSS, and 8 control liver samples revealed a significant differential expression of ACBP, CCBL1, GPC3, HAMP, PALLD, VCAM1, and WEE1. Immunohistochemistry and Western blotting confirmed an increased expression of VCAM1 in IHPSS but its absence in EHPSS, an increased WEE1 expression in IHPSS but not in EHPSS, and a decreased expression of CCBL1 in both shunt types. Regarding their physiologic functions, these findings may indicate a causative role for VCAM1 in IHPSS and WEE1 for IHPSS. CCBL1 could be an interesting candidate to study not yet elucidated aspects in the pathophysiology of hepatic encephalopathy.	[van Steenbeek, Frank G.; Van den Bossche, Lindsay; Kummeling, Anne; van Gils, Ingrid H. M.; Penning, Louis C.; Rothuizen, Jan; Leegwater, Peter A. J.; Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; van Leenen, Dik; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	van Steenbeek, FG (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	f.g.vansteenbeek@uu.nl	Holstege, Frank/AAM-9944-2021; Kummeling, Anne/GNW-3198-2022; van Steenbeek, F.G./AFL-0046-2022; Penning, Louis/AAC-7524-2019; Fiumefreddo, Andrea/T-2977-2019	van Steenbeek, F.G./0000-0001-5460-6540; Leegwater, Peter/0000-0002-4100-015X; Grinwis, Guy/0000-0002-1583-9648; Groot Koerkamp, Marian JA/0000-0002-0867-0821	European Commission [LUPA-GA-201370]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was partly funded by the European Commission (LUPA-GA-201370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Caretti E, 2008, J CELL BIOCHEM, V103, P556, DOI 10.1002/jcb.21426; Coceani F, 2012, SEMIN PERINATOL, V36, P92, DOI 10.1053/j.semperi.2011.09.018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Hong KS, 2011, EXPT MOL MED; Hunt GB, 2004, AUST VET J, V82, P746, DOI 10.1111/j.1751-0813.2004.tb13233.x; Ijzer J, 2010, VET J, V184, P308, DOI 10.1016/j.tvjl.2009.02.016; Kamlin COF, 2006, J PEDIATR-US, V148, P585, DOI 10.1016/j.jpeds.2005.12.050; Lamb CR, 1998, VET REC, V142, P55, DOI 10.1136/vr.142.3.55; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Mariani G, 2007, J PEDIATR-US, V150, P418, DOI 10.1016/j.jpeds.2006.12.015; MARTIN RA, 1993, VET CLIN N AM-SMALL, V23, P609, DOI 10.1016/S0195-5616(93)50309-1; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Meyer H P, 1991, Tijdschr Diergeneeskd, V116 Suppl 1, p80S; MEYER HP, 1995, VET REC, V136, P13, DOI 10.1136/vr.136.1.13; PAYNE JT, 1990, SEMIN VET MED SURG, V5, P76; PERRY S, 1995, FEBS LETT, V360, P277, DOI 10.1016/0014-5793(95)00123-Q; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabi Y, 2006, J PEDIATR-US, V148, P590, DOI 10.1016/j.jpeds.2005.12.047; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; ROTHUIZEN J, 1982, RES VET SCI, V33, P22, DOI 10.1016/S0034-5288(18)32353-1; Schotanus BA, 2009, LIVER INT, V29, P1241, DOI 10.1111/j.1478-3231.2009.02024.x; Spee Bart, 2007, Comp Hepatol, V6, P8, DOI 10.1186/1476-5926-6-8; STARLING MB, 1974, PROSTAGLANDINS, V8, P187, DOI 10.1016/0090-6980(74)90042-2; Stringer MD, 2008, CLIN ANAT, V21, P147, DOI 10.1002/ca.20574; TISDALL PLC, 1994, AUST VET J, V71, P174, DOI 10.1111/j.1751-0813.1994.tb03382.x; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; Tobias KM, 2003, J AM ANIM HOSP ASSOC, V39, P385, DOI 10.5326/0390385; Treiber G, 2005, DIGEST DIS, V23, P6, DOI 10.1159/000084720; Ubbink GJ, 1998, AM J VET RES, V59, P1553; Uchino T, 1999, J PEDIATR-US, V135, P254, DOI 10.1016/S0022-3476(99)70031-4; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Steenbeek FG, 2009, J VET INTERN MED, V23, P950, DOI 10.1111/j.1939-1676.2009.0319.x; van Steenbeek FG, 2012, MAMM GENOME, V23, P76, DOI 10.1007/s00335-011-9364-0; van Straten G, 2005, J VET INTERN MED, V19, P321, DOI 10.1892/0891-6640(2005)19[321:ICEPSI]2.0.CO;2; VANDENINGH TSGAM, 1995, VET QUART, V17, P70, DOI 10.1080/01652176.1995.9694536; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VULGAMOTT JC, 1985, VET CLIN N AM-SMALL, V15, P229, DOI 10.1016/S0195-5616(85)50013-3; Winkler JT, 2003, J AM ANIM HOSP ASSOC, V39, P169, DOI 10.5326/0390169; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yokoyama Y, 2007, J HEPATO-BILIARY-PAN, V14, P159, DOI 10.1007/s00534-006-1125-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57662	10.1371/journal.pone.0057662	http://dx.doi.org/10.1371/journal.pone.0057662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451256	Green Published, gold			2022-12-27	WOS:000316849500124
J	Venkatakrishnan, S; Mackey, D; Meier, I				Venkatakrishnan, Sowmya; Mackey, David; Meier, Iris			Functional Investigation of the Plant-Specific Long Coiled-Coil Proteins PAMP-INDUCED COILED-COIL (PICC) and PICC-LIKE (PICL) in Arabidopsis thaliana	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTOR; TAIL-ANCHORED PROTEINS; ABSCISIC-ACID; DEFENSE RESPONSES; SECRETORY PATHWAY; GENE-EXPRESSION; IN-VITRO; MEMBRANE; RESISTANCE; SYSTEM	We have identified and characterized two Arabidopsis long coiled-coil proteins PAMP-INDUCED COILED-COIL (PICC) and PICC-LIKE (PICL). PICC (147 kDa) and PICL (87 kDa) are paralogs that consist predominantly of a long coiled-coil domain (expanded in PICC), with a predicted transmembrane domain at the immediate C-terminus. Orthologs of PICC and PICL were found exclusively in vascular plants. PICC and PICL GFP fusion proteins are anchored to the cytoplasmic surface of the endoplasmic reticulum (ER) membrane by a C-terminal transmembrane domain and a short tail domain, via a tail-anchoring mechanism. T-DNA-insertion mutants of PICC and PICL as well as the double mutant show an increased sensitivity to the plant abiotic stress hormone abscisic acid (ABA) in a post-germination growth response. PICC, but not PICL gene expression is induced by the bacterial pathogen-associated molecular pattern (PAMP) flg22. T-DNA insertion alleles of PICC, but not PICL, show increased susceptibility to the non-virulent strain P. syringae pv. tomato DC3000 hrcC, but not to the virulent strain P. syringae pv. tomato DC3000. This suggests that PICC mutants are compromised in PAMP-triggered immunity (PTI). The data presented here provide first evidence for the involvement of a plant long coiled-coil protein in a plant defense response.	[Venkatakrishnan, Sowmya; Mackey, David; Meier, Iris] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Mackey, David] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Meier, I (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12Th Ave, Columbus, OH 43210 USA.	meier.56@osu.edu			National Science Foundation [NSF-MCB-0641271]	National Science Foundation(National Science Foundation (NSF))	This work has been funded by a grant from the National Science Foundation (NSF-MCB-0641271; http://www.nsf.gov/div/index.jsp?div=MCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2011, PLANT CELL REP, V30, P137, DOI 10.1007/s00299-010-0925-6; Afzal AJ, 2011, PLANT CELL, V23, P3798, DOI 10.1105/tpc.111.088708; Agusti J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-127; Aung K, 2011, PLANT CELL, V23, P4446, DOI 10.1105/tpc.111.090142; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Candela H, 1999, DEV BIOL, V205, P205, DOI 10.1006/dbio.1998.9111; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gay PA, 2000, CAN J BOT, V78, P1144, DOI 10.1139/cjb-78-9-1144; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Grunwald I, 2003, PHYSIOL PLANTARUM, V119, P192, DOI 10.1034/j.1399-3054.2003.00202.x; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hugouvieux V, 1998, MOL PLANT MICROBE IN, V11, P537, DOI 10.1094/MPMI.1998.11.6.537; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Iyer K., 2005, SCI STKE SIGNAL TRAN, V2005, pl3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jeong SY, 2003, NUCLEIC ACIDS RES, V31, P5175, DOI 10.1093/nar/gkg693; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kim Min Gab, 2008, V415, P443, DOI 10.1007/978-1-59745-570-1_26; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Kriechbaumer V, 2009, TRAFFIC, V10, P1753, DOI 10.1111/j.1600-0854.2009.00991.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee YRJ, 2004, PLANT PHYSIOL, V136, P3877, DOI 10.1104/pp.104.052621; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Liu CM, 2002, PLANT J, V29, P405, DOI 10.1046/j.1365-313x.2002.01224.x; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MATSUI M, 1995, P NATL ACAD SCI USA, V92, P4239, DOI 10.1073/pnas.92.10.4239; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Passarinho PA, 2001, PLANTA, V212, P556, DOI 10.1007/s004250000464; Pedrazzini E, 2009, J PLANT BIOL, V52, P88, DOI 10.1007/s12374-009-9014-1; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Rose A, 2004, PLANT PHYSIOL, V134, P927, DOI 10.1104/pp.103.035626; Runions J, 2006, J EXP BOT, V57, P43, DOI 10.1093/jxb/eri289; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SAMAC DA, 1991, PLANT CELL, V3, P1063, DOI 10.1105/tpc.3.10.1063; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Sparkes I, 2010, PLANT CELL, V22, P1333, DOI 10.1105/tpc.110.074385; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Underwood W, 2008, J EXP BOT, V59, P3501, DOI 10.1093/jxb/ern205; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang PW, 2011, PLANT J, V66, P613, DOI 10.1111/j.1365-313X.2011.04522.x; Watanabe K, 2009, PLANT CELL, V21, P2688, DOI 10.1105/tpc.108.060525; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu XM, 2007, CURR BIOL, V17, P1157, DOI 10.1016/j.cub.2007.05.076; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhao Q, 2006, PLANT PHYSIOL, V140, P869, DOI 10.1104/pp.105.075499; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	91	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57283	10.1371/journal.pone.0057283	http://dx.doi.org/10.1371/journal.pone.0057283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451199	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500084
J	Wedde, M; Wahlisch, S; Wolff, T; Schweiger, B				Wedde, Marianne; Waehlisch, Stephanie; Wolff, Thorsten; Schweiger, Brunhilde			Predominance of HA-222D/G Polymorphism in Influenza A(H1N1)pdm09 Viruses Associated with Fatal and Severe Outcomes Recently Circulating in Germany	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; RECEPTOR-BINDING; IMMUNE-RESPONSE; SEVERE DISEASE; HEMAGGLUTININ; SUBSTITUTION; ORIGIN; D222G; ERYTHROCYTES	Influenza A(H1N1)pdm09 viruses cause sporadically very severe disease including fatal clinical outcomes associated with pneumonia, viremia and myocarditis. A mutation characterized by the substitution of aspartic acid (wild-type) to glycine at position 222 within the haemagglutinin gene (HA-D222G) was recorded during the 2009 H1N1 pandemic in Germany and other countries with significant frequency in fatal and severe cases. Additionally, A(H1N1)pdm09 viruses exhibiting the polymorphism HA-222D/G/N were detected both in the respiratory tract and in blood. Specimens from mild, fatal and severe cases were collected to study the heterogeneity of HA-222 in A(H1N1)pdm09 viruses circulating in Germany between 2009 and 2011. In order to enable rapid and large scale analysis we designed a pyrosequencing (PSQ) assay. In 2009/2010, the 222D wild-type of A(H1N1)pdm09 viruses predominated in fatal and severe outcomes. Moreover, co-circulating virus mutants exhibiting a D222G or D222E substitution (8/6%) as well as HA-222 quasispecies were identified (10%). Both the 222D/G and the 222D/G/N/V/Y polymorphisms were confirmed by TA cloning. PSQ analyses of viruses associated with mild outcomes revealed mainly the wild-type 222D and no D222G change in both seasons. However, an increase of variants with 222D/G polymorphism (60%) was characteristic for A(H1N1)pdm09 viruses causing fatal and severe cases in the season 2010/2011. Pure 222G viruses were not observed. Our results support the hypothesis that the D222G change may result from adaptation of viral receptor specificity to the lower respiratory tract. This could explain why transmission of the 222G variant is less frequent among humans. Thus, amino acid changes at HA position 222 may be the result of viral intra-host evolution leading to the generation of variants with an altered viral tropism.	[Wedde, Marianne; Waehlisch, Stephanie; Wolff, Thorsten; Schweiger, Brunhilde] Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany	Robert Koch Institute	Wedde, M (corresponding author), Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany.	WeddeM@rki.de						Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Baldanti F, 2011, EURO SURVEILL, V16; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Bratincsak A, 2010, J AM COLL CARDIOL, V55, P928, DOI 10.1016/j.jacc.2010.01.004; Buda S, 2011, INFLUENZA WOCHENBERI; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; CORNACOFF JB, 1983, J CLIN INVEST, V71, P236, DOI 10.1172/JCI110764; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ellis J, 2011, EURO SURVEILL, V16, P19760; European Centre for Disease Prevention and Control, 2009, PAND INFL A H1N1 VIR; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Hua Yang, 2010, CHINA TECHNOLOGY REV, P1, DOI DOI 10.1371/CURRENTS.RRN1152; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Khouzam RN, 2011, HEART LUNG, V40, P566, DOI 10.1016/j.hrtlng.2011.01.004; Kilander A, 2010, EUROSURVEILLANCE, V4, P15; Kilander A, 2010, EURO SURVEILL, V15; Levine M, 2011, J CLIN MICROBIOL, V49, P1307, DOI 10.1128/JCM.02424-10; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; MILLER RR, 2010, EURO SURVEILL, V15; Morera D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-89; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; POWERS JH, 1995, INFECT IMMUN, V63, P1329, DOI 10.1128/IAI.63.4.1329-1335.1995; Puzelli S., 2010, EURO SURVEILL, V15, P19696; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Weinheimer V.K., 2012, J INFECT DI IN PRESS; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P21; World Health Organization, 2009, CLIN MAN HUM INF PAN	39	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57059	10.1371/journal.pone.0057059	http://dx.doi.org/10.1371/journal.pone.0057059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451145	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500058
J	Xie, F; Fu, H; Hou, JF; Jiao, K; Costigan, M; Chen, J				Xie, Fang; Fu, Han; Hou, Jun-Feng; Jiao, Kai; Costigan, Michael; Chen, Jun			High Energy Diets-Induced Metabolic and Prediabetic Painful Polyneuropathy in Rats	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ZUCKER DIABETIC FATTY; KININ B-1 RECEPTOR; BB-WISTAR-RAT; NEUROPATHIC PAIN; INSULIN-RESISTANCE; SENSORY NEUROPATHY; NEUROLOGICAL COMPLICATIONS; PHARMACOLOGICAL MANAGEMENT; PERIPHERAL NEUROPATHY	To establish the role of the metabolic state in the pathogenesis of polyneuropathy, an age- and sex-matched, longitudinal study in rats fed high-fat and high-sucrose diets (HFSD) or high-fat, high-sucrose and high-salt diets (HFSSD) relative to controls was performed. Time courses of body weight, systolic blood pressure, fasting plasma glucose (FPG), insulin, free fatty acids (FFA), homeostasis model assessment-insulin resistance index (HOMA-IR), thermal and mechanical sensitivity and motor coordination were measured in parallel. Finally, large and small myelinated fibers (LMF, SMF) as well as unmyelinated fibers (UMF) in the sciatic nerves and ascending fibers in the spinal dorsal column were quantitatively assessed under electron microscopy. The results showed that early metabolic syndrome (hyperinsulinemia, dyslipidemia, and hypertension) and prediabetic conditions (impaired fasting glucose) could be induced by high energy diet, and these animals later developed painful polyneuropathy characterized by myelin breakdown and LMF loss in both peripheral and central nervous system. In contrast SMF and UMF in the sciatic nerves were changed little, in the same animals. Therefore the phenomenon that high energy diets induce bilateral mechanical, but not thermal, pain hypersensitivity is reflected by severe damage to LMF, but mild damage to SMF and UMF. Moreover, dietary sodium (high-salt) deteriorates the neuropathic pathological process induced by high energy diets, but paradoxically high salt consumption, may reduce, at least temporarily, chronic pain perception in these animals.	[Xie, Fang; Fu, Han; Hou, Jun-Feng; Chen, Jun] Fourth Mil Med Univ, Tangdu Hosp, Inst Biomed Sci Pain, Xian 710032, Peoples R China; [Xie, Fang; Fu, Han; Hou, Jun-Feng; Chen, Jun] Fourth Mil Med Univ, Tangdu Hosp, Inst Funct Brain Disorders, Xian 710032, Peoples R China; [Xie, Fang; Fu, Han; Chen, Jun] PLA, Key Lab Brain Stress & Behav, Xian, Peoples R China; [Hou, Jun-Feng; Jiao, Kai] Fourth Mil Med Univ, Tangdu Hosp, Dept Endocrinol, Xian 710032, Peoples R China; [Costigan, Michael] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Harvard University; Boston Children's Hospital	Chen, J (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Inst Biomed Sci Pain, Xian 710032, Peoples R China.	junchen@fmmu.edu.cn	Chen, Jun/R-8412-2017	Chen, Jun/0000-0003-2637-8442	MOST [2011CB504100, 2013BAI04B04]; NSFC [81171049]; NIH [R01NS074430]; Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074430] Funding Source: NIH RePORTER	MOST; NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the MOST (2011CB504100 and 2013BAI04B04) and the NSFC (81171049) to J.C. M.C. thanks the NIH (R01NS074430) and the Adelson Medical Research Foundation for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; BENARROCH IS, 1979, ACTA DIABETOL LAT, V16, P211, DOI 10.1007/BF02629114; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bokura H, 2008, STROKE, V39, P1607, DOI 10.1161/STROKEAHA.107.508630; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Brussee V, 2008, DIABETES, V57, P1664, DOI 10.2337/db07-1737; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Chen J, 1999, PAIN, V83, P67, DOI 10.1016/S0304-3959(99)00075-5; Chen YS, 2005, DIABETES, V54, P3112, DOI 10.2337/diabetes.54.11.3112; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dias JP, 2007, BRIT J PHARMACOL, V152, P280, DOI 10.1038/sj.bjp.0707388; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Dyck PJ, 2011, DIABETES-METAB RES, V27, P620, DOI 10.1002/dmrr.1226; Estrella JS, 2008, MICROVASC RES, V75, P403, DOI 10.1016/j.mvr.2007.12.002; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Ghione S, 1996, HYPERTENSION, V28, P494, DOI 10.1161/01.HYP.28.3.494; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Gregory JA, 2012, ACTA NEUROPATHOL, V124, P561, DOI 10.1007/s00401-012-1012-6; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hennes MMI, 1997, DIABETES, V46, P57, DOI 10.2337/diabetes.46.1.57; HILDEBRAND J, 1968, ARCH NEUROL-CHICAGO, V18, P633, DOI 10.1001/archneur.1968.00470360055005; Hughes RAC, 2004, BRAIN, V127, P1723, DOI 10.1093/brain/awh192; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Ismael MA, 2008, EUR J PHARMACOL, V589, P66, DOI 10.1016/j.ejphar.2008.05.006; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Kamiya H, 2006, DIABETOLOGIA, V49, P2763, DOI 10.1007/s00125-006-0379-0; Kamiya H, 2005, DIABETES-METAB RES, V21, P448, DOI 10.1002/dmrr.541; Katsumata T, 2010, NEUROL RES, V32, P743, DOI 10.1179/016164109X12608733393755; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Lennertz RC, 2011, J NEUROPHYSIOL, V106, P905, DOI 10.1152/jn.01123.2010; Lin YH, 2012, DIABETES TECHNOL THE, V14, P430, DOI 10.1089/dia.2011.0244; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Lungu C, 2007, NEUROPEPTIDES, V41, P375, DOI 10.1016/j.npep.2007.09.005; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MENEELY GR, 1961, MED CLIN N AM, V45, P271, DOI 10.1016/S0025-7125(16)33891-3; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Mimran A, 2008, NEPHROL DIAL TRANSPL, V23, P2138, DOI 10.1093/ndt/gfn160; Mizisin AP, 2007, ACTA NEUROPATHOL, V113, P431, DOI 10.1007/s00401-006-0163-8; Mizisin AP, 1998, ACTA NEUROPATHOL, V95, P171, DOI 10.1007/s004010050783; Mizisin AP, 2002, J NEUROPATH EXP NEUR, V61, P872, DOI 10.1093/jnen/61.10.872; Mohseni S, 1998, ACTA NEUROPATHOL, V96, P151, DOI 10.1007/s004010050875; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nowicki M, 2012, J NEUROSCI RES, V90, P122, DOI 10.1002/jnr.22728; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Oltman CL, 2005, AM J PHYSIOL-ENDOC M, V289, pE113, DOI 10.1152/ajpendo.00594.2004; Papanas N, 2011, NAT REV ENDOCRINOL, V7, P682, DOI 10.1038/nrendo.2011.113; Paton JFR, 2009, NEUROSCI BIOBEHAV R, V33, P89, DOI 10.1016/j.neubiorev.2008.05.020; Peltier A, 2009, MUSCLE NERVE, V39, P529, DOI 10.1002/mus.21210; Perry RC, 1999, DIABETES CARE, V22, P883, DOI 10.2337/diacare.22.6.883; Piercy V, 1999, J DIABETES COMPLICAT, V13, P163, DOI 10.1016/S1056-8727(99)00034-3; Romanovsky D, 2008, NEUROSCI LETT, V445, P220, DOI 10.1016/j.neulet.2008.08.087; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Segura B, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-64; SHARMA AK, 1974, J NEUROL SCI, V23, P1, DOI 10.1016/0022-510X(74)90136-1; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; SIMA AAF, 1983, METABOLISM, V32, P136, DOI 10.1016/S0026-0495(83)80027-4; SIMA AAF, 1980, ACTA NEUROPATHOL, V51, P223, DOI 10.1007/BF00687389; Singleton J Rob, 2007, Curr Diab Rep, V7, P420, DOI 10.1007/s11892-007-0070-y; Singleton J Robinson, 2005, Curr Treat Options Neurol, V7, P33, DOI 10.1007/s11940-005-0004-4; Singleton JR, 2006, NAT CLIN PRACT NEURO, V2, P276, DOI 10.1038/ncpneuro0172; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Singleton JR, 2001, MUSCLE NERVE, V24, P1225, DOI 10.1002/mus.1136; Smith AG, 2008, J NEUROL SCI, V273, P25, DOI 10.1016/j.jns.2008.06.005; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Smith AG, 2012, J PERIPHER NERV SYST, V17, P15, DOI 10.1111/j.1529-8027.2012.00390.x; Sugimoto K, 2008, DIABETES-METAB RES, V24, P642, DOI 10.1002/dmrr.903; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Szilvassy Z, 2012, METABOLISM, V61, P776, DOI 10.1016/j.metabol.2011.10.010; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Tracy JA, 2008, PHYS MED REH CLIN N, V19, P1, DOI 10.1016/j.pmr.2007.10.010; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Uzu T, 2012, AM J HYPERTENS, V25, P1170, DOI 10.1038/ajh.2012.102; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Vinik Aaron I, 2012, Front Endocrinol (Lausanne), V3, P71, DOI 10.3389/fendo.2012.00071; Walker D, 2001, J PERIPHER NERV SYST, V6, P219, DOI 10.1046/j.1529-8027.2001.01023.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Watcho P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/268547; YAGIHASHI S, 1990, AM J PATHOL, V136, P1365; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796; Zilliox L, 2011, NEUROLOGY, V76, P1099, DOI 10.1212/WNL.0b013e3182120147	97	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57427	10.1371/journal.pone.0057427	http://dx.doi.org/10.1371/journal.pone.0057427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451227	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500103
J	Errami, Y; Brim, H; Oumouna-Benachour, K; Oumouna, M; Naura, AS; Kim, H; Ju, JH; Davis, CJ; Kim, JG; Ashktorab, H; Fallon, K; Xu, M; Zhang, JH; Del Valle, L; Boulares, AH				Errami, Youssef; Brim, Hassan; Oumouna-Benachour, Karine; Oumouna, Mustapha; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Davis, Christian J.; Kim, Jong G.; Ashktorab, Hassan; Fallon, Kenneth; Xu, Ming; Zhang, Jianhua; Del Valle, Luis; Boulares, A. Hamid			ICAD Deficiency in Human Colon Cancer and Predisposition to Colon Tumorigenesis: Linkage to Apoptosis Resistance and Genomic Instability	PLOS ONE			English	Article							DNA-FRAGMENTATION FACTOR; POLY(ADP-RIBOSE) POLYMERASE PARP; CASPASE-ACTIVATED DNASE; TNF-ALPHA; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; FACTOR DFF45; EXPRESSION; ENDONUCLEASE; BUTYRATE	We previously showed that DNA fragmentation factor, which comprises a caspase-3-activated DNase (CAD) and its inhibitor (ICAD), may influence the rate of cell death by generating PARP-1-activating DNA breaks. Here we tested the hypothesis that ICAD-deficient colon epithelial cells exhibiting resistance to death stimuli may accumulate additional genetic modifications, leading to a tumorigenic phenotype. We show that ICAD deficiency may be associated with colon malignancy in humans. Indeed, an examination of ICAD expression using immunohistochemistry in an array of both colon cancer and normal tissues revealed that ICAD expression levels were severely compromised in the cancerous tissues. Upon DNA damage caused by a low dose of irradiation, ICAD cells acquire a tumorigenic phenotype. Colon epithelial cells derived from ICAD mice showed a significant resistance to death induced by the colon carcinogen dimethylhydrazine in vitro and in mice. Such resistance was associated with a decrease in PARP-1 activation. In an animal model of dimethylhydrazine-induced colon tumorigenesis, ICAD(-/-) mice developed significantly higher numbers of tumors with markedly larger sizes than the wild-type counterparts. Interestingly, the phenotype of the ICAD(-/-) mice was not associated with a significant increase in the precancerous aberrant crypt foci suggesting a potential link to tumor progression rather than initiation. More importantly, ICAD deficiency was associated with severe genomic instability as assessed by array comparative genomic hybridization. Such genomic instability consisted most prominently of amplifications but with sizable deletions as compared to the wild-type counterparts affecting several cancer-related genes including RAF-1, GSN, LMO3, and Fzd6 independently of p53. Altogether, our results present a viable case for the involvement of ICAD deficiency in colon carcinogenesis and show that apoptosis and genomic instability may comprise the means by which such deficiency may contribute to the process of increasing susceptibility to carcinogen-induced tumorigenesis.	[Errami, Youssef; Oumouna-Benachour, Karine; Oumouna, Mustapha; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Davis, Christian J.; Kim, Jong G.; Del Valle, Luis; Boulares, A. Hamid] Louisiana State Univ, Stanley Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA USA; [Brim, Hassan; Ashktorab, Hassan] Howard Univ, Dept Pathol, Washington, DC 20059 USA; [Brim, Hassan; Ashktorab, Hassan] Howard Univ, Ctr Canc, Washington, DC 20059 USA; [Fallon, Kenneth; Zhang, Jianhua] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Howard University; Howard University; University of Alabama System; University of Alabama Birmingham; University of Chicago	Boulares, AH (corresponding author), Louisiana State Univ, Stanley Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA USA.	hboulr@lsuhsc.edu	Del Valle, Luis/J-4085-2015; Ashktorab, hassan/AAJ-2908-2020	Del Valle, Luis/0000-0003-3894-9206; Zhang, Jianhua/0000-0002-2128-9574; Errami, Youssef/0000-0002-0432-4331; mustapha, oumouna/0000-0001-9228-1185	American Cancer Society [RSG-116608]; National Institutes of Health [HL072889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grant RSG-116608 from the American Cancer Society (http://www.cancer.org/) and grant HL072889 from the National Institutes of Health (http://www.nhlbi.nih.gov/) to AHB. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel F, 2004, INT J ONCOL, V25, P1297; Abel F, 2002, BRIT J CANCER, V86, P596, DOI 10.1038/sj.bjc.6600111; An JH, 2011, BIOCHEM BIOPH RES CO, V412, P44, DOI 10.1016/j.bbrc.2011.07.034; Boulares AH, 2002, CANCER RES, V62, P4439; Boulares AH, 2002, BIOCHEM BIOPH RES CO, V290, P796, DOI 10.1006/bbrc.2001.6280; Boulares AH, 2001, J BIOL CHEM, V276, P38185; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brustmann H, 2007, PATHOL RES PRACT, V203, P65, DOI 10.1016/j.prp.2006.12.003; Brustmann H, 2006, PATHOL RES PRACT, V202, P713, DOI 10.1016/j.prp.2006.06.003; COHEN GM, 1994, J IMMUNOL, V153, P507; de Leon MP, 2001, DIGEST LIVER DIS, V33, P372; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Giardina C, 1999, BBA-MOL CELL RES, V1448, P425, DOI 10.1016/S0167-4889(98)00156-6; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Guda K, 2004, ONCOGENE, V23, P3813, DOI 10.1038/sj.onc.1207489; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hao XP, 2000, CANCER RES, V60, P18; He Y, 2011, ONCOGENE, V30, P1032, DOI 10.1038/onc.2010.477; Hyzd'alova M, 2008, CYTOKINE, V44, P33, DOI 10.1016/j.cyto.2008.06.003; Katoh M, 2006, INT J ONCOL, V29, P163; Konishi S, 2002, CANCER-AM CANCER SOC, V95, P2473, DOI 10.1002/cncr.10987; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Kwong LN, 2009, ADV EXP MED BIOL, V656, P85, DOI 10.1007/978-1-4419-1145-2_8; Larsen S, 2010, BIOCHEM BIOPH RES CO, V392, P252, DOI 10.1016/j.bbrc.2009.12.010; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Nambiar PR, 2003, INT J ONCOL, V22, P145; Naura AS, 2009, EUR RESPIR J, V33, P252, DOI 10.1183/09031936.00089008; NEAMATI N, 1995, J IMMUNOL, V154, P3788; Neta G, 2011, CARCINOGENESIS, V32, P1231, DOI 10.1093/carcin/bgr100; Nhan TQ, 2005, ARTERIOSCL THROM VAS, V25, P895, DOI 10.1161/01.ATV.0000159519.07181.33; Oumouna-Benachour K, 2007, MOL CARCINOGEN, V46, P993, DOI 10.1002/mc.20351; Pajak B, 2007, J PHYSIOL PHARMACOL, V58, P163; Pajak B, 2005, J Physiol Pharmacol, V56 Suppl 3, P101; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Reiterer G, 2010, CELL CYCLE, V9, P3297, DOI 10.4161/cc.9.16.12631; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yan B, 2006, ONCOGENE, V25, P5370, DOI 10.1038/sj.onc.1209535; Yan B, 2006, P NATL ACAD SCI USA, V103, P1504, DOI 10.1073/pnas.0507779103; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; Zhang JH, 1999, J BIOL CHEM, V274, P37450, DOI 10.1074/jbc.274.52.37450; Zhang JH, 2000, BIOCHEM BIOPH RES CO, V274, P225, DOI 10.1006/bbrc.2000.3122	54	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57871	10.1371/journal.pone.0057871	http://dx.doi.org/10.1371/journal.pone.0057871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451280	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800120
J	Jack, APM; Bussemer, S; Hahn, M; Punzeler, S; Snyder, M; Wells, M; Csankovszki, G; Solovei, I; Schotta, G; Hake, SB				Jack, Antonia P. M.; Bussemer, Silva; Hahn, Matthias; Puenzeler, Sebastian; Snyder, Martha; Wells, Michael; Csankovszki, Gyorgyi; Solovei, Irina; Schotta, Gunnar; Hake, Sandra B.			H3K56me3 Is a Novel, Conserved Heterochromatic Mark That Largely but Not Completely Overlaps with H3K9me3 in Both Regulation and Localization	PLOS ONE			English	Article							H3 LYSINE-56 ACETYLATION; DNA-DAMAGE RESPONSE; HISTONE H3; CAENORHABDITIS-ELEGANS; GENOME INTEGRITY; X-CHROMOSOMES; HUMAN-CELLS; CHROMATIN; METHYLTRANSFERASES; TRIMETHYLATION	Histone lysine (K) methylation has been shown to play a fundamental role in modulating chromatin architecture and regulation of gene expression. Here we report on the identification of histone H3K56, located at the pivotal, nucleosome DNA entry/exit point, as a novel methylation site that is evolutionary conserved. We identify trimethylation of H3K56 (H3K56me3) as a modification that is present during all cell cycle phases, with the exception of S-phase, where it is underrepresented on chromatin. H3K56me3 is a novel heterochromatin mark, since it is enriched at pericentromeres but not telomeres and is thereby similar, but not identical, to the localization of H3K9me3 and H4K20me3. Possibly due to H3 sequence similarities, Suv39h enzymes, responsible for trimethylation of H3K9, also affect methylation of H3K56. Similarly, we demonstrate that trimethylation of H3K56 is removed by members of the JMJD2 family of demethylases that also target H3K9me3. Furthermore, we identify and characterize mouse mJmjd2E and its human homolog hKDM4L as novel, functionally active enzymes that catalyze the removal of two methyl groups from trimethylated H3K9 and K56. H3K56me3 is also found in C. elegans, where it co-localizes with H3K9me3 in most, but not all, tissues. Taken together, our findings raise interesting questions regarding how methylation of H3K9 and H3K56 is regulated in different organisms and their functional roles in heterochromatin formation and/or maintenance.	[Jack, Antonia P. M.; Bussemer, Silva; Hahn, Matthias; Puenzeler, Sebastian; Schotta, Gunnar; Hake, Sandra B.] Univ Munich, Dept Mol Biol, Adolf Butenandt Inst, CIPSM, Munich, Germany; [Snyder, Martha; Wells, Michael; Csankovszki, Gyorgyi] Univ Michigan, Dept MCDB, Ann Arbor, MI 48109 USA; [Solovei, Irina] Univ Munich, Dept Biol 2, LMU Biozentrum, Planegg Martinsried, Germany	University of Munich; University of Michigan System; University of Michigan; University of Munich	Hake, SB (corresponding author), Univ Munich, Dept Mol Biol, Adolf Butenandt Inst, CIPSM, Munich, Germany.	sandra.hake@med.uni-muenchen.de	Wells, Michael/GOP-0974-2022; Solovei, Irina/K-1191-2014	Wells, Michael/0000-0002-4278-1824; Schotta, Gunnar/0000-0003-4940-6135; Csankovszki, Gyorgyi/0000-0001-5918-034X; Solovei, Irina/0000-0002-6813-7279	DFG [HA 5437/3-1, SO1054/1, SFB TR5]; CIPSM; National Institutes of Health (NIH) [R01 GM079533]; BioImaging Network Munich; BMBF (EpiSys);  [SPP1356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079533] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); CIPSM; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioImaging Network Munich; BMBF (EpiSys)(Federal Ministry of Education & Research (BMBF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the DFG (HA 5437/3-1 and SFB TR5), as well as CIPSM to S.B.H. and from the National Institutes of Health (NIH) R01 GM079533 to G.C. I.S. was supported by DFG (SO1054/1) and BioImaging Network Munich and G.S. by SFB TR5, SPP1356 and BMBF (EpiSys). A.P.M.J. and S.P. are members of the IMPRS/LS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010851; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Bonisch C, 2012, NUCL ACIDS RES; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tian XQ, 2007, ACTA BIOCH BIOPH SIN, V39, P81, DOI 10.1111/j.1745-7270.2007.00272.x; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Trievel RC, 2004, CRIT REV EUKAR GENE, V14, P147, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.10; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wells MB, 2012, MOL CELL BIOL, V32, P1710, DOI 10.1128/MCB.06546-11; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wiedemann SM, 2010, J CELL BIOL, V190, P777, DOI 10.1083/jcb.201002043; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yu Y, 2012, MOL CELL; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620	53	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e51765	10.1371/journal.pone.0051765	http://dx.doi.org/10.1371/journal.pone.0051765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451023	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800001
J	Taher, C; de Boniface, J; Mohammad, AA; Religa, P; Hartman, J; Yaiw, KC; Frisell, J; Rahbar, A; Soderberg-Naucler, C				Taher, Chato; de Boniface, Jana; Mohammad, Abdul-Aleem; Religa, Piotr; Hartman, Johan; Yaiw, Koon-Chu; Frisell, Jan; Rahbar, Afsar; Soderberg-Naucler, Cecilia			High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IE2 PROTEINS; IE86 PROTEIN; INFECTION; TRANSFORMATION; LOCALIZATION; INHIBITION; ACTIVATION; CARCINOMA; KINASE	Background: Breast cancer is a leading cause of death among women worldwide. Increasing evidence implies that human cytomegalovirus (HCMV) infection is associated with several malignancies. We aimed to examine whether HCMV is present in breast cancer and sentinel lymph node (SLN) metastases. Materials and Methods: Formalin-fixed paraffin-embedded tissue specimens from breast cancer and paired sentinel lymph node (SLN) samples were obtained from patients with (n = 35) and without SLN metastasis (n = 38). HCMV immediate early (IE) and late (LA) proteins were detected using a sensitive immunohistochemistry (IHC) technique and HCMV DNA by real-time PCR. Results: HCMV IE and LA proteins were abundantly expressed in 100% of breast cancer specimens. In SLN specimens, 94% of samples with metastases (n = 34) were positive for HCMV IE and LA proteins, mostly confined to neoplastic cells while some inflammatory cells were HCMV positive in 60% of lymph nodes without metastases (n = 35). The presence of HCMV DNA was confirmed in 12/12 (100%) of breast cancer and 10/11 (91%) SLN specimens from the metastatic group, but was not detected in 5/5 HCMV-negative, SLN-negative specimens. There was no statistically significant association between HCMV infection grades and progesterone receptor, estrogen receptor alpha and Elston grade status. Conclusions: The role of HCMV in the pathogenesis of breast cancer is unclear. As HCMV proteins were mainly confined to neoplastic cells in primary breast cancer and SLN samples, our observations raise the question whether HCMV contributes to the tumorigenesis of breast cancer and its metastases.	[Taher, Chato; Mohammad, Abdul-Aleem; Religa, Piotr; Yaiw, Koon-Chu; Rahbar, Afsar; Soderberg-Naucler, Cecilia] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [de Boniface, Jana; Frisell, Jan] Karolinska Univ Hosp, Dept Breast & Endocrine Surg, Stockholm, Sweden; [Hartman, Johan] Karolinska Univ Hosp, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Soderberg-Naucler, C (corresponding author), Karolinska Univ Hosp, Dept Med, Stockholm, Sweden.	Cecilia.Naucler@ki.se	de Boniface, Jana/ABH-4020-2020; Yaiw, Koon-Chu/AAJ-9682-2020; Hartman, Johan/N-1406-2015	de Boniface, Jana/0000-0001-9518-0902; Yaiw, Koon-Chu/0000-0001-5329-1815; Hartman, Johan/0000-0002-6500-8527; Rahbar, Afsar/0000-0003-1158-2512; Religa, Piotr/0000-0002-3884-2954	RATOS; Ragnar Soderbergs Research Foundation; Swedish Research Council; Swedish Children Cancer Research Foundation; Swedish Cancer Foundation; Swedish Society for Medical Research (SLS); Percy Falks foundation; The Royal Swedish Academy of Sciences (KVA); Goljes Memory Foundation; Magnus Bergvalls Foundation; Tore Nilsons Foundation; Kurdistan Regional Government/Iraq; Roche	RATOS; Ragnar Soderbergs Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children Cancer Research Foundation; Swedish Cancer Foundation; Swedish Society for Medical Research (SLS); Percy Falks foundation; The Royal Swedish Academy of Sciences (KVA); Goljes Memory Foundation; Magnus Bergvalls Foundation; Tore Nilsons Foundation; Kurdistan Regional Government/Iraq; Roche(Roche Holding)	This work was supported by RATOS, the Ragnar Soderbergs Research Foundation, the Swedish Research Council, the Swedish Children Cancer Research Foundation, the Swedish Cancer Foundation, Swedish Society for Medical Research (SLS), Percy Falks foundation, The Royal Swedish Academy of Sciences (KVA), Goljes Memory Foundation, Magnus Bergvalls Foundation, Tore Nilsons Foundation, and CT was supported by a scholarship from Kurdistan Regional Government/Iraq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: CSN has received speakers fees and travel grants from Roche to present the groups data on molecular mechanisms of CMV infection at scientific meeting and at one SAB meeting for Roche and also earlier held an independent investigational grant from Roche to perform a clinical trial on anti-CMV treatment in glioblastoma patients. All this was more than 3 years ago. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Altundag K, 2006, BRIT J CANCER, V94, P338, DOI 10.1038/sj.bjc.6602944; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Andersson Y, 2010, J CLIN ONCOL, V28, P2868, DOI 10.1200/JCO.2009.24.5001; Asanuma H, 1996, MICROBIOL IMMUNOL, V40, P201, DOI 10.1111/j.1348-0421.1996.tb03335.x; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bergkvist L, 2008, ANN SURG, V247, P150, DOI 10.1097/SLA.0b013e318153ff40; BOLDOGH I, 1990, SCIENCE, V247, P561, DOI 10.1126/science.1689075; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; BRITT WJ, 1996, FIELDS VIROLOGY; Cinati J, 2004, TRENDS MOL MED, V10, P19, DOI 10.1016/j.molmed.2003.11.002; Cinatl J, 2004, FEMS MICROBIOL REV, V28, P59, DOI 10.1016/j.femsre.2003.07.005; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cox B, 2010, BRIT J CANCER, V102, P1665, DOI 10.1038/sj.bjc.6605675; DALTON LW, 1994, CANCER, V73, P2765, DOI 10.1002/1097-0142(19940601)73:11<2765::AID-CNCR2820731119>3.0.CO;2-K; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; GEDER L, 1977, CANCER TREAT REP, V61, P139; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Joshi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008180; Kalejta RF, 2008, MICROBIOL MOL BIOL R, V72, P249, DOI 10.1128/MMBR.00040-07; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Melana SM, 2010, J VIROL METHODS, V163, P157, DOI 10.1016/j.jviromet.2009.09.015; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Michaelis M, 2009, MED MICROBIOL IMMUN, V198, P79, DOI 10.1007/s00430-009-0107-8; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; NELSON JA, 1982, J VIROL, V43, P83, DOI 10.1128/JVI.43.1.83-91.1982; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Price RL, 2012, CANCER RES, V72, P5669, DOI 10.1158/0008-5472.CAN-12-2425; Rahbar Afsar, 2012, Herpesviridae, V3, P3, DOI 10.1186/2042-4280-3-3; Richardson A, 1997, MED HYPOTHESES, V48, P491, DOI 10.1016/S0306-9877(97)90118-3; Shen YQ, 1997, P NATL ACAD SCI USA, V94, P3341, DOI 10.1073/pnas.94.7.3341; Sissons JGP, 2002, J INFECTION, V44, P73, DOI 10.1053/jinf.2001.0948; Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x; Song YJ, 2005, J VIROL, V79, P2597, DOI 10.1128/JVI.79.4.2597-2603.2005; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Speir E, 1995, SCAND J INFECT DIS, P78; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Straat K, 2009, JNCI-J NATL CANCER I, V101, P488, DOI 10.1093/jnci/djp031; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsai JH, 2007, J CANCER RES CLIN, V133, P13, DOI 10.1007/s00432-006-0141-5; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	51	95	98	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56795	10.1371/journal.pone.0056795	http://dx.doi.org/10.1371/journal.pone.0056795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451089	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800038
J	Bodur, C; Kutuk, O; Karsli-Uzunbas, G; Isimjan, TT; Harrison, P; Basaga, H				Bodur, Cagri; Kutuk, Ozgur; Karsli-Uzunbas, Gizem; Isimjan, Tayirjan T.; Harrison, Paul; Basaga, Huveyda			Pramanicin Analog Induces Apoptosis in Human Colon Cancer Cells: Critical Roles for Bcl-2, Bim, and p38 MAPK Signaling	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTOR; DEPENDENT APOPTOSIS; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; ANTIFUNGAL AGENT; GENE-EXPRESSION; FAMILY PROTEINS; BREAST-CANCER	Pramanicin (PMC) is an antifungal agent that was previously demonstrated to exhibit antiangiogenic and anticancer properties in a few in vitro studies. We initially screened a number of PMC analogs for their cytotoxic effects on HCT116 human colon cancer cells. PMC-A, the analog with the most potent antiproliferative effect was chosen to further interrogate the underlying mechanism of action. PMC-A led to apoptosis through activation of caspase-9 and -3. The apoptotic nature of cell death was confirmed by abrogation of cell death with pretreatment with specific caspase inhibitors. Stress-related MAPKs JNK and p38 were both activated concomittantly with the intrinsic apoptotic pathway. Moreover, pharmacological inhibition of p38 proved to attenuate the cell death induction while pretreatment with JNK inhibitor did not exhibit a protective effect. Resistance of Bax -/- cells and the protective nature of caspase-9 inhibition indicate that mitochondria play a central role in PMC-A induced apoptosis. Early post-exposure elevation of cellular Bim and Bax was followed by a marginal Bcl-2 depletion and Bid cleavage. Further analysis revealed that Bcl-2 downregulation occurs at the mRNA level and is critical to mediate PMC-A induced apoptosis, as ectopic Bcl-2 expression substantially spared the cells from death. Conversely, forced expression of Bim proved to significantly increase cell death. In addition, analyses of p53-/- cells demonstrated that Bcl-2/Bim/Bax modulation and MAPK activations take place independently of p53 expression. Taken together, p53-independent transcriptional Bcl-2 downregulation and p38 signaling appear to be the key modulatory events in PMC-A induced apoptosis.	[Bodur, Cagri; Karsli-Uzunbas, Gizem; Basaga, Huveyda] Sabanci Univ, Biol Sci & Bioengn Program, Istanbul, Turkey; [Kutuk, Ozgur] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Isimjan, Tayirjan T.; Harrison, Paul] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada	Sabanci University; Harvard University; Dana-Farber Cancer Institute; McMaster University	Basaga, H (corresponding author), Sabanci Univ, Biol Sci & Bioengn Program, Istanbul, Turkey.	huveyda@sabanciuniv.edu	KUTUK, OZGUR/AAH-1671-2019; Harrison, Paul/Q-9417-2019	KUTUK, OZGUR/0000-0001-9854-7220; 	Sabanci University faculty research funds	Sabanci University faculty research funds(Sabanci University)	The funding for the work was provided by Sabanci University faculty research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SF, 2012, EUR J IMMUNOL, V42, P1327, DOI 10.1002/eji.201142226; Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Bentires-Alj M, 2001, ONCOGENE, V20, P2805, DOI 10.1038/sj.onc.1204343; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Bodur C, 2012, CURR MED CHEM, V19, P1804, DOI 10.2174/092986712800099839; Bodur C, 2012, J CELL PHYSIOL, V227, P3556, DOI 10.1002/jcp.24057; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; Christoffers J, 2003, EUR J ORG CHEM, V2003, P425; delasAlas MM, 1997, J NATL CANCER I, V89, P1537, DOI 10.1093/jnci/89.20.1537; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; GREEN DR, 1994, IMMUNOL REV, V142, P321, DOI 10.1111/j.1600-065X.1994.tb00895.x; Grimm T, 2005, BLOOD, V105, P3263, DOI 10.1182/blood-2004-07-2752; Hara S, 2008, INT HEART J, V49, P329, DOI 10.1536/ihj.49.329; Harrison PHM, 2000, J CHEM SOC PERK T 1, P4390, DOI 10.1039/b006007k; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; Heist RS, 2010, J THORAC ONCOL, V5, P1637, DOI 10.1097/JTO.0b013e3181e8f4dc; Igata E, 1999, GENE, V238, P407, DOI 10.1016/S0378-1119(99)00348-0; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kutuk O, 2005, APOPTOSIS, V10, P597, DOI 10.1007/s10495-005-1894-z; Kwan CY, 2003, J PHARMACOL SCI, V92, P203; Kwan CY, 2003, VASC PHARMACOL, V40, P35, DOI 10.1016/S1537-1891(02)00314-2; Kwan CY, 2001, JPN J PHARMACOL, V85, P234, DOI 10.1254/jjp.85.234; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li QX, 2006, HISTOL HISTOPATHOL, V21, P533, DOI 10.14670/HH-21.533; Li ZL, 2003, J HISTOCHEM CYTOCHEM, V51, P1601, DOI 10.1177/002215540305101204; Lim EJ, 2007, EXP MOL MED, V39, P239, DOI 10.1038/emm.2007.27; MIYASHITA T, 1995, CELL, V80, P293; Moulder SL, 2008, CLIN CANCER RES, V14, P7909, DOI 10.1158/1078-0432.CCR-08-1104; NAGASAKA T, 1995, CHEM PHARM BULL, V43, P1081; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nesbit CE, 1998, BLOOD, V92, P1003; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Paik PK, 2010, CANCER CHEMOTH PHARM, V66, P1079, DOI 10.1007/s00280-010-1265-5; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sheikh MS, 1998, CANCER RES, V58, P1593; Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Vitale I, 2008, CELL CYCLE, V7, P1956, DOI 10.4161/cc.7.13.6073; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Weecharangsan W, 2009, MOL PHARMACEUT, V6, P1848, DOI 10.1021/mp900150g; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang T, 2009, MOL CANCER RES, V7, P1408, DOI 10.1158/1541-7786.MCR-08-0533	69	17	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56369	10.1371/journal.pone.0056369	http://dx.doi.org/10.1371/journal.pone.0056369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441183	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200040
J	Goh, KS; Sheu, HS; Hua, TE; Kang, MH; Li, CW				Goh, King-Siang; Sheu, Hwo-Shuenn; Hua, Tzu-En; Kang, Mei-Hua; Li, Chia-Wei			Uric Acid Spherulites in the Reflector Layer of Firefly Light Organ	PLOS ONE			English	Article							MONOSODIUM URATE; EVOLUTION; SOLUBILITY; DEGRADATION; PEROXISOMES; LAMPYRIDAE; PHYSIOLOGY; DIHYDRATE; CRYSTALS	Background: In firefly light organs, reflector layer is a specialized tissue which is believed to play a key role for increasing the bioluminescence intensity through reflection. However, the nature of this unique tissue remains elusive. In this report, we investigated the role, fine structure and nature of the reflector layer in the light organ of adult Luciola cerata. Principal Findings: Our results indicated that the reflector layer is capable of reflecting bioluminescence, and contains abundant uric acid. Electron microscopy (EM) demonstrated that the cytosol of the reflector layer's cells is filled with densely packed spherical granules, which should be the uric acid granules. These granules are highly regular in size (similar to 700 nm in diameter), and exhibit a radial internal structure. X-ray diffraction (XRD) analyses revealed that an intense single peak pattern with a d-spacing value of 0.320 nm is specifically detected in the light organ, and is highly similar to the diffraction peak pattern and d-spacing value of needle-formed crystals of monosodium urate monohydrate. However, the molar ratio evaluation of uric acid to various cations (K+, Na+, Ca2+ and Mg2+) in the light organ deduced that only a few uric acid molecules were in the form of urate salts. Thus, non-salt uric acid should be the source of the diffraction signal detected in the light organ. Conclusions: In the light organ, the intense single peak diffraction signal might come from a unique needle-like uric acid form, which is different from other known structures of non-salt uric acid form. The finding of a radial structure in the granules of reflector layer implies that the spherical uric acid granules might be formed by the radial arrangement of needle-formed packing matter.	[Goh, King-Siang; Kang, Mei-Hua; Li, Chia-Wei] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Dept Life Sci, Hsinchu, Taiwan; [Hua, Tzu-En] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu, Taiwan; [Sheu, Hwo-Shuenn] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Synchrotron Radiation Research Center	Li, CW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Dept Life Sci, Hsinchu, Taiwan.	cwli@life.nthu.edu.tw			National Science Council (Taiwan, R.O.C) [NSC97-2311-B-007-001-MY3]	National Science Council (Taiwan, R.O.C)(Ministry of Science and Technology, Taiwan)	Funding was provided by NSC97-2311-B-007-001-MY3 from the National Science Council (Taiwan, R.O.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BUCK JB, 1948, ANN NY ACAD SCI, V49, P397, DOI 10.1111/j.1749-6632.1948.tb30944.x; Casotti G, 2004, J EXP ZOOL PART A, V301A, P579, DOI 10.1002/jez.a.85; Coleman NRB, 2001, MICROPOR MESOPOR MAT, V44, P73, DOI 10.1016/S1387-1811(01)00170-6; Drees LR, 1996, CATENA, V27, P287, DOI 10.1016/0341-8162(96)00022-7; FOLK RL, 1969, SCIENCE, V166, P1516, DOI 10.1126/science.166.3912.1516; Ghiradella H, 2004, INTEGR COMP BIOL, V44, P203, DOI 10.1093/icb/44.3.203; Goh KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029576; Granasy L, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011605; HAYASHI S, 1989, J BIOL CHEM, V264, P3211; Hayashi S, 2000, CELL BIOCHEM BIOPHYS, V32, P123, DOI 10.1385/CBB:32:1-3:123; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Imrie CT, 2004, J MATER CHEM, V14, P2486, DOI 10.1039/b404319g; IWATA H, 1989, J UROLOGY, V142, P1095, DOI 10.1016/S0022-5347(17)39003-1; KLOHN M, 1986, UROL RES, V14, P315; Koksharova TV, 2002, RUSS J COORD CHEM+, V28, P505, DOI 10.1023/A:1016257429532; Lambert CC, 1998, J EXP ZOOL, V282, P323, DOI 10.1002/(SICI)1097-010X(19981015)282:3<323::AID-JEZ5>3.3.CO;2-7; Lewis SM, 2008, ANNU REV ENTOMOL, V53, P293, DOI 10.1146/annurev.ento.53.103106.093346; LONSDALE K, 1971, SCIENCE, V172, P958, DOI 10.1126/science.172.3986.958; Lund EJ, 1911, J EXP ZOOL, V11, P415, DOI 10.1002/jez.1400110405; Magill JH, 2001, J MATER SCI, V36, P3143, DOI 10.1023/A:1017974016928; MANDEL NS, 1980, ARTHRITIS RHEUM, V23, P772, DOI 10.1002/art.1780230610; MCNABB RA, 1980, COMP BIOCHEM PHYS A, V67, P27, DOI 10.1016/0300-9629(80)90405-3; MINNICH JE, 1972, COMP BIOCHEM PHYSIOL, V41, P551, DOI 10.1016/0300-9629(72)90012-6; Ninomiya Y, 2006, J INSECT PHYSIOL, V52, P638, DOI 10.1016/j.jinsphys.2006.03.002; Perrin CM, 2012, CRYSTENGCOMM, V14, P1709, DOI 10.1039/c2ce05985a; Perrin CM, 2011, CRYSTENGCOMM, V13, P1111, DOI 10.1039/c0ce00737d; PETERSON MK, 1968, BIOL BULL, V135, P335, DOI 10.2307/1539786; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Rao QL, 2005, APPL SURF SCI, V240, P28, DOI 10.1016/j.apsusc.2004.07.059; Sabina EP, 2008, J PHARM PHARM SCI, V11, P46; Sheu HS, 2004, INT J BIOL MACROMOL, V34, P325, DOI 10.1016/j.ijbiomac.2004.09.004; TAMURA T, 1990, Cytologia (Tokyo), V55, P519, DOI 10.1508/cytologia.55.519; TOJO S, 1972, J INSECT PHYSIOL, V18, P403, DOI 10.1016/0022-1910(72)90073-X; Ugarova NN, 2002, LUMINESCENCE, V17, P321, DOI 10.1002/bio.688; WILCOX WR, 1972, MED BIOL ENG, V10, P522, DOI 10.1007/BF02474201; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Wu CH, 2010, COLEOPTS BULL, V64, P235, DOI 10.1649/0010-065X-64.3.235.9; Zellelow AZ, 2010, CRYST GROWTH DES, V10, P418, DOI 10.1021/cg9010218	40	8	8	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56406	10.1371/journal.pone.0056406	http://dx.doi.org/10.1371/journal.pone.0056406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441187	gold, Green Submitted, Green Published			2022-12-27	WOS:000315159200044
J	Bejugam, PR; Kuppili, RR; Singh, N; Gadewal, N; Chaganti, LK; Sastry, GM; Bose, K				Bejugam, Pruthvi Raj; Kuppili, Raja R.; Singh, Nitu; Gadewal, Nikhil; Chaganti, Lalith K.; Sastry, G. Madhavi; Bose, Kakoli			Allosteric Regulation of Serine Protease HtrA2 through Novel Non-Canonical Substrate Binding Pocket	PLOS ONE			English	Article							PROMOTES CELL-DEATH; PDZ DOMAINS; FUNCTIONAL-ANALYSIS; ACCURATE DOCKING; GLIDE; SPECIFICITY; ACTIVATION; INHIBITOR; APOPTOSIS; PROTEINS	HtrA2, a trimeric proapoptotic serine protease is involved in several diseases including cancer and neurodegenerative disorders. Its unique ability to mediate apoptosis via multiple pathways makes it an important therapeutic target. In HtrA2, C-terminal PDZ domain upon substrate binding regulates its functions through coordinated conformational changes the mechanism of which is yet to be elucidated. Although allostery has been found in some of its homologs, it has not been characterized in HtrA2 so far. Here, with an in silico and biochemical approach we have shown that allostery does regulate HtrA2 activity. Our studies identified a novel non-canonical selective binding pocket in HtrA2 which initiates signal propagation to the distal active site through a complex allosteric mechanism. This non-classical binding pocket is unique among HtrA family proteins and thus unfolds a novel mechanism of regulation of HtrA2 activity and hence apoptosis.	[Bejugam, Pruthvi Raj; Kuppili, Raja R.; Singh, Nitu; Gadewal, Nikhil; Chaganti, Lalith K.; Bose, Kakoli] Tata Mem Hosp, ACTREC, Kharghar, Navi Mumbai, India; [Sastry, G. Madhavi] Schrodinger, Hyderabad, Andhra Pradesh, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Bose, K (corresponding author), Tata Mem Hosp, ACTREC, Kharghar, Navi Mumbai, India.	kbose@actrec.gov.in	Bejugam, Pruthvi raj/AAU-1244-2020; Gadewal, Nikhil/ABA-2942-2020	Bejugam, Pruthvi raj/0000-0002-0802-9153; Gadewal, Nikhil/0000-0003-3552-0703	Department of Biotechnology (DBT), Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	The project was funded by a grant provided by Department of Biotechnology (DBT), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beuming T, 2009, PROTEIN SCI, V18, P1609, DOI 10.1002/pro.177; Bowers K.J., 2006, P ACM IEEE C SUP SC0, DOI 10.1109/SC.2006.54; Christopoulos A, 2004, BIOCHEM SOC T, V32, P873, DOI 10.1042/BST0320873; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Feng W, 2002, J BIOL CHEM, V277, P41140, DOI 10.1074/jbc.M207206200; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; HUMPHREYS DD, 1994, J PHYS CHEM-US, V98, P6885, DOI 10.1021/j100078a035; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ibrahim Azza Mostafa, 2012, Lab Hematol, V18, P1, DOI 10.1532/LH96.09013; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Johnson F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007100; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kooistra J, 2009, J ALZHEIMERS DIS, V17, P281, DOI 10.3233/JAD-2009-1037; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Lin CB, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606513; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma SC, 2007, SCI CHINA SER C, V50, P412, DOI 10.1007/s11427-007-0037-x; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MAZAT JP, 1976, BIOCHEMISTRY-US, V15, P4053, DOI 10.1021/bi00663a021; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Nagata M, 2011, BRIT J CANCER, V105, P1322, DOI 10.1038/bjc.2011.387; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Nam MK, 2006, EXP MOL MED, V38, P36, DOI 10.1038/emm.2006.5; Navakanit Ruxapon, 2007, Journal of the Medical Association of Thailand, V90, P2416; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Savopoulos JW, 2000, PROTEIN EXPRES PURIF, V19, P227, DOI 10.1006/prep.2000.1240; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Sugiyama H, 1998, LEUKEMIA LYMPHOMA, V30, P55, DOI 10.3109/10428199809050929; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Zeng J, 1999, PROTEIN ENG, V12, P457, DOI 10.1093/protein/12.6.457	46	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55416	10.1371/journal.pone.0055416	http://dx.doi.org/10.1371/journal.pone.0055416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457469	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700017
J	Bloom-Feshbach, K; Alonso, WJ; Charu, V; Tamerius, J; Simonsen, L; Miller, MA; Viboud, C				Bloom-Feshbach, Kimberly; Alonso, Wladimir J.; Charu, Vivek; Tamerius, James; Simonsen, Lone; Miller, Mark A.; Viboud, Cecile			Latitudinal Variations in Seasonal Activity of Influenza and Respiratory Syncytial Virus (RSV): A Global Comparative Review	PLOS ONE			English	Review							CLINICAL CHARACTERISTICS; ABSOLUTE-HUMIDITY; TRACT INFECTIONS; GROUP-A; CHILDREN; EPIDEMICS; TRANSMISSION; MORTALITY; DYNAMICS; TAIWAN	Background: There is limited information on influenza and respiratory syncytial virus (RSV) seasonal patterns in tropical areas, although there is renewed interest in understanding the seasonal drivers of respiratory viruses. Methods: We review geographic variations in seasonality of laboratory-confirmed influenza and RSV epidemics in 137 global locations based on literature review and electronic sources. We assessed peak timing and epidemic duration and explored their association with geography and study settings. We fitted time series model to weekly national data available from the WHO influenza surveillance system (FluNet) to further characterize seasonal parameters. Results: Influenza and RSV activity consistently peaked during winter months in temperate locales, while there was greater diversity in the tropics. Several temperate locations experienced semi-annual influenza activity with peaks occurring in winter and summer. Semi-annual activity was relatively common in tropical areas of Southeast Asia for both viruses. Biennial cycles of RSV activity were identified in Northern Europe. Both viruses exhibited weak latitudinal gradients in the timing of epidemics by hemisphere, with peak timing occurring later in the calendar year with increasing latitude (P < 0.03). Time series model applied to influenza data from 85 countries confirmed the presence of latitudinal gradients in timing, duration, seasonal amplitude, and between-year variability of epidemics. Overall, 80% of tropical locations experienced distinct RSV seasons lasting 6 months or less, while the percentage was 50% for influenza. Conclusion: Our review combining literature and electronic data sources suggests that a large fraction of tropical locations experience focused seasons of respiratory virus activity in individual years. Information on seasonal patterns remains limited in large undersampled regions, included Africa and Central America. Future studies should attempt to link the observed latitudinal gradients in seasonality of viral epidemics with climatic and population factors, and explore regional differences in disease transmission dynamics and attack rates.	[Bloom-Feshbach, Kimberly; Alonso, Wladimir J.; Charu, Vivek; Simonsen, Lone; Miller, Mark A.; Viboud, Cecile] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Bloom-Feshbach, Kimberly] Mt Sinai Sch Med, New York, NY USA; [Charu, Vivek] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Tamerius, James] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Columbia University; George Washington University	Viboud, C (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	viboudc@mail.nih.gov	Alonso, Wladimir J./N-9223-2017; Simonsen, Lone/K-4531-2014	Alonso, Wladimir J./0000-0001-7038-0801; Simonsen, Lone/0000-0003-1535-8526	in-house Influenza Research Program of the Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health; International Influenza Unit, Office of Global Affairs, Department of Health and Human Services; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security	in-house Influenza Research Program of the Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health; International Influenza Unit, Office of Global Affairs, Department of Health and Human Services; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security	This work was supported by the in-house Influenza Research Program of the Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, which is funded by the International Influenza Unit, Office of Global Affairs, Department of Health and Human Services, and by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security (to L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajjar S, 1998, ANN TROP PAEDIATR, V18, P87, DOI 10.1080/02724936.1998.11747933; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Australian Government Department of Health and Ageing, INFL NAT INFL SURV S; Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Bedoya VI, 1996, PEDIATR INFECT DIS J, V15, P1123, DOI 10.1097/00006454-199612000-00014; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chatterjee S, 1996, Acta Microbiol Pol, V45, P279; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Eriksson M, 2002, ACTA PAEDIATR, V91, P593, DOI 10.1080/080352502753711740; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096; Lee W. K., 2006, Hong Kong Medical Journal, V12, P119; Light M, 2007, PEDIATR INFECT DIS J, V26, pS55, DOI 10.1097/INF.0b013e318157dac1; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maitreyi RS, 2000, J CLIN VIROL, V16, P41, DOI 10.1016/S1386-6532(99)00075-X; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Mlinaric-Galinovic G, 2011, PEDIAT INT; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nguyen HT, 2009, VACCINE, V28, P398, DOI 10.1016/j.vaccine.2009.09.139; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Panozzo CA, 2007, PEDIATR INFECT DIS J, V26, pS41, DOI 10.1097/INF.0b013e318157da82; Panozzo CA, 2010, PEDIATRICS, V126, pE116, DOI 10.1542/peds.2009-3221; Pecchini R, 2008, BRAZ J INFECT DIS, V12, P476, DOI 10.1590/S1413-86702008000600006; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Richard SA, 2010, VACCINE, V28, P2693, DOI 10.1016/j.vaccine.2010.01.053; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Robinson JL, 2005, J MED VIROL, V76, P98, DOI 10.1002/jmv.20329; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Schuck-Paim C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041918; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Suzuki Y, 2009, J CLIN MICROBIOL, V47, P623, DOI 10.1128/JCM.01760-08; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Torzillo P, 1999, PEDIATR INFECT DIS J, V18, P714, DOI 10.1097/00006454-199908000-00012; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Tseng RK, 1996, JPN J MED SCI BIOL, V49, P77, DOI 10.7883/yoken1952.49.77; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WARIS M, 1991, J INFECT DIS, V163, P464, DOI 10.1093/infdis/163.3.464; Weber A, 2001, MATH BIOSCI, V172, P95, DOI 10.1016/S0025-5564(01)00066-9; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Zamberi S, 2003, Med J Malaysia, V58, P681	68	229	240	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54445	10.1371/journal.pone.0054445	http://dx.doi.org/10.1371/journal.pone.0054445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457451	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700007
J	Park, SJ; Kim, YH; Lee, Y; Kim, KM; Kim, HS; Lee, SR; Kim, SU; Kim, SH; Kim, JS; Jeong, KJ; Lee, KM; Huh, JW; Chang, KT				Park, Sang-Je; Kim, Young-Hyun; Lee, Youngjeon; Kim, Kyoung-Min; Kim, Heui-Soo; Lee, Sang-Rae; Kim, Sun-Uk; Kim, Sang-Hyun; Kim, Ji-Su; Jeong, Kang-Jin; Lee, Kyoung-Min; Huh, Jae-Won; Chang, Kyu-Tae			Selection of Appropriate Reference Genes for RT-qPCR Analysis in a Streptozotocin-Induced Alzheimer's Disease Model of Cynomolgus Monkeys (Macaca fascicularis)	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; INTERNAL REFERENCE GENES; GROWTH-FACTOR EXPRESSION; RHESUS MACAQUE; BRAIN; INSULIN; PCR	Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) has been widely used to quantify relative gene expression because of the specificity, sensitivity, and accuracy of this technique. In order to obtain reliable gene expression data from RT-qPCR experiments, it is important to utilize optimal reference genes for the normalization of target gene expression under varied experimental conditions. Previously, we developed and validated a novel icv-STZ cynomolgus monkey model for Alzheimer's disease (AD) research. However, in order to enhance the reliability of this disease model, appropriate reference genes must be selected to allow meaningful analysis of the gene expression levels in the icv-STZ cynomolgus monkey brain. In this study, we assessed the expression stability of 9 candidate reference genes in 2 matched-pair brain samples (5 regions) of control cynomolgus monkeys and those who had received intracerebroventricular injection of streptozotocin (icv-STZ). Three well-known analytical programs geNorm, NormFinder, and BestKeeper were used to choose the suitable reference genes from the total sample group, control group, and icv-STZ group. Combination analysis of the 3 different programs clearly indicated that the ideal reference genes are RPS19 and YWHAZ in the total sample group, GAPDH and RPS19 in the control group, and ACTB and GAPDH in the icv-STZ group. Additionally, we validated the normalization accuracy of the most appropriate reference genes (RPS19 and YWHAZ) by comparison with the least stable gene (TBP) using quantification of the APP and MAPT genes in the total sample group. To the best of our knowledge, this research is the first study to identify and validate the appropriate reference genes in cynomolgus monkey brains. These findings provide useful information for future studies involving the expression of target genes in the cynomolgus monkey.	[Park, Sang-Je; Kim, Young-Hyun; Lee, Youngjeon; Kim, Kyoung-Min; Lee, Sang-Rae; Kim, Sun-Uk; Kim, Sang-Hyun; Kim, Ji-Su; Jeong, Kang-Jin; Huh, Jae-Won; Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Ochang, Chungbuk, South Korea; [Park, Sang-Je; Kim, Heui-Soo] Pusan Natl Univ, Dept Biol Sci, Coll Nat Sci, Pusan, South Korea; [Kim, Young-Hyun; Kim, Kyoung-Min; Huh, Jae-Won; Chang, Kyu-Tae] Univ Sci & Technol, Natl Primate Res Ctr, Korea Res Inst Biosci & Biotechnol, Chungbuk, South Korea; [Lee, Youngjeon] Inje Univ, Dept Rehabil Sci, Interdisciplinary PhD Program, Grad Sch, Gimhae, Gyeongnam, South Korea; [Lee, Kyoung-Min] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Inje University; Seoul National University (SNU); Seoul National University Hospital	Huh, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Ochang, Chungbuk, South Korea.	huhjw@kribb.re.kr; changkt@kribb.re.kr	Kim, Heui-Soo/ABF-3773-2021	Kim, Heui-Soo/0000-0002-5226-6594; Lee, Sang-Rae/0000-0001-8400-5973; Lee, Youngjeon/0000-0002-5387-3441	KRIBB Research Initiative Program [KGM4241231]	KRIBB Research Initiative Program	This research was supported by a grant from the KRIBB Research Initiative Program (KGM4241231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang Z, 2010, ANAL BIOCHEM, V406, P214, DOI 10.1016/j.ab.2010.07.021; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; Heo JH, 2011, J ALZHEIMERS DIS, V25, P517, DOI 10.3233/JAD-2011-102079; Huh JW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-163; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Li WD, 2010, METAB BRAIN DIS, V25, P277, DOI 10.1007/s11011-010-9207-9; Ma YL, 2012, J CEREBR BLOOD F MET, V32, P633, DOI 10.1038/jcbfm.2011.166; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Mistur R, 2009, J CLIN NEUROL, V5, P153, DOI 10.3988/jcn.2009.5.4.153; Miura C, 2012, GENE IN PRESS; Noriega NC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-47; Noriega NC, 2009, METHODS, V49, P42, DOI 10.1016/j.ymeth.2009.05.008; Park SJ, 2012, MOL BIOTECH IN PRESS; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Rozen S, 2000, Methods Mol Biol, V132, P365; Saigusa S, 2012, J CANC RES IN PRESS; Shen B, 2011, EXP THER MED, V2, P1151, DOI 10.3892/etm.2011.331; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tachaudomdach C, 2012, EXP THER MED, V3, P713, DOI 10.3892/etm.2012.473; Uchida A, 2012, BRAIN, V135, P833, DOI 10.1093/brain/awr348; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Yuasa K, 2012, FEBS LETT, V586, P3464, DOI 10.1016/j.febslet.2012.07.074	32	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56034	10.1371/journal.pone.0056034	http://dx.doi.org/10.1371/journal.pone.0056034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457495	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700035
J	Huber, RM; Rajski, M; Sivasankaran, B; Moncayo, G; Hemmings, BA; Merlo, A				Huber, Roland M.; Rajski, Michal; Sivasankaran, Balasubramanian; Moncayo, Gerald; Hemmings, Brian A.; Merlo, Adrian			Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival	PLOS ONE			English	Article							HUMAN GLIOMAS; GENE-EXPRESSION; DOWN-REGULATION; NOTCH RECEPTOR; BRAIN-TUMORS; STEM-CELLS; PATHWAY; CANCER; DIFFERENTIATION; REGULATOR	Glioblastoma (GBM) is a highly malignant primary tumor of the central nervous system originating in glial cells. GBM results in more years of life lost than any other cancer type. Low levels of Notch receptor expression correlates with prolonged survival in various high grade gliomas independent of other markers. Different downstream pathways of Notch receptors have been identified. We tested if the Notch/Deltex pathway, which is distinct from the canonical, CSL-mediated pathway, has a role in GBM. We show that the alternative or non-canonical Notch pathway functioning through Deltex1 (DTX1) mediates key features of glioblastoma cell aggressiveness. For example, DTX1 activates the RTK/PI3K/PKB and the MAPK/ERK mitotic pathways and induces anti-apoptotic Mcl-1. The clonogenic and growth potential of established glioma cells correlated with DTX1 levels. Microarray gene expression analysis further identified a DTX1-specific, MAML1-independent transcriptional program - including microRNA-21- which is functionally linked to the changes in tumor cell aggressiveness. Over-expression of DTX1 increased cell migration and invasion correlating to ERK activation, miR-21 levels and endogenous Notch levels. In contrast to high and intermediate expressors, patients with low DTX1 levels have a more favorable prognosis. The alternative Notch pathway via DTX1 appears to be an oncogenic factor in glioblastoma and these findings offer new potential therapeutic targets.	[Huber, Roland M.; Sivasankaran, Balasubramanian; Merlo, Adrian] Univ Basel, Dept Biomed, Basel, Switzerland; [Huber, Roland M.; Moncayo, Gerald; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Mech Canc Program, Basel, Switzerland; [Rajski, Michal] Univ Zurich, Inst Physiol, Zurich, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research; University of Zurich	Huber, RM (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	rhuber@fhcrc.org	Sivasankaran, Balasubramanian/D-1527-2015	Sivasankaran, Balasubramanian/0000-0001-6207-5516	Oncosuisse grant [OCS-01613-12-2004]	Oncosuisse grant	This study was supported by Oncosuisse grant #OCS-01613-12-2004 (www.swisscancer.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Boulay JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000576; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Grzmil M, 2010, BBA-PROTEINS PROTEOM, V1804, P476, DOI 10.1016/j.bbapap.2009.10.018; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Hu QD, 2004, ANN ACAD MED SINGAP, V33, P581; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; HUETTNER C, 1995, AM J PATHOL, V146, P317; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Lino M, 2009, CURR OPIN CELL BIOL, V21, P311, DOI 10.1016/j.ceb.2008.12.009; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sivasankaran B, 2009, CANCER RES, V69, P458, DOI 10.1158/0008-5472.CAN-08-2610; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Stupp R, 2005, ONKOLOGIE, V28, P315, DOI 10.1159/000085575; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Suzuki K, 2005, BIOORGAN MED CHEM, V13, P4014, DOI 10.1016/j.bmc.2005.03.053; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314; Zhang P, 2010, ONCOGENE, V29, P2916, DOI 10.1038/onc.2010.62; Zhang X, 2011, CANC SCI; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	56	32	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57793	10.1371/journal.pone.0057793	http://dx.doi.org/10.1371/journal.pone.0057793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451269	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500134
J	Ma, Y; Bian, JM; Cao, HY				Ma, Yong; Bian, Jianmin; Cao, Hongyong			MDM2 SNP309 rs2279744 Polymorphism and Gastric Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; SUSCEPTIBILITY; PROMOTER; CARDIA	Background: MDM2 is a major negative regulator of p53, and a single nucleotide polymorphism (SNP) in the MDM2 promoter region SNP309 has been demonstrated to be associated with an increased MDM2 expression and a significantly earlier age of onset of several tumors, including gastric cancer. Several studies were published to evaluate the association between SNP309 and gastric cancer risk. However, the results remain conflicting rather than conclusive. Objective: The aim of this study was to assess the association between the MDM2 SNP309 polymorphism and gastric risk. Methods: We performed a meta-analysis to investigate this relationship. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association. The pooled ORs were performed for codominant model, dominant model, and recessive model, respectively. Results: Five published case-control studies, including 1,621 gastric cancer cases and 2,639 controls were identified. We found that the MDM2 SNP309 polymorphism was associated with a significantly increased risk of gastric cancer risk when all studies were pooled into the meta-analysis (GG versus TT, OR = 1.54; 95%CI = 1.04-2.29, and GG versus GT/TT, OR = 1.49, 95% CI = 1.30-1.72). Furthermore, Egger's test did not show any evidence of publication bias (P = 0.799 for GG versus TT). Conclusion: Our results suggest that the MDM2 SNP309 polymorphism may be a low-penetrant risk factor for the development of gastric cancer.	[Ma, Yong; Bian, Jianmin; Cao, Hongyong] Nanjing Med Univ, Nanjing Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Ma, Y (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	njmayong@163.com						Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; [曹延延 CAO Yanyan], 2007, [肿瘤, Tumor], V27, P628; Cho YG, 2008, NEOPLASMA, V55, P256; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Geng Jing-shu, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P53; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Moll UM, 2003, MOL CANCER RES, V1, P1001; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Olivier Magali, 2004, IARC Sci Publ, P247; Wang XY, 2009, HELICOBACTER, V14, P114, DOI 10.1111/j.1523-5378.2009.00712.x; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Zhang ZF, 1997, NUTR CANCER, V27, P298, DOI 10.1080/01635589709514541	17	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56918	10.1371/journal.pone.0056918	http://dx.doi.org/10.1371/journal.pone.0056918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451111	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500043
J	Popat, H; Richmond, S; Zhurov, AI; Rosin, PL; Marshall, D				Popat, Hashmat; Richmond, Stephen; Zhurov, Alexei I.; Rosin, Paul L.; Marshall, David			A Geometric Morphometric Approach to the Analysis of Lip Shape during Speech: Development of a Clinical Outcome Measure	PLOS ONE			English	Article							FACIAL EXPRESSIONS; REPRODUCIBILITY; MOVEMENT; GROWTH; MOTION	Objective assessments of lip movement can be beneficial in many disciplines including visual speech recognition, for surgical outcome assessment in patients with cleft lip and for the rehabilitation of patients with facial nerve impairments. The aim of this study was to develop an outcome measure for lip shape during speech using statistical shape analysis techniques. Lip movements during speech were captured from a sample of adult subjects considered as average using a three-dimensional motion capture system. Geometric Morphometrics was employed to extract three-dimensional coordinate data for lip shape during four spoken words decomposed into seven visemes (which included the resting lip shape). Canonical variate analysis was carried out in an attempt to statistically discriminate the seven visemes. The results showed that the second canonical variate discriminated the resting lip shape from articulation of the utterances and accounted for 17.2% of the total variance of the model. The first canonical variate was significant in discriminating between the utterances and accounted for 72.8% of the total variance of the model. The outcome measure was created using the 95% confidence intervals of the canonical variate scores for each subject plotted as ellipses for each viseme. The method and outcome model is proposed as reference to compare lip movement during speech in similar population groups.	[Popat, Hashmat; Richmond, Stephen; Zhurov, Alexei I.] Cardiff Univ, Sch Dent, Cardiff CF10 3AX, S Glam, Wales; [Rosin, Paul L.; Marshall, David] Cardiff Univ, Cardiff Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Popat, H (corresponding author), Cardiff Univ, Sch Dent, Cardiff CF10 3AX, S Glam, Wales.	popath@cardiff.ac.uk	Zhurov, Alexei I/P-4410-2014; Richmond, Steve/K-6696-2012	Zhurov, Alexei I/0000-0002-5594-0740; Richmond, Steve/0000-0001-5449-5318; Rosin, Paul/0000-0002-4965-3884	Cardiff University	Cardiff University	The study was funded by Cardiff University as a Ph.D. project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens H, 1958, BIOMETRIKA TABLES ST; Aleksic PS, 2009, ESSENTIAL GUIDE TO VIDEO PROCESSING, 2ND EDITION, P689, DOI 10.1016/B978-0-12-374456-2.00024-4; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; Dawes KS, 2005, MED ENG PHYS, V27, P523, DOI 10.1016/j.medengphy.2004.11.007; Duffy J. R., 2020, MOTOR SPEECH DISORDE, V4th; Fidell L., 2007, USING MULTIVARIATE S, P607; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gupta S, 2010, INT J COMPUT VISION, V90, P331, DOI 10.1007/s11263-010-0360-8; HANS MG, 1994, AM J ORTHOD DENTOFAC, V105, P598, DOI 10.1016/S0889-5406(94)70145-8; Hennessy RJ, 2001, EUR J ORTHODONT, V23, P275, DOI 10.1093/ejo/23.3.275; HOUSE JW, 1983, LARYNGOSCOPE, V93, P1056; Johnston DJ, 2003, CLEFT PALATE-CRAN J, V40, P291, DOI 10.1597/1545-1569(2003)040<0291:AFER>2.0.CO;2; Kau CH, 2005, J ORTHOD, V32, P282, DOI 10.1179/146531205225021285; Mishima K, 2006, COMPUT MED IMAG GRAP, V30, P53, DOI 10.1016/j.compmedimag.2005.11.002; Neely JG, 2010, OTOL NEUROTOL, V31, P1488, DOI 10.1097/MAO.0b013e3181edb6b8; PEARSON D, 1981, IEEE T COMMUN, V29, P1986, DOI 10.1109/TCOM.1981.1094934; Popat H, 2012, ORTHOD CRANIOFAC RES, V15, P92, DOI 10.1111/j.1601-6343.2011.01539.x; Popat H, 2009, COMPUT MED IMAG GRAP, V33, P377, DOI 10.1016/j.compmedimag.2009.03.003; Popat H, 2010, OTOLARYNG HEAD NECK, V142, P867, DOI 10.1016/j.otohns.2010.03.003; Qifeng Z, 2000, USE VARIABLE FRAME R, P1783; Roach Peter., 2004, J INT PHON ASSOC, V34, P239, DOI [DOI 10.1017/S0025100304001768, 10.1017/S0025100304001768]; Savran A, 2008, LECT NOTES COMPUT SC, V5372, P47, DOI 10.1007/978-3-540-89991-4_6; Sawyer AR, 2009, OTOLARYNG HEAD NECK, V140, P76, DOI 10.1016/j.otohns.2008.09.007; Sell D, 1999, INT J LANG COMM DIS, V34, P17; Sidorov K. A., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2401, DOI 10.1109/CVPR.2011.5995632; Sjogreen L, 2011, J ORAL REHABIL, V38, P410, DOI 10.1111/j.1365-2842.2010.02168.x; Toma AM, 2009, ORTHOD CRANIOFAC RES, V12, P33, DOI 10.1111/j.1601-6343.2008.01435.x; WOOD DA, 1994, AM J OTOL, V15, P61	29	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57368	10.1371/journal.pone.0057368	http://dx.doi.org/10.1371/journal.pone.0057368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451213	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500093
J	Sehgal, P; Chaturvedi, P; Kumaran, RI; Kumar, S; Parnaik, VK				Sehgal, Poonam; Chaturvedi, Pankaj; Kumaran, R. Ileng; Kumar, Satish; Parnaik, Veena K.			Lamin A/C Haploinsufficiency Modulates the Differentiation Potential of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; A-TYPE LAMINS; NUCLEAR LAMINS; TRANSCRIPTION FACTORS; VISCERAL ENDODERM; DILATED CARDIOMYOPATHY; DEFINITIVE ENDODERM; ALPHA-FETOPROTEIN; EXPRESSION; GENE	Background: Lamins are structural proteins that are the major determinants of nuclear architecture and play important roles in various nuclear functions including gene regulation and cell differentiation. Mutations in the human lamin A gene cause a spectrum of genetic diseases that affect specific tissues. Most available mouse models for laminopathies recapitulate disease symptoms for muscle diseases and progerias. However, loss of human lamin A/C also has highly deleterious effects on fetal development. Hence it is important to understand the impact of lamin A/C expression levels on embryonic differentiation pathways. Methodology and Principal Findings: We have investigated the differentiation potential of mouse embryonic stem cells containing reduced levels of lamin A/C by detailed lineage analysis of embryoid bodies derived from these cells by in vitro culture. We initially carried out a targeted disruption of one allele of the mouse lamin A/C gene (Lmna). Undifferentiated wild-type and Lmna(+/-) embryonic stem cells showed similar expression of pluripotency markers and cell cycle profiles. Upon spontaneous differentiation into embryoid bodies, markers for visceral endoderm such as alpha-fetoprotein were highly upregulated in haploinsufficient cells. However, neuronal markers such as beta-III tubulin and nestin were downregulated. Furthermore, we observed a reduction in the commitment of Lmna(+/-) cells into the myogenic lineage, but no discernible effects on cardiac, adipocyte or osteocyte lineages. In the next series of experiments, we derived embryonic stem cell clones expressing lamin A/C short hairpin RNA and examined their differentiation potential. These cells expressed pluripotency markers and, upon differentiation, the expression of lineage-specific markers was altered as observed with Lmna(+/-) embryonic stem cells. Conclusions: We have observed significant effects on embryonic stem cell differentiation to visceral endoderm, neuronal and myogenic lineages upon depletion of lamin A/C. Hence our results implicate lamin A/C level as an important determinant of lineage-specific differentiation during embryonic development.	[Sehgal, Poonam; Chaturvedi, Pankaj; Kumaran, R. Ileng; Kumar, Satish; Parnaik, Veena K.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Parnaik, VK (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	veenap@ccmb.res.in	Sehgal, Poonam/AAA-7935-2021; Chaturvedi, Pankaj/ABC-4658-2020	Sehgal, Poonam/0000-0003-3704-6283; Chaturvedi, Pankaj/0000-0001-7596-2165	JC Bose national fellowship from the Department of Science and Technology, India; Council of Scientific and Industrial Research, India; Department of Science and Technology; Council of Scientific and Industrial Research	JC Bose national fellowship from the Department of Science and Technology, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	VKP is a recipient of the JC Bose national fellowship from the Department of Science and Technology, India. PS and RIK were supported by pre-doctoral fellowships from the Council of Scientific and Industrial Research, India. PC was supported by a research fellowship from the Department of Science and Technology. Financial support from the Department of Science and Technology and Council of Scientific and Industrial Research for this work is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; ANG SL, 1993, DEVELOPMENT, V119, P1301; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Coffinier C, 1999, DEVELOPMENT, V126, P4785; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Cupesi M, 2010, J MOL CELL CARDIOL, V48, P1290, DOI 10.1016/j.yjmcc.2009.10.024; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dufort D, 1998, DEVELOPMENT, V125, P3015; Duque G, 2011, BONE, V49, P412, DOI 10.1016/j.bone.2011.04.023; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V43, P289; Favreau C, 2004, MOL CELL BIOL, V24, P1481, DOI 10.1128/MCB.24.4.1481-1492.2004; Foster HA, 2007, CHROMOSOME RES, V15, P163, DOI 10.1007/s10577-006-1088-8; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Hall VJ, 2005, MOL REPROD DEV, V72, P471, DOI 10.1002/mrd.20381; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Jung HJ, 2012, P NATL ACAD SCI USA, V109, pE423, DOI 10.1073/pnas.1111780109; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Kennedy KAM, 2010, J BIOL CHEM, V285, P17974, DOI 10.1074/jbc.M109.084616; Kim WK, 2008, ENDOCR J, V55, P827, DOI 10.1507/endocrj.K08E-115; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; MARTIN GR, 1977, DEV BIOL, V61, P230, DOI 10.1016/0012-1606(77)90294-9; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Metzger JM, 1996, CIRC RES, V78, P547, DOI 10.1161/01.RES.78.4.547; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Niwa H, 2010, DEV GROWTH DIFFER, V52, P275, DOI 10.1111/j.1440-169X.2009.01166.x; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Parnaik VK, 2006, J BIOSCIENCES, V31, P405, DOI 10.1007/BF02704113; Parnaik VK, 2011, J BIOSCIENCES, V36, P471, DOI 10.1007/s12038-011-9085-2; Pekovic V, 2008, J ANAT, V213, P5, DOI 10.1111/j.1469-7580.2008.00928.x; Perrien DS, 2006, J CLIN ENDOCR METAB, V91, P1848, DOI 10.1210/jc.2005-2423; ROBER RA, 1989, DEVELOPMENT, V105, P365; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4727, DOI 10.1073/pnas.82.14.4727; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tong J, 2011, MECH AGEING DEV, V132, P552, DOI 10.1016/j.mad.2011.09.004; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Young SG, 2012, J BIOL CHEM, V287, P16103, DOI 10.1074/jbc.R112.354407; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	71	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57891	10.1371/journal.pone.0057891	http://dx.doi.org/10.1371/journal.pone.0057891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451281	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000316849500143
J	Shekarabi, M; Lafreniere, RG; Gaudet, R; Laganiere, J; Marcinkiewicz, MM; Dion, PA; Rouleau, GA				Shekarabi, Masoud; Lafreniere, Ron G.; Gaudet, Rebecca; Laganiere, Janet; Marcinkiewicz, Martin M.; Dion, Patrick A.; Rouleau, Guy A.			Comparative Analysis of the Expression Profile of Wnk1 and Wnk1/Hsn2 Splice Variants in Developing and Adult Mouse Tissues	PLOS ONE			English	Article							CL-COTRANSPORTER; BLOOD-PRESSURE; KINASE; GENE; MUTATIONS; HYPERTENSION; POTASSIUM; EPITHELIA; ISOFORMS; PATHWAY	The With No lysine (K) family of serine/threonine kinase (WNK) defines a small family of kinases with significant roles in ion homeostasis. WNK1 has been shown to have different isoforms due to what seems to be largely tissue specific splicing. Here, we used two distinct in situ hybridization riboprobes on developing and adult mouse tissues to make a comparative analysis of Wnk1 and its sensory associated splice isoform, Wnk1/Hsn2. The hybridization signals in developing mouse tissues, which were prepared at embryonic day e10.5 and e12.5, revealed a homogenous expression profile with both probes. At e15.5 and in the newborn mouse, the two probes revealed different expression profiles with prominent signals in nervous system tissues and also other tissues such as kidney, thymus and testis. In adult mouse tissues, the two expression profiles appeared even more restricted to the nervous tissues, kidney, thymus and testis, with no detectable signal in the other tissues. Throughout the nervous system, sensory tissues, as well as in Cornu Ammonis 1 (CA1), CA2 and CA3 areas of the hippocampus, were strongly labeled with both probes. Hybridization signals were also strongly detected in Schwann and supporting satellite cells. Our results show that the expression profiles of Wnk1 isoforms change during the development, and that the expression of the Wnk1 splice variant containing the Hsn2 exon is prominent during developing and in adult mouse tissues, suggesting its important role in the development and maintenance of the nervous system.	[Shekarabi, Masoud; Lafreniere, Ron G.; Gaudet, Rebecca; Laganiere, Janet; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, CRCHUM, Univ Montreal CENUM, Ctr Excellence Neurosci, Montreal, PQ, Canada; [Marcinkiewicz, Martin M.] Cytochem Inc, Montreal, PQ, Canada; [Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Paediat & Biochem, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, CRCHUM, Univ Montreal CENUM, Ctr Excellence Neurosci, Montreal, PQ, Canada.	guy.rouleau@umontreal.ca			Canadian Institutes of Health Research [IG1-78904]; Fondation de Jumelle Coude	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation de Jumelle Coude	This work was supported by a research grant (IG1-78904) from the Canadian Institutes of Health Research to GAR and the Fondation de Jumelle Coude. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergaya S, 2012, CURR OPIN NEPHROL HY, V21, P39, DOI 10.1097/MNH.0b013e32834d2fde; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Glover M, 2009, J AM SOC NEPHROL, V20, P1314, DOI 10.1681/ASN.2008050542; Holden S, 2004, GENE, V335, P109, DOI 10.1016/j.gene.2004.03.009; Hoorn EJ, 2011, J AM SOC NEPHROL, V22, P605, DOI 10.1681/ASN.2010080827; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Thastrup JO, 2011, BIOCH J; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vidal-Petiot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037751; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094	21	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57807	10.1371/journal.pone.0057807	http://dx.doi.org/10.1371/journal.pone.0057807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451271	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500136
J	van der Marel, K; Homberg, JR; Otte, WM; Dijkhuizen, RM				van der Marel, Kajo; Homberg, Judith R.; Otte, Willem M.; Dijkhuizen, Rick M.			Functional and Structural Neural Network Characterization of Serotonin Transporter Knockout Rats	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; GENETIC-VARIATION; DOPAMINE TRANSPORTER; CORPUS-CALLOSUM; COCAINE REWARD; BRAIN; ISOFLURANE; CONNECTIVITY; 5-HTTLPR; ANXIETY	Brain serotonin homeostasis is crucially maintained by the serotonin transporter (5-HTT), and its down-regulation has been linked to increased vulnerability for anxiety- and depression-related behavior. Studies in 5-HTT knockout (5-HTT-/-) rodents have associated inherited reduced functional expression of 5-HTT with increased sensitivity to adverse as well as rewarding environmental stimuli, and in particular cocaine hyperresponsivity. 5-HTT down-regulation may affect normal neuronal wiring of implicated corticolimbic cerebral structures. To further our understanding of its contribution to potential alterations in basal functional and structural properties of neural network configurations, we applied resting-state functional MRI (fMRI), pharmacological MRI of cocaine-induced activation, and diffusion tensor imaging (DTI) in 5-HTT-/- rats and wildtype controls (5-HTT+/+). We found that baseline functional connectivity values and cocaine-induced neural activity within the corticolimbic network was not significantly altered in 5-HTT-/- versus 5-HTT+/+ rats. Similarly, DTI revealed mostly intact white matter structural integrity, except for a reduced fractional anisotropy in the genu of the corpus callosum of 5-HTT-/- rats. At the macroscopic level, analyses of complex graphs constructed from either functional connectivity values or structural DTI-based tractography results revealed that key properties of brain network organization were essentially similar between 5-HTT+/+ and 5-HTT-/- rats. The individual tests for differences between 5-HTT+/+ and 5-HTT-/- rats were capable of detecting significant effects ranging from 5.8% (fractional anisotropy) to 26.1% (pharmacological MRI) and 29.3% (functional connectivity). Tentatively, lower fractional anisotropy in the genu of the corpus callosum could indicate a reduced capacity for information integration across hemispheres in 5-HTT-/- rats. Overall, the comparison of 5-HTT-/- and wild-type rats suggests mostly limited effects of 5-HTT genotype on MRI-based measures of brain morphology and function.	[van der Marel, Kajo; Otte, Willem M.; Dijkhuizen, Rick M.] Univ Med Ctr Utrecht, Image Sci Inst, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands; [Homberg, Judith R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pediat Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	van der Marel, K (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands.	kajo@isi.uu.nl	Otte, Willem M./J-6140-2019; Homberg, Judith R/D-2473-2010; Homberg, J.R./N-4172-2019; Otte, Willem M/I-1228-2013	Otte, Willem M./0000-0003-1511-6834; Otte, Willem M/0000-0003-1511-6834; Dijkhuizen, Rick/0000-0002-4623-4078; van der Marel, Kajo/0000-0003-1099-9498	Netherlands Brain Foundation [15F07(2).20]; Utrecht University's High Potential program	Netherlands Brain Foundation; Utrecht University's High Potential program	This work has been financially supported by a grant of the Netherlands Brain Foundation (15F07(2).20) (JRH), and Utrecht University's High Potential program (RMD). The grant providers had no further role in the design of the study, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.	Altamura C, 2007, CEREB CORTEX, V17, P1394, DOI 10.1093/cercor/bhl051; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bearer EL, 2007, NEUROIMAGE, V37, pS37, DOI 10.1016/j.neuroimage.2007.04.053; Bearer EL, 2009, NEUROIMAGE, V46, P1091, DOI 10.1016/j.neuroimage.2009.03.026; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Byas-Smith MG, 2004, SYNAPSE, V53, P68, DOI 10.1002/syn.20037; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Du CW, 2009, EUR J NEUROSCI, V30, P1565, DOI 10.1111/j.1460-9568.2009.06931.x; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; Gerra G, 2007, AM J MED GENET B, V144B, P52, DOI 10.1002/ajmg.b.30388; Gokturk C, 2008, ARCH WOMEN MENT HLTH, V11, P347, DOI 10.1007/s00737-008-0033-6; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Homberg JR, 2008, PSYCHOPHARMACOLOGY, V200, P367, DOI 10.1007/s00213-008-1212-x; Homberg JR, 2012, NEUROSCI BIOBEHAV R, V36, P218, DOI 10.1016/j.neubiorev.2011.06.001; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Koob GF, 2009, PHARMACOPSYCHIATRY, V42, pS32, DOI 10.1055/s-0029-1216356; Lee TW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-33; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Lowe AS, 2008, NMR BIOMED, V21, P859, DOI 10.1002/nbm.1272; Mandeville JB, 2004, MAGNET RESON MED, V52, P1272, DOI 10.1002/mrm.20278; Margoob Mushtaq A, 2011, Indian J Psychiatry, V53, P289, DOI 10.4103/0019-5545.91901; MARTIN DC, 1990, NEUROCHEM RES, V15, P969, DOI 10.1007/BF00965741; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011; Nonkes LJP, 2013, ADDICT BIOL, V18, P434, DOI 10.1111/j.1369-1600.2011.00351.x; Nonkes LJP, 2011, BEHAV PHARMACOL, V22, P723, DOI 10.1097/FBP.0b013e32834d6260; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Olivier JDA, 2010, EXPT MODELS SEROTONI, P170, DOI [10.1017/CBO9780511729935, DOI 10.1017/CBO9780511729935]; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Pang RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023869; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pendse GV, 2010, J MAGN RESON IMAGING, V31, P1445, DOI 10.1002/jmri.22180; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Reyes-Haro D, 2003, J NEUROSCI RES, V74, P97, DOI 10.1002/jnr.10724; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Tsukada H, 1999, BRAIN RES, V849, P85, DOI 10.1016/S0006-8993(99)02018-1; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Upton AL, 2002, NEUROSCIENCE, V111, P597, DOI 10.1016/S0306-4522(01)00602-9; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Viviani R, 2010, BIOL PSYCHIAT, V67, P317, DOI 10.1016/j.biopsych.2009.08.035; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Whittington RA, 2006, ANESTH ANALG, V103, P92, DOI 10.1213/01.ane.0000221488.48352.61; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009	94	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57780	10.1371/journal.pone.0057780	http://dx.doi.org/10.1371/journal.pone.0057780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451267	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500132
J	Yang, J; Yang, ZX; Lv, HJ; Lou, Y; Wang, J; Wu, NP				Yang, Jin; Yang, Zongxing; Lv, Hangjun; Lou, Yi; Wang, Juan; Wu, Nanping			Bridging HIV-1 Cellular Latency and Clinical Long-Term Non-Progressor: An Interactomic View	PLOS ONE			English	Article							LOW-LEVEL VIREMIA; GENE-EXPRESSION; TRANSCRIPTIONAL PROFILES; BIOLOGICAL NETWORKS; T-CELLS; INFECTION; REACTIVATION; IDENTIFICATION; PROTEINS	Development of an effective HIV management is enticed by the fact that long-term non-progressors (LTNP) restrict viral replication spontaneously, but is hindered by HIV-1 latency. Given that the most overlapping characteristics found between HIV-1 LTNP and latency, detailed analysis of the difference would disclose the essentials of latency. In this study, microarray data from our previous study was combined with HIV-1 latency and LTNP data obtained from NCBI GEO database. Principal variance component analysis and hierarchical clustering verified the removal of batch effect across platform. The analysis revealed a total of 456 differential expressed genes with >2-fold change and B-statistic >0. Bayesian inference was used to reconstitute the transcriptional network of HIV-1 latency or LTNP, respectively. Gene regulation was reprogrammed under different disease condition. By network interference, KPNA2 and ATP5G3 were identified as the hubs in latency network which mediate nuclear export and RNA processing. These data offer comparative insights into HIV-1 latency, which will facilitate the understanding of the genetic basis of HIV-1 latency in vivo and serve as a clue for future treatment dealing with key targets in HIV-1 latency.	[Yang, Jin; Yang, Zongxing; Wang, Juan; Wu, Nanping] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Inst In, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Jin; Lv, Hangjun] Blood Ctr Zhejiang Prov, Dept Med, Hangzhou, Zhejiang, Peoples R China; [Lou, Yi] Hangzhou Normal Univ, Dept Med, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University	Wu, NP (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Inst In, Hangzhou 310003, Zhejiang, Peoples R China.	flwnp@yahoo.com.cn	yu, yu/AAL-5178-2020	, Jin Yang/0000-0001-8018-4556	National Natural Science Foundation of China [87024787, 81273313]; National Key Projects of China [2012ZX10001-003-004]; Zhejiang medical development project [2012KYA060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Projects of China; Zhejiang medical development project	This work was supported by the National Natural Science Foundation of China (Grant No. 87024787, No. 81273313), National Key Projects of China (Grant No. 2012ZX10001-003-004), Zhejiang medical development project (Grant No. 2012KYA060); http://isisn.nsfc.gov.cn/egrantweb/; http://www.zjmed.org.cn/20120504/2012050400001.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Caly L, 2012, ANTIVIR RES, V95, P202, DOI 10.1016/j.antiviral.2012.06.008; Cheng G, 2011, BIOMED PHARMACOTHER, V65, P230, DOI 10.1016/j.biopha.2011.02.012; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Dahl V, 2010, ANTIVIR RES, V85, P286, DOI 10.1016/j.antiviral.2009.09.016; Diboun I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-252; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Fujimura K, 2010, BBA-MOL CELL RES, V1803, P865, DOI 10.1016/j.bbamcr.2010.03.020; Gandhi RT, 2010, J INFECT DIS, V201, P293, DOI 10.1086/649569; Hakre S, 2012, FEMS MICROBIOL REV, V36, P706, DOI 10.1111/j.1574-6976.2012.00335.x; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Ooi BNS, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-13; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pentchev K, 2010, BIOINFORMATICS, V26, P2796, DOI 10.1093/bioinformatics/btq522; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Salgado M, 2011, VIROLOGY, V411, P103, DOI 10.1016/j.virol.2010.12.037; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Shen A, 2005, IMMUNOLOGY, V116, P276, DOI 10.1111/j.1365-2567.2005.02222.x; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tyler AL, 2009, BIOESSAYS, V31, P220, DOI 10.1002/bies.200800022; Veloso S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-63; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Wu JQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-18; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	53	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55791	10.1371/journal.pone.0055791	http://dx.doi.org/10.1371/journal.pone.0055791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451031	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500005
J	Zhang, Y; Jiang, N; Zarnitsyna, VI; Klopocki, AG; McEver, RP; Zhu, C				Zhang, Yan; Jiang, Ning; Zarnitsyna, Veronika I.; Klopocki, Arkadiusz G.; McEver, Rodger P.; Zhu, Cheng			P-Selectin Glycoprotein Ligand-1 Forms Dimeric Interactions with E-Selectin but Monomeric Interactions with L-Selectin on Cell Surfaces	PLOS ONE			English	Article							CLATHRIN-COATED PITS; LEUKOCYTE ADHESION; 2-DIMENSIONAL KINETICS; BINDING-KINETICS; RECEPTOR; INTEGRIN; TRANSMEMBRANE; DIMERIZATION; BONDS; IDENTIFICATION	Interactions of selectins with cell surface glycoconjugates mediate the first step of the adhesion and signaling cascade that recruits circulating leukocytes to sites of infection or injury. P-selectin dimerizes on the surface of endothelial cells and forms dimeric bonds with P-selectin glycoprotein ligand-1 (PSGL-1), a homodimeric sialomucin on leukocytes. It is not known whether leukocyte L-selectin or endothelial cell E-selectin are monomeric or oligomeric. Here we used the micropipette technique to analyze two-dimensional binding of monomeric or dimeric L- and E-selectin with monomeric or dimeric PSGL-1. Adhesion frequency analysis demonstrated that E-selectin on human aortic endothelial cells supported dimeric interactions with dimeric PSGL-1 and monomeric interactions with monomeric PSGL-1. In contrast, L- selectin on human neutrophils supported monomeric interactions with dimeric or monomeric PSGL-1. Our work provides a new method to analyze oligomeric cross-junctional molecular binding at the interface of two interacting cells.	[Zhang, Yan; Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Jiang, Ning; Zarnitsyna, Veronika I.; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Klopocki, Arkadiusz G.; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Jiang, Ning/M-5448-2017	Jiang, Ning/0000-0003-1103-5922; Zhu, Cheng/0000-0002-1718-565X; Zarnitsyna, Veronika/0000-0003-3096-3695; Zhang, Yan/0000-0001-5791-4389	National Institutes of Health grant [AI077343, HL034363]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034363, R01HL034363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077343, R56AI077343] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI077343 and HL034363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkalow FJ, 2000, BLOOD, V96, P3070; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Dwir O, 2002, J BIOL CHEM, V277, P21130, DOI 10.1074/jbc.M201999200; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; ERBE DV, 1992, J CELL BIOL, V119, P215, DOI 10.1083/jcb.119.1.215; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; Laplantine E, 2002, BIOL CELL, V94, P375, DOI 10.1016/S0248-4900(02)00009-6; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P219; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Myou S, 2002, IMMUNOLOGY, V107, P77, DOI 10.1046/j.1365-2567.2002.01486.x; Newton JP, 1999, BIOCHEM BIOPH RES CO, V261, P283, DOI 10.1006/bbrc.1999.1018; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Powell MS, 2006, J IMMUNOL, V176, P7489, DOI 10.4049/jimmunol.176.12.7489; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Rose SL, 2007, ANN BIOMED ENG, V35, P1382, DOI 10.1007/s10439-007-9311-0; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Sarangapani KK, 2011, J BIOL CHEM, V286, P9567, DOI 10.1074/jbc.M110.196485; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Setiadi H, 2003, J CELL BIOL, V163, P1385, DOI 10.1083/jcb.200307178; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shao B, 2012, J BIOL CHEM IN PRESS; Sigalov AB, 2008, ADV EXP MED BIOL, V640, P121, DOI 10.1007/978-0-387-09789-3_12; Srinivasan S, 2011, BBA-BIOMEMBRANES, V1808, P1709, DOI 10.1016/j.bbamem.2011.02.006; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Sulchek T, 2006, BIOPHYS J, V90, P4686, DOI 10.1529/biophysj.105.080291; Troyanovsky RB, 2007, MOL BIOL CELL, V18, P4343, DOI 10.1091/mbc.E07-01-0084; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Xia LJ, 2004, BLOOD, V104, P3091, DOI 10.1182/blood-2004-02-0650; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Zarnitsyna VI, 2011, JOVE-J VIS EXP, DOI 10.3791/3519; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200	65	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57202	10.1371/journal.pone.0057202	http://dx.doi.org/10.1371/journal.pone.0057202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451187	Green Published, gold			2022-12-27	WOS:000316849500078
J	Al Dhaheri, Y; Eid, A; AbuQamar, S; Attoub, S; Khasawneh, M; Aiche, G; Hisaindee, S; Iratni, R				Al Dhaheri, Yusra; Eid, Ali; AbuQamar, Synan; Attoub, Samir; Khasawneh, Mohammad; Aiche, Ghenima; Hisaindee, Soleiman; Iratni, Rabah			Mitotic Arrest and Apoptosis in Breast Cancer Cells Induced by Origanum majorana Extract: Upregulation of TNF-alpha and Downregulation of Survivin and Mutant p53	PLOS ONE			English	Article							VOLATILE OIL; INHIBITION; PHYTOCHEMICALS; EXPRESSION; TOXICITY; PROTEINS; RECEPTOR	Background: In the present study, we investigated the effect of Origanum majorana ethanolic extract on the survival of the highly proliferative and invasive triple-negative p53 mutant breast cancer cell line MDA-MB-231. Results: We found that O. majorana extract (OME) was able to inhibit the viability of the MDA-MB-231 cells in a time- and concentration-dependent manner. The effect of OME on cellular viability was further confirmed by the inhibition of colony growth. We showed, depending on the concentration used, that OME elicited different effects on the MDA-MB 231 cells. Concentrations of 150 and 300 mu g/mL induced an accumulation of apoptotic-resistant population of cells arrested in mitotis and overexpressing the cyclin-dependent kinase inhibitor, p21 and the inhibitor of apoptosis, survivin. On the other hand, higher concentrations of OME (450 and 600 mu g/mL) triggered a massive apoptosis through the extrinsic pathway, including the activation of tumor necrosis factor-alpha (TNF-alpha), caspase 8, caspase 3, and cleavage of PARP, downregulation of survivin as well as depletion of the mutant p53 in MDA-MB-231 cells. Furthermore, OME induced an upregulation of gamma-H2AX, a marker of double strand DNA breaks and an overall histone H3 and H4 hyperacetylation. Conclusion: Our findings provide strong evidence that O. majorana may be a promising chemopreventive and therapeutic candidate against cancer especially for highly invasive triple negative p53 mutant breast cancer; thus validating its complementary and alternative medicinal use.	[Al Dhaheri, Yusra; Eid, Ali; AbuQamar, Synan; Iratni, Rabah] United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates; [Attoub, Samir] United Arab Emirates Univ, Dept Pharmacol & Therapeut, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Khasawneh, Mohammad; Hisaindee, Soleiman] United Arab Emirates Univ, Dept Chem, Coll Sci, UAE Univ, Al Ain, U Arab Emirates; [Aiche, Ghenima] Univ Mouloud Mammeri, Dept Biochem & Microbiol, Fac Sci Biol & Agron, Tizi Ouzou, Algeria	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; Universite Mouloud Mammeri de Tizi Ouzou	Iratni, R (corresponding author), United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates.	R_iratni@uaeu.ac.ae	Attoub, Samir/N-6852-2018; Eid, Ali Hussein/ABD-6291-2021; Hisaindee, Soleiman/AAK-4862-2020; AbuQamar, Synan/AAV-1229-2021	Eid, Ali Hussein/0000-0003-3004-5675; Hisaindee, Soleiman/0000-0003-0084-8362; AbuQamar, Synan/0000-0002-2129-7689	Faculty of Science interdisciplinary research grant UAE University; Emirates Foundation research grant [2009-80]	Faculty of Science interdisciplinary research grant UAE University; Emirates Foundation research grant	This work was supported by the Faculty of Science interdisciplinary research grant UAE University and by the Emirates Foundation research grant (2009-80) to R. Iratni. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LS, 2010, CANCER RES, V70, P3594, DOI 10.1158/0008-5472.CAN-09-3565; Al-Harbi NO, 2011, J MED PLANTS RES, V5, P5479; American Cancer Society, 2012, CANC FACTS FIG; Attoub S, 2011, EUR J PHARMACOL, V651, P18, DOI 10.1016/j.ejphar.2010.10.063; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Cai Y, 2007, CANCER BIOL THER, V6, P1794, DOI 10.4161/cbt.6.11.4860; Chandele A, 2004, NEOPLASIA, V6, P29, DOI 10.1016/S1476-5586(04)80051-4; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Cragg GM, 2000, EXPERT OPIN INV DRUG, V9, P2783, DOI 10.1517/13543784.9.12.2783; El-Ashmawy I.M., 2007, ALEX J PHARM SCI, V21, P29; El-Ashmawy IM, 2007, BASIC CLIN PHARMACOL, V101, P320, DOI 10.1111/j.1742-7835.2007.00125.x; El-Ashmawy IM, 2005, BASIC CLIN PHARMACOL, V97, P238, DOI 10.1111/j.1742-7843.2005.pto_136.x; Fojo T, 2002, DRUG RESIST UPDATE, V5, P209, DOI 10.1016/S1368-7646(02)00119-X; Gu YH, 2006, ONCOL REP, V15, P417; Gupta S, 2003, INT J ONCOL, V22, P15; Han J, 2012, ONCOL REP, V27, P517, DOI 10.3892/or.2011.1511; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Kaczirek K, 2004, J CLIN ENDOCR METAB, V89, P2397, DOI 10.1210/jc.2003-031314; Konopleva M, 1999, ADV EXP MED BIOL, V457, P217; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Lee HS, 2008, J NUTR BIOCHEM, V19, P313, DOI 10.1016/j.jnutbio.2007.05.008; Leeja L, 2007, J ENVIRON BIOL, V28, P145; Lin LT, 2002, PHYTOTHER RES, V16, P440, DOI 10.1002/ptr.937; Ljungman M, 2010, ENVIRON MOL MUTAGEN, V51, P879, DOI 10.1002/em.20597; Maurer M, 2009, ANN NY ACAD SCI, V1171, P250, DOI 10.1111/j.1749-6632.2009.04717.x; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miron TL, 2011, J CHROMATOGR A, V1218, P4918, DOI 10.1016/j.chroma.2010.11.055; Nawab A., 2011, Molecular and Cellular Pharmacology, V3, P21; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Selivanova G, 2001, Curr Opin Investig Drugs, V2, P1136; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Tamm I, 1998, CANCER RES, V58, P5315; Teiten MH, 2010, GENES NUTR, V5, P61, DOI 10.1007/s12263-009-0152-3; Tsimogiannis D, 2006, INT J FOOD SCI TECH, V41, P39, DOI 10.1111/j.1365-2621.2006.01259.x; Vagi E, 2005, J AGR FOOD CHEM, V53, P17, DOI 10.1021/jf048777p; Vogel C, 2007, CANCER RES, V67, P339, DOI 10.1158/0008-5472.CAN-06-2548; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XT, 2011, J MED CHEM, V54, P809, DOI 10.1021/jm101199t; Watson WH, 2000, ANNU REV NUTR, V20, P485, DOI 10.1146/annurev.nutr.20.1.485; Yazdanparast R, 2008, VASC PHARMACOL, V48, P32, DOI 10.1016/j.vph.2007.11.003; Zhu H, 2007, MOL CANCER THER, V6, P484, DOI 10.1158/1535-7163.MCT-06-0584; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	46	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56649	10.1371/journal.pone.0056649	http://dx.doi.org/10.1371/journal.pone.0056649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451065	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800024
J	Meyer, J; Gorbach, AM; Liu, WM; Medic, N; Young, M; Nelson, C; Arceo, S; Desai, A; Metcalfe, DD; Komarow, HD				Meyer, Joseph; Gorbach, Alexander M.; Liu, Wei-Min; Medic, Nevenka; Young, Michael; Nelson, Celeste; Arceo, Sarah; Desai, Avanti; Metcalfe, Dean D.; Komarow, Hirsh D.			Mast Cell Dependent Vascular Changes Associated with an Acute Response to Cold Immersion in Primary Contact Urticaria	PLOS ONE			English	Article							ALLERGIC INFLAMMATION; CHOLINERGIC URTICARIA; HISTAMINE; ANAPHYLAXIS; BASOPHILS; TRYPTASE; RELEASE; MICROCIRCULATION; PATHOPHYSIOLOGY; DEGRANULATION	Background: While a number of the consequences of mast cell degranulation within tissues have been documented including tissue-specific changes such as bronchospasm and the subsequent cellular infiltrate, there is little known about the immediate effects of mast cell degranulation on the associated vasculature, critical to understanding the evolution of mast cell dependent inflammation. Objective: To characterize the microcirculatory events that follow mast cell degranulation. Methodology/Principal Findings: Perturbations in dermal blood flow, temperature and skin color were analyzed using laser-speckle contrast imaging, infrared and polarized-light colorimetry following cold-hand immersion (CHI) challenge in patients with cold-induced urticaria compared to the response in healthy controls. Evidence for mast cell degranulation was established by documentation of serum histamine levels and the localized release of tryptase in post-challenge urticarial biopsies. Laser-speckle contrast imaging quantified the attenuated response to cold challenge in patients on cetirizine. We found that the histamine-associated vascular response accompanying mast cell degranulation is rapid and extensive. At the tissue level, it is characterized by a uniform pattern of increased blood flow, thermal warming, vasodilation, and recruitment of collateral circulation. These vascular responses are modified by the administration of an antihistamine. Conclusions/Significance: Monitoring the hemodynamic responses within tissues that are associated with mast cell degranulation provides additional insight into the evolution of the acute inflammatory response and offers a unique approach to assess the effectiveness of treatment intervention.	[Meyer, Joseph; Gorbach, Alexander M.; Liu, Wei-Min] Natl Inst Biomed Imaging & Bioengn, Infrared Imaging & Thermometry Unit, NIH, Bethesda, MD USA; [Medic, Nevenka; Nelson, Celeste; Arceo, Sarah; Desai, Avanti; Metcalfe, Dean D.; Komarow, Hirsh D.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Young, Michael] NCI, Clin Res Directorate, CMRP, SAIC Frederick, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Komarow, HD (corresponding author), NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	komarowh@niaid.nih.gov		Liu, Wei-Min/0000-0002-3617-1739	Division of Intramural Research, NIAID, NIH; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000078] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Division of Intramural Research, NIAID, NIH. Support by M.Y. for this project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; COWEN T, 1979, BRIT J DERMATOL, V100, P635, DOI 10.1111/j.1365-2133.1979.tb08066.x; Cuss FM, 1999, CLIN EXP ALLERGY, V29, P54; Foster B, 2002, J ALLERGY CLIN IMMUN, V109, P287, DOI 10.1067/mai.2002.121454; Fromy B, 2010, J INVEST DERMATOL, V130, P849, DOI 10.1038/jid.2009.279; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gentinetta T, 2011, J ALLERGY CLIN IMMUN, V128, P1227, DOI 10.1016/j.jaci.2011.07.021; GRANDEL KE, 1985, NEW ENGL J MED, V313, P405, DOI 10.1056/NEJM198508153130702; Haas N, 1998, ARCH DERMATOL, V134, P41, DOI 10.1001/archderm.134.1.41; JUHLIN L, 1961, JAMA-J AM MED ASSOC, V177, P371, DOI 10.1001/jama.1961.73040320001004; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; KAPLAN AP, 1975, J ALLERGY CLIN IMMUN, V55, P394, DOI 10.1016/0091-6749(75)90078-0; Kingwell BA, 2003, DIABETES CARE, V26, P899, DOI 10.2337/diacare.26.3.899; KleinJan A, 2000, J ALLERGY CLIN IMMUN, V106, P677, DOI 10.1067/mai.2000.109621; LAWLOR F, 1989, CLIN EXP DERMATOL, V14, P416, DOI 10.1111/j.1365-2230.1989.tb02601.x; Leutenegger M, 2011, BIOMED OPT EXPRESS, V2, P1470, DOI 10.1364/BOE.2.001470; Lin RY, 2000, J ALLERGY CLIN IMMUN, V106, P65, DOI 10.1067/mai.2000.107600; MCCLEAN SP, 1989, J ALLERGY CLIN IMMUN, V83, P738, DOI 10.1016/0091-6749(89)90008-0; Merla A, 2002, IEEE ENG MED BIOL, V21, P73, DOI 10.1109/MEMB.2002.1175141; MINER PB, 1991, J INVEST DERMATOL, V96, pS40, DOI 10.1111/1523-1747.ep12469015; MURPHY GF, 1987, J ALLERGY CLIN IMMUN, V80, P603, DOI 10.1016/0091-6749(87)90015-7; Nhan BR, 2009, PHYSIOL MEAS, V30, pN23, DOI 10.1088/0967-3334/30/4/N01; O'Doherty J, 2007, SKIN RES TECHNOL, V13, P472, DOI 10.1111/j.1600-0846.2007.00253.x; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Pearlman DS, 1999, J ALLERGY CLIN IMMUN, V104, pS132, DOI 10.1016/S0091-6749(99)70308-8; Pellaton C, 2002, AM HEART J, V144, P269, DOI 10.1067/mhj.2002.123842; Cruz GAS, 2009, APPL RADIAT ISOTOPES, V67, pS54, DOI 10.1016/j.apradiso.2009.03.093; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V75, P479, DOI 10.1016/S0091-6749(85)80021-X; SOTER NA, 1976, NEW ENGL J MED, V294, P687, DOI 10.1056/NEJM197603252941302; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Taylor S, 2006, J AM ACAD DERMATOL, V54, pS282, DOI 10.1016/j.jaad.2005.12.041; Wanderer AA, 2004, IMMUNOL ALLERGY CLIN, V24, P259, DOI 10.1016/j.iac.2004.01.001	33	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56773	10.1371/journal.pone.0056773	http://dx.doi.org/10.1371/journal.pone.0056773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451084	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800036
J	Shakibaei, M; Mobasheri, A; Lueders, C; Busch, F; Shayan, P; Goel, A				Shakibaei, Mehdi; Mobasheri, Ali; Lueders, Cora; Busch, Franziska; Shayan, Paviz; Goel, Ajay			Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-kappa B and Src Protein Kinase Signaling Pathways	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; COLON-CANCER; ADJUVANT THERAPY; TUMOR-CELLS; APOPTOSIS; RESISTANCE; INFLAMMATION; SUPPRESSION; METASTASIS; ACTIVATION	Objective: Development of treatment resistance and adverse toxicity associated with classical chemotherapeutic agents highlights the need for safer and effective therapeutic approaches. Herein, we examined the effectiveness of a combination treatment regimen of 5-fluorouracil (5-FU) and curcumin in colorectal cancer (CRC) cells. Methods: Wild type HCT116 cells and HCT116+ch3 cells (complemented with chromosome 3) were treated with curcumin and 5-FU in a time- and dose-dependent manner and evaluated by cell proliferation assays, DAPI staining, transmission electron microscopy, cell cycle analysis and immunoblotting for key signaling proteins. Results: The individual IC50 of curcumin and 5-FU were approximately 20 mu M and 5 mu M in HCT116 cells and 5 mu M and 1 mu M in HCT116+ch3 cells, respectively (p<0.05). Pretreatment with curcumin significantly reduced survival in both cells; HCT116+ch3 cells were considerably more sensitive to treatment with curcumin and/or 5-FU than wild-type HCT116 cells. The IC50 values for combination treatment were approximately 5 mu M and 1 mu M in HCT116 and 5 mu M and 0.1 mu M in HCT116+ch3, respectively (p<0.05). Curcumin induced apoptosis in both cells by inducing mitochondrial degeneration and cytochrome c release. Cell cycle analysis revealed that the anti-proliferative effect of curcumin and/or 5-FU was preceded by accumulation of CRC cells in the S cell cycle phase and induction of apoptosis. Curcumin potentiated 5-FU-induced expression or cleavage of pro-apoptotic proteins (caspase-8, -9, -3, PARP and Bax), and down-regulated anti-apoptotic (Bcl-xL) and proliferative (cyclin D1) proteins. Although 5-FU activated NF-kappa B/PI-3K/Src pathway in CRC cells, this was down-regulated by curcumin treatment through inhibition of I kappa B alpha kinase activation and I kappa B alpha phosphorylation. Conclusions: Combining curcumin with conventional chemotherapeutic agents such as 5-FU could provide more effective treatment strategies against chemoresistant colon cancer cells. The mechanisms involved may be mediated via NF-kappa B/PI-3K/Src pathways and NF-kappa B regulated gene products.	[Shakibaei, Mehdi; Busch, Franziska] Univ Munich, Inst Anat, Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Med, Loughborough, England; [Lueders, Cora] German Heart Inst, Lab Tissue Engn, Dept Thorac & Cardiovasc Surg, Berlin, Germany; [Shayan, Paviz] Invest Inst Mol Biol Syst Transfer, Tehran, Iran; [Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Div Gastroenterol,Baylor Res Inst, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA	University of Munich; University of Nottingham; German Heart Center Berlin; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Goel, Ajay/0000-0003-1396-6341				Aebi S, 1997, CLIN CANCER RES, V3, P1763; Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Benson AB, 2006, ONCOLOGIST, V11, P973, DOI 10.1634/theoncologist.11-9-973; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bharti AC, 2002, ANN NY ACAD SCI, V973, P392, DOI 10.1111/j.1749-6632.2002.tb04671.x; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Chauhan DP, 2002, CURR PHARM DESIGN, V8, P1695, DOI 10.2174/1381612023394016; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; George JA, 2005, CANCER RES, V65, P10381, DOI 10.1158/0008-5472.CAN-05-1822; Griffiths GJ, 2004, J BIOL CHEM, V279, P46113, DOI 10.1074/jbc.M408550200; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Lujambio A, 2009, CELL CYCLE, V8, P377, DOI 10.4161/cc.8.3.7526; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Ng SSW, 2001, CLIN CANCER RES, V7, P3269; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Verma SP, 1998, ENVIRON HEALTH PERSP, V106, P807, DOI 10.2307/3434124; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193	57	156	161	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57218	10.1371/journal.pone.0057218	http://dx.doi.org/10.1371/journal.pone.0057218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451189	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800092
J	Ustinova, EE; Shurin, GV; Gutkin, DW; Shurin, MR				Ustinova, Elena E.; Shurin, Galina V.; Gutkin, Dmitriy W.; Shurin, Michael R.			The Role of TLR4 in the Paclitaxel Effects on Neuronal Growth In Vitro	PLOS ONE			English	Article							DENDRITIC CELL-FUNCTION; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; SUPPORTING CELLS; NONCYTOTOXIC CONCENTRATIONS; MURINE MACROPHAGES; SENSORY NEURONS; TAXOL; INHIBITION; CULTURES	Paclitaxel (Pac) is an antitumor agent that is widely used for treatment of solid cancers. While being effective as a chemotherapeutic agent, Pac in high doses is neurotoxic, specifically targeting sensory innervations. In view of these toxic effects associated with conventional chemotherapy, decreasing the dose of Pac has been recently suggested as an alternative approach, which might limit neurotoxicity and immunosuppression. However, it remains unclear if low doses of Pac retain its neurotoxic properties or might exhibit unusual effects on neuronal cells. The goal of this study was to analyze the concentration-dependent effect of Pac on isolated and cultured DRG neuronal cells from wild-type and TLR4 knockout mice. Three different morphological parameters were analyzed: the number of neurons which developed neurites, the number of neurites per cell and the total length of neurites per cell. Our data demonstrate that low concentrations of Pac (0.1 nM and 0.5 nM) do not influence the neuronal growth in cultures in both wild type and TLR4 knockout mice. Higher concentrations of Pac (1-100 nM) had a significant effect on DRG neurons from wild type mice, affecting the number of neurons which developed neurites, number of neurites per cell, and the length of neurites. In DRG from TLR4 knockout mice high concentrations of Pac showed a similar effect on the number of neurons which developed neurites and the length of neurites. At the same time, the number of neurites per cell, indicating the process of growth cone initiation, was not affected by high concentrations of Pac. Thus, our data showed that Pac in high concentrations has a significant damaging effect on axonal growth and that this effect is partially mediated through TLR4 pathways. Low doses of Pac are devoid of neuronal toxicity and thus can be safely used in a chemomodulation mode.	[Ustinova, Elena E.; Shurin, Galina V.; Gutkin, Dmitriy W.; Shurin, Michael R.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ustinova, EE (corresponding author), Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15260 USA.	eustinova@hotmail.com		Shurin, Michael/0000-0002-6570-7395	NIH NCI [RO1 CA154369]; NATIONAL CANCER INSTITUTE [R01CA154369] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported in part by NIH NCI RO1 CA154369 (to M.R. Shurin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barajon I, 2009, J HISTOCHEM CYTOCHEM, V57, P1013, DOI 10.1369/jhc.2009.953539; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; CAVALETTI G, 1995, EXP NEUROL, V133, P64, DOI 10.1006/exnr.1995.1008; CHUANG LT, 1994, CANCER RES, V54, P1286; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Crume KP, 2007, EXP BIOL MED, V232, P607; Goldspiel BR, 1997, PHARMACOTHERAPY, V17, pS110; Hagiwara Hiroki, 2004, Breast Cancer, V11, P82, DOI 10.1007/BF02968008; Hua Z, 2007, CLIN CANCER RES, V13, P5455, DOI 10.1158/1078-0432.CCR-07-0517; Jimenez-Andrade JM, 2006, NEUROSCI LETT, V405, P62, DOI 10.1016/j.neulet.2006.06.043; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; John J, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-14; Kaneno R, 2011, CELL ONCOL, V34, P97, DOI 10.1007/s13402-010-0005-5; Kaneno R, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-58; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; KIRIKAE F, 1995, INFECT IMMUN, V63, P486, DOI 10.1128/IAI.63.2.486-497.1995; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Marupudi NI, 2007, EXPERT OPIN DRUG SAF, V6, P609, DOI 10.1517/14740338.6.5.609; MASUROVSKY EB, 1983, NEUROSCIENCE, V10, P491, DOI 10.1016/0306-4522(83)90148-3; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mekhail Tarek M, 2002, Expert Opin Pharmacother, V3, P755; Michels T, 2012, J IMMUNOTOX IN PRESS; Naiditch H, 2011, IMMUNOL RES, V50, P276, DOI 10.1007/s12026-011-8213-2; Nowicki M, 2010, J NEUROSCI RES, V88, P403, DOI 10.1002/jnr.22205; Park SB, 2011, MUSCLE NERVE, V43, P367, DOI 10.1002/mus.21874; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Pfannenstiel LW, 2010, CELL IMMUNOL, V263, P79, DOI 10.1016/j.cellimm.2010.03.001; Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Scuteri A, 2006, ANTICANCER RES, V26, P1065; Sevko A, 2012, J IMMUNOTOX IN PRESS; Shurin GV, 2012, CANCER IMMUNOL IMMUN, V61, P223, DOI 10.1007/s00262-011-1138-8; Shurin GV, 2009, J IMMUNOL, V183, P137, DOI 10.4049/jimmunol.0900734; Shurin M, 2012, CURRENT MED IN PRESS; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tichomirowa MA, 2008, INT J CANCER, V123, P1956, DOI 10.1002/ijc.23737; van Noort JM, 2009, PROG BRAIN RES, V175, P139, DOI 10.1016/S0079-6123(09)17509-X; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Wang J, 2002, BRIT J HAEMATOL, V118, P638, DOI 10.1046/j.1365-2141.2002.03645.x; Wozniak KM, 2011, CANCER RES, V71, P3952, DOI 10.1158/0008-5472.CAN-10-4184; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Zimmer SM, 2008, J BIOL CHEM, V283, P27916, DOI 10.1074/jbc.M802826200	47	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56886	10.1371/journal.pone.0056886	http://dx.doi.org/10.1371/journal.pone.0056886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441224	Green Published, gold, Green Accepted			2022-12-27	WOS:000315159200081
J	Xiao, HJ; Wu, SH; Chen, C; Xue, FS				Xiao, HaiJun; Wu, ShaoHui; Chen, Chao; Xue, FangSen			Optimal Low Temperature and Chilling Period for Both Summer and Winter Diapause Development in Pieris melete: Based on a Similar Mechanism	PLOS ONE			English	Article							LARVAL DIAPAUSE; LEPIDOPTERA PIERIDAE; EMBRYONIC DIAPAUSE; INSECT DIAPAUSE; EMERGENCE TIME; DELIA-ANTIQUA; ONION MAGGOT; TERMINATION; HYMENOPTERA; PHOTOPERIOD	The cabbage butterfly, Pieris melete hibernates and aestivates as a diapausing pupa. We present evidence that the optimum of low temperature and optimal chilling periods for both summer and winter diapause development are based on a similar mechanism. Summer or winter diapausing pupae were exposed to different low temperatures of 1, 5, 10 or 15 degrees C for different chilling periods (ranging from 30 to 120 d) or chilling treatments started at different stages of diapause, and were then transferred to 20 degrees C, LD12.5:11.5 to terminate diapause. Chilling temperature and duration had a significant effect on the development of aestivating and hibernating pupae. The durations of diapause for both aestivating and hibernating pupae were significantly shorter when they were exposed to low temperatures of 1, 5 or 10 degrees C for 50 or 60 days, suggesting that the optimum chilling temperatures for diapause development were between 1 and 10 degrees C and the required optimal chilling period was about 50-60 days. Eighty days of chilling was efficient for the completion of both summer and winter diapause. When chilling periods were >= 90 days, the durations of summer and winter diapause were significantly lengthened; however, the adult emergence was more synchronous. The adaptive significance of a similar mechanism on summer and winter diapause development is discussed.	[Xiao, HaiJun; Chen, Chao; Xue, FangSen] Jiangxi Agr Univ, Inst Entomol, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Peoples R China; [Xiao, HaiJun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wu, ShaoHui] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA	Jiangxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Virginia Polytechnic Institute & State University	Xiao, HJ (corresponding author), Jiangxi Agr Univ, Inst Entomol, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Peoples R China.	hjxiao@yahoo.com.cn; xue_fangsen@hotmail.com	Wu, Shaohui/AAH-2795-2019; Xiao, Haijun/HGE-3088-2022; XIAO, Haijun/AAJ-5321-2021	Xiao, Haijun/0000-0002-0832-0493; XIAO, Haijun/0000-0002-0832-0493	National Natural Science Foundation of China [30900916]; New Teachers' Fund of doctoral program; Ministry of Education of China [20093603120002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund of doctoral program; Ministry of Education of China(Ministry of Education, China)	This work was supported by a grant from National Natural Science Foundation of China (30900916) and New Teachers' Fund of doctoral program sponsored by Ministry of Education of China (20093603120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO Y, 1993, PHYSIOL ENTOMOL, V18, P1, DOI 10.1111/j.1365-3032.1993.tb00442.x; Bosch J, 2003, ENVIRON ENTOMOL, V32, P711, DOI 10.1603/0046-225X-32.4.711; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; Broufas GD, 2006, ENVIRON ENTOMOL, V35, P1216, DOI 10.1603/0046-225X(2006)35[1216:EOCEAP]2.0.CO;2; Damos PT, 2010, PHYSIOL ENTOMOL, V35, P64, DOI 10.1111/j.1365-3032.2009.00715.x; DANKS HV, 1987, BIOL SURVEY CANADA M, V1; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Ding L, 2003, J INSECT PHYSIOL, V49, P1153, DOI 10.1016/j.jinsphys.2003.08.012; Eizaguirre M, 2008, J INSECT PHYSIOL, V54, P1057, DOI 10.1016/j.jinsphys.2008.04.011; Fisher JR, 1997, ENVIRON ENTOMOL, V26, P906, DOI 10.1093/ee/26.4.906; Higaki M, 2005, J INSECT PHYSIOL, V51, P1352, DOI 10.1016/j.jinsphys.2005.08.006; HODEK I, 1988, ENTOMOL EXP APPL, V49, P153, DOI 10.1007/BF00188248; Hodek I, 2002, EUR J ENTOMOL, V99, P163, DOI 10.14411/eje.2002.024; Ishikawa Y, 2000, J INSECT PHYSIOL, V46, P161, DOI 10.1016/S0022-1910(99)00112-2; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2000, J INSECT PHYSIOL, V46, P417, DOI 10.1016/S0022-1910(99)00124-9; Larios GLB, 2007, APPL ENTOMOL ZOOL, V42, P587, DOI 10.1303/aez.2007.587; Nomura M, 2000, J INSECT PHYSIOL, V46, P373, DOI 10.1016/S0022-1910(99)00120-1; Quesada-Moraga E, 2000, PHYSIOL ENTOMOL, V25, P191, DOI 10.1046/j.1365-3032.2000.00185.x; Shimoda M, 1997, APPL ENTOMOL ZOOL, V32, P617, DOI 10.1303/aez.32.617; Tachibana SI, 2004, ZOOL SCI, V21, P197, DOI 10.2108/zsj.21.197; Takeda M, 2006, APPL ENTOMOL ZOOL, V41, P429, DOI 10.1303/aez.2006.429; TAUBER MJ, 1986, SEASONAL ADAPTIONS I; Trudel R, 2002, AGR FOREST ENTOMOL, V4, P301, DOI 10.1046/j.1461-9563.2002.00155.x; WIPKING W, 1995, OECOLOGIA, V102, P202, DOI 10.1007/BF00333252; Xiao HJ, 2012, B ENTOMOL RES, V102, P267, DOI 10.1017/S0007485311000587; Xiao HJ, 2006, EUR J ENTOMOL, V103, P537, DOI 10.14411/eje.2006.071; Xiao HJ, 2009, J INSECT PHYSIOL, V55, P488, DOI 10.1016/j.jinsphys.2008.12.012; Xiao HJ, 2008, EUR J ENTOMOL, V105, P607, DOI 10.14411/eje.2008.081; Xiao HJ, 2008, J INSECT PHYSIOL, V54, P755, DOI 10.1016/j.jinsphys.2008.01.009; Xue FS, 1997, J INSECT PHYSIOL, V43, P701, DOI 10.1016/S0022-1910(97)00053-X; Zhu DH, 2009, ENTOMOL EXP APPL, V133, P1, DOI 10.1111/j.1570-7458.2009.00901.x	32	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56404	10.1371/journal.pone.0056404	http://dx.doi.org/10.1371/journal.pone.0056404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441185	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200042
J	Schneider, K; Nwizu, C; Kaplan, R; Anderson, J; Wilson, DP; Emery, S; Cooper, DA; Boyd, MA				Schneider, Karen; Nwizu, Chidi; Kaplan, Richard; Anderson, Jonathan; Wilson, David P.; Emery, Sean; Cooper, David A.; Boyd, Mark A.			The Potential Cost and Benefits of Raltegravir in Simplified Second-Line Therapy among HIV Infected Patients in Nigeria and South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SAFETY; RESISTANCE; REGIMENS; EFFICACY; TENOFOVIR/EMTRICITABINE; TOLERABILITY; MORTALITY; OUTCOMES; FAILURE	Background: There is an urgent need to improve the evidence base for provision of second-line antiretroviral therapy (ART) following first-line virological failure. This is particularly the case in Sub-Saharan Africa where 70% of all people living with HIV/AIDS (PHA) reside. The aim of this study was to simulate the potential risks and benefits of treatment simplification in second-line therapy compared to the current standard of care (SOC) in a lower-middle income and an upper-middle income country in Sub-Saharan Africa. Methods: We developed a microsimulation model to compare outcomes associated with reducing treatment discontinuations between current SOC for second-line therapy in South Africa and Nigeria and an alternative regimen: ritonavir-boosted lopinavir (LPV/r) combined with raltegravir (RAL). We used published studies and collaborating sites to estimate efficacy, adverse effect and cost. Model outcomes were reported as incremental cost effectiveness ratios (ICERs) in 2011 USD per quality adjusted life year ($/QALY) gained. Results: Reducing treatment discontinuations with LPV/r+RAL resulted in an additional 0.4 discounted QALYs and increased the undiscounted life expectancy by 0.8 years per person compared to the current SOC. The average incremental cost was $6,525 per treated patient in Nigeria and $4,409 per treated patient in South Africa. The cost-effectiveness ratios were $16,302/QALY gained and $11,085/QALY gained for Nigeria and South Africa, respectively. Our results were sensitive to the probability of ART discontinuation and the unit cost for RAL. Conclusions: The combination of raltegravir and ritonavir-boosted lopinavir was projected to be cost-effective in South Africa. However, at its current price, it is unlikely to be cost-effective in Nigeria.	[Schneider, Karen; Anderson, Jonathan; Wilson, David P.; Emery, Sean; Cooper, David A.; Boyd, Mark A.] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Nwizu, Chidi] Univ Maryland, Sch Med, Dept Med, Inst Human Virol, Baltimore, MD 21201 USA; [Kaplan, Richard] Desmond Tutu HIV Fdn, Cape Town, South Africa; [Cooper, David A.] St Vincents Hosp, Ctr Appl Med Res SVH AMR, Sydney, NSW 2010, Australia; [Boyd, Mark A.] St Vincents Hosp, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; University System of Maryland; University of Maryland Baltimore; St Vincents Hospital Sydney; St Vincents Hospital Sydney	Schneider, K (corresponding author), Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.	KSchneider@kirby.unsw.edu.au; DWilson@kirby.unsw.edu.au; MBoyd@kirby.unsw.edu.au	Emery, Sean/J-3825-2017; Wilson, David P/G-4614-2013; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Kaplan, Richard/0000-0003-1565-4704; Anderson, Jonathan/0000-0002-7316-428X; Boyd, Mark/0000-0002-6848-3307	Australian Research Council; University of New South Wales; Australian Government, Department of Health and Ageing	Australian Research Council(Australian Research Council); University of New South Wales; Australian Government, Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The authors acknowledge funding from the Australian Research Council and the University of New South Wales. The Kirby Institute is funded by the Australian Government, Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Cahn P, 2008, WHO EXPERT CONSULTAT; Chimbete C, 2009, 16 C RETR OPP INF 8; CLEARY S, 2004, COST EFFECTIVENESS A; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; CRITCHFIELD GC, 1986, MED DECIS MAKING, V6, P85, DOI 10.1177/0272989X8600600205; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kumarasamy N, 2003, AIDS, V17, P2267, DOI 10.1097/00002030-200310170-00019; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Manosuthi W, 2010, AIDS RES HUM RETROV, V26, P609, DOI 10.1089/aid.2009.0107; Medicins Sans Frontieres, 2011, UNT WEB ANT PRIC RED; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mrus JM, 2003, MED DECIS MAKING, V23, P414, DOI 10.1177/0272989X03256884; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Rockstroh JK, 2011, CLIN INFECT DIS, V53, P807, DOI 10.1093/cid/cir510; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2007, CLIN INFECT DIS, V45, P1062, DOI 10.1086/521933; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tsevat J, 1999, ANN INTERN MED, V131, P194, DOI 10.7326/0003-4819-131-3-199908030-00006; UNAIDS, 2011, GLOB HIV AIDS RESP E; van Wyk J, 2012, 6 IAS C HIV PATH TRE	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e54435	10.1371/journal.pone.0054435	http://dx.doi.org/10.1371/journal.pone.0054435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457450	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700005
J	Zeman, A; Obst, O; Brooks, KR; Rich, AN				Zeman, Astrid; Obst, Oliver; Brooks, Kevin R.; Rich, Anina N.			The Muller-Lyer Illusion in a Computational Model of Biological Object Recognition	PLOS ONE			English	Article							RECEPTIVE-FIELDS; LENGTH	Studying illusions provides insight into the way the brain processes information. The Muller-Lyer Illusion (MLI) is a classical geometrical illusion of size, in which perceived line length is decreased by arrowheads and increased by arrowtails. Many theories have been put forward to explain the MLI, such as misapplied size constancy scaling, the statistics of image-source relationships and the filtering properties of signal processing in primary visual areas. Artificial models of the ventral visual processing stream allow us to isolate factors hypothesised to cause the illusion and test how these affect classification performance. We trained a feed-forward feature hierarchical model, HMAX, to perform a dual category line length judgment task (short versus long) with over 90% accuracy. We then tested the system in its ability to judge relative line lengths for images in a control set versus images that induce the MLI in humans. Results from the computational model show an overall illusory effect similar to that experienced by human subjects. No natural images were used for training, implying that misapplied size constancy and image-source statistics are not necessary factors for generating the illusion. A post-hoc analysis of response weights within a representative trained network ruled out the possibility that the illusion is caused by a reliance on information at low spatial frequencies. Our results suggest that the MLI can be produced using only feed-forward, neurophysiological connections.	[Zeman, Astrid; Brooks, Kevin R.; Rich, Anina N.] Macquarie Univ, Dept Cognit Sci, Macquarie Pk, NSW, Australia; [Zeman, Astrid; Brooks, Kevin R.; Rich, Anina N.] Macquarie Univ, ARC Ctr Excellence Cognit & Disorders CCD, Macquarie Pk, NSW, Australia; [Zeman, Astrid; Obst, Oliver] CSIRO, ICT Ctr, Marsfield, NSW, Australia; [Brooks, Kevin R.] Macquarie Univ, Dept Psychol, Macquarie Pk, NSW, Australia	Macquarie University; Macquarie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Macquarie University	Zeman, A (corresponding author), Macquarie Univ, Dept Cognit Sci, Macquarie Pk, NSW, Australia.	astrid.zeman@mq.edu.au	Zeman, Astrid/AAC-4079-2019; Obst, Oliver/A-5296-2008	Obst, Oliver/0000-0002-8284-2062; Rich, Anina/0000-0002-5702-6450; Zeman, Astrid/0000-0003-3341-0025; Brooks, Kevin/0000-0003-1424-4092	Australian Research Council [DP0984494]; Menzies Foundation; CSIRO Top-Up Scholarship by the Australian Federal Government; Australian Postgraduate Award (APA) by the Australian Federal Government; Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council(Australian Research Council); Menzies Foundation; CSIRO Top-Up Scholarship by the Australian Federal Government; Australian Postgraduate Award (APA) by the Australian Federal Government; Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	Anina N. Rich is supported by the Australian Research Council (DP0984494) and the Menzies Foundation. Astrid Zeman is supported by a CSIRO Top-Up Scholarship and the Australian Postgraduate Award (APA) provided by the Australian Federal Government. Astrid Zeman, Kevin Brooks and Anina Rich are supported by the Australian Research Council Centre of Excellence for Cognition and its Disorders (CE110001021) http://www.ccd.edu.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertulis A., 2001, BIOMEDICINE, V1, P3, DOI DOI 10.1068/P270183; BRIGELL M, 1979, PERCEPTION, V8, P187, DOI 10.1068/p080187; CARRASCO M, 1986, PERCEPTION, V15, P553, DOI 10.1068/p150553; COREN S, 1970, Q J EXP PSYCHOL, V22, P274, DOI 10.1080/00335557043000212; COREN S, 1984, PERCEPT PSYCHOPHYS, V35, P313, DOI 10.3758/BF03206334; Corney D, 2007, PLOS COMPUT BIOL, V3, P1790, DOI 10.1371/journal.pcbi.0030180; Cun YL, 1989, IEEE COMMUNICATIONS, V27, P41; DEWAR RE, 1967, CAN J PSYCHOLOGY, V21, P504, DOI 10.1037/h0083002; FELLOWS BJ, 1967, Q J EXP PSYCHOL, V19, P208, DOI 10.1080/14640746708400094; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Ginsburg A, 1978, THESIS AEROSPACE MED; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GREGORY RL, 1963, NATURE, V199, P678, DOI 10.1038/199678a0; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1234, DOI 10.1073/pnas.0409314102; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; Muller-Lyer F. C., 1896, Z PSYCHOL, V9, P1; Muller-Lyer F. C., 1896, Z PSYCHOL PHYSIOL SI, V10, P421; Muller-Lyer FC., 1889, ARCHIV F R ANATOMIE, V2, P263; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Ogawa T., 1999, 6 INT C NEUR INF PRO, V2, P550; Predebon J, 1997, J PREDEBON, V27, P183; RESTLE F, 1977, PERCEPT PSYCHOPHYS, V21, P489, DOI 10.3758/BF03198729; Serre T, 2004, 2004017 AI MIT CSAIL; Serre T., 2005, P 2005 IEEE COMP SOC, P886, DOI 10.1109/CVPR.2005.254; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2010, COMMUN ACM, V53, P54, DOI 10.1145/1831407.1831425; Weidner R, 2010, CEREB CORTEX, V20, P1586, DOI 10.1093/cercor/bhp217; Weidner R, 2007, CEREB CORTEX, V17, P878, DOI 10.1093/cercor/bhk042	29	7	7	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56126	10.1371/journal.pone.0056126	http://dx.doi.org/10.1371/journal.pone.0056126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457510	Green Submitted, gold, Green Published			2022-12-27	WOS:000315603700023
J	Ruebner, M; Strissel, PL; Ekici, AB; Stiegler, E; Dammer, U; Goecke, TW; Faschingbauer, F; Fahlbusch, FB; Beckmann, MW; Strick, R				Ruebner, Matthias; Strissel, Pamela L.; Ekici, Arif B.; Stiegler, Elisabeth; Dammer, Ulf; Goecke, Tamme W.; Faschingbauer, Florian; Fahlbusch, Fabian B.; Beckmann, Matthias W.; Strick, Reiner			Reduced Syncytin-1 Expression Levels in Placental Syndromes Correlates with Epigenetic Hypermethylation of the ERVW-1 Promoter Region	PLOS ONE			English	Article							TROPHOBLAST CELL-FUSION; ELEVATED LIVER-ENZYMES; W ENV GLYCOPROTEIN; DNA METHYLATION; TRANSCRIPTIONAL ACTIVITY; CPG METHYLATION; HELLP-SYNDROME; BEWO CELLS; HERV-W; HISTONE METHYLATION	Terminal differentiation of villous cytotrophoblasts (CT) ends in formation of the multinucleated syncytiotrophoblast representing the fetal-maternal interface. Aberrations during this cell-fusion process are associated with Intrauterine Growth Restriction (IUGR), Preeclampsia (PE) and High Elevated Liver and Low Platelets (HELLP) Syndrome. Syncytin-1, the envelope gene of the human Endogenous Retrovirus ERVW-1, is one of the most important genes involved in cell-fusion and showed decreased gene expression during these pathological pregnancies. The aim of this study was to determine the methylation pattern of the entire promoter of ERVW-1 and to correlate these findings with the expression profile of Syncytin-1 in the placental syndromes. 14 isolated villous cytotrophoblasts from control (n = 3), IUGR (n = 3), PE (n = 3), PE/IUGR (n = 3) and HELLP/IUGR (n = 2) placentae were used to determine the mean methylation level (ML) for the ERVW-1 promoter region. ML rose significantly from 29% in control CTs to 49% in IUGR, 53% in PE, 47% in PE/IUGR and 64% in HELLP/IUGR indicating an epigenetic down-regulation of Syncytin-1 by promoter hypermethylation. DNA demethylation of the trophoblast like cell lines BeWo, JEG-3 and JAR with 5-AZA-2'desoxycytidine (AZA) showed an increased Syncytin-1 expression and fusion ability in all cell lines. Promoter activity of the 5'LTR could be inhibited by hypermethylation 42-fold using a luciferase based reporter-gene assay. Finally overexpression of the methyltransferases DNMT3a and LSH could be responsible for a decreased Syncytin-1 expression by promoter hypermethylation of ERVW-1. Our study linked decreased Syncytin-1 expression to an epigenetic hypermethylation of the entire promoter of ERVW-1. Based on our findings we are predicting a broad aberrant epigenetic DNA-methylation pattern in pathological placentae affecting placentogenesis, but also the development of the fetus and the mother during pregnancy.	[Ruebner, Matthias; Strissel, Pamela L.; Stiegler, Elisabeth; Dammer, Ulf; Goecke, Tamme W.; Faschingbauer, Florian; Beckmann, Matthias W.; Strick, Reiner] Univ Clin Erlangen, Dept Obstet & Gynaecol, Mol Med Lab, Erlangen, Germany; [Ekici, Arif B.] Univ Clin Erlangen, Inst Human Genet, Erlangen, Germany; [Fahlbusch, Fabian B.] Univ Clin Erlangen, Dept Paediat & Adolescent Med, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Ruebner, M (corresponding author), Univ Clin Erlangen, Dept Obstet & Gynaecol, Mol Med Lab, Erlangen, Germany.	Matthias.Ruebner@uk-erlangen.de	Ekici, Arif B/C-3971-2013	Ekici, Arif B/0000-0001-6099-7066; Fahlbusch, Fabian/0000-0001-5480-0204	'Deutsche Forschungsgemeinschaft' (DFG) [STR 923/1-1, STR 923/3-1]	'Deutsche Forschungsgemeinschaft' (DFG)(German Research Foundation (DFG))	This work was supported by grants of the 'Deutsche Forschungsgemeinschaft' (DFG) to STR 923/1-1 and STR 923/3-1 (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; BERTAKIS KD, 1986, WESTERN J MED, V144, P81; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Biswas S, 2008, J OBSTET GYNAECOL RE, V34, P487, DOI 10.1111/j.1447-0756.2008.00719.x; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Cetin I, 2004, PLACENTA, V25, P753, DOI 10.1016/j.placenta.2004.02.004; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cheng YH, 2004, BIOL REPROD, V70, P694, DOI 10.1095/biolreprod.103.023473; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; de Parseval N, 2005, CYTOGENET GENOME RES, V110, P318, DOI 10.1159/000084964; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033503; GETZOWA S, 1950, J OBSTET GYN BRIT EM, V57, P388; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Guilbert LJ, 2007, PLACENTA, V28, P348, DOI 10.1016/j.placenta.2006.04.011; Howard JH, 2009, CANCER BIOL THER, V8, P94, DOI 10.4161/cbt.8.1.7469; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Kim TH, 2004, MOL CELLS, V18, P87; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Kjeldbjerg AL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-266; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Knerr I, 2003, AM J OBSTET GYNECOL, V189, P583, DOI 10.1067/S0002-9378(03)00538-6; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Larsen JM, 2009, CANCER LETT, V280, P44, DOI 10.1016/j.canlet.2009.02.008; Larsson LI, 2007, HUM PATHOL, V38, P726, DOI 10.1016/j.humpath.2006.10.018; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Macaulay EC, 2011, MAMM GENOME, V22, P722, DOI 10.1007/s00335-011-9355-1; Malassine A, 2005, PLACENTA, V26, P556, DOI 10.1016/j.placenta.2004.09.002; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P287, DOI 10.1016/0163-7258(85)90053-1; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Newby D, 2007, PLACENTA, V28, P350, DOI 10.1016/j.placenta.2006.04.012; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Parsons BL, 2003, P NATL ACAD SCI USA, V100, P14601, DOI 10.1073/pnas.2637169100; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Ruebner M, 2012, J CELL BIOCHEM, V113, P2383, DOI 10.1002/jcb.24110; Ruebner M, 2010, J MOL MED, V88, P1143, DOI 10.1007/s00109-010-0656-8; Saphier CJ, 1998, SEMIN PERINATOL, V22, P118, DOI 10.1016/S0146-0005(98)80044-X; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Smiraglia DJ, 2002, ONCOGENE, V21, P3909, DOI 10.1038/sj.onc.1205488; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Sun Y, 2010, LEUKEMIA RES, V34, P1195, DOI 10.1016/j.leukres.2010.03.016; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Tallarek AC, 2012, GEBURTSH FRAUENHEILK, V72, P27; Tao YG, 2011, P NATL ACAD SCI USA, V108, P5626, DOI 10.1073/pnas.1017000108; Tao YG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009163; Trejbalova K, 2011, NUCLEIC ACIDS RES, V39, P8728, DOI 10.1093/nar/gkr562; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Wich C, 2009, GYNECOL OBSTET INVES, V68, P9, DOI 10.1159/000209396; Wilson ML, 2003, OBSTET GYNECOL SURV, V58, P39, DOI 10.1097/00006254-200301000-00022; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699; Yan QS, 2003, EMBO J, V22, P5154, DOI 10.1093/emboj/cdg493; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	76	59	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56145	10.1371/journal.pone.0056145	http://dx.doi.org/10.1371/journal.pone.0056145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457515	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700049
J	Tranulis, C; Lecomte, T; El-Khoury, B; Lavarenne, A; Brodeur-Cote, D				Tranulis, Constantin; Lecomte, Tania; El-Khoury, Bassam; Lavarenne, Anais; Brodeur-Cote, Daniel			Changing the Name of Schizophrenia: Patient Perspectives and Implications for DSM-V	PLOS ONE			English	Article							MENTAL-ILLNESS STIGMA; RENAMING SCHIZOPHRENIA; LINKING BIOLOGY; SALIENCE; PHENOMENOLOGY; PHARMACOLOGY; SEMANTICS; PSYCHOSIS; DIAGNOSIS	Introduction: The diagnosis of schizophrenia is increasingly contested by researchers, clinicians, patients and family members. Preeminent researchers proposed its replacement with the salience syndrome concept, arguing for increased validity and less stigmatizing potential. This is the first study exploring the effects on stigma of this nosological proposal. Methods: Two studies were conducted: one with 161 undergraduate students regarding their stigmatizing attitudes linked to the label of schizophrenia or salience syndrome, the other involved in-depth qualitative interviews with 19 participants treated in a first episode psychosis program. The interviews explored the subjective validity, acceptability and effects on stigma of a diagnosis of schizophrenia or salience syndrome. Results: Overall, no significant differences were found between labels in study 1. For study 2, the majority of participants preferred a diagnosis of salience syndrome, considering it less stigmatizing mostly because of its novelty and the concealing potential of the new diagnostic entity, though many found it hard to relate to and somewhat difficult to understand. Discussion: Our results suggest that the label change does not impact the stigmatizing potential for individuals who are not familiar with mental illness - they appear to base their attitudes on descriptions rather than the label alone. For those suffering from mental illness, a name change for schizophrenia to "salience syndrome" might offer only a temporary relief from stigma. Claims of de-stigmatizing effects should be grounded in sound scientific models of stigma and ideally in empirical data.	[Tranulis, Constantin] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Tranulis, Constantin] Louis H Lafontaine Hosp, Montreal, PQ, Canada; [Lecomte, Tania; El-Khoury, Bassam; Lavarenne, Anais; Brodeur-Cote, Daniel] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Tranulis, C (corresponding author), Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada.	constantin.tranulis@gmail.com			Fonds de Recherche en Sante du Quebec; ARUC Internationale Sante mentale et Citoyennete	Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); ARUC Internationale Sante mentale et Citoyennete	This study was supported by a salary grant from Fonds de Recherche en Sante du Quebec and a research grant from the ARUC Internationale Sante mentale et Citoyennete. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, BMJ, V334, P108; APA, 2000, DIAGN STAT MAN MENT; Bleuler E., 1908, ALLG Z PSYCHIAT, V65, P436; Corrigan PW, 2007, AUST PSYCHOL, V42, P90, DOI 10.1080/00050060701280573; First MB., 2006, DECONSTRUCTING PSYCH; George B, 2010, J MENT HEALTH, V19, P479, DOI 10.3109/09638237.2010.526157; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Kapur S, 2005, SCHIZOPHR RES, V79, P59, DOI 10.1016/j.schres.2005.01.003; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kingdon D, 2008, SOC PSYCH PSYCH EPID, V43, P239, DOI 10.1007/s00127-007-0284-y; Kingdon D, 2008, PSYCHIATR BULL, V32, P419, DOI 10.1192/pb.bp.107.018515; Kingdon DG, 2007, BMJ-BRIT MED J, V334, P221, DOI 10.1136/bmj.39108.396852.1F; Lieberman JA, 2007, BRIT MED J, V334, P108, DOI 10.1136/bmj.39057.662373.80; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Link BG, 2004, SCHIZOPHRENIA BULL, V30, P511, DOI 10.1093/oxfordjournals.schbul.a007098; Ritsher JB, 2003, PSYCHIAT RES, V121, P31, DOI 10.1016/j.physchres.2003.08.008; Sato M, 2006, WORLD PSYCHIATRY, V5, P53; Takahashi H, 2009, SCHIZOPHR RES, V112, P149, DOI 10.1016/j.schres.2009.03.037; van Os J, 2009, ACTA PSYCHIAT SCAND, V120, P363, DOI 10.1111/j.1600-0447.2009.01456.x	19	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55998	10.1371/journal.pone.0055998	http://dx.doi.org/10.1371/journal.pone.0055998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457490	Green Submitted, gold, Green Published			2022-12-27	WOS:000315602700030
J	Womble, JN; Gende, SM				Womble, Jamie N.; Gende, Scott M.			Post-Breeding Season Migrations of a Top Predator, the Harbor Seal (Phoca vitulina richardii), from a Marine Protected Area in Alaska	PLOS ONE			English	Article							BAY NATIONAL-PARK; GLACIER BAY; SITE FIDELITY; BYCATCH MORTALITY; CONSERVATION; PATTERNS; TELEMETRY; POPULATION; FISHERIES; DESIGN	Marine protected areas (MPAs) are increasingly being used as a conservation tool for highly mobile marine vertebrates and the focus is typically on protecting breeding areas where individuals are aggregated seasonally. Yet movements during the non-breeding season can overlap with threats that may be equally as important to population dynamics. Thus understanding habitat use and movements of species during the non-breeding periods is critical for conservation. Glacier Bay National Park, Alaska, is one of the largest marine mammal protected areas in the world and has the only enforceable protection measures for reducing disturbance to harbor seals in the United States. Yet harbor seals have declined by up to 11.5%/year from 1992 to 2009. We used satellite-linked transmitters that were attached to 37 female harbor seals to quantify the post-breeding season migrations of seals and the amount of time that seals spent inside vs. outside of the MPA of Glacier Bay. Harbor seals traveled extensively beyond the boundaries of the MPA of Glacier Bay during the post-breeding season, encompassing an area (25,325 km(2)) significantly larger than that used by seals during the breeding season (8,125 km(2)). These movements included the longest migration yet recorded for a harbor seal (3,411 km) and extended use (up to 23 days) of pelagic areas by some seals. Although the collective utilization distribution of harbor seals during the post-breeding season was quite expansive, there was a substantial degree of individual variability in the percentage of days that seals spent in the MPA. Nevertheless, harbor seals demonstrated a high degree of inter-annual site fidelity (93%) to Glacier Bay the following breeding season. Our results highlight the importance of understanding the threats that seals may interact with outside of the boundaries of the MPA of Glacier Bay for understanding population dynamics of seals in Glacier Bay.	[Womble, Jamie N.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Womble, Jamie N.; Gende, Scott M.] Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK USA	Oregon State University; United States Department of the Interior	Womble, JN (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	Jamie_Womble@nps.gov		Womble, Jamie/0000-0002-6635-1490	National Park Service (NPS)-Natural Resource Preservation Program [35747]; Glacier Bay National Park Preserve; NPS Coastal Cluster Program; Alaska Fisheries Science Center-National Marine Mammal Laboratory-Polar Ecosystem Program; Alaska Department of Fish Game; Alaska Sealife Center; United States Fish & Wildlife Service; Horace M. Albright-Conrad L. Wirth Fellowship through the National Park Foundation; Oregon State University (OSU) Hatfield Marine Science Center Mamie Markham Research Fellowship; OSU Marine Mammal Institute; OSU Pinniped Ecology Applied Research Laboratory; OSU Department of Fisheries & Wildlife Munson Wildlife Fellowship; NPS NRAC Professional Development Grants	National Park Service (NPS)-Natural Resource Preservation Program; Glacier Bay National Park Preserve; NPS Coastal Cluster Program; Alaska Fisheries Science Center-National Marine Mammal Laboratory-Polar Ecosystem Program; Alaska Department of Fish Game; Alaska Sealife Center; United States Fish & Wildlife Service; Horace M. Albright-Conrad L. Wirth Fellowship through the National Park Foundation; Oregon State University (OSU) Hatfield Marine Science Center Mamie Markham Research Fellowship; OSU Marine Mammal Institute; OSU Pinniped Ecology Applied Research Laboratory; OSU Department of Fisheries & Wildlife Munson Wildlife Fellowship; NPS NRAC Professional Development Grants	Funding and logistical support was provided by the National Park Service (NPS)-Natural Resource Preservation Program (Project# 35747), Glacier Bay National Park & Preserve, the NPS Coastal Cluster Program, the Alaska Fisheries Science Center-National Marine Mammal Laboratory-Polar Ecosystem Program, the Alaska Department of Fish & Game, the Alaska Sealife Center, and the United States Fish & Wildlife Service. JNW was supported by a Horace M. Albright-Conrad L. Wirth Fellowship through the National Park Foundation, the Oregon State University (OSU) Hatfield Marine Science Center Mamie Markham Research Fellowship, the OSU Marine Mammal Institute, the OSU Pinniped Ecology Applied Research Laboratory, the OSU Department of Fisheries & Wildlife Munson Wildlife Fellowship, and NPS NRAC Professional Development Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BM, 2012, AFSC234 NOAA NMFS US; Arimitsu ML, 2008, FISH OCEANOGR, V17, P137, DOI 10.1111/j.1365-2419.2008.00470.x; Ballard G, 2012, BIOL CONSERV, V156, P72, DOI 10.1016/j.biocon.2011.11.017; Barlow Jay, 1994, Reports of the International Whaling Commission Special Issue, V15, P405; Berry KJ, 2001, SPRINGER SERIES STAT; Bjorge A, 2002, ICES J MAR SCI, V59, P29, DOI 10.1006/jmsc.2001.1137; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Blundell GM, 2008, MAR MAMMAL SCI, V24, P577, DOI 10.1111/j.1748-7692.2008.00194.x; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Bodkin J. L., 2007, P 4 GLAC BAY SCI S O, P133; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Botsford LW, 2003, ECOL APPL, V13, pS25; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Campbell RA, 2008, BIOL LETTERS, V4, P139, DOI 10.1098/rsbl.2007.0487; Catton T, 1995, LAND REBORN LAND REB; Cooper WS, 1937, GEOGR REV, V27, P37, DOI 10.2307/209660; Daniel RG, 2003, MAR MAMMAL SCI, V19, P128, DOI 10.1111/j.1748-7692.2003.tb01097.x; De Laguna F., 1972, SMITHSONIAN CONTRIBU, V7; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Emmons G.T., 1991, TLINGIT INDIANS; Etherington LL, 2007, ESTUAR COAST, V30, P927, DOI 10.1007/BF02841386; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Field WO, 1947, GEOGR REV, V37, P369, DOI 10.2307/211127; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gerber LR, 2011, CONSERV LETT, V4, P417, DOI 10.1111/j.1755-263X.2011.00197.x; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Gerber LR, 2003, ECOL APPL, V13, pS47; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; Gormley AM, 2012, J APPL ECOL, V49, P474, DOI 10.1111/j.1365-2664.2012.02121.x; HALL DK, 1995, PHYS GEOGR, V16, P27, DOI 10.1080/02723646.1995.10642541; Hamer D. J., 2011, Endangered Species Research, V14, P203, DOI 10.3354/esr00353; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; Hendrix AN, 2012, CAN J FISH AQUAT SCI, V69, P1783, DOI [10.1139/F2012-101, 10.1139/f2012-101]; Hill DF, 2009, ESTUAR COAST SHELF S, V82, P95, DOI 10.1016/j.ecss.2008.12.019; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hooker SK, 2002, BIOL CONSERV, V104, P51, DOI 10.1016/S0006-3207(01)00153-7; Hooker SK, 1999, CONSERV BIOL, V13, P592, DOI 10.1046/j.1523-1739.1999.98099.x; Horning M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030173; Howell Evan A., 2008, Endangered Species Research, V5, P267, DOI 10.3354/esr00096; Hoyt E., 2011, MARINE PROTECTED ARE; Hueffer K, 2011, J WILDLIFE DIS, V47, P984, DOI 10.7589/0090-3558-47.4.984; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kenow KP, 2002, WATERBIRDS, V25, P449, DOI 10.1675/1524-4695(2002)025[0449:UOSTTI]2.0.CO;2; Kenyon K. W, 1969, N AM FAUNA; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Leslie HM, 2005, CONSERV BIOL, V19, P1701, DOI 10.1111/j.1523-1739.2005.00268.x; Lowry LF, 2001, MAR MAMMAL SCI, V17, P835, DOI 10.1111/j.1748-7692.2001.tb01301.x; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; Lubchenco J, 2003, ECOL APPL, V13, pS3; LUNN NJ, 1991, J MAMMAL, V72, P202, DOI 10.2307/1381999; Mackovjack J, 2010, NAVIGATING TROUBLED; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; Mathews EA, 1996, MAR MAMMAL SCI, V12, P483, DOI 10.1111/j.1748-7692.1996.tb00603.x; Mathews EA, 2011, MAR MAMMAL SCI, V27, P852, DOI 10.1111/j.1748-7692.2010.00455.x; Matkin CO, 1980, MMX78107 US MAR MAMM; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; McCune B., 2006, PC ORD MULTIVARIATE; MIELKE PW, 1976, COMMUN STAT A-THEOR, V5, P1409, DOI 10.1080/03610927608827451; National Research Council, 2001, MAR PROT AR TOOLS SU; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Peterson SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039046; Pomeroy PP, 2000, ETHOLOGY, V106, P899, DOI 10.1046/j.1439-0310.2000.00610.x; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Robards MD, 2003, ECOLOGY SELECTED MAR; Roberts CM, 2003, ECOL APPL, V13, pS215; Rojas-Bracho L, 1999, MAR MAMMAL SCI, V15, P974, DOI 10.1111/j.1748-7692.1999.tb00873.x; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sharples RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037216; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Small RJ, 2005, MAR MAMMAL SCI, V21, P671, DOI 10.1111/j.1748-7692.2005.tb01259.x; Small RJ, 2003, MAR MAMMAL SCI, V19, P344, DOI 10.1111/j.1748-7692.2003.tb01113.x; Thompson PM, 1998, CAN J ZOOL, V76, P1044, DOI 10.1139/cjz-76-6-1044; THOMPSON PM, 1989, J ZOOL, V217, P281, DOI 10.1111/j.1469-7998.1989.tb02488.x; Westlake RL, 2002, J MAMMAL, V83, P1111, DOI 10.1644/1545-1542(2002)083<1111:MSAPOG>2.0.CO;2; Wolfe RJ, 2009, 339 AL DEP FISH GAM; Womble JN, 2010, MAR MAMMAL SCI, V26, P686, DOI 10.1111/j.1748-7692.2009.00360.x; Womble JN, 2009, J BIOGEOGR, V36, P439, DOI 10.1111/j.1365-2699.2007.01873.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; YOCHEM PK, 1987, MAR MAMMAL SCI, V3, P323, DOI 10.1111/j.1748-7692.1987.tb00319.x; Yorio P, 2009, CONSERV LETT, V2, P171, DOI 10.1111/j.1755-263X.2009.00062.x; Young C., 2009, THESIS SAN JOSE STAT; Zydelis R, 2011, P ROY SOC B-BIOL SCI, V278, P3191, DOI 10.1098/rspb.2011.0330	91	31	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55386	10.1371/journal.pone.0055386	http://dx.doi.org/10.1371/journal.pone.0055386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457468	Green Submitted, gold, Green Published			2022-12-27	WOS:000315602700016
J	Dong, Y; Stephens, C; Walpole, C; Swedberg, JE; Boyle, GM; Parsons, PG; McGuckin, MA; Harris, JM; Clements, JA				Dong, Ying; Stephens, Carson; Walpole, Carina; Swedberg, Joakim E.; Boyle, Glen M.; Parsons, Peter G.; McGuckin, Michael A.; Harris, Jonathan M.; Clements, Judith A.			Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; PLASMINOGEN ACTIVATION SYSTEM; HUMAN TISSUE KALLIKREINS; EXTRACELLULAR-MATRIX; DRUG-RESISTANCE; SERINE-PROTEASE; CARCINOMA CELLS; EXPRESSION; TUMOR; KLK4	High tumor kallikrein-related-peptidase 4 (KLK4) levels are associated with a poor outcome for women with serous epithelial ovarian cancer (EOC), for which peritoneal dissemination and chemoresistance are key events. To determine the role of KLK4 in these events, we examined KLK4-transfected SKOV-3 and endogenous KLK4 expressing OVCA432 cells in 3-dimensional (3D) suspension culture to mimic the ascites microenvironment. KLK4-SKOV-3 cells formed multicellular aggregates (MCAs) as seen in ascites, as did SKOV-3 cells treated with active KLK4. MCA formation was reduced by treatment with a KLK4 blocking antibody or the selective active site KLK4 sunflower trypsin inhibitor (SFTI-FCQR). KLK4-MCAs formed larger cancer cell foci in mesothelial cell monolayers than those formed by vector and native SKOV-3 cells, suggesting KLK4-MCAs are highly invasive in the peritoneal microenvironment. A high level of KLK4 is expressed by ascitic EOC cells compared to matched primary tumor cells, further supporting its role in the ascitic microenvironment. Interestingly, KLK4 transfected SKOV-3 cells expressed high levels of the KLK4 substrate, urokinase plasminogen activator (uPA), particularly in 3D-suspension, and high levels of both KLK4 and uPA were observed in patient cells taken from ascites. Importantly, the KLK4-MCAs were paclitaxel resistant which was reversed by SFTI-FCQR and to a lesser degree by the general serine protease inhibitor, Aprotinin, suggesting that in addition to uPA, other as yet unidentified substrates of KLK4 must be involved. Nonetheless, these data suggest that KLK4 inhibition, in conjunction with paclitaxel, may improve the outcome for women with serous epithelial ovarian cancer and high KLK4 levels in their tumors.	[Dong, Ying; Stephens, Carson; Walpole, Carina; Swedberg, Joakim E.; Harris, Jonathan M.; Clements, Judith A.] Queensland Univ Technol, Canc Program, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Dong, Ying; Stephens, Carson; Walpole, Carina; Swedberg, Joakim E.; Harris, Jonathan M.; Clements, Judith A.] Queensland Univ Technol, Fac Sci & Technol, Kelvin Grove, Qld, Australia; [Boyle, Glen M.; Parsons, Peter G.] Queensland Inst Med Res, Div Canc & Cell Biol, Drug Discovery Grp, Herston, Qld 4006, Australia; [McGuckin, Michael A.] Mater Med Res Inst, Immun Infect & Inflammat Program, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Mater Research	Clements, JA (corresponding author), Queensland Univ Technol, Canc Program, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.	j.clements@qut.edu.au	Parsons, Peter G/H-8163-2015; Boyle, Glen/G-1347-2013; McGuckin, Michael/G-2310-2010; Parsons, Peter/J-4683-2013; swedberg, Joakim/K-1501-2014	Parsons, Peter G/0000-0002-0473-3346; Boyle, Glen/0000-0002-1385-529X; McGuckin, Michael/0000-0002-8375-2675; Parsons, Peter/0000-0002-0473-3346; swedberg, Joakim/0000-0003-4243-8660; Harris, Jonathan/0000-0003-4209-2380; Walpole, Carina/0000-0002-9599-3396; Clements, Judith/0000-0001-6026-1964	National Health and Medical Research Council (NHMRC) of Australia [242220, 390123, 550523]; Cancer Council of Queensland; Queensland University of Technology; Science and Technology Facilities Council [ST/L001314/1, ST/I005765/1] Funding Source: researchfish; UK Space Agency [ST/J004812/1, ST/G003874/1] Funding Source: researchfish; STFC [ST/I005765/1, ST/L001314/1] Funding Source: UKRI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); Queensland University of Technology; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The project is supported by National Health and Medical Research Council (NHMRC) of Australia grants 242220, 390123, and 550523; the Cancer Council of Queensland and Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, BRIT J CANCER, V92, P1475, DOI 10.1038/sj.bjc.6602495; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Beaufort N, 2006, BIOL CHEM, V387, P217, DOI 10.1515/BC.2006.029; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2004, MOL CANCER RES, V2, P257; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chen H, 2009, BRIT J CANCER, V101, P432, DOI 10.1038/sj.bjc.6605185; Clements JA, 2004, CRIT REV CL LAB SCI, V41, P265, DOI 10.1080/10408360490471931; Cristea Mihaela, 2010, Ther Adv Med Oncol, V2, P175, DOI 10.1177/1758834010361333; Davidowitz RA, 2012, JOVE-J VIS EXP, DOI 10.3791/3888; Davidson B, 2005, AM J CLIN PATHOL, V123, P360, DOI 10.1309/PTBB5BPCKX8K9V69; Davidson B, 2003, GYNECOL ONCOL, V90, P248, DOI 10.1016/S0090-8258(03)00321-4; Davidson B, 2000, J PATHOL, V192, P460; Davidson B, 2010, HISTOL HISTOPATHOL, V25, P1591, DOI 10.14670/HH-25.1591; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Dong Y, 2003, CLIN CANCER RES, V9, P1710; Dong Y, 2001, CLIN CANCER RES, V7, P2363; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Dorn J, 2011, ANN ONCOL, V22, P877, DOI 10.1093/annonc/mdq462; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Frankel A, 1997, CANCER RES, V57, P2388; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goodman MT, 2003, CANCER, V97, P2648, DOI 10.1002/cncr.11347; Huang L, 2010, J CANCER RES CLIN, V136, P447, DOI 10.1007/s00432-009-0675-4; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Kobayashi H, 2004, INT J CANCER, V110, P134, DOI 10.1002/ijc.20082; Kuhn W, 1999, BRIT J CANCER, V79, P1746, DOI 10.1038/sj.bjc.6690278; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Magdolen V, 2003, RECENT RESULTS CANC, V162, P43; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Obiezu CV, 2006, BIOL CHEM, V387, P749, DOI 10.1515/BC.2006.094; Obiezu CV, 2001, CLIN CANCER RES, V7, P2380; Oikonomopoulou K, 2010, BIOL CHEM, V391, P381, DOI 10.1515/BC.2010.045; Pepin D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026075; Puls LE, 1996, GYNECOL ONCOL, V61, P109, DOI 10.1006/gyno.1996.0106; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rauh-Adelmann C, 2000, MOL CARCINOGEN, V28, P236, DOI 10.1002/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H; Ryu O, 2002, EUR J ORAL SCI, V110, P358, DOI 10.1034/j.1600-0722.2002.21349.x; SAKATA K, 1991, BRIT J CANCER, V64, P809, DOI 10.1038/bjc.1991.405; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Shih LM, 2007, GYNECOL ONCOL, V105, P501, DOI 10.1016/j.ygyno.2007.01.018; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Sun XY, 2001, CARCINOGENESIS, V22, P1775, DOI 10.1093/carcin/22.11.1775; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; Witz CA, 2001, J SOC GYNECOL INVEST, V8, P299, DOI 10.1016/S1071-5576(01)00122-8; Xi ZJ, 2004, GYNECOL ONCOL, V94, P80, DOI 10.1016/j.ygyno.2004.03.044; Yamakoshi Y, 2011, EUR J ORAL SCI, V119, P234, DOI 10.1111/j.1600-0722.2011.00863.x; Yousef GM, 2003, CANCER RES, V63, P2223	60	45	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57056	10.1371/journal.pone.0057056	http://dx.doi.org/10.1371/journal.pone.0057056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451143	Green Published, gold			2022-12-27	WOS:000316849500056
J	Eberhardt, RY; Bartholdson, SJ; Punta, M; Bateman, A				Eberhardt, Ruth Y.; Bartholdson, S. Josefin; Punta, Marco; Bateman, Alex			The SHOCT Domain: A Widespread Domain Under-Represented in Model Organisms	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; ANAEROTRUNCUS-COLIHOMINIS; SPFH DOMAIN; PROTEINS; PREDICTION; SEQUENCE; KINASES; ORIGIN	We have identified a new protein domain, which we have named the SHOCT domain (Short C-terminal domain). This domain is widespread in bacteria with over a thousand examples. But we found it is missing from the most commonly studied model organisms, despite being present in closely related species. It's predominantly C-terminal location, co-occurrence with numerous other domains and short size is reminiscent of the Gram-positive anchor motif, however it is present in a much wider range of species. We suggest several hypotheses about the function of SHOCT, including oligomerisation and nucleic acid binding. Our initial experiments do not support its role as an oligomerisation domain.	[Eberhardt, Ruth Y.; Punta, Marco; Bateman, Alex] European Bioinformat Inst, Hinxton, England; [Eberhardt, Ruth Y.; Bartholdson, S. Josefin; Punta, Marco; Bateman, Alex] Wellcome Trust Sanger Inst, Hinxton, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Eberhardt, RY (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, England.	re3@sanger.ac.uk	Punta, Marco/ABH-4698-2020; Bateman, Alex/H-2861-2019	Punta, Marco/0000-0002-0050-0676; Bateman, Alex/0000-0002-6982-4660; Bartholdson Scott, Sara Josefin/0000-0003-3380-4446; Eberhardt, Ruth/0000-0001-6152-1369	Wellcome Trust [WT098051]	Wellcome Trust(Wellcome Trust)	This work was supported by the Wellcome Trust, grant number WT098051 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Grishin NV, 2000, J MOL BIOL, V299, P1165, DOI 10.1006/jmbi.2000.3841; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Krishna SS, 2004, CELL CYCLE, V3, P1046; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lau SKP, 2006, J CLIN PATHOL, V59, P748, DOI 10.1136/jcp.2005.031773; Lawson PA, 2004, INT J SYST EVOL MICR, V54, P413, DOI 10.1099/ijs.0.02653-0; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Musset B, 2010, CHANNELS, V4, P260, DOI 10.4161/chan.4.4.12789; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Petrey D, 2009, P NATL ACAD SCI USA, V106, P17377, DOI 10.1073/pnas.0907971106; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Rackham OJL, 2010, J MOL BIOL, V403, P480, DOI 10.1016/j.jmb.2010.08.032; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Tanaka H, 2009, SCIENCE, V323, P384, DOI 10.1126/science.1164975; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tropp BE, 1997, BBA-LIPID LIPID MET, V1348, P192, DOI 10.1016/S0005-2760(97)00100-8; Verma A, 2003, INFECT IMMUN, V71, P5772, DOI 10.1128/IAI.71.10.5772-5784.2003; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	45	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57848	10.1371/journal.pone.0057848	http://dx.doi.org/10.1371/journal.pone.0057848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451277	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500140
J	Jacob, NK; Cooley, JV; Yee, TN; Jacob, J; Alder, H; Wickramasinghe, P; Maclean, KH; Chakravarti, A				Jacob, Naduparambil Korah; Cooley, James V.; Yee, Tamara N.; Jacob, Jidhin; Alder, Hansjuerg; Wickramasinghe, Priyankara; Maclean, Kirsteen H.; Chakravarti, Arnab			Identification of Sensitive Serum microRNA Biomarkers for Radiation Biodosimetry	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; MIR-150; CANCER; CELLS; POPULATION; MECHANISM; PROTEINS; VESICLES; MARKER	Exposure to ionizing radiation through environmental, occupational or a nuclear reactor accident such as the recent Fukushima Daiichi incident often results in major consequences to human health. The injury caused by radiation can manifest as acute radiation syndromes within weeks in organs with proliferating cells such as hematopoietic and gastrointestinal systems. Cancers, fibrosis and degenerative diseases are also reported in organs with differentiated cells, months or years later. Studies conducted on atom bomb survivors, nuclear reactor workers and animal models have shown a direct correlation of these effects with the absorbed dose. Physical dosimeters and the available radio-responsive biologics in body fluids, whose responses are rather indirect, have limitations to accurately evaluate the extent of post exposure damage. We have used an amplification-free, hybridization based quantitative assay utilizing the nCounter multiplex platform developed by nanoString Technologies to compare the levels of over 600 miRNAs in serum from mice irradiated at a range of 1 to 12 Gy at 24 and 48 hr time points. Development of a novel normalization strategy using multiple spike-in oligonucleotides allowed accurate measurement of radiation dose and time dependent changes in serum miRNAs. The response of several evolutionarily conserved miRNAs abundant in serum, were found to be robust and sensitive in the dose range relevant for medical triage and in patients who receive total body radiation as preparative regimen for bone marrow transplantation. Notably, miRNA-150, abundant in lymphocytes, exhibited a dose and time dependent decrease in serum, which we propose as a sensitive marker indicative of lymphocyte depletion and bone marrow damage. Our study has identified several markers useful for evaluation of an individual's response by minimally invasive methods, relevant to triage in case of a radiation accident and evaluation of toxicity and response during and after therapeutic radiation.	[Jacob, Naduparambil Korah; Cooley, James V.; Yee, Tamara N.; Jacob, Jidhin; Chakravarti, Arnab] Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, Columbus, OH 43210 USA; [Alder, Hansjuerg] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Wickramasinghe, Priyankara] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Maclean, Kirsteen H.] NanoString Technol, Seattle, WA USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; The Wistar Institute	Jacob, NK (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, Columbus, OH 43210 USA.	Naduparambil.Jacob@osumc.edu			Ohio State University Comprehensive Cancer Center Research funds; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Ohio State University Comprehensive Cancer Center Research funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Ohio State University Comprehensive Cancer Center Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2012, CELL REP, V2, P1048, DOI 10.1016/j.celrep.2012.09.014; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barcellos-Hoff MH, 1998, RADIAT RES, V150, pS109, DOI 10.2307/3579813; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blakely WF, 2010, HEALTH PHYS, V99, pS184, DOI 10.1097/HP.0b013e3181f26895; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Chng WJ, 2004, CLIN DIAGN LAB IMMUN, V11, P168, DOI 10.1128/CDLI.11.1.168-173.2004; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goans RE, 1997, HEALTH PHYS, V72, P513, DOI 10.1097/00004032-199704000-00001; Hall EJ, 2012, RADIOBIOLOGY RADIOLO, P193; HANSON WR, 1984, RADIAT RES, V100, P290, DOI 10.2307/3576350; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Li CW, 2012, CLIN BIOCHEM, V45, P727, DOI 10.1016/j.clinbiochem.2012.04.013; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Macnaughton WK, 2000, ALIMENT PHARM THER, V14, P523; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Scholl V, 2012, LEUKEMIA RES, V36, P119, DOI 10.1016/j.leukres.2011.08.023; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Singh VK, 2010, EXP HEMATOL, V38, P61, DOI 10.1016/j.exphem.2009.10.008; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Teichler S, 2011, BLOOD, V118, P1899, DOI 10.1182/blood-2010-09-306258; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF ION RAD, VII; UNSCEAR, 2000, SOURC EFF ION RAD UN, VI; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhu Y, 2010, INT J CLIN EXP MED, V3, P211	47	91	102	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57603	10.1371/journal.pone.0057603	http://dx.doi.org/10.1371/journal.pone.0057603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451251	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500120
J	Byers, JE; McDowell, WG; Dodd, SR; Haynie, RS; Pintor, LM; Wilde, SB				Byers, James E.; McDowell, William G.; Dodd, Shelley R.; Haynie, Rebecca S.; Pintor, Lauren M.; Wilde, Susan B.			Climate and pH Predict the Potential Range of the Invasive Apple Snail (Pomacea insularum) in the Southeastern United States	PLOS ONE			English	Article							VACUOLAR MYELINOPATHY; SPECIES DISTRIBUTION; AQUATIC PLANTS; WATER; IMPACTS; PROJECTIONS; DYNAMICS; MODELS; RISK; AREA	Predicting the potential range of invasive species is essential for risk assessment, monitoring, and management, and it can also inform us about a species' overall potential invasiveness. However, modeling the distribution of invasive species that have not reached their equilibrium distribution can be problematic for many predictive approaches. We apply the modeling approach of maximum entropy (MaxEnt) that is effective with incomplete, presence-only datasets to predict the distribution of the invasive island apple snail, Pomacea insularum. This freshwater snail is native to South America and has been spreading in the USA over the last decade from its initial introductions in Texas and Florida. It has now been documented throughout eight southeastern states. The snail's extensive consumption of aquatic vegetation and ability to accumulate and transmit algal toxins through the food web heighten concerns about its spread. Our model shows that under current climate conditions the snail should remain mostly confined to the coastal plain of the southeastern USA where it is limited by minimum temperature in the coldest month and precipitation in the warmest quarter. Furthermore, low pH waters (pH<5.5) are detrimental to the snail's survival and persistence. Of particular note are low-pH blackwater swamps, especially Okefenokee Swamp in southern Georgia (with a pH below 4 in many areas), which are predicted to preclude the snail's establishment even though many of these areas are well matched climatically. Our results elucidate the factors that affect the regional distribution of P. insularum, while simultaneously presenting a spatial basis for the prediction of its future spread. Furthermore, the model for this species exemplifies that combining climatic and habitat variables is a powerful way to model distributions of invasive species.	[Byers, James E.; McDowell, William G.; Pintor, Lauren M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Dodd, Shelley R.; Haynie, Rebecca S.; Wilde, Susan B.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Pintor, Lauren M.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University	Byers, JE (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jebyers@uga.edu	Byers, James/AFJ-8413-2022; McDowell, William/AAC-7707-2019	Byers, James/0000-0001-9240-0287; McDowell, William/0000-0003-0937-9435; Wilde, Susan/0000-0002-5388-9582	State Wildlife Grant Program	State Wildlife Grant Program	Funding came from the State Wildlife Grant Program to Georgia Department of Natural Resources to JEB and SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P, 2010, J MOLLUS STUD, V76, P138, DOI 10.1093/mollus/eyp050; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barnes MA, 2008, J N AM BENTHOL SOC, V27, P738, DOI 10.1899/08-013.1; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Benson AJ, 2010, POMACEA INSULARUM; Berry JP, 2010, TOXICON, V55, P930, DOI 10.1016/j.toxicon.2009.07.035; Blank L., 2012, HYDROBIOLOGIA, V685, P121; Bossenbroek JM, 2001, ECOL APPL, V11, P1778, DOI 10.2307/3061095; Bradley BA, 2006, ECOL APPL, V16, P1132, DOI 10.1890/1051-0761(2006)016[1132:CTLDOA]2.0.CO;2; Burlakova LE, 2010, BIOL INVASIONS, V12, P927, DOI 10.1007/s10530-009-9513-5; Burlakova LE, 2009, RESTOR ECOL, V17, P433, DOI 10.1111/j.1526-100X.2008.00429.x; Byers JE, 2002, CONSERV BIOL, V16, P630, DOI 10.1046/j.1523-1739.2002.01057.x; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Cattau CE, 2010, BIOL CONSERV, V143, P513, DOI 10.1016/j.biocon.2009.11.022; Conner SL, 2008, J MOLLUS STUD, V74, P355, DOI 10.1093/mollus/eyn024; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Darby Philip C., 2007, Florida Field Naturalist, V35, P79; de Rivera CE, 2011, DIVERS DISTRIB, V17, P1198, DOI 10.1111/j.1472-4642.2011.00790.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Estebenet A.L., 1992, Malacological Review, V25, P1; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Glass NH, 2009, AQUAT ECOL, V43, P1085, DOI 10.1007/s10452-008-9226-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Howells RG, 2007, GLOBAL ADV ECOLOGY M, P73; Howells RG., 2001, TEXAS PARKS WILDLIFE, V188; HUNTER RD, 1990, CAN J ZOOL, V68, P1578, DOI 10.1139/z90-233; Jarnevich CS, 2006, DIVERS DISTRIB, V12, P511, DOI 10.1111/j.1366-9516.2006.00278.x; Jarnevich CS, 2009, BIOL INVASIONS, V11, P1373, DOI 10.1007/s10530-008-9345-8; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Karatayev AY, 2009, HYDROBIOLOGIA, V619, P181, DOI 10.1007/s10750-008-9639-y; KEAWJAM R S, 1986, Malacological Review, V19, P61; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lv S, 2011, FRESHWATER BIOL, V56, P717, DOI 10.1111/j.1365-2427.2011.02579.x; Milanovich JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012189; Morisette JT, 2006, FRONT ECOL ENVIRON, V4, P11, DOI 10.1890/1540-9295(2006)004[0012:ATHSMF]2.0.CO;2; Naylor R, 1996, AMBIO, V25, P443; OKLAND J, 1992, ENVIRON POLLUT, V78, P127, DOI 10.1016/0269-7491(92)90020-B; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Perera G., 1996, APPLE SNAILS AQUARIU; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qian SS, 2001, ENVIRON SCI TECHNOL, V35, P941, DOI 10.1021/es0013069; RAMAKRISHNAN V, 2007, SALINITY PH TEMPERAT; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Robertson S, 2012, THESIS U GEORGIA ATH; Rosalino LM, 2010, VIE MILIEU, V60, P39; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; STORET, 1995, STORAGE RETRIEVAL US; Thomas NJ, 1998, VET PATHOL, V35, P479, DOI 10.1177/030098589803500602; Turner Richard L., 1996, Florida Scientist, V59, P34; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wilde SB, 2005, ENVIRON TOXICOL, V20, P348, DOI 10.1002/tox.20111	57	58	63	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56812	10.1371/journal.pone.0056812	http://dx.doi.org/10.1371/journal.pone.0056812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451090	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800039
J	Huynh, D; Akcora, D; Malaterre, J; Chan, CK; Dai, XM; Bertoncello, I; Stanley, ER; Ramsay, RG				Duy Huynh; Akcora, Dilara; Malaterre, Jordane; Chan, Chee Kai; Dai, Xu-Ming; Bertoncello, Ivan; Stanley, E. Richard; Ramsay, Robert G.			CSF-1 Receptor-Dependent Colon Development, Homeostasis and Inflammatory Stress Response	PLOS ONE			English	Article							STIMULATING FACTOR-I; EPITHELIAL-CELL TYPES; MOUSE SMALL INTESTINE; MACROPHAGE PROGENITOR CELLS; STEM-CELLS; C-MYB; DIFFERENTIAL SUSCEPTIBILITY; CLONOGENIC GROWTH; FACTOR-1 RECEPTOR; GENE-EXPRESSION	The colony stimulating factor-1 (CSF-1) receptor (CSF-1R) directly regulates the development of Paneth cells (PC) and influences proliferation and cell fate in the small intestine (SI). In the present study, we have examined the role of CSF-1 and the CSF-1R in the large intestine, which lacks PC, in the steady state and in response to acute inflammation induced by dextran sulfate sodium (DSS). As previously shown in mouse, immunohistochemical (IHC) analysis of CSF-1R expression showed that the receptor is baso-laterally expressed on epithelial cells of human colonic crypts, indicating that this expression pattern is shared between species. Colons from Csf1r null and Csf1(op/op) mice were isolated and sectioned for IHC identification of enterocytes, enteroendocrine cells, goblet cells and proliferating cells. Both Csf1r(-/-) and Csf1(op/op) mice were found to have colon defects in enterocytes and enteroendocrine cell fate, with excessive goblet cell staining and reduced cell proliferation. In addition, the gene expression profiles of the cell cycle genes, cyclinD1, c-myc, c-fos, and c-myb were suppressed in Csf1r(-/-) colonic crypt, compared with those of WT mice and the expression of the stem cell marker gene Lgr5 was markedly reduced. However, analysis of the proliferative responses of immortalized mouse colon epithelial cells (lines; Immorto-5 and YAMC) indicated that CSF-1R is not a major regulator of colonocyte proliferation and that its effects on proliferation are indirect. In an examination of the acute inflammatory response, Csf1r(+/-) male mice were protected from the adverse affects of DSS-induced colitis compared with WT mice, while Csf1r(+/-) female mice were significantly less protected. These data indicate that CSF-1R signaling plays an important role in colon homeostasis and stem cell gene expression but that the receptor exacerbates the response to inflammatory challenge in male mice.	[Duy Huynh; Akcora, Dilara; Malaterre, Jordane; Ramsay, Robert G.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Duy Huynh; Chan, Chee Kai] La Trobe Univ, Dept Genet, Melbourne, Vic, Australia; [Akcora, Dilara; Ramsay, Robert G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Malaterre, Jordane; Ramsay, Robert G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Dai, Xu-Ming; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Bertoncello, Ivan] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; La Trobe University; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Yeshiva University; University of Melbourne	Ramsay, RG (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	rob.ramsay@petermac.org	Stanley, Evan R/J-9154-2013; Chan, Chee Kai/C-1504-2011; Ramsay, Robert G/C-3291-2015; Bertoncello, Ivan/B-9235-2008	Stanley, Evan R/0000-0002-2910-2065; Chan, Chee Kai/0000-0002-2436-3282; Ramsay, Robert G/0000-0001-5003-0433; Dai, Xuming/0000-0003-3092-9323; AKCORA YILDIZ, Dilara/0000-0003-2586-4385	National Health and Medical Research Council of Australia Program [487922]; Cancer Council of Victoria project grant [400217]; National Institutes of Health grant [CA32551]; Albert Einstein College of Medicine Cancer Center grant [5P30-CA13330]; American Society of Hematology Fellow Scholar Award; Leukaemia and Lymphoma Society Special Fellow Award; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA032551] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria project grant(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Cancer Center grant; American Society of Hematology Fellow Scholar Award; Leukaemia and Lymphoma Society Special Fellow Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia Program # 487922, the Cancer Council of Victoria project grant #400217 (R.R.), National Institutes of Health grant CA32551 (E.R.S), the Albert Einstein College of Medicine Cancer Center grant 5P30-CA13330, an American Society of Hematology Fellow Scholar Award (X-M. D.) and a Leukaemia and Lymphoma Society Special Fellow Award (X-M.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; ALEXANDER RJ, 1995, DIGEST DIS SCI, V40, P485, DOI 10.1007/BF02064355; ALTMANN GG, 1983, AM J ANAT, V167, P95, DOI 10.1002/aja.1001670109; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BEDARD M, 1993, AM J RESP CELL MOL, V9, P455, DOI 10.1165/ajrcmb/9.4.455; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; BERTONCELLO I, 1986, J IMMUNOL, V136, P3219; BERTONCELLO I, 1981, EXP HEMATOL, V9, P604; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BRADLEY TR, 1979, BLOOD, V54, P1446; Calatayud S, 2002, CYTOKINE, V20, P163, DOI 10.1006/cyto.2002.1999; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Cheasley D, 2011, STEM CELLS; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P481, DOI 10.1002/aja.1001410404; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Harnish DC, 2004, AM J PHYSIOL-GASTR L, V286, pG118, DOI 10.1152/ajpgi.00024.2003; Hocker M, 1998, ANN NY ACAD SCI, V859, P160, DOI 10.1111/j.1749-6632.1998.tb11120.x; HORIGUCHI J, 1988, BIOCHEM BIOPH RES CO, V157, P395, DOI 10.1016/S0006-291X(88)80060-3; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Marshall D, 2007, INFLAMM BOWEL DIS, V13, P219, DOI 10.1002/ibd.20055; Martin GR, 2006, EXP BIOL MED, V231, P130; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; ORLOFSKY A, 1987, EMBO J, V6, P2947, DOI 10.1002/j.1460-2075.1987.tb02599.x; Pollard JW, 1997, MOL REPROD DEV, V46, P54, DOI 10.1002/(SICI)1098-2795(199701)46:1&lt;54::AID-MRD9&gt;3.0.CO;2-Q; Pollard JW., 1996, ADV D BIOCH, V4, P153; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Ramsay RG, 2004, MOL CANCER RES, V2, P354; Ramsay RG, 2004, J INTERF CYTOK RES, V24, P416, DOI 10.1089/1079990041535638; Romberg-Camps M, 2010, INFLAMM BOWEL DIS, V16, P1397, DOI 10.1002/ibd.21189; Rosenthal MA, 1996, CELL GROWTH DIFFER, V7, P961; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Roussel MF, 1997, MOL REPROD DEV, V46, P11, DOI 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U; ROUSSEL MF, 1994, J CELL SCI, P105; Saleiro D, 2012, INT J CANCER, V131, P2553, DOI 10.1002/ijc.27578; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sapi E, 1999, P SOC EXP BIOL MED, V220, P1, DOI 10.1046/j.1525-1373.1999.d01-1.x; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Staley EM, 2009, INFLAMM BOWEL DIS, V15, P684, DOI 10.1002/ibd.20824; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WIKTORJEDRZEJCZAK W, 1992, EXP HEMATOL, V20, P1004; Yazbeck R, 2008, FRONT BIOSCI-LANDMRK, V13, P6850, DOI 10.2741/3193; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	64	30	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56951	10.1371/journal.pone.0056951	http://dx.doi.org/10.1371/journal.pone.0056951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451116	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800051
J	Follet, H; Farlay, D; Bala, Y; Viguet-Carrin, S; Gineyts, E; Burt-Pichat, B; Wegrzyn, J; Delmas, P; Boivin, G; Chapurlat, R				Follet, Helene; Farlay, Delphine; Bala, Yohann; Viguet-Carrin, Stephanie; Gineyts, Evelyne; Burt-Pichat, Brigitte; Wegrzyn, Julien; Delmas, Pierre; Boivin, Georges; Chapurlat, Roland			Determinants of Microdamage in Elderly Human Vertebral Trabecular Bone	PLOS ONE			English	Article							COLLAGEN CROSS-LINKS; HUMAN CORTICAL BONE; CANCELLOUS BONE; NONENZYMATIC GLYCATION; MECHANICAL-PROPERTIES; ORGANIC MATRIX; DIFFUSE DAMAGE; FRACTURE; ACCUMULATION; MINERALIZATION	Previous studies have shown that microdamage accumulates in bone as a result of physiological loading and occurs naturally in human trabecular bone. The purpose of this study was to determine the factors associated with pre-existing microdamage in human vertebral trabecular bone, namely age, architecture, hardness, mineral and organic matrix. Trabecular bone cores were collected from human L2 vertebrae (n = 53) from donors 54-95 years of age (22 men and 30 women, 1 unknown) and previous cited parameters were evaluated. Collagen cross-link content (PYD, DPD, PEN and % of collagen) was measured on surrounding trabecular bone. We found that determinants of microdamage were mostly the age of donors, architecture, mineral characteristics and mature enzymatic cross-links. Moreover, linear microcracks were mostly associated with the bone matrix characteristics whereas diffuse damage was associated with architecture. We conclude that linear and diffuse types of microdamage seemed to have different determinants, with age being critical for both types.	[Follet, Helene; Farlay, Delphine; Bala, Yohann; Viguet-Carrin, Stephanie; Gineyts, Evelyne; Burt-Pichat, Brigitte; Wegrzyn, Julien; Delmas, Pierre; Boivin, Georges; Chapurlat, Roland] INSERM, UMR 1033, F-69008 Lyon, France; [Follet, Helene; Farlay, Delphine; Bala, Yohann; Viguet-Carrin, Stephanie; Gineyts, Evelyne; Burt-Pichat, Brigitte; Wegrzyn, Julien; Delmas, Pierre; Boivin, Georges; Chapurlat, Roland] Univ Lyon, UMR 1033, Lyon, France; [Wegrzyn, Julien] Hop Edouard Herriot, Dept Chirurg Orthoped, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Follet, H (corresponding author), INSERM, UMR 1033, F-69008 Lyon, France.	Helene.Follet@inserm.fr	Follet, Hélène/E-5536-2010; FARLAY, Delphine/AGF-1234-2022; CHAPURLAT, ROLAND/AAU-1165-2021	Follet, Hélène/0000-0002-3290-2899; FARLAY, Delphine/0000-0001-6487-0337; Gineyts, Evelyne/0000-0003-3868-5810	Eli Lilly	Eli Lilly(Eli Lilly)	This study was supported in part by an unrestricted educational grant from Eli Lilly to INSERM. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by an unrestricted educational grant from Eli Lilly to INSERM. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen MR., 2007, BONEKEY OSTEOVISION, V4, P49; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Bala Y, 2011, J MECH BEHAV BIOMED, V4, P1473, DOI 10.1016/j.jmbbm.2011.05.017; Bala Y, 2012, J BONE MINER RES, V27, P825, DOI 10.1002/jbmr.1501; Bala Y, 2010, BONE, V46, P1204, DOI 10.1016/j.bone.2009.11.032; Boivin G, 2008, BONE, V43, P532, DOI 10.1016/j.bone.2008.05.024; Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0; Burr D. B., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P201; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Burt-Pichat B, 2011, J BONE MINER METAB, V29, P756, DOI 10.1007/s00774-011-0291-7; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215, DOI 10.1615/CritRevBiomedEng.v34.i3.20; Durchschlag E, 2006, J BONE MINER RES, V21, P1581, DOI 10.1359/JBMR.060701; Fantner GE, 2004, BONE, V35, P1013, DOI 10.1016/j.bone.2004.05.027; Fantner GE, 2006, COMPOS SCI TECHNOL, V66, P1205, DOI 10.1016/j.compscitech.2005.10.005; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Fazzalari NL, 1998, BONE, V23, P373, DOI 10.1016/S8756-3282(98)00111-2; Fazzalari NL, 1998, BONE, V22, P381, DOI 10.1016/S8756-3282(97)00298-6; Fazzalari NL, 2002, BONE, V31, P697, DOI 10.1016/S8756-3282(02)00906-7; Follet H, 2011, J ORTHOP RES, V29, P481, DOI 10.1002/jor.21275; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Kuliwaba JS, 2009, BONE, V44, pS151, DOI 10.1016/j.bone.2009.01.331; LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Luo Q, 2010, J BIOMECH, V43, P2356, DOI 10.1016/j.jbiomech.2010.04.026; MARTIN RB, 1982, J BIOMECH, V15, P137, DOI 10.1016/S0021-9290(82)80001-8; MONGIORGI R, 1983, BIOMATERIALS, V4, P192, DOI 10.1016/0142-9612(83)90009-1; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Najafi AR, 2007, J BIOMECH, V40, P2788, DOI 10.1016/j.jbiomech.2007.01.017; Norman TL, 1997, BONE, V20, P375, DOI 10.1016/S8756-3282(97)00004-5; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214; Peterlik H, 2006, NAT MATER, V5, P52, DOI 10.1038/nmat1545; Saito M, 2008, OSTEOPOROSIS INT, V19, P1343, DOI 10.1007/s00198-008-0585-3; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Shi XT, 2010, BONE, V46, P1260, DOI 10.1016/j.bone.2010.02.005; Soicher MA, 2011, BONE, V48, P663, DOI 10.1016/j.bone.2010.11.009; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Vashishth D, 2000, BONE, V26, P147, DOI 10.1016/S8756-3282(99)00253-7; Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8; Viguet-Carrin S, 2009, J CHROMATOGR B, V877, P1, DOI 10.1016/j.jchromb.2008.10.043; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Viguet-Carrin S, 2010, BONE, V46, P342, DOI 10.1016/j.bone.2009.10.001; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wang X, 2008, J BIOMECH, V41, P2654, DOI 10.1016/j.jbiomech.2008.06.011; Wang X, 2008, J BIOMED MATER RES B, V85B, P68, DOI 10.1002/jbm.b.30918; Wasserman Nicholas, 2005, European Journal of Morphology, V42, P43, DOI 10.1080/09243860500095471; Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5; Yeni YN, 2006, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000200239.29931.56; Yeni YN, 2003, ANN BIOMED ENG, V31, P726, DOI 10.1114/1.1569264; Yerramshetty JS, 2008, BONE, V42, P476, DOI 10.1016/j.bone.2007.12.001	56	16	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55232	10.1371/journal.pone.0055232	http://dx.doi.org/10.1371/journal.pone.0055232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457465	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700011
J	Cheng, CW; Su, JL; Lin, CW; Su, CW; Shih, CH; Yang, SF; Chien, MH				Cheng, Chao-Wen; Su, Jen-Liang; Lin, Chiao-Wen; Su, Chun-Wen; Shih, Chun-Han; Yang, Shun-Fa; Chien, Ming-Hsien			Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features	PLOS ONE			English	Article							NF-KAPPA-B; FUNCTIONAL INSERTION/DELETION POLYMORPHISM; HEPATITIS-B; PROMOTER POLYMORPHISMS; INCREASES SUSCEPTIBILITY; CONSTITUTIVE ACTIVATION; ALPHA POLYMORPHISM; GASTRIC-CANCER; BREAST CANCERS; RISK	Background: Constitutive activation of nuclear factor (NF)-kappa B is frequently observed in hepatocellular carcinoma (HCC). The current study examined associations of polymorphisms within promoter regions of NFKB1 encoding NF-kappa B1 and NFKBIA encoding IkB alpha with the susceptibility of developing HCC and clinicopathological characteristics of the tumors. Methodology and Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (PCR) in 135 HCC patients and 520 healthy controls. The genotypic frequency of the NFKB1-94 Ins polymorphism in HCC patients was significantly higher than that of the controls (adjusted odds ratio (AOR) = 2.23; 95% confidence interval (CI) 1.32 similar to 3.77). No statistical significance was observed for the distribution frequency of the NFKBIA - 2519 C/T, -826 C/T, or -881 A/G genotype and haplotype polymorphisms between HCC patients and controls. Furthermore, female HCC patients carrying the NFKB1 -94 Ins polymorphism were associated with lower clinical stages and smaller tumor sizes. Conclusions: Our results indicate that the NFKB1 -94 Ins promoter polymorphism increased the risk of HCC, and may be applied as a predictive factor for the clinical stage and tumor size in female HCC patients.	[Cheng, Chao-Wen; Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Su, Jen-Liang] China Med Univ, Grad Inst Canc Biol, Coll Med, Taichung, Taiwan; [Su, Jen-Liang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Su, Jen-Liang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Su, Jen-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Su, Chun-Wen; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Shih, Chun-Han] Taipei Med Univ, Wan Fang Hosp, Dept Trauma & Emergency Surg, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fan Hosp, Taipei, Taiwan	Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; National Taiwan University; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Taipei Medical University-Wan Fang Hospital [101swf03]	Taipei Medical University-Wan Fang Hospital	This study was supported by a grant from Taipei Medical University-Wan Fang Hospital (grant no. 101swf03 to Drs. Chien and Yang). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah A, 2003, GENES IMMUN, V4, P450, DOI 10.1038/sj.gene.6364001; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Akkiz H, 2009, CANCER EPIDEMIOL, V33, P261, DOI 10.1016/j.canep.2009.06.001; Arbuthnot P, 2000, J GASTROEN HEPATOL, V15, P357, DOI 10.1046/j.1440-1746.2000.02069.x; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Chang CC, 2009, CLIN CHEM LAB MED, V47, P412, DOI 10.1515/CCLM.2009.092; Chen DS, 2007, HEPATOL RES, V37, pS101, DOI 10.1111/j.1872-034X.2007.00170.x; Chen F, 1999, CLIN CHEM, V45, P7; Chien MH, 2011, J SURG ONCOL, V104, P299, DOI 10.1002/jso.21929; Curran JE, 2002, CANCER LETT, V188, P103, DOI 10.1016/S0304-3835(02)00460-3; Drent M, 2001, SARCOIDOSIS VASC DIF, V18, P50; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Firpi Roberto J, 2006, Hematology Am Soc Hematol Educ Program, P375; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kato N, 2000, HEPATOLOGY, V32, P405, DOI 10.1053/jhep.2000.9198; Li RN, 2010, J CLIN IMMUNOL, V30, P676, DOI 10.1007/s10875-010-9439-9; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035078; Lin SC, 2006, CANCER LETT, V243, P47, DOI 10.1016/j.canlet.2005.11.019; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; Lo SS, 2009, SURGERY, V145, P280, DOI 10.1016/j.surg.2008.11.001; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Qiao L, 2006, HUM GENE THER, V17, P280, DOI 10.1089/hum.2006.17.280; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang SY, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-15; Xu HW, 2012, J PATHOL, V228, P216, DOI 10.1002/path.4009; Yano Y, 2006, LIVER INT, V26, P789, DOI 10.1111/j.1478-3231.2006.01310.x; Yokoo H, 2011, HEPATOL RES, V41, P240, DOI 10.1111/j.1872-034X.2010.00758.x; Yu MW, 2003, HEPATOLOGY, V38, P1393, DOI 10.1016/j.hep.2003.09.041; Zhang P, 2009, CANCER GENET CYTOGEN, V191, P73, DOI 10.1016/j.cancergencyto.2009.01.017; Zhou B, 2010, ANN ONCOL, V21, P506, DOI 10.1093/annonc/mdp507; Zhou B, 2009, CANCER LETT, V275, P72, DOI 10.1016/j.canlet.2008.10.002; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006; Zou YF, 2011, CANCER INVEST, V29, P78, DOI 10.3109/07357907.2010.535054	40	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56130	10.1371/journal.pone.0056130	http://dx.doi.org/10.1371/journal.pone.0056130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457512	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700046
J	Chiplunkar, AR; Lung, TK; Alhashem, Y; Koppenhaver, BA; Salloum, FN; Kukreja, RC; Haar, JL; Lloyd, JA				Chiplunkar, Aditi R.; Lung, Tina K.; Alhashem, Yousef; Koppenhaver, Benjamin A.; Salloum, Fadi N.; Kukreja, Rakesh C.; Haar, Jack L.; Lloyd, Joyce A.			Kruppel-Like Factor 2 Is Required for Normal Mouse Cardiac Development	PLOS ONE			English	Article							UDP-GLUCOSE DEHYDROGENASE; CONGENITAL HEART-DEFECTS; HOLT-ORAM-SYNDROME; GENE-EXPRESSION; VALVE FORMATION; PRIMITIVE ERYTHROPOIESIS; TRANSCRIPTION FACTORS; ENDOCARDIAL CUSHION; CELLS; TRANSFORMATION	Kruppel-like factor 2 (KLF2) is expressed in endothelial cells in the developing heart, particularly in areas of high shear stress, such as the atrioventricular (AV) canal. KLF2 ablation leads to myocardial thinning, high output cardiac failure and death by mouse embryonic day 14.5 (E14.5) in a mixed genetic background. This work identifies an earlier and more fundamental role for KLF2 in mouse cardiac development in FVB/N mice. FVB/N KLF2-/- embryos die earlier, by E11.5. E9.5 FVB/N KLF2-/- hearts have multiple, disorganized cell layers lining the AV cushions, the primordia of the AV valves, rather than the normal single layer. By E10.5, traditional and endothelial-specific FVB/N KLF2-/- AV cushions are hypocellular, suggesting that the cells accumulating at the AV canal have a defect in endothelial to mesenchymal transformation (EMT). E10.5 FVB/N KLF2-/- hearts have reduced glycosaminoglycans in the cardiac jelly, correlating with the reduced EMT. However, the number of mesenchymal cells migrating from FVB/N KLF2-/- AV explants into a collagen matrix is reduced considerably compared to wild-type, suggesting that the EMT defect is not due solely to abnormal cardiac jelly. Echocardiography of E10.5 FVB/N KLF2-/- embryos indicates that they have abnormal heart function compared to wild-type. E10.5 C57BL/6 KLF2-/- hearts have largely normal AV cushions. However, E10.5 FVB/N and C57BL/6 KLF2-/- embryos have a delay in the formation of the atrial septum that is not observed in a defined mixed background. KLF2 ablation results in reduced Sox9, UDP-glucose dehydrogenase (Ugdh), Gata4 and Tbx5 mRNA in FVB/N AV canals. KLF2 binds to the Gata4, Tbx5 and Ugdh promoters in chromatin immunoprecipitation assays, indicating that KLF2 could directly regulate these genes. In conclusion, KLF2-/- heart phenotypes are genetic background-dependent. KLF2 plays a role in EMT through its regulation of important cardiovascular genes.	[Chiplunkar, Aditi R.; Lung, Tina K.; Alhashem, Yousef; Koppenhaver, Benjamin A.; Lloyd, Joyce A.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Salloum, Fadi N.; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Haar, Jack L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Lloyd, Joyce A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	jlloyd@vcu.edu	Salloum, Fadi N/C-2391-2008	Salloum, Fadi N/0000-0002-8947-9315; Khandekar, Aditi/0000-0001-5362-1335; Alhashem, Yousef N./0000-0003-4435-3003	National Institutes of Health [NIH R01 DK074694]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM090084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH R01 DK074694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Alhashem YN, 2011, J BIOL CHEM, V286, P24819, DOI 10.1074/jbc.M111.247536; Sophie A, 2007, MECH DEVELOP, V124, P551, DOI 10.1016/j.mod.2007.05.004; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; BERNANKE DH, 1982, DEV BIOL, V91, P235, DOI 10.1016/0012-1606(82)90030-6; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; Corrigan N, 2010, REPROD SCI, V17, P147, DOI 10.1177/1933719109348923; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Hyde AS, 2012, J BIOL CHEM, V287, P32708, DOI 10.1074/jbc.M112.395202; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Joziasse IC, 2008, BASIC RES CARDIOL, V103, P216, DOI 10.1007/s00395-008-0713-4; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KRUG EL, 1985, DEV BIOL, V112, P414, DOI 10.1016/0012-1606(85)90414-2; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lin ZY, 2010, ARTERIOSCL THROM VAS, V30, P1952, DOI 10.1161/ATVBAHA.110.211474; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Redmond LC, 2008, DEV DYNAM, V237, P436, DOI 10.1002/dvdy.21426; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wood HB, 1997, BLOOD, V90, P2300	47	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54891	10.1371/journal.pone.0054891	http://dx.doi.org/10.1371/journal.pone.0054891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457456	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700010
J	Dijkstra, JK; Lindenberg, S; Zijlstra, L; Bouma, E; Veenstra, R				Dijkstra, Jan Kornelis; Lindenberg, Siegwart; Zijlstra, Lieuwe; Bouma, Esther; Veenstra, Rene			The Secret Ingredient for Social Success of Young Males: A Functional Polymorphism in the 5HT(2A) Serotonin Receptor Gene	PLOS ONE			English	Article							POPULARITY; ENVIRONMENT; ENHANCEMENT; AGGRESSION; DOMINANCE; BREAKING	In adolescence, being socially successful depends to a large extent on being popular with peers. Even though some youths have what it takes to be popular, they are not, whereas others seem to have a secret ingredient that just makes the difference. In this study the G-allele of a functional polymorphism in the promotor region of the 5HT(2A) serotonin receptor gene (-G1438A) was identified as a secret ingredient for popularity among peers. These findings build on and extend previous work by Burt (2008, 2009). Tackling limitations from previous research, the role of the 5HT(2A) serotonin receptor gene was examined in adolescent males (N = 285; average age 13) using a unique sample of the TRAILS study. Carrying the G-allele enhanced the relation between aggression and popularity, particularly for those boys who have many female friends. This seems to be an "enhancer" effect of the G-allele whereby popularity relevant characteristics are made more noticeable. There is no "popularity gene", as the G-allele by itself had no effect on popularity.	[Dijkstra, Jan Kornelis; Lindenberg, Siegwart; Zijlstra, Lieuwe; Veenstra, Rene] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Dijkstra, Jan Kornelis; Lindenberg, Siegwart; Veenstra, Rene] Univ Groningen, Interuniv Ctr Social Sci Theory & Methodol ICS, Groningen, Netherlands; [Lindenberg, Siegwart] Tilburg Univ, Tilburg Sch Social & Behav Sci, NL-5000 LE Tilburg, Netherlands; [Lindenberg, Siegwart] Tilburg Univ, TIBER, NL-5000 LE Tilburg, Netherlands; [Bouma, Esther] Univ Groningen, Fac Math & Nat Sci, Groningen, Netherlands	University of Groningen; University of Groningen; Tilburg University; Tilburg University; University of Groningen	Dijkstra, JK (corresponding author), Univ Groningen, Dept Sociol, Groningen, Netherlands.	jan.dijkstra@rug.nl	Dijkstra, Jan/E-9338-2013; Veenstra, René/G-6696-2011; Lindenberg, Siegwart/E-2932-2013	Veenstra, René/0000-0001-6686-6307; Lindenberg, Siegwart/0000-0003-0053-3651; bouma, esther/0000-0003-2993-7086; Zijlstra, Lieuwe/0000-0002-3977-3890	Netherlands Organization for Scientific Research NWO (Medical Research Council program) [GB-MW 940-38-011, 100-001-004, 60-60600-97-118, 261-98-710, GB-MaGW 480-01-006, GB-MaGW 480-07-001, GB-MaGW 452-04-314, GB-MaGW 452-06-004, 175.010.2003.005, 481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Netherlands Organisation for Scientific Research (NWO) Vernieuwingsimpuls (VENI) Project [451-10-012]	Netherlands Organization for Scientific Research NWO (Medical Research Council program)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Netherlands Organisation for Scientific Research (NWO) Vernieuwingsimpuls (VENI) Project	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), and the participating universities. The authors are grateful to all adolescents, their parents and teachers who participated in this research and to everyone who worked on this project and made it possible (www.trails.nl). Part of this research was funded by the Netherlands Organisation for Scientific Research (NWO) Vernieuwingsimpuls (VENI) Project number 451-10-012 awarded to JKD (2010)(www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL YSR 1991 PROF; Aiken L. S., 1991, MULTIPLE REGRESSION; Back MD, 2010, J PERS SOC PSYCHOL, V98, P132, DOI 10.1037/a0016338; Burt A, 2009, J PERS SOC PSYCHOL, V96, P783, DOI 10.1037/a0013702; Burt SA, 2008, PSYCHOL SCI, V19, P112, DOI 10.1111/j.1467-9280.2008.02055.x; Cillessen AHN, 2005, CURR DIR PSYCHOL SCI, V14, P102, DOI 10.1111/j.0963-7214.2005.00343.x; Cillessen AHN, 2004, CHILD DEV, V75, P147, DOI 10.1111/j.1467-8624.2004.00660.x; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Dijkstra JK, 2010, J EARLY ADOLESCENCE, V30, P773, DOI 10.1177/0272431609350926; Dijkstra JK, 2009, J RES ADOLESCENCE, V19, P401, DOI 10.1111/j.1532-7795.2009.00594.x; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Lindenberg S. M., 2012, ENV PSYCHOL INTRO, P119; Paulhus DL, 1998, J PERS SOC PSYCHOL, V74, P1197, DOI 10.1037/0022-3514.74.5.1197; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Vaillancourt T, 2006, AGGRESSIVE BEHAV, V32, P396, DOI 10.1002/ab.20138	19	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54821	10.1371/journal.pone.0054821	http://dx.doi.org/10.1371/journal.pone.0054821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457454	Green Submitted, gold, Green Published			2022-12-27	WOS:000315602700008
J	Giubellino, A; Sourbier, C; Lee, MJ; Scroggins, B; Bullova, P; Landau, M; Ying, WW; Neckers, L; Trepel, JB; Pacak, K				Giubellino, Alessio; Sourbier, Carole; Lee, Min-Jung; Scroggins, Brad; Bullova, Petra; Landau, Michael; Ying, Weiwen; Neckers, Len; Trepel, Jane B.; Pacak, Karel			Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma	PLOS ONE			English	Article							MOLECULAR CHAPERONE; HSP90 INHIBITORS; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; CANCER-THERAPY; GROWTH-FACTOR; PHASE-I; COMPLEX; PARAGANGLIOMAS; EXPRESSION	Metastatic pheochromocytoma represents one of the major clinical challenges in the field of neuroendocrine oncology. Recent molecular characterization of pheochromocytoma suggests new treatment options with targeted therapies. In this study we investigated the 90 kDa heat shock protein (Hsp90) as a potential therapeutic target for advanced pheochromocytoma. Both the first generation, natural product Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin), and the second-generation synthetic Hsp90 inhibitor STA-9090 (ganetespib) demonstrated potent inhibition of proliferation and migration of pheochromocytoma cell lines and induced degradation of key Hsp90 clients. Furthermore, ganetespib induced dose-dependent cytotoxicity in primary pheochromocytoma cells. Using metastatic models of pheochromocytoma, we demonstrate the efficacy of 17-AAG and ganetespib in reducing metastatic burden and increasing survival. Levels of Hsp70 in plasma from the xenograft studies served as a proximal biomarker of drug treatment. Our study suggests that targeting Hsp90 may benefit patients with advanced pheochromocytoma.	[Giubellino, Alessio; Bullova, Petra; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Sourbier, Carole; Scroggins, Brad; Neckers, Len] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Lee, Min-Jung; Landau, Michael; Trepel, Jane B.] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Ying, Weiwen] Synta Pharmaceut, Lexington, MA USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giubellino, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA.	giubella@mail.nih.gov; karel@mail.nih.gov	Bullova, Petra/ABG-5262-2020; Giubellino, Alessio/H-3432-2019	Bullova, Petra/0000-0002-5411-2185; Giubellino, Alessio/0000-0002-5352-0662	Eunice Kennedy Shriver National Institute of Child Health and Human Development; Center for Cancer Research, National Cancer Institute of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICSC006743, ZIASC010074] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Center for Cancer Research, National Cancer Institute of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by intramural research funding of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Center for Cancer Research, National Cancer Institute of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Benn DE, 2003, ONCOGENE, V22, P1358, DOI 10.1038/sj.onc.1206300; Bishop SC, 2007, CURR CANCER DRUG TAR, V7, P369, DOI 10.2174/156800907780809778; Boltze C, 2003, J CLIN ENDOCR METAB, V88, P4280, DOI 10.1210/jc.2002-021299; Brieger J, 2005, ORL-J OTO-RHIN-LARYN, V67, P119, DOI 10.1159/000085171; Buffet A, 2012, HORM METAB RES, V44, P359, DOI 10.1055/s-0032-1304594; Cascon A, 2012, ENDOCR PATHOL, V23, P15, DOI 10.1007/s12022-012-9195-x; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Druce MR, 2009, HORM METAB RES, V41, P697, DOI 10.1055/s-0029-1220687; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Favier J, 2005, HORM RES, V63, P171, DOI 10.1159/000084685; Favier J, 2002, AM J PATHOL, V161, P1235, DOI 10.1016/S0002-9440(10)64400-8; Favier J, 2012, ENDOCR PATHOL, V23, P34, DOI 10.1007/s12022-011-9189-0; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Giubellino A, 2012, CANCER LETT, V316, P46, DOI 10.1016/j.canlet.2011.10.019; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grogan RH, 2011, CANCER CONTROL, V18, P104, DOI 10.1177/107327481101800205; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Jimenez C, 2009, J CLIN ENDOCR METAB, V94, P386, DOI 10.1210/jc.2008-1972; Jyung RW, 2000, LARYNGOSCOPE, V110, P161, DOI 10.1097/00005537-200001000-00029; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Korpershoek E, 2012, ENDOCR PATHOL, V23, P43, DOI 10.1007/s12022-012-9194-y; Lai EW, 2007, CELL CYCLE, V6, P1946, DOI 10.4161/cc.6.15.4521; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Nolting S, 2012, ENDOCR PATHOL, V23, P21, DOI 10.1007/s12022-012-9199-6; Pacak K, 2011, Endocr Regul, V45, P65; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Rajan A, 2011, CLIN CANCER RES, V17, P6831, DOI 10.1158/1078-0432.CCR-11-0821; Rooijens PPGM, 2004, ENDOCR PATHOL, V15, P39, DOI 10.1385/EP:15:1:39; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Tischler AS, 2004, HISTOL HISTOPATHOL, V19, P883, DOI 10.14670/HH-19.883; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; Weber A, 2012, HORM CANC; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Zhang H, 2006, MOL CANCER THER, V5, P1256, DOI 10.1158/1535-7163.MCT-05-0537; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	51	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56083	10.1371/journal.pone.0056083	http://dx.doi.org/10.1371/journal.pone.0056083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457505	Green Submitted, gold, Green Published			2022-12-27	WOS:000315602700042
J	Roth, M; Zhong, J; Zumkeller, C; S'ng, CT; Goulet, S; Tamm, M				Roth, Michael; Zhong, Jun; Zumkeller, Celine; S'ng, Chong Teck; Goulet, Stephanie; Tamm, Michael			The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling	PLOS ONE			English	Article							HOUSE-DUST MITE; EXTRACELLULAR-MATRIX PROTEINS; COLLAGEN EXPRESSION; ALLERGIC-ASTHMA; MURINE MODEL; MAST-CELLS; FIBRONECTIN; LUNG; PROLIFERATION; SENSITIZATION	Background: In allergic asthma, IgE increases airway remodelling but the mechanism is incompletely understood. Airway remodelling consists of two independent events increased cell numbers and enhanced extracellular matrix deposition, and the mechanism by which IgE up-regulates cell proliferation and extracellular matrix deposition by human airway smooth muscle cells in asthma is unclear. Objective: Characterise the role of the two IgE receptors and associated signalling cascades in airway smooth muscle cell remodelling. Methods: Primary human airway smooth muscle cells (8 asthmatics, 8 non-asthmatics) were stimulated with human purified antibody-activated IgE. Proliferation was determined by direct cell counts. Total collagen deposition was determined by Sircol; collagen species deposition by ELISA. IgE receptors were silenced by siRNA and mitogen activated protein kinase (MAPK) signalling was blocked by chemical inhibitors. Results: IgE dose-dependently increased extracellular matrix and collagen deposition by airway smooth muscle cells as well as their proliferation. Specifically in cells of asthma patients IgE increased the deposition of collagen-type-I, -III, -VII and fibronectin, but did not affect the deposition of collagens type-IV. IgE stimulated collagen type-I and type-VII deposition through IgE receptor-I and Erk1/2 MAPK. Proliferation and deposition of collagens type-III and fibronectin involved both IgE receptors as well as Erk1/2 and p38 MAPK. Pre-incubation (30 minutes) with Omalizumab prevented all remodelling effects completely. We observed no changes in gelatinase activity or their inhibitors. Conclusion & Clincal Relevance: Our study provides the molecular biological mechanism by which IgE increases airway remodelling in asthma through increased airway smooth muscle cell proliferation and deposition of pro-inflammatory collagens and fibronectin. Blocking IgE action prevents several aspects of airway smooth muscle cell remodelling. Our findings may explain the recently described reduction of airway wall thickness in severe asthma patients treated with humanised anti-IgE antibodies.	[Roth, Michael; Zhong, Jun; Zumkeller, Celine; S'ng, Chong Teck; Goulet, Stephanie] Univ Basel, Dept Biomed, Basel, Switzerland; [Roth, Michael; Tamm, Michael] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Roth, M (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	michael.roth@usb.ch	Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821	Swiss National Foundation [310030_130740]; Novartis	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis(Novartis)	Michael Roth received a research grant from the Swiss National Foundation (310030_130740). Michael Tamm received an unrestricted research grant from Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri H, 2011, ALLERGY, V66, P1231, DOI 10.1111/j.1398-9995.2011.02616.x; Belleau Joseph T, 2005, Clin Mol Allergy, V3, P6, DOI 10.1186/1476-7961-3-6; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Bonacci JV, 2006, BRIT J PHARMACOL, V149, P365, DOI 10.1038/sj.bjp.0706881; Brellier F, FEBS LETT, V585, P913; Burgess JK, 2009, PULM PHARMACOL THER, V22, P379, DOI 10.1016/j.pupt.2008.12.007; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chuang GS, 2004, CLIN EXP DERMATOL, V29, P304, DOI 10.1111/j.1365-2230.2004.01495.x; Dekkers BGJ, 2012, BRIT J PHARMACOL, V166, P359, DOI 10.1111/j.1476-5381.2011.01773.x; Demoule A, 2006, INTENS CARE MED, V32, P413, DOI 10.1007/s00134-005-0043-z; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Evans MJ, 2010, AM J PHYSIOL-LUNG C, V298, pL543, DOI 10.1152/ajplung.00337.2009; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Grunstein MM, 2001, AM J PHYSIOL-LUNG C, V280, pL229, DOI 10.1152/ajplung.2001.280.2.L229; Hoshino M, 2012, RESPIRATION, V83, P520, DOI 10.1159/000334701; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Joks R, 2011, RECENT PATENTS INFLA, V5, P221, DOI 10.2174/187221311797264919; Kang JY, 2010, J ASTHMA, V47, P374, DOI 10.3109/02770901003801972; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kim SJ, 2009, J ASTHMA, V46, P884, DOI 10.3109/02770900903089998; Kohan M, 2011, J ALLERGY CLIN IMMUN, V127, P439, DOI 10.1016/j.jaci.2010.10.021; Koziol-White CJ, 2011, EXPERT REV RESP MED, V5, P767, DOI [10.1586/ERS.11.77, 10.1586/ers.11.77]; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; McParland BE, 2004, J APPL PHYSIOL, V97, P556, DOI 10.1152/japplphysiol.00982.2003; Mor A, 2010, INFLAMMATION, V33, P119, DOI 10.1007/s10753-009-9165-8; Nam YH, 2012, J INVEST ALLERG CLIN, V22, P20; Nelea V, 2008, PROTEIN J, V27, P223, DOI 10.1007/s10930-008-9128-1; Nihlberg K, 2010, THORAX, V65, P670, DOI 10.1136/thx.2009.129320; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Rabe KF, 2011, ALLERGY, V66, P1142, DOI 10.1111/j.1398-9995.2011.02617.x; Redhu NS, 2012, PULM PHARM IN PRESS; Riccio AM, 2012, INT J IMMUNOPATH PH, V25, P475, DOI 10.1177/039463201202500217; Royce SG, 2009, ANN ALLERG ASTHMA IM, V102, P238, DOI 10.1016/S1081-1206(10)60087-7; Schuliga M, 2011, AM J RESP CELL MOL, V44, P831, DOI 10.1165/rcmb.2009-0469OC; Soucy PA, 2011, ACTA BIOMATER, V7, P96, DOI 10.1016/j.actbio.2010.07.021; Yick CY, 2012, ALLERGY, V67, P552, DOI 10.1111/j.1398-9995.2011.02773.x	46	45	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56015	10.1371/journal.pone.0056015	http://dx.doi.org/10.1371/journal.pone.0056015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457493	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700033
J	Cervadoro, A; Giverso, C; Pande, R; Sarangi, S; Preziosi, L; Wosik, J; Brazdeikis, A; Decuzzi, P				Cervadoro, Antonio; Giverso, Chiara; Pande, Rohit; Sarangi, Subhasis; Preziosi, Luigi; Wosik, Jarek; Brazdeikis, Audrius; Decuzzi, Paolo			Design Maps for the Hyperthermic Treatment of Tumors with Superparamagnetic Nanoparticles	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; RADIOFREQUENCY ABLATION; DRUG-DELIVERY; HEAT-TRANSFER; TEMPERATURE; THERAPY; CYTOSKELETON; NANOCUBES; MELANOMA; TISSUE	A plethora of magnetic nanoparticles has been developed and investigated under different alternating magnetic fields (AMF) for the hyperthermic treatment of malignant tissues. Yet, clinical applications of magnetic hyperthermia are sporadic, mostly due to the low energy conversion efficiency of the metallic nanoparticles and the high tissue concentrations required. Here, we study the hyperthermic performance of commercially available formulations of superparamagnetic iron oxide nanoparticles (SPIOs), with core diameter of 5, 7 and 14 nm, in terms of absolute temperature increase Delta T and specific absorption rate (SAR). These nanoparticles are operated under a broad range of AMF conditions, with frequency f varying between 0.2 and 30 MHz; field strength H ranging from 4 to 10 kA m(-1); and concentration c(MNP) varying from 0.02 to 3.5 mg ml(-1). At high frequency field (similar to 30 MHz), non specific heating dominates and Delta T correlates with the electrical conductivity of the medium. At low frequency field (<1 MHz), non specific heating is negligible and the relaxation of the SPIO within the AMF is the sole energy source. We show that the Delta T of the medium grows linearly with c(MNP), whereas the SAR(MNP) of the magnetic nanoparticles is independent of c(MNP) and varies linearly with f and H-2. Using a computational model for heat transport in a biological tissue, the minimum requirements for local hyperthermia (T-tissue >42 degrees C) and thermal ablation (T-tissue >50 degrees C) are derived in terms of c(MNP), operating AMF conditions and blood perfusion. The resulting maps can be used to rationally design hyperthermic treatments and identifying the proper route of administration - systemic versus intratumor injection - depending on the magnetic and biodistribution properties of the nanoparticles.	[Cervadoro, Antonio; Decuzzi, Paolo] Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX 77030 USA; [Cervadoro, Antonio] Politecn Torino, Dept Mech, Turin, Italy; [Giverso, Chiara; Preziosi, Luigi] Politecn Torino, Dept Math Sci, Turin, Italy; [Pande, Rohit; Wosik, Jarek] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Pande, Rohit; Sarangi, Subhasis; Wosik, Jarek; Brazdeikis, Audrius] Univ Houston, Texas Ctr Superconduct, Houston, TX USA; [Brazdeikis, Audrius] Univ Houston, Dept Phys, Houston, TX USA; [Decuzzi, Paolo] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	The Methodist Hospital System; The Methodist Hospital - Houston; Polytechnic University of Turin; Polytechnic University of Turin; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; Magna Graecia University of Catanzaro	Decuzzi, P (corresponding author), Methodist Hosp, Res Inst, Dept Translat Imaging, 6535 Fannin, Houston, TX 77030 USA.	pdecuzzi@tmhs.org	Decuzzi, Paolo/F-1899-2016; Brazdeikis, Audrius/H-3837-2015; Preziosi, Luigi/AAF-4875-2020	Decuzzi, Paolo/0000-0001-6050-4188; Brazdeikis, Audrius/0000-0001-9536-1586; CERVADORO, ANTONIO/0000-0003-3087-2363	Cancer Prevention Research Institute of Texas [CPRIT RP110262]; National Institutes of Health (United States of America) [U54CA143837, U54CA151668]; NATIONAL CANCER INSTITUTE [U54CA143837, U54CA151668] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; National Institutes of Health (United States of America)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Cancer Prevention Research Institute of Texas through the grant CPRIT RP110262. (CPRIT: www.cprit.state.tx.us/). PD also aknowledges partial support through grants from the National Institutes of Health (United States of America) U54CA143837 and U54CA151668 (www.cancer.gov). AC acknowledges travel support from the Scuola Interpolitecnica di Dottorato - SCUDO. (http://dottorato.polito.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Cancer Prevention Research Institute of Texas through the grant CPRIT RP110262. This work was also partially supported through grants from the National Institutes of Health (USA) (NIH) U54CA143837 and U54CA151668. AC acknowledges travel support from the Scuola Interpolitecnica di Dottorato - SCUDO.	Arciero CA, 2008, SEMIN ONCOL, V35, P147, DOI 10.1053/j.seminoncol.2007.12.004; ARKIN H, 1994, IEEE T BIO-MED ENG, V41, P97, DOI 10.1109/10.284920; ATKINSON WJ, 1984, IEEE T BIO-MED ENG, V31, P70, DOI 10.1109/TBME.1984.325372; Bae KH, 2012, ACS NANO, V6, P5266, DOI 10.1021/nn301046w; Bekovic M, 2010, IEEE T MAGN, V46, P4; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Cherukuri P, 2010, ADV DRUG DELIVER REV, V62, P339, DOI 10.1016/j.addr.2009.11.006; Coleman A, 2009, EXPERT REV ANTICANC, V9, P1599, DOI 10.1586/ERA.09.126; Coss RA, 1996, INT J HYPERTHER, V12, P173, DOI 10.3109/02656739609022507; Crayton SH, 2012, BIOMATERIALS, V33, P1509, DOI 10.1016/j.biomaterials.2011.10.077; Curley SA, 2003, ANN SURG ONCOL, V10, P338, DOI 10.1245/ASO.2003.07.017; Dennis CL, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/13/134020; Dennis CL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/39/395103; dos Santos I, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-21; Elsherbini AAM, 2011, MAGN RESON IMAGING, V29, P272, DOI 10.1016/j.mri.2010.08.010; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Gannon CJ, 2007, CANCER-AM CANCER SOC, V110, P2654, DOI 10.1002/cncr.23155; Garcia MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035489; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; Gobin AM, 2010, SMALL, V6, P745, DOI 10.1002/smll.200901557; Godin B, 2012, ADV FUNCT MATER, V22, P4225, DOI 10.1002/adfm.201200869; Guardia P, 2012, ACS NANO, V6, P3080, DOI 10.1021/nn2048137; Heidsieck A, 2012, MOL PHARM; Hergt R, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/38/385214; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hildebrandt B, 2007, Cancer Treat Res, V134, P171; Huang SH, 1999, J CELL BIOCHEM, V75, P327, DOI 10.1002/(SICI)1097-4644(19991101)75:2<327::AID-JCB14>3.3.CO;2-7; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Jia DW, 2010, EXPERT REV MED DEVIC, V7, P407, DOI [10.1586/erd.10.13, 10.1586/ERD.10.13]; Kallumadil M, 2009, J MAGN MAGN MATER, V321, P1509, DOI 10.1016/j.jmmm.2009.02.075; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Laurent S, 2011, ADV COLLOID INTERFAC; Laurent S, 2010, FUTURE MED CHEM, V2, P427, DOI [10.4155/fmc.09.164, 10.4155/FMC.09.164]; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; Levy M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395103; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li YF, 2011, SMALL, V7, P2965, DOI 10.1002/smll.201101059; Li ZX, 2010, MAT SCI ENG C-MATER, V30, P990, DOI 10.1016/j.msec.2010.04.016; Lobo SM, 2004, RADIOLOGY, V230, P175, DOI 10.1148/radiol.2301021512; Lu W, 2011, CANCER RES, V71, P6116, DOI 10.1158/0008-5472.CAN-10-4557; MAJDA JA, 1994, EXP CELL RES, V210, P46, DOI 10.1006/excr.1994.1007; Manthe RL, 2010, MOL PHARMACEUT, V7, P1880, DOI 10.1021/mp1001944; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Pennes HH, 1998, J APPL PHYSIOL, V85, P5, DOI 10.1152/jappl.1998.85.1.5; Purushotham S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3432757; Rao Wei, 2010, Critical Reviews in Biomedical Engineering, V38, P101, DOI 10.1615/CritRevBiomedEng.v38.i1.80; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Schutt DJ, 2008, MED PHYS, V35, P3462, DOI 10.1118/1.2948388; Shenoi MM, 2009, IEEE ENG MED BIO, P1979, DOI 10.1109/IEMBS.2009.5333447; Stafford RJ, 2011, INT J HYPERTHER, V27, P782, DOI 10.3109/02656736.2011.614671; Stern JM, 2008, J UROLOGY, V179, P748, DOI 10.1016/j.juro.2007.09.018; Suzuki M, 2003, MELANOMA RES, V13, P129, DOI 10.1097/00008390-200304000-00004; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; von Maltzahn G, 2009, CANCER RES, V69, P3892, DOI 10.1158/0008-5472.CAN-08-4242; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5	60	73	74	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57332	10.1371/journal.pone.0057332	http://dx.doi.org/10.1371/journal.pone.0057332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451208	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500091
J	Hong, SB; Zalesky, A; Cocchi, L; Fornito, A; Choi, EJ; Kim, HH; Suh, JE; Kim, CD; Kim, JW; Yi, SH				Hong, Soon-Beom; Zalesky, Andrew; Cocchi, Luca; Fornito, Alex; Choi, Eun-Jung; Kim, Ho-Hyun; Suh, Jeong-Eun; Kim, Chang-Dai; Kim, Jae-Won; Yi, Soon-Hyung			Decreased Functional Brain Connectivity in Adolescents with Internet Addiction	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SPONTANEOUS FLUCTUATIONS; PREFRONTAL CORTEX; BASAL GANGLIA; NETWORKS; SCHIZOPHRENIA; FMRI; DISORDER; DURATION; TOOLBOX	Background: Internet addiction has become increasingly recognized as a mental disorder, though its neurobiological basis is unknown. This study used functional neuroimaging to investigate whole-brain functional connectivity in adolescents diagnosed with internet addiction. Based on neurobiological changes seen in other addiction related disorders, it was predicted that connectivity disruptions in adolescents with internet addiction would be most prominent in cortico-striatal circuitry. Methods: Participants were 12 adolescents diagnosed with internet addiction and 11 healthy comparison subjects. Resting-state functional magnetic resonance images were acquired, and group differences in brain functional connectivity were analyzed using the network-based statistic. We also analyzed network topology, testing for between-group differences in key graph-based network measures. Results: Adolescents with internet addiction showed reduced functional connectivity spanning a distributed network. The majority of impaired connections involved cortico-subcortical circuits (similar to 24% with prefrontal and similar to 27% with parietal cortex). Bilateral putamen was the most extensively involved subcortical brain region. No between-group difference was observed in network topological measures, including the clustering coefficient, characteristic path length, or the small-worldness ratio. Conclusions: Internet addiction is associated with a widespread and significant decrease of functional connectivity in cortico-striatal circuits, in the absence of global changes in brain functional network topology.	[Hong, Soon-Beom; Zalesky, Andrew; Fornito, Alex] Univ Melbourne & Melbourne Hlth, Dept Psychiat, Melbourne Neuropsychiat Ctr, Parkville, Vic, Australia; [Hong, Soon-Beom] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Hong, Soon-Beom; Kim, Jae-Won] Seoul Natl Univ, Coll Med, Dept Psychiat, Div Child & Adolescent Psychiat, Seoul, South Korea; [Cocchi, Luca] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Fornito, Alex] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3052, Australia; [Fornito, Alex] Univ Melbourne, NICTA Victorian Res Lab, Parkville, Vic 3052, Australia; [Choi, Eun-Jung; Yi, Soon-Hyung] Seoul Natl Univ, Dept Child Dev & Family Studies, Coll Human Ecol, Seoul, South Korea; [Kim, Ho-Hyun] Seoul Natl Univ, Coll Educ, Interdisciplinary Program Early Childhood Educ Ma, Seoul, South Korea; [Suh, Jeong-Eun] Seoul Natl Univ, Ctr Campus Life & Culture, Seoul, South Korea; [Kim, Chang-Dai] Seoul Natl Univ, Dept Educ Educ Counseling Major, Coll Educ, Seoul, South Korea	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Seoul National University (SNU); University of Queensland; University of Melbourne; University of Melbourne; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Yi, SH (corresponding author), Seoul Natl Univ, Dept Child Dev & Family Studies, Coll Human Ecol, Seoul, South Korea.	ysh@snu.ac.kr	Cocchi, Luca/G-7611-2011; Alex, Fornito/N-8214-2013; Cocchi, Luca/AAC-3337-2019	Cocchi, Luca/0000-0003-3651-2676; Alex, Fornito/0000-0001-9134-480X; Cocchi, Luca/0000-0003-3651-2676; ZALESKY, ANDREW/0000-0003-2298-9908	Seoul National University Brain Fusion Program Research Fund; National Research Foundation of Korea grant (Global Internship Program); Korean government; National Health and Medical Research Council CJ Martin Fellowship [454797]	Seoul National University Brain Fusion Program Research Fund; National Research Foundation of Korea grant (Global Internship Program); Korean government(Korean Government); National Health and Medical Research Council CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Seoul National University Brain Fusion Program Research Fund. SBH was supported by a National Research Foundation of Korea grant (Global Internship Program) funded by the Korean government. AF was supported by a National Health and Medical Research Council CJ Martin Fellowship (ID: 454797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045938; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Clarke AR, 2008, INT J PSYCHOPHYSIOL, V67, P35, DOI 10.1016/j.ijpsycho.2007.10.001; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Cole DM, 2012, CEREB CORTEX; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Dong GH, 2011, J PSYCHIATR RES, V45, P1525, DOI 10.1016/j.jpsychires.2011.06.017; Duan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032532; Fletcher P, 1999, NEUROIMAGE, V9, P337, DOI 10.1006/nimg.1998.0411; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gordon EM, 2011, CEREB CORTEX; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Han DH, 2012, J PSYCHIATR RES, V46, P507, DOI 10.1016/j.jpsychires.2012.01.004; Han DH, 2010, CYBERPSYCH BEH SOC N, V13, P655, DOI 10.1089/cyber.2009.0327; Han DH, 2011, COMPR PSYCHIAT, V52, P88, DOI 10.1016/j.comppsych.2010.04.004; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hou HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/854524; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Killgore WDS, 2012, NEUROREPORT, V23, P741, DOI 10.1097/WNR.0b013e3283565056; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Kim YS, 2004, YONSEI MED J, V45, P81, DOI 10.3349/ymj.2004.45.1.81; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lin FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030253; Liu J, 2010, CHINESE MED J-PEKING, V123, P1904, DOI 10.3760/cma.j.issn.0366-6999.2010.14.014; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Martinez K, 2012, HUM BRAIN MAPP; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pettigrew JD, 1998, P ROY SOC B-BIOL SCI, V265, P2141, DOI 10.1098/rspb.1998.0551; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rieckmann A, 2011, J NEUROSCI, V31, P14284, DOI 10.1523/JNEUROSCI.3114-11.2011; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P467, DOI 10.1152/jn.1982.48.2.467; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Spencer KM, 2003, J NEUROSCI, V23, P7407; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tomasi D, 2012, CRIT REV BIOCHEM MOL; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Widyanto L, 2004, CYBERPSYCHOL BEHAV, V7, P443, DOI 10.1089/cpb.2004.7.443; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuan Kai, 2011, Commun Integr Biol, V4, P637; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	88	103	108	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57831	10.1371/journal.pone.0057831	http://dx.doi.org/10.1371/journal.pone.0057831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451272	gold, Green Published			2022-12-27	WOS:000316849500137
J	Liu, YY; Evans, JP; McCabe, MF; de Jeu, RAM; van Dijk, AIJM; Dolman, AJ; Saizen, I				Liu, Yi Y.; Evans, Jason P.; McCabe, Matthew F.; de Jeu, Richard A. M.; van Dijk, Albert I. J. M.; Dolman, Albertus J.; Saizen, Izuru			Changing Climate and Overgrazing Are Decimating Mongolian Steppes	PLOS ONE			English	Article							POLARIZATION DIFFERENCE INDEX; VEGETATION OPTICAL DEPTH; MICROWAVE EMISSION; WATER-CONTENT; PRECIPITATION; GRASSLAND; DATABASE; SOILS; MODEL	Satellite observations identify the Mongolian steppes as a hotspot of global biomass reduction, the extent of which is comparable with tropical rainforest deforestation. To conserve or restore these grasslands, the relative contributions of climate and human activities to degradation need to be understood. Here we use a recently developed 21-year (1988-2008) record of satellite based vegetation optical depth (VOD, a proxy for vegetation water content and aboveground biomass), to show that nearly all steppe grasslands in Mongolia experienced significant decreases in VOD. Approximately 60% of the VOD declines can be directly explained by variations in rainfall and surface temperature. After removing these climate induced influences, a significant decreasing trend still persists in the VOD residuals across regions of Mongolia. Correlations in spatial patterns and temporal trends suggest that a marked increase in goat density with associated grazing pressures and wild fires are the most likely non-climatic factors behind grassland degradation.	[Liu, Yi Y.; McCabe, Matthew F.] Univ New S Wales, Sch Civil & Environm Engn, Water Res Ctr, Sydney, NSW, Australia; [Liu, Yi Y.; Evans, Jason P.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Liu, Yi Y.; de Jeu, Richard A. M.; Dolman, Albertus J.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Earth Sci, Amsterdam, Netherlands; [Liu, Yi Y.; van Dijk, Albert I. J. M.] CSIRO Land & Water, Black Mt Labs, Canberra, ACT, Australia; [McCabe, Matthew F.] King Abdullah Univ Sci & Technol, Water Desalinat & Reuse Ctr, Thuwal, Saudi Arabia; [van Dijk, Albert I. J. M.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Saizen, Izuru] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan	University of New South Wales Sydney; University of New South Wales Sydney; Vrije Universiteit Amsterdam; Commonwealth Scientific & Industrial Research Organisation (CSIRO); King Abdullah University of Science & Technology; Australian National University; Kyoto University	Liu, YY (corresponding author), Univ New S Wales, Sch Civil & Environm Engn, Water Res Ctr, Sydney, NSW, Australia.	yiliu001@gmail.com	de Jeu, Richard/AAE-6922-2019; McCabe, Matthew F/G-5194-2011; Liu, Yi/H-9226-2013; Evans, Jason P./F-3716-2011; Van Dijk, Albert/B-3106-2011; Liu, Yi/M-7169-2015	McCabe, Matthew F/0000-0002-1279-5272; Evans, Jason P./0000-0003-1776-3429; Van Dijk, Albert/0000-0002-6508-7480; Liu, Yi/0000-0001-9059-8269; Dolman, A.J./0000-0003-0099-0457	University of New South Wales International Postgraduate Award; CSIRO Water for a Healthy Country Flagship Program scholarship; Research Institute for Humanity and Nature [D-04]	University of New South Wales International Postgraduate Award; CSIRO Water for a Healthy Country Flagship Program scholarship; Research Institute for Humanity and Nature	Funding for this research was through a University of New South Wales International Postgraduate Award and CSIRO Water for a Healthy Country Flagship Program scholarship. The data used in Figure 3b were supported through the Research Institute for Humanity and Nature (project number D-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MONG STAT ENV 2002; Badarch M., 2009, MONGOLIANS 4 NATL RE; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Ceccato P, 2002, REMOTE SENS ENVIRON, V82, P198, DOI [10.1016/S0034-4257(02)00036-6, 10.1016/S0034-4257(02)00037-8]; Chu T., 2012, EARTH SCI RES, V1, P1, DOI [10.5539/esr.v1n2p279, DOI 10.5539/ESR.V1N2P279]; ERDENESAIKHAN N, 1999, INT FOREST FIRE NEWS, V21, P71; Evans J, 2004, J ARID ENVIRON, V57, P535, DOI 10.1016/S0140-1963(03)00121-6; Farukh M.A., 2009, J NAT DISASTER SCI, V31, P23, DOI [10.2328/jnds.31.23, DOI 10.2328/JNDS.31.23]; Guo R, 2006, J ENVIRON SCI, V18, P1024, DOI 10.1016/S1001-0742(06)60033-8; Hirsch R. M., 2002, STAT METHODS WATER R; Holmes TRH, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010257; Hu ZM, 2007, SCI CHINA SER D, V50, P754, DOI 10.1007/s11430-007-0010-3; Indree T, 2007, INT FOREST FIRE NEWS, V36, P67; JACKSON TJ, 1991, REMOTE SENS ENVIRON, V36, P203, DOI 10.1016/0034-4257(91)90057-D; Karnieli A, 2006, INT J REMOTE SENS, V27, P2017, DOI 10.1080/01431160500121727; KERR YH, 1990, IEEE T GEOSCI REMOTE, V28, P384, DOI 10.1109/36.54364; Kirdyashev K. P., 1979, Radio Engineering and Electronic Physics, V24, P37; Liu YY, 2013, GLOBAL ECOL BIOGEOGR, V22, P692, DOI 10.1111/geb.12024; Liu YY, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048684; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Matsuura K., 2009, TERRESTRIAL AIR TEMP; Meesters AGCA, 2005, IEEE GEOSCI REMOTE S, V2, P121, DOI 10.1109/LGRS.2005.843983; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nyamjav B, 2008, 1 INT CENTR AS WILDL; Owe M, 2001, IEEE T GEOSCI REMOTE, V39, P1643, DOI 10.1109/36.942542; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Rudolf B., 2005, P 2 WORKSH INT PREC, P231; Sato T, 2007, J HYDROL, V333, P144, DOI 10.1016/j.jhydrol.2006.07.023; WANG JR, 1980, IEEE T GEOSCI REMOTE, V18, P288, DOI 10.1109/TGRS.1980.350304; Xu ZZ, 2005, PLANT SOIL, V269, P131, DOI 10.1007/s11104-004-0397-y	31	80	86	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57599	10.1371/journal.pone.0057599	http://dx.doi.org/10.1371/journal.pone.0057599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451249	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500119
J	Queiroz, DMM; Rocha, AMC; Melo, FF; Rocha, GA; Teixeira, KN; Carvalho, SD; Bittencourt, PFS; Castro, LPF; Crabtree, JE				Magalhaes Queiroz, Dulciene Maria; Camargos Rocha, Andreia Maria; Melo, Fabricio Freire; Rocha, Gifone Aguiar; Teixeira, Kadima Nayara; Carvalho, Simone Diniz; Souto Bittencourt, Paulo Fernando; Fonseca Castro, Lucia Porto; Crabtree, Jean E.			Increased Gastric IL-1 beta Concentration and Iron Deficiency Parameters in H. pylori Infected Children	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HELICOBACTER-PYLORI; IMMUNE-RESPONSE; ACID-SECRETION; PARIETAL-CELLS; INTERLEUKIN-1-BETA; HEPCIDIN; ANEMIA; RISK; ERADICATION	Association between H. pylori infection, iron deficiency and iron deficiency anaemia has been described, but the mechanisms involved have not been established. We hypothesized that in H. pylori infected children increased gastric concentrations of IL-1 beta and/or TNF-alpha, both potent inhibitors of gastric acid secretion that is essential for iron absorption, are predictors for low blood concentrations of ferritin and haemoglobin, markers of early depletion of iron stores and anaemia, respectively. We evaluated 125 children undergoing endoscopy to clarify the origin of gastrointestinal symptoms. Gastric specimens were obtained for H. pylori status and cytokine evaluation and blood samples for determination of iron deficiency/iron deficiency anaemia parameters and IL1 cluster and TNFA polymorphisms that are associated with increased cytokine secretions. Higher IL-1 beta and TNF-alpha gastric concentrations were observed in H. pylori-positive (n = 47) than in -negative (n = 78) children. Multiple linear regression models revealed gastric IL-1 beta, but not TNF-alpha, as a significant predictor of low ferritin and haemoglobin concentrations; results were reproduced in young children in whom IL1RN polymorphic genotypes associated with higher gastric IL-1 beta expression and lower blood ferritin and haemoglobin concentrations. In conclusion, high gastric levels of IL-1 beta can be the link between H. pylori infection and iron deficiency/iron deficiency anaemia in childhood.	[Magalhaes Queiroz, Dulciene Maria; Camargos Rocha, Andreia Maria; Melo, Fabricio Freire; Rocha, Gifone Aguiar; Teixeira, Kadima Nayara] Univ Fed Minas Gerais, Fac Med, Lab Res Bacteriol, Belo Horizonte, MG, Brazil; [Carvalho, Simone Diniz; Souto Bittencourt, Paulo Fernando] Univ Fed Minas Gerais, Univ Hosp, Endoscopy Serv, Belo Horizonte, MG, Brazil; [Fonseca Castro, Lucia Porto] Univ Fed Minas Gerais, Fac Med, Dept Pathol, Belo Horizonte, MG, Brazil; [Crabtree, Jean E.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Leeds	Queiroz, DMM (corresponding author), Univ Fed Minas Gerais, Fac Med, Lab Res Bacteriol, Belo Horizonte, MG, Brazil.	dqueiroz@medicina.ufmg.br	Rocha, Gifone A/N-6913-2018; Queiroz, Dulciene/AAU-9386-2020; de Melo, Fabrício/AAN-5517-2020	Rocha, Gifone A/0000-0002-1858-3166; Queiroz, Dulciene/0000-0003-1334-9423; de Melo, Fabrício/0000-0002-5680-2753	Sixth Framework Programme of the European Union, Project CONTENT [INCO-DEV-3-032136]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil); Instituto de Biomedicina do Semi-Arido (INCT-IBISAB/Brazil)	Sixth Framework Programme of the European Union, Project CONTENT; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto de Biomedicina do Semi-Arido (INCT-IBISAB/Brazil)	The study was supported by the Sixth Framework Programme of the European Union, Project CONTENT (INCO-DEV-3-032136); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil) and Instituto de Biomedicina do Semi-Arido (INCT-IBISAB/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale B, 2003, GUT, V52, P496, DOI 10.1136/gut.52.4.496; Baggett HC, 2006, PEDIATRICS, V117, pE396, DOI 10.1542/peds.2005-1129; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Cardinali LDC, 2003, J CLIN MICROBIOL, V41, P3334, DOI 10.1128/JCM.41.7.3334-3335.2003; Choe YH, 2000, ACTA PAEDIATR, V89, P154, DOI 10.1080/080352500750028753; Correa P, 2008, DIGEST LIVER DIS, V40, P490, DOI 10.1016/j.dld.2008.02.035; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; de Melo FF, 2012, MICROBES INFECT, V14, P341, DOI 10.1016/j.micinf.2011.11.008; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FOX JG, 1991, INFECT IMMUN, V59, P1875, DOI 10.1128/IAI.59.6.1875-1880.1991; Harford WV, 2000, GUT, V47, P467, DOI 10.1136/gut.47.4.467; Hurtado EK, 1999, AM J CLIN NUTR, V69, P115; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; Inamura J, 2005, HEPATOL RES, V33, P198, DOI 10.1016/j.hepres.2005.08.005; Kurekci AE, 2005, J TROP PEDIATRICS, V51, P166, DOI 10.1093/tropej/fmi015; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; MANSFIELD JC, 1994, GASTROENTEROLOGY, V106, P637, DOI 10.1016/0016-5085(94)90696-3; Marignani M, 1997, SCAND J GASTROENTERO, V32, P617, DOI 10.3109/00365529709025109; Queiroz DMM, 2004, GASTROENTEROLOGY, V127, P73, DOI 10.1053/j.gastro.2004.03.069; Rocha GA, 2005, INT J CANCER, V115, P678, DOI 10.1002/ijc.20935; Schwarz P, 2012, GUT, V61, P193, DOI 10.1136/gut.2011.241208; Soares TF, 2005, SCAND J IMMUNOL, V62, P63, DOI 10.1111/j.1365-3083.2005.01638.x; SOBALA GM, 1991, GUT, V32, P1415, DOI 10.1136/gut.32.11.1415; Takashima M, 2001, GUT, V48, P765, DOI 10.1136/gut.48.6.765; Vannella L, 2008, ALIMENT PHARM THER, V28, P422, DOI 10.1111/j.1365-2036.2008.03741.x; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Windle HJ, 2007, PEDIATRICS, V119, pE754, DOI 10.1542/peds.2006-2196; World Health Organization, 2001, IR DEF AN ASS PREV C; Yip R, 1997, JAMA-J AM MED ASSOC, V277, P1135, DOI 10.1001/jama.277.14.1135; Yokota S, 2008, CLIN INFECT DIS, V46, pE31, DOI 10.1086/526784; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57420	10.1371/journal.pone.0057420	http://dx.doi.org/10.1371/journal.pone.0057420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451225	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500102
J	Rebelo, MD; Figueiredo, ED; Mariante, RM; Nobrega, A; de Barros, CM; Allodi, S				Rebelo, Mauro de Freitas; Figueiredo, Eliane de Souza; Mariante, Rafael M.; Nobrega, Alberto; de Barros, Cintia Monteiro; Allodi, Silvana			New Insights from the Oyster Crassostrea rhizophorae on Bivalve Circulating Hemocytes	PLOS ONE			English	Article							MYTILUS-GALLOPROVINCIALIS; MONOCLONAL-ANTIBODIES; MERCENARIA-MERCENARIA; HEMOLYMPH CELLS; MORPHOLOGY; VIRGINICA; ADULT; CLAM; PROLIFERATION; PHAGOCYTOSIS	Hemocytes are the first line of defense of the immune system in invertebrates, but despite their important role and enormous potential for the study of gene-environment relationships, research has been impeded by a lack of consensus on their classification. Here we used flow cytometry combined with histological procedures, histochemical reactions and transmission electron microscopy to characterize the hemocytes from the oyster Crassostrea rhizophorae. Transmission electron microscopy revealed remarkable morphological characteristics, such as the presence of membranous cisternae in all mature cells, regardless of size and granulation. Some granular cells contained many cytoplasmic granules that communicated with each other through a network of channels, a feature never previously described for hemocytes. The positive reactions for esterase and acid phosphatase also indicated the presence of mature cells of all sizes and granule contents. Flow cytometry revealed a clear separation in complexity between agranular and granular populations, which could not be differentiated by size, with cells ranging from 2.5 to 25 mu m. Based on this evidence we suggest that, at least in C. rhizophorae, the different subpopulations of hemocytes may in reality be different stages of one type of cell, which accumulates granules and loses complexity (with no reduction in size) as it degranulates in the event of an environmental challenge.	[Rebelo, Mauro de Freitas; Figueiredo, Eliane de Souza; Mariante, Rafael M.; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Nobrega, Alberto] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [de Barros, Cintia Monteiro] Univ Fed Rio de Janeiro, Nucleo Pesquisa & Desenvolvimento Socioambiental, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Allodi, S (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	sallodi@biof.ufrj.br	Mariante, Rafael/AAM-6010-2021; Mariante, Rafael/A-2971-2015; S, Allodi/AAR-7968-2020; Nobrega, Alberto/U-1161-2019; de Barros, Cintia Monteiro/AAP-8834-2021; Allodi, Silvana/G-1781-2012	Mariante, Rafael/0000-0001-8024-9612; Mariante, Rafael/0000-0001-8024-9612; Allodi, Silvana/0000-0002-3053-3866; Nobrega, Alberto/0000-0002-9840-0103	Conselho Nacional de Desenvolvimento Cientifico e Tenologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio/Universidade Federal do Rio de Janeiro, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tenologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio/Universidade Federal do Rio de Janeiro, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tenologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria Jose Bonifacio/Universidade Federal do Rio de Janeiro, Brazil. M.F.R., A.N. and S.A. are CNPq research fellows. R.M.M. holds a post-doctoral fellowship from PAPDRJ (FAPERJ/CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladaileh S, 2007, J INVERTEBR PATHOL, V96, P48, DOI 10.1016/j.jip.2007.02.011; Allam B, 2002, FISH SHELLFISH IMMUN, V13, P141, DOI 10.1006/fsim.2001.0389; Ashton-Alcox KA, 1998, TISSUE CELL, V30, P195, DOI 10.1016/S0040-8166(98)80068-2; Beaven AE, 1999, BIOL BULL-US, V196, P26, DOI 10.2307/1543163; CAJARAVILLE MP, 1995, CELL STRUCT FUNCT, V20, P355, DOI 10.1247/csf.20.355; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; da Silva PGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039267; Cheng T. C., 1996, HEMOCYTES FORMS FUNC, P299; Cima F, 2000, FISH SHELLFISH IMMUN, V10, P677, DOI 10.1006/fsim.2000.0282; de Barros CM, 2007, J BIOL CHEM, V282, P1615, DOI 10.1074/jbc.M604056200; Donaghy L, 2010, FISH SHELLFISH IMMUN, V28, P87, DOI 10.1016/j.fsi.2009.10.006; Dyrynda EA, 1997, CELL TISSUE RES, V289, P527, DOI 10.1007/s004410050898; Fawcett DW, 1981, GOLGI APPARATUS, P369; Fawcett DW, 1981, CELL, P641; FOLEY DA, 1974, BIOL BULL, V146, P343, DOI 10.2307/1540410; FOLEY DA, 1975, J INVERTEBR PATHOL, V25, P189, DOI 10.1016/0022-2011(75)90068-3; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Hegaret H, 2003, J EXP MAR BIOL ECOL, V293, P237, DOI 10.1016/S0022-0981(03)00236-3; Hine PM, 1999, FISH SHELLFISH IMMUN, V9, P367, DOI 10.1006/fsim.1998.0205; Kelley ML, 2001, ONCOGENE, V20, P748, DOI 10.1038/sj.onc.1204144; Lambert C, 2007, AQUACULTURE, V270, P276, DOI 10.1016/j.aquaculture.2007.03.016; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; Ottaviani E, 1998, ITAL J ZOOL, V65, P349, DOI 10.1080/11250009809386772; Pearse A.G.E., 1968, HISTOCHEMISTRY THEOR, V3rd, P1518; RODRICK GE, 1984, HELGOLANDER MEERESUN, V37, P167, DOI 10.1007/BF01989301; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Sun JF, 2006, J SHELLFISH RES, V25, P55, DOI 10.2983/0730-8000(2006)25[55:MSAFCO]2.0.CO;2; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P249, DOI 10.1016/S1050-4648(02)00164-X; Xue Q, 2001, DEV COMP IMMUNOL, V25, P187, DOI 10.1016/S0145-305X(00)00058-6; Zhang P, 2011, VET PARASITOL, V182, P287, DOI 10.1016/j.vetpar.2011.05.053; Zhang Y, 2009, DEV NEUROBIOL, V69, P415, DOI 10.1002/dneu.20717; Zhang ZF, 2006, FISH SHELLFISH IMMUN, V21, P159, DOI 10.1016/j.fsi.2005.11.003	34	73	75	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57384	10.1371/journal.pone.0057384	http://dx.doi.org/10.1371/journal.pone.0057384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451217	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500096
J	Zanet, DL; Saberi, S; Oliveira, L; Sattha, B; Gadawski, I; Cote, HCF				Zanet, DeAnna L.; Saberi, Sara; Oliveira, Laura; Sattha, Beheroze; Gadawski, Izabella; Cote, Helene C. F.			Blood and Dried Blood Spot Telomere Length Measurement by qPCR: Assay Considerations	PLOS ONE			English	Article							HEMATOLOGICAL PARAMETERS; SAMPLE COLLECTION; QUANTITATIVE PCR; VENOUS-BLOOD; DNA; CAPILLARY; STABILITY; DISEASE; QUALITY; STORAGE	Measurement of telomere length is crucial for the study of telomere maintenance and its role in molecular pathophysiology of diseases and in aging. Several methods are used to measure telomere length, the choice of which usually depends on the type and size of sample to be assayed, as well as cost and throughput considerations. The goal of this study was to investigate the factors that may influence the reliability of qPCR-based relative telomere length measurements in whole blood. Day to day intra-individual variability, types of blood anticoagulant, sample storage conditions, processing and site of blood draw were investigated. Two qPCR-based methods to measure telomere length (monoplex vs. multiplex) were also investigated and showed a strong correlation between them. Freezing and thawing of the blood and storage of the blood at 4 degrees C for up to 4 days did not affect telomere length values. Telomere lengths in dried blood spots were significantly higher than both whole blood and peripheral mononuclear blood cells, and were highly correlated with both. We found that telomere length measurements were significantly higher in dried blood spots collected directly from fingertip prick compared to dried blood spots prepared with anticoagulated whole blood collected from the finger, and non-blotted whole blood taken from both finger and arm venipuncture. This suggests that DNA from cells blotted on paper is not equivalent to that collected from venipuncture whole blood, and caution should be taken when comparing between blood sample types.	[Zanet, DeAnna L.; Saberi, Sara; Oliveira, Laura; Sattha, Beheroze; Gadawski, Izabella; Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Cote, HCF (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	helene.cote@ubc.ca	Cote, Helene/K-7896-2012		CIHR [HET-85515, YSH-80511]; CFI-New Opportunity [10427]	CIHR(Canadian Institutes of Health Research (CIHR)); CFI-New Opportunity	This research was supported in part by a CIHR emerging team grant in HIV therapy and aging (to HCFC), (#HET-85515). HCFC was partially supported by a CIHR New Investigator award (YSH-80511) and a CFI-New Opportunity (#10427). http://www.cihr-irsc.gc.ca/e/193.html https://www2.innovation.ca/pls/fci/fcienrep.base. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A., 2011, NUCL ACIDS RES, V39; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; DAAE LNW, 1988, SCAND J CLIN LAB INV, V48, P723, DOI 10.3109/00365518809085796; DAAE LNW, 1991, SCAND J CLIN LAB INV, V51, P651, DOI 10.3109/00365519109104576; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fazili Z, 2012, CLIN CHIM ACTA, V413, P966, DOI 10.1016/j.cca.2012.02.003; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Halfon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033000; Halsall A, 2008, INT J EPIDEMIOL, V37, P7, DOI 10.1093/ije/dym278; Holland NT, 2005, TOXICOL APPL PHARM, V206, P261, DOI 10.1016/j.taap.2004.10.024; Holland NT, 2003, MUTAT RES-REV MUTAT, V543, P217, DOI 10.1016/S1383-5742(02)00090-X; Imam T, 2012, JAIDS-J ACQ IMM DEF, V60, P495, DOI 10.1097/QAI.0b013e31825aa89c; Kayiran SM, 2003, CLIN LAB HAEMATOL, V25, P9, DOI 10.1046/j.1365-2257.2003.00484.x; Kimura M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr235; Kume K, 2012, EUR J NEUROL, V19, P905, DOI 10.1111/j.1468-1331.2011.03655.x; Lauzon W, 2000, CYTOMETRY, V42, P159, DOI 10.1002/1097-0320(20000615)42:3<159::AID-CYTO1>3.0.CO;2-9; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Mas S, 2007, BASIC CLIN PHARMACOL, V101, P132, DOI 10.1111/j.1742-7843.2007.00089.x; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schalk E, 2007, VOX SANG, V93, P348, DOI 10.1111/j.1423-0410.2007.00978.x; Visvikis S, 1998, CLIN CHEM LAB MED, V36, P551, DOI 10.1515/CCLM.1998.094; Xu Y, 2011, CHEM SOC REV, V40, P2719, DOI 10.1039/c0cs00134a; Yang ZW, 2001, CLIN LAB HAEMATOL, V23, P155, DOI 10.1046/j.1365-2257.2001.00388.x	32	53	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57787	10.1371/journal.pone.0057787	http://dx.doi.org/10.1371/journal.pone.0057787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451268	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500133
J	Kohl, C; Riccio, O; Grosse, J; Zanoletti, O; Fournier, C; Schmidt, MV; Sandi, C				Kohl, Christine; Riccio, Orbicia; Grosse, Jocelyn; Zanoletti, Olivia; Fournier, Celine; Schmidt, Mathias V.; Sandi, Carmen			Hippocampal Neuroligin-2 Overexpression Leads to Reduced Aggression and Inhibited Novelty Reactivity in Rats	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; BORDERLINE PERSONALITY; SYNAPTIC-TRANSMISSION; RISK-FACTORS; AUTISM; MICE; SCHIZOPHRENIA; NEUROBIOLOGY; NEUREXINS; MATURATION	Disturbances of the excitation/inhibition (E/I) balance in the brain were recently suggested as potential factors underlying disorders like autism and schizophrenia resulting in associated behavioral alterations including changes in social and emotional behavior as well as abnormal aggression. Neuronal cell adhesion molecules (nCAMs) and mutations in these genes were found to be strongly implicated in the pathophysiology of these disorders. Neuroligin2 (nlgn2) is a postsynaptic cell adhesion molecule, which is predominantly expressed at inhibitory synapses and required for synapse specification and stabilization. Changes in the expression of nlgn2 were shown to result in alterations of social behavior as well as altered inhibitory synaptic transmission, hence modifying the E/I balance. In our study, we focused on the role of nlgn2 in the dorsal hippocampus in the regulation of emotional and social behaviors. To this purpose, we injected an AAV construct overexpressing nlgn2 in the hippocampus of rats and investigated the effects on behavior and on markers for the E/I ratio. We could show an increase in GAD65, a GABA-synthesizing protein in neuronal terminals, and furthermore, reduced exploration of novel stimuli and less offensive behavior. Our data suggest nlgn2 in the hippocampus to be strongly implicated in maintaining the E/I balance in the brain and thereby modulating social and emotional behavior.	[Kohl, Christine; Riccio, Orbicia; Grosse, Jocelyn; Zanoletti, Olivia; Fournier, Celine; Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, Lausanne, Switzerland; [Kohl, Christine; Schmidt, Mathias V.] Max Planck Inst Psychiat, Munich, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society	Schmidt, MV (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	mschmidt@mpipsykl.mpg.de; carmen.sandi@epfl.ch		Schmidt, Mathias/0000-0002-3788-2268; Sandi, Carmen/0000-0001-7713-8321	European Union integrated project MEMSTICK [FP7-HEALTH-F2M-2007-201600]; Swiss National Science Foundation [310000-120791, 31003AB-135710]; Sinergia [CRSIK3-122691]; NCCR; Swiss Network for International Studies (SNIS); EPFL	European Union integrated project MEMSTICK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia; NCCR(Swiss National Science Foundation (SNSF)); Swiss Network for International Studies (SNIS); EPFL	This work was supported by grants from the European Union integrated project MEMSTICK (FP7-HEALTH-F2M-2007-201600; MemStick), the Swiss National Science Foundation (310000-120791 and 31003AB-135710; Sinergia CRSIK3-122691; and the NCCR "The synaptic basis of mental diseases" and the Swiss Network for International Studies (SNIS) as well as intramural funding from the EPFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann N, 2010, NEUROCHEM RES, V35, P1875, DOI 10.1007/s11064-010-0298-9; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belligni EF, 2012, EUR J MED GENET, V55, P222, DOI 10.1016/j.ejmg.2012.01.016; Bisaz R, 2009, NEUROBIOL LEARN MEM, V91, P333, DOI 10.1016/j.nlm.2008.11.003; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bottos A, 2011, CELL MOL LIFE SCI, V68, P2655, DOI 10.1007/s00018-011-0664-z; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comai S, 2012, J CLIN PSYCHOPHARM, V32, P83, DOI 10.1097/JCP.0b013e31823f8770; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; CRUSIO WE, 1989, J NEUROGENET, V5, P87, DOI 10.3109/01677068909167267; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dell'Osso B, 2010, NEUROPSYCHOBIOLOGY, V61, P169, DOI 10.1159/000297734; Ekinci O, 2012, NORD J PSYCHIAT, P1; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Fantin M, 2012, REGULATION IN PRESS; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; File SE, 1998, BEHAV NEUROSCI, V112, P1423, DOI 10.1037/0735-7044.112.6.1423; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Gregg TR, 2001, PROG NEURO-PSYCHOPH, V25, P91, DOI 10.1016/S0278-5846(00)00150-0; GUILLOT PV, 1994, BRAIN RES, V660, P167, DOI 10.1016/0006-8993(94)90852-4; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hasan KM, 2012, J CHILD NEUROL; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jackson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035557; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lewis MD, 2006, ANN NY ACAD SCI, V1094, P164, DOI 10.1196/annals.1376.017; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Maskey M, 2012, J AUTISM DEV DISORD; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Moses SN, 2002, BRAIN RES BULL, V58, P517, DOI 10.1016/S0361-9230(02)00820-1; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Paz RD, 2008, EUR NEUROPSYCHOPHARM, V18, P773, DOI 10.1016/j.euroneuro.2008.06.005; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rossi R, 2012, PSYCHIAT RES-NEUROIM, V203, P132, DOI 10.1016/j.pscychresns.2011.12.004; Sala M, 2011, J AFFECT DISORDERS, V131, P417, DOI 10.1016/j.jad.2010.11.036; Sandi C, 2011, EUR NEUROPSYCHOPHARM, V21, pS211, DOI 10.1016/S0924-977X(11)70303-0; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Sun C, 2011, HUM MOL GENET, P1; Sustkova-Fiserova M, 2009, NEUROENDOCRINOL LETT, V30, P79; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	61	43	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56871	10.1371/journal.pone.0056871	http://dx.doi.org/10.1371/journal.pone.0056871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451101	gold, Green Published			2022-12-27	WOS:000316658800044
J	Moustakas, A; Kunin, WE; Cameron, TC; Sankaran, M				Moustakas, Aristides; Kunin, William E.; Cameron, Tom C.; Sankaran, Mahesh			Facilitation or Competition? Tree Effects on Grass Biomass across a Precipitation Gradient	PLOS ONE			English	Article							SOUTHERN AFRICAN SAVANNA; POSITIVE INTERACTIONS; PLANT-COMMUNITIES; UNDERSTOREY VEGETATION; CENTRAL CALIFORNIA; TEMPERATE SAVANNA; HYDRAULIC LIFT; WOODY COVER; ENVIRONMENTS; FIRE	Savanna ecosystems are dominated by two distinct plant life forms, grasses and trees, but the interactions between them are poorly understood. Here, we quantified the effects of isolated savanna trees on grass biomass as a function of distance from the base of the tree and tree height, across a precipitation gradient in the Kruger National Park, South Africa. Our results suggest that mean annual precipitation (MAP) mediates the nature of tree-grass interactions in these ecosystems, with the impact of trees on grass biomass shifting qualitatively between 550 and 737 mm MAP. Tree effects on grass biomass were facilitative in drier sites (MAP <= 550 mm), with higher grass biomass observed beneath tree canopies than outside. In contrast, at the wettest site (MAP = 737 mm), grass biomass did not differ significantly beneath and outside tree canopies. Within this overall precipitation-driven pattern, tree height had positive effect on sub-canopy grass biomass at some sites, but these effects were weak and not consistent across the rainfall gradient. For a more synthetic understanding of tree-grass interactions in savannas, future studies should focus on isolating the different mechanisms by which trees influence grass biomass, both positively and negatively, and elucidate how their relative strengths change over broad environmental gradients.	[Moustakas, Aristides; Kunin, William E.; Cameron, Tom C.; Sankaran, Mahesh] Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Moustakas, Aristides] Univ London, Sch Biol & Chem Sci, London, England; [Cameron, Tom C.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Sankaran, Mahesh] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India	University of Leeds; University of London; Umea University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Moustakas, A (corresponding author), Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	arismoustakas@gmail.com	Moustakas, Aristides/ABE-2662-2020; Cameron, Tom/H-9555-2012	Cameron, Tom/0000-0002-5875-1494; Moustakas, Aristides (Aris)/0000-0002-6334-747X	NERC Research Grant [NE-E017436-1]; University of Leeds; Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Government of India; Natural Environment Research Council [NE/E017436/1] Funding Source: researchfish; NERC [NE/E017436/1] Funding Source: UKRI	NERC Research Grant; University of Leeds; Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Government of India; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a NERC Research Grant to MS, WEK, and AM (NE-E017436-1). TCC was funded by the University of Leeds. MS would also like to acknowledge support provided by the Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Government of India. AM thanks the School of Biological and Chemical Sciences, Queen Mary University of London and the Head of School, Matthew Evans for covering the publications fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier N, 2008, ECOLOGY, V89, P1521, DOI 10.1890/07-0365.1; BELSKY AJ, 1993, J APPL ECOL, V30, P143, DOI 10.2307/2404278; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bransby D. I., 1977, Proceedings of the Grassland Society of Southern Africa, V12, P115; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bullock JM, 2009, J ECOL, V97, P646, DOI 10.1111/j.1365-2745.2009.01502.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURROWS WH, 1990, J BIOGEOGR, V17, P503, DOI 10.2307/2845383; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Callaway RM, 2005, ECOLOGY, V86, P1856, DOI 10.1890/04-0784; CALLAWAY RM, 1993, ECOLOGY, V74, P1567, DOI 10.2307/1940084; CALLAWAY RM, 1991, ECOLOGY, V72, P1484, DOI 10.2307/1941122; Dickie IA, 2005, ECOL LETT, V8, P1191, DOI 10.1111/j.1461-0248.2005.00822.x; Dohn J, 2013, J ECOL, V101, P202, DOI 10.1111/1365-2745.12010; du Toit J.T., 2003, KRUGER EXPERIENCE EC; Durr PA, 2002, AGROFOREST SYST, V54, P99, DOI 10.1023/A:1015070203455; Freckleton RP, 2009, J ECOL, V97, P379, DOI 10.1111/j.1365-2745.2009.01497.x; Frost PGH, 1986, BIOL INT SPEC ISSUE, V10, P1; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Grouzis M, 1997, J ARID ENVIRON, V35, P285, DOI 10.1006/jare.1995.0138; HARMON ME, 1989, ECOLOGY, V70, P48, DOI 10.2307/1938411; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hoffmann WA, 2005, OECOLOGIA, V145, P307, DOI 10.1007/s00442-005-0129-x; Kikvidze Z, 2006, J VEG SCI, V17, P77, DOI 10.1111/j.1654-1103.2006.tb02425.x; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Ludwig F, 2004, ECOL LETT, V7, P623, DOI 10.1111/j.1461-0248.2004.00615.x; Ludwig F, 2004, PLANT ECOL, V170, P93, DOI 10.1023/B:VEGE.0000019023.29636.92; Ludwig F, 2003, OECOLOGIA, V134, P293, DOI 10.1007/s00442-002-1119-x; Ludwig F, 2001, J VEG SCI, V12, P579, DOI 10.2307/3237009; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; MILCHUNAS DG, 1989, VEGETATIO, V80, P11, DOI 10.1007/BF00049137; Mlambo D, 2005, FOREST ECOL MANAG, V212, P394, DOI 10.1016/j.foreco.2005.03.022; MORDELET P, 1995, J VEG SCI, V6, P223, DOI 10.2307/3236217; Moustakas A., 2010, FRONT BIOGEOGR, V2, P47, DOI DOI 10.21425/F5FBG12335; Pinheiro JC, 2004, MIXED EFFECTS MODES; R Development Core Team, 2012, R LANG ENV STAT COMP; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Riginos C, 2009, J ECOL, V97, P1337, DOI 10.1111/j.1365-2745.2009.01563.x; Riginos C, 2009, ECOLOGY, V90, P335, DOI 10.1890/08-0462.1; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Schade JD, 2003, J VEG SCI, V14, P743, DOI 10.1658/1100-9233(2003)014[0743:TIOPCO]2.0.CO;2; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; STUARTHILL GC, 1989, J APPL ECOL, V26, P285, DOI 10.2307/2403668; Tirado R, 2005, OIKOS, V111, P437, DOI 10.1111/j.1600-0706.2005.14094.x; Treydte AC, 2008, J VEG SCI, V19, P663, DOI 10.3170/2008-8-18435; Treydte AC, 2007, PERSPECT PLANT ECOL, V8, P197, DOI 10.1016/j.ppees.2007.03.001; Treydte AC, 2010, J ARID ENVIRON, V74, P1597, DOI 10.1016/j.jaridenv.2010.07.003; Trollope W. S. W., 1986, Journal of the Grassland Society of Southern Africa, V3, P148; WALKER BH, 1986, S AFR J BOT, V52, P397, DOI 10.1016/S0254-6299(16)31502-2; Walter H., 1971, ECOLOGY TROPICAL SUB; Weltzin JF, 1997, OECOLOGIA, V112, P156, DOI 10.1007/s004420050295; WELTZIN JF, 1990, J VEG SCI, V1, P325, DOI 10.2307/3235707; Weltzin JF, 2000, ECOLOGY, V81, P1902, DOI 10.1890/0012-9658(2000)081[1902:IOPRFS]2.0.CO;2; Xu C, 2011, J ARID ENVIRON, V75, P953, DOI 10.1016/j.jaridenv.2011.04.037; Xu C, 2012, PLANT ECOL, V213, P225, DOI 10.1007/s11258-011-0018-9	65	48	48	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57025	10.1371/journal.pone.0057025	http://dx.doi.org/10.1371/journal.pone.0057025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451137	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000316658800063
J	Tamamiya, Y; Hiraki, K				Tamamiya, Yoshiyuki; Hiraki, Kazuo			Individual Differences in the Recognition of Facial Expressions: An Event-Related Potentials Study	PLOS ONE			English	Article							FUSIFORM FACE AREA; EMOTIONAL EXPRESSION; SOCIAL COGNITION; N170; PERCEPTION; INVERSION; DEFICITS; LATERALIZATION; DISCRIMINATION; REPETITION	Previous studies have shown that early posterior components of event-related potentials (ERPs) are modulated by facial expressions. The goal of the current study was to investigate individual differences in the recognition of facial expressions by examining the relationship between ERP components and the discrimination of facial expressions. Pictures of 3 facial expressions (angry, happy, and neutral) were presented to 36 young adults during ERP recording. Participants were asked to respond with a button press as soon as they recognized the expression depicted. A multiple regression analysis, where ERP components were set as predictor variables, assessed hits and reaction times in response to the facial expressions as dependent variables. The N170 amplitudes significantly predicted for accuracy of angry and happy expressions, and the N170 latencies were predictive for accuracy of neutral expressions. The P2 amplitudes significantly predicted reaction time. The P2 latencies significantly predicted reaction times only for neutral faces. These results suggest that individual differences in the recognition of facial expressions emerge from early components in visual processing.	[Tamamiya, Yoshiyuki; Hiraki, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo	Tamamiya, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	tamamiya@ardbeg.c.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan Research [22240026]; "Pedagogical Machine: Developmental cognitive science approach to create teaching/teachable machines" the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21118001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; "Pedagogical Machine: Developmental cognitive science approach to create teaching/teachable machines" the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Hiraki is supported by a Research Project Grant-in-aid for Scientific Research (A) (22240026) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and "Pedagogical Machine: Developmental cognitive science approach to create teaching/teachable machines" the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency. Mr. Tamamiya has no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA (American Psychological Association), 2010, PUBL MAN AM PSYCH AS; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Batty M, 2011, J EXP CHILD PSYCHOL, V109, P430, DOI 10.1016/j.jecp.2011.02.001; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; Clark US, 2008, NEUROPSYCHOLOGIA, V46, P2300, DOI 10.1016/j.neuropsychologia.2008.03.014; Galli G, 2006, BRAIN RES, V1119, P190, DOI 10.1016/j.brainres.2006.08.076; Gordon EM, 2012, HUM BRAIN MAPP, V33, P1536, DOI 10.1002/hbm.21306; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hargrave R, 2002, J NEUROPSYCH CLIN N, V14, P64, DOI 10.1176/jnp.14.1.64; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Herrmann MJ, 2004, AM J PSYCHIAT, V161, P915, DOI 10.1176/appi.ajp.161.5.915; Herzmann G, 2010, J COGNITIVE NEUROSCI, V22, P571, DOI 10.1162/jocn.2009.21249; Ibanez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037306; Ibanez A, 2012, PSYCHIAT RES, V195, P18, DOI 10.1016/j.psychres.2011.07.027; Ibanez A, 2011, SOC NEUROSCI-UK, V6, P464, DOI 10.1080/17470919.2011.620769; Ibanez A, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-8; Isaacowitz DM, 2007, PSYCHOL AGING, V22, P147, DOI 10.1037/0882-7974.22.1.147; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; James MS, 2001, J PSYCHOPHYSIOL, V15, P275, DOI 10.1027//0269-8803.15.4.275; Kahler CW, 2012, PERS INDIV DIFFER, V52, P444, DOI 10.1016/j.paid.2011.11.009; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Latinus M, 2005, J COGNITIVE NEUROSCI, V17, P1316, DOI 10.1162/0898929055002490; Latinus M, 2006, BRAIN RES, V1123, P179, DOI 10.1016/j.brainres.2006.09.031; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Petroni A, 2011, NEUROSCI LETT, V505, P41, DOI 10.1016/j.neulet.2011.09.062; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schefter M, 2012, NEUROPSYCHOLOGY DEV, P37; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Taylor SF, 2012, BIOL PSYCHIAT, V71, P136, DOI 10.1016/j.biopsych.2011.09.007; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972	51	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57325	10.1371/journal.pone.0057325	http://dx.doi.org/10.1371/journal.pone.0057325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451205	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800099
J	Williams, AD; Andrews, G				Williams, Alishia D.; Andrews, Gavin			The Effectiveness of Internet Cognitive Behavioural Therapy (iCBT) for Depression in Primary Care: A Quality Assurance Study	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; PSYCHOLOGICAL TREATMENTS; COMORBIDITY; DISTRESS; PROGRAM; PHQ-9	Background: Depression is a common, recurrent, and debilitating problem and Internet delivered cognitive behaviour therapy (iCBT) could offer one solution. There are at least 25 controlled trials that demonstrate the efficacy of iCBT. The aim of the current paper was to evaluate the effectiveness of an iCBT Program in primary care that had been demonstrated to be efficacious in two randomized controlled trials (RCTs). Method: Quality assurance data from 359 patients prescribed the Sadness Program in Australia from October 2010 to November 2011 were included. Results: Intent-to-treat marginal model analyses demonstrated significant reductions in depressive symptoms (PHQ9), distress (K10), and impairment (WHODAS-II) with medium-large effect sizes (Cohen's d = .51-1.13.), even in severe and/or suicidal patients (Cohen's d = .50-1.49.) Secondary analyses on patients who completed all 6 lessons showed levels of clinically significant change as indexed by established criteria for remission, recovery, and reliable change. Conclusions: The Sadness Program is effective when prescribed by primary care practitioners and is consistent with a cost-effective stepped-care framework.	[Williams, Alishia D.; Andrews, Gavin] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Williams, Alishia D.; Andrews, Gavin] St Vincents Hosp, Clin Res Unit Anxiety & Depress, Sydney, NSW 2010, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney	Williams, AD (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	alishia.williams@unsw.edu.au			National Health and Medical Research Council (NHMRC) of Australia [630746]; University of New South Wales Faculty of Medicine Fellowship Enhancement Scheme	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales Faculty of Medicine Fellowship Enhancement Scheme	A. Williams is supported by a National Health and Medical Research Council (NHMRC) of Australia (Fellowship 630746) and a University of New South Wales Faculty of Medicine Fellowship Enhancement Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Andrews G, 2007, TOLKIEN 2 A NEEDS BA; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; [Anonymous], PLOS ONE; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Conradi HJ, 2007, PSYCHOL MED, V37, P849, DOI 10.1017/S0033291706009809; Cuijpers P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021274; Dear BF, 2011, BEHAV RES THER, V49, P830, DOI 10.1016/j.brat.2011.09.007; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Devilly GJ, 2009, J CONSULT CLIN PSYCH, V77, P1159, DOI 10.1037/a0016878; Federici S, 2009, LIFE SPAN DISABIL, V12, P85; Gonda T, 2012, AUST NZ J PSYCHIAT, V46, P651, DOI 10.1177/0004867412445527; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hilvert-Bruce Z, 2012, BEHAV RES THER, V50, P463, DOI 10.1016/j.brat.2012.04.001; Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ERN.12.63, 10.1586/ern.12.63]; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; McMillan D, 2010, J AFFECT DISORDERS, V127, P122, DOI 10.1016/j.jad.2010.04.030; Mewton L, 2012, DEPRESS ANXIETY, V29, P843, DOI 10.1002/da.21995; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; NICE, 2009, DEPR MAN DEPR PRIM 2; Perini S, 2008, E J APPL PSYCHOL, V4, P18; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Roy-Byrne PP, 2003, PSYCHIAT SERV, V54, P327, DOI 10.1176/appi.ps.54.3.327; Salim A, 2008, PSYCHIAT RES, V160, P335, DOI 10.1016/j.psychres.2007.08.005; Schulberg HC, 1998, ARCH GEN PSYCHIAT, V55, P1121, DOI 10.1001/archpsyc.55.12.1121; Sunderland M, 2012, BEHAV RES THER, V50, P374, DOI 10.1016/j.brat.2012.03.005; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Waller R, 2009, PSYCHOL MED, V39, P705, DOI 10.1017/S0033291708004224; Wolf NJ, 2008, CLIN PSYCHOL REV, V28, P131, DOI 10.1016/j.cpr.2007.04.004; Zuithoff NPA, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-98	38	98	99	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57447	10.1371/journal.pone.0057447	http://dx.doi.org/10.1371/journal.pone.0057447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451231	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800108
J	Agaisse, H; Derre, I				Agaisse, Herve; Derre, Isabelle			A C-trachomatis Cloning Vector and the Generation of C-trachomatis Strains Expressing Fluorescent Proteins under the Control of a C-trachomatis Promoter	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; INCLUSION MEMBRANE-PROTEINS; CHLAMYDIA-TRACHOMATIS; COXIELLA-BURNETII; TRANSPOSON MUTAGENESIS; RICKETTSIA-PROWAZEKII; GENE-TRANSFER; IN-VITRO; Q-FEVER; FUSION	Here we describe a versatile cloning vector for conducting genetic experiments in C. trachomatis. We successfully expressed various fluorescent proteins (i.e. GFP, mCherry and CFP) from C. trachomatis regulatory elements (i.e. the promoter and terminator of the incDEFG operon) and showed that the transformed strains produced wild type amounts of infectious particles and recapitulated major features of the C. trachomatis developmental cycle. C. trachomatis strains expressing fluorescent proteins are valuable tools for studying the C. trachomatis developmental cycle. For instance, we show the feasibility of investigating the dynamics of inclusion fusion and interaction with host proteins and organelles by time-lapse video microscopy.	[Agaisse, Herve; Derre, Isabelle] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Derre, I (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	isabelle.derre@yale.edu			National Institutes of Health grant [R21 AI088312]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088312] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R21 AI088312 to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-86; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008965; Bannantine JP, 1998, INFECT IMMUN, V66, P6017, DOI 10.1128/IAI.66.12.6017-6021.1998; Beare PA, 2012, APPL ENVIRON MICROB, V78, P4580, DOI 10.1128/AEM.00881-12; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00097; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Binet R, 2009, P NATL ACAD SCI USA, V106, P292, DOI 10.1073/pnas.0806768106; CAMPBELL S, 1989, J GEN MICROBIOL, V135, P1153; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; DeMars R, 2008, J BACTERIOL, V190, P1605, DOI 10.1128/JB.01592-07; DeMars R, 2007, J BACTERIOL, V189, P991, DOI 10.1128/JB.00845-06; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Renesto P, 2002, MICROB PATHOGENESIS, V33, P17, DOI 10.1006/mpat.2002.0508; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; TAM JE, 1994, CAN J MICROBIOL, V40, P583, DOI 10.1139/m94-093; Van Ooij C, 1998, INFECT IMMUN, V66, P5364, DOI 10.1128/IAI.66.11.5364-5371.1998; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258	53	74	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57090	10.1371/journal.pone.0057090	http://dx.doi.org/10.1371/journal.pone.0057090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441233	gold, Green Submitted, Green Published			2022-12-27	WOS:000315159200090
J	Schoen, CJ; Burmeister, M; Lesperance, MM				Schoen, Cynthia J.; Burmeister, Margit; Lesperance, Marci M.			Diaphanous homolog 3 (Diap3) Overexpression Causes Progressive Hearing Loss and Inner Hair Cell Defects in a Transgenic Mouse Model of Human Deafness	PLOS ONE			English	Article							DENDRITIC SPINE PLASTICITY; AUDITORY-NERVE; MECHANICAL TRANSDUCTION; MICE; CYTOSKELETON; ACTIN; MICROTUBULES; IMPAIRMENT; NEUROPATHY; DROSOPHILA	We previously demonstrated that a mutation in the 5' untranslated region of Diaphanous homolog 3 (DIAPH3) results in 2 to 3-fold overexpression of the gene, leading to a form of delayed onset, progressive human deafness known as AUNA1 (auditory neuropathy, nonsyndromic, autosomal dominant, 1). To investigate the mechanism of deafness, we generated two lines of transgenic mice overexpressing Diap3, the murine ortholog of DIAPH3, on an FVB/NJ background. Line 771 exhibits a relatively mild 20 dB hearing loss at 12 kHz at 4 and 8 weeks of age, progressing to 40 dB and 60 dB losses at 16 and 24 weeks, respectively, at 12 and 24 kHz. Line 924 shows no hearing loss at 4 or 8 weeks, but manifests 35 and 50 dB threshold shifts at 16 and 24 weeks, respectively, at both 12 and 24 kHz. Notably, mice from the two transgenic lines retain distortion product otoacoustic emissions, indicative of normal cochlear outer hair cell (OHC) function despite elevation of auditory thresholds. Scanning electron microscopy of the organ of Corti demonstrates striking anomalies of the inner hair cell (IHC) stereocilia, while OHCs are essentially intact. Over time, IHCs of both lines develop elongated stereocilia that appear fused with neighboring stereocilia, in parallel to the time course of hearing loss in each line. Furthermore, we observe significant reduction in the number of IHC ribbon synapses over 24 weeks in both lines, although this reduction does not correlate temporally with onset and progression of hearing loss or stereociliary anomalies. In summary, overexpression of wild-type Diap3 in two lines of transgenic mice results in hearing loss that recapitulates human AUNA1 deafness. These findings suggest an essential role of Diap3 in regulating assembly and/or maintenance of actin filaments in IHC stereocilia, as well as a potential role at the IHC ribbon synapse.	[Schoen, Cynthia J.] Univ Michigan Hlth Syst, Neurosci Program, Ann Arbor, MI USA; [Schoen, Cynthia J.; Burmeister, Margit] Univ Michigan Hlth Syst, Mol & Behav Neurosci Inst, Ann Arbor, MI USA; [Burmeister, Margit] Univ Michigan Hlth Syst, Dept Human Genet, Ann Arbor, MI USA; [Burmeister, Margit] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA; [Lesperance, Marci M.] Univ Michigan Hlth Syst, Div Pediat Otolaryngol, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lesperance, MM (corresponding author), Univ Michigan Hlth Syst, Div Pediat Otolaryngol, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA.	lesperan@umich.edu	Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434	National Institutes of Health [R01 DC007380, F31 DC011428, T32 DC000011, P30 DC005188]; University of Michigan Office of the Vice President for Research; University of Michigan Nathan Shock Aging Rodent Core; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007380, T32DC000011, F31DC011428, P30DC005188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Office of the Vice President for Research(University of Michigan System); University of Michigan Nathan Shock Aging Rodent Core; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grants R01 DC007380 (to MML), F31 DC011428 (to CJS), T32 DC000011 (supported CJS), and P30 DC005188 (in support of the University of Michigan Auditory Physiology and Histology-Pathology Cores), the University of Michigan Office of the Vice President for Research, and the University of Michigan Nathan Shock Aging Rodent Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Beyer LA, 2000, J NEUROCYTOL, V29, P227, DOI 10.1023/A:1026515619443; Brzostowski Joseph A., 2009, Communicative & Integrative Biology, V2, P337; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013; DeWard AD, 2010, BBA-MOL CELL RES, V1803, P226, DOI 10.1016/j.bbamcr.2009.11.006; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hoogenraad CC, 2010, NEUROSCIENTIST, V16, P650, DOI 10.1177/1073858410386357; JAEGER RG, 1994, HEARING RES, V77, P207, DOI 10.1016/0378-5955(94)90268-2; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; Karolyi IJ, 2007, MAMM GENOME, V18, P596, DOI 10.1007/s00335-007-9038-0; Kim TB, 2004, J MED GENET, V41, P872, DOI 10.1136/jmg.2004.020628; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Muller M, 2005, NEUROREPORT, V16, P1183; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OSBORNE MP, 1991, SCANNING MICROSCOPY, V5, P555; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schoen CJ, 2010, P NATL ACAD SCI USA, V107, P13396, DOI 10.1073/pnas.1003027107; Self T, 1998, DEVELOPMENT, V125, P557; Stamataki S, 2006, HEARING RES, V221, P104, DOI 10.1016/j.heares.2006.07.014; Starr A, 2004, JARO-J ASSOC RES OTO, V5, P411, DOI 10.1007/s10162-004-5014-5; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Thumkeo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025465; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012	41	26	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56520	10.1371/journal.pone.0056520	http://dx.doi.org/10.1371/journal.pone.0056520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441200	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200057
J	Starke, IC; Zentek, J; Vahjen, W				Starke, Ingo C.; Zentek, Juergen; Vahjen, Wilfried			Ex Vivo - Growth Response of Porcine Small Intestinal Bacterial Communities to Pharmacological Doses of Dietary Zinc Oxide	PLOS ONE			English	Article							PIGS	Piglets were fed diets containing 57 (low) or 2425 (high) mg zinc from analytical grade zinc oxide (ZnO) .kg(-1) feed. Digesta samples from the stomach and jejuna of 32, 39, 46 and 53 d old animals (n = 6 per group) were incubated in media containing 80, 40, 20 and 0 mu g.mL(-1) soluble zinc from ZnO. Turbidity was recorded for 16 h and growth parameters were calculated. Additionally, DNA extracts of selected samples were analyzed via qPCR for different bacterial groups. Samples from animals fed the low dietary zinc concentration always showed highest rate of growth and lowest lag times in media without added zinc. However, media supplemented with zinc displayed highest growth rates and lowest lag time in the high dietary zinc group. Specific growth rates and lag time showed significant differences on day 32 and 39 of age, but rarely on days 46 and 53 of age. Bacterial growth in digesta samples from the high dietary zinc group was less influenced by zinc and recovered growth more rapidly than in the low dietary zinc group. Specific growth rates and bacterial cell numbers from qPCR results showed that lactobacilli were most susceptible to zinc, while bifidobacteria, enterobacteria and enterococci exhibited increased growth rates in samples of animals from the high dietary zinc treatment. No treatment related differences were observed for clostridial cluster IV and the Bacteroides-Prevotella-Porphyromonas cluster. The diversity of enterobacteria after incubation was always higher in the high dietary zinc treatment or in medium supplemented with 80 mu g.mL(-1) soluble ZnO. This study has shown that a pharmacological dosage of ZnO leads to a reduced ex vivo-bacterial growth rate of bacteria from the stomach and jejunum of weaned piglets. In view of the rapid bacterial adaptation to dietary zinc, the administration of ZnO in feeds for weaned piglets might only be beneficial in a short period after weaning.	[Starke, Ingo C.; Zentek, Juergen; Vahjen, Wilfried] Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany	Free University of Berlin	Starke, IC (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany.	starke@zedat.fu-berlin.de			Deutsche Forschungsgemeinschaft (DFG) through Collaborative Research Group (SFB) 852/Project A1	Deutsche Forschungsgemeinschaft (DFG) through Collaborative Research Group (SFB) 852/Project A1	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) through grant of the Collaborative Research Group (SFB) 852/Project A1, "Nutrition and intestinal microbiota - host interactions in the pig". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardinal F, 2006, J SWINE HEALTH PROD, V14, P10; DINTZIS FR, 1995, J ANIM SCI, V73, P1138; HILL GM, 1983, J ANIM SCI, V57, P130, DOI 10.2527/jas1983.571130x; Hojberg O, 2005, APPL ENVIRON MICROB, V71, P2267, DOI 10.1128/AEM.71.5.2267-2277.2005; Janczyk P, 2007, FEMS MICROBIOL ECOL, V61, P132, DOI 10.1111/j.1574-6941.2007.00317.x; Katouli M, 1999, J APPL MICROBIOL, V87, P564, DOI 10.1046/j.1365-2672.1999.00853.x; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Liedtke J, 2012, VET MICROBIOL, V160, P251, DOI 10.1016/j.vetmic.2012.05.013; Martin L., 2012, 12 INT S DIG PHYS PI; Mertens J, 2006, ENVIRON MICROBIOL, V8, P2170, DOI 10.1111/j.1462-2920.2006.01100.x; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Perumbakkam S, 2011, FEMS MICROBIOL ECOL, V76, P156, DOI 10.1111/j.1574-6941.2011.01042.x; Pettigrew JE, 2006, ANIM BIOTECHNOL, V17, P207, DOI 10.1080/10495390600956946; Pieper R, 2008, MICROB ECOL, V56, P474, DOI 10.1007/s00248-008-9366-y; Starke IC, 2012, P 12 INT S DIG PHYS, P39; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Vahjen W, 2007, Curr Issues Intest Microbiol, V8, P1; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09	20	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56405	10.1371/journal.pone.0056405	http://dx.doi.org/10.1371/journal.pone.0056405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441186	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200043
J	Yang, JY; Cho, SW; An, JH; Jung, JY; Kim, SW; Kim, SY; Kim, JE; Shin, CS				Yang, Jae-Yeon; Cho, Sun Wook; An, Jee Hyun; Jung, Ju Yeon; Kim, Sang Wan; Kim, Seong Yeon; Kim, Jung Eun; Shin, Chan Soo			Osteoblast-Targeted Overexpression of TAZ Increases Bone Mass In Vivo	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR TAZ; STEM-CELL DIFFERENTIATION; ACTIVATED RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; PROTEIN; OSF2/CBFA1; EXPRESSION; FAMILY; BETA; MICE	Osteoblasts are derived from mesenchymal progenitors. Differentiation to osteoblasts and adipocytes is reciprocally regulated. Transcriptional coactivator with a PDZ-binding motif (TAZ) is a transcriptional coactivator that induces differentiation of mesenchymal cells into osteoblasts while blocking differentiation into adipocytes. To investigate the role of TAZ on bone metabolism in vivo, we generated transgenic mice that overexpress TAZ under the control of the procollagen type 1 promoter (Col1-TAZ). Whole body bone mineral density (BMD) of 6- to 19-week-old Col-TAZ mice was 4% to 7% higher than that of their wild-type (WT) littermates, whereas no difference was noticed in Col.1-TAZ female mice. Microcomputed tomography analyses of proximal tibiae at 16 weeks of age demonstrated a significant increase in trabecular bone volume (26.7%) and trabecular number (26.6%) with a reciprocal decrease in trabecular spacing (14.2%) in Col1-TAZ mice compared with their WT littermates. In addition, dynamic histomorphometric analysis of the lumbar spine revealed increased mineral apposition rate (42.8%) and the serum P1NP level was also significantly increased (53%) in Col.1-TAZ mice. When primary calvaria cells were cultured in osteogenic medium, alkaline phosphatase (ALP) activity was significantly increased and adipogenesis was significantly suppressed in Col1-TAZ mice compared with their WT littermates. Quantitative real-time polymerase chain reaction analyses showed that expression of collagen type 1, bone sialoprotein, osteocalcin, ALP, osterix, and Runx2 was significantly increased in calvaria cells from Col1-TAZ mice compared to their WT littermates. In vitro, TAZ enhanced Runx2-mediated transcriptional activity while suppressing the peroxisome proliferator-activated receptor gamma signaling pathway. TAZ also enhanced transcriptional activity from 3TP-Lux, which reflects transforming growth factor-beta (TGF-beta)-mediated signaling. In addition, TAZ enhanced TGF-beta-dependent nuclear translocation of Smad2/3 and Smad4. Taken together, these results suggest that TAZ positively regulates bone formation in vivo, which seems to be mediated by enhancing both Runx2 and TGF-beta signaling.	[Yang, Jae-Yeon; Cho, Sun Wook; An, Jee Hyun; Jung, Ju Yeon; Kim, Sang Wan; Kim, Seong Yeon; Shin, Chan Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Jung Eun] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Taegu, South Korea	Seoul National University (SNU); Kyungpook National University	Shin, CS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	csshin@snu.ac.kr	Kim, Sang Wan/J-5399-2012	Kim, Sang Wan/0000-0001-9561-9110	Ministry of Education, Science and Technology of Korea [2009-0077579]	Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the Ministry of Education, Science and Technology of Korea (grant # 2009-0077579, http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boban I, 2006, BONE, V39, P1302, DOI 10.1016/j.bone.2006.06.025; Byun MR, 2012, FEBS LETT, V586, P1086, DOI 10.1016/j.febslet.2012.03.008; Cho SW, 2011, J BONE MINER RES, V26, P1939, DOI 10.1002/jbmr.366; Ciavarella S, 2009, STEM CELLS DEV, V18, P1211, DOI 10.1089/scd.2008.0340; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Jang EJ, 2012, BRIT J PHARMACOL, V165, P1584, DOI 10.1111/j.1476-5381.2011.01664.x; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Jung H, 2009, BIOCHEM PHARMACOL, V78, P1323, DOI 10.1016/j.bcp.2009.07.001; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; TAPSCOTT SJ, 1991, J CLIN INVEST, V87, P1133, DOI 10.1172/JCI115109; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	40	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56585	10.1371/journal.pone.0056585	http://dx.doi.org/10.1371/journal.pone.0056585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441207	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200064
J	Pyrgos, V; Seitz, AE; Steiner, CA; Prevots, DR; Williamson, PR				Pyrgos, Vasilios; Seitz, Amy E.; Steiner, Claudia A.; Prevots, D. Rebecca; Williamson, Peter R.			Epidemiology of Cryptococcal Meningitis in the US: 1997-2009	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; ACTIVE SURVEILLANCE; NEOFORMANS; UPDATE; MANAGEMENT; MYCOSES; GATTII; HAART; ERA	Cryptococcal meningitis (CM) causes significant morbidity and mortality globally; however, recent national trends have not been described. Incidence and trends for CM-associated hospitalizations in 18 states were estimated using the Agency for Healthcare and Research Quality (AHRQ) State Inpatient Databases (SID) datasets for 1997 through 2009. We identified 30,840 hospitalizations coded for CM, of which 21.6% were among HIV-uninfected patients. CM in-hospital mortality was significant (12.4% for women and 10.8% for men) with a total of 3,440 deaths over the study period. Co-morbidities of CM coded at increased frequency in HIV-uninfected CM hospitalized populations included hydrocephalus and acute/chronic renal failure as well as possible predispositions including transplantation, combined T and B cell defects, Cushing's syndrome, liver disease and hypogammaglobulinemia. Median hospitalization costs were significant for CM and higher for HIV-uninfected patients (16,803.01 vs. 15,708.07; p<0.0001). Cryptococcal meningitis remains a disease with significant morbidity and mortality in the U.S. and the relative burden among persons without HIV infection is increasing.	[Pyrgos, Vasilios; Seitz, Amy E.; Prevots, D. Rebecca; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Steiner, Claudia A.] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Healthcare Cost & Utilizat Project, Rockville, MD USA; [Williamson, Peter R.] Univ Chicago, Dept Med, Chicago Coll Med, Infect Dis Sect, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Agency for Healthcare Research & Quality; University of Chicago	Williamson, PR (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001124] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional outside funding was obtained.	Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Baddley JW, 2008, EUR J CLIN MICROBIOL, V27, P937, DOI 10.1007/s10096-008-0529-z; Battal B, 2011, BRIT J RADIOL, V84, P758, DOI 10.1259/bjr/66206791; Baumgardner DJ, 2004, WILD ENVIRON MED, V15, P250, DOI 10.1580/1080-6032(2004)015[0250:SOPBNW]2.0.CO;2; Bonnet F, 2005, SCAND J INFECT DIS, V37, P482, DOI 10.1080/00365540510035328; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Chang DC, 2008, INFECT CONT HOSP EP, V29, P25, DOI 10.1086/524324; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chetchotisakd P, 2004, HIV MED, V5, P140, DOI 10.1111/j.1468-1293.2004.00201.x; Chu JH, 2006, CLIN INFECT DIS, V42, P822, DOI 10.1086/500405; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; EMMONS CW, 1955, AM J HYG, V62, P227, DOI 10.1093/oxfordjournals.aje.a119775; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; Harris JR, 2011, CLIN INFECT DIS, V53, P1188, DOI 10.1093/cid/cir723; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; Jiang H J, 2001, Jt Comm J Qual Improv, V27, P200; Joshi NS, 2010, PEDIATR INFECT DIS J, V29, pE91, DOI 10.1097/INF.0b013e3181fbc83d; Kaufman L, 1978, CRYPTOCOCCOSIS AWAKE, P176; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; LITTMAN ML, 1968, MYCOPATH MYCOL APPL, V35, P329, DOI 10.1007/BF02050749; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; MANGHAM D, 1983, ARCH INTERN MED, V143, P728, DOI 10.1001/archinte.143.4.728; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; MUKHERJEE J, 1993, P NATL ACAD SCI USA, V90, P3636, DOI 10.1073/pnas.90.8.3636; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park MK, 1999, CLIN INFECT DIS, V28, P629, DOI 10.1086/515161; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955; Sickbert-Bennett EE, 2010, AM J EPIDEMIOL, V172, P1299, DOI 10.1093/aje/kwq285; Singh N, 2004, MEDICINE, V83, P188, DOI 10.1097/01.md.0000126760.45299.69; Subramaniam KS, 2010, J IMMUNOL, V184, P5755, DOI 10.4049/jimmunol.0901638; TRUELSEN K, 1992, INFECT IMMUN, V60, P3937, DOI 10.1128/IAI.60.9.3937-3939.1992; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; WYKE RJ, 1980, GUT, V21, P643, DOI 10.1136/gut.21.8.643; Zonios DI, 2007, MEDICINE, V86, P78, DOI 10.1097/md.0b013e31803b52f5	41	188	198	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56269	10.1371/journal.pone.0056269	http://dx.doi.org/10.1371/journal.pone.0056269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457543	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700039
J	Maldonado, M; Kapphahn, RJ; Terluk, MR; Heuss, ND; Yuan, C; Gregerson, DS; Ferrington, DA				Maldonado, Marcela; Kapphahn, Rebecca J.; Terluk, Marcia R.; Heuss, Neal D.; Yuan, Ching; Gregerson, Dale S.; Ferrington, Deborah A.			Immunoproteasome Deficiency Modifies the Alternative Pathway of NF kappa B Signaling	PLOS ONE			English	Article							IN-VIVO; PROTEASOME; SUBUNIT; LMP2; ACTIVATION; MICE; CELLS; EXPRESSION; CROSSTALK; MUTATION	Immunoproteasome is a protease abundant in immune cells and also present, albeit at lower concentrations, in cells outside the immune system. Recent evidence supports a novel role for the immunoproteasome in the cellular stress response potentially through regulation of NF kappa B signaling, which is the primary response to multiple stressors. The current study tests whether the Classical or Alternative Pathways are regulated by immunoproteasome following chronic TNF alpha exposure in cultured retinal pigment epithelial cells isolated from wild-type mice and mice deficient in one (LMP2, L2) or two (LMP7 and MECL-1, L7M1) immunoproteasome subunits. Assays were performed to assess the expression of NF kappa B responsive genes, the content and activity of NF kappa B transcription factors (p65, p50, p52, cRel, RelB), and expression and content of regulatory proteins (I kappa B alpha, A20, RPS3). Major findings include distinct differences in expression of NF kappa B responsive genes in both KO cells. The mechanism responsible for the altered gene expression could not be established for L7M1 since no major differences in NF kappa B transcription factor content or activation were observed. However, L2 cells exhibited substantially higher content and diminished activation of NF kappa B transcription factors associated with the Alternative Pathway and delayed termination of the Classical Pathway. These results provide strong experimental evidence supporting a role for immunoproteasome in modulating NF kappa B signaling.	[Maldonado, Marcela; Kapphahn, Rebecca J.; Terluk, Marcia R.; Heuss, Neal D.; Yuan, Ching; Gregerson, Dale S.; Ferrington, Deborah A.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ferrington, DA (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	ferri013@umn.edu		Ferrington, Deborah/0000-0003-2561-7464; Gregerson, Dale/0000-0001-5769-796X	National Institutes of Health (NIH) [EY013623, AG032391, EY016376, EY019552, P30-EY11374]; NIH T32 Training Grant [AG029796]; Research to Prevent Blindness, Inc., New York, NY; Minnesota Medical Foundation, Minnesota Lions and Lioness Clubs; NATIONAL EYE INSTITUTE [P30EY011374, R01EY013623, R01EY016376, R01EY021996, R21EY019552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796, R21AG032391] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); Minnesota Medical Foundation, Minnesota Lions and Lioness Clubs; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the National Institutes of Health (NIH) (EY013623, AG032391 to DAF, EY016376 to DSG, EY019552 to CY, and P30-EY11374 Core Grant for Vision Research). MM was supported by an NIH T32 Training Grant AG029796. Additional support was through an unrestricted grant to the Department of Ophthalmology and Visual Neurosciences at the University of Minnesota from Research to Prevent Blindness, Inc., New York, NY; the Minnesota Medical Foundation, Minnesota Lions and Lioness Clubs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Atkinson S, 2012, STEM CELLS; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Basler M, 2012, J IMMUNOL, V189, P1868, DOI 10.4049/jimmunol.1103592; Basler M, 2011, J IMMUNOL, V187, P5548, DOI 10.4049/jimmunol.1101064; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Ferrington DA, 2006, EXP EYE RES, V83, P638, DOI 10.1016/j.exer.2006.03.003; Ferrington DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054347; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Gavilan MP, 2009, J NEUROCHEM, V108, P260, DOI 10.1111/j.1471-4159.2008.05762.x; Gregerson DS, 2007, INVEST OPHTH VIS SCI, V48, P4654, DOI 10.1167/iovs.07-0286; Gregerson DS, 2006, INVEST OPHTH VIS SCI, V47, P5385, DOI 10.1167/iovs.06-0636; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Hayashi T, 2000, J BIOL CHEM, V275, P5238, DOI 10.1074/jbc.275.7.5238; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Hussong SA, 2011, INVEST OPHTH VIS SCI, V52, P714, DOI 10.1167/iovs.10-6032; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Jang ER, 2012, MOL BIOSYST, V8, P2295, DOI 10.1039/c2mb25125f; Kanazawa N, 2012, J DERMATOL SCI, V66, P183, DOI 10.1016/j.jdermsci.2012.01.004; Kessler BM, 2000, NAT MED, V6, P1064, DOI 10.1038/80346; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; Malek R, 2007, PHARMACOL REP, V59, P25; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pickering AM, 2012, ARCH BIOCHEM BIOPHYS, V523, P181, DOI 10.1016/j.abb.2012.04.018; Reis J, 2011, CELL BIOCHEM BIOPHYS, V60, P77, DOI 10.1007/s12013-011-9182-8; Runnels HA, 2000, NAT MED, V6, P1064, DOI 10.1038/80349; Saeki Y, 2012, METHODS MOL BIOL, V832, P315, DOI 10.1007/978-1-61779-474-2_22; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Zu LY, 2010, J MOL CELL CARDIOL, V49, P5, DOI 10.1016/j.yjmcc.2010.02.007	54	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56187	10.1371/journal.pone.0056187	http://dx.doi.org/10.1371/journal.pone.0056187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457524	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700058
J	Kilarski, WW; Guc, E; Teo, JCM; Oliver, SR; Lund, AW; Swartz, MA				Kilarski, Witold W.; Guec, Esra; Teo, Jeremy C. M.; Oliver, S. Ryan; Lund, Amanda W.; Swartz, Melody A.			Intravital Immunofluorescence for Visualizing the Microcirculatory and Immune Microenvironments in the Mouse Ear Dermis	PLOS ONE			English	Article							IN-VIVO; FLUORESCENCE MICROSCOPY; LEUKOCYTE MIGRATION; LYMPHATIC VESSELS; CELLS; TUMORS; TRAFFICKING; COLLAGEN; MICE; ADHESION	Visualizing the dynamic behaviors of immune cells in living tissue has dramatically increased our understanding of how cells interact with their surroundings, contributing important insights into mechanisms of leukocyte trafficking, tumor cell invasion, and T cell education by dendritic cells, among others. Despite substantial advances with various intravital imaging techniques including two-photon microscopy and the generation of multitudes of reporter mice, there is a growing need to assess cell interactions in the context of specific extracellular matrix composition and microvascular functions, and as well, simpler and more widely accessible methods are needed to image cell behaviors in the context of living tissue physiology. Here we present an antibody-based method for intravital imaging of cell interactions with the blood, lymphatic, and the extracellular matrix compartments of the living dermis while simultaneously assessing capillary permeability and lymphatic drainage function. Using the exposed dorsal ear of the anesthetized mouse and a fluorescence stereomicroscope, such events can be imaged in the context of specific extracellular matrix proteins, or matrix-bound chemokine stores. We developed and optimized the method to minimize tissue damage to the ear, rapidly immunostain for multiple extracellular or cell surface receptors of interest, minimize immunotoxicity with pre-blocking Fc gamma receptors and phototoxicity with extracellular antioxidants, and highlight the major dermal tissue structures with basement membrane markers. We demonstrate differential migration behaviors of bone marrow-derived dendritic cells, blood-circulating leukocytes, and dermal dendritic cells, with the latter entering sparse CCL21-positive areas of pre-collecting lymphatic vessels. This new method allows simultaneous imaging of cells and tissue structures, microvascular function, and extracellular microenvironment in multiple skin locations for 12 hours or more, with the flexibility of immunolabeling in addition to genetic-based fluorescent reporters.	[Kilarski, Witold W.; Guec, Esra; Teo, Jeremy C. M.; Oliver, S. Ryan; Lund, Amanda W.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Teo, Jeremy C. M.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland; [Teo, Jeremy C. M.] Khalifa Univ Sci Technol & Res, Abu Dhabi, U Arab Emirates	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Khalifa University of Science & Technology	Kilarski, WW (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland.	witold.kilarski@epfl.ch; melody.swartz@epfl.ch	Kilarski, Witold W./G-8673-2012; Teo, Jeremy CM/D-7590-2015; Kilarski, Witold/AAA-1843-2019; Teo, Jeremy C.M./J-6440-2019	Kilarski, Witold W./0000-0003-0734-4749; Teo, Jeremy CM/0000-0001-6869-3833; Teo, Jeremy C.M./0000-0001-6869-3833; Lund, Amanda/0000-0001-7389-9983	European Research Commission (DC-Lymph) [206653-2]; European Framework Project 7 (AngioScaff); Swiss National Science Foundation [31-135756]; U.S. National Institutes of Health (NIH)/NIH Heart, Lung, and Blood Institute (NHLBI) [RO1 HL096539]; Robert Wenner Award (Swiss Cancer League); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096539] Funding Source: NIH RePORTER	European Research Commission (DC-Lymph); European Framework Project 7 (AngioScaff); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. National Institutes of Health (NIH)/NIH Heart, Lung, and Blood Institute (NHLBI); Robert Wenner Award (Swiss Cancer League); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the European Research Commission (DC-Lymph, 206653-2), the European Framework Project 7 (AngioScaff), the Swiss National Science Foundation (31-135756), and the U.S. National Institutes of Health (NIH)/NIH Heart, Lung, and Blood Institute (NHLBI) (RO1 HL096539). Additionally, funds from the Robert Wenner Award (Swiss Cancer League) allowed the purchase the Leica stereomicroscope used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Brown E, 2010, COLD SPRING HARB PRO, P5452; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Eichten A, 2005, CURR PROTOC CYTOM, V12; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Haessler U, 2011, P NATL ACAD SCI USA, P3; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hubner MP, 2012, J IMMUNOL, V188, P559, DOI 10.4049/jimmunol.1100335; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Jenne CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025109; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Kilarski WW, 2009, NAT MED, V15, P657, DOI 10.1038/nm.1985; Kimpton WG, 2009, ENCY LIFE SCI; Kuijpers TW, 2001, ENCY LIFE SCI, P1; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinez-Corral I, 2012, P NATL ACAD SCI US; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Roos A., 2005, ENCY LIFE SCI, P1; Saetzler RK, 1997, J HISTOCHEM CYTOCHEM, V45, P505, DOI 10.1177/002215549704500403; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spangrude GJ, 2001, CURRENT PROTOCOLS IM; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Steinbauer M, 2000, LANGENBECK ARCH SURG, V385, P290, DOI 10.1007/s004239900108; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Truman LA, 2012, AM J PATHOL, V180, P1715, DOI 10.1016/j.ajpath.2011.12.026; Vigl B, 2011, BLOOD, P1; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Zhi L, 2011, J IMMUNOL, V187, P2244, DOI 10.4049/jimmunol.1100670	45	52	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57135	10.1371/journal.pone.0057135	http://dx.doi.org/10.1371/journal.pone.0057135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451163	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500068
J	Seo, JW; Cho, SC; Park, SJ; Lee, EJ; Lee, JH; Han, SS; Pyo, BS; Park, DH; Kim, BH				Seo, Joung-Wook; Cho, Soon-Chang; Park, Sang-Joon; Lee, Eun-Ji; Lee, Jong-Hwa; Han, Sang-Seop; Pyo, Byeong Sik; Park, Dae-Hun; Kim, Bong-Hee			1 '-Acetoxychavicol Acetate Isolated from Alpinia galanga Ameliorates Ovalbumin-Induced Asthma in Mice	PLOS ONE			English	Article							ALLERGIC-ASTHMA; CYTOKINE PRODUCTION; CELLS; DISEASES; HYPERREACTIVITY; INFLAMMATION; EOSINOPHILIA; RELEASE; ALPHA; GAMMA	The World Health Organization reports that 235 million people are currently affected by asthma. This disease is associated with an imbalance of Th1 and Th2 cells, which results in the upregulation of cytokines that promote chronic inflammation of the respiratory system. The inflammatory response causes airway obstruction and can ultimately result in death. In this study we evaluated the effect of 1'-acetoxychavicol acetate (ACA) isolated from Alpinia galanga rhizomes in a mouse model of ovalbumin (OVA)-induced asthma. To generate the mouse model, BALB/c mice were sensitized by intraperitoneal injection of OVA and then challenged with OVA inhalation for 5 days. Mice in the vehicle control group were sensitized with OVA but not challenged with OVA. Treatment groups received dexamethasone, 25 mg/kg/day ACA, or 50 mg/kg/day ACA for 5 days. Asthma-related inflammation was assessed by bronchoalveolar lavage fluid cell counts and histopathological and immunohistochemical analysis of lung tissues. Our results showed that ACA reduced the infiltration of white blood cells (especially eosinophils) and the level of IgE in the lungs of mice challenged with OVA and suppressed histopathological changes such as airway remodeling, goblet-cell hyperplasia, eosinophil infiltration, and glycoprotein secretion. In addition, ACA inhibited expression of the Th2 cytokines interleukin (IL)-4 and IL-13, and Th1 cytokines IL-12 alpha and interferon-gamma. Because asthmatic reactions are mediated by diverse immune and inflammatory pathways, ACA shows promise as an antiasthmatic drug candidate.	[Seo, Joung-Wook; Lee, Jong-Hwa] Korea Inst Toxicol, Taejon, South Korea; [Seo, Joung-Wook; Kim, Bong-Hee] Chungnam Natl Univ, Coll Pharm, Taejon, South Korea; [Cho, Soon-Chang] Youngdong Univ, Ctr Senior Ind, Yeongdong, South Korea; [Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Taegu, South Korea; [Lee, Eun-Ji] Chungnam Natl Univ, Coll Vet Med, Taejon, South Korea; [Han, Sang-Seop] Konyang Univ, Taejon, South Korea; [Pyo, Byeong Sik; Park, Dae-Hun] Dongshin Univ, Naju, South Korea	Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Chungnam National University; Kyungpook National University; Chungnam National University; Konyang University; Dongshin University	Park, DH (corresponding author), Dongshin Univ, Naju, South Korea.	dhj1221@paran.com; bhkimnh@cnu.ac.kr		Lee, Jong-Hwa/0000-0002-5131-0514	National Research Foundation of Korea [2009-0073116]; Business for Cooperative RD [C0018727]	National Research Foundation of Korea(National Research Foundation of Korea); Business for Cooperative RD	This work was supported by a grant (Code No. 2009-0073116) from National Research Foundation of Korea and a grant (Code No. C0018727) from Business for Cooperative R&D between Industry, Academy, and Research Institute funded Korea Small and Medium Business Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2005, BIOORGAN MED CHEM, V13, P3289, DOI 10.1016/j.bmc.2005.02.022; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V101, pS427, DOI 10.1016/S0091-6749(98)70154-X; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Brightling CE, 2002, J ALLERGY CLIN IMMUN, V110, P899, DOI 10.1067/mai.2002.129698; Carson F. L., 2009, HISTOTECHNOLOGY SELF, V3th, P137; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; CORRIGAN CJ, 1991, INT ARCH ALLER A IMM, V94, P270, DOI 10.1159/000235380; DING JY, 1989, J STEROID BIOCHEM, V33, P1139, DOI 10.1016/0022-4731(89)90421-4; Ferreira MAR, 2004, RESPIROLOGY, V9, P16, DOI 10.1111/j.1440-1843.2003.00516.x; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; KAM JC, 1993, J IMMUNOL, V151, P3460; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Magnan AO, 2000, AM J RESP CRIT CARE, V161, P1790, DOI 10.1164/ajrccm.161.6.9906130; Mamessier E, 2006, EUR J DERMATOL, V16, P103; Matsuda H, 2003, BIOORG MED CHEM LETT, V13, P3197, DOI 10.1016/S0960-894X(03)00710-8; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Min HJ, 2009, INT IMMUNOPHARMACOL, V9, P448, DOI 10.1016/j.intimp.2009.01.008; Miteva L, 2008, HUM IMMUNOL, V69, P562, DOI 10.1016/j.humimm.2008.07.008; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; National asthma education and prevention program, 2002, J ALLERGY CLIN IMM S, V110, pS141; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Warrier PK, 1993, INDIAN MED PLANTS, V1-5; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; World Health Organization, 2011, ASTHMA; ZHENG GQ, 1993, J AGR FOOD CHEM, V41, P153, DOI 10.1021/jf00026a001; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	31	45	49	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56447	10.1371/journal.pone.0056447	http://dx.doi.org/10.1371/journal.pone.0056447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451048	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500016
J	Wall, NA; Chue, CD; Edwards, NC; Pankhurst, T; Harper, L; Steeds, RP; Lauder, S; Townend, JN; Moss, P; Ferro, CJ				Wall, Nadezhda A.; Chue, Colin D.; Edwards, Nicola C.; Pankhurst, Tanya; Harper, Lorraine; Steeds, Richard P.; Lauder, Sarah; Townend, Jonathan N.; Moss, Paul; Ferro, Charles J.			Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							HELICOBACTER-PYLORI; ENDOTHELIAL DYSFUNCTION; HEART-TRANSPLANTATION; CHLAMYDIA-PNEUMONIAE; AORTIC STIFFNESS; CONTROLLED-TRIAL; RISK-FACTOR; YOUNG MEN; INFECTION; ATHEROSCLEROSIS	Background: Patients with chronic kidney disease have an increased cardiovascular risk that is not fully explained by traditional risk factors but appears to be related to increased arterial stiffness. Cytomegalovirus (CMV) infection is associated with increased cardiovascular risk although the mechanisms for this are unknown. We examined whether CMV seropositivity was associated with increased arterial stiffness in patients with chronic kidney disease. Methodology and Principal Findings: In 215 non-diabetic patients with chronic kidney disease, CMV seropositivity was determined using an anti-CMV IgG ELISA. Pulse wave velocity was measured and aortic distensibility assessed in the ascending, proximal descending and distal descending thoracic aorta. Patients seropositive for CMV had a higher pulse wave velocity and lower aortic distensibility at all 3 levels. These differences (except for ascending aortic distensibility) persisted in a subcohort matched for age, gender and renal function, and when the whole cohort was divided into quartiles of age. In multivariable analyses, CMV seropositivity was an independent determinant of pulse wave velocity and proximal and distal descending aortic distensibility. Conclusions: In patients with chronic kidney disease, CMV seropositivity is associated with increased arterial stiffness and decreased distensibility of the proximal descending and distal aorta. These findings suggest that further research is required to examine CMV as a possible cause of arterial disease and increased cardiovascular risk in patients with CKD and may be relevant more widely for CMV seropositive patients with normal renal function.	[Wall, Nadezhda A.; Pankhurst, Tanya; Harper, Lorraine; Ferro, Charles J.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England; [Wall, Nadezhda A.; Harper, Lorraine; Ferro, Charles J.] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England; [Chue, Colin D.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Chue, Colin D.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.] Queen Elizabeth Hosp, Dept Cardiol, Birmingham B15 2TH, W Midlands, England; [Lauder, Sarah; Moss, Paul] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Ferro, CJ (corresponding author), Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England.	charles.ferro@uhb.nhs.uk	Moss, Paul/D-1728-2009; Ferro, Charles J./O-8912-2016; ferro, charles/L-7250-2019	Moss, Paul/0000-0002-6895-1967; Ferro, Charles J./0000-0003-0577-7081; ferro, charles/0000-0003-0577-7081; Steeds, Richard/0000-0001-5687-2535; Townend, Jonathan/0000-0002-5881-5806; harper, lorraine/0000-0003-1343-9234	Department of Renal Medicine; Department of Haematology; British Heart Foundation [FS/11/17/28700] Funding Source: researchfish; National Institute for Health Research [ACF-2010-09-008, PDF-2012-05-205] Funding Source: researchfish	Department of Renal Medicine; Department of Haematology; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work has received no external funding and was supported by internal departmental funds from Departments of Renal Medicine and Haematology to prime future grant applications. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SP, 1998, J INFECT DIS, V177, P209, DOI 10.1086/517355; BLAND JM, 1994, BRIT MED J, V309, P1128, DOI 10.1136/bmj.309.6962.1128; Blum A, 1998, AM J CARDIOL, V81, P866, DOI 10.1016/S0002-9149(98)00019-8; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Caposio P, 2011, VIRUS RES, V157, P204, DOI 10.1016/j.virusres.2010.09.011; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Doyle A, 2008, NEPHRON CLIN PRACT, V109, pC1, DOI 10.1159/000130170; Edwards NC, 2006, QJM-INT J MED, V99, P723, DOI 10.1093/qjmed/hcl101; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Espinola-Klein C, 2000, STROKE, V31, P2127, DOI 10.1161/01.STR.31.9.2127; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Grahame-Clarke C, 2003, CIRCULATION, V108, P678, DOI 10.1161/01.CIR.0000084505.54603.C7; Groenink M, 1998, AM J CARDIOL, V82, P203, DOI 10.1016/S0002-9149(98)00315-4; Haarala A, 2012, CLIN EXP IMMUNOL, V167, P309, DOI 10.1111/j.1365-2249.2011.04513.x; Haider AW, 2002, J AM COLL CARDIOL, V40, P1408, DOI 10.1016/S0735-1097(02)02272-6; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Joly L, 2009, EUR J NUCL MED MOL I, V36, P979, DOI 10.1007/s00259-008-1047-z; Khairy P, 2003, CIRCULATION, V107, P1966, DOI 10.1161/01.CIR.0000064895.89033.97; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MERIGAN TC, 1992, NEW ENGL J MED, V326, P1182, DOI 10.1056/NEJM199204303261803; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Oshima T, 2005, J AM COLL CARDIOL, V45, P1219, DOI 10.1016/j.jacc.2005.01.019; Parrinello CM, 2012, J INFECT DIS; Persoons MCJ, 1997, CARDIOVASC RES, V36, P282, DOI 10.1016/S0008-6363(97)00189-2; Potena L, 2006, TRANSPLANTATION, V82, P398, DOI 10.1097/01.tp.0000229039.87735.76; Simmonds J, 2008, CIRCULATION, V117, P2657, DOI 10.1161/CIRCULATIONAHA.107.718874; Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Stassen FR, 2008, PHARMACOL REP, V60, P85; Steptoe A, 2008, HEART, V94, P1075, DOI 10.1136/hrt.2008.143305; Yi L, 2008, ACTA VIROL, V52, P99; Yi L, 2008, J FORMOS MED ASSOC, V107, P774, DOI 10.1016/S0929-6646(08)60190-4	37	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55686	10.1371/journal.pone.0055686	http://dx.doi.org/10.1371/journal.pone.0055686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451030	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500004
J	Zhang, SH; Tian, HZ; Wu, J; Zhao, SM; Li, CT				Zhang, Suhua; Tian, Huaizhou; Wu, Jun; Zhao, Shumin; Li, Chengtao			A New Multiplex Assay of 17 Autosomal STRs and Amelogenin for Forensic Application	PLOS ONE			English	Article							TANDEM REPEAT LOCI; LINKAGE DISEQUILIBRIUM; DNA; GENOME	This paper describes a newly devised autosomal short tandem repeat (STR) multiplex polymerase chain reaction (PCR) systems for 17 autosomal loci (D1S1656, D2S441, D3S1358, D3S3045, D6S477, D7S3048, D8S1132, D10S1435, D10S1248, D11S2368, D13S325, D14S608, D15S659, D17S1290, D18S535, D19S253 and D22-GATA198B05) and Amelogenin. Primers for the loci were designed and optimized so that all of the amplicons were distributed from 50 base pairs (bp) to less than 500 bp within a five-dye chemistry design with the fifth dye reserved for the sizing standard. Strategies were developed to overcome challenges that encountered in creating the final assay. The limits of the multiplex were tested, resulting in the successful amplification of genomic DNA range from 0.25-4 ng with 30 PCR cycles. A total of 681 individuals from the Chinese Han population were studied and forensic genetic data were present. No significant deviations from Hardy-Weinberg equilibrium were observed. A total of 180 alleles were detected for the 17 autosomal STRs. The cumulative mean exclusion chance in duos (CMECD) was 0.999967, and cumulative mean exclusion chance in trios (CMECT) was 0.99999995. We conclude that the present 17plex autosomal STRs assay provides an additional powerful tool for forensic applications.	[Zhang, Suhua; Zhao, Shumin; Li, Chengtao] Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai, Peoples R China; [Tian, Huaizhou; Wu, Jun] PEOPLESPOTINC Res & Dev, Beijing, Peoples R China	Institute of Forensic Science Ministry of Justice PRC	Li, CT (corresponding author), Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai, Peoples R China.	lichengtaohla@163.com		Zhang, Suhua/0000-0002-3984-9728; Li, Chengtao/0000-0001-6852-9144	National Natural Science Foundation of People's Republic of China [30901701, 81172908]; National Key Technology Research & Development Program of the Ministry of Science and Technology of People's Republic of China [2012BAK16B01]	National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research & Development Program of the Ministry of Science and Technology of People's Republic of China	This study was supported by grants from the National Natural Science Foundation of People's Republic of China (No.30901701, 81172908, http://www.nsfc.gov.cn/Portal0/default166.htm) and the National Key Technology Research & Development Program of the Ministry of Science and Technology of People's Republic of China (2012BAK16B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Chakraborty R, 1999, ELECTROPHORESIS, V20, P1682; Hill CR, 2009, J FORENSIC SCI, V54, P1008, DOI 10.1111/j.1556-4029.2009.01110.x; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Opel KL, 2007, J FORENSIC SCI, V52, P1263, DOI 10.1111/j.1556-4029.2007.00584.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Service SK, 2001, HUM MOL GENET, V10, P545, DOI 10.1093/hmg/10.5.545; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wenk RE, 2003, TRANSFUSION, V43, P979, DOI 10.1046/j.1537-2995.2003.00439.x	12	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57471	10.1371/journal.pone.0057471	http://dx.doi.org/10.1371/journal.pone.0057471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451235	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500108
J	Walter, V; Yin, XY; Wilkerson, MD; Cabanski, CR; Zhao, N; Du, Y; Ang, MK; Hayward, MC; Salazar, AH; Hoadley, KA; Fritchie, K; Sailey, CG; Weissler, MC; Shockley, WW; Zanation, AM; Hackman, T; Thorne, LB; Funkhouser, WD; Muldrew, KL; Olshan, AF; Randell, SH; Wright, FA; Shores, CG; Hayes, DN				Walter, Vonn; Yin, Xiaoying; Wilkerson, Matthew D.; Cabanski, Christopher R.; Zhao, Ni; Du, Ying; Ang, Mei Kim; Hayward, Michele C.; Salazar, Ashley H.; Hoadley, Katherine A.; Fritchie, Karen; Sailey, Charles G.; Weissler, Mark C.; Shockley, William W.; Zanation, Adam M.; Hackman, Trevor; Thorne, Leigh B.; Funkhouser, William D.; Muldrew, Kenneth L.; Olshan, Andrew F.; Randell, Scott H.; Wright, Fred A.; Shores, Carol G.; Hayes, D. Neil			Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; CYCLIN D1 AMPLIFICATION; HUMAN-PAPILLOMAVIRUS; EXPRESSION; MICROARRAYS; SURVIVAL; TUMORS; LUNG; ABERRATIONS	Head and neck squamous cell carcinoma (HNSCC) is a frequently fatal heterogeneous disease. Beyond the role of human papilloma virus (HPV), no validated molecular characterization of the disease has been established. Using an integrated genomic analysis and validation methodology we confirm four molecular classes of HNSCC (basal, mesenchymal, atypical, and classical) consistent with signatures established for squamous carcinoma of the lung, including deregulation of the KEAP1/NFE2L2 oxidative stress pathway, differential utilization of the lineage markers SOX2 and TP63, and preference for the oncogenes PIK3CA and EGFR. For potential clinical use the signatures are complimentary to classification by HPV infection status as well as the putative high risk marker CCND1 copy number gain. A molecular etiology for the subtypes is suggested by statistically significant chromosomal gains and losses and differential cell of origin expression patterns. Model systems representative of each of the four subtypes are also presented.	[Walter, Vonn; Yin, Xiaoying; Wilkerson, Matthew D.; Cabanski, Christopher R.; Zhao, Ni; Du, Ying; Ang, Mei Kim; Hayward, Michele C.; Salazar, Ashley H.; Hoadley, Katherine A.; Wright, Fred A.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yin, Xiaoying; Weissler, Mark C.; Shockley, William W.; Zanation, Adam M.; Hackman, Trevor; Shores, Carol G.; Hayes, D. Neil] Univ N Carolina, Dept Otolaryngol, Chapel Hill, NC USA; [Cabanski, Christopher R.] Washington Univ, Genome Inst, St Louis, MO USA; [Zhao, Ni; Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Ang, Mei Kim] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Fritchie, Karen] Mayo Clin, Dept Pathol, Rochester, MN USA; [Sailey, Charles G.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Thorne, Leigh B.; Funkhouser, William D.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Muldrew, Kenneth L.] Univ Toledo, Dept Pathol, Toledo, OH 43606 USA; [Olshan, Andrew F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Hayes, D. Neil] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; National Cancer Centre Singapore (NCCS); Mayo Clinic; University of Arkansas System; University of Arkansas Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Toledo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hayes, DN (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	hayes@med.unc.edu	Walter, Vonn/AAI-3450-2021; , Pathology Services Core/CEZ-2246-2022; Zhao, Ni/P-9086-2014	Walter, Vonn/0000-0001-6114-6714; Zhao, Ni/0000-0002-7762-3949; Hoadley, Katherine/0000-0002-1216-477X; Hayes, D. Neil/0000-0001-6203-7771	UNC Lineberger Comprehensive Cancer Center [K12-RR-023248]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES014843] Funding Source: NIH RePORTER	UNC Lineberger Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Clinical/Translational Award from the UNC Lineberger Comprehensive Cancer Center; http://unclineberger.org/research/research/research/developmental-research-awards K12-RR-023248; http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ang KK, 2002, CANCER RES, V62, P7350; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Chen Chao, 2010, Cancers (Basel), V2, P1528, DOI 10.3390/cancers2031528; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Edge SB, 2009, AJCC CANC STAGING MA, V7; Fujii M, 2001, CANCER LETT, V172, P187, DOI 10.1016/S0304-3835(01)00651-6; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Martin A, 2010, NAT CELL BIOL, V12, P924, DOI 10.1038/ncb1010-924; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Mehanna H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4690; Namazie A, 2002, LARYNGOSCOPE, V112, P472, DOI 10.1097/00005537-200203000-00013; Okami K, 1999, ONCOGENE, V18, P3541, DOI 10.1038/sj.onc.1202837; Patmore HS, 2005, ANN SURG ONCOL, V12, P831, DOI 10.1245/ASO.2005.09.017; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh B, 2001, CANCER RES, V61, P4506; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Therneau TM, 2012, PACKAGE SURVIVAL S R; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	50	200	200	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56823	10.1371/journal.pone.0056823	http://dx.doi.org/10.1371/journal.pone.0056823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451093	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800040
J	Zhang, J; Wang, JH; Geng, DY; Li, YX; Song, DL; Gu, YX				Zhang, Jun; Wang, Jianhong; Geng, Daoying; Li, Yuxin; Song, Donglei; Gu, Yuxiang			Whole-Brain CT Perfusion and CT Angiography Assessment of Moyamoya Disease before and after Surgical Revascularization: Preliminary Study with 256-Slice CT	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INITIAL-EXPERIENCE; IMAGING TECHNIQUES; STENOSIS	Background/Aims: The 256-slice CT enables the entire brain to be scanned in a single examination. We evaluated the application of 256-slice whole-brain CT perfusion (CTP) in determining graft patency as well as investigating cerebral hemodynamic changes in Moyamoya disease before and after surgical revascularization. Methods: Thirty-nine cases of Moyamoya disease were evaluated before and after surgical revascularization with 256-slice CT. Whole-brain perfusion images and dynamic 3D CT angiographic images generated from perfusion source data were obtained in all patients. Cerebral blood flow (CBF), cerebral blood volume (CBV), time to peak (TTP) and mean transit time (MTT) of one hemisphere in the region of middle cerebral artery (MCA) distribution and contralateral mirroring areas were measured. Relative CTP values (rCBF, rCBV, rTTP, rMTT) were also obtained. Differences in pre- and post-operation perfusion CT values were assessed with paired t test or matched-pairs signed-ranks test. Results: Preoperative CBF, MTT and TTP of potential surgical side were significantly different from those of contralateral side (P<0.01 for all). All graft patencies were displayed using the 3D-CTA images. Postoperative CBF, rCBF and rCBV values of surgical side in the region of MCA were significantly higher than those before operation (P<0.01 for all). Postoperative MTT, TTP, rMTT and rTTP values of the surgical side in the region of MCA were significantly lower than those before operation (P<0.05 for all). Conclusion: The 256-slice whole-brain CTP can be used to evaluate cerebral hemodynamic changes in Moyamoya disease before and after surgery and the 3D-CTA is useful for assessing the abnormalities of intracranial arteries and graft patencies.	[Zhang, Jun; Geng, Daoying; Li, Yuxin] Fudan Univ, Dept Radiol, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Jianhong] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Song, Donglei; Gu, Yuxiang] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Geng, DY (corresponding author), Fudan Univ, Dept Radiol, Huashan Hosp, Shanghai 200433, Peoples R China.	fdhsgdy@163.com	gu, yu/GSD-4507-2022; li, Yu/HCI-9086-2022; Cao, Xin/AAX-8367-2021; wang, jian/GVS-0711-2022; Li, yu/HHZ-5236-2022; Li, yuxin/GSD-1668-2022; li, yu/HGL-9518-2022	zhang, jun/0000-0003-1849-9199	Science and Technical committee of Shanghai Municipality [12ZR1441600, 12XD1401500]	Science and Technical committee of Shanghai Municipality	This work was supported by the grant from Science and Technical committee of Shanghai Municipality (12ZR1441600, 12XD1401500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Eastwood JD, 2002, RADIOLOGY, V222, P227, DOI 10.1148/radiol.2221010471; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; Kang KH, 2008, AM J NEURORADIOL, V29, P1487, DOI 10.3174/ajnr.A1129; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Murayama K, 2009, RADIOLOGY, V250, P202, DOI 10.1148/radiol.2501071809; Nguyen-Huynh MN, 2008, STROKE, V39, P1184, DOI 10.1161/STROKEAHA.107.502906; Rim NJ, 2008, AM J NEURORADIOL, V29, P1658, DOI 10.3174/ajnr.A1229; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Scott RM, 2004, J NEUROSURG, V100, P142, DOI 10.3171/ped.2004.100.2.0142; So Y, 2005, STROKE, V36, P1485, DOI 10.1161/01.STR.0000170709.95185.b1; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Togao O, 2006, AM J NEURORADIOL, V27, P391; Turk AS, 2007, NEURORADIOLOGY, V49, P955, DOI 10.1007/s00234-007-0276-3; Waaijer A, 2007, AM J NEURORADIOL, V28, P927; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wintermark M, 2001, AM J NEURORADIOL, V22, P905	17	39	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57595	10.1371/journal.pone.0057595	http://dx.doi.org/10.1371/journal.pone.0057595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451248	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800112
J	Pan, XH; Zhang, XL; Sun, HL; Zhang, JJ; Yan, MM; Zhang, HB				Pan, Xiaohong; Zhang, Xiuli; Sun, Hongliu; Zhang, Jinjin; Yan, Miaomiao; Zhang, Huaibin			Autophagy Inhibition Promotes 5-Fluorouraci-Induced Apoptosis by Stimulating ROS Formation in Human Non-Small Cell Lung Cancer A549 Cells	PLOS ONE			English	Article							DOWN-REGULATION; DEATH; 5-FU; MECHANISMS; EXPRESSION; INDUCTION; PROTEIN	Chemotherapy is an important option for the treatment of various cancers including lung cancer. However, tumor resistance towards cytotoxic chemotherapy has become more common. It has been reported that autophagy is one of the processes contributing to this resistance. In the present study, we found that the anti-cancer drug 5-fluorouraci(5-FU) could induce autophagy in A549 cells. 5-FU treatment could lead to the conversion of LC3 I/II, the up-regulation of Beclin-1, the down-regulation of p62 and the formation of acidic vesicular organelles (AVOs) in A549 cells. Pre-treatment of cancer cells with 3-MA or siAtg7 could enhance 5-FU-induced apoptosis through the activation of caspases, and the caspase inhibitor z-VAD-fmk rescued the cell viability reduction. Furthermore, the inhibition of autophagy also stimulated ROS formation and scavenging of ROS by antioxidant NAC inhibited caspase-3 activity, prevented the release of cyt-c from mitochondria and eventually rescued cancer cells from 5-FU-mediated apoptosis. These results suggest that 5-FU-elicited autophagic response plays a protective role against cell apoptosis and the inhibition of autophagy could sensitize them to 5-FU-induced caspase-dependent apoptosis through the stimulation of ROS formation.	[Pan, Xiaohong; Zhang, Xiuli; Sun, Hongliu; Yan, Miaomiao; Zhang, Huaibin] Binzhou Med Univ, Dept Pharmaceut Sci, Yantai, Shandong, Peoples R China; [Zhang, Jinjin] Binzhou Med Univ, Med Res Ctr, Yantai, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Pan, XH (corresponding author), Binzhou Med Univ, Dept Pharmaceut Sci, Yantai, Shandong, Peoples R China.	panxh_2008@126.com	zhang, jin/GXV-9154-2022		Project of Shandong Province Higher Educational Science and Technology Program [J10LC66]; National Natural Science Foundation of China [81102828, 81273037, 81202516]	Project of Shandong Province Higher Educational Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by A Project of Shandong Province Higher Educational Science and Technology Program (J10LC66) and the National Natural Science Foundation of China (Grant Nos. 81102828, 81273037, 81202516). The authors also wanted to show appreciation to the Natural Science Foundation of Shandong province of China (No. ZR2011HM011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellot GL, 2012, MITOCHONDRION; Chen CY, 2006, CHINESE J PHYSIOL, V49, P31; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Galluzzi L, 2008, CURR MOL MED, V8, P78; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Jiang H, 2009, METHOD ENZYMOL, V453, P273, DOI 10.1016/S0076-6879(08)04013-5; Kaminskyy V, 2011, AUTOPHAGY, V7, P83, DOI 10.4161/auto.7.1.13893; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li X, 2011, TOXICOL APPL PHARM, V251, P146, DOI 10.1016/j.taap.2010.12.007; Lin HI, 2005, CANCER LETT, V230, P248, DOI 10.1016/j.canlet.2004.12.044; Ling YH, 2011, CLIN CANCER RES, V17, P5353, DOI 10.1158/1078-0432.CCR-10-1948; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu J, 2012, J PHARM PHARMACOL, V64, P146, DOI 10.1111/j.2042-7158.2011.01371.x; Macchioni L, 2011, J BIOENERG BIOMEMBR, V43, P507, DOI 10.1007/s10863-011-9375-2; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Miyake M, 2012, ONCOL LETT, V3, P1195, DOI 10.3892/ol.2012.662; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nicolau-Galmes F, 2011, APOPTOSIS, V16, P1253, DOI 10.1007/s10495-011-0640-y; Nordman IC, 2006, ANZ J SURG, V76, P373, DOI 10.1111/j.1445-2197.2006.03726.x; Noro R, 2010, CANCER SCI, V101, P1424, DOI 10.1111/j.1349-7006.2010.01559.x; Nyhan MJ, 2012, BRIT J CANCER, V106, P711, DOI 10.1038/bjc.2011.604; Pan XH, 2008, BIOORGAN MED CHEM, V16, P9093, DOI 10.1016/j.bmc.2008.09.046; Qin L, 2008, BIOCHEM BIOPH RES CO, V371, P531, DOI 10.1016/j.bbrc.2008.04.117; Saleem A, 2012, PROSTATE, V72, P1374, DOI 10.1002/pros.22487; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Sharma N, 2012, CANCER LETT, V326, P143, DOI 10.1016/j.canlet.2012.07.029; Wang CZ, 2009, ANTICANCER RES, V29, P2927; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Xiong HY, 2010, CANCER LETT, V288, P68, DOI 10.1016/j.canlet.2009.06.039; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yi H, 2012, KOREAN J PHYSIOL PHA, V16, P11, DOI 10.4196/kjpp.2012.16.1.11; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Zhang T, 2012, AUTOPHAGY, V8, P559, DOI 10.4161/auto.18867	38	83	88	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56679	10.1371/journal.pone.0056679	http://dx.doi.org/10.1371/journal.pone.0056679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441212	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200069
J	Petruno, SK; Clark, RE; Reinagel, P				Petruno, Sarah K.; Clark, Robert E.; Reinagel, Pamela			Evidence That Primary Visual Cortex Is Required for Image, Orientation, and Motion Discrimination by Rats	PLOS ONE			English	Article							STRIATE CORTEX; RESPONSE PROPERTIES; RESIDUAL VISION; AREA MT; FUNCTIONAL SPECIALIZATION; CONTOUR DISCRIMINATION; SUPERIOR COLLICULUS; RECEPTIVE-FIELDS; AFFERENT BASIS; LESIONS	The pigmented Long-Evans rat has proven to be an excellent subject for studying visually guided behavior including quantitative visual psychophysics. This observation, together with its experimental accessibility and its close homology to the mouse, has made it an attractive model system in which to dissect the thalamic and cortical circuits underlying visual perception. Given that visually guided behavior in the absence of primary visual cortex has been described in the literature, however, it is an empirical question whether specific visual behaviors will depend on primary visual cortex in the rat. Here we tested the effects of cortical lesions on performance of two-alternative forced-choice visual discriminations by Long-Evans rats. We present data from one highly informative subject that learned several visual tasks and then received a bilateral lesion ablating >90% of primary visual cortex. After the lesion, this subject had a profound and persistent deficit in complex image discrimination, orientation discrimination, and full-field optic flow motion discrimination, compared with both pre-lesion performance and sham-lesion controls. Performance was intact, however, on another visual two-alternative forced-choice task that required approaching a salient visual target. A second highly informative subject learned several visual tasks prior to receiving a lesion ablating >90% of medial extrastriate cortex. This subject showed no impairment on any of the four task categories. Taken together, our data provide evidence that these image, orientation, and motion discrimination tasks require primary visual cortex in the Long-Evans rat, whereas approaching a salient visual target does not.	[Petruno, Sarah K.; Reinagel, Pamela] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Clark, Robert E.] Univ Calif San Diego, Vet Affairs Med Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Reinagel, P (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	preinagel@ucsd.edu	Reinagel, Pamela/ABI-7659-2020	Reinagel, Pamela/0000-0002-6338-2611	National Eye Institute [R01 5R01EY016856]; J.S. McDonnell Foundation Scholar Award; Kavli Institute for Mind and Brain at UCSD - Innovative Research Grant; VA Merit Review [NSF IOS1120395]; NSF Temporal Dynamics of Learning Center at UCSD; NATIONAL EYE INSTITUTE [R01EY016856] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); J.S. McDonnell Foundation Scholar Award; Kavli Institute for Mind and Brain at UCSD - Innovative Research Grant; VA Merit Review(US Department of Veterans Affairs); NSF Temporal Dynamics of Learning Center at UCSD; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by National Eye Institute R01 5R01EY016856 (www.nei.nih.gov/; Reinagel, PI), a J.S. McDonnell Foundation Scholar Award (www.jsmf.org/; Reinagel, PI), a Kavli Institute for Mind and Brain at UCSD - Innovative Research Grant (kibm.ucsd.edu/; Reinagel, PI), a VA Merit Review (http://www.sandiego.va.gov/; Clark, PI), NSF IOS1120395 (nsf.gov; Clark; Squire, PI), and the NSF Temporal Dynamics of Learning Center at UCSD (tdlc.ucsd.edu/; Clark, Subproject Leader). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander I, 2009, EXP BRAIN RES, V192, P407, DOI 10.1007/s00221-008-1508-4; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; BLAND BH, 1969, J COMP PHYSIOL PSYCH, V69, P345, DOI 10.1037/h0028160; BLAND BH, 1970, PHYSIOL BEHAV, V5, P211, DOI 10.1016/0031-9384(70)90067-3; BLYTHE IM, 1987, BRAIN, V110, P887, DOI 10.1093/brain/110.4.887; BLYTHE IM, 1986, NATURE, V320, P619, DOI 10.1038/320619a0; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; BRAUN JJ, 1970, BRAIN RES, V20, P283, DOI 10.1016/0006-8993(70)90295-7; BRIDGEMAN B, 1982, VISION RES, V22, P1199, DOI 10.1016/0042-6989(82)90085-2; Brigman JL, 2005, BEHAV NEUROSCI, V119, P839, DOI 10.1037/0735-7044.119.3.839; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Campion J, 1983, BEHAV BRAIN SCI, P6; Ch'ng YH, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00020; Clark RE, 2011, NEURON, V70, P132, DOI 10.1016/j.neuron.2011.03.007; COOGAN TA, 1993, J NEUROSCI, V13, P3749; COWEY A, 1971, BRAIN RES, V30, P241, DOI 10.1016/0006-8993(71)90076-X; Cowey A, 2010, CURR BIOL, V20, pR702, DOI 10.1016/j.cub.2010.07.014; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; DEAN P, 1981, EXP BRAIN RES, V43, P145; DEAN P, 1978, BRAIN RES, V156, P17, DOI 10.1016/0006-8993(78)90076-8; ESPINOZA SG, 1983, BRAIN RES, V272, P137, DOI 10.1016/0006-8993(83)90370-0; GOLDSTEIN LH, 1987, BEHAV BRAIN RES, V24, P181, DOI 10.1016/0166-4328(87)90056-8; GROSS CG, 1991, NEUROPSYCHOLOGIA, V29, P497, DOI 10.1016/0028-3932(91)90007-U; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Lashley KS, 1931, J COMP NEUROL, V53, P419, DOI 10.1002/cne.900530304; Lashley KS, 1934, J COMP PSYCHOL, V17, P355, DOI 10.1037/h0073094; Lashley KS, 1939, J COMP NEUROL, V70, P45, DOI 10.1002/cne.900700104; LAVOND DG, 1980, PHYSIOL PSYCHOL, V8, P1; Lavond DG, 1970, PHYSL PSYCHOL, V6, P471; LEWELLYN D, 1969, J COMP PHYSIOL PSYCH, V69, P25, DOI 10.1037/h0027927; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P238, DOI 10.1016/0010-0285(83)90010-5; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Meier P, 2011, J VIS, V11, P22; MESTRE DR, 1992, NEUROPSYCHOLOGIA, V30, P783, DOI 10.1016/0028-3932(92)90082-W; Millner AD, 1995, VISUAL BRAIN ACTION; MIZE RR, 1971, PHYSIOL BEHAV, V6, P241; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; OAKLEY DA, 1981, BEHAV BRAIN RES, V3, P55, DOI 10.1016/0166-4328(81)90028-0; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perenin MT, 1996, NEUROREPORT, V7, P793, DOI 10.1097/00001756-199602290-00027; PERENIN MT, 1991, NEUROREPORT, V2, P397, DOI 10.1097/00001756-199107000-00011; PERENIN MT, 1975, NEUROPSYCHOLOGIA, V13, P1, DOI 10.1016/0028-3932(75)90041-X; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Ptito A, 2007, NEUROSCIENTIST, V13, P506, DOI 10.1177/1073858407300598; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Rees G, 2008, BRAIN, V131, P1414, DOI 10.1093/brain/awn089; Reinagel P, 2012, 12060311 ARXIV; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rumberger A, 2001, NEUROSCIENCE, V102, P35, DOI 10.1016/S0306-4522(00)00475-9; SANDERS MD, 1974, LANCET, V1, P707; Schmid MC, 2010, NATURE, V466, P373, DOI 10.1038/nature09179; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; SOLOMON SJ, 1981, EXP BRAIN RES, V44, P259; Tafazoli S, 2012, J NEUROSCI, V32, P21, DOI 10.1523/JNEUROSCI.3932-11.2012; THOMPSON R, 1969, J COMP PHYSIOL PSYCH, V69, P1, DOI 10.1037/h0028219; THOMPSON VE, 1970, J COMP PHYSIOL PSYCH, V72, P444, DOI 10.1037/h0029733; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 1987, BRAIN, V110, P77, DOI 10.1093/brain/110.1.77; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Whishaw IQ, 2004, BEHAV BRAIN RES, V155, P177, DOI 10.1016/j.bbr.2004.04.013; ZIHL J, 1980, BEHAV BRAIN RES, V1, P287; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	76	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56543	10.1371/journal.pone.0056543	http://dx.doi.org/10.1371/journal.pone.0056543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441202	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200059
J	Lu, YJ; Zhang, PZ; Liu, JF; Li, J; Deng, SS				Lu, Yingjie; Zhang, Pengzhu; Liu, Jingfang; Li, Jia; Deng, Shasha			Health-Related Hot Topic Detection in Online Communities Using Text Clustering	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; INCOMPLETE DATA; INTERNET; PATIENT; CANCER; WEB	Recently, health-related social media services, especially online health communities, have rapidly emerged. Patients with various health conditions participate in online health communities to share their experiences and exchange healthcare knowledge. Exploring hot topics in online health communities helps us better understand patients' needs and interest in health-related knowledge. However, the statistical topic analysis employed in previous studies is becoming impractical for processing the rapidly increasing amount of online data. Automatic topic detection based on document clustering is an alternative approach for extracting health-related hot topics in online communities. In addition to the keyword-based features used in traditional text clustering, we integrate medical domain-specific features to represent the messages posted in online health communities. Three disease discussion boards, including boards devoted to lung cancer, breast cancer and diabetes, from an online health community are used to test the effectiveness of topic detection. Experiment results demonstrate that health-related hot topics primarily include symptoms, examinations, drugs, procedures and complications. Further analysis reveals that there also exist some significant differences among the hot topics discussed on different types of disease discussion boards.	[Lu, Yingjie; Zhang, Pengzhu; Liu, Jingfang; Li, Jia; Deng, Shasha] Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai 200030, Peoples R China; [Li, Jia] E China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China	Shanghai Jiao Tong University; East China University of Science & Technology	Lu, YJ (corresponding author), Shanghai Jiao Tong Univ, Antai Coll Econ & Management, Shanghai 200030, Peoples R China.	luyingjie982@163.com		lu, yingjie/0000-0001-9607-3607	National Natural Science Foundation of China (NSFC) [71171131]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC) grants 71171131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JG, 2003, J MED SYST, V27, P67, DOI 10.1023/A:1021061229743; Bansil P., 2006, PREVENTING CHRONIC D, V3, P1; Basch EM, 2004, CANCER-AM CANCER SOC, V100, P2476, DOI 10.1002/cncr.20261; Boehmke MM, 2006, ONCOL NURS FORUM, V33, P1121, DOI 10.1188/06.ONF.1121-1127; Brody Samuel, 2010, AMIA Annu Symp Proc, V2010, P202; Buis LR, 2011, CIN-COMPUT INFORM NU, V29, P461, DOI 10.1097/NCN.0b013e318214093b; Castleton K, 2011, SUPPORT CARE CANCER, V19, P1183, DOI 10.1007/s00520-010-0935-5; Chen AT, 2012, PATIENT EDUC COUNS, V87, P250, DOI 10.1016/j.pec.2011.08.017; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Denecke K, 2009, INFORM SCIENCES, V179, P1870, DOI 10.1016/j.ins.2009.01.025; Gerber BS, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e15; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Jones S., 2009, GENERATIONS ONLINE 2; Kandula Sasikiran, 2011, AMIA Annu Symp Proc, V2011, P674; Kinnane NA, 2010, SUPPORT CARE CANCER, V18, P1123, DOI 10.1007/s00520-010-0863-4; Klemm P, 1998, Oncol Nurs Forum, V25, P673; Li N, 2010, DECIS SUPPORT SYST, V48, P354, DOI 10.1016/j.dss.2009.09.003; Lin YJ, 2007, J AM MED INFORM ASSN, V14, P651, DOI 10.1197/jamia.M2215; Monnier J, 2002, CANCER PRACT, V10, P305, DOI 10.1046/j.1523-5394.2002.106005.x; Patterson Olga, 2011, AMIA Annu Symp Proc, V2011, P1099; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Schultz Pamela N, 2003, Clin J Oncol Nurs, V7, P663; Tyson T R, 2000, J Ambul Care Manage, V23, P1; Umefjord G, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.4.e26; Witten I. H., 2005, DATA MINING PRACTICA; Yang C, 2010, INTELLIGENT SYSTEMS, V27, P44	27	66	69	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56221	10.1371/journal.pone.0056221	http://dx.doi.org/10.1371/journal.pone.0056221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457530	gold, Green Submitted, Green Published			2022-12-27	WOS:000315603700028
J	Jiang, J; Qi, YX; Zhang, P; Gu, WT; Yan, ZQ; Shen, BR; Yao, QP; Kong, H; Chien, S; Jiang, ZL				Jiang, Jun; Qi, Ying-Xin; Zhang, Ping; Gu, Wen-Tian; Yan, Zhi-Qiang; Shen, Bao-Rong; Yao, Qing-Ping; Kong, Han; Chien, Shu; Jiang, Zong-Lai			Involvement of Rab28 in NF-kappa B Nuclear Transport in Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; VASCULAR ENDOTHELIUM; MOLECULAR-MECHANISM; SHEAR-STRESS; GTPASES; HYPERTENSION; ACTIVATION; FLOW; INHIBITION	Our previous proteomic analysis revealed the expression of Rab28 in arteries of rats. However, the function of Rab28 in mammalian cells, and its role in vessels are still unknown. Coarctation of abdominal aorta above left kidney artery in rat was used as hypertensive animal model. FX-4000 cyclic strain loading system was used to mimic the mechanical condition on vascular cells during hypertension in vitro. Immunofluorescence and co-immunoprecipitation (Co-IP) were used to identify distribution and interaction of Rab28 and nuclear factor kappa B (NF-kappa B). Rab28 expression was significantly increased in carotid arteries of hypertensive rats. High cyclic strain induced Rab28 expression of endothelial cells (ECs) through a paracrine control of vascular smooth muscles cells (VSMCs), which at least partly via angiotensin II (Ang II). Rab28 knockdown decreased proliferation of ECs, while increased apoptosis and migration. Immunofluorescence revealed that Ang II stimulated the co-translocation of Rab28 and NF-kappa B from cytoplasm into nucleus. Knockdown of Rab28 attenuated NF-kappa B activation. Co-IP of NF-kappa B p65 and Rab28 indicated their interaction. Our results revealed that Rab28, as a novel regulator of NF-kappa B nuclear transport, might participate in the disturbance of EC homeostasis.	[Jiang, Jun; Qi, Ying-Xin; Zhang, Ping; Gu, Wen-Tian; Yan, Zhi-Qiang; Shen, Bao-Rong; Yao, Qing-Ping; Kong, Han; Chien, Shu; Jiang, Zong-Lai] Shanghai Jiao Tong Univ, Inst Mechanobiol & Med Engn, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Chien, Shu] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Shanghai Jiao Tong University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Jiang, ZL (corresponding author), Shanghai Jiao Tong Univ, Inst Mechanobiol & Med Engn, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	zljiang@sjtu.edu.cn			National Natural Science Foundation of China [31170892, 11232010, 1172178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 31170892, 11232010 and 1172178, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Balcells M, 2010, CIRCULATION, V121, P2192, DOI 10.1161/CIRCULATIONAHA.109.877282; Bayliss R, 2000, TRAFFIC, V1, P448, DOI 10.1034/j.1600-0854.2000.010602.x; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Brauers A, 1996, EUR J BIOCHEM, V237, P833, DOI 10.1111/j.1432-1033.1996.0833p.x; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Chiu JJ, 2003, BLOOD, V101, P2667, DOI 10.1182/blood-2002-08-2560; Cines DB, 1998, BLOOD, V91, P3527; Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Humphrey JD, 2008, HYPERTENSION, V52, P195, DOI 10.1161/HYPERTENSIONAHA.107.103440; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Lee SH, 2008, FEBS LETT, V582, P4107, DOI 10.1016/j.febslet.2008.11.008; Lemarie CA, 2003, CIRC RES, V93, P207, DOI 10.1161/01.RES.0000086942.13523.88; Li Q, 1997, Hypertens Res, V20, P217, DOI 10.1291/hypres.20.217; Liu G, 2010, HYPERTENS RES, V33, P1250, DOI 10.1038/hr.2010.187; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Lumb JH, 2011, J CELL SCI, V124, P3771, DOI 10.1242/jcs.079178; Ono Y, 1999, HYPERTENSION, V34, P609, DOI 10.1161/01.HYP.34.4.609; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Ruiz-Ortega M, 2000, CIRC RES, V86, P1266, DOI 10.1161/01.RES.86.12.1266; SAFAR ME, 1981, CIRCULATION, V63, P393, DOI 10.1161/01.CIR.63.2.393; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011; Yung YC, 2009, P NATL ACAD SCI USA, V106, P15279, DOI 10.1073/pnas.0905891106; Zhang LP, 2005, CIRC RES, V97, P975, DOI 10.1161/01.RES.0000190589.52286.41	36	7	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56076	10.1371/journal.pone.0056076	http://dx.doi.org/10.1371/journal.pone.0056076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457503	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700041
J	Ma, DL; Zhong, HJ; Fu, WC; Chan, DSH; Kwan, HY; Fong, WF; Chung, LH; Wong, CY; Leung, CH				Ma, Dik-Lung; Zhong, Hai-Jing; Fu, Wai-Chung; Chan, Daniel Shiu-Hin; Kwan, Hiu-Yee; Fong, Wang-Fun; Chung, Lai-Hon; Wong, Chun-Yuen; Leung, Chung-Hang			Phosphorescent Imaging of Living Cells Using a Cyclometalated Iridium(III) Complex	PLOS ONE			English	Article							LIGHT-EMITTING DEVICES; ELECTROCHEMICAL PROPERTIES; PLATINUM(II) COMPLEXES; METAL-COMPLEXES; IN-VIVO; EFFICIENT; PROBES; MICROSCOPY; EMISSION; PHOTOPHYSICS	A cell permeable cyclometalated iridium(III) complex has been developed as a phosphorescent probe for cell imaging. The iridium(III) solvato complex [Ir(phq)(2)(H2O](2))] preferentially stains the cytoplasm of both live and dead cells with a bright luminescence.	[Ma, Dik-Lung; Fu, Wai-Chung; Chan, Daniel Shiu-Hin] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Zhong, Hai-Jing; Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Kwan, Hiu-Yee; Fong, Wang-Fun] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon, Hong Kong, Peoples R China; [Chung, Lai-Hon; Wong, Chun-Yuen] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	Hong Kong Baptist University; University of Macau; Hong Kong Baptist University; City University of Hong Kong	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk	Wong, Chun-Yuen/H-2272-2011; Fu, Wai Chung/HGC-1135-2022; Fu, Wai-Chung/C-4487-2013	Wong, Chun-Yuen/0000-0003-4780-480X; Fu, Wai Chung/0000-0002-7181-0057; Fu, Wai-Chung/0000-0002-7181-0057; Ma, Dik-Lung/0000-0002-9515-340X; Zhong, Hai-Jing/0000-0002-1247-3150; KWAN, Hiu Yee/0000-0002-6088-7323; Chung, Lai-Hon/0000-0002-0482-1362	Hong Kong Baptist University [FRG2/11-12/009]; Environment and Conservation Fund (ECF) [3/2010]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/11101212]; Research Grants Council [HKBU/201811]; University of Macau [SRG013-ICMS12-LCH, MYRG091(Y1-L2)-ICMS12-LCH, MYRG121(Y1-L2)-ICMS12-LCH]	Hong Kong Baptist University; Environment and Conservation Fund (ECF); Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); University of Macau	This work is supported by Hong Kong Baptist University (FRG2/11-12/009), Environment and Conservation Fund (ECF Project 3/2010), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/11101212), the Research Grants Council (HKBU/201811) and the University of Macau (SRG013-ICMS12-LCH, MYRG091(Y1-L2)-ICMS12-LCH and MYRG121(Y1-L2)-ICMS12-LCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso AJ, 2007, CHEM COMMUN, P3066, DOI 10.1039/b706657k; Baggaley E, 2012, COORDIN CHEM REV, V256, P1762, DOI 10.1016/j.ccr.2012.03.018; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Baldo MA, 2000, NATURE, V403, P750, DOI 10.1038/35001541; Ballas SK, 2004, MICROCIRCULATION, V11, P209, DOI 10.1080/10739680490279410; Beeby A, 2003, J MATER CHEM, V13, P80, DOI 10.1039/b207502d; Botchway SW, 2008, P NATL ACAD SCI USA, V105, P16071, DOI 10.1073/pnas.0804071105; Chen FC, 2002, APPL PHYS LETT, V80, P2308, DOI 10.1063/1.1462862; Coppo P, 2004, CHEM COMMUN, P1774, DOI 10.1039/b406851c; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Fernandez-Moreira V, 2010, CHEM COMMUN, V46, P186, DOI 10.1039/b917757d; Finkenzeller WJ, 2007, INORG CHEM, V46, P5076, DOI 10.1021/ic0622860; Gill MR, 2012, CHEM SOC REV, V41, P3179, DOI 10.1039/c2cs15299a; Grushin VV, 2001, CHEM COMMUN, P1494, DOI 10.1039/b103490c; Guerchais V, 2011, COORDIN CHEM REV, V255, P2448, DOI 10.1016/j.ccr.2011.04.006; Hanson K, 2010, INORG CHEM, V49, P6077, DOI 10.1021/ic100633w; Ho ML, 2006, ORG BIOMOL CHEM, V4, P98, DOI 10.1039/b511943j; HORNE MK, 1981, AM J MED, V70, P288, DOI 10.1016/0002-9343(81)90764-6; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Ikai M, 2001, APPL PHYS LETT, V79, P156, DOI 10.1063/1.1385182; Kim JI, 2005, J AM CHEM SOC, V127, P1614, DOI 10.1021/ja043721x; Koo CK, 2010, CHEM-EUR J, V16, P3942, DOI 10.1002/chem.200902919; Kuil J, 2011, CHEMBIOCHEM, V12, P1896, DOI 10.1002/cbic.201100271; Kwon TH, 2009, ADV FUNCT MATER, V19, P711, DOI 10.1002/adfm.200801231; Lau JSY, 2009, INORG CHEM, V48, P708, DOI 10.1021/ic801818x; Lau MK, 2004, J ORGANOMET CHEM, V689, P2401, DOI 10.1016/j.jorganchem.2004.04.033; Lee PK, 2011, DALTON T, V40, P2180, DOI 10.1039/c0dt00501k; Lee PK, 2011, INORG CHEM, V50, P8570, DOI 10.1021/ic201153d; Li CY, 2011, J AM CHEM SOC, V133, P11231, DOI 10.1021/ja202344c; Liu HW, 2010, ORGANOMETALLICS, V29, P3474, DOI 10.1021/om100597g; Liu JL, 2011, J AM CHEM SOC, V133, P15276, DOI 10.1021/ja205907y; Lo KKW, 2007, CHEM-EUR J, V13, P7110, DOI 10.1002/chem.200700530; Lo KKW, 2006, COORDIN CHEM REV, V250, P1724, DOI 10.1016/j.ccr.2006.01.010; Lo KKW, 2012, DALTON T, V41, P6021, DOI 10.1039/c2dt11892k; Lo KKW, 2006, CHEM-EUR J, V12, P1500, DOI 10.1002/chem.200500885; Lo KKW, 2005, COORDIN CHEM REV, V249, P1434, DOI 10.1016/j.ccr.2004.10.004; Louie MW, 2009, ORGANOMETALLICS, V28, P4297, DOI 10.1021/om900311s; Lowry MS, 2004, J AM CHEM SOC, V126, P14129, DOI 10.1021/ja047156+; Ma DL, 2008, ANGEW CHEM INT EDIT, V47, P3735, DOI 10.1002/anie.200705319; Man BYW, 2011, CHEM SCI, V2, P917, DOI 10.1039/c0sc00636j; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; McDaniel ND, 2008, J AM CHEM SOC, V130, P210, DOI 10.1021/ja074478f; Murphy L, 2010, CHEM COMMUN, V46, P8743, DOI 10.1039/c0cc03705b; Nazeeruddin MK, 2003, J AM CHEM SOC, V125, P8790, DOI 10.1021/ja021413y; Neugebauer U, 2008, CHEM COMMUN, P5307, DOI 10.1039/b810403d; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; O'Connor NA, 2009, CHEM COMMUN, P2640, DOI 10.1039/b900290a; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Puckett CA, 2007, J AM CHEM SOC, V129, P46, DOI 10.1021/ja0677564; Rausch AF, 2009, J PHYS CHEM A, V113, P5927, DOI 10.1021/jp902261c; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sandee AJ, 2004, J AM CHEM SOC, V126, P7041, DOI 10.1021/ja039445o; Schaferling M, 2012, ANGEW CHEM INT EDIT, V51, P3532, DOI 10.1002/anie.201105459; Slinker JD, 2004, J AM CHEM SOC, V126, P2763, DOI 10.1021/ja0345221; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Steunenberg P, 2012, INORG CHEM, V51, P2105, DOI 10.1021/ic201860s; Tamayo AB, 2003, J AM CHEM SOC, V125, P7377, DOI 10.1021/ja034537z; Tan WJ, 2011, CHEM-ASIAN J, V6, P1263, DOI 10.1002/asia.201000820; Tian XH, 2011, CHEMBIOCHEM, V12, P548, DOI 10.1002/cbic.201000743; Tsuboyama A, 2004, DALTON T, P1115, DOI 10.1039/b404101c; Ulbricht C, 2009, ADV MATER, V21, P4418, DOI 10.1002/adma.200803537; Wu C, 2010, J AM CHEM SOC, V132, P3133, DOI 10.1021/ja9097725; Wu HZ, 2011, DALTON T, V40, P1969, DOI 10.1039/c0dt01366h; Wu P, 2009, CHEM-EUR J, V15, P3652, DOI 10.1002/chem.200802707; Wu YQ, 2011, INORG CHEM, V50, P7412, DOI 10.1021/ic102082k; Xiong LQ, 2010, INORG CHEM, V49, P6402, DOI 10.1021/ic902266x; Yam VWW, 2011, CHEM COMMUN, V47, P11579, DOI 10.1039/c1cc13767k; Yang TS, 2011, J MATER CHEM, V21, P5360, DOI 10.1039/c0jm04235h; Yang Y.Z.Q, 2012, CHEM REV, DOI org/10.1021/cr2004103; You Y, 2011, J AM CHEM SOC, V133, P18328, DOI 10.1021/ja207163r; You Y, 2011, J AM CHEM SOC, V133, P11488, DOI 10.1021/ja204997c; Yu MX, 2008, CHEM COMMUN, P2115, DOI 10.1039/b800939b; Yu MX, 2009, ANAL CHEM, V81, P930, DOI 10.1021/ac802072d; Zhang KY, 2010, INORG CHEM, V49, P2530, DOI 10.1021/ic902465b; Zhang R, 2012, BIOCONJUGATE CHEM, V23, P725, DOI 10.1021/bc200506w; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Zhao Q, 2011, CHEM SOC REV, V40, P2508, DOI 10.1039/c0cs00114g; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Zhao Q, 2010, ORGANOMETALLICS, V29, P1085, DOI 10.1021/om900691r	79	28	28	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55751	10.1371/journal.pone.0055751	http://dx.doi.org/10.1371/journal.pone.0055751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457478	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700021
J	Choquet, H; Kasberger, J; Hamidovic, A; Jorgenson, E				Choquet, Helene; Kasberger, Jay; Hamidovic, Ajna; Jorgenson, Eric			Contribution of Common PCSK1 Genetic Variants to Obesity in 8,359 Subjects from Multi-Ethnic American Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; DESIGN; ADULTS	Common PCSK1 variants (notably rs6232 and rs6235) have been shown to be associated with obesity in European, Asian and Mexican populations. To determine whether common PCSK1 variants contribute to obesity in American population, we conducted association analyses in 8,359 subjects using two multi-ethnic American studies: the Coronary Artery Risk Development in Young Adults (CARDIA) study and the Multi-Ethnic Study of Atherosclerosis (MESA). By evaluating the contribution of rs6232 and rs6235 in each ethnic group, we found that in European-American subjects from CARDIA, only rs6232 was associated with BMI (P = 0.006) and obesity (P = 0.018) but also increased the obesity incidence during the 20 years of follow-up (HR = 1.53 [1.07-2.19], P = 0.019). Alternatively, in African-American subjects from CARDIA, rs6235 was associated with BMI (P = 0.028) and obesity (P = 0.018). Further, by combining the two case-control ethnic groups from the CARDIA study in a meta-analysis, association between rs6235 and obesity risk remained significant (OR = 1.23 [1.05-1.45], P = 9.5 x 10(-3)). However, neither rs6232 nor rs6235 was associated with BMI or obesity in the MESA study. Interestingly, rs6232 was associated with BMI (P = 4.2 x 10(-3)) and obesity (P = 3.4 x 10(-3)) in the younger European-American group combining samples from the both studies [less than median age (53 years)], but not among the older age group (P = 0.756 and P = 0.935 for BMI and obesity, respectively). By combining all the case-control ethnic groups from CARDIA and MESA in a meta-analysis, we found no significant association for the both variants and obesity risk. Finally, by exploring the full PCSK1 locus, we observed that no variant remained significant after correction for multiple testing. These results indicate that common PCSK1 variants (notably rs6232 and rs6235) contribute modestly to obesity in multi-ethnic American population. Further, these results suggest that the association of rs6232 with obesity may be age-dependent in European-Americans. However, multiple replication studies in multi-ethnic American population are needed to confirm our findings.	[Choquet, Helene; Kasberger, Jay; Jorgenson, Eric] Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Choquet, Helene; Jorgenson, Eric] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Choquet, Helene] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; [Hamidovic, Ajna] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northwestern University	Choquet, H (corresponding author), Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	ChoquetH@anesthesia.ucsf.edu		Choquet, Helene/0000-0001-9839-8667				Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Choquet H, 2011, CURR GENOMICS, V12, P154, DOI 10.2174/138920211795677921; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Creemers JW, 2011, DIABETES; Creemers JWM, 1998, SEMIN CELL DEV BIOL, V9, P3, DOI 10.1006/scdb.1997.0195; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010590; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rouskas K, 2011, OBESITY SILVER SPRIN; Sandholt CH, 2010, DIABETES, V59, P1667, DOI 10.2337/db09-1042; Sirois F, 2012, J COMMUNITY GENET; Venables WN, 2002, MODERN APPL STAT S, pxi; Villalobos-Comparan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039037; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	31	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57857	10.1371/journal.pone.0057857	http://dx.doi.org/10.1371/journal.pone.0057857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451278	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500141
J	Itzhaki, O; Greenberg, E; Shalmon, B; Kubi, A; Treves, AJ; Shapira-Frommer, R; Avivi, C; Ortenberg, R; Ben-Ami, E; Schachter, J; Besser, MJ; Markel, G				Itzhaki, Orit; Greenberg, Eyal; Shalmon, Bruria; Kubi, Adva; Treves, Avraham J.; Shapira-Frommer, Ronnie; Avivi, Camilla; Ortenberg, Rona; Ben-Ami, Eytan; Schachter, Jacob; Besser, Michal J.; Markel, Gal			Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma	PLOS ONE			English	Article							SCHIFF-POSITIVE PATTERNS; TUMOR-CELL PLASTICITY; CANCER STEM-CELLS; VE-CADHERIN; EMBRYONIC VASCULOGENESIS; PROGNOSTIC-SIGNIFICANCE; MALIGNANT-MELANOMA; EXPRESSION; DIFFERENTIATION; IMMUNOTHERAPY	Vasculogenic mimicry (VM) describes functional vascular channels composed only of tumor cells and its presence predicts poor prognosis in melanoma patients. Inhibition of this alternative vascularization pathway might be of clinical importance, especially as several anti-angiogenic therapies targeting endothelial cells are largely ineffective in melanoma. We show the presence of VM structures histologically in a series of human melanoma lesions and demonstrate that cell cultures derived from these lesions form tubes in 3D cultures ex vivo. We tested the ability of nicotinamide, the amide form of vitamin B3 (niacin), which acts as an epigenetic gene regulator through unique cellular pathways, to modify VM. Nicotinamide effectively inhibited the formation of VM structures and destroyed already formed ones, in a dose-dependent manner. Remarkably, VM formation capacity remained suppressed even one month after the complete withdrawal of Nicotimamid. The inhibitory effect of nicotinamide on VM formation could be at least partially explained by a nicotinamide-driven downregulation of vascular endothelial cadherin (VE-Cadherin), which is known to have a central role in VM. Further major changes in the expression profile of hundreds of genes, most of them clustered in biologically-relevant clusters, were observed. In addition, nicotinamide significantly inhibited melanoma cell proliferation, but had an opposite effect on their invasion capacity. Cell cycle analysis indicated moderate changes in apoptotic indices. Therefore, nicotinamide could be further used to unravel new biological mechanisms that drive VM and tumor progression. Targeting VM, especially in combination with anti-angiogenic strategies, is expected to be synergistic and might yield substantial anti neoplastic effects in a variety of malignancies.	[Itzhaki, Orit; Greenberg, Eyal; Kubi, Adva; Shapira-Frommer, Ronnie; Ortenberg, Rona; Ben-Ami, Eytan; Schachter, Jacob; Besser, Michal J.; Markel, Gal] Chaim Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel; [Greenberg, Eyal; Ortenberg, Rona; Besser, Michal J.; Markel, Gal] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Treves, Avraham J.] Chaim Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Shalmon, Bruria; Avivi, Camilla] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Markel, Gal] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Besser, MJ (corresponding author), Chaim Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel.	michal.besser@sheba.health.gov.il; markel@post.tau.ac.il			Recanty foundation for medical research	Recanty foundation for medical research	This study was supported by a grant from the Recanty foundation for medical research (GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arganda-Carreras I, 2010, MICROSC RES TECH; Ascierto PA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-38; Audrito V, 2011, CANCER RES, V71, P4473, DOI 10.1158/0008-5472.CAN-10-4452; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Besser MJ, 2009, J IMMUNOTHER, V32, P415, DOI 10.1097/CJI.0b013e31819c8bda; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; CHAPLIN DJ, 1990, JNCI-J NATL CANCER I, V82, P672, DOI 10.1093/jnci/82.8.672; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cong RH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-124; Emmett MS, 2011, AM J CANCER RES, V1, P852; Fan YZ, 2010, WORLD J GASTRO SURG, V2, P117, DOI 10.4240/wjgs.v2.i4.117; Farina HG, 2006, ONCOL REP, V16, P885; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Folberg R, 2004, APMIS, V112, P508, DOI 10.1111/j.1600-0463.2004.apm11207-0810.x; Gensler HL, 1999, NUTR CANCER, V34, P36, DOI 10.1207/S15327914NC340105; Girouard SD, 2011, LAB INVEST, V91, P647, DOI 10.1038/labinvest.2011.50; Gloster HM, 1996, DERMATOL SURG, V22, P217, DOI 10.1111/j.1524-4725.1996.tb00312.x; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018936; Guzman G, 2007, ARCH PATHOL LAB MED, V131, P1776; Hardy KM, 2010, CANCER RES, V70, P10340, DOI 10.1158/0008-5472.CAN-10-0705; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hess AR, 2007, DEV DYNAM, V236, P3283, DOI 10.1002/dvdy.21190; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; Hess AR, 2001, CANCER RES, V61, P3250; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; HORSMAN MR, 1989, RADIAT RES, V118, P139, DOI 10.2307/3577429; Hoskin PJ, 2010, J CLIN ONCOL, V28, P4912, DOI 10.1200/JCO.2010.28.4950; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Iwata K, 2003, BIOSCI BIOTECH BIOCH, V67, P1132, DOI 10.1271/bbb.67.1132; JACOBSON EL, 1993, J INTERN MED, V233, P59, DOI 10.1111/j.1365-2796.1993.tb00649.x; Josko J, 2000, Med Sci Monit, V6, P1047; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Kim WJ, 2011, J UROLOGY, V185, P2366, DOI 10.1016/j.juro.2011.02.017; Kirkwood JM, 2008, J CLIN ONCOL, V26, P3445, DOI 10.1200/JCO.2007.14.6423; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Monzani E, 2008, STEM CELL REV, V4, P51, DOI 10.1007/s12015-008-9009-1; Namazi MR, 2003, FASEB J, V17, P1377, DOI 10.1096/fj.03-0002hyp; Orgaz JL, 2009, ONCOGENE, V28, P4147, DOI 10.1038/onc.2009.284; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Qu B, 2010, MED HYPOTHESES, V74, P360, DOI 10.1016/j.mehy.2009.08.020; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Rybak SM, 2003, CANCER RES, V63, P2812; Seftor EA, 2006, J CELL MOL MED, V10, P174, DOI 10.1111/j.1582-4934.2006.tb00299.x; Seftor REB, 2001, CANCER RES, V61, P6322; Shirakawa K, 2002, INT J CANCER, V99, P821, DOI 10.1002/ijc.10423; Sood AK, 2002, CANCER BIOL THER, V1, P661, DOI 10.4161/cbt.316; Strizzi L, 2011, LAB INVEST, V91, P819, DOI 10.1038/labinvest.2011.63; Sun BC, 2006, ONCOL REP, V16, P693; Surjana D, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/157591; Thies A, 2001, J PATHOL, V195, P537, DOI 10.1002/path.988; Vaca P, 2003, TRANSPL P, V35, P2021, DOI 10.1016/S0041-1345(03)00735-8; van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/0008-5472.CAN-05-2468; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Vartanian A, 2011, MELANOMA RES, V21, P91, DOI 10.1097/CMR.0b013e328343a237; Vartanian AA, 2009, CAN J UROL, V16, P4726; VINDELOV LL, 1983, CYTOMETRY, V3, P328, DOI 10.1002/cyto.990030504; Warso MA, 2001, CLIN CANCER RES, V7, P473; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Yiasemides E, 2009, CARCINOGENESIS, V30, P101, DOI 10.1093/carcin/bgn248; Zhang SW, 2007, CANCER LETT, V254, P157, DOI 10.1016/j.canlet.2006.12.036	71	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57160	10.1371/journal.pone.0057160	http://dx.doi.org/10.1371/journal.pone.0057160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451174	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500073
J	He, Y; Zeng, Q; Li, XH; Liu, BH; Wang, PY				He, Yuan; Zeng, Qiang; Li, Xiaohui; Liu, Baohua; Wang, Peiyu			The Association between Subclinical Atherosclerosis and Uterine Fibroids	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PREMENOPAUSAL WOMEN; BREAST-CANCER; BODY-SIZE; PLASMA HOMOCYSTEINE; RISK-FACTORS; BLACK-WOMEN; LEIOMYOMA; HYPERTENSION; ETIOLOGY	Objective(s): To explore the atherogenic hypothesis of uterine fibroids among Chinese women. Methods: In a case-control study, 335 patients confirmed by ultrasound or hysterectomy surgery and 539 controls were enrolled between October 1, 2009 and April 1, 2012. Unconditional logistic regressions were used to calculate the odds ratios (ORs) for the associations of subclinical atherogenic and cardiovascular risk parameters with uterine fibroids in the overall case group and hysterectomy-confirmed case group, respectively. Results: Higher level of ankle-brachial index (ABI) was independently associated with increased odds of uterine fibroids. The odds of UF among women in the highest tertile of ABI were 1.88 times higher (95%CI: 1.17, 3.02, P-trend = 0.008) compared to those in the lowest tertile. The serum concentration of homocysteine was inversely related to fibroids (middle vs. low: OR 0.56, 95%CI: 0.36, 0.85; high vs. low: OR 0.50, 95% CI: 0.32, 0.79; P-trend = 0.002). In the hysterectomy-confirmed group, an inverse association was suggested between high-density lipoprotein cholesterol (HDL-C) and fibroids (OR 0.46, 95% CI: 0.25, 0.84, P-trend = 0.014). Moreover, the effect of homocysteine concentration was not observed in this group. Conclusion(s): These findings suggest that women with uterine fibroids might have an increased risk of subclinical atherosclerosis.	[He, Yuan; Zeng, Qiang; Li, Xiaohui] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [He, Yuan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China; [Liu, Baohua; Wang, Peiyu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University; Peking University	Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China.	zq301@126.com; wpeiyu@bjmu.edu.cn			state science and technology support program [2012BAI37B04]; Institutional Review Board of the PLA General Hospital	state science and technology support program; Institutional Review Board of the PLA General Hospital	This study was supported by the state science and technology support program [grant number: 2012BAI37B04]. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the Institutional Review Board of the PLA General Hospital for supporting the study.	Agrawal Alok, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P235; Al-Awadi F, 2008, ANTICANCER RES, V28, P2541; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Borgfeldt C, 2000, ACTA OBSTET GYN SCAN, V79, P202, DOI 10.1034/j.1600-0412.2000.079003202.x; Boynton-Jarrett R, 2005, AM J EPIDEMIOL, V161, P628, DOI 10.1093/aje/kwi072; Buttram V C Jr, 1986, Prog Clin Biol Res, V225, P275; Chou YC, 2007, BREAST CANCER RES TR, V101, P199, DOI 10.1007/s10549-006-9278-9; Danese C, 2006, Clin Ter, V157, P9; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; DORGAN JF, 1995, CANCER EPIDEM BIOMAR, V4, P381; Downes E, 2010, EUR J OBSTET GYN R B, V152, P96, DOI 10.1016/j.ejogrb.2010.05.012; Faerstein E, 2001, AM J EPIDEMIOL, V153, P11, DOI 10.1093/aje/153.1.11; Faerstein E, 2001, AM J EPIDEMIOL, V153, P1, DOI 10.1093/aje/153.1.1; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; GARFAGNINI A, 1995, EUR HEART J, V16, P465, DOI 10.1093/oxfordjournals.eurheartj.a060937; Hamed SA, 2005, J PHARMACOL SCI, V98, P340, DOI 10.1254/jphs.CRJ05003X; Hasimu B, 2006, HYPERTENS RES, V29, P23, DOI 10.1291/hypres.29.23; Held C, 2008, VASC MED, V13, P245, DOI 10.1177/1358863X08092102; HOCUTT JE, 1979, DEL MED J, V51, P697; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Isobe A, 2008, HUM REPROD, V23, P440, DOI 10.1093/humrep/dem247; Kaminski B T, 1994, Ceska Gynekol, V59, P247; Laughlin SK, 2010, SEMIN REPROD MED, V28, P203, DOI 10.1055/s-0030-1251477; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Luoto R, 2001, J REPROD MED, V46, P359; Marshall LM, 1998, EPIDEMIOLOGY, V9, P511, DOI 10.1097/00001648-199809000-00007; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; MOSS NS, 1975, AM J PATHOL, V78, P175; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Parazzini F, 2004, EUR J EPIDEMIOL, V19, P249, DOI 10.1023/B:EJEP.0000020448.43323.2a; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; RATECH H, 1982, DIAGN GYNECOL OBSTET, V4, P21; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Sadlonova J, 2008, INT J GYNECOL OBSTET, V102, P50, DOI 10.1016/j.ijgo.2008.01.022; Schwartz SM, 2000, ENVIRON HEALTH PERSP, V108, P821, DOI 10.2307/3454313; Silver Marc A, 2005, J Clin Hypertens (Greenwich), V7, P664, DOI 10.1111/j.1524-6175.2005.04384.x; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Takeda T, 2008, GYNECOL OBSTET INVES, V66, P14, DOI 10.1159/000114250; Templeman C, 2009, FERTIL STERIL, V92, P1436, DOI 10.1016/j.fertnstert.2008.08.074; Terry KL, 2007, EPIDEMIOLOGY, V18, P758, DOI 10.1097/EDE.0b013e3181567eed; van Popele NM, 2006, J HYPERTENS, V24, P2371, DOI 10.1097/01.hjh.0000251896.62873.c4; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Williams VSL, 2006, J WOMENS HEALTH, V15, P818, DOI 10.1089/jwh.2006.15.818; Wise LA, 2005, EPIDEMIOLOGY, V16, P346, DOI 10.1097/01.ede.0000158742.11877.99; Zeigler-Johnson CM, 1998, STROKE, V29, P759, DOI 10.1161/01.STR.29.4.759; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373; Zhu BT, 2003, INT J ONCOL, V22, P499	50	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57089	10.1371/journal.pone.0057089	http://dx.doi.org/10.1371/journal.pone.0057089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451155	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800072
J	Lau, JTF; Wang, ZX; Kim, JH; Lau, M; Lai, CHY; Mo, PKH				Lau, Joseph T. F.; Wang, Zixin; Kim, Jean H.; Lau, Mason; Lai, Coco H. Y.; Mo, Phoenix K. H.			Acceptability of HPV Vaccines and Associations with Perceptions Related to HPV and HPV Vaccines Among Men Who Have Sex with Men in Hong Kong	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; SEXUALLY-TRANSMITTED-DISEASES; SOCIAL MARKETING CAMPAIGN; UNITED-STATES; GENITAL WARTS; BISEXUAL MEN; PLANNED BEHAVIOR; RISK BEHAVIORS; INFECTION; HIV	HPV vaccines are available to men but there are few studies investigating the acceptability of HPV vaccines among men who have sex with men (MSM), a high risk group. We assessed the intention to take up HPV vaccines among MSM in Hong Kong and the associated factors related to cognitions on HPV and HPV vaccines, basing on the Health Belief Model (n = 542). The acceptability of HPV vaccines was 20% (unconditional on efficacies and price), 29.2% (conditional on efficacies and market price), 51.7% (conditional on efficacies and discounted price) and 79.1% (conditional on efficacies and free price). Adjusting for background variables, composite scores of perceived susceptibility, perceived severity, perceived barriers and cue to actions were significantly associated with acceptability of HPV vaccines conditional on specific efficacies and the market price. Acceptability of HPV vaccines was highly price sensitive. Future studies need to use conditional measures. Implementation and translational researches are warranted.	[Lau, Joseph T. F.; Wang, Zixin; Kim, Jean H.; Lau, Mason; Lai, Coco H. Y.; Mo, Phoenix K. H.] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022; Mo, Phoenix K.H./K-2853-2013	Mo, Phoenix K.H./0000-0001-9822-5424; /0000-0002-5799-5913	Merck Sharp &Dohme (Asia) Ltd. [IISP 37671]	Merck Sharp &Dohme (Asia) Ltd.(Merck & Company)	This study was funded by the Merck Sharp &Dohme (Asia) Ltd. (Ref: IISP 37671), http://www.hkexporter.net/medicine/merck-sharp.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Merck Sharp & Dohme (Asia) Ltd. (MSD ref: IISP 37671). The authors declare that none of the authors served as paid employees, consultants or board members of above mentioned company. No patent has been applied in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2012, HPV CANC; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Auvert B, 2010, JAIDS-J ACQ IMM DEF, V53, P111, DOI 10.1097/QAI.0b013e3181b327e7; Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Bushley AW, 2005, PREV MED, V41, P98, DOI 10.1016/j.ypmed.2004.10.019; Center for Disease Control and Prevention, 2012, HPV VACC; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Department of Health The Government of Hong Kong Special Adminstrative Region, 2011, FAC PRISM HIV PREV R; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; EASTWOOD CM, 1985, J ADV NURS, V10, P245, DOI 10.1111/j.1365-2648.1985.tb00519.x; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; European Medicines Agency, 2012, GARD EPAR PROD INF; Ford CA, 2004, PERSPECT SEX REPRO H, V36, P258, DOI 10.1363/3625804; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Gilbert P, 2011, AM J MENS HEALTH, V5, P297, DOI 10.1177/1557988310372802; Gilbert PA, 2011, J LOW GENIT TRACT DI, V15, P83, DOI 10.1097/LGT.0b013e3181f1a960; Giordano TP, 2013, AIDS BEHAV, V17, P104, DOI 10.1007/s10461-012-0295-x; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Gu J, 2011, PUBLIC HEALTH, V125, P275, DOI 10.1016/j.puhe.2011.01.010; H. Lee Mofitt Cancer Center and Research Institute, STUD GARD MID MAL MA; Hinman AR, 2005, HEALTH AFFAIR, V24, P701, DOI 10.1377/hlthaff.24.3.701; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Jin F, 2007, SEX TRANSM DIS, V34, P488, DOI 10.1097/01.olq.0000245960.52668.e5; Juraskova I, 2012, INT J BEHAV MED, V19, P518, DOI 10.1007/s12529-011-9182-5; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Kreuter A, 2010, BRIT J DERMATOL, V162, P1269, DOI 10.1111/j.1365-2133.2010.09712.x; Lau JTF, 2008, AIDS CARE, V20, P820, DOI 10.1080/09540120701694048; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2004, SEX TRANSM DIS, V31, P568, DOI 10.1097/01.olq.0000137905.94154.0a; Lau JTF, 2002, ARCH SEX BEHAV, V31, P367, DOI 10.1023/A:1016280411280; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Lee N. R., 2011, SOCIAL MARKETING INF; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; Lin CQ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-272; Logie CH, 2012, SOC SCI MED, V74, P1261, DOI 10.1016/j.socscimed.2012.01.008; Mehta P, 2011, J COMMUNITY MED HTLH, V1; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; National Institute of Allergy and Infectious Diseases (NIAID), EV EFF QUADR HUM PAP; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Pedrana A, 2012, SEX TRANSM DIS, V39, P651, DOI 10.1097/OLQ.0b013e318255df06; Poulos C, 2011, SOC SCI MED, V73, P226, DOI 10.1016/j.socscimed.2011.05.029; Rees R, 2004, HIV HLTH PROMOTION M; Reiter PL, 2010, SEX TRANSM DIS, V37, P197, DOI 10.1097/OLQ.0b013e3181bf542c; Rispel LC, 2011, J PUBLIC HEALTH POL, V32, pS137, DOI 10.1057/jphp.2011.29; Sanchez DM, 2012, INT J STD AIDS, V23, P41, DOI 10.1258/ijsa.2011.011163; Scarinci IC, 2012, HEALTH PROMOT PRACT, V13, P29, DOI 10.1177/1524839910366416; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Stupiansky NW, 2012, CURR OPIN INFECT DIS, V25, P86, DOI 10.1097/QCO.0b013e32834ed5be; Suarez-Almazor ME, 2011, OSTEOPOROSIS INT, V22, pS461, DOI 10.1007/s00198-011-1699-6; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; The Society of Physicians of Hong Kong, 2012, YOUTH HPV PREV PROGR; Thompson C, 1997, INT J STD AIDS, V8, P412; Wheldon CW, 2011, VACCINE, V29, P8060, DOI 10.1016/j.vaccine.2011.08.045; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yang H., 2010, SEXUALLY TRANSMITTED	62	27	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57204	10.1371/journal.pone.0057204	http://dx.doi.org/10.1371/journal.pone.0057204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451188	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800091
J	Lu, LL; Tian, SK; Liao, HB; Zhang, J; Yang, XE; Labavitch, JM; Chen, WR				Lu, Lingli; Tian, Shengke; Liao, Haibing; Zhang, Jie; Yang, Xiaoe; Labavitch, John M.; Chen, Wenrong			Analysis of Metal Element Distributions in Rice (Oryza sativa L.) Seeds and Relocation during Germination Based on X-Ray Fluorescence Imaging of Zn, Fe, K, Ca, and Mn	PLOS ONE			English	Article							PHYTIC ACID; BROWN RICE; ZINC; LOCALIZATION; SPECIATION; GRAIN; IRON; SEQUESTRATION; TRANSLOCATION; HOMEOSTASIS	Knowledge of mineral localization within rice grains is important for understanding the role of different elements in seed development, as well as for facilitating biofortification of seed micronutrients in order to enhance seeds' values in human diets. In this study, the concentrations of minerals in whole rice grains, hulls, brown rice, bran and polished rice were quantified by inductively coupled plasma mass spectroscopy. The in vivo mineral distribution patterns in rice grains and shifts in those distribution patterns during progressive stages of germination were analyzed by synchrotron X-ray microfluorescence. The results showed that half of the total Zn, two thirds of the total Fe, and most of the total K, Ca and Mn were removed by the milling process if the hull and bran were thoroughly polished. Concentrations of all elements were high in the embryo regions even though the local distributions within the embryo varied between elements. Mobilization of the minerals from specific seed locations during germination was also element-specific. High mobilization of K and Ca from grains to growing roots and leaf primordia was observed; the flux of Zn to these expanding tissues was somewhat less than that of K and Ca; the mobilization of Mn or Fe was relatively low, at least during the first few days of germination.	[Lu, Lingli; Tian, Shengke; Liao, Haibing; Zhang, Jie; Yang, Xiaoe] Zhejiang Univ, Coll Environm & Resources Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Liao, Haibing; Chen, Wenrong] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Tian, Shengke; Labavitch, John M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Zhejiang University; Zhejiang Normal University; University of California System; University of California Davis	Chen, WR (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	cwr@zjnu.cn	Zhang, Jie/E-4768-2013; Tian, Shengke/G-8307-2016	Zhang, Jie/0000-0002-8344-5907; Tian, Shengke/0000-0001-8242-3581	Normal project from the National Natural Science Foundation of China [30900921, 31000935]; Fundamental Research Funds for the Central Universities [2012FZA6008]	Normal project from the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by Normal project from the National Natural Science Foundation of China (30900921, 31000935), and the Fundamental Research Funds for the Central Universities (2012FZA6008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, WHO TECHN REP SER; Arora S, 2010, FOOD CHEM, V119, P779, DOI 10.1016/j.foodchem.2009.07.035; Bam R. K., 2006, Asian Journal of Plant Sciences, V5, P948; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2009, J TRACE ELEM MED BIO, V23, P281, DOI 10.1016/j.jtemb.2009.05.002; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gibson RS, 2006, P NUTR SOC, V65, P51, DOI 10.1079/PNS2005474; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Iwai T, 2012, PLANT PHYSIOL, V160, P2007, DOI 10.1104/pp.112.206573; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kranner I, 2011, ENVIRON EXP BOT, V72, P93, DOI 10.1016/j.envexpbot.2010.05.005; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Lamberts L, 2007, FOOD CHEM, V100, P1496, DOI 10.1016/j.foodchem.2005.11.042; Lombi E, 2009, NEW PHYTOL, V184, P193, DOI 10.1111/j.1469-8137.2009.02912.x; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Meharg AA, 2008, ENVIRON SCI TECHNOL, V42, P1051, DOI 10.1021/es702212p; Nakano K, 2006, BUNSEKI KAGAKU, V55, P427, DOI 10.2116/bunsekikagaku.55.427; Omary MB, 2012, CEREAL CHEM, V89, P1, DOI 10.1094/CCHEM-01-11-0008; Ozturk L, 2006, PHYSIOL PLANTARUM, V128, P144, DOI 10.1111/j.1399-3054.2006.00737.x; Patil SB, 2011, J FOOD SCI TECH MYS, V48, P661, DOI 10.1007/s13197-011-0232-4; Punshon T, 2009, ANN BOT-LONDON, V103, P665, DOI 10.1093/aob/mcn264; Sun GX, 2010, ENVIRON SCI TECHNOL, V44, P6706, DOI 10.1021/es101843x; Takahashi M, 2009, PLANT SOIL, V325, P39, DOI 10.1007/s11104-009-0045-7; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Tian SK, 2009, NEW PHYTOL, V182, P116, DOI 10.1111/j.1469-8137.2008.02740.x; Tian SK, 2011, PLANT PHYSIOL, V157, P1914, DOI 10.1104/pp.111.183947; Tian SK, 2010, ENVIRON SCI TECHNOL, V44, P5920, DOI 10.1021/es903921t; Walker EL, 2011, CURR OPIN PLANT BIOL, V14, P318, DOI 10.1016/j.pbi.2011.03.025; Wang KM, 2011, J CEREAL SCI, V54, P116, DOI 10.1016/j.jcs.2011.03.002; Wei YY, 2012, J AGR FOOD CHEM, V60, P1871, DOI 10.1021/jf205025b; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; Welch RM, 1999, FIELD CROP RES, V60, P1, DOI 10.1016/S0378-4290(98)00129-4; West M, 2007, J ANAL ATOM SPECTROM, V22, P1304, DOI 10.1039/b712079f; WHO, 2006, MICR DEF IR DEF AN; Zhang Y, 2012, PLANT J, V72, P400, DOI 10.1111/j.1365-313X.2012.05088.x; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x	41	84	85	4	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57360	10.1371/journal.pone.0057360	http://dx.doi.org/10.1371/journal.pone.0057360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451212	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800102
J	Akefeldt, SO; Maisse, C; Belot, A; Mazzorana, M; Salvatore, G; Bissay, N; Jurdic, P; Arico, M; Rabourdin-Combe, C; Henter, JI; Delprat, C				Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Arico, Maurizio; Rabourdin-Combe, Chantal; Henter, Jan-Inge; Delprat, Christine			Chemoresistance of Human Monocyte-Derived Dendritic Cells Is Regulated by IL-17A	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 HOMOLOG; T-CELLS; EXPRESSION; FAMILY; BFL-1; INTERLEUKIN-17; CYTOKINES; GENE	Dendritic cells initiate adaptive immune responses, leading either to control cancer by effector T cells or to exacerbate cancer by regulatory T cells that inhibit IFN-gamma-mediated Th1-type response. Dendritic cells can also induce Th17-type immunity, mediated by IL-17A. However, the controversial role of this cytokine in cancer requires further investigations. We generated dendritic cells from peripheral blood monocytes to investigate lifespan, phenotype and chemoresistance of dendritic cells, treated with IL-17A with or without IFN-gamma. Studying the expression of Bcl-2 family members, we demonstrated that dendritic cells constitutively express one pro-survival Bcl-2 member: MCL1. Immature dendritic cells were CD40(low)HLADR(low) CD1a(+) MCL1(+), did not express CD14, CD68 or BCL2A1, and displayed a short 2-day lifespan. IL-17A-treated DC exhibited a semi-mature (CD40(high)HLADR(low)) pre-M2 (CCL22(+) CD206(+) CD163(+) IL1RN(+) IL-10(-) CXCL10(-) IL-12(-)) mixed (CD1a(+) CD14+ CD68(+)) macrophage-dendritic cell phenotype. They efficiently exerted mannose receptor-mediated endocytosis and did not produce superoxide anions, in the absence of TLR engagement. Interestingly, IL-17A promoted a long-term survival of dendritic cells, beyond 12 days, that correlated to BCL2A1 induction, a pro-survival Bcl-2 family member. BCL2A1 transcription was activated by NF-kappa B, downstream of IL-17A transduction. Thus, immature dendritic cells only express MCL1, whereas IL-17A-treated dendritic cells concomitantly expressed two pro-survival Bcl-2 family members: MCL1 and BCL2A1. These latter developed chemoresistance to 11 of the 17 chemotherapy agents tested. However, high doses of either vinblastine or cytarabine decreased MCL1 expression and induced dendritic cell death. When IL-17A is produced in vivo, administration of anti-IL-17A biotherapy may impair dendritic cell survival by targeting BCL2A1 expression. Consequently, depending on the effector or regulatory role of dendritic cells, blocking IL-17A, may be either dangerous or beneficial for cancer outcomes, thus contributing to the apparent controversy around the role of IL-17A in cancer.	[Akefeldt, Selma Olsson; Henter, Jan-Inge] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Salvatore, Giulia; Bissay, Nathalie; Delprat, Christine] CNRS, UMR5239, Lab Biol Mol Cellule, Lyon, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Delprat, Christine] Ecole Normale Super Lyon, F-69364 Lyon, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Rabourdin-Combe, Chantal; Delprat, Christine] Univ Lyon, Lyon, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Rabourdin-Combe, Chantal; Delprat, Christine] Univ Lyon 1, F-69622 Villeurbanne, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Rabourdin-Combe, Chantal; Delprat, Christine] UMS3444 US8, Lyon, France; [Belot, Alexandre] Hop Femme Mere Enfant, Hosp Civils Lyon, Bron, France; [Mazzorana, Marlene; Jurdic, Pierre] CNRS, UMR5242, Inst Genom Fonct Lyon, Lyon, France; [Salvatore, Giulia] Univ Florence, Florence, Italy; [Salvatore, Giulia; Arico, Maurizio] Azienda Osped Univ Meyer Children Hosp, Dept Pediat Hematol Oncol, Florence, Italy; [Rabourdin-Combe, Chantal] INSERM, U851, F-69008 Lyon, France; [Delprat, Christine] Inst Univ France, Paris, France	Karolinska Institutet; Karolinska University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Florence; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France	Delprat, C (corresponding author), CNRS, UMR5239, Lab Biol Mol Cellule, Lyon, France.	cdelprat@free.fr	Belot, Alexandre/C-7378-2013; Arico, Maurizio/S-3039-2019	Belot, Alexandre/0000-0003-4902-5332; Arico, Maurizio/0000-0002-1908-6671; Salvatore, Giulia/0000-0003-3573-9254; MAZZORANA, Marlene/0000-0002-3956-4319; Henter, Jan-Inge/0000-0002-0629-2126; Maisse, Carine/0000-0003-2848-1638	CNRS; INSERM; Universite de Lyon; Institut Universitaire de France; Fondation Innovations en Infectiologie; Fondation de France [2008002100]; Agence Nationale de la Recherche [08-MIEN-001-02]; (USA) Histiocytosis Association of America; Ministero Sanita; Progetto di Ricerca Finalizzata; Regione Toscana; Progetto di Ricerca Malattie Rare; Associazione Italiana Ricerca Istiocitosi (AIRI); Swedish Children's Cancer Foundation; Swedish Research Council; Marta och Gunnar V Philipson's Foundation; Cancer and Allergy Foundation of Sweden; Karolinska Institutet (KID project); Stockholm County Council (ALF project)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Lyon; Institut Universitaire de France; Fondation Innovations en Infectiologie; Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR)); (USA) Histiocytosis Association of America; Ministero Sanita; Progetto di Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Regione Toscana(Regione Toscana); Progetto di Ricerca Malattie Rare; Associazione Italiana Ricerca Istiocitosi (AIRI); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marta och Gunnar V Philipson's Foundation; Cancer and Allergy Foundation of Sweden; Karolinska Institutet (KID project); Stockholm County Council (ALF project)(Stockholm County Council)	This work was supported by grants from (F) CNRS, INSERM, Universite de Lyon, Institut Universitaire de France, Fondation Innovations en Infectiologie, Fondation de France 2008002100, Agence Nationale de la Recherche 08-MIEN-001-02; (USA) Histiocytosis Association of America 2008; (I) Ministero Sanita, Progetto di Ricerca Finalizzata 2008: "Getting deeper in histiocytosis", Regione Toscana, Progetto di Ricerca Malattie Rare 2008, Associazione Italiana Ricerca Istiocitosi (AIRI); (S) the Swedish Children's Cancer Foundation, the Swedish Research Council, Marta och Gunnar V Philipson's Foundation, the Cancer and Allergy Foundation of Sweden, Karolinska Institutet (KID project) and the Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; BINASCHI M, 1990, INT J CANCER, V45, P347, DOI 10.1002/ijc.2910450223; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Chao D, 1999, BRIT J CANCER, V81, P1280, DOI 10.1038/sj.bjc.6694366; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chuang PI, 2002, BLOOD, V99, P3350, DOI 10.1182/blood.V99.9.3350; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; D'Souza BN, 2004, J VIROL, V78, P1800, DOI 10.1128/JVI.78.4.1800-1816.2004; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Feuerhake F, 2005, BLOOD, V106, P1392, DOI 10.1182/blood-2004-12-4901; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Johnson SA, 2000, CLIN PHARMACOKINET, V39, P5, DOI 10.2165/00003088-200039010-00002; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Kriehuber E, 2005, BLOOD, V106, P175, DOI 10.1182/blood-2004-08-3072; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Macaire H, 2012, J BIOL CHEM, V287, P21357, DOI 10.1074/jbc.M112.340992; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Olsson A, 2007, BRIT J CANCER, V97, P769, DOI 10.1038/sj.bjc.6603951; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rivollier A, 2004, BLOOD, V104, P4029, DOI 10.1182/blood-2004-01-0041; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Tanikawa T, 2012, CANCER RES, V72, P420, DOI 10.1158/0008-5472.CAN-10-4627; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820	40	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56865	10.1371/journal.pone.0056865	http://dx.doi.org/10.1371/journal.pone.0056865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441221	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200078
J	da Silva, M; Santos, DVV; Costa, KM				da Silva Filho, Manoel; Vasconcelos Santos, Daniel Valle; Costa, Kaue Machado			A New Low Cost Wide-Field Illumination Method for Photooxidation of Intracellular Fluorescent Markers	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; CORRELATED LIGHT; BRAIN-SLICES; PHOTOCONVERSION; DII; NEURONS; MONKEY; EOSIN	Analyzing cell morphology is crucial in the fields of cell biology and neuroscience. One of the main methods for evaluating cell morphology is by using intracellular fluorescent markers, including various commercially available dyes and genetically encoded fluorescent proteins. These markers can be used as free radical sources in photooxidation reactions, which in the presence of diaminobenzidine (DAB) forms an opaque and electron-dense precipitate that remains localized within the cellular and organelle membranes. This method confers many methodological advantages for the investigator, including absence of photo-bleaching, high visual contrast and the possibility of correlating optical imaging with electron microscopy. However, current photooxidation techniques require the continuous use of fluorescent or confocal microscopes, which wastes valuable mercury lamp lifetime and limits the conversion process to a few cells at a time. We developed a low cost optical apparatus for performing photooxidation reactions and propose a new procedure that solves these methodological restrictions. Our "photooxidizer" consists of a high power light emitting diode (LED) associated with a custom aluminum and acrylic case and a microchip-controlled current source. We demonstrate the efficacy of our method by converting intracellular DiI in samples of developing rat neocortex and post-mortem human retina. DiI crystals were inserted in the tissue and allowed to diffuse for 20 days. The samples were then processed with the new photooxidation technique and analyzed under optical microscopy. The results show that our protocols can unveil the fine morphology of neurons in detail. Cellular structures such as axons, dendrites and spine-like appendages were well defined. In addition to its low cost, simplicity and reliability, our method precludes the use of microscope lamps for photooxidation and allows the processing of many labeled cells simultaneously in relatively large tissue samples with high efficacy.	[da Silva Filho, Manoel; Vasconcelos Santos, Daniel Valle; Costa, Kaue Machado] Fed Univ Para, Inst Biol Sci, BR-66059 Belem, Para, Brazil	Universidade Federal do Para	da Silva, M (corresponding author), Fed Univ Para, Inst Biol Sci, BR-66059 Belem, Para, Brazil.	manoel@ufpa.br	Costa, Kauê M/H-5574-2012; da Silva Filho, Manoel/C-6684-2013	Costa, Kauê M/0000-0002-5562-6495; 	National Counsel of Technological and Scientific Development (CNPQ) [470827/2009-2]; Coordination for the Improvement of Higher Education Personnel (CAPES)	National Counsel of Technological and Scientific Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by the National Counsel of Technological and Scientific Development (CNPQ; grant number 470827/2009-2). DVVS received a graduate student fellowship from the Coordination for the Improvement of Higher Education Personnel (CAPES). MSF is a CNPQ research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTIVOGLIO M, 1990, NEUROSCI LETT, V113, P127, DOI 10.1016/0304-3940(90)90291-G; BUHL EH, 1989, NEUROSCIENCE, V28, P3, DOI 10.1016/0306-4522(89)90227-3; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; Dantuma NP, 1998, J HISTOCHEM CYTOCHEM, V46, P1085, DOI 10.1177/002215549804600913; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Dos Santos SN, 2005, VISUAL NEUROSCI, V22, P405, DOI 10.1017/S0952523805224033; Ghosh KK, 1999, J COMP NEUROL, V413, P417, DOI 10.1002/(SICI)1096-9861(19991025)413:3<417::AID-CNE5>3.0.CO;2-H; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Lubke J, 1993, MICROSC RES TECHNIQ, V1, P2; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Meisslitzer-Ruppitsch C, 2009, J MICROSC-OXFORD, V235, P322, DOI 10.1111/j.1365-2818.2009.03220.x; Mezey SE, 2003, NEUROSCI RES, V47, P299, DOI 10.1016/S0168-0102(03)00219-0; PAPADOPOULOS GC, 1993, J NEUROSCI METH, V46, P251, DOI 10.1016/0165-0270(93)90074-2; Prusky G, 1999, BRAIN RES PROTOC, V3, P313, DOI 10.1016/S1385-299X(98)00055-5; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; Santos DVV, 2012, BRAZ J MED BIOL RES, V45, P1221, DOI 10.1590/S0100-879X2012007500137; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Singleton CD, 1996, J NEUROSCI METH, V64, P47, DOI 10.1016/0165-0270(95)00097-6; VONBARTHELD CS, 1990, J HISTOCHEM CYTOCHEM, V38, P725, DOI 10.1177/38.5.2185313	19	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56512	10.1371/journal.pone.0056512	http://dx.doi.org/10.1371/journal.pone.0056512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441199	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200056
J	Frey, S; Goldstone, RL				Frey, Seth; Goldstone, Robert L.			Cyclic Game Dynamics Driven by Iterated Reasoning	PLOS ONE			English	Article							STRATEGIC THINKING; COORDINATION; BIODIVERSITY; ATTRACTION; PROMOTES; MODEL; COST	Recent theories from complexity science argue that complex dynamics are ubiquitous in social and economic systems. These claims emerge from the analysis of individually simple agents whose collective behavior is surprisingly complicated. However, economists have argued that iterated reasoning-what you think I think you think-will suppress complex dynamics by stabilizing or accelerating convergence to Nash equilibrium. We report stable and efficient periodic behavior in human groups playing the Mod Game, a multi-player game similar to Rock-Paper-Scissors. The game rewards subjects for thinking exactly one step ahead of others in their group. Groups that play this game exhibit cycles that are inconsistent with any fixed-point solution concept. These cycles are driven by a "hopping'' behavior that is consistent with other accounts of iterated reasoning: agents are constrained to about two steps of iterated reasoning and learn an additional one-half step with each session. If higher-order reasoning can be complicit in complex emergent dynamics, then cyclic and chaotic patterns may be endogenous features of real-world social and economic systems.	[Frey, Seth; Goldstone, Robert L.] Indiana Univ, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Frey, S (corresponding author), Indiana Univ, Bloomington, IN 47405 USA.	sethfrey@indiana.edu	Frey, Seth/AAF-8499-2021	Frey, Seth/0000-0002-5298-5089	National Science Foundation IGERT training grant in the Dynamics of Brain-Body-Environment Systems at Indiana University [0903495]; National Science Foundation REESE grant [0910218]; Department of Education IES grant [R305A1100060]	National Science Foundation IGERT training grant in the Dynamics of Brain-Body-Environment Systems at Indiana University; National Science Foundation REESE grant; Department of Education IES grant	This research was supported in part by National Science Foundation IGERT training grant 0903495 in the Dynamics of Brain-Body-Environment Systems at Indiana University, National Science Foundation REESE grant 0910218, and Department of Education IES grant R305A1100060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Bednar J, 2012, GAME ECON BEHAV, V74, P12, DOI 10.1016/j.geb.2011.06.009; BLOOMFIELD R, 1994, J ECON BEHAV ORGAN, V25, P411, DOI 10.1016/0167-2681(94)90108-2; Bottazzi G, 2007, J EVOL ECON, V17, P241, DOI 10.1007/s00191-006-0040-6; BROWN JN, 1990, ECONOMETRICA, V58, P1065, DOI 10.2307/2938300; Camerer C. F., 2002, COGNITIVE HIERACHY T, P1; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Camerer CF, 2002, J ECON THEORY, V104, P137, DOI 10.1006/jeth.2002.2927; Camerer CF, 2003, BEHAV GAME THEORY EX, p[270, 322]; Cason TN, 2005, J ECON DYN CONTROL, V29, P801, DOI 10.1016/j.jedc.2003.07.007; Cason TN, 2012, CYCLES INSTABILITY R; Costa-Gomes MA, 2009, J EUR ECON ASSOC, V7, P365, DOI 10.1162/JEEA.2009.7.2-3.365; Crawford VP, 2007, AM ECON REV, V97, P1731, DOI 10.1257/aer.97.5.1731; Crawford VP, 2007, ECONOMETRICA, V75, P1721, DOI 10.1111/j.1468-0262.2007.00810.x; Duffy J, 1997, ECON J, V107, P1684, DOI 10.1111/1468-0297.00250; Duffy J, 2005, GAME ECON BEHAV, V51, P31, DOI 10.1016/j.geb.2004.04.007; Eckert A, 2004, ANN REGIONAL SCI, V38, P25, DOI 10.1007/s00168-003-0144-y; Edgeworth F, 1925, ROYAL EC SOC, V2, P118; Frey S, 2011, 2011 P COGN SCI SOC; FUDENBERG D, 1993, GAME ECON BEHAV, V5, P320, DOI 10.1006/game.1993.1021; Galla T, 2011, ARXIV11094250; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Ho TH, 2011, DYNAMIC LEVEL K MODE; Hoffman M, 2012, EXPT TEST NASH EQUIL; Hommes CH, 2012, GAME ECON BEHAV, V74, P434, DOI 10.1016/j.geb.2011.05.014; JORDAN JS, 1993, GAME ECON BEHAV, V5, P368, DOI 10.1006/game.1993.1022; Kantz H., 2003, NONLINEAR TIME SERIE; Kawagoe T, 2012, J ECON BEHAV ORGAN, V82, P548, DOI 10.1016/j.jebo.2012.03.010; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; KLEINBERG R., 2011, S INN COMP SCI ICS; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; Nagel R, 1995, AM ECON REV, V85, P1313; Noel MD, 2007, REV ECON STAT, V89, P324, DOI 10.1162/rest.89.2.324; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; RAPOPORT A, 1992, J EXP PSYCHOL GEN, V121, P352, DOI 10.1037/0096-3445.121.3.352; Reichenbach T, 2008, J THEOR BIOL, V254, P368, DOI 10.1016/j.jtbi.2008.05.014; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Rubinstein A, 1993, NAIVE STRATEGIES ZER; Sato Y, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.015206; Sato Y, 2005, PHYSICA D, V210, P21, DOI 10.1016/j.physd.2005.06.031; Sato Y, 2002, P NATL ACAD SCI USA, V99, P4748, DOI 10.1073/pnas.032086299; Selten R, 1998, EUR ECON REV, V42, P413, DOI 10.1016/S0014-2921(97)00148-7; Selten Reinhard., 1991, GAME EQUILIBRIUM MOD, P98; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shapley L. S., 1964, ADV GAME THEORY; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SMITH VL, 1993, ECON INQ, V31, P245, DOI 10.1111/j.1465-7295.1993.tb00881.x; Stahl DO, 2000, GAME ECON BEHAV, V32, P105, DOI 10.1006/game.1999.0754; Sumpter D, 2010, COLLECTIVE ANIMAL BE, P149; Tang FF, 2001, J ECON BEHAV ORGAN, V44, P221, DOI 10.1016/S0167-2681(00)00155-4; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Wilensky U., NETLOGO; Wilensky U, HUBNET; Winkler AA, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.060901; Zhang X, 2005, PRICE CYCLES ONLINE	59	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56416	10.1371/journal.pone.0056416	http://dx.doi.org/10.1371/journal.pone.0056416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092YP	23441191	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200048
J	Bjerk, SM; Baker, JV; Emery, S; Neuhaus, J; Angus, B; Gordin, FM; Pett, SL; Stephan, C; Kunisaki, KM				Bjerk, Sonja M.; Baker, Jason V.; Emery, Sean; Neuhaus, Jacqueline; Angus, Brian; Gordin, Fred M.; Pett, Sarah L.; Stephan, Christoph; Kunisaki, Ken M.		Insight Smart Study Grp	Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HUMAN-IMMUNODEFICIENCY-VIRUS; COMMUNITY-ACQUIRED PNEUMONIA; ACTIVE ANTIRETROVIRAL THERAPY; STATIN THERAPY; SERUM; COHORT; HOSPITALIZATION; DISEASE; ALPHA	Background: Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patients do not currently exist. Methods: We performed a nested, matched, case-control study among participants randomized to continuous combination antiretroviral therapy (cART) in the Strategies for Management of Antiretroviral Therapy trial. Patients who developed bacterial pneumonia (cases) and patients without bacterial pneumonia (controls) were matched 1: 1 on clinical center, smoking status, age, and baseline cART use. Baseline levels of Club Cell Secretory Protein 16 (CC16), Surfactant Protein D (SP-D), C-reactive protein (hsCRP), interleukin-6 (IL-6), and d-dimer were compared between cases and controls. Results: Cases (n = 72) and controls (n = 72) were 25.7% female, 51.4% black, 65.3% current smokers, 9.7% diabetic, 36.1% co-infected with Hepatitis B/C, and 75.0% were on cART at baseline. Median (IQR) age was 45 (41, 51) years with CD4+ count of 553 (436, 690) cells/mm(3). Baseline CC16 and SP-D were similar between cases and controls, but hsCRP was significantly higher in cases than controls (2.94 mu g/mL in cases vs. 1.93 mu g/mL in controls; p = 0.02). IL-6 and d-dimer levels were also higher in cases compared to controls, though differences were not statistically significant (p-value 0.06 and 0.10, respectively). Conclusions: In patients with cART-treated HIV infection, higher levels of systemic inflammatory markers were associated with increased bacterial pneumonia risk, while two pulmonary-specific inflammatory biomarkers, CC16 and SP-D, were not associated with bacterial pneumonia risk.	[Bjerk, Sonja M.; Kunisaki, Ken M.] Univ Minnesota, Div Pulm Allergy Crit Care & Sleep Med, Minneapolis, MN 55455 USA; [Baker, Jason V.] Hennepin Cty Med Ctr, Div Infect Dis, Minneapolis, MN 55415 USA; [Emery, Sean; Pett, Sarah L.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Neuhaus, Jacqueline] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Angus, Brian] Univ Oxford, Nuffield Dept Med, Oxford, OH USA; [Gordin, Fred M.] Washington DC Vet Affairs Med Ctr, Div Infect Dis, Washington, DC USA; [Gordin, Fred M.] George Washington Univ, Div Infect Dis, Washington, DC USA; [Pett, Sarah L.] St Vincent Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW, Australia; [Stephan, Christoph] Goethe Univ Frankfurt, Div Infect Dis, D-60054 Frankfurt, Germany; [Kunisaki, Ken M.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; University of New South Wales Sydney; Kirby Institute; University of Minnesota System; University of Minnesota Twin Cities; George Washington University; St Vincents Hospital Sydney; Goethe University Frankfurt; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Kunisaki, KM (corresponding author), Univ Minnesota, Div Pulm Allergy Crit Care & Sleep Med, Minneapolis, MN 55455 USA.	kunis001@umn.edu	Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017; Ostergaard, Lars/AAA-3020-2020; Kunisaki, Ken/A-6950-2009; Brites, Carlos/D-1353-2013; Pulido, Federico/B-8417-2009; Stephan, Christoph/D-1305-2014; IBIS, VIH/O-8856-2015; Angus, Brian/L-9246-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Ostergaard, Lars/0000-0003-2459-0511; Kunisaki, Ken/0000-0001-8644-2827; Brites, Carlos/0000-0002-4673-6991; Pulido, Federico/0000-0002-7414-8812; Stephan, Christoph/0000-0003-3777-9006; Angus, Brian/0000-0003-3598-7784; Medland, Nicholas Andrew/0000-0003-0403-8930; Cabie, Andre/0000-0003-0117-3061; Kozal, Michael/0000-0002-3100-8254; Easterbrook, Philippa/0000-0002-2603-5418; Ristola, Matti/0000-0001-5115-2811; ABEL, Sylvie/0000-0002-3351-0547; Koirala, Janak/0000-0002-3608-474X; Gayet-Ageron, Angele/0000-0002-6164-9693; REUTER, TANIA/0000-0003-2176-5603; Ostergaard, Lars/0000-0002-7619-605X; Leen, Clifford/0000-0001-8439-7719; Okhuysen, Pablo/0000-0002-1596-3411	US National Institutes of Health [K12 RR023247, U01 AI042170, U01 AI046362, U01 AI068641]; University of New South Wales; Minnesota Veterans Medical Research and Education Foundation; Medical Research Council [MC_U122886352, MC_UU_12023/16] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068641, U01AI046362, U01AI042170, UM1AI068641] Funding Source: NIH RePORTER; MRC [MC_U122886352, MC_UU_12023/16] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New South Wales; Minnesota Veterans Medical Research and Education Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the US National Institutes of Health (K12 RR023247, U01 AI042170, U01 AI046362, U01 AI068641, U01 AI068641), the University of New South Wales, and the Minnesota Veterans Medical Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; Aslangul E, 2011, AIDS, V25, P1128, DOI 10.1097/QAD.0b013e328346be29; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Boschini A, 1996, CLIN INFECT DIS, V23, P107, DOI 10.1093/clinids/23.1.107; Broeckaert F, 2000, CLIN EXP ALLERGY, V30, P469; Calza L, 2012, HIV CLIN TRIALS, V13, P153, DOI 10.1310/hct1303-153; Cappabianca G, 2006, ANN THORAC SURG, V82, P2170, DOI 10.1016/j.athoracsur.2006.06.039; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Determann Rogier M, 2009, BMC Pulm Med, V9, P49, DOI 10.1186/1471-2466-9-49; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gekonge B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041153; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gordin FM, 2008, AM J RESP CRIT CARE, V178, P630, DOI 10.1164/rccm.200804-617OC; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; Lesur O, 2006, INTENS CARE MED, V32, P1167, DOI 10.1007/s00134-006-0235-1; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lomas DA, 2009, EUR RESPIR J, V34, P95, DOI 10.1183/09031936.00156508; Meduri GU, 1999, AM J RESP CRIT CARE, V160, P961, DOI 10.1164/ajrccm.160.3.9807080; Mezzomo A, 2011, ARQ BRAS CARDIOL, V97, P365, DOI 10.1590/S0066-782X2011005000092; Morris AM, 2000, AM J RESP CRIT CARE, V162, P612, DOI 10.1164/ajrccm.162.2.9912058; Mullerova H, 2012, RESP MED, V106, P1124, DOI 10.1016/j.rmed.2012.04.008; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Novack V, 2012, CAN MED ASSOC J, V184, pE367, DOI 10.1503/cmaj.111017; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rodriguez-Barradas MC, 2008, CLIN INFECT DIS, V46, P1093, DOI 10.1086/529201; Shebl FM, 2010, JAIDS-J ACQ IMM DEF, V55, P375, DOI 10.1097/QAI.0b013e3181eef4f7; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Sin Don D, 2008, Ther Adv Respir Dis, V2, P65, DOI 10.1177/1753465808088903; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Sogaard OS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007022; Twigg HL, 2008, J INFECT DIS, V197, P109, DOI 10.1086/523766; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC	42	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56249	10.1371/journal.pone.0056249	http://dx.doi.org/10.1371/journal.pone.0056249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457535	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700032
J	Geissler, C; Nadrowski, K; Kuhn, P; Baruffol, M; Bruelheide, H; Schmid, B; Scholten, T				Geissler, Christian; Nadrowski, Karin; Kuehn, Peter; Baruffol, Martin; Bruelheide, Helge; Schmid, Bernhard; Scholten, Thomas			Kinetic Energy of Throughfall in Subtropical Forests of SE China - Effects of Tree Canopy Structure, Functional Traits, and Biodiversity	PLOS ONE			English	Article							DROP-SIZE DISTRIBUTION; SOIL-EROSION; SPLASH DETACHMENT; RAINFALL; INTERCEPTION; DIVERSITY; TRANSFORMATION; ECOLOGY; IMPACT; VOLUME	Throughfall kinetic energy (TKE) plays an important role in soil erosion in forests. We studied TKE as a function of biodiversity, functional diversity as well as structural stand variables in a secondary subtropical broad-leaved forest in the Gutianshan National Nature Reserve (GNNR) in south-east China, a biodiversity hotspot in the northern hemisphere with more than 250 woody species present. Using a mixed model approach we could identify significant effects of all these variables on TKE: TKE increased with rarefied tree species richness and decreased with increasing proportion of needle-leaved species and increasing leaf area index (LAI). Furthermore, for average rainfall amounts TKE was decreasing with tree canopy height whereas for high rainfall amounts this was not the case. The spatial pattern of throughfall was stable across several rain events. The temporal variation of TKE decreased with rainfall intensity and increased with tree diversity. Our results show that more diverse forest stands over the season have to cope with higher cumulative raindrop energy than less diverse stands. However, the kinetic energy (KE) of one single raindrop is less predictable in diverse stands since the variability in KE is higher. This paper is the first to contribute to the understanding of the ecosystem function of soil erosion prevention in diverse subtropical forests.	[Geissler, Christian; Kuehn, Peter; Scholten, Thomas] Univ Tubingen, Inst Geog, Tubingen, Germany; [Nadrowski, Karin] Univ Leipzig, D-04109 Leipzig, Germany; [Baruffol, Martin; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot, D-06108 Halle, Germany; [Bruelheide, Helge] Univ Halle Wittenberg, Bot Garden, D-06108 Halle, Germany	Eberhard Karls University of Tubingen; Leipzig University; University of Zurich; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Geissler, C (corresponding author), Univ Tubingen, Inst Geog, Tubingen, Germany.	christian.geissler@uni-tuebingen.de	Schmid, Bernhard/C-8625-2009; Baruffol, Martin/A-2406-2014; Kühn, Peter/A-9146-2009; Bruelheide, Helge/G-3907-2013; Scholten, Thomas/E-4024-2012	Schmid, Bernhard/0000-0002-8430-3214; Baruffol, Martin/0000-0001-9358-5885; Kühn, Peter/0000-0002-4417-5633; Bruelheide, Helge/0000-0003-3135-0356; Scholten, Thomas/0000-0002-4875-2602; Nadrowski, Karin/0000-0001-5358-5469	German Research Foundation [DFG FOR 891/1]; National Science Foundation of China (NSFC) [30710103907, 309300005]; DFG; NSFC; Sino-German Centre for Research Promotion in Beijing [GZ 524, 592, 698, 699]	German Research Foundation(German Research Foundation (DFG)); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); DFG(German Research Foundation (DFG)); NSFC(National Natural Science Foundation of China (NSFC)); Sino-German Centre for Research Promotion in Beijing	The funding by the German Research Foundation (DFG FOR 891/1) and by the National Science Foundation of China (NSFC 30710103907 and 309300005), as well as various travel grants to prepare the project financed by DFG, NSFC and the Sino-German Centre for Research Promotion in Beijing (GZ 524, 592, 698 and 699) are highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDHOUS P, 1993, SCIENCE, V259, P1390, DOI 10.1126/science.259.5100.1390; ARMSTRONG CL, 1988, T ASAE, V31, P1400; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bates D, 2012, LME4 LINEAR MIXED EF; Both S, 2011, J VEG SCI, V22, P1120, DOI 10.1111/j.1654-1103.2011.01324.x; BRANDT J, 1988, J BIOGEOGR, V15, P41, DOI 10.2307/2845044; BROOKS SM, 1994, GEOGR ANN A, V76, P143, DOI 10.2307/521033; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Chen JM, 1997, J GEOPHYS RES-ATMOS, V102, P29429, DOI 10.1029/97JD01107; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crockford RH, 2000, HYDROL PROCESS, V14, P2903, DOI [10.1002/1099-1085(200011/12)14:16/17<2903::AID-HYP126>3.0.CO;2-6, 10.1002/1099-1085(200011/12)14:16/17&lt;2903::AID-HYP126&gt;3.0.CO;2-6]; Frasson RPD, 2011, AGR FOREST METEOROL, V151, P1244, DOI 10.1016/j.agrformet.2011.05.001; Geissler C, 2012, CATENA, V91, P85, DOI 10.1016/j.catena.2010.10.009; Geissler C, 2012, AGR FOREST METEOROL, V156, P31, DOI 10.1016/j.agrformet.2011.12.005; Geissler C, 2010, J EARTH SCI-CHINA, V21, P897, DOI 10.1007/s12583-010-0132-y; Gomez JA, 2001, AGR WATER MANAGE, V49, P65, DOI 10.1016/S0378-3774(00)00116-5; HALL RL, 1993, J GEOPHYS RES-ATMOS, V98, P18465, DOI 10.1029/93JD01498; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hu Z, 2008, FRONT BIOL CHINA, V3, P45, DOI DOI 10.1007/S11515-008-0011-4; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; IUSS Working Group WRB, 2006, WORLD REF BAS SOIL R, V103; Korner C, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P3; KWAAD FJPM, 1977, EARTH SURF PROC LAND, V2, P161, DOI 10.1002/esp.3290020208; Lal R, 1998, SOIL TILL RES, V48, P103, DOI 10.1016/S0167-1987(98)00109-3; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Levia DF, 2006, PROG PHYS GEOG, V30, P605, DOI 10.1177/0309133306071145; Loescher HW, 2002, J TROP ECOL, V18, P397, DOI 10.1017/S0266467402002274; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marks R, 1998, STUDIES ENV HIST; Molnar P, 2004, ANNU REV EARTH PL SC, V32, P67, DOI 10.1146/annurev.earth.32.091003.143456; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Morgan R.P.C., 2005, EROSION HAZARD ASS; MOSLEY MP, 1982, EARTH SURF PROC LAND, V7, P103, DOI 10.1002/esp.3290070204; Murakami S, 2006, J HYDROL, V319, P72, DOI 10.1016/j.jhydrol.2005.07.002; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nanko K, 2008, CATENA, V72, P348, DOI 10.1016/j.catena.2007.07.002; Nanko K, 2004, J FOREST RES-JPN, V9, P157, DOI 10.1007/s10310-003-0067-6; Nanko K, 2006, J HYDROL, V329, P422, DOI 10.1016/j.jhydrol.2006.02.036; Nanko K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033010; Pimentel D, 1998, ECOSYSTEMS, V1, P416, DOI 10.1007/s100219900035; R Core Team, 2016, R FDN STAT COMP; Scherer-Lorenzen M, 2010, FUNCTIONAL SIGNIFICA; Scholten T, 2011, J PLANT NUTR SOIL SC, V174, P596, DOI 10.1002/jpln.201000349; Smith J R, 1914, Science, V39, P858, DOI 10.1126/science.39.1015.858; VIS M, 1986, EARTH SURF PROC LAND, V11, P591, DOI 10.1002/esp.3290110603; Wakiyama Y, 2010, EARTH SURF PROC LAND, V35, P993, DOI 10.1002/esp.1844; Wang K, 2005, PEDOSPHERE, V15, P620; Wiersum K. F., 1985, Soil erosion and conservation, P79; Zuur Alain F., 2009, P1	51	30	31	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e49618	10.1371/journal.pone.0049618	http://dx.doi.org/10.1371/journal.pone.0049618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457440	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315603700002
J	Tweya, H; Feldacker, C; Phiri, S; Ben-Smith, A; Fenner, L; Jahn, A; Kalulu, M; Weigel, R; Kamba, C; Banda, R; Egger, M; Keiser, O				Tweya, Hannock; Feldacker, Caryl; Phiri, Sam; Ben-Smith, Anne; Fenner, Lukas; Jahn, Andreas; Kalulu, Mike; Weigel, Ralf; Kamba, Chancy; Banda, Rabecca; Egger, Matthias; Keiser, Olivia			Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic, Malawi	PLOS ONE			English	Article							SURVIVAL; THERAPY	Background: Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of important issues. Methods: All adult smear-positive pulmonary TB patients diagnosed between 2008 and 2010 in Malawi's largest public, integrated TB/HIV clinic were included in the study to assess treatment outcomes by HIV and antiretroviral therapy status using logistic regression. Results: Of 2,361 new smear-positive pulmonary TB patients, 86% had successful treatment outcome (were cured or completed treatment), 5% died, 6% were lost to follow-up, 1% failed treatment, and 2% transferred-out. Overall HIV prevalence was 56%. After adjusting for gender, age and TB registration year, treatment success was higher among HIV-negative than HIV-positive patients (adjusted odds ratio 1.49; 95% CI: 1.14-1.94). Of 1,275 HIV-infected pulmonary TB patients, 492 (38%) received antiretroviral therapy during the study. Pulmonary TB patients on antiretroviral therapy were more likely to have successful treatment outcomes than those not on ART (adjusted odds ratio : 1.83; 95% CI: 1.29-2.60). Conclusion: HIV co-infection was associated with poor TB treatment outcomes. Despite high HIV prevalence and the integrated TB/HIV setting, only a minority of patients started antiretroviral therapy. Intensified patient education and provider training on the benefits of antiretroviral therapy could increase antiretroviral therapy uptake and improve TB treatment success among these most infectious patients.	[Tweya, Hannock] Int Union TB & Lung Dis, Paris, France; [Tweya, Hannock; Feldacker, Caryl; Phiri, Sam; Kalulu, Mike; Weigel, Ralf; Banda, Rabecca] Lighthouse Trust, Lilongwe, Malawi; [Feldacker, Caryl; Jahn, Andreas] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Ben-Smith, Anne] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA; [Fenner, Lukas; Egger, Matthias; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Jahn, Andreas] Minist Hlth, Dept HIV & AIDS, Cent Monitoring & Evaluat Div, Lilongwe, Malawi; [Weigel, Ralf] Univ Liverpool, Liverpool Sch Trop Med, Dis Control Strategy Grp, Liverpool L3 5QA, Merseyside, England; [Kamba, Chancy] Lilongwe Dist Hlth Off, Minist Hlth, Lilongwe, Malawi	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bern; Liverpool School of Tropical Medicine; University of Liverpool	Tweya, H (corresponding author), Int Union TB & Lung Dis, Paris, France.	h_tweya@lighthouse.org.mw	Weigel, Ralf/ABD-2310-2020; Jahn, Andreas/ABB-7796-2020	Weigel, Ralf/0000-0001-9034-2634; Jahn, Andreas/0000-0003-4645-1600; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132; Feldacker, Caryl/0000-0002-8152-6754; Fenner, Lukas/0000-0003-3309-4835	US Department of Health and Human Services, Health Resources and Services Administration (HRSA) [U91HA06801]; PROSPER grant from the Swiss National Science Foundation; NIH (NIAID, NICHD, NCI) [U01AI069924]; PEPFAR [3 U01 AI069924-05S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	US Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); PROSPER grant from the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); NIH (NIAID, NICHD, NCI); PEPFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Hannock Tweya is supported as an Operational Research Fellow by the International Union Against Tuberculosis and Lung Disease, Paris, France. Caryl Feldacker was supported with funding from Cooperative Agreement U91HA06801 from the US Department of Health and Human Services, Health Resources and Services Administration (HRSA) and Olivia Keiser is supported by a PROSPER grant from the Swiss National Science Foundation. This publication was made possible by Grant Number U01AI069924 from the NIH (NIAID, NICHD, NCI) and 3 U01 AI069924-05S1 from PEPFAR. (PI: Egger and Davies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Banerjee A, 1997, T ROY SOC TROP MED H, V91, P707, DOI 10.1016/S0035-9203(97)90533-2; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; El-Sony AI, 2002, INT J TUBERC LUNG D, V6, P1058; Gareta D, 2011, TROP MED INT HLTH; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Malawi Ministry of Health, 2007, MAL NAT TUB CONTR PR; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; MOH, 2011, CLIN MAN HIV CHILDR; Muvunyi CM, 2010, AFR J MICROBIOL RES, V4, P88; Oguntibeju OO, 2012, HIV AIDS-RES PALLIAT, V4, P117, DOI 10.2147/HIV.S32321; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Sume G E, 2009, East Afr Med J, V86, P469; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; WHO, 2011, GLOB TUB CONTR REP; WHO, 2010, GLOB TUB CONTR REP G; World Health Organization, 2008, JOINT WHO HIV AIDS T; World Health Organization, 2009, GLOB TUB CONTR EP ST	19	41	42	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56248	10.1371/journal.pone.0056248	http://dx.doi.org/10.1371/journal.pone.0056248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457534	Green Accepted, Green Published, gold			2022-12-27	WOS:000315603700031
J	Choi, JK; He, XM				Choi, Jung Kyu; He, Xiaoming			In Vitro Maturation of Cumulus-Oocyte Complexes for Efficient Isolation of Oocytes from Outbred Deer Mice	PLOS ONE			English	Article							DEVELOPMENTAL COMPETENCE; EMBRYO DEVELOPMENT; FERTILIZATION; SUPEROVULATION; PERFORMANCE; CULTURE; INVITRO; SPERM	In Background: The outbred (as with humans) deer mice have been a useful animal model of research on human behavior and biology including that of the reproductive system. One of the major challenges in using this species is that the yield of oocyte isolation via superovulation is dismal according to the literature to date less than similar to 5 oocytes per animal can be obtained so far. Objective: The goal of this study is to improve the yield of oocyte isolation from outbred deer mice close to that of most laboratory mice by in vitro maturation (IVM) of cumulus-oocyte complexes (COCs). Methods: Oocytes were isolated by both superovulation and IVM. For the latter, COCs were obtained by follicular puncture of antral follicles in both the surface and inner cortical layers of ovaries. Immature oocytes in the COCs were then cultured in vitro under optimized conditions to obtain metaphase II (MII) oocytes. Quality of the oocytes from IVM and superovulation was tested by in vitro fertilization (IVF) and embryo development. Results: Less than similar to 5 oocytes per animal could be isolated by superovulation only. However, we successfully obtained 20.3 +/- 2.9 oocytes per animal by IVM (16.0 +/- 2.5) and superovulation (4.3 +/- 1.3) in this study. Moreover, IVF and embryo development studies suggest that IVM oocytes have even better quality than that from superovulation The latter never developed to beyond 2-cell stage as usual while 9% of the former developed to 4-cells. Significance: We have successfully established the protocol for isolating oocytes from deer mice with high yield by IVM. Moreover, this is the first ever success to develop in vitro fertilized deer mice oocytes beyond the 2-cell stage in vitro. Therefore, this study is of significance to the use of deer mice for reproductive biology research.	[Choi, Jung Kyu; He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Choi, Jung Kyu; He, Xiaoming] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [He, Xiaoming] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA	Ohio State University; Ohio State University; James Cancer Hospital & Solove Research Institute; Ohio State University	He, XM (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	He.429@osu.edu	He, Xiaoming/C-5499-2008	He, Xiaoming/0000-0003-0125-6086	National Institutes of Health [R01EB012108]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health (Grant#:R01EB012108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeydeera LR, 1998, BIOL REPROD, V58, P1316, DOI 10.1095/biolreprod58.5.1316; Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1; Anckaert E, 2013, HUM REPROD UPDATE, V19, P52, DOI 10.1093/humupd/dms042; ANDERIESZ C, 1995, HUM REPROD, V10, P2377; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; Chappell MA, 2003, J EXP BIOL, V206, P1221, DOI 10.1242/jeb.00255; Combelles CMH, 2003, BIOL REPROD, V68, P812, DOI 10.1095/biolreprod.102.008656; deMatos DG, 1997, BIOL REPROD, V57, P1420, DOI 10.1095/biolreprod57.6.1420; Dewey MJ, 2001, GENESIS, V29, P105, DOI 10.1002/gene.1011; Duselis Amanda R, 2007, J Vis Exp, P185, DOI 10.3791/185; Eppig JJ, 1998, THERIOGENOLOGY, V49, P415, DOI 10.1016/S0093-691X(97)00413-5; Fisher HS, 2010, NATURE, V463, P801, DOI 10.1038/nature08736; FUKUDA Y, 1979, J EXP ZOOL, V207, P481, DOI 10.1002/jez.1402070316; Holzer H, 2007, FERTIL STERIL, V88, P62, DOI 10.1016/j.fertnstert.2006.11.087; Joyner Charlotte P., 1998, ILAR J, V39, P322; KLEIN MS, 1981, J EXP ZOOL, V218, P183, DOI 10.1002/jez.1402180211; Lee ST, 2006, FERTIL STERIL, V86, P1164, DOI 10.1016/j.fertnstert.2006.01.059; Lee ST, 2006, MOL REPROD DEV, V73, P1022, DOI 10.1002/mrd.20500; Lee ST, 2005, FERTIL STERIL, V83, P1264, DOI 10.1016/j.fertnstert.2004.09.039; Marchesi DE, 2012, SEMIN REPROD MED, V30, P323, DOI 10.1055/s-0032-1320013; MARSTON JH, 1966, J EMBRYOL EXP MORPH, V15, P169; Martin-Coello J, 2008, THERIOGENOLOGY, V70, P1004, DOI 10.1016/j.theriogenology.2008.06.002; Mott R, 2007, NAT GENET, V39, P1054, DOI 10.1038/ng0907-1054; Niu Y, 2009, J ZOOL, V278, P42, DOI 10.1111/j.1469-7998.2008.00546.x; SCHMIDT PM, 1989, GAMETE RES, V23, P11, DOI 10.1002/mrd.1120230103; Shorter KR, 2012, GENET RES INT, V2012, DOI 10.1155/2012/179159; Spearow JL, 1999, BIOL REPROD, V61, P851, DOI 10.1095/biolreprod61.4.851; Takagi M, 1998, THERIOGENOLOGY, V50, P307, DOI 10.1016/S0093-691X(98)00139-3; Tropea A, 2004, ANN NY ACAD SCI, V1034, P211, DOI 10.1196/annals.1335.023; Veres M, 2012, THERIOGENOLOGY, V77, P311, DOI 10.1016/j.theriogenology.2011.07.044; Vergara GJ, 1997, THERIOGENOLOGY, V47, P1245, DOI 10.1016/S0093-691X(97)00104-0; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Yuan Y, 2012, METHODS MOL BIOL, V825, P183, DOI 10.1007/978-1-61779-436-0_14; ZHANG X, 1991, MOL REPROD DEV, V28, P292, DOI 10.1002/mrd.1080280312	35	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56158	10.1371/journal.pone.0056158	http://dx.doi.org/10.1371/journal.pone.0056158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457518	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700052
J	Dogac, E; Kandemir, I; Taskin, V				Dogac, Ersin; Kandemir, Irfan; Taskin, Vatan			The Genetic Polymorphisms and Colonization Process of Olive Fly Populations in Turkey	PLOS ONE			English	Article							BACTROCERA-CUCURBITAE DIPTERA; PEST FRUIT-FLY; MICROSATELLITE MARKERS; DACUS-OLEAE; ALLOZYME VARIATION; MELON FLY; TEPHRITIDAE; DNA; LOCI; FLOW	The olive fruit fly, Bactrocera oleae, is the most important pest of olives in olive growing regions worldwide, especially in the Mediterranean basin and North America. Despite the economic importance of the olive fly, the colonization route of this species is unclear. We used nuclear microsatellite markers and mitochondrial DNA to provide information about the population structure and invasion route of olive fly populations in Turkey, as representative of the Eastern Mediterranean region. Adult fly samples were collected from 38 sublocations covering all olive growing regions in Turkey. The simple sequence variability data revealed a significant genetic variability in olive fly populations and a certain degree of differentiation between Mediterranean and Aegean populations. Mediterranean populations harbor higher levels of microsatellite variation than Aegean populations, which points to the eastern part of the Mediterranean as the putative source of invasion. mtDNA results suggest olive flies from the western part of Turkey are closely related to Italo-Aegean flies of the Mediterranean basin and the olive fly populations have invaded the northern part of the Mediterranean basin through western Turkey. In addition, finding specific American haplotypes in high frequencies might indicate that Turkey is the possible source of American olive fly populations. In order to more precisely characterize the population structure and invasion routes of this organism, more DNA-based sequence analysis should be carried out worldwide.	[Dogac, Ersin; Taskin, Vatan] Mugla Sitki Kocman Univ, Dept Biol, Fac Sci, Mugla, Turkey; [Kandemir, Irfan] Ankara Univ, Dept Biol, Fac Sci, TR-06100 Ankara, Turkey	Mugla Sitki Kocman University; Ankara University	Taskin, V (corresponding author), Mugla Sitki Kocman Univ, Dept Biol, Fac Sci, Mugla, Turkey.	tvatan@mu.edu.tr	kandemir, irfan/L-3944-2019	DOGAC, ERSIN/0000-0003-4426-2187; kandemir, irfan/0000-0002-2888-1044	Scientific and Technological Research Council of Turkey (TUBITAK-TBAG) [110T190]; Mugla Sitki Kocman University Scientific Research Funds [MUBAP- 2010/26, 2012/46]; Scientific and Technological Research Council of Turkey	Scientific and Technological Research Council of Turkey (TUBITAK-TBAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Mugla Sitki Kocman University Scientific Research Funds(Mugla Sitki Kocman University); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was financially supported by The Scientific and Technological Research Council of Turkey (TUBITAK-TBAG), project number 110T190, and Mugla Sitki Kocman University Scientific Research Funds (MUBAP- 2010/26 and 2012/46). ED was financially supported by a fellowship from The Scientific and Technological Research Council of Turkey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 1997, MONOGRAPHS POPULATIO, V29; Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Augustinos AA, 2005, GENETICA, V125, P231, DOI 10.1007/s10709-005-8692-y; Augustinos AA, 2002, MOL ECOL NOTES, V2, P278, DOI 10.1046/j.1471-8286.2002.00222.x; Augustinos AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-618; Baker GC., 2002, T ROY SOC TROP MED H, V96, P21; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basoglu I.M., 2009, THESIS CUKUROVA U AD; Belkhir K, 1996, 5000 CNRS UMR; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Bonizzoni M, 2001, MOL ECOL, V10, P2515, DOI 10.1046/j.0962-1083.2001.01376.x; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Burrack HJ, 2008, J ECON ENTOMOL, V101, P750, DOI 10.1603/0022-0493(2008)101[750:OFFDTO]2.0.CO;2; Bush GL, 1979, RES GENETIC STRUCTUR, P11; Cameron EC, 2010, B ENTOMOL RES, V100, P197, DOI 10.1017/S0007485309990150; Cornuet JM, 1996, GENETICS, V144, P2001; Downie DA, 2001, EVOLUTION, V55, P1345, DOI 10.1111/j.0014-3820.2001.tb00657.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fletcher B.S., 1989, FRUIT FLIES THEIR B, P195; FLETCHER BS, 1989, FRUIT FLIES THEIR B, V3, P209; Gilchrist AS, 2010, HEREDITY, V105, P165, DOI 10.1038/hdy.2009.163; GILLESPIE JH, 1974, GENETICS, V76, P837; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Gumusay B, 1990, ACTA HORTIC, V286, P359; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Iannotta N., 1999, Acta Horticulturae, P545; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Langella O, 2002, POPULATIONS 1 2 29 P; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOUKAS M, 1985, ANN ENTOMOL SOC AM, V78, P159, DOI 10.1093/aesa/78.2.159; Loukas M, 1989, ELECTROPHORETIC STUD, P69; Lumaret R, 2004, HEREDITY, V92, P343, DOI 10.1038/sj.hdy.6800430; MANTEL N, 1967, CANCER RES, V27, P209; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Montiel Bueno A, 2002, BULLETIN, V25, P1; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nardi F., 2011, TEAM NEWS LETT, V10, P3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; NEUENSCHWANDER P, 1985, Z ANGEW ENTOMOL, V100, P174; Ochando MD, 2000, J APPL ENTOMOL, V124, P177, DOI 10.1046/j.1439-0418.2000.00460.x; Oybak G, 2005, THESIS MUGLA SITKI K; Ozdogan M, 2007, TURKIYEDE NEOLITIK D; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pritchard JK, 2000, GENETICS, V155, P945; Rice R. E., 2003, California Agriculture, V57, P122, DOI 10.3733/ca.v057n04p122; Rice RE, 2000, U CALIFORNIA PLANT P, V10, P2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Segura MD, 2008, J APPL ENTOMOL, V132, P706, DOI 10.1111/j.1439-0418.2008.01366.x; Shi W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037083; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TSAKAS S, 1975, GENETICS, V79, P675; TSAKAS SC, 1980, ENTOMOL EXP APPL, V28, P268, DOI 10.1007/BF00366313; van Asch B, 2012, GENETICA, V140, P181, DOI 10.1007/s10709-012-9669-2; Wan XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025238; WAPLES RS, 1987, EVOLUTION, V41, P385, DOI 10.1111/j.1558-5646.1987.tb05805.x; Wu Y, 2011, J ECON ENTOMOL, V104, P1065, DOI 10.1603/EC10395; Yeh F.C., 1999, MICROSOFT WINDOWS BA; YONG HS, 1992, COMP BIOCHEM PHYS B, V102, P367, DOI 10.1016/0305-0491(92)90136-F; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley; ZOUROS E, 1969, GENET RES, V14, P249, DOI 10.1017/S0016672300002081; Zygouridis NE, 2009, HEREDITY, V102, P402, DOI 10.1038/hdy.2008.125	68	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56067	10.1371/journal.pone.0056067	http://dx.doi.org/10.1371/journal.pone.0056067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457499	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700038
J	van den Heuvel, DMA; Hellemons, AJCGM; Pasterkamp, RJ				van den Heuvel, Dianne M. A.; Hellemons, Anita J. C. G. M.; Pasterkamp, R. Jeroen			Spatiotemporal Expression of Repulsive Guidance Molecules (RGMs) and Their Receptor Neogenin in the Mouse Brain	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MORPHOGENETIC PROTEIN CORECEPTOR; EMBRYONIC VERTEBRATE FOREBRAIN; CENTRAL-NERVOUS-SYSTEM; NEURAL-TUBE CLOSURE; AXON GUIDANCE; HEPCIDIN EXPRESSION; GROWTH CONE; NEURONAL DIFFERENTIATION; COLORECTAL-CANCER	Neogenin has been implicated in a variety of developmental processes such as neurogenesis, neuronal differentiation, apoptosis, migration and axon guidance. Binding of repulsive guidance molecules (RGMs) to Neogenin inhibits axon outgrowth of different neuronal populations. This effect requires Neogenin to interact with co-receptors of the uncoordinated locomotion-5 (Unc5) family to activate downstream Rho signaling. Although previous studies have reported RGM, Neogenin, and/or Unc5 expression, a systematic comparison of RGM and Neogenin expression in the developing nervous system is lacking, especially at later developmental stages. Furthermore, information on RGM and Neogenin expression at the protein level is limited. To fill this void and to gain further insight into the role of RGM-Neogenin signaling during mouse neural development, we studied the expression of RGMa, RGMb, Neogenin and Unc5A-D using in situ hybridization, immunohistochemistry and RGMa section binding. Expression patterns in the primary olfactory system, cortex, hippocampus, habenula, and cerebellum were studied in more detail. Characteristic cell layer-specific expression patterns were detected for RGMa, RGMb, Neogenin and Unc5A-D. Furthermore, strong expression of RGMa, RGMb and Neogenin protein was found on several major axon tracts such as the primary olfactory projections, anterior commissure and fasciculus retroflexus. These data not only hint at a role for RGM-Neogenin signaling during the development of different neuronal systems, but also suggest that Neogenin partners with different Unc5 family members in different systems. Overall, the results presented here will serve as a framework for further dissection of the role of RGM-Neogenin signaling during neural development.	[van den Heuvel, Dianne M. A.; Hellemons, Anita J. C. G. M.; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Pasterkamp, RJ (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	r.j.pasterkamp@umcutrecht.nl		Pasterkamp, Jeroen/0000-0003-1631-6440	Human Frontier Science Program Organization; Hersenstichting; Netherlands Organization for Health Research and Development (VIDI)	Human Frontier Science Program Organization(Human Frontier Science Program); Hersenstichting; Netherlands Organization for Health Research and Development (VIDI)	This work was funded by the Human Frontier Science Program Organization (Career Development Award), Hersenstichting, and The Netherlands Organization for Health Research and Development (VIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Amaral David G., 1995, P443; Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bradford D, 2010, J COMP NEUROL, V518, P3237, DOI 10.1002/cne.22397; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Cho J, 2009, MOL NEUROBIOL, V39, P1, DOI 10.1007/s12035-008-8047-7; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Conrad S, 2010, MOL CELL NEUROSCI, V43, P222, DOI 10.1016/j.mcn.2009.11.003; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Endo M, 2009, J NEUROSCI, V29, P6649, DOI 10.1523/JNEUROSCI.0927-09.2009; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fitzgerald DP, 2007, GENE EXPR PATTERNS, V7, P784, DOI 10.1016/j.modgep.2007.05.004; Fitzgerald DP, 2006, DEV DYNAM, V235, P1720, DOI 10.1002/dvdy.20744; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Gessert S, 2008, BIOL CELL, V100, P659, DOI 10.1042/BC20080023; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Gruber C, 2007, NEUROSCI LETT, V427, P165, DOI 10.1016/j.neulet.2007.09.016; Guijarro P, 2006, MOL CELL NEUROSCI, V33, P389, DOI 10.1016/j.mcn.2006.08.010; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hagihara M, 2011, J BIOL CHEM, V286, P5157, DOI 10.1074/jbc.M110.180919; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Jorge EC, 2012, DEV DYNAM, V241, P1886, DOI 10.1002/dvdy.23889; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kanomata K, 2009, GENES CELLS, V14, P695, DOI 10.1111/j.1365-2443.2009.01302.x; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; Key B, 2012, CELL ADHES MIGR, V6, P85, DOI 10.4161/cam.20167; Kim D, 2011, J NEUROSCI, V31, P2167, DOI 10.1523/JNEUROSCI.5254-10.2011; Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Kuramoto T, 2004, MOL BRAIN RES, V122, P103, DOI 10.1016/j.molbrainres.2003.12.003; Lah GJ, 2012, DEV NEUROBIOL, V72, P1458, DOI 10.1002/dneu.22010; Lah GJ, 2012, MOL CELL BIOL, V32, P968, DOI 10.1128/MCB.06128-11; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li J, 2012, J CELL BIOCHEM, V113, P2523, DOI 10.1002/jcb.24128; Liu XX, 2009, BIOCHEM BIOPH RES CO, V382, P795, DOI 10.1016/j.bbrc.2009.03.115; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Manitt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011463; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Metzger M, 2007, J NEUROCHEM, V103, P2665, DOI 10.1111/j.1471-4159.2007.04994.x; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Muramatsu R, 2010, BRAIN, V133, P60, DOI 10.1093/brain/awp266; Murase S, 2002, J NEUROSCI, V22, P3568; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Okamura Y, 2011, NEUROSCI RES, V71, P63, DOI 10.1016/j.neures.2011.05.012; Oldekamp J, 2004, GENE EXPR PATTERNS, V4, P283, DOI 10.1016/j.modgep.2003.11.008; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; PHILLIPSON OT, 1982, EXP BRAIN RES, V45, P89; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Schnichels S, 2012, GRAEF ARCH CLIN EXP, V250, P39, DOI 10.1007/s00417-011-1791-9; Schnichels S, 2011, J NEUROSCI RES, V89, P490, DOI 10.1002/jnr.22584; Schwab JM, 2005, EUR J NEUROSCI, V21, P1569, DOI 10.1111/j.1460-9568.2005.03962.x; Severyn CJ, 2009, BIOCHEM J, V422, P393, DOI 10.1042/BJ20090978; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Takemoto M, 2011, CEREB CORTEX, V21, P1925, DOI 10.1093/cercor/bhq265; Tassew NG, 2008, MOL CELL NEUROSCI, V37, P761, DOI 10.1016/j.mcn.2008.01.002; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001; Yoshida J, 2008, BIOCHEM BIOPH RES CO, V372, P725, DOI 10.1016/j.bbrc.2008.05.124; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhong Y, 2004, CEREB CORTEX, V14, P1144, DOI 10.1093/cercor/bhh074; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	93	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55828	10.1371/journal.pone.0055828	http://dx.doi.org/10.1371/journal.pone.0055828			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457482	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700023
J	Bartus, K; Pigott, B; Garthwaite, J				Bartus, Katalin; Pigott, Beatrice; Garthwaite, John			Cellular Targets of Nitric Oxide in the Hippocampus	PLOS ONE			English	Article							SOLUBLE GUANYLYL CYCLASE; LONG-TERM POTENTIATION; CYCLIC-GMP; SPECIES-DIFFERENCES; GABAERGIC SYNAPSES; RAT-BRAIN; CGMP; RECEPTOR; LOCALIZATION; NO	In the hippocampus, as in many other CNS areas, nitric oxide (NO) participates in synaptic plasticity, manifested as changes in pre- and/or postsynaptic function. While it is known that these changes are brought about by cGMP following activation of guanylyl cyclase-coupled NO receptors attempts to locate cGMP by immunocytochemistry in hippocampal slices in response to NO have failed to detect the cGMP elevation where expected, i.e. in the pyramidal neurones. Instead, astrocytes, unidentified varicose fibres and GABA-ergic nerve terminals are reported to be the prominent NO targets, raising the possibility that NO acts indirectly via other cells. We have re-investigated the distribution of cGMP generated in response to endogenous and exogenous NO in hippocampal slices using immunohistochemistry and new conditions designed to optimise cGMP accumulation and, hence, its detectability. The conditions included use of tissue from the developing rat hippocampus, a potent inhibitor of phosphodiesterase-2, and an allosteric enhancer of the NO-receptive guanylyl cyclase. Under these conditions, cGMP was formed in response to endogenous NO and was found in a population of pyramidal cell somata in area CA3 and subiculum as well as in structures described previously. The additional presence of exogenous NO resulted in hippocampal cGMP reaching the highest level recorded for brain tissue (1700 pmol/mg protein) and in cGMP immunolabelling throughout the pyramidal cell layer. Populations of axons and interneurones were also stained. According with these results, immunohistochemistry for the common NO receptor beta 1-subunit indicated widespread expression. A similar staining pattern for the alpha 1-subunit with an antibody used previously in the hippocampus and elsewhere, however, proved to be artefactual. The results indicate that the targets of NO in the hippocampus are more varied and extensive than previous evidence had suggested and, in particular, that the pyramidal neurones participating in NO-dependent synaptic plasticity are direct NO targets.	[Bartus, Katalin; Pigott, Beatrice; Garthwaite, John] UCL, Wolfson Inst Biomed Res, London, England	University of London; University College London	Garthwaite, J (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	john.garthwaite@ucl.ac.uk			Wellcome Trust [081512/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by The Wellcome Trust (grant number 081512/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Arancio O, 2001, J NEUROSCI, V21, P143, DOI 10.1523/JNEUROSCI.21-01-00143.2001; Bellamy TC, 2001, MOL PHARMACOL, V59, P54, DOI 10.1124/mol.59.1.54; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; BOULTON CL, 1994, EUR J NEUROSCI, V6, P1528, DOI 10.1111/j.1460-9568.1994.tb00543.x; Burette A, 2002, J NEUROSCI, V22, P8961; Cserep C, 2011, CEREB CORTEX, V21, P2065, DOI 10.1093/cercor/bhq281; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; deVente J, 1996, J CHEM NEUROANAT, V10, P241, DOI 10.1016/0891-0618(95)00144-1; Ding JD, 2004, J COMP NEUROL, V472, P437, DOI 10.1002/cne.20054; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; Feil Robert, 2008, V184, P529; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Fukutani T, 2009, ARCH HISTOL CYTOL, V72, P117, DOI 10.1679/aohc.72.117; GARTHWAITE G, 1989, J NEUROSCI METH, V29, P33, DOI 10.1016/0165-0270(89)90106-4; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gibb BJ, 2001, EUR J NEUROSCI, V13, P539, DOI 10.1046/j.1460-9568.2001.01421.x; Hall CN, 2006, J PHYSIOL-LONDON, V577, P549, DOI 10.1113/jphysiol.2006.118380; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Huang RH, 2007, EXP BIOL MED, V232, P118; Iino S, 2008, NEUROSCIENCE, V152, P437, DOI 10.1016/j.neuroscience.2007.12.044; Lin DTS, 2010, SYNAPSE, V64, P460, DOI 10.1002/syn.20750; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Lu YF, 1999, J NEUROSCI, V19, P10250; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Makara JK, 2007, J NEUROSCI, V27, P10211, DOI 10.1523/JNEUROSCI.2104-07.2007; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Mo E, 2004, J BIOL CHEM, V279, P26149, DOI 10.1074/jbc.M400916200; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; Neitz A, 2011, EUR J NEUROSCI, V33, P1611, DOI 10.1111/j.1460-9568.2011.07654.x; Pifarre P, 2007, J COMP NEUROL, V500, P942, DOI 10.1002/cne.21241; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Szabadits E, 2007, J NEUROSCI, V27, P8101, DOI 10.1523/JNEUROSCI.1912-07.2007; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Tanaka J, 1997, GLIA, V19, P286; Taqatqeh F, 2009, J NEUROSCI, V29, P9344, DOI 10.1523/JNEUROSCI.1902-09.2009; van Langen J, 2012, EUR J PHARMACOL, V696, P111, DOI 10.1016/j.ejphar.2012.09.016; van Staveren WCG, 2005, BRAIN RES, V1036, P77, DOI 10.1016/j.brainres.2004.12.040; van Staveren WCG, 2004, EUR J NEUROSCI, V19, P2155, DOI 10.1111/j.0953-816X.2004.03327.x; van Staveren WCG, 2003, J COMP NEUROL, V467, P566, DOI 10.1002/cne.10955; van Staveren WCG, 2001, BRAIN RES, V888, P275, DOI 10.1016/S0006-8993(00)03081-X; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Wilson GW, 2010, EUR J NEUROSCI, V31, P1935, DOI 10.1111/j.1460-9568.2010.07226.x; Wood KC, 2011, J BIOL CHEM, V286, P43172, DOI 10.1074/jbc.M111.289777	54	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57292	10.1371/journal.pone.0057292	http://dx.doi.org/10.1371/journal.pone.0057292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451200	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500085
J	Dai, L; Xu, C; Tian, M; Sang, J; Zou, D; Li, A; Liu, GC; Chen, F; Wu, JY; Xiao, JF; Wang, XM; Yu, J; Zhang, Z				Dai, Lin; Xu, Chao; Tian, Ming; Sang, Jian; Zou, Dong; Li, Ang; Liu, Guocheng; Chen, Fei; Wu, Jiayan; Xiao, Jingfa; Wang, Xumin; Yu, Jun; Zhang, Zhang			Community Intelligence in Knowledge Curation: An Application to Managing Scientific Nomenclature	PLOS ONE			English	Article							WEB 2.0; WIKI-DATABASE; BIG DATA; ANNOTATION; RESOURCE; FUTURE	Harnessing community intelligence in knowledge curation bears significant promise in dealing with communication and education in the flood of scientific knowledge. As knowledge is accumulated at ever-faster rates, scientific nomenclature, a particular kind of knowledge, is concurrently generated in all kinds of fields. Since nomenclature is a system of terms used to name things in a particular discipline, accurate translation of scientific nomenclature in different languages is of critical importance, not only for communications and collaborations with English-speaking people, but also for knowledge dissemination among people in the non-English-speaking world, particularly young students and researchers. However, it lacks of accuracy and standardization when translating scientific nomenclature from English to other languages, especially for those languages that do not belong to the same language family as English. To address this issue, here we propose for the first time the application of community intelligence in scientific nomenclature management, namely, harnessing collective intelligence for translation of scientific nomenclature from English to other languages. As community intelligence applied to knowledge curation is primarily aided by wiki and Chinese is the native language for about one-fifth of the world's population, we put the proposed application into practice by developing a wiki-based English-to-Chinese Scientific Nomenclature Dictionary (ESND; http://esnd.big.ac.cn). ESND is a wiki-based, publicly editable and open-content platform, exploiting the whole power of the scientific community in collectively and collaboratively managing scientific nomenclature, demonstrating a valuable application of community intelligence is knowledge curation.	[Dai, Lin; Xu, Chao; Tian, Ming] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing 100081, Peoples R China; [Dai, Lin; Zou, Dong; Li, Ang; Liu, Guocheng; Chen, Fei; Wu, Jiayan; Xiao, Jingfa; Wang, Xumin; Yu, Jun; Zhang, Zhang] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Sang, Jian] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China	Beijing Institute of Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhang, Z (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	zhangzhang@big.ac.cn	zhang, zhang/GQZ-6804-2022; wang, xumin/HII-8627-2022; zhang, zheng/HCH-9684-2022	wu, jia yan/0000-0001-6048-405X; chen, fei/0000-0003-3895-6318	National Natural Science Foundation of China [60803050, 61132009]; "100-Talent Program" of Chinese Academy of Sciences [Y1SLXb1365]; National Programs for High Technology Research and Development (863 Program) [2012AA020409]; Ministry of Science and chnology of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "100-Talent Program" of Chinese Academy of Sciences(Chinese Academy of Sciences); National Programs for High Technology Research and Development (863 Program); Ministry of Science and chnology of the People's Republic of China	This work was supported by grants from National Natural Science Foundation of China (60803050, 61132009), the "100-Talent Program" of Chinese Academy of Sciences (Y1SLXb1365), and National Programs for High Technology Research and Development (863 Program; Grant No. 2012AA020409), the Ministry of Science and chnology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NATURE, V489, P19, DOI 10.1038/489019a; Bolser DM, 2012, NUCLEIC ACIDS RES, V40, pD1250, DOI 10.1093/nar/gkr1099; Callaway E, 2010, NATURE, V468, P358; Cariaso M, 2012, NUCLEIC ACIDS RES, V40, pD1308, DOI 10.1093/nar/gkr798; Csosz E, 2009, AMINO ACIDS, V36, P615, DOI 10.1007/s00726-008-0121-y; Daub J, 2008, RNA, V14, P2462, DOI 10.1261/rna.1200508; Feng Z, 2005, TERMINOLOGY STANDARD, V2, P4; Finn RD, 2012, NUCLEIC ACIDS RES, V40, pD9, DOI 10.1093/nar/gkr1195; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Giles J, 2007, NATURE, V445, P691, DOI 10.1038/445691a; Good BM, 2012, NUCLEIC ACIDS RES, V40, pD1255, DOI 10.1093/nar/gkr925; Groza T, 2012, J BIOMED INFORM, DOI 10.1016/j.jbi.2012.11.007; Hodis E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r121; Hoehndorf R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S5-S5; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Hu JC, 2008, SCIENCE, V320, P1289, DOI 10.1126/science.320.5881.1289b; Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kumar S, 2012, NUCLEIC ACIDS RES, V40, pD1295, DOI 10.1093/nar/gkr826; Li J, 2000, CHINESE SCIENCE AND, V2, P6; Li JW, 2012, NUCLEIC ACIDS RES, V40, pD1313, DOI 10.1093/nar/gkr1058; Lu Y, 2006, ACTA EDITOLOGICA, V4, P241; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; McIntosh BK, 2012, NUCLEIC ACIDS RES, V40, pD1270, DOI 10.1093/nar/gkr880; McLean R, 2007, MED J AUSTRALIA, V187, P174, DOI 10.5694/j.1326-5377.2007.tb01180.x; Meng L.X, 2011, CHIN SCI TECHNOL TRA, V24, P28; Mons B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r89; OReilly Tim, 2005, WHAT IS WEB 2 0; Orii N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049029; Renfro DP, 2012, NUCLEIC ACIDS RES, V40, pD1262, DOI 10.1093/nar/gkr907; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Stehr H, 2010, DATABASE-OXFORD, V2010; Stokes TH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S18; Sun N, 1990, MOLECULAR GENETICS; Waldrop M, 2008, NATURE, V455, P22, DOI 10.1038/455022a; Zhang H, 2007, CHINA TERMINOLOGY, V9, P49; Zhang Z, 2011, BIOINFORMATICS TREND; Zhang Z, 2009, BRIEF BIOINFORM, V10, P1, DOI 10.1093/bib/bbn041; Zhao DY, 2012, OMICS, V16, P357, DOI 10.1089/omi.2011.0139	40	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56961	10.1371/journal.pone.0056961	http://dx.doi.org/10.1371/journal.pone.0056961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451119	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500046
J	Stahl, JS; Thumser, ZC				Stahl, John S.; Thumser, Zachary C.			4-Aminopyridine Does Not Enhance Flocculus Function in Tottering, a Mouse Model of Vestibulocerebellar Dysfunction and Ataxia	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; VESTIBULO-OCULAR REFLEX; DOWNBEAT NYSTAGMUS; EYE-MOVEMENTS; MULTIPLE-SCLEROSIS; ZONAL ORGANIZATION; POTASSIUM CHANNELS; SMOOTH-PURSUIT; QUICK PHASE; GUINEA-PIGS	The potassium channel antagonist 4-aminopyridine (4-AP) improves a variety of motor abnormalities associated with disorders of the cerebellum. The most rigorous quantitative data relate to 4-AP's ability to improve eye movement deficits in humans referable to dysfunction of the cerebellar flocculus. Largely based on work in the ataxic mouse mutant tottering (which carries a mutation of the Cacna1a gene of the P/Q voltage-activated calcium channel), 4-AP is hypothesized to function by enhancing excitability or rhythmicity of floccular Purkinje cells. We tested this hypothesis by determining whether systemic or intrafloccular administration of 4-AP would ameliorate the eye movement deficits in tottering that are attributable to flocculus dysfunction, including the reductions in amplitude of the yaw-axis vestibulo-ocular reflex (VOR) and vision-enhanced vestibulo-ocular reflex (VVOR), and the optokinetic reflex (OKR) about yaw and roll axes. Because tottering's deficits increase with age, both young and elderly mutants were tested to detect any age-dependent 4-AP effects. 4-AP failed to improve VOR, VVOR, and OKR gains during sinusoidal stimuli, although it may have reduced the tendency of the mutants' responses to VOR and VVOR to decline over the course of a one-hour recording session. For constant-velocity optokinetic stimuli, 4-AP generated some enhancement of yaw OKR and upward-directed roll OKR, but the effects were also seen in normal C57BL/6 controls, and thus do not represent a specific reversal of the electrophysiological consequences of the tottering mutation. Data support a possible extra-floccular locus for the effects of 4-AP on habituation and roll OKR. Unilateral intrafloccular 4-AP injections did not affect ocular motility, except to generate mild eye elevations, consistent with reduced floccular output. Because 4-AP did not produce the effects expected if it normalized outputs of floccular Purkinje cells, there is a need for further studies to elucidate the drug's mechanism of action on cerebellar motor dysfunction.	[Stahl, John S.; Thumser, Zachary C.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Div Neurol, Cleveland, OH USA; [Stahl, John S.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Stahl, JS (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Div Neurol, Cleveland, OH USA.	jss6@case.edu			Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development) [1 I01 BX000278-01]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000278] Funding Source: NIH RePORTER	Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development)(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, application #1 I01 BX000278-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvina K, 2010, J NEUROSCI, V30, P7258, DOI 10.1523/JNEUROSCI.3582-09.2010; Alvina K, 2010, J NEUROSCI, V30, P7249, DOI 10.1523/JNEUROSCI.6341-09.2010; Balaban CD, 2000, NEUROSCIENCE, V99, P669, DOI 10.1016/S0306-4522(00)00232-3; Bense S, 2006, NEUROREPORT, V17, P599, DOI 10.1097/00001756-200604240-00009; BEVER CT, 1994, NEUROLOGY, V44, P1054, DOI 10.1212/WNL.44.6.1054; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Capacio BR, 1996, BIOMED CHROMATOGR, V10, P111, DOI 10.1002/(SICI)1099-0801(199605)10:3<111::AID-BMC569>3.0.CO;2-E; Capacio BR, 1997, DRUG CHEM TOXICOL, V20, P151, DOI 10.3109/01480549709003876; Chen G, 2009, J NEUROPHYSIOL, V101, P234, DOI 10.1152/jn.90829.2008; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Curthoys IS, 2002, EXP BRAIN RES, V143, P397, DOI 10.1007/s00221-002-1022-z; Etzion Y, 2001, EXP BRAIN RES, V139, P419, DOI 10.1007/s002210100788; Etzion Y, 1998, EXP BRAIN RES, V122, P283, DOI 10.1007/s002210050516; FURMAN JM, 1981, BRAIN RES, V206, P490, DOI 10.1016/0006-8993(81)90553-9; Glasauer S, 2005, ANN NY ACAD SCI, V1039, P528, DOI 10.1196/annals.1325.060; Glasauer S, 2011, ANN NY ACAD SCI, V1233, P162, DOI 10.1111/j.1749-6632.2011.06149.x; Glasauer S, 2009, CEREBELLUM, V8, P385, DOI 10.1007/s12311-009-0109-5; GODAUX E, 1984, J PHYSIOL-LONDON, V346, P155, DOI 10.1113/jphysiol.1984.sp015013; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; HALMAGYI GM, 1983, ARCH NEUROL-CHICAGO, V40, P777; HASSUL M, 1976, BRAIN RES, V118, P339, DOI 10.1016/0006-8993(76)90722-8; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Hourez R, 2011, J NEUROSCI, V31, P11795, DOI 10.1523/JNEUROSCI.0905-11.2011; ISAACS KR, 1995, BRAIN RES BULL, V36, P309, DOI 10.1016/0361-9230(94)00207-H; ISAACS KR, 1992, DEV NEUROSCI-BASEL, V14, P386, DOI 10.1159/000111687; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; Kalla R, 2006, NEUROLOGY, V66, P281, DOI 10.1212/01.wnl.0000194242.28018.d9; Kalla R, 2004, NEUROLOGY, V62, P1228, DOI 10.1212/01.WNL.0000118287.68294.E5; Kalla R, 2007, BRAIN, V130, P2441, DOI 10.1093/brain/awm172; Kalla R, 2011, J NEURO-OPHTHALMOL, V31, P320, DOI 10.1097/WNO.0b013e3182258086; Kim CH, 2012, J PHYSIOL-LONDON, V590, P273, DOI 10.1113/jphysiol.2011.221846; LANGER T, 1985, J COMP NEUROL, V235, P26, DOI 10.1002/cne.902350103; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; LEMEIGNAN M, 1984, BRAIN RES, V304, P166, DOI 10.1016/0006-8993(84)90875-8; Luthman J, 2011, CEREBELLUM, V10, P667, DOI 10.1007/s12311-011-0295-9; Marti S, 2002, ANN NEUROL, V52, P712, DOI 10.1002/ana.10370; Marti S, 2008, EXP BRAIN RES, V188, P613, DOI 10.1007/s00221-008-1396-7; Martina M, 2003, J NEUROSCI, V23, P5698; MOLGO J, 1985, EUR J MED CHEM, V20, P149; NAGAO S, 1989, EXP BRAIN RES, V77, P531; NICHOLSON C, 1985, BRAIN RES, V333, P325, DOI 10.1016/0006-8993(85)91586-0; Oommen BS, 2008, BRAIN RES, V1193, P57, DOI 10.1016/j.brainres.2007.11.053; Potter PJ, 1998, SPINAL CORD, V36, P147, DOI 10.1038/sj.sc.3100559; Quartel A, 2010, CURR MED RES OPIN, V26, P1363, DOI 10.1185/03007991003745209; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Sacco T, 2002, J PHYSIOL-LONDON, V543, P505, DOI 10.1113/jphysiol.2002.022525; Sander T, 2011, J NEUROL, V258, P618, DOI 10.1007/s00415-010-5806-y; Sanders DB, 1998, ANN NY ACAD SCI, V841, P811, DOI 10.1111/j.1749-6632.1998.tb11022.x; SATO Y, 1990, J NEUROPHYSIOL, V64, P551, DOI 10.1152/jn.1990.64.2.551; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Sedehizadeh S, 2012, CLIN NEUROPHARMACOL, V35, P191, DOI 10.1097/WNF.0b013e31825a68c5; SERAFIN M, 1990, EXP BRAIN RES, V82, P187, DOI 10.1007/BF00230850; Shin M, 2011, J NEUROSCI, V31, P10776, DOI 10.1523/JNEUROSCI.0768-11.2011; Stahl JS, 2012, J VESTIBUL RES-EQUIL, V22, P221, DOI 10.3233/VES-120463; Stahl JS, 2008, PROG BRAIN RES, V171, P503, DOI 10.1016/S0079-6123(08)00672-9; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2006, J NEUROPHYSIOL, V95, P1588, DOI 10.1152/jn.00318.2005; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1396, DOI 10.1152/jn.1995.73.4.1396; Stahl JS, 2012, CHALLENGE NYSTAGMUS, P59; Stahl JS, 2010, SOC NEUR ABSTR, V36; Stahl JS., 2008, EYE RETINA VISUAL SY, V2008, P872; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; Strupp M, 2011, NEUROLOGY, V77, P269, DOI 10.1212/WNL.0b013e318225ab07; Strupp M, 2003, NEUROLOGY, V61, P165, DOI 10.1212/01.WNL.0000078893.41040.56; Strupp M, 2006, CURR OPIN NEUROL, V19, P33, DOI 10.1097/01.wco.0000196156.00481.e1; Strupp M, 2007, NEUROTHERAPEUTICS, V4, P267, DOI 10.1016/j.nurt.2007.01.014; Strupp Michael, 2009, Ther Adv Neurol Disord, V2, P223, DOI 10.1177/1756285609103120; VANDERSTEEN J, 1994, J NEUROPHYSIOL, V72, P31, DOI 10.1152/jn.1994.72.1.31; VANDIEMEN HAM, 1993, CLIN NEUROPHARMACOL, V16, P195, DOI 10.1097/00002826-199306000-00002; VANNEERVEN J, 1991, PROG BRAIN RES, V88, P485; Vollmer T, 2009, CLIN THER, V31, P2215, DOI 10.1016/j.clinthera.2009.10.007; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; WEBER RB, 1972, VISION RES, V12, P467, DOI 10.1016/0042-6989(72)90090-9; Weisz CJC, 2005, J NEUROSCI, V25, P4141, DOI 10.1523/JNEUROSCI.0098-05.2005; Womack MD, 2009, NEUROSCIENCE, V162, P989, DOI 10.1016/j.neuroscience.2009.05.016; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	78	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57895	10.1371/journal.pone.0057895	http://dx.doi.org/10.1371/journal.pone.0057895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451282	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500144
J	Arriazu, R; Duran, E; Pozuelo, JM; Santamaria, L				Arriazu, Riansares; Duran, Esther; Pozuelo, Jose M.; Santamaria, Luis			Expression of Lysophosphatidic Acid Receptor 1 and Relation with Cell Proliferation, Apoptosis, and Angiogenesis on Preneoplastic Changes Induced by Cadmium Chloride in the Rat Ventral Prostate	PLOS ONE			English	Article							LPA RECEPTORS; ZINC-CHLORIDE; CANCER; CARCINOGENESIS; P53; CHEMOPREVENTION; IDENTIFICATION; EFFICACY	Background: Lysophosphatidic acid (LPA) is a phospholipid growth factor involved in cell proliferation, differentiation, migration, inflammation, angiogenesis, wound healing, cancer invasion, and survival. This study was directed to evaluate the immunoexpression of LPA-1, cell proliferation, apoptosis, and angiogenesis markers in preneoplastic lesions induced with cadmium chloride in rat prostate. Methods: The following parameters were calculated in ventral prostate of normal rats and rats that received Cd in drinking water during 24 months: percentages of cells immunoreactive to LPA-1 (LILPA1), PCNA (LIPCNA), MCM7 (LIMCM7), ubiquitin (LIUBI), apoptotic cells (LIAPO), and p53 (LIp53); volume fraction of Bcl-2 (V(F)Bcl-2); and length of microvessels per unit of volume (LVMV/mm3). Data were analyzed using Student's t-test and Pearson correlation test. Results: The LILPA1 in dysplastic lesions and normal epithelium of Cd-treated rats was significantly higher than those in the control group. Markers of proliferation were significantly increased in dysplastic lesions, whereas some apoptotic markers were significantly decreased. No significant differences between groups were found in V(F)Bcl-2. Dysplastic lesions showed a significant increase of LIp53. The length of microvessels per unit of volume was elevated in dysplastic acini. Statistically significant correlations were found only between LILPA1 and LIUBI. Conclusions: Our results suggest that LPA-1 might be implicated in dysplastic lesions induced by cadmium chloride development. More studies are needed to confirm its potential contribution to the disease.	[Arriazu, Riansares; Duran, Esther] CEU San Pablo Univ, Histol Lab, Inst Appl Mol Med, Dept Basic Med Sci,Sch Med, Madrid, Spain; [Pozuelo, Jose M.] CEU San Pablo Univ, Inst Appl Mol Med, Sch Med, Dept Basic Med Sci,Cell Biol Lab, Madrid, Spain; [Santamaria, Luis] Autonomous Univ Madrid, Dept Morphol, Sch Med, E-28049 Madrid, Spain	San Pablo CEU University; San Pablo CEU University; Autonomous University of Madrid	Arriazu, R (corresponding author), CEU San Pablo Univ, Histol Lab, Inst Appl Mol Med, Dept Basic Med Sci,Sch Med, Madrid, Spain.	arriazun@ceu.es	Arriazu, Riánsares/J-6764-2012	Arriazu, Riánsares/0000-0001-6253-9552; Santamaria Solis, Luis/0000-0001-6560-2502	San Pablo-CEU University; Santander Bank [USP-BS-PPC04/2011]	San Pablo-CEU University; Santander Bank	This study was supported in part by a financial grant from San Pablo-CEU University and Santander Bank (USP-BS-PPC04/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimola P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033647; Arakawa A, 1997, PROSTATE CANCER P D, V1, P32, DOI 10.1038/sj.pcan.4500204; Aronson KJ, 1996, AM J EPIDEMIOL, V143, P363; Arriazu R, 2005, HORMONAL CARCINOGENESIS IV, P522, DOI 10.1007/0-387-23761-5_58; Arriazu R, 2005, PROSTATE, V63, P347, DOI 10.1002/pros.20192; Arriazu R, 2006, J HISTOCHEM CYTOCHEM, V54, P981, DOI 10.1369/jhc.5A6733.2006; Arunkumar A, 2006, BIOL PHARM BULL, V29, P375, DOI 10.1248/bpb.29.375; Bonkhoff H, 1998, PATHOLOGE, V19, P33, DOI 10.1007/s002920050252; BOSARI S, 1992, VIRCHOWS ARCH A, V421, P291, DOI 10.1007/BF01660975; Bosland MC, 1999, EUR UROL, V35, P459, DOI 10.1159/000019879; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chen SU, 2008, ENDOCRINOLOGY, V149, P5888, DOI 10.1210/en.2008-0314; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Delves GH, 2007, SEMIN THROMB HEMOST, V33, P75, DOI 10.1055/s-2006-958465; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guo R, 2006, ENDOCRINOLOGY, V147, P4883, DOI 10.1210/en.2005-1635; Ishino H, 2011, DOMEST ANIM ENDOCRIN, V41, P207, DOI 10.1016/j.domaniend.2011.07.002; Knillova Jana, 2003, Biomedical Papers (Olomouc), V147, P3; KOLONEL L, 1977, LANCET, V2, P566; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; LAUWERYS RR, 1994, CLIN CHEM, V40, P1391; Lin CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041096; Lundequist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018192; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Marshall J R, 2001, IARC Sci Publ, V154, P191; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Martin JJ, 2001, PROSTATE, V46, P11; Morrissey C, 2002, J ANDROL, V23, P341; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Nicholson B, 2003, HISTOL HISTOPATHOL, V18, P275, DOI 10.14670/HH-18.275; OBRIEN TS, 1995, BRIT J UROL, V76, P675, DOI 10.1111/j.1464-410X.1995.tb00755.x; Ota T, 2011, MODERN PATHOL, V24, P277, DOI 10.1038/modpathol.2010.202; Pollard M, 2001, CANCER LETT, V173, P127, DOI 10.1016/S0304-3835(01)00673-5; Reisman D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/808934; RITTMASTER RS, 1995, ENDOCRINOLOGY, V136, P741, DOI 10.1210/en.136.2.741; Santamaria L, 2008, OPEN PROSTATE CANC J, V2, P46; SILVESTRINI R, 1993, J NATL CANCER I, V85, P965, DOI 10.1093/jnci/85.12.965; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tang DG, 1998, CANCER RES, V58, P3466; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; WAALKES MP, 1989, CANCER RES, V49, P4282; Yamashita H, 2010, J ONCOL, V2010, DOI 10.1155/2010/107075; Yanagida K, 2011, J BIOCHEM, V150, P223, DOI 10.1093/jb/mvr087; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhu GB, 2011, ONCOL LETT, V2, P1213, DOI 10.3892/ol.2011.410	49	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57742	10.1371/journal.pone.0057742	http://dx.doi.org/10.1371/journal.pone.0057742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451264	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800116
J	Elliott, JA; Abdulhadi, NN; Al-Maniri, AA; Al-Shafaee, MA; Wahlstrom, R				Elliott, James A.; Abdulhadi, Nadia Noor; Al-Maniri, Abdullah A.; Al-Shafaee, Mohammed A.; Wahlstrom, Rolf			Diabetes Self-Management and Education of People Living with Diabetes: A Survey in Primary Health Care in Muscat Oman	PLOS ONE			English	Article							DISEASE; PREVALENCE; KNOWLEDGE; MELLITUS; ILLNESS	Background: Although the prevalence of type 2 diabetes in Oman is high and rising, information on how people were self-managing their disease has been lacking. The objective of this study was therefore to assess diabetes self-management and education (DSME) among people living with type 2 diabetes in Oman. Methods: A questionnaire survey was conducted in public primary health care centres in Muscat. Diabetes self-management and education was assessed by asking how patients recognized and responded to hypo- and hyperglycaemia, and if they had developed strategies to maintain stable blood glucose levels. Patients' demographic information, self-treatment behaviours, awareness of potential long-term complications, and attitudes concerning diabetes management were also recorded. Associations between these factors and diabetes self-management and education were analysed. Results: In total, 309 patients were surveyed. A quarter (26%, n = 83) were unaware how to recognize hypoglycaemia or respond to it (26%, n = 81). Around half (49%, n = 151), could not recognize hyperglycaemia and more than half could not respond to it (60%, n = 184). Twelve percent (n = 37) of the patients did not have any strategies to stabilize their blood glucose levels. Patients with formal education generally had more diabetes self-management and education than those without (p<0.001), as had patients with longer durations of diabetes (p<0.01). Self-monitoring of blood glucose was practiced by 38% (n = 117) of the patients, and insulin was used by 22% (n = 67), of which about one third independently adjusted dosages. Patients were most often aware of complications concerning loss of vision, renal failure and cardiac problems. Many patients desired further health education. Conclusions: Many patients displayed dangerous diabetes self-management and education knowledge gaps. The findings suggest a need for improving knowledge transfer to people living with diabetes in the Omani clinical setting.	[Elliott, James A.; Abdulhadi, Nadia Noor; Wahlstrom, Rolf] Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Abdulhadi, Nadia Noor] Minist Hlth, Dept Hlth Affairs, Muscat, Oman; [Al-Maniri, Abdullah A.; Al-Shafaee, Mohammed A.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Family Med & Publ Hlth, Muscat, Oman; [Wahlstrom, Rolf] Uppsala Univ, Dept Publ Hlth & Caring Sci Family Med & Clin Epi, Uppsala, Sweden	Karolinska Institutet; Sultan Qaboos University; Uppsala University	Abdulhadi, NN (corresponding author), Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden.	nadia.abdulhadi@ki.se		Elliott, James/0000-0001-7150-6074; Al Shafaee, Mohammed/0000-0002-4816-1706	Ministry of Health, Oman; Karolinska Institutet, Sweden; Sultan Qaboos University in Oman	Ministry of Health, Oman; Karolinska Institutet, Sweden(Karolinska Institutet); Sultan Qaboos University in Oman	Funding provided by Ministry of Health, Oman; Karolinska Institutet, Sweden (www.ki.se) and Sultan Qaboos University in Oman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhadi N., 2006, BMC Family Practice, V7; Al Shafaee MA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-249; Al-Lawati JA, 2002, DIABETIC MED, V19, P954, DOI 10.1046/j.1464-5491.2002.00818.x; Al-Lawati Jawad A, 2008, Prev Chronic Dis, V5, pA99; Al-Moosa Siba, 2006, Popul Health Metr, V4, P5, DOI 10.1186/1478-7954-4-5; Al-Shafaee Mohammed Ali, 2008, Metabolic Syndrome and Related Disorders, V6, P275, DOI 10.1089/met.2008.0019; Al-Shahib W, 2003, INT J FOOD SCI NUTR, V54, P247, DOI [10.1080/09637480120091982, 10.1080/096374803766666120]; Assal J P, 1995, Pharmacoeconomics, V8 Suppl 1, P68; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Fitzner K, 2008, POPUL HEALTH MANAG, V11, P329, DOI 10.1089/pop.2008.0012; Funnell Martha M, 2004, Crit Care Nurs Q, V27, P201; Funnell MM, 2002, AM J PREV MED, V22, P3, DOI 10.1016/S0749-3797(02)00431-2; Ganguly S S, 2009, East Mediterr Health J, V15, P209; Hjelm K, 2003, INT J NURS STUD, V40, P627, DOI 10.1016/S0020-7489(03)00020-8; Holmstrom IM, 2005, J ADV NURS, V49, P146, DOI 10.1111/j.1365-2648.2004.03274.x; Insight Guides, 2009, OMAN UAE; Kendall DM, 2001, AM J MANAG CARE, V7, pS327; Krosnick JA, 2010, HANDBOOK OF SURVEY RESEARCH, 2ND EDITION, P263; Lawrence P, 2001, J Transcult Nurs, V12, P228, DOI 10.1177/104365960101200307; Marrero David G, 2007, Clin Cornerstone, V8, P33; Ministry of Health Sultanate of Oman, 2003, DIAB MELL MAN GUID P; Ministry of Health Sultanate of Oman, 2008, WORLD HLTH SURV; Ministry of Information Sultanate of Oman, 2002, TRAD MOD; National Diabetes Information Clearinghouse, 2011, NAT DIAB STAT 2011; National Diabetes Information Clearinghouse, 2008, HYP; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Otero LM, 2008, REV LAT-AM ENFERM, V16, P231, DOI 10.1590/S0104-11692008000200010; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Rothman RL, 2005, DIABETES EDUCATOR, V31, P215, DOI 10.1177/0145721705275002; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sidorov J, 2002, DIABETES CARE, V25, P684, DOI 10.2337/diacare.25.4.684; Thompson DM, 1999, CAN MED ASSOC J, V161, P959; Travaline JM, 2005, J AM OSTEOPATH ASSOC, V105, P13; United Nations Development Program, 2010, 40 YEAR TRENDS AN SH; Urbanski P, 2008, J AM DIET ASSOC, V108, pS6, DOI 10.1016/j.jada.2008.01.019; Veg A, 2006, J ADV NURS, V56, P44, DOI 10.1111/j.1365-2648.2006.03978.x; Weiss BD, 2009, HLTH LIT PATIENT SAF, P1; Westphal SA, 2010, ENDOCR PRACT, V16, P506, DOI 10.4158/EP09344.RA; White J.R., 2003, CLIN DIABETES, V21, P14; WHO, 2010, COUNTR COOP STRAT WH	40	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57400	10.1371/journal.pone.0057400	http://dx.doi.org/10.1371/journal.pone.0057400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451219	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800104
J	Ku, ZQ; Ye, XH; Huang, XL; Cai, YC; Liu, QW; Li, Y; Su, ZG; Huang, Z				Ku, Zhiqiang; Ye, Xiaohua; Huang, Xulin; Cai, Yicun; Liu, Qingwei; Li, Yan; Su, Zhiguo; Huang, Zhong			Neutralizing Antibodies Induced by Recombinant Virus-Like Particles of Enterovirus 71 Genotype C4 Inhibit Infection at Pre- and Post-attachment Steps	PLOS ONE			English	Article							MOUTH-DISEASE; VP1 PROTEIN; MICE; HAND; IMMUNIZATION; VACCINE; LETHAL; IDENTIFICATION; CHALLENGE; OUTBREAK	Background: Enterovirus 71 (EV71) is a major causative agent of hand, foot and mouth disease, which has been prevalent in Asia-Pacific regions, causing significant morbidity and mortality in young children. Antibodies elicited by experimental EV71 vaccines could neutralize infection in vitro and passively protect animal models from lethal challenge, indicating that neutralizing antibodies play an essential role in protection. However, how neutralizing antibodies inhibit infection in vitro remains unclear. Methods/Findings: In the present study, we explored the mechanisms of neutralization by antibodies against EV71 virus-like particles (VLPs). Recombinant VLPs of EV71 genotype C4 were produced in insect cells using baculovirus vectors. Immunization with the VLPs elicited a high-titer, EV71-specific antibody response in mice. Anti-VLP mouse sera potently neutralized EV71 infection in vitro. The neutralizing antibodies in the anti-VLP mouse sera were found to target mainly an extremely conserved epitope (FGEHKQEKDLEYGAC) located at the GH loop of the VP1 protein. The neutralizing anti-VLP antisera were able to inhibit virus binding to target cells efficiently. In addition, post-attachment treatment of virus-bound cells with the anti-VLP antisera also neutralized virus infection, although the antibody concentration required was higher than that of the pre-attachment treatment. Conclusions: Collectively, our findings represent a valuable addition to the understanding of mechanisms of EV71 neutralization and have strong implications for EV71 vaccine development.	[Ku, Zhiqiang; Ye, Xiaohua; Huang, Xulin; Cai, Yicun; Liu, Qingwei; Huang, Zhong] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Yan; Su, Zhiguo] Chinese Acad Sci, Natl Key Lab Biochem Engn, Inst Proc Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Institute of Process Engineering, CAS	Huang, Z (corresponding author), Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	huangzhong@ips.ac.cn	Ku, Zhiqiang/D-9283-2018; Ye, Xiaohua/U-6501-2017	Ku, Zhiqiang/0000-0001-8347-0013; Ye, Xiaohua/0000-0002-2300-4739; Huang, Zhong/0000-0002-2161-1359	Chinese Academy of Sciences "100 Talents" program [KSCX2-YW-BR-2]; Open Funding Project of the National Key Laboratory of Biochemical Engineering [2010KF-07]	Chinese Academy of Sciences "100 Talents" program(Chinese Academy of Sciences); Open Funding Project of the National Key Laboratory of Biochemical Engineering	This work was supported by a grant (#KSCX2-YW-BR-2) from the Chinese Academy of Sciences "100 Talents" program and a grant (#2010KF-07) from the Open Funding Project of the National Key Laboratory of Biochemical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HF, 2006, VACCINE, V24, P2944, DOI 10.1016/j.vaccine.2005.12.047; Chen HL, 2008, VACCINE, V26, P2882, DOI 10.1016/j.vaccine.2008.03.041; Chung CY, 2010, VACCINE, V28, P6951, DOI 10.1016/j.vaccine.2010.08.052; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Feng Yan-fang, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P535; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Ku Z, 2012, J VIROL METHODS; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Liu QW, 2012, VACCINE, V30, P6642, DOI 10.1016/j.vaccine.2012.08.071; Liu QW, 2011, J VIROL METHODS, V173, P115, DOI 10.1016/j.jviromet.2011.01.016; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	27	59	66	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57601	10.1371/journal.pone.0057601	http://dx.doi.org/10.1371/journal.pone.0057601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451250	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800113
J	Lau, E; Fisher, MC; Steudler, PA; Cavanaugh, CM				Lau, Evan; Fisher, Meredith C.; Steudler, Paul A.; Cavanaugh, Colleen M.			The Methanol Dehydrogenase Gene, mxaF, as a Functional and Phylogenetic Marker for Proteobacterial Methanotrophs in Natural Environments	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SP NOV.; ACIDOPHILIC BACTERIUM; ATMOSPHERIC METHANE; ANAEROBIC OXIDATION; MUSSELS; BIOGEOGRAPHY; CONGRUENCE; METABOLISM; MYTILIDAE	The mxaF gene, coding for the large (a) subunit of methanol dehydrogenase, is highly conserved among distantly related methylotrophic species in the Alpha-, Beta- and Gammaproteobacteria. It is ubiquitous in methanotrophs, in contrast to other methanotroph-specific genes such as the pmoA and mmoX genes, which are absent in some methanotrophic proteobacterial genera. This study examined the potential for using the mxaF gene as a functional and phylogenetic marker for methanotrophs. mxaF and 16S rRNA gene phylogenies were constructed based on over 100 database sequences of known proteobacterial methanotrophs and other methylotrophs to assess their evolutionary histories. Topology tests revealed that mxaF and 16S rDNA genes of methanotrophs do not show congruent evolutionary histories, with incongruencies in methanotrophic taxa in the Methylococcaceae, Methylocystaceae, and Beijerinckiacea. However, known methanotrophs generally formed coherent clades based on mxaF gene sequences, allowing for phylogenetic discrimination of major taxa. This feature highlights the mxaF gene's usefulness as a biomarker in studying the molecular diversity of proteobacterial methanotrophs in nature. To verify this, PCR-directed assays targeting this gene were used to detect novel methanotrophs from diverse environments including soil, peatland, hydrothermal vent mussel tissues, and methanotroph isolates. The placement of the majority of environmental mxaF gene sequences in distinct methanotroph-specific clades (Methylocystaceae and Methylococcaceae) detected in this study supports the use of mxaF as a biomarker for methanotrophic proteobacteria.	[Lau, Evan] W Liberty Univ, Dept Nat Sci & Math, W Liberty, WV USA; [Lau, Evan; Fisher, Meredith C.; Cavanaugh, Colleen M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Steudler, Paul A.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	Harvard University; Marine Biological Laboratory - Woods Hole	Lau, E (corresponding author), W Liberty Univ, Dept Nat Sci & Math, W Liberty, WV USA.	evanlau28@gmail.com		Lau, Evan/0000-0002-7434-4362	U.S. National Science Foundation Ecosystems Studies program [DEB9708092, DEB0089738]	U.S. National Science Foundation Ecosystems Studies program	This work was supported in part by grants from the U.S. National Science Foundation Ecosystems Studies program (awards # DEB9708092 and DEB0089738). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anthony C, 2004, ARCH BIOCHEM BIOPHYS, V428, P2, DOI 10.1016/j.abb.2004.03.038; Anthony C, 2000, Subcell Biochem, V35, P73; Auman AJ, 2000, APPL ENVIRON MICROB, V66, P5259, DOI 10.1128/AEM.66.12.5259-5266.2000; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berestovskaya JJ, 2012, INT J SYST EVOL MICR, V62, P638, DOI 10.1099/ijs.0.007005-0; Buckley TR, 2002, SYST BIOL, V51, P4, DOI 10.1080/106351502753475844; Chen Y, 2010, J BACTERIOL, V192, P3840, DOI 10.1128/JB.00506-10; Chistoserdova L, 2011, ENVIRON MICROBIOL, V13, P2603, DOI 10.1111/j.1462-2920.2011.02464.x; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; DeChaine EG, 2006, ENVIRON MICROBIOL, V8, P1902, DOI 10.1111/j.1462-2920.2005.01113.x; Dedysh SN, 2005, J BACTERIOL, V187, P3884, DOI 10.1128/JB.187.11.3884-3888.2005; Dedysh SN, 2002, INT J SYST EVOL MICR, V52, P251, DOI 10.1099/00207713-52-1-251; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Dlugokencky EJ, 2011, PHILOS T R SOC A, V369, P2058, DOI 10.1098/rsta.2010.0341; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Fuse H, 1998, BIOSCI BIOTECH BIOCH, V62, P1925, DOI 10.1271/bbb.62.1925; Gulledge J, 2004, FEMS MICROBIOL ECOL, V49, P389, DOI 10.1016/j.femsec.2004.04.013; Gulledge J, 2001, APPL ENVIRON MICROB, V67, P4726, DOI 10.1128/AEM.67.10.4726-4733.2001; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Heyer J, 2002, MICROBIOL-SGM, V148, P2831, DOI 10.1099/00221287-148-9-2831; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Kalyuzhnaya MG, 2008, J BACTERIOL, V190, P3817, DOI 10.1128/JB.00180-08; Keitel T, 2000, J MOL BIOL, V297, P961, DOI 10.1006/jmbi.2000.3603; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lau E, 2007, FEMS MICROBIOL ECOL, V60, P490, DOI 10.1111/j.1574-6941.2007.00308.x; Lidstrom ME, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P618, DOI 10.1007/0-387-30742-7_20; LIDSTROM ME, 1994, FEMS MICROBIOL LETT, V117, P103, DOI 10.1111/j.1574-6968.1994.tb06749.x; Luesken FA, 2012, ENVIRON MICROBIOL, V14, P1024, DOI 10.1111/j.1462-2920.2011.02682.x; MARIN LE, 1990, BIOGEOCHEMISTRY, V11, P63; McDonald IR, 2008, APPL ENVIRON MICROB, V74, P1305, DOI 10.1128/AEM.02233-07; McDonald IR, 1997, APPL ENVIRON MICROB, V63, P3218, DOI 10.1128/AEM.63.8.3218-3224.1997; MCDONALD IR, 1995, APPL ENVIRON MICROB, V61, P116, DOI 10.1128/AEM.61.1.116-121.1995; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Petersen J. E., 2009, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Schmidt S, 2010, MICROBIOL-SGM, V156, P2575, DOI 10.1099/mic.0.038570-0; Stewart FJ, 2005, TRENDS MICROBIOL, V13, P439, DOI 10.1016/j.tim.2005.07.007; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Suzuki R, 2009, J GEN APPL MICROBIOL, V55, P101, DOI 10.2323/jgam.55.101; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vorob'ev AV, 2009, INT J SYST EVOL MICR, V59, P2538, DOI 10.1099/ijs.0.010074-0; Vorobev AV, 2011, INT J SYST EVOL MICR, V61, P2456, DOI 10.1099/ijs.0.028118-0; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Whittenbury R, 1970, J GEN MICROBIOL, V59, P2771; Wick LY, 1998, ENVIRON SCI TECHNOL, V32, P1319, DOI 10.1021/es970544+; Won YJ, 2003, APPL ENVIRON MICROB, V69, P6785, DOI 10.1128/AEM.69.11.6785-6792.2003; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2; Wu ML, 2011, BIOCHEM SOC T, V39, P243, DOI 10.1042/BST0390243; Zhang M, 2003, MICROBIOL-SGM, V149, P1033, DOI 10.1099/mic.0.26105-0	59	33	33	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56993	10.1371/journal.pone.0056993	http://dx.doi.org/10.1371/journal.pone.0056993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451130	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800060
J	Manyando, C; Njunju, EM; D'Alessandro, U; Van Geertruyden, JP				Manyando, Christine; Njunju, Eric M.; D'Alessandro, Umberto; Van Geertruyden, Jean-Pierre			Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A Systematic Review	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; SUB-SAHARAN AFRICA; INSECTICIDE-TREATED BEDNETS; INFECTED UGANDAN CHILDREN; FOLIC-ACID ANTAGONISTS; SULFADOXINE-PYRIMETHAMINE; PREGNANT-WOMEN; PLACENTAL MALARIA; WESTERN KENYA	Introduction: Cotrimoxazole (CTX) has been used for half a century. It is inexpensive hence the reason for its almost universal availability and wide clinical spectrum of use. In the last decade, CTX was used for prophylaxis of opportunistic infections in HIV infected people. It also had an impact on the malaria risk in this specific group. Objective: We performed a systematic review to explore the efficacy and safety of CTX used for P. falciparum malaria treatment and prophylaxis. Result: CTX is safe and efficacious against malaria. Up to 75% of the safety concerns relate to skin reactions and this increases in HIV/AIDs patients. In different study areas, in HIV negative individuals, CTX used as malaria treatment cleared 56%-97% of the malaria infections, reduced fever and improved anaemia. CTX prophylaxis reduces the incidence of clinical malaria in HIV-1 infected individuals from 46%-97%. In HIV negative non pregnant participants, CTX prophylaxis had 39.5%-99.5% protective efficacy against clinical malaria. The lowest figures were observed in zones of high sulfadoxine-pyrimethamine resistance. There were no data reported on CTX prophylaxis in HIV negative pregnant women. Conclusion: CTX is safe and still efficacious for the treatment of P.falciparum malaria in non-pregnant adults and children irrespective of HIV status and antifolate resistance profiles. There is need to explore its effect in pregnant women, irrespective of HIV status. CTX prophylaxis in HIV infected individuals protects against malaria and CTX may have a role for malaria prophylaxis in specific HIV negative target groups.	[Manyando, Christine] Trop Dis Res Ctr, Dept Publ Hlth, Ndola, Zambia; [D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Van Geertruyden, Jean-Pierre] Univ Antwerp, Antwerp, Belgium; [Njunju, Eric M.] Trop Dis Res Ctr, Dept Biomed Sci, Ndola, Zambia	Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; University of Antwerp	Manyando, C (corresponding author), Trop Dis Res Ctr, Dept Publ Hlth, Ndola, Zambia.	cmanyando@yahoo.com	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364	Belgian Development Co-operation	Belgian Development Co-operation	Belgian Development Co-operation funded the process through an institutional collaboration between the Tropical Disease Research Center, Ndola, Zambia, and the Institute of Tropical Medicine, Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akim NIJ, 2000, AM J TROP MED HYG, V63, P199, DOI 10.4269/ajtmh.2000.63.199; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Anglaret X, 2010, LANCET, V375, P1231, DOI 10.1016/S0140-6736(10)60200-0; [Anonymous], 2008, FOOD NUTR BULL, V29, pS3; [Anonymous], 2012, INT PREV TREATM MAL; Ayisi JG, 2003, AIDS, V17, P585, DOI 10.1097/00002030-200303070-00014; Badri M, 1999, LANCET, V354, P334, DOI 10.1016/S0140-6736(05)75237-5; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; Briand V, 2009, ANN TROP PAEDIATR, V29, P71, DOI 10.1179/146532809X440699; BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x; Byakika-Kibwika Pauline, 2007, Afr Health Sci, V7, P86; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; Czeizel AE, 2001, REPROD TOXICOL, V15, P637, DOI 10.1016/S0890-6238(01)00178-2; DARAMOLA OO, 1991, T ROY SOC TROP MED H, V85, P345, DOI 10.1016/0035-9203(91)90285-7; DARRELL JH, 1968, J CLIN PATHOL, V21, P202, DOI 10.1136/jcp.21.2.202; Dorsey G, 2004, AM J TROP MED HYG, V71, P758, DOI 10.4269/ajtmh.2004.71.758; Farrell J, 2003, J PHARMACOL EXP THER, V306, P229, DOI 10.1124/jpet.103.050112; FASAN PO, 1971, ANN TROP MED PARASIT, V65, P117, DOI 10.1080/00034983.1971.11686737; Fehintola F A, 2010, Afr J Med Med Sci, V39, P63; Feikin DR, 2000, J INFECT DIS, V181, P1501, DOI 10.1086/315382; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Forna F, 2006, AIDS REV, V8, P24; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Gasasira AF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-177; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gill CJ, 2004, B WORLD HEALTH ORGAN, V82, P290; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Hamel MJ, 2005, AM J TROP MED HYG, V73, P609, DOI 10.4269/ajtmh.2005.73.609; HANSFORD CF, 1982, S AFR MED J, V61, P512; Heimpel H, 1987, Infection, V15 Suppl 5, pS248, DOI 10.1007/BF01643198; Hernandez-Diaz S, 2001, AM J EPIDEMIOL, V153, P961, DOI 10.1093/aje/153.10.961; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Ho JMW, 2011, CAN MED ASSOC J, V183, P1851, DOI 10.1503/cmaj.111152; Inion I, 2003, J INFECT DIS, V188, P1675, DOI 10.1086/379737; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; JOOS B, 1995, ANTIMICROB AGENTS CH, V39, P2661, DOI 10.1128/AAC.39.12.2661; Kamya MR, 2007, AIDS, V21, P2059, DOI 10.1097/QAD.0b013e3282ef6da1; Kapito-Tembo A, 2011, J INFECT DIS, V203, P464, DOI 10.1093/infdis/jiq072; Kilian AHD, 1998, T ROY SOC TROP MED H, V92, P197, DOI 10.1016/S0035-9203(98)90748-9; Kone A, 2010, INT J PARASITOL, V40, P1221, DOI 10.1016/j.ijpara.2010.05.004; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kyabayinze D, 2003, AM J TROP MED HYG, V69, P247, DOI 10.4269/ajtmh.2003.69.247; Ladner J, 2003, AIDS, V17, P275, DOI 10.1097/00002030-200301240-00025; Lynen L, 2007, T ROY SOC TROP MED H, V101, P1059, DOI 10.1016/j.trstmh.2007.07.001; Malamba S, 2010, AM J TROP MED HYG, V82, P766, DOI 10.4269/ajtmh.2010.08-0408; Malamba SS, 2006, AM J TROP MED HYG, V75, P375, DOI 10.4269/ajtmh.2006.75.375; Mendez F, 2002, AM J EPIDEMIOL, V156, P230, DOI 10.1093/aje/kwf030; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Mutabingwa TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005138; Mutabingwa TK, 1996, T R SOC TROP MED HYG, V90, P476; Nakanjako D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-66; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newman PM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-254; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Omar SA, 2001, T ROY SOC TROP MED H, V95, P657, DOI 10.1016/S0035-9203(01)90107-5; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; PETERSEN E, 1987, T ROY SOC TROP MED H, V81, P238, DOI 10.1016/0035-9203(87)90226-4; Petri WA, 2012, GILMAN GOODMANS PHAR; REEVES DS, 1969, BRIT MED J, V1, P541, DOI 10.1136/bmj.1.5643.541; Robert V, 2000, AM J TROP MED HYG, V62, P210, DOI 10.4269/ajtmh.2000.62.210; Sandison TG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1617; Santos F, 2011, BJOG-INT J OBSTET GY, V118, P1374, DOI 10.1111/j.1471-0528.2011.03041.x; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Siega-Riz AM, 2004, AM J OBSTET GYNECOL, V191, P1851, DOI 10.1016/j.ajog.2004.07.076; Sowunmi A, 2006, ANN TROP MED PARASIT, V100, P205, DOI 10.1179/136485906X91503; Sowunmi A, 2005, MEM I OSWALDO CRUZ, V100, P451, DOI 10.1590/S0074-02762005000400019; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P100, DOI 10.4269/ajtmh.2003.68.100; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P68, DOI 10.4269/ajtmh.2003.68.68; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; Ticconi C, 2003, JAIDS-J ACQ IMM DEF, V34, P289, DOI 10.1097/00126334-200311010-00005; Tomasulo Patricia, 2007, Medical Reference Services Quarterly, V26, P51, DOI 10.1300/J115v26n01_05; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P95; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; Van Eijk AM, 2001, AM J TROP MED HYG, V65, P623, DOI 10.4269/ajtmh.2001.65.623; Van Geertruyden JP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-134; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S115; von Seidlein L, 2001, TROP MED INT HEALTH, V6, P92, DOI 10.1046/j.1365-3156.2001.00683.x; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Walter J, 2006, J INFECT DIS, V194, P1510, DOI 10.1086/508996; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, WHO POL REC IPTI; WHO, 2010, GUID TREATM MAL, V2nd; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; WILKINSON RN, 1973, T ROY SOC TROP MED H, V67, P148, DOI 10.1016/0035-9203(73)90340-4; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Yoshimine H, 2001, AM J TROP MED HYG, V64, P172; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	104	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56916	10.1371/journal.pone.0056916	http://dx.doi.org/10.1371/journal.pone.0056916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451110	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800048
J	Pang, JB; Rhodes, DH; Pini, M; Akasheh, RT; Castellanos, KJ; Cabay, RJ; Cooper, D; Perretti, M; Fantuzzi, G				Pang, Jingbo; Rhodes, Davina H.; Pini, Maria; Akasheh, Rand T.; Castellanos, Karla J.; Cabay, Robert J.; Cooper, Dianne; Perretti, Mauro; Fantuzzi, Giamila			Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice	PLOS ONE			English	Article							GALECTIN-3/AGE-RECEPTOR-3 KNOCKOUT MICE; RECEPTOR-MEDIATED MECHANISMS; INDUCED GLOMERULAR INJURY; DIET-INDUCED OBESITY; INSULIN SENSITIVITY; AGE-RECEPTOR; FATTY LIVER; LIPOXIDATION; ACTIVATION; EXPRESSION	Obesity and type 2 diabetes are associated with increased production of Galectin-3 (Gal-3), a protein that modulates inflammation and clearance of glucose adducts. We used Lean and Diet-induced Obese (DIO) WT and Gal-3 KO mice to investigate the role of Gal-3 in modulation of adiposity, glucose metabolism and inflammation. Deficiency of Gal-3 lead to age-dependent development of excess adiposity and systemic inflammation, as indicated by elevated production of acute-phase proteins, number of circulating pro-inflammatory Ly6C(high) monocytes and development of neutrophilia, microcytic anemia and thrombocytosis in 20-week-old Lean and DIO male Gal-3 KO mice. This was associated with impaired fasting glucose, heightened response to a glucose tolerance test and reduced adipose tissue expression of adiponectin, Gal-12, ATGL and PPAR gamma, in the presence of maintained insulin sensitivity and hepatic expression of gluconeogenic enzymes in 20-week- old Gal-3 KO mice compared to their diet-matched WT controls. Expression of PGC-1 alpha and FGF-21 in the liver of Lean Gal-3 KO mice was comparable to that observed in DIO animals. Impaired fasting glucose and altered responsiveness to a glucose load preceded development of excess adiposity and systemic inflammation, as demonstrated in 12-week-old Gal-3 KO mice. Finally, a role for the microflora in mediating the fasting hyperglycemia, but not the excessive response to a glucose load, of 12-week-old Gal-3 KO mice was demonstrated by administration of antibiotics. In conclusion, Gal-3 is an important modulator of glucose metabolism, adiposity and inflammation.	[Pang, Jingbo; Rhodes, Davina H.; Pini, Maria; Akasheh, Rand T.; Castellanos, Karla J.; Fantuzzi, Giamila] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA; [Cabay, Robert J.] Univ Illinois, Dept Pathol, Chicago, IL USA; [Cooper, Dianne; Perretti, Mauro] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of London; Queen Mary University London	Fantuzzi, G (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA.	giamila@uic.edu	Akasheh, Rand/AAY-2606-2020; Cabay, Robert J./AAP-9570-2021; Fantuzzi, Giamila/A-1758-2009; Castellanos, Karla/D-1164-2018; Pini, Maria/AAC-2530-2021; Pini, Maria/T-6292-2018; Pini, Maria/O-8620-2019	Cabay, Robert J./0000-0001-8473-296X; Fantuzzi, Giamila/0000-0001-5334-0082; Castellanos, Karla/0000-0002-8723-6475; Pini, Maria/0000-0002-9995-5370; Pini, Maria/0000-0002-9995-5370; Pang, Jingbo/0000-0001-8325-8434	NIH [DK083328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.F. is supported by NIH grant DK083328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Chakrabarti P, 2011, CURR DIABETES REV, V7, P270, DOI 10.2174/157339911796397866; Darrow AL, 2011, PHYSIOL GENOMICS, V43, P1144, DOI 10.1152/physiolgenomics.00035.2011; de Boer RA, 2011, J INTERN MED; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Iacobini C, 2005, AM J PHYSIOL-RENAL, V289, pF611, DOI 10.1152/ajprenal.00435.2004; Iacobini C, 2004, FASEB J, V18, P1773, DOI 10.1096/fj.04-2031fje; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Iacobini C, 2009, J PATHOL, V218, P360, DOI 10.1002/path.2536; Iacobini C, 2009, ARTERIOSCL THROM VAS, V29, P831, DOI 10.1161/ATVBAHA.109.186791; Kiwaki K, 2007, OBESITY, V15, P32, DOI 10.1038/oby.2007.526; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Nomoto K, 2006, J PATHOL, V210, P469, DOI 10.1002/path.2065; Nomoto K, 2012, SCI WORLD J, P1, DOI 10.1100/2012/959824; Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pini M, 2012, J LEUKOCYTE BIOL, V91, P957, DOI 10.1189/jlb.1211627; Pini M, 2011, CYTOKINE, V56, P708, DOI 10.1016/j.cyto.2011.09.015; Pugliese G, 2001, FASEB J, V15, P2471, DOI 10.1096/fj.01-0006com; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Rhodes DH, 2012, OBESITY IN PRESS; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Savino B, 2012, BLOOD, V119, P5250, DOI 10.1182/blood-2011-10-388082; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Weigert J, 2010, J CLIN ENDOCR METAB, V95, P1404, DOI 10.1210/jc.2009-1619; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200	42	73	75	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57915	10.1371/journal.pone.0057915	http://dx.doi.org/10.1371/journal.pone.0057915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451284	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800121
J	Xu, ZB; Fang, X; Wood, TK; Huang, ZJ				Xu, Zhaobin; Fang, Xin; Wood, Thomas K.; Huang, Zuyi Jacky			A Systems-Level Approach for Investigating Pseudomonas aeruginosa Biofilm Formation	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BIOFILMS; METABOLIC NETWORK ANALYSIS; CONSTRAINT-BASED MODELS; ESCHERICHIA-COLI; QUANTITATIVE PREDICTION; STREPTOCOCCUS-MUTANS; CELLULAR-METABOLISM; GENE-EXPRESSION; COBRA TOOLBOX; RESISTANCE	Prevention of the initiation of biofilm formation is the most important step for combating biofilm-associated pathogens, as the ability of pathogens to resist antibiotics is enhanced 10 to 1000 times once biofilms are formed. Genes essential to bacterial growth in the planktonic state are potential targets to treat biofilm-associated pathogens. However, the biofilm formation capability of strains with mutations in these essential genes must be evaluated, since the pathogen might form a biofilm before it is eliminated. In order to address this issue, this work proposes a systems-level approach to quantifying the biofilm formation capability of mutants to determine target genes that are essential for bacterial metabolism in the planktonic state but do not induce biofilm formation in their mutants. The changes of fluxes through the reactions associated with the genes positively related to biofilm formation are used as soft sensors in the flux balance analysis to quantify the trend of biofilm formation upon the mutation of an essential gene. The essential genes whose mutants are predicted not to induce biofilm formation are regarded as gene targets. The proposed approach was applied to identify target genes to treat Pseudomonas aeruginosa infections. It is interesting to find that most essential gene mutants exhibit high potential to induce the biofilm formation while most non-essential gene mutants do not. Critically, we identified four essential genes, lysC, cysH, adk, and galU, that constitute gene targets to treat P. aeruginosa. They have been suggested by existing experimental data as potential drug targets for their crucial role in the survival or virulence of P. aeruginosa. It is also interesting to find that P. aeruginosa tends to survive the essential-gene mutation treatment by mainly enhancing fluxes through 8 metabolic reactions that regulate acetate metabolism, arginine metabolism, and glutamate metabolism.	[Xu, Zhaobin; Huang, Zuyi Jacky] Villanova Univ, Dept Chem Engn, Villanova, PA 19085 USA; [Fang, Xin] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Wood, Thomas K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Wood, Thomas K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Huang, Zuyi Jacky] Villanova Univ, Ctr Nonlinear Dynam & Control, Villanova, PA 19085 USA; [Huang, Zuyi Jacky] Villanova Univ, VCASE, Villanova, PA 19085 USA	Villanova University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Villanova University; Villanova University	Huang, ZJ (corresponding author), Villanova Univ, Dept Chem Engn, Villanova, PA 19085 USA.	zuyi.huang@villanova.edu	Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; xu, zhaobin/0000-0002-1136-5684; Wood, Thomas/0000-0002-6258-529X	Villanova University [SRF-RSG 217030-7252, 420492]; National Institutes of Health [R01 GM089999]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089999] Funding Source: NIH RePORTER	Villanova University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Z.H. was supported by Villanova University (grant SRF-RSG 217030-7252; VCASE seed grant 420492). T.W. was supported by the National Institutes of Health (R01 GM089999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Burton E, 2006, ANTIMICROB AGENTS CH, V50, P1835, DOI 10.1128/AAC.50.5.1835-1840.2006; Cao B, 2004, J HOSP INFECT, V57, P112, DOI 10.1016/j.jhin.2004.03.021; Chandra H, 2010, MICROBIOL-SGM, V156, P3669, DOI 10.1099/mic.0.043828-0; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; ewBonofiglio L, 2005, CURR MICROBIOL, V51, P217; Garavaglia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031252; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Hancock V, 2010, APPL ENVIRON MICROB, V76, P3836, DOI 10.1128/AEM.00241-10; Heinemann M, 2005, BIOTECHNOL BIOENG, V92, P850, DOI 10.1002/bit.20663; Itzek A, 2011, J BACTERIOL, V193, P6912, DOI 10.1128/JB.05791-11; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Jones MB, 2005, J INFECT DIS, V191, P1881, DOI 10.1086/429696; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Kim HU, 2010, MOL BIOSYST, V6, P339, DOI 10.1039/b916446d; Kopriva S, 2002, J BIOL CHEM, V277, P21786, DOI 10.1074/jbc.M202152200; Kroukamp O, 2009, APPL ENVIRON MICROB, V75, P4391, DOI 10.1128/AEM.01567-08; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu J, 2011, CURR MICROBIOL, V62, P235, DOI 10.1007/s00284-010-9696-0; Lu CD, 2004, J BACTERIOL, V186, P3855, DOI 10.1128/JB.186.12.3855-3861.2004; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; Makhorin A, GLPK GNU LINEAR PROG; Markaryan A, 2001, J BACTERIOL, V183, P3345, DOI 10.1128/JB.183.11.3345-3352.2001; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Mueller RS, 2007, J BACTERIOL, V189, P5348, DOI 10.1128/JB.01867-06; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Pruss BM, 2010, ARCH MICROBIOL, V192, P715, DOI 10.1007/s00203-010-0599-z; Rathsam C, 2005, J PROTEOME RES, V4, P2161, DOI 10.1021/pr0502471; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; Serra DO, 2008, PROTEOMICS, V8, P4995, DOI 10.1002/pmic.200800218; Shiba Y, 2012, MICROBIOL-SGM, V158, P1238, DOI 10.1099/mic.0.056945-0; Sigurdsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034337; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Yoshida A, 2007, ACTA CRYSTALLOGR F, V63, P96, DOI 10.1107/S1744309106055837; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	54	26	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57050	10.1371/journal.pone.0057050	http://dx.doi.org/10.1371/journal.pone.0057050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451140	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800066
J	Zhang, BB; Liu, XZ; Sun, J; Yin, YW; Sun, QQ				Zhang, Bei-Bei; Liu, Xing-Zhen; Sun, Jin; Yin, Yan-Wei; Sun, Qian-Qian			Association between TNF alpha Gene Polymorphisms and the Risk of Duodenal Ulcer: A Meta-Analysis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HELICOBACTER-PYLORI INFECTION; PEPTIC-ULCER; IL-1; INTERLEUKIN-1-BETA; SUSCEPTIBILITY; DISEASE; GASTRITIS; PROMOTER; HOST	Background: Epidemiological studies have evaluated the association between tumor necrosis factor alpha (TNF-alpha) single nucleotide polymorphisms (SNPs) and duodenal ulcer (DU), but the results remain inconclusive. The aim of this study was to perform a meta-analysis to investigate a more authentic association between TNF-alpha SNPs and DU. Methods: We performed the meta-analysis by searching PubMed, Embase, and Web of Science databases from the first available year to Sep. 5, 2012. Additionally, checking reference lists from identified articles, reviews, and the abstracts presented at related scientific societies meetings were also performed. All case-control studies investigating the association between TNF-alpha SNPs and DU risk were included. The association was assessed by odds ratio (OR) with 95% confidence interval (CI). Publication bias was analyzed by Begg's funnel plot and Egger's regression test. Results: A total of sixteen studies reporting TNF-alpha -308G/A, -1031T/C, -863C/A, -857C/T, and -238G/A polymorphism were included in our final meta-analysis. There was no statistically significant association between -308G/A polymorphism and DU in the overall study population, as well as subgroup analyses by ethnicity, study design, and H. pylori status. As for -1031T/C, -863C/A, -857C/T, and -238G/A, results of our meta-analyses showed no statistical evidence of significant association. Power calculation on the combined sample size showed that the statistical powers were all lower than 80% for all the meta-analyses. Conclusions: The data suggests that there is no statistical evidence of significant association between the studied TNF-alpha SNPs and DU. However, this conclusion should be interpreted with caution as low statistical powers were revealed by power calculations. In future, larger sample-size studies with homogeneous DU patients and well-matched controls are required.	[Zhang, Bei-Bei] PLA Chengdu Mil Area Command, Gen Hosp, Dept Med Affairs, Chengdu, Peoples R China; [Liu, Xing-Zhen] Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Sun, Jin] PLA Chengdu Mil Area Command, Gen Hosp, Dept Gynecol & Obstet, Chengdu, Peoples R China; [Yin, Yan-Wei] Chinese PLA AF Gen Hosp, Dept Emergency, Beijing, Peoples R China; [Sun, Qian-Qian] Jinsong Sanat Beijing AF, Beijing, Peoples R China	Naval Medical University	Zhang, BB (corresponding author), PLA Chengdu Mil Area Command, Gen Hosp, Dept Med Affairs, Chengdu, Peoples R China.	zbb1983918@163.com	Kim, Seongman/N-6910-2014					Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Chakravorty M, 2008, J GENET, V87, P299, DOI 10.1007/s12041-008-0048-9; Cheng HH, 2010, J GASTROEN HEPATOL, V25, P1443, DOI 10.1111/j.1440-1746.2010.06310.x; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAN XG, 1995, J CLIN PATHOL, V48, P133, DOI 10.1136/jcp.48.2.133; Fischer-Rosinsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003852; Garcia-Gonzalez MA, 2005, INT J IMMUNOGENET, V32, P299, DOI 10.1111/j.1744-313X.2005.00528.x; Garcia-Gonzalez MA, 2002, GASTROENTEROLOGY, V122, pA427; Gillen D, 2005, CLIN GASTROENTEROL H, V3, P1180, DOI 10.1016/S1542-3565(05)00896-7; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Gyulai Z, 2004, EUR CYTOKINE NETW, V15, P353; Hellmig S, 2002, GASTROENTEROLOGY, V122, pA19; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kim N, 2006, HELICOBACTER, V11, P105, DOI 10.1111/j.1523-5378.2006.00384.x; Kunstmann E, 1999, ELECTROPHORESIS, V20, P1756, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1756::AID-ELPS1756>3.3.CO;2-2; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; Lee JY, 2005, CANCER LETT, V225, P207, DOI 10.1016/j.canlet.2004.11.028; Lee SG, 2004, CYTOKINE, V28, P75, DOI 10.1016/j.cyto.2004.06.009; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Li C, 2005, AM J GASTROENTEROL, V100, P290, DOI 10.1111/j.1572-0241.2005.40806.x; Lu CC, 2005, AM J GASTROENTEROL, V100, P1274, DOI 10.1111/j.1572-0241.2005.40852.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; McColl KEL, 2000, GASTROENTEROL CLIN N, V29, P687, DOI 10.1016/S0889-8553(05)70138-2; Mei Q, 2010, INT J IMMUNOGENET, V37, P9, DOI 10.1111/j.1744-313X.2009.00882.x; Barbosa HPM, 2009, WORLD J GASTROENTERO, V15, P1465, DOI 10.3748/wjg.15.1465; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; PIPER DW, 1984, SCAND J GASTROENTERO, V19, P1015; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P51, DOI 10.1111/j.1440-1746.2006.04442.x; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wilschanski M, 2002, GASTROENTEROLOGY, V122, pA227; Wilschanski T, 2007, J PEDIATR GASTR NUTR, V45, P199, DOI 10.1097/MPG.0b013e3180616bbe; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Xia Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019606; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Yin YW, 2013, HUM IMMUNOL, V74, P125, DOI 10.1016/j.humimm.2012.09.006; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zapata-Colindres JC, 2006, CAN J GASTROENTEROL, V20, P277, DOI 10.1155/2006/175217; Zhang BB, 2012, HUM IMMUNOL, V73, P1200, DOI 10.1016/j.humimm.2012.08.006; Zhang BB, 2012, GENE, V506, P188, DOI 10.1016/j.gene.2012.06.058; Zhou JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042881; Zhou P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022092	45	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57167	10.1371/journal.pone.0057167	http://dx.doi.org/10.1371/journal.pone.0057167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451177	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800084
J	D'Armiento, JM; Goldklang, MP; Hardigan, AA; Geraghty, P; Roth, MD; Connett, JE; Wise, RA; Sciurba, FC; Scharf, SM; Thankachen, J; Islam, M; Ghio, AJ; Foronjy, RF				D'Armiento, Jeanine M.; Goldklang, Monica P.; Hardigan, Andrew A.; Geraghty, Patrick; Roth, Michael D.; Connett, John E.; Wise, Robert A.; Sciurba, Frank C.; Scharf, Steven M.; Thankachen, Jincy; Islam, Monirul; Ghio, Andrew J.; Foronjy, Robert F.			Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; ADULT-ONSET EMPHYSEMA; CIGARETTE-SMOKE; ALVEOLAR MACROPHAGES; LUNG-FUNCTION; MATRIX-METALLOPROTEINASE-9; EXPRESSION; COPD; MICE	Rationale: Though matrix metalloproteinases (MMPs) are critical in the pathogenesis of COPD, their utility as a disease biomarker remains uncertain. This study aimed to determine whether bronchoalveolar lavage (BALF) or plasma MMP measurements correlated with disease severity or functional decline in emphysema. Methods: Enzyme-linked immunosorbent assay and luminex assays measured MMP-1, -9, -12 and tissue inhibitor of matrix metalloproteinase-1 in the BALF and plasma of non-smokers, smokers with normal lung function and moderate-to-severe emphysema subjects. In the cohort of 101 emphysema subjects correlative analyses were done to determine if MMP or TIMP-1 levels were associated with key disease parameters or change in lung function over an 18-month time period. Main Results: Compared to non-smoking controls, MMP and TIMP-1 BALF levels were significantly elevated in the emphysema cohort. Though MMP-1 was elevated in both the normal smoker and emphysema groups, collagenase activity was only increased in the emphysema subjects. In contrast to BALF, plasma MMP-9 and TIMP-1 levels were actually decreased in the emphysema cohort compared to the control groups. Both in the BALF and plasma, MMP and TIMP-1 measurements in the emphysema subjects did not correlate with important disease parameters and were not predictive of subsequent functional decline. Conclusions: MMPs are altered in the BALF and plasma of emphysema; however, the changes in MMPs correlate poorly with parameters of disease intensity or progression. Though MMPs are pivotal in the pathogenesis of COPD, these findings suggest that measuring MMPs will have limited utility as a prognostic marker in this disease.	[D'Armiento, Jeanine M.; Goldklang, Monica P.; Thankachen, Jincy; Islam, Monirul] Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Hardigan, Andrew A.; Geraghty, Patrick; Foronjy, Robert F.] St Lukes Roosevelt Hlth Sci Ctr, Div Pulm & Crit Care Med, New York, NY 10032 USA; [Roth, Michael D.] Univ Calif Los Angeles, Div Pulm & Crit Care Med, Los Angeles, CA USA; [Connett, John E.] Univ Minnesota, Dept Biostat CCBR, St Paul, MN USA; [Wise, Robert A.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Sciurba, Frank C.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Scharf, Steven M.] Univ Maryland, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Ghio, Andrew J.] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; United States Environmental Protection Agency	Foronjy, RF (corresponding author), St Lukes Roosevelt Hlth Sci Ctr, Div Pulm & Crit Care Med, New York, NY 10032 USA.	rforonjy@chpnet.org	Sciurba, Frank/AAZ-9339-2021	sciurba, frank/0000-0001-7468-2225; Geraghty, Patrick/0000-0003-1647-5505; Wise, Robert/0000-0002-8353-2349; Goldklang, Monica/0000-0002-7019-3130	National Institutes of Health [HL086936-04, 5R01HL098528-04]; Flight Attendant Medical Research Institute [074047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086936, R01HL098528, T32HL007343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL086936-04, 5R01HL098528-04) and the Flight Attendant Medical Research Institute (Clinical Innovator Award 074047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Atkinson JJ, 2011, AM J RESP CRIT CARE, V183, P876, DOI 10.1164/rccm.201005-0718OC; BIETH J, 1974, BIOCHEM MED METAB B, V11, P350, DOI 10.1016/0006-2944(74)90134-3; Boedeker KL, 2004, RADIOLOGY, V232, P295, DOI 10.1148/radiol.2321030383; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; Croxton TL, 2003, AM J RESP CRIT CARE, V167, P1142, DOI 10.1164/rccm.200207-756WS; D'Armiento JM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-113; FEINSTEIN G, 1973, BIOCHEM BIOPH RES CO, V50, P1020, DOI 10.1016/0006-291X(73)91508-8; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Foronjy RF, 2003, AM J PHYSIOL-LUNG C, V284, pL727, DOI 10.1152/ajplung.00349.2002; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Haq I, 2011, THORAX, V66, P970, DOI 10.1136/thx.2011.159087; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang YL, 2008, J TOXICOL ENV HEAL A, V71, P1490, DOI 10.1080/15287390802350030; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Lee SY, 2010, RESPIRATION, V80, P133, DOI 10.1159/000284926; MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861; MOORE S, 1948, FED PROC, V7, P174; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Navratilova Z, 2012, RESPIROLOGY; Ohnishi K, 1998, LAB INVEST, V78, P1077; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Roth MD, 2006, CHEST, V130, P1334, DOI 10.1378/chest.130.5.1334; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shiomi T, 2001, EXP LUNG RES; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789; Zucker S, 2004, ADV CLIN CHEM, V38, P37, DOI 10.1016/S0065-2423(04)38002-9	37	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56352	10.1371/journal.pone.0056352	http://dx.doi.org/10.1371/journal.pone.0056352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441181	Green Published, Green Accepted, gold			2022-12-27	WOS:000315159200038
J	Sonnemann, I; Hempel, S; Beutel, M; Hanauer, N; Reidinger, S; Wurst, S				Sonnemann, Ilja; Hempel, Stefan; Beutel, Maria; Hanauer, Nicola; Reidinger, Stefan; Wurst, Susanne			The Root Herbivore History of the Soil Affects the Productivity of a Grassland Plant Community and Determines Plant Response to New Root Herbivore Attack	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SPECIES-SPECIFIC RESPONSES; POPULATION-DYNAMICS; TRIFOLIUM-REPENS; AGRIOTES SPP.; COLONIZATION; INDICATORS; SUSTAINABILITY; IDENTIFICATION; RHIZOSPHERE	Insect root herbivores can alter plant community structure by affecting the competitive ability of single plants. However, their effects can be modified by the soil environment. Root herbivory itself may induce changes in the soil biota community, and it has recently been shown that these changes can affect plant growth in a subsequent season or plant generation. However, so far it is not known whether these root herbivore history effects (i) are detectable at the plant community level and/or (ii) also determine plant species and plant community responses to new root herbivore attack. The present greenhouse study determined root herbivore history effects of click beetle larvae (Elateridae, Coleoptera, genus Agriotes) in a model grassland plant community consisting of six common species (Achillea millefolium, Plantago lanceolata, Taraxacum officinale, Holcus lanatus, Poa pratensis, Trifolium repens). Root herbivore history effects were generated in a first phase of the experiment by growing the plant community in soil with or without Agriotes larvae, and investigated in a second phase by growing it again in the soils that were either Agriotes trained or not. The root herbivore history of the soil affected plant community productivity (but not composition), with communities growing in root herbivore trained soil producing more biomass than those growing in untrained soil. Additionally, it influenced the response of certain plant species to new root herbivore attack. Effects may partly be explained by herbivore-induced shifts in the community of arbuscular mycorrhizal fungi. The root herbivore history of the soil proved to be a stronger driver of plant growth on the community level than an actual root herbivore attack which did not affect plant community parameters. History effects have to be taken into account when predicting the impact of root herbivores on grasslands.	[Sonnemann, Ilja; Hempel, Stefan; Beutel, Maria; Hanauer, Nicola; Wurst, Susanne] Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany; [Reidinger, Stefan] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Free University of Berlin; University of York - UK	Sonnemann, I (corresponding author), Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany.	i.sonnemann@fu-berlin.de			Deutsche Forschungsgemeinschaft [1374, DFG-WU 603/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work has been funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (DFG-WU 603/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett RD, 1999, ECOL LETT, V2, P357; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Borstler B, 2006, BIOL FERT SOILS, V42, P286, DOI 10.1007/s00374-005-0026-9; Brown V.K., 1990, Advances in Ecological Research, V20, P1, DOI 10.1016/S0065-2504(08)60052-5; Currie AF, 2006, SOIL BIOL BIOCHEM, V38, P1994, DOI 10.1016/j.soilbio.2005.11.015; Currie AF, 2011, APPL SOIL ECOL, V47, P77, DOI 10.1016/j.apsoil.2010.12.002; Dawson LA, 2002, SOIL BIOL BIOCHEM, V34, P609, DOI 10.1016/S0038-0717(01)00217-6; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Dosdall LM, 2004, AGRON J, V96, P1306, DOI 10.2134/agronj2004.1306; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Araujo ASF, 2012, AGRON SUSTAIN DEV, V32, P215, DOI 10.1007/s13593-011-0026-0; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fitzjohn RG, 2007, MOL ECOL NOTES, V7, P583, DOI 10.1111/j.1471-8286.2007.01744.x; Gange AC, 2002, ECOL RES, V17, P217, DOI 10.1046/j.1440-1703.2002.00481.x; Gange AC, 2001, NEW PHYTOL, V150, P611, DOI 10.1046/j.1469-8137.2001.00137.x; GANGE AC, 1994, ENTOMOL EXP APPL, V70, P115, DOI 10.1007/BF02380519; Hemerik L, 2003, J INSECT BEHAV, V16, P647, DOI 10.1023/B:JOIR.0000007701.04296.45; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jedlicka P, 2007, BIOLOGIA, V62, P103, DOI 10.2478/s11756-007-0017-4; KALB DW, 1994, PLANT DIS, V78, P491, DOI 10.1094/PD-78-0491; Klausnitzer B, 1994, LARVEN KAEFER MITTEL; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kosola KR, 1999, OECOLOGIA, V118, P69, DOI 10.1007/s004420050704; Kostenko O, 2012, ECOL LETT, V15, P813, DOI 10.1111/j.1461-0248.2012.01801.x; Martin SL, 2012, SOIL BIOL BIOCHEM, V49, P167, DOI 10.1016/j.soilbio.2012.02.036; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Parker WE, 1997, ANN APPL BIOL, V130, P409, DOI 10.1111/j.1744-7348.1997.tb07671.x; R Core Team, 2016, R FDN STAT COMP; Rodriguez-Echeverria S, 2009, BASIC APPL ECOL, V10, P131, DOI 10.1016/j.baae.2008.01.004; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sonnemann I, 2012, BASIC APPL ECOL, V13, P579, DOI 10.1016/j.baae.2012.09.010; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Treonis AM, 2005, APPL SOIL ECOL, V28, P203, DOI 10.1016/j.apsoil.2004.08.004; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Watt MS, 2008, FOREST ECOL MANAG, V256, P180, DOI 10.1016/j.foreco.2008.04.024; Watt MS, 2005, FOREST ECOL MANAG, V216, P51, DOI 10.1016/j.foreco.2005.05.064; Wurst S, 2008, J CHEM ECOL, V34, P1360, DOI 10.1007/s10886-008-9537-9; Wurst S, 2007, BASIC APPL ECOL, V8, P491, DOI 10.1016/j.baae.2006.09.015; Yeates GW, 1998, NEMATOLOGICA, V44, P81, DOI 10.1163/005225998X00082; Zaller JG, 2011, EUR J SOIL BIOL, V47, P175, DOI 10.1016/j.ejsobi.2011.03.001; Zuur Alain F., 2009, P1	44	10	10	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56524	10.1371/journal.pone.0056524	http://dx.doi.org/10.1371/journal.pone.0056524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441201	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200058
J	MacInnis, RJ; Severi, G; Baglietto, L; Dowty, JG; Jenkins, MA; Southey, MC; Hopper, JL; Giles, GG				MacInnis, Robert J.; Severi, Gianluca; Baglietto, Laura; Dowty, James G.; Jenkins, Mark A.; Southey, Melissa C.; Hopper, John L.; Giles, Graham G.			Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E	PLOS ONE			English	Article							FAMILY; PENETRANCE	The HOXB13 missense mutation G84E (rs138213197) is associated with increased risk of prostate cancer, but the current estimate of increased risk has a wide confidence interval (width of 95% confidence interval (CI) >200-fold) so the point estimate of 20-fold increased risk could be misleading. Population-based family studies can be more informative for estimating risks for rare variants, therefore, we screened for mutations in an Australian population-based series of early-onset prostate cancer cases (probands). We found that 19 of 1,384 (1.4%) probands carried the missense mutation, and of these, six (32%) had a family history of prostate cancer. We tested the 22 relatives of carriers diagnosed from 1998 to 2008 for whom we had a DNA sample, and found seven more carriers and one obligate carrier. The age-specific incidence for carriers was estimated to be, on average, 16.4 (95% CI 2.5-107.2) times that for the population over the time frame when the relatives were at risk prior to baseline. We then estimated the age and birth year-specific cumulative risk of prostate cancer (penetrance) for carriers. For example, the penetrance for an unaffected male carrier born in 1950 was 19% (95% CI 5-46%) at age 60 years, 44% (95% CI 18-74%) at age 70 years and 60% (95% CI 30-85%) at age 80 years. Our study has provided a population-based estimate of the average risk of prostate cancer for HOXB13 missense mutation G84E carriers that can be used to guide clinical practice and research. This study has also shown that the majority of hereditary prostate cancers due to the HOXB13 missense mutation are 'sporadic' in the sense that unselected cases with the missense mutation do not typically report having a family history of prostate cancer.	[MacInnis, Robert J.; Severi, Gianluca; Baglietto, Laura; Hopper, John L.; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [MacInnis, Robert J.; Severi, Gianluca; Baglietto, Laura; Dowty, James G.; Jenkins, Mark A.; Giles, Graham G.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Melbourne, Vic 3010, Australia	Cancer Council Victoria; University of Melbourne; University of Melbourne	Hopper, JL (corresponding author), Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia.	j.hopper@unimelb.edu.au	Severi, Gianluca/H-3774-2018; Baglietto, Laura/AAB-9051-2019; Severi, Gianluca/Q-1824-2019; Jenkins, Mark/P-7803-2015	Severi, Gianluca/0000-0001-7157-419X; Severi, Gianluca/0000-0001-7157-419X; Jenkins, Mark/0000-0002-8964-6160; Dowty, James/0000-0003-2383-0886; Baglietto, Laura/0000-0002-8193-7529; MacInnis, Robert/0000-0002-1627-5047; Giles, Graham/0000-0003-4946-9099; Southey, Melissa/0000-0002-6313-9005	Cancer Council Victoria; Tattersall's charitable programme; Whitten Foundation; PricewaterhouseCoopers Australia charitable programme; National Health and Medical Research Council	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Tattersall's charitable programme; Whitten Foundation; PricewaterhouseCoopers Australia charitable programme; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported largely by infrastructure and core funding provided by Cancer Council Victoria. Additional support was provided by Tattersall's charitable programme, The Whitten Foundation, PricewaterhouseCoopers Australia charitable programme and by grants from the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2012, J NATL CANC I; Australian Institute of Health and Welfare (AIHW), 2011, ACIM AUSTR CANC INC; Breyer JP, 2012, CANC EPIDEMIOL BIOMA; Byrnes GB, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2099; Cui JS, 2000, CANCER EPIDEM BIOMAR, V9, P805; Etzioni R, 1998, AM J EPIDEMIOL, V148, P775; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Gong G, 2010, GENET EPIDEMIOL, V34, P373, DOI 10.1002/gepi.20493; Hopper JL, 2005, LANCET, V366, P1397, DOI 10.1016/S0140-6736(05)67570-8; Karlsson R, 2012, EUR UROL; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lange K, 1997, GENETICS, V147, P1423; MacInnis RJ, 2010, GENET EPIDEMIOL, V34, P42, DOI 10.1002/gepi.20433; ROYSTON P, 1991, STATA TECH B, V3, P7	14	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e54727	10.1371/journal.pone.0054727	http://dx.doi.org/10.1371/journal.pone.0054727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457453	Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700007
J	Phillips, AN; Cambiano, V; Nakagawa, F; Brown, AE; Lampe, F; Rodger, A; Miners, A; Elford, J; Hart, G; Johnson, AM; Lundgren, J; Delpech, VC				Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Brown, Alison E.; Lampe, Fiona; Rodger, Alison; Miners, Alec; Elford, Jonathan; Hart, Graham; Johnson, Anne M.; Lundgren, Jens; Delpech, Valerie C.			Increased HIV Incidence in Men Who Have Sex with Men Despite High Levels of ART-Induced Viral Suppression: Analysis of an Extensively Documented Epidemic	PLOS ONE			English	Article							RISK BEHAVIOR; ANTIRETROVIRAL THERAPY; GAY MEN; COMMUNITY SAMPLES; HOMOSEXUAL-MEN; INFECTION; TRANSMISSION; PREVENTION; LONDON; SPREAD	Background: There is interest in expanding ART to prevent HIV transmission, but in the group with the highest levels of ART use, men-who-have-sex-with-men (MSM), numbers of new infections diagnosed each year have not decreased as ARTcoverage has increased for reasons which remain unclear. Methods: We analysed data on the HIV-epidemic in MSM in the UK from a range of sources using an individual-based simulation model. Model runs using parameter sets found to result in good model fit were used to infer changes in HIV-incidence and risk behaviour. Results: HIV-incidence has increased (estimated mean incidence 0.30/100 person-years 1990-1997, 0.45/100 py 1998-2010), associated with a modest (26%) rise in condomless sex. We also explored counter-factual scenarios: had ART not been introduced, but the rise in condomless sex had still occurred, then incidence 2006-2010 was 68% higher; a policy of ART initiation in all diagnosed with HIV from 2001 resulted in 32% lower incidence; had levels of HIV testing been higher (68% tested/year instead of 25%) incidence was 25% lower; a combination of higher testing and ART at diagnosis resulted in 62% lower incidence; cessation of all condom use in 2000 resulted in a 424% increase in incidence. In 2010, we estimate that undiagnosed men, the majority in primary infection, accounted for 82% of new infections. Conclusion: A rise in HIV-incidence has occurred in MSM in the UK despite an only modest increase in levels of condomless sex and high coverage of ART. ART has almost certainly exerted a limiting effect on incidence. Much higher rates of HIV testing combined with initiation of ART at diagnosis would be likely to lead to substantial reductions in HIV incidence. Increased condom use should be promoted to avoid the erosion of the benefits of ART and to prevent other serious sexually transmitted infections.	[Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Lampe, Fiona; Rodger, Alison; Hart, Graham; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Brown, Alison E.; Delpech, Valerie C.] Hlth Protect Agcy, London, England; [Miners, Alec] London Sch Hyg & Trop Med, London WC1, England; [Elford, Jonathan] City Univ London, London EC1V 0HB, England; [Lundgren, Jens] Univ Copenhagen Hosp, Rigshosp, DK-2100 Copenhagen, Denmark; [Lundgren, Jens] Univ Copenhagen, Copenhagen, Denmark	University of London; University College London; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; City University London; Rigshospitalet; University of Copenhagen; University of Copenhagen	Phillips, AN (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	andrew.phillips@ucl.ac.uk	Lampe, Fiona/I-5826-2019; Phillips, Andrew N/B-4427-2008; Lundgren, Jens/AAE-6876-2019	Lampe, Fiona/0000-0001-6851-5471; Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850; delpech, valerie/0000-0002-9952-8109; Johnson, Anne/0000-0003-1330-7100; Nakagawa, Fumiyo/0000-0002-6646-8744; Hart, Graham/0000-0001-9676-6577	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme [RP-PG-0608-10142]; National Institute for Health Research [NF-SI-0611-10255, RP-PG-0608-10142] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10142). The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker AG, 2012, CLIN TRIALS, V9, P144; Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Cambiano V, 2011, CURR OPIN INFECT DIS, V24, P19, DOI 10.1097/QCO.0b013e3283422c8c; CARNE CA, 1987, LANCET, V1, P656; Charlebois ED, 2011, CLIN INFECT DIS, V52, P1046, DOI 10.1093/cid/cir085; Clements MS, 2004, JAIDS-J ACQ IMM DEF, V35, P401, DOI 10.1097/00126334-200404010-00010; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Department of Health and Human Services, PAN ANT GUID AD AD G; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Elford J, 2004, SEX TRANSM INFECT, V80, P451, DOI 10.1136/sti.2004.010785; Elford J, 2002, AIDS, V16, P1537, DOI 10.1097/00002030-200207260-00011; Fisher M, 2007, AIDS, V21, P2309, DOI 10.1097/QAD.0b013e3282ef9fed; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Health Protection Agency, HIV AIDS SURV; Hickson FCI, 1996, AIDS, V10, P771, DOI 10.1097/00002030-199606001-00012; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lampe FC, 2007, ARCH INTERN MED, V167, P692, DOI 10.1001/archinte.167.7.692; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Mercer CH, 2004, AIDS, V18, P1453, DOI 10.1097/01.aids.0000131331.36386.de; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Murray JM, 2011, SEX HEALTH, V8, P304, DOI 10.1071/SH10114; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Rodger A, 2012, 19 C RETR OPP INF SE; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; THOMPSON JLP, 1993, AM J PUBLIC HEALTH, V83, P1409, DOI 10.2105/AJPH.83.10.1409; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Torrone EA, 2011, JAIDS-J ACQ IMM DEF, V58, P328, DOI 10.1097/QAI.0b013e31822e1075; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Vemazza P., 2008, B MED SUISSES, V89, P5; Williamson LM, 2008, AIDS, V22, P1063, DOI 10.1097/QAD.0b013e3282f8af9b; Williamson LM, 2006, JAIDS-J ACQ IMM DEF, V42, P238, DOI 10.1097/01.qai.0000214816.03411.c9; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010	46	154	155	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55312	10.1371/journal.pone.0055312	http://dx.doi.org/10.1371/journal.pone.0055312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457467	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000315603700012
J	Verschuren, JJW; Trompet, S; Deelen, J; Stott, DJ; Sattar, N; Buckley, BM; Ford, I; Heijmans, BT; Guchelaar, HJ; Houwing-Duistermaat, JJ; Slagboom, PE; Jukema, JW				Verschuren, Jeffrey J. W.; Trompet, Stella; Deelen, Joris; Stott, David J.; Sattar, Naveed; Buckley, Brendan M.; Ford, Ian; Heijmans, Bastiaan T.; Guchelaar, Henk-Jan; Houwing-Duistermaat, Jeanine J.; Slagboom, P. Eline; Jukema, J. Wouter			Non-Homologous End-Joining Pathway Associated with Occurrence of Myocardial Infarction: Gene Set Analysis of Genome-Wide Association Study Data	PLOS ONE			English	Article							STRAND BREAK REPAIR; OXIDATIVE DNA-DAMAGE; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; CELL SENESCENCE; MRE11 COMPLEX; RISK; ATHEROSCLEROSIS; TELOMERASE; SUSCEPTIBILITY	Purpose: DNA repair deficiencies have been postulated to play a role in the development and progression of cardiovascular disease (CVD). The hypothesis is that DNA damage accumulating with age may induce cell death, which promotes formation of unstable plaques. Defects in DNA repair mechanisms may therefore increase the risk of CVD events. We examined whether the joints effect of common genetic variants in 5 DNA repair pathways may influence the risk of CVD events. Methods: The PLINK set-based test was used to examine the association to myocardial infarction (MI) of the DNA repair pathway in GWAS data of 866 subjects of the GENetic DEterminants of Restenosis (GENDER) study and 5,244 subjects of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study. We included the main DNA repair pathways (base excision repair, nucleotide excision repair, mismatch repair, homologous recombination and non-homologous end-joining (NHEJ)) in the analysis. Results: The NHEJ pathway was associated with the occurrence of MI in both GENDER (P = 0.0083) and PROSPER (P = 0.014). This association was mainly driven by genetic variation in the MRE11A gene (P-GENDER = 0.0001 and P-PROSPER = 0.002). The homologous recombination pathway was associated with MI in GENDER only (P = 0.011), for the other pathways no associations were observed. Conclusion: This is the first study analyzing the joint effect of common genetic variation in DNA repair pathways and the risk of CVD events, demonstrating an association between the NHEJ pathway and MI in 2 different cohorts.	[Verschuren, Jeffrey J. W.; Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Dept Geriatr & Gerontol, Med Ctr, Leiden, Netherlands; [Deelen, Joris; Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Leiden, Netherlands; [Stott, David J.] Univ Glasgow, Acad Sect Geriatr Med, Glasgow, Lanark, Scotland; [Stott, David J.; Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Buckley, Brendan M.] Cork Univ Hosp, Dept Pharmacol & Therapeut, Cork, Ireland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Guchelaar, Henk-Jan] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Deelen, Joris; Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Netherlands Consortium Hlth Ageing, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst ICIN, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; University of Glasgow; University College Cork; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jukema, JW (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands.	j.w.jukema@lumc.nl	Ford, Ian/ABE-6145-2020; Houwing-Duistermaat, Jeanne/V-9048-2018; Jukema, J. Wouter/ABD-6503-2021; Slagboom, P. Eline/R-4790-2016; guchelaar, henk-jan/AAP-1381-2021; Deelen, Joris/H-3201-2019	Jukema, J. Wouter/0000-0002-3246-8359; Slagboom, P. Eline/0000-0002-2875-4723; Deelen, Joris/0000-0003-4483-3701; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Guchelaar, Henk-Jan/0000-0002-7085-1383	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework FP7 Programme [HEALTH-F2-2009-223004]; Center for Medical Systems Biology (CMSB); center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO); Netherlands Consortium for Healthy Ageing (NCHA)	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework FP7 Programme; Center for Medical Systems Biology (CMSB); center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO); Netherlands Consortium for Healthy Ageing (NCHA)	This work was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) http://www.icin.nl/, the European Community Framework FP7 Programme under grant agreement [no HEALTH-F2-2009-223004], the Center for Medical Systems Biology (CMSB) [http://www.cmsb.nl], a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO), and the Netherlands Consortium for Healthy Ageing (NCHA) [http://www.healthy-ageing.nl]. JWJ is an established clinical investigator of the Netherlands Heart Foundation (2001D032) [http://www.hartstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Allen-Brady K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-99; Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; Bazo Ana Paula, 2011, Cardiovasc Pathol, V20, pe9, DOI 10.1016/j.carpath.2009.12.004; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Borde V, 2009, INT J BIOCHEM CELL B, V41, P1249, DOI 10.1016/j.biocel.2008.12.013; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Choudhury A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-69; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gizard F, 2011, ARTERIOSCL THROM VAS, V31, P245, DOI 10.1161/ATVBAHA.110.219808; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu SC, 2005, CARDIOVASC PATHOL, V14, P232, DOI 10.1016/j.carpath.2005.05.006; Loizidou MA, 2009, BREAST CANCER RES TR, V115, P623, DOI 10.1007/s10549-008-0084-4; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Mahabir S, 2007, J EPIDEMIOL COMMUN H, V61, P737, DOI 10.1136/jech.2006.048934; Mahmoudi M, 2006, CARDIOVASC RES, V71, P259, DOI 10.1016/j.cardiores.2006.03.002; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Ozturk S, 2011, HISTOL HISTOPATHOL, V26, P505, DOI 10.14670/HH-26.505; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Perez-Rivero G, 2006, CIRCULATION, V114, P309, DOI 10.1161/CIRCULATIONAHA.105.611111; Poch E, 2004, FASEB J, V18, P418, DOI 10.1096/fj.03-0710fje; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rossi ML, 2004, CIRCULATION, V110, P1767, DOI 10.1161/01.CIR.0000142865.04816.89; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Shimada MK, 2009, NUCLEIC ACIDS RES, V37, pD810, DOI 10.1093/nar/gkn798; Shyu HY, 2012, J ATHEROSCLER THROMB, V19, P316, DOI 10.5551/jat.10967; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Thorne D, 2009, MUTAT RES-GEN TOX EN, V673, P3, DOI 10.1016/j.mrgentox.2008.11.008; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Trompet S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-131; Voghel G, 2010, MECH AGEING DEV, V131, P354, DOI 10.1016/j.mad.2010.04.004; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zeller T, 2012, CLIN CHEM, V58, P92, DOI 10.1373/clinchem.2011.170431	58	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56262	10.1371/journal.pone.0056262	http://dx.doi.org/10.1371/journal.pone.0056262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457540	Green Published, gold, Green Accepted			2022-12-27	WOS:000315603700036
J	Zhang, WL; Yang, WP; Wang, MC; Wang, W; Zeng, GP; Chen, ZW; Cai, YL				Zhang, Wenlong; Yang, Wenpeng; Wang, Mingchun; Wang, Wei; Zeng, Guiping; Chen, Zhiwei; Cai, Yilin			Increasing Lysine Content of Waxy Maize through Introgression of Opaque-2 and Opaque-16 Genes Using Molecular Assisted and Biochemical Development	PLOS ONE			English	Article							RESISTANCE; SELECTION; MUTANT; DNA	The low lysine content of waxy maize cannot meet the nutritional requirements of humans, livestock, or poultry. In the present study, the high-lysine genes o2 and o16 were backcrossed into wx lines using the maize high-lysine inbreds TAIXI19 (o2o2) and QCL3021 (o16o16) as donors and the waxy maize inbred line QCL5019 (wxwx) as a receptor. In the triple-cross F-1, backcross, and inbred generations, the SSR markers phi027 and phi112 within the wx and o2 genes and the SSR marker umc1121 linked to the o16 gene were used for foreground selection. Background selection of the whole-genome SSR markers was performed for the selected individuals. The grain lysine content was determined using the dye-binding lysine method. The waxiness of the grain was determined with the I-2-KI staining and dual-wavelength spectrophotometric analysis. The BC2F2 generation included 7 plants of genotype wxwxo2o2O16_, 19 plants of genotype wxwxo16o16O2_, and 3 plants of genotype wxwxo2o2o16o16. In these seeds, the average amylopectin content was 96.67%, 96.87%, and 96.62%, respectively, which is similar to that of QCL5019. The average lysine content was 0.555%, 0.380%, and 0.616%, respectively, representing increases of 75.1%, 19.9%, 94.3%, respectively, over QCL5019. The average genetic background recovery rate of the BC2F3 families was 95.3%, 94.3%, 94.2%, respectively. Among these 3 wxwxo2o2O16O16 families, 4 wxwxo2o2O16o16 families, and 3 wxwxo2o2o16o16 families, the longest imported parent donor fragment was 113.35 cM and the shortest fragment was 11.75 cM. No significant differences in lysine content were found between the BC2F4 seeds and the BC2F3 seeds in these 10 families. This allowed us to increase the lysine content of waxy corn and produce seeds with excellent nutritional characteristics suitable for human consumption, animal feed, and food processing. This may be of significance in the breeding of high-quality corn and in improvement of the nutrition of humans, livestock, and poultry.	[Zhang, Wenlong; Yang, Wenpeng; Wang, Mingchun; Wang, Wei; Chen, Zhiwei] Guizhou Acad Agr Sci, Guizhou Inst Upland Food Crops, Guiyang, Guizhou, Peoples R China; [Zhang, Wenlong; Chen, Zhiwei; Cai, Yilin] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Zhang, Wenlong] Guizhou Agr Comm, Guizhou Gen Seed Stn, Guiyang, Guizhou, Peoples R China; [Yang, Wenpeng] Guizhou Acad Agr Sci, Guizhou Key Lab Agr Biotechnol, Guiyang, Guizhou, Peoples R China; [Zeng, Guiping] Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China	Guizhou Academy of Agricultural Sciences; Southwest University - China; Guizhou Academy of Agricultural Sciences; Guizhou University	Yang, WP (corresponding author), Guizhou Acad Agr Sci, Guizhou Inst Upland Food Crops, Guiyang, Guizhou, Peoples R China.	ywpmaize@126.com			National Natural Science Foundation of China [30560079, 31160307]; National Basic Research Program of China [2006CB708206]; Special Foundation of Guizhou Academy of Agricultural Sciences [052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Special Foundation of Guizhou Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (No.30560079 and No.31160307; http://www.nsfc.gov.cn/Portal0/default166.htm), the National Basic Research Program of China (No.2006CB708206; http://www.most.gov.cn/eng/index.htm) and the Special Foundation of Guizhou Academy of Agricultural Sciences (No.052, 2010; http://www.gzaas.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman CJ, 2000, RICE GENETICS S, V4, P22; BRIGGS RW, 1965, NATURE, V207, P890, DOI 10.1038/207890a0; Collins GN, 1909, BUREAU PLANT IND B, V161, P1; Fang MingJing, 2005, Acta Agronomica Sinica, V31, P1359; He Guang-Ming, 2004, Acta Genetica Sinica, V31, P836; He ZF, 1981, PROG BIOCHEM BIOPHYS, V1, P70; He ZF, 1985, QUALITY CEREALS OILS; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; HOSPITAL F, 1992, GENETICS, V132, P1199; KLOSGEN RB, 1986, MOL GEN GENET, V203, P237, DOI 10.1007/BF00333960; KULESHOV N. N., 1954, Ann. Mo. Bot. Gdn., V41, P271, DOI 10.2307/2394586; LAUGHNAN JR, 1953, GENETICS, V38, P485; Li X. Y., 1993, Acta Agronomica Sinica, V19, P460; Li XH, 2003, J MAIZE SCI, P14; Liu Jian, 2005, Journal of Maize Sciences, V13, P60; [柳李旺 Liu Liwang], 2003, [分子植物育种, Molecular Plant Breeding], V1, P48; Liu Z, 2003, J ANHUI TECHNICAL TE, V17, P32; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; McClintock B., 1963, Year Book of the Carnegie Institution of Washington 1962-1963, V62, P486; McClintock B., 1964, Yearbook of the Carnegie Institution of Washington 1963-64, P592; Meng ZD, 2001, J MAIZE SCI, V9, P14; Ming R, 1997, THEOR APPL GENET, V95, P271, DOI 10.1007/s001220050559; NELSON OE, 1962, BIOCHEM BIOPH RES CO, V9, P297, DOI 10.1016/0006-291X(62)90043-8; Neuffer MG, 1997, MUTANTS MAIZE; Sanchez AC, 2000, CROP SCI, V40, P792, DOI 10.2135/cropsci2000.403792x; Schneider KA, 1997, CROP SCI, V37, P51, DOI 10.2135/cropsci1997.0011183X003700010008x; Sprague G. F., 1943, JOUR AMER SOC AGRON, V35, P817; Sun Z, 1998, J BEIJING AGR COLL, V13, P1; [田清震 Tian Qingzhen], 2004, [玉米科学, Maize Science], V12, P108; Weatherwax P, 1922, GENETICS, V7, P568; WESSLER S, 1990, P NATL ACAD SCI USA, V87, P8731, DOI 10.1073/pnas.87.22.8731; [夏军红 Xia Junhong], 2002, [作物学报, Acta Agronomica Sinica], V28, P339; Xia Tao, 1997, Acta Agronomica Sinica, V23, P753; Yang W, 2004, PLANT MOL BIOL REP, V22, P361, DOI 10.1007/BF02772679; Yang WP, 2008, HEREDITAS, V145, P225, DOI 10.1111/j.1601-5223.2008.02056.x; Yang WP, 2005, MOL BREEDING, V15, P257, DOI 10.1007/s11032-004-5947-8; Yang WP, 2005, THESIS HUAZHONG AGR; Yang Yin-fu, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P2213; [杨子贤 Yang Zixian], 2004, [分子植物育种, Molecular Plant Breeding], V2, P473; Zeng MQ, 1987, CROP BREED RESOURCE, V3, P8; Zhai FL, 1991, BREEDING CROP QUALIT; Zhang JianHua, 2006, Southwest China Journal of Agricultural Sciences, V19, P543; Zhang Wenfang, 2010, J BUILDING STRUCTURE, V21, P36; [张增艳 Zhang Zengyan], 2002, [中国农业科学, Scientia Agricultura Sinica], V35, P789	44	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56227	10.1371/journal.pone.0056227	http://dx.doi.org/10.1371/journal.pone.0056227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457531	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700029
J	Avci, U; Pattathil, S; Singh, B; Brown, VL; Hahn, MG; Haigler, CH				Avci, Utku; Pattathil, Sivakumar; Singh, Bir; Brown, Virginia L.; Hahn, Michael G.; Haigler, Candace H.			Cotton Fiber Cell Walls of Gossypium hirsutum and Gossypium barbadense Have Differences Related to Loosely-Bound Xyloglucan	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PECTIN STRUCTURE; ELONGATION; GROWTH; GENES; POLYSACCHARIDES; LOCALIZATION; EVOLUTION; PATHWAYS; GENOMICS	Cotton fiber is an important natural textile fiber due to its exceptional length and thickness. These properties arise largely through primary and secondary cell wall synthesis. The cotton fiber of commerce is a cellulosic secondary wall surrounded by a thin cuticulated primary wall, but there were only sparse details available about the polysaccharides in the fiber cell wall of any cotton species. In addition, Gossypium hirsutum (Gh) fiber was known to have an adhesive cotton fiber middle lamella (CFML) that joins adjacent fibers into tissue-like bundles, but it was unknown whether a CFML existed in other commercially important cotton fibers. We compared the cell wall chemistry over the time course of fiber development in Gh and Gossypium barbadense (Gb), the two most important commercial cotton species, when plants were grown in parallel in a highly controlled greenhouse. Under these growing conditions, the rate of early fiber elongation and the time of onset of secondary wall deposition were similar in fibers of the two species, but as expected the Gb fiber had a prolonged elongation period and developed higher quality compared to Gh fiber. The Gb fibers had a CFML, but it was not directly required for fiber elongation because Gb fiber continued to elongate rapidly after CFML hydrolysis. For both species, fiber at seven ages was extracted with four increasingly strong solvents, followed by analysis of cell wall matrix polysaccharide epitopes using antibody-based Glycome Profiling. Together with immunohistochemistry of fiber cross-sections, the data show that the CFML of Gb fiber contained lower levels of xyloglucan compared to Gh fiber. Xyloglucan endo-hydrolase activity was also higher in Gb fiber. In general, the data provide a rich picture of the similarities and differences in the cell wall structure of the two most important commercial cotton species.	[Avci, Utku; Pattathil, Sivakumar; Brown, Virginia L.; Hahn, Michael G.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Hahn, Michael G.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University	Haigler, CH (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	candace_haigler@ncsu.edu	Hahn, Michael/AHC-5847-2022; AVCI, UTKU/AAC-5794-2020	AVCI, UTKU/0000-0001-5355-9906; Hahn, Michael/0000-0003-2136-5191; , Sivakumar Pattathil/0000-0003-3870-4137; Haigler, Candace/0000-0001-7810-4035	Cotton Incorporated, Cary, NC [10-754]; National Science Foundation (NSF) Plant Genome Program grant [IOS-0923992]; NSF Plant Genome Program [DBI-0421683]; Division Of Integrative Organismal Systems [0923992] Funding Source: National Science Foundation	Cotton Incorporated, Cary, NC; National Science Foundation (NSF) Plant Genome Program grant(National Science Foundation (NSF)); NSF Plant Genome Program(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this research was provided by: (a) Cotton Incorporated, Cary, NC (www.cottoninc.com) via a grant (number 10-754 to CHH) and in-kind HVI and AFIS fiber quality analysis; and (b) an National Science Foundation (NSF) (www.nsf.gov) Plant Genome Program grant (number IOS-0923992 to MGH). The generation of CCRC series of plant cell wall glycan-directed monoclonal antibodies used in this work was also supported by the NSF Plant Genome Program (grant number DBI-0421683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Alabady MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-295; Avci Utku, 2012, Methods Mol Biol, V908, P73, DOI 10.1007/978-1-61779-956-3_7; BEASLEY CA, 1979, PHYSIOL PLANTARUM, V45, P77, DOI 10.1111/j.1399-3054.1979.tb01667.x; BEASLEY CA, 1977, PLANT PHYSIOL, V59, P203, DOI 10.1104/pp.59.2.203; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; Bowling AJ, 2011, PROTOPLASMA, V248, P579, DOI 10.1007/s00709-010-0212-y; Bowman DT, 1997, USDA TECH B; Buchala AJ, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P113; BUCHALA AJ, 1981, CARBOHYD RES, V89, P137, DOI 10.1016/S0008-6215(00)85235-0; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chen XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030056; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Claverie M, 2012, THEOR APPL GENET, V124, P665, DOI 10.1007/s00122-011-1738-x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DeMartini JD, 2011, ENERG ENVIRON SCI, V4, P4332, DOI 10.1039/c1ee02112e; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fry S. C, 1988, GROWING PLANT CELL W, DOI DOI 10.1016/0031-9422(88)83079-6; Fry SC, 2011, ANNU PLANT REV, V41, P1, DOI 10.1002/9781444391015.ch1; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Haigler Candace H., 2009, V3, P385, DOI 10.1007/978-0-387-70810-2_16; Hawkins RS, 1930, J AGRIC RES, V40, P1017; HAYASHI T, 1988, CARBOHYD RES, V181, P273, DOI 10.1016/0008-6215(88)84047-3; Hequet EF, 2006, TEXT RES J, V76, P576, DOI 10.1177/0040517506064710; Hovav R, 2008, GENETICS, V179, P1725, DOI 10.1534/genetics.108.089656; JAQUET JP, 1982, PLANTA, V156, P481, DOI 10.1007/BF00393321; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Lee J, 2010, PLANTA, V232, P1191, DOI 10.1007/s00425-010-1246-2; Lee KJD, 2011, MOL PLANT, V4, P212, DOI 10.1093/mp/ssq075; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; MALTBY D, 1979, PLANT PHYSIOL, V63, P1158, DOI 10.1104/pp.63.6.1158; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; O'Neill M. A., 2003, PLANT CELL WALL, P1, DOI DOI 10.1002/9781119312994.APR0067; Obro J, 2011, ANNU PLANT REV, V41, P367, DOI 10.1002/9781444391015.ch15; Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; PUHLMANN J, 1994, PLANT PHYSIOL, V104, P699, DOI 10.1104/pp.104.2.699; Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540; Salnikov VV, 2003, PROTOPLASMA, V221, P175, DOI 10.1007/s00709-002-0079-7; SCHUBERT AM, 1976, CROP SCI, V16, P539, DOI 10.2135/cropsci1976.0011183X001600040026x; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; SULOVA Z, 1995, ANAL BIOCHEM, V229, P80, DOI 10.1006/abio.1995.1381; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Zhu XH, 2010, MOL PLANT, V3, P818, DOI 10.1093/mp/ssq023	50	37	38	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56315	10.1371/journal.pone.0056315	http://dx.doi.org/10.1371/journal.pone.0056315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457548	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700067
J	Chen, FF; Bai, J; Li, W; Mei, PJ; Liu, H; Li, LL; Pan, ZQ; Wu, YP; Zheng, JN				Chen, Feifei; Bai, Jin; Li, Wang; Mei, Pengjin; Liu, Hui; Li, Linlin; Pan, Zhenqiang; Wu, Yongping; Zheng, Junnian			RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell Carcinoma	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; MATRIX METALLOPROTEINASES; EXPRESSION; GENE; METHYLATION	RUNX3 (runt-related transcription factor-3) is a known tumor suppressor gene which exhibits potent antitumor activity in several carcinomas. However, little is known about the role of RUNX3 in human renal cell carcinoma (RCC). To investigate the clinical relevance of RUNX3 in RCC patients, immunohistochemistry was performed to detect the clinical relevance of RUNX3 in 75 RCC tissues and paired non-cancerous tissues by using tissue microarray (TMA). We also investigated the role of RUNX3 in RCC cell migration, invasion and angiogenesis. The RUNX3 expression was decreased dramatically in human RCC tissue. The RUNX3 expression was significantly correlated with tumor size (P<0.001), depth of invasion (P<0.001), and of TNM stage (P<0.001). Restoration of RUNX3 significantly decreased renal carcinoma cell migration and invasion capacity compared with controls. In addition, we found that overexpression of RUNX3 reduced the proliferation and tube formation of human umbilical vascular endothelial cells (HUVECs). Gelatin zymography and Western blot showed that RUNX3 expression suppressed matrix metalloproteinase-9 (MMP-9) protein level and enzyme activity. Western blot and ELISA showed that RUNX3 restoration inhibited the expression and secretion of vascular endothelial growth factor (VEGF). Taken together, our studies indicate that decreased expression of RUNX3 in human RCC tissue is significantly correlated with RCC progression. Restoration of RUNX3 expression significantly inhibits RCC cells migration, invasion and angiogenesis. These findings provide new insights into the significance of RUNX3 in migration, invasion and angiogenesis of RCC.	[Chen, Feifei; Bai, Jin; Mei, Pengjin; Pan, Zhenqiang; Zheng, Junnian] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China; [Li, Wang; Mei, Pengjin; Liu, Hui; Li, Linlin; Zheng, Junnian] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Liu, Hui; Li, Linlin; Wu, Yongping] Xuzhou Med Coll, Sch Pathol, Xuzhou, Jiangsu, Peoples R China; [Pan, Zhenqiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Icahn School of Medicine at Mount Sinai	Wu, YP (corresponding author), Xuzhou Med Coll, Sch Pathol, Xuzhou, Jiangsu, Peoples R China.	WYP@xzmc.edu.cn; jnzheng@xzmc.edu.cn	Liu, Hui/AAJ-4339-2020	Liu, Hui/0000-0002-7669-9386	National Natural Science Foundation of China [81201636]; Science and Technology Department of Jiangsu province [BK2012139]; China Postdoctoral Science Foundation [2012M511323]; Natural Science Foundation for colleges and universities in Jiangsu Province [10KJB320023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Jiangsu province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation for colleges and universities in Jiangsu Province	This project is supported by grants from the National Natural Science Foundation of China (No. 81201636), the Science and Technology Department of Jiangsu province (No. BK2012139), China Postdoctoral Science Foundation (No. 2012M511323) and Natural Science Foundation for colleges and universities in Jiangsu Province (No. 10KJB320023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Bae SC, 2004, ONCOGENE, V23, P4336, DOI 10.1038/sj.onc.1207286; BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Degue S, 2012, J WOMENS HLTH LARCHM; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Hsu PI, 2009, ANN SURG ONCOL, V16, P1686, DOI 10.1245/s10434-009-0428-2; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mei PJ, 2011, J CANCER RES CLIN, V137, P1823, DOI 10.1007/s00432-011-1063-4; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Pennison M, 2007, CURR OPIN ONCOL, V19, P579, DOI 10.1097/CCO.0b013e3282f0ad0e; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sakakura C, 2005, CLIN CANCER RES, V11, P6479, DOI 10.1158/1078-0432.CCR-05-0729; Stephenson CP, 2012, AUST NZ J PSYCHIAT; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Volpe A, 2010, WORLD J UROL, V28, P319, DOI 10.1007/s00345-010-0540-8; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838; Zisman A, 2002, J CLIN ONCOL, V20, P4559, DOI 10.1200/JCO.2002.05.111	26	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56241	10.1371/journal.pone.0056241	http://dx.doi.org/10.1371/journal.pone.0056241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457532	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700061
J	Collins, HF; Biedendieck, R; Leech, HK; Gray, M; Escalante-Semerena, JC; McLean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ; Lawrence, AD				Collins, Hannah F.; Biedendieck, Rebekka; Leech, Helen K.; Gray, Michael; Escalante-Semerena, Jorge C.; McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.; Lawrence, Andrew D.			Bacillus megaterium Has Both a Functional BluB Protein Required for DMB Synthesis and a Related Flavoprotein That Forms a Stable Radical Species	PLOS ONE			English	Article							LOWER LIGAND; COBALAMIN VITAMIN-B-12; BIOSYNTHESIS; IDENTIFICATION; 5,6-DIMETHYLBENZIMIDAZOLE; FLAVIN; DIMETHYLBENZIMIDAZOLE; PURIFICATION; COFACTORS; SEQUENCE	Despite the extensive study of the biosynthesis of the complex molecule B-12 (cobalamin), the mechanism by which the lower ligand 5,6-dimethylbenzimidazole (DMB) is formed has remained something of a mystery. However, recent work has identified and characterized a DMB-synthase (BluB) responsible for the oxygen-dependent, single enzyme conversion of FMN to DMB. In this work, we have identified BluB homologs from the aerobic purple, nonsulfur, photosynthetic bacterium Rhodobacter capsulatus and the aerobic soil bacterium Bacillus megaterium and have demonstrated DMB synthesis by the use of a novel complementation assay in which a B-12 deficient strain, substituted with the precursor cobinamide is recovered either by the addition of DMB or by the recombinant expression of a bluB gene. The DMB-synthetic activity of the purified recombinant BluB enzymes was further confirmed in vitro by providing the enzyme with FMNH2 and oxygen and observing the formation of DMB by HPLC. The formation of a 4a-peroxyflavin intermediate, the first step in the oxygen dependent mechanism of DMB biosynthesis, is reported here and is the first intermediate in the enzyme catalysed reaction to be demonstrated experimentally to date. The identification and characterization of an FMN-binding protein found on the cobl operon of B. megaterium, CbiY, is also detailed, revealing an FMN-containing enzyme which is able to stabilize a blue flavin semiquinone upon reduction with a 1-electron donor.	[Collins, Hannah F.; Leech, Helen K.; Warren, Martin J.; Lawrence, Andrew D.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Biedendieck, Rebekka] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Gray, Michael; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	University of Kent; Braunschweig University of Technology; University of Wisconsin System; University of Wisconsin Madison; University of Manchester	Warren, MJ (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.	m.j.warren@kent.ac.uk; a.lawrence-219@kent.ac.uk	McLean, Kirsty J/GXI-2853-2022; Collins, Hannah/GSD-5229-2022; Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X; Warren, Martin/0000-0002-6028-6456; McLean, Kirsty/0000-0002-7193-5044; Biedendieck, Rebekka/0000-0002-3567-6196; Gray, Michael/0000-0002-7112-4188	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G014361/1]; BBSRC [BB/G014361/1, BB/E002889/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G014361/1, BB/E002889/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) - BB/G014361/1 to MJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2008, J BACTERIOL, V190, P1160, DOI 10.1128/JB.01386-07; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Banerjee R., 1999, CHEM BIOCH B 12; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Dutton P L, 1978, Methods Enzymol, V54, P411; Ealick SE, 2007, NATURE, V446, P387, DOI 10.1038/446387a; Fan CG, 2008, J BIOL CHEM, V283, P11322, DOI 10.1074/jbc.M800287200; Gray MJ, 2007, P NATL ACAD SCI USA, V104, P2921, DOI 10.1073/pnas.0609270104; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOLLRIEGL V, 1982, ARCH MICROBIOL, V132, P155, DOI 10.1007/BF00508722; Kay CWM, 2005, MAGN RESON CHEM, V43, pS96, DOI 10.1002/mrc.1667; Kurreck H, 1988, ELECT NUCL DOUBLE RE, P308; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; Maggio-Hall LA, 2003, ORG LETT, V5, P2211, DOI 10.1021/ol034530m; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; Minot GR, 1926, J AMER MED ASSOC, V87, P470, DOI 10.1001/jama.1926.02680070016005; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; OTOOLE GA, 1994, J BIOL CHEM, V269, P26503; Palmer G., 1971, FLAVINS FLAVOPROTEIN, P123; POLLICH M, 1995, J BACTERIOL, V177, P4481, DOI 10.1128/jb.177.15.4481-4487.1995; Raleigh EA, 1989, CURRENT PROTOCOLS MO, P1; Raux E, 1998, BIOCHEM J, V335, P159, DOI 10.1042/bj3350159; Raux E, 2000, CELL MOL LIFE SCI, V57, P1880, DOI 10.1007/PL00000670; Raux E, 1999, BIOORG CHEM, V27, P100, DOI 10.1006/bioo.1998.1125; Renz P., 1999, Chemistry and biochemistry of B12., P557; RENZ P, 1972, FEBS LETT, V22, P124, DOI 10.1016/0014-5793(72)80236-9; ROOF DM, 1992, J BACTERIOL, V174, P6634, DOI 10.1128/JB.174.20.6634-6643.1992; Sambrook J., 2001, MOL CLONING LAB MANU; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Schleicher E, 2010, APPL MAGN RESON, V37, P339, DOI 10.1007/s00723-009-0101-8; Schweiger A, 2001, PRINCIPLES PULSE ELE, P360; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; TANG LB, 1990, GENE, V96, P89, DOI 10.1016/0378-1119(90)90345-R; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang XL, 2011, J AM CHEM SOC, V133, P4079, DOI 10.1021/ja1106207; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wolthers KR, 2003, BIOCHEMISTRY-US, V42, P3911, DOI 10.1021/bi027290b	42	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55708	10.1371/journal.pone.0055708	http://dx.doi.org/10.1371/journal.pone.0055708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457476	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700020
J	Khan, R; Khan, AQ; Lateef, A; Rehman, MU; Tahir, M; Ali, F; Hamiza, OO; Sultana, S				Khan, Rehan; Khan, Abdul Quaiyoom; Lateef, Abdul; Rehman, Muneeb U.; Tahir, Mir; Ali, Farrah; Hamiza, Oday O.; Sultana, Sarwat			Glycyrrhizic Acid Suppresses the Development of Precancerous Lesions via Regulating the Hyperproliferation, Inflammation, Angiogenesis and Apoptosis in the Colon of Wistar Rats	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; MUCIN-DEPLETED FOCI; K-RAS MUTATIONS; CHRONIC HEPATITIS-C; NF-KAPPA-B; MAST-CELLS; PRENEOPLASTIC LESIONS; PROMYELOTIC LEUKEMIA; OXIDATIVE STRESS; CANCER	Background: Colon carcinogenesis is a multistep process and it emanates from a series of molecular and histopathological alterations. Glycyrrhizic acid (GA) is a natural and major pentacyclic triterpenoid glycoside of licorice roots extracts. It has several pharmacological and biological properties such as anti-inflammatory, anti-viral, and anti-cancer. In the present study, we investigated the chemopreventive potential of GA against 1,2-dimethyhydrazine (DMH)-induced precancerous lesions i.e., aberrant crypt foci (ACF) and mucin depleted foci (MDF), and its role in regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats. Methods: Animals were divided into 5 groups. In group III, IV and V, GA was administered at the dose of 15 mg/kg b. wt. orally while in group II, III and IV, DMH was administered subcutaneously in the groin at the dose of 20 mg/kg b. wt once a week for first 5 weeks and animals were euthanized after 9 weeks. Results: GA supplementation suppressed the development of precancerous lesions and it also reduced the infiltration of mast cells, suppressed the immunostaining of Ki-67, NF-kB-p65, COX-2, iNOS and VEGF while enhanced the immunostaining of p53, connexin-43, caspase-9 and cleaved caspase-3. GA treatment significantly attenuated the level of TNF-alpha and it also reduced the depletion of the mucous layer as well as attenuated the shifting of sialomucin to sulphomucin. Conclusion: Our findings suggest that GA has strong chemopreventive potential against DMH-induced colon carcinogenesis but further studies are warranted to elucidate the precise mechanism of action of GA.	[Khan, Rehan; Khan, Abdul Quaiyoom; Lateef, Abdul; Rehman, Muneeb U.; Tahir, Mir; Ali, Farrah; Hamiza, Oday O.; Sultana, Sarwat] Jamia Hamdard, Sect Mol Carcinogenesis & Chemoprevent, Dept Med Elementol & Toxicol, New Delhi, India	Jamia Hamdard University	Sultana, S (corresponding author), Jamia Hamdard, Sect Mol Carcinogenesis & Chemoprevent, Dept Med Elementol & Toxicol, New Delhi, India.	sarwat786@rediffmail.com	TAHIR, MIR/AAO-4255-2020; Khan, Rehan/AAR-4803-2020; Lateef, Abdul/D-9074-2013	TAHIR, MIR/0000-0002-7294-3660; Khan, Rehan/0000-0001-8724-5788; Lateef, Abdul/0000-0001-7924-1381; U Rehman, Muneeb/0000-0002-9995-6576; Khan, Rehan/0000-0002-2406-1129	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL R, 1991, NUTR CANCER, V15, P187, DOI 10.1080/01635589109514126; Andoh A, 2006, ONCOL REP, V16, P103; Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Caderni G, 2003, CANCER RES, V63, P2388; Cherng JM, 2011, RADIAT RES, V176, P177, DOI 10.1667/RR2510.1; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Curreli F, 2005, J CLIN INVEST, V115, P642, DOI 10.1172/JCI200523334; DAVIS EA, 1991, MOL CELL ENDOCRINOL, V78, P1, DOI 10.1016/0303-7207(91)90179-V; Dimitriadou V, 1997, ANTICANCER RES, V17, P1541; Femia AP, 2008, INT J CANCER, V122, P117, DOI 10.1002/ijc.23065; Femia AP, 2007, INT J CANCER, V120, P2301, DOI 10.1002/ijc.22145; Femia AP, 2007, CANCER RES, V67, P445, DOI 10.1158/0008-5472.CAN-06-3861; Femia AP, 2012, INT J CANCER, V131, P529, DOI 10.1002/ijc.26406; Femia AP, 2009, INT J CANCER, V125, P541, DOI 10.1002/ijc.24417; Femia AP, 2008, CANCER PREV RES, V1, P562, DOI 10.1158/1940-6207.CAPR-08-0125; Femia AP, 2005, INT J CANCER, V116, P9, DOI 10.1002/ijc.20981; FILIPE MI, 1974, CANCER-AM CANCER SOC, V34, P282, DOI 10.1002/1097-0142(197408)34:2<282::AID-CNCR2820340211>3.0.CO;2-W; FILIPE MI, 1975, BRIT J CANCER, V32, P60, DOI 10.1038/bjc.1975.134; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; He SH, 2004, WORLD J GASTROENTERO, V10, P309; Hibasami H, 2006, INT J MOL MED, V17, P215; Hibasami H, 2005, INT J MOL MED, V16, P233; Hirayama C., 1983, ASIAN MED J, V26, P423, DOI DOI 10.1093/JNCI/53.5.1515; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JEN J, 1994, CANCER RES, V54, P5523; Jin SK, 2001, J CELL SCI, V114, P4139; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Khan R, 2012, TOXICOL APPL PHARM, V258, P315, DOI 10.1016/j.taap.2011.11.013; Khan R, 2011, CHEM-BIOL INTERACT, V192, P193, DOI 10.1016/j.cbi.2011.03.009; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Mori H, 2005, CHEM-BIOL INTERACT, V155, P1, DOI 10.1016/j.cbi.2005.04.005; Nakai Y, 2007, CANCER RES, V67, P1378, DOI 10.1158/0008-5472.CAN-06-1336; Nucci MR, 1997, HUM PATHOL, V28, P1396, DOI 10.1016/S0046-8177(97)90230-6; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okamura N, 2003, BIOL PHARM BULL, V26, P658, DOI 10.1248/bpb.26.658; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Paulsen JE, 2005, CANCER RES, V65, P121; Paulsen JE, 2001, CANCER RES, V61, P5010; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; PRETLOW TP, 1991, CANCER RES, V51, P1564; PRETLOW TP, 1993, J NATL CANCER I, V85, P2004, DOI 10.1093/jnci/85.24.2004; PRETLOW TP, 1994, INT J CANCER, V56, P599, DOI 10.1002/ijc.2910560422; RAO BNN, 1994, J BIOL CHEM, V269, P19663; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; RONCUCCI L, 1991, HUM PATHOL, V22, P287, DOI 10.1016/0046-8177(91)90163-J; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sakai E, 2012, CANCER SCI, V103, P144, DOI 10.1111/j.1349-7006.2011.02125.x; SANDFORTH F, 1988, EUR J CLIN INVEST, V18, P655, DOI 10.1111/j.1365-2362.1988.tb01283.x; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shiota G, 1999, CARCINOGENESIS, V20, P59, DOI 10.1093/carcin/20.1.59; Sirnes S, 2012, INT J CANCER, V131, P570, DOI 10.1002/ijc.26392; Siu IM, 1997, AM J PATHOL, V150, P1805; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; STOPERA SA, 1992, CARCINOGENESIS, V13, P1863, DOI 10.1093/carcin/13.10.1863; STOPERA SA, 1992, CARCINOGENESIS, V13, P573, DOI 10.1093/carcin/13.4.573; STOPERA SA, 1992, CARCINOGENESIS, V13, P2081, DOI 10.1093/carcin/13.11.2081; Takeda S, 1996, J PHARM PHARMACOL, V48, P902, DOI 10.1111/j.2042-7158.1996.tb05998.x; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; Thirugnanam S, 2008, ONCOL REP, V20, P1387, DOI 10.3892/or_00000157; Van Rossum TGJ, 1999, J GASTROEN HEPATOL, V14, P1093, DOI 10.1046/j.1440-1746.1999.02008.x; VIVONA AA, 1993, CARCINOGENESIS, V14, P1777, DOI 10.1093/carcin/14.9.1777; Wargovich MJ, 2000, CARCINOGENESIS, V21, P1149, DOI 10.1093/carcin/21.6.1149; WARGOVICH MJ, 1983, JNCI-J NATL CANCER I, V71, P125; Wedemeyer J, 2005, LAB INVEST, V85, P388, DOI 10.1038/labinvest.3700232; YASUKAWA K, 1988, YAKUGAKU ZASSHI, V108, P794, DOI 10.1248/yakushi1947.108.8_794; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398	73	86	93	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56020	10.1371/journal.pone.0056020	http://dx.doi.org/10.1371/journal.pone.0056020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457494	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700034
J	Qin, X; Peng, QL; Chen, ZP; Deng, Y; Huang, S; Xu, JJ; Li, HW; Li, S; Zhao, JM				Qin, Xue; Peng, Qiliu; Chen, Zhiping; Deng, Yan; Huang, Shan; Xu, Juanjuan; Li, Haiwei; Li, Shan; Zhao, Jinmin			The Association between MTHFR Gene Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; COMMON MUTATION; C677T POLYMORPHISM; A1298C POLYMORPHISMS; POOLED ANALYSES; CANCER; DISEASE; POPULATION; CIRRHOSIS; ALCOHOL	Background: The association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and hepatocellular carcinoma (HCC) risk was inconsistent and underpowered. To clarify the effects of MTHFR gene polymorphisms on the risk of HCC, a meta-analysis of all available studies relating C677T and/or A1298C polymorphisms of MTHFR gene to the risk of HCC was conducted. Methods: The authors searched PubMed, EMBASE, Cochrane Library, Web of Science, and Chinese Biomedical Literature database (CBM) for the period up to July 2012. Data were extracted by two independent authors and pooled odds ratio (OR) with 95% confidence interval (CI) was calculated. Metaregression and subgroup analyses were performed to identify the source of heterogeneity. Results: Finally, 12 studies with 2,351 cases and 4,091 controls were included for C677T polymorphism and 6 studies with 1,333 cases and 1,878 controls were included for A1298C polymorphism. With respect to A1298C polymorphism, significantly decreased HCC risk was found in the overall population (CC vs. AA: OR = 0.660, 95% CI 0.460-0.946, P = 0.024; recessive model: OR = 0.667, 95% CI = 0.470-0.948, P = 0.024). In subgroup analyses, significantly decreased HCC risk was found in Asian population (CC vs. AA: OR = 0.647, 95% CI = 0.435-0.963; P = 0.032) and population-based studies (CC vs. AA: OR = 0.519, 95% CI = 0.327-0.823; P = 0.005). With respect to C677T polymorphism, no significant association with HCC risk was demonstrated in overall and stratified analyses. Conclusions: We concluded that MTHFR A1298C polymorphism may play a protective role in the carcinogenesis of HCC. Further large and well-designed studies are needed to confirm this association.	[Qin, Xue; Peng, Qiliu; Deng, Yan; Huang, Shan; Xu, Juanjuan; Li, Haiwei; Li, Shan] Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Chen, Zhiping] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Zhao, Jinmin] Guangxi Med Univ, Dept Orthoped Trauma Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Peng, Qiliu] Baise City Peoples Hosp, Dept Clin Lab, Baise, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	lis8858@126.com; zhaojinmin@126.com		Zhao, Jinmin/0000-0002-1047-8820	National Natural Science Fundation [81060199]	National Natural Science Fundation(National Natural Science Foundation of China (NSFC))	The work described in this paper was supported by the National Natural Science Fundation (No. 81060199). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; Boccia S, 2008, AM J EPIDEMIOL, V167, P505, DOI 10.1093/aje/kwm344; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Cui LH, 2011, MED ONCOL; D'Amico M, 2009, J THROMB THROMBOLYS, V28, P70, DOI 10.1007/s11239-008-0246-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fabris C, 2009, ALCOHOL CLIN EXP RES, V33, P102, DOI 10.1111/j.1530-0277.2008.00816.x; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Heijmans BT, 2003, CANCER RES, V63, P1249; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jin F, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-39; Kamen B, 1997, SEMIN ONCOL, V24, P30; Kim YI, 2005, NUTR REV, V63, P398, DOI 10.1111/j.1753-4887.2005.tb00377.x; Kwak SY, 2008, ANTICANCER RES, V28, P2807; Liu JJ, 2010, SHI JIE HUA REN XIAO, V18, P1555; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mu LN, 2007, CANCER CAUSE CONTROL, V18, P665, DOI 10.1007/s10552-007-9012-x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pereira AC, 2004, CLIN CHIM ACTA, V340, P99, DOI 10.1016/j.cccn.2003.09.016; Rosenblatt DS, 2001, CLIN INVEST MED, V24, P56; Saffroy R, 2004, CARCINOGENESIS, V25, P1443, DOI 10.1093/carcin/bgh147; Samonakis DN, 2004, DIGEST DIS SCI, V49, P854, DOI 10.1023/B:DDAS.0000030099.13397.28; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taioli E, 2009, AM J EPIDEMIOL, V170, P1207, DOI 10.1093/aje/kwp275; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Ventura P, 2005, LIVER INT, V25, P49, DOI 10.1111/j.1478-3231.2005.01042.x; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Yang H., 2007, GENETIC ASS CANDIDAT; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x; Yuan JM, 2007, HEPATOLOGY, V46, P749, DOI 10.1002/hep.21735; Zhu Zhong-zheng, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P196; Zintzaras E, 2006, CLIN GENET, V69, P327, DOI 10.1111/j.1399-0004.2006.00605.x	40	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56070	10.1371/journal.pone.0056070	http://dx.doi.org/10.1371/journal.pone.0056070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457501	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700040
J	Stetz, J; Hunt, K; Kendall, KC; Wasser, SK				Stetz, Jeff; Hunt, Kathleen; Kendall, Katherine C.; Wasser, Samuel K.			Effects of Exposure, Diet, and Thermoregulation on Fecal Glucocorticoid Measures in Wild Bears	PLOS ONE			English	Article							STRESS; EXCRETION; ALBERTA	We examined fecal glucocorticoid (fGC) measures of nutrition and thermoregulatory demands on wild bears in Glacier National Park, Montana, and assessed how these measures changed in samples left in the field. Both ambient temperature and exposure can impact thermoregulation and sample degradation. Bear diets vary markedly with season, affecting body condition and thus fGC. We collected fecal samples during September and October, 2001, when ambient temperatures ranged from 30 degrees C to -5 degrees C. We collected half of each sample immediately and left the other half in its original location for 1-28 days. We used generalized linear models (GLM) to first predict fGC concentrations in fresh samples based on proxies of nutrition, ambient temperature, thermal exposure, and precipitation. These same covariates were then used to predict degradation-based differences in fGC concentrations between the paired sample halves. Variation in fGC was predicted by diet, Julian date, aspect, and the interaction between Julian date and aspect in both fresh and exposed samples. Cumulative precipitation was also a significant predictor of fGC concentrations in the exposed samples, independent of time, indicating that precipitation contributes to sample degradation but not enough to mask effects of other environmental factors on fGC concentrations. Differences between sample halves were only predicted by cumulative precipitation and exposure time; cumulative precipitation decreased, whereas exposure time increased, fGC concentrations in the exposed sample halves. Results indicate that fGC can provide reliable indices of nutrition and thermoregulatory demands in bears and that sample degradation impacts on these relations are minimal and can be virtually eliminated by controlling for cumulative precipitation over the estimated exposure times.	[Stetz, Jeff] Sinopah Wildlife Res Associates, Missoula, MT USA; [Hunt, Kathleen; Wasser, Samuel K.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kendall, Katherine C.] US Geol Survey, Northern Rocky Mt Sci Ctr, West Glacier, MT USA	University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey	Stetz, J (corresponding author), Sinopah Wildlife Res Associates, Missoula, MT USA.	jeff.stetz@gmail.com	Wasser, Samuel K/I-5542-2015		JBS; University of Washington Center for Conservation Biology; University of Montana	JBS; University of Washington Center for Conservation Biology; University of Montana	Field work for this study was primarily funded by JBS, but there were no potential financial gains to any author via this work. The USGS provided office space, IT support, and a field vehicle. All laboratory analyses were supported by the University of Washington Center for Conservation Biology. Additional lab support was provided by the University of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Correa-Calderon A, 2004, INT J BIOMETEOROL, V48, P142, DOI 10.1007/s00484-003-0194-y; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; GOLDIN BR, 1981, CANCER RES, V41, P3771; GOLDIN BR, 1982, NEW ENGL J MED, V307, P1542, DOI 10.1056/NEJM198212163072502; Hayward LS, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00199.1; Hunt KE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P918, DOI 10.1086/380209; Kitaysky AS, 2005, HORM BEHAV, V47, P606, DOI 10.1016/j.yhbeh.2005.01.005; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Stage AR, 2007, FOREST SCI, V53, P486; von der Ohe CG, 2004, PHYSIOL BIOCHEM ZOOL, V77, P313, DOI 10.1086/378139; Washburn BE, 2002, GEN COMP ENDOCR, V127, P217, DOI 10.1016/S0016-6480(02)00056-4; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; WASSER SK, 1988, BIOL REPROD, V39, P862, DOI 10.1095/biolreprod39.4.862; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wasser SK, 1996, BIOL REPROD, V55, P393, DOI 10.1095/biolreprod55.2.393; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; WERNER R, 1985, J COMP PHYSIOL B, V155, P219, DOI 10.1007/BF00685216; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]	26	27	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e55967	10.1371/journal.pone.0055967	http://dx.doi.org/10.1371/journal.pone.0055967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457488	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700028
J	Fukuzawa, T; Fukazawa, M; Ueda, O; Shimada, H; Kito, A; Kakefuda, M; Kawase, Y; Wada, NA; Goto, C; Fukushima, N; Jishage, K; Honda, K; King, GL; Kawabe, Y				Fukuzawa, Taku; Fukazawa, Masanori; Ueda, Otoya; Shimada, Hideaki; Kito, Aki; Kakefuda, Mami; Kawase, Yosuke; Wada, Naoko A.; Goto, Chisato; Fukushima, Naoshi; Jishage, Kou-ichi; Honda, Kiyofumi; King, George L.; Kawabe, Yoshiki			SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TRANSPORTER; METABOLIC SYNDROME; RAT-KIDNEY; GLUT2; EXPRESSION; DISEASE; CONSUMPTION; INTESTINE; MANNOSE	Although excessive fructose intake is epidemiologically linked with dyslipidemia, obesity, and diabetes, the mechanisms regulating plasma fructose are not well known. Cells transfected with sodium/glucose cotransporter 5 (SGLT5), which is expressed exclusively in the kidney, transport fructose in vitro; however, the physiological role of this transporter in fructose metabolism remains unclear. To determine whether SGLT5 functions as a fructose transporter in vivo, we established a line of mice lacking the gene encoding SGLT5. Sodium-dependent fructose uptake disappeared in renal brush border membrane vesicles from SGLT5-deficient mice, and the increased urinary fructose in SGLT5-deficient mice indicated that SGLT5 was the major fructose reabsorption transporter in the kidney. From this, we hypothesized that urinary fructose excretion induced by SGLT5 deficiency would ameliorate fructose-induced hepatic steatosis. To test this hypothesis we compared SGLT5-deficient mice with wild-type mice under conditions of long-term fructose consumption. Paradoxically, however, fructose-induced hepatic steatosis was exacerbated in the SGLT5-deficient mice, and the massive urinary fructose excretion was accompanied by reduced levels of plasma triglycerides and epididymal fat but fasting hyperinsulinemia compared with fructose-fed wild-type mice. There was no difference in food consumption, water intake, or plasma fructose between the two types of mice. No compensatory effect by other transporters reportedly involved in fructose uptake in the liver and kidney were indicated at the mRNA level. These surprising findings indicated a previously unrecognized link through SGLT5 between renal fructose reabsorption and hepatic lipid metabolism.	[Fukuzawa, Taku; Fukazawa, Masanori; Ueda, Otoya; Shimada, Hideaki; Kito, Aki; Wada, Naoko A.; Fukushima, Naoshi; Jishage, Kou-ichi; Honda, Kiyofumi; Kawabe, Yoshiki] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan; [Kakefuda, Mami; Kawase, Yosuke; Goto, Chisato] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [King, George L.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Fukazawa, M (corresponding author), Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan.	fukazawamsn@chugai-pharm.co.jp		Kawabe, Yoshiki/0000-0002-6465-7146	Chugai Pharmaceutical Co., Ltd.; Sanofi Aventis	Chugai Pharmaceutical Co., Ltd.; Sanofi Aventis(Sanofi-Aventis)	No sources of funding outside Chugai Pharmaceutical Co., Ltd. supported this work, and there are no current external funding sources for this study.; T. Fukuzawa, M. Fukazawa, O. Ueda, H. Shimada, A. Kito, N.A. Wada, N. Fukushima, K. Jishage, K. Honda, and Y. Kawabe are employees of Chugai Pharmaceutical Co., Ltd. M. Kakefuda, Y. Kawase, and C. Goto are employees of Chugai Research Institute for Medical Science, Inc. These employments do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. George L. King has received a grant from Sanofi Aventis for research unrelated to the current study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Angrand P O, 1999, Nucleic Acids Res, V27, pe16, DOI 10.1093/nar/27.17.e16; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; BURANT CF, 1992, J BIOL CHEM, V267, P14523; CHEESEMAN CI, 1993, GASTROENTEROLOGY, V105, P1050, DOI 10.1016/0016-5085(93)90948-C; DAVIDSON NO, 1992, AM J PHYSIOL, V262, pC795, DOI 10.1152/ajpcell.1992.262.3.C795; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Grempler R, 2012, FEBS LETT, V586, P248, DOI 10.1016/j.febslet.2011.12.027; Horiba N, 2003, FEBS LETT, V546, P276, DOI 10.1016/S0014-5793(03)00600-8; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kadowaki T, 2012, DIABETES, V61, pA22; Kawasaki T, 2004, METABOLISM, V53, P583, DOI 10.1016/j.metabol.2003.12.007; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kemp M, 2004, BRIT J ANAESTH, V93, P63, DOI 10.1093/bja/aeh148; Leicht S, 2006, HSGLT5 SLC5A10 IS SO, P1512; Leturque A, 2005, J PHYSIOL BIOCHEM, V61, P529, DOI 10.1007/BF03168378; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Ohi A, 2011, AM J PHYSIOL-RENAL, V301, pF1105, DOI 10.1152/ajprenal.00663.2010; Pitkanen E, 1996, CLIN CHIM ACTA, V251, P91, DOI 10.1016/0009-8981(96)06284-5; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Stanhope KL, 2010, ANN NY ACAD SCI, V1190, P15, DOI 10.1111/j.1749-6632.2009.05266.x; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Sugawara-Yokoo M, 1999, KIDNEY INT, V56, P1022, DOI 10.1046/j.1523-1755.1999.00635.x; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tazawa S, 2005, LIFE SCI, V76, P1039, DOI 10.1016/j.lfs.2004.10.016; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; THORENS B, 1990, AM J PHYSIOL, V259, pC286; Wei YR, 2004, AM J PHYSIOL-ENDOC M, V287, pE926, DOI 10.1152/ajpendo.00185.2004; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Xia MF, 2011, CLIN EXP PHARMACOL P, V38, P373, DOI 10.1111/j.1440-1681.2011.05519.x	40	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56681	10.1371/journal.pone.0056681	http://dx.doi.org/10.1371/journal.pone.0056681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451068	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500022
J	Nkenfou, CN; Nana, CT; Payne, VK				Nkenfou, Celine Nguefeu; Nana, Christelle Tafou; Payne, Vincent Khan			Intestinal Parasitic Infections in HIV Infected and Non-Infected Patients in a Low HIV Prevalence Region, West-Cameroon	PLOS ONE			English	Article								The magnitude of intestinal parasitic infection in acquired immunodeficiency syndrome patients requires careful consideration in the developing world where poor nutrition is associated with poor hygiene and several tropical diseases. However, there have been very few studies addressing this issue in Cameroon. This study was conducted to determine the prevalence of intestinal parasitosis in HIV/AIDS patients in Dschang -Cameroon. Stool and blood specimens from HIV/AIDS patients and control group were screened respectively for intestinal parasites and for HIV antibodies. Intestinal parasites were identified using direct microscopy, formalin-ether concentration and Ziehl Neelsen methods. Out of 396 participants recruited among patients consulting at hospital, 42 (10.6%) were HIV positive, thirty of them treatment naive. The overall prevalence of intestinal parasites was 14.64%. Out of 42 HIV/AIDS patients, 59.5% (25/42) were infected with intestinal parasites, while only 9.32% (33/354) of the HIV negative patients were infected with intestinal parasites. The parasites detected in our study population included Crystosporidium parvum (2.53%), Entamoeba histolytica (7.52%), Entamoeba coli (4.04%), Giardia lamblia (0.25%), Trichuris trichura (0.25%), Strongyloides stercoralis (0.25%) and Taenia spp. (0.25%). In the HIV infected group, Crystosporidium parvum (19.04%), Entamoeba histolytica (19.04%), Entamoeba coli (21.42%), Giardia lamblia (2.38%), Strongyloides stercoralis (0.25%) and Taenia spp. (0.25%) were found. Crystosporidium parvum was found to be significantly higher in HIV/AIDS patients than in controls (P<0.05). Multivariate analysis showed that the HIV status and the quality of water were the major risk factors for intestinal parasitosis. Routine examinations of stool samples for parasites would significantly benefit the HIV patients by contributing in reducing morbidity and improving the efficiency of antiretroviral treatment. Even after the introduction of free anti-retroviral drugs, opportunistic intestinal infections are still a threat. HIV patients should be screened routinely for intestinal parasites and treated for their overall well being.	[Nkenfou, Celine Nguefeu] Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Lab Syst Biol, Yaounde, Cameroon; [Nkenfou, Celine Nguefeu] Univ Yaounde I, Higher Teacher Training Coll, Dept Biol Sci, Yaounde, Cameroon; [Nana, Christelle Tafou; Payne, Vincent Khan] Univ Dschang, Dept Anim Biol, Fac Sci, Dschang, Cameroon	University of Yaounde I	Nkenfou, CN (corresponding author), Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Lab Syst Biol, Yaounde, Cameroon.	nkenfou@yahoo.com			"Chantal Biya'' International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC); University of Dschang	"Chantal Biya'' International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC); University of Dschang	The "Chantal Biya'' International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC) and University of Dschang provided funding to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu H, 2009, ETHIOP J HEALTH DEV, V23, P133; Alyoune M, 1991, MED MAGHREB, V25, P5; Babatunde SK, 2010, ANN AFR MED, V9, P123, DOI 10.4103/1596-3519.68356; Barbot L., 2001, Annales Pharmaceutiques Francaises, V59, P305; Collins CH, 1989, MICROBIOLOGICAL METH, P93; Corbett EL, 2002, LANCET, V359, P2177, DOI 10.1016/S0140-6736(02)09095-5; Da Silva CV, 2005, SCAND J INFECT DIS, V37, P211, DOI 10.1080/00365540410020875; Ekejindu IM, 2010, WORLD J MED SCI, V5, P71; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Garcia L. S., 2001, DIAGNOSTIC MED PARAS, P723; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Ilboudo D., 1997, Medecine d'Afrique Noire, V44, P69; Konate A, 2005, Bull Soc Pathol Exot, V98, P33; Lehman LG, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-P48; OMS, 1987, INT MAL TROP INF VIH; ONUSIDA, 2005, POINT SIDA; Oumar AA, 2008, DOUVAIN MED, V127, P12; Sarfati C, 2006, AM J TROP MED HYG, V74, P162, DOI 10.4269/ajtmh.2006.74.162; Tian Li-Guang, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P168; Tian LG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-36; Veas F, 1991, CAHIERS SANTE, V1, P189; Wiwanitkit V, 2001, BMC Gastroenterol, V1, P3, DOI 10.1186/1471-230X-1-3; Wumba R, 2007, Med Trop (Mars), V67, P145	23	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57914	10.1371/journal.pone.0057914	http://dx.doi.org/10.1371/journal.pone.0057914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451283	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500145
J	Shen, MJ; Ding, XP; Li, TJ; Chen, GY; Zhou, X				Shen, Mengjie; Ding, Xianping; Li, Tianjun; Chen, Gangyi; Zhou, Xiao			Sequence Variation Analysis of HPV-18 Isolates in Southwest China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; RETINOBLASTOMA GENE-PRODUCT; CERVICAL-CANCER PATIENTS; TRANSFORMATION FUNCTIONS; CRYSTAL-STRUCTURE; E2; PROTEIN; E6; VARIANTS; E7	Intratypic variations of HPV-18 are known to differ in the persistence of the infection, frequency of carcinogenesis and the progression of precursor lesions to advanced cervical cancer. This study was designed to analyze sequence variations of HPV-18 isolates in order to discover novel HPV-18 variants and to evaluate the variations among infected women in southwest China. Cervical biopsies from 56 HPV-18-positive women with cervical neoplasia were assayed by PCR amplification and sequencing of all eight genes (E1, E2, E4, E5, E6, E7, L1, L2) of the HPV-18 genome. The most frequently observed variation was a C to G transversion at nucleotide 287 of E6, which was found in 48.2% of samples. Analysis of E7 revealed only one specimen as having sequence variations. In addition, we have identified several novel variations: A551C in E6, G6906A in L1, and C4915T and C5147A in L2. The mutations in E6 and L2 are silent, while the E7 mutation results in a single amino acid change. This study complements and expands on previous descriptions of HPV-18 variants. The sequence variation data presented here provides a foundation for future research on HPV-induced oncogenesis and may prove valuable for developing diagnostic probes and in the design of HPV vaccines for targeted populations.	[Shen, Mengjie; Ding, Xianping; Li, Tianjun; Chen, Gangyi; Zhou, Xiao] Sichuan Univ, Bioresource Res & Utilizat Joint Key Lab Sichuan, Inst Med Genet, Coll Life Sci, Chengdu 610064, Peoples R China; [Shen, Mengjie; Ding, Xianping; Li, Tianjun; Chen, Gangyi] Sichuan Univ, Inst Med Genet, Coll Life Sci, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Ding, XP (corresponding author), Sichuan Univ, Bioresource Res & Utilizat Joint Key Lab Sichuan, Inst Med Genet, Coll Life Sci, Chengdu 610064, Peoples R China.	xianping2011@yeah.net			Science and Technology Department of Sichuan Province, China	Science and Technology Department of Sichuan Province, China	This work was supported by funds from the Science and Technology Department of Sichuan Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Amador-Molina A, 2012, J GEN VIROL; ANDROPHY EJ, 1987, NATURE, V325, P70, DOI 10.1038/325070a0; Angulo M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-33; [Anonymous], 2011, MON EV CARC RISKS B, V100; Arias-Pulido H, 2005, VIROLOGY, V338, P22, DOI 10.1016/j.virol.2005.04.022; Arroyo SL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-258; Bellanger S, 2011, AM J CANCER RES, V1, P373; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Blachon S, 2003, BIOCHIMIE, V85, P813, DOI 10.1016/j.biochi.2003.09.008; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Cai HB, 2010, EJSO-EUR J SURG ONC, V36, P160, DOI 10.1016/j.ejso.2009.07.186; Chang CH, 2005, J CLIN VIROL, V32, P33, DOI 10.1016/j.jcv.2004.06.011; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cooper CS, 1998, VIROLOGY, V241, P312, DOI 10.1006/viro.1997.8941; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Demeret C, 1998, VIROLOGY, V242, P378, DOI 10.1006/viro.1997.9023; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fragoso-Ontiveros V, 2012, VIROLOGY, V432, P81, DOI 10.1016/j.virol.2012.05.029; Frati E, 2011, INFECT GENET EVOL, V11, P2119, DOI 10.1016/j.meegid.2011.06.014; Garcia-Vallve S, 2005, TRENDS MICROBIOL, V13, P514, DOI 10.1016/j.tim.2005.09.003; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Harris SF, 1999, SCIENCE, V284, P1673, DOI 10.1126/science.284.5420.1673; Liu SQ, 2010, BIOCHIMIE, V92, P901, DOI 10.1016/j.biochi.2010.02.028; Londesborough P, 1996, INT J CANCER, V69, P364; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Paavonen J, 2007, INT J INFECT DIS, V11, pS3, DOI 10.1016/S1201-9712(07)60015-0; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Rhond CK, 2009, J PNAS, V106, P20458; Rose BR, 1997, GYNECOL ONCOL, V66, P282, DOI 10.1006/gyno.1997.4740; Sathish N, 2005, CANCER LETT, V229, P93, DOI 10.1016/j.canlet.2005.04.026; Stephen AL, 2000, INT J CANCER, V86, P695, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;695::AID-IJC15&gt;3.0.CO;2-C; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Todorovic B, 2011, J VIROL, V85, P10048, DOI 10.1128/JVI.00643-11; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; WALKER J, 1989, OBSTET GYNECOL, V74, P781; Wang Y, 2004, J BIOL CHEM, V279, P6976, DOI 10.1074/jbc.M311376200; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wu MH, 2007, INT J BIOCHEM CELL B, V39, P413, DOI 10.1016/j.biocel.2006.09.008; Wu YP, 2006, J GEN VIROL, V87, P1181, DOI 10.1099/vir.0.81649-0; Yatsudo M, 1988, VIROLOGY, V166, P594; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605; Yumin W, 2012, AFRICAN J MICROBIOLO, V6, P1048; Zehbe I, 1998, CANCER RES, V58, P829	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56614	10.1371/journal.pone.0056614	http://dx.doi.org/10.1371/journal.pone.0056614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451059	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500018
J	Ozeki, K; Tanida, S; Morimoto, C; Inoue, Y; Mizoshita, T; Tsukamoto, H; Shimura, T; Kataoka, H; Kamiya, T; Nishiwaki, E; Ishiguro, H; Higashiyama, S; Joh, T				Ozeki, Keiji; Tanida, Satoshi; Morimoto, Chie; Inoue, Yoshimasa; Mizoshita, Tsutomu; Tsukamoto, Hironobu; Shimura, Takaya; Kataoka, Hiromi; Kamiya, Takeshi; Nishiwaki, Eiji; Ishiguro, Hiroshi; Higashiyama, Shigeki; Joh, Takashi			Telmisartan Inhibits Cell Proliferation by Blocking Nuclear Translocation of ProHB-EGF C-Terminal Fragment in Colon Cancer Cells	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; ACTIVATED-RECEPTOR-GAMMA; II TYPE-1 RECEPTOR; GROWTH-FACTOR; HB-EGF; GASTRIC-CANCER; THERAPY; CHEMOTHERAPY; MECHANISM; CETUXIMAB	Background & Aims: Current treatment target toward advanced colorectal cancers is mainly focused on the epidermal growth factor receptor (EGFR) signaling, but its additive effects with chemotherapy are still limited. A disintegrin and metalloproteinase (ADAM) cleaves the proheparin-binding epidermal growth factor like growth factor (proHB-EGF). And soluble HB-EGF activates EGFR. In parallel, the carboxy-terminal fragment of proHB-EGF (HB-EGF-CTF) translocates into the inner nuclear membrane, and subsequently exerts on the regulation of cell proliferation by binding nuclear promyelocytic leukemia zinc finger (PLZF) protein, a transcriptional repressor, thereby causing its nuclear export. We hypothesized that the inhibition of HB-EGF-CTF nuclear translocation may be a new strategy in preventing cell proliferation. Methods: 12-O-tetradecanoylphorbor-13-acetate (TPA) was treated to activate ADAM. Nine-thousand chemical compounds were screened for their efficacies in blocking the binding of HB-EGF-CTF to promyelocytic leukemia zinc finger (PLZF) with Alphascreen system. The obtained candidates were then used to block the binding of HB-EGF-CTF to PLZF in colon cancer cells, HT29 and HCT116. Cell proliferation was investigated with a growth curve assay. The intracellular localization, and association between HB-EGF-CTF and PLZF, was assessed with immunofluorescent staining, and immunoprecipitation and Western blotting, respectively. The effects of obtained candidates on EGFR phosphorylation and on nuclear translocation of HB-EGF-CTF and export of PLZF during the angiotensin II type1 receptor (AT1R) knockdown were also investigated. Results: Telmisartan and candesartan were found to be potential candidates. Telmisartan inhibited TPA-induced cell proliferation stronger than candesartan. Telmisartan, but not candesartan blocked the nuclear translocation of HB-EGF-CTF, and binding of HB-EGF-CTF to PLZF, during TPA stimulation. Both telmisartan and candesartan did not inhibit TPA-induced EGFR phosphorylation, and telmisartan, but not candesartan, inhibited TPA-induced nuclear translocation of HB-EGF-CTF after knockdown of AT1R. Conclusions: The inhibition of HB-EGF-CTF nuclear translocation with telmisartan may be a novel strategy in preventing cell proliferation.	[Ozeki, Keiji; Tanida, Satoshi; Mizoshita, Tsutomu; Tsukamoto, Hironobu; Shimura, Takaya; Kataoka, Hiromi; Kamiya, Takeshi; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Morimoto, Chie] Matsuyama Shinonome Jr Coll, Nutr Course, Dept Life Sci, Matsuyama, Ehime, Japan; [Inoue, Yoshimasa; Nishiwaki, Eiji] Carna Biosci Incorp, Kobe, Hyogo, Japan; [Ishiguro, Hiroshi] Gifu Univ Med Sci, Sch Hlth Sci, Dept Med Technol, Seki, Gifu, Japan; [Higashiyama, Shigeki] Ehime Univ, Proteomed Res Ctr, Dept Cell Growth & Tumor Regulat, Toon, Ehime, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime, Japan	Nagoya City University; Ehime University; Ehime University	Tanida, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan.	stanida@med.nagoya-cu.ac.jp; shigeki@m.ehime-u.ac.jp	Tanida, Satoshi/AAA-1805-2021	Shimura, Takaya/0000-0002-6048-0021	Japan Society for the Promotion of Science (JSPS) [KAKENHI 22590704]; Grants-in-Aid for Scientific Research [23790802] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in Aid for scientific research C (KAKENHI 22590704) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Imayama I, 2006, CARDIOVASC RES, V72, P184, DOI 10.1016/j.cardiores.2006.07.014; Isobe A, 2008, HUM REPROD, V23, P440, DOI 10.1093/humrep/dem247; Kinney EL, 2008, J CELL PHYSIOL, V216, P621, DOI 10.1002/jcp.21437; Kopp R, 2003, RECENT RESULTS CANC, V162, P115; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Saika K, 2011, JPN J CLIN ONCOL, V41, P1153, DOI 10.1093/jjco/hyr130; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; Shimura T, 2008, CLIN CANCER RES, V14, P3956, DOI 10.1158/1078-0432.CCR-07-4794; Shimura T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-205; Tanida S, 2004, GASTROENTEROLOGY, V127, P559, DOI 10.1053/j.gastro.2004.05.017; Tanida S, 2010, DIGESTION, V82, P145, DOI 10.1159/000310903; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Wienen W, 2000, CARDIOVASC DRUG REV, V18, P127; Yoshida M, 2012, J CANC RES CLIN ONCO; Yoshida T, 2006, DIABETOLOGIA, V49, P3094, DOI 10.1007/s00125-006-0437-7; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015	27	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56770	10.1371/journal.pone.0056770	http://dx.doi.org/10.1371/journal.pone.0056770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451083	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800035
J	Pan, XH; Zhu, YY; Wang, Q; Zheng, H; Chen, X; Su, J; Peng, ZH; Yu, RB; Wang, N				Pan, Xiaohong; Zhu, Yingying; Wang, Qing; Zheng, Hui; Chen, Xin; Su, Jing; Peng, Zhihang; Yu, Rongbin; Wang, Ning			Prevalence of HIV, Syphilis, HCV and Their High Risk Behaviors among Migrant Workers in Eastern China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; TO-URBAN MIGRATION; RURAL MIGRANTS; SEX WORKERS; INFECTION; POPULATION; SHANGHAI; ACCEPTANCE; RESIDENTS; ATTITUDES	Objective: The goal of this study was to understand the knowledge about AIDS, identify the correlates and determine the prevalence of HIV infection, syphilis, HCV among migrant workers in Zhejiang, China. Methods: A cross-sectional study using face-to-face anonymous questionnaire interviews was conducted and blood samples were collected for HIV, syphilis and Hepatitis C infection screening. Results: 17,377 (92.8%) of 18,730 migrant workers approached were interviewed. Among 17,377 participants, the HIV/AIDS knowledge rate was 66.2%. A total of 12,694 (73%) of the participants reported having ever had sexual intercourse, with 30.1% of single participants reporting having had sexual intercourse. Among those respondents with sexual experiences, 7.5% admitted they had two or more sexual partners and 4.9% reported having had sex with casual (unpaid) partners in the previous 12 months, whilst 3.7% had paid for sex. More than half of those who had paid for sex (59.4%) had not used a condom every time in their sexual acts with the sex workers. Multiple logistic regression analysis indicated that high risk sexual behavior (defined as sex with a casual or commercial sex partner without using a condom consistently) was associated with being divorced or widowed (P<0.05 for single); male gender; shorter duration of stay in Zhejiang; working in factory, market or domestic service (P<0.05 for odd job); having a province of origin inside Zhejiang; and drug use. The prevalence of HIV and HCV infections were 0.02% (95% CI: 0.01%-0.06%) and 0.40% (95% CI: 0.31%-0.51%), respectively. The prevalence of syphilis among those who were sexually active was 0.55% (95% CI: 0.43%-0.70%). Risk factors for syphilis included shorter duration of stay in Zhejiang, ethnic minority status, being divorced or widowed and having had multiple sex partners. Conclusions: Much greater efforts are needed to promote safer sex, and programs for the control of syphilis need to be tailored for migrant workers in China.	[Zhu, Yingying; Wang, Qing; Zheng, Hui; Chen, Xin; Su, Jing; Peng, Zhihang; Yu, Rongbin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Pan, Xiaohong] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Zhejiang Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Peng, ZH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhihangpeng@yahoo.com.cn			National Natural Science Foundation of China [81001288]; Natural Science Foundation Key Project of Jiangsu Province, China [BK2010079]; National S & T Major Project Foundation of China [2012ZX10001-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Key Project of Jiangsu Province, China; National S & T Major Project Foundation of China	This work was supported in part by National Natural Science Foundation of China (81001288), Natural Science Foundation Key Project of Jiangsu Province, China (BK2010079) and "National S & T Major Project Foundation of China" (2012ZX10001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; Arneborn M, 2007, EURO SURVEILL, V12; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Burns FM, 2009, AIDS, V23, P262, DOI 10.1097/QAD.0b013e32831c546b; *CDCP, 2009, HIV AIDS SURV REP 20; *CHIN STAT COUNC A, 2007, JOINT ASS HIV AIDS P; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cui Q, 2011, INFECT GENET EVOL, V11, P1682, DOI 10.1016/j.meegid.2011.06.016; Duan C., 2008, POPULATION RES, V32, P30; Duan S, 2010, SCI DECISION MAKING, V10, P47; Gunn RA, 2005, SEX TRANSM DIS, V32, P328, DOI 10.1097/01.olq.0000154562.51908.c6; Hahm H, 2008, J YOUTH ADOLESCENCE, V37, P74, DOI 10.1007/s10964-007-9234-y; Hargreaves S, 2008, LANCET INFECT DIS, V8, P470, DOI 10.1016/S1473-3099(08)70169-5; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; He N, 2009, AIDS EDUC PREV, V21, P570, DOI 10.1521/aeap.2009.21.6.570; Hesketh T, 2006, SEX TRANSM INFECT, V82, P11, DOI 10.1136/sti.2004.014043; Hesketh T, 2005, SEX TRANSM INFECT, V81, P108, DOI 10.1136/sti.2004.009704; Hong Y, 2009, AIDS CARE, V21, P212, DOI 10.1080/09540120801932165; Hu Z, 2006, PUBLIC HEALTH, V120, P339, DOI 10.1016/j.puhe.2005.10.016; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Liu YJ, 2012, EUR J CONTRACEP REPR, V17, P219, DOI 10.3109/13625187.2012.662544; Locke TF, 2008, HEALTH PSYCHOL, V27, P337, DOI 10.1037/0278-6133.27.3.337; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; *MIN HLTH CHIN, 2011, EST HIV AIDS EP CHIN; Ministry of Health China Joint United Nations Programme on HIV/AIDS World Health Organization, 2009, EST HIV AIDS EP CHIN; Ministry of Health in China UNAIDS WHO, 2005, 2005 UPD HIV AIDS EP; Nansheng Bai, 2002, SHEHUIXUE YANJIU, V3, P64; National Center for AIDS/STD Control and Prevention of China CDC, 2009, NAT HIV SURV SURV RE; Nguyen HV, 2012, ARCH SEX BEHAV, V41, P1231, DOI 10.1007/s10508-012-9904-z; Qiu PY, 2011, J AFFECT DISORDERS, V134, P198, DOI 10.1016/j.jad.2011.05.043; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Riaz M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-368; Srithanaviboonchai K, 2002, AIDS, V16, P929, DOI 10.1097/00002030-200204120-00015; USAID, 2008, HIV AIDS HLTH PROFIL; Vaidya NK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-310; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang B, 2007, SEX TRANSM DIS, V34, P1, DOI 10.1097/01.olq.0000222668.95038.03; Wang B, 2007, AIDS PATIENT CARE ST, V21, P57, DOI 10.1089/apc.2006.0031; Wong DFK, 2008, INT J SOC PSYCHIATR, V54, P131, DOI 10.1177/0020764007083877; Xia DY, 2011, CHIN J AIDS STD, V17, P430; Xu F, 2010, ZHEJIANG PREV MED, V22, P8; Zhang ZQ., 2007, STAT RES, V24, P9; Zhejiang Provincial Government, 2012, POP STAT 2010; Zhuang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031986	47	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57258	10.1371/journal.pone.0057258	http://dx.doi.org/10.1371/journal.pone.0057258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451193	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800095
J	Bailey, DP; Boddy, LM; Savory, LA; Denton, SJ; Kerr, CJ				Bailey, Daniel P.; Boddy, Lynne M.; Savory, Louise A.; Denton, Sarah J.; Kerr, Catherine J.			Choice of Activity-Intensity Classification Thresholds Impacts upon Accelerometer-Assessed Physical Activity-Health Relationships in Children	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; REFERENCE CURVES; INDEPENDENT ASSOCIATIONS; CARDIOMETABOLIC RISK; METABOLIC SYNDROME; RT3 ACCELEROMETER; ADOLESCENTS; YOUTH; ADIPOSITY	Background: It is unknown whether using different published thresholds (PTs) for classifying physical activity (PA) impacts upon activity-health relationships. This study explored whether relationships between PA (sedentary [SED], light PA [LPA], moderate PA [MPA], moderate-to-vigorous PA, vigorous PA [VPA]) and health markers differed in children when classified using three different PTs. Methods: 104 children (63 girls) aged 10-14 years wore an RT3 triaxial accelerometer for seven days and measures of adiposity and cardiometabolic risk markers were taken. Results: Significant associations (p<.05) in boys were found between LPA and body mass index z-score and waist circumference z-score for the Rowlands et al PT only (beta=.459 and. 401, respectively) and body fat% (BF%) for the Chu et al PT only (beta=.322) and in girls with BF% for the Rowlands et al PT only (beta=.303) and systolic BP and blood glucose for the Vanhelst et al PT only (beta=-2.298 and -2.283, respectively). MPA was significantly (p<05) associated with BF%, diastolic BP, and cardiorespiratory fitness (CRF) for the Chu et al PT only in girls (beta=-.436, -.529, and .446, respectively). SED was significantly (p<.05) associated with triglycerides (beta=.492) for the Rowlands et al PT only in boys and VPA with CRF (p<.05) for the Rowlands et al and Vanhelst et al PTs only in girls (beta=.416 and .352, respectively). Conclusions: The choice of PT impacted upon activity-health relationships. A consensus on appropriate accelerometer thresholds for quantifying PA intensity and sedentary behaviour is needed in order to make accurate evidence-based recommendations for health promotion.	[Bailey, Daniel P.; Savory, Louise A.; Denton, Sarah J.; Kerr, Catherine J.] Univ Bedfordshire, ISPAR, Bedford, England; [Boddy, Lynne M.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	University of Bedfordshire; Liverpool John Moores University	Bailey, DP (corresponding author), Univ Bedfordshire, ISPAR, Bedford, England.	daniel.bailey@beds.ac.uk	Bailey, Daniel/HDL-7697-2022	Boddy, Lynne/0000-0002-7477-4389; Charman, Sarah/0000-0002-3029-7672; Bailey, Daniel/0000-0003-3772-630X	Bedford Charity [166/308]	Bedford Charity	This work was funded by the Bedford Charity (grant number 166/308; http://www.bedfordcharity.org.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires L, 2010, J PHYS ACT HEALTH, V7, P54, DOI 10.1123/jpah.7.1.54; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Bailey DP, 2012, EUR J PEDIATR, V171, P1317, DOI 10.1007/s00431-012-1719-3; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Camhi SM, 2010, INT J PEDIATR OBES, V5, P122, DOI 10.3109/17477160903111763; Chaput JP, 2012, PEDIATR OBES, V7, P251, DOI 10.1111/j.2047-6310.2011.00028.x; Chu EYW, 2007, MED SCI SPORT EXER, V39, P2085, DOI 10.1249/mss.0b013e318148436c; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; *DEP HLTH, 2008, HLTH SURV ENGL 2008; Department of Health, 2011, START ACT STAY ACT R; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Ekelund U, 2009, AM J CLIN NUTR, V89, P90, DOI 10.3945/ajcn.2008.26649; Ferreira I, 2005, ARCH INTERN MED, V165, P42, DOI 10.1001/archinte.165.1.42; Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gaya AR, 2009, ANN HUM BIOL, V36, P379, DOI 10.1080/03014460902817976; Gutin B, 2005, AM J CLIN NUTR, V81, P746, DOI 10.1093/ajcn/81.4.746; Hussey J, 2007, BRIT J SPORT MED, V41, P311, DOI 10.1136/bjsm.2006.032045; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Krekoukia M, 2007, METABOLISM, V56, P206, DOI 10.1016/j.metabol.2006.09.014; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Parikh P, 2009, AM J HEALTH PROMOT, V23, P279, DOI 10.4278/ajhp.071221140; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rowlands AV, 2008, PREV MED, V46, P317, DOI 10.1016/j.ypmed.2007.11.004; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7; Shemesh T, 2006, CLIN CHIM ACTA, V367, P69, DOI 10.1016/j.cca.2005.11.014; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stone MR, 2009, J SPORT SCI MED, V8, P136; Vahlkvist S, 2009, ALLERGY, V64, P1649, DOI 10.1111/j.1398-9995.2009.02081.x; Vanhelst J, 2010, J SPORT SCI, V28, P381, DOI 10.1080/02640410903508821	38	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57101	10.1371/journal.pone.0057101	http://dx.doi.org/10.1371/journal.pone.0057101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441234	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200091
J	Hu, YS; Xu, HP; Li, ZH; Zheng, XJ; Jia, XZ; Nie, QH; Zhang, XQ				Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan			Comparison of the Genome-Wide DNA Methylation Profiles between Fast-Growing and Slow-Growing Broilers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CARCASS TRAITS; CPG ISLANDS; CHROMATIN-STRUCTURE; SIGNALING PATHWAY; BODY-COMPOSITION; F-2 INTERCROSS; GROWTH-FACTORS; CHICKEN; GENE	Introduction: Growth traits are important in poultry production, however, little is known for its regulatory mechanism at epigenetic level. Therefore, in this study, we aim to compare DNA methylation profiles between fast-and slow-growing broilers in order to identify candidate genes for chicken growth. Methylated DNA immunoprecipitation-sequencing (MeDIP-seq) was used to investigate the genome-wide DNA methylation pattern in high and low tails of Recessive White Rock (WRRh; WRRl) and that of Xinhua Chickens (XHh; XHl) at 7 weeks of age. The results showed that the average methylation density was the lowest in CGIs followed by promoters. Within the gene body, the methylation density of introns was higher than that of UTRs and exons. Moreover, different methylation levels were observed in different repeat types with the highest in LINE/CR1. Methylated CGIs were prominently distributed in the intergenic regions and were enriched in the size ranging 200-300 bp. In total 13,294 methylated genes were found in four samples, including 4,085 differentially methylated genes of WRRh Vs. WRRl, 5,599 of XHh Vs. XHl, 4,204 of WRRh Vs. XHh, as well as 7,301 of WRRl Vs. XHl. Moreover, 132 differentially methylated genes related to growth and metabolism were observed in both inner contrasts (WRRh Vs. WRRl and XHh Vs. XHl), whereas 129 differentially methylated genes related to growth and metabolism were found in both across-breed contrasts (WRRh Vs. XHh and WRRl Vs. XHl). Further analysis showed that overall 75 genes exhibited altered DNA methylation in all four contrasts, which included some well-known growth factors of IGF1R, FGF12, FGF14, FGF18, FGFR2, and FGFR3. In addition, we validate the MeDIP-seq results by bisulfite sequencing in some regions. Conclusions: This study revealed the global DNA methylation pattern of chicken muscle, and identified candidate genes that potentially regulate muscle development at 7 weeks of age at methylation level.	[Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan] S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Key Lab Chicken Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Nie, QH (corresponding author), S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China.	nqinghua@scau.edu.cn	Jia, Xinzheng/W-7312-2019; xu, haiping/GSJ-1374-2022; li, zh/HII-5698-2022; jia, xinzheng/K-7220-2017	Jia, Xinzheng/0000-0001-5699-8285; jia, xinzheng/0000-0001-5699-8285	National Natural Scientific Foundation of China [31172200, 31000544]; National Broiler Industry Technology System [CARS-42-G05]; National High Technology Research and Development Program (863) of China [2011AA100301, 2010AA10A102]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Broiler Industry Technology System; National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China)	This research was supported by grants from the National Natural Scientific Foundation of China (31172200; 31000544), the National Broiler Industry Technology System (CARS-42-G05) and the National High Technology Research and Development Program (863) of China (2011AA100301; 2010AA10A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Ankra-Badu GA, 2010, ANIM GENET, V41, P400, DOI 10.1111/j.1365-2052.2009.02017.x; Arbabi S, 2002, CRIT CARE MED, V30, pS74, DOI 10.1097/00003246-200201001-00010; Balda MS, 1998, J CELL SCI, V111, P541; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen KF, 2012, ANIM BIOTECHNOL, V23, P43, DOI 10.1080/10495398.2011.630897; Conerly M, 2010, DIS MODEL MECH, V3, P290, DOI 10.1242/dmm.004812; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cormier S, 2005, GENE EXPR PATTERNS, V5, P569, DOI 10.1016/j.modgep.2004.10.008; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deeb N, 2002, J HERED, V93, P107, DOI 10.1093/jhered/93.2.107; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029173; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lei MM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-70; Li QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019428; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Nadaf J, 2009, PHYSIOL GENOMICS, V38, P241, DOI 10.1152/physiolgenomics.90384.2008; Ohuchi H, 2000, MECH DEVELOP, V95, P55, DOI 10.1016/S0925-4773(00)00331-2; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sasaki H., 1993, Experientia Supplementum (Basel), V64, P469; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Sati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031621; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SCANES CG, 1984, POULTRY SCI, V63, P2062, DOI 10.3382/ps.0632062; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Uemoto Y, 2009, POULTRY SCI, V88, P477, DOI 10.3382/ps.2008-00296; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Zhang H, 2011, J ANIM BREED GENET, V128, P366, DOI 10.1111/j.1439-0388.2011.00927.x; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou H, 2006, POULTRY SCI, V85, P1700, DOI 10.1093/ps/85.10.1700	56	62	68	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56411	10.1371/journal.pone.0056411	http://dx.doi.org/10.1371/journal.pone.0056411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441189	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200046
J	Jiang, Z; Li, CX; Li, FY; Wang, XS				Jiang, Zheng; Li, Chunxiang; Li, Fuyuan; Wang, Xishan			EGFR Gene Copy Number as a Prognostic Marker in Colorectal Cancer Patients Treated with Cetuximab or Panitumumab: A Systematic Review and Meta Analysis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; PREDICTIVE BIOMARKER; IRINOTECAN-CETUXIMAB; MUTATION STATUS; KRAS MUTATION; OPEN-LABEL; CHEMOTHERAPY; METAANALYSIS; EXPRESSION	Background: The epidermal growth factor receptor (EGFR) gene copy number (GCN) has been previously demonstrated to correlate with the clinical outcome of colorectal cancer (CRC) treated with anti-EGFR monoclonal antibodies (mAbs), although it remains controversial. We conducted a systematic review and meta-analysis to assess EGFR GCN as a potential biomarker of survival for patients with advanced CRC receiving treatment with anti-EGFR mAbs. Methods: We systematically identified articles investigating EGFR GCN by fluorescent or chromogenic in situ hybridization or other detection techniques in patients with metastatic CRC treated with panitumumab or cetuximab, (last search: 10 August 2012). Eligible studies had to report on overall survival (OS), progression-free survival (PFS) or time-toprogression (TTP), stratified by EGFR GCN. Summary hazard ratios (HRs) were calculated using random-effects models. Results: Among 13 identified studies, 10 (776 patients, 302 with increased GCN), 8 (893 patients, 282 with increased GCN) and 3 (149 patients, 66 with increased GCN) were eligible for the OS, PFS and TTP meta-analyses, respectively. Increased EGFR GCN was associated with increased OS (HR = 0.62; 95% CI 0.50-0.77; P<0.001), PFS (HR = 0.65; 95% CI 0.47-0.89; P = 0.008) but not TTP (HR = 0.71; 95% CI 0.44-1.14; P = 0.157). It was also shown that EGFR GCN is independent of other factors such as KRAS status. Among those populations received second-line or higher treatment, increased EGFR GCN was strongly associated with improved survival (for OS, HR = 0.60; 95% CI 0.47-0.75; P<0.001; for PFS, HR = 0.59; 95% CI 0.470.75; P<0.001), whereas it did not influence survival in patients that received first-line therapy. Conclusion: Among the anti-EGFR-treated patients, increased EGFR GCN appears to be associated with improved survival outcomes. The effect on survival appears to be related to patients receiving the line of treatment.	[Jiang, Zheng; Wang, Xishan] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Harbin, Heilongjiang, Peoples R China; [Jiang, Zheng; Wang, Xishan] Heilongjiang Acad Med Sci, Colorectal Canc Inst, Harbin, Heilongjiang, Peoples R China; [Li, Chunxiang] Harbin Med Univ, Med Genet Lab, Harbin, Heilongjiang, Peoples R China; [Li, Fuyuan] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Wang, XS (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Harbin, Heilongjiang, Peoples R China.	wxshan1208@yahoo.com.cn			China Postdoctoral Science Foundation [2011M500060]; Heilongjiang Postdoctoral Grant [LRB2010-87864]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Grant	This work was supported by China Postdoctoral Science Foundation (2011M500060) and Heilongjiang Postdoctoral Grant (LRB2010-87864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Bengala C, 2010, BRIT J CANCER, V103, P1019, DOI 10.1038/sj.bjc.6605853; Campanella C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-36; Cappuzzo F, 2008, ANN ONCOL, V19, P717, DOI 10.1093/annonc/mdm492; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dahabreh IJ, 2011, ANN ONCOL, V22, P545, DOI 10.1093/annonc/mdq432; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goncalves A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-169; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Li YH, 2011, CLIN CANCER RES, V17, P382, DOI 10.1158/1078-0432.CCR-10-0208; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lin JK, 2011, J SURG ONCOL, V104, P661, DOI 10.1002/jso.21993; Martin V, 2009, J CLIN PATHOL, V62, P314, DOI 10.1136/jcp.2008.059592; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2012, J CLIN PATHOL, V65, P218, DOI 10.1136/jclinpath-2011-200353; Scartozzi M, 2012, ANN ONCOL, V23, P1706, DOI 10.1093/annonc/mdr558; Scartozzi M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-303; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Van Cutsem E, 2008, ANN ONCOL, V19, P92, DOI 10.1093/annonc/mdm399; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Yang ZY, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-52	37	47	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56205	10.1371/journal.pone.0056205	http://dx.doi.org/10.1371/journal.pone.0056205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441167	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200024
J	Scholz, I; Lange, SJ; Hein, S; Hess, WR; Backofen, R				Scholz, Ingeborg; Lange, Sita J.; Hein, Stephanie; Hess, Wolfgang R.; Backofen, Rolf			CRISPR-Cas Systems in the Cyanobacterium Synechocystis sp PCC6803 Exhibit Distinct Processing Pathways Involving at Least Two Cas6 and a Cmr2 Protein	PLOS ONE			English	Article							SECONDARY STRUCTURES; ANTIVIRAL DEFENSE; IMMUNE-SYSTEMS; RNA CLEAVAGE; BACTERIA; ARCHAEA; COMPLEX; RECOGNITION; PROKARYOTES; GENES	The CRISPR-Cas (Clustered Regularly Interspaced Short Palindrome Repeats - CRISPR associated proteins) system provides adaptive immunity in archaea and bacteria. A hallmark of CRISPR-Cas is the involvement of short crRNAs that guide associated proteins in the destruction of invading DNA or RNA. We present three fundamentally distinct processing pathways in the cyanobacterium Synechocystis sp. PCC6803 for a subtype I-D (CRISPR1), and two type III systems (CRISPR2 and CRISPR3), which are located together on the plasmid pSYSA. Using high-throughput transcriptome analyses and assays of transcript accumulation we found all CRISPR loci to be highly expressed, but the individual crRNAs had profoundly varying abundances despite single transcription start sites for each array. In a computational analysis, CRISPR3 spacers with stable secondary structures displayed a greater ratio of degradation products. These structures might interfere with the loading of the crRNAs into RNP complexes, explaining the varying abundancies. The maturation of CRISPR1 and CRISPR2 transcripts depends on at least two different Cas6 proteins. Mutation of gene sll7090, encoding a Cmr2 protein led to the disappearance of all CRISPR3-derived crRNAs, providing in vivo evidence for a function of Cmr2 in the maturation, regulation of expression, Cmr complex formation or stabilization of CRISPR3 transcripts. Finally, we optimized CRISPR repeat structure prediction and the results indicate that the spacer context can influence individual repeat structures.	[Scholz, Ingeborg; Hein, Stephanie; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Genet & Expt Bioinformat Grp, D-79106 Freiburg, Germany; [Lange, Sita J.; Backofen, Rolf] Univ Freiburg, Bioinformat Grp, Dept Comp Sci, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Hess, WR (corresponding author), Univ Freiburg, Fac Biol, Genet & Expt Bioinformat Grp, Hugstetter Str 55, D-79106 Freiburg, Germany.	wolfgang.hess@biologie.uni-freiburg.de	Backofen, Rolf/AAC-1569-2021	Saunders, Sita/0000-0002-2243-5422; Backofen, Rolf/0000-0001-8231-3323; Hess, Wolfgang/0000-0002-5340-3423	German Research Foundation (DFG) program FOR1680 "Unravelling the Prokaryotic Immune System'' [HE 2544/8-1, BA 2168/5-1]; Microsoft Corporation	German Research Foundation (DFG) program FOR1680 "Unravelling the Prokaryotic Immune System''(German Research Foundation (DFG)); Microsoft Corporation(Microsoft)	Support by the German Research Foundation (DFG) program FOR1680 "Unravelling the Prokaryotic Immune System'' (grants HE 2544/8-1 and BA 2168/5-1) to WRH and RB is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The utilised software FASTQC and FASTX are unpublished and have been developed by the Bioinformatics Group at the Babraham Institute in Cambridge, UK, and the Computational Biology Service Unit from Cornell University in Ithaca, New York, USA, which is partially funded by Microsoft Corporation, respectively. We would also like to thank Elena Conti and Christian Benda for helpful dicussion on possible Cmr2 functions, and Daniel Maticzka, Steve Hoffmann, and Christian Otto for sharing their expertise in the mapping of large-scale sequencing reads.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-43; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cocozaki AI, 2012, STRUCTURE, V20, P545, DOI 10.1016/j.str.2012.01.018; Danika T, 2012, DNA RES, V19, P435, DOI 10.1093/dnares/dss024; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Djordjevic M, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-24; Garrett RA, 2011, BIOCHEM SOC T, V39, P51, DOI 10.1042/BST0390051; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Haurwitz RE, 2012, EMBO J; Hein S, 2013, RNA BIOL IN PRESS; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Juranek S, 2012, RNA, V18, P783, DOI 10.1261/rna.031468.111; Kaneko T, 2003, DNA RES, V10, P221, DOI 10.1093/dnares/10.5.221; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; Lawrence CM, 2011, STRUCTURE, V19, P142, DOI 10.1016/j.str.2011.01.003; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	57	91	95	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56470	10.1371/journal.pone.0056470	http://dx.doi.org/10.1371/journal.pone.0056470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441196	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200053
J	Sun, SY; Kjelleberg, S; McDougald, D				Sun, Shuyang; Kjelleberg, Staffan; McDougald, Diane			Relative Contributions of Vibrio Polysaccharide and Quorum Sensing to the Resistance of Vibrio cholerae to Predation by Heterotrophic Protists	PLOS ONE			English	Article							O1 EL-TOR; SECRETION SYSTEM; GRAZING RESISTANCE; COLONY MORPHOLOGY; BIOFILM FORMATION; BACTERIA; VIRULENCE; SURVIVAL; IDENTIFICATION; COLONIZATION	Protozoan grazing is a major mortality factor faced by bacteria in the environment. Vibrio cholerae, the causative agent of the disease cholera, is a natural inhabitant of aquatic ecosystems, and its survival depends on its ability to respond to stresses, such as predation by heterotrophic protists. Previous results show that grazing pressure induces biofilm formation and enhances a smooth to rugose morphotypic shift, due to increased expression of Vibrio polysaccharide (VPS). In addition to negatively controlling vps genes, the global quorum sensing (QS) regulator, HapR, plays a role in grazing resistance as the DhapR strain is efficiently consumed while the wild type (WT) is not. Here, the relative and combined contributions of VPS and QS to grazing resistance were investigated by exposing VPS and HapR mutants and double mutants in VPS and HapR encoding genes at different phases of biofilm development to amoeboid and flagellate grazers. Data show that the WT biofilms were grazing resistant, the VPS mutants were less resistant than the WT strain, but more resistant than the QS mutant strain, and that QS contributes to grazing resistance mainly in mature biofilms. In addition, grazing effects on biofilms of mixed WT and QS mutant strains were investigated. The competitive fitness of each strain in mixed biofilms was determined by CFU and microscopy. Data show that protozoa selectively grazed the QS mutant in mixed biofilms, resulting in changes in the composition of the mixed community. A small proportion of QS mutant cells which comprised 4% of the mixed biofilm biovolume were embedded in grazing resistant WT microcolonies and shielded from predation, indicating the existence of associational protection in mixed biofilms.	[Sun, Shuyang; Kjelleberg, Staffan; McDougald, Diane] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Kjelleberg, Staffan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [McDougald, Diane] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [McDougald, Diane] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Nanyang Environm & Water Inst, Singapore 639798, Singapore	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	McDougald, D (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	D.McDougald@unsw.edu.au	McDougald, Diane/AAF-4799-2020; McDougald, Diane/B-5564-2009; Kjelleberg, Staffan/AAB-4641-2020; SUN, SHUYANG/E-6671-2016; Kjelleberg, Staffan/C-9229-2015	McDougald, Diane/0000-0001-5827-8441; McDougald, Diane/0000-0001-5827-8441; Kjelleberg, Staffan/0000-0003-4271-6413; SUN, SHUYANG/0000-0001-6013-0614; Kjelleberg, Staffan/0000-0003-4271-6413	Australian Research Council [DP1096481]; Centre for Marine Bio-Innovation; University of New South Wales, Sydney	Australian Research Council(Australian Research Council); Centre for Marine Bio-Innovation; University of New South Wales, Sydney	This project was supported by the Australian Research Council grant DP1096481 and the Centre for Marine Bio-Innovation, the University of New South Wales, Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/pnas.0705599104; ALEXEYEV MF, 1995, GENE, V160, P59, DOI 10.1016/0378-1119(95)00141-R; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Boenigk J, 2000, J EUKARYOT MICROBIOL, V47, P350, DOI 10.1111/j.1550-7408.2000.tb00060.x; BROWN RC, 1975, NATURE, V254, P434, DOI 10.1038/254434a0; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Erken M, 2011, FEMS MICROBIOL ECOL, V76, P504, DOI 10.1111/j.1574-6941.2011.01067.x; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; Grossart HP, 2010, ENV MICROBIOL REP, V2, P706, DOI 10.1111/j.1758-2229.2010.00179.x; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Huq A, 1996, APPL ENVIRON MICROB, V62, P2508, DOI 10.1128/AEM.62.7.2508-2512.1996; Huws SA, 2005, J APPL MICROBIOL, V98, P238, DOI 10.1111/j.1365-2672.2004.02449.x; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Jousset A, 2009, ISME J, V3, P666, DOI 10.1038/ismej.2009.26; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Macek M, 1997, AQUAT MICROB ECOL, V13, P257, DOI 10.3354/ame013257; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2004, ENVIRON MICROBIOL, V6, P218, DOI 10.1111/j.1462-2920.2004.00556.x; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; Mueller RS, 2007, J BACTERIOL, V189, P5348, DOI 10.1128/JB.01867-06; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Parry JD, 2007, LETT APPL MICROBIOL, V45, P364, DOI 10.1111/j.1472-765X.2007.02213.x; Pruzzo C, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P217; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; RICE EW, 1992, LANCET, V340, P740, DOI 10.1016/0140-6736(92)92289-R; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; VAATANEN P, 1976, W A DENOTTBECK F SCI, V1, P1; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; Weitere M, 2005, ENVIRON MICROBIOL, V7, P1593, DOI 10.1111/j.1462-2920.2005.00851.x; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Worden AZ, 2006, ENVIRON MICROBIOL, V8, P21, DOI 10.1111/j.1462-2920.2005.00863.x; Worner U, 2000, MICROB ECOL, V40, P209; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	56	25	28	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56338	10.1371/journal.pone.0056338	http://dx.doi.org/10.1371/journal.pone.0056338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441178	Green Published, gold			2022-12-27	WOS:000315159200035
J	Nguyen, DB; Do, NT; Shiraishi, RW; Le, YN; Tran, QH; Nguyen, HH; Medland, N; Nguyen, LT; Struminger, BB				Duc Bui Nguyen; Nhan Thi Do; Shiraishi, Ray W.; Yen Ngoc Le; Quang Hong Tran; Hai Huu Nguyen; Medland, Nicholas; Long Thanh Nguyen; Struminger, Bruce Baird			Outcomes of Antiretroviral Therapy in Vietnam: Results from a National Evaluation	PLOS ONE			English	Article							INJECTION-DRUG USERS; FOLLOW-UP; TREATMENT PROGRAM; PATIENTS LOST; SCALE-UP; MULTIPLE IMPUTATION; MISSING VALUES; SOUTH-AFRICA; RISK-FACTORS; HIV	Objectives: Vietnam has significantly scaled up its national antiretroviral therapy (ART) program since 2005. With the aim of improving Vietnam's national ART program, we conducted an outcome evaluation of the first five years of the program in this concentrated HIV epidemic where the majority of persons enrolled in HIV care and treatment services are people who inject drugs (PWID). The results of this evaluation may have relevance for other national ART programs with significant PWID populations. Design: Retrospective cohort analysis of patients at 30 clinics randomly selected with probability proportional to size among 120 clinics with at least 50 patients on ART. Methods: Charts of patients whose ART initiation was at least 6 months prior to the study date were abstracted. Depending on clinic size, either all charts or a random sample of 300 charts were selected. Analyses were limited to treatment-naive patients. Multiple imputations were used for missing data. Results: Of 7,587 patient charts sampled, 6,875 were those of treatment-naive patients (74.4% male, 95% confidence interval [CI]: 72.4-76.5, median age 30, interquartile range [IQR]: 26-34, 62.0% reported a history of intravenous drug use, CI: 58.6-65.3). Median baseline CD4 cell count was 78 cells/mm 3 (IQR: 30-162) and 30.4% (CI: 25.8-35.1) of patients were at WHO stage IV. The majority of patients started d4T/3TC/NVP (74.3%) or d4T/3TC/EFV (18.6%). Retention rates after 6, 12, 24, and 36 months were 88.4% (CI: 86.8-89.9), 84.0% (CI: 81.8-86.0), 78.8% (CI: 75.7-81.6), and 74.6% (CI: 69.6-79.0). Median CD4 cell count gains after 6, 12, 24, and 36 months were 94 (IQR: 45-153), 142 (IQR: 78-217), 213 (IQR: 120-329), and 254 (IQR: 135-391) cells/mm(3). Patients who were PWID showed significantly poorer retention. Conclusions: The study showed good retention and immunological response to ART among a predominantly PWID group of patients despite advanced HIV infections at baseline.	[Duc Bui Nguyen; Yen Ngoc Le; Medland, Nicholas; Struminger, Bruce Baird] US Ctr Dis Control & Prevent, Hanoi, Vietnam; [Nhan Thi Do; Hai Huu Nguyen; Long Thanh Nguyen] Vietnam Adm HIV AIDS Control, Minist Hlth, Hanoi, Vietnam; [Shiraishi, Ray W.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Quang Hong Tran] Hanoi Sch Publ Hlth, Hanoi, Vietnam	Centers for Disease Control & Prevention - USA; Hanoi University of Public Health	Nguyen, DB (corresponding author), US Ctr Dis Control & Prevent, Hanoi, Vietnam.	vif8@cdc.gov		Medland, Nicholas Andrew/0000-0003-0403-8930; Shiraishi, Ray/0000-0001-7640-0666	Emory AIDS International Training and Research Program [NIH/FIC D43 TW01042]; United States's President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention [1U2GPS000747]; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER	Emory AIDS International Training and Research Program; United States's President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This evaluation was supported by the United States's President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of 1U2GPS000747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the data collection and entry team, as well as the clinic staff whose generous assistance made this survey possible. We would also like to thank the staff from the provincial Departments of Health and AIDS Control Centers where we collected data. We thank Dr. Mitchell Wolfe and Mr. Raymond Ransom from U.S. CDC for their contributions to the protocol development, and we thank Dr. Michelle McConnell, Dr. Anh Van Ho and Patrick Nadol from CDC Vietnam office for their valuable contributions to the study and the manuscript. We thank Dr. Stefan Wiktor and Dr. Andrew Baughman of CDC's Division of Global HIV/AIDS, and Timothy Dondero of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention for their scientific reviews. We thank Dr. Michael Iademarco from U.S. CDC for his review of the manuscript. The team also acknowledges general support from the VAAC and U.S. CDC Vietnam office. Dr. Duc Bui Nguyen received training support from the Emory AIDS International Training and Research Program (NIH/FIC D43 TW01042).	Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Dronda F, 2004, AIDS, V18, P2210, DOI 10.1097/00002030-200411050-00018; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Grigoryan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004445; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Malta M, 2009, JAIDS-J ACQ IMM DEF, V52, P629, DOI 10.1097/QAI.0b013e3181b31b8a; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Ministry of Health, 2009, NAT GUID DIAGN TREAT; Ministry of Health, 2008, HIV SENT SURV; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Mojumdar K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-416; Moore RD, 2004, JAIDS-J ACQ IMM DEF, V35, P46, DOI 10.1097/00126334-200401010-00006; Morris John D, 2007, AIDS Res Ther, V4, P12, DOI 10.1186/1742-6405-4-12; Muga R, 2007, AIDS, V21, P2521, DOI 10.1097/QAD.0b013e3282f1c933; National Committee for Aids Drugs Control and Prostitution Prevention UNAIDS, 2012, VIET NAM AIDS RESP P; Nguyen Duc, 2011, 10 INT C AIDS AS PAC; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Solomon SS, 2008, INDIAN J MED RES, V127, P447; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Vietnam Administration of HIV/AIDS Control, 2012, VIETN HIV AIDS EST P; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2008, HIV MED, V9, P503, DOI 10.1111/j.1468-1293.2008.00582.x; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	38	57	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55750	10.1371/journal.pone.0055750	http://dx.doi.org/10.1371/journal.pone.0055750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457477	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700017
J	De Groote, K; Cools, M; De Schepper, J; Craen, M; Francois, I; Devos, D; Carbonez, K; Eyskens, B; De Wolf, D				De Groote, Katya; Cools, Martine; De Schepper, Jean; Craen, Margarita; Francois, Inge; Devos, Daniel; Carbonez, Karlien; Eyskens, Benedicte; De Wolf, Daniel			Cardiovascular Pathology in Males and Females with 45,X/46,XY Mosaicism	PLOS ONE			English	Article							GROWTH-HORMONE TREATMENT; TURNER-SYNDROME; CLINICAL-PRACTICE; AORTIC DILATION; BLOOD-PRESSURE; PREVALENCE; DISSECTION; PHENOTYPE; MORTALITY; INTERVAL	Context: The phenotype of 45,X/46,XY mosaicism is heterogeneous ranging from females with Turner syndrome (TS) to apparently normal males. Males with 45,X/46,XY frequently show stigmata typically associated with TS. We hypothesised that males with 45,X/46,XY have similar cardiovascular pathology as females with 45,X/46,XY. Objective: To investigate cardiovascular abnormalities in 45,X/46,XY males and to compare them with 45,X/46,XY females. Design: Patients with 45,X/46,XY mosaicism were selected from the Belgian Registry for Growth and Puberty problems and via the multidisciplinary clinic for disorders of sexual development. Patients: Eighteen patients were included: 8 raised as females (F) and 10 as males (M). Intervention: Complete cardiac examination with blood pressure measurement, ECG, echocardiography and MRI. Main Outcome Measurement: Cardiac parameters were registered for both groups. In a second phase, clinical features and external masculinisation score (EMS) were retrospectively collected from the medical files. Results: A structural heart defect was diagnosed before inclusion in 1 F with coarctation and 1 M with spontaneously closed VSD. A bicuspid aortic valve was found in 8 (3 F, 5 M). Dilation of the ascending aorta was present in 4 M and was severe in 2 young boys. QTc was prolonged in 3 F and 2 M. Conclusion: Males with 45, X/46, XY mosaicism have similar cardiovascular pathology as 45, X/46, XY females. Dilation of the ascending aorta can be important, also in males. We advise cardiac screening and life-long monitoring in all males with 45, X/46, XY mosaicism according to the existing guidelines for Turner syndrome.	[De Groote, Katya; De Wolf, Daniel] Ghent Univ Hosp, Dept Pediat, Div Pediat Cardiol, Ghent, Belgium; [De Groote, Katya; Cools, Martine; De Schepper, Jean; Craen, Margarita; Devos, Daniel; De Wolf, Daniel] Univ Ghent, B-9000 Ghent, Belgium; [Cools, Martine; De Schepper, Jean; Craen, Margarita] Ghent Univ Hosp, Dept Pediat, Div Pediat Endocrinol, Ghent, Belgium; [Devos, Daniel] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium; [Eyskens, Benedicte] Katholieke Univ Leuven Hosp, Dept Pediat, Div Pediat Cardiol, Louvain, Belgium; [Francois, Inge] Katholieke Univ Leuven Hosp, Div Pediat Endocrinol, Dept Pediat, Louvain, Belgium; [Carbonez, Karlien] Clin Univ St Luc, Div Pediat Cardiol, Dept Pediat, B-1200 Brussels, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	De Groote, K (corresponding author), Ghent Univ Hosp, Dept Pediat, Div Pediat Cardiol, Ghent, Belgium.	katya.degroote@uzgent.be	Cools, Martine/J-4580-2012; de wolf, daniel/F-7481-2013	Cools, Martine/0000-0002-9552-4899; de wolf, daniel/0000-0002-0846-8914	Nationale Stichting voor Onderzoek op Gebied van Kindercardiologie (KDG); Belgian Study Group for Pediatric Endocrinology; Flanders Research Foundation	Nationale Stichting voor Onderzoek op Gebied van Kindercardiologie (KDG); Belgian Study Group for Pediatric Endocrinology; Flanders Research Foundation(FWO)	Financial support was provided by Nationale Stichting voor Onderzoek op Gebied van Kindercardiologie (KDG), Belgian Study Group for Pediatric Endocrinology and Flanders Research Foundation (M. Cools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2000, BJU INT, V85, P120, DOI 10.1046/j.1464-410x.2000.00354.x; Bakoto N, 2011, ANN ENDOCRINOL-PARIS, V72, P45, DOI 10.1016/j.ando.2010.06.004; Bondy CA, 2006, MEDICINE, V85, P75, DOI 10.1097/01.md.0000205629.16302.bc; Bondy CA, 2006, J CLIN ENDOCR METAB, V91, P1785, DOI 10.1210/jc.2005-2625; Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374; Bondy CA, 2006, PEDIATRICS, V118, pE1220, DOI 10.1542/peds.2006-0776; CHANG HJ, 1990, AM J HUM GENET, V46, P156; DESCHEPPER J, 1994, J CLIN ENDOCR METAB, V79, P489, DOI 10.1210/jc.79.2.489; Freed K, 1997, AM J ROENTGENOL, V168, P481, DOI 10.2214/ajr.168.2.9016231; GOTZSCHE CO, 1994, ARCH DIS CHILD, V71, P433, DOI 10.1136/adc.71.5.433; Gravholt CH, 2005, NAT CLIN PRACT ENDOC, V1, P41, DOI 10.1038/ncpendmet0024; Gravholt CH, 2006, J HYPERTENS, V24, P353, DOI 10.1097/01.hjh.0000200509.17947.0f; Gravholt CH, 2006, CARDIOL YOUNG, V16, P430, DOI 10.1017/S1047951106000928; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hjerrild BE, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-12; Ho VB, 2004, CIRCULATION, V110, P1694, DOI 10.1161/01.CIR.0000142290.35842.B0; LIN AE, 1986, J PEDIATR-US, V109, P820, DOI 10.1016/S0022-3476(86)80700-4; Lin AE, 2007, J PEDIATR-US, V150, P572, DOI 10.1016/j.jpeds.2007.03.038; Lindhardt JM, 2012, J CLIN ENDOCRINOL ME; Lopez L, 2008, PEDIATRICS, V121, pE1622, DOI 10.1542/peds.2007-2807; Matura LA, 2007, CIRCULATION, V116, P1663, DOI 10.1161/CIRCULATIONAHA.106.685487; Mazzanti L, 2006, INT C SER, V1298, P123; Mortensen KH, 2012, ENDOCR REV, V33, P677, DOI 10.1210/er.2011-1059; Nathwani NC, 2000, CLIN ENDOCRINOL, V52, P363; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ostberg JE, 2004, J CLIN ENDOCR METAB, V89, P5966, DOI 10.1210/jc.2004-1090; Prandstraller D, 1999, PEDIATR CARDIOL, V20, P108, DOI 10.1007/s002469900416; Prandstraller D, 2009, CARDIOL YOUNG, V19, P264, DOI 10.1017/S1047951109004016; Rijnbeek PR, 2001, EUR HEART J, V22, P702, DOI 10.1053/euhj.2000.2399; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Schoemaker MJ, 2008, J CLIN ENDOCR METAB, V93, P4735, DOI 10.1210/jc.2008-1049; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Stochholm K, 2006, J CLIN ENDOCR METAB, V91, P3897, DOI 10.1210/jc.2006-0558; Sybert VP, 2004, NEW ENGL J MED, V351, P1227, DOI 10.1056/NEJMra030360; Telvi L, 1999, PEDIATRICS, V104, P304, DOI 10.1542/peds.104.2.304; van den Berg J, 2008, J CLIN ENDOCR METAB, V93, P2553, DOI 10.1210/jc.2007-2313	36	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54977	10.1371/journal.pone.0054977	http://dx.doi.org/10.1371/journal.pone.0054977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457457	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700011
J	Malde, K; Furmanek, T				Malde, Ketil; Furmanek, Tomasz			Increasing Sequence Search Sensitivity with Transitive Alignments	PLOS ONE			English	Article							DATABASE; PROTEIN; TOOL	Sequence alignment is an important bioinformatics tool for identifying homology, but searching against the full set of available sequences is likely to result in many hits to poorly annotated sequences providing very little information. Consequently, we often want alignments against a specific subset of sequences: for instance, we are looking for sequences from a particular species, sequences that have known 3d-structures, sequences that have a reliable (curated) function annotation, and so on. Although such subset databases are readily available, they only represent a small fraction of all sequences. Thus, the likelihood of finding close homologs for query sequences is smaller, and the alignments will in general have lower scores. This makes it difficult to distinguish hits to homologous sequences from random hits to unrelated sequences. Here, we propose a method that addresses this problem by first aligning query sequences against a large database representing the corpus of known sequences, and then constructing indirect (or transitive) alignments by combining the results with alignments from the large database against the desired target database. We compare the results to direct pairwise alignments, and show that our method gives us higher sensitivity alignments against the target database.	[Malde, Ketil; Furmanek, Tomasz] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway	Malde, K (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	ketil.malde@imr.no	M, Ketil/AAH-5604-2020		Norwegian Department of Fisheries and Coastal Affairs	Norwegian Department of Fisheries and Coastal Affairs	This study was funded by the Norwegian Department of Fisheries and Coastal Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Demattei MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023693; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Grundy WN, 1998, J COMPUT BIOL, V5, P479, DOI 10.1089/cmb.1998.5.479; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Malde K, 2008, BIOINFORMATICS, V24, P897, DOI 10.1093/bioinformatics/btn052; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Selden Paul A, 2010, Nat Commun, V1, P50, DOI 10.1038/ncomms1049; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337	20	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e54422	10.1371/journal.pone.0054422	http://dx.doi.org/10.1371/journal.pone.0054422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457449	gold, Green Published, Green Submitted			2022-12-27	WOS:000315602700006
J	Blair, C; Arcos, VHJ; de la Cruz, FRM; Murphy, RW				Blair, Christopher; Jimenez Arcos, Victor H.; Mendez de la Cruz, Fausto R.; Murphy, Robert W.			Landscape Genetics of Leaf-Toed Geckos in the Tropical Dry Forest of Northern Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; CONSERVATION PRIORITIES; MULTIPLE-REGRESSION; DISTANCE MATRICES; SPATIAL-ANALYSIS; MANTEL TEST; FLOW; CONNECTIVITY; DISPERSAL; BARRIERS	Habitat fragmentation due to both natural and anthropogenic forces continues to threaten the evolution and maintenance of biological diversity. This is of particular concern in tropical regions that are experiencing elevated rates of habitat loss. Although less well-studied than tropical rain forests, tropical dry forests (TDF) contain an enormous diversity of species and continue to be threatened by anthropogenic activities including grazing and agriculture. However, little is known about the processes that shape genetic connectivity in species inhabiting TDF ecosystems. We adopt a landscape genetic approach to understanding functional connectivity for leaf-toed geckos (Phyllodactylus tuberculosus) at multiple sites near the northernmost limit of this ecosystem at Alamos, Sonora, Mexico. Traditional analyses of population genetics are combined with multivariate GIS-based landscape analyses to test hypotheses on the potential drivers of spatial genetic variation. Moderate levels of within-population diversity and substantial levels of population differentiation are revealed by F-ST and D-est. Analyses using STRUCTURE suggest the occurrence of from 2 to 9 genetic clusters depending on the model used. Landscape genetic analysis suggests that forest cover, stream connectivity, undisturbed habitat, slope, and minimum temperature of the coldest period explain more genetic variation than do simple Euclidean distances. Additional landscape genetic studies throughout TDF habitat are required to understand species-specific responses to landscape and climate change and to identify common drivers. We urge researchers interested in using multivariate distance methods to test for, and report, significant correlations among predictor matrices that can impact results, particularly when adopting least-cost path approaches. Further investigation into the use of information theoretic approaches for model selection is also warranted.	[Blair, Christopher; Murphy, Robert W.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Blair, Christopher; Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Jimenez Arcos, Victor H.; Mendez de la Cruz, Fausto R.] Univ Nacl Autonoma Mexico, Inst Biol, Lab Herpetol, Mexico City 04510, DF, Mexico; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	University of Toronto; Royal Ontario Museum; Universidad Nacional Autonoma de Mexico; Chinese Academy of Sciences; Kunming Institute of Zoology	Blair, C (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	Christopher.Blair@utoronto.ca	Mendez, Fausto R./O-3512-2018; Mendez, Fausto/HGD-1205-2022; Jiménez-Arcos, Victor H/GPX-4805-2022	Mendez, Fausto R./0000-0002-5084-1276; Murphy, Robert/0000-0001-8555-2338	Natural Sciences and Engineering Research Council of Canada [3148]; Theodore Roosevelt Memorial Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Theodore Roosevelt Memorial Fund	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant 3148) and the Theodore Roosevelt Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D, 2012, LME4 LINEAR MIXED EF; Becerra JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003436; Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Blair C, 2012, CONSERV GENET RESOUR, V4, P807, DOI 10.1007/s12686-012-9649-y; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bowne DR, 2004, LANDSCAPE ECOL, V19, P1, DOI 10.1023/B:LAND.0000018357.45262.b9; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Burgos A, 2004, AGR ECOSYST ENVIRON, V104, P475, DOI 10.1016/j.agee.2004.01.038; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cascante A, 2002, CONSERV BIOL, V16, P137, DOI 10.1046/j.1523-1739.2002.00317.x; Ceballos G, 1995, CONSERV BIOL, V9, P1349, DOI 10.1046/j.1523-1739.1995.09061349.x; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Clobert J, 2001, DISPERSAL, P452; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dixon JR, 1964, NEW MEXICO STATE U S, V64-1, P1; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Etherington TR, 2011, METHODS ECOL EVOL, V2, P52, DOI 10.1111/j.2041-210X.2010.00048.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Garcia A, 2006, BIOL CONSERV, V130, P25, DOI 10.1016/j.biocon.2005.11.030; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goslee S, 2008, DISSIMILARITY BASED; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Halekoh U., 2012, PBKRTEST PARAMETRIC; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hirao AS, 2008, HEREDITY, V100, P424, DOI 10.1038/hdy.2008.1; Hirao AS, 2004, HEREDITY, V93, P290, DOI 10.1038/sj.hdy.6800503; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Sigala-Rodriguez JJ, 2009, REV MEX BIODIVERS, V80, P231; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kutner M. H., 2004, APPL LINEAR REGRESSI; Kuznetsova A., 2012, MIXMOD ANAL MIXED MO; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Leclerc E, 2008, MOL ECOL, V17, P1702, DOI 10.1111/j.1365-294X.2008.03710.x; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Michels E, 2001, MOL ECOL, V10, P1929, DOI 10.1046/j.1365-294X.2001.01340.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Miller MP, 1997, TOOLS POPULATION GEN; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neel MC, 2008, BIOL CONSERV, V141, P938, DOI 10.1016/j.biocon.2007.12.031; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; Raeymaekers JAM, 2008, EVOL APPL, V1, P475, DOI 10.1111/j.1752-4571.2008.00019.x; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Robichaux R. H., 2000, TROPICAL DECIDUOUS F; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Shah V.B.., 2008, PROC 7 PYTHON SCI C, V7, P62; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2008, MOL ECOL, V17, P4642, DOI 10.1111/j.1365-294X.2008.03952.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Spear SF, 2010, BIOL CONSERV, V143, P778, DOI 10.1016/j.biocon.2009.12.021; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Vignieri SN, 2005, MOL ECOL, V14, P1925, DOI 10.1111/j.1365-294X.2005.02568.x; VilSS, 2003, P ROY SOC LOND B BIO, V270, P91, DOI [DOI 10.1098/RSPB.2002.2184, 10.1098/rspb.2002.2184]; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson L.D., 2010, CONSERVATION MESOAME; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Wofford JEB, 2005, ECOL APPL, V15, P628, DOI 10.1890/04-0095; Wright S, 1943, GENETICS, V28, P139	117	23	25	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57433	10.1371/journal.pone.0057433	http://dx.doi.org/10.1371/journal.pone.0057433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451230	Green Published, gold			2022-12-27	WOS:000316849500105
J	Mu, YN; Lian, FM; Teng, YB; Ao, JQ; Jiang, YL; He, YX; Chen, YX; Zhou, CZ; Chen, XH				Mu, Yinnan; Lian, Fu-Ming; Teng, Yan-Bin; Ao, Jingqun; Jiang, Yong-Liang; He, Yong-Xing; Chen, Yuxing; Zhou, Cong-Zhao; Chen, Xinhua			The N-Terminal beta-Sheet of Peroxiredoxin 4 in the Large Yellow Croaker Pseudosciaena crocea Is Involved in Its Biological Functions	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; KAPPA-B; SACCHAROMYCES-CEREVISIAE; 2-CYS PEROXIREDOXINS; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; THIOREDOXIN; REDUCTASE; PROTEIN; IV	Peroxiredoxins (Prxs) are thiol-specific antioxidant proteins that exhibit peroxidase and peroxynitrite reductase activities involved in the reduction of reactive oxygen species. The peroxiredoxin Prx4 from the large yellow croaker Pseudosciaena crocea is a typical 2-Cys Prx with an N-terminal signal peptide. We solved the crystal structure of Prx4 at 1.90 angstrom and revealed an N-terminal antiparallel beta-sheet that contributes to the dimer interface. Deletion of this beta-sheet decreased the in vitro peroxidase activity to about 50% of the wild-type. In vivo assays further demonstrated that removal of this beta-sheet led to some impairment in the ability of Prx4 to negatively regulate nuclear factor-kappa B (NF-kappa B) activity and to perform its role in anti-bacterial immunity. These results provide new insights into the structure and function relationship of a peroxiredoxin from bony fish.	[Mu, Yinnan; Ao, Jingqun; Chen, Xinhua] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian, Peoples R China; [Lian, Fu-Ming; Teng, Yan-Bin; Jiang, Yong-Liang; He, Yong-Xing; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Lian, Fu-Ming; Teng, Yan-Bin; Jiang, Yong-Liang; He, Yong-Xing; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	State Oceanic Administration; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zcz@ustc.edu.cn; Chenxinh@tom.com	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Lian, Fu-Ming/0000-0001-7999-6565; Jiang, YongLiang/0000-0001-5441-4936; Chen, Yuxing/0000-0002-7560-1922	National Natural Science Foundation of China [31125027, 30870490, 31001131]; National Basic Research Program of China [2012CB114402, 2006CB910202]; Nation '863' Project of China [2012AA092202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Nation '863' Project of China	This work was supported by the National Natural Science Foundation of China (31125027, 30870490 and 31001131), the National Basic Research Program of China (2012CB114402 and 2006CB910202), and the Nation '863' Project of China (2012AA092202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; DeLano W.L., PYMOL MOL GRAPHICS S; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Haridas V, 1998, J IMMUNOL, V161, P1; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Joensson Thomas J., 2007, V44, P115; Karplus P. Andrew, 2007, V44, P41; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2010, J BIOCHEM, V147, P109, DOI 10.1093/jb/mvp154; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Pineyro MD, 2005, J STRUCT BIOL, V150, P11, DOI 10.1016/j.jsb.2004.12.005; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yu SH, 2010, J PROTEOME RES, V9, P1424, DOI 10.1021/pr900961x; Zhang Y, 2008, ACTA CRYSTALLOGR F, V64, P323, DOI 10.1107/S1744309108004612; Zhang ZY, 2009, BBA-PROTEINS PROTEOM, V1794, P124, DOI 10.1016/j.bbapap.2008.09.011	41	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57061	10.1371/journal.pone.0057061	http://dx.doi.org/10.1371/journal.pone.0057061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451146	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500059
J	Sugahara, M; Takehira, M; Yutani, K				Sugahara, Michihiro; Takehira, Michiyo; Yutani, Katsuhide			Effect of Heavy Atoms on the Thermal Stability of alpha-Amylase from Aspergillus oryzae	PLOS ONE			English	Article							CHEMICAL CROSS-LINKING; CONFORMATIONAL STABILITY; PROTEIN CRYSTALLIZATION; TRYPTOPHAN SYNTHASE; AUTOMATED-SYSTEM; DATABASE-SYSTEM; STABILIZATION; BINDING; OPTIMIZATION; SEQUENCE	Currently, there are no versatile and established methods for improving stability of proteins. In an entirely different approach from conventional techniques such as mutagenesis, we attempted to enhance enzyme stability of alpha-amylase from Aspergillus oryzae using a heavy-atom derivatization technique. We evaluated changes in stability using differential scanning calorimetry (DSC). Candidate heavy atoms were identified using the Heavy-Atom Database System HATODAS, a Web-based tool designed to assist in heavy-atom derivatization of proteins for X-ray crystallography. The denaturation temperature of alpha-amylase derivatized with gadolinium (Gd) or samarium (Sm) ions increased by 6.2 or 5.7 degrees C, respectively, compared to that of the native protein (60.6 degrees C). The binding of six Gd ions was confirmed by X-ray crystallography of the enzyme at 1.5 angstrom resolution. DSC and dynamic light-scattering data revealed a correlation between stability and the aggregation state upon addition of Gd ions. These results show that HATODAS search is an effective tool for selecting heavy atoms for stabilization of this protein.	[Sugahara, Michihiro; Takehira, Michiyo; Yutani, Katsuhide] RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan	RIKEN	Sugahara, M (corresponding author), RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan.	msuga@spring8.or.jp			Hyogo Science and Technology Association [22S022]; Japan Society for the Promotion of Science (KAKENHI) [22770116]	Hyogo Science and Technology Association; Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a '2010 Incentive Research Grant' from Hyogo Science and Technology Association (No. 22S022) and by a 'Grant in Aid for Scientific Research' from Japan Society for the Promotion of Science (KAKENHI No. 22770116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABORI S, 1954, J BIOCHEM-TOKYO, V41, P577, DOI 10.1093/oxfordjournals.jbchem.a126475; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blundell T. L., 1976, PROTEIN CRYSTALLOGRA, P183; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; CHANG CT, 1995, BIOCHEM MOL BIOL INT, V36, P185; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; DONOVAN JW, 1975, J BIOL CHEM, V250, P6022; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Funahashi J, 2001, PROTEIN ENG, V14, P127, DOI 10.1093/protein/14.2.127; Jeyakanthan J., 2009, J BIOPHYS, V2009; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; KUROKI R, 1992, P NATL ACAD SCI USA, V89, P6803, DOI 10.1073/pnas.89.15.6803; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; MATSUURA Y, 1979, J BIOCHEM-TOKYO, V86, P1773, DOI 10.1093/oxfordjournals.jbchem.a132699; MATSUURA Y, 1980, J BIOCHEM-TOKYO, V87, P1555, DOI 10.1093/oxfordjournals.jbchem.a132896; Ogasahara K, 2003, J BIOL CHEM, V278, P8922, DOI 10.1074/jbc.M210893200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1988, J BIOL CHEM, V263, P11820; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; PETERS K, 1977, ANNU REV BIOCHEM, V46, P523, DOI 10.1146/annurev.bi.46.070177.002515; Richardson TH, 2002, J BIOL CHEM, V277, P26501, DOI 10.1074/jbc.M203183200; SCHELLMAN JA, 1976, BIOPOLYMERS, V15, P999, DOI 10.1002/bip.1976.360150513; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; Sugahara M, 2005, ACTA CRYSTALLOGR D, V61, P1302, DOI 10.1107/S0907444905019670; Sugahara M, 2008, ACTA CRYSTALLOGR D, V64, P686, DOI 10.1107/S0907444908009980; Sugahara M, 2011, CRYST GROWTH DES, V11, P110, DOI 10.1021/cg100987g; Sugahara M, 2010, J APPL CRYSTALLOGR, V43, P940, DOI 10.1107/S0021889810018595; Sugahara M, 2009, J APPL CRYSTALLOGR, V42, P540, DOI 10.1107/S0021889809012370; SWIFT HJ, 1991, ACTA CRYSTALLOGR B, V47, P535, DOI 10.1107/S0108768191001970; Takano K, 1997, BIOCHEMISTRY-US, V36, P688, DOI 10.1021/bi9621829; Tripathi P, 2008, BIOPHYS CHEM, V137, P95, DOI 10.1016/j.bpc.2008.07.007; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veprintsev DB, 1999, PROTEINS, V37, P65, DOI 10.1002/(SICI)1097-0134(19991001)37:1<65::AID-PROT7>3.3.CO;2-U; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vujicic-Zagar A, 2006, ACTA CRYSTALLOGR F, V62, P716, DOI 10.1107/S1744309106024729; Wold F, 1972, Methods Enzymol, V25, P623, DOI 10.1016/S0076-6879(72)25061-3; WONG SS, 1992, ENZYME MICROB TECH, V14, P866, DOI 10.1016/0141-0229(92)90049-T; Xiao ZZ, 2006, ANAL BIOCHEM, V351, P146, DOI 10.1016/j.ab.2006.01.036; Xue YL, 2009, J BIOCHEM, V146, P193, DOI 10.1093/jb/mvp055; YUTANI K, 1987, P NATL ACAD SCI USA, V84, P4441, DOI 10.1073/pnas.84.13.4441	47	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57432	10.1371/journal.pone.0057432	http://dx.doi.org/10.1371/journal.pone.0057432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451229	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500104
J	Wang, K; Jiang, Y; Zheng, WY; Liu, ZY; Li, H; Lou, JZ; Gu, MD; Wang, XJ				Wang, Kai; Jiang, Yu; Zheng, Weiyan; Liu, Zhiyong; Li, Hui; Lou, Jianzhou; Gu, Meidi; Wang, Xiaojian			Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Enhances Rituximab-Induced Death and Chemosensitization in B-Cell Lymphoma	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; TRAIL-INDUCED APOPTOSIS; DRUG-INDUCED APOPTOSIS; KINASE INHIBITOR PROTEIN; ALPHA-INDUCED APOPTOSIS; BREAST-CANCER CELLS; SIGNALING PATHWAY; DEXAMETHASONE REGIMEN; ELDERLY-PATIENTS; DOWN-REGULATION	Rituximab is the first line drug to treat non Hodgkin's lymphoma (B-NHL) alone or in combination with chemotherapy. However, 30-40% of B-NHL patients are unresponsive to rituximab or resistant after therapy. Human phosphatidylethanolamine-binding protein 4 (hPEBP4) is a novel member of PEBP family and functions as an anti-apoptotic molecule. In this study, we found hPEBP4 to be expressed in up to 90% of B-cell lymphoma patients, but in only 16.7% of normal lymph nodes. Interestingly, hPEBP4 overexpression inhibited rituximab-mediated complement dependent cytotoxicity (R-CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC) in B-NHL cells while downregulation of hPEBP4 augmented the therapeutic efficacy of rituximab both in vitro and in vivo. Furthermore, hPEBP4 silencing sensitized the primary B-acute lymphocytic leukemia (B-ALL) cells to R-CDC. During rituximab-mediated complement dependent cytotoxicity, hPEBP4 was recruited to the cell membrane in a PE-binding domain dependent manner and inhibited R-CDC induced calcium flux and reactive oxygen species (ROS) generation. These events contributed to the decrease of cell death induced by R-CDC in B-cell lymphomas. Meanwhile, hPEBP4 knockdown potentiated the chemosensitization of the rituximab in B-cell lymphoma cells by regulating the expression of Bcl-xl, Cycline E, p21(waf/cip1) and p53 and the activation of caspase-3 and caspase-9. Considering that hPEBP4 conferred cellular resistance to rituximab treatment and was preferentially expressed in lymphoma tissue, it could be a potential valuable target for adjuvant therapy for B-cell lymphoma.	[Wang, Kai] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Yu; Liu, Zhiyong; Li, Hui; Lou, Jianzhou; Gu, Meidi; Wang, Xiaojian] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Weiyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Wang, XJ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	wangxiaojian@cad.zju.edu.cn	Liu, Zhiyong/CAF-2366-2022	Liu, Zhiyong/0000-0001-6473-348X	Zhejiang major science and technology special project [2009C13018]; National Natural Science Foundation of China [81072437, 81272353]; SRF for ROCS, SEM; Fundamental Research Funds for the Central Universities	Zhejiang major science and technology special project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Zhejiang major science and technology special project (2009C13018), The National Natural Science Foundation of China (81072437, 81272353), The Project-sponsored by SRF for ROCS, SEM and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Beum PV, 2011, EUR J IMMUNOL, V41, P2436, DOI 10.1002/eji.201041204; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Du ZY, 2009, J BIOL CHEM, V284, P27808, DOI 10.1074/jbc.M109.028324; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hauptrock B, 2008, BIOL-TARGETS THER, V2, P619; Jacquemin G, 2012, HAEMATOL-HEMATOL J, V97, P38, DOI 10.3324/haematol.2011.046466; Jak M, 2011, LEUKEMIA, V25, P968, DOI 10.1038/leu.2011.39; Janas E, 2005, CLIN EXP IMMUNOL, V139, P439, DOI 10.1111/j.1365-2249.2005.02720.x; Jazirehi AR, 2011, METHODS MOL BIOL, V731, P407, DOI 10.1007/978-1-61779-080-5_33; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jazirehi AR, 2003, MOL CANCER THER, V2, P1183; Jazirehi AR, 2005, CANCER RES, V65, P264; Li BH, 2008, CANCER RES, V68, P2400, DOI 10.1158/0008-5472.CAN-07-6663; Li BH, 2009, BLOOD, V114, P5007, DOI 10.1182/blood-2009-06-225474; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Li P, 2006, INT J MOL MED, V18, P505; Liu HY, 2012, TUMOR BIOL, V33, P267, DOI 10.1007/s13277-011-0279-x; Molina A, 2008, ANNU REV MED, V59, P237, DOI 10.1146/annurev.med.59.060906.220345; Niitsu N, 2007, CANCER SCI, V98, P109, DOI 10.1111/j.1349-7006.2006.00349.x; Niitsu N, 2006, CANCER SCI, V97, P933, DOI 10.1111/j.1349-7006.2006.00249.x; Nijmeijer BA, 2010, BLOOD, V116, P5930, DOI 10.1182/blood-2010-01-262006; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Qiu JM, 2010, J BIOL CHEM, V285, P12241, DOI 10.1074/jbc.M110.111898; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Shimizu R, 2010, LEUKEMIA, V24, P1760, DOI 10.1038/leu.2010.157; Stolz C, 2009, LEUKEMIA LYMPHOMA, V50, P873, DOI 10.1080/10428190902878471; Suzuki E, 2007, ONCOGENE, V26, P6184, DOI 10.1038/sj.onc.1210448; Turturro F, 2007, CLIN CANCER RES, V13, P3724, DOI 10.1158/1078-0432.CCR-07-0244; Unruh TL, 2005, IMMUNOLOGY, V116, P223, DOI 10.1111/j.1365-2567.2005.02213.x; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vega MI, 2005, ONCOGENE, V24, P8114, DOI 10.1038/sj.onc.1208954; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; You T, 2011, CELL MOL IMMUNOL, V8, P157, DOI 10.1038/cmi.2010.35; Yu GP, 2011, TUMOR BIOL, V32, P1257, DOI 10.1007/s13277-011-0230-1; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312	45	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56829	10.1371/journal.pone.0056829	http://dx.doi.org/10.1371/journal.pone.0056829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451095	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500033
J	Yamada, T; Urano-Tashiro, Y; Tanaka, S; Akiyama, H; Tashiro, F				Yamada, Takeyuki; Urano-Tashiro, Yumiko; Tanaka, Saori; Akiyama, Hirotada; Tashiro, Fumio			Involvement of Crosstalk between Oct4 and Meis1a in Neural Cell Fate Decision	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; PLURIPOTENT STEM-CELLS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTOR; SELF-RENEWAL; SEGMENTAL EXPRESSION; PBX; COMPLEXES; NEUROGENESIS; GLIOGENESIS	Oct4 plays a critical role both in maintaining pluripotency and the cell fate decision of embryonic stem (ES) cells. Nonetheless, in the determination of the neuroectoderm (NE) from ES cells, the detailed regulation mechanism of the Oct4 gene expression is poorly understood. Here, we report that crosstalk between Oct4 and Meis1a, a Pbx-related homeobox protein, is required for neural differentiation of mouse P19 embryonic carcinoma (EC) cells induced by retinoic acid (RA). During neural differentiation, Oct4 expression was transiently enhanced during 6-12 h of RA addition and subsequently disappeared within 48 h. Coinciding with up-regulation of Oct4 expression, the induction of Meis1a expression was initiated and reached a plateau at 48 h, suggesting that transiently induced Oct4 activates Meis1a expression and the up-regulated Meis1a then suppresses Oct4 expression. Chromatin immunoprecipitation (ChIP) and luciferase reporter analysis showed that Oct4 enhanced Meis1a expression via direct binding to the Meis1 promoter accompanying histone H3 acetylation and appearance of 5-hydoxymethylcytosine (5hmC), while Meis1a suppressed Oct4 expression via direct association with the Oct4 promoter together with histone deacetylase 1 (HDAC1). Furthermore, ectopic Meis1a expression promoted neural differentiation via formation of large neurospheres that expressed Nestin, GLAST, BLBP and Sox1 as neural stem cell (NSC)/neural progenitor markers, whereas its down-regulation generated small neurospheres and repressed neural differentiation. Thus, these results imply that crosstalk between Oct4 and Meis1a on mutual gene expressions is essential for the determination of NE from EC cells.	[Yamada, Takeyuki; Urano-Tashiro, Yumiko; Tanaka, Saori; Akiyama, Hirotada; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 278, Japan	Tokyo University of Science	Tashiro, F (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 278, Japan.	ftashir@rs.noda.tus.ac.jp	TASHIRO, Yumiko/AAV-2054-2020	Tashiro, Yumiko/0000-0002-8328-2634	MEXT (Ministry of Education, Cultures, Science and Technology of Japan) [S1001020]; Grants-in-Aid for Scientific Research [23701104, 23501271] Funding Source: KAKEN	MEXT (Ministry of Education, Cultures, Science and Technology of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FT acknowledges support from the 'Academic Frontier' for Private Universities: Matching Fund Subsidy from MEXT (Ministry of Education, Cultures, Science and Technology of Japan), 2010-2014 (S1001020) (URL: http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Barnea E, 2000, J BIOL CHEM, V275, P6608, DOI 10.1074/jbc.275.9.6608; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Ferretti E, 2000, DEVELOPMENT, V127, P155; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Jezierski A, 2012, J NEUROSCI RES, V90, P2362, DOI 10.1002/jnr.23118; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Salzberg A, 1999, MECH DEVELOP, V80, P3, DOI 10.1016/S0925-4773(98)00187-7; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOORLEMMER J, 1994, MOL CELL BIOL, V14, P1122, DOI 10.1128/MCB.14.2.1122; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shibata T, 1997, J NEUROSCI, V17, P9212; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Snow GE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-383; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Teramoto S, 2005, ONCOL REP, V14, P1231; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; TOMOOKA Y, 1993, P NATL ACAD SCI USA, V90, P9683, DOI 10.1073/pnas.90.20.9683; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Urano Y, 2006, J BIOL CHEM, V281, P7498, DOI 10.1074/jbc.M510881200; Urano-Tashiro Y, 2010, J NEUROSCI RES, V88, P2787, DOI 10.1002/jnr.22455; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139	52	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56997	10.1371/journal.pone.0056997	http://dx.doi.org/10.1371/journal.pone.0056997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451132	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500051
J	Yin, H; Gao, M; Leoni, L; Han, HF; Zhang, X; Fu, ZR				Yin, Hao; Gao, Ming; Leoni, Lara; Han, Huifang; Zhang, Xing; Fu, Zhiren			The Therapeutic Role of Monocyte Chemoattractant Protein-1 in a Renal Tissue Engineering Strategy for Diabetic Patients	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ISLET TRANSPLANTATION; IN-VITRO; ELECTROSPUN SCAFFOLD; GLYCEMIC CONTROL; MICE; INFLAMMATION; REGENERATION; NEPHROPATHY; NANOFIBERS	In this study we aim to boost the functional output of the intra-kidney islet transplantation for diabetic patients using a tissue engineered polymeric scaffold. This highly porous electrospun scaffold featured randomly distributed fibers composed of polycaprolactone (PCL) and poliglecaprone (PGC). It successfully sustained murine islets in vitro for up to 4 weeks without detected cytotoxicity. The in vivo study showed that the islet population proliferated by 89% within 12 weeks when they were delivered by the scaffold but only 18% if freely injected. Correspondingly, the islet population delivered by the scaffold unleashed a greater capability to produce insulin that in turn further drove down the blood glucose within 12 weeks after the surgery. Islets delivered by the scaffold most effectively prevented diabetic deterioration of kidney as evidenced by the lack of a kidney or glomerular enlargement and physiological levels of creatinine, urea nitrogen and albumin through week 12 after the surgery. Unlike traditional wisdom in diabetic research, the mechanistic study suggested that monocytes chemoattractant protein-1 (MCP-1) was responsible for the improved preservation of renal functions. This study revealed a therapeutic role of MCP-1 in rescuing kidneys in diabetic patients, which can be integrated into a tissue engineered scaffold to simultaneously preserved renal functions and islet transplantation efficacy. Also, this study affords a simple yet effective solution to improve the clinical output of islet transplantation.	[Yin, Hao; Fu, Zhiren] Shanghai Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Surg, Shanghai, Peoples R China; [Yin, Hao; Gao, Ming; Han, Huifang] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Leoni, Lara] Univ Chicago, Integrated Small Anim Imaging Res Ctr, Chicago, IL 60637 USA; [Gao, Ming] Shanghai Chongming Hosp, Dept Surg, Shanghai, Chongming Count, Peoples R China; [Zhang, Xing] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Naval Medical University; University of Chicago; University of Chicago; Harvard University	Fu, ZR (corresponding author), Shanghai Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Surg, Shanghai, Peoples R China.	zhirenfu.sh@gmail.com	han, han/HDL-7807-2022		China's Natural Science Foundation [30772056]	China's Natural Science Foundation	The authors acknowledge the financial support from China's Natural Science Foundation (grant number 30772056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann B, 2003, DIABETES CARE, V26, P2421, DOI 10.2337/diacare.26.8.2421; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655; Chen YZ, 2011, ARCH BIOCHEM BIOPHYS, V507, P241, DOI 10.1016/j.abb.2010.12.020; Cho H, 2012, ACTA BIOMATER, V8, P154, DOI 10.1016/j.actbio.2011.08.029; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Grossman EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008749; Guo ZG, 1997, TRANSPLANTATION, V63, P711, DOI 10.1097/00007890-199703150-00017; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Jaeger C, 1997, DIABETES, V46, P1907, DOI 10.2337/diabetes.46.11.1907; Kong JA, 2010, AM J PATHOL, V177, P622, DOI 10.2353/ajpath.2010.091292; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Ohtsuki K, 2001, CIRCULATION, V104, P203, DOI 10.1161/01.CIR.104.2.203; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Thomas V, 2007, BIOMED MATER, V2, P224, DOI 10.1088/1748-6041/2/4/004; Thomas V, 2009, BIOTECHNOL BIOENG, V104, P1025, DOI 10.1002/bit.22467; Tian YF, 2011, SOFT MATTER, V7, P6005, DOI 10.1039/c1sm05504f; Yin DP, 2006, DIABETES, V55, P3256, DOI 10.2337/db05-1275; Zhang X, 2011, J BIOMED MATER RES A, V97A, P145, DOI 10.1002/jbm.a.33040; Zhang X, 2010, BIOMATERIALS, V31, P4376, DOI 10.1016/j.biomaterials.2010.02.017; Zhang X, 2010, J MATER SCI-MATER M, V21, P541, DOI 10.1007/s10856-009-3922-y; Zhang X, 2009, J BIOMED MATER RES B, V89B, P135, DOI 10.1002/jbm.b.31196	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57635	10.1371/journal.pone.0057635	http://dx.doi.org/10.1371/journal.pone.0057635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451253	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500122
J	Dangardt, F; Chen, Y; Berggren, K; Osika, W; Friberg, P				Dangardt, Frida; Chen, Yun; Berggren, Krister; Osika, Walter; Friberg, Peter			Increased Rate of Arterial Stiffening with Obesity in Adolescents: A Five-Year Follow-Up Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PULSE-WAVE VELOCITY; BODY-MASS INDEX; CAROTID-ARTERY; WALL THICKNESS; YOUNG FINNS; ALL-CAUSE; CHILDREN; CHILDHOOD; STIFFNESS	Background: We prospectively and longitudinally determined the effects of childhood obesity on arterial stiffening and vascular wall changes. Changes in arterial stiffness measured as pulse wave velocity (PWV) and vascular morphology of the radial (RA) and dorsal pedal arteries (DPA) were examined in obese adolescents compared to lean subjects in a 5-year follow-up study. Methodology/Principal Findings: A total of 28 obese subjects and 14 lean controls participated in both baseline (14 years old) and follow-up studies. PWV was measured by tonometer (SphygmoCor (R)) and recorded at RA and carotid artery, respectively. Intima thickness (IT), intima-media thickness (IMT) and RA and DPA diameters were measured using high-resolution ultrasound (Vevo 770 (TM)). Over the course of 5 years, PWV increased by 25% in the obese subjects as compared to 3% in the controls (p = 0.01). Diastolic blood pressure (DBP) increased by 23% in the obese subjects as opposed to 6% in controls (p = 0.009). BMI increased similarly in both groups, as did the IT and IMT. The change in PWV was strongly associated to the baseline BMI z -score (r = 0.51, p<0.001), as was the change in DBP (r = 0.50, p = 0.001). Conclusions/Significance: During the transition from early to late adolescence, there was a general increase in arterial stiffness, which was aggravated by childhood obesity. The increase in arterial stiffness and DBP after 5 years was closely correlated to the baseline BMI z -score, indicating that childhood obesity has an adverse impact on vascular adaptation.	[Dangardt, Frida; Chen, Yun; Berggren, Krister; Osika, Walter; Friberg, Peter] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Dangardt, F (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden.	frida.dangardt@gu.se	Dangardt, Frida/AHC-9294-2022; Osika, Walter/AAH-7966-2020; Dangardt, Frida/V-9640-2019; Stefanadis, Christodoulos/ABH-2232-2020	Osika, Walter/0000-0002-1583-7319; Chen, Yun/0000-0002-3746-594X; Dangardt, Frida/0000-0003-4632-3916; Stefanadis, Christodoulos/0000-0001-5974-6454	Swedish Council for Medical Research (Vetenskapsr (A) over tilde (sic)det); Heart and Lung Foundation; Public Health committee of the Western Region of Sweden; Sahlgrenska University Hospital/Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden	Swedish Council for Medical Research (Vetenskapsr (A) over tilde (sic)det); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Public Health committee of the Western Region of Sweden; Sahlgrenska University Hospital/Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden	This study was supported by the Swedish Council for Medical Research (Vetenskapsr (A) over tilde (sic)det), Heart and Lung Foundation, Public Health committee of the Western Region of Sweden and Sahlgrenska University Hospital/Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatola H, 2010, HYPERTENSION, V55, P806, DOI 10.1161/HYPERTENSIONAHA.109.145102; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dangardt F, 2008, CLIN PHYSIOL FUNCT I, V28, P287, DOI 10.1111/j.1475-097X.2008.00806.x; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; De Angelis L, 2004, HYPERTENSION, V44, P67, DOI 10.1161/01.HYP.0000130482.81883.fd; Donald AE, 2010, EUR HEART J, V31, P1502, DOI 10.1093/eurheartj/ehq062; FOLKOW B, 1990, HYPERTENSION, V16, P89, DOI 10.1161/01.HYP.16.1.89; Friberg P, 2004, EUR HEART J, V25, P987, DOI 10.1016/j.ehj.2004.03.018; Kapiotis S, 2006, ARTERIOSCL THROM VAS, V26, P2541, DOI 10.1161/01.ATV.0000245795.08139.70; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; MESSERLI FH, 1981, ARCH INTERN MED, V141, P81, DOI 10.1001/archinte.141.1.81; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Osika W, 2007, ARTERIOSCL THROM VAS, V27, P671, DOI 10.1161/01.ATV.0000256468.95403.6f; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Sakuragi S, 2009, HYPERTENSION, V53, P611, DOI 10.1161/HYPERTENSIONAHA.108.123364; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; WENDELHAG I, 1991, CLIN PHYSIOL, V11, P565, DOI 10.1111/j.1475-097X.1991.tb00676.x; Whincup PH, 2005, CIRCULATION, V112, P1789, DOI 10.1161/CIRCULATIONAHA.104.532663	23	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57454	10.1371/journal.pone.0057454	http://dx.doi.org/10.1371/journal.pone.0057454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451232	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800109
J	Garcia-Cortes, LA; Legarra, A; Chevalet, C; Toro, MA				Garcia-Cortes, Luis Alberto; Legarra, Andres; Chevalet, Claude; Toro, Miguel Angel			Variance and Covariance of Actual Relationships between Relatives at One Locus	PLOS ONE			English	Article							COEFFICIENTS	The relationship between pairs of individuals is an important topic in many areas of population and quantitative genetics. It is usually measured as the proportion of thegenome identical by descent shared by the pair and it can be inferred from pedigree information. But there is a variance in actual relationships as a consequence of Mendelian sampling, whose general formula has not been developed. The goal of this work is to develop this general formula for the one-locus situation,. We provide simple expressions for the variances and covariances of all actual relationships in an arbitrary complex pedigree. The proposed method relies on the use of the nine identity coefficients and the generalized relationship coefficients; formulas have been checked by computer simulation. Finally two examples for a short pedigree of dogs and a long pedigree of sheep are given.	[Garcia-Cortes, Luis Alberto] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Legarra, Andres] INRA, UR SAGA 631, F-31326 Castanet Tolosan, France; [Chevalet, Claude] INRA, UMR LGC 444, F-31326 Castanet Tolosan, France; [Toro, Miguel Angel] Univ Politecn Madrid, Dept Anim Prod, Madrid, Spain	INRAE; INRAE; Universidad Politecnica de Madrid	Legarra, A (corresponding author), INRA, UR SAGA 631, F-31326 Castanet Tolosan, France.	andres.legarra@toulouse.inra.fr	Toro, Miguel Angel Angel/H-9370-2015; Legarra, Andres/AAW-2371-2021; Toro, Miguel Angel/AAA-1309-2019; garcia, luis/C-5971-2008; Legarra, Andres/G-9451-2012	Toro, Miguel Angel Angel/0000-0001-7460-2483; Legarra, Andres/0000-0001-8893-7620; Toro, Miguel Angel/0000-0001-7460-2483; garcia, luis/0000-0003-1116-7271; Legarra, Andres/0000-0001-8893-7620	Ministerio de Ciencia e Innovacion (Spain) [CGL2009-1327-C02-02]; ANR project Rules Tools (France); action X-Gen of the SelGen metaprogram (INRA, France); platform bioinformatics Toulouse Midi-Pyrenees	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ANR project Rules Tools (France)(French National Research Agency (ANR)); action X-Gen of the SelGen metaprogram (INRA, France); platform bioinformatics Toulouse Midi-Pyrenees	This work has been partially supported by project CGL2009-1327-C02-02 of the Ministerio de Ciencia e Innovacion (Spain), ANR project Rules & Tools (France) and action X-Gen of the SelGen metaprogram (INRA, France). Project partially supported by the platform bioinformatics Toulouse Midi-Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boichard D., 2002, Proceedings of the 7th World Congress on Genetics Applied to Livestock Production, Montpellier, France, August, 2002. Session 28, P1; Colleau JJ, 2011, J ANIM BREED GENET, V128, P163, DOI 10.1111/j.1439-0388.2010.00899.x; Gillois M, 1964, THESIS FACULTE SCI P; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; HARRIS DL, 1964, GENETICS, V50, P1319; Hill WG, 2011, GENET RES, V93, P47, DOI 10.1017/S0016672310000480; Hill WG, 2007, THEOR POPUL BIOL, V72, P179, DOI 10.1016/j.tpb.2006.05.006; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; Laverack E, 1872, SETTER; Lynch M., 1998, GENETICS ANAL QUANTI; MacCluer JW, 1986, ZOO BIOL, V5, P149; PEREZENCISO M, 1992, THEOR APPL GENET, V84, P173, DOI 10.1007/BF00223997; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980	14	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57003	10.1371/journal.pone.0057003	http://dx.doi.org/10.1371/journal.pone.0057003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451134	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800062
J	Salmon, B; Bardet, C; Khaddam, M; Naji, J; Coyac, BR; Baroukh, B; Letourneur, F; Lesieur, J; Decup, F; Le Denmat, D; Nicoletti, A; Poliard, A; Rowe, PS; Huet, E; Vital, SO; Linglart, A; Mckee, MD; Chaussain, C				Salmon, Benjamin; Bardet, Claire; Khaddam, Mayssam; Naji, Jiar; Coyac, Benjamin R.; Baroukh, Brigitte; Letourneur, Franck; Lesieur, Julie; Decup, Franck; Le Denmat, Dominique; Nicoletti, Antonino; Poliard, Anne; Rowe, Peter S.; Huet, Eric; Vital, Sibylle Opsahl; Linglart, Agnes; McKee, Marc D.; Chaussain, Catherine			MEPE-Derived ASARM Peptide Inhibits Odontogenic Differentiation of Dental Pulp Stem Cells and Impairs Mineralization in Tooth Models of X-Linked Hypophosphatemia	PLOS ONE			English	Article							D-RESISTANT RICKETS; EXFOLIATED DECIDUOUS TEETH; VITAMIN-D; PHEX GENE; MOTIF PEPTIDE; IN-VIVO; BONE; PHOSPHATE; PROTEINS; COLLAGEN	Mutations in PHEX (phosphate-regulating gene with homologies to endopeptidases on the X-chromosome) cause X-linked familial hypophosphatemic rickets (XLH), a disorder having severe bone and tooth dentin mineralization defects. The absence of functional PHEX leads to abnormal accumulation of ASARM (acidic serine- and aspartate-rich motif) peptide - a substrate for PHEX and a strong inhibitor of mineralization - derived from MEPE (matrix extracellular phosphoglycoprotein) and other matrix proteins. MEPE-derived ASARM peptide accumulates in tooth dentin of XLH patients where it may impair dentinogenesis. Here, we investigated the effects of ASARM peptides in vitro and in vivo on odontoblast differentiation and matrix mineralization. Dental pulp stem cells from human exfoliated deciduous teeth (SHEDs) were seeded into a 3D collagen scaffold, and induced towards odontogenic differentiation. Cultures were treated with synthetic ASARM peptides (phosphorylated and nonphosphorylated) derived from the human MEPE sequence. Phosphorylated ASARM peptide inhibited SHED differentiation in vitro, with no mineralized nodule formation, decreased odontoblast marker expression, and upregulated MEPE expression. Phosphorylated ASARM peptide implanted in a rat molar pulp injury model impaired reparative dentin formation and mineralization, with increased MEPE immunohistochemical staining. In conclusion, using complementary models to study tooth dentin defects observed in XLH, we demonstrate that the MEPE-derived ASARM peptide inhibits both odontogenic differentiation and matrix mineralization, while increasing MEPE expression. These results contribute to a partial mechanistic explanation of XLH pathogenesis: direct inhibition of mineralization by ASARM peptide leads to the mineralization defects in XLH teeth. This process appears to be positively reinforced by the increased MEPE expression induced by ASARM. The MEPE-ASARM system can therefore be considered as a potential therapeutic target.	[Salmon, Benjamin; Bardet, Claire; Khaddam, Mayssam; Naji, Jiar; Coyac, Benjamin R.; Baroukh, Brigitte; Lesieur, Julie; Decup, Franck; Le Denmat, Dominique; Poliard, Anne; Vital, Sibylle Opsahl; Chaussain, Catherine] Univ Paris Descartes PRES Sorbonne Paris Cite, UFR Odontol, EA 2496, Montrouge, France; [Salmon, Benjamin; Coyac, Benjamin R.; Vital, Sibylle Opsahl; Chaussain, Catherine] Hop Univ Paris Nord Val Seine, AP HP, Odontol Dept Bretonneau Louis Mourier, Paris, France; [Salmon, Benjamin; Vital, Sibylle Opsahl; Linglart, Agnes; Chaussain, Catherine] AP HP, Ctr Reference Malad Rares Metab Phosphore & Calci, Le Kremlin Bicetre, France; [Letourneur, Franck] Univ Paris Descartes PRES Sorbonne Paris Cite, Inst Cochin, Paris, France; [Rowe, Peter S.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Decup, Franck] AP HP Odontol, Dept Charles Foix, Ivry, France; [Huet, Eric] Univ Paris Est, Lab CRRET, CNRS, Creteil, France; [Linglart, Agnes] Bicetre Paris Sud Hosp, APHP Endocrinol & Diabetol Children, Le Kremlin Bicetre, France; [Linglart, Agnes] Univ Paris 11, Le Kremlin Bicetre, France; [Coyac, Benjamin R.; McKee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Coyac, Benjamin R.; McKee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Nicoletti, Antonino] INSERM, UMRS698, Paris, France; [Nicoletti, Antonino] Denis Diderot Univ, UMRS698, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Kansas; University of Kansas Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chaussain, C (corresponding author), Univ Paris Descartes PRES Sorbonne Paris Cite, UFR Odontol, EA 2496, Montrouge, France.	catherine.chaussain@parisdescartes.fr	SALMON, Benjamin/X-4286-2019; HUET, Eric/R-3178-2018; McKee, Marc D/E-2187-2011; Linglart, Agnès/A-8047-2016; Coyac, Benjamin R./M-3743-2013; Nicoletti, Antonino/A-9460-2015; Vital, Sibylle/AAK-3479-2021; Coyac, Benny R./AAA-4775-2021	SALMON, Benjamin/0000-0001-8739-2753; HUET, Eric/0000-0002-5541-5954; McKee, Marc D/0000-0001-8349-965X; Linglart, Agnès/0000-0003-3455-002X; Coyac, Benjamin R./0000-0003-0105-6703; Nicoletti, Antonino/0000-0002-2623-0897; Vital, Sibylle/0000-0001-6352-2525; Coyac, Benny R./0000-0003-0105-6703; Bardet, Claire/0000-0002-0874-4843; Chaussain, Catherine/0000-0002-3463-3936; Lesieur, Julie/0000-0002-5981-3458	University Paris Descartes; Fondation pour la Recherche Medicale; Fondation de l'Avenir [EA2496]; National Institutes of Health grant [5RO-1-AR51598-01]; Societe Francaise des Tissus Mineralises; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051598] Funding Source: NIH RePORTER	University Paris Descartes; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de l'Avenir; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Societe Francaise des Tissus Mineralises; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from University Paris Descartes, Fondation pour la Recherche Medicale, Fondation de l'Avenir to EA2496, and by the National Institutes of Health grant (5RO-1-AR51598-01 to PSR). MDM is a member of the Fonds de Recherche Quebec-Sante (FRQ-S) Reseau de Recherche en Sante Buccodentaire et Osseuse, the FRQ-S Groupe de Recherche Axe sur la Structure des Proteines, and the Jamson T.N. Wong Laboratories in Calcified Tissue Research of the McGill Centre for Bone and Periodontal Research. The Ph.D. program of BS was supported by the Fondation pour la Recherche Medicale and by the Societe Francaise des Tissus Mineralises. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MDM has received research contracts and consulting honoraria from Enobia Pharma (now Alexion Pharmaceuticals). The other authors state no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Argiro L, 2001, GENOMICS, V74, P342, DOI 10.1006/geno.2001.6553; Arnold WH, 2007, ANN ANAT, V189, P183, DOI 10.1016/j.aanat.2006.09.008; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Baroukh B, 2000, BONE, V27, P627, DOI 10.1016/S8756-3282(00)00372-0; Barragan-Adjemian C, 2006, CALCIFIED TISSUE INT, V79, P340, DOI 10.1007/s00223-006-0107-2; Barros NM, 2012, J BONE MINER RES; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bitar M, 2008, BIOMACROMOLECULES, V9, P129, DOI 10.1021/bm701112w; Boskey AL, 2010, CALCIFIED TISSUE INT, V86, P42, DOI 10.1007/s00223-009-9313-z; Boukpessi T, 2006, CALCIFIED TISSUE INT, V79, P294, DOI 10.1007/s00223-006-0182-4; Boukpessi T, 2010, AM J PATHOL, V177, P803, DOI 10.2353/ajpath.2010.091231; Bresler D, 2004, J ENDOCRINOL, V183, pR1, DOI 10.1677/joe.1.05989; Carpenter TO, 2011, J BONE MINER RES, V26, P1381, DOI 10.1002/jbmr.340; Chaussain C, 2009, EUR CELLS MATER, V18, P84, DOI 10.22203/eCM.v018a08; Chaussain-Miller C, 2007, ORAL DIS, V13, P482, DOI 10.1111/j.1601-0825.2006.01326.x; Chaussain-Miller C, 2003, J PEDIATR-US, V142, P324, DOI 10.1067/mpd.2003.119; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; COULOMB B, 1984, BRIT J DERMATOL, V111, P83, DOI 10.1111/j.1365-2133.1984.tb15585.x; David V, 2011, AM J PHYSIOL-RENAL, V300, pF783, DOI 10.1152/ajprenal.00304.2010; David V, 2009, ENDOCRINOLOGY, V150, P4012, DOI 10.1210/en.2009-0216; Econs MJ, 1998, J CLIN ENDOCR METAB, V83, P3459, DOI 10.1210/jc.83.10.3459; Estes BT, 2011, METHODS MOL BIOL, V702, P201, DOI 10.1007/978-1-61737-960-4_15; Filisetti D, 1999, EUR J HUM GENET, V7, P615, DOI 10.1038/sj.ejhg.5200341; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Gaucher C, 2009, CELLS TISSUES ORGANS, V189, P219, DOI 10.1159/000151382; Gaucher C, 2009, HUM GENET, V125, P401, DOI 10.1007/s00439-009-0631-z; Gorski JP, 2011, FRONT BIOSCI-LANDMRK, V16, P2598, DOI 10.2741/3875; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; Kerkis I, 2012, TISSUE ENG PART B-RE, V18, P129, DOI [10.1089/ten.teb.2011.0327, 10.1089/ten.TEB.2011.0327]; Liu H, 2005, ARCH ORAL BIOL, V50, P923, DOI 10.1016/j.albchoralbio.2005.03.003; Liu SG, 2007, J ENDOCRINOL, V192, P261, DOI 10.1677/joe.1.07059; Lorenz-Depiereux B, 2004, MAMM GENOME, V15, P151, DOI 10.1007/s00335-003-2310-z; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mishima H, 1998, EUR J ORAL SCI, V106, P392, DOI 10.1111/j.1600-0722.1998.tb02204.x; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Murayama T, 2000, ORAL SURG ORAL MED O, V90, P310, DOI 10.1067/moe.2000.107522; Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70; Pedraza CE, 2010, TISSUE ENG PT A, V16, P781, DOI [10.1089/ten.tea.2009.0351, 10.1089/ten.TEA.2009.0351]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; Rowe PSN, 2012, CELL BIOCHEM FUNCT, V30, P355, DOI 10.1002/cbf.2841; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Rowe PSN, 2004, CRIT REV ORAL BIOL M, V15, P264, DOI 10.1177/154411130401500503; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; Rowe PSN, 1997, HUM MOL GENET, V6, P539, DOI 10.1093/hmg/6.4.539; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Sakai V T, 2011, Adv Dent Res, V23, P325, DOI 10.1177/0022034511405325; Seow W. Kim, 1995, Pediatric Dentistry, V17, P346; SEOW WK, 1984, AUST DENT J, V29, P371, DOI 10.1111/j.1834-7819.1984.tb05304.x; Six N, 2007, J DENT RES, V86, P780, DOI 10.1177/154405910708600818; Staines KA, 2012, BONE, V51, P418, DOI 10.1016/j.bone.2012.06.022; Suzumura Shinya, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. 22nd International Conference on Artificial Neural Networks, P1, DOI 10.1007/978-3-642-33266-1_1; Szpalski C, 2011, TISSUE ENG B; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Wang HG, 2010, BIOCHEM BIOPH RES CO, V398, P406, DOI 10.1016/j.bbrc.2010.06.085; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034	66	47	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56749	10.1371/journal.pone.0056749	http://dx.doi.org/10.1371/journal.pone.0056749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451077	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800032
J	Targher, G; Valbusa, F; Bonapace, S; Bertolini, L; Zenari, L; Rodella, S; Zoppini, G; Mantovani, W; Barbieri, E; Byrne, CD				Targher, Giovanni; Valbusa, Filippo; Bonapace, Stefano; Bertolini, Lorenzo; Zenari, Luciano; Rodella, Stefano; Zoppini, Giacomo; Mantovani, William; Barbieri, Enrico; Byrne, Christopher D.			Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; GAMMA-GLUTAMYL-TRANSFERASE; C-REACTIVE PROTEIN; MYOCARDIAL STEATOSIS; PERICARDIAL FAT; HEART-FAILURE; RISK-FACTORS; PREVALENCE; PREDICTOR; ENZYMES	Background: The relationship between non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) in type 2 diabetes is currently unknown. We examined the relationship between NAFLD and risk of incident AF in people with type 2 diabetes. Methods and Results: We prospectively followed for 10 years a random sample of 400 patients with type 2 diabetes, who were free from AF at baseline. A standard 12-lead electrocardiogram was undertaken annually and a diagnosis of incident AF was confirmed in affected participants by a single cardiologist. At baseline, NAFLD was defined by ultrasonographic detection of hepatic steatosis in the absence of other liver diseases. During the 10 years of follow-up, there were 42 (10.5%) incident AF cases. NAFLD was associated with an increased risk of incident AF (odds ratio [OR] 4.49, 95% CI 1.6-12.9, p<0.005). Adjustments for age, sex, hypertension and electrocardiographic features (left ventricular hypertrophy and PR interval) did not attenuate the association between NAFLD and incident AF (adjusted-OR 6.38, 95% CI 1.7-24.2, p = 0.005). Further adjustment for variables that were included in the 10-year Framingham Heart Study-derived AF risk score did not appreciably weaken this association. Other independent predictors of AF were older age, longer PR interval and left ventricular hypertrophy. Conclusions: Our results indicate that ultrasound-diagnosed NAFLD is strongly associated with an increased incidence of AF in patients with type 2 diabetes even after adjustment for important clinical risk factors for AF.	[Targher, Giovanni; Zoppini, Giacomo] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, I-37100 Verona, Italy; [Targher, Giovanni; Zoppini, Giacomo] Azienda Osped Univ Integrata Verona, Verona, Italy; [Valbusa, Filippo] Sacro Cuore Hosp Negrar, Div Gen Med, Verona, Italy; [Bonapace, Stefano; Barbieri, Enrico] Sacro Cuore Hosp Negrar, Div Cardiol, Verona, Italy; [Bertolini, Lorenzo; Zenari, Luciano] Sacro Cuore Hosp Negrar, Diabet Unit, Verona, Italy; [Rodella, Stefano] Sacro Cuore Hosp Negrar, Div Radiol, Verona, Italy; [Mantovani, William] Univ Verona, Dept Publ Hlth & Community Med, Sect Hyg & Prevent Environm & Occupat Med, I-37100 Verona, Italy; [Mantovani, William] Publ Hlth Trust, Dept Prevent, Trento, Italy; [Byrne, Christopher D.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Byrne, Christopher D.] Southampton Univ Hosp, Southampton Natl Inst Hlth Res Biomed Res Ctr, Southampton, Hants, England	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Southampton; University of Southampton	Targher, G (corresponding author), Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, I-37100 Verona, Italy.	giovanni.targher@univr.it	zoppini, giacomo/AAA-9000-2022; Targher, Giovanni/AAB-9008-2019	zoppini, giacomo/0000-0003-1085-554X; Targher, Giovanni/0000-0002-4325-3900; Bonapace, Stefano/0000-0001-9122-2642; Valbusa, Filippo/0000-0001-7527-6974; Byrne, Christopher D/0000-0001-6322-7753				[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Conen D, 2010, EUR HEART J, V31, P1730, DOI 10.1093/eurheartj/ehq146; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; Dhingra R, 2010, ARTERIOSCL THROM VAS, V30, P1855, DOI 10.1161/ATVBAHA.110.207340; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; Goland S, 2006, J CLIN GASTROENTEROL, V40, P949, DOI 10.1097/01.mcg.0000225668.53673.e6; Hallsworth K, 2013, J HEPATOL, V58, P757, DOI 10.1016/j.jhep.2012.11.015; Jabre P, 2011, CIRCULATION, V123, P1587, DOI 10.1161/CIRCULATIONAHA.110.986661; Lin YK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0293-1; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Makar GA, 2008, PHARMACOEPIDEM DR S, V17, P43, DOI 10.1002/pds.1514; Mehta SR, 2008, WORLD J GASTROENTERO, V14, P3476, DOI 10.3748/wjg.14.3476; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Ng ACT, 2010, CIRCULATION, V122, P2538, DOI 10.1161/CIRCULATIONAHA.110.955542; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Psaty BM, 1997, CIRCULATION, V96, P2455; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rosenberg MA, 2012, EUR HEART J, V33, P904, DOI 10.1093/eurheartj/ehr378; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Sinner MF, 2013, AM J CARDIOL, V111, P219, DOI 10.1016/j.amjcard.2012.09.021; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Targher G, 2009, SEMIN THROMB HEMOST, V35, P277, DOI 10.1055/s-0029-1222606; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Vanezis AP, 2008, J ELECTROCARDIOL, V41, P404, DOI 10.1016/j.jelectrocard.2008.02.013; Wannamethee SG, 2012, ARTERIOSCL THROM VAS, V32, P830, DOI 10.1161/ATVBAHA.111.240457	36	108	115	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57183	10.1371/journal.pone.0057183	http://dx.doi.org/10.1371/journal.pone.0057183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451184	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000316658800089
J	Hanley, MB; Lomas, W; Mittar, D; Maino, V; Park, E				Hanley, Mary Beth; Lomas, Woodrow; Mittar, Dev; Maino, Vernon; Park, Emily			Detection of Low Abundance RNA Molecules in Individual Cells by Flow Cytometry	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; IN-SITU HYBRIDIZATION; TRANSCRIPTS; PROBES; LEUKEMIA; CANCER; FISH; PCR; SEQ	A variety of RNA analysis technologies are available for the detection of RNA transcripts from bulk cell populations. However, the techniques for RNA detection from individual cells have been limited. Here we adapt a novel in situ signal amplification method (the RNAScope (R) detection platform) for the analysis of intracellular RNAs in individual cells by flow cytometry. Using novel target-specific probes that were designed to suppress background signals, we demonstrate the specific detection of HIV gag RNAs in HIV-infected cellular samples, in addition to bcr and abl mRNAs in the K562 cell line. This method was capable of distinguishing cells expressing low abundance RNA transcripts and correlated well with quantitative imaging analysis. Furthermore, multiple distinct RNA targets were simultaneously detected with a high specificity without interference. Overall, the sensitivity and specificity of this method will be useful for the analysis of functionally important RNA species from individual cells, even at very low copy numbers.	[Hanley, Mary Beth; Lomas, Woodrow; Mittar, Dev; Maino, Vernon; Park, Emily] BD Biosci, Res & Dev, San Jose, CA USA		Park, E (corresponding author), BD Biosci, Res & Dev, San Jose, CA USA.	emily_park@bd.com						Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Crouch J, 1997, CYTOMETRY, V29, P50, DOI 10.1002/(SICI)1097-0320(19970901)29:1<50::AID-CYTO5>3.3.CO;2-R; De Spiegelaere Ward, 2012, Methods Mol Biol, V853, P29, DOI 10.1007/978-1-61779-567-1_4; Di Carlo Dino, 2012, Methods Mol Biol, V853, P1, DOI 10.1007/978-1-61779-567-1_1; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Freeman WM, 2000, BIOTECHNIQUES, V29, P1042, DOI 10.2144/00295rv01; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gourronc FA, 2010, EXP DERMATOL, V19, P279, DOI 10.1111/j.1600-0625.2009.00916.x; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Iacobucci I, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.6; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luo Y, 2010, MULTIPLEX DETECTION; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, METHOD ENZYMOL, V472, P365, DOI 10.1016/S0076-6879(10)72004-8; Robertson KL, 2010, RNA, V16, P1679, DOI 10.1261/rna.2016410; Robertson KL, 2009, ANAL BIOCHEM, V390, P109, DOI 10.1016/j.ab.2009.04.026; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Symmans WF, 2003, CANCER, V97, P2960, DOI 10.1002/cncr.11435; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	32	39	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57002	10.1371/journal.pone.0057002	http://dx.doi.org/10.1371/journal.pone.0057002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441230	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200087
J	Yost, SE; Pastorino, S; Rozenzhak, S; Smith, EN; Chao, YS; Jiang, PF; Kesari, S; Frazer, KA; Harismendy, O				Yost, Shawn E.; Pastorino, Sandra; Rozenzhak, Sophie; Smith, Erin N.; Chao, Ying S.; Jiang, Pengfei; Kesari, Santosh; Frazer, Kelly A.; Harismendy, Olivier			High-Resolution Mutational Profiling Suggests the Genetic Validity of Glioblastoma Patient-Derived Pre-Clinical Models	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; TYROSINE KINASE GENES; CELL-LINES; STEM-CELLS; IN-VIVO; AMPLIFICATION; IDH1; EGFR; SUBPOPULATIONS; HETEROGENEITY	Recent advances in the ability to efficiently characterize tumor genomes is enabling targeted drug development, which requires rigorous biomarker-based patient selection to increase effectiveness. Consequently, representative DNA biomarkers become equally important in pre-clinical studies. However, it is still unclear how well these markers are maintained between the primary tumor and the patient-derived tumor models. Here, we report the comprehensive identification of somatic coding mutations and copy number aberrations in four glioblastoma (GBM) primary tumors and their matched pre-clinical models: serum-free neurospheres, adherent cell cultures, and mouse xenografts. We developed innovative methods to improve the data quality and allow a strict comparison of matched tumor samples. Our analysis identifies known GBM mutations altering PTEN and TP53 genes, and new actionable mutations such as the loss of PIK3R1, and reveals clear patient-to-patient differences. In contrast, for each patient, we do not observe any significant remodeling of the mutational profile between primary to model tumors and the few discrepancies can be attributed to stochastic errors or differences in sample purity. Similarly, we observe similar to 96% primary-to-model concordance in copy number calls in the high-cellularity samples. In contrast to previous reports based on gene expression profiles, we do not observe significant differences at the DNA level between in vitro compared to in vivo models. This study suggests, at a remarkable resolution, the genome-wide conservation of a patient's tumor genetics in various pre-clinical models, and therefore supports their use for the development and testing of personalized targeted therapies.	[Yost, Shawn E.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Yost, Shawn E.; Rozenzhak, Sophie; Smith, Erin N.; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Dept Pediat, Div Genome Informat Sci, La Jolla, CA 92093 USA; [Yost, Shawn E.; Rozenzhak, Sophie; Smith, Erin N.; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Rady Childrens Hosp, La Jolla, CA 92093 USA; [Pastorino, Sandra; Chao, Ying S.; Jiang, Pengfei; Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Pastorino, Sandra; Chao, Ying S.; Jiang, Pengfei; Kesari, Santosh] Univ Calif San Diego, Translat Neurooncol Labs, La Jolla, CA 92093 USA; [Kesari, Santosh; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Clin & Translat Res Inst, La Jolla, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kesari, S (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	skesari@ucsd.edu; oharismendy@ucsd.edu	Jiang, Pengfei/M-1759-2013; Harismendy, Olivier/AAM-2072-2021; Kesari, Santosh/E-8461-2013	Jiang, Pengfei/0000-0003-1912-8824; Harismendy, Olivier/0000-0002-8098-9888; Frazer, Kelly/0000-0002-6060-8902; Yost, Shawn/0000-0001-6653-1056	Center for Translational Science Award from the National Center for Research Resources [UL1RR031980, UL1TR000100]; National Cancer Institute [1R21CA152613-01, 1R21CA155615-01A1, CA69375]; National Institutes of Health [3P30CA023100-25S8, K08CA124804]; National Brain Tumor Foundation; James S. McDonnell Foundation; California Institute for Regenerative Medicine [CL1-00502, RT1-01108, TR1-01250]; NATIONAL CANCER INSTITUTE [P30CA023100, R21CA152613, R01CA069375, K08CA124804, R21CA155615] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER	Center for Translational Science Award from the National Center for Research Resources; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Foundation; James S. McDonnell Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Center for Translational Science Award (UL1RR031980 and UL1TR000100) from the National Center for Research Resources, three grants (1R21CA152613-01, 1R21CA155615-01A1, CA69375) from the National Cancer Institute. This work was also supported in part by grants from National Institutes of Health (3P30CA023100-25S8 and K08CA124804), National Brain Tumor Foundation, and James S. McDonnell Foundation to SK. Dr. Laurent's contribution was supported by California Institute for Regenerative Medicine grants CL1-00502, RT1-01108, and TR1-01250 to Jeanne F. Loring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2012, NATURE; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fraley C, 2007, MCLUST VERSION 3 R N; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Jeuken JWM, 2000, J NEUROSURG, V92, P652, DOI 10.3171/jns.2000.92.4.0652; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Koboldt DC, 2012, GENOME RES; Krzywinski MI, 2009, GENOME RES; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leuraud P, BR J CANC, V89, P2327; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Masramon L, 2006, J CELL SCI, V119, P1477, DOI 10.1242/jcs.02871; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pastor DM, 2010, INT J CLIN EXP MED, V3, P69; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Shah SP, 2012, NATURE; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	48	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56185	10.1371/journal.pone.0056185	http://dx.doi.org/10.1371/journal.pone.0056185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441165	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200022
J	Sanciangco, JC; Carpenter, KE; Etnoyer, PJ; Moretzsohn, F				Sanciangco, Jonnell C.; Carpenter, Kent E.; Etnoyer, Peter J.; Moretzsohn, Fabio			Habitat Availability and Heterogeneity and the Indo-Pacific Warm Pool as Predictors of Marine Species Richness in the Tropical Indo-Pacific	PLOS ONE			English	Article							WEST PACIFIC; LATITUDINAL GRADIENTS; FISH BIODIVERSITY; CORAL-REEFS; DIVERSITY; PATTERNS; BIOGEOGRAPHY; SPECIATION; ORIGINS; MODEL	Range overlap patterns were observed in a dataset of 10,446 expert-derived marine species distribution maps, including 8,295 coastal fishes, 1,212 invertebrates (crustaceans and molluscs), 820 reef-building corals, 50 seagrasses, and 69 mangroves. Distributions of tropical Indo-Pacific shore fishes revealed a concentration of species richness in the northern apex and central region of the Coral Triangle epicenter of marine biodiversity. This pattern was supported by distributions of invertebrates and habitat-forming primary producers. Habitat availability, heterogeneity, and sea surface temperatures were highly correlated with species richness across spatial grains ranging from 23,000 to 5,100,000 km(2) with and without correction for autocorrelation. The consistent retention of habitat variables in our predictive models supports the area of refuge hypothesis which posits reduced extinction rates in the Coral Triangle. This does not preclude support for a center of origin hypothesis that suggests increased speciation in the region may contribute to species richness. In addition, consistent retention of sea surface temperatures in models suggests that available kinetic energy may also be an important factor in shaping patterns of marine species richness. Kinetic energy may hasten rates of both extinction and speciation. The position of the Indo-Pacific Warm Pool to the east of the Coral Triangle in central Oceania and a pattern of increasing species richness from this region into the central and northern parts of the Coral Triangle suggests peripheral speciation with enhanced survival in the cooler parts of the Coral Triangle that also have highly concentrated available habitat. These results indicate that conservation of habitat availability and heterogeneity is important to reduce extinction of marine species and that changes in sea surface temperatures may influence the evolutionary potential of the region.	[Sanciangco, Jonnell C.; Carpenter, Kent E.] Int Union Conservat Nat, Marine Biodivers Unit Global Marine Species Asses, Global Species Programme, Gland, Switzerland; [Sanciangco, Jonnell C.; Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Etnoyer, Peter J.] NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA; [Moretzsohn, Fabio] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX USA	Old Dominion University; National Oceanic Atmospheric Admin (NOAA) - USA; Texas A&M University System	Sanciangco, JC (corresponding author), Int Union Conservat Nat, Marine Biodivers Unit Global Marine Species Asses, Global Species Programme, Gland, Switzerland.	jsanc005@odu.edu	Moretzsohn, Fabio/B-8142-2012	Sanciangco, Jonnell Cueto/0000-0001-8268-3180; Etnoyer, Peter/0000-0002-9932-3066	New Hampshire Charitable Foundation; Thomas W. Haas Foundation	New Hampshire Charitable Foundation; Thomas W. Haas Foundation	This research was generously supported by core funding from the Tom Haas and the New Hampshire Charitable Foundation, and the Thomas W. Haas Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2009, QUATERNARY SCI REV, V28, P2794, DOI 10.1016/j.quascirev.2009.07.006; Allen G. R., 2007, AQUAT CONSERV, V17, P1; Allen GR, 2003, ZOOL STUD, V42, P1; Amante C., 2008, NGDC24 NOAA NESDIS; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; [Anonymous], 1953, ZOOGEOGRAPHY SEA; [Anonymous], 2020, CATALOG FISHES; [Anonymous], 1997, WORLD MANGROVE ATLAS; Badgley C, 2000, J BIOGEOGR, V27, P1437, DOI 10.1046/j.1365-2699.2000.00498.x; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; BEST MB, 1989, NETH J SEA RES, V23, P107, DOI 10.1016/0077-7579(89)90005-7; Bini LM, 2004, J BIOGEOGR, V31, P1819, DOI 10.1111/j.1365-2699.2004.01126.x; Bivand R., 2009, SPDEP SPATIAL DEPEND; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; BRIGGS JC, 1992, GLOBAL ECOL BIOGEOGR, V2, P149, DOI 10.2307/2997803; Briggs JC, 2000, J BIOGEOGR, V27, P1183, DOI 10.1046/j.1365-2699.2000.00459.x; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY, V14; Briggs JC, 2007, J BIOGEOGR, V34, P193, DOI 10.1111/j.1365-2699.2006.01632.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CARPENTER K.E, 1998, LIVING MARINE RESOUR, V1, P1; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Cleary DFR, 2006, BIODIVERS CONSERV, V15, P3653, DOI 10.1007/s10531-004-4692-y; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; Colwell RK, 2009, EVOL ECOL RES, V11, P355; Connolly SR, 2003, ECOLOGY, V84, P2178, DOI 10.1890/02-0254; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Crandall ED, 2012, MOL BIOL EVOL, V29, P707, DOI 10.1093/molbev/msr227; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Diniz JAF, 2004, OECOLOGIA, V140, P633, DOI 10.1007/s00442-004-1577-4; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Eschmeyer WN, 2010, ZOOTAXA, P19; Etnoyer PJ, 2001, THESIS DUKE U DURHAM; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Green E.P., 2003, WORLD ATLAS SEAGRASS; Halas D, 2009, J BIOGEOGR, V36, P1847, DOI 10.1111/j.1365-2699.2009.02103.x; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hawkins BA, 2012, J BIOGEOGR, V39, P998, DOI 10.1111/j.1365-2699.2012.02716.x; Hawkins BA, 2012, J BIOGEOGR, V39, P1, DOI 10.1111/j.1365-2699.2011.02637.x; Herre A. H., 1953, RES REPORT; Hoeksema BW, 2012, RAFFLES B ZOOL, V60, P183; Hoeksema BW, 2007, BIOGEOGRAPHY TIME PL, P416; Holloway JD, 1998, BIOGEOGRAPHY GEOLOGI, P419; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Kuhn I, 2012, J BIOGEOGR, V39, P995, DOI 10.1111/j.1365-2699.2012.02707.x; LADD HS, 1960, AM J SCI, V258, P137; Lomolino MV, 2006, BIOGEOGRAPHY; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; McClain CR, 2007, GLOBAL ECOL BIOGEOGR, V16, P257, DOI 10.1111/j.1466-8238.2007.00286.x; MCCOY ED, 1976, SYST ZOOL, V25, P201, DOI 10.2307/2412488; McGarigal K., 1995, SPATIAL PATTERN ANAL; McManus J. W., 1985, P 5 INT COR REEF C T, P133; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Moretzsohn F, 2004, 30 JOHN D CT MAC FDN; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nanola CL, 2011, ENVIRON BIOL FISH, V90, P405, DOI 10.1007/s10641-010-9750-6; Nathan SA, 2009, PALAEOGEOGR PALAEOCL, V274, P140, DOI 10.1016/j.palaeo.2009.01.007; Nichols G., 2009, SEDIMENTOLOGY STRATI, P163; Nogues-Bravo D, 2006, GLOBAL ECOL BIOGEOGR, V15, P452, DOI 10.1111/j.1566-822x.2006.00240.x; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Peterson M. S., 2000, Wetlands Ecology and Management, V8, P209, DOI 10.1023/A:1008452805584; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Potts D. C., 1985, PROC 5 INT CORAL REE, V4, P127; Randall JE, 1998, ZOOL STUD, V37, P227; Read CI, 2006, MOL PHYLOGENET EVOL, V38, P808, DOI 10.1016/j.ympev.2005.08.001; Reaka ML, 2008, P NATL ACAD SCI USA, V105, P11474, DOI 10.1073/pnas.0802594105; Reaka ML, 2008, P 11 INT COR REEF C, V2, P1384; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ricklefs Robert E., 1993, P350; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosen B. R., 1988, GEOLOGICAL SOC SPECI, V37, P275; ROSEN BR, 1988, HELGOLANDER MEERESUN, V42, P269, DOI 10.1007/BF02366046; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Santini F, 2002, J BIOGEOGR, V29, P189, DOI 10.1046/j.1365-2699.2002.00669.x; Shannon C.E., 1963, MATH THEORY COMMUNIC; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Smith TM, 1998, J CLIMATE, V11, P3320, DOI 10.1175/1520-0442(1998)011<3320:AHRGSS>2.0.CO;2; SOLURI EA, 1990, INT HYDROGR REV, V67, P27; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Vermeij GJ, 2001, MARINE COMMUNITY ECOLOGY, P39; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Wallace Carden C., 1997, P365; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willette DA, 2011, J FISH BIOL, V79, P2087, DOI 10.1111/j.1095-8649.2011.03133.x; Williams ST, 2004, EVOLUTION, V58, P2227; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x; Wilson Moyra E. J., 1998, P165; Woodland David J., 1990, Indo-Pacific Fishes, V19, P1; WOODLAND DJ, 1983, B MAR SCI, V33, P713; YAN XH, 1992, SCIENCE, V258, P1643, DOI 10.1126/science.258.5088.1643	119	69	75	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56245	10.1371/journal.pone.0056245	http://dx.doi.org/10.1371/journal.pone.0056245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457533	Green Submitted, Green Published, gold			2022-12-27	WOS:000315603700030
J	Marlow, MA; Mattos, MD; Makowiecky, ME; Eger, I; Rossetto, AL; Grisard, EC; Steindel, M				Marlow, Mariel Asbury; Mattos, Marise da Silva; Makowiecky, Maria Ernestina; Eger, Iriane; Rossetto, Andre Luiz; Grisard, Edmundo Carlos; Steindel, Mario			Divergent Profile of Emerging Cutaneous Leishmaniasis in Subtropical Brazil: New Endemic Areas in the Southern Frontier	PLOS ONE			English	Article							SPECIES INFECTING PATIENTS; VIANNIA BRAZILIENSIS; TEGUMENTARY LEISHMANIASIS; SANTA-CATARINA; STATE; EPIDEMIOLOGY; VECTORS; DISEASE; DIPTERA; REGION	Background: Although known to be highly endemic in the Amazon regions of Brazil, the presence of cutaneous leishmaniasis (CL) in the subtropical southern part of the country has largely been ignored. This study was conducted to demonstrate CL is emerging in the Brazilian state of Santa Catarina, as well as to characterize the epidemiological profile and Leishmania species involved. Methodology/Principal Findings: For this cross-sectional study, data from all CL cases from Santa Catarina, Brazil, reported to the Brazilian National Notifiable Diseases Information System from 2001 to 2009 were investigated. Amplification of the kDNA minicircle conserved region followed by restriction fragment length polymorphism (PCR-RFLP) was conducted to screen for Leishmania species present in patient biopsy. Overall, 542 CL cases were reported, with majority resulting from autochthonous transmission (n = 401, 73.99%) and occurring in urban zones (n = 422, 77.86%). Age, gender, zone of residence, origin of case, clinical form and case outcome were found to differ significantly by region. Imported cases were over seven times more likely to relapse (95% CI 2.56-21.09). Mapping of cases revealed new endemic areas in northeastern Santa Catarina with two species present. With the exception of three L. (Leishmania) amazonensis cases (1.20%), majority of PCR positive samples were found to be L. (Viannia) braziliensis (n = 248, 98.80%). Conclusions/Significance: CL is now endemic in the state of Santa Catarina, Brazil, with case profiles varying significantly by region. L. (V.) braziliensis has been identified as the predominant species in the region.	[Marlow, Mariel Asbury; Grisard, Edmundo Carlos; Steindel, Mario] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil; [Mattos, Marise da Silva] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Makowiecky, Maria Ernestina] Secretaria Estadual Saude Santa Catarina, Dept Zoonoses, Diretoria Vigilancia Epidemiol, Florianopolis, SC, Brazil; [Eger, Iriane; Rossetto, Andre Luiz] Univ Vale Itajai, Ctr Hlth Sci, Itajai, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Rio de Janeiro; Universidade do Vale do Itajai	Steindel, M (corresponding author), Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil.	mario.steindel@ufsc.br	Grisard, Edmundo C/A-7338-2015; Steindel, Mario/N-2040-2018; Steindel, Mario/H-2945-2015; Rossetto, André/U-1756-2019	Grisard, Edmundo C/0000-0001-8916-8296; Steindel, Mario/0000-0002-2768-7469; Steindel, Mario/0000-0002-2768-7469; 	CAPES; FAPESC; PPSUS; CNPq; CAPES scholarship (Brazilian Government Agency)	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESC(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); PPSUS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES scholarship (Brazilian Government Agency)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to express their gratitude to the funding agencies, CAPES, FAPESC, PPSUS and CNPq. M.A.M. is recipient of a CAPES scholarship (Brazilian Government Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SANT CAT EST; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004; Carvalho MDR, 2006, ACTA TROP, V98, P277, DOI 10.1016/j.actatropica.2006.06.001; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Guerra JAD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000980; Dengue in Brazil, DENG BRAZ CURR SIT A; Falqueto A, 2003, MEM I OSWALDO CRUZ, V98, P1003, DOI 10.1590/S0074-02762003000800004; Grisard EC, 2000, ACTA TROP, V74, P89, DOI 10.1016/S0001-706X(99)00054-6; IBGE - Instituto Brasileiro de Geografia e Estatistica (Brazilian Institute of Geography and Statistics), 2010, DEM CENS SANT CAT; Lainson Ralph, 2010, Revista Pan-Amazonica de Saude, V1, P13; Lima Filho JHC, 1998, ARQ CATARINENSES MED, V27, P25; Marcondes CB, 2009, T ROY SOC TROP MED H, V103, P1093, DOI 10.1016/j.trstmh.2008.12.006; Marcondes CB, 2005, REV SOC BRAS MED TRO, V38, P353, DOI 10.1590/S0037-86822005000400016; Ministerio Da Saude, 2007, MAN SURV AM CUT LEIS; Ministerio Da Saude, 2007, EP SIT MAL BRAZ YEAR; Mitropoulos P, 2010, J AM ACAD DERMATOL, V63, P309, DOI 10.1016/j.jaad.2009.06.088; Monteiro WM, 2009, REV SOC BRAS MED TRO, V42, P509, DOI 10.1590/S0037-86822009000500007; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Oliveira CCG, 2004, ACTA TROP, V90, P155, DOI 10.1016/j.actatropica.2003.11.011; Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Pires Menezes ML, 2000, REV ELECT GEOGRAFIA, V69; Pocai E. A., 1998, Ciencia Rural, V28, P501, DOI 10.1590/S0103-84781998000300025; Razera F, 2005, REV AMRIGS PORTO ALE, V49, P165; Reithinger R, 1999, AM J TROP MED HYG, V61, P530, DOI 10.4269/ajtmh.1999.61.530; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Ribeiro de Oliveira AT, 2011, INTERNAL MIGRATION P; Sambrook J., 1989, MOL CLONING LAB MANU, DOI [10.1016/0092-8674(90)90210-6, DOI 10.1016/0092-8674(90)90210-6]; Sharma Umakant, 2008, Journal of Vector Borne Diseases, V45, P255; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Souza GD, 2009, MEM I OSWALDO CRUZ, V104, P1181, DOI 10.1590/S0074-02762009000800017; Tarso Sao P. de, 1990, Revista da Sociedade Brasileira de Medicina Tropical, V23, P201, DOI 10.1590/S0037-86821990000400003; Volf P, 2007, TRENDS PARASITOL, V23, P91, DOI 10.1016/j.pt.2006.12.010; Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008; YOSHIDA ELA, 1990, MEM I OSWALDO CRUZ, V85, P133, DOI 10.1590/S0074-02761990000100026	38	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56177	10.1371/journal.pone.0056177	http://dx.doi.org/10.1371/journal.pone.0056177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457521	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700055
J	Niesser, M; Demmelmair, H; Weith, T; Moretti, D; Rauh-Pfeiffer, A; van Lipzig, M; Vaes, W; Koletzko, B; Peissner, W				Niesser, Mareile; Demmelmair, Hans; Weith, Thea; Moretti, Diego; Rauh-Pfeiffer, Astrid; van Lipzig, Marola; Vaes, Wouter; Koletzko, Berthold; Peissner, Wolfgang			Folate Catabolites in Spot Urine as Non-Invasive Biomarkers of Folate Status during Habitual Intake and Folic Acid Supplementation	PLOS ONE			English	Article							LYMPHOCYTE DNA METHYLATION; TANDEM MASS-SPECTROMETRY; NEURAL-TUBE DEFECTS; PLASMA FOLATE; PARA-ACETAMIDOBENZOYLGLUTAMATE; P-AMINOBENZOYLGLUTAMATE; CARDIOVASCULAR-DISEASE; QUANTITATIVE-ANALYSIS; POSTMENOPAUSAL WOMEN; HOMOCYSTEINE LEVELS	Background: Folate status, reflected by red blood cell (RCF) and plasma folates (PF), is related to health and disease risk. Folate degradation products para-aminobenzoylglutamate (pABG) and para-acetamidobenzoylglutamate (apABG) in 24 hour urine have recently been shown to correlate with blood folate. Aim: Since blood sampling and collection of 24 hour urine are cumbersome, we investigated whether the determination of urinary folate catabolites in fasted spot urine is a suitable non-invasive biomarker for folate status in subjects before and during folic acid supplementation Study Design and Methods: Immediate effects of oral folic acid bolus intake on urinary folate catabolites were assessed in a short-term pre-study. In the main study we included 53 healthy men. Of these, 29 were selected for a 12 week folic acid supplementation (400 mu g). Blood, 24 hour and spot urine were collected at baseline and after 6 and 12 weeks and PF, RCF, urinary apABG and pABG were determined. Results: Intake of a 400 mu g folic acid bolus resulted in immediate increase of urinary catabolites. In the main study pABG and apABG concentrations in spot urine correlated well with their excretion in 24 hour urine. In healthy men consuming habitual diet, pABG showed closer correlation with PF (r(s) = 0.676) and RCF (r(s) = 0.649) than apABG (r(s) = 0.264, ns and 0.543). Supplementation led to significantly increased folate in plasma and red cells as well as elevated urinary folate catabolites, while only pABG correlated significantly with PF (r(s) = 0.574) after 12 weeks. Conclusion: Quantification of folate catabolites in fasted spot urine seems suitable as a non-invasive alternative to blood or 24 hour urine analysis for evaluation of folate status in populations consuming habitual diet. In non-steady-state conditions (folic acid supplementation) correlations between folate marker (RCF, PF, urinary catabolites) decrease due to differing kinetics.	[Niesser, Mareile; Demmelmair, Hans; Weith, Thea; Rauh-Pfeiffer, Astrid; Koletzko, Berthold; Peissner, Wolfgang] Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp Med Ctr, Munich, Germany; [Moretti, Diego] Unilever Res Labs, Unilever Food & Hlth Res Inst, Vlaardingen, Netherlands; [Moretti, Diego] Swiss Fed Inst Technol, Human Nutr Lab, Zurich, Switzerland; [van Lipzig, Marola; Vaes, Wouter] TNO Innovat Life, Zeist, Netherlands	University of Munich; Unilever; Swiss Federal Institutes of Technology Domain; ETH Zurich; Netherlands Organization Applied Science Research	Koletzko, B (corresponding author), Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp Med Ctr, Munich, Germany.	office.koletzko@med.uni-muenchen.de	Moretti, Diego/AAC-9028-2019; Vaes, Wouter/AAA-2751-2021; Moretti, Diego/G-5212-2013	Moretti, Diego/0000-0002-7366-2182; Moretti, Diego/0000-0002-7366-2182	Kompetenznetz Adipositas ("Competence Network for Adiposity"); Federal Ministry of Education and Research [FKZ: 01GI1126]; Commission of the European Communities, within the 7th Framework Programme, NUTRIMENTHE [FP7-212652]; Munich Center of Health Sciences (McHealth); Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY, USA	Kompetenznetz Adipositas ("Competence Network for Adiposity"); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Commission of the European Communities, within the 7th Framework Programme, NUTRIMENTHE; Munich Center of Health Sciences (McHealth); Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY, USA(Bristol-Myers Squibb)	This work was supported financially by the "Kompetenznetz Adipositas" ("Competence Network for Adiposity") funded by the Federal Ministry of Education and Research (FKZ: 01GI1126). Further support by the Commission of the European Communities, within the 7th Framework Programme, NUTRIMENTHE, FP7-212652 and by the Munich Center of Health Sciences (McHealth) is gratefully acknowledged. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. BK is a recipient of the Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez B, 2010, J CHROMATOGR A; BARTELS H, 1972, CLIN CHIM ACTA, V37, P193, DOI 10.1016/0009-8981(72)90432-9; Bozbas H, 2011, TURK KARDIYOL DERN A, V39, P122, DOI 10.5543/tkda.2011.01205; Caudill MA, 1998, J NUTR, V128, P204, DOI 10.1093/jn/128.2.204; Caudill MA, 2002, J NUTR, V132, P2613, DOI 10.1093/jn/132.9.2613; Chuang SC, 2011, EUR J CANCER, V47, P1808, DOI 10.1016/j.ejca.2011.02.007; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Ericson U, 2010, J NUTR, V140, P1661, DOI 10.3945/jn.110.124313; GEOGHEGAN FL, 1995, J NUTR, V125, P2563; Gregory JF, 1998, J NUTR, V128, P1896, DOI 10.1093/jn/128.11.1896; GREGORY JF, 1988, ANAL BIOCHEM, V170, P94, DOI 10.1016/0003-2697(88)90094-2; Gregory JF, 2002, ANNU REV NUTR, V22, P199, DOI 10.1146/annurev.nutr.22.120701.083554; Gregory JF, 2001, J NUTR, V131, P1928, DOI 10.1093/jn/131.7.1928; Gregory JF, 2000, J NUTR, V130, P2949, DOI 10.1093/jn/130.12.2949; Hannisdal R, 2010, J NUTR, V140, P522, DOI 10.3945/jn.109.116418; Hao L, 2008, AM J CLIN NUTR, V88, P448, DOI 10.1093/ajcn/88.2.448; Harris SA, 2000, AIHAJ, V61, P649, DOI 10.1080/15298660008984574; Herrmann M, 2006, EUR J HEART FAIL, V8, P571, DOI 10.1016/j.ejheart.2005.11.016; Hooshmand B, 2012, J INTERN MED, V271, P204, DOI 10.1111/j.1365-2796.2011.02484.x; Houghton LA, 2011, AM J CLIN NUTR, V94, P136, DOI 10.3945/ajcn.110.004549; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Kim HA, 2008, J NUTR SCI VITAMINOL, V54, P291, DOI 10.3177/jnsv.54.291; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; KOWNACKIBROWN PA, 1993, J NUTR, V123, P1101; Lobo A, 1999, AM J CARDIOL, V83, P821, DOI 10.1016/S0002-9149(98)01041-8; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; MATCHAR DB, 1987, ANN INTERN MED, V106, P707, DOI 10.7326/0003-4819-106-5-707; McKay DL, 2000, J NUTR, V130, P3090, DOI 10.1093/jn/130.12.3090; MCPARTLIN J, 1992, ANAL BIOCHEM, V206, P256, DOI 10.1016/0003-2697(92)90363-C; Minchin RF, 2007, INT J BIOCHEM CELL B, V39, P1999, DOI 10.1016/j.biocel.2006.12.006; Monch S, 2010, ANAL BIOCHEM, V398, P150, DOI 10.1016/j.ab.2009.11.007; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Park JY, 2012, MOL NUTR FOOD RES; Pietrzik K, 2007, AM J CLIN NUTR, V86, P1414, DOI 10.1093/ajcn/86.5.1414; Prinz-Langenohl R, 1999, J NUTR, V129, P913, DOI 10.1093/jn/129.4.913; Prinz-Langenohl R, 2001, EUR J NUTR, V40, P98, DOI 10.1007/PL00007387; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Scott KC, 1996, J NUTR BIOCHEM, V7, P261, DOI 10.1016/0955-2863(96)00026-5; Seppala J, 2012, J AFFECT DISORDERS, V138, P473, DOI 10.1016/j.jad.2012.01.007; Shane B, 2001, CLIN RES REGUL AFF, V18, P137, DOI 10.1081/CRP-100108170; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Sokoro AAH, 2006, J CHROMATOGR B, V832, P9, DOI 10.1016/j.jchromb.2005.11.053; Sr SB, 2012, CONTRACEPTION, V85, P42, DOI 10.1016/j.contraception.2011.05.013; Stites TE, 1997, AM J CLIN NUTR, V65, P53, DOI 10.1093/ajcn/65.1.53; Tomaszewski JJ, 2011, PROSTATE, V71, P1287, DOI 10.1002/pros.21346; Uitenbroek DG, 1997, CALCULATE BINOMIAL P; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S115; Wald DS, 2001, ARCH INTERN MED, V161, P695, DOI 10.1001/archinte.161.5.695; West AA, 2012, AM J CLIN NUTR, V96, P789, DOI 10.3945/ajcn.112.037523; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292; Wolfe JM, 2003, AM J CLIN NUTR, V77, P919, DOI 10.1093/ajcn/77.4.919	56	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56194	10.1371/journal.pone.0056194	http://dx.doi.org/10.1371/journal.pone.0056194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457526	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700059
J	Candia, CNH; Martinez, ST; Gutierrez-Medina, B				Hernandez Candia, Carmen Noemi; Tafoya Martinez, Sara; Gutierrez-Medina, Braulio			A Minimal Optical Trapping and Imaging Microscopy System	PLOS ONE			English	Article							INDIVIDUAL MICROTUBULES; PARTICLE TRACKING; DNA-MOLECULES; SINGLE; KINESIN; FORCE; ELASTICITY; TWEEZERS; MANIPULATION; MOVEMENT	We report the construction and testing of a simple and versatile optical trapping apparatus, suitable for visualizing individual microtubules (similar to 25 nm in diameter) and performing single-molecule studies, using a minimal set of components. This design is based on a conventional, inverted microscope, operating under plain bright field illumination. A single laser beam enables standard optical trapping and the measurement of molecular displacements and forces, whereas digital image processing affords real-time sample visualization with reduced noise and enhanced contrast. We have tested our trapping and imaging instrument by measuring the persistence length of individual double-stranded DNA molecules, and by following the stepping of single kinesin motor proteins along clearly imaged microtubules. The approach presented here provides a straightforward alternative for studies of biomaterials and individual biomolecules.	[Hernandez Candia, Carmen Noemi] Inst Potosino Invest Cient & Tecnol, Program Mol Biol, San Luis Potosi, Mexico; [Tafoya Martinez, Sara] Univ Autonoma San Luis Potosi, Program Phys, San Luis Potosi, Mexico; [Gutierrez-Medina, Braulio] Inst Potosino Invest Cient & Tecnol, Adv Mat Div, San Luis Potosi, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma de San Luis Potosi; Instituto Potosino Investigacion Cientifica y Tecnologica	Gutierrez-Medina, B (corresponding author), Inst Potosino Invest Cient & Tecnol, Adv Mat Div, San Luis Potosi, Mexico.	bgutierrez@ipicyt.edu.mx		Gutierrez-Medina, Braulio/0000-0003-2810-6774	Fondos Sectoriales-SEP from Consejo Nacional de Ciencia y Tecnologia (CONACYT) [S-3158]; UC MEXUS-CONACYT grant; George E Brown Jr Award	Fondos Sectoriales-SEP from Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UC MEXUS-CONACYT grant; George E Brown Jr Award	This work was supported by grant Fondos Sectoriales-SEP-2009 (S-3158) from Consejo Nacional de Ciencia y Tecnologia (CONACYT, http://www.conacyt.gob.mx) to BG, and by a UC MEXUS-CONACYT (http://ucmexus.ucr.edu/) grant and a George E Brown Jr Award to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Agero U, 2004, MICROSC RES TECHNIQ, V65, P159, DOI 10.1002/jemt.20117; Appleyard DC, 2007, AM J PHYS, V75, P5, DOI 10.1119/1.2366734; Asbury CL, 2005, CURR OPIN CELL BIOL, V17, P89, DOI 10.1016/j.ceb.2004.12.002; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Block SM, 1998, CELL, V93, P5, DOI 10.1016/S0092-8674(00)81138-1; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Fazal FM, 2011, NAT PHOTONICS, V5, P318, DOI 10.1038/nphoton.2011.100; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Gutierrez-Medina B, 2010, AM J PHYS, V78, P1152, DOI 10.1119/1.3453264; Gutierrez-Medina B, 2010, METHOD ENZYMOL, V475, P377, DOI 10.1016/S0076-6879(10)75015-1; Inoue S, 1986, VIDEO MICROSCOPY; KURIYAMA R, 1975, J CELL SCI, V19, P607; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; MacDonald MP, 2002, SCIENCE, V296, P1101, DOI 10.1126/science.1069571; Mack AH, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3053122; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Oldenbourg R, 1998, BIOPHYS J, V74, P645, DOI 10.1016/S0006-3495(98)77824-5; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Rohrbach A, 2003, OPT LETT, V28, P411, DOI 10.1364/OL.28.000411; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Salmon ED, 1998, METHOD CELL BIOL, V81, P335; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; Schnapp BJ, 1986, METHOD ENZYMOL, P561; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Waterman-Storer CM, 1998, MOL BIOL CELL, V9, P3263, DOI 10.1091/mbc.9.12.3263; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	38	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57383	10.1371/journal.pone.0057383	http://dx.doi.org/10.1371/journal.pone.0057383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451216	Green Published, gold			2022-12-27	WOS:000316849500095
J	Pal, PB; Sinha, K; Sil, PC				Pal, Pabitra Bikash; Sinha, Krishnendu; Sil, Parames C.			Mangiferin, a Natural Xanthone, Protects Murine Liver in Pb(II) Induced Hepatic Damage and Cell Death via MAP Kinase, NF-kappa B and Mitochondria Dependent Pathways	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; CAJANUS-INDICUS L; 43 KD PROTEIN; PHYLLANTHUS-NIRURI; ARJUNOLIC ACID; LEAD-EXPOSURE; INDUCED CYTOTOXICITY; ACTIVATOR PROTEIN-1; L. EXTRACT; IN-VITRO	One of the most well-known naturally occurring environmental heavy metals, lead (Pb) has been reported to cause liver injury and cellular apoptosis by disturbing the prooxidant-antioxidant balance via oxidative stress. Several studies, on the other hand, reported that mangiferin, a naturally occurring xanthone, has been used for a broad range of therapeutic purposes. In the present study, we, therefore, investigated the molecular mechanisms of the protective action of mangiferin against lead-induced hepatic pathophysiology. Lead [Pb(II)] in the form of Pb(NO3)(2) (at a dose of 5 mg/kg body weight, 6 days, orally) induced oxidative stress, hepatic dysfunction and cell death in murine liver. Post treatment of mangiferin at a dose of 100 mg/kg body weight (6 days, orally), on the other hand, diminished the formation of reactive oxygen species (ROS) and reduced the levels of serum marker enzymes [alanine aminotranferase (ALT) and alkaline phosphatase (ALP)]. Mangiferin also reduced Pb(II) induced alterations in antioxidant machineries, restored the mitochondrial membrane potential as well as mutual regulation of Bcl-2/Bax. Furthermore, mangiferin inhibited Pb(II)-induced activation of mitogen-activated protein kinases (MAPKs) (phospho-ERK 1/2, phosphor-JNK phospho- p38), nuclear translocation of NF-kappa B and apoptotic cell death as was evidenced by DNA fragmentation, FACS analysis and histological assessment. In vitro studies using hepatocytes as the working model also showed the protective effect of mangiferin in Pb(II) induced cytotoxicity. All these beneficial effects of mangiferin contributes to the considerable reduction of apoptotic hepatic cell death induced by Pb(II). Overall results demonstrate that mangiferin exhibit both antioxidative and antiapoptotic properties and protects the organ in Pb(II) induced hepatic dysfunction.	[Pal, Pabitra Bikash; Sinha, Krishnendu; Sil, Parames C.] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Sil, PC (corresponding author), Bose Inst, Div Mol Med, P-1-12,CIT Scheme 7 M, Kolkata, India.	parames_95@yahoo.co.in		Sinha, Krishnendu/0000-0001-9590-3875				Aderibigbe AO, 1999, PHYTOTHER RES, V13, P504, DOI 10.1002/(SICI)1099-1573(199909)13:6&lt;504::AID-PTR533&gt;3.0.CO;2-9; Agency for Toxic Substances and Disease Registry (ATSDR), 1992, CAS STUD ENV MED LEA; Ahamed M, 2007, CLIN CHIM ACTA, V383, P57, DOI 10.1016/j.cca.2007.04.024; Aiyelaagbe O.O., 2009, OYO STATE PLANT SCI, V2, P11; Anila L, 2002, J ETHNOPHARMACOL, V79, P81, DOI 10.1016/S0378-8741(01)00361-0; ARITOMI M, 1969, TETRAHEDRON LETT, P941; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF LEAD; Bairy Indira, 2002, Indian J Pathol Microbiol, V45, P307; Bhattacharjee Rajesh, 2006, Biomedical Research (Aligarh), V17, P75; Bhattacharjee R, 2007, FOOD CHEM TOXICOL, V45, P817, DOI 10.1016/j.fct.2006.10.029; Bhattacharjee R, 2007, TOXICOL MECH METHOD, V17, P41, DOI 10.1080/15376510600970034; Bhattacharjee R, 2006, PHYTOTHER RES, V20, P595, DOI 10.1002/ptr.1933; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Centers for Disease Control and Prevention, 1991, PREV LEAD POIS YOUNG; Chandrasekaran VRM, 2009, SHOCK, V32, P89, DOI 10.1097/SHK.0b013e31818ede6f; Chatterjee Mary, 2006, Pathophysiology, V13, P95, DOI 10.1016/j.pathophys.2006.02.003; Chatterjee M, 2006, INDIAN J BIOCHEM BIO, V43, P299; Chatterjee M, 2007, INDIAN J CLIN BIOCHE, V22, P109, DOI 10.1007/BF02912892; CHRISTIE NT, 1984, BIOL TRACE ELEM RES, V6, P139, DOI 10.1007/BF02916931; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; Das J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012602; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Farghali H, 2000, PHARMACOL RES, V41, P231, DOI 10.1006/phrs.1999.0575; Garcia D, 2003, PHYTOTHER RES, V17, P1203, DOI 10.1002/ptr.1343; Ghosh A, 2009, CHEM-BIOL INTERACT, V177, P96, DOI 10.1016/j.cbi.2008.09.006; Ghosh A, 2008, BIOL PHARM BULL, V31, P1651, DOI 10.1248/bpb.31.1651; Ghosh A, 2007, J BIOCHEM MOL BIOL, V40, P1039; Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Ghosh M, 2012, FREE RADICAL RES, V46, P116, DOI 10.3109/10715762.2011.644240; GOYER RA, 1993, ENVIRON HEALTH PERSP, V100, P177, DOI 10.2307/3431524; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guha S, 1996, CHEMOTHERAPY, V42, P443, DOI 10.1159/000239478; Gurer H., 2000, FREE RADIC BIOL MED, V299, P27; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Keeble JA, 2007, CELL RES, V17, P976, DOI 10.1038/cr.2007.101; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Leiro J, 2004, INT IMMUNOPHARMACOL, V4, P763, DOI 10.1016/j.intimp.2004.03.002; Madesh M, 1997, INDIAN J BIOCHEM BIO, V34, P535; Makare N, 2001, J ETHNOPHARMACOL, V78, P133, DOI 10.1016/S0378-8741(01)00326-9; Manna P, 2011, EVID-BASED COMPL ALT, DOI [10.1155/2010/neq065, DOI 10.1155/2010/NEQ065]; Manna P, 2008, REDOX REP, V13, P67, DOI 10.1179/135100008X259169; Manna P, 2007, J BIOCHEM MOL BIOL, V40, P382; Manna Prasenjit, 2006, BMC Complement Altern Med, V6, P33, DOI 10.1186/1472-6882-6-33; Manna P, 2010, FREE RADICAL BIO MED, V48, P1465, DOI 10.1016/j.freeradbiomed.2010.02.025; Manna P, 2009, TOXICOLOGY, V257, P53, DOI 10.1016/j.tox.2008.12.008; MARCOCCI L, 1994, BIOCHEM BIOPH RES CO, V201, P748, DOI 10.1006/bbrc.1994.1764; Martinez G, 2000, PHYTOTHER RES, V14, P424, DOI 10.1002/1099-1573(200009)14:6&lt;424::AID-PTR643&gt;3.0.CO;2-8; Mingatto FE, 2002, J PHARMACOL EXP THER, V303, P601, DOI 10.1124/jpet.102.038620; Mishra B, 2006, RADIAT PHYS CHEM, V75, P70, DOI 10.1016/j.radphyschem.2005.05.015; Muruganandan S, 2002, TOXICOLOGY, V176, P165, DOI 10.1016/S0300-483X(02)00069-0; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Pagliara P, 2003, COMP HEPATOL, V2, P1; Pal Pabitra Bikash, 2012, Pathophysiology, V19, P101, DOI 10.1016/j.pathophys.2012.02.001; Patil Arun J., 2006, Journal of Basic and Clinical Physiology and Pharmacology, V17, P213; Patra RC, 2001, TOXICOLOGY, V162, P81, DOI 10.1016/S0300-483X(01)00345-6; Ramesh GT, 1999, TOXICOL APPL PHARM, V155, P280, DOI 10.1006/taap.1999.8624; Ramesh GT, 2001, TOXICOL LETT, V123, P195, DOI 10.1016/S0378-4274(01)00395-2; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Sairam K, 2003, J ETHNOPHARMACOL, V84, P11, DOI 10.1016/S0378-8741(02)00250-7; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanchez GM, 2000, PHARMACOL RES, V42, P565, DOI 10.1006/phrs.2000.0727; Sarkar K, 2005, HEPATOL RES, V33, P39, DOI 10.1016/j.hepres.2005.06.007; Sarkar K, 2007, TOXICOL MECH METHOD, V17, P305, DOI 10.1080/15376510601031919; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Sarkar Kasturi, 2011, Pathophysiology, V18, P295, DOI 10.1016/j.pathophys.2011.05.001; Sarkar K, 2006, PROTEIN J, V25, P411, DOI 10.1007/s10930-006-9030-7; Sarkar MK, 2010, TOXICOL IN VITRO, V24, P1711, DOI 10.1016/j.tiv.2010.05.014; Sarkar Mrinal K, 2007, Pathophysiology, V14, P113, DOI 10.1016/j.pathophys.2007.08.001; Sarkar MK, 2009, FOOD CHEM, V114, P1405, DOI 10.1016/j.foodchem.2008.11.022; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Sharma V., 2011, TOXICOL INT, V17, P12; Sharma V., 2011, INT J PHARM SCI REV, V7, P116; Sinha M, 2008, J BIOCHEM MOL TOXIC, V22, P15, DOI 10.1002/jbt.20209; Sinha M, 2007, ARCH TOXICOL, V81, P397, DOI 10.1007/s00204-007-0176-7; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Yedjou Clement G, 2007, Int J Environ Res Public Health, V4, P132, DOI 10.3390/ijerph2007040007; Yoshimi N, 2001, CANCER LETT, V163, P163, DOI 10.1016/S0304-3835(00)00678-9	85	69	74	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56894	10.1371/journal.pone.0056894	http://dx.doi.org/10.1371/journal.pone.0056894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451106	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500041
J	Wood, JR; Wilmshurst, JM; Rawlence, NJ; Bonner, KI; Worthy, TH; Kinsella, JM; Cooper, A				Wood, Jamie R.; Wilmshurst, Janet M.; Rawlence, Nicolas J.; Bonner, Karen I.; Worthy, Trevor H.; Kinsella, John M.; Cooper, Alan			A Megafauna's Microfauna: Gastrointestinal Parasites of New Zealand's Extinct Moa (Aves: Dinornithiformes)	PLOS ONE			English	Article							ANCIENT DNA; PALEOPARASITOLOGICAL ANALYSIS; GROUND SLOTH; N-G; COPROLITES; DIET; PLANT; NEMATODA; MIOCENE; REMAINS	We perform the first multidisciplinary study of parasites from an extinct megafaunal clade using coprolites from the New Zealand moa (Aves: Dinornithiformes). Ancient DNA and microscopic analyses of 84 coprolites deposited by four moa species (South Island giant moa, Dinornis robustus; little bush moa, Anomalopteryx didiformis; heavy-footed moa, Pachyornis elephantopus; and upland moa, Megalapteryx didinus) reveal an array of gastrointestinal parasites including coccidians (Cryptosporidium and members of the suborder Eimeriorina), nematodes (Heterakoidea, Trichostrongylidae, Trichinellidae) and a trematode (Echinostomida). Parasite eggs were most prevalent and diverse in coprolites from lowland sites, where multiple sympatric moa species occurred and host density was therefore probably higher. Morphological and phylogenetic evidence supports a possible vicariant Gondwanan origin for some of the moa parasites. The discovery of apparently host-specific parasite taxa suggests paleoparasitological studies of megafauna coprolites may provide useful case-studies of coextinction.	[Wood, Jamie R.; Wilmshurst, Janet M.; Bonner, Karen I.] Landcare Res, Canterbury, New Zealand; [Rawlence, Nicolas J.; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Worthy, Trevor H.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Kinsella, John M.] HelmWest Lab, Missoula, MT USA	Landcare Research - New Zealand; University of Adelaide; University of New South Wales Sydney	Wood, JR (corresponding author), Landcare Res, Canterbury, New Zealand.	woodj@landcareresearch.co.nz	Cooper, Alan/E-8171-2012; Wood, Jamie/A-9393-2008; Wilmshurst, Janet M/C-2209-2009; Worthy, Trevor/B-3781-2012; Wilmshurst, Janet/O-8611-2019; Wood, Jamie/AAU-5530-2021	Cooper, Alan/0000-0002-7738-7851; Wood, Jamie/0000-0001-8008-6083; Wilmshurst, Janet M/0000-0002-4474-8569; Worthy, Trevor/0000-0001-7047-4680; Wilmshurst, Janet/0000-0002-4474-8569; 	Royal Society of New Zealand Marsden Fund [08-LCR-012]	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was funded by the Royal Society of New Zealand Marsden Fund (08-LCR-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret O, 1999, HOLOCENE, V9, P175, DOI 10.1191/095968399666631581; Allentoft ME, 2012, ANN ANAT, V194, P36, DOI 10.1016/j.aanat.2011.04.002; Araujo A, 2003, MEM I OSWALDO CRUZ, V98, P5, DOI 10.1590/S0074-02762003000900003; ARAUJO AJG, 1982, J PARASITOL, V68, P511, DOI 10.2307/3280974; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Barton DP, 2005, KEYS TREMATODA, V2; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P47, DOI 10.1590/S0074-02762003000900009; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; BUSH AO, 1994, INT J PARASITOL, V24, P1333, DOI 10.1016/0020-7519(94)90199-6; Clayton DH, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P310; Cooper A, 2000, SCIENCE, V289, P1139; Craig Thomas M., 1996, P115; DAVIS O K, 1984, Carnegie Museum of Natural History Special Publication, P267; Dickison MJ, 2007, THESIS DUKE U US; Dunn Robert R., 2009, P167; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; FERREIRA LF, 1993, J PARASITOL, V79, P440, DOI 10.2307/3283583; Fleming C.A., 1975, BIOGEOGRAPHY ECOLOGY, V27, P1; Fugassa MH, 2007, J PARASITOL, V93, P421, DOI 10.1645/GE-989R.1; Fugassa MH, 2006, J PARASITOL, V92, P1110, DOI 10.1645/GE-876R1.1; Gibbs G., 2006, GHOSTS GONDWANA HIST; Gill B.J., 2010, CHECKLIST BIRDS NZ N, V4th edition; Gordo FP, 2002, VET PARASITOL, V107, P137; Holmstad PR, 2005, OIKOS, V111, P377, DOI 10.1111/j.0030-1299.2005.13640.x; Fugassa MH, 2010, J ARCHAEOL SCI, V37, P880, DOI 10.1016/j.jas.2009.11.018; Horrocks M, 2004, EMU, V104, P149, DOI 10.1071/MU03019; Horrocks M, 2008, REV PALAEOBOT PALYNO, V149, P229, DOI 10.1016/j.revpalbo.2007.12.009; INGLIS WG, 1990, SYST PARASITOL, V15, P75, DOI 10.1007/BF00009919; INGLIS WG, 1991, SYST PARASITOL, V20, P89, DOI 10.1007/BF00007385; Iniguez AM, 2003, MEM I OSWALDO CRUZ, V98, P67, DOI 10.1590/S0074-02762003000900013; James HF, 1997, BIOL J LINN SOC, V62, P279, DOI 10.1111/j.1095-8312.1997.tb01627.x; Jones MEH, 2009, P ROY SOC B-BIOL SCI, V276, P1385, DOI 10.1098/rspb.2008.1785; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Kropf M, 2007, QUATERNARY RES, V67, P143, DOI 10.1016/j.yqres.2006.10.002; Le Bailly M, 2003, J PARASITOL, V89, P1073, DOI 10.1645/GE-3202RN; Loreille O, 2001, INT J PARASITOL, V31, P1101, DOI 10.1016/S0020-7519(01)00214-4; Marshall BA, 2011, MOLLUSCAN RES, V31, P47; McKenna P., 2010, WEBMED CENTRAL PARAS, V1, pWMC00705; Mitchell D, 2005, MUTAT RES-FUND MOL M, V571, P265, DOI 10.1016/j.mrfmmm.2004.06.060; Moore P.D., 1991, BLACKWELL SCI PUBLI; Morley NJ, 2008, AQUAT SCI, V70, P107, DOI 10.1007/s00027-007-7052-7; Poinar G, 2006, PARASITOLOGY, V133, P245, DOI 10.1017/S0031182006000138; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Reinhard KJ, 1998, MUMMIES DIS ANCIENT, P377; Ryan U, 2010, EXP PARASITOL, V124, P113, DOI 10.1016/j.exppara.2009.02.002; Sardella NH, 2009, J PARASITOL, V95, P646, DOI 10.1645/GE-1809.1; SCHMIDT GD, 1992, J PARASITOL, V78, P811, DOI 10.2307/3283310; Sianto L, 2005, J PARASITOL, V91, P972, DOI 10.1645/GE-3445RN.1; Waters JM, 2006, SYST BIOL, V55, P351, DOI 10.1080/10635150600681659; WATVE MG, 1995, P NATL ACAD SCI USA, V92, P8945, DOI 10.1073/pnas.92.19.8945; Williams PJ, 2005, NATION, V281, P13; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Wood JR, 2011, NEW ZEAL J GEOL GEOP, V54, P431, DOI 10.1080/00288306.2011.590212; Wood JR, 2012, CONSERV BIOL, V26, P1091, DOI 10.1111/j.1523-1739.2012.01931.x; Wood JR, 2012, NEW ZEAL J ECOL, V36, P164; Wood JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040025; Wood JR, 2008, QUATERNARY SCI REV, V27, P2593, DOI 10.1016/j.quascirev.2008.09.019; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; Worthy TH, 2010, J VERTEBR PALEONTOL, V30, P479, DOI 10.1080/02724631003618033; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578	60	56	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57315	10.1371/journal.pone.0057315	http://dx.doi.org/10.1371/journal.pone.0057315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451203	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500088
J	Caughlin, TT; Ruktanonchai, N; Acevedo, MA; Lopiano, KK; Prosper, O; Eagle, N; Tatem, AJ				Caughlin, T. Trevor; Ruktanonchai, Nick; Acevedo, Miguel A.; Lopiano, Kenneth K.; Prosper, Olivia; Eagle, Nathan; Tatem, Andrew J.			Place-Based Attributes Predict Community Membership in a Mobile Phone Communication Network	PLOS ONE			English	Article							MODULARITY; SPREAD	Social networks can be organized into communities of closely connected nodes, a property known as modularity. Because diseases, information, and behaviors spread faster within communities than between communities, understanding modularity has broad implications for public policy, epidemiology and the social sciences. Explanations for community formation in social networks often incorporate the attributes of individual people, such as gender, ethnicity or shared activities. High modularity is also a property of large-scale social networks, where each node represents a population of individuals at a location, such as call flow between mobile phone towers. However, whether or not place-based attributes, including land cover and economic activity, can predict community membership for network nodes in large-scale networks remains unknown. We describe the pattern of modularity in a mobile phone communication network in the Dominican Republic, and use a linear discriminant analysis (LDA) to determine whether geographic context can explain community membership. Our results demonstrate that place-based attributes, including sugar cane production, urbanization, distance to the nearest airport, and wealth, correctly predicted community membership for over 70% of mobile phone towers. We observed a strongly positive correlation (r = 0.97) between the modularity score and the predictive ability of the LDA, suggesting that place-based attributes can accurately represent the processes driving modularity. In the absence of social network data, the methods we present can be used to predict community membership over large scales using solely place-based attributes.	[Caughlin, T. Trevor; Ruktanonchai, Nick] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Acevedo, Miguel A.] Univ Florida, Sch Nat Resources & Conservat, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Lopiano, Kenneth K.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Prosper, Olivia] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Eagle, Nathan] MIT, Media Lab, Cambridge, MA 02139 USA; [Eagle, Nathan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Massachusetts Institute of Technology (MIT); The Santa Fe Institute; State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Caughlin, TT (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	trevor.caughlin@gmail.com		Tatem, Andrew/0000-0002-7270-941X; Caughlin, T. Trevor/0000-0001-6752-2055; Prosper, Olivia/0000-0002-8042-0616	National Science Foundation at the University of Florida [0801544]; Bill and Melinda Gates Foundation [49446, OPP1032350]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	National Science Foundation at the University of Florida; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	TTC, NR, MAA, KL, and OP were supported by the National Science Foundation (http://www.nsf.gov/) under grant 0801544 at the University of Florida. AJT is supported by grants from the Bill and Melinda Gates Foundation (www.gatesfoundation.org/) under grants 49446 and OPP1032350). AJT also acknowledges funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security (www.dhs.gov), and the Fogarty International Center, National Institutes of Health (http://www.fic.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 2004, SCIENCE, V305, P1915, DOI 10.1126/science.1103179; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; CIESIN, 2004, GLOB RUR URB MAPP PR; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; FELD SL, 1981, AM J SOCIOL, V86, P1015, DOI 10.1086/227352; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Good BH, 2009, ARXIV09100165; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Lomi A, 2012, SOC NETWORKS, V34, P101, DOI 10.1016/j.socnet.2010.10.005; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Padilla Mark, 2007, CARIBBEAN PLEASURE I; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Rutstein S. O., 2004, DHS WEALTH INDEX; Schaefer DR, 2012, SOC NETWORKS, V34, P141, DOI 10.1016/j.socnet.2011.02.001; Schrank A, 2005, COMP POLIT, V38, P43, DOI 10.2307/20072912; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; The Nature Conservancy, 2012, CONS INF SYST; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; Yuan Y, 2011, COMPUTERS ENV URBAN	31	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56057	10.1371/journal.pone.0056057	http://dx.doi.org/10.1371/journal.pone.0056057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451034	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000316658800006
J	Emery, VJ; Tsutsui, ND				Emery, Virginia J.; Tsutsui, Neil D.			Recognition in a Social Symbiosis: Chemical Phenotypes and Nestmate Recognition Behaviors of Neotropical Parabiotic Ants	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; INTERSPECIFIC RECOGNITION; HYMENOPTERA-FORMICIDAE; ARGENTINE ANT; DISCRIMINATION; PARASITISM; COMPONENT; MIMICRY; GARDENS; ODORS	Social organisms rank among the most abundant and ecologically dominant species on Earth, in part due to exclusive recognition systems that allow cooperators to be distinguished from exploiters. Exploiters, such as social parasites, manipulate their hosts' recognition systems, whereas cooperators are expected to minimize interference with their partner's recognition abilities. Despite our wealth of knowledge about recognition in single-species social nests, less is known of the recognition systems in multi-species nests, particularly involving cooperators. One uncommon type of nesting symbiosis, called parabiosis, involves two species of ants sharing a nest and foraging trails in ostensible cooperation. Here, we investigated recognition cues (cuticular hydrocarbons) and recognition behaviors in the parabiotic mixed-species ant nests of Camponotus femoratus and Crematogaster levior in North-Eastern Amazonia. We found two sympatric, cryptic Cr. levior chemotypes in the population, with one type in each parabiotic colony. Although they share a nest, very few hydrocarbons were shared between Ca. femoratus and either Cr. levior chemotype. The Ca. femoratus hydrocarbons were also unusually long-chained branched alkenes and dienes, compounds not commonly found amongst ants. Despite minimal overlap in hydrocarbon profile, there was evidence of potential interspecific nestmate recognition =Cr. levior ants were more aggressive toward Ca. femoratus non-nestmates than Ca. femoratus nestmates. In contrast to the prediction that sharing a nest could weaken conspecific recognition, each parabiotic species also maintains its own aggressive recognition behaviors to exclude conspecific non-nestmates. This suggests that, despite cohabitation, parabiotic ants maintain their own species-specific colony odors and recognition mechanisms. It is possible that such social symbioses are enabled by the two species each using their own separate recognition cues, and that interspecific nestmate recognition may enable this multi-species cooperative nesting.	[Emery, Virginia J.; Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Emery, VJ (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	vj.emery@berkeley.edu	Emery, Vincent/G-8928-2013	Emery, Vincent/0000-0001-5893-9756	American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Society for Integrative and Comparative Biology Fellowship for Graduate Student Travel; Margaret C. Walker Fund for Teaching and Research in Systematic Entomology; Johannes Joos Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)	American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Society for Integrative and Comparative Biology Fellowship for Graduate Student Travel; Margaret C. Walker Fund for Teaching and Research in Systematic Entomology; Johannes Joos Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award, the Society for Integrative and Comparative Biology Fellowship for Graduate Student Travel, the Margaret C. Walker Fund for Teaching and Research in Systematic Entomology, the Johannes Joos Fund, and a Post-Graduate Fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) to VJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding URLs: http://www.aaas.org/, http://www.sicb.org/, http://www.nserc-crsng.gc.ca/.	Achenbach A, 2010, BEHAV ECOL, V21, P948, DOI 10.1093/beheco/arq008; BAGNERES AG, 1991, J CHEM ECOL, V17, P1641, DOI 10.1007/BF00984695; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Blumstein DT, 2004, P ROY SOC B-BIOL SCI, V271, P1851, DOI 10.1098/rspb.2004.2808; Bos N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00083; Bos N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019435; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; BREED MD, 1983, ANIM BEHAV, V31, P86, DOI 10.1016/S0003-3472(83)80176-6; BREED MD, 1985, P NATL ACAD SCI USA, V82, P3058, DOI 10.1073/pnas.82.9.3058; BUCKLE GR, 1981, ANIM BEHAV, V29, P802, DOI 10.1016/S0003-3472(81)80014-0; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; CARLIN NF, 1983, SCIENCE, V222, P1027, DOI 10.1126/science.222.4627.1027; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; ERRARD C, 1992, ANIM BEHAV, V43, P787, DOI 10.1016/S0003-3472(05)80201-5; Errard C, 2008, INSECT SOC, V55, P115, DOI 10.1007/s00040-008-0979-4; Errard C, 2006, BEHAV ECOL SOCIOBIOL, V59, P353, DOI 10.1007/s00265-005-0058-z; Errard C, 2003, INSECT SOC, V50, P268, DOI 10.1007/s00040-003-0677-1; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; ESPELIE KE, 1988, BIOCHEM SYST ECOL, V16, P505, DOI 10.1016/0305-1978(88)90053-1; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Huang MH, 2008, ECOL ENTOMOL, V33, P589, DOI 10.1111/j.1365-2311.2008.01005.x; Johnson BR, 2011, BEHAV ECOL SOCIOBIOL, V65, P935, DOI 10.1007/s00265-010-1094-x; Katritzky AR, 2000, ANAL CHEM, V72, P101, DOI 10.1021/ac990800w; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Lenoir A, 1997, BIOCHEM SYST ECOL, V25, P379, DOI 10.1016/S0305-1978(97)00025-2; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Liebert AE, 2004, ANN ZOOL FENN, V41, P747; Longino J. T., 2007, TAXONOMIC REV GENUS; Longino John T., 2003, Zootaxa, V151, P1; Magrath RD, 2009, BEHAV ECOL, V20, P745, DOI 10.1093/beheco/arp055; Mann William M., 1912, Psyche Boston, V19, DOI 10.1155/1912/68363; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Menzel F, 2010, J ANIM ECOL, V79, P71, DOI 10.1111/j.1365-2656.2009.01628.x; Menzel F, 2009, INSECT SOC, V56, P251, DOI 10.1007/s00040-009-0018-0; Menzel F, 2011, EVOLUTION, V66, P869; Menzel F, 2008, ANIM BEHAV, V75, P837, DOI 10.1016/j.anbehav.2007.07.005; Menzel F, 2010, ECOL ENTOMOL, V35, P711, DOI 10.1111/j.1365-2311.2010.01231.x; Menzel F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-16; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Orivel J, 2011, MYRMECOL NEWS, V14, P73; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Sledge MF, 2001, P ROY SOC B-BIOL SCI, V268, P2253, DOI 10.1098/rspb.2001.1799; Sturgis SJ, 2012, MYRMECOL NEWS, V16, P101; SWAIN RB, 1980, INSECT SOC, V27, P377, DOI 10.1007/BF02223730; Team RCD, 2012, R LANG ENV STAT COMP; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; van Wilgenburg E, 2012, BIOL LETTERS, V8, P17, DOI 10.1098/rsbl.2011.0643; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806; Vantaux A, 2007, INSECT SOC, V54, P95, DOI 10.1007/s00040-007-0914-0; VIENNE C, 1995, INSECT SOC, V42, P267, DOI 10.1007/BF01240421; von Beeren C, 2012, J CHEM ECOL, V38, P262, DOI 10.1007/s10886-012-0083-0; Weber NA, 1943, ECOLOGY, V24, P400, DOI 10.2307/1930541; Weddle CB, 2012, J EVOLUTION BIOL, V25, P2112, DOI 10.1111/j.1420-9101.2012.02593.x; Wheeler WM, 1921, ECOLOGY, V2, P89, DOI 10.2307/1928921; Yeo K, 2006, INSECT SOC, V53, P435, DOI 10.1007/s00040-005-0890-9; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105	60	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56492	10.1371/journal.pone.0056492	http://dx.doi.org/10.1371/journal.pone.0056492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451053	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800016
J	Pastar, I; Nusbaum, AG; Gil, J; Patel, SB; Chen, J; Valdes, J; Stojadinovic, O; Plano, LR; Tomic-Canic, M; Davis, SC				Pastar, Irena; Nusbaum, Aron G.; Gil, Joel; Patel, Shailee B.; Chen, Juan; Valdes, Jose; Stojadinovic, Olivera; Plano, Lisa R.; Tomic-Canic, Marjana; Davis, Stephen C.			Interactions of Methicillin Resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in Polymicrobial Wound Infection	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SOFT-TISSUE INFECTIONS; IN-VIVO; BACTERIAL DIVERSITY; PRESSURE ULCERS; MOUSE MODEL; VIRULENCE; BIOFILMS; SKIN; COLONIZATION	Understanding the pathology resulting from Staphylococcus aureus and Pseudomonas aeruginosa polymicrobial wound infections is of great importance due to their ubiquitous nature, increasing prevalence, growing resistance to antimicrobial agents, and ability to delay healing. Methicillin-resistant S. aureus USA300 is the leading cause of community-associated bacterial infections resulting in increased morbidity and mortality. We utilized a well-established porcine partial thickness wound healing model to study the synergistic effects of USA300 and P. aeruginosa on wound healing. Wound re-epithelialization was significantly delayed by mixed-species biofilms through suppression of keratinocyte growth factor 1. Pseudomonas showed an inhibitory effect on USA300 growth in vitro while both species co-existed in cutaneous wounds in vivo. Polymicrobial wound infection in the presence of P. aeruginosa resulted in induced expression of USA300 virulence factors Panton-Valentine leukocidin and alpha-hemolysin. These results provide evidence for the interaction of bacterial species within mixed-species biofilms in vivo and for the first time, the contribution of virulence factors to the severity of polymicrobial wound infections.	[Pastar, Irena; Nusbaum, Aron G.; Gil, Joel; Patel, Shailee B.; Valdes, Jose; Stojadinovic, Olivera; Plano, Lisa R.; Tomic-Canic, Marjana; Davis, Stephen C.] Univ Miami, Miller Sch Med, Wound Healing & Regenerat Med Res Program, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Chen, Juan; Plano, Lisa R.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Plano, Lisa R.] Univ Miami, Miller Sch Med, Dept Immunol & Microbiol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Davis, SC (corresponding author), Univ Miami, Miller Sch Med, Wound Healing & Regenerat Med Res Program, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	sdavis@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198				Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Biswas L, 2009, APPL ENVIRON MICROB, V75, P6910, DOI 10.1128/AEM.01211-09; Black CE, 2010, SURG CLIN N AM, V90, P1147, DOI 10.1016/j.suc.2010.08.009; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Co EM, 2011, MIL MED, V176, P89; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Davis SC, 2001, DERMATOL SURG, V27, P783, DOI 10.1046/j.1524-4725.2001.00322.x; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Ebright JR, 2005, NURS CLIN N AM, V40, P207, DOI 10.1016/j.cnur.2004.09.003; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fadeev S. B., 2009, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P114; Fazli M, 2011, WOUND REPAIR REGEN, V19, P387, DOI 10.1111/j.1524-475X.2011.00681.x; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Frank DN, 2009, WOUND REPAIR REGEN, V17, P163, DOI 10.1111/j.1524-475X.2009.00472.x; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gomez R, 2009, J AM COLL SURGEONS, V208, P348, DOI 10.1016/j.jamcollsurg.2008.11.012; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Heggers John P., 1992, Journal of Burn Care and Rehabilitation, V13, P512, DOI 10.1097/00004630-199209000-00003; Hongo I, 2009, J INFECT DIS, V200, P715, DOI 10.1086/605332; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Keen EF, 2010, BURNS, V36, P461, DOI 10.1016/j.burns.2009.10.012; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lipinska U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022864; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Madsen SM, 1996, APMIS, V104, P895, DOI 10.1111/j.1699-0463.1996.tb04955.x; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Martin JM, 2010, J INVEST DERMATOL, V130, P38, DOI 10.1038/jid.2009.221; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Nakagami G, 2011, WOUND REPAIR REGEN, V19, P214, DOI 10.1111/j.1524-475X.2010.00653.x; Nusbaum AG, 2012, J SURG RES, V176, P701, DOI 10.1016/j.jss.2011.11.1040; O'Hara FP, 2012, MICROB DRUG RESIST; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Pastar Irena, 2008, Surg Technol Int, V17, P105; Pechter PM, 2012, WOUND REPAIR REGEN, V20, P236, DOI 10.1111/j.1524-475X.2012.00768.x; PFALLER MA, 1989, DIAGN MICR INFEC DIS, V12, P1, DOI 10.1016/0732-8893(89)90035-7; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Roghmann MC, 2001, J HOSP INFECT, V47, P98, DOI 10.1053/jhin.2000.0903; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Schierle CF, 2009, WOUND REPAIR REGEN, V17, P354, DOI 10.1111/j.1524-475X.2009.00489.x; Seth AK, 2012, J AM COLL SURG; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; Soong G, 2012, J INFECT DIS, V205, P1571, DOI 10.1093/infdis/jis244; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682; Yang L, 2011, FEMS IMMUNOL MED MIC, V62, P339, DOI 10.1111/j.1574-695X.2011.00820.x; Zhao G, 2012, WOUND REPAIR REGEN, V20, P342, DOI 10.1111/j.1524-475X.2012.00793.x; Zhao G, 2010, WOUND REPAIR REGEN, V18, P467, DOI 10.1111/j.1524-475X.2010.00608.x	72	205	217	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56846	10.1371/journal.pone.0056846	http://dx.doi.org/10.1371/journal.pone.0056846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451098	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800043
J	Rostila, M; Saarela, J; Kawachi, I				Rostila, Mikael; Saarela, Jan; Kawachi, Ichiro			Fatal Stroke after the Death of a Sibling: A Nationwide Follow-Up Study from Sweden	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK-FACTORS; MORTALITY; BEREAVEMENT; STRESS; PARENTS; CHILD; MEN	Background: Although less studied than other types of familial losses, the loss of a sibling could be a potential trigger of stroke as it represents a stressful life event. We studied the association between loss of a sibling and fatal stroke up to 18 years since bereavement. Methodology/Principal Findings: We conducted a follow-up study between 1981 and 2002, based on register data covering the total population of Swedes aged 40-69 years (n = 1,617,010). An increased risk of fatal stroke (1.31 CI: 1.05, 1.62) was found among women who had experienced the loss of a sibling. No increase in the overall mortality risk was found in men (1.11 CI: 0.92, 1.33). An elevated risk in the short term (during the second and third half-year after the death) was found among both men and women, whereas longer-term elevation in risk was found primarily for women. Both external (1.47 CI: 1.00, 2.17) and not external (1.26 CI: 1.00, 1.60) causes of sibling death showed associations among women. In men, an association was found only if the sibling also died from stroke (1.78 CI: 1.00, 3.17). However, among women, we found an increased risk of stroke mortality if the sibling died from causes other than stroke (1.30 CI: 1.04, 1.62). Conclusions/Significance: The findings suggest an increased risk of dying from stroke mortality after the death of a sibling, and that bereavement affects particularly women. It is important for health care workers to follow bereaved siblings and recognize potential changes of stress-levels and health related behaviours that could lead to risk of stroke.	[Rostila, Mikael] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden; [Saarela, Jan] Abo Akad Univ, Vaasa, Finland; [Saarela, Jan] Univ Helsinki, Vaasa, Finland; [Saarela, Jan] Abo Akad Univ, Helsinki, Finland; [Saarela, Jan] Univ Helsinki, Helsinki, Finland; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Karolinska Institutet; Stockholm University; Abo Akademi University; University of Helsinki; Abo Akademi University; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health	Rostila, M (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden.	mikael.rostila@chess.su.se			Swedish Council for Working Life and Social Research [2009-0547]; Swedish Research Council [421-2011-1649]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Council for Working Life and Social Research (grant number 2009-0547) and the Swedish Research Council (grant number 421-2011-1649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALK D, 1983, J YOUTH ADOLESCENCE, V12, P137, DOI 10.1007/BF02088310; BOWLING A, 1987, SOC SCI MED, V24, P117, DOI 10.1016/0277-9536(87)90244-9; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Engstrom G, 2004, CEREBROVASC DIS, V18, P318, DOI 10.1159/000080770; Guiraud V, 2010, STROKE, V41, P2669, DOI 10.1161/STROKEAHA.110.597443; HARMSEN P, 1990, STROKE, V21, P223, DOI 10.1161/01.STR.21.2.223; Hendrickson Karrie Cummings, 2009, Palliat Support Care, V7, P109, DOI 10.1017/S1478951509000133; Hogan N., 1996, CONTINUING BONDS NEW, P235; Kammersgaard LP, 2006, CEREBROVASC DIS, V21, P187, DOI 10.1159/000090531; Kasiman K, 2012, CIRC-CARDIOVASC GENE, V5, P226, DOI 10.1161/CIRCGENETICS.111.962241; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Li J, 2003, NEUROEPIDEMIOLOGY, V22, P211, DOI 10.1159/000069898; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Milberg A, 2008, J PAIN SYMPTOM MANAG, V35, P58, DOI 10.1016/j.jpainsymman.2007.02.039; Movahed MR, 2007, CARDIOVASC REVASCULA, V8, P289, DOI 10.1016/j.carrev.2007.02.001; Nakamura K, 2012, CEREBROVASC DIS, V33, P480, DOI 10.1159/000336764; Oki I, 2006, CEREBROVASC DIS, V22, P409, DOI 10.1159/000094860; REED MD, 1991, SUICIDE LIFE-THREAT, V21, P385; Robinson L, 1997, DEATH STUD, V21, P477; Rostila M., 2007, HLTH INEQUALITIES WE, P157; Rostila M, 2012, AM J EPIDEMIOL, V176, P338, DOI 10.1093/aje/kws163; Rostila M, 2011, J MARRIAGE FAM, V73, P236, DOI 10.1111/j.1741-3737.2010.00801.x; SEGAL NL, 1995, PERS INDIV DIFFER, V18, P511, DOI 10.1016/0191-8869(94)00174-Q; STROEBE MS, 1994, J COMMUNITY APPL SOC, V4, P47, DOI 10.1002/casp.2450040110; Truelsen T, 2003, STROKE, V34, P856, DOI 10.1161/01.STR.0000062345.80774.40; Tsutsumi A, 2009, ARCH INTERN MED, V169, P56, DOI 10.1001/archinternmed.2008.503; Umberson D, 1996, AM SOCIOL REV, V61, P837, DOI 10.2307/2096456; Valdimarsdottir U, 2003, SCAND J PUBLIC HEALT, V31, P31, DOI 10.1080/14034940210165109; Wittstein Ilan S, 2007, Cleve Clin J Med, V74 Suppl 1, pS17; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	32	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56994	10.1371/journal.pone.0056994	http://dx.doi.org/10.1371/journal.pone.0056994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451131	Green Published, gold			2022-12-27	WOS:000316658800061
J	Weber, S; Fernandez-Cachon, ML; Nascimento, JM; Knauer, S; Offermann, B; Murphy, RF; Boerries, M; Busch, H				Weber, Sebastian; Fernandez-Cachon, Maria L.; Nascimento, Juliana M.; Knauer, Steffen; Offermann, Barbara; Murphy, Robert F.; Boerries, Melanie; Busch, Hauke			Label-Free Detection of Neuronal Differentiation in Cell Populations Using High-Throughput Live-Cell Imaging of PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; ERK; FATE; SEQUENCES; CULTURE; MODELS	Detection of neuronal cell differentiation is essential to study cell fate decisions under various stimuli and/or environmental conditions. Many tools exist that quantify differentiation by neurite length measurements of single cells. However, quantification of differentiation in whole cell populations remains elusive so far. Because such populations can consist of both proliferating and differentiating cells, the task to assess the overall differentiation status is not trivial and requires a high-throughput, fully automated approach to analyze sufficient data for a statistically significant discrimination to determine cell differentiation. We address the problem of detecting differentiation in a mixed population of proliferating and differentiating cells over time by supervised classification. Using nerve growth factor induced differentiation of PC12 cells, we monitor the changes in cell morphology over 6 days by phase-contrast live-cell imaging. For general applicability, the classification procedure starts out with many features to identify those that maximize discrimination of differentiated and undifferentiated cells and to eliminate features sensitive to systematic measurement artifacts. The resulting image analysis determines the optimal post treatment day for training and achieves a near perfect classification of differentiation, which we confirmed in technically and biologically independent as well as differently designed experiments. Our approach allows to monitor neuronal cell populations repeatedly over days without any interference. It requires only an initial calibration and training step and is thereafter capable to discriminate further experiments. In conclusion, this enables long-term, large-scale studies of cell populations with minimized costs and efforts for detecting effects of external manipulation of neuronal cell differentiation.	[Weber, Sebastian; Fernandez-Cachon, Maria L.; Nascimento, Juliana M.; Knauer, Steffen; Murphy, Robert F.; Boerries, Melanie; Busch, Hauke] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Weber, Sebastian; Fernandez-Cachon, Maria L.; Nascimento, Juliana M.; Knauer, Steffen; Offermann, Barbara; Murphy, Robert F.; Boerries, Melanie; Busch, Hauke] Univ Freiburg, Ctr Biol Syst Anal, D-79106 Freiburg, Germany; [Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	University of Freiburg; University of Freiburg; Carnegie Mellon University; Carnegie Mellon University	Boerries, M (corresponding author), Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Hugstetter Str 55, D-79106 Freiburg, Germany.	melanie.boerries@frias.uni-freiburg.de; hauke.busch@frias.uni-freiburg.de	Boerries, Melanie/AAM-2602-2021; Nascimento, Juliana M/B-8764-2009; Busch, Hauke/R-6452-2016	Nascimento, Juliana M/0000-0003-3126-4984; Busch, Hauke/0000-0003-4763-4521	Excellence Initiative of the German Federal and State Governments (FRIAS LIFENET); German Federal Ministry of Education and Research (Gerontosys I) [0315896A]; Alexander von Humboldt Research Foundation	Excellence Initiative of the German Federal and State Governments (FRIAS LIFENET); German Federal Ministry of Education and Research (Gerontosys I); Alexander von Humboldt Research Foundation(Alexander von Humboldt Foundation)	This study was supported by the Excellence Initiative of the German Federal and State Governments (FRIAS LIFENET to HB, MB, MF, JN, RFM) and by the German Federal Ministry of Education and Research (Gerontosys I, 0315896A, to SW and MB). RFM was supported by a Research Award from the Alexander von Humboldt Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi O, 2006, IEEE T BIO-MED ENG, V53, P1109, DOI 10.1109/TBME.2006.873565; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06; BREUSCH TS, 1978, AUST ECON PAP, V17, P334, DOI 10.1111/j.1467-8454.1978.tb00635.x; Chen JY, 2012, MOL CELL, V45, P196, DOI 10.1016/j.molcel.2011.11.023; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; Dehmelt L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-100; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Fanti Z, 2011, DEV NEUROBIOL, V71; Frimat JP, 2010, LAB CHIP, V10, P701, DOI 10.1039/b922193j; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUPTA M, 1987, BRAIN RES BULL, V18, P555, DOI 10.1016/0361-9230(87)90119-5; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Keenan TM, 2006, J NEUROSCI METH, V151, P232, DOI 10.1016/j.jneumeth.2005.07.010; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Narro ML, 2007, BRAIN RES, V1138, P57, DOI 10.1016/j.brainres.2006.10.094; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114; Ramm P, 2003, J BIOMOL SCREEN, V8, P7, DOI 10.1177/1087057102239779; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wei N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-449; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Wu CH, 2010, NEUROINFORMATICS, V8, P83, DOI 10.1007/s12021-010-9067-9; Yeyeodu Susan T, 2010, Curr Chem Genomics, V4, P74, DOI 10.2174/1875397301004010074	33	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56690	10.1371/journal.pone.0056690	http://dx.doi.org/10.1371/journal.pone.0056690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451069	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800026
J	Zhang, Y; Han, YL; Dong, L; Yu, HF; Cheng, L; Zhao, XX; Ding, MJ				Zhang, Yan; Han, Yuling; Dong, Liang; Yu, Huafeng; Cheng, Lu; Zhao, Xiuxia; Ding, Mingjie			Genetic Variation of ITGB3 Is Associated with Asthma in Chinese Han Children	PLOS ONE			English	Article							ALLERGIES; EXPOSURE	Previous studies have demonstrated that integrins are involved in the aetiology of asthma. Several single-nucleotide polymorphisms (SNPs) in the integrin beta 3 (ITGB3) gene are significantly associated with asthma in Western populations. Given the important roles of environmental exposures in the development of asthma, we evaluated the associations between six SNPs in ITGB3 and asthma in Chinese Han children. A total of 321 unrelated Chinese children with asthma and 315 healthy children were recruited for the study. SNP genotyping was performed by high-resolution melting analysis (HRM). The selected SNPs were well genotyped by HRM, and SNP rs3809865 in the 3' untranslated region (3'UTR) of ITGB3 was found to be strongly associated with asthma (adjusted p = 0.004). The minor allele of rs3809865 showed a protective effect against asthma (OR: 0.59; 95% CI: 0.43-0.8). The seed regions of two miRNAs (hsa-mir-124 and hsa-mir-506) were predicted to bind to the sequence containing rs3809865 by TargetScan and PITA. Luciferase reporter assays demonstrated that the T allele of rs3809865 was more efficiently targeted by hsa-mir-124 than was the A allele, which suggested that rs3809865 could affect the binding of hsa-mir-124 to ITGB3. Furthermore, the transfection of A549 cells with hsa-mir-124 resulted in the downregulation of ITGB3 expression. Our results revealed that rs3809865 was significantly associated with asthma due to its effect on the binding of hsa-mir-124 to ITGB3.	[Zhang, Yan; Han, Yuling; Yu, Huafeng; Cheng, Lu; Zhao, Xiuxia; Ding, Mingjie] Shandong Univ, QiLu Childrens Hosp, Dept Resp Med, Jinan 250100, Shandong, Peoples R China; [Han, Yuling; Dong, Liang] Shandong Univ, Dept Resp Med, QiLu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Han, YL (corresponding author), Shandong Univ, QiLu Childrens Hosp, Dept Resp Med, Jinan 250100, Shandong, Peoples R China.	evelyn.han@163.com; ding.mj@126.com		Dong, Liang/0000-0001-7707-9982	project of tackle key problems in science and technology of Shandong province [2006GG2202030]	project of tackle key problems in science and technology of Shandong province	This work was supported by the project of tackle key problems in science and technology of Shandong province (No. 2006GG2202030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Custovic A, 2012, EXPERT REV RESP MED, V6, P301, DOI [10.1586/ERS.12.24, 10.1586/ers.12.24]; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032060; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Rogers Angela J, 2009, Am J Respir Crit Care Med, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Shi F, 2012, MOL CELL BIOCHEM, V361, P111, DOI 10.1007/s11010-011-1095-8; Simpson A, 2005, CURR ALLERGY ASTHM R, V5, P212, DOI 10.1007/s11882-005-0040-x; Subspecialty Group of Respiratory Diseases Society of Pediatrics, 2008, Zhonghua Er Ke Za Zhi, V46, P745; Thompson EE, 2007, J ALLERGY CLIN IMMUN, V119, P1423, DOI 10.1016/j.jaci.2007.03.029; Torres-Borrego J, 2012, ALLERGOL IMMUNOPATH, V40, P244, DOI 10.1016/j.aller.2011.12.006; Weiss LA, 2005, AM J RESP CRIT CARE, V172, P67, DOI 10.1164/rccm.200411-1555OC	12	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56914	10.1371/journal.pone.0056914	http://dx.doi.org/10.1371/journal.pone.0056914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451109	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800047
J	Knight, EJ; Min, HK; Hwang, SC; Marsh, MP; Paek, S; Kim, I; Felmlee, JP; Abulseoud, OA; Bennet, KE; Frye, MA; Lee, KH				Knight, Emily J.; Min, Hoon-Ki; Hwang, Sun-Chul; Marsh, Michael P.; Paek, Seungleal; Kim, Inyong; Felmlee, Joel P.; Abulseoud, Osama A.; Bennet, Kevin E.; Frye, Mark A.; Lee, Kendall H.			Nucleus Accumbens Deep Brain Stimulation Results in Insula and Prefrontal Activation: A Large Animal fMRI Study	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; GLUCOSE METABOLIC-RATES; CEREBRAL-BLOOD-FLOW; CAPSULAR STIMULATION; SYMPTOM PROVOCATION; FUNCTIONAL MRI; BASAL GANGLIA; NEGATIVE BOLD; LONG-TERM; DEPRESSION	Background: Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) has previously been investigated clinically for the treatment of several psychiatric conditions, including obsessive-compulsive disorder and treatment resistant depression. However, the mechanism underlying the therapeutic benefit of DBS, including the brain areas that are activated, remains largely unknown. Here, we utilized 3.0 T functional Magnetic Resonance Imaging (fMRI) changes in Blood Oxygenation Level-Dependent (BOLD) signal to test the hypothesis that NAc/internal capsule DBS results in global neural network activation in a large animal (porcine) model Methods: Animals (n = 10) were implanted in the NAc/internal capsule with DBS electrodes and received stimulation (1, 3, and 5 V, 130 Hz, and pulse widths of 100 and 500 mu sec). BOLD signal changes were evaluated using a gradient echo-echo planar imaging (GRE-EPI) sequence in 3.0 T MRI. We used a normalized functional activation map for group analysis and applied general linear modeling across subjects (FDR<0.001). The anatomical location of the implanted DBS lead was confirmed with a CT scan Results: We observed stimulation-evoked activation in the ipsilateral prefrontal cortex, insula, cingulate and bilateral parahippocampal region along with decrease in BOLD signal in the ipsilateral dorsal region of the thalamus. Furthermore, as the stimulation voltage increased from 3 V to 5 V, the region of BOLD signal modulation increased in insula, thalamus, and parahippocampal cortex and decreased in the cingulate and prefrontal cortex. We also demonstrated that right and left NAc/internal capsule stimulation modulates identical areas ipsilateral to the side of the stimulation Conclusions: Our results suggest that NAc/internal capsule DBS results in modulation of psychiatrically important brain areas notably the prefrontal cortex, cingulate, and insular cortex, which may underlie the therapeutic effect of NAc DBS in psychiatric disorders. Finally, our fMRI setup in the large animal may be a useful platform for translational studies investigating the global neuromodulatory effects of DBS	[Knight, Emily J.; Min, Hoon-Ki; Hwang, Sun-Chul; Marsh, Michael P.; Paek, Seungleal; Kim, Inyong; Lee, Kendall H.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Hwang, Sun-Chul] Soonchunhyang Univ, Busheon Hosp, Dept Neurosurg, Puchon, South Korea; [Felmlee, Joel P.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Abulseoud, Osama A.; Frye, Mark A.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Bennet, Kevin E.] Mayo Clin, Div Engn, Rochester, MN USA; [Lee, Kendall H.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Soonchunhyang University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Lee, KH (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.	lee.kendall@mayo.edu	Min, Hoon-Ki/A-6025-2018	Min, Hoon-Ki/0000-0002-1084-2469; Knight, Emily/0000-0002-6971-1148	National Institutes of Health [K08 NS 52232, R01 NS 70872]; Oxley Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070872, K08NS052232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxley Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (K08 NS 52232 and R01 NS 70872 awards to KHL) and the Oxley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Angenstein F, 2010, NEUROIMAGE, V50, P1364, DOI 10.1016/j.neuroimage.2010.01.070; Angenstein F, 2009, J NEUROSCI, V29, P2428, DOI 10.1523/JNEUROSCI.5015-08.2009; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Babiloni C, 2009, INT REV NEUROBIOL, V86, P67, DOI 10.1016/S0074-7742(09)86005-4; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; BENKELFAT C, 1990, ARCH GEN PSYCHIAT, V47, P840; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Brooks JO, 2009, AM J GERIAT PSYCHIAT, V17, P1022, DOI 10.1097/JGP.0b013e3181ad4d47; CALDWELL AE, 1967, DIS NERV SYST, V28, P816; Carmichael DW, 2007, NEUROIMAGE, V37, P508, DOI 10.1016/j.neuroimage.2007.04.058; Craig AD, 2011, BRAIN, V134, DOI 10.1093/brain/awq308; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2011, BRAIN J NEUROLOGY, V134, pe165; Craig AD, 2011, BRAIN, V133, P2528; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Franzini A, 2010, NEUROL SCI, V31, P353, DOI 10.1007/s10072-009-0214-8; Georgi JC, 2004, MAGNET RESON MED, V51, P380, DOI 10.1002/mrm.10699; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Greenberg BD, 2010, NEUROPSYCHOPHARMACOL, V35, P317, DOI 10.1038/npp.2009.128; Grubert C, 2011, WORLD J BIOL PSYCHIA, V12, P516, DOI 10.3109/15622975.2011.583940; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Heimer L, 2003, AM J PSYCHIAT, V160, P1726, DOI 10.1176/appi.ajp.160.10.1726; Henderson MB, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.4.FOCUS10105; Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; Jin T, 2008, NEUROIMAGE, V43, P1, DOI 10.1016/j.neuroimage.2008.06.029; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Knapp CM, 2009, PHARMACOL BIOCHEM BE, V92, P474, DOI 10.1016/j.pbb.2009.01.017; Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004; Kuhn J, 2009, BMJ CASE REPORTS, V2009; Kuhn J, 2007, J NEUROL, V254, P963, DOI 10.1007/s00415-006-0404-8; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lippitz BE, 1999, NEUROSURGERY, V44, P452, DOI 10.1097/00006123-199903000-00005; Liu HY, 2008, ADDICT BIOL, V13, P40, DOI 10.1111/j.1369-1600.2007.00088.x; Lujan JL, 2011, HUMAN BRAIN MAPPING; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Min HHSC, 2012, NEUROIMAGE IN PRESS; Miocinovic S, 2007, J NEUROSCI METH, V162, P32, DOI 10.1016/j.jneumeth.2006.12.007; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; Mundt A, 2009, EUR J NEUROSCI, V29, P2401, DOI 10.1111/j.1460-9568.2009.06777.x; Neuner Irene, 2009, Biol Psychiatry, V65, pe5, DOI 10.1016/j.biopsych.2008.09.030; Nuttin BJ, 2003, NEUROSURGERY, V52, P1263, DOI 10.1227/01.NEU.0000064565.49299.9A; Rauch SL, 2006, J NEUROSURG, V104, P558, DOI 10.3171/jns.2006.104.4.558; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Servello D, 2010, NEUROMODULATION, V13, P187, DOI 10.1111/j.1525-1403.2009.00253.x; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shon YM, 2010, NEUROSCI LETT, V475, P136, DOI 10.1016/j.neulet.2010.03.060; Teneback CC, 1999, J NEUROPSYCH CLIN N, V11, P426; van Eijsden P, 2009, NEUROIMAGE, V45, P1047, DOI 10.1016/j.neuroimage.2008.08.026; Van Gompel JJ, 2011, EPILEPSIA, V52, pE49, DOI 10.1111/j.1528-1167.2011.03096.x; Van Laere K, 2006, J NUCL MED, V47, P740; Vassoler FM, 2008, J NEUROSCI, V28, P8735, DOI 10.1523/JNEUROSCI.5277-07.2008; Wakeman DR, 2006, REGEN MED, V1, P405, DOI 10.2217/17460751.1.4.405; Zabek M, 2008, NEUROL NEUROCHIR POL, V42, P554	71	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56640	10.1371/journal.pone.0056640	http://dx.doi.org/10.1371/journal.pone.0056640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441210	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200067
J	Sakabe, T; Tsuchiya, H; Kanki, K; Azumi, J; Gonda, K; Mizuta, Y; Yamada, D; Wada, H; Shomori, K; Nagano, H; Shiota, G				Sakabe, Tomohiko; Tsuchiya, Hiroyuki; Kanki, Keita; Azumi, Junya; Gonda, Kazue; Mizuta, Yusuke; Yamada, Daisaku; Wada, Hiroshi; Shomori, Kohei; Nagano, Hiroaki; Shiota, Goshi			Identification of the Genes Chemosensitizing Hepatocellular Carcinoma Cells to Interferon-alpha/5-Fluorouracil and Their Clinical Significance	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; 5-FLUOROURACIL INDUCES APOPTOSIS; SUBCUTANEOUS INTERFERON-ALPHA; COMBINATION THERAPY; INTRAARTERIAL 5-FLUOROURACIL; UP-REGULATION; EXPRESSION; RECEPTOR; PATHWAY	The incidence of advanced hepatocellular carcinoma (HCC) is increasing worldwide, and its prognosis is extremely poor. Interferon-alpha (IFN-alpha)/5-fluorouracil (5-FU) therapy is reportedly effective in some HCC patients. In the present study, to improve HCC prognosis, we identified the genes that are sensitizing to these agents. The screening strategy was dependent on the concentration of ribozymes that rendered HepG2 cells resistant to 5-FU by the repeated transfection of ribozymes into the cells. After 10 cycles of transfection, which was initiated by 5,902,875 sequences of a ribozyme library, three genes including protein kinase, adenosine monophosphate (AMP)-activated, gamma 2 non-catalytic subunit (PRKAG2); transforming growth factor-beta receptor II (TGFBR2); and exostosin 1 (EXT1) were identified as 5-FU-sensitizing genes. Adenovirus-mediated transfer of TGFBR2 and EXT1 enhanced IFN-alpha/5-FU-induced cytotoxicity as well as 5-FU, although the overexpression of these genes in the absence of IFN-alpha/5-FU did not induce cell death. This effect was also observed in a tumor xenograft model. The mechanisms of TGFBR2 and EXT1 include activation of the TGF-beta signal and induction of endoplasmic reticulum stress, resulting in apoptosis. In HCC patients treated with IFN-alpha/5-FU therapy, the PRKAG2 mRNA level in HCC tissues was positively correlated with survival period, suggesting that PRKAG2 enhances the effect of IFN-alpha/5-FU and serves as a prognostic marker for IFN-alpha/5-FU therapy. In conclusion, we identified three genes that chemosensitize the effects of 5-FU and IFN-alpha/5-FU on HCC cells and demonstrated that PRKAG2 mRNA can serve as a prognostic marker for IFN-alpha/5-FU therapy.	[Sakabe, Tomohiko; Kanki, Keita; Azumi, Junya; Gonda, Kazue; Mizuta, Yusuke; Shiota, Goshi] Tottori Univ, Div Mol & Genet Med, Grad Sch Med, Dept Genet Med & Regenerat Therapeut, Yonago, Tottori, Japan; [Tsuchiya, Hiroyuki] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 607, Japan; [Yamada, Daisaku; Wada, Hiroshi; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan; [Shomori, Kohei] Tottori Univ, Fac Med, Dept Pathol & Microbiol, Yonago, Tottori 683, Japan	Tottori University; Kyoto Pharmaceutical University; Osaka University; Tottori University	Shiota, G (corresponding author), Tottori Univ, Div Mol & Genet Med, Grad Sch Med, Dept Genet Med & Regenerat Therapeut, Yonago, Tottori, Japan.	gshiota@med.tottori-u.ac.jp			Japan Society for the Promotion of Science; Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by a Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science and by Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini P, 2012, LAB INVEST, V92, P1297, DOI 10.1038/labinvest.2012.94; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Buenemann CL, 2001, CARCINOGENESIS, V22, P447, DOI 10.1093/carcin/22.3.447; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Damdinsuren B, 2007, HEPATOL RES, V37, P77, DOI 10.1111/j.1872-034X.2007.00007.x; Eguchi H, 2000, CLIN CANCER RES, V6, P2881; Hagiwara S, 2011, J GASTROENTEROL, V46, P212, DOI 10.1007/s00535-010-0294-5; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V332, P433, DOI 10.1016/j.bbrc.2005.04.143; Ishii K, 2008, HEPATOLOGY, V48, P597, DOI 10.1002/hep.22362; Kondo M, 2005, CLIN CANCER RES, V11, P1277; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Lee YY, 2010, BIOCHEM BIOPH RES CO, V397, P735, DOI 10.1016/j.bbrc.2010.06.022; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liao JH, 2001, CELL RES, V11, P89, DOI 10.1038/sj.cr.7290072; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Malo A, 2010, AM J PHYSIOL-GASTR L, V299, pG877, DOI 10.1152/ajpgi.00423.2009; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; Musch A, 2005, DIGESTION, V71, P78, DOI 10.1159/000084523; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Obi S, 2006, CANCER-AM CANCER SOC, V106, P1990, DOI 10.1002/cncr.21832; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Ota H, 2005, BRIT J CANCER, V93, P557, DOI 10.1038/sj.bjc.6602742; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patt YZ, 2003, J CLIN ONCOL, V21, P421, DOI 10.1200/JCO.2003.10.103; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ray S, 2003, J GASTROEN HEPATOL, V18, P393, DOI 10.1046/j.1440-1746.2003.02985.x; Raynal S, 1997, INT J CANCER, V72, P356, DOI 10.1002/(SICI)1097-0215(19970717)72:2<356::AID-IJC26>3.3.CO;2-J; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Ropero S, 2004, HUM MOL GENET, V13, P2753, DOI 10.1093/hmg/ddh298; Sakon M, 2002, CANCER, V94, P435, DOI 10.1002/cncr.10246; Sun CK, 2011, NEOPLASIA, V13, P735, DOI 10.1593/neo.11664; Teramoto T, 1998, BIOCHEM BIOPH RES CO, V251, P56, DOI 10.1006/bbrc.1998.9411; Tobin SW, 2001, CELL GROWTH DIFFER, V12, P109; Uka K, 2007, J GASTROENTEROL, V42, P845, DOI 10.1007/s00535-007-2099-8; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Verfaillie Tom, 2010, Int J Cell Biol, V2010, P930509, DOI 10.1155/2010/930509; Wada H, 2007, ONCOL REP, V18, P801; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Watanabe Y, 2008, BIOCHEM BIOPH RES CO, V366, P840, DOI 10.1016/j.bbrc.2007.12.028; William WN, 2012, ANN ONCOL, V23, P78, DOI 10.1093/annonc/mdr036; World Health Organisation, 1979, HDB REP RES CANC TRE; Yau T, 2009, CANCER-AM CANCER SOC, V115, P428, DOI 10.1002/cncr.24029; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yin HP, 2011, CANCER LETT, V306, P34, DOI 10.1016/j.canlet.2011.02.017; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033	53	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56197	10.1371/journal.pone.0056197	http://dx.doi.org/10.1371/journal.pone.0056197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457527	Green Published, Green Submitted, gold			2022-12-27	WOS:000315603700026
J	Soto-Liebe, K; Lopez-Cortes, XA; Fuentes-Valdes, JJ; Stucken, K; Gonzalez-Nilo, F; Vasquez, M				Soto-Liebe, Katia; Lopez-Cortes, Xaviera A.; Jose Fuentes-Valdes, Juan; Stucken, Karina; Gonzalez-Nilo, Fernando; Vasquez, Monica			In Silico Analysis of Putative Paralytic Shellfish Poisoning Toxins Export Proteins in Cyanobacteria	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIUM; SAXITOXIN; STRAINS; NITROGEN; SODIUM; GROWTH; IDENTIFICATION; OPTIMIZATION; HOMOLOGY	Paralytic shellfish poisoning toxins (PSTs) are a family of more than 30 natural alkaloids synthesized by dinoflagellates and cyanobacteria whose toxicity in animals is mediated by voltage-gated Na+ channel blocking. The export of PST analogues may be through SxtF and SxtM, two putative MATE (multidrug and toxic compound extrusion) family transporters encoded in PSTs biosynthetic gene cluster (sxt). sxtM is present in every sxt cluster analyzed; however, sxtF is only present in the Cylindrospermopsis-Raphidiopsis clade. These transporters are energetically coupled with an electrochemical gradient of proton (H+) or sodium (Na+) ions across membranes. Because the functional role of PSTs remains unknown and methods for genetic manipulation in PST-producing organisms have not yet been developed, protein structure analyses will allow us to understand their function. By analyzing the sxt cluster of eight PST-producing cyanobacteria, we found no correlation between the presence of sxtF or sxtM and a specific PSTs profile. Phylogenetic analyses of SxtF/M showed a high conservation of SxtF in the Cylindrospermopsis-Raphidiopsis clade, suggesting conserved substrate affinity. Two domains involved in Na+ and drug recognition from NorM proteins (MATE family) of Vibrio parahaemolyticus and V. cholerae are present in SxtF/M. The Na+ recognition domain was conserved in both SxtF/M, indicating that Na+ can maintain the role as a cation anti-transporter. Consensus motifs for toxin binding differed between SxtF and SxtM implying differential substrate binding. Through protein modeling and docking analysis, we found that there is no marked affinity between the recognition domain and a specific PST analogue. This agrees with our previous results of PST export in R. brookii D9, where we observed that the response to Na+ incubation was similar to different analogues. These results reassert the hypothesis regarding the involvement of Na+ in toxin export, as well as the motifs L(398)XGLQD(403) (SxtM) and L(390)VGLRD(395) (SxtF) in toxin recognition.	[Soto-Liebe, Katia; Jose Fuentes-Valdes, Juan; Vasquez, Monica] Pontificia Univ Catolica Chile, Santiago, Chile; [Lopez-Cortes, Xaviera A.] Univ Talca, Nanobiotechnol Div, Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Talca, Chile; [Stucken, Karina] Univ Dusseldorf, Inst Mol Evolut Heinrich Heine, D-40225 Dusseldorf, Germany; [Gonzalez-Nilo, Fernando] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Talca; Heinrich Heine University Dusseldorf; Universidad Andres Bello	Vasquez, M (corresponding author), Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile.	mvasquez@bio.puc.cl	González Nilo, Fernando Danilo/M-5368-2017; lopez, xaviera/R-1027-2019; González-Nilo, Fernando/M-5671-2016; Stucken, Karina/AAI-8343-2021	González Nilo, Fernando Danilo/0000-0001-6857-3575; González-Nilo, Fernando/0000-0001-6857-3575; Stucken, Karina/0000-0002-2783-4342; lopez cortes, xaviera/0000-0002-7514-8777	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1050433, 1080075]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The first author KSL is a Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) PhD fellow. This work was financed and supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1050433 and 1080075. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; ANDZELM J, 1992, J CHEM PHYS, V96, P1280, DOI 10.1063/1.462165; APTE SK, 1986, EUR J BIOCHEM, V154, P395, DOI 10.1111/j.1432-1033.1986.tb09411.x; Bernard C, 2003, ENVIRON TOXICOL, V18, P176, DOI 10.1002/tox.10112; Carmichael WW, 1997, APPL ENVIRON MICROB, V63, P3104, DOI 10.1128/AEM.63.8.3104-3110.1997; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Cembella AD, 2003, PHYCOLOGIA, V42, P420, DOI 10.2216/i0031-8884-42-4-420.1; Christiansen G, 2008, MOL BIOL EVOL, V25, P1695, DOI 10.1093/molbev/msn120; Cusick KD, 2012, ENVIRON SCI TECHNOL, V46, P2959, DOI 10.1021/es204027m; Dauber-Osguthorpe P, 1998, PROTEINS, V4, P31; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gugger M, 2005, APPL ENVIRON MICROB, V71, P1097, DOI 10.1128/AEM.71.2.1097-1100.2005; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Jiang YG, 2012, APPL ENVIRON MICROB, V78, P2256, DOI 10.1128/AEM.07321-11; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; KRATZ WA, 1955, AM J BOT, V42, P282, DOI 10.2307/2438564; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Livshits VA, 2003, RES MICROBIOL, V154, P123, DOI 10.1016/S0923-2508(03)00036-6; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Llewellyn LE, 2001, ENVIRON SCI TECHNOL, V35, P1445, DOI 10.1021/es001575z; MAHMOOD NA, 1986, TOXICON, V24, P175, DOI 10.1016/0041-0101(86)90120-0; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; NARAHASHI T, 1967, SCIENCE, V157, P1441, DOI 10.1126/science.157.3795.1441; Neilan BA, 2008, ADV EXP MED BIOL, V619, P417; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Onodera Hideyuki, 1997, Natural Toxins, V5, P146; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Singh AK, 2006, ANTIMICROB AGENTS CH, V50, P3717, DOI 10.1128/AAC.00460-06; Soto-Liebe K, 2012, TOXICON, V60, P1324, DOI 10.1016/j.toxicon.2012.09.001; Soto-Liebe K, 2010, TOXICON, V56, P1350, DOI 10.1016/j.toxicon.2010.07.022; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Su Z, 2004, J PHARMACOL EXP THER, V308, P324, DOI 10.1124/jpet.103.056564; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; Wang JX, 2003, J GEN PHYSIOL, V121, P583, DOI 10.1085/jgp.200308812; Wilson K, 1990, CURRENT PROTOCOLS MO, P241	48	10	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55664	10.1371/journal.pone.0055664	http://dx.doi.org/10.1371/journal.pone.0055664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457475	Green Published, gold			2022-12-27	WOS:000315603700016
J	Halder, S; Hammer, EM; Kleih, SC; Bogdan, M; Rosenstiel, W; Birbaumer, N; Kubler, A				Halder, Sebastian; Hammer, Eva Maria; Kleih, Sonja Claudia; Bogdan, Martin; Rosenstiel, Wolfgang; Birbaumer, Niels; Kuebler, Andrea			Prediction of Auditory and Visual P300 Brain-Computer Interface Aptitude	PLOS ONE			English	Article							SPELLING SYSTEM; POTENTIALS; PARADIGM; ERP; COMMUNICATION; PERFORMANCE; COMPONENT; ERROR; P3A	Objective: Brain-computer interfaces (BCIs) provide a non-muscular communication channel for patients with late-stage motoneuron disease (e.g., amyotrophic lateral sclerosis (ALS)) or otherwise motor impaired people and are also used for motor rehabilitation in chronic stroke. Differences in the ability to use a BCI vary from person to person and from session to session. A reliable predictor of aptitude would allow for the selection of suitable BCI paradigms. For this reason, we investigated whether P300 BCI aptitude could be predicted from a short experiment with a standard auditory oddball. Methods: Forty healthy participants performed an electroencephalography (EEG) based visual and auditory P300-BCI spelling task in a single session. In addition, prior to each session an auditory oddball was presented. Features extracted from the auditory oddball were analyzed with respect to predictive power for BCI aptitude. Results: Correlation between auditory oddball response and P300 BCI accuracy revealed a strong relationship between accuracy and N2 amplitude and the amplitude of a late ERP component between 400 and 600 ms. Interestingly, the P3 amplitude of the auditory oddball response was not correlated with accuracy. Conclusions: Event-related potentials recorded during a standard auditory oddball session moderately predict aptitude in an audiory and highly in a visual P300 BCI. The predictor will allow for faster paradigm selection. Significance: Our method will reduce strain on patients because unsuccessful training may be avoided, provided the results can be generalized to the patient population.	[Halder, Sebastian; Hammer, Eva Maria; Kleih, Sonja Claudia; Kuebler, Andrea] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany; [Halder, Sebastian; Birbaumer, Niels; Kuebler, Andrea] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Halder, Sebastian; Bogdan, Martin; Rosenstiel, Wolfgang] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Tubingen, Germany; [Birbaumer, Niels] Ist Ricovero & Cura Carattere Sci, Osped San Camillo, Venice, Italy; [Bogdan, Martin] Univ Leipzig, D-04109 Leipzig, Germany	University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Leipzig University	Halder, S (corresponding author), Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany.	sebastian.halder@uni-wuerzburg.de	Halder, Sebastian/J-6144-2019; Halder, Sebastian/G-3745-2012; Kleih-Dahms, Sonja/AAA-6650-2022	Halder, Sebastian/0000-0003-1017-3696; Kubler, Andrea/0000-0003-4876-0415; Birbaumer, Niels/0000-0002-6786-5127	Deutsche Forschungsgemeinschaft (DFG) [KU 1453/3-1, BI 195/58-1]; European ICT Programme [FP7-224631, SFB 550/B5, SFB 550/C6]; BMBF (Bundesministerium fur Bildung und Forschung) Bernstein Center for Neurocomputation [01GQ0831]; European Research Council Grant [ERC 227632-BCCI]; European Community's, Seventh Framework Programme FP7, BackHome project [288566]; German Reasearch Foundation (DFG); University of Wurzburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European ICT Programme; BMBF (Bundesministerium fur Bildung und Forschung) Bernstein Center for Neurocomputation(Federal Ministry of Education & Research (BMBF)); European Research Council Grant(European Research Council (ERC)); European Community's, Seventh Framework Programme FP7, BackHome project; German Reasearch Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	Funded by Deutsche Forschungsgemeinschaft (DFG) KU 1453/3-1 and BI 195/58-1. This work is supported by the European ICT Programme Project FP7-224631, SFB 550/B5 and C6, BMBF (Bundesministerium fur Bildung und Forschung) Bernstein Center for Neurocomputation (Nr 01GQ0831) and the European Research Council Grant (ERC 227632-BCCI). The research leading to these results has also received funding from the European Community's, Seventh Framework Programme FP7/2007-2013, BackHome project grant agreement number 288566. This publication was funded by the German Reasearch Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Averbuch-Heller L, 1998, ANN NEUROL, V44, P641, DOI 10.1002/ana.410440410; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cichocki A, 2005, CLIN NEUROPHYSIOL, V116, P729, DOI 10.1016/j.clinph.2004.09.017; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2007, P ANN INT IEEE EMBS, P2516, DOI 10.1109/IEMBS.2007.4352840; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Halder Sebastian, 2007, Comput Intell Neurosci, P82069, DOI 10.1155/2007/82069; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Hill N, 2004, ADV NEURAL INFORM PR, V17; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Iturrate I, 2009, IEEE INT C ROB AUT; JACOBS L, 1981, NEUROLOGY, V31, P1282, DOI 10.1212/WNL.31.10.1282; Kathner I, 2013, CLIN NEUROPHYSIOL, V124, P327, DOI 10.1016/j.clinph.2012.08.006; Katayama J, 1999, CLIN NEUROPHYSIOL, V110, P463, DOI 10.1016/S1388-2457(98)00035-2; Kaufmann T, 2011, P 5 INT BRAIN COMP I, P136; Kaufmann T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00072; Kaufmann T, 2012, INT J PSYCHOPHYSIOL, V83, P336, DOI 10.1016/j.ijpsycho.2011.11.018; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; Kotchoubey B, 2003, NEUROSCI RES, V45, P369, DOI 10.1016/S0168-0102(02)00250-X; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; Kotchoubey B, 2000, EXP AGING RES, V26, P15, DOI 10.1080/036107300243669; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 2005, PROG BRAIN RES, V150, P513, DOI 10.1016/S0079-6123(05)50035-9; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Kubler A, 2009, ANN NY ACAD SCI, V1157, P90, DOI 10.1111/j.1749-6632.2008.04122.x; LANG T, 1991, IEEE T CIRCUITS SYST, V38, P499, DOI 10.1109/31.76486; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; MCCALLUM WC, 1981, ELECTROEN CLIN NEURO, V51, P123, DOI 10.1016/0013-4694(81)90001-8; Munssinger JI, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00182; Mugler EM, 2010, IEEE T NEUR SYS REH, V18, P599, DOI 10.1109/TNSRE.2010.2068059; Naatanen R, 1986, Electroencephalogr Clin Neurophysiol Suppl, V38, P169; Naatanen R, 1983, ADV PSYCHOL, P119, DOI DOI 10.1016/S0166-4115(08)62036-1; Neshige Ryuji, 2006, Suppl Clin Neurophysiol, V59, P35; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Nykopp T., 2001, THESIS HELSINKI U TE; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Pichiorri F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025020; Pierce J.R., 1980, INTRO INFORM THEORY; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RITTER W, 1979, SCIENCE, V203, P1358, DOI 10.1126/science.424760; Robles L., 2007, SENSES COMPREHENSIVE, P413; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Schlogl A, 2007, BRAIN COMPUTER INTER, P373; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Silvoni S, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.20.001.2009; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; Spuler M, 2012, CLIN NEUROPHYSIOL, V123, P1328, DOI 10.1016/j.clinph.2011.11.082; SQUIRES NK, 1977, J EXP PSYCHOL HUMAN, V3, P299, DOI 10.1037/0096-1523.3.2.299; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Vieregge P, 1999, COGNITIVE BRAIN RES, V8, P27, DOI 10.1016/S0926-6410(99)00004-X; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409	71	44	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e53513	10.1371/journal.pone.0053513	http://dx.doi.org/10.1371/journal.pone.0053513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457444	Green Published, gold			2022-12-27	WOS:000315602700003
J	Akl, EA; Johnston, BC; Alonso-Coello, P; Neumann, I; Ebrahim, S; Briel, M; Cook, DJ; Guyatt, GH				Akl, Elie A.; Johnston, Bradley C.; Alonso-Coello, Pablo; Neumann, Ignacio; Ebrahim, Shanil; Briel, Matthias; Cook, Deborah J.; Guyatt, Gordon H.			Addressing Dichotomous Data for Participants Excluded from Trial Analysis: A Guide for Systematic Reviewers	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; FOLLOW-UP INFORMATION; CLINICAL-TRIALS; LOST-IT; INTENTION; OUTCOMES; IMPACT; TREAT	Introduction: Systematic reviewer authors intending to include all randomized participants in their meta-analyses need to make assumptions about the outcomes of participants with missing data. Objective: The objective of this paper is to provide systematic reviewer authors with a relatively simple guidance for addressing dichotomous data for participants excluded from analyses of randomized trials. Methods: This guide is based on a review of the Cochrane handbook and published methodological research. The guide deals with participants excluded from the analysis who were considered 'non-adherent to the protocol' but for whom data are available, and participants with missing data. Results: Systematic reviewer authors should include data from 'non-adherent' participants excluded from the primary study authors' analysis but for whom data are available. For missing, unavailable participant data, authors may conduct a complete case analysis (excluding those with missing data) as the primary analysis. Alternatively, they may conduct a primary analysis that makes plausible assumptions about the outcomes of participants with missing data. When the primary analysis suggests important benefit, sensitivity meta-analyses using relatively extreme assumptions that may vary in plausibility can inform the extent to which risk of bias impacts the confidence in the results of the primary analysis. The more plausible assumptions draw on the outcome event rates within the trial or in all trials included in the meta-analysis. The proposed guide does not take into account the uncertainty associated with assumed events. Conclusions: This guide proposes methods for handling participants excluded from analyses of randomized trials. These methods can help in establishing the extent to which risk of bias impacts meta-analysis results.	[Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Akl, Elie A.; Johnston, Bradley C.; Neumann, Ignacio; Ebrahim, Shanil; Briel, Matthias; Cook, Deborah J.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Johnston, Bradley C.] Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON M5G 1X8, Canada; [Johnston, Bradley C.] SickKids Res Inst, Toronto, ON, Canada; [Alonso-Coello, Pablo] CIBERESP IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Cook, Deborah J.; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada	American University of Beirut; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Basel; McMaster University	Akl, EA (corresponding author), Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon.	ea32@aub.edu.lb	Akl, Elie/K-5269-2019; Akl, Elie A/R-2079-2016; Briel, Matthias/AAT-9284-2021; Neumann, Ignacio/ABB-5013-2020	Akl, Elie A/0000-0002-3444-8618; Alonso-Coello, Pablo/0000-0002-8001-8504; Briel, Matthias/0000-0002-2070-5230	Cochrane Collaboration through the Methods Innovation Fund; Canadian Institutes of Health Research Doctoral Award	Cochrane Collaboration through the Methods Innovation Fund; Canadian Institutes of Health Research Doctoral Award(Canadian Institutes of Health Research (CIHR))	The Cochrane Collaboration funded this study through the Methods Innovation Fund. Shanil Ebrahim is supported by a Canadian Institutes of Health Research Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Akl EA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-40; Alshurafa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049163; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2008, CLIN TRIALS, V5, P225, DOI 10.1177/1740774508091600; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Magder LS, 2003, CONTROL CLIN TRIALS, V24, P411, DOI 10.1016/S0197-2456(03)00021-7; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Neumann I, 2012, ANN INTERNAL MED; Riele WWT, 2010, BRIT J SURG, V97, P1535, DOI 10.1002/bjs.7130; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; Vervolgyi E, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-130; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	18	119	119	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57132	10.1371/journal.pone.0057132	http://dx.doi.org/10.1371/journal.pone.0057132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451162	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500067
J	Hollegaard, B; Byars, SG; Lykke, J; Boomsma, JJ				Hollegaard, Birgitte; Byars, Sean G.; Lykke, Jacob; Boomsma, Jacobus J.			Parent-Offspring Conflict and the Persistence of Pregnancy-Induced Hypertension in Modern Humans	PLOS ONE			English	Article							WEIGHT PERCENTILE CURVES; FETAL-GROWTH; IMPRINTING CENTER; GESTATIONAL-AGE; BLOOD-PRESSURE; PREECLAMPSIA; MORTALITY; OUTCOMES; GENES; COMPLICATIONS	Preeclampsia is a major cause of perinatal mortality and disease affecting 5-10% of all pregnancies worldwide, but its etiology remains poorly understood despite considerable research effort. Parent-offspring conflict theory suggests that such hypertensive disorders of pregnancy may have evolved through the ability of fetal genes to increase maternal blood pressure as this enhances general nutrient supply. However, such mechanisms for inducing hypertension in pregnancy would need to incur sufficient offspring health benefits to compensate for the obvious risks for maternal and fetal health towards the end of pregnancy in order to explain why these disorders have not been removed by natural selection in our hunter-gatherer ancestors. We analyzed >750,000 live births in the Danish National Patient Registry and all registered medical diagnoses for up to 30 years after birth. We show that offspring exposed to pregnancy-induced hypertension (PIH) in trimester 1 had significantly reduced overall later-life disease risks, but increased risks when PIH exposure started or developed as preeclampsia in later trimesters. Similar patterns were found for first-year mortality. These results suggest that early PIH leading to improved postpartum survival and health represents a balanced compromise between the reproductive interests of parents and offspring, whereas later onset of PIH may reflect an unbalanced parent-offspring conflict at the detriment of maternal and offspring health.	[Hollegaard, Birgitte; Byars, Sean G.; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [Lykke, Jacob] Roskilde Hosp, Dept Obstet & Gynaecol, Roskilde, Denmark	University of Copenhagen	Boomsma, JJ (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	JJBoomsma@bio.ku.dk	Boomsma, Jacobus J/M-2785-2014	Boomsma, Jacobus J/0000-0002-3598-1609; Byars, Sean/0000-0002-3797-8112; Lykke, Jacob Alexander/0000-0002-3698-9792	Danish National Research Foundation; Marie Curie International Incoming Fellowship [FP7-PEOPLE-2010-IIF-276565]	Danish National Research Foundation(Danmarks Grundforskningsfond); Marie Curie International Incoming Fellowship(European Commission)	The Centre for Social Evolution is funded by the Danish National Research Foundation. S. G. Byars was also supported by a Marie Curie International Incoming Fellowship FP7-PEOPLE-2010-IIF-276565. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2006, CYTOGENET GENOME RES, V113, P262, DOI 10.1159/000090841; Almog B, 2011, PLACENTA, V32, P58, DOI 10.1016/j.placenta.2010.10.008; Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; Bakker R, 2011, AM J EPIDEMIOL, V174, P797, DOI 10.1093/aje/kwr151; Buchbinder A, 2002, AM J OBSTET GYNECOL, V186, P66, DOI 10.1067/mob.2002.120080; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Chen XK, 2007, BJOG-INT J OBSTET GY, V114, P24, DOI 10.1111/j.1471-0528.2006.01177.x; Cruz MO, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.033; Gluckman PD, 2009, PRINCIPLES EVOLUTION, P124; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; Haig D., 2008, EVOLUTION HLTH DIS, P65; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Hibbard JU, 1999, CHESLEYS HYPERTENSIV, pxiv; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Kliman HJ, 2012, REPROD SCI, V19, P16, DOI 10.1177/1933719111424445; Kolliker M, 2001, ANIM BEHAV, V62, P395, DOI 10.1006/anbe.2001.1792; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lykke JA, 2010, PAEDIATR PERINAT EP, V24, P323, DOI 10.1111/j.1365-3016.2010.01120.x; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; NAEYE RL, 1981, AM J OBSTET GYNECOL, V141, P780, DOI 10.1016/0002-9378(81)90704-3; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Oudejans CBM, 2004, MOL HUM REPROD, V10, P589, DOI 10.1093/molehr/gah080; Rabinovitz S, 2012, P NATL ACAD SCI USA, V109, P7403, DOI 10.1073/pnas.1116661109; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Robillard PY, 2002, AM J REPROD IMMUNOL, V47, P104, DOI 10.1034/j.1600-0897.2002.1o043.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; SYMONDS EM, 1980, J ROY SOC MED, V73, P871, DOI 10.1177/014107688007301210; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; TRIVERS RL, 1974, AM ZOOL, V14, P249; Turner JA, 2010, INT J WOMENS HEALTH, V2, P327, DOI 10.2147/IJWH.S8550; von Dadelszen P, 2005, OBSTET GYNECOL, V106, P335, DOI 10.1097/01.AOG.0000171121.31564.14; Wagner LK, 2004, AM FAM PHYSICIAN, V70, P2317; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wu CS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.046; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Xia Y, 2009, CLIN IMMUNOL, V133, P1, DOI 10.1016/j.clim.2009.05.004; Yuan HT, 2005, CURR TOP DEV BIOL, V71, P297, DOI 10.1016/S0070-2153(05)71009-7	47	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56821	10.1371/journal.pone.0056821	http://dx.doi.org/10.1371/journal.pone.0056821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451092	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500032
J	Kadohama, N; Goh, T; Ohnishi, M; Fukaki, H; Mimura, T; Suzuki, Y				Kadohama, Noriaki; Goh, Tatsuaki; Ohnishi, Miwa; Fukaki, Hidehiro; Mimura, Tetsuro; Suzuki, Yoshihiro			Sudden Collapse of Vacuoles in Saintpaulia sp Palisade Cells Induced by a Rapid Temperature Decrease	PLOS ONE			English	Article							CYTOPLASMIC PH REGULATION; CHLOROPHYLL FLUORESCENCE; COLD-ACCLIMATION; PHOTOSYSTEM-II; HEAT-STRESS; LEAF-SPOT; IN-VIVO; PHOTOSYNTHETIC ACTIVITY; REGULATORY NETWORKS; CULTURED-CELLS	It is well known that saintpaulia leaf is damaged by the rapid temperature decrease when cold water is irrigated onto the leaf surface. We investigated this temperature sensitivity and the mechanisms of leaf damage in saintpaulia (Saintpaulia sp. cv. 'Iceberg') and other Gesneriaceae plants. Saintpaulia leaves were damaged and discolored when subjected to a rapid decrease in temperature, but not when the temperature was decreased gradually. Sensitivity to rapid temperature decrease increased within 10 to 20 min during pre-incubation at higher temperature. Injury was restricted to the palisade mesophyll cells, where there was an obvious change in the color of the chloroplasts. During a rapid temperature decrease, chlorophyll fluorescence monitored by a pulse amplitude modulated fluorometer diminished and did not recover even after rewarming to the initial temperature. Isolated chloroplasts were not directly affected by the rapid temperature decrease. Intracellular pH was monitored with a pH-dependent fluorescent dye. In palisade mesophyll cells damaged by rapid temperature decrease, the cytosolic pH decreased and the vacuolar membrane collapsed soon after a temperature decrease. In isolated chloroplasts, chlorophyll fluorescence declined when the pH of the medium was lowered. These results suggest that a rapid temperature decrease directly or indirectly affects the vacuolar membrane, resulting in a pH change in the cytosol that subsequently affects the chloroplasts in palisade mesophyll cells. We further confirmed that the same physiological damage occurs in other Gesneriaceae plants. These results strongly suggested that the vacuoles of palisade mesophyll cells collapsed during the initial phase of leaf injury.	[Kadohama, Noriaki; Goh, Tatsuaki; Ohnishi, Miwa; Fukaki, Hidehiro; Mimura, Tetsuro] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Suzuki, Yoshihiro] Kanagawa Univ, Grad Sch Sci, Dept Biol Sci, Hiratsuka, Kanagawa, Japan; [Ohnishi, Miwa; Fukaki, Hidehiro; Mimura, Tetsuro] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Kobe University; Kanagawa University; Japan Science & Technology Agency (JST)	Mimura, T (corresponding author), Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 657, Japan.	mimura@kobe-u.ac.jp	Goh, Tatsuaki/H-4538-2011		Japanese Ministry of Education, Culture, Sports, Science and Technology [22120006]; CREST of JST (Japan Science and Technology Agency)	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST of JST (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (22120006) by the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm) and CREST of JST (Japan Science and Technology Agency) (http://www.jst.go.jp/kisoken/crest/en/index.html) to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taweel K, 2007, PLANT PHYSIOL, V145, P258, DOI 10.1104/pp.107.101733; ANSARI AQ, 1959, AM J BOT, V46, P713, DOI 10.1002/j.1537-2197.1959.tb07076.x; Baatvik S. T., 1993, Fragmenta Floristica et Geobotanica, P97; Barbagallo RP, 2003, PLANT PHYSIOL, V132, P485, DOI 10.1104/pp.102.018093; BODNER M, 1987, ANGEW BOT, V61, P225; Bohn M, 2007, J PLANT PHYSIOL, V164, P146, DOI 10.1016/j.jplph.2005.12.008; BROWN MS, 1974, PLANT PHYSIOL, V53, P709, DOI 10.1104/pp.53.5.709; Burtt B.L, 1998, DIVERSITY TAXONOMY T, P1; CRIDDLE RS, 1994, PLANT CELL ENVIRON, V17, P233, DOI 10.1111/j.1365-3040.1994.tb00289.x; DANIELL JW, 1969, PLANT PHYSIOL, V44, P1684, DOI 10.1104/pp.44.12.1684; Danon A, 2012, ADV PHOTOSYNTH RESP, V34, P319, DOI 10.1007/978-94-007-1579-0_15; ELLIOTT FH, 1946, P AM SOC HORTIC SCI, V47, P511; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; ESPIE GS, 1981, PLANTA, V153, P210, DOI 10.1007/BF00383889; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fujikawa S, 1999, J PLANT RES, V112, P237, DOI 10.1007/PL00013880; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Good R., 1974, GEOGRAPHY FLOWERING; Grennan AK, 2007, PHOTOSYNTH RES, V94, P375, DOI 10.1007/s11120-007-9169-x; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; HEBER U, 1994, PLANT CELL PHYSIOL, V35, P479; JOHANSSON DR, 1978, BIOL CONSERV, V14, P45, DOI 10.1016/0006-3207(78)90005-8; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; KATSUHARA M, 1989, PLANT PHYSIOL, V90, P1102, DOI 10.1104/pp.90.3.1102; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kawamura Y, 2008, PLANT CELL ENVIRON, V31, P288, DOI 10.1111/j.1365-3040.2007.01762.x; Kim C, 2012, PLANT CELL, V24, P3026, DOI 10.1105/tpc.112.100479; Kitao M, 2000, PHYSIOL PLANTARUM, V109, P284, DOI 10.1034/j.1399-3054.2000.100309.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kratsch HA, 2000, PLANT CELL ENVIRON, V23, P337, DOI 10.1046/j.1365-3040.2000.00560.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kudoh H, 2002, PLANTA, V215, P541, DOI 10.1007/s00425-002-0790-9; LARCHER W, 1989, PLANT PHYSIOL, V89, P740, DOI 10.1104/pp.89.3.740; LILLEY RM, 1975, NEW PHYTOL, V75, P1, DOI 10.1111/j.1469-8137.1975.tb01365.x; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; MADISON M, 1977, Selbyana, V2, P1; MAEKAWA S, 1987, J JPN SOC HORTIC SCI, V55, P484, DOI 10.2503/jjshs.55.484; MELLOR RS, 1964, PLANTA, V61, P56, DOI 10.1007/BF01895390; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; MIYADAI K, 1990, PLANT PHYSIOL, V92, P1215, DOI 10.1104/pp.92.4.1215; Obara K, 2001, PLANT PHYSIOL, V125, P615, DOI 10.1104/pp.125.2.615; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Poesch GH, 1942, P AM SOC HORTIC SCI, V47, P381; ROBERTS JKM, 1984, P NATL ACAD SCI-BIOL, V81, P3379, DOI 10.1073/pnas.81.11.3379; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savchenko G, 2000, PLANTA, V211, P246, DOI 10.1007/s004250000280; SMILLIE RM, 1983, PLANT PHYSIOL, V72, P1043, DOI 10.1104/pp.72.4.1043; Smith JF, 1997, ANN MO BOT GARD, V84, P50, DOI 10.2307/2399953; Stael S, 2012, J EXP BOT, V63, P1525, DOI 10.1093/jxb/err394; Suzuki Y, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P2517; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YL, 2007, PLANT PHYSIOL, V143, P629, DOI 10.1104/pp.106.090712; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; WITHERS LA, 1979, PLANT PHYSIOL, V64, P675, DOI 10.1104/pp.64.5.675; Xu CC, 1999, PHYSIOL PLANTARUM, V107, P447, DOI 10.1034/j.1399-3054.1999.100411.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SJ, 2001, SCI HORTIC-AMSTERDAM, V88, P59, DOI 10.1016/S0304-4238(00)00235-1; Yang XH, 2007, PLANTA, V225, P719, DOI 10.1007/s00425-006-0380-3; Yasuda Y, 1997, ACTA HISTOCHEM CYTOC, V30, P303, DOI 10.1267/ahc.30.303; YOSHIDA S, 1994, PLANT PHYSIOL, V104, P1131, DOI 10.1104/pp.104.4.1131; YOSHIDA S, 1995, PLANT CELL PHYSIOL, V36, P1075, DOI 10.1093/oxfordjournals.pcp.a078850; Yun JaeGill, 2001, Korean Journal of Horticultural Science & Technology, V19, P153; Yun JG, 1998, SCI HORTIC-AMSTERDAM, V72, P157, DOI 10.1016/S0304-4238(97)00068-X; Yun JG, 1997, PLANT SCI, V127, P25, DOI 10.1016/S0168-9452(97)00112-X; Yun JG, 1996, J PLANT RES, V109, P339, DOI 10.1007/BF02344482	74	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57259	10.1371/journal.pone.0057259	http://dx.doi.org/10.1371/journal.pone.0057259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451194	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500081
J	Ramadoss, NS; Zhou, X; Keiler, KC				Ramadoss, Nitya S.; Zhou, Xin; Keiler, Kenneth C.			tmRNA Is Essential in Shigella flexneri	PLOS ONE			English	Article							NONSTOP MESSENGER-RNAS; PEPTIDYL-TRANSFER-RNA; ESCHERICHIA-COLI; RIBOSOME-RESCUE; STALLED RIBOSOMES; TRANS-TRANSLATION; QUALITY-CONTROL; TAGGING SYSTEM; PROTEIN; SSRA	Nonstop mRNAs pose a challenge for bacteria, because translation cannot terminate efficiently without a stop codon. The trans-translation pathway resolves nonstop translation complexes by removing the nonstop mRNA, the incomplete protein, and the stalled ribosome. P1 co-transduction experiments demonstrated that tmRNA, a key component of the trans-translation pathway, is essential for viability in Shigella flexneri. tmRNA was previously shown to be dispensable in the closely related species Escherichia coli, because E. coli contains a backup system for trans-translation mediated by the alternative release factor ArfA. Genome sequence analysis showed that S. flexneri does not have a gene encoding ArfA. E. coli ArfA could suppress the requirement for tmRNA in S. flexneri, indicating that tmRNA is essential in S. flexneri because there is no functional backup system. These data suggest that resolution of nonstop translation complexes is required for most bacteria.	[Ramadoss, Nitya S.; Zhou, Xin; Keiler, Kenneth C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Keiler, KC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kkeiler@psu.edu		Keiler, Kenneth/0000-0001-8753-335X	NIH grant [GM68720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068720] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM68720. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ausubel FM, 1994, CURRENT PROTOCOLS MO; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Novoa PG, 2004, NUCLEIC ACIDS RES, V32, pD104, DOI 10.1093/nar/gkh102; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dulebohn DP, 2006, J BIOL CHEM, V281, P28536, DOI 10.1074/jbc.M605137200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028413; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, J BIOL CHEM, V271, P2589, DOI 10.1074/jbc.271.5.2589; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2007, CURR OPIN MICROBIOL, V10, P169, DOI 10.1016/j.mib.2007.03.014; Keiler KC, 2011, BIOCHIMIE, V93, P1993, DOI 10.1016/j.biochi.2011.05.029; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; OH BK, 1991, MOL GEN GENET, V229, P52, DOI 10.1007/BF00264212; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; Schaub RE, 2012, J BIOL CHEM, V287, P29765, DOI 10.1074/jbc.M112.374074; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; WU TT, 1966, GENETICS, V54, P405; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803	39	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57537	10.1371/journal.pone.0057537	http://dx.doi.org/10.1371/journal.pone.0057537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451240	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500112
J	Corsinotti, A; Kapopoulou, A; Gubelmann, C; Imbeault, M; de Sio, FRS; Rowe, HM; Mouscaz, Y; Deplancke, B; Trono, D				Corsinotti, Andrea; Kapopoulou, Adamandia; Gubelmann, Carine; Imbeault, Michael; de Sio, Francesca R. Santoni; Rowe, Helen M.; Mouscaz, Yoann; Deplancke, Bart; Trono, Didier			Global and Stage Specific Patterns of Kruppel-Associated-Box Zinc Finger Protein Gene Expression in Murine Early Embryonic Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR TIF1-BETA; GROUND-STATE PLURIPOTENCY; STEM-CELLS; REPRESSION DOMAIN; LEUKEMIA-VIRUS; X-CHROMOSOME; SELF-RENEWAL; HUMAN GENOME; SSX GENES; DIFFERENTIATION	Highly coordinated transcription networks orchestrate the self-renewal of pluripotent stem cell and the earliest steps of mammalian development. KRAB-containing zinc finger proteins represent the largest group of transcription factors encoded by the genomes of higher vertebrates including mice and humans. Together with their putatively universal cofactor KAP1, they have been implicated in events as diverse as the silencing of endogenous retroelements, the maintenance of imprinting and the pluripotent self-renewal of embryonic stem cells, although the genomic targets and specific functions of individual members of this gene family remain largely undefined. Here, we first generated a list of Ensembl-annotated KRAB-containing genes encoding the mouse and human genomes. We then defined the transcription levels of these genes in murine early embryonic cells. We found that the majority of KRAB-ZFP genes are expressed in mouse pluripotent stem cells and other early progenitors. However, we also identified distinctively cell- or stage-specific patterns of expression, some of which are pluripotency-restricted. Finally, we determined that individual KRAB-ZFP genes exhibit highly distinctive modes of expression, even when grouped in genomic clusters, and that these cannot be correlated with the presence of prototypic repressive or activating chromatin marks. These results pave the way to delineating the role of specific KRAB-ZFPs in early embryogenesis.	[Corsinotti, Andrea; Kapopoulou, Adamandia; Gubelmann, Carine; Imbeault, Michael; de Sio, Francesca R. Santoni; Rowe, Helen M.; Mouscaz, Yoann; Deplancke, Bart; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Corsinotti, Andrea; Kapopoulou, Adamandia; Gubelmann, Carine; Imbeault, Michael; de Sio, Francesca R. Santoni; Rowe, Helen M.; Mouscaz, Yoann; Deplancke, Bart; Trono, Didier] Ecole Polytech Fed Lausanne, Frontiers Genet Program, Lausanne, Switzerland; [Kapopoulou, Adamandia; Mouscaz, Yoann] Swiss Inst Bioinformat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland.	didier.trono@epfl.ch	de Sio, Francesca Santoni/AAF-3432-2020; Rowe, Helen/AAQ-7138-2021	Rowe, Helen/0000-0001-5881-0290; Imbeault, Michael/0000-0002-0073-0922; MOUSCAZ, Yoann/0000-0001-7352-3740; Deplancke, Bart/0000-0001-9935-843X; Santoni de Sio, Francesca Romana/0000-0002-6522-0499	European Research Council [268721]; Swiss National Science Foundation Programme National de Recherche 63 subside [406340_128157]	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation Programme National de Recherche 63 subside	Grants: European Research Council contract number 268721, Swiss National Science Foundation Programme National de Recherche 63 subside 406340_128157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2002, J CELL SCI, V115, P3439; Cammas F, 2000, GENE, V253, P231, DOI 10.1016/S0378-1119(00)00263-8; Cammas F, 2007, DIFFERENTIATION, V75, P627, DOI 10.1111/j.1432-0436.2007.00166.x; Chen YT, 2003, GENOMICS, V82, P628, DOI 10.1016/S0888-7543(03)00183-6; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; de Sio FRS, 2012, BLOOD, V119, P4675, DOI 10.1182/blood-2011-12-401117; deLeeuw B, 1996, CYTOGENET CELL GENET, V73, P179, DOI 10.1159/000134334; Ding G, 2009, NUCLEIC ACIDS RES, V37, pD267, DOI 10.1093/nar/gkn782; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Lin ZY, 2011, STEM CELLS, V29, P1963, DOI 10.1002/stem.752; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Peng HZ, 2009, J BIOL CHEM, V284, P35670, DOI 10.1074/jbc.M109.032086; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Rowe HM, 2012, GENOME RES; Santoni de Sio FR, 2012, FASEB J; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Shannon M, 1996, GENOMICS, V33, P112, DOI 10.1006/geno.1996.0166; Shannon M, 1998, DNA SEQUENCE, V8, P303, DOI 10.3109/10425179809034075; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	73	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56721	10.1371/journal.pone.0056721	http://dx.doi.org/10.1371/journal.pone.0056721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451074	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800030
J	Strigens, A; Schipprack, W; Reif, JC; Melchinger, AE				Strigens, Alexander; Schipprack, Wolfgang; Reif, Jochen C.; Melchinger, Albrecht E.			Unlocking the Genetic Diversity of Maize Landraces with Doubled Haploids Opens New Avenues for Breeding	PLOS ONE			English	Article							CORE COLLECTION; EARLY GROWTH; FLINT; LINES; POPULATIONS; HYBRIDS; PERFORMANCE; HISTORY; YIELD; INDIVIDUALS	Landraces are valuable genetic resources for broadening the genetic base of elite germplasm in maize. Extensive exploitation of landraces has been hampered by their genetic heterogeneity and heavy genetic load. These limitations may be overcome by the in-vivo doubled haploid (DH) technique. A set of 132 DH lines derived from three European landraces and 106 elite flint (EF) lines were genotyped for 56,110 single nucleotide polymorphism (SNP) markers and evaluated in field trials at five locations in Germany in 2010 for several agronomic traits. In addition, the landraces were compared with synthetic populations produced by intermating DH lines derived from the respective landrace. Our objectives were to (1) evaluate the phenotypic and molecular diversity captured within DH lines derived from European landraces, (2) assess the breeding potential (usefulness) of DH lines derived from landraces to broaden the genetic base of the EF germplasm, and (3) compare the performance of each landrace with the synthetic population produced from the respective DH lines. Large genotypic variances among DH lines derived from landraces allowed the identification of DH lines with grain yields comparable to those of EF lines. Selected DH lines may thus be introgressed into elite germplasm without impairing its yield level. Large genetic distances of the DH lines to the EF lines demonstrated the potential of DH lines derived from landraces to broaden the genetic base of the EF germplasm. The comparison of landraces with their respective synthetic population showed no yield improvement and no reduction of phenotypic diversity. Owing to the low population structure and rapid decrease of linkage disequilibrium within populations of DH lines derived from landraces, these would be an ideal tool for association mapping. Altogether, the DH technology opens new opportunities for characterizing and utilizing the genetic diversity present in gene bank accessions of maize.	[Strigens, Alexander; Schipprack, Wolfgang; Melchinger, Albrecht E.] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, Stuttgart, Germany; [Reif, Jochen C.] Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany	University Hohenheim; University Hohenheim	Melchinger, AE (corresponding author), Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, Stuttgart, Germany.	melchinger@uni-hohenheim.de		Strigens, Alexander/0000-0001-8809-1899; Melchinger, Albrecht E./0000-0002-8346-7786; Reif, Jochen/0000-0002-6742-265X	German Research Foundation (DFG) [RE2254/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was and financed by the German Research Foundation (DFG, RE2254/3-1, http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barriere Y, 2006, MAYDICA, V51, P435; Betran FJ, 2003, FIELD CROP RES, V83, P51, DOI 10.1016/S0378-4290(03)00061-3; Butler D., 2007, ANAL MIXED MODELS S; CHARLESWORTH D, 1992, EVOLUTION, V46, P703, DOI [10.2307/2409639, 10.1111/j.1558-5646.1992.tb02077.x]; CIMMYT International Maize and Wheat Improvement Center, 2005, LAB PROT CIMMYT APPL, VThird; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; CROSSA J, 1987, CROP SCI, V27, P187, DOI 10.2135/cropsci1987.0011183X002700020008x; Duvick DN, 2005, MAYDICA, V50, P193; Eder J, 2002, THEOR APPL GENET, V104, P703, DOI 10.1007/s00122-001-0773-4; EDMEADES GO, 1993, CROP SCI, V33, P1029, DOI 10.2135/cropsci1993.0011183X003300050031x; Eschholz TW, 2010, GENET RESOUR CROP EV, V57, P71, DOI 10.1007/s10722-009-9452-0; Eschholz TW, 2008, GENET RESOUR CROP EV, V55, P971, DOI 10.1007/s10722-007-9304-8; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferro RA, 2007, GENET RESOUR CROP EV, V54, P295, DOI 10.1007/s10722-005-4500-x; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Frascaroli E, 2012, THEORETICAL IN PRESS; GALLAIS A, 1990, GENETICS, V124, P199; Gallais A, 1990, THEORIE SELECTION AM; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gouesnard B, 2005, MAYDICA, V50, P225; Gouesnard B, 1997, AGRONOMIE, V17, P491, DOI 10.1051/agro:19970906; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; LASHERMES P, 1988, THEOR APPL GENET, V76, P570, DOI 10.1007/BF00260910; Lauer S, 2012, CROP SCI, V52, P1033, DOI [10.2135/cropsci2011.05.0274, 10.2135/cropsci2011.12.0668]; Lucchin M, 2003, GENET RESOUR CROP EV, V50, P315, DOI 10.1023/A:1023578207258; Malvar RA, 2007, CROP PROT, V26, P775, DOI 10.1016/j.cropro.2006.07.004; Malvar RA, 2004, J ECON ENTOMOL, V97, P628, DOI 10.1603/0022-0493-97.2.628; Martin M, 2012, CROP SCI, V52, P32, DOI 10.2135/cropsci2011.04.0214; MELCHINGER AE, 1985, MAYDICA, V30, P395; Melchinger AE, 2003, THEOR APPL GENET, V106, P332, DOI 10.1007/s00122-002-1000-7; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Messmer MM, 1992, THEOR APPL GENET, V83, P1003, DOI 10.1007/BF00232964; Montes JM, 2011, FIELD CROP RES, V121, P268, DOI 10.1016/j.fcr.2010.12.017; MURIGNEUX A, 1993, THEOR APPL GENET, V87, P278, DOI 10.1007/BF00223777; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; PATTERSON HD, 1976, BIOMETRIKA, V63, P83, DOI 10.1093/biomet/63.1.83; Peter R, 2009, FIELD CROP RES, V110, P157, DOI 10.1016/j.fcr.2008.07.015; Peter R, 2009, CROP SCI, V49, P169, DOI 10.2135/cropsci2007.10.0538; Prigge V, 2012, EUPHYTICA, V185, P453, DOI 10.1007/s10681-012-0626-z; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebourg C, 2003, THEOR APPL GENET, V106, P895, DOI 10.1007/s00122-002-1140-9; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Revilla P, 2006, EUPHYTICA, V152, P275, DOI 10.1007/s10681-006-9214-4; Rodriguez VM, 2010, GENET RESOUR CROP EV, V57, P329, DOI 10.1007/s10722-009-9529-9; Rober FK, 2005, MAYDICA, V50, P275; Schneider DN, 2011, MAYDICA, V56, P33; Schnell F, 1983, PROBLEME ELTERNWAHL; Schnell FW, 1959, DREISSIG JAHRE ZUCHT, P140; Strigens A, 2012, PLANT CELL IN PRESS; Strigens A, 2012, CROP SCI, V52, P1084, DOI 10.2135/cropsci2011.08.0426; Tenaillon MI, 2011, CR BIOL, V334, P221, DOI 10.1016/j.crvi.2010.12.015; Troyer AF, 2009, CROP SCI, V49, P1969, DOI 10.2135/cropsci2009.04.0170; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Wilde K, 2010, PLANT BREEDING, V129, P181, DOI 10.1111/j.1439-0523.2009.01677.x; Wright S., 1978, EVOLUTION GENETIC PO; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	59	46	48	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57234	10.1371/journal.pone.0057234	http://dx.doi.org/10.1371/journal.pone.0057234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451190	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800093
J	Suzuki, I; Tsuboi, Y; Shinoda, M; Shibuta, K; Honda, K; Katagiri, A; Kiyomoto, M; Sessle, BJ; Matsuura, S; Ohara, K; Urata, K; Iwata, K				Suzuki, Ikuko; Tsuboi, Yoshiyuki; Shinoda, Masamichi; Shibuta, Kazuo; Honda, Kuniya; Katagiri, Ayano; Kiyomoto, Masaaki; Sessle, Barry J.; Matsuura, Shingo; Ohara, Kinuyo; Urata, Kentaro; Iwata, Koichi			Involvement of ERK Phosphorylation of Trigeminal Spinal Subnucleus Caudalis Neurons in Thermal Hypersensitivity in Rats with Infraorbital Nerve Injury	PLOS ONE			English	Article							INFERIOR ALVEOLAR NERVE; EXPERIMENTAL PERIPHERAL NEUROPATHY; PRIMARY AFFERENT NEURONS; SIGNAL-REGULATED KINASE; LONG-TERM POTENTIATION; DORSAL-HORN NEURONS; FIBER-EVOKED POTENTIALS; ROOT GANGLION NEURONS; SCIATIC-NERVE; MAP KINASE	To evaluate the involvement of the mitogen-activated protein kinase (MAPK) cascade in orofacial neuropathic pain mechanisms, this study assessed nocifensive behavior evoked by mechanical or thermal stimulation of the whisker pad skin, phosphorylation of extracellular signal-regulated kinase (ERK) in trigeminal spinal subnucleus caudalis (Vc) neurons, and Vc neuronal responses to mechanical or thermal stimulation of the whisker pad skin in rats with the chronic constriction nerve injury of the infraorbital nerve (ION-CCI). The mechanical and thermal nocifensive behavior was significantly enhanced on the side ipsilateral to the ION-CCI compared to the contralateral whisker pad or sham rats. ION-CCI rats had an increased number of phosphorylated ERK immunoreactive (pERK-IR) cells which also manifested NeuN-IR but not GFAP-IR and Iba1-IR, and were significantly more in ION-CCI rats compared with sham rats following noxious but not non-noxious mechanical stimulation. After intrathecal administration of the MEK1 inhibitor PD98059 in ION-CCI rats, the number of pERK-IR cells after noxious stimulation and the enhanced thermal nocifensive behavior but not the mechanical nocifensive behavior were significantly reduced in ION-CCI rats. The enhanced background activities, afterdischarges and responses of wide dynamic range neurons to noxious mechanical and thermal stimulation in ION-CCI rats were significantly depressed following i.t. administration of PD98059, whereas responses to non-noxious mechanical and thermal stimulation were not altered. The present findings suggest that pERK-IR neurons in the Vc play a pivotal role in the development of thermal hypersensitivity in the face following trigeminal nerve injury.	[Suzuki, Ikuko; Tsuboi, Yoshiyuki; Shinoda, Masamichi; Shibuta, Kazuo; Honda, Kuniya; Katagiri, Ayano; Kiyomoto, Masaaki; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 101, Japan; [Honda, Kuniya] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Chiyoda Ku, Tokyo 101, Japan; [Sessle, Barry J.] Univ Toronto, Fac Dent, Dept Oral Physiol, Toronto, ON, Canada; [Matsuura, Shingo; Ohara, Kinuyo] Nihon Univ, Sch Dent, Dept Endodont, Chiyoda Ku, Tokyo 101, Japan; [Urata, Kentaro] Nihon Univ, Sch Dent, Dept Prosthodont, Chiyoda Ku, Tokyo 101, Japan; [Iwata, Koichi] Nihon Univ, Sch Dent, Div Funct Morphol, Dent Res Ctr, Tokyo 101, Japan; [Iwata, Koichi] Nihon Univ, Grad Sch Med Sci, Div Appl Syst Neurosci, Adv Med Res Ctr, Tokyo, Japan	Nihon University; Nihon University; University of Toronto; Nihon University; Nihon University; Nihon University; Nihon University	Iwata, K (corresponding author), Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 101, Japan.	iwata-k@dent.nihon-u.ac.jp	Sessle, Barry/AAD-7771-2022		Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology [22792021]; Japan-Canada (CIHR) Joint Health Research Program; National Institutes of Health grant [DE015420]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015420] Funding Source: NIH RePORTER	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Canada (CIHR) Joint Health Research Program(Canadian Institutes of Health Research (CIHR)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported in part by Research grants from Sato and Uemura Funds from Nihon University School of Dentistry, and Grant from Dental Research Center, Nihon University School of Dentistry; Nihon University multidisciplinary research grant and Individual Research Grant; a Grant from the Ministry of Education, Culture, Sports, Science and Technology to promote multi-disciplinary research Projects (KAKENHI (Grant-in-Aid for Young Scientist (B)) # 22792021 to MS); grants from the Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research projects "Brain Mechanisms for Cognition, Memory and Behavior" and "Translational Research Network on Orofacial Neurological Disorders" at Nihon University, and Japan-Canada (CIHR) Joint Health Research Program, and National Institutes of Health grant DE015420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-8; Allchorne AJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-36; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CARLTON SM, 1991, NEUROSCI LETT, V131, P88, DOI 10.1016/0304-3940(91)90343-R; Dai Y, 2002, J NEUROSCI, V22, P7737; Fields RD, 1997, J NEUROSCI, V17, P7252; Fields RD, 1998, J NEUROBIOL, V37, P158, DOI 10.1002/(SICI)1097-4695(199810)37:1<158::AID-NEU12>3.0.CO;2-A; Forssell H, 2007, NEUROLOGY, V69, P1451, DOI 10.1212/01.wnl.0000277274.83301.c0; Fukui T, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-18; GAUTRON M, 1990, NEUROSCI LETT, V111, P28, DOI 10.1016/0304-3940(90)90339-B; GUILBAUD G, 1990, J NEUROPHYSIOL, V64, P1537, DOI 10.1152/jn.1990.64.5.1537; Honda K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-59; Imamura Y, 1997, EXP BRAIN RES, V116, P97, DOI 10.1007/PL00005748; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868, DOI 10.1152/jn.2001.86.6.2868; Jaaskelainen SK, 2004, J OROFAC PAIN, V18, P355; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; KAJANDER KC, 1992, J NEUROPHYSIOL, V68, P734, DOI 10.1152/jn.1992.68.3.734; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Kobayashi A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-12; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; LAIRD JMA, 1993, J NEUROPHYSIOL, V69, P2072, DOI 10.1152/jn.1993.69.6.2072; LISNEY SJW, 1987, BRAIN RES, V415, P122, DOI 10.1016/0006-8993(87)90275-7; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; Nakagawa K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-9; Nakajima A, 2011, J DENT RES, V90, P777, DOI 10.1177/0022034511401406; NOGUCHI K, 1994, J NEUROSCI RES, V37, P596, DOI 10.1002/jnr.490370506; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; PALECEK J, 1992, J NEUROPHYSIOL, V68, P1951, DOI 10.1152/jn.1992.68.6.1951; PALECEK J, 1992, J NEUROPHYSIOL, V67, P1562, DOI 10.1152/jn.1992.67.6.1562; Peng GD, 2009, J BIOL CHEM, V284, P30138, DOI 10.1074/jbc.M109.036756; Robinson PP, 2004, J OROFAC PAIN, V18, P287; Saito K, 2008, J NEUROPHYSIOL, V99, P2251, DOI 10.1152/jn.00794.2007; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Shibuta K, 2012, BRAIN RES, V1451, P74, DOI 10.1016/j.brainres.2012.02.023; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; SHIR Y, 1990, NEUROSCI LETT, V115, P62, DOI 10.1016/0304-3940(90)90518-E; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; Suzuki I, 2008, NEUROSCI LETT, V442, P39, DOI 10.1016/j.neulet.2008.07.003; Svendsen F, 1998, NEUROREPORT, V9, P1185, DOI 10.1097/00001756-199804200-00041; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Tal M, 1996, PAIN, V64, P511, DOI 10.1016/0304-3959(95)00175-1; Truelove E, 2004, J OROFAC PAIN, V18, P374; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Vickers ER, 1998, ORAL SURG ORAL MED O, V85, P24, DOI 10.1016/S1079-2104(98)90393-6; Vikman KS, 2005, NEUROSCIENCE, V135, P969, DOI 10.1016/j.neuroscience.2005.06.059; VOS BP, 1994, J NEUROSCI, V14, P2708; Woolf CJ, 2001, ANESTHESIOLOGY, V95, P241, DOI 10.1097/00000542-200107000-00034; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Xu M, 2008, J PAIN, V9, P1036, DOI 10.1016/j.jpain.2008.06.006; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	60	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57278	10.1371/journal.pone.0057278	http://dx.doi.org/10.1371/journal.pone.0057278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451198	gold, Green Published, Green Submitted			2022-12-27	WOS:000316658800097
J	Takata, Y; Shu, XO; Gao, YT; Li, HL; Zhang, XL; Gao, J; Cai, H; Yang, G; Xiang, YB; Zheng, W				Takata, Yumie; Shu, Xiao-Ou; Gao, Yu-Tang; Li, Honglan; Zhang, Xianglan; Gao, Jing; Cai, Hui; Yang, Gong; Xiang, Yong-Bing; Zheng, Wei			Red Meat and Poultry Intakes and Risk of Total and Cause-Specific Mortality: Results from Cohort Studies of Chinese Adults in Shanghai	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LUNG-CANCER; CONSUMPTION; STROKE; MEN; REPRODUCIBILITY; TESTOSTERONE; ASSOCIATIONS; VALIDITY	Most previous studies of meat intake and total or cause-specific mortality were conducted in North America, whereas studies in other areas have been limited and reported inconsistent results. This study investigated the association of red meat or poultry intake with risk of total and cause-specific mortality, including cancer and cardiovascular disease (CVD), in two large population-based prospective cohort studies of 134,290 Chinese adult women and men in Shanghai. Meat intakes were assessed through validated food frequency questionnaires administered in person at baseline. Vital status and dates and causes of deaths were ascertained through annual linkage to the Shanghai Vital Statistics Registry and Shanghai Cancer Registry databases and home visits every 2-3 years. Cox regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of death associated with quintiles of meat intake. During 803,265 person-years of follow up for women and 334,281 person-years of follow up for men, a total of 4,210 deaths in women and 2,733 deaths in men accrued. The median intakes of red meat were 43 g/day among women and 54 g/day among men, and pork constituted at least 95% of total meat intake for both women and men. Red meat intake was associated with increased total mortality among men, but not among women; the HR (95% CI) comparing the highest with the lowest quintiles were 1.18 (1.02-1.35) and 0.92 (0.82-1.03), respectively. This sex difference was statistically significant (P = 0.01). Red meat intake was associated with increased risk of ischemic heart disease mortality (HR = 1.41, 95% CI = 1.05-1.89) and with decreased risk of hemorrhagic stroke mortality (HR = 0.62, 95% CI = 0.45-0.87). There were suggestive inverse associations of poultry intake with risk of total and all-CVD mortality among men, but not among women. Further investigations are needed to elucidate the sex-specific associations between red meat intake and mortality.	[Takata, Yumie; Shu, Xiao-Ou; Zhang, Xianglan; Cai, Hui; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Gao, Yu-Tang; Li, Honglan; Gao, Jing; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Vanderbilt University; Shanghai Jiao Tong University	Shu, XO (corresponding author), Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA.	xiao-ou.shu@vanderbilt.edu	Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; zhang, weihua/GXV-1334-2022; Zheng, Wei/O-3351-2013; Gao, Yu/HGE-1937-2022	Zheng, Wei/0000-0003-1226-070X; 	National Cancer Institute [R37CA070867, R01 CA082729]; National Heart, Lung, and Blood Institute [R0 1HL095931]; NATIONAL CANCER INSTITUTE [R01CA082729, R37CA070867] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095931] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Cancer Institute grants (R37CA070867, PI: WZ; R01 CA082729, PI: XOS) and the National Heart, Lung, and Blood Institute (R0 1HL095931, PI: XZ). The funders had no role in study design, data	Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Choi JS, 2007, ATHEROSCLEROSIS, V192, P445, DOI 10.1016/j.atherosclerosis.2007.03.006; Silva EOD, 2009, ARCH INTERN MED, V169, P1538, DOI 10.1001/archinternmed.2009.278; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du SF, 2000, J NUTR, V130, P193, DOI 10.1093/jn/130.2.193; Fang Jing, 2006, J Immigr Minor Health, V8, P387, DOI 10.1007/s10903-006-9009-7; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; He K, 2003, BRIT MED J, V327, P777, DOI 10.1136/bmj.327.7418.777; Hyde Z, 2012, CANCER EPIDEM BIOMAR, V21, P1319, DOI 10.1158/1055-9965.EPI-12-0129; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mirvish SS, 2002, J NUTR, V132, p3526S, DOI 10.1093/jn/132.11.3526S; Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Skog KI, 1998, FOOD CHEM TOXICOL, V36, P879, DOI 10.1016/S0278-6915(98)00061-1; Sugimura T, 1990, Princess Takamatsu Symp, V21, P279; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189; Warlow CP, 1998, LANCET S3, V352, pSIII1, DOI DOI 10.1016/S0140-6736(98)90086-1; World Health Organization, 1977, INT CLASS DIS 9 VERS; Yang WS, 2012, ANN ONCOL, V23, P3163, DOI 10.1093/annonc/mds207; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	35	62	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56963	10.1371/journal.pone.0056963	http://dx.doi.org/10.1371/journal.pone.0056963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451121	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800054
J	Wei, WJ; Wang, YL; Li, DS; Wang, Y; Wang, XF; Zhu, YX; Yang, YJ; Wang, ZY; Ma, YY; Wu, Y; Jin, L; Ji, QH; Wang, JC				Wei, Wen-Jun; Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Xiao-Feng; Zhu, Yong-Xue; Yang, Ya-jun; Wang, Zhuo-Ying; Ma, Yan-yun; Wu, Yi; Jin, Li; Ji, Qing-Hai; Wang, Jiu-Cun			Association between the rs2910164 Polymorphism in Pre-Mir-146a Sequence and Thyroid Carcinogenesis	PLOS ONE			English	Article							HASHIMOTOS-THYROIDITIS; COMMON VARIANTS; RISK-FACTORS; CANCER-RISK; CARCINOMA; NODULES; MICRORNAS; TSH; CONFIRMATION; LINKAGE	Background: Rs2910164, a Single nucleotide polymorphism (SNP) located in the precursor microRNA sequence of miR-146a, is the only MicroRNA sequence SNP studied in papillary thyroid cancer (PTC). Association studies had been performed in US and UK-Northern European populations, but results were inconsistence. This study evaluated the association between rs2910164 and the risk of PTC as well as benign thyroid tumor (BN), and examined the clinicopathological characteristics of PTC and BN for different genotypes. Methods: This case-control study genotyped rs2910164 in 753 PTCs, 484 BNs and 760 controls in a Chinese Han population. Clinicopathological and genetic data were collected and compared. Multivariate logistic regression was performed to calculate adjusted odds ratios (ORs). Results: There were no differences in rs2910164 genotype distributions between the three groups. PTC cases with three genotypes (CC, CG, GG) had similar clinicopathological characteristics except the existence of "para-cancer" BN (PTC/BN, P = 0.006). PTC/BN patients were older (P = 0.009), and had smaller cancer lesions (P<0.001), lower serum thyrotropin levels (1.82 +/- 1.42 vs. 2.21 +/- 1.74, P = 0.04), and lower rates of level VI lymph node metastasis (20.8% vs. 52.7%, P < 0.001) and lateral neck lymph node metastasis (11.5% vs. 23.0%, P = 0.011) compared with PTC only. Then we supposed a possible progression from BN to PTC which may involve rs2910164 in and performed a multivariate logistic regression analysis of PTC/BN and BN cases to determine risk factors of this progression. Results showed that the rs2910164 GG homozygote (OR = 2.25, 95% CI 1.22-4.14, P = 0.01) was the only risk factor in this study. Conclusion: Rs2910164 was not associated with increased risk of PTC and BN in Chinese patients, but may play a latent role in the transformation from BN to PTC.	[Wei, Wen-Jun; Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Wang, Zhuo-Ying; Wu, Yi; Ji, Qing-Hai] Fudan Univ, Dept Head & Neck Surg, Canc Hosp, Shanghai 200433, Peoples R China; [Wei, Wen-Jun; Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Wang, Zhuo-Ying; Wu, Yi; Ji, Qing-Hai] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Ji, QH (corresponding author), Fudan Univ, Dept Head & Neck Surg, Canc Hosp, Shanghai 200433, Peoples R China.	jiqinghai@shca.org.cn; jcwang@fudan.edu.cn	Wang, Jiucun/J-8744-2012; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Wang, Yu-Long/AEF-9362-2022; MA, YAN/HHN-2912-2022	Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; Wang, Yu-Long/0000-0002-3830-7257; Wei, Wen-Jun/0000-0003-1963-2609	National Science Foundation of China [81001204, 30872958, 30971594]; Ministry of Health [201002007]; Ministry of Science and Technology [2011BAI09B00]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Science Foundation of China (81001204 to Y.-L. Wang, 30872958 to Q.-H. Ji and 30971594 to J.-C. Wang), the grants from the Ministry of Health (201002007 to L. Jin) and the Ministry of Science and Technology (2011BAI09B00 to L. Jin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil C, 2010, THYROID, V20, P601, DOI 10.1089/thy.2009.0450; Arora N, 2008, WORLD J SURG, V32, P1237, DOI 10.1007/s00268-008-9484-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bevan S, 2001, J CLIN ENDOCR METAB, V86, P3701, DOI 10.1210/jc.86.8.3701; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Botrugno I, 2011, AM SURGEON, V77, P1553; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; de la Chapelle A, 2011, J CLIN ENDOCR METAB, V96, P3326, DOI 10.1210/jc.2011-1004; Fiore E, 2011, ENDOCR-RELAT CANCER, V18, P429, DOI [10.1530/ERC-11-0028, 10.1530/ERC-11-002]; Fiore E, 2012, J CLIN ENDOCR METAB, V97, P1134, DOI 10.1210/jc.2011-2735; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Haymart MR, 2008, J CLIN ENDOCR METAB, V93, P809, DOI 10.1210/jc.2007-2215; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kim ES, 2010, THYROID, V20, P885, DOI 10.1089/thy.2009.0384; Kim KW, 2011, HEAD NECK-J SCI SPEC, V33, P691, DOI 10.1002/hed.21518; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Leone V, 2011, J CLIN ENDOCR METAB, V96, pE1388, DOI 10.1210/jc.2011-0345; Lesueur F, 1999, J CLIN ENDOCR METAB, V84, P2157, DOI 10.1210/jc.84.6.2157; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Trocchi P, 2012, LANGENBECK ARCH SURG, V397, P421, DOI 10.1007/s00423-011-0897-1; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wang YL, 2008, EJSO-EUR J SURG ONC, V34, P77, DOI 10.1016/j.ejso.2007.08.012; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Zhang L, 2012, J CLIN ENDOCR METAB, V97, P1250, DOI 10.1210/jc.2011-1546	30	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56638	10.1371/journal.pone.0056638	http://dx.doi.org/10.1371/journal.pone.0056638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451063	Green Published, Green Submitted, gold			2022-12-27	WOS:000316658800023
J	Buniello, A; Hardisty-Hughes, RE; Pass, JC; Bober, E; Smith, RJ; Steel, KP				Buniello, Annalisa; Hardisty-Hughes, Rachel E.; Pass, Johanna C.; Bober, Eva; Smith, Richard J.; Steel, Karen P.			Headbobber: A Combined Morphogenetic and Cochleosaccular Mouse Model to Study 10qter Deletions in Human Deafness	PLOS ONE			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; SEMICIRCULAR CANAL FORMATION; SENSORY ORGAN DEVELOPMENT; MURINE INNER-EAR; PROTEIN EXPRESSION; NERVOUS-SYSTEM; MICE LACKING; GENE FAMILY; LONG ARM; C-KIT	The recessive mouse mutant headbobber (hb) displays the characteristic behavioural traits associated with vestibular defects including headbobbing, circling and deafness. This mutation was caused by the insertion of a transgene into distal chromosome 7 affecting expression of native genes. We show that the inner ear of hb/hb mutants lacks semicircular canals and cristae, and the saccule and utricle are fused together in a single utriculosaccular sac. Moreover, we detect severe abnormalities of the cochlear sensory hair cells, the stria vascularis looks severely disorganised, Reissner's membrane is collapsed and no endocochlear potential is detected. Myo7a and Kcnj10 expression analysis show a lack of the melanocyte-like intermediate cells in hb/hb stria vascularis, which can explain the absence of endocochlear potential. We use Trp2 as a marker of melanoblasts migrating from the neural crest at E12.5 and show that they do not interdigitate into the developing strial epithelium, associated with abnormal persistence of the basal lamina in the hb/hb cochlea. We perform array CGH, deep sequencing as well as an extensive expression analysis of candidate genes in the headbobber region of hb/hb and littermate controls, and conclude that the headbobber phenotype is caused by: 1) effect of a 648 kb deletion on distal Chr7, resulting in the loss of three protein coding genes (Gpr26, Cpmx2 and Chst15) with expression in the inner ear but unknown function; and 2) indirect, long range effect of the deletion on the expression of neighboring genes on Chr7, associated with downregulation of Hmx3, Hmx2 and Nkx1.2 homeobox transcription factors. Interestingly, deletions of the orthologous region in humans, affecting the same genes, have been reported in nineteen patients with common features including sensorineural hearing loss and vestibular problems. Therefore, we propose that headbobber is a useful model to gain insight into the mechanisms underlying deafness in human 10qter deletion syndrome.	[Buniello, Annalisa; Pass, Johanna C.; Steel, Karen P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Buniello, Annalisa; Pass, Johanna C.; Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Hardisty-Hughes, Rachel E.; Smith, Richard J.; Steel, Karen P.] MRC Inst Hearing Res, Nottingham, England; [Bober, Eva] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Wellcome Trust Sanger Institute; University of London; King's College London; Max Planck Society	Steel, KP (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	karen.steel@kcl.ac.uk		Smith, Richard/0000-0003-1201-6731; Buniello, Annalisa/0000-0002-4623-8642	Wellcome Trust Sanger Institute Hinxton UK [098051]; Medical Research Council (MRC) (UK); Telethon Foundation; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish; MRC [MC_qA137918, G0300212] Funding Source: UKRI	Wellcome Trust Sanger Institute Hinxton UK; Medical Research Council (MRC) (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon Foundation(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Sanger Institute Hinxton UK (grant no098051) (http://www.wellcome.ac.uk/), Medical Research Council (MRC) (UK) (http://www.mrc.ac.uk/index.htm), and Telethon Foundation (http://www.telethon.it/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Buniello A, 2004, GENOMICS, V83, P812, DOI 10.1016/j.ygeno.2003.10.011; CABLE J, 1993, PIGM CELL RES, V6, P215, DOI 10.1111/j.1600-0749.1993.tb00605.x; CABLE J, 1994, PIGM CELL RES, V7, P17, DOI 10.1111/j.1600-0749.1994.tb00015.x; CABLE J, 1992, HEARING RES, V64, P6, DOI 10.1016/0378-5955(92)90164-I; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Cecconi F, 2004, DEVELOPMENT, V131, P2125, DOI 10.1242/dev.01082; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chatterjee S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-68; Chen P, 1999, DEVELOPMENT, V126, P1581; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Ebmeyer J, 2010, OTOL NEUROTOL, V31, P42, DOI 10.1097/MAO.0b013e3181b4e3e3; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Gavalas A, 1998, DEVELOPMENT, V125, P1123; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hadrys T, 1998, DEVELOPMENT, V125, P33; Hardisty R, 1997, THESIS U NOTTINGHAM; Hardisty RE, 1998, BRIT J AUDIOL, V32, P118; Hardisty RE, 1999, BRIT J AUDIOL, V33, P82; HARVEY D, 1992, HEARING RES, V61, P137, DOI 10.1016/0378-5955(92)90044-N; Huang MQ, 2008, DEV DYNAM, V237, P3305, DOI 10.1002/dvdy.21735; Hunter-Duvar, 1978, ACTA OTO-LARYNGOL, V351, P1; Irving M, 2003, AM J MED GENET A, V123A, P153, DOI 10.1002/ajmg.a.20220; Jones PG, 2007, BBA-GEN SUBJECTS, V1770, P890, DOI 10.1016/j.bbagen.2007.01.013; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, BRAIN RES, V1091, P270, DOI 10.1016/j.brainres.2006.02.037; Koo SK, 2009, DEV BIOL, V333, P14, DOI 10.1016/j.ydbio.2009.06.016; Lee DK, 2000, BBA-GENE STRUCT EXPR, V1490, P311, DOI 10.1016/S0167-4781(99)00241-9; LEWANDOWSKI RC, 1978, HUM GENET, V42, P339, DOI 10.1007/BF00291317; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; Miller ND, 2009, AM J MED GENET A, V149A, P669, DOI 10.1002/ajmg.a.32705; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Morsli H, 1999, DEVELOPMENT, V126, P2335; Morsli H, 1998, J NEUROSCI, V18, P3327; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Petersen B, 1998, AM J MED GENET, V77, P60, DOI 10.1002/(SICI)1096-8628(19980428)77:1<60::AID-AJMG13>3.3.CO;2-Z; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rhodes CR, 2003, J NEUROCYTOL, V32, P1143, DOI 10.1023/B:NEUR.0000021908.98337.91; RinkwitzBrandt S, 1996, HEARING RES, V99, P129, DOI 10.1016/S0378-5955(96)00093-7; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodgers KD, 2001, HEARING RES, V158, P39, DOI 10.1016/S0378-5955(01)00283-0; Sajan SA, 2011, HUM MOL GENET, V20, P1262, DOI 10.1093/hmg/ddq567; Salgueiro AM, 2006, INT J DEV BIOL, V50, P705, DOI 10.1387/ijdb.062168as; Salminen M, 2000, DEVELOPMENT, V127, P13; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; SCHUBERT FR, 1995, MECH DEVELOP, V51, P99, DOI 10.1016/0925-4773(95)00358-8; Simeone A, 1998, EMBO J, V17, P6790, DOI 10.1093/emboj/17.23.6790; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somma G, 2012, JARO-J ASSOC RES OTO, V13, P335, DOI 10.1007/s10162-012-0316-5; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; STEEL KP, 1987, HEARING RES, V27, P11, DOI 10.1016/0378-5955(87)90022-0; Steel KP, 1999, TRENDS GENET, V15, P207, DOI 10.1016/S0168-9525(99)01753-9; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEEL KP, 1989, DEVELOPMENT, V107, P453; Steel KP, 1995, ANNU REV GENET, V29, P675; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Steel KP, 1991, ANN NY ACAD SCI, V630, P68; Tekin M, 2001, LANCET, V358, P1082, DOI 10.1016/S0140-6736(01)06186-4; Theisen A, 2008, NATURE ED, V1, P1; Torres MA, 1996, DEVELOPMENT, V122, P3381; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang WD, 2005, EXP CELL RES, V306, P373, DOI 10.1016/j.yexcr.2005.03.016; Wang WD, 2004, DEV CELL, V7, P439, DOI 10.1016/j.devcel.2004.06.016; Wang WD, 2001, DEVELOPMENT, V128, P5017; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3; Wang WD, 1998, DEVELOPMENT, V125, P621; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wei J, 2000, HUM MUTAT, V15, P387, DOI 10.1002/(SICI)1098-1004(200004)15:4<387::AID-HUMU26>3.0.CO;2-T; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; WULFSBERG EA, 1989, AM J MED GENET, V32, P364, DOI 10.1002/ajmg.1320320319; Xin XN, 1998, DNA CELL BIOL, V17, P897, DOI 10.1089/dna.1998.17.897; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069; Zheng JL, 1997, J NEUROSCI, V17, P8270; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628; Zou D, 2006, DEV BIOL, V298, P430, DOI 10.1016/j.ydbio.2006.06.049	86	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56274	10.1371/journal.pone.0056274	http://dx.doi.org/10.1371/journal.pone.0056274			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457544	Green Submitted, Green Published, gold			2022-12-27	WOS:000315602700063
J	Himes, BE; Sheppard, K; Berndt, A; Leme, AS; Myers, RA; Gignoux, CR; Levin, AM; Gauderman, WJ; Yang, JJ; Mathias, RA; Romieu, I; Torgerson, DG; Roth, LA; Huntsman, S; Eng, C; Klanderman, B; Ziniti, J; Senter-Sylvia, J; Szefler, SJ; Lemanske, RF; Zeiger, RS; Strunk, RC; Martinez, FD; Boushey, H; Chinchilli, VM; Israel, E; Mauger, D; Koppelman, GH; Postma, DS; Nieuwenhuis, MAE; Vonk, JM; Lima, JJ; Irvin, CG; Peters, SP; Kubo, M; Tamari, M; Nakamura, Y; Litonjua, AA; Tantisira, KG; Raby, BA; Bleecker, ER; Meyers, DA; London, SJ; Barnes, KC; Gilliland, FD; Williams, LK; Burchard, EG; Nicolae, DL; Ober, C; DeMeo, DL; Silverman, EK; Paigen, B; Churchill, G; Shapiro, SD; Weiss, ST				Himes, Blanca E.; Sheppard, Keith; Berndt, Annerose; Leme, Adriana S.; Myers, Rachel A.; Gignoux, Christopher R.; Levin, Albert M.; Gauderman, W. James; Yang, James J.; Mathias, Rasika A.; Romieu, Isabelle; Torgerson, Dara G.; Roth, Lindsey A.; Huntsman, Scott; Eng, Celeste; Klanderman, Barbara; Ziniti, John; Senter-Sylvia, Jody; Szefler, Stanley J.; Lemanske, Robert F., Jr.; Zeiger, Robert S.; Strunk, Robert C.; Martinez, Fernando D.; Boushey, Homer; Chinchilli, Vernon M.; Israel, Elliot; Mauger, David; Koppelman, Gerard H.; Postma, Dirkje S.; Nieuwenhuis, Maartje A. E.; Vonk, Judith M.; Lima, John J.; Irvin, Charles G.; Peters, Stephen P.; Kubo, Michiaki; Tamari, Mayumi; Nakamura, Yusuke; Litonjua, Augusto A.; Tantisira, Kelan G.; Raby, Benjamin A.; Bleecker, Eugene R.; Meyers, Deborah A.; London, Stephanie J.; Barnes, Kathleen C.; Gilliland, Frank D.; Williams, L. Keoki; Burchard, Esteban G.; Nicolae, Dan L.; Ober, Carole; DeMeo, Dawn L.; Silverman, Edwin K.; Paigen, Beverly; Churchill, Gary; Shapiro, Steve D.; Weiss, Scott T.			Integration of Mouse and Human Genome-Wide Association Data Identifies KCNIP4 as an Asthma Gene	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; INDUCED AIRWAY HYPERRESPONSIVENESS; SUBSPECIFIC ORIGIN; CHILDHOOD ASTHMA; SEARCH; MODEL; LINKAGE; SCREEN; RISK; RESPONSIVENESS	Asthma is a common chronic respiratory disease characterized by airway hyperresponsiveness (AHR). The genetics of asthma have been widely studied in mouse and human, and homologous genomic regions have been associated with mouse AHR and human asthma-related phenotypes. Our goal was to identify asthma-related genes by integrating AHR associations in mouse with human genome-wide association study (GWAS) data. We used Efficient Mixed Model Association (EMMA) analysis to conduct a GWAS of baseline AHR measures from males and females of 31 mouse strains. Genes near or containing SNPs with EMMA p-values <0.001 were selected for further study in human GWAS. The results of the previously reported EVE consortium asthma GWAS meta-analysis consisting of 12,958 diverse North American subjects from 9 study centers were used to select a subset of homologous genes with evidence of association with asthma in humans. Following validation attempts in three human asthma GWAS (i.e., Sepracor/LOCCS/LODO/Illumina, GABRIEL, DAG) and two human AHR GWAS (i.e., SHARP, DAG), the Kv channel interacting protein 4 (KCNIP4) gene was identified as nominally associated with both asthma and AHR at a gene- and SNP-level. In EVE, the smallest KCNIP4 association was at rs6833065 (P-value 2.9e-04), while the strongest associations for Sepracor/LOCCS/LODO/Illumina, GABRIEL, DAG were 1.5e-03, 1.0e-03, 3.1e-03 at rs7664617, rs4697177, rs4696975, respectively. At a SNP level, the strongest association across all asthma GWAS was at rs4697177 (P-value 1.1e-04). The smallest P-values for association with AHR were 2.3e-03 at rs11947661 in SHARP and 2.1e-03 at rs402802 in DAG. Functional studies are required to validate the potential involvement of KCNIP4 in modulating asthma susceptibility and/or AHR. Our results suggest that a useful approach to identify genes associated with human asthma is to leverage mouse AHR association data.	[Himes, Blanca E.; Ziniti, John; Senter-Sylvia, Jody; Litonjua, Augusto A.; Tantisira, Kelan G.; Raby, Benjamin A.; DeMeo, Dawn L.; Silverman, Edwin K.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Himes, Blanca E.; Ziniti, John; Senter-Sylvia, Jody; Litonjua, Augusto A.; Tantisira, Kelan G.; Raby, Benjamin A.; DeMeo, Dawn L.; Silverman, Edwin K.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA; [Himes, Blanca E.] Childrens Hosp Informat Program, Boston, MA USA; [Himes, Blanca E.; Klanderman, Barbara; Weiss, Scott T.] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Sheppard, Keith; Paigen, Beverly; Churchill, Gary] Jackson Lab, Bar Harbor, ME 04609 USA; [Berndt, Annerose; Leme, Adriana S.; Shapiro, Steve D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Myers, Rachel A.; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gignoux, Christopher R.; Torgerson, Dara G.; Roth, Lindsey A.; Huntsman, Scott; Eng, Celeste; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Levin, Albert M.; Yang, James J.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Gauderman, W. James; Gilliland, Frank D.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Mathias, Rasika A.; Barnes, Kathleen C.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Romieu, Isabelle] Int Agcy Res Canc, F-69372 Lyon, France; [Szefler, Stanley J.] Natl Jewish Hlth, Denver, CO USA; [Szefler, Stanley J.] Univ Colorado, Denver Sch Med, Denver, CO 80202 USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Zeiger, Robert S.] Kaiser Permanente Southern Calif Reg, San Diego, CA USA; [Zeiger, Robert S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Strunk, Robert C.] Washington Univ, Sch Med, St Louis, MO USA; [Martinez, Fernando D.] Univ Arizona, Coll Med, Arizona Resp Ctr, Tucson, AZ USA; [Boushey, Homer] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care & Allergy Immunol, San Francisco, CA USA; [Chinchilli, Vernon M.; Mauger, David] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Israel, Elliot] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,GRIAC Res Inst, Groningen, Netherlands; [Postma, Dirkje S.; Nieuwenhuis, Maartje A. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol & TB, GRIAC Res Inst, Groningen, Netherlands; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, GRIAC Res Inst, Groningen, Netherlands; [Lima, John J.] Ctr Pharmacogen & Translat Res, Nemours Childrens Clin, Jacksonville, FL USA; [Irvin, Charles G.] Univ Vermont, Dept Physiol & Med, Vermont Lung Ctr, Burlington, VT USA; [Peters, Stephen P.; Bleecker, Eugene R.; Meyers, Deborah A.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Kubo, Michiaki; Tamari, Mayumi] RIKEN, Ctr Genom Med, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan; [London, Stephanie J.] NIEHS, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Dept Internal Med, Detroit, MI USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Partners Healthcare System; Jackson Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; University of California System; University of California San Francisco; Henry Ford Health System; Henry Ford Hospital; University of Southern California; Johns Hopkins University; World Health Organization; International Agency for Research on Cancer (IARC); National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Wisconsin System; University of Wisconsin Madison; Kaiser Permanente; University of California System; University of California San Diego; Washington University (WUSTL); University of Arizona; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Brigham & Women's Hospital; University of Groningen; University of Groningen; University of Groningen; University of Vermont; Wake Forest University; RIKEN; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Henry Ford Health System; Henry Ford Hospital	Himes, BE (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	blanca.himes@channing.harvard.edu	Raby, Benjamin/AAK-3866-2021; Tamari, Mayumi/N-5378-2015; Vonk, Judith/K-8477-2019; Koppelman, Gerard/AAG-9187-2020; Churchill, Gary/AAY-7496-2020; London, Stephanie/C-3734-2019; Kubo, Michiaki/N-7947-2015; Vonk, Judith M/ABA-3009-2020	Vonk, Judith/0000-0001-7531-4547; Churchill, Gary/0000-0001-9190-9284; London, Stephanie/0000-0003-4911-5290; Vonk, Judith M/0000-0001-7531-4547; Litonjua, Augusto/0000-0003-0422-5875; Szefler, Stanley/0000-0002-6911-3199; Ober, Carole/0000-0003-4626-9809; Sheppard, Keith/0000-0003-0842-9365; Koppelman, Gerard/0000-0001-8567-3252; Nicolae, Dan/0000-0002-0918-4630; Zeiger, Robert/0000-0001-5788-5063	NHLBI, National Institutes of Health (NIH) [U01 HL075419, U01 HL65899, P01 HL083069, R01 HL086601, T32 HL07427]; NIH [U01 HL65899, U10 HL064287, U10 HL064288, U10 HL064295, U10 HL064305, U10 HL064307, U01 HL064313, RC2 HL101487, R01 HL087699, K99 HL105663]; NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; BioBank Japan project; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; American Asthma Foundation; Fund for Henry Ford Hospital; NIH from the National Institute of Allergy and Infectious Diseases (NIAID) [R01AI079139, R01AI061774]; Mary Beryl Patch Turnbull Scholar Program; Division of Intramural Research, National Institute of Environmental Health Sciences; Netherlands Asthma Foundation grant AF [AF 95.09, AF 98.48, AF 3.2.02.51, AF 3.2.07.015]; University Medical Center Groningen; Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences; Royal Netherlands Academy of Arts and Sciences Honorary Professorship; National Heart, Lung and Blood Institute (NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, U10HL064307, R01HL087699, RC2HL101487, U10HL064313, K99HL105663, U01HL065899, U10HL064295, U10HL064305, U10HL064288, U10HL064287, R00HL105663, P01HL083069, R01HL086601, U01HL075419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061390, U01GM061390] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; BioBank Japan project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); American Asthma Foundation; Fund for Henry Ford Hospital; NIH from the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mary Beryl Patch Turnbull Scholar Program; Division of Intramural Research, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Netherlands Asthma Foundation grant AF; University Medical Center Groningen; Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences; Royal Netherlands Academy of Arts and Sciences Honorary Professorship; National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL086601, and T32 HL07427 from the NHLBI, National Institutes of Health (NIH). Additional support was provided by NIH U10 HL064287, U10 HL064288, U10 HL064295, U10 HL064305, U10 HL064307, U01 HL064313, RC2 HL101487, R01 HL087699 and U01 HL65899, an NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance and by funding from the BioBank Japan project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. We thank the American Lung Association Asthma Clinical Research Centers (ALA-ACRC) for use of LOCCS and LODO study samples. B.E.H. was supported by NIH K99 HL105663. L.K.W. is funded by the American Asthma Foundation, the Fund for Henry Ford Hospital, and by NIH R01AI079139 and R01AI061774 from the National Institute of Allergy and Infectious Diseases (NIAID). K.C.B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program. S.J.L. is supported by the Division of Intramural Research, National Institute of Environmental Health Sciences. D.A.G. was supported by the Netherlands Asthma Foundation grant AF (AF 95.09, AF 98.48, AF 3.2.02.51 and AF 3.2.07.015) and a grant from the University Medical Center Groningen. GHK was supported by a Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences. D.S.P. was supported by a Royal Netherlands Academy of Arts and Sciences Honorary Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all CAMP subjects for their ongoing participation in this study. We acknowledge the CAMP investigators and research team, supported by the National Heart, Lung and Blood Institute (NHLBI), for collection of CAMP Genetic Ancillary Study data. All work on data collected from the CAMP Genetic Ancillary Study was conducted at the Channing Laboratory of the Brigham and Women's Hospital under appropriate CAMP policies and human subject's protections. We acknowledge the following GALA 1 investigators: Michael A. LeNoir, MD (Bay Area Pediatrics, Oakland, CA, USA), Harold J. Farber, MD (Section of Pulmonology, Baylor College of Medicine, Houston, TX, USA), Rajesh Kumar, MD, MPH (Division of Allergy and Immunology, Children's Memorial Hospital, Chicago, IL, USA), Pedro C. Avila, MD (Department of Medicine, Northwestern University, Chicago, IL, USA), Kelley Meade, MD (Children's Hospital of Oakland, Oakland, CA, USA), Denise Serebrisky, MD (Jacobi Medical Center and Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA), Shannon Thyne, MD (Department of Medicine, University of California, San Francisco, San Francisco, CA, USA), William Rodriguez-Cintron, MD (Veterans Affairs Medical Center, San Juan, Puerto Rico), Jose R. Rodriguez-Santana, MD (Centro de Neumologia Pediatrica, San Juan, Puerto Rico), Luisa N. Borrell, DDS, PhD (Department of Health Sciences, Lehman College, City University of New York, New York, NY, USA).	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Akinbami O.J., 2012, TRENDS ASTHMA PREVAL; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], GLOB STRAT DIAGN MAN; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Eleftherohorinou H, 2011, HUM MOL GENET, V20, P3494, DOI 10.1093/hmg/ddr248; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; Hong MG, 2012, HUM MUTAT, V33, P521, DOI 10.1002/humu.22009; Irvin CG, 2007, AM J RESP CRIT CARE, V175, P235, DOI 10.1164/rccm.200603-416OC; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kim SH, 2009, CLIN EXP ALLERGY, V39, P203, DOI 10.1111/j.1365-2222.2008.03117.x; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Lasky-Su J, 2012, CLIN EXP ALLERGY, V42, P1724, DOI 10.1111/cea.12000; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Myers RA, 2012, J ALLERGY C IN PRESS; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Szefler SJ, 2012, THORAX, V67, P450, DOI 10.1136/thoraxjnl-2012-201876; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Ten Broeke R, 2004, CLIN EXP ALLERGY, V34, P170; Ten Broeke R, 2003, EUR J PHARMACOL, V476, P151, DOI 10.1016/S0014-2999(03)02016-8; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Vonk JM, 2010, PHARMACOGENET GENOM, V20, P179, DOI 10.1097/FPC.0b013e328336c7fd; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WillsKarp M, 1997, AM J RESP CRIT CARE, V156, pS89, DOI 10.1164/ajrccm.156.4.12-tac-3; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Xu JF, 2001, AM J HUM GENET, V68, P1437, DOI 10.1086/320589; Xu X, 2001, AM J HUM GENET, V69, P1271, DOI 10.1086/324650; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201; Zhang YM, 1999, HUM MOL GENET, V8, P601, DOI 10.1093/hmg/8.4.601; Zosky GR, 2008, CLIN EXP ALLERGY, V38, P829, DOI 10.1111/j.1365-2222.2007.02884.x	57	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56179	10.1371/journal.pone.0056179	http://dx.doi.org/10.1371/journal.pone.0056179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457522	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000315602700056
J	Chen, XL; Anel, JA; Su, ZB; de la Torre, L; Kelder, H; van Peet, J; Ma, YM				Chen, Xuelong; Anel, Juan A.; Su, Zhongbo; de la Torre, Laura; Kelder, Hennie; van Peet, Jacob; Ma, Yaoming			The Deep Atmospheric Boundary Layer and Its Significance to the Stratosphere and Troposphere Exchange over the Tibetan Plateau	PLOS ONE			English	Article							GLOBAL WATER CYCLE; LAGRANGIAN ANALYSIS; ASIAN MONSOON; SURFACE OZONE; EVOLUTION; TRANSPORT; SUMMER; CHINA; AIR; CONVECTION	In this study the depth of the atmospheric boundary layer (ABL) over the Tibetan Plateau was measured during a regional radiosonde observation campaign in 2008 and found to be deeper than indicated by previously measurements. Results indicate that during fair weather conditions on winter days, the top of the mixed layers can be up to 5 km above the ground (9.4 km above sea level). Measurements also show that the depth of the ABL is quite distinct for three different periods (winter, monsoon-onset, and monsoon seasons). Turbulence at the top of a deep mixing layer can rise up to the upper troposphere. As a consequence, as confirmed by trajectory analysis, interaction occurs between deep ABLs and the low tropopause during winter over the Tibetan Plateau.	[Chen, Xuelong; Ma, Yaoming] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China; [Chen, Xuelong; Su, Zhongbo] Univ Twente, Fac Geoinformat Sci & Earth Observat, NL-7500 AE Enschede, Netherlands; [Anel, Juan A.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England; [Anel, Juan A.; de la Torre, Laura] Univ Vigo, Fac Sci, EPhysLab, Orense, Spain; [Kelder, Hennie] Eindhoven Univ, Eindhoven, Netherlands; [van Peet, Jacob] Royal Netherlands Meteorol Inst KNMI, Utricht, Netherlands	Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; University of Twente; University of Oxford; Universidade de Vigo; Eindhoven University of Technology; Royal Netherlands Meteorological Institute	Ma, YM (corresponding author), Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China.	ymma@itpcas.ac.cn	, Juan Antonio Añel Cabanelas/N-1866-2019; de la Torre, Laura/Y-3723-2019; Su, Z. (Bob)/D-4383-2009; Chen, Xuelong/C-2748-2014; Chen, Xuelong/AAF-6616-2019	, Juan Antonio Añel Cabanelas/0000-0003-2448-4647; de la Torre, Laura/0000-0001-5305-6946; Chen, Xuelong/0000-0003-3892-5298; Chen, Xuelong/0000-0003-3892-5298; van Peet, J.C.A./0000-0002-8979-5000; Su, Zhongbo/0000-0003-2096-1733	Chinese National Key Programme for Developing Basic Sciences [2010CB951701]; Chinese National Natural Science Foundation [40825015, 40810059006]; KNAW; European Regional Development Fund	Chinese National Key Programme for Developing Basic Sciences; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); KNAW; European Regional Development Fund(European Commission)	This research was funded by the Chinese National Key Programme for Developing Basic Sciences (2010CB951701), and the Chinese National Natural Science Foundation (40825015 and 40810059006). Xuelong Chen acknowledges the support of KNAW. The authors thank all the participants from China and Japan for their work during the JICA Tibetan Plateau meteorological observations. Laura de la Torre was partially supported by the European Regional Development Fund. The funders played no part in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. No additional external funding was received for this study.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Anel JC, 2012, SCI WORLD J, V2012, P1; Anel JA, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009697; Ao CO, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017598; Bergman JW, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016992; Betts AK, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000158; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; Callies J, 2000, ESA BULL-EUR SPACE, P28; Chen B, 2012, ATMOS CHEM PHYS, V12, P5827, DOI 10.5194/acp-12-5827-2012; [陈闯 Chen Chuang], 2012, [高原气象, Plateau Meteorology], V31, P295; Chen XL, 2011, ATMOS CHEM PHYS, V11, P5113, DOI 10.5194/acp-11-5113-2011; Cooper OR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005783; Cuesta J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009417; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Fan SJ, 2011, ATMOS CHEM PHYS, V11, P6297, DOI 10.5194/acp-11-6297-2011; Fu R, 2006, P NATL ACAD SCI USA, V103, P5664, DOI 10.1073/pnas.0601584103; Gamo M, 1996, BOUND-LAY METEOROL, V79, P265, DOI 10.1007/BF00119441; GAO YX, 1981, B AM METEOROL SOC, V62, P31, DOI 10.1175/1520-0477(1981)062<0031:SAORRO>2.0.CO;2; Griffiths M, 2000, Q J ROY METEOR SOC, V126, P125, DOI 10.1002/qj.49712656207; Hennemuth B, 2006, BOUND-LAY METEOROL, V120, P181, DOI [10.1007/s10546-005-9035-3, 10.1007/S10546-005-9035-3]; Holzworth G.C., 1964, MON WEATHER REV, V92, P235, DOI [DOI 10.1175/1520-0493(1964)092<0235:EOMMMD>2.3.CO;2, 10.1175/1520-0493(1964)092%3C0235:eommmd%3E2.3.co;2, DOI 10.1175/1520-0493(1964)0922.3.CO;2]; Hu XM, 2012, ATMOS ENVIRON, V46, P354, DOI 10.1016/j.atmosenv.2011.09.054; JOHNSON WB, 1981, ATMOS ENVIRON, V15, P1309, DOI 10.1016/0004-6981(81)90325-5; Ladstatter-Weissenmayer A, 2004, ATMOS CHEM PHYS, V4, P903, DOI 10.5194/acp-4-903-2004; Langford AO, 1998, J GEOPHYS RES-ATMOS, V103, P31265, DOI 10.1029/98JD02596; [李茂善 LI Maoshan], 2006, [高原气象, Plateau Meteorology], V25, P807; Li Y, 2007, ARCT ANTARCT ALP RES, V39, P708, DOI 10.1657/1523-0430(07-504)[LI]2.0.CO;2; Lin JT, 2008, ATMOS ENVIRON, V42, P8470, DOI 10.1016/j.atmosenv.2008.08.012; Ma Y, 2009, HYDROL EARTH SYST SC, V13, P1103, DOI 10.5194/hess-13-1103-2009; Ma YM, 2002, HYDROL PROCESS, V16, P2963, DOI 10.1002/hyp.1079; Randel WJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007904; Rao ST, 2003, PURE APPL GEOPHYS, V160, P21, DOI 10.1007/s00024-003-8764-9; Rodgers C. D, 2000, INVERSE METHODS ATMO; Santanello JA, 2005, J APPL METEOROL, V44, P917, DOI 10.1175/JAM2240.1; Seibert P, 2000, ATMOS ENVIRON, V34, P1001, DOI 10.1016/S1352-2310(99)00349-0; Seidel DJ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018143; Skerlak B, 2012, GLOBAL ERA INTERIM C, P1249; Sprenger M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002587; STENSRUD DJ, 1993, J ATMOS SCI, V50, P2284, DOI 10.1175/1520-0469(1993)050<2284:ERLATI>2.0.CO;2; Stohl A, 2005, J HYDROMETEOROL, V6, P961, DOI 10.1175/JHM470.1; Stohl A, 2004, J HYDROMETEOROL, V5, P656, DOI 10.1175/1525-7541(2004)005<0656:ALAOTA>2.0.CO;2; Stull R.B., 1988, ATMOSPHERIC OCEANOGR; Sun FL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029484; TAO SY, 1981, B AM METEOROL SOC, V62, P23, DOI 10.1175/1520-0477(1981)062<0023:OEOTIO>2.0.CO;2; von Engeln A, 2006, ATMOSPHERE AND CLIMATE: STUDIES BY OCCULTATION METHODS, P265; Wang T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006527; WMO, 1957, WMO B, V6, P134; Xu GR, 2009, TORRENTIAL RAIN DISA, V28, P112; Xu XD, 2002, SCI CHINA SER D, V45, P577, DOI 10.1360/02yd9060; Xu XD, 2008, B AM METEOROL SOC, V89, P1492, DOI 10.1175/2008BAMS2557.1; YANAI M, 1994, MON WEATHER REV, V122, P305, DOI 10.1175/1520-0493(1994)122<0305:MOHATB>2.0.CO;2; YANAI MH, 1992, J METEOROL SOC JPN, V70, P319, DOI 10.2151/jmsj1965.70.1B_319; Yang K, 2004, J METEOROL SOC JPN, V82, P1777, DOI 10.2151/jmsj.82.1777; Yang X, 1999, J GEOPHYS RES-ATMOS, V104, P30341, DOI 10.1029/1999JD900810; Zhang GZ, 2003, ADV ATMOS SCI, V20, P349, DOI 10.1007/BF02690793; Zhang J, 1999, J APPL METEOROL, V38, P1674, DOI 10.1175/1520-0450(1999)038<1674:TROVMI>2.0.CO;2; Zhang Q, 2011, SCI CHINA EARTH SCI, V54, P1586, DOI 10.1007/s11430-011-4207-0; Zhou X., 2006, J METEOROL RES-PRC, V20, P129; Zuo HC, 2005, PROG NAT SCI-MATER, V15, P239	59	42	48	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56909	10.1371/journal.pone.0056909	http://dx.doi.org/10.1371/journal.pone.0056909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451108	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500042
J	Cunha, DB; de Souza, BDN; Pereira, RA; Sichieri, R				Cunha, Diana B.; de Souza, Barbara da S. N.; Pereira, Rosangela A.; Sichieri, Rosely			Effectiveness of a Randomized School-Based Intervention Involving Families and Teachers to Prevent Excessive Weight Gain among Adolescents in Brazil	PLOS ONE			English	Article							OBESITY PREVENTION; CHILDHOOD OBESITY; FOOD-CONSUMPTION; CHILDREN; BEHAVIOR; PROGRAM; US; METAANALYSIS; OVERWEIGHT; STRATEGIES	Objective: To evaluate the effectiveness of a school-based intervention involving the families and teachers that aimed to promote healthy eating habits in adolescents; the ultimate aim of the intervention was to reduce the increase in body mass index (BMI) of the students. Design: Paired cluster randomized school-based trial conducted with a sample of fifth graders. Setting: Twenty classes were randomly assigned into either an intervention group or a control group. Participants: From a total of 574 eligible students, 559 students participated in the study (intervention: 10 classes with 277 participants; control: 10 classes with 282 participants). The mean age of students was 11 years. Intervention: Students attended 9 nutritional education sessions during the 2010 academic year. Parents/guardians and teachers received information on the same subjects. Main Outcome Measurement: Changes in BMI and percentage of body fat. Results: Intention-to-treat analysis showed that changes in BMI were not significantly different between the 2 groups (beta = 0.003; p = 0.75). There was a major reduction in the consumption of sugar-sweetened beverages and cookies in the intervention group; students in this group also consumed more fruits. Conclusion: Encouraging the adoption of healthy eating habits promoted important changes in the adolescent diet, but this did not lead to a reduction in BMI gain. Strategies based exclusively on the quality of diet may not reduce weight gain among adolescents.	[Cunha, Diana B.; de Souza, Barbara da S. N.; Sichieri, Rosely] Univ Estado Rio De Janeiro, Dept Social Med, Rio De Janeiro, Brazil; [Pereira, Rosangela A.] Univ Fed Rio de Janeiro, Dept Nutr, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Cunha, DB (corresponding author), Univ Estado Rio De Janeiro, Dept Social Med, Rio De Janeiro, Brazil.	dianabcunha@gmail.com	Pereira, Rosangela Alves/D-8830-2013	Pereira, Rosangela Alves/0000-0002-9886-9796	Foundation of Support of Research of the State of Rio de Janeiro - FAPERJ [E261029422008]; National Counsel of Technological and Scientific Development - CNPQ [474288/2009-9]; Pan American Health and Education Foundation - PAHEF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	Foundation of Support of Research of the State of Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Counsel of Technological and Scientific Development - CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pan American Health and Education Foundation - PAHEF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Foundation of Support of Research of the State of Rio de Janeiro - FAPERJ (E261029422008); National Counsel of Technological and Scientific Development - CNPQ (474288/2009-9); Pan American Health and Education Foundation - PAHEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MC, 2010, J AM DIET ASSOC, V110, P1170, DOI 10.1016/j.jada.2010.05.008; Baranowski T, 2010, NEW ENGL J MED, V363, P443, DOI 10.1056/NEJMoa1001933; Bertin Renata Labronici, 2008, Rev. Bras. Saude Mater. Infant., V8, P435, DOI 10.1590/S1519-38292008000400009; Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-22; Brug J, 2010, PUBLIC HEALTH NUTR, V13, P1676, DOI 10.1017/S1368980010002211; Bruss MB, 2010, INT J ED POLICY LEAD, P5; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Chan SF, 2004, CONTROL CLIN TRIALS, V25, P408, DOI 10.1016/j.cct.2004.06.001; Vargas ICD, 2011, REV SAUDE PUBL, V45, P59, DOI 10.1590/S0034-89102011000100007; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Donnelly JE, 2009, PREV MED, V49, P336, DOI 10.1016/j.ypmed.2009.07.022; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Freire P, 2015, PEDAGOGY INDIGNATION; Gonzalez-Suarez C, 2009, AM J PREV MED, V37, P418, DOI 10.1016/j.amepre.2009.07.012; Gordon CC, 1988, ANTHR STAND REF MANU, P3; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Greening L, 2011, OBESITY, V19, P1213, DOI 10.1038/oby.2010.329; Hoffman JA, 2011, PREV MED, V52, P370, DOI 10.1016/j.ypmed.2011.02.013; IBGE, 2011, NAT HOUS BUDG SURV 2; IBGE, 2000, DEM CENS; Jansen W, 2011, INT J PEDIATR OBES, V6, pE70, DOI 10.3109/17477166.2011.575151; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x; Leal Greisse Viero da Silva, 2010, Rev. bras. epidemiol., V13, P457, DOI 10.1590/S1415-790X2010000300009; Ledoux TA, 2011, OBES REV, V12, pe143, DOI 10.1111/j.1467-789X.2010.00786.x; Levy RB, 2010, CIENC SAUDE COLETIVA, V15, P3085, DOI 10.1590/S1413-81232010000800013; Lubans DR, 2012, ARCH PEDIAT ADOL MED, V166, P821, DOI 10.1001/archpediatrics.2012.41; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McLanahan P, 2006, CHILDHOOD OBESITY TH; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; MUST A, 1991, AM J CLIN NUTR, V53, P839, DOI 10.1093/ajcn/53.4.839; Neumark-Sztainer DR, 2010, AM J PREV MED, V39, P421, DOI 10.1016/j.amepre.2010.07.017; Piantadosi S, 2005, WILEY SER PROBAB ST, P251; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Puder JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6195; Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1-17, 10.1301/nr.2004.jan.1&ndash;17, 10.1111/j.1753-4887.2004.tb00001.x]; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Seo DC, 2010, J ADOLESCENT HEALTH, V46, P309, DOI 10.1016/j.jadohealth.2009.11.202; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Sichieri R, 2008, CAD SAUDE PUBLICA, V24, pS209, DOI 10.1590/S0102-311X2008001400002; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Singhal N, 2010, EUR J CLIN NUTR, V64, P364, DOI 10.1038/ejcn.2009.150; Stice E, 2006, PSYCHOL BULL, V132, P667, DOI 10.1037/0033-2909.132.5.667; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Thivel D, 2011, EUR J PEDIATR, V170, P1435, DOI 10.1007/s00431-011-1466-x; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; Toral N, 2007, REV NUTR, V20, P449, DOI 10.1590/S1415-52732007000500001; Utter J, 2011, OBES REV, V12, P51, DOI 10.1111/j.1467-789X.2011.00905.x; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Vos RC, 2011, QUAL LIFE RES; WHO, 2009, ANTHROPLUS PERS COMP	51	46	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57498	10.1371/journal.pone.0057498	http://dx.doi.org/10.1371/journal.pone.0057498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451237	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500110
J	Dalquen, DA; Altenhoff, AM; Gonnet, GH; Dessimoz, C				Dalquen, Daniel A.; Altenhoff, Adrian M.; Gonnet, Gaston H.; Dessimoz, Christophe			The Impact of Gene Duplication, Insertion, Deletion, Lateral Gene Transfer and Sequencing Error on Orthology Inference: A Simulation Study	PLOS ONE			English	Article							EUKARYOTIC GENOMES; PROTEIN FAMILIES; EVOLUTION; IDENTIFICATION; PERFORMANCE; FRAMEWORK; PARALOGS	The identification of orthologous genes, a prerequisite for numerous analyses in comparative and functional genomics, is commonly performed computationally from protein sequences. Several previous studies have compared the accuracy of orthology inference methods, but simulated data has not typically been considered in cross-method assessment studies. Yet, while dependent on model assumptions, simulation-based benchmarking offers unique advantages: contrary to empirical data, all aspects of simulated data are known with certainty. Furthermore, the flexibility of simulation makes it possible to investigate performance factors in isolation of one another. Here, we use simulated data to dissect the performance of six methods for orthology inference available as standalone software packages (Inparanoid, OMA, OrthoInspector, OrthoMCL, QuartetS, SPIMAP) as well as two generic approaches (bidirectional best hit and reciprocal smallest distance). We investigate the impact of various evolutionary forces (gene duplication, insertion, deletion, and lateral gene transfer) and technological artefacts (ambiguous sequences) on orthology inference. We show that while gene duplication/loss and insertion/deletion are well handled by most methods (albeit for different trade-offs of precision and recall), lateral gene transfer disrupts all methods. As for ambiguous sequences, which might result from poor sequencing, assembly, or genome annotation, we show that they affect alignment score-based orthology methods more strongly than their distance-based counterparts.	[Dalquen, Daniel A.; Altenhoff, Adrian M.; Gonnet, Gaston H.; Dessimoz, Christophe] Eldgenoss Tech Hsch Zurich, Dept Comp Sci, Zurich, Switzerland; [Dalquen, Daniel A.; Altenhoff, Adrian M.; Gonnet, Gaston H.; Dessimoz, Christophe] Swiss Inst Bioinformat, Zurich, Switzerland; [Dessimoz, Christophe] European Bioinformat Inst, Cambridge, England	Swiss Institute of Bioinformatics; European Molecular Biology Laboratory (EMBL)	Dalquen, DA (corresponding author), Eldgenoss Tech Hsch Zurich, Dept Comp Sci, Zurich, Switzerland.	ddalquen@ethz.ch; dessimoz@ebi.ac.uk	Altenhoff, Adrian Michael/P-5024-2019; Dessimoz, Christophe/D-3678-2011	Altenhoff, Adrian Michael/0000-0001-7492-1273; Dessimoz, Christophe/0000-0002-2170-853X	Eldgenossische Technische Hochschule Independent Investigators' Research Award; Swiss National Science Foundation [136461]	Eldgenossische Technische Hochschule Independent Investigators' Research Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Part of the work was funded by an Eldgenossische Technische Hochschule Independent Investigators' Research Award to GHG and CD, and by a Swiss National Science Foundation advanced researcher fellowship (#136461) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Altenhoff AM, 2012, METHODS MOL BIOL, V855, P259, DOI 10.1007/978-1-61779-582-4_9; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altenhoff AM, 2012, GRAPH BASED AL UNPUB; BENNER SA, 1993, J MOL BIOL, V229, P1065, DOI 10.1006/jmbi.1993.1105; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dalquen DA, 2012, MOL BIOL EVOL, V29, P1115, DOI 10.1093/molbev/msr268; Dessimoz C, 2012, OMA STANDALONE CLIEN; Dessimoz C, 2006, NUCLEIC ACIDS RES, V34, P3309, DOI 10.1093/nar/gkl433; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linard B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-11; Milinkovitch MC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r16; Ohno S., 1970, EVOLUTION GENE DUPLI; Rasmussen MD, 2011, MOL BIOL EVOL, V28, P273, DOI 10.1093/molbev/msq189; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Sennblad B, 2009, SYST BIOL, V58, P411, DOI 10.1093/sysbio/syp046; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yu CG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr308; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	32	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56925	10.1371/journal.pone.0056925	http://dx.doi.org/10.1371/journal.pone.0056925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451112	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500044
J	Lee, YR; Yu, DS; Liang, YC; Huang, KF; Chou, SJ; Chen, TC; Lee, CC; Chen, CL; Chiou, SH; Huang, HS				Lee, Yu-Ru; Yu, Dah-Shyong; Liang, Ya-Chun; Huang, Kuo-Feng; Chou, Shih-Jie; Chen, Tsung-Chih; Lee, Chia-Chung; Chen, Chun-Liang; Chiou, Shih-Hwa; Huang, Hsu-Shan			New Approaches of PARP-1 Inhibitors in Human Lung Cancer Cells and Cancer Stem-Like Cells by Some Selected Anthraquinone-Derived Small Molecules	PLOS ONE			English	Article							HUMAN TELOMERASE INHIBITION; POLY(ADP-RIBOSE) POLYMERASE-1 PARP-1; RAPID COLORIMETRIC ASSAY; ANTICANCER DRUG SCREEN; ADP-RIBOSE POLYMERASE; CYTOTOXICITY; DERIVATIVES; ROLES; ADENOCARCINOMA; IDENTIFICATION	Poly (ADP-ribose) polymerase-1 (PARP-1) and telomerase, as well as DNA damage response pathways are targets for anticancer drug development, and specific inhibitors are currently under clinical investigation. The purpose of this work is to evaluate anticancer activities of anthraquinone-derived tricyclic and tetracyclic small molecules and their structure-activity relationships with PARP-1 inhibition in non-small cell lung cancer (NSCLC) and NSCLC-overexpressing Oct4 and Nanog clone, which show high-expression of PARP-1 and more resistance to anticancer drug. We applied our library selected compounds to NCI's 60 human cancer cell-lines (NCI-60) in order to generate systematic profiling data. Based on our analysis, it is hypothesized that these drugs might be, directly and indirectly, target components to induce mitochondrial permeability transition and the release of pro-apoptotic factors as potential anti-NSCLC or PARP inhibitor candidates. Altogether, the most active NSC747854 showed its cytotoxicity and dose-dependent PARP inhibitory manner, thus it emerges as a promising structure for anti-cancer therapy with no significant negative influence on normal cells. Our studies present evidence that telomere maintenance should be taken into consideration in efforts not only to overcome drug resistance, but also to optimize the use of telomere-based therapeutics. These findings will be of great value to facilitate structure-based design of selective PARP inhibitors, in general, and telomerase inhibitors, in particular. Together, the data presented here expand our insight into the PARP inhibitors and support the resource-demanding lead optimization of structurally related small molecules for human cancer therapy.	[Lee, Yu-Ru; Chen, Tsung-Chih; Lee, Chia-Chung; Chen, Chun-Liang; Huang, Hsu-Shan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yu, Dah-Shyong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Liang, Ya-Chun; Huang, Hsu-Shan] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Yu, Dah-Shyong] Triserv Gen Hosp, Urooncol Lab, Div Urol, Dept Surg, Taipei, Taiwan; [Huang, Hsu-Shan] Triserv Gen Hosp, Dept Pharm Practice, Taipei, Taiwan; [Huang, Kuo-Feng; Chou, Shih-Jie] Chi Mei Med Ctr, Tainan, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; Chi Mei Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chiou, SH (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.	shchiou@vghtpe.gov.tw; huanghs@ndmctsgh.edu.tw	Park, Chankyu/C-1936-2011	CHEN, Tsung-Chih/0000-0001-8256-6240; Huang, Hsu-Shan/0000-0001-8162-5608	National Science Council [NSC99-2113-M-016-001, NSC100-2113-M-016-001, NSC 97-3111-B-075-001-MY3, CMNDMC10101]; NIH-NCI	National Science Council(Ministry of Science and Technology, Taiwan); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present study was supported by National Science Council Grants NSC99-2113-M-016-001, NSC100-2113-M-016-001 and NSC 97-3111-B-075-001-MY3 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by National Science Council Grants NSC100-2113-M-016-001, NSC97-3111-B-075-001-MY3 and CMNDMC10101, respectively. We are grateful to NIH-NCI for their support and also wish to thank the stem cell project of Taipei Veterans General Hospital, Taipei, Taiwan.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Bradshaw TD, 2005, CANCER RES, V65, P3911, DOI 10.1158/0008-5472.CAN-04-4141; Castiel A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-412; Cepeda V, 2006, RECENT PAT ANTI-CANC, V1, P39, DOI 10.2174/157489206775246430; Chang YL, 2011, INT J BIOCHEM CELL B, V43, P1720, DOI 10.1016/j.biocel.2011.08.006; Chen CL, 2013, EUR J MED CHEM, V60, P29, DOI 10.1016/j.ejmech.2012.11.032; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cheng MH, 2012, ANTI-CANCER DRUG, V23, P191, DOI 10.1097/CAD.0b013e32834cd277; Chevanne M, 2010, J CELL PHYSIOL, V222, P401, DOI 10.1002/jcp.21964; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clark GR, 2003, J AM CHEM SOC, V125, P4066, DOI 10.1021/ja0297988; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ferraris D, 2003, BIOORGAN MED CHEM, V11, P3695, DOI 10.1016/S0968-0896(03)00333-X; Gartner EM, 2010, CANCER J, V16, P83, DOI 10.1097/PPO.0b013e3181d78223; Guyen B, 2004, ORG BIOMOL CHEM, V2, P981, DOI 10.1039/b316055f; Haider SM, 2003, J MOL BIOL, V326, P117, DOI 10.1016/S0022-2836(02)01354-2; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Huang HS, 2006, CHEM PHARM BULL, V54, P458, DOI 10.1248/cpb.54.458; Huang HS, 2005, BIOORGAN MED CHEM, V13, P1435, DOI 10.1016/j.bmc.2004.12.036; Huang HS, 2004, BIOORGAN MED CHEM, V12, P6163, DOI 10.1016/j.bmc.2004.09.001; Huang HS, 2008, BIOORGAN MED CHEM, V16, P6976, DOI 10.1016/j.bmc.2008.05.072; Huang HS, 2007, CHEM PHARM BULL, V55, P284, DOI 10.1248/cpb.55.284; Huang HS, 2010, ANTI-CANCER DRUG, V21, P169, DOI 10.1097/CAD.0b013e3283324d0a; Huang HS, 2009, BIOORGAN MED CHEM, V17, P7418, DOI 10.1016/j.bmc.2009.09.033; Iwasaki H, 2006, CANCER CHEMOTH PHARM, V58, P451, DOI 10.1007/s00280-005-0183-4; Iwasaki H, 2010, CANCER CHEMOTH PHARM, V65, P719, DOI 10.1007/s00280-009-1077-7; Jagtap P, 2002, CRIT CARE MED, V30, P1071, DOI 10.1097/00003246-200205000-00019; Jones C, 2008, BRIT J RADIOL, V81, pS2, DOI 10.1259/bjr/30872348; Kanjanabuch T, 2007, KIDNEY INT, V71, P1232, DOI 10.1038/sj.ki.5002248; Kaye SB, 2012, J CLIN ONCOL, V30, P372, DOI 10.1200/JCO.2011.36.9215; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kruse V, 2011, ACTA CLIN BELG, V66, P2, DOI 10.1179/ACB.66.1.2062507; Lee CC, 2012, EUR J MED CHEM, V47, P323, DOI 10.1016/j.ejmech.2011.10.059; Lin SG, 2003, ARCH BIOCHEM BIOPHYS, V418, P99, DOI 10.1016/j.abb.2003.08.004; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Mattson MP, 2001, J NEUROSCI RES, V63, P1; Mertins SD, 2004, MOL CANCER THER, V3, P849; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Monks A, 1997, ANTI-CANCER DRUG DES, V12, P533; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munoz-Gamez JA, 2005, BIOCHEM J, V386, P119, DOI 10.1042/BJ20040776; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Nguyen TL, 2006, BIOORGAN MED CHEM, V14, P6097, DOI 10.1016/j.bmc.2006.05.001; Nukuzuma S, 2012, J MED VIROL; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; Perry PJ, 1998, J MED CHEM, V41, P3253, DOI 10.1021/jm9801105; Perry PJ, 1998, J MED CHEM, V41, P4873, DOI 10.1021/jm981067o; POHLE W, 1990, BIOPHYS CHEM, V35, P213, DOI 10.1016/0301-4622(90)80010-5; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SIKIC BI, 1991, J NATL CANCER I, V83, P738, DOI 10.1093/jnci/83.11.738; Smith V, 2009, J CHEMOTHERAPY, V21, P542, DOI 10.1179/joc.2009.21.5.542; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	62	67	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56284	10.1371/journal.pone.0056284	http://dx.doi.org/10.1371/journal.pone.0056284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451039	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500010
J	Matthaei, M; Budt, M; Wolff, T				Matthaei, Markus; Budt, Matthias; Wolff, Thorsten			Highly Pathogenic H5N1 Influenza A Virus Strains Provoke Heterogeneous IFN-alpha/beta Responses That Distinctively Affect Viral Propagation in Human Cells	PLOS ONE			English	Article							LOWER RESPIRATORY-TRACT; I INTERFERON INDUCTION; SINGLE-AMINO-ACID; NF-KAPPA-B; AVIAN-INFLUENZA; NS1 PROTEIN; RIG-I; TRANSCRIPTION FACTORS; RECEPTOR SPECIFICITY; ANTIVIRAL RESPONSES	The fatal transmissions of highly pathogenic avian influenza A viruses (IAV) of the H5N1 subtype to humans and high titer replication in the respiratory tract indicate that these pathogens can overcome the bird-to-human species barrier. While type I interferons (IFN-alpha/beta) are well described to contribute to the species barrier of many zoonotic viruses, current data to the role of these antiviral cytokines during human H5N1 IAV infections is limited and contradictory. We hypothesized an important role for the IFN system in limiting productive infection of avian H5N1 strains in human cells. Hence, we examined IFN-alpha/beta gene activation by different avian and human H5N1 isolates, if the IFN-alpha/beta response restricts H5N1 growth and whether the different strains were equally capable to regulate the IFN-alpha/beta system via their IFN-antagonistic NS1 proteins. Two human H5N1 isolates and a seasonal H3N2 strain propagated efficiently in human respiratory cells and induced little IFN-beta, whereas three purely avian H5N1 strains were attenuated for replication and provoked higher IFN secretion. Replication of avian viruses was significantly enhanced on interferon-deficient cells, and exogenous IFN potently limited the growth of all strains in human cells. Moreover, IFN-alpha/beta activation by all strains depended on retinoic acid-inducible gene I excluding principal differences in receptor activation between the different viruses. Interestingly, all H5N1 NS1 proteins suppressed IFN-alpha/beta induction comparably well to the NS1 of seasonal IAV. Thus, our study shows that H5N1 strains are heterogeneous in their capacity to activate human cells in an NS1-independent manner. Our findings also suggest that H5N1 viruses need to acquire adaptive changes to circumvent strong IFN-alpha/beta activation in human host cells. Since no single amino acid polymorphism could be associated with a respective high- or low induction phenotype we propose that the necessary adaptations to overcome the human IFN-alpha/beta barrier involve mutations in multiple H5N1 genes.	[Matthaei, Markus; Budt, Matthias; Wolff, Thorsten] Robert Koch Inst, Div Influenza Resp Viruses, Berlin, Germany	Robert Koch Institute	Wolff, T (corresponding author), Robert Koch Inst, Div Influenza Resp Viruses, Berlin, Germany.	wolfft@rki.de	Budt, Matthias/E-7735-2018; Matthaei, Markus/G-1230-2010	Budt, Matthias/0000-0001-5960-515X	German Research Council [Wo 554/3-2]; FLURESEARCHNET; German Federal Ministry of Research and Education (BMBF) [01 KI 1006 C]	German Research Council(German Research Foundation (DFG)); FLURESEARCHNET; German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants to TW of the German Research Council (www.dfg.de) (Wo 554/3-2) and FLURESEARCHNET, which is funded by the German Federal Ministry of Research and Education (BMBF grant 01 KI 1006 C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Deng R, 2008, J PATHOL, V216, P328, DOI 10.1002/path.2417; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Didcock L, 1999, J VIROL, V73, P3125, DOI 10.1128/JVI.73.4.3125-3133.1999; Dudek SE, 2011, BIOL CHEM; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gao RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013315; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Haasbach E, 2011, J INTERF CYTOK RES, V31, P515, DOI 10.1089/jir.2010.0071; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayman A, 2007, J VIROL, V81, P2318, DOI 10.1128/JVI.01856-06; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hui KPY, 2011, J INFECT DIS, V204, P1866, DOI 10.1093/infdis/jir665; Imai H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001106; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kalthoff D, 2010, VET MICROBIOL, V140, P237, DOI 10.1016/j.vetmic.2009.08.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Le QM, 2010, J GEN VIROL, V91, P2485, DOI 10.1099/vir.0.021659-0; Lee MH, 2011, J GEN VIROL; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Lycett SJ, 2009, J VIROL, V83, P9901, DOI 10.1128/JVI.00608-09; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Sirinonthanawech N, 2011, J MED VIROL, V83, P1418, DOI 10.1002/jmv.22146; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Terrier O, 2012, VIROLOGY, V432, P204, DOI 10.1016/j.virol.2012.05.019; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Unterstab G, 2005, P NATL ACAD SCI USA, V102, P13640, DOI 10.1073/pnas.0502883102; Valmas C, 2011, J VIROL, V85, P4309, DOI 10.1128/JVI.02575-10; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weinheimer VK, 2012, J INFECT DIS; Wolff T, 2008, BIOL CHEM, V389, P1299, DOI 10.1515/BC.2008.146; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027	100	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56659	10.1371/journal.pone.0056659	http://dx.doi.org/10.1371/journal.pone.0056659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451066	Green Published, gold			2022-12-27	WOS:000316849500021
J	Rackham, CL; Jones, PM; King, AJF				Rackham, Chloe L.; Jones, Peter M.; King, Aileen J. F.			Maintenance of Islet Morphology Is Beneficial for Transplantation Outcome in Diabetic Mice	PLOS ONE			English	Article							MOUSE PANCREATIC-ISLETS; STEM-CELLS PREVENT; EXTRACELLULAR-MATRIX; INSULIN-SECRETION; GRAFT FUNCTION; ISOLATED RAT; BETA-CELLS; SHORT-TERM; REVASCULARIZATION; MASS	We have previously shown that co-transplantation of islets and Mesenchymal Stem Cells (MSCs) improves islet graft function and revascularisation, which was associated with the maintenance of normal islet morphology. The aim of the current study was to determine whether maintaining islet morphology in the absence of additional islet-helper cells would improve transplantation outcome in diabetic mice. Islets were isolated from C57BL/6 mice. Recipient streptozotocin-diabetic C57BL/6 mice were transplanted with a minimal mass of 150 islets as a single pellet or islets that were either manually dispersed or dispersed within a matrigel plug beneath the kidney capsule. Blood glucose concentrations were monitored for one month. Islet graft morphology and vascularisation were analysed by histology. Islets dispersed either alone or within matrigel plugs maintained near normal morphology, in contrast to pelleted islets, where individual islets fused to form large endocrine aggregates. The vascularisation of manually dispersed islets and islets dispersed within matrigel plugs was increased relative to respective control pelleted islet grafts. After one month 1/6 mice transplanted with pelleted islets cured compared to 5/6 mice transplanted with manually dispersed islets. The curative capacity of islets dispersed in matrigel was also better than that of pelleted islets (5/8 islet-matrigel implanted mice vs. 1/7 mice transplanted with pelleted islets cured by one month). Therefore, this study demonstrates that the maintenance of islet morphology is associated with improved graft function and revascularisation in diabetic mice.	[Rackham, Chloe L.; Jones, Peter M.; King, Aileen J. F.] Kings Coll London, Div Diabet & Nutr Sci, Sch Med, Diabet Res Grp, London WC2R 2LS, England	University of London; King's College London	Rackham, CL (corresponding author), Kings Coll London, Div Diabet & Nutr Sci, Sch Med, Diabet Res Grp, London WC2R 2LS, England.	chloe.rackham@kcl.ac.uk	King, Aileen/I-5935-2013; Rackham, Chloe/AAW-3941-2020	King, Aileen/0000-0001-5759-7985; Rackham, Chloe/0000-0003-4314-6109; Jones, Peter/0000-0003-1201-2335	Biotechnology and Biological Sciences Research Council; Novo Nordisk UK Research Foundation; Diabetes UK [06/0003387, 11/0004290]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novo Nordisk UK Research Foundation; Diabetes UK(Diabetes UK)	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (CR), Novo Nordisk UK Research Foundation (A. K) and Diabetes UK (AK, PJ; 06/0003387; 11/0004290) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Carlsson PO, 2011, UPSALA J MED SCI, V116, P1, DOI 10.3109/03009734.2010.548609; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Carvell MJ, 2007, CELL PHYSIOL BIOCHEM, V20, P617, DOI 10.1159/000107545; Christoffersson G, 2010, DIABETES, V59, P2569, DOI 10.2337/db10-0205; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12; Emamaullee JA, 2007, DIABETES, V56, P1289, DOI 10.2337/db06-1653; Figliuzzi M, 2009, TRANSPL P, V41, P1797, DOI 10.1016/j.transproceed.2008.11.015; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Jalili RB, 2011, J CELL PHYSIOL, V226, P1813, DOI 10.1002/jcp.22515; Johansson M, 2009, ENDOCRINOLOGY, V150, P1646, DOI 10.1210/en.2008-1318; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kampf C, 2006, CELL TRANSPLANT, V15, P205, DOI 10.3727/000000006783982124; Kerby A, 2012, CYTOTHERAPY IN PRESS; King A, 2005, DIABETOLOGIA, V48, P2074, DOI 10.1007/s00125-005-1922-0; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lau J, 2009, TRANSPLANTATION, V87, P322, DOI 10.1097/TP.0b013e3181943b3d; Longoni B, 2010, DIABETES TECHNOL THE, V12, P435, DOI 10.1089/dia.2009.0154; Lund T, 2010, J SURG RES, V160, P145, DOI 10.1016/j.jss.2008.11.009; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Mattsson G, 2003, TRANSPLANTATION, V75, P736, DOI 10.1097/01.TP.0000052592.92966.FE; MENGER MD, 1992, EUR SURG RES, V24, P89, DOI 10.1159/000129193; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; Morini S, 2007, J ANAT, V210, P565, DOI 10.1111/j.1469-7580.2007.00717.x; Nagata N, 2001, CELL TRANSPLANT, V10, P447; O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8; Olsson R, 2005, DIABETOLOGIA, V48, P469, DOI 10.1007/s00125-004-1650-x; Perfetti R, 1996, PANCREAS, V13, P47, DOI 10.1097/00006676-199607000-00006; Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Rackham CL, 2012, CYTOTHERAPY IN PRESS; Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; SWARM RL, 1963, J NATL CANCER I, V31, P953; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; VANDEIJNEN JHM, 1992, CELL TISSUE RES, V267, P139, DOI 10.1007/BF00318700; Zhao Y, 2010, TRANSPL P, V42, P4638, DOI 10.1016/j.transproceed.2010.09.154	50	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57844	10.1371/journal.pone.0057844	http://dx.doi.org/10.1371/journal.pone.0057844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451276	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500139
J	Wen, CJ; Long, X; Mu, YF				Wen, Chengjian; Long, Xiang; Mu, Yifen			Adaptive Controller for Dynamic Power and Performance Management in the Virtualized Computing Systems	PLOS ONE			English	Article								Power and performance management problem in large scale computing systems like data centers has attracted a lot of interests from both enterprises and academic researchers as power saving has become more and more important in many fields. Because of the multiple objectives, multiple influential factors and hierarchical structure in the system, the problem is indeed complex and hard. In this paper, the problem will be investigated in a virtualized computing system. Specifically, it is formulated as a power optimization problem with some constraints on performance. Then, the adaptive controller based on least-square self-tuning regulator(LS-STR) is designed to track performance in the first step; and the resource solved by the controller is allocated in order to minimize the power consumption as the second step. Some simulations are designed to test the effectiveness of this method and to compare it with some other controllers. The simulation results show that the adaptive controller is generally effective: it is applicable for different performance metrics, for different workloads, and for single and multiple workloads; it can track the performance requirement effectively and save the power consumption significantly.	[Wen, Chengjian; Long, Xiang] Beihang Univ, Dept Comp Sci & Engn, Beijing, Peoples R China; [Mu, Yifen] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China	Beihang University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Wen, CJ (corresponding author), Beihang Univ, Dept Comp Sci & Engn, Beijing, Peoples R China.	wenchengjian@gmail.com			National High Technology Research and Development Program('863' Program) of China [2007AA01Z118]; Aeronautics Research Funding [20081951033]	National High Technology Research and Development Program('863' Program) of China(National High Technology Research and Development Program of China); Aeronautics Research Funding	The work was supported by National High Technology Research and Development Program('863' Program) of China (2007AA01Z118) and Aeronautics Research Funding (20081951033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers S, 2010, COMMUN ACM, V53, P86, DOI 10.1145/1735223.1735245; ASTROM KJ, 1983, AUTOMATICA, V19, P471, DOI 10.1016/0005-1098(83)90002-X; Bender MA, 2000, P 12 ANN ACM S PAR A, P13; Chen HZ, 2010, IEEE SYS MAN CYBERN, DOI 10.1109/greencom-cpscom.2010.137; Dai XZ, 2008, PROC IEEE INT SYMP, P1018; GUO L, 1994, SIAM J CONTROL OPTIM, V32, P187, DOI 10.1137/S0363012992229604; GUO L, 1991, IEEE T AUTOMAT CONTR, V36, P802; Krishnan Bhavani, 2010, Performance Evaluation Review, V38, P56, DOI 10.1145/1925019.1925031; Kusic D, 2009, CLUSTER COMPUT, V12, P1, DOI 10.1007/s10586-008-0070-y; Lim H, 2011, P 2011 USENIX C USEN, P5; Ljung L., 1999, SYSTEM IDENTIFICATIO; Vengerov D, 2007, ENG APPL ARTIF INTEL, V20, P383, DOI 10.1016/j.engappai.2006.06.019; Wang YF, 2008, REAL TIM SYST SYMP P, P303, DOI 10.1109/RTSS.2008.20; Wen Chengjian, 2010, P 2010 IEEE ACM INT, P163; Wieder U, 2007, SPAA'07: PROCEEDINGS OF THE NINETEENTH ANNUAL SYMPOSIUM ON PARALLELISM IN ALGORITHMS AND ARCHITECTURES, P188; Xu W, 2006, IEEE IFIP NETW OPER, P115, DOI 10.1109/NOMS.2006.1687544	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57551	10.1371/journal.pone.0057551	http://dx.doi.org/10.1371/journal.pone.0057551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451241	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500113
J	Yang, YF; Cao, ZH; Tian, L; Garvey, WT; Cheng, GJ				Yang, Youfeng; Cao, Zehong; Tian, Ling; Garvey, W. Timothy; Cheng, Guangjie			VPO1 Mediates ApoE Oxidation and Impairs the Clearance of Plasma Lipids	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; VASCULAR PEROXIDASE 1; APOLIPOPROTEIN-E; DEFICIENT MICE; CHOLESTEROL EFFLUX; TNF-ALPHA; ATHEROSCLEROSIS; MYELOPEROXIDASE; BINDING; HYPOCHLORITE	Objective: ApoE is an abundant component of chylomicron, VLDL, IDL, and HDL. It binds to multiple types of lipids and is implicated in cholesterol and triglyceride homeostasis. Oxidation of ApoE plays a crucial role in the genesis of atherosclerosis. It is proposed that heme-containing peroxidases (hPx) are major mediators of lipoprotein oxidization. Vascular peroxidase 1 (VPO1) is a recently-discovered hPx, which is expressed in cardiovascular system, lung, liver etc. and secreted into plasma. Its plasma concentration is three orders of magnitude of that of myeloperoxidase. If VPO1 mediates ApoE oxidation and affects the lipid metabolism remains to be elucidated. Methods: Recombinant ApoE and VPO1 were expressed and purified from stably-expressing cell lines deriving from HEK293 cells. ApoE oxidation was carried out by VPO1 in the presence of H2O2 and chloride. ApoE oxidation was verified by a variety of approaches including immunoblot and amino acid analyses. To evaluate the functional changes in VPO1-oxidized ApoE, lipid emulsion particle binding assays were employed. Results: Oxidized ApoE binds weaker to lipid emulsion particles, which mimic the large lipid complexes in vivo. In lipid efflux assay, oxidized ApoE showed reduced capability in efflux of lipids from foam cells. Mice administrated with oxidized ApoE via blood exhibited weaker clearance ability of plasma lipids. Conclusions: Our data suggest that VPO1 is a new mediator regulating lipid homeostasis, implying a role in genesis and development of atherosclerosis.	[Yang, Youfeng; Cao, Zehong; Cheng, Guangjie] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Tian, Ling; Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA; [Garvey, W. Timothy] Birmingham VA Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Cheng, GJ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA.	gjcheng@uab.edu		Cheng, Guangjie/0000-0002-9368-379X	National Heart, Blood, and Lung Institute; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 HL086836, R21AI101642]; National Institutes of Health [DK-083562, DK-038764]; Merit Review program of the Department of Veterans Affairs; UAB Diabetes Research and Training Center [P60-DK079626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, R01DK083562] Funding Source: NIH RePORTER	National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review program of the Department of Veterans Affairs(US Department of Veterans Affairs); UAB Diabetes Research and Training Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Blood, and Lung Institute, and National Institute of Allergy and Infectious Diseases, National Institutes of Health under Award Number R01 HL086836 and R21AI101642 (to GC). WTG was supported by the National Institutes of Health (Award Number DK-083562 and DK-038764), the Merit Review program of the Department of Veterans Affairs, and the UAB Diabetes Research and Training Center (P60-DK079626). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABAEV VR, 1990, ATHEROSCLEROSIS, V85, P239, DOI 10.1016/0021-9150(90)90116-Z; Bai YP, 2011, FREE RADICAL BIO MED, V51, P1492, DOI 10.1016/j.freeradbiomed.2011.07.004; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chantepie S, 2009, ARCH BIOCHEM BIOPHYS, V487, P28, DOI 10.1016/j.abb.2009.05.005; Cheng GJ, 2011, FREE RADICAL BIO MED, V51, P1445, DOI 10.1016/j.freeradbiomed.2011.07.002; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Choy PC, 2004, BIOCHEM CELL BIOL, V82, P212, DOI 10.1139/o03-085; Cox RA., 1990, CLIN METHODS HIST PH, V3rd, P153; Dornelles FN, 2009, J PHARMACOL EXP THER, V330, P756, DOI 10.1124/jpet.109.155762; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gaudreault N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035816; Guzik TJ, 2000, CIRC RES, V86, pE85, DOI 10.1161/01.RES.86.9.e85; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Hasty AH, 1999, J LIPID RES, V40, P1529; Hasty AH, 1999, CIRCULATION, V99, P2571, DOI 10.1161/01.CIR.99.19.2571; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; Itabe H, 2011, J LIPIDS, V2011, DOI 10.1155/2011/418313; Jerlich A, 2000, EUR J BIOCHEM, V267, P4137, DOI 10.1046/j.1432-1327.2000.01449.x; Jolivalt C, 1996, NEUROSCI LETT, V210, P61, DOI 10.1016/0304-3940(96)12661-6; Jolivalt C, 2000, FREE RADICAL BIO MED, V28, P129, DOI 10.1016/S0891-5849(99)00232-4; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Li H, 2012, FREE RADICAL BIO MED, V53, P1954, DOI 10.1016/j.freeradbiomed.2012.08.597; Li H, 2012, INFECT IMMUN, V80, P2528, DOI 10.1128/IAI.06337-11; Lin CY, 1999, J LIPID RES, V40, P1618; LUC G, 1991, AM J CLIN NUTR, V53, pS206, DOI 10.1093/ajcn/53.1.206S; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Malle E, 2006, ARCH BIOCHEM BIOPHYS, V445, P245, DOI 10.1016/j.abb.2005.08.008; Marsche G, 2002, J BIOL CHEM, V277, P32172, DOI 10.1074/jbc.M200503200; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; OBRIEN KD, 1994, AM J PATHOL, V144, P538; Panzenboeck U, 1997, J BIOL CHEM, V272, P29711, DOI 10.1074/jbc.272.47.29711; Park JG, 2011, BMB REP, V44, P497, DOI 10.5483/BMBRep.2011.44.8.497; Pennathur Subramaniam, 2007, Curr Diab Rep, V7, P257, DOI 10.1007/s11892-007-0041-3; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sharp JS, 2007, BIOPHYS J, V92, P1682, DOI 10.1529/biophysj.106.099093; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; SING CF, 1985, AM J HUM GENET, V37, P268; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Smith JD, 1996, J BIOL CHEM, V271, P30647, DOI 10.1074/jbc.271.48.30647; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Szasz T, 2007, EXP BIOL MED, V232, P27; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; Tian L, 2009, ATHEROSCLEROSIS, V202, P152, DOI 10.1016/j.atherosclerosis.2008.04.011; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57571	10.1371/journal.pone.0057571	http://dx.doi.org/10.1371/journal.pone.0057571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451244	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500115
J	Gardner, MP; Adams, A; Jeffreys, M				Gardner, Michael P.; Adams, Abbey; Jeffreys, Mona			Interventions to Increase the Uptake of Mammography amongst Low Income Women: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; AFRICAN-AMERICAN WOMEN; BREAST-CANCER; PROMOTE MAMMOGRAPHY; SOCIOECONOMIC INEQUALITIES; SCREENING INTERVENTION; UNITED-STATES; CARE; POPULATION; TELEPHONE	Background: Two previous reviews found that access-enhancing interventions were effective in increasing mammography uptake amongst low-income women. The purpose of this study was to estimate the magnitude of the effect of interventions used to increase uptake of mammography amongst low-income women. Methods: Searches were conducted in MEDLINE and EMBASE (2002-April 2012) using relevant MeSH terms and keywords. Randomised controlled trials which aimed to increase mammography use in an asymptomatic low-income population and which had as an outcome receipt of a mammogram, were eligible for inclusion. The primary outcome was the post-intervention difference in the proportion of women who had a mammogram in the intervention and control groups. The quality of the studies was assessed using the Cochrane risk of bias tool. We calculated summary estimates using random effects meta-analyses. Possible reasons for heterogeneity were investigated using sub-group analyses and meta-regression. Publication bias was assessed using Egger's test. Results: Twenty-one studies met the inclusion criteria, including 33 comparisons. Interventions increased the uptake of mammography in low income women by an additional 8.9% (95% CI 7.3 to 10.4%) compared to the control group. There was some evidence that interventions with multiple strategies were more effective than those with single strategies (p = 0.03). There was some suggestion of publication bias. The quality of the included studies was often unclear. Omitting those with high risk of bias has little effect on the results. Conclusions: Interventions can increase mammography uptake among low-income women, multiple interventions being the most effective strategy. Given the robustness of the results to sensitivity analyses, the results are likely to be reliable. The generalisability of the results beyond the US is unclear.	[Gardner, Michael P.; Jeffreys, Mona] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Adams, Abbey] Univ Bristol, Bristol, Avon, England	University of Bristol; University of Bristol	Gardner, MP (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	mike.gardner@bristol.ac.uk	Jeffreys, Mona/W-3425-2019	Jeffreys, Mona/0000-0002-2617-0361	Wellcome Trust Institutional Strategic Support Funds	Wellcome Trust Institutional Strategic Support Funds(Wellcome Trust)	MJ is a recipient of Wellcome Trust Institutional Strategic Support Funds, which paid salary contribution to MG for the duration of the project. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 2010, CANCER EPIDEM BIOMAR, V19, P1790, DOI 10.1158/1055-9965.EPI-10-0141; Atri J, 1997, BRIT MED J, V315, P1356, DOI 10.1136/bmj.315.7119.1356; Bailey TM, 2005, AM J HEALTH PROMOT, V20, P96, DOI 10.4278/0890-1171-20.2.96; Bonfill X., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002943, DOI 10.1002/14651858.CD002943]; Botha Johannes L., 1993, Ethnicity and Disease, V3, P189; Champion V, 2007, PATIENT EDUC COUNS, V65, P416, DOI 10.1016/j.pec.2006.09.014; Champion VL, 2006, CANCER DETECT PREV, V30, P535, DOI 10.1016/j.cdp.2006.10.003; Denhaerynck K, 2003, AM J PREV MED, V25, P195, DOI 10.1016/S0749-3797(03)00201-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dietrich AJ, 2006, ANN INTERN MED, V144, P563, DOI 10.7326/0003-4819-144-8-200604180-00006; Dietrich AJ, 2007, ANN FAM MED, V5, P320, DOI 10.1370/afm.701; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Gotzsche PC, 2012, CANCER CAUSE CONTROL, V23, P15, DOI 10.1007/s10552-011-9867-8; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Han HR, 2009, NURS RES, V58, P246, DOI 10.1097/NNR.0b013e3181ac0f7f; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOARE T, 1994, J PUBLIC HEALTH MED, V16, P179, DOI 10.1093/oxfordjournals.pubmed.a042954; Howard M, 2009, CANCER CAUSE CONTROL, V20, P1, DOI 10.1007/s10552-008-9228-4; Jibaja-Weiss ML, 2003, PATIENT EDUC COUNS, V50, P123; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katz SJ, 2000, AM J PUBLIC HEALTH, V90, P799, DOI 10.2105/AJPH.90.5.799; Kim YH, 2004, ONCOL NURS FORUM, V31, P105, DOI 10.1188/04.ONF.105-110; Kreuter MW, 2005, PREV MED, V41, P53, DOI 10.1016/j.ypmed.2004.10.013; Legler J, 2002, CANCER EPIDEM BIOMAR, V11, P59; Lyratzopoulos G, 2011, ANN ONCOL, V22, P1661, DOI 10.1093/annonc/mdq647; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Maxwell AE, 2003, PREV MED, V37, P102, DOI 10.1016/S0091-7435(03)00088-4; McKenzie F, 2012, EUR J PUBLIC HEALTH, V22, P418, DOI 10.1093/eurpub/ckr107; Mishra SI, 2007, CANCER EPIDEM BIOMAR, V16, P2594, DOI 10.1158/1055-9965.EPI-07-0148; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nuno T, 2011, CANCER CAUSE CONTROL, V22, P367, DOI 10.1007/s10552-010-9705-4; O'Connor AM, 1998, J MED SCREEN, V5, P49, DOI 10.1136/jms.5.1.49; Oleske DM, 2007, BREAST J, V13, P19, DOI 10.1111/j.1524-4741.2006.00358.x; Page A, 2006, AUST NZ J PUBL HEAL, V30, P111, DOI 10.1111/j.1467-842X.2006.tb00101.x; Paskett E, 2006, JNCI-J NATL CANCER I, V98, P1226, DOI 10.1093/jnci/djj333; Phillips CE, 2011, J GEN INTERN MED, V26, P123, DOI 10.1007/s11606-010-1527-2; Powell ME, 2005, J HEALTH CARE POOR U, V16, P11, DOI 10.1353/hpu.2005.0129; Puschel K, 2010, CANCER EPIDEM BIOMAR, V19, P2254, DOI 10.1158/1055-9965.EPI-10-0313; Reuben DB, 2002, AM J ROENTGENOL, V179, P1509, DOI 10.2214/ajr.179.6.1791509; Rimer Barbara K., 1994, Annals of Behavioral Medicine, V16, P317; Russell KM, 2010, CANCER EPIDEM BIOMAR, V19, P201, DOI 10.1158/1055-9965.EPI-09-0569; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Sin JP, 1999, J MED SCREEN, V6, P170, DOI 10.1136/jms.6.4.170; Slater JS, 2005, CANCER EPIDEM BIOMAR, V14, P2346, DOI 10.1158/1055-9965.EPI-05-0034; SUTTON S, 1994, J EPIDEMIOL COMMUN H, V48, P65, DOI 10.1136/jech.48.1.65; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; The Information Centre, BREAST SCREEN PROGR; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; West DS, 2004, HEALTH EDUC BEHAV, V31, p29S, DOI 10.1177/1090198104266033; Young RF, 2002, J CANCER EDUC, V17, P231; Zhu KM, 2002, PREV MED, V34, P536, DOI 10.1006/pmed.2002.1016	56	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e55574	10.1371/journal.pone.0055574	http://dx.doi.org/10.1371/journal.pone.0055574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451028	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800004
J	Wu, AL; Feng, B; Chen, MZ; Kolumam, G; Zavala-Solorio, J; Wyatt, SK; Gandham, VD; Carano, RAD; Sonoda, J				Wu, Ai-Luen; Feng, Bo; Chen, Mark Z.; Kolumam, Ganesh; Zavala-Solorio, Jose; Wyatt, Shelby K.; Gandham, Vineela D.; Carano, Richard A. D.; Sonoda, Junichiro			Antibody-Mediated Activation of FGFR1 Induces FGF23 Production and Hypophosphatemia	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; VITAMIN-D; MORPHOMETRIC-ANALYSIS; PHOSPHATE; BONE; EXPRESSION; MUTATIONS; RECEPTOR; MINERALIZATION; PROTEIN	The phosphaturic hormone Fibroblast Growth Factor 23 (FGF23) controls phosphate homeostasis by regulating renal expression of sodium-dependent phosphate co-transporters and cytochrome P450 enzymes involved in vitamin D catabolism. Multiple FGF Receptors (FGFRs) can act as receptors for FGF23 when bound by the co-receptor Klotho expressed in the renal tubular epithelium. FGFRs also regulate skeletal FGF23 secretion; ectopic FGFR activation is implicated in genetic conditions associated with FGF23 overproduction and hypophosphatemia. The identity of FGFRs that mediate the activity of FGF23 or that regulate skeletal FGF23 secretion remains ill defined. Here we report that pharmacological activation of FGFR1 with monoclonal anti-FGFR1 antibodies (R1MAb) in adult mice is sufficient to cause an elevation in serum FGF23 and mild hypophosphatemia. In cultured rat calvariae osteoblasts, R1MAb induces FGF23 mRNA expression and FGF23 protein secretion into the culture medium. In a cultured kidney epithelial cell line, R1MAb acts as a functional FGF23 mimetic and activates the FGF23 program. siRNA-mediated Fgfr1 knockdown induced the opposite effects. Taken together, our work reveals the central role of FGFR1 in the regulation of FGF23 production and signal transduction, and has implications in the pathogenesis of FGF23-related hypophosphatemic disorders.	[Wu, Ai-Luen; Feng, Bo; Chen, Mark Z.; Sonoda, Junichiro] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kolumam, Ganesh; Zavala-Solorio, Jose; Wyatt, Shelby K.; Gandham, Vineela D.; Carano, Richard A. D.] Genentech Inc, Biomed Imaging, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Sonoda, J (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	junichis@gene.com						Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bhatia A, 2012, J MECH BEHAV BIOMED, V5, P1, DOI 10.1016/j.jmbbm.2011.08.026; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Brown AP, 2005, TOXICOL PATHOL, V33, P449, DOI 10.1080/01926230590961845; Brownstein CA, 2010, ENDOCRINOLOGY, V151, P492, DOI 10.1210/en.2009-0564; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Ito M, 2005, AM J PHYSIOL-ENDOC M, V288, pE1101, DOI 10.1152/ajpendo.00502.2004; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/ng0501-37; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200	42	81	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57322	10.1371/journal.pone.0057322	http://dx.doi.org/10.1371/journal.pone.0057322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451204	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800098
J	Ryberg, WA; Hill, MT; Painter, CW; Fitzgerald, LA				Ryberg, Wade A.; Hill, Michael T.; Painter, Charles W.; Fitzgerald, Lee A.			Landscape Pattern Determines Neighborhood Size and Structure within a Lizard Population	PLOS ONE			English	Article							DYNAMICS; MODELS	Although defining population structure according to discrete habitat patches is convenient for metapopulation theories, taking this approach may overlook structure within populations continuously distributed across landscapes. For example, landscape features within habitat patches direct the movement of organisms and define the density distribution of individuals, which can generate spatial structure and localized dynamics within populations as well as among them. Here, we use the neighborhood concept, which describes population structure relative to the scale of individual movements, to illustrate how localized dynamics within a population of lizards (Sceloporus arenicolus) arise in response to variation in landscape pattern within a continuous habitat patch. Our results emphasize links between individual movements at small scales and the emergence of spatial structure within populations which resembles metapopulation dynamics at larger scales. We conclude that population dynamics viewed in a landscape context must consider the explicit distribution and movement of individuals within continuous habitat as well as among habitat patches.	[Ryberg, Wade A.; Hill, Michael T.; Fitzgerald, Lee A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Painter, Charles W.] New Mexico Dept Game & Fish, Endangered Species Program, Santa Fe, NM USA	Texas A&M University System; Texas A&M University College Station; New Mexico Department of Game and Fish	Ryberg, WA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	waryberg@tamu.edu	Fitzgerald, Lee A/I-5193-2013	Fitzgerald, Lee/0000-0001-5648-9480; Ryberg, Wade/0000-0003-2548-8113	Bureau of Land Management	Bureau of Land Management	This study was funded by the Bureau of Land Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1987, OIKOS, V49, P340, DOI 10.2307/3565770; AMARASEKARE P, 1994, OECOLOGIA, V100, P166, DOI 10.1007/BF00317143; Chan LM, 2009, CONSERV GENET, V10, P131, DOI 10.1007/s10592-008-9537-x; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Degenhardt W.G., 1996, AMPHIBIANS REPTILES; Diez J. M., 2011, Sources, sinks and sustainability, P291; Fitzgerald L.A., 2009, LIZARDS AM SW, P128; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; FRANKLIN AB, 1992, WILDLIFE 2001 : POPULATIONS, P815; Fraterrigo JM, 2009, LANDSCAPE ECOL, V24, P863, DOI 10.1007/s10980-009-9364-6; Gilpin ME, 1987, VIABLE POPULATIONS C, P126; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski I., 1999, METAPOPULATION ECOLO; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; KERSTER HW, 1964, EVOLUTION, V18, P445, DOI 10.2307/2406355; Laurencio LR, 2010, ATLAS DISTRIBUTION H; McCauley David E., 1995, IALE Studies in Landscape Ecology, V2, P178; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Neville P, 2005, NATURAL HERITAGE NEW, V05-GTR-285; PACALA SW, 1985, AM NAT, V125, P385, DOI 10.1086/284349; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ritchie M.E., 2009, SCALE HETEROGENEITY; Roy M, 2008, J THEOR BIOL, V255, P152, DOI 10.1016/j.jtbi.2008.07.022; Ryberg WA, W N AM NAT IN PRESS; Smolensky NL, 2011, SOUTHWEST NAT, V56, P315, DOI 10.1894/F03-MLK-21.1; Smolensky NL, 2010, J HERPETOL, V44, P372, DOI 10.1670/10-008.1; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Turchin Peter, 1998; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wiens J. A., 2011, Sources, sinks and sustainability, P507; Wiens John A., 1997, P43, DOI 10.1016/B978-012323445-2/50005-5; With Kimberly A., 2004, P23, DOI 10.1016/B978-012323448-3/50004-0; WRIGHT S, 1946, GENETICS, V31, P39	35	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56856	10.1371/journal.pone.0056856	http://dx.doi.org/10.1371/journal.pone.0056856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441217	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200074
J	Schneider, RM; Thurtell, MJ; Eisele, S; Lincoff, N; Bala, E; Leigh, RJ				Schneider, Rosalyn M.; Thurtell, Matthew J.; Eisele, Sylvia; Lincoff, Norah; Bala, Elisa; Leigh, R. John			Neurological Basis for Eye Movements of the Blind	PLOS ONE			English	Article							HEIMANN-BIELSCHOWSKY PHENOMENON; OCULOMOTOR BURST GENERATOR; MONOCULAR VISUAL-LOSS; NEURAL-NETWORK MODEL; VESTIBULOOCULAR REFLEX; OCULAR OSCILLATIONS; VERTICAL NYSTAGMUS; ON-DIRECTIONS; NEURONS; VISION	When normal subjects fix their eyes upon a stationary target, their gaze is not perfectly still, due to small movements that prevent visual fading. Visual loss is known to cause greater instability of gaze, but reported comparisons with normal subjects using reliable measurement techniques are few. We measured binocular gaze using the magnetic search coil technique during attempted fixation (monocular or binocular viewing) of 4 individuals with childhood-onset of monocular visual loss, 2 individuals with late-onset monocular visual loss due to age-related macular degeneration, 2 individuals with bilateral visual loss, and 20 healthy control subjects. We also measured saccades to visual or somatosensory cues. We tested the hypothesis that gaze instability following visual impairment is caused by loss of inputs that normally optimize the performance of the neural network (integrator), which ensures both monocular and conjugate gaze stability. During binocular viewing, patients with early-onset monocular loss of vision showed greater instability of vertical gaze in the eye with visual loss and, to a lesser extent, in the normal eye, compared with control subjects. These vertical eye drifts were much more disjunctive than upward saccades. In individuals with late monocular visual loss, gaze stability was more similar to control subjects. Bilateral visual loss caused eye drifts that were larger than following monocular visual loss or in control subjects. Accurate saccades could be made to somatosensory cues by an individual with acquired blindness, but voluntary saccades were absent in an individual with congenital blindness. We conclude that the neural gaze-stabilizing network, which contains neurons with both binocular and monocular discharge preferences, is under adaptive visual control. Whereas monocular visual loss causes disjunctive gaze instability, binocular blindness causes both disjunctive and conjugate gaze instability (drifts and nystagmus). Inputs that bypass this neural network, such as projections to motoneurons for upward saccades, remain conjugate.	[Schneider, Rosalyn M.; Eisele, Sylvia; Leigh, R. John] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Thurtell, Matthew J.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Thurtell, Matthew J.] Vet Affairs Med Ctr, Neurol Serv, Iowa City, IA 52242 USA; [Thurtell, Matthew J.] Vet Affairs Med Ctr, Ctr Prevent & Treatment Visual Loss, Iowa City, IA 52242 USA; [Lincoff, Norah] SUNY Buffalo, Jacobs Neurol Inst, Buffalo, NY 14260 USA; [Bala, Elisa] Cleveland Clin Fdn, Dept Ophthalmol, Cleveland, OH 44195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cleveland Clinic Foundation	Leigh, RJ (corresponding author), Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.	rjl4@case.edu		Thurtell, Matthew/0000-0002-1546-5463	National Institutes of Health [NIH R01 EY06717]; Department of Veterans Affairs; Evenor Armington Fund of Case Medical Center; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Evenor Armington Fund of Case Medical Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health (NIH R01 EY06717), the Department of Veterans Affairs, and the Evenor Armington Fund of Case Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; Bielschowsky A, 1931, ARCH OPHTHALMOL-CHIC, V125, P493; Carpenter RHS, 1991, EYE MOVEMENTS, V8, P1; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P183, DOI 10.1113/jphysiol.1988.sp017285; Das VE, 2000, EXP BRAIN RES, V133, P189, DOI 10.1007/s002210000367; Davey K, 1998, AUST NZ J OPHTHALMOL, V26, P237, DOI 10.1111/j.1442-9071.1998.tb01318.x; FERMAN L, 1987, VISION RES, V27, P811, DOI 10.1016/0042-6989(87)90078-2; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Garbutt S, 2003, VISION RES, V43, P347, DOI 10.1016/S0042-6989(02)00387-5; Gonzalez EG, 2012, INVEST OPHTH VIS SCI, V53, P5386, DOI 10.1167/iovs.12-9941; Gottlob I, 1996, GRAEF ARCH CLIN EXP, V234, P369, DOI 10.1007/BF00190713; Hall EC, 2000, OPTOMETRY VISION SCI, V77, P511, DOI 10.1097/00006324-200010000-00005; Heimann E, 1902, KLIN MONATSBLAT AUGE, V49, P99; Helmchen C, 1998, EXP BRAIN RES, V119, P436, DOI 10.1007/s002210050359; Jeong S-H, 2008, Br J Ophthalmol, V92, P1402, DOI 10.1136/bjo.2007.135624; KOMPF D, 1987, J NEUROL, V234, P337, DOI 10.1007/BF00314291; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; LEIGH RJ, 1980, INVEST OPHTH VIS SCI, V19, P328; LEIGH RJ, 1989, INVEST OPHTH VIS SCI, V30, P288; Liao K, 2008, EXP BRAIN RES, V185, P553, DOI 10.1007/s00221-007-1181-z; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; Migliaccio AA, 2010, J PHYSIOL-LONDON, V588, P3855, DOI 10.1113/jphysiol.2010.196287; MOSCHOVAKIS AK, 1991, J NEUROPHYSIOL, V65, P203, DOI 10.1152/jn.1991.65.2.203; MOSCHOVAKIS AK, 1990, SCIENCE, V248, P1118, DOI 10.1126/science.2343316; MOSCHOVAKIS AK, 1991, J NEUROPHYSIOL, V65, P218, DOI 10.1152/jn.1991.65.2.218; Nau A, 2012, BRAIN STRUCT FUNCT, V217, P761, DOI 10.1007/s00429-012-0392-7; Navarro-Lopez JD, 2005, J NEUROSCI, V25, P9902, DOI 10.1523/JNEUROSCI.2061-05.2005; Ono S, 2012, INVEST OPHTH VIS SCI, V53, P2038, DOI 10.1167/iovs.11-9011; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Rahman W, 2006, AM J OPHTHALMOL, V141, P221, DOI 10.1016/j.ajo.2005.08.022; Ramat S, 1999, INVEST OPHTH VIS SCI, V40, P1681; ROBINSON DA, 1975, INVEST OPHTH VISUAL, V14, P413; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROBINSON DA, 1974, BRAIN RES, V71, P195, DOI 10.1016/0006-8993(74)90961-5; Schor CM, 2009, OPTOMETRY VISION SCI, V86, P788, DOI 10.1097/OPX.0b013e3181ae00a5; Schubert MC, 2010, RESTOR NEUROL NEUROS, V28, P9, DOI 10.3233/RNN-2010-0523; SHERMAN KR, 1986, INVEST OPHTH VIS SCI, V27, P1154; SKAVENSKI AA, 1973, J NEUROPHYSIOL, V36, P724, DOI 10.1152/jn.1973.36.4.724; SMITH JL, 1982, J CLIN NEURO-OPHTHAL, V2, P85; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; STRAUMANN D, 1991, INT J BIOMED COMPUT, V29, P61, DOI 10.1016/0020-7101(91)90013-5; Surachatkumtonekul Thammanoon, 2009, Journal of the Medical Association of Thailand, V92, P373; Sylvestre PA, 2003, J NEUROPHYSIOL, V90, P739, DOI 10.1152/jn.00123.2003; Tarita-Nistor L, 2011, INVEST OPHTH VIS SCI, V52, P1887, DOI 10.1167/iovs.10-6059; WALLS GL, 1962, VISION RES, V2, P69, DOI 10.1016/0042-6989(62)90064-0; YEE RD, 1979, OPHTHALMOLOGY, V86, P511; YGGE J, 1995, VISION RES, V35, P3169, DOI 10.1016/0042-6989(95)00125-J; ZEE DS, 1984, AM J OPHTHALMOL, V97, P587, DOI 10.1016/0002-9394(84)90377-5	50	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56556	10.1371/journal.pone.0056556	http://dx.doi.org/10.1371/journal.pone.0056556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441203	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200060
J	Shoemaker, CJ; Schornberg, KL; Delos, SE; Scully, C; Pajouhesh, H; Olinger, GG; Johansen, LM; White, JM				Shoemaker, Charles J.; Schornberg, Kathryn L.; Delos, Sue E.; Scully, Corinne; Pajouhesh, Hassan; Olinger, Gene G.; Johansen, Lisa M.; White, Judith M.			Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection	PLOS ONE			English	Article							ATOMIC PHYSICOCHEMICAL PARAMETERS; SMALL-MOLECULE INHIBITORS; ACID SPHINGOMYELINASE; QUANTITATIVE STRUCTURE; CATHEPSIN-L; LOG-P; GLYCOPROTEIN; PROTEIN; CELLS; PATHOGENESIS	Ebola virus (EBOV) is an enveloped RNA virus that causes hemorrhagic fever in humans and non-human primates. Infection requires internalization from the cell surface and trafficking to a late endocytic compartment, where viral fusion occurs, providing a conduit for the viral genome to enter the cytoplasm and initiate replication. In a concurrent study, we identified clomiphene as a potent inhibitor of EBOV entry. Here, we screened eleven inhibitors that target the same biosynthetic pathway as clomiphene. From this screen we identified six compounds, including U18666A, that block EBOV infection (IC50 1.6 to 8.0 mu M) at a late stage of entry. Intriguingly, all six are cationic amphiphiles that share additional chemical features. U18666A induces phenotypes, including cholesterol accumulation in endosomes, associated with defects in Niemann-Pick C1 protein (NPC1), a late endosomal and lysosomal protein required for EBOV entry. We tested and found that all six EBOV entry inhibitors from our screen induced cholesterol accumulation. We further showed that higher concentrations of cationic amphiphiles are required to inhibit EBOV entry into cells that overexpress NPC1 than parental cells, supporting the contention that they inhibit EBOV entry in an NPC1-dependent manner. A previously reported inhibitor, compound 3.47, inhibits EBOV entry by blocking binding of the EBOV glycoprotein to NPC1. None of the cationic amphiphiles tested had this effect. Hence, multiple cationic amphiphiles (including several FDA approved agents) inhibit EBOV entry in an NPC1-dependent fashion, but by a mechanism distinct from that of compound 3.47. Our findings suggest that there are minimally two ways of perturbing NPC1-dependent pathways that can block EBOV entry, increasing the attractiveness of NPC1 as an anti-filoviral therapeutic target.	[Shoemaker, Charles J.; Schornberg, Kathryn L.; Delos, Sue E.; White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA; [Scully, Corinne; Olinger, Gene G.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Pajouhesh, Hassan; Johansen, Lisa M.] Zalicus Inc, Cambridge, MA USA; [White, Judith M.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; Zalicus Inc; University of Virginia	White, JM (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA.	jw7g@virginia.edu	Shoemaker, Charles J/F-5575-2019; Shoemaker, Charles/L-9283-2019	Shoemaker, Charles J/0000-0002-8974-7033; Shoemaker, Charles/0000-0002-8974-7033; Olinger, Gene/0000-0001-7338-0292	DTRA [4.10007_08_RD_B, W81XWH-08-0051, W81XWH-12-P-0007]; National Institutes of Health [U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, T32AI055432, U54AI057168] Funding Source: NIH RePORTER	DTRA(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work was supported by: DTRA project 4.10007_08_RD_B (G.G.O) and subcontracts W81XWH-08-0051 (L.M.J) and W81XWH-12-P-0007(JMW) as well as a grant from the National Institutes of Health: U54 AI057168 (J.M.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBOUZ S, 1986, LIFE SCI, V38, P357, DOI 10.1016/0024-3205(86)90083-4; Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Arenz C, 2010, CELL PHYSIOL BIOCHEM, V26, P1, DOI 10.1159/000315100; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Cenedella RJ, 2004, J LIPID RES, V45, P1232, DOI 10.1194/jlr.M300469-JLR200; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Duvvuri M, 2005, BIOCHEMISTRY-US, V44, P15743, DOI 10.1021/bi051759w; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Ertl P, 1997, QUANT STRUCT-ACT REL, V16, P377, DOI 10.1002/qsar.19970160505; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Haines KM, 2012, VIROLOGY, V432, P20, DOI 10.1016/j.virol.2012.05.018; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Konig G, 2008, MONATSH CHEM, V139, P401, DOI 10.1007/s00706-007-0819-7; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Liu RH, 2009, J BIOL CHEM, V284, P1840, DOI 10.1074/jbc.M803741200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Manicassamy B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-75; Martinez O, 2010, CELL MICROBIOL, V12, P148, DOI 10.1111/j.1462-5822.2009.01385.x; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Miller ME, 2012, J VIROL, V86, P7473, DOI 10.1128/JVI.00136-12; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Owens CM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.32; Ponce-Balbuena D, 2009, J PHARMACOL EXP THER, V331, P563, DOI 10.1124/jpet.109.156075; REKKER RF, 1993, QUANT STRUCT-ACT REL, V12, P152, DOI 10.1002/qsar.19930120207; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Shoemaker CJ, 2012, MECH EBOLAVIRUS ENTR; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; SLATER B, 1994, J PHARM SCI, V83, P1280, DOI 10.1002/jps.2600830918; Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SOKOL J, 1988, J BIOL CHEM, V263, P3411; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; White JM, 2012, NAT REV MICROBIOL, V10, P317, DOI 10.1038/nrmicro2764; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	63	114	120	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56265	10.1371/journal.pone.0056265	http://dx.doi.org/10.1371/journal.pone.0056265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441171	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200028
J	Toniolo, A; Buccellati, C; Pinna, C; Gaion, RM; Sala, A; Bolego, C				Toniolo, Alice; Buccellati, Carola; Pinna, Christian; Gaion, Rosa Maria; Sala, Angelo; Bolego, Chiara			Cyclooxygenase-1 and Prostacyclin Production by Endothelial Cells in the Presence of Mild Oxidative Stress	PLOS ONE			English	Article							CARDIOVASCULAR RISK; HYDROGEN-PEROXIDE; COX-2 INHIBITORS; TEA POLYPHENOL; H SYNTHASE-1; NITRIC-OXIDE; (-)-EPIGALLOCATECHIN-3-GALLATE; BIOSYNTHESIS; EXPRESSION	This study aimed at evaluating the relative contribution of endothelial cyclooxygenase-1 and -2 (COX-1 and COX-2) to prostacyclin (PGI(2)) production in the presence of mild oxidative stress resulting from autooxidation of polyphenols such as (-)-epigallocatechin 3-gallate (EGCG), using both endothelial cells in culture and isolated blood vessels. EGCG treatment resulted in an increase in hydrogen peroxide formation in human umbilical vein endothelial cells. In the presence of exogenous arachidonic acid and EGCG, PGI(2) production was preferentially inhibited by a selective COX-1 inhibitor. This effect of selective inhibition was also substantially reversed by catalase. In addition, EGCG caused vasorelaxation of rat aortic ring only partially abolished by a nitric oxide synthase inhibitor. Concomitant treatment with a selective COX-1 inhibitor completely prevented the vasorelaxation as well as the increase in PGI(2) accumulation in the perfusate observed in EGCG-treated aortic rings, while a selective COX-2 inhibitor was completely uneffective. Our data strongly support the notions that H2O2 generation affects endothelial PGI(2) production, making COX-1, and not COX-2, the main source of endothelial PGI(2) under altered oxidative tone conditions. These results might be relevant to the reappraisal of the impact of COX inhibitors on vascular PGI(2) production in patients undergoing significant oxidative stress.	[Toniolo, Alice; Gaion, Rosa Maria; Bolego, Chiara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Buccellati, Carola; Pinna, Christian; Sala, Angelo] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Sala, Angelo] CNR, IBIM, Palermo, Italy	University of Padua; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Sala, A (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	angelo.sala@unimi.it	Sala, Angelo/H-5478-2019	Sala, Angelo/0000-0001-9290-0257	University of Padova; University of Milan	University of Padova; University of Milan	Chiara Bolego acknowledges support from institutional funding of the University of Padova. Angelo Sala acknowledges support from institutional funding of the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LD, 2004, KIDNEY INT, V65, P551, DOI 10.1111/j.1523-1755.2004.00405.x; Alvarez E, 2006, BRIT J PHARMACOL, V147, P269, DOI 10.1038/sj.bjp.0706507; Auger C, 2010, BIOCHEM BIOPH RES CO, V393, P162, DOI 10.1016/j.bbrc.2010.01.112; Bolego C, 2009, FASEB J, V23, P605, DOI 10.1096/fj.08-106591; Camacho M, 1998, CIRC RES, V83, P353, DOI 10.1161/01.RES.83.4.353; Cannon CP, 2012, SCIENCE, V336, P1386, DOI 10.1126/science.1224398; Carnini C, 2011, FASEB J, V25, P3519, DOI 10.1096/fj.10-177030; Chen W, 1999, J BIOL CHEM, V274, P20301, DOI 10.1074/jbc.274.29.20301; Elbling L, 2010, FREE RADICAL BIO MED, V49, P1444, DOI 10.1016/j.freeradbiomed.2010.08.008; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Karim S, 1996, J BIOL CHEM, V271, P12042, DOI 10.1074/jbc.271.20.12042; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Li ZM, 2011, BASIC CLIN PHARMACOL, V109, P47, DOI 10.1111/j.1742-7843.2011.00683.x; Long LH, 2010, ARCH BIOCHEM BIOPHYS, V501, P162, DOI 10.1016/j.abb.2010.06.012; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Okahara K, 1998, ARTERIOSCL THROM VAS, V18, P1922, DOI 10.1161/01.ATV.18.12.1922; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; SHATOS MA, 1991, ARTERIOSCLER THROMB, V11, P594, DOI 10.1161/01.ATV.11.3.594; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sun L, 2004, ANN BIOMED ENG, V32, P1193, DOI 10.1114/B:ABME.0000039353.97347.28; WHORTON AR, 1985, J CLIN INVEST, V76, P295, DOI 10.1172/JCI111960; Zou MH, 1996, FEBS LETT, V382, P101, DOI 10.1016/0014-5793(96)00160-3	27	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56683	10.1371/journal.pone.0056683	http://dx.doi.org/10.1371/journal.pone.0056683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441213	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200070
J	Fogarty, MJ; Smallcombe, KL; Yanagawa, Y; Obata, K; Bellingham, MC; Noakes, PG				Fogarty, Matthew J.; Smallcombe, Karen L.; Yanagawa, Yuchio; Obata, Kunihiko; Bellingham, Mark C.; Noakes, Peter G.			Genetic Deficiency of GABA Differentially Regulates Respiratory and Non-Respiratory Motor Neuron Development	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; PROGRAMMED CELL-DEATH; VESICULAR ACETYLCHOLINE TRANSPORTER; EMBRYO SPINAL-CORD; MOTONEURON SURVIVAL; NEUROMUSCULAR ACTIVITY; SYNAPTIC TRANSMISSION; STEREOLOGICAL METHODS; MICE LACKING; RAT-BRAIN	Central nervous system GABAergic and glycinergic synaptic activity switches from postsynaptic excitation to inhibition during the stage when motor neuron numbers are being reduced, and when synaptic connections are being established onto and by motor neurons. In mice this occurs between embryonic (E) day 13 and birth (postnatal day 0). Our previous work on mice lacking glycinergic transmission suggested that altered motor neuron activity levels correspondingly regulated motor neuron survival and muscle innervation for all respiratory and non respiratory motor neuron pools, during this period of development [1]. To determine if GABAergic transmission plays a similar role, we quantified motor neuron number and the extent of muscle innervation in four distinct regions of the brain stem and spinal cord; hypoglossal, phrenic, brachial and lumbar motor pools, in mice lacking the enzyme GAD67. These mice display a 90% drop in CNS GABA levels ( [2]; this study). For respiratory-based motor neurons (hypoglossal and phrenic motor pools), we have observed significant drops in motor neuron number (17% decline for hypoglossal and 23% decline for phrenic) and muscle innervations (55% decrease). By contrast for non-respiratory motor neurons of the brachial lateral motor column, we have observed an increase in motor neuron number (43% increase) and muscle innervations (99% increase); however for more caudally located motor neurons within the lumbar lateral motor column, we observed no change in either neuron number or muscle innervation. These results show in mice lacking physiological levels of GABA, there are distinct regional changes in motor neuron number and muscle innervation, which appear to be linked to their physiological function and to their rostral-caudal position within the developing spinal cord. Our results also suggest that for more caudal (lumbar) regions of the spinal cord, the effect of GABA is less influential on motor neuron development compared to that of glycine.	[Fogarty, Matthew J.; Smallcombe, Karen L.; Bellingham, Mark C.; Noakes, Peter G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Noakes, Peter G.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] CREST, Japan Sci & Technol Agcy, Tokyo, Japan; [Obata, Kunihiko] RIKEN Brain Sci Inst, Obata Res Unit, Saitama, Japan	University of Queensland; University of Queensland; Gunma University; Japan Science & Technology Agency (JST); RIKEN	Noakes, PG (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	p.noakes@uq.edu.au	Noakes, Peter/X-9825-2019; Bellingham, Mark/G-1697-2011	Noakes, Peter/0000-0001-9821-8478; Bellingham, Mark/0000-0001-9189-4430	NHMRC [568680]; MNDRI project grant; University of Queensland; Australian Government; MEXT, Japan; Takeda Science Foundation; ARC LIEF grant [LE100100074]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MNDRI project grant; University of Queensland(University of Queensland); Australian Government(Australian GovernmentCGIAR); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ARC LIEF grant(Australian Research Council)	The work was funded by project grant 568680 from NHMRC to PGN and MCB, and by a MNDRI project grant to PGN. KLS was supported by postgraduate scholarship from the University of Queensland, and MJF was supported by and APA Scholarship from the Australian Government. YY was supported by a Grant-in aid for scientific research on innovative areas "Mesoscopic Neurocircuitry" and scientific research (B) from MEXT, Japan and Takeda Science Foundation. An ARC LIEF grant LE100100074 funded the stereology system. The authors declare no financial or commercial ties to the production or interpretation of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain AE, 2004, BRAIN RES, V1000, P134, DOI 10.1016/j.brainres.2003.11.071; Allain AE, 2006, J COMP NEUROL, V496, P832, DOI 10.1002/cne.20967; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bacskai T, 2012, BRAIN STRUCT FUNCT; Ballion B, 2002, DEV BRAIN RES, V137, P81, DOI 10.1016/S0165-3806(02)00414-5; Banks GB, 2001, J COMP NEUROL, V429, P156, DOI 10.1002/1096-9861(20000101)429:1<156::AID-CNE12>3.0.CO;2-3; Banks GB, 2005, J NEUROSCI, V25, P1249, DOI 10.1523/JNEUROSCI.1786-04.2005; Banks GB, 2003, DEV BIOL, V257, P71, DOI 10.1016/S0012-1606(03)00056-3; Banks GB, 2002, INT J DEV BIOL, V46, P551; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bhumbra GS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00008; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; DAHM LM, 1991, J NEUROSCI, V11, P238; DAHM LM, 1988, DEV BIOL, V130, P621, DOI 10.1016/0012-1606(88)90357-0; DING R, 1983, J NEUROCYTOL, V12, P887, DOI 10.1007/BF01153341; Drummond GB, 2009, J PHYSIOL-LONDON, V587, P713, DOI 10.1113/jphysiol.2008.167387; Dumoulin A, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.028.2009; Duveau V, 2011, EUR J NEUROSCI, V34, P362, DOI 10.1111/j.1460-9568.2011.07782.x; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Ferraro E, 2012, J CACHEXIA SARCOPENI, V3, P13, DOI 10.1007/s13539-011-0041-7; Fortin G, 1999, NAT NEUROSCI, V2, P873, DOI 10.1038/13172; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gao BX, 2001, J NEUROPHYSIOL, V86, P492, DOI 10.1152/jn.2001.86.1.492; Gilmor ML, 1996, J NEUROSCI, V16, P2179; Glover JC, 2000, PHYSIOL REV, V80, P615, DOI 10.1152/physrev.2000.80.2.615; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; KIRSCH J, 1993, BRAIN RES, V621, P301, DOI 10.1016/0006-8993(93)90120-C; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; KOPRIWA BM, 1984, J HISTOCHEM CYTOCHEM, V32, P552, DOI 10.1177/32.5.6201530; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1978, FED PROC, V37, P2016; LANDMESSER L, 1992, J NEUROBIOL, V23, P1131, DOI 10.1002/neu.480230906; Landmesser LT, 1998, CURR BIOL, V8, pR564, DOI 10.1016/S0960-9822(07)00362-4; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lorenzo LE, 2006, EUR J NEUROSCI, V23, P3161, DOI 10.1111/j.1460-9568.2006.04863.x; Mantilla CB, 2008, J APPL PHYSIOL, V104, P1818, DOI 10.1152/japplphysiol.01192.2007; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; MCLENNAN IS, 1982, DEV BIOL, V92, P263, DOI 10.1016/0012-1606(82)90171-3; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; NARAYANAN CH, 1971, BEHAVIOUR, V40, P100, DOI 10.1163/156853971X00357; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Noakes PG, 1999, J COMP NEUROL, V410, P531; Obata K, 2008, BIOCHEM BIOPH RES CO, V370, P429, DOI 10.1016/j.bbrc.2008.03.110; Oppenheim RW, 2008, DEV NEUROBIOL, V68, P972, DOI 10.1002/dneu.20636; Oppenheim RW, 2003, MOL CELL NEUROSCI, V22, P331, DOI 10.1016/S1044-7431(02)00020-9; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1982, NATURE, V295, P57, DOI 10.1038/295057a0; OPPENHEIM RW, 1989, DEVELOPMENT, V107, P331; OPPENHEIM RW, 1986, DEV BIOL, V114, P426, DOI 10.1016/0012-1606(86)90207-1; Oppenheim RW, 1997, J COMP NEUROL, V381, P353, DOI 10.1002/(SICI)1096-9861(19970512)381:3<353::AID-CNE7>3.0.CO;2-1; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PITTMAN R, 1979, J COMP NEUROL, V187, P425, DOI 10.1002/cne.901870210; PITTMAN RH, 1978, NATURE, V271, P364, DOI 10.1038/271364a0; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Rasband W.S., 1997, IMAGE J; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Ren J, 2003, J NEUROPHYSIOL, V89, P1187, DOI 10.1152/jn.00539.2002; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rozzo A, 2002, EUR J NEUROSCI, V15, P1747, DOI 10.1046/j.1460-9568.2002.02013.x; Sands SA, 2003, BRAIN RES, V972, P197, DOI 10.1016/S0006-8993(03)02534-4; Sibilla S, 2009, PROG NEUROBIOL, V89, P46, DOI 10.1016/j.pneurobio.2009.06.001; Singer JH, 2000, BRAIN RES BULL, V53, P553, DOI 10.1016/S0361-9230(00)00389-0; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; TANG JC, 1993, J NEUROSCI, V13, P3095; Tsunekawa N, 2005, EUR J NEUROSCI, V21, P173, DOI 10.1111/j.1460-9568.2004.03860.x; Velez-Fort M, 2012, NEUROSCIENTIST, V18, P237, DOI 10.1177/1073858411403317; Waagepetersen HS, 1999, J NEUROCHEM, V73, P1335, DOI 10.1046/j.1471-4159.1999.0731335.x; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Watson C, 2009, CHEMOARCHITECTURE AL; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; WOLFF JR, 1978, NATURE, V274, P72, DOI 10.1038/274072a0; Young SZ, 2012, J NEUROSCI, V32, P13630, DOI 10.1523/JNEUROSCI.2864-12.2012; Yvert B, 2004, J NEUROPHYSIOL, V91, P2101, DOI 10.1152/jn.01095.2003	89	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56257	10.1371/journal.pone.0056257	http://dx.doi.org/10.1371/journal.pone.0056257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457538	gold, Green Submitted, Green Published			2022-12-27	WOS:000315603700034
J	Smith, BT; Klicka, J				Smith, Brian Tilston; Klicka, John			Examining the Role of Effective Population Size on Mitochondrial and Multilocus Divergence Time Discordance in a Songbird	PLOS ONE			English	Article							SPECIES TREES; MUTATION-RATE; GENE TREES; DNA; EVOLUTION; ISLAND; SUBSTITUTION; DIVERSITY; INFERENCE; SUPPORT	Estimates of speciation times are subject to a number of potential errors. One source of bias is that effective population size (N-e) has been shown to influence substitution rates. This issue is of particular interest for phylogeographic studies because population sizes can vary dramatically among genetically structured populations across species' ranges. In this study, we used multilocus data to examine temporal phylogeographic patterns in a widespread North American songbird, the Northern Cardinal (Cardinalis cardinalis). Species tree estimation indicated that the phylogeographic structure of C. cardinalis was comprised of four well-supported mainland lineages with large population sizes (large N-e) and two island lineages comprised of much smaller populations (small N-e). We inferred speciation times from mtDNA and multilocus data and found there was discordance between events that represented island-mainland divergences, whereas both estimates were similar for divergences among mainland lineages. We performed coalescent simulations and found that the difference in speciation times could be attributed to stochasticity for a recently diverged island lineage. However, the magnitude of the change between speciation times estimated from mtDNA and multilocus data of an older island lineage was substantially greater than predicted by coalescent simulations. For this divergence, we found the discordance in time estimates was due to a substantial increase in the mtDNA substitution rate in the small island population. These findings indicate that in phylogeographic studies the relative tempo of evolution between mtDNA and nuclear DNA can become highly discordant in small populations.	[Smith, Brian Tilston] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Smith, Brian Tilston; Klicka, John] Univ Nevada, Marjorie Barrick Museum Nat Hist, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Smith, BT (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	briantilstonsmith@gmail.com			UNLV International Studies Scholarship; UNLV GPSA grant; AMNH Chapman Grant	UNLV International Studies Scholarship; UNLV GPSA grant; AMNH Chapman Grant	This work was partially funded by a UNLV International Studies Scholarship, a UNLV GPSA grant, and an AMNH Chapman Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Bromham L, 2005, MOL BIOL EVOL, V22, P1393, DOI 10.1093/molbev/msi133; Bryson RW, 2010, EVOLUTION, V64, P2315, DOI 10.1111/j.1558-5646.2010.01014.x; Cabanne GS, 2013, J ORNITHOL, V154, P371, DOI 10.1007/s10336-012-0901-8; Carling MD, 2008, GENETICS, V178, P363, DOI 10.1534/genetics.107.076422; Creevey CJ, 2003, BIOINFORMATICS, V19, P1726, DOI 10.1093/bioinformatics/btg225; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DESALLE R, 1988, EVOLUTION, V42, P1076, DOI 10.1111/j.1558-5646.1988.tb02525.x; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; EASTEAL S, 1994, MOL BIOL EVOL, V11, P643; Edwards SV, 2000, EVOLUTION, V54, P1839; Halkin SL, 1999, BIRDS N AM ONLINE; Heads M, 2011, SYST BIOL, V60, P204, DOI 10.1093/sysbio/syq075; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heslewood MM, 1998, ELECTROPHORESIS, V19, P142, DOI 10.1002/elps.1150190203; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Johnson KP, 2001, MOL BIOL EVOL, V18, P874, DOI 10.1093/oxfordjournals.molbev.a003869; Kimball RT, 2009, MOL PHYLOGENET EVOL, V50, P654, DOI 10.1016/j.ympev.2008.11.018; KIMURA M, 1962, GENETICS, V47, P713; Klicka J, 2007, MOL PHYLOGENET EVOL, V45, P1014, DOI 10.1016/j.ympev.2007.07.006; Ksepka DT, 2009, CLADISTICS, V25, P173, DOI 10.1111/j.1096-0031.2009.00250.x; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Maddison WP, 2009, MESQUITE MODULAR SYS; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MCCLOY C, 1988, MAR MICROPALEONTOL, V13, P193, DOI 10.1016/0377-8398(88)90003-5; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Nylander J., 2004, MRMODELTEST V 2 3; OHTA T, 1972, J MOL EVOL, V1, P305, DOI 10.1007/BF01653959; Peters JL, 2012, MOL ECOL, V21, P3562, DOI 10.1111/j.1365-294X.2012.05612.x; Peterson GI, 2009, MOL BIOL EVOL, V26, P2595, DOI 10.1093/molbev/msp175; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Rannala B, 2003, GENETICS, V164, P1645; Reid N, 2012, SYST BIOL, V61, P44, DOI 10.1093/sysbio/syr094; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SLADE RW, 1993, MOL ECOL, V2, P359, DOI 10.1111/j.1365-294X.1993.tb00029.x; Smith BT, 2013, MOL ECOL, V22, P483, DOI 10.1111/mec.12118; Smith BT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-136; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Spaw R.H., 1978, GULF COAST ASS GEOLO, V28, P601, DOI [10.1306/2fa1add9aa-0dfe-11d7-8641000102c1865d, DOI 10.1306/2FA1ADD9AA-0DFE-11D7-8641000102C1865D]; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D.L., 2002, PAUP V 4 0B10 PHYLOG; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Woolfit M, 2005, P ROY SOC B-BIOL SCI, V272, P2277, DOI 10.1098/rspb.2005.3217; Woolfit M, 2003, MOL BIOL EVOL, V20, P1545, DOI 10.1093/molbev/msg167; Woolfit M, 2009, BIOL LETTERS, V5, P417, DOI 10.1098/rsbl.2009.0155; Wright SD, 2009, EVOLUTION, V63, P2275, DOI 10.1111/j.1558-5646.2009.00717.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	51	33	34	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55161	10.1371/journal.pone.0055161	http://dx.doi.org/10.1371/journal.pone.0055161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457463	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700010
J	Liu, DS; Loh, KH; Lam, SS; White, KA; Ting, AY				Liu, Daniel S.; Loh, Ken H.; Lam, Stephanie S.; White, Katharine A.; Ting, Alice Y.			Imaging Trans-Cellular Neurexin-Neuroligin Interactions by Enzymatic Probe Ligation	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; PROTEIN-PROTEIN INTERACTIONS; LIVING CELLS; MONOVALENT STREPTAVIDIN; SYNAPSE DEVELOPMENT; NEURONS; SITE; BIOTINYLATION; LIGASE; CYCLOADDITION	Neurexin and neuroligin are transmembrane adhesion proteins that play an important role in organizing the neuronal synaptic cleft. Our lab previously reported a method for imaging the trans-synaptic binding of neurexin and neuroligin called BLINC (Biotin Labeling of INtercellular Contacts). In BLINC, biotin ligase (BirA) is fused to one protein while its 15-amino acid acceptor peptide substrate (AP) is fused to the binding partner. When the two fusion proteins interact across cellular junctions, BirA catalyzes the site-specific biotinylation of AP, which can be read out by staining with streptavidin-fluorophore conjugates. Here, we report that BLINC in neurons cannot be reproduced using the reporter constructs and labeling protocol previously described. We uncover the technical reasons for the lack of reproducibilty and then re-design the BLINC reporters and labeling protocol to achieve neurexin-neuroligin BLINC imaging in neuron cultures. In addition, we introduce a new method, based on lipoic acid ligase instead of biotin ligase, to image trans-cellular neurexin-neuroligin interactions in human embryonic kidney cells and in neuron cultures. This method, called ID-PRIME for Interaction-Dependent PRobe Incorporation Mediated by Enzymes, is more robust than BLINC due to higher surface expression of lipoic acid ligase fusion constructs, gives stronger and more localized labeling, and is more versatile than BLINC in terms of signal readout. ID-PRIME expands the toolkit of methods available to study trans-cellular protein-protein interactions in living systems.	[Liu, Daniel S.; Loh, Ken H.; Lam, Stephanie S.; White, Katharine A.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	ating@mit.edu	White, Katharine A./X-9101-2019; White, Katharine/G-8700-2013	White, Katharine A./0000-0002-5831-1886; Ting, Alice/0000-0002-8277-5226	National Institutes of Health [DP1 OD003961]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by the National Institutes of Health (DP1 OD003961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Baruah H, 2008, ANGEW CHEM INT EDIT, V47, P7018, DOI 10.1002/anie.200802088; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Fu Y, 2010, P NATL ACAD SCI USA, V107, P22699, DOI 10.1073/pnas.1011233108; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Liu DS, 2012, J AM CHEM SOC, V134, P792, DOI 10.1021/ja209325n; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Puthenveetil S, 2009, J AM CHEM SOC, V131, P16430, DOI 10.1021/ja904596f; Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Slavoff SA, 2011, J AM CHEM SOC, V133, P19769, DOI 10.1021/ja206435e; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Tanaka H, 2012, CELL REPORTS, V2, P101, DOI 10.1016/j.celrep.2012.06.009; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Thyagarajan A, 2010, CELL, V143, P456, DOI 10.1016/j.cell.2010.09.025; Uttamapinant C, 2012, ANGEW CHEM INT EDIT, V51, P5852, DOI 10.1002/anie.201108181; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Wheeler DG, 2001, J BIOL CHEM, V276, P31978, DOI 10.1074/jbc.M103667200; White KA, 2012, THESIS MIT CAMBRIDGE; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Yao JZ, 2012, J AM CHEM SOC, V134, P3720, DOI 10.1021/ja208090p	38	34	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e52823	10.1371/journal.pone.0052823	http://dx.doi.org/10.1371/journal.pone.0052823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457442	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700002
J	Bajwa, UI; Taj, IA; Anwar, MW; Wang, X				Bajwa, Usama Ijaz; Taj, Imtiaz Ahmad; Anwar, Muhammad Waqas; Wang, Xuan			A Multifaceted Independent Performance Analysis of Facial Subspace Recognition Algorithms	PLOS ONE			English	Article							FACE-RECOGNITION; 2-DIMENSIONAL PCA; COMPONENT; REPRESENTATION; LAPLACIANFACES; EIGENFACES	Face recognition has emerged as the fastest growing biometric technology and has expanded a lot in the last few years. Many new algorithms and commercial systems have been proposed and developed. Most of them use Principal Component Analysis (PCA) as a base for their techniques. Different and even conflicting results have been reported by researchers comparing these algorithms. The purpose of this study is to have an independent comparative analysis considering both performance and computational complexity of six appearance based face recognition algorithms namely PCA, 2DPCA, A2DPCA, (2D)(2)PCA, LPP and 2DLPP under equal working conditions. This study was motivated due to the lack of unbiased comprehensive comparative analysis of some recent subspace methods with diverse distance metric combinations. For comparison with other studies, FERET, ORL and YALE databases have been used with evaluation criteria as of FERET evaluations which closely simulate real life scenarios. A comparison of results with previous studies is performed and anomalies are reported. An important contribution of this study is that it presents the suitable performance conditions for each of the algorithms under consideration.	[Bajwa, Usama Ijaz; Anwar, Muhammad Waqas] COMSATS Inst Informat Technol, Dept Comp Sci, Abbottabad, Pakistan; [Bajwa, Usama Ijaz; Taj, Imtiaz Ahmad] Muhammad Ali Jinnah Univ, Vis & Pattern Recognit Syst Res Grp, Islamabad, Pakistan; [Bajwa, Usama Ijaz] CASE, Islamabad, Pakistan; [Wang, Xuan] Shenzen Grad Sch, Harbin Inst Technol, Dept Comp Sci & Technol, Shenzhen, Peoples R China	COMSATS University Islamabad (CUI); Mohammad Ali Jinnah University; Harbin Institute of Technology	Bajwa, UI (corresponding author), COMSATS Inst Informat Technol, Dept Comp Sci, Abbottabad, Pakistan.	usama@ciit.net.pk		Bajwa, Usama/0000-0001-5755-1194; Taj, Imtiaz Ahmad/0000-0003-1813-5563	DOD Counterdrug Technology Development Program Office	DOD Counterdrug Technology Development Program Office	Portions of the research in this paper use the FERET database of facial images collected under the FERET programme, sponsored by the DOD Counterdrug Technology Development Program Office. The authors are thankful to Mr. Xiaofei He [23] for valuable comments and suggestions regarding Laplacianfaces and to Mr. Kresimir Delac [18] for valuable comments regarding FERET training set.	Abate AF, 2007, PATTERN RECOGN LETT, V28, P1885, DOI 10.1016/j.patrec.2006.12.018; Baek K, 2002, PROCEEDINGS OF THE 6TH JOINT CONFERENCE ON INFORMATION SCIENCES, P824; Bajwa U, 2011, FACERECEVAL MATLAB B; Bajwa UI, 2011, IMAGING SCI J, V59, P32, DOI 10.1179/136821910X12816888370061; Bartlett MS, 2002, IEEE T NEURAL NETWOR, V13, P1450, DOI 10.1109/TNN.2002.804287; Bartlett MS, 1998, P SOC PHOTO-OPT INS, V3299, P528, DOI 10.1117/12.320144; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Beveridge JR, 2001, PROC CVPR IEEE, P535; Bhatti Z E, 2009, P IEEE INT MUL C, P1; Bhatti Z E, 2009, FACEREC PROVIDES BAS; Chakrabarty A, 2012, ENG APPL AR IN PRESS; CSU, 2003, CSU FAC ID EV SYST; Delac K, 2005, INT J IMAG SYST TECH, V15, P252, DOI 10.1002/ima.20059; He XF, 2005, IEEE T PATTERN ANAL, V27, P328, DOI 10.1109/TPAMI.2005.55; Kelly MD, 1971, AAI7112934; Kumar R, 2009, PROC CVPR IEEE, P150, DOI 10.1109/CVPRW.2009.5206837; Manjunath B. S., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P373, DOI 10.1109/CVPR.1992.223162; Nefian AV, 1998, INT CONF ACOUST SPEE, P2721, DOI 10.1109/ICASSP.1998.678085; NIST, 2004, FERET DAT; Niu B, 2008, PATTERN RECOGN, V41, P3237, DOI 10.1016/j.patcog.2007.12.001; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Ruiz-Del-Solar J, 2005, IEEE T SYST MAN CY C, V35, P315, DOI 10.1109/TSMCC.2005.848201; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wiskott L, 1997, IEEE T PATTERN ANAL, V19, P775, DOI 10.1109/34.598235; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Zhang DQ, 2005, NEUROCOMPUTING, V69, P224, DOI 10.1016/j.neucom.2005.06.004; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56510	10.1371/journal.pone.0056510	http://dx.doi.org/10.1371/journal.pone.0056510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451054	gold, Green Published			2022-12-27	WOS:000316849500017
J	Malcolm, KC; Nichols, EM; Caceres, SM; Kret, JE; Martiniano, SL; Sagel, SD; Chan, ED; Caverly, L; Solomon, GM; Reynolds, P; Bratton, DL; Taylor-Cousar, JL; Nichols, DP; Saavedra, MT; Nick, JA				Malcolm, Kenneth C.; Nichols, E. Michelle; Caceres, Silvia M.; Kret, Jennifer E.; Martiniano, Stacey L.; Sagel, Scott D.; Chan, Edward D.; Caverly, Lindsay; Solomon, George M.; Reynolds, Paul; Bratton, Donna L.; Taylor-Cousar, Jennifer L.; Nichols, David P.; Saavedra, Milene T.; Nick, Jerry A.			Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; CYSTIC-FIBROSIS; BIOFILM DEVELOPMENT; LUNG-DISEASE; INFECTION; OUTBREAK	Mycobacterium abscessus is a rapidly growing mycobacterium increasingly detected in the neutrophil-rich environment of inflamed tissues, including the cystic fibrosis airway. Studies of the immune reaction to M. abscessus have focused primarily on macrophages and epithelial cells, but little is known regarding the neutrophil response despite the predominantly neutrophillic inflammation typical of these infections. In the current study, human neutrophils released less superoxide anion in response to M. abscessus than to Staphylococcus aureus, a pathogen that shares common sites of infection. Exposure to M. abscessus induced neutrophil-specific chemokine and proinflammatory cytokine genes. Although secretion of these protein products was confirmed, the quantity of cytokines released, and both the number and level of gene induction, was reduced compared to S. aureus. Neutrophils mediated killing of M. abscessus, but phagocytosis was reduced when compared to S. aureus, and extracellular DNA was detected in response to both bacteria, consistent with extracellular trap formation. In addition, M. abscessus did not alter cell death compared to unstimulated cells, while S. aureus enhanced necrosis and inhibited apoptosis. However, neutrophils augment M. abscessus biofilm formation. The response of neutrophils to M. abscessus suggests that the mycobacterium exploits neutrophil-rich settings to promote its survival and that the overall neutrophil response was reduced compared to S. aureus. These studies add to our understanding of M. abscessus virulence and suggest potential targets of therapy.	[Malcolm, Kenneth C.; Nichols, E. Michelle; Caceres, Silvia M.; Kret, Jennifer E.; Chan, Edward D.; Solomon, George M.; Reynolds, Paul; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Caverly, Lindsay; Reynolds, Paul; Bratton, Donna L.; Nichols, David P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Malcolm, Kenneth C.; Chan, Edward D.; Solomon, George M.; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Martiniano, Stacey L.; Sagel, Scott D.; Nichols, David P.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Sagel, Scott D.; Caverly, Lindsay] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [Chan, Edward D.] Denver Vet Affair Med Ctr, Denver, CO USA; [Reynolds, Paul] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Reynolds, Paul] Univ Colorado, Denver, CO 80202 USA	National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; National Jewish Health; University of Colorado System; University of Colorado Denver	Malcolm, KC (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	malcolmk@njhealth.org	Reynolds, Paul/ABD-9094-2020	Nichols, David/0000-0001-8611-7960; Malcolm, Kenneth/0000-0002-8097-6059	Cystic Fibrosis Foundation; National Institutes of Health (NIH) [HL090991, HL34303]; Rebecca Runyon Bryan Chair for Cystic Fibrosis; Wonsowicz Family; Ira and Libbie Pink Charitable Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090991, P01HL034303] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rebecca Runyon Bryan Chair for Cystic Fibrosis; Wonsowicz Family; Ira and Libbie Pink Charitable Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Cystic Fibrosis Foundation, the National Institutes of Health (NIH, HL090991), the Rebecca Runyon Bryan Chair for Cystic Fibrosis, Wonsowicz Family, and Ira and Libbie Pink Charitable Fund (JAN); and NIH HL34303 (DLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOXERBAUM B, 1980, J PEDIATR-US, V96, P689, DOI 10.1016/S0022-3476(80)80743-8; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Cullen AR, 2000, AM J RESP CRIT CARE, V161, P641, DOI 10.1164/ajrccm.161.2.9903062; Daley CL, 2002, CLIN CHEST MED, V23, P623, DOI 10.1016/S0272-5231(02)00021-7; Davidson LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029148; Esteban J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-184; Garcia-Perez BE, 2011, IMMUNOBIOLOGY, V216, P925, DOI 10.1016/j.imbio.2011.01.004; Fauroux B, 1997, PEDIATR INFECT DIS J, V16, P354, DOI 10.1097/00006454-199704000-00004; Freeman R, 2006, APPL ENVIRON MICROB, V72, P7554, DOI 10.1128/AEM.01633-06; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; Giron RM, 2008, ARCH BRONCONEUMOL, V44, P679, DOI 10.1016/S1579-2129(09)60006-9; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; HASLETT C, 1985, AM J PATHOL, V119, P101; HJELTE L, 1990, THORAX, V45, P397, DOI 10.1136/thx.45.5.397; Howard ST, 2000, MICROBES INFECT, V2, P1845, DOI 10.1016/S1286-4579(00)01338-1; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kapur N, 2012, PEDIATR PULM, V47, P300, DOI 10.1002/ppul.21550; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; King P, 2011, PAEDIATR RESPIR REV, V12, P104, DOI 10.1016/j.prrv.2010.10.011; Lee HM, 2012, IMMUNOL CELL BIOL, V90, P601, DOI 10.1038/icb.2011.72; Malcolm KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021958; MOORE M, 1953, J INVEST DERMATOL, V20, P133, DOI 10.1038/jid.1953.18; Oberley-Deegan RE, 2010, FREE RADICAL BIO MED, V49, P1666, DOI 10.1016/j.freeradbiomed.2010.08.026; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Robertson DM, 2011, INVEST OPHTH VIS SCI, V52, P2844, DOI 10.1167/iovs.10-6469; Rodriguez G, 1997, BRIT J DERMATOL, V137, P214, DOI 10.1046/j.1365-2133.1997.18081891.x; Roux AL, 2011, CELL MICROBIOL, V13, P692, DOI 10.1111/j.1462-5822.2010.01565.x; Saavedra MT, 2008, AM J RESP CRIT CARE, V178, P929, DOI 10.1164/rccm.200803-387OC; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sampaio EP, 2008, AM J RESP CELL MOL, V39, P431, DOI 10.1165/rcmb.2007-0413OC; Schorey JS, 2008, GLYCOBIOLOGY, V18, P832, DOI 10.1093/glycob/cwn076; Shin DM, 2008, CELL MICROBIOL, V10, P1608, DOI 10.1111/j.1462-5822.2008.01151.x; Shin JH, 2008, J MICROBIOL, V46, P608, DOI 10.1007/s12275-008-0102-6; Song JY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-6; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; WALLACE RJ, 1983, REV INFECT DIS, V5, P657; Williams MM, 2009, APPL ENVIRON MICROB, V75, P2091, DOI 10.1128/AEM.00166-09; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; ZHANG Y, 1991, MOL MICROBIOL, V5, P381, DOI 10.1111/j.1365-2958.1991.tb02120.x	54	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57402	10.1371/journal.pone.0057402	http://dx.doi.org/10.1371/journal.pone.0057402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451220	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500098
J	Masse, V; Valiquette, L; Boukhoudmi, S; Bonenfant, F; Talab, Y; Carvalho, JC; Alarie, I; Carrier, N; Farand, P				Masse, Vincent; Valiquette, Louis; Boukhoudmi, Soraya; Bonenfant, Francis; Talab, Yasmine; Carvalho, Jean-Christophe; Alarie, Isabelle; Carrier, Nathalie; Farand, Paul			Impact of Methicillin Resistant Staphylococcus aureus Contact Isolation Units on Medical Care	PLOS ONE			English	Article							OF-THE-LITERATURE; PRECAUTIONS	Background: Patient isolation using contact precautions has gained widespread use to halt MRSA transmission, however supportive data is scarce and concerns regarding patient safety and satisfaction have been raised. At our institution, MRSA patients are isolated on a dedicated ward (cohort isolation), rather than in separate rooms. Our objectives were (1) to determine the proportion of bedside medical visits to patients on an isolation ward, (2) to quantify complications in those patients and (3) to determine if those complications are related to isolation and if they can be prevented. Methods: This retrospective case-control study was performed on the two sites of a tertiary teaching hospital in Sherbrooke, QC, Canada. We matched MRSA patients with an admission diagnosis of heart failure or chronic obstructive pulmonary disease to similar non-isolated controls. The proportion of bedside visits was ascertained through the number of progress notes with subjective elements or with a physical examination. Complications were sought through an extensive file review, and events were analysed according to Baker's CAES causality and preventability scales. Results: Overall, 111 patient pairs were analysed (35 with heart failure and 76 with COPD). Isolated patients received less bedside visits (subjective notes/1,000 patient-days: 849.6 vs. 983.3, p = 0,001). Attending physicians (454.5 vs. 451.4, p = 0,02) and residents (347.0 vs. 416.9, p = 0.01) are responsible for this discrepancy, while medical students appear to visit isolated and non-isolated patients equally (116.5 vs. 114.9, p = 0.90). Isolated patients showed a tendency towards longer stay and more preventable complications, although no difference in the total number of complications was observed. Conclusion: Isolated patients have less documented care that suggests less bedside visits from the medical staff, which could hamper the therapeutical relationship. Further studies are needed to explain this finding.	[Masse, Vincent; Valiquette, Louis; Boukhoudmi, Soraya; Alarie, Isabelle] Ctr Hosp Univ Sherbrooke, Div Infect Dis, Sherbrooke, PQ, Canada; [Bonenfant, Francis; Talab, Yasmine; Carvalho, Jean-Christophe; Farand, Paul] Ctr Hosp Univ Sherbrooke, Div Internal Med, Sherbrooke, PQ, Canada; [Valiquette, Louis; Farand, Paul] Ctr Hosp Univ Sherbrooke, Etienne Lessel Res Ctr, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Farand, P (corresponding author), Ctr Hosp Univ Sherbrooke, Div Internal Med, Sherbrooke, PQ, Canada.	Paul.Farand@USherbrooke.ca			University of Sherbrooke	University of Sherbrooke	Funding for the chart review process came from institutional scholarships grants from the University of Sherbrooke. Y.T. received salary support from these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2010, J HOSP INFECT, V76, P97, DOI 10.1016/j.jhin.2010.04.027; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Edmond M, 2008, PUBLIC HEALTH ETH-UK, V1, P235, DOI 10.1093/phe/phn014; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Kirkland KB, 2009, CLIN INFECT DIS, V48, P766, DOI 10.1086/597090; Marshall C, 2004, J HOSP INFECT, V56, P253, DOI 10.1016/j.jhin.2004.02.001; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1016/S0196-6553(02)48250-8; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899	13	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57057	10.1371/journal.pone.0057057	http://dx.doi.org/10.1371/journal.pone.0057057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451144	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500057
J	Patel, N; Itakura, T; Gonzalez, JM; Schwartz, SG; Fini, ME				Patel, Nitin; Itakura, Tatsuo; Gonzalez, Jose M., Jr.; Schwartz, Stephen G.; Fini, M. Elizabeth			GPR158, an Orphan Member of G Protein-Coupled Receptor Family C: Glucocorticoid-Stimulated Expression and Novel Nuclear Role	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; INTRAVITREAL TRIAMCINOLONE ACETONIDE; INTRAOCULAR-PRESSURE; OUTFLOW PATHWAY; TIGHT JUNCTIONS; AQUEOUS OUTFLOW; MOLECULAR-BASIS; FLUID-FLOW; LOCALIZATION; PERMEABILITY	Members of the large G protein-coupled receptor (GPCR) clan are implicated in many physiological and disease processes, making them important therapeutic drug targets. In the present study, we follow up on results of a pilot study suggesting a functional relationship between glucocorticoid (GC)-induced ocular hypertension and GPR158, one of three orphan members of the GPCR Family C. GC treatment increases levels of GPR158 mRNA and protein through transcriptional mechanisms, in cultured trabecular meshwork (TBM) cells derived from the eye's aqueous outflow pathway. Like treatment with GCs, transient overexpression of GPR158 stimulates cell proliferation, while siRNA knockdown of endogenous GPR158 has the opposite effect. Both endogenous and overexpressed GPR158 show an unusual subcellular localization pattern, being found almost entirely in the nucleus. However, when cells are treated with inhibitors of clathrin-mediated endocytosis, GPR158 is shifted to the plasma membrane. Mutation of a bipartite nuclear localization signal (NLS) in the 8th helix also shifts GPR158 out of the nucleus, but in this case the protein is found in vesicles localized in the cytoplasm. These results suggest that newly synthesized GPR158 first traffics to the plasma membrane, where it rapidly undergoes endocytosis and translocation to the nucleus. Significantly, mutation of the NLS abrogates GPR158-mediated enhancement of cell proliferation, indicating a functional requirement for nuclear localization. GPR158 overexpression upregulates levels of the cell cycle regulator cyclin D1, but mutation of the NLS reverses this. Overexpression of GPR158 enhances the barrier function of a TBM cell monolayer, which is associated with an increase in the levels of tight junction proteins ZO-1 and occludin, similar to reported studies on GC treatment. Regulated paracellular permeability controls aqueous outflow facility in vivo. Since GCs stimulate GPR158 expression, the result is consistent with a role for elevation of GPR158 expression in GC-induced ocular hypertension.	[Patel, Nitin; Itakura, Tatsuo; Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Gonzalez, Jose M., Jr.] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Schwartz, Stephen G.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	University of Southern California; Doheny Eye Institute; Bascom Palmer Eye Institute; University of Miami	Patel, N (corresponding author), Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA.	nitinpat@usc.edu			National Institutes of Health [R01-EY09828, P30-0EY03040]; foundation Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R01EY009828, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); foundation Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants [R01-EY09828] to MEF and [P30-0EY03040] to Doheny Eye Institute. The foundation Research to Prevent Blindness, New York, NY, also provided support for conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Alvarado JA, 1998, INVEST OPHTH VIS SCI, V39, P1813; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Bakunowicz-Lazarczyk A., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P17; BALDA MS, 1993, AM J PHYSIOL, V264, pC918, DOI 10.1152/ajpcell.1993.264.4.C918; Beaulieu JM, 2005, CELL, V123, P755, DOI 10.1016/j.cell.2005.11.010; Beaumont V, 1998, J BIOL CHEM, V273, P33174, DOI 10.1074/jbc.273.50.33174; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; CHAN GCK, 1991, J BIOL CHEM, V266, P22634; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Fay JF, 2005, BIOCHEMISTRY-US, V44, P8757, DOI 10.1021/bi0472651; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Fini ME, 2011, INVEST OPHTHALMOL VI, V52; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Goetzl EJ, 2007, FASEB J, V21, P638, DOI 10.1096/fj.06-6624hyp; Gould DB, 2004, INT J DEV BIOL, V48, P1015, DOI 10.1387/ijdb.041865dg; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jeon JW, 2003, YONSEI MED J, V44, P299, DOI 10.3349/ymj.2003.44.2.299; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Li AF, 2004, MOL VIS, V10, P750; Lundstrom K, 2005, IDRUGS, V8, P909; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Menaa F, 2011, MOLECULES, V16, P5402, DOI 10.3390/molecules16075402; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Quentien MH, 2006, J NEUROENDOCRINOL, V18, P633, DOI 10.1111/j.1365-2826.2006.01461.x; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Rhee DJ, 2006, BRIT J OPHTHALMOL, V90, P999, DOI 10.1136/bjo.2006.090340; Shepard AR, 2001, INVEST OPHTH VIS SCI, V42, P3173; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smithen LM, 2004, AM J OPHTHALMOL, V138, P740, DOI 10.1016/j.ajo.2004.06.067; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Strungaru MH, 2001, INVEST OPHTH VIS SCI, V52, P7625; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Underwood JL, 1999, AM J PHYSIOL-CELL PH, V277, pC330, DOI 10.1152/ajpcell.1999.277.2.C330; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Yang K, 1996, BIOCHEMISTRY-US, V35, P14040, DOI 10.1021/bi962113u	54	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57843	10.1371/journal.pone.0057843	http://dx.doi.org/10.1371/journal.pone.0057843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451275	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849500138
J	Penn, L; White, M; Lindstrom, J; den Boer, AT; Blaak, E; Eriksson, JG; Feskens, E; Ilanne-Parikka, P; Keinanen-Kiukaanniemi, SM; Walker, M; Mathers, JC; Uusitupa, M; Tuomilehto, J				Penn, Linda; White, Martin; Lindstrom, Jaana; den Boer, Annemieke Th.; Blaak, Ellen; Eriksson, Johan G.; Feskens, Edith; Ilanne-Parikka, Pirjo; Keinanen-Kiukaanniemi, Sirkka M.; Walker, Mark; Mathers, John C.; Uusitupa, Matti; Tuomilehto, Jaakko			Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; FOLLOW-UP; PROGRAM; MELLITUS; BEHAVIOR; OBESITY; ADULTS	Background: Prevalence of type 2 diabetes (T2D) is increasing worldwide. T2D prevention by lifestyle intervention is effective. Pragmatic scalable interventions are needed, with evidence to efficiently target and monitor such interventions. We report pooled analyses of data from three European trial cohorts: to analyse T2D incidence, sustained weight loss and utility of risk predictors. Methods: We analysed data on 749 adults with impaired glucose tolerance (278 men and 471 women, mean age 56 years, mean BMI 31 kgm(-2)) recruited between 1993 and 2003, and randomised to intensive lifestyle intervention (I) or lifestyle advice control (C). The intervention aimed to increase physical activity, modify diet, and promote weight loss >= 5%. Using Cox-regression survival analysis, we assessed T2D incidence and the impact on T2D incidence of sustained weight loss, and of baseline cut-point values of FINDRISC score, fasting plasma glucose (FPG), and HbA(1c). Results: Mean follow-up duration was 3.1 years. T2D was diagnosed in 139 participants (I = 45/379, C = 94/370). Cumulative T2D incidence was 57% lower in the intervention compared with the control group (HR 0.42 (95% CI 0.29 to 0.60) P<0.001). Participants with >= 5% weight loss at one year had 65% lower T2D incidence (HR 0.35 (95% CI 0.22 to 0.56) P<0.001); maintaining >= 5% weight loss for two and three years further reduced T2D incidence. Recommended cut-points to identify those at high risk for T2D would have identified different proportions of European Diabetes Prevention Study (EDIPS) participants with similar hazard-ratios for intervention effect. Conclusions: Pooled analysis of EDIPS trial data reinforces evidence for T2D prevention by lifestyle intervention. Analysis showed the preventive effect of >= 5% weight loss, especially if maintained long term, which has utility for intervention monitoring. Analysis of proposed cut-points demonstrates difficulties in balancing risk and benefit, to efficiently target interventions and suggests evidence is needed to define clinical policy.	[Penn, Linda; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lindstrom, Jaana] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Helsinki, Finland; [den Boer, Annemieke Th.; Blaak, Ellen] Maastricht Univ, Med Ctr, Sch Nutr Toxicol Metab, Dept Human NUTRIM, Maastricht, Netherlands; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Feskens, Edith] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Ilanne-Parikka, Pirjo] Finnish Diabet Assoc, Ctr Diabet, Tampere, Finland; [Keinanen-Kiukaanniemi, Sirkka M.] Univ Oulu, Inst Hlth Sci Gen Practice, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka M.] Cent Hosp, Oulu, Finland; [Walker, Mark] Newcastle Univ, Inst Cellular Med Diabet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] Hosp Univ La Paz, Madrid, Spain; [Tuomilehto, Jaakko] Danube Univ, Ctr Vasc Prevent, Krems, Austria	Newcastle University - UK; Finland National Institute for Health & Welfare; Maastricht University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Wageningen University & Research; University of Oulu; Newcastle University - UK; Newcastle University - UK; University of Eastern Finland; Hospital Universitario La Paz; Danube University Krems	Penn, L (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	linda.penn@ncl.ac.uk	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Feskens, Edith/ABI-1446-2020; Blaak, Ellen/E-3459-2015	Feskens, Edith/0000-0001-5819-2488; Lindstrom, Jaana/0000-0001-9255-020X; Blaak, Ellen/0000-0002-2496-3464; White, Martin/0000-0002-1861-6757; Mathers, John/0000-0003-3406-3002; Eriksson, Johan/0000-0002-2516-2060	European Union Concerted Action (CA) [BMH4-CT98-3759 (DG 12-SSMI)]; Academy of Finland [8473/2298, 40758/5767, 38387/54175, 128315, 129330]; Ministry of Education; Novo Nordisk Foundation; Yrjo Jahnsson Foundation; Juho Vainio Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Unilever; Tampere University Hospital; Kuopio University Hospital; Oulu University Hospital; Wellcome Trust [057146/Z/99/Z]; Dutch Diabetes Research Foundation [DFN 98.901, 2000.00.020, 2007.15.002]; Netherlands Organization for Health Research and Development [ZonMW 940-35-034]; Netherlands Organization for Scientific Research [NWO 2200.0139]; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1, G0700718B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10150] Funding Source: researchfish; ESRC [ES/G007470/1] Funding Source: UKRI	European Union Concerted Action (CA); Academy of Finland(Academy of Finland); Ministry of Education; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Yrjo Jahnsson Foundation; Juho Vainio Foundation; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Unilever(Unilever); Tampere University Hospital; Kuopio University Hospital; Oulu University Hospital; Wellcome Trust(Wellcome TrustEuropean Commission); Dutch Diabetes Research Foundation; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The EDIPS collaboration was funded by European Union Concerted Action (CA) Contract No BMH4-CT98-3759 (DG 12-SSMI). The Diabetes Prevention Study was financially supported by the Academy of Finland (grants 8473/2298, 40758/5767, 38387/54175, 128315, and 129330), Ministry of Education, Novo Nordisk Foundation, Yrjo Jahnsson Foundation, Juho Vainio Foundation, Finnish Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, Unilever, and Competitive Research Funding from Tampere, Kuopio, and Oulu University Hospitals. EDIPS-Newcastle was funded by the Wellcome Trust (Grant No. 057146/Z/99/Z). The Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht was supported by grants from the Dutch Diabetes Research Foundation (DFN 98.901, 2000.00.020 and 2007.15.002), the Netherlands Organization for Health Research and Development (ZonMW 940-35-034) and the Netherlands Organization for Scientific Research (NWO 2200.0139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Absetz P, 2009, DIABETES CARE, V32, P1418, DOI 10.2337/dc09-0039; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Chatterton H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4624; Costa B, 2012, DIABETOLOGIA, P1; Dombrowski SU, 2010, OBESITY FACTS, V3, P377, DOI 10.1159/000323076; Douglas A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-220; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; International Diabetes Federation, 2011, DIABETES ATLAS, V6th; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Netherlands Nutrition Council, 1986, GUID HLTH DIET; NICE, 2012, PH 38 PREV TYP 2 DIA; NICE, 2011, PH35 PREV TYP 2 DIAB; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Penn L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-235; Penn L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-342; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rollnick S, 1999, HLTH BEHAV CHANGE; Roumen C, 2008, DIABETIC MED, V25, P597, DOI 10.1111/j.1464-5491.2008.02417.x; Roumen C, 2011, EUR J CLIN NUTR, V65, P1141, DOI 10.1038/ejcn.2011.74; Saaristo T, 2007, INT J CIRCUMPOL HEAL, V66, P101, DOI 10.3402/ijch.v66i2.18239; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; The Finnish Diabetes Association, 2003, DEHKO DEV PROGR PREV; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Uusitupa M, 2011, NUTR METAB CARDIOVAS, V21, P380, DOI 10.1016/j.numecd.2010.12.007; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; World Health Organization, 1999, DEF DIAGN CLASS DI 1	35	77	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57143	10.1371/journal.pone.0057143	http://dx.doi.org/10.1371/journal.pone.0057143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451166	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500069
J	Ye, XH; Fu, JJ; Yang, Y; Chen, SD				Ye, Xiaohua; Fu, Jinjian; Yang, Yi; Chen, Sidong			Dose-Risk and Duration-Risk Relationships between Aspirin and Colorectal Cancer: A Meta-Analysis of Published Cohort Studies	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DAILY SOLUBLE ASPIRIN; ADENOMA RECURRENCE; PRIMARY PREVENTION; COLON-CANCER; NSAIDS; BIAS; SEX	Background: In previous meta-analyses, aspirin use has been associated with reduced risk of colorectal cancer. However, uncertainty remains on the exact dose-risk and duration-risk relationships. Methods: We identified studies by searching several English and Chinese electronic databases and reviewing relevant articles. The dose-response meta-analysis was performed by linear trend regression and restricted cubic spline regression. Subgroup analyses were conducted to explore possible heterogeneity among studies. Potential heterogeneity was calculated as Q statistic and I-2 value. Publication bias was evaluated using funnel plots and quantified by the Begg's and Egger's test. Results: Twelve studies were included in this meta-analysis. An inverse association between aspirin use and colorectal cancer was observed in both the overall group (RR = 0.74, 95% CI 0.64-0.83 for aspirin dose; RR = 0.80, 95% CI 0.75-0.85 for frequency of aspirin use; RR = 0.75, 95% CI 0.68-0.81 for years of aspirin use) and subgroups stratified by sex and cancer site. The dose-response meta-analysis showed that there was a 20% statistically significant decreased risk of colorectal cancer for 325 mg aspirin per day increment, 18% decreased risk for 7 times aspirin per week increment and 18% decreased risk for 10 years aspirin increment. Conclusion: Long-term (>5 years), low-dose (75-325 mg per day) and regular aspirin use (2-7 times per week) can effectively reduce the risk of colorectal cancer.	[Ye, Xiaohua; Fu, Jinjian] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Ye, Xiaohua; Fu, Jinjian; Yang, Yi; Chen, Sidong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Fu, Jinjian] Liuzhou Municipal Matern & Child Healthcare Hosp, Liuzhou, Guangxi, Peoples R China	Southern Medical University - China; Guangdong Pharmaceutical University	Chen, SD (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.	chensidong1@126.com			International cooperation project of the Guangzhou Science and Technology Bureau [2011J5200017]	International cooperation project of the Guangzhou Science and Technology Bureau	This work was supported by fund from International cooperation project of the Guangzhou Science and Technology Bureau (No. 2011J5200017). The funders had no role in study design, data collection and analysis, and interpretation of the data.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Allison M, 2006, AM J EPIDEMIOL, V164, P567, DOI 10.1093/aje/kwj250; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Benamouzig R, 2012, GUT, V61, P255, DOI 10.1136/gutjnl-2011-300113; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7; Brasky TM, 2012, CANCER CAUSE CONTROL, V23, P431, DOI 10.1007/s10552-011-9891-8; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chu Huei-An, 2006, Int J Environ Res Public Health, V3, P316, DOI 10.3390/ijerph2006030039; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Harris RE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-237; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Irving HM, 2009, J PANCREAS, V10, P387; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Jana NR, 2008, CELL MOL LIFE SCI, V65, P1295, DOI 10.1007/s00018-008-7511-x; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Larsson SC, 2006, BRIT J CANCER, V95, P1277, DOI 10.1038/sj.bjc.6603442; Leopoldo S, 2008, ANN SURG ONCOL, V15, P1429, DOI 10.1245/s10434-007-9757-1; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Mahipal A, 2006, CANCER EPIDEM BIOMAR, V15, P1785, DOI 10.1158/1055-9965.EPI-05-0674; Meade TW, 1998, LANCET, V351, P233; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rothwell PM, 2011, OBSTET GYNECOL SURV, V66, P222, DOI 10.1097/OGX.0b013e318225cec2; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Ruder EH, 2011, AM J GASTROENTEROL, V106, P1340, DOI 10.1038/ajg.2011.38; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218; Vinogradova Y, 2007, GASTROENTEROLOGY, V133, P393, DOI 10.1053/j.gastro.2007.05.023; Wu XC, 2004, CANCER EPIDEM BIOMAR, V13, P1215; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014	53	40	45	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57578	10.1371/journal.pone.0057578	http://dx.doi.org/10.1371/journal.pone.0057578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451245	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849500116
J	Kazem, AJN; Widdig, A				Kazem, Anahita J. N.; Widdig, Anja			Visual Phenotype Matching: Cues to Paternity Are Present in Rhesus Macaque Faces	PLOS ONE			English	Article							KIN RECOGNITION SIGNALS; INBREEDING AVOIDANCE; SOCIAL RELATIONSHIPS; MACACA-MULATTA; RESEMBLANCE; RELATEDNESS; KINSHIP; EVOLUTION; DISCRIMINATION; FATHER	The ability to recognize kin and thus behaviourally discriminate between conspecifics based on genetic relatedness is of importance both in acquiring inclusive fitness benefits and to enable optimal inbreeding. In primates, mechanisms allowing recognition of paternal relatives are of particular interest, given that in these mating systems patrilineal information is unlikely to be available via social familiarity. Humans use visual phenotype matching based on facial features to identify their own and other's close relatives, and recent studies suggest similar abilities may be present in other species. However it is unclear to what extent familial resemblances remain detectable against the background levels of relatedness typically found within demes in the wild - a necessary condition if facial cues are to function in kin recognition under natural conditions. Here, we experimentally investigate whether parent-offspring relationships are discernible in rhesus macaque (Macaca mulatta) faces drawn from a large free-ranging population more representative of the latter scenario, and in which genetic relatedness has been well quantified from pedigrees determined via molecular markers. We used the human visual system as a means of integrating multiple types of facial cue simultaneously, and demonstrate that paternal, as well as maternal, resemblance to both sons and daughters can be detected even by human observers. Experts performed better than participants who lacked previous experience working with nonhuman primates. However the finding that even naive individuals succeeded at the task underlines the strength of the phenotypic cues present in faces.	[Kazem, Anahita J. N.; Widdig, Anja] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, Leipzig, Germany; [Kazem, Anahita J. N.] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway; [Widdig, Anja] Univ Leipzig, Behav Ecol Res Grp, Inst Biol, D-04109 Leipzig, Germany	Max Planck Society; Norwegian University of Science & Technology (NTNU); Leipzig University	Kazem, AJN (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, Leipzig, Germany.	anahita.kazem@bio.ntnu.no			National Center for Research Resources [8 P40 OD012217-25]; Office of Research Infrastructure Programs of the National Institutes of Health; German Research Foundation within the Emmy-Noether Program [WI 1808/3-1]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation within the Emmy-Noether Program(German Research Foundation (DFG)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Maintenance of the Cayo Santiago population is supported by grant number 8 P40 OD012217-25 from the National Center for Research Resources, and the Office of Research Infrastructure Programs of the National Institutes of Health (http://www.nih.gov). This project was funded by the German Research Foundation (http://www.dfg.de), within the Emmy-Noether Program (grant No. WI 1808/3-1 to AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 1999, P ROY SOC B-BIOL SCI, V266, P1501, DOI 10.1098/rspb.1999.0807; Alvergne A, 2009, INT J PRIMATOL, V30, P199, DOI 10.1007/s10764-009-9339-0; Alvergne A, 2009, ANIM BEHAV, V78, P61, DOI 10.1016/j.anbehav.2009.03.019; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2009, LANGUAGER DATA SETS; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bateson P., 1983, P257; Bercovitch FB, 2003, NATURWISSENSCHAFTEN, V90, P309, DOI 10.1007/s00114-003-0436-1; BLOUIN SF, 1988, TRENDS ECOL EVOL, V3, P230, DOI 10.1016/0169-5347(88)90164-4; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bower S, 2012, J COMP PSYCHOL, V126, P318, DOI 10.1037/a0025081; Brandvain Y, 2011, TRENDS GENET, V27, P251, DOI 10.1016/j.tig.2011.04.005; Bressan P, 2004, EVOL HUM BEHAV, V25, P133, DOI 10.1016/j.evolhumbehav.2004.03.001; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Burch RL, 2000, EVOL HUM BEHAV, V21, P429, DOI 10.1016/S1090-5138(00)00056-8; Carson EA, 2006, AM J PHYS ANTHROPOL, V131, P169, DOI 10.1002/ajpa.20424; Celerier A, 2010, J EXP BIOL, V213, P1399, DOI 10.1242/jeb.038349; Chapais B., 2004, KINSHIP BEHAV PRIMAT; Charpentier M, 2005, BEHAV ECOL, V16, P614, DOI 10.1093/beheco/ari034; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Charpentier MJE, 2007, ANIM BEHAV, V73, P37, DOI 10.1016/j.anbehav.2006.02.026; Charpentier MJE, 2010, ANIM BEHAV, V80, P101, DOI 10.1016/j.anbehav.2010.04.005; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P151, DOI 10.1002/ajpa.1330590205; Dal Martello MF, 2006, J VISION, V6, P1356, DOI 10.1167/6.12.2; DASSER V, 1988, ANIM BEHAV, V36, P225, DOI 10.1016/S0003-3472(88)80265-3; de Ruiter JR, 1998, P ROY SOC B-BIOL SCI, V265, P79, DOI 10.1098/rspb.1998.0267; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2009, VISION RES, V49, P38, DOI 10.1016/j.visres.2008.09.025; Dubuc C, 2011, BEHAV ECOL SOCIOBIOL, V65, P1615, DOI 10.1007/s00265-011-1172-8; Dufour V, 2010, J ETHOL, V28, P231, DOI 10.1007/s10164-009-0174-8; Fletcher D. J. C., 1987, KIN RECOGNITION; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fox M, 2010, P ROY SOC B-BIOL SCI, V277, P567, DOI 10.1098/rspb.2009.1660; Gaulin SJC, 1997, HUM NATURE-INT BIOS, V8, P139, DOI 10.1007/s12110-997-1008-4; Haig D, 2011, P NATL ACAD SCI USA, V108, P10878, DOI 10.1073/pnas.1100295108; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hepper PG., 1991, KIN RECOGNITION; Holmes WG, 2004, ANN ZOOL FENN, V41, P691; HOLMES WG, 1982, AM ZOOL, V22, P491; Jelenkovic A, 2010, HOMO, V61, P191, DOI 10.1016/j.jchb.2009.10.003; Jeon J, 2007, P R SOC B, V274, P1181, DOI 10.1098/rspb.2006.0366; Johnstone RA, 1997, P ROY SOC B-BIOL SCI, V264, P1547, DOI 10.1098/rspb.1997.0215; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaminski G, 2009, P ROY SOC B-BIOL SCI, V276, P3193, DOI 10.1098/rspb.2009.0677; KUESTER J, 1994, ANIM BEHAV, V48, P1183, DOI 10.1006/anbe.1994.1350; Kulik L, 2012, MOL ECOL, V21, P699, DOI 10.1111/j.1365-294X.2011.05250.x; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Mateo JM, 2002, P ROY SOC B-BIOL SCI, V269, P721, DOI 10.1098/rspb.2001.1947; Muniz L, 2006, CURR BIOL, V16, pR156, DOI 10.1016/j.cub.2006.02.055; Nurnberg P, 1998, AM J PRIMATOL, V44, P1; Pagel M, 1997, ANIM BEHAV, V53, P973, DOI 10.1006/anbe.1996.0317; Parr LA, 2011, PHILOS T R SOC B, V366, P1764, DOI 10.1098/rstb.2010.0358; Parr LA, 2010, J COMP PSYCHOL, V124, P343, DOI 10.1037/a0020545; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; R Core Team, 2020, R LANG ENV STAT COMP; Rawlins RG., 1986, CAYO SANTIAGO MACAQU; Rice WR, 2010, P ROY SOC B-BIOL SCI, V277, P2727, DOI 10.1098/rspb.2010.0409; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schino G, 2006, ANIM BEHAV, V71, P1069, DOI 10.1016/j.anbehav.2005.07.019; Scott LS, 2009, PSYCHOL SCI, V20, P676, DOI 10.1111/j.1467-9280.2009.02348.x; SHERMAN PW, 1980, AM NAT, V116, P604, DOI 10.1086/283652; Sherwood RJ, 2011, ANAT REC, V294, P664, DOI 10.1002/ar.21337; SILK J, 1993, INT J PRIMATOL, V14, P95, DOI 10.1007/BF02196505; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, PHILOS T R SOC B, V364, P3243, DOI 10.1098/rstb.2009.0118; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith K, 2003, P ROY SOC B-BIOL SCI, V270, P503, DOI 10.1098/rspb.2002.2277; Stewart-Williams S, 2007, EVOL HUM BEHAV, V28, P193, DOI 10.1016/j.evolhumbehav.2007.01.002; Todrank J, 2003, ADV STUD BEHAV, V32, P77, DOI 10.1016/S0065-3454(03)01002-7; Vokey JR, 2004, J COMP PSYCHOL, V118, P194, DOI 10.1037/0735-7036.118.2.194; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848	85	26	26	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e55846	10.1371/journal.pone.0055846	http://dx.doi.org/10.1371/journal.pone.0055846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451032	Green Submitted, Green Published, gold			2022-12-27	WOS:000316658800005
J	Konno-Shimizu, M; Yamamichi, N; Inada, K; Kageyama-Yahara, N; Shiogama, K; Takahashi, Y; Asada-Hirayama, I; Yamamichi-Nishina, M; Nakayama, C; Ono, S; Kodashima, S; Fujishiro, M; Tsutsumi, Y; Ichinose, M; Koike, K				Konno-Shimizu, Maki; Yamamichi, Nobutake; Inada, Ken-ichi; Kageyama-Yahara, Natsuko; Shiogama, Kazuya; Takahashi, Yu; Asada-Hirayama, Itsuko; Yamamichi-Nishina, Mitsue; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Fujishiro, Mitsuhiro; Tsutsumi, Yutaka; Ichinose, Masao; Koike, Kazuhiko			Cathepsin E Is a Marker of Gastric Differentiation and Signet-Ring Cell Carcinoma of Stomach: A Novel Suggestion on Gastric Tumorigenesis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; GENE-EXPRESSION; CADHERIN EXPRESSION; DIFFUSE-TYPE; RISK-FACTORS; E DEFICIENCY; GENOME-WIDE; CANCER; EPIDEMIOLOGY; METAPLASIA	Gastric cancer (GC) presents various histological features, though the mechanism underlying its diversity is seldom elucidated. It is mainly classified into well differentiated tubular adenocarcinoma (tub1), moderately differentiated tubular adenocarcinoma (tub2), poorly differentiated adenocarcinoma (por), signet-ring cell carcinoma (sig), mucinous adenocarcinoma (muc), and papillary adenocarcinoma (pap). By screening, we found cathepsin E (CTSE) expresses universally in sig-type, occasionally in por-type, and rarely in tub1/tub2-type GC cell lines. In surgically-resected specimens, CTSE was immunostained in 50/51 sig-type (98.0%), 3/10 tub1-type (30.0%), 7/18 tub2-type (38.9%), 15/26 por-type (57.7%), 4/10 pap-type (40.0%), and 0/3 muc-type (0.0%) GC. In endoscopically-resected specimens, 6/7 sig-type (85.7%), 7/52 tub1-type (13.7%), 5/12 tub2-type (41.7%), 2/7 pap-type (28.6%) GC and 0/6 adenoma (0.0%) expressed CTSE. For non-malignant tissues, CTSE is universally expressed in normal fundic, pyloric, and cardiac glands of stomach, but hardly in other digestive organs. In the precancerous intestinal metaplasia of stomach, CTSE is mostly observed in mixed gastric-and-intestinal type and deficient in solely-intestinal type. CTSE expression is positively correlated with gastric marker MUC5AC (p<0.0001) and negatively correlated with intestinal marker MUC2 (p = 0.0019). For sig-type GC, in both tumors and background mucosa, expression of MUC5AC and CTSE is high whereas that of MUC2 is low, indicating that sig-type GC reflects the features of background mucosa. For gastric adenoma and tub1/tub2-type GC, more undifferentiated tumors tend to show higher expression of CTSE with MUC5AC and lower expression of MUC2 in tumors, but they tend to present lower expression of CTSE, MUC5AC and MUC2 in background mucosa. These suggest that more malignant gastric adenocarcinoma with stronger gastric and weaker intestinal properties tend to arise from background mucosa with decreased both gastric and intestinal features. In conclusion, CTSE is a marker of both gastric differentiation and signet-ring cell carcinoma, which should shed light on the mechanism of gastric tumorigenesis.	[Konno-Shimizu, Maki; Yamamichi, Nobutake; Kageyama-Yahara, Natsuko; Takahashi, Yu; Asada-Hirayama, Itsuko; Yamamichi-Nishina, Mitsue; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Inada, Ken-ichi; Shiogama, Kazuya; Tsutsumi, Yutaka] Fujita Hlth Univ, Sch Med, Dept Pathol 1, Aichi, Japan; [Ichinose, Masao] Wakayama Med Coll, Dept Internal Med 2, Wakayama 640, Japan	University of Tokyo; Fujita Health University; Wakayama Medical University	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	Ichinose, Masao/HAB-1645-2022; 藤城, 光弘/AAN-3131-2020; Ono, Satoshi/AFP-6208-2022; Ono, Satoshi/H-7900-2019; Takahashi, Yu/I-4665-2015	Ono, Satoshi/0000-0002-9864-348X; Takahashi, Yu/0000-0002-3066-9501	Sato Memorial Foundation for Cancer Research; Nakayama Cancer Research Institute; Foundation for promotion of Cancer Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Grants-in-Aid for Scientific Research [25460381] Funding Source: KAKEN	Sato Memorial Foundation for Cancer Research; Nakayama Cancer Research Institute; Foundation for promotion of Cancer Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from Sato Memorial Foundation for Cancer Research, in part by a research grant from Nakayama Cancer Research Institute, in part by a research grant from Foundation for promotion of Cancer Research, and also in part by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). But all the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 1997, CANCER, V80, P179, DOI 10.1002/(SICI)1097-0142(19970715)80:2<179::AID-CNCR2>3.0.CO;2-P; BECKER KF, 1994, CANCER RES, V54, P3845; Boussioutas A, 2003, CANCER RES, V63, P2569; Chu PG, 2004, AM J CLIN PATHOL, V121, P884, DOI 10.1309/A09ERYMFR64NERDW; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dohchin A, 2000, CANCER, V89, P482, DOI 10.1002/1097-0142(20000801)89:3<482::AID-CNCR2>3.0.CO;2-5; Farinati F, 1996, CARCINOGENESIS, V17, P2581, DOI 10.1093/carcin/17.12.2581; Fenoglio-Preiser C., 2000, WHO CLASSIFICATION T, P37; FILIPE MI, 1994, INT J CANCER, V57, P324, DOI 10.1002/ijc.2910570306; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Grotzinger C, 2001, GUT, V49, P73, DOI 10.1136/gut.49.1.73; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hippo Y, 2002, CANCER RES, V62, P233; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jiang CG, 2011, J SURG ONCOL, V103, P700, DOI 10.1002/jso.21878; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kakehashi H, 2007, J IMMUNOL, V179, P5728, DOI 10.4049/jimmunol.179.9.5728; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; KUBOTA K, 1977, J NATL CANCER I, V59, P1599, DOI 10.1093/jnci/59.6.1599; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2010, BRIT J SURG, V97, P732, DOI 10.1002/bjs.6941; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; MAEHARA Y, 1992, CANCER, V69, P1645, DOI 10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X; Matsuo K, 1996, HUM PATHOL, V27, P184, DOI 10.1016/S0046-8177(96)90373-1; Matsushita M, 1986, JPN J GASTROENTEROL, V19, P1925; MAYER B, 1993, CANCER RES, V53, P1690; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Otsuji E, 1998, J SURG ONCOL, V67, P216, DOI 10.1002/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.0.CO;2-B; Otsuki S, 2011, ONCOL REP, V25, P1235, DOI 10.3892/or.2011.1185; SAKU T, 1990, GUT, V31, P1250, DOI 10.1136/gut.31.11.1250; Saqui-Salces M, 2010, BBA-MOL CELL RES, V1803, P786, DOI 10.1016/j.bbamcr.2010.03.008; Tong JH, 2011, SURGERY, V149, P356, DOI 10.1016/j.surg.2010.07.006; Tsukamoto Tetsuya, 2006, Gastric Cancer, V9, P156, DOI 10.1007/s10120-006-0375-6; Tsukuba T, 2003, J BIOCHEM, V134, P893, DOI 10.1093/jb/mvg216; Tsukuba T, 2000, MOL CELLS, V10, P601, DOI 10.1007/s100590000019; Wakatsuki K, 2008, J SURG ONCOL, V98, P124, DOI 10.1002/jso.21093; WATANABE M, 1989, BIOCHEM MED METAB B, V42, P21, DOI 10.1016/0885-4505(89)90037-6; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yamamichi N, 2009, EXP CELL RES, V315, P1779, DOI 10.1016/j.yexcr.2009.01.006; Yamamichi-Nishina M, 2003, J BIOL CHEM, V278, P7422, DOI 10.1074/jbc.M208458200; Yanagawa M, 2007, J BIOL CHEM, V282, P1851, DOI 10.1074/jbc.M604143200; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Yokota T, 1998, TOHOKU J EXP MED, V186, P121, DOI 10.1620/tjem.186.121; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V367, P517, DOI 10.1016/j.bbrc.2007.12.163; Zhang M, 2010, J GASTROINTEST SURG, V14, P601, DOI 10.1007/s11605-009-1127-9	49	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56766	10.1371/journal.pone.0056766	http://dx.doi.org/10.1371/journal.pone.0056766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451082	Green Published, gold, Green Submitted			2022-12-27	WOS:000316658800034
J	Rodriguez, M; Rau, D; Angioi, SA; Bellucci, E; Bitocchi, E; Nanni, L; Knupffer, H; Negri, V; Papa, R; Attene, G				Rodriguez, Monica; Rau, Domenico; Angioi, Simonetta A.; Bellucci, Elisa; Bitocchi, Elena; Nanni, Laura; Knuepffer, Helmut; Negri, Valeria; Papa, Roberto; Attene, Giovanna			European Phaseolus coccineus L. landraces: Population Structure and Adaptation, as Revealed by cpSSRs and Phenotypic Analyses	PLOS ONE			English	Article							GENETIC DIVERSITY; VULGARIS L.; COMMON; DIFFERENTIATION; CHLOROPLAST; GERMPLASM; RESISTANCE; SOFTWARE; DISEASE; TRAITS	Relatively few studies have extensively analysed the genetic diversity of the runner bean through molecular markers. Here, we used six chloroplast microsatellites (cpSSRs) to investigate the cytoplasmic diversity of 331 European domesticated accessions of the scarlet runner bean (Phaseolus coccineus L.), including the botanical varieties albiflorus, bicolor and coccineus, and a sample of 49 domesticated and wild accessions from Mesoamerica. We further explored the pattern of diversity of the European landraces using 12 phenotypic traits on 262 individuals. For 158 European accessions, we studied the relationships between cpSSR polymorphisms and phenotypic traits. Additionally, to gain insights into the role of gene flow and migration, for a subset of 115 accessions, we compared and contrasted the results obtained by cpSSRs and phenotypic traits with those obtained in a previous study with 12 nuclear microsatellites (nuSSRs). Our results suggest that both demographic and selective factors have roles in the shaping of the population genetic structure of the European runner bean. In particular, we infer the existence of a moderate-to-strong cytoplasmic bottleneck that followed the expansion of the crop into Europe, and we deduce multiple domestication events for this species. We also observe an adaptive population differentiation in the phenology across a latitudinal gradient, which suggests that selection led to the diversification of the runner bean in Europe. The botanical varieties albiflorus, bicolor and coccineus, which are based solely on flower colour, cannot be distinguished based on these cpSSRs and nuSSRs, nor according to the 12 quantitative traits.	[Rodriguez, Monica; Rau, Domenico; Angioi, Simonetta A.; Attene, Giovanna] Univ Sassari, Sez Agron Coltivazioni Erbacee & Genet, Dipartimento Agr, I-07100 Sassari, Italy; [Bellucci, Elisa; Bitocchi, Elena; Nanni, Laura; Papa, Roberto] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy; [Knuepffer, Helmut] Leibniz Inst Plant Genet & Crop Plant Res, Genebank Dept, Gatersleben, Germany; [Negri, Valeria] Univ Perugia, Dipartimento Biol Applicata, I-06100 Perugia, Italy; [Papa, Roberto] Agr Res Council, Cereal Res Ctr, Foggia, Italy; [Attene, Giovanna] Univ Sassari, Ctr Conservaz & Valorizzaz Biodiversita Vegetale, Surigheddu Alghero, Italy	University of Sassari; Marche Polytechnic University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Perugia; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Sassari	Attene, G (corresponding author), Univ Sassari, Sez Agron Coltivazioni Erbacee & Genet, Dipartimento Agr, I-07100 Sassari, Italy.	attene@uniss.it	Rodriguez, Monica/G-6731-2012; papa, roberto/F-9510-2014; Bitocchi, Elena/J-7996-2019; negri, valeria/G-5598-2013; Bellucci, Elisa/AAS-9237-2021; Nanni, Laura/HDN-7936-2022	Rodriguez, Monica/0000-0001-8926-2987; papa, roberto/0000-0001-9598-3131; Bitocchi, Elena/0000-0002-2152-4634; Negri, Valeria/0000-0003-2941-121X; Bellucci, Elisa/0000-0002-1636-0719; Knupffer, Helmut/0000-0002-0525-9244; Rau, Domenico/0000-0002-5294-9053	Italian Government (MIUR) Grant [2005071310]	Italian Government (MIUR) Grant	This study was supported by the Italian Government (MIUR) Grant no. # 2005071310, Project PRIN 2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora A, 2007, EUPHYTICA, V157, P69, DOI 10.1007/s10681-007-9397-3; Alvarez MT, 1998, GENET RESOUR CROP EV, V45, P243, DOI 10.1023/A:1008604127933; Angioi SA, 2011, PLANT GENET RESOUR-C, V9, P197, DOI 10.1017/S1479262111000190; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; Angioi SA, 2009, PLANT BIOLOGY, V11, P598, DOI 10.1111/j.1438-8677.2008.00143.x; [Anonymous], 1981, HDB LEGUMES WORLD EC; Bitocchi E, 2012, NEW PHYTOLO IN PRESS; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Boczkowska M, 2012, GENET RESOUR CROP EV, V59, P473, DOI 10.1007/s10722-012-9798-6; Busogoro JP, 1999, PLANT BREEDING, V118, P417, DOI 10.1046/j.1439-0523.1999.00413.x; CAMPION B, 1991, Journal of Genetics and Breeding, V45, P173; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Debouck D. G., 1995, EVOLUTION CROP PLANT, P287; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; ESCALANTE AM, 1994, AM J BOT, V81, P1096, DOI 10.2307/2445471; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 1996, GENETICS, V144, P1933; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Hammer K, 2011, COLLECTING PLANT GEN; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LLACA V, 1994, THEOR APPL GENET, V88, P646, DOI 10.1007/BF01253966; MANSFELD R., 1951, ZUCHTER, V21, P41, DOI 10.1007/BF00710527; MANTEL N, 1967, CANCER RES, V27, P209; Negri V, 2002, GENET RESOUR CROP EV, V49, P511, DOI 10.1023/A:1020902508166; NEI M, 1974, GENETICS, V76, P379; Nowosielski J, 2002, CELL MOL BIOL LETT, V7, P753; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Papa R, 2006, DARWINS HARVEST; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Rodino AP, 2007, EUPHYTICA, V155, P63, DOI 10.1007/s10681-006-9301-6; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Salinas A. D., 1988, Genetic resources of Phaseolus beans., P441; Santalla M, 2004, EUPHYTICA, V135, P205, DOI 10.1023/B:EUPH.0000014912.07993.e7; *SAS I INC, 2007, JMP; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sicard D, 2005, PLANT BREEDING, V124, P464, DOI 10.1111/j.1439-0523.2005.01137.x; Singh SP, 1999, CROP SCI, V39, P80, DOI 10.2135/cropsci1999.0011183X003900010013x; Spataro G, 2011, THEOR APPL GENET, V122, P1281, DOI 10.1007/s00122-011-1530-y; Stinchcombe JR, 2005, AM J BOT, V92, P1701, DOI 10.3732/ajb.92.10.1701; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Wallace D. H., 1985, Plant Breeding Reviews, V3, P21; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westphal E, 1974, PULSES ETHIOPIA THEI; WHITE JW, 1989, FIELD CROP RES, V22, P113, DOI 10.1016/0378-4290(89)90062-2; ZEVEN AC, 1993, EUPHYTICA, V68, P155, DOI 10.1007/BF00024164	47	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57337	10.1371/journal.pone.0057337	http://dx.doi.org/10.1371/journal.pone.0057337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451209	gold, Green Submitted, Green Published			2022-12-27	WOS:000316658800100
J	Ji, XM; Xie, CH; Hu, DS; Fan, X; Zhou, YJ; Zheng, YJ				Ji, Xuemei; Xie, Conghua; Hu, Desheng; Fan, Xia; Zhou, Yajuan; Zheng, Yingjie			Survival Benefit of Adding Chemotherapy to Intensity Modulated Radiation in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; IN-VIVO; RADIOTHERAPY; CANCER; EXPERIENCE; RADIOSENSITIZATION; CHEMORADIOTHERAPY; GEMCITABINE; POPULATION	Background: To evaluate the contribution of chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by intensity modulated radiotherapy (IMRT) and to identify the optimal combination treatment strategy. Patients and Methods: Between 2006 and 2010, 276 patients with stage II-IVb NPC were treated by IMRT alone or IMRT plus chemotherapy. Cisplatin-based chemotherapy included neoadjuvant or concurrent, or neoadjuvant plus concurrent protocols. The IMRT alone and chemoradiotherapy groups were well-matched for prognostic factors, except N stage, with more advanced NPC in the chemoradiotherapy arm. Results: With a mean follow-up of 33.8 months, the 3-year actuarial rates of overall survival (OS), metastasis-free survival (MFS), relapse-free survival (RFS), and disease-free survival (DFS) were 90.3%, 84.2%, 80.3%, and 69.2% for all of the patients, respectively. Compared with the IMRT alone arm, patients treated by concurrent chemoradiotherapy had a significantly better DFS (HR = 2.64; 95% CI, 1.12-6.22; P = 0.03), patients with neoadjuvant-concurrent chemoradiotherapy had a significant improvement in RFS and DFS (HR = 4.03; 95% CI, 1.35-12.05; P = 0.01 and HR = 2.43; 95% CI, 1.09-5.44; P = 0.03), neoadjuvant chemoradiotherapy provided no significant benefit in OS, MFS, RFS, and DFS. Stage group and alcohol consumption were prognostic factors for OS and N stage was a significant predictor for DFS. Conclusions: Addition of concurrent or neoadjuvant-concurrent chemotherapy to IMRT is available to prolong RFS or DFS for locoregionally advanced NPC. Such work could be helpful to guide effective individualized therapy.	[Ji, Xuemei; Zheng, Yingjie] Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiat Oncol, Beijing, Peoples R China; [Ji, Xuemei; Xie, Conghua; Fan, Xia] Wuhan Univ, Dept Radiat & Med Oncol, Zhongnan Hosp, Wuhan 430072, Peoples R China; [Hu, Desheng; Zhou, Yajuan] Tumor Hosptal Hubei Prov, Dept Radiat Oncol, Wuhan, Peoples R China	Capital Medical University; Wuhan University	Ji, XM (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiat Oncol, Beijing, Peoples R China.	xuemei.ji@yahoo.com; chxie65@hotmail.com	Ji, Xuemei/B-9774-2015	Ji, Xuemei/0000-0001-7416-9122	National Natural Science Foundation of China [81101561]; UICC American Cancer Society Beginning Investigators Fellowship; American Cancer Society; Scientific Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UICC American Cancer Society Beginning Investigators Fellowship; American Cancer Society(American Cancer Society); Scientific Research Foundation	This work was supported by National Natural Science Foundation of China (81101561); a UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society; the Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry, China to Xuemei Ji. URL of National Natural Science Foundation of China: http://www.nsfc.gov.cn/Portal0/default152.htm, URL of the American Cancer Society: http://www.cancer.org/, and URL of State Education Ministry, China: http://www.moe.edu.cn/. There are no grant numbers for a UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society, whose certification is available if needed or can be found in URL: http://www.uicc.org/fellowships/beginning-investigators. There are also no grant numbers for the Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry to Xuemei Ji, which is available if needed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; BEGG AC, 1986, INT J RADIAT BIOL, V50, P871, DOI 10.1080/09553008614551291; Chinese Center for Disease Control and Prevention, 2010, 2008 CAUS DEATH DAT, P57; Fang FM, 2008, INT J RADIAT ONCOL, V72, P356, DOI 10.1016/j.ijrobp.2007.12.054; FERLITO A, 1993, ANN OTO RHINOL LARYN, V102, P666, DOI 10.1177/000348949310200903; Fields MT, 2000, INT J RADIAT ONCOL, V47, P785, DOI 10.1016/S0360-3016(00)00447-8; Ji XM, 2011, INT J CANCER, V129, P724, DOI 10.1002/ijc.25696; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Laskar S, 2008, INT J RADIAT ONCOL, V72, P728, DOI 10.1016/j.ijrobp.2008.01.032; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; LEVINE PH, 1992, CANCER, V70, P1024, DOI 10.1002/1097-0142(19920901)70:5<1024::AID-CNCR2820700503>3.0.CO;2-4; Lin SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-39; Lu HM, 2008, CANCER TREAT REV, V34, P27, DOI 10.1016/j.ctrv.2007.08.004; Miles EA, 2005, RADIOTHER ONCOL, V77, P241, DOI 10.1016/j.radonc.2005.10.011; National Marine Fisheries Service Southeast Fisheries Science Center, 2008, NOAA TECHNICAL MEMOR, P92; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Rosier JF, 1999, INT J RADIAT BIOL, V75, P245, DOI 10.1080/095530099140708; Su Sheng-Fa, 2011, Chin J Cancer, V30, P565, DOI 10.5732/cjc.010.10547; Teicher BA, 1998, INT J ONCOL, V13, P437; Tham IWK, 2010, AM J CLIN ONCOL-CANC, V33, P294, DOI 10.1097/COC.0b013e3181d2edab; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Vaughan TL, 1996, CANCER EPIDEM BIOMAR, V5, P587; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; YU MC, 1988, CANCER RES, V48, P1954; Zhou GQ, 2012, INT J RADIAT ONCOL, V82, pE359, DOI 10.1016/j.ijrobp.2011.06.1967; ZHU KM, 1995, CANCER CAUSE CONTROL, V6, P507, DOI 10.1007/BF00054158	32	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56208	10.1371/journal.pone.0056208	http://dx.doi.org/10.1371/journal.pone.0056208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441169	gold, Green Published, Green Submitted			2022-12-27	WOS:000315159200026
J	Mamrut, S; Harony, H; Sood, R; Shahar-Gold, H; Gainer, H; Shi, YJ; Barki-Harrington, L; Wagner, S				Mamrut, Shimrat; Harony, Hala; Sood, Rapita; Shahar-Gold, Hadar; Gainer, Harold; Shi, Yi-Jun; Barki-Harrington, Liza; Wagner, Shlomo			DNA Methylation of Specific CpG Sites in the Promoter Region Regulates the Transcription of the Mouse Oxytocin Receptor	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMARY-GLAND; ESTROGEN; AUTISM; RAT; VASOPRESSIN; SP1; CANCER; BEHAVIOR; ELEMENTS	Oxytocin is a peptide hormone, well known for its role in labor and suckling, and most recently for its involvement in mammalian social behavior. All central and peripheral actions of oxytocin are mediated through the oxytocin receptor, which is the product of a single gene. Transcription of the oxytocin receptor is subject to regulation by gonadal steroid hormones, and is profoundly elevated in the uterus and mammary glands during parturition. DNA methylation is a major epigenetic mechanism that regulates gene transcription, and has been linked to reduced expression of the oxytocin receptor in individuals with autism. Here, we hypothesized that transcription of the mouse oxytocin receptor is regulated by DNA methylation of specific sites in its promoter, in a tissue-specific manner. Hypothalamus-derived GT1-7, and mammary-derived 4T1 murine cell lines displayed negative correlations between oxytocin receptor transcription and methylation of the gene promoter, and demethylation caused a significant enhancement of oxytocin receptor transcription in 4T1 cells. Using a reporter gene assay, we showed that methylation of specific sites in the gene promoter, including an estrogen response element, significantly inhibits transcription. Furthermore, methylation of the oxytocin receptor promoter was found to be differentially correlated with oxytocin receptor expression in mammary glands and the uterus of virgin and post-partum mice, suggesting that it plays a distinct role in oxytocin receptor transcription among tissues and under different physiological conditions. Together, these results support the hypothesis that the expression of the mouse oxytocin receptor gene is epigenetically regulated by DNA methylation of its promoter.	[Mamrut, Shimrat; Harony, Hala; Shahar-Gold, Hadar; Wagner, Shlomo] Univ Haifa, Dept Neurobiol, IL-31999 Haifa, Israel; [Sood, Rapita; Barki-Harrington, Liza] Univ Haifa, Dept Human Biol, IL-31999 Haifa, Israel; [Gainer, Harold; Shi, Yi-Jun] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA	University of Haifa; University of Haifa; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wagner, S (corresponding author), Univ Haifa, Dept Neurobiol, IL-31999 Haifa, Israel.	shlomow@research.haifa.ac.il		Wagner, Shlomo/0000-0002-7618-0752	Legacy Heritage Bio-Medical Program of the Israel Science Foundation [1901/08]; Autism Speaks Foundation [3613]	Legacy Heritage Bio-Medical Program of the Israel Science Foundation; Autism Speaks Foundation	This research was supported by the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant #1901/08 to SW and LBH) and by the Autism Speaks Foundation (grant #3613 to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 1997, ENDOCRINOLOGY, V138, P1151, DOI 10.1210/en.138.3.1151; Bartz JA, 2008, PROG BRAIN RES, V170, P451, DOI 10.1016/S0079-6123(08)00435-4; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Breton C, 2001, J MOL ENDOCRINOL, V27, P175, DOI 10.1677/jme.0.0270175; Breton C, 1997, ENDOCRINOLOGY, V138, P1857, DOI 10.1210/en.138.5.1857; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Douet V, 2007, BIOCHEM BIOPH RES CO, V354, P66, DOI 10.1016/j.bbrc.2006.12.151; Fleming JGW, 2006, ENDOCRINOLOGY, V147, P899, DOI 10.1210/en.2005-1120; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Gurrieri F, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-63; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Harony H, 2010, NEUROSIGNALS, V18, P82, DOI 10.1159/000321035; Hoare S, 1999, J BIOL CHEM, V274, P28682, DOI 10.1074/jbc.274.40.28682; Horn S, 1998, HUM REPROD UPDATE, V4, P605, DOI 10.1093/humupd/4.5.605; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Ivell R, 2001, EXP PHYSIOL, V86, P289, DOI 10.1113/eph8602185; Ivell R, 1999, MOL CELL ENDOCRINOL, V151, P95, DOI 10.1016/S0303-7207(99)00025-8; Kimura T, 2003, J MOL ENDOCRINOL, V30, P109, DOI 10.1677/jme.0.0300109; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Kusui C, 2001, BIOCHEM BIOPH RES CO, V289, P681, DOI 10.1006/bbrc.2001.6024; LARCHER A, 1995, ENDOCRINOLOGY, V136, P5350, DOI 10.1210/en.136.12.5350; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Leung ST, 2000, J REPROD FERTIL, V119, P287, DOI 10.1530/reprod/119.2.287; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Michelotti GA, 2007, FASEB J, V21, P1979, DOI 10.1096/fj.06-7118com; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Neo SJ, 2009, ANAL CHEM, V81, P3344, DOI 10.1021/ac802543x; Petz LN, 2000, MOL ENDOCRINOL, V14, P972, DOI 10.1210/me.14.7.972; QuinonesJenab V, 1997, NEUROENDOCRINOLOGY, V65, P9, DOI 10.1159/000127160; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; SOLOFF MS, 1983, CAN J BIOCHEM CELL B, V61, P631, DOI 10.1139/o83-079; SOLOFF MS, 1979, SCIENCE, V204, P1313, DOI 10.1126/science.221972; Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Zelko IN, 2010, FREE RADICAL BIO MED, V48, P895, DOI 10.1016/j.freeradbiomed.2010.01.007; Zhong M, 2003, ENDOCRINOLOGY, V144, P2947, DOI 10.1210/en.2002-221039; Zingg HH, 2003, TRENDS ENDOCRIN MET, V14, P222, DOI 10.1016/S1043-2760(03)00080-8; ZINGG HH, 1995, RECENT PROG HORM RES, V50, P255	49	71	73	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56869	10.1371/journal.pone.0056869	http://dx.doi.org/10.1371/journal.pone.0056869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441222	Green Published, gold, Green Submitted			2022-12-27	WOS:000315159200079
J	Walter, SD; Riddell, CA; Rabachini, T; Villa, LL; Franco, EL				Walter, Stephen D.; Riddell, Corinne A.; Rabachini, Tatiana; Villa, Luisa L.; Franco, Eduardo L.			Accuracy of p53 Codon 72 Polymorphism Status Determined by Multiple Laboratory Methods: A Latent Class Model Analysis	PLOS ONE			English	Article							TESTS; METAANALYSIS; NEOPLASIA; STANDARD; CANCER; ERROR; RISK	Introduction: Studies on the association of a polymorphism in codon 72 of the p53 tumour suppressor gene (rs1042522) with cervical neoplasia have inconsistent results. While several methods for genotyping p53 exist, they vary in accuracy and are often discrepant. Methods: We used latent class models (LCM) to examine the accuracy of six methods for p53 determination, all conducted by the same laboratory. We also examined the association of p53 with cytological cervical abnormalities, recognising potential test inaccuracy. Results: Pairwise disagreement between laboratory methods occurred approximately 10% of the time. Given the estimated true p53 status of each woman, we found that each laboratory method is most likely to classify a woman to her correct status. Arg/Arg women had the highest risk of squamous intraepithelial lesions (SIL). Test accuracy was independent of cytology. There was no strong evidence for correlations of test errors. Discussion: Empirical analyses ignore possible laboratory errors, and so are inherently biased, but test accuracy estimated by the LCM approach is unbiased when model assumptions are met. LCM analysis avoids ambiguities arising from empirical test discrepancies, obviating the need to regard any of the methods as a "gold'' standard measurement. The methods we presented here to analyse the p53 data can be applied in many other situations where multiple tests exist, but where none of them is a gold standard.	[Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Riddell, Corinne A.; Franco, Eduardo L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Rabachini, Tatiana; Villa, Luisa L.] Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, Sao Paulo, Brazil; [Franco, Eduardo L.] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McMaster University; McGill University; Ludwig Institute for Cancer Research; McGill University	Walter, SD (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	walter@mcmaster.ca	USP, Oncologia/F-9053-2014; Papilomavirus, Inct/I-2406-2013; VILLA, LUISA/AAH-4761-2019; Walter, Stephen/AAB-5548-2022; Rabachini, Tatiana/B-1460-2014; Franco, Eduardo/C-6445-2014	VILLA, LUISA/0000-0003-4074-2335; Walter, Stephen/0000-0003-4157-8928; Rabachini, Tatiana/0000-0003-0636-2558; Franco, Eduardo/0000-0002-4409-8084	National Institutes of Health [CA70269]; Canadian Institutes of Health Research [MOP-53111, CRN-83320, 49396]; NATIONAL CANCER INSTITUTE [R01CA070269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the study was provided by grants from the National Institutes of Health (CA70269) and Canadian Institutes of Health Research (MOP-53111, CRN-83320, 49396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2009, STAT MED, V28, P780, DOI 10.1002/sim.3514; Chu HT, 2009, J AM STAT ASSOC, V104, P512, DOI 10.1198/jasa.2009.0017; Cicchetti DV, 1971, AM J EEG TECHNOLOGY; ESPELAND MA, 1989, BIOMETRICS, V45, P587, DOI 10.2307/2531499; Fleiss J.L., 2013, STAT METHODS RATES P; Formann A K, 1996, Stat Methods Med Res, V5, P179, DOI 10.1177/096228029600500205; Franco E, 1999, Rev Panam Salud Publica, V6, P223, DOI 10.1590/S1020-49891999000900001; Glauser W, 2010, CAN MED ASSOC J, V182, pE705, DOI 10.1503/cmaj.109-3669; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; KALDOR J, 1985, STAT MED, V4, P327, DOI 10.1002/sim.4780040312; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Koushik A, 2004, CANCER EPIDEM BIOMAR, V13, P11, DOI 10.1158/1055-9965.EPI-083-3; Lau TS, 1997, STAT MED, V16, P2283, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2283::AID-SIM658>3.0.CO;2-T; Rabachini T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-44; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; SZATMARI P, 1995, J AM ACAD CHILD PSY, V34, P216, DOI 10.1097/00004583-199502000-00017; Team R. D. C, 2011, R LANG ENV STAT COMP; TorranceRynard VL, 1997, STAT MED, V16, P2157, DOI 10.1002/(SICI)1097-0258(19971015)16:19<2157::AID-SIM653>3.0.CO;2-X; Vermunt JK, 1997, LEM GEN PROGRAM ANAL; WALTER SD, 1988, J CLIN EPIDEMIOL, V41, P923, DOI 10.1016/0895-4356(88)90110-2; WALTER SD, 1984, REV EPIDEMIOL SANTE, V32, P206; Walter SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-51	23	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56430	10.1371/journal.pone.0056430	http://dx.doi.org/10.1371/journal.pone.0056430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441193	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200050
J	Bodenhausen, N; Horton, MW; Bergelson, J				Bodenhausen, Natacha; Horton, Matthew W.; Bergelson, Joy			Bacterial Communities Associated with the Leaves and the Roots of Arabidopsis thaliana	PLOS ONE			English	Article							PYROSEQUENCING REVEALS; MICROBIAL COMMUNITIES; RIBOSOMAL-RNA; SOIL TYPE; DIVERSITY; PLANT; RHIZOSPHERE; ENDOPHYTES; COLONIZATION; VARIABILITY	Diverse communities of bacteria inhabit plant leaves and roots and those bacteria play a crucial role for plant health and growth. Arabidopsis thaliana is an important model to study plant pathogen interactions, but little is known about its associated bacterial community under natural conditions. We used 454 pyrosequencing to characterize the bacterial communities associated with the roots and the leaves of wild A. thaliana collected at 4 sites; we further compared communities on the outside of the plants with communities in the endophytic compartments. We found that the most heavily sequenced bacteria in A. thaliana associated community are related to culturable species. Proteobacteria, Actinobacteria, and Bacteroidetes are the most abundant phyla in both leaf and root samples. At the genus level, sequences of Massilia and Flavobacterium are prevalent in both samples. Organ (leaf vs root) and habitat (epiphytes vs endophytes) structure the community. In the roots, richness is higher in the epiphytic communities compared to the endophytic compartment (P = 0.024), while the reverse is true for the leaves (P = 0.032). Interestingly, leaf and root endophytic compartments do not differ in richness, diversity and evenness, while they differ in community composition (P = 0.001). The results show that although the communities associated with leaves and roots share many bacterial species, the associated communities differ in structure.	[Bodenhausen, Natacha; Horton, Matthew W.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Bodenhausen, Natacha/Y-6203-2019	Bodenhausen, Natacha/0000-0001-9680-1176; Bergelson, Joy/0000-0001-7893-7387; Horton, Matthew/0000-0002-7537-0730	National Science Foundation, NSF, entitled Microbial Observatories: Forces shaping microbial communities in the phyllosphere of Arabidopsis thaliana [MCB 0603515]; National Institute of Health, NIH, entitled Evolutionary genetics of R gene loci in Arabidopsis [GM057994]; Swiss National Science Foundation through the postdoc mobility fellowship; Swiss National Science Foundation through the Marie Heim-Vogtlin fellowship; National Science Foundation through a predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057994] Funding Source: NIH RePORTER	National Science Foundation, NSF, entitled Microbial Observatories: Forces shaping microbial communities in the phyllosphere of Arabidopsis thaliana(National Science Foundation (NSF)); National Institute of Health, NIH, entitled Evolutionary genetics of R gene loci in Arabidopsis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation through the postdoc mobility fellowship; Swiss National Science Foundation through the Marie Heim-Vogtlin fellowship; National Science Foundation through a predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by two grants to JB: National Science Foundation, NSF, MCB 0603515 entitled Microbial Observatories: Forces shaping microbial communities in the phyllosphere of Arabidopsis thaliana and National Institute of Health, NIH, GM057994 entitled Evolutionary genetics of R gene loci in Arabidopsis. NB acknowledges funding from the Swiss National Science Foundation through the postdoc mobility and Marie Heim-Vogtlin fellowships. MWH acknowledges funding from the National Science Foundation through a predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; Beattie GA, 1999, PHYTOPATHOLOGY, V89, P353, DOI 10.1094/PHYTO.1999.89.5.353; Becker R, 2008, FEMS MICROBIOL ECOL, V66, P411, DOI 10.1111/j.1574-6941.2008.00562.x; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Berry KJ, 2003, PSYCHOL REP, V92, P1141; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crosby LD, 2003, BIOTECHNIQUES, V34, P790, DOI 10.2144/03344rr01; Czajkowski R, 2010, PHYTOPATHOLOGY, V100, P134, DOI 10.1094/PHYTO-100-2-0134; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; ERCOLANI GL, 1991, MICROBIAL ECOL, V21, P35, DOI 10.1007/BF02539143; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Kniskern JM, 2007, MOL PLANT MICROBE IN, V20, P1512, DOI 10.1094/MPMI-20-12-1512; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Legendre P, 2005, J AGR BIOL ENVIR ST, V10, P226, DOI 10.1198/108571105X46642; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Qvit-Raz N, 2008, GENETICS, V178, P1615, DOI 10.1534/genetics.107.082164; Rasche F, 2006, CAN J MICROBIOL, V52, P1036, DOI 10.1139/W06-059; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Reisberg EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/s10482-011-9669-8; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SHELDON AL, 1969, ECOLOGY, V50, P466, DOI 10.2307/1933900; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Timms-Wilson T. M., 2006, Microbial ecology of aerial plant surfaces, P21, DOI 10.1079/9781845930615.0021; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	55	423	446	16	336	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e56329	10.1371/journal.pone.0056329	http://dx.doi.org/10.1371/journal.pone.0056329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EQ	23457551	Green Submitted, gold, Green Published			2022-12-27	WOS:000315603700041
J	Humphreys, DK; Eisner, MP; Wiebe, DJ				Humphreys, David K.; Eisner, Manuel P.; Wiebe, Douglas J.			Evaluating the Impact of Flexible Alcohol Trading Hours on Violence: An Interrupted Time Series Analysis	PLOS ONE			English	Article							LICENSING ACT 2003; HUMAN-AGGRESSION; LAW; CONSUMPTION; ATTENDANCES; DRINKING; DISORDER; ENGLAND; CRIME	Background: On November 24th 2005, the Government of England and Wales removed regulatory restrictions on the times at which licensed premises could sell alcohol. This study tests availability theory by treating the implementation of Licensing Act (2003) as a natural experiment in alcohol policy. Methods: An interrupted time series design was employed to estimate the Act's immediate and delayed impact on violence in the City of Manchester (Population 464,200). We collected police recorded rates of violence, robbery, and total crime between the 1st of February 2004 and the 31st of December 2007. Events were aggregated by week, yielding a total of 204 observations (95 pre-, and 109 post-intervention). Secondary analysis examined changes in daily patterns of violence. Pre- and post-intervention events were separated into four three-hour segments 18:00-20:59, 21:00-23.59, 00:00-02:59, 03:00-05:59. Results: Analysis found no evidence that the Licensing Act (2003) affected the overall volume of violence. However, analyses of night-time violence found a gradual and permanent shift of weekend violence into later parts of the night. The results estimated an initial increase of 27.5% between 03:00 to 06:00 (omega = 0.2433, 95% CI = 0.06, 0.42), which increased to 36% by the end of the study period (delta = -0.897, 95% CI = -1.02, -0.77). Conclusions: This study found no evidence that a national policy increasing the physical availability of alcohol affected the overall volume of violence. There was, however, evidence suggesting that the policy may be associated with changes to patterns of violence in the early morning (3 a.m. to 6 a.m.).	[Humphreys, David K.] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Eisner, Manuel P.] Univ Cambridge, Inst Criminol, Cambridge CB3 9DT, England; [Wiebe, Douglas J.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Cambridge; University of Cambridge; University of Pennsylvania	Humphreys, DK (corresponding author), Univ Cambridge, Inst Publ Hlth, Cambridge, England.	dkh25@medschl.cam.ac.uk	Wiebe, Douglas J/Q-1168-2017	Humphreys, David K./0000-0002-7761-5746	Economic and Social Research Council (ESRC)	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors are grateful for support from Economic and Social Research Council (ESRC) who funded a 1+3 Doctoral Studentship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb P., 2007, VIOLENT CRIME DISORD; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Bellis MA, 2006, EFFECTS ALCOHOL MISU; BIDERMAN AD, 1967, ANN AM ACAD POLIT SS, V374, P1, DOI 10.1177/000271626737400102; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Bushman B J, 1997, Recent Dev Alcohol, V13, P227; BUSHMAN BJ, 1990, PSYCHOL BULL, V107, P341, DOI 10.1037/0033-2909.107.3.341; Cabinet Office Strategy Unit, 2003, ALC MIS MUCH DOES IT; CAMPBELL DT, 1969, AM PSYCHOL, V24, P409, DOI 10.1037/h0027982; Carpenter C, 2010, ALCOHOL REGULATION C; Chikritzhs T, 2002, J STUD ALCOHOL, V63, P591, DOI 10.15288/jsa.2002.63.591; Cochran WG, 2006, OBSERVATIONAL STUDIE; Coleman Clive, 1996, UNDERSTANDING CRIME; Cook T.C., 1979, QUASIEXPERIMENTATION; Coryn C.L.S., 2011, NEW DIRECTIONS EVALU, V131, P31, DOI [10.1002/ev, DOI 10.1002/EV]; Craig P, 2011, USING NATURAL EXPT E; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Duffy JC, 1996, ADDICT RES, V4, P245, DOI 10.3109/16066359609005571; Durnford AJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-379; Eisner M, 1999, EUROPEAN J CRIMINAL, V7, P427; El-Maaytah M, 2008, BRIT J ORAL MAX SURG, V46, P460, DOI 10.1016/j.bjoms.2008.01.018; Graham K, 1998, ADDICTION, V93, P659, DOI 10.1046/j.1360-0443.1998.9356593.x; Hadfield P., 2009, NIGHTLIFE CRIME SOCI; Home Office, 2000, TIM REF PROP MOD OUR; Home Office, 2008, HOM OFF COUNT RUL RE; Hope Tim, 1986, HOME OFFICE RES PLAN, V20, P5; Hough M, 2008, CRIMINOL CRIM JUSTIC, V8, P239, DOI 10.1177/1748895808092428; Humphreys DK, 2010, CRIMINOL PUBLIC POL, V9, P41, DOI 10.1111/j.1745-9133.2010.00609.x; Humphreys DK, 2010, DO FLEXIBLE OPENING; Jones LA, 2010, EMERG MED J, V27, P688, DOI 10.1136/emj.2009.077487; Kirby S, 2011, SAFER COMMUNITIES, V10, P31, DOI 10.5042/sc.2011.0041; Lipsey M W, 1997, Recent Dev Alcohol, V13, P245; Marsh P., 1992, DRINKING PUBLIC DISO; McCain LJ, 1979, QUASIEXPERIMENTATION; McCleary R., 1980, APPL TIME SERIES ANA; McDowall D., 1980, INTERRUPTED TIME SER; Mercer SL, 2007, AM J PREV MED, V33, P139, DOI 10.1016/j.amepre.2007.04.005; Middleton JC, 2010, AM J PREV MED, V39, P575, DOI 10.1016/j.amepre.2010.09.015; Newton A D, 2008, BRIT CRIMINOLOGY C; Newton A, 2007, EMERG MED J, V24, P532, DOI 10.1136/emj.2007.046094; Peirce BH, 2011, EUR J EMERG MED, V18, P351, DOI 10.1097/MEJ.0b013e3283468ee0; Pernanen K., 1991, ALCOHOL HUMAN VIOLEN; Pike S, 2008, EARLY EXPERIENCES LI; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; Ragnarsdottir P, 2002, EFFECTS NORDIC ALCOH; Raistrick D, 1999, TACKLING ALCOHOL TOG; Romelsjo A, 2010, ALCOHOL ALCOHOLISM, V45, P468, DOI 10.1093/alcalc/agq055; ROSS HL, 1973, J LEGAL STUD, V2, P1, DOI 10.1086/467491; Rossow I, 2012, ADDICTION, V107, P530, DOI 10.1111/j.1360-0443.2011.03643.x; Shadish W, 2002, EXPT QUASI EXPERIMEN; Stockwell T., 2003, ESSENTIAL HDB TREATM, P213; Stockwell T, 2009, CRIME PREV COMMUNITY, V11, P153, DOI 10.1057/cpcs.2009.11; Tabachnick BG, 2006, USING MULTIVARIATE S; Tuck M, 1989, DRINKING DISORDER ST; Wikstrom P, 1990, URBAN CRIME CRIMINAL	55	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2013	8	2							e55581	10.1371/journal.pone.0055581	http://dx.doi.org/10.1371/journal.pone.0055581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EQ	23457474	gold, Green Published, Green Submitted			2022-12-27	WOS:000315603700015
J	Jaussent, I; Empana, JP; Ancelin, ML; Besset, A; Helmer, C; Tzourio, C; Ritchie, K; Bouyer, J; Dauvilliers, Y				Jaussent, Isabelle; Empana, Jean-Philippe; Ancelin, Marie-Laure; Besset, Alain; Helmer, Catherine; Tzourio, Christophe; Ritchie, Karen; Bouyer, Jean; Dauvilliers, Yves			Insomnia, Daytime Sleepiness and Cardio-Cerebrovascular Diseases in the Elderly: A 6-Year Prospective Study	PLOS ONE			English	Article							OLDER-ADULTS; MYOCARDIAL-INFARCTION; HEART-DISEASE; RISK-FACTOR; 3 CITY; HEALTH; POPULATION; MORTALITY; COMPLAINTS; STROKE	Objective: To examine 1) the associations between history of cardio-cerebrovascular diseases (CVD) and insomnia complaints and excessive daytime sleepiness (EDS), and 2) the relationships between sleep complaints and future CVD in persons over 65. Methods: CVD was assessed at baseline and during two, four, and six-year follow-up in 5494 non-demented subjects. Self-reported insomnia complaints (poor sleep quality, difficulty in initiating sleep, difficulty in maintening sleep, and early morning awakening), EDS and sleep medication use were evaluated at baseline. Logistic regression models and Cox proportional hazard models, with delayed entry and age of participants as the time scale, were adjusted for socio-demographic, lifestyle and clinical variables. Results: At baseline, 748 participants had a past-history of CVD. A past-history of CVD was associated with EDS (OR = 1.28 95%CI = [1.05-1.57]) and the number of insomnia complaints (OR = 1.26 95%CI = [1.03-1.55] for 1-2 insomnia complaints; OR = 1.32 95%CI = [1.03-1.71] for >= 3 complaints). In longitudinal analyses, neither the four components of insomnia nor the number of insomnia complaints were significantly associated with first or recurrent CVD events (n = 391 events). EDS was independently associated with future CVD events even after adjusting for prescribed sleep medication and past-history of CVD (HR = 1.35 95%CI = [1.06-1.71]). Conclusion: Our results suggest that the relationships between sleep complaints and CVD could be complex. Insomnia complaints are more likely a consequence of CVD, whereas EDS appears to be a determinant of CVD independently of past-history of CVD. EDS screening may thus constitute a means of detecting persons at high risk of CVD.	[Jaussent, Isabelle; Ancelin, Marie-Laure; Besset, Alain; Ritchie, Karen; Dauvilliers, Yves] INSERM, U1061, Montpellier, France; [Jaussent, Isabelle; Ancelin, Marie-Laure; Besset, Alain; Ritchie, Karen; Dauvilliers, Yves] Univ Montpellier I, Montpellier, France; [Empana, Jean-Philippe] Univ Paris 05, Paris Cardiovasc Res Ctr PARCC, Sorbonne Paris Cite, UMR S970, Paris, France; [Helmer, Catherine; Tzourio, Christophe] INSERM, U897, Bordeaux, France; [Helmer, Catherine; Tzourio, Christophe] Univ Bordeaux 2, ISPED, F-33076 Bordeaux, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Bouyer, Jean] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Reprod & Child Dev U1018, Villejuif, France; [Bouyer, Jean] Univ Paris Sud, UMR S1018, Villejuif, France; [Dauvilliers, Yves] Hop Gui de Chauliac, CHU Montpellier, Serv Neurol, Unite Troubles Sommeil, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier	Dauvilliers, Y (corresponding author), INSERM, U1061, Montpellier, France.	ydauvilliers@yahoo.fr	Ancelin, Marie-Laure/L-1198-2019; HELMER, Catherine/I-6581-2015; bouyer, jean/G-2717-2013; Tzourio, christophe/B-4015-2009; HELMER, Catherine/AAG-5126-2021; Ancelin, Marie-Laure/F-3079-2013; Tzourio, christophe/L-6344-2019; Empana, Jean-Philippe/AAF-6923-2021; Ritchie, Karen/G-3571-2013	Ancelin, Marie-Laure/0000-0002-1149-4320; HELMER, Catherine/0000-0002-5169-7421; bouyer, jean/0000-0003-4861-0783; Tzourio, christophe/0000-0002-6517-2984; Ancelin, Marie-Laure/0000-0002-1149-4320; Tzourio, christophe/0000-0002-6517-2984; Empana, Jean-Philippe/0000-0002-1469-7772; Ritchie, Karen/0000-0002-0688-8982; Jaussent, Isabelle/0000-0002-8205-7590; Dauvilliers, yves/0000-0003-0683-6506	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon; Fondation de France; Eisai; Agence Nationale de la Recherche (ANR) [07-LVIE-004, 06-PNRA-005]; Fondation Plan Alzheimer; Fondation de Recherche sur l'Hypertension Arterielle; ABBOTT company; French National Research Agency (ANR); UCB pharma; Cephalon; Jazz; Novartis; Bioprojet; Ministry of Research-Inserm Programme "Cohorts and collection of biological material"	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Regional Governments of Aquitaine; Bourgogne and Languedoc-Roussillon(Region Occitanie); Fondation de France(Fondation de France); Eisai(Eisai Co Ltd); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation Plan Alzheimer; Fondation de Recherche sur l'Hypertension Arterielle; ABBOTT company; French National Research Agency (ANR)(French National Research Agency (ANR)); UCB pharma(UCB Pharma SA); Cephalon; Jazz(Jazz Pharmaceuticals); Novartis(Novartis); Bioprojet; Ministry of Research-Inserm Programme "Cohorts and collection of biological material"	The 3C Study is conducted under a partnership agreement between Inserm, the Victor Segalen-Bordeaux II University and Sanofi-Synthelabo and was supported by the Fondation pour la Recherche Medicale, the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Regional Governments of Aquitaine, Bourgogne and Languedoc-Roussillon and, the Fondation de France, the Ministry of Research-Inserm Programme "Cohorts and collection of biological material". The Lille Genopole received a grant from Eisai. Part of this project is financed by two grants from the Agence Nationale de la Recherche (ANR) (projects 07-LVIE-004 and 06-PNRA-005). Isabelle Jaussent, Dr. Jean Bouyer, Dr. Marie-Laure Ancelin, Dr. Catherine Helmer and Dr. Alain Besset report no disclosures. Dr. Jean-Philippe Empana has received consultancy honoraria from Lundbeck and speaker honoraria from Pfizer. Dr. Karen Ritchie serves on scientific advisory boards for the Biomedical Research Centre, King's College London, and MRC Strategic Steering Committee (Longitudinal Health and Aging Research Unit); and serves on the editorial advisory boards of the International Journal of Geriatric Psychiatry, Dementia, International Psychogeriatrics, Journal of Clinical and Experimental Gerontology, Psychogeriatrics, Neuronale, Neurologie-Psychiatrie-Geriatrie, and Gerontology. Dr. Christophe Tzourio has received fees from the Fondation Plan Alzheimer, the Fondation de Recherche sur l'Hypertension Arterielle, and the ABBOTT company for participating in scientific committees. He has also received investigator-initiated research funding from the French National Research Agency (ANR) and the Fondation Plan Alzheimer for the 3C study. He serves on the editorial advisory board of Neuroepidemiology, Journal of Hypertension, and Journal of Alzheimer's disease. Pr. Yves Dauvilliers has received funds for speaking and board engagements with UCB pharma, Cephalon, Jazz, Novartis, and Bioprojet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Isabelle Jaussent, Dr. Jean Bouyer, Dr. Marie-Laure Ancelin, Dr. Catherine Helmer and Dr. Alain Besset report no disclosures. Dr. Jean-Philippe Empana has received consultancy honoraria from Lundbeck and speaker honoraria from Pfizer. Dr. Karen Ritchie serves on scientific advisory boards for the Biomedical Research Centre, King's College London, and MRC Strategic Steering Committee (Longitudinal Health and Aging Research Unit); and serves on the editorial advisory boards of the International Journal of Geriatric Psychiatry, Dementia, International Psychogeriatrics, Journal of Clinical and Experimental Gerontology, Psychogeriatrics, Neuronale, Neurologie-Psychiatrie-Geriatrie, and Gerontology. Dr. Christophe Tzourio has received fees from the Fondation Plan Alzheimer, the Fondation de Recherche sur l'Hypertension Arterielle, and the ABBOTT company for participating in scientific committees. He has also received investigator-initiated research funding from the French National Research Agency (ANR) and the Fondation Plan Alzheimer for the 3C study. He serves on the editorial advisory board of Neuroepidemiology, Journal of Hypertension, and Journal of Alzheimer's disease. Pr. Yves Dauvilliers has received funds for speaking and board engagements with UCB pharma, Cephalon, Jazz, Novartis, and Bioprojet. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Blachier M, 2012, ANN NEUROL, V71, P661, DOI 10.1002/ana.22656; Boden-Albala B, 2012, CIRC-CARDIOVASC QUAL, V5, P500, DOI 10.1161/CIRCOUTCOMES.111.963801; Divani AA, 2011, STROKE, V42, P1821, DOI 10.1161/STROKEAHA.110.607630; Empana JP, 2007, STROKE, V38, P893, DOI 10.1161/01.STR.0000257983.62530.75; Empana JP, 2009, STROKE, V40, P1219, DOI 10.1161/STROKEAHA.108.530824; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gooneratne NS, 2011, SLEEP, V34, P435, DOI 10.1093/sleep/34.4.435; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Jaussent I, 2011, AM J GERIAT PSYCHIAT, V19, P88, DOI 10.1097/JGP.0b013e3181e049b6; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Mendis S., 2011, GLOB ATL CARD DIS PR; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pack AI, 2006, ANN NEUROL, V59, P893, DOI 10.1002/ana.20863; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schwartz S, 1999, J PSYCHOSOM RES, V47, P313, DOI 10.1016/S0022-3999(99)00029-X; Schwartz SW, 1998, ANN EPIDEMIOL, V8, P384, DOI 10.1016/S1047-2797(97)00238-X; Tsuno N, 2007, J SLEEP RES, V16, P364, DOI 10.1111/j.1365-2869.2007.00606.x; Vitiello MV, 1997, J GERONTOL A-BIOL, V52, pM189, DOI 10.1093/gerona/52A.4.M189; Whitney CW, 1998, SLEEP, V21, P27, DOI 10.1093/sleep/21.1.27; WHO, 2001, WHO INT CLASS FUNCT; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	26	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56048	10.1371/journal.pone.0056048	http://dx.doi.org/10.1371/journal.pone.0056048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099EJ	23457496	Green Published, gold, Green Submitted			2022-12-27	WOS:000315602700036
J	Rommer, A; Steinmetz, B; Herbst, F; Hackl, H; Heffeter, P; Heilos, D; Filipits, M; Steinleitner, K; Hemmati, S; Herbacek, I; Schwarzinger, I; Hartl, K; Rondou, P; Glimm, H; Karakaya, K; Kramer, A; Berger, W; Wieser, R				Rommer, Anna; Steinmetz, Birgit; Herbst, Friederike; Hackl, Hubert; Heffeter, Petra; Heilos, Daniela; Filipits, Martin; Steinleitner, Katarina; Hemmati, Shayda; Herbacek, Irene; Schwarzinger, Ilse; Hartl, Katharina; Rondou, Pieter; Glimm, Hanno; Karakaya, Kadin; Kraemer, Alwin; Berger, Walter; Wieser, Rotraud			EVI1 Inhibits Apoptosis Induced by Antileukemic Drugs via Upregulation of CDKN1A/p21/WAF in Human Myeloid Cells	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; JUVENILE MYELOMONOCYTIC LEUKEMIA; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; DOWN-REGULATION; SELF-RENEWAL; PROGNOSTIC-SIGNIFICANCE; DIFFERENTIATION; P21; ONCOGENE	Overexpression of ecotropic viral integration site 1 (EVI1) is associated with aggressive disease in acute myeloid leukemia (AML). Despite of its clinical importance, little is known about the mechanism through which EVI1 confers resistance to antileukemic drugs. Here, we show that a human myeloid cell line constitutively overexpressing EVI1 after infection with a retroviral vector (U937_EVI1) was partially resistant to etoposide and daunorubicin as compared to empty vector infected control cells (U937_vec). Similarly, inducible expression of EVI1 in HL-60 cells decreased their sensitivity to daunorubicin. Gene expression microarray analyses of U937_EVI1 and U937_vec cells cultured in the absence or presence of etoposide showed that 77 and 419 genes were regulated by EVI1 and etoposide, respectively. Notably, mRNA levels of 26 of these genes were altered by both stimuli, indicating that EVI1 regulated genes were strongly enriched among etoposide regulated genes and vice versa. One of the genes that were induced by both EVI1 and etoposide was CDKN1A/p21/WAF, which in addition to its function as a cell cycle regulator plays an important role in conferring chemotherapy resistance in various tumor types. Indeed, overexpression of CDKN1A in U937 cells mimicked the phenotype of EVI1 overexpression, similarly conferring partial resistance to antileukemic drugs.	[Rommer, Anna; Steinmetz, Birgit; Heilos, Daniela; Steinleitner, Katarina; Hartl, Katharina; Wieser, Rotraud] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Rommer, Anna; Steinmetz, Birgit; Heffeter, Petra; Heilos, Daniela; Filipits, Martin; Steinleitner, Katarina; Hartl, Katharina; Berger, Walter; Wieser, Rotraud] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Herbst, Friederike; Hemmati, Shayda; Glimm, Hanno] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Herbst, Friederike; Hemmati, Shayda; Glimm, Hanno] German Canc Res Ctr, Heidelberg, Germany; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, A-6020 Innsbruck, Austria; [Heffeter, Petra; Filipits, Martin; Herbacek, Irene; Berger, Walter] Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria; [Heffeter, Petra; Filipits, Martin; Herbacek, Irene; Berger, Walter] Med Univ Vienna, Res Platform Translat Canc Therapy Res, Vienna, Austria; [Schwarzinger, Ilse] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Rondou, Pieter] Ghent Univ Hosp, Ctr Med Genet Ghent, Ghent, Belgium; [Karakaya, Kadin; Kraemer, Alwin] German Canc Res Ctr, Clin Cooperat Unit Mol Haematol Oncol, Heidelberg, Germany	Medical University of Vienna; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Ghent University; Ghent University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Wieser, R (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	rotraud.wieser@meduniwien.ac.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; Wieser, Rotraud/0000-0003-4384-6658; Filipits, Martin/0000-0003-2847-4534; Heffeter, Petra/0000-0001-6401-8646; Lupinek, Daniela/0000-0001-5749-9701; Berger, Walter/0000-0003-0014-1658	Austrian Science Foundation (FWF) [P20920, P19795, P21401]; Deutsche Forschungsgemeinschaft [SFB873]; Austrian Science Fund (FWF) [P 21401, P 20920] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Foundation (FWF), grants no. P20920, P19795, and P21401 to RW (http://www.fwf.ac.at/) and Deutsche Forschungsgemeinschaft, grant SFB873 to FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahmed W, 2004, CELL CYCLE, V3, P1305, DOI 10.4161/cc.3.10.1161; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Balgobind BV, 2010, LEUKEMIA, V24, P942, DOI 10.1038/leu.2010.47; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Bastin-Coyette L, 2011, BIOCHEM PHARMACOL, V81, P586, DOI 10.1016/j.bcp.2010.12.009; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Buonamici S, 2005, J BIOL CHEM, V280, P428, DOI 10.1074/jbc.M410836200; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Daghistani M, 2010, BLOOD, V116, P6014, DOI 10.1182/blood-2010-01-264234; Dasmahapatra G, 2007, CLIN CANCER RES, V13, P4280, DOI 10.1158/1078-0432.CCR-07-0835; FICHELSON S, 1992, LEUKEMIA, V6, P93; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Forster K, 2008, ANN HEMATOL, V87, P183, DOI 10.1007/s00277-007-0400-9; Gerhardt TM, 1997, BRIT J HAEMATOL, V99, P882, DOI 10.1046/j.1365-2141.1997.4983304.x; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Haas K, 2008, GENE CHROMOSOME CANC, V47, P288, DOI 10.1002/gcc.20532; Hamaguchi H, 1997, BRIT J HAEMATOL, V98, P399, DOI 10.1046/j.1365-2141.1997.2143029.x; Ichihara E, 2011, BIOCHEM BIOPH RES CO, V416, P239, DOI 10.1016/j.bbrc.2011.10.061; Karakaya K, 2012, CELL CYCLE, V11, P3492, DOI 10.4161/cc.21801; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Laricchia-Robbio L, 2008, BLOOD CELL MOL DIS, V40, P141, DOI 10.1016/j.bcmd.2007.07.012; Lazzarini R, 2008, CLIN CANCER RES, V14, P5099, DOI 10.1158/1078-0432.CCR-08-0255; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Pardee TS, 2011, EXP HEMATOL, V39, P473, DOI 10.1016/j.exphem.2011.01.009; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Poppe B, 2006, GENE CHROMOSOME CANC, V45, P349, DOI 10.1002/gcc.20295; Privitera E, 1997, LEUKEMIA, V11, P2045, DOI 10.1038/sj.leu.2400865; Saito Y, 2011, LEUKEMIA, V25, P921, DOI 10.1038/leu.2011.36; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Santamaria CM, 2009, BLOOD, V114, P148, DOI 10.1182/blood-2008-11-187724; Shimizu S, 2002, BIOCHEM BIOPH RES CO, V292, P609, DOI 10.1006/bbrc.2002.6693; Steinleitner K, 2012, ANTICANCER RES, V32, P4883; Steinman RA, 2000, MOL MED, V6, P736, DOI 10.1007/BF03402190; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tamburini J, 2007, BLOOD, V110, P1025, DOI 10.1182/blood-2006-12-061283; Tang JJ, 2006, MOL CELL BIOCHEM, V291, P139, DOI 10.1007/s11010-006-9206-7; Taschner S, 2007, BLOOD, V109, P971, DOI 10.1182/blood-2006-04-020552.7; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Vinatzer U, 2003, GENE CHROMOSOME CANC, V36, P80, DOI 10.1002/gcc.10144; Wang ZL, 2000, DIFFERENTIATION, V66, P1, DOI 10.1046/j.1432-0436.2000.066001001.x; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Wieser R, 2012, CELL CYCLE, V11, P3915, DOI 10.4161/cc.22392; Wolf S, 2013, ONCOGENE, V32, P3028, DOI 10.1038/onc.2012.329; Wu JR, 2010, J BIOPHARM STAT, V20, P954, DOI 10.1080/10543401003618983; Yamakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030706; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Zhang W, 1995, CLIN CANCER RES, V1, P1051	68	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2013	8	2							e56308	10.1371/journal.pone.0056308	http://dx.doi.org/10.1371/journal.pone.0056308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099EJ	23457546	Green Published, Green Submitted, gold			2022-12-27	WOS:000315602700065
J	Dolan, D; Nelson, G; Zupanic, A; Smith, G; Shanley, D				Dolan, David; Nelson, Glyn; Zupanic, Anze; Smith, Graham; Shanley, Daryl			Systems Modelling of NHEJ Reveals the Importance of Redox Regulation of Ku70/80 in the Dynamics of DNA Damage Foci	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; CELL-CYCLE ARREST; COMPLEX; REPAIR; ATM; END; ELECTROSTATICS; PDB2PQR; BINDING	The presence of DNA double-stranded breaks in a mammalian cell typically activates the Non-Homologous End Joining (NHEJ) pathway to repair the damage and signal to downstream systems that govern cellular decisions such as apoptosis or senescence. The signalling system also stimulates effects such as the generation of reactive oxygen species (ROS) which in turn feed back into the damage response. Although the overall process of NHEJ is well documented, we know little of the dynamics and how the system operates as a whole. We have developed a computational model which includes DNA Protein Kinase (DNA-PK) dependent NHEJ (D-NHEJ) and back-up NHEJ mechanisms (B-NHEJ) and use it to explain the dynamic response to damage induced by different levels of gamma irradiation in human fibroblasts. Our work suggests that the observed shift from fast to slow repair of DNA damage foci at higher levels of damage cannot be explained solely by inherent stochasticity in the NHEJ system. Instead, our model highlights the importance of Ku oxidation which leads to increased Ku dissociation rates from DNA damage foci and shifts repair in favour of the less efficient B-NHEJ system.	[Dolan, David; Nelson, Glyn; Zupanic, Anze; Smith, Graham; Shanley, Daryl] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Shanley, D (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daryl.shanley@ncl.ac.uk	Zupanic, Anze/B-9396-2008; nelson, glyn/A-6346-2009	Zupanic, Anze/0000-0003-3303-9086; nelson, glyn/0000-0002-1895-4772; Shanley, Daryl/0000-0003-3096-6386	Biotechnology and Biological Sciences Research Council, BBSRC	Biotechnology and Biological Sciences Research Council, BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, BBSRC (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EA, 2009, MUTAT RES-FUND MOL M, V683, P84; Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Anderson CW, 1996, CURR TOP MICROBIOL, V217, P91; Andrews BJ, 2006, J BIOL CHEM, V281, P13596, DOI 10.1074/jbc.M512787200; Bachman JA, 2011, NAT METHODS, V8, P130, DOI 10.1038/nmeth0211-130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bennett SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-86; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brenkman AB, 2010, FASEB J, V24, P4271, DOI 10.1096/fj.10-158717; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cann KL, 2007, BIOCHEM CELL BIOL, V85, P663, DOI 10.1139/O07-135; Covo S, 2009, NUCLEIC ACIDS RES, V37, P6737, DOI 10.1093/nar/gkp703; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Drager A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-39; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gross A, 2008, TRENDS BIOCHEM SCI, V33, P514, DOI 10.1016/j.tibs.2008.08.005; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Iliakis G, 2009, RADIOTHER ONCOL, V92, P310, DOI 10.1016/j.radonc.2009.06.024; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mason KA, 2012, AM J CLIN ONCOL-CANC, DOI [10.1097/COC.1090-b1013e3182467dce, DOI 10.1097/C0C.1090-B1013E3182467DCE]; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Nelson G, 2002, J CELL SCI, V115, P1137; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Paddock MN, 2011, DNA REPAIR, V10, P338, DOI 10.1016/j.dnarep.2010.12.005; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singh SK, 2011, INT J RADIAT ONCOL, V79, P540, DOI 10.1016/j.ijrobp.2010.08.018; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Spagnolo L, 2012, NUCL ACIDS RES; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suzuki K, 2009, MUTAT RES-FUND MOL M, V683, P29; Symington LS, 2011, ANN REV GENETICS, V45; Tapia PC, 2006, MED HYPOTHESES, V66, P332, DOI 10.1016/j.mehy.2005.08.032; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wu XJ, 2005, MUTAT RES-FUND MOL M, V579, P115, DOI 10.1016/j.mrfmmm.2005.02.026; Xiao D, 2005, ONCOGENE, V24, P6256, DOI 10.1038/sj.onc.1208759	60	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55190	10.1371/journal.pone.0055190	http://dx.doi.org/10.1371/journal.pone.0055190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23457464	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400066
J	Hu, YF; Jiang, HS; Wang, Q; Xie, ZS; Pan, SY				Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue			Identification of a Novel Nonsense Mutation p.Tyr1957Ter of CACNA1A in a Chinese Family with Episodic Ataxia 2	PLOS ONE			English	Article							CALCIUM-CHANNEL; CLINICAL SPECTRUM; TYPE-2; GENE; SCA6	Type 2 episodic ataxia (EA2) is the most common subtype among a group of rare hereditary syndromes characterized by recurrent attacks of ataxia. More than 60 mutations and several gene rearrangements due to large deletions in CACNA1A gene have been reported so far for the cause of EA2. Because CACNA1A gene is a large gene containing 47 exons and there is no hot spot mutation, direct sequencing will be a challenge in clinical genetic testing. In this study, we used next generation sequencing technology to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncated protein without 305 amino acids in the c-terminus. Sanger sequencing confirmed the heterozygous mutation of CACNA1A in a Chinese family with 11 affected individuals. Affected individuals experienced recurrent attacks with or without nystagmus, dysarthria, seizure, myokymia, dystonia, weakness, blurred vision, visual field defects, diplopia, migraine, dizziness, nausea and vomiting, sweating and abdominal pain. This is the first report of EA2 in a Chinese family that carries a novel mutation in CACNA1A gene and had abdominal pain as a novel phenotype associated with EA2.	[Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue] So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Pan, SY (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	pansuyue82@yahoo.com.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Nanfang Hospital, Southern Medical University, China	Nanfang Hospital, Southern Medical University, China	This work was supported by the chief program funding of Nanfang Hospital, Southern Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Eunson LH, 2005, NEUROLOGY, V65, P308, DOI 10.1212/01.wnl.0000169020.82223.dd; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Jen J, 2004, NEUROLOGY, V62, P17, DOI 10.1212/01.WNL.0000101675.61074.50; Jen JC, 2007, BRAIN, V130, P2484, DOI 10.1093/brain/awm126; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Labrum RW, 2009, J MED GENET, V46, P786, DOI 10.1136/jmg.2009.067967; Mantuano E, 2010, J NEUROL SCI, V291, P30, DOI 10.1016/j.jns.2010.01.010; Matsuyama Z, 2003, J NEUROL SCI, V210, P91, DOI 10.1016/S0022-510X(03)00008-X; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Riant F, 2008, ARCH NEUROL-CHICAGO, V65, P817, DOI 10.1001/archneur.65.6.817; Riant F, 2010, NEUROGENETICS, V11, P101, DOI 10.1007/s10048-009-0208-y; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wan Jijun, 2011, Front Neurol, V2, P51, DOI 10.3389/fneur.2011.00051; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	25	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56362	10.1371/journal.pone.0056362	http://dx.doi.org/10.1371/journal.pone.0056362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441182	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200039
J	Hu, YJ; Rillig, MC; Xiang, D; Hao, ZP; Chen, BD				Hu, Yajun; Rillig, Matthias C.; Xiang, Dan; Hao, Zhipeng; Chen, Baodong			Changes of AM Fungal Abundance along Environmental Gradients in the Arid and Semi-Arid Grasslands of Northern China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SOIL ORGANIC-CARBON; PARTICLE-SIZE; NITROGEN; GROWTH; TEMPERATURE; PLANT; PHOSPHORUS; DISTRIBUTIONS; COMMUNITIES	Arbuscular mycorrhizal (AM) fungi are ubiquitous symbionts of higher plants in terrestrial ecosystems, while the occurrence of the AM symbiosis is influenced by a complex set of abiotic and biotic factors. To reveal the regional distribution pattern of AM fungi as driven by multiple environmental factors, and to understand the ecological importance of AM fungi in natural ecosystems, we conducted a field investigation on AM fungal abundance along environmental gradients in the arid and semi-arid grasslands of northern China. In addition to plant parameters recorded in situ, soil samples were collected, and soil chemo-physical and biological parameters were measured in the lab. Statistical analyses were performed to reveal the relative contribution of climatic, edaphic and vegetation factors to AM fungal abundance, especially for extraradical hyphal length density (HLD) in the soil. The results indicated that HLD were positively correlated with mean annual temperature (MAT), soil clay content and soil pH, but negatively correlated with both soil organic carbon (SOC) and soil available N. The multiple regressions and structural equation model showed that MAT was the key positive contributor and soil fertility was the key negative contributor to HLD. Furthermore, both the intraradical AM colonization (IMC) and relative abundance of AM fungi, which was quantified by real-time PCR assay, tended to decrease along the increasing SOC content. With regard to the obvious negative correlation between MAT and SOC in the research area, the positive correlation between MAT and HLD implied that AM fungi could potentially mitigate soil carbon losses especially in infertile soils under global warming. However, direct evidence from long-term experiments is still expected to support the AM fungal contribution to soil carbon pools.	[Hu, Yajun; Xiang, Dan; Hao, Zhipeng; Chen, Baodong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, Berlin, Germany; [Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Free University of Berlin	Chen, BD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bdchen@rcees.ac.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-JC403, KZCX2-YW-BR-17]; Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences [STSN-21-04]; State Key Laboratory of Urban and Regional Ecology, P.R. China [SKLURE2008-1-03]; Alexander-von-Humboldt Foundation fellowship	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Urban and Regional Ecology, P.R. China; Alexander-von-Humboldt Foundation fellowship(Alexander von Humboldt Foundation)	The study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-JC403 and KZCX2-YW-BR-17), Joint Project of Ministry of Environmental Protection, P.R. China and the Chinese Academy of Sciences (STSN-21-04) and State Key Laboratory of Urban and Regional Ecology, P.R. China (Project SKLURE2008-1-03). BC was supported by an Alexander-von-Humboldt Foundation fellowship during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; Cai Xiaobu, 2005, Yingyong Shengtai Xuebao, V16, P859; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Gaur A, 2000, MYCORRHIZA, V10, P43, DOI 10.1007/s005720050286; Gavito ME, 2005, NEW PHYTOL, V168, P179, DOI 10.1111/j.1469-8137.2005.01481.x; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; HAYMAN DS, 1982, PHYTOPATHOLOGY, V72, P1119; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jennings D.H., 1995, PHYSL FUNGAL NUTR; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KOSKE RE, 1987, MYCOLOGIA, V79, P55, DOI 10.2307/3807744; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liu A, 2000, PLANT SOIL, V221, P157, DOI 10.1023/A:1004777821422; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; SOEDARJO M, 1995, MYCORRHIZA, V5, P337, DOI 10.1007/BF00207406; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tian H, 2009, LAND DEGRAD DEV, V20, P41, DOI 10.1002/ldr.876; Treseder KK, 2006, ECOSYSTEMS, V9, P305, DOI 10.1007/s10021-005-0110-x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot A., 1986, PHYSL GENETICAL ASPE, V39, P217, DOI DOI 10.1177/004057368303900411; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Verbruggen E, 2013, NEW PHYTOL, V197, P366, DOI 10.1111/nph.12079; Wan YF, 2011, AGR ECOSYST ENVIRON, V141, P23, DOI 10.1016/j.agee.2011.02.004; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Yang HS, 2011, CATENA, V87, P70, DOI 10.1016/j.catena.2011.05.009; [周涛 Zhou Tao], 2003, [地理学报, Acta Geographica Sinica], V58, P727; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	55	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57593	10.1371/journal.pone.0057593	http://dx.doi.org/10.1371/journal.pone.0057593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23441182	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500118
J	Yu, JH; Peng, Y; Wu, LC; Xie, ZL; Deng, YC; Hughes, T; He, S; Mo, XK; Chiu, M; Wang, QE; He, XM; Liu, SJ; Grever, MR; Chan, KK; Liu, ZF				Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Xie, Zhiliang; Deng, Youcai; Hughes, Tiffany; He, Shun; Mo, XiaoKui; Chiu, Ming; Wang, Qi-En; He, Xiaoming; Liu, Shujun; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa			Curcumin Down-Regulates DNA Methyltransferase 1 and Plays an Anti-Leukemic Role in Acute Myeloid Leukemia	PLOS ONE			English	Article							CANCER-THERAPY; METHYLATION; TRANSCRIPTION; INHIBITORS; ACETYLTRANSFERASE; HYPOMETHYLATION; DECITABINE; DELIVERY; TARGET; GENES	Bioactive components from dietary supplements such as curcumin may represent attractive agents for cancer prevention or treatment. DNA methylation plays a critical role in acute myeloid leukemia (AML) development, and presents an excellent target for treatment of this disease. However, it remains largely unknown how curcumin, a component of the popular Indian spice turmeric, plays a role in DNA hypomethylation to reactivate silenced tumor suppressor genes and to present a potential treatment option for AML. Here we show that curcumin down-regulates DNMT1 expression in AML cell lines, both in vitro and in vivo, and in primary AML cells ex vivo. Mechanistically, curcumin reduced the expression of positive regulators of DNMT1, p65 and Sp1, which correlated with a reduction in binding of these transcription factors to the DNMT1 promoter in AML cell lines. This curcumin-mediated down-regulation of DNMT1 expression was concomitant with p15(INK4B) tumor suppressor gene reactivation, hypomethylation of the p15(INK4B) promoter, G1 cell cycle arrest, and induction of tumor cell apoptosis in vitro. In mice implanted with the human AML MV4-11 cell line, administration of curcumin resulted in remarkable suppression of AML tumor growth. Collectively, our data indicate that curcumin shows promise as a potential treatment for AML, and our findings provide a basis for future studies to test the clinical efficacy of curcumin - whether used as a single agent or as an adjuvant - for AML treatment.	[Yu, Jianhua; Grever, Michael R.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Deng, Youcai; Hughes, Tiffany; He, Shun; Wang, Qi-En; He, Xiaoming; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wu, Lai-Chu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Xie, Zhiliang; Chiu, Ming; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Deng, Youcai] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Mo, XiaoKui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Liu, Shujun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Army Medical University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System	Yu, JH (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.	Jianhua.yu@osumc.edu; liu.550@osu.edu	Wu, Lai-Chu/E-4328-2011; Liu, Zhongfa/G-8549-2013; He, Xiaoming/C-5499-2008; Deng, Youcai/GZK-9548-2022; He, Shun/K-7448-2014	Wu, Lai-Chu/0000-0002-1348-269X; He, Xiaoming/0000-0003-0125-6086; Deng, Youcai/0000-0001-5488-8576; Ye, Xiaojian/0000-0003-2402-5782; He, Dannong/0000-0003-4921-1063; Li, Kai/0000-0001-5436-4836; Wang, Meiyan/0000-0002-2118-6647	U.S. National Institutes of Health (NIH) [CA155521, CA135478]; Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society [IRG-67-003-47]; National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE [R01CA151248, R01CA155521, P30CA016058, R21CA135478] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society(American Cancer Society); National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the U.S. National Institutes of Health (NIH) grants CA155521 (to JY) and CA135478 (to ZL), the Experimental Therapeutic Program seed grant (to ZL), and the Biomedical Mass Spectrometric Laboratory (KKC and ZL) at The Ohio State University. It was also supported in part by Grant # IRG-67-003-47 from the American Cancer Society and by a National Blood Foundation Scientific Research Grant (both to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Blum William, 2005, Clin Adv Hematol Oncol, V3, P855; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chim CS, 2006, LEUKEMIA LYMPHOMA, V47, P815, DOI 10.1080/10428190500513827; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; de Vos D, 2005, ANN HEMATOL, V84, P3, DOI 10.1007/s00277-005-0008-x; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Fu SQ, 2010, CANCER-AM CANCER SOC, V116, P4670, DOI 10.1002/cncr.25414; Grovdal M, 2007, CLIN CANCER RES, V13, P7107, DOI 10.1158/1078-0432.CCR-07-1193; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Li Xin-gang, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P551; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu Z, 2009, ANAL BIOCH; Liu ZF, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1156; Liu ZF, 2012, CANCER CHEMOTH PHARM, V69, P679, DOI 10.1007/s00280-011-1749-y; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Moiseeva EP, 2007, MOL CANCER THER, V6, P3071, DOI 10.1158/1535-7163.MCT-07-0117; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Pouton CW, 2000, EUR J PHARM SCI, V11, pS93, DOI 10.1016/S0928-0987(00)00167-6; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shishodia S, 2007, ADV EXP MED BIOL, V595, P127; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; vanIersel MLPS, 1996, CHEM-BIOL INTERACT, V102, P117, DOI 10.1016/S0009-2797(96)03739-8; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251	36	104	111	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55934	10.1371/journal.pone.0055934	http://dx.doi.org/10.1371/journal.pone.0055934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23483914	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300068
J	Zheng, SQ; Ding, AJ; Li, GP; Wu, GS; Luo, HR				Zheng, Shan-Qing; Ding, Ai-Jun; Li, Guo-Ping; Wu, Gui-Sheng; Luo, Huai-Rong			Drug Absorption Efficiency in Caenorhbditis elegans Delivered by Different Methods	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; CALORIC RESTRICTION; DIETARY RESTRICTION; SMALL MOLECULES; MODEL; IDENTIFICATION; INCREASE; WORM; BIOACTIVITY	Background: Caenorhbditis elegans has being vigorously used as a model organism in many research fields and often accompanied by administrating with various drugs. The methods of delivering drugs to worms are varied from one study to another, which make difficult in comparing results between studies. Methodology/Principal Findings: We evaluated the drug absorption efficiency in C. elegans using five frequently used methods with resveratrol with low aqueous solubility and water-soluble 5-Fluoro-2'-deoxyuridine (FUDR) as positive compounds. The drugs were either applied to the LB medium with bacteria OP50, before spreading onto Nematode Growth Medium (NGM) plates (LB medium method), or to the NGM with live (NGM live method) or dead bacteria (NGM dead method), or spotting the drug solution to the surface of plates directly (spot dead method), or growing the worms in liquid medium (liquid growing method). The concentration of resveratrol and FUDR increased gradually within C. elegans and reached the highest during 12 hours to one day and then decreased slowly. At the same time point, the higher the drug concentration, the higher the metabolism rate. The drug concentrations in worms fed with dead bacteria were higher than with live bacteria at the same time point. Consistently, the drug concentration in medium with live bacteria decreased much faster than in medium with dead bacteria, reach to about half of the original concentration within 12 hours. Conclusion: Resveratrol with low aqueous solubility and water-soluble FUDR have the same absorption and metabolism pattern. The drug metabolism rate in worms was both dosage and time dependent. NGM dead method and liquid growing method achieved the best absorption efficiency in worms. The drug concentration within worms was comparable with that in mice, providing a bridge for dose translation from worms to mammals.	[Zheng, Shan-Qing; Ding, Ai-Jun; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Zheng, Shan-Qing; Ding, Ai-Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Inst Geriatr, Minist Hlth, Beijing, Peoples R China; [Wu, Gui-Sheng] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Hospital; Chinese Academy of Sciences; Kunming Institute of Zoology	Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.	luohuairong@mail.kib.ac.cn	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Yunnan provincial government [20080A007]; 100 Talents Program of the Chinese Academy of Sciences; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany [P2008-ZZ21, T2009-KF05]	Yunnan provincial government; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany	This work was partially supported by the Yunnan provincial government (20080A007), the 100 Talents Program of the Chinese Academy of Sciences, and the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany (P2008-ZZ21 and T2009-KF05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg AT, 2010, RAPID COMMUN MASS SP, V24, P1447, DOI 10.1002/rcm.4535; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Anastassopoulou CG, 2011, CURR PHARM DESIGN, V17, P1225, DOI 10.2174/138161211795703753; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Desalermos A, 2011, EXPERT OPIN DRUG DIS, V6, P645, DOI 10.1517/17460441.2011.573781; Dexter PM, 2012, NEUROTHERAPEUTICS, V9, P393, DOI 10.1007/s13311-012-0109-x; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Kim S, 2008, BIOCHEM BIOPH RES CO, V368, P588, DOI 10.1016/j.bbrc.2008.01.131; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2003, GENETICS, V163, P159; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Masuda M, 2004, ANAL CHEM, V76, P728, DOI 10.1021/ac034840i; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nass R, 2001, PARKINSONISM RELAT D, V7, P185, DOI 10.1016/S1353-8020(00)00056-0; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Sellers WR, 2011, CELL, V147, P26, DOI 10.1016/j.cell.2011.09.016; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stiernagle Theresa, 2006, WormBook, P1; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wypijewska A, 2010, FEBS J, V277, P3003, DOI 10.1111/j.1742-4658.2010.07709.x; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zheng J, 2012, INT J OBESITY, V36, P186, DOI 10.1038/ijo.2011.93	50	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56877	10.1371/journal.pone.0056877	http://dx.doi.org/10.1371/journal.pone.0056877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24058503	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849500039
J	Zhang, XP; Wang, H; Duvernay, MT; Zhu, S; Wu, GY				Zhang, Xiaoping; Wang, Hong; Duvernay, Matthew T.; Zhu, Shu; Wu, Guangyu			The Angiotensin II Type 1 Receptor C-Terminal Lys Residues Interact with Tubulin and Modulate Receptor Export Trafficking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; CARDIAC MYOCYTES; ALPHA(2)-ADRENERGIC RECEPTORS; ANTEROGRADE TRAFFICKING; ADRENERGIC-RECEPTORS; INTRACELLULAR LOOP; ADENYLYL-CYCLASE	The physiological and pathological functions of angiotensin II are largely mediated through activating the cell surface angiotensin II type 1 receptor (AT1R). However, the molecular mechanisms underlying the transport of newly synthesized AT1R from the endoplasmic reticulum (ER) to the cell surface remain poorly defined. Here we demonstrated that the C-terminus (CT) of AT1R directly and strongly bound to tubulin and the binding domains were mapped to two consecutive Lys residues at positions 310 and 311 in the CT membrane-proximal region of AT1R and the acidic CT of tubulin, suggestive of essentially ionic interactions between AT1R and tubulin. Furthermore, mutation to disrupt tubulin binding dramatically inhibited the cell surface expression of AT1R, arrested AT1R in the ER, and attenuated AT1R-mediated signaling measured as ERK1/2 activation. These data demonstrate for the first time that specific Lys residues in the CT juxtamembrane region regulate the processing of AT1R through interacting with tubulin. These data also suggest an important role of the microtubule network in the cell surface transport of AT1R.	[Zhang, Xiaoping; Wang, Hong; Duvernay, Matthew T.; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Wang, Hong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zhu, Shu; Wu, Guangyu] Georgia Regents Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University; University System of Georgia; Augusta University	Wu, GY (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA.	guwu@gru.edu	zhang, xiaoping/G-9688-2013; Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	National Institutes of Health grant [R01GM076167]	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01GM076167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Ciruela F, 2001, J NEUROCHEM, V76, P750, DOI 10.1046/j.1471-4159.2001.00099.x; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050416; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MIZUNO M, 1994, J CELL SCI, V107, P1321; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; POPOVA JS, 1994, J BIOL CHEM, V269, P21748; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; SADOSHIMA J, 1995, CIRC RES, V76, P1; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; SARASTE J, 1991, J CELL SCI, V100, P415; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Saugstad JA, 2002, J NEUROCHEM, V80, P980, DOI 10.1046/j.0022-3042.2002.00778.x; Saunders C, 2000, MOL PHARMACOL, V57, P44; Saunders C, 1997, J BIOL CHEM, V272, P19035, DOI 10.1074/jbc.272.30.19035; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Touyz RM, 2000, PHARMACOL REV, V52, P639; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Yin HJ, 2011, INT J BIOCHEM CELL B, V43, P401, DOI 10.1016/j.biocel.2010.11.010; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	51	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57805	10.1371/journal.pone.0057805	http://dx.doi.org/10.1371/journal.pone.0057805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451270	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849500135
J	Ding, Y; Song, LR; Sedmak, B				Ding, Yi; Song, Lirong; Sedmak, Bojan			UVB Radiation as a Potential Selective Factor Favoring Microcystin Producing Bloom Forming Cyanobacteria	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; LIGHT; SOLAR; BIOSYNTHESIS; AERUGINOSA; EVOLUTION; GROWTH; DAMAGE; GENES	Due to the stratospheric ozone depletion, several organisms will become exposed to increased biologically active UVB (280-320nm) radiation, not only at polar but also at temperate and tropical latitudes. Bloom forming cyanobacteria are exposed to UVB radiation on a mass scale, particularly during the surface bloom and scum formation that can persist for long periods of time. All buoyant species of cyanobacteria are at least periodically exposed to higher irradiation during their vertical migration to the surface that usually occurs several times a day. The aim of this study is to assess the influence on cyanobacteria of UVB radiation at realistic environmental intensities. The effects of two UVB intensities of 0.5 and 0.99 W/m(2) in up to 0.5 cm water depth were studied in vitro on Microcystis aeruginosa strains, two microcystin producing and one non-producing. After UVB exposure their ability to proliferate was estimated by cell counting, while cell fitness and integrity were evaluated using light microscopy, autofluorescence and immunofluorescence. Gene damage was assessed by TUNEL assay and SYBR Green staining of the nucleoide area. We conclude that UVB exposure causes damage to the genetic material, cytoskeletal elements, higher sedimentation rates and consequent cell death. In contrast to microcystin producers (PCC7806 and FACHB905), the microcystin non-producing strain PCC7005 is more susceptible to the deleterious effects of radiation, with weak recovery ability. The ecological relevance of the results is discussed using data from eleven years' continuous UVB radiation measurements within the area of Ljubljana city (Slovenia, Central Europe). Our results suggest that increased solar radiation in temperate latitudes can have its strongest effect during cyanobacterial bloom formation in spring and early summer. UVB radiation in this period may significantly influence strain composition of cyanobacterial blooms in favor of microcystin producers.	[Ding, Yi; Song, Lirong] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Ding, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sedmak, Bojan] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Institute of Biology - Slovenia	Sedmak, B (corresponding author), Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia.	bojan.sedmak@nib.si	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was supported by Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp), Research Program P1-0245ARRS: Ecotoxicology, Toxicogenomics and Carcinogenesis - (BS salary, reagents, materials, analysis tools), and Ministry of Defence Administration for Civil Protection and Dosaster Relief (Contract No URSZR 4300-1117/2009-1) "Cyanobacterial toxins in surface waters,'' which co-financed the Laminar Flow Cabinet. Chinese grants from the Natural Science Foundation of China-Yunnan Project (U0833604) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and '973' Program (2008CB418000) funded the nine-month stay of Ding Yi at the National Institute of Biology in Ljubljana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; Codd GA, 2000, ECOL ENG, V16, P51, DOI 10.1016/S0925-8574(00)00089-6; Ding Y, 2012, PHYCOLOGIA, V51, P567, DOI 10.2216/11-107.1; DONKOR V, 1991, FEMS MICROBIOL ECOL, V86, P159; Dziallas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025569; EKELUND NGA, 1991, J PLANT PHYSIOL, V138, P274, DOI 10.1016/S0176-1617(11)80287-7; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gan NQ, 2012, ENVIRON MICROBIOL, V14, P730, DOI 10.1111/j.1462-2920.2011.02624.x; Gumbo JR, 2011, AFR J BIOTECHNOL, V10, P8054; Hader DP, 2005, MUTAT RES-FUND MOL M, V571, P221, DOI 10.1016/j.mrfmmm.2004.11.017; Harel M, 2012, ENV MICROBIOL REP, V4, P342, DOI 10.1111/j.1758-2229.2012.00339.x; He YY, 2002, J PHOTOCH PHOTOBIO B, V66, P73, DOI 10.1016/S1011-1344(01)00278-0; Hessen DO, 2008, SOLAR RAD HUMAN HLTH, P123, DOI DOI 10.1038/NRG2897; Jungblut AD, 2006, ARCH MICROBIOL, V185, P107, DOI 10.1007/s00203-005-0073-5; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kulandaivelu G, 1989, PHOTOSYNTHESIS MOL B, P305; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P787, DOI 10.1128/AEM.69.2.787-795.2003; Ma ZL, 2009, ENVIRON EXP BOT, V66, P265, DOI 10.1016/j.envexpbot.2009.02.006; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Phelan RR, 2011, J PHYCOL, V47, P1241, DOI 10.1111/j.1529-8817.2011.01056.x; QUESADA A, 1995, J PHYCOL, V31, P242, DOI 10.1111/j.0022-3646.1995.00242.x; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; SCHERER S, 1988, PLANT PHYSIOL, V88, P1055, DOI 10.1104/pp.88.4.1055; Schopf JW., 2000, ECOLOGY CYANOBACTERI, P13; Sedmak B, 2005, MICROB ECOL, V50, P298, DOI 10.1007/s00248-004-0189-1; Sedmak B, 1998, J PLANKTON RES, V20, P691, DOI 10.1093/plankt/20.4.691; Sedmak B, 2009, J PLANKTON RES, V31, P1321, DOI 10.1093/plankt/fbp076; Shi L, 1999, J BIOL CHEM, V274, P10039, DOI 10.1074/jbc.274.15.10039; Sinha RP, 1998, J PHOTOCH PHOTOBIO B, V47, P83, DOI 10.1016/S1011-1344(98)00198-5; UTKILEN H, 1992, APPL ENVIRON MICROB, V58, P1321, DOI 10.1128/AEM.58.4.1321-1325.1992; WALSBY AE, 1987, CYANOBACTERIA, P377; Weatherhead EC, 2006, NATURE, V441, P39, DOI 10.1038/nature04746; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	36	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73919	10.1371/journal.pone.0073919	http://dx.doi.org/10.1371/journal.pone.0073919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058503	Green Published, gold, Green Submitted			2022-12-27	WOS:000324408400043
J	Kim, HS; Park, SH; Gunzl, A; Cross, GAM				Kim, Hee-Sook; Park, Sung Hee; Guenzl, Arthur; Cross, George A. M.			MCM-BP Is Required for Repression of Life-Cycle Specific Genes Transcribed by RNA Polymerase I in the Mammalian Infectious Form of Trypanosoma brucei	PLOS ONE			English	Article							VSG EXPRESSION SITE; ORIGIN RECOGNITION COMPLEX; BLOOD-STREAM FORMS; POLO-LIKE KINASE; DNA-REPLICATION; ANTIGENIC VARIATION; TOPOISOMERASE-II; DISTINCT ROLES; PROTEIN; TELOMERES	Trypanosoma brucei variant surface glycoprotein (VSG) expression is a classic example of allelic exclusion. While the genome of T. brucei contains >2,000 VSG genes and VSG pseudogenes, only one allele is expressed at the surface of each infectious trypanosome and the others are repressed. Along with recombinatorial VSG switching, allelic exclusion provides a major host evasion mechanism for trypanosomes, a phenomenon known as antigenic variation. To extend our understanding of how trypanosomes escape host immunity by differential expression of VSGs, we attempted to identify genes that contribute to VSG silencing, by performing a loss-of-silencing screen in T. brucei using a transposon-mediated random insertional mutagenesis. One identified gene, which we initially named LOS1, encodes a T. brucei MCM-Binding Protein (TbMCM-BP). Here we show that TbMCM-BP is essential for viability of infectious bloodstream-form (BF) trypanosome and is required for proper cell-cycle progression. Tandem affinity purification of TbMCM-BP followed by mass spectrometry identified four subunits (MCM4-MCM7) of the T. brucei MCM complex, a replicative helicase, and MCM8, a subunit that is uniquely co-purified with TbMCM-BP. TbMCM-BP is required not only for repression of subtelomeric VSGs but also for silencing of life-cycle specific, insect-stage genes, procyclin and procyclin-associated genes (PAGs), that are normally repressed in BF trypanosomes and are transcribed by RNA polymerase I. Our study uncovers a functional link between chromosome maintenance and RNA pol I-mediated gene silencing in T. brucei.	[Kim, Hee-Sook; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA; [Park, Sung Hee; Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Storrs, CT 06269 USA; [Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Storrs, CT 06269 USA	Rockefeller University; University of Connecticut; University of Connecticut	Kim, HS (corresponding author), Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA.	khee-sook@rockefeller.edu	; Cross, George/B-7444-2011	Gunzl, Arthur/0000-0002-7487-2261; Cross, George/0000-0003-1374-6955	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH) [R01 AI021729, R01 AI059377]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729, R01AI059377] Funding Source: NIH RePORTER	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Rockefeller University Women in Science Fellowship to HK and by grants R01 AI021729 (GAMC) and R01 AI059377 (AG) from the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases (NIAID) or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON CM, 1994, MOL CELL BIOL, V14, P5579, DOI 10.1128/MCB.14.8.5579; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Alsford S, 2012, NUCLEIC ACIDS RES, V40, P10150, DOI 10.1093/nar/gks813; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Benmerzouga I, 2013, MOL MICROBIOL, V87, P196, DOI 10.1111/mmi.12093; Biebinger S, 1996, NUCLEIC ACIDS RES, V24, P1202, DOI 10.1093/nar/24.7.1202; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; BRUN R, 1979, ACTA TROP, V36, P289; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; DaFonseca CJ, 2001, P NATL ACAD SCI USA, V98, P3034, DOI 10.1073/pnas.061487598; Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Denninger V, 2010, MOL MICROBIOL, V78, P459, DOI 10.1111/j.1365-2958.2010.07350.x; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Germe T, 2009, EMBO J, V28, P2803, DOI 10.1038/emboj.2009.223; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GueirosFilho FJ, 1996, MOL CELL BIOL, V16, P5655; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Horn D, 2010, CURR OPIN MICROBIOL, V13, P700, DOI 10.1016/j.mib.2010.08.009; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kawahara T, 2008, MOL MICROBIOL, V69, P1054, DOI 10.1111/j.1365-2958.2008.06346.x; Kim HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000992; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Landeira D, 2009, J CELL BIOL, V186, P243, DOI 10.1083/jcb.200902119; Leal S, 2004, J BIOL CHEM, V279, P28979, DOI 10.1074/jbc.M403479200; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; NAGOSHI YL, 1995, MOL BIOCHEM PARASIT, V72, P33, DOI 10.1016/0166-6851(95)00062-6; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peacock L, 2011, P NATL ACAD SCI USA, V108, P3671, DOI 10.1073/pnas.1019423108; Ploubidou A, 1999, J CELL SCI, V112, P4641; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Povelones ML, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003010; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Tiengwe C, 2012, CELL REP, V2, P185, DOI 10.1016/j.celrep.2012.06.007; Tiengwe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032674; Nguyen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035931; Tu XM, 2005, EUKARYOT CELL, V4, P755, DOI 10.1128/EC.4.4.755-764.2005; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; Wang QP, 2010, MOL MICROBIOL, V77, P1237, DOI 10.1111/j.1365-2958.2010.07284.x; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037	80	100	102	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57001	10.1371/journal.pone.0057001	http://dx.doi.org/10.1371/journal.pone.0057001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24086697	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500052
J	Zhang, XD; Qi, L; Wu, JC; Qin, ZH				Zhang, Xing-Ding; Qi, Lin; Wu, Jun-Chao; Qin, Zheng-Hong			DRAM1 Regulates Autophagy Flux through Lysosomes	PLOS ONE			English	Article							3-NITROPROPIONIC ACID; MITOCHONDRIAL TOXIN; CELL-DEATH; PROTEIN-DEGRADATION; INTRALYSOSOMAL PH; CORTICAL-NEURONS; RAT STRIATUM; H+-ATPASE; APOPTOSIS; ACTIVATION	We have previously reported that the mitochondria inhibitor 3-nitropropionic acid (3-NP), induces the expression of DNA damage-regulated autophagy modulator1 (DRAM1) and activation of autophagy in rat striatum. Although the role of DRAM1 in autophagy has been previously characterized, the detailed mechanism by which DRAM1 regulates autophagy activity has not been fully understood. The present study investigated the role of DRAM1 in regulating autophagy flux. In A549 cells expressing wilt-type TP53, 3-NP increased the protein levels of DRAM1 and LC3-II, whereas decreased the levels of SQSTM1 (sequestosome 1). The increase in LC3-II and decrease in SQSTM1 were blocked by the autophagy inhibitor 3-methyl-adenine. Lack of TP53 or knock-down of TP53 in cells impaired the induction of DRAM1. Knock-down of DRAM1 with siRNA significantly reduced 3-NP-induced upregulation of LC3-II and downregulation of SQSTM1, indicating DRAM1 contributes to autophagy activation. Knock-down of DRAM1 robustly decreased rate of disappearance of induced autophagosomes, increased RFP-LC3 fluorescence dots and decreased the decline of LC3-II after withdraw of rapamycin, indicating DRAM1 promotes autophagy flux. DRAM1 siRNA inhibited lysosomal V-ATPase and acidification of lysosomes. As a result, DRAM1 siRNA reduced activation of lysosomal cathepsin D. Similar to DRAM1 siRNA, lysosomal inhibitors E64d and chloroquine also inhibited clearance of autophagosomes and activation of lysosomal cathapsin D after 3-NP treatment. These data suggest that DRAM1 plays important roles in autophagy activation induced by mitochondria dysfunction. DRAM1 affects autophagy through argument of lysosomal acidification, fusion of lysosomes with autophagosomes and clearance of autophagosomes.	[Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Qin, ZH (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China.	zhqin5@hotmail.com	zhang, xiaoping/G-9688-2013; Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	National Natural Science Foundation of China [30930035]; National Basic Science Key Project (973 project) [CB510003]; Priority Academic Program development of Jiangsu Higher Education Institutes; Graduate Training Innovation Project of Jiangsu Province [CX09B_042Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science Key Project (973 project)(National Basic Research Program of China); Priority Academic Program development of Jiangsu Higher Education Institutes; Graduate Training Innovation Project of Jiangsu Province	This work was partially supported by the National Natural Science Foundation of China (No 30930035), by the National Basic Science Key Project (973 project, CB510003), by the Priority Academic Program development of Jiangsu Higher Education Institutes, and by Graduate Training Innovation Project of Jiangsu Province (CX09B_042Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; BEAL MF, 1993, J NEUROSCI, V13, P4181; BEHRENS MI, 1995, NEUROREPORT, V6, P545, DOI 10.1097/00001756-199502000-00034; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; EZAKI J, 1992, J BIOCHEM, V112, P33, DOI 10.1093/oxfordjournals.jbchem.a123861; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; HOLTZMAN E, 1969, J CELL BIOL, V40, P863, DOI 10.1083/jcb.40.3.863; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim GW, 2002, J CEREBR BLOOD F MET, V22, P798, DOI 10.1097/00004647-200207000-00005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Layton GT, 2001, INFLAMM RES, V50, P400, DOI 10.1007/PL00000262; Leventhal L, 2000, J COMP NEUROL, V425, P471, DOI 10.1002/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Qin ZH, 1999, J NEUROSCI, V19, P4023; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SMITH ML, 1987, J BIOL CHEM, V262, P1244; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	37	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63245	10.1371/journal.pone.0063245	http://dx.doi.org/10.1371/journal.pone.0063245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23451270	Green Published, Green Submitted, gold			2022-12-27	WOS:000319107900030
J	Kim, BJ; Zaveri, HP; Shchelochkov, OA; Yu, ZY; Hernandez-Garcia, A; Seymour, ML; Oghalai, JS; Pereira, FA; Stockton, DW; Justice, MJ; Lee, B; Scott, DA				Kim, Bum Jun; Zaveri, Hitisha P.; Shchelochkov, Oleg A.; Yu, Zhiyin; Hernandez-Garcia, Andres; Seymour, Michelle L.; Oghalai, John S.; Pereira, Fred A.; Stockton, David W.; Justice, Monica J.; Lee, Brendan; Scott, Daryl A.			An Allelic Series of Mice Reveals a Role for RERE in the Development of Multiple Organs Affected in Chromosome 1p36 Deletions	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; HISTONE DEACETYLASE; CALRETININ IMMUNOREACTIVITY; SKI PROTOONCOGENE; DENTATE GYRUS; MONOSOMY 1P36; GENE; ZEBRAFISH; DEFECTS; MODELS	Individuals with terminal and interstitial deletions of chromosome 1p36 have a spectrum of defects that includes eye anomalies, postnatal growth deficiency, structural brain anomalies, seizures, cognitive impairment, delayed motor development, behavior problems, hearing loss, cardiovascular malformations, cardiomyopathy, and renal anomalies. The proximal 1p36 genes that contribute to these defects have not been clearly delineated. The arginine-glutamic acid dipeptide (RE) repeats gene (RERE) is located in this region and encodes a nuclear receptor coregulator that plays a critical role in embryonic development as a positive regulator of retinoic acid signaling. Rere-null mice die of cardiac failure between E9.5 and E11.5. This limits their usefulness in studying the role of RERE in the latter stages of development and into adulthood. To overcome this limitation, we created an allelic series of RERE-deficient mice using an Rere-null allele, om, and a novel hypomorphic Rere allele, eyes3 (c.578T>C, p.Val193Ala), which we identified in an N-ethyl-N-nitrosourea (ENU)-based screen for autosomal recessive phenotypes. Analyses of these mice revealed microphthalmia, postnatal growth deficiency, brain hypoplasia, decreased numbers of neuronal nuclear antigen (NeuN)-positive hippocampal neurons, hearing loss, cardiovascular malformations-aortic arch anomalies, double outlet right ventricle, and transposition of the great arteries, and perimembranous ventricular septal defects-spontaneous development of cardiac fibrosis and renal agenesis. These findings suggest that RERE plays a critical role in the development and function of multiple organs including the eye, brain, inner ear, heart and kidney. It follows that haploinsufficiency of RERE may contribute-alone or in conjunction with other genetic, environmental, or stochastic factors-to the development of many of the phenotypes seen in individuals with terminal and interstitial deletions that include the proximal region of chromosome 1p36.	[Kim, Bum Jun; Zaveri, Hitisha P.; Yu, Zhiyin; Hernandez-Garcia, Andres; Justice, Monica J.; Lee, Brendan; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shchelochkov, Oleg A.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Seymour, Michelle L.; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Seymour, Michelle L.; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Oghalai, John S.] Stanford Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA USA; [Pereira, Fred A.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Stockton, David W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Stockton, David W.] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Lee, Brendan] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; University of Iowa; Baylor College of Medicine; Baylor College of Medicine; Stanford University; Baylor College of Medicine; Wayne State University; Wayne State University; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	dscott@bcm.edu	wu, mingming/GXN-1864-2022; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; KIM, BEUM JUN/G-6829-2011	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; KIM, BEUM JUN/0000-0003-1797-5026; Hannanta-anan, Pimkhuan/0000-0002-9450-0799; Pereira, Fred/0000-0003-2100-0280	National Institutes of Health (NIH) [R01HD064667, U01HD39372, R03EY014854]; BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [5P30HD024064]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development	This project was supported by National Institutes of Health (NIH; http://www.nih.gov/) grants R01HD064667 to DAS, U01HD39372 to MJJ and R03EY014854 to DWS. The project described was also supported by the BCM IDDRC grant number 5P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (http://www.nichd.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2006, P NATL ACAD SCI USA, V103, P9069, DOI 10.1073/pnas.0603453103; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Beck TF, 2012, HUM MOL GENET; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Choudhary R, 2008, AM J PHYSIOL-HEART C, V294, pH633, DOI 10.1152/ajpheart.01301.2007; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Gajecka M, 2005, EUR J HUM GENET, V13, P139, DOI 10.1038/sj.ejhg.5201302; Giraudeau F, 2001, J MED GENET, V38, P121, DOI 10.1136/jmg.38.2.121; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; Hentges KE, 2006, GENE EXPR PATTERNS, V6, P653, DOI 10.1016/j.modgep.2005.11.015; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Liu Y, 1996, EXP BRAIN RES, V108, P389; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Murakawa R, 1999, J COMP NEUROL, V411, P413; Nicoulaz A, 2011, AM J MED GENET A, V155A, P1964, DOI 10.1002/ajmg.a.33210; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; Probst FJ, 2010, METHOD ENZYMOL, V477, P297, DOI 10.1016/S0076-6879(10)77015-4; Restivo A, 2006, ANAT REC PART A, V288A, P936, DOI 10.1002/ar.a.20367; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Rudnik-Schoneborn S, 2008, AM J MED GENET A, V146A, P2018, DOI 10.1002/ajmg.a.32405; Sanford LP, 2000, METH MOL B, V158, P217; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schilling TF, 1996, DEVELOPMENT, V123, P329; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Slavotinek A, 1999, J MED GENET, V36, P657; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stojanovska J, 2012, J THORAC IMAG, V27, P73, DOI 10.1097/RTI.0b013e318218923c; Szabadics J, 2010, J NEUROSCI, V30, P8296, DOI 10.1523/JNEUROSCI.5602-09.2010; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Windpassinger C, 2002, GENE, V292, P25, DOI 10.1016/S0378-1119(02)00649-2; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Xia AP, 2010, DIS MODEL MECH, V3, P209, DOI 10.1242/dmm.004135; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; ZHOU MD, 1995, P NATL ACAD SCI USA, V92, P7391, DOI 10.1073/pnas.92.16.7391; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	60	106	111	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57460	10.1371/journal.pone.0057460	http://dx.doi.org/10.1371/journal.pone.0057460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451234	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500107
J	Okumura, N; Kay, EP; Nakahara, M; Hamuro, J; Kinoshita, S; Koizumi, N				Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Hamuro, Junji; Kinoshita, Shigeru; Koizumi, Noriko			Inhibition of TGF-beta Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; ALLOGRAFT-REJECTION; AMNIOTIC MEMBRANE; ROCK INHIBITOR; AQUEOUS-HUMOR; RABBIT MODEL; TRANSPLANTATION; KERATOPLASTY; PRIMATE; VIVO	Corneal endothelial dysfunctions occurring in patients with Fuchs' endothelial corneal dystrophy, pseudoexfoliation syndrome, corneal endotheliitis, and surgically induced corneal endothelial damage cause blindness due to the loss of endothelial function that maintains corneal transparency. Transplantation of cultivated corneal endothelial cells (CECs) has been researched to repair endothelial dysfunction in animal models, though the in vitro expansion of human CECs (HCECs) is a pivotal practical issue. In this study we established an optimum condition for the cultivation of HCECs. When exposed to culture conditions, both primate and human CECs showed two distinct phenotypes: contact-inhibited polygonal monolayer and fibroblastic phenotypes. The use of SB431542, a selective inhibitor of the transforming growth factor-beta (TGF-beta) receptor, counteracted the fibroblastic phenotypes to the normal contact-inhibited monolayer, and these polygonal cells maintained endothelial physiological functions. Expression of ZO-1 and Na+/K+-ATPase maintained their subcellular localization at the plasma membrane. Furthermore, expression of type I collagen and fibronectin was greatly reduced. This present study may prove to be the substantial protocol to provide the efficient in vitro expansion of HCECs with an inhibitor to the TGF-beta receptor, and may ultimately provide clinicians with a new therapeutic modality in regenerative medicine for the treatment of corneal endothelial dysfunctions.	[Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Okumura, Naoki; Hamuro, Junji; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Doshisha University; Kyoto Prefectural University of Medicine	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan [LS117]; Grants-in-Aid for Scientific Research [23659818] Funding Source: KAKEN	Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by the Highway Program for realization of regenerative medicine (Kinoshita and Okumura); http://www.mext.go.jp/english/; and the Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan (Koizumi: LS117); http://www.jsps.go.jp/english/e-jisedai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Chen KH, 1999, INVEST OPHTH VIS SCI, V40, P2513; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Darlington JK, 2006, OPHTHALMOLOGY, V113, P2171, DOI 10.1016/j.ophtha.2006.06.034; Engelmann K, 2004, EXP EYE RES, V78, P573, DOI 10.1016/S0014-4835(03)00209-4; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kawaguchi R, 2001, CORNEA, V20, P100, DOI 10.1097/00003226-200101000-00019; Khaireddin R, 2003, GRAEF ARCH CLIN EXP, V241, P1020, DOI 10.1007/s00417-003-0759-9; Kim TY, 2001, INVEST OPHTH VIS SCI, V42, P3142; Ko MK, 2001, EXP CELL RES, V264, P363, DOI 10.1006/excr.2000.5155; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2008, OPHTHALMOLOGY, V115, P292, DOI 10.1016/j.ophtha.2007.04.053; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Melles GRJ, 2000, OPHTHALMOLOGY, V107, P1850, DOI 10.1016/S0161-6420(00)00253-0; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Naumann GOH, 2000, OPHTHALMOLOGY, V107, P1111, DOI 10.1016/S0161-6420(00)00087-7; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Patel SV, 2009, INVEST OPHTH VIS SCI, V50, P2123, DOI 10.1167/iovs.08-2653; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Simic P, 2007, EMBO REP, V8, P327, DOI 10.1038/sj.embor.7400943; Song JS, 2010, INVEST OPHTH VIS SCI, V51, P822, DOI 10.1167/iovs.09-4240; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	45	147	152	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e58000	10.1371/journal.pone.0058000	http://dx.doi.org/10.1371/journal.pone.0058000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451286	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500147
J	Zhang, Y; Tan, XJ; Cui, AL; Mao, NY; Xu, ST; Zhu, Z; Zhou, JH; Shi, J; Zhao, YP; Wang, XJ; Huang, XY; Zhu, SL; Zhang, Y; Tang, W; Ling, H; Xu, WB				Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Zhou, Jianhui; Shi, Jing; Zhao, Yueping; Wang, Xianjun; Huang, Xueyong; Zhu, Shuangli; Zhang, Yong; Tang, Wei; Ling, Hua; Xu, Wenbo			Complete Genome Analysis of the C4 Subgenotype Strains of Enterovirus 71: Predominant Recombination C4 Viruses Persistently Circulating in China for 14 Years	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; HAND; FOOT; COXSACKIEVIRUS; EMERGENCE; EVOLUTION; INFECTION; OUTBREAK; SINGAPORE	Genetic recombination is a well-known phenomenon for enteroviruses. To investigate the genetic characterization and the potential recombination of enterovirus 71 (EV71) circulating in China, we determined the 16 complete genome sequences of EV71 isolated from Hand Foot Mouth Disease (HFMD) patients during the large scale outbreak and non-outbreak years since 1998 in China. The full length genome sequences of 16 Chinese EV71 in present study were aligned with 186 genome sequences of EV71 available from GenBank, including 104 China mainland and 82 international sequences, covering the time period of 1970-2011. The oldest strains of each subgenotype of EV71 and prototype strains of HEV-A were included to do the phylogenetic and Simplot analysis. Phylogenetic analysis indicated that all Chinese strains were clustered into C4 subgenotype of EV71, except for HuB/CHN/2009 clustered into A and Xiamen/CHN/2009 clustered into B5 subgenotype. Most of C4 EV71 were clustered into 2 predominant evolutionary branches: C4b and C4a evolutionary brunches. Our comprehensive recombination analysis showed the evidence of genome recombination of subgenotype C4 (including C4a and C4b) sequences between structural genes from genotype C EV71 and non-structural genes from the prototype strains of CAV16, 14 and 4, but the evidence of intratypic recombination between C4 strains and B subgenotype was not enough strong. This intertypic recombination C4 viruses were first seen in 1998 and became the predominant endemic viruses circulating in China mainland for at least 14 years. A shift between C4a and C4b evolutionary brunches of C4 recombination viruses were observed, and C4a viruses have been associated with large scale nationwide HFMD outbreak with higher morbidity and mortality since 2007.	[Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Shi, Jing; Zhu, Shuangli; Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhou, Jianhui] Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China; [Shi, Jing] Capital Univ Med Sci, Beijing Children Hosp, Beijing, Peoples R China; [Zhao, Yueping] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wang, Xianjun] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Tang, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Ling, Hua] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Shanghai Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	National Basic Research Program of China (973 Program) [2011CB504902]; National Natural Science Foundation of China [30901259]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]; Science and Technology Development Plan of Shandong Province [2009GG10002055]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of National Ministry of Science; Science and Technology Development Plan of Shandong Province	This study was supported by National Basic Research Program of China (973 Program): (Grant No. 2011CB504902); Projects of the National Natural Science Foundation of China (Grant No. 30901259); Key Technologies R&D Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003); and Science and Technology Development Plan of Shandong Province (2009GG10002055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yamayoshi S, 2012, J VIROL, V86, P5686, DOI 10.1128/JVI.00020-12; Yang F, 2001, SCI CHINA SER C, V44, P178, DOI 10.1007/BF02879323; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034401; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	38	67	107	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56341	10.1371/journal.pone.0056341	http://dx.doi.org/10.1371/journal.pone.0056341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23516601	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200036
J	Kim, BJ; Hannanta-Anan, P; Chau, M; Kim, YS; Swartz, MA; Wu, MM				Kim, Beum Jun; Hannanta-Anan, Pimkhuan; Chau, Michelle; Kim, Yoon Soo; Swartz, Melody A.; Wu, Mingming			Cooperative Roles of SDF-1 alpha and EGF Gradients on Tumor Cell Migration Revealed by a Robust 3D Microfluidic Model	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; CANCER; CHEMOTAXIS; MACROPHAGES; EXPRESSION; MECHANISM; INVASION; DEVICE	Chemokine-mediated directed tumor cell migration within a three dimensional (3D) matrix, or chemoinvasion, is an important early step in cancer metastasis. Despite its clinical importance, it is largely unknown how cytokine and growth factor gradients within the tumor microenvironment regulate chemoinvasion. We studied tumor cell chemoinvasion in well-defined and stable chemical gradients using a robust 3D microfluidic model. We used CXCL12 (also known as SDF-1 alpha) and epidermal growth factor (EGF), two well-known extracellular signaling molecules that co-exist in the tumor microenvironment (e. g. lymph nodes or intravasation sites), and a malignant breast tumor cell line, MDA-MB-231, embedded in type I collagen. When subjected to SDF-1 alpha gradients alone, MDA-MB-231 cells migrated up the gradient, and the measured chemosensitivity (defined as the average cell velocity along the direction of the gradient) followed the ligand - receptor (SDF-1 alpha - CXCR4) binding kinetics. On the other hand, when subjected to EGF gradients alone, tumor cells increased their overall motility, but without statistically significant chemotactic (directed) migration, in contrast to previous reports using 2D chemotaxis assays. Interestingly, we found that the chemoinvasive behavior to SDF-1 alpha gradients was abrogated or even reversed in the presence of uniform concentrations of EGF; however, the presence of SDF-1 alpha and EGF together modulated tumor cell motility cooperatively. These findings demonstrate the capabilities of our microfluidic model in re-creating complex microenvironments for cells, and the importance of cooperative roles of multiple cytokine and growth factor gradients in regulating cell migration in 3D environments.	[Kim, Beum Jun; Hannanta-Anan, Pimkhuan; Chau, Michelle; Kim, Yoon Soo; Wu, Mingming] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	Cornell University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Wu, MM (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA.	mw272@cornell.edu	wu, mingming/GXN-1864-2022; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; KIM, BEUM JUN/G-6829-2011	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; KIM, BEUM JUN/0000-0003-1797-5026; Hannanta-anan, Pimkhuan/0000-0002-9450-0799; Pereira, Fred/0000-0003-2100-0280	National Cancer Institute [R21CA138366]; Swiss National Science Foundation [IZK0Z3-129723-1]; Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute [U54CA143876]; Cornell NanoScale Science and Technology; Cornell Nanobiotechnology Center	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cornell NanoScale Science and Technology; Cornell Nanobiotechnology Center	This work was supported by the National Cancer Institute (Award No R21CA138366), the Swiss National Science Foundation (Award No IZK0Z3-129723-1, International Cooperation), the Cornell Center on the Microenvironment & Metastasis (Award No U54CA143876 from the National Cancer Institute), and the Cornell NanoScale Science and Technology and the Cornell Nanobiotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; Haessler U, 2012, INTEGR BIOL-UK, V4, P401, DOI 10.1039/c1ib00128k; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hughes-Alford SK, 2012, CURR OPIN CELL BIOL, V24, P284, DOI 10.1016/j.ceb.2012.01.001; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim BJ, 2012, ANN BIOMED ENG, V40, P1316, DOI 10.1007/s10439-011-0489-9; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LEBRUN L, 1993, ENZYME MICROB TECH, V15, P1057, DOI 10.1016/0141-0229(93)90054-6; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; Mosadegh B, 2008, BIOTECHNOL BIOENG, V100, P1205, DOI 10.1002/bit.21851; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Price JT, 1999, CANCER RES, V59, P5475; Raja WK, 2010, INTEGR BIOL-UK, V2, P696, DOI 10.1039/c0ib00044b; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sawyer C, 2003, CANCER RES, V63, P1667; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Soon L, 2005, CELL MOTIL CYTOSKEL, V62, P27, DOI 10.1002/cm.20082; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Taylor Anne M., 2006, V321, P167; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Wang WG, 2002, CANCER RES, V62, P6278; White JB, 2011, INTEGR BIOL-UK, V3, P1003, DOI 10.1039/c1ib00040c; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	49	106	111	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68422	10.1371/journal.pone.0068422	http://dx.doi.org/10.1371/journal.pone.0068422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23451234	Green Submitted, Green Published, gold			2022-12-27	WOS:000323110600016
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200037
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400011
